PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Kuo, WC; Yang, KT; Hsieh, SL; Lai, MZ				Kuo, W-C; Yang, K-T; Hsieh, S-L; Lai, M-Z			Ezrin is a negative regulator of death receptor-induced apoptosis	ONCOGENE			English	Article						Fas; ezrin; apoptosis; moesin; DISC	ERM PROTEINS; IMMUNOLOGICAL SYNAPSE; ACTIN CYTOSKELETON; T-LYMPHOCYTES; CD95; FAS; MOESIN; PHOSPHORYLATION; ACTIVATION; CELLS	Ezrin links cortical actin filaments with the cell membrane, and has a critical role in many membrane-initiated events. Fas is directly associated with ezrin, but conflicting results have been reported for the involvement of ezrin in Fas-induced cell death. In this study we show that ezrin was associated with Fas in T cells before stimulation and was released shortly after Fas ligand (FasL) engagement. The knockdown of ezrin moderately increased Fas-triggered or tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-triggered cell death in normal T lymphocytes and in H9 cells, but had no effect on death receptor-induced apoptosis in type II cells, such as Jurkat and CEM. Expression of a dominant-negative form of ezrin also led to an increased Fas-induced apoptosis in H9 cells. Ezrin deficiency did not affect the internalization of Fas after Fas ligation. Instead, an enhanced formation of death-inducing signaling complex (DISC) was observed in H9 cells with ezrin knockdown, leading to accelerated caspase-8 activation. Together, our results suggest that ezrin has a negative role in the recruitment of Fas into signaling complexes in type I T cells. Loss of ezrin likely removes the constraint imposed by ezrin and facilitates the assembly of death receptor complex in T cells. Oncogene (2010) 29, 1374-1383; doi:10.1038/onc.2009.417; published online 23 November 2009	[Kuo, W-C; Yang, K-T; Lai, M-Z] Acad Sinica, Inst Mol Biol, Taipei 11529, Taiwan; [Kuo, W-C; Hsieh, S-L; Lai, M-Z] Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei 112, Taiwan; [Hsieh, S-L] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Lai, M-Z] Natl Taiwan Univ, Inst Immunol, Taipei 10764, Taiwan	Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; National Taiwan University	Lai, MZ (corresponding author), Acad Sinica, Inst Mol Biol, 128 Acad Rd,Sect 2, Taipei 11529, Taiwan.	mblai@ccvax.sinica.edu.tw	Hsieh, Shie-Liang Edmond/ABA-9184-2021; Lai, Ming-Zong/AAA-4408-2021	Lai, Ming-Zong/0000-0002-3237-4803	National Health Research Institute [NHRI-EX96-9527NI]; National Science Council [NSC 95-2320-B001-023]; Academia Sinica, Taiwan, ROC.	National Health Research Institute(National Health Research Institutes - Taiwan); National Science Council(Ministry of Science and Technology, Taiwan); Academia Sinica, Taiwan, ROC.(Academia Sinica - Taiwan)	This work was supported by Grant NHRI-EX96-9527NI from National Health Research Institute, NSC 95-2320-B001-023 from National Science Council and an Academia Sinica Investigator Award from Academia Sinica, Taiwan, ROC. We thank Drs I-Chen Ho, Gina Costa and Garry Nolan for critical reagents, Yamin Lin and FACS Core of Institute of Molecular Biology, Academia Sinica for cell sorting and Dr Harry Wilson for editing this paper.	Algeciras-Schimnich A, 2002, MOL CELL BIOL, V22, P207, DOI 10.1128/MCB.22.1.207-220.2002; Allenspach EJ, 2001, IMMUNITY, V15, P739, DOI 10.1016/S1074-7613(01)00224-2; Belkina NV, 2009, P NATL ACAD SCI USA, V106, P4707, DOI 10.1073/pnas.0805963106; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Brown MJ, 2003, BLOOD, V102, P3890, DOI 10.1182/blood-2002-12-3807; Chakrabandhu K, 2008, CELL DEATH DIFFER, V15, P1824, DOI 10.1038/cdd.2008.115; Chakrabandhu K, 2007, EMBO J, V26, P209, DOI 10.1038/sj.emboj.7601456; Delon J, 2001, IMMUNITY, V15, P691, DOI 10.1016/S1074-7613(01)00231-X; Faure S, 2004, NAT IMMUNOL, V5, P272, DOI 10.1038/ni1039; Feig C, 2007, EMBO J, V26, P221, DOI 10.1038/sj.emboj.7601460; Gautreau A, 2002, CURR OPIN CELL BIOL, V14, P104, DOI 10.1016/S0955-0674(01)00300-3; Gupta N, 2006, NAT IMMUNOL, V7, P625, DOI 10.1038/ni1337; Hao JJ, 2009, J CELL BIOL, V184, P451, DOI 10.1083/jcb.200807047; Hebert M, 2008, J IMMUNOL, V181, P5963, DOI 10.4049/jimmunol.181.9.5963; Ilani T, 2007, J CELL BIOL, V179, P733, DOI 10.1083/jcb.200707199; Kondo T, 1997, J CELL BIOL, V139, P749, DOI 10.1083/jcb.139.3.749; Kulms D, 2002, CELL DEATH DIFFER, V9, P598, DOI 10.1038/sj.cdd.4401002; Lee KH, 2006, EMBO J, V25, P1009, DOI 10.1038/sj.emboj.7601016; Li YS, 2007, J IMMUNOL, V178, P1938, DOI 10.4049/jimmunol.178.3.1938; Lozupone F, 2004, J BIOL CHEM, V279, P9199, DOI 10.1074/jbc.M305561200; Mrass P, 2008, IMMUNITY, V29, P971, DOI 10.1016/j.immuni.2008.10.015; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; Niggli V, 2008, INT J BIOCHEM CELL B, V40, P344, DOI 10.1016/j.biocel.2007.02.012; Parlato S, 2000, EMBO J, V19, P5123, DOI 10.1093/emboj/19.19.5123; Peter ME, 2007, CELL, V129, P447, DOI 10.1016/j.cell.2007.04.031; Peter ME, 2003, CELL DEATH DIFFER, V10, P26, DOI 10.1038/sj.cdd.4401186; Piazzolla D, 2005, J CELL BIOL, V171, P1013, DOI 10.1083/jcb.200504137; Ramaswamy M, 2007, J IMMUNOL, V179, P6384, DOI 10.4049/jimmunol.179.10.6384; Roumier A, 2001, IMMUNITY, V15, P715, DOI 10.1016/S1074-7613(01)00225-4; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Shaffer MH, 2009, J IMMUNOL, V182, P1021, DOI 10.4049/jimmunol.182.2.1021; Shcherbina A, 1999, FEBS LETT, V443, P31, DOI 10.1016/S0014-5793(98)01674-3; Strasser A, 2009, IMMUNITY, V30, P180, DOI 10.1016/j.immuni.2009.01.001	33	20	22	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 4	2010	29	9					1374	1383		10.1038/onc.2009.417	http://dx.doi.org/10.1038/onc.2009.417			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	563XJ	19935704				2022-12-25	WOS:000275170600012
J	Hader, C; Marlier, A; Cantley, L				Hader, C.; Marlier, A.; Cantley, L.			Mesenchymal-epithelial transition in epithelial response to injury: the role of Foxc2	ONCOGENE			English	Article						Foxc2; kidney; E-cadherin; vimentin; migration	FORKHEAD TRANSCRIPTION FACTORS; MARROW-DERIVED CELLS; POSTISCHEMIC KIDNEY; NEPHRON SEGMENTS; EXPRESSION; REPAIR; PROLIFERATION; INSULIN; BOX; MECHANISM	Overexpression of the forkhead family transcription factor Foxc2 has been shown to activate epithelial-mesenchymal transition (EMT) and correlate with tumor metastasis. In this study, we show that both mRNA and protein levels of Foxc2 increase 1 day after kidney ischemia/reperfusion in sublethally injured tubular cells and that the protein is located in the cytoplasm rather than the nucleus of these cells. in vitro studies of cultured tubular cells confirm the cytoplasmic location of Foxc2 and show that increased cytoplasmic expression of Foxc2 correlates with epithelial differentiation rather than dedifferentiation. Silencing of Foxc2 by RNAi in these cells led to EMT and increased cell migration. In contrast, Foxc2 is found in both the nucleus and cytoplasm of cultured fibroblasts, with RNAi leading to increased expression of epithelial markers and impaired cell migration. Consistent with a subcellular localization dependence of Foxc2 function, overexpression of Foxc2 in renal epithelial cells resulted in de novo nuclear expression of the protein and promotion of a mesenchymal/fibroblast phenotype. These results suggest that Foxc2 may have regulatory functions independent of its nuclear transcriptional activity and that upregulation of endogenous Foxc2 in the cytoplasm of injured tubular cells activates epithelial cell redifferentiation rather than dedifferentiation during organ repair. Oncogene (2010) 29, 1031-1040; doi:10.1038/onc.2009.397; published online 23 November 2009	[Hader, C.; Marlier, A.; Cantley, L.] Yale Univ, Sch Med, Nephrol Sect, Dept Internal Med, New Haven, CT 06520 USA	Yale University	Cantley, L (corresponding author), Yale Univ, Sch Med, Nephrol Sect, Dept Internal Med, 333 Cedar St,POB 208029, New Haven, CT 06520 USA.	lloyd.cantley@yale.edu			NIH [DK65109, DK66216]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065109, R01DK066216] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH awards to LGC (DK65109 and DK66216). We thank Dr Robert Weinberg for the generous gift of the plasmids for expression of Foxc2, Insa Schmidt for providing the PTEC cells and Dr Jiankan Guo for his experimental assistance.	Arden KC, 2006, EXP GERONTOL, V41, P709, DOI 10.1016/j.exger.2006.05.015; Bard JBL, 2008, DEV DYNAM, V237, P2748, DOI 10.1002/dvdy.21652; Berry FB, 2005, HUM MOL GENET, V14, P2619, DOI 10.1093/hmg/ddi295; Birkenkamp KU, 2003, BIOCHEM SOC T, V31, P292, DOI 10.1042/bst0310292; Bois PRJ, 2003, EMBO J, V22, P1147, DOI 10.1093/emboj/cdg116; Bonventre JV, 2003, J AM SOC NEPHROL, V14, pS55, DOI 10.1097/01.ASN.0000067652.51441.21; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Coffer PJ, 2004, NAT REV IMMUNOL, V4, P889, DOI 10.1038/nri1488; Duffield JS, 2005, KIDNEY INT, V68, P1956, DOI 10.1111/j.1523-1755.2005.00629.x; Fujita H, 2006, CIRC RES, V98, P626, DOI 10.1161/01.RES.0000207407.51752.3c; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Gronning LM, 2002, MOL ENDOCRINOL, V16, P873, DOI 10.1210/me.16.4.873; Hayashi H, 2008, J BIOL CHEM, V283, P23791, DOI 10.1074/jbc.M800190200; Hayashi H, 2008, BIOCHEM BIOPH RES CO, V367, P584, DOI 10.1016/j.bbrc.2007.12.183; Ishibe S, 2008, CURR OPIN NEPHROL HY, V17, P379, DOI 10.1097/MNH.0b013e3283046507; Ishibe S, 2006, MOL CELL BIOL, V26, P9232, DOI 10.1128/MCB.01312-06; Kale S, 2003, J CLIN INVEST, V112, P42, DOI 10.1172/JCI200317856; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Karihaloo A, 2005, MOL CELL BIOL, V25, P7441, DOI 10.1128/MCB.25.17.7441-7448.2005; Lin FM, 2005, J CLIN INVEST, V115, P1756, DOI 10.1172/JCI23015; Liu YH, 2004, J AM SOC NEPHROL, V15, P1, DOI 10.1097/01.ASN.0000106015.29070.E7; Mani SA, 2007, P NATL ACAD SCI USA, V104, P10069, DOI 10.1073/pnas.0703900104; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Obsil T, 2008, ONCOGENE, V27, P2263, DOI 10.1038/onc.2008.20; Schafer JA, 1997, AM J PHYSIOL-RENAL, V273, pF650, DOI 10.1152/ajprenal.1997.273.4.F650; Schwab TS, 2005, APOPTOSIS, V10, P831, DOI 10.1007/s10495-005-0429-y; Sinha D, 2003, AM J PHYSIOL-RENAL, V284, pF488, DOI 10.1152/ajprenal.00172.2002; STRUTZ F, 1995, J CELL BIOL, V130, P393, DOI 10.1083/jcb.130.2.393; WALLIN A, 1992, LAB INVEST, V66, P474; WITZGALL R, 1994, J CLIN INVEST, V93, P2175, DOI 10.1172/JCI117214; Xu L, 2004, NAT REV MOL CELL BIO, V5, P209, DOI 10.1038/nrm1331	31	64	70	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 18	2010	29	7					1031	1040		10.1038/onc.2009.397	http://dx.doi.org/10.1038/onc.2009.397			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	556PV	19935708	Green Accepted			2022-12-25	WOS:000274604400009
J	Treins, C; Warne, PH; Magnuson, MA; Pende, M; Downward, J				Treins, C.; Warne, P. H.; Magnuson, M. A.; Pende, M.; Downward, J.			Rictor is a novel target of p70 S6 kinase-1	ONCOGENE			English	Article						Rictor; S6K; feedback; amino acids; Akt/PKB; mTORC2	CELL-GROWTH CONTROL; MTOR COMPLEX 2; PROTEIN-KINASE; CAENORHABDITIS-ELEGANS; SUBSTRATE-SPECIFICITY; MOTIF PHOSPHORYLATION; MASS-SPECTROMETRY; BINDING PARTNER; TOR COMPLEX-2; AKT	The rapamycin-insensitive companion of mammalian target of rapamycin (mTOR) (Rictor) is a key member of mTOR complex-2 (mTORC2), which phosphorylates the AGC kinases Akt/PKB, PKC and SGK1 at a C-terminal hydrophobic motif. We identified several novel sites on Rictor that are phosphorylated, including Thr1135, which is conserved across all vertebrates. Phosphorylation of this site on Rictor is stimulated by amino acids and growth factors through a rapamycin-sensitive signaling cascade. We demonstrate here that Rictor is a direct target of the ribosomal protein S6 kinase-1 (S6K1). Rictor phosphorylation at Thr1135 does not lead to major changes in mTORC2-kinase activity. However, phosphorylation of this site turns over rapidly and mediates 14-3-3 binding to Rictor and mTORC2, providing possibility for altered interactions of the complex. These findings reveal an unexpected signaling input into mTORC2, which is regulated by amino acids, growth factors and rapamycin. Oncogene (2010) 29, 1003-1016; doi:10.1038/onc.2009.401; published online 23 November 2009	[Treins, C.; Warne, P. H.; Downward, J.] Canc Res UK London Res Inst, Signal Transduct Lab, London WC2A 3PX, England; [Magnuson, M. A.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Med Ctr, Nashville, TN 37232 USA; [Magnuson, M. A.] Vanderbilt Univ, Ctr Stem Cell Biol, Med Ctr, Nashville, TN 37232 USA; [Treins, C.; Pende, M.] Paris Descartes Univ, Sch Med, Inserm U845, Lab Cell Growth Control Nutrients, Paris, France	Cancer Research UK; Vanderbilt University; Vanderbilt University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite de Franche-Comte	Downward, J (corresponding author), Canc Res UK London Res Inst, Signal Transduct Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.	julian.downward@cancer.org.uk	Pende, Mario/AFR-1348-2022; Downward, Julian/A-3251-2012; Magnuson, Mark/AAY-7172-2021; Magnuson, Mark A/B-1335-2009	Pende, Mario/0000-0002-7864-8937; Magnuson, Mark/0000-0002-8824-6499; Magnuson, Mark A/0000-0002-8824-6499; Downward, Julian/0000-0002-2331-4729	Cancer Research UK	Cancer Research UK(Cancer Research UK)	We thank Julie Bastien, Megan Cully, David Hancock and Oliver Pardo for helpful discussions and technical advice. This work was funded by Cancer Research UK.	Akcakanat A, 2007, BIOCHEM BIOPH RES CO, V362, P330, DOI 10.1016/j.bbrc.2007.07.151; Alessi DR, 1996, FEBS LETT, V399, P333, DOI 10.1016/S0014-5793(96)01370-1; Aronova S, 2008, CELL METAB, V7, P148, DOI 10.1016/j.cmet.2007.11.015; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Cantin GT, 2008, J PROTEOME RES, V7, P1346, DOI 10.1021/pr0705441; Dai J, 2007, J PROTEOME RES, V6, P250, DOI 10.1021/pr0604155; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; Frias MA, 2006, CURR BIOL, V16, P1865, DOI 10.1016/j.cub.2006.08.001; Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Guertin DA, 2009, CANCER CELL, V15, P148, DOI 10.1016/j.ccr.2008.12.017; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Hermeking H, 2003, NAT REV CANCER, V3, P931, DOI 10.1038/nrc1230; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; Inoki K, 2005, MICROBIOL MOL BIOL R, V69, P79, DOI 10.1128/MMBR.69.1.79-100.2005; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Jones KT, 2009, PLOS BIOL, V7, P604, DOI 10.1371/journal.pbio.1000060; Kamada Y, 2005, MOL CELL BIOL, V25, P7239, DOI 10.1128/MCB.25.16.7239-7248.2005; Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kumar A, 2008, MOL CELL BIOL, V28, P61, DOI 10.1128/MCB.01405-07; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Manning BD, 2004, J CELL BIOL, V167, P399, DOI 10.1083/jcb.200408161; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Pearce LR, 2007, BIOCHEM J, V405, P513, DOI 10.1042/BJ20070540; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; Pende M, 2000, NATURE, V408, P994, DOI 10.1038/35050135; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Radimerski T, 2002, GENE DEV, V16, P2627, DOI 10.1101/gad.239102; Richardson CJ, 2004, CURR BIOL, V14, P1540, DOI 10.1016/j.cub.2004.08.061; Ruvinsky I, 2006, TRENDS BIOCHEM SCI, V31, P342, DOI 10.1016/j.tibs.2006.04.003; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Schalm SS, 2002, CURR BIOL, V12, P632, DOI 10.1016/S0960-9822(02)00762-5; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Shima H, 1998, EMBO J, V17, P6649, DOI 10.1093/emboj/17.22.6649; Shiota C, 2006, DEV CELL, V11, P583, DOI 10.1016/j.devcel.2006.08.013; Soukas AA, 2009, GENE DEV, V23, P496, DOI 10.1101/gad.1775409; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Wang XR, 2008, CANCER RES, V68, P7409, DOI 10.1158/0008-5472.CAN-08-1522; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206; Zanivan S, 2008, J PROTEOME RES, V7, P5314, DOI 10.1021/pr800599n; Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222	60	119	120	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 18	2010	29	7					1003	1016		10.1038/onc.2009.401	http://dx.doi.org/10.1038/onc.2009.401			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	556PV	19935711				2022-12-25	WOS:000274604400007
J	Goldman, JA; Garlick, JD; Kingston, RE				Goldman, Joseph A.; Garlick, Joseph D.; Kingston, Robert E.			Chromatin Remodeling by Imitation Switch (ISWI) Class ATP-dependent Remodelers Is Stimulated by Histone Variant H2A.Z	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOSOME SURFACE; PROMOTERS; COMPLEXES; TRANSCRIPTION; SWI/SNF; GENES; RECEPTOR; REGIONS; GENOME; ALTERS	ATP-dependent chromatin remodeling complexes rearrange nucleosomes by altering the position of DNA around the histone octamer. Although chromatin remodelers and the histone variant H2A.Z colocalize on transcriptional control regions, whether H2A.Z directly affects remodeler association or activity is unclear. We determined the relative association of remodelers with H2A.Z chromatin and tested whether replacement of H2A.Z in a nucleosome altered the activity of remodeling enzymes. Many families of remodelers showed increased association with H2A.Z chromatin, but only the ISWI family of chromatin remodelers showed stimulated activity in vitro. An acidic patch on the nucleosome surface, extended by inclusion of H2A.Z in nucleosomes and essential for viability, is required for ISWI stimulation. We conclude that H2A.Z incorporation increases nucleosome remodeling activity of the largest class of mammalian remodelers (ISWI) and that it correlates with increased association of other remodelers to chromatin. This reveals two possible modes for regulation of a remodeler by a histone variant.	[Kingston, Robert E.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02215 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Kingston, RE (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	Kingston@molbio.mgh.harvard.edu		Goldman, Joseph/0000-0002-0800-6189				Aalfs JD, 2001, J BIOL CHEM, V276, P34270, DOI 10.1074/jbc.M104163200; Altaf M, 2009, BIOCHEM CELL BIOL, V87, P35, DOI 10.1139/O08-140; Ausubel FM., 1987, CURRENT PROTOCOLS MO, DOI 10.1002/mrd.1080010210; Boyer LA, 2000, J BIOL CHEM, V275, P18864, DOI 10.1074/jbc.M002810200; Chang EY, 2008, BIOCHEMISTRY-US, V47, P13726, DOI 10.1021/bi8016944; Clapier CR, 2001, MOL CELL BIOL, V21, P875, DOI 10.1128/MCB.21.3.875-883.2001; Clarkson MJ, 1999, NATURE, V399, P694, DOI 10.1038/21436; Creyghton MP, 2008, CELL, V135, P649, DOI 10.1016/j.cell.2008.09.056; Dorigo B, 2003, J MOL BIOL, V327, P85, DOI 10.1016/S0022-2836(03)00025-1; Faast R, 2001, CURR BIOL, V11, P1183, DOI 10.1016/S0960-9822(01)00329-3; Fan JY, 2004, MOL CELL, V16, P655, DOI 10.1016/j.molcel.2004.10.023; Fan JY, 2002, NAT STRUCT BIOL, V9, P172, DOI 10.1038/nsb767; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Gevry N, 2007, GENE DEV, V21, P1869, DOI 10.1101/gad.1545707; Gevry N, 2009, GENE DEV, V23, P1522, DOI 10.1101/gad.1787109; Guillemette B, 2005, PLOS BIOL, V3, P2100, DOI 10.1371/journal.pbio.0030384; Hanai K, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000011; He X, 2006, J BIOL CHEM, V281, P28636, DOI 10.1074/jbc.M603008200; Jin CY, 2009, NAT GENET, V41, P941, DOI 10.1038/ng.409; John S, 2008, MOL CELL, V29, P611, DOI 10.1016/j.molcel.2008.02.010; Kagalwala MN, 2004, EMBO J, V23, P2092, DOI 10.1038/sj.emboj.7600220; Li B, 2005, P NATL ACAD SCI USA, V102, P18385, DOI 10.1073/pnas.0507975102; Lindstrom KC, 2006, MOL CELL BIOL, V26, P6117, DOI 10.1128/MCB.00642-06; Logie C, 1997, EMBO J, V16, P6772, DOI 10.1093/emboj/16.22.6772; Luger K, 1999, METH MOL B, V119, P1; Narlikar GJ, 2001, MOL CELL, V8, P1219, DOI 10.1016/S1097-2765(01)00412-9; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Ridgway P, 2004, J BIOL CHEM, V279, P43815, DOI 10.1074/jbc.M408409200; Santisteban MS, 2000, CELL, V103, P411, DOI 10.1016/S0092-8674(00)00133-1; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Sif S, 1998, GENE DEV, V12, P2842, DOI 10.1101/gad.12.18.2842; THATCHER TH, 1994, NUCLEIC ACIDS RES, V22, P174, DOI 10.1093/nar/22.2.174; Tolstorukov MY, 2009, GENOME RES, V19, P967, DOI 10.1101/gr.084830.108; TSUKIYAMA T, 1995, CELL, V83, P1021, DOI 10.1016/0092-8674(95)90217-1; Whitehouse I, 2007, NATURE, V450, P1031, DOI 10.1038/nature06391; WU RS, 1981, CELL, V27, P321, DOI 10.1016/0092-8674(81)90415-3; Yang JG, 2006, NAT STRUCT MOL BIOL, V13, P1078, DOI 10.1038/nsmb1170; Zhang HY, 2005, CELL, V123, P219, DOI 10.1016/j.cell.2005.08.036	39	49	52	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4645	4651		10.1074/jbc.M109.072348	http://dx.doi.org/10.1074/jbc.M109.072348			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	19940112	Green Published, hybrid			2022-12-25	WOS:000275274800043
J	Cockrell, LM; Puckett, MC; Goldman, EH; Khuri, FR; Fu, H				Cockrell, L. M.; Puckett, M. C.; Goldman, E. H.; Khuri, F. R.; Fu, H.			Dual engagement of 14-3-3 proteins controls signal relay from ASK2 to the ASK1 signalosome	ONCOGENE			English	Article						ASK1; ASK2; 14-3-3; apoptosis; mitogen-activated protein kinase	KINASE KINASE KINASE; REGULATING KINASE-1; AMPHIPATHIC GROOVE; CELL-DEATH; APOPTOSIS; ACTIVATION; STRESS; 14-3-3-PROTEINS; PHOSPHORYLATION; DISSOCIATION	Faithful and efficient transmission of biological signals through mitogen-activated protein kinase (MAPK) pathways requires engagement of highly regulated cellular machinery in response to diverse environmental cues. Here, we report a novel mechanism controlling signal relay between two MAP3Ks, apoptosis signal-regulating kinase (ASK) 1 and ASK2. We show that ASK2 specifically interacts with 14-3-3 proteins through phosphorylated S964. Although a 14-3-3-binding defective mutant of ASK1 (S967A) has no effect on the ASK2/14-3-3 interaction, both overexpression of the analogous ASK2 (S964A) mutant and knockdown of ASK2 dramatically reduced the amount of ASK1 complexed with 14-3-3. These data suggest a dominant role of ASK2 in 14-3-3 control of ASK1 function. Indeed, ASK2 S964A-induced dissociation of 14-3-3 from ASK1 correlated with enhanced phosphorylation of ASK1 at T838 and increased c-Jun N-terminal kinase phosphorylation, the two biological readouts of ASK1 activation. Our results suggest a model in which upstream signals couple ASK2 S964 phosphorylation to the ASK1 signalosome through dual engagement of 14-3-3. Oncogene (2010) 29, 822-830; doi:10.1038/onc.2009.382; published online 23 November 2009	[Fu, H.] Emory Univ, Dept Pharmacol, Grad Div Biol & Biomed Sci, Program Mol & Syst Pharmacol,Rollins Res Ctr 5111, Atlanta, GA 30322 USA; [Cockrell, L. M.; Puckett, M. C.; Goldman, E. H.; Fu, H.] Emory Univ, Dept Pharmacol, Rollins Res Ctr, Atlanta, GA 30322 USA; [Khuri, F. R.; Fu, H.] Emory Univ, Winship Canc Inst, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University	Fu, H (corresponding author), Emory Univ, Dept Pharmacol, Grad Div Biol & Biomed Sci, Program Mol & Syst Pharmacol,Rollins Res Ctr 5111, 1510 Clifton Rd, Atlanta, GA 30322 USA.	hfu@emory.edu	Khuri, Fadlo R./AAU-4942-2020	Khuri, Fadlo R./0000-0002-8638-7618	National Cancer Institute [5F31CA117057]; National Science Foundation Facilitating Academic Careers in Engineering and Science Fellowship [0450303 (I6660663)]; NIH [T32 GM008602, RO1GM53165]; Emory URC; NIH/NCI [PO1CA116676, USAMRMC05075002]; NATIONAL CANCER INSTITUTE [F31CA117057, P01CA116676] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053165, T32GM008602] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Science Foundation Facilitating Academic Careers in Engineering and Science Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emory URC; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the past and present members of the Fu laboratory for many stimulating discussions, as well as Zhengbin Yao for helpful suggestions. This work was supported by a National Cancer Institute National Research Service Award Grant 5F31CA117057 and a National Science Foundation Facilitating Academic Careers in Engineering and Science Fellowship 0450303 (I6660663) to LMC, an NIH Pharmacological Sciences Training Grant T32 GM008602 to MCP, NIH Grant RO1GM53165 and Emory URC grant to HF, and NIH/NCI Grant PO1CA116676 and USAMRMC05075002 to FRK and HF. HF is a Georgia Research Alliance Distinguished Investigator, and FRK and HF are Georgia Cancer Coalition Distinguished Cancer Scholars.	Aitken A, 2006, SEMIN CANCER BIOL, V16, P162, DOI 10.1016/j.semcancer.2006.03.005; Chang HY, 1998, SCIENCE, V281, P1860, DOI 10.1126/science.281.5384.1860; COHEN P, 1989, FEBS LETT, V250, P596, DOI 10.1016/0014-5793(89)80803-8; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Gardino AK, 2006, SEMIN CANCER BIOL, V16, P173, DOI 10.1016/j.semcancer.2006.03.007; Goldman EH, 2004, J BIOL CHEM, V279, P10442, DOI 10.1074/jbc.M311129200; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Imoto K, 2006, DIABETES, V55, P1197, DOI 10.2337/db05-1187; Iriyama T, 2009, EMBO J, V28, P843, DOI 10.1038/emboj.2009.32; Izumiya Y, 2003, CIRC RES, V93, P874, DOI 10.1161/01.RES.0000100665.67510.F5; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Mackintosh C, 2004, BIOCHEM J, V381, P329, DOI 10.1042/BJ20031332; Matsuzawa A, 2005, NAT IMMUNOL, V6, P587, DOI 10.1038/ni1200; Min W, 2008, CIRC RES, V102, P840, DOI 10.1161/CIRCRESAHA.107.168153; Morrison DK, 2009, TRENDS CELL BIOL, V19, P16, DOI 10.1016/j.tcb.2008.10.003; Muslin AJ, 2005, CURR TOP DEV BIOL, V65, P211; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302; Osaka N, 2007, J CELL BIOL, V176, P903, DOI 10.1083/jcb.200611015; Petosa C, 1998, J BIOL CHEM, V273, P16305, DOI 10.1074/jbc.273.26.16305; Subramanian RR, 2004, EXP CELL RES, V294, P581, DOI 10.1016/j.yexcr.2003.12.009; Takeda K, 2008, ANNU REV PHARMACOL, V48, P199, DOI 10.1146/annurev.pharmtox.48.113006.094606; Takeda K, 2007, J BIOL CHEM, V282, P7522, DOI 10.1074/jbc.M607177200; Thorson JA, 1998, MOL CELL BIOL, V18, P5229, DOI 10.1128/MCB.18.9.5229; Wang BC, 1999, BIOCHEMISTRY-US, V38, P12499, DOI 10.1021/bi991353h; Wang HN, 1998, J BIOL CHEM, V273, P16297, DOI 10.1074/jbc.273.26.16297; Wang XHS, 1996, J BIOL CHEM, V271, P31607; Wang XHSN, 1998, BIOCHEM BIOPH RES CO, V253, P33, DOI 10.1006/bbrc.1998.9749; Winter-Vann AM, 2007, J CELL BIOCHEM, V102, P848, DOI 10.1002/jcb.21522; Yaffe MB, 2002, FEBS LETT, V513, P53, DOI 10.1016/S0014-5793(01)03288-4; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Zhang LX, 1999, BIOCHEMISTRY-US, V38, P12159, DOI 10.1021/bi991019l; Zhang LX, 1999, P NATL ACAD SCI USA, V96, P8511, DOI 10.1073/pnas.96.15.8511; Zhang R, 2003, J CLIN INVEST, V111, P1933, DOI 10.1172/JCI200317790	34	22	24	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 11	2010	29	6					822	830		10.1038/onc.2009.382	http://dx.doi.org/10.1038/onc.2009.382			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	553WP	19935702				2022-12-25	WOS:000274397800005
J	Han, JX; Clement, JM; Li, J; King, A; Ng, S; Jaworski, JG				Han, Jixiang; Clement, Joel M.; Li, Jia; King, Andrew; Ng, Shirley; Jaworski, Jan G.			The Cytochrome P450 CYP86A22 Is a Fatty Acyl-CoA omega-Hydroxylase Essential for Estolide Synthesis in the Stigma of Petunia hybrida	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IONIZATION MASS-SPECTROMETRY; ARABIDOPSIS-THALIANA; NICOTIANA-TABACUM; HIGHER-PLANTS; ACID; LIPIDS; GENE; EXPRESSION; POLLEN; P450	The stigmatic estolide is a lipid-based polyester constituting the major component of exudate in solanaceous plants. Although the exudate is believed to play important roles in the pollination process, the biosynthetic pathway of stigmatic estolide, including genes encoding the key enzymes, remains unknown. Here we report the cloning and characterization of the cytochrome P450 gene CYP86A22, which encodes a fatty acyl-CoA omega-hydroxylase involved in estolide biosynthesis in the stigma of Petunia hybrida. A CYP86A22 cDNA was isolated from a developing stigma cDNA library, and the corresponding gene was shown to express predominantly in the developing stigma. Among six P450 genes isolated from this library, only CYP86A22 was implicated in omega-hydroxylation following RNA interference (RNAi)-mediated suppression. Unlike wild-type plants in which omega-hydroxy fatty acids (mainly in the form of 18-hydroxy oleic acid and 18-hydroxy linoleic acid) compose 96% of total stigma fatty acids, the omega-hydroxy fatty acids were essentially absent in the stigmas from 18 of 46 CYP86A22-RNAi transgenic plants and had varying levels of suppression in the remaining 28 plants. Furthermore, lipids in the 18 CYP86A22-RNAi stigmas were predominantly triacylglycerols and diacylglycerols instead of the estolides, which characterize the wild-type stigma. Analyses of recombinant CYP86A22 conclusively demonstrated that this P450 is a omega-hydroxylase with a substrate preference for both saturated and unsaturated acyl-CoAs rather than free fatty acids. We conclude that the cytochrome P450 enzyme CYP86A22 is the key fatty acyl-CoA omega-hydroxylase essential for the production of omega-hydroxy fatty acids and the biosynthesis of triacylglycerol-/diacylglycerol-based estolide polyesters in the petunia stigma.	[Han, Jixiang; Clement, Joel M.; Li, Jia; King, Andrew; Ng, Shirley; Jaworski, Jan G.] Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA	Donald Danforth Plant Science Center	Jaworski, JG (corresponding author), Donald Danforth Plant Sci Ctr, 975 N Warson Rd, St Louis, MO 63132 USA.	jjaworski@danforthcenter.org	King, Andrew/A-9887-2011; Jaworski, Jan/N-2255-2014	King, Andrew/0000-0002-2388-6081; Jaworski, Jan/0000-0003-3309-4915	National Science Foundation [DBI-0521250]	National Science Foundation(National Science Foundation (NSF))	This work was funded by Dow Chemical Co.(Midland, MI) and Dow AgroSciences LLC (Indianapolis, IN). The 4000 Q-TRAP system was supported by the National Science Foundation (Grant DBI-0521250).	Benveniste I, 1998, BIOCHEM BIOPH RES CO, V243, P688, DOI 10.1006/bbrc.1998.8156; BENVENISTE I, 1982, PLANT PHYSIOL, V70, P122, DOI 10.1104/pp.70.1.122; Bernhardt R, 2006, J BIOTECHNOL, V124, P128, DOI 10.1016/j.jbiotec.2006.01.026; Christie W. W., 2003, LIPID ANAL, P91; CRESTI M, 1986, AM J BOT, V73, P1713, DOI 10.2307/2444237; Duan H, 2005, PLANT PHYSIOL, V137, P1067, DOI 10.1104/pp.104.055715; Edlund AF, 2004, PLANT CELL, V16, pS84, DOI 10.1105/tpc.015800; HlousekRadojcic A, 1995, PLANT J, V8, P803, DOI 10.1046/j.1365-313X.1995.8060803.x; Holcapek M, 2003, J CHROMATOGR A, V1010, P195, DOI 10.1016/S0021-9673(03)01030-6; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; Hsu FF, 1999, J AM SOC MASS SPECTR, V10, P587, DOI 10.1016/S1044-0305(99)00035-5; JEFFERSON RA, 1987, EMBO J, V6, P3901; Johnson EF, 1996, FASEB J, V10, P1241, DOI 10.1096/fasebj.10.11.8836037; KANDASAMY MK, 1987, ANN BOT-LONDON, V60, P427, DOI 10.1093/oxfordjournals.aob.a087464; King A, 2007, PLANTA, V226, P381, DOI 10.1007/s00425-007-0489-z; KOIWAI A, 1988, PHYTOCHEMISTRY, V27, P2827, DOI 10.1016/0031-9422(88)80671-X; KOLATTUKUDY PE, 1974, LIPIDS, V9, P682, DOI 10.1007/BF02532176; Kolattukudy PE, 2001, ADV BIOCHEM ENG BIOT, V71, P1; KONAR RN, 1966, PLANTA, V71, P372, DOI 10.1007/BF00396322; KONAR RN, 1966, PLANTA, V71, P356, DOI 10.1007/BF00396321; Larson TR, 2001, PLANT J, V25, P115, DOI 10.1046/j.1365-313x.2001.00929.x; Le Bouquin R, 2001, EUR J BIOCHEM, V268, P3083, DOI 10.1046/j.1432-1327.2001.02207.x; Lord EM, 2002, ANNU REV CELL DEV BI, V18, P81, DOI 10.1146/annurev.cellbio.18.012502.083438; MACKENZIE CJ, 1990, AM J BOT, V77, P1111, DOI 10.2307/2444621; Magnes C, 2005, ANAL CHEM, V77, P2889, DOI 10.1021/ac048314i; MARTIN FW, 1969, AM J BOT, V56, P1023, DOI 10.2307/2440924; MATSUZAKI T, 1983, AGR BIOL CHEM TOKYO, V47, P77, DOI 10.1080/00021369.1983.10865578; MATSUZAKI T, 1986, AGR BIOL CHEM TOKYO, V50, P1581, DOI 10.1080/00021369.1986.10867599; MATSUZAKI T, 1983, PLANT CELL PHYSIOL, V24, P207, DOI 10.1093/pcp/24.2.207; MIZUTANI M, 1998, PLANT PHYSIOL, V357, P367; NAWRATH C, 2002, BIOPOLYMERS CUTIN SU, P1; Okita RT, 2001, CURR DRUG METAB, V2, P265; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Rupasinghe SG, 2007, PROTEINS, V68, P279, DOI 10.1002/prot.21335; Schuler MA, 2003, ANNU REV PLANT BIOL, V54, P629, DOI 10.1146/annurev.arplant.54.031902.134840; SEGHEZZI W, 1991, GENE, V106, P51, DOI 10.1016/0378-1119(91)90565-S; Simpson AECM, 1997, GEN PHARMACOL-VASC S, V28, P351, DOI 10.1016/S0306-3623(96)00246-7; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tijet N, 1998, BIOCHEM J, V332, P583, DOI 10.1042/bj3320583; Urban P, 1997, J BIOL CHEM, V272, P19176, DOI 10.1074/jbc.272.31.19176; Wellesen K, 2001, P NATL ACAD SCI USA, V98, P9694, DOI 10.1073/pnas.171285998; Wolters-Arts M, 2002, PLANT CELL ENVIRON, V25, P513, DOI 10.1046/j.1365-3040.2002.00827.x; Wolters-Arts M, 1998, NATURE, V392, P818, DOI 10.1038/33929; Xiao FM, 2004, EMBO J, V23, P2903, DOI 10.1038/sj.emboj.7600290; Zimmer T, 1996, BIOCHEM BIOPH RES CO, V224, P784, DOI 10.1006/bbrc.1996.1100	45	22	25	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3986	3996		10.1074/jbc.M109.050765	http://dx.doi.org/10.1074/jbc.M109.050765			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19940120	Green Published, hybrid			2022-12-25	WOS:000275254000052
J	Heikkinen, PT; Nummela, M; Leivonen, SK; Westermarck, J; Hill, CS; Kahari, VM; Jaakkola, PM				Heikkinen, Pekka T.; Nummela, Marika; Leivonen, Suvi-Katri; Westermarck, Jukka; Hill, Caroline S.; Kahari, Veli-Matti; Jaakkola, Panu M.			Hypoxia-activated Smad3-specific Dephosphorylation by PP2A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PHOSPHATASE 2A; FACTOR GENE-EXPRESSION; FACTOR-BETA PATHWAYS; TGF-BETA; SERINE/THREONINE PHOSPHATASES; PROLYL HYDROXYLATION; OKADAIC ACID; HIF-ALPHA; GROWTH; SMAD3	The transforming growth factor-beta (TGF-beta) maintains epithelial homeostasis and suppresses early tumor formation, but paradoxically at later stages of tumor progression, TGF-beta promotes malignancy. TGF-beta activates phosphorylation of Smad2 and -3 effectors. Smad2 and -3 are known to have different functions, but differential regulation of their phosphorylation has not been described. Here we show that upon hypoxia, the TGF-beta-induced phosphorylation of Smad3 was inhibited, although Smad2 remained phosphorylated. The inhibition of Smad3 phosphorylation was not due to TGF-beta receptor inactivation. We show that Smad3 was dephosphorylated by PP2A (protein phosphatase 2A) specifically under hypoxic conditions. The hypoxic Smad3 dephosphorylation required intact expression of the essential scaffold component PR65 of PP2A. PP2A physically interacted with Smad3 that occurred only in hypoxia. Accordingly, Smad3-associated PP2A activity was found under hypoxic conditions. Hypoxia attenuated the nuclear accumulation of TGF-beta-induced Smad3 but did not affect Smad2. Moreover, the influence of TGF-beta on a set of Smad3-activated genes was attenuated by hypoxia, and this was reversed by chemical PP2A inhibition. Our data demonstrate the existence of a Smad3-specific phosphatase and identify a novel role for PP2A. Moreover, our data implicate a novel mechanism by which hypoxia regulates growth factor responses.	[Jaakkola, Panu M.] Turku Univ, Turku Ctr Biotechnol, FI-20520 Turku, Finland; [Jaakkola, Panu M.] Abo Akad Univ, FI-20520 Turku, Finland; [Heikkinen, Pekka T.] Turku Univ, Sch Biol Sci, FI-20520 Turku, Finland; [Leivonen, Suvi-Katri; Kahari, Veli-Matti] Turku Univ, Med Res Labs, FI-20520 Turku, Finland; [Westermarck, Jukka] Tampere Univ, Inst Med Technol, FI-33014 Tampere, Finland; [Westermarck, Jukka] Tampere Univ, Univ Hosp, FI-33014 Tampere, Finland; [Hill, Caroline S.] Canc Res UK London Res Inst, London WC2A 3PX, England; [Kahari, Veli-Matti] Univ Turku, Dept Dermatol, FI-20520 Turku, Finland; [Jaakkola, Panu M.] Turku Univ Hosp, Dept Radiotherapy & Oncol, FI-20520 Turku, Finland	University of Turku; Abo Akademi University; University of Turku; University of Turku; Tampere University; Tampere University; Tampere University Hospital; Cancer Research UK; University of Turku; University of Turku	Jaakkola, PM (corresponding author), Turku Ctr Biotechnol, Tykistokatu 6B, FIN-20520 Turku, Finland.	panjaa@utu.fi	Westermarck, Jukka/AAL-6464-2020; Leivonen, Suvi-Katri/AAK-3096-2021; Kähäri, Veli-Matti/E-5144-2011; Jaakkola, Panu M/B-4355-2012; Kahari, Veli-Matti/T-4925-2019	Westermarck, Jukka/0000-0001-7478-3018; Kähäri, Veli-Matti/0000-0003-2421-9368; Kahari, Veli-Matti/0000-0003-2421-9368; Hill, Caroline/0000-0002-8632-0480; Heikkinen, Marika/0000-0002-3287-4437; Leivonen, Suvi-Katri/0000-0003-3224-0757; Jaakkola, Panu/0000-0002-2365-4985	Academy of Finland [200779, 210282, 8212695]; Sigrid Juselius Foundation; Emil Aaltonen Foundation; Finnish Cancer Research Foundation; Turku University [13336, 13031]; Cancer Foundation Finland sr [100104] Funding Source: researchfish	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Emil Aaltonen Foundation; Finnish Cancer Research Foundation; Turku University; Cancer Foundation Finland sr	The work was supported by Academy of Finland Grants 200779, 210282, and 8212695, the Sigrid Juselius Foundation, the Emil Aaltonen Foundation, the Finnish Cancer Research Foundation, and Turku University Hospital Grants EVO 13336 and 13031.	Arnold HK, 2006, MOL CELL BIOL, V26, P2832, DOI 10.1128/MCB.26.7.2832-2844.2006; Ashcroft GS, 1999, NAT CELL BIOL, V1, P260, DOI 10.1038/12971; Batut J, 2008, DEVELOPMENT, V135, P2927, DOI 10.1242/dev.020842; Bengtsson L, 2009, J CELL SCI, V122, P1248, DOI 10.1242/jcs.039552; BIALOJAN C, 1988, BIOCHEM J, V256, P283, DOI 10.1042/bj2560283; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Chen W, 2004, CANCER CELL, V5, P127, DOI 10.1016/S1535-6108(04)00026-1; Cohen PTW, 1997, TRENDS BIOCHEM SCI, V22, P245, DOI 10.1016/S0968-0004(97)01060-8; Cui W, 1996, CELL, V86, P531, DOI 10.1016/S0092-8674(00)80127-0; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Duan XY, 2006, J BIOL CHEM, V281, P36526, DOI 10.1074/jbc.M605169200; Fernandez JJ, 2002, CURR MED CHEM, V9, P229, DOI 10.2174/0929867023371247; Heyer J, 1999, P NATL ACAD SCI USA, V96, P12595, DOI 10.1073/pnas.96.22.12595; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Junttila MR, 2005, PROTEOMICS, V5, P1199, DOI 10.1002/pmic.200400991; Knockaert M, 2006, P NATL ACAD SCI USA, V103, P11940, DOI 10.1073/pnas.0605133103; KOKABU S, 2010, J BONE MINE IN PRESS; Kretschmer A, 2003, ONCOGENE, V22, P6748, DOI 10.1038/sj.onc.1206791; Kretzschmar M, 1997, GENE DEV, V11, P984, DOI 10.1101/gad.11.8.984; Leivonen SK, 2002, J BIOL CHEM, V277, P46338, DOI 10.1074/jbc.M206535200; Levy L, 2007, MOL CELL BIOL, V27, P6068, DOI 10.1128/MCB.00664-07; Li JJ, 2008, NEUROSCIENCE, V156, P662, DOI 10.1016/j.neuroscience.2008.07.061; Lin X, 2006, CELL, V125, P915, DOI 10.1016/j.cell.2006.03.044; LIU YX, 1995, CIRC RES, V77, P638, DOI 10.1161/01.RES.77.3.638; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Masson N, 2001, EMBO J, V20, P5197, DOI 10.1093/emboj/20.18.5197; Moustakas A, 2001, J CELL SCI, V114, P4359; Mumby M, 2007, CELL, V130, P21, DOI 10.1016/j.cell.2007.06.034; Oft M, 2002, NAT CELL BIOL, V4, P487, DOI 10.1038/ncb807; Piek E, 2001, J BIOL CHEM, V276, P19945, DOI 10.1074/jbc.M102382200; Sanchez-Elsner T, 2002, J BIOL CHEM, V277, P43799, DOI 10.1074/jbc.M207160200; Sanchez-Elsner T, 2001, J BIOL CHEM, V276, P38527, DOI 10.1074/jbc.M104536200; Scheid A, 2002, FASEB J, V16, P411, DOI 10.1096/fj.01-0496fje; Shi WB, 2004, J CELL BIOL, V164, P291, DOI 10.1083/jcb.200307151; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Stasyk T, 2005, MOL BIOL CELL, V16, P4765, DOI 10.1091/mbc.E05-03-0257; TEN DP, 2004, TRENDS BIOCHEM SCI, V29, P265; Walsh AH, 1997, FEBS LETT, V416, P230, DOI 10.1016/S0014-5793(97)01210-6; WIESER R, 1995, EMBO J, V14, P2199, DOI 10.1002/j.1460-2075.1995.tb07214.x; Wrighton KH, 2006, J BIOL CHEM, V281, P38365, DOI 10.1074/jbc.M607246200; Wykoff CC, 2000, CANCER RES, V60, P7075; Zhang H, 2003, BLOOD, V101, P2253, DOI 10.1182/blood-2002-02-0629; Zhu YA, 1998, CELL, V94, P703, DOI 10.1016/S0092-8674(00)81730-4	48	45	47	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3740	3749		10.1074/jbc.M109.042978	http://dx.doi.org/10.1074/jbc.M109.042978			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19951945	Green Published, hybrid			2022-12-25	WOS:000275254000026
J	Brailoiu, E; Hooper, R; Cai, XJ; Brailoiu, GC; Keebler, MV; Dun, NJ; Marchant, JS; Patel, S				Brailoiu, Eugen; Hooper, Robert; Cai, Xinjiang; Brailoiu, G. Cristina; Keebler, Michael V.; Dun, Nae J.; Marchant, Jonathan S.; Patel, Sandip			An Ancestral Deuterostome Family of Two-pore Channels Mediates Nicotinic Acid Adenine Dinucleotide Phosphate-dependent Calcium Release from Acidic Organelles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC ADP-RIBOSE; SEA-URCHIN EGGS; MOBILIZES CALCIUM; CA2+ RELEASE; NAADP; RECEPTORS; MESSENGERS; STORES	Nicotinic acid adenine dinucleotide phosphate (NAADP) is a potent and widespread calcium-mobilizing messenger, the properties of which have been most extensively described in sea urchin eggs. The molecular basis for calcium release by NAADP, however, is not clear and subject to controversy. Recent studies have provided evidence that members of the two-pore channel (TPC) family in mammals are the long sought after target channels for NAADP. Here, we show that the TPC3 gene, which has yet to be functionally characterized, is present throughout the deuterostome lineage but is a pseudogene in humans and other primates. We report the molecular cloning of the complete ancestral TPC gene family from the sea urchin and demonstrate that all three isoforms localize to acidic organelles to mediate NAADP-dependent calcium release. Our data highlight the functional divergence of this novel gene family during deuterostome evolution and provide further evidence that NAADP mediates calcium release from acidic stores through activation of TPCs.	[Hooper, Robert; Patel, Sandip] UCL, Dept Cell & Dev Biol, London WC1E 6BT, England; [Brailoiu, Eugen; Brailoiu, G. Cristina; Dun, Nae J.] Temple Univ, Dept Pharmacol, Sch Med, Philadelphia, PA 19140 USA; [Cai, Xinjiang] Duke Univ, Div Cardiol, Dept Med, Med Ctr, Durham, NC 27710 USA; [Keebler, Michael V.; Marchant, Jonathan S.] Univ Minnesota, Sch Med, Dept Pharmacol, Minneapolis, MN 55455 USA	University of London; University College London; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Duke University; University of Minnesota System; University of Minnesota Twin Cities	Patel, S (corresponding author), UCL, Dept Cell & Dev Biol, London WC1E 6BT, England.	patel.s@ucl.ac.uk	Marchant, Jonathan/Q-5484-2019; MARCHANT, Jonathan/B-8051-2009; Cai, Xinjiang/F-4843-2010; Patel, Sandip/O-9591-2015	Marchant, Jonathan/0000-0001-6592-0877; MARCHANT, Jonathan/0000-0001-6592-0877; Cai, Xinjiang/0000-0001-8933-7133; Patel, Sandip/0000-0001-7247-2013	National Institutes of Health [GM088790, HL 090804, HL 090804-01A2S109]; Biotechnology and Biological Sciences Research Council [BB/D018110/1, BB/G013721/1]; American Heart Association Fellowship Award [0625403U]; BBSRC [BB/D018110/1, BB/G013721/1] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088790] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); American Heart Association Fellowship Award(American Heart Association); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM088790 (to J. S. M.), HL 090804 (to E. B.), and HL 090804-01A2S109 (to E. B.). This work was also supported by Biotechnology and Biological Sciences Research Council Grants BB/D018110/1 and BB/G013721/1 (to S. P.) and American Heart Association Fellowship Award 0625403U (to X. C.).	Beck A, 2006, FASEB J, V20, P962, DOI 10.1096/fj.05-5538fje; Berridge G, 2002, J BIOL CHEM, V277, P43717, DOI 10.1074/jbc.M203224200; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Brailoiu E, 2009, J CELL BIOL, V186, P201, DOI 10.1083/jcb.200904073; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Chini EN, 1996, BIOCHEM J, V316, P709, DOI 10.1042/bj3160709; Churamani D, 2006, BIOCHEM J, V397, P313, DOI 10.1042/BJ20060179; Churchill GC, 2002, CELL, V111, P703, DOI 10.1016/S0092-8674(02)01082-6; Dammermann W, 2009, P NATL ACAD SCI USA, V106, P10678, DOI 10.1073/pnas.0809997106; Galione A, 2000, BIOL CELL, V92, P197, DOI 10.1016/S0248-4900(00)01070-4; Gerasimenko JV, 2006, J CELL SCI, V119, P226, DOI 10.1242/jcs.02721; Guse AH, 2009, CURR BIOL, V19, pR521, DOI 10.1016/j.cub.2009.05.045; Guse AH, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.144re10; LEE HC, 1995, J BIOL CHEM, V270, P2152, DOI 10.1074/jbc.270.5.2152; Lee HC, 2001, ANNU REV PHARMACOL, V41, P317, DOI 10.1146/annurev.pharmtox.41.1.317; Lee HC, 2005, J BIOL CHEM, V280, P33693, DOI 10.1074/jbc.R500012200; Lim D, 2001, FASEB J, V15, P2257, DOI 10.1096/fj.01-0157com; Menteyne A, 2006, CURR BIOL, V16, P1931, DOI 10.1016/j.cub.2006.07.070; Vannier B, 1999, P NATL ACAD SCI USA, V96, P2060, DOI 10.1073/pnas.96.5.2060; ZHANG F, 2008, J CELL MOL IN PRESS; Zhang F, 2007, J BIOL CHEM, V282, P25259, DOI 10.1074/jbc.M701614200; Zong XG, 2009, PFLUG ARCH EUR J PHY, V458, P891, DOI 10.1007/s00424-009-0690-y	22	96	97	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5							2897	10.1074/jbc.C109.081943	http://dx.doi.org/10.1074/jbc.C109.081943			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19940116	hybrid, Green Published			2022-12-25	WOS:000273829000003
J	Lee, J; Kim, KY; Lee, J; Paik, YK				Lee, Jeeyong; Kim, Kwang-Youl; Lee, Jihyun; Paik, Young-Ki			Regulation of Dauer Formation by O-GlcNAcylation in Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN DEPOLYMERIZING FACTOR; INSULIN-RESISTANCE; PHOSPHORYLATION DYNAMICS; GLYCOSYLATION; METABOLISM; ACTIVATION; EXPRESSION; LONGEVITY; GLCNACASE; PROTEINS	Modification of proteins at serine or threonine residues with N-acetylglucosamine, termed O-GlcNAcylation, plays an important role in most eukaryotic cells. To understand the molecular mechanism by which O-GlcNAcylation regulates the entry of Caenorhabditis elegans into the non-aging dauer state, we performed proteomic studies using two mutant strains: the O-GlcNAc transferase-deficient ogt-1(ok430) strain and the O-GlcNAcase-defective oga-1(ok1207) strain. In the presence of the dauer pheromone daumone, ogt-1 showed suppression of dauer formation, whereas oga-1 exhibited enhancement of dauer formation. Consistent with these findings, treatment of wild-type N2 worms with low concentrations of daumone and the O-GlcNAcase inhibitor O-(2-acetamido-2-deoxy-D-glucopyranosylidene) amino-N-phenylcarbamate (PUGNAc) enhanced dauer formation, which was dependent on intact O-GlcNAcylation metabolism. We also found that the treatment of daumone enhanced O-GlcNAcylation in vivo. Seven proteins, identified by coupled two-dimensional electrophoresis/liquid chromatography-mass spectroscopy (LC-MS) analysis, were differentially expressed in oga-1(ok1207) worms compared with wild-type N2 worms. The identities of these proteins suggest that O-GlcNAcylation influences stress resistance, protein folding, and mitochondrial function. Using O-GlcNAc labeling with fluorescent dye combined with two-dimensional electrophoresis/LC-MS analysis, we also identified five proteins that were differentially O-GlcNAcylated during dauer formation. Analysis of these candidate O-GlcNAcylated proteins suggests that O-GlcNAcylation may regulate cytoskeleton modifications and protein turnover during dauer formation.	[Paik, Young-Ki] Yonsei Univ, Coll Life Sci & Biotechnol, World Class Univ Program, Dept Biochem & Biomed Sci, Seoul 120749, South Korea; Yonsei Univ, Yonsei Proteome Res Ctr, Seoul 120749, South Korea	Yonsei University; Yonsei University	Paik, YK (corresponding author), Yonsei Univ, Coll Life Sci & Biotechnol, World Class Univ Program, Dept Biochem & Biomed Sci, Rm 423,Ind Univ Res Bldg,134 Shinchon Dong, Seoul 120749, South Korea.	paikyk@yonsei.ac.kr		kim, kwangyoul/0000-0001-8667-3369	Korea Forest Service [S110707L0501501]; Ministry of Education, Science and Technology [R31-2008-000-10086-0]; Ministry of Health and Welfare of the Republic of Korea [A030003]	Korea Forest Service(Korea Forest Service); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ministry of Health and Welfare of the Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by Forest Science and Technology Project Grant S110707L0501501 (to Y.-K. P.) from the Korea Forest Service; the World Class University (WCU) Program from the National Research Foundation of Korea, funded by Grant R31-2008-000-10086-0 from the Ministry of Education, Science and Technology; and Grant A030003 from the Korea Health 21 R&D Project, Ministry of Health and Welfare of the Republic of Korea (to Y.-K. P.).	Antebi A, 1998, DEVELOPMENT, V125, P1191; Arias EB, 2004, DIABETES, V53, P921, DOI 10.2337/diabetes.53.4.921; Bairoch A, 2008, NUCLEIC ACIDS RES, V36, pD190, DOI 10.1093/nar/gkm895; BRENNER S, 1974, GENETICS, V77, P71; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Cho YM, 2003, PROTEOMICS, V3, P1883, DOI 10.1002/pmic.200300562; Choi BK, 2003, MOL CELL PROTEOMICS, V2, P1086, DOI 10.1074/mcp.M300036-MCP200; Clark PM, 2008, J AM CHEM SOC, V130, P11576, DOI 10.1021/ja8030467; Cooper G. M., 2004, CELL MOL APPROACH, P436; Cui YX, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r122; Dong MQ, 2007, SCIENCE, V317, P660, DOI 10.1126/science.1139952; EMMONS SW, 1979, P NATL ACAD SCI USA, V76, P1333, DOI 10.1073/pnas.76.3.1333; Fisher AL, 2006, AGING CELL, V5, P127, DOI 10.1111/j.1474-9726.2006.00203.x; Forsythe ME, 2006, P NATL ACAD SCI USA, V103, P11952, DOI 10.1073/pnas.0601931103; Francisco H, 2009, DEV NEUROBIOL, V69, P162, DOI 10.1002/dneu.20695; Gao Y, 2000, ARCH BIOCHEM BIOPHYS, V383, P296, DOI 10.1006/abbi.2000.2094; GOLDEN JW, 1984, DEV BIOL, V102, P368, DOI 10.1016/0012-1606(84)90201-X; Hanover JA, 2005, P NATL ACAD SCI USA, V102, P11266, DOI 10.1073/pnas.0408771102; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Jeong PY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004162; Jeong PY, 2005, NATURE, V433, P541, DOI 10.1038/nature03201; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Lee HJ, 2008, PROTEOMICS, V8, P3371, DOI 10.1002/pmic.200800111; Lee HJ, 2008, PROTEOMICS, V8, P2168, DOI 10.1002/pmic.200701022; Li J, 2007, DEV BIOL, V301, P82, DOI 10.1016/j.ydbio.2006.10.013; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Meberg PJ, 1998, CELL MOTIL CYTOSKEL, V39, P172, DOI 10.1002/(SICI)1097-0169(1998)39:2<172::AID-CM8>3.0.CO;2-8; MILLER DJ, 1993, DEVELOPMENT, V118, P1279; Nakae J, 1999, J BIOL CHEM, V274, P15982, DOI 10.1074/jbc.274.23.15982; PERKINS LA, 1986, DEV BIOL, V117, P456, DOI 10.1016/0012-1606(86)90314-3; Rea SL, 2007, PLOS BIOL, V5, P2312, DOI 10.1371/journal.pbio.0050259; Ren PF, 1996, SCIENCE, V274, P1389, DOI 10.1126/science.274.5291.1389; Riddle DL, 1997, C ELEGANS, P739; SCHMIDT RE, 1981, DIABETES, V30, P416, DOI 10.2337/diabetes.30.5.416; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; Vosseller K, 2002, P NATL ACAD SCI USA, V99, P5313, DOI 10.1073/pnas.072072399; Wang Z, 2008, P NATL ACAD SCI USA, V105, P13793, DOI 10.1073/pnas.0806216105; Weigel NL, 2007, MOL ENDOCRINOL, V21, P2311, DOI 10.1210/me.2007-0101; Wells L, 2002, MOL CELL PROTEOMICS, V1, P791, DOI 10.1074/mcp.M200048-MCP200; Wells L, 2001, SCIENCE, V291, P2376, DOI 10.1126/science.1058714; Wolf M, 2008, J CELL PHYSIOL, V214, P721, DOI 10.1002/jcp.21269	41	27	35	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5							2930	10.1074/jbc.M109.022665	http://dx.doi.org/10.1074/jbc.M109.022665			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19940149	Green Published, hybrid			2022-12-25	WOS:000273829000007
J	Sakaue, T; Takeuchi, K; Maeda, T; Yamamoto, Y; Nishi, K; Ohkubo, I				Sakaue, Tomohisa; Takeuchi, Keisuke; Maeda, Toshinaga; Yamamoto, Yoshio; Nishi, Katsuji; Ohkubo, Iwao			Factor H in Porcine Seminal Plasma Protects Sperm against Complement Attack in Genital Tracts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE COFACTOR PROTEIN; HEMOLYTIC-UREMIC SYNDROME; FUNCTIONALLY ACTIVE COMPLEMENT; DECAY-ACCELERATING FACTOR; INHIBITING ACTIVITY; REGULATORY PROTEIN; MOLECULAR-CLONING; PROSTASOMAL CD59; CD46; SYSTEM	We found that factor H (FH) exists in porcine seminal plasma. Purified FH strongly inhibited serum alternative pathway complement activation against lipopolysaccharide. The molecular weight, pI, and heparin-binding activity of the purified protein were different from those of purified FH from porcine serum. The complement regulatory activity of seminal plasma FH was similar to 2-fold stronger than that of serum FH. Treatment of purified serum FH with sialidase and N-glycosidase F gave almost the same results as those of seminal plasma FH. The deletion of sialic acid from the carbohydrate chains of both FHs contributed to heparin-binding and complement regulatory activities. Results of reverse transcriptase-PCR, Western blot analysis, and immunohistochemistry showed that seminal plasma FH is mainly secreted from epithelial cells of the seminal vesicle in male genital tracts. FH was also detected in the outer acrosomal region of ejaculated sperm by immunofluorescence staining, and found that the purified FH from the sperm membrane has the same complement regulatory activity as that of seminal plasma FH. The ejaculated sperm possessing FH in the outer acrosomal region considerably evaded complement attack. We also found that there is strong complement activity in fluids from female genital tract ducts. These findings indicate that FH bound to the outer acrosomal region and soluble FH play important roles in protecting sperm against complement attack in male and female genital tracts.	[Sakaue, Tomohisa; Takeuchi, Keisuke; Maeda, Toshinaga; Ohkubo, Iwao] Shiga Univ Med Sci, Dept Med Biochem, Otsu, Shiga 5202192, Japan; [Nishi, Katsuji] Shiga Univ Med Sci, Dept Legal Med, Otsu, Shiga 5202192, Japan; [Yamamoto, Yoshio] Mie Univ, Cooperat Res Ctr, Iga Res Inst, Iga, Mie 5180131, Japan	Shiga University of Medical Science; Shiga University of Medical Science; Mie University	Ohkubo, I (corresponding author), Shiga Univ Med Sci, Dept Med Biochem, Otsu, Shiga 5202192, Japan.	ionfox@belle.shiga-med.ac.jp			Ministry of Education, Science and Culture of Japan [19590304]; President's Discretionary Fund of Shiga University of Medical Science	Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); President's Discretionary Fund of Shiga University of Medical Science	This work was supported in part by Grant-in-Aid for Scientific Research 19590304 (to I.O.) from the Ministry of Education, Science and Culture of Japan and by the President's Discretionary Fund of Shiga University of Medical Science (to K. T.).	Amirlak I, 2006, NEPHROLOGY, V11, P213, DOI 10.1111/j.1440-1797.2006.00556.x; Babiker AA, 2005, PROSTATE, V62, P105, DOI 10.1002/pros.20102; Babiker AA, 2002, AM J REPROD IMMUNOL, V47, P183, DOI 10.1034/j.1600-0897.2002.1o023.x; BLENK H, 1991, INFECTION, V19, pS138, DOI 10.1007/BF01643683; Boit R, 2003, ANDROLOGIA, V35, P93, DOI 10.1046/j.1439-0272.2003.00545.x; Chabottaux V, 2006, CANCER RES, V66, P5165, DOI 10.1158/0008-5472.CAN-05-3012; Chowdhury NA, 1996, ARCH ANDROLOGY, V36, P109, DOI 10.3109/01485019608987086; de Cordoba SR, 2008, CLIN EXP IMMUNOL, V151, P1, DOI 10.1111/j.1365-2249.2007.03574.x; DUTOIT D, 1994, ARCH ANDROLOGY, V32, P21, DOI 10.3109/01485019408987762; FUJITA T, 1988, IMMUNOLOGY, V64, P369; Fujita T, 2004, IMMUNOL REV, V198, P185, DOI 10.1111/j.0105-2896.2004.0123.x; Harris CL, 2006, MOL IMMUNOL, V43, P57, DOI 10.1016/j.molimm.2005.06.026; Hegasy GA, 2003, IMMUNOGENETICS, V55, P462, DOI 10.1007/s00251-003-0605-6; JENNE DE, 1989, P NATL ACAD SCI USA, V86, P7123, DOI 10.1073/pnas.86.18.7123; JIN MS, 1991, AM J REPROD IMMUNOL, V26, P53, DOI 10.1111/j.1600-0897.1991.tb00970.x; KITAMURA M, 1995, IMMUNOLOGY, V84, P626; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LISZEWSKI MK, 1991, ANNU REV IMMUNOL, V9, P431, DOI 10.1146/annurev.iy.09.040191.002243; LUBLIN DM, 1989, ANNU REV IMMUNOL, V7, P35, DOI 10.1146/annurev.immunol.7.1.35; Mancini G, 1965, Immunochemistry, V2, P235, DOI 10.1016/0019-2791(65)90004-2; Manuelian T, 2003, J CLIN INVEST, V111, P1181, DOI 10.1172/JCI200316651; McLaughlin PJ, 1996, J REPROD IMMUNOL, V31, P209, DOI 10.1016/0165-0378(96)00967-9; Miwa T, 2001, INT IMMUNOPHARMACOL, V1, P445, DOI 10.1016/S1567-5769(00)00043-6; NICHOLSONWELLER A, 1982, J IMMUNOL, V129, P184; NILSSON UR, 1965, J EXP MED, V122, P277, DOI 10.1084/jem.122.2.277; NISHI K, 1992, INT J LEGAL MED, V105, P75, DOI 10.1007/BF02340827; OGLESBY TJ, 1998, HUMAN COMPLEMENT SYS, P355; PANGBURN MK, 1977, J EXP MED, V146, P257, DOI 10.1084/jem.146.1.257; PERRICONE R, 1992, CLIN EXP IMMUNOL, V89, P154, DOI 10.1111/j.1365-2249.1992.tb06895.x; PETERSEN BH, 1980, J LAB CLIN MED, V96, P582; PRICE RJ, 1984, AM J REPROD IMMUNOL, V6, P92, DOI 10.1111/j.1600-0897.1984.tb00121.x; Rahimi A, 1999, AM J REPROD IMMUNOL, V41, P330; ROLLINS SA, 1990, J IMMUNOL, V144, P3478; Schmidt CQ, 2008, J IMMUNOL, V181, P2610, DOI 10.4049/jimmunol.181.4.2610; SEYA T, 1993, EUR J IMMUNOL, V23, P1322, DOI 10.1002/eji.1830230620; Sienel W, 2007, CLIN CANCER RES, V13, P3840, DOI 10.1158/1078-0432.CCR-06-2507; SIM RB, 1982, BIOCHEM J, V205, P285, DOI 10.1042/bj2050285; SIMPSON KL, 1994, J REPROD FERTIL, V102, P419; Takeuchi K, 2007, COMP BIOCHEM PHYS B, V146, P215, DOI 10.1016/j.cbpb.2006.10.108; TARTER TH, 1984, AM J REPROD IMMUNOL, V6, P28, DOI 10.1111/j.1600-0897.1984.tb00105.x; TAYLOR CT, 1994, HUM REPROD, V9, P907, DOI 10.1093/oxfordjournals.humrep.a138615; TURNER TT, 1979, INVEST UROL, V16, P311; VANDERPUYE OA, 1993, INT ARCH ALLERGY IMM, V101, P376, DOI 10.1159/000236480; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; WEILER JM, 1976, P NATL ACAD SCI USA, V73, P3268, DOI 10.1073/pnas.73.9.3268; WHALEY K, 1976, J EXP MED, V144, P1147, DOI 10.1084/jem.144.5.1147; Zipfel PF, 2006, CURR OPIN RHEUMATOL, V18, P548, DOI 10.1097/01.bor.0000240370.47336.ae	47	19	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2010	285	3					2184	2192		10.1074/jbc.M109.063495	http://dx.doi.org/10.1074/jbc.M109.063495			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	541PJ	19920146	Green Published, hybrid			2022-12-25	WOS:000273429100062
J	Bewick, S; Yang, RT; Zhang, MJ				Bewick, Sharon; Yang, Ruoting; Zhang, Mingjun			The Danger Is Growing! A New Paradigm for Immune System Activation and Peripheral Tolerance	PLOS ONE			English	Article							REGULATORY T-CELLS; SINGLE-STRANDED RNA; TH17; DIFFERENTIATION; RECOGNITION; T(H)17; HYPOTHESIS; INDUCTION; RECEPTOR; FAMILY	Successful immune defense is a complex balancing act. In order to protect a host against invasion by harmful pathogens, an immune response must be rapid and vigorous, and must eliminate foreign invaders before their populations grow beyond control. That same immune response, however, must be selective enough to recognize and ignore commensal bacteria, environmental antigens and host tissue itself. How the immune system makes the crucial decision whether or not to attack a particular antigen has been a long-standing question central to the study of immunology. Here we show that the structure of the signaling network between regulatory T-cells and type 17 helper T-cells allows the immune system to selectively attack pathogens based on whether or not the pathogens represent a growing, and thus dangerous population. We term this mechanism for immune system activation the 'Growth Detection Paradigm', because it offers an entirely new explanation for immune system regulation and peripheral tolerance.	[Bewick, Sharon; Yang, Ruoting; Zhang, Mingjun] Univ Tennessee, Mech Aerosp & Biomed Engn Dept, Knoxville, TN 37996 USA	University of Tennessee System; University of Tennessee Knoxville	Bewick, S (corresponding author), Univ Tennessee, Mech Aerosp & Biomed Engn Dept, Knoxville, TN 37996 USA.	mjzhang@utk.edu						Abbas AK, 2007, J AUTOIMMUN, V28, P59, DOI 10.1016/j.jaut.2007.02.002; Abbas AK., 2020, BASIC IMMUNOLOGY, V6a; ANNUNZIATO F, 2008, INT IMMUNOL; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Betti M, 2006, ANN ONCOL, V17, P235; Bi YJ, 2007, J CELL PHYSIOL, V211, P273, DOI 10.1002/jcp.20973; Bluestone JA, 2003, NAT REV IMMUNOL, V3, P253, DOI 10.1038/nri1032; Boehme KW, 2006, J IMMUNOL, V177, P7094, DOI 10.4049/jimmunol.177.10.7094; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Du JG, 2008, J IMMUNOL, V180, P4785, DOI 10.4049/jimmunol.180.7.4785; Furuzawa-Carballeda J, 2007, AUTOIMMUN REV, V6, P169, DOI 10.1016/j.autrev.2006.10.002; HATTON RD, 2009, F1000 BIOL REPORTS, V1, P1; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Ho PP, 2008, CELL RES, V18, P605, DOI 10.1038/cr.2008.63; Kaiko GE, 2008, IMMUNOLOGY, V123, P326, DOI 10.1111/j.1365-2567.2007.02719.x; Li MO, 2007, IMMUNITY, V26, P579, DOI 10.1016/j.immuni.2007.03.014; Liu AH, 2003, J ALLERGY CLIN IMMUN, V111, P471, DOI 10.1067/mai.2003.172; Liu C, 2001, J BIOL CHEM, V276, P34686, DOI 10.1074/jbc.M105566200; Lohr J, 2006, IMMUNOL REV, V212, P149, DOI 10.1111/j.0105-2896.2006.00414.x; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; McGeachy MJ, 2008, IMMUNITY, V28, P445, DOI 10.1016/j.immuni.2008.03.001; Miller SI, 2005, NAT REV MICROBIOL, V3, P36, DOI 10.1038/nrmicro1068; Mira A, 2001, TRENDS GENET, V17, P589, DOI 10.1016/S0168-9525(01)02447-7; Miyara M, 2007, TRENDS MOL MED, V13, P108, DOI 10.1016/j.molmed.2007.01.003; Muzio M, 2000, J IMMUNOL, V164, P5998, DOI 10.4049/jimmunol.164.11.5998; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Piccirillo CA, 2008, CYTOKINE, V43, P395, DOI 10.1016/j.cyto.2008.07.469; Rock FL, 1998, P NATL ACAD SCI USA, V95, P588, DOI 10.1073/pnas.95.2.588; Romagnani S, 2004, IMMUNOLOGY, V112, P352, DOI 10.1111/j.1365-2567.2004.01925.x; Sakaguchi S, 2001, IMMUNOL REV, V182, P18, DOI 10.1034/j.1600-065X.2001.1820102.x; Schmidt-Weber CB, 2007, J ALLERGY CLIN IMMUN, V120, P247, DOI 10.1016/j.jaci.2007.06.039; Selvaraj RK, 2007, J IMMUNOL, V178, P7667, DOI 10.4049/jimmunol.178.12.7667; Steinman L, 2007, NAT MED, V13, P139, DOI 10.1038/nm1551; Steinman RM, 2002, P NATL ACAD SCI USA, V99, P351, DOI 10.1073/pnas.231606698; Stockinger B, 2007, CURR OPIN IMMUNOL, V19, P281, DOI 10.1016/j.coi.2007.04.005; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Yates A, 2004, J THEOR BIOL, V231, P181, DOI 10.1016/j.jtbi.2004.06.013; Yazdanbakhsh M, 2002, SCIENCE, V296, P490, DOI 10.1126/science.296.5567.490; Young D, 2002, NAT IMMUNOL, V3, P1026, DOI 10.1038/ni1102-1026; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Zhu JF, 2008, BLOOD, V112, P1557, DOI 10.1182/blood-2008-05-078154	42	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2009	4	12							e8112	10.1371/journal.pone.0008112	http://dx.doi.org/10.1371/journal.pone.0008112			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MU	19956616	gold, Green Submitted, Green Published			2022-12-25	WOS:000272828800010
J	Ay, F; Xu, F; Kahveci, T				Ay, Ferhat; Xu, Fei; Kahveci, Tamer			Scalable Steady State Analysis of Boolean Biological Regulatory Networks	PLOS ONE			English	Article							GENETIC-CONTROL; P53 PATHWAY; MODEL; DIFFERENTIATION; ALGORITHM; DYNAMICS; PREDICTS	Background: Computing the long term behavior of regulatory and signaling networks is critical in understanding how biological functions take place in organisms. Steady states of these networks determine the activity levels of individual entities in the long run. Identifying all the steady states of these networks is difficult due to the state space explosion problem. Methodology: In this paper, we propose a method for identifying all the steady states of Boolean regulatory and signaling networks accurately and efficiently. We build a mathematical model that allows pruning a large portion of the state space quickly without causing any false dismissals. For the remaining state space, which is typically very small compared to the whole state space, we develop a randomized traversal method that extracts the steady states. We estimate the number of steady states, and the expected behavior of individual genes and gene pairs in steady states in an online fashion. Also, we formulate a stopping criterion that terminates the traversal as soon as user supplied percentage of the results are returned with high confidence. Conclusions: This method identifies the observed steady states of boolean biological networks computationally. Our algorithm successfully reported the G1 phases of both budding and fission yeast cell cycles. Besides, the experiments suggest that this method is useful in identifying co-expressed genes as well. By analyzing the steady state profile of Hedgehog network, we were able to find the highly co-expressed gene pair GL1-SMO together with other such pairs. Availability: Source code of this work is available at http://bioinformatics.cise.ufl.edu/palSteady.html twocolumnfalse]	[Ay, Ferhat; Xu, Fei; Kahveci, Tamer] Univ Florida, Gainesville, FL 32610 USA	State University System of Florida; University of Florida	Ay, F (corresponding author), Univ Florida, Gainesville, FL 32610 USA.	fay@cise.ufl.edu	Ay, Ferhat/J-7800-2019	Ay, Ferhat/0000-0002-0708-6914	NSF [CCF-0829867, DBI-0606607, IIS-0845439]	NSF(National Science Foundation (NSF))	This work was supported partially by NSF under grants CCF-0829867, DBI-0606607 and IIS-0845439. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2003, J THEOR BIOL, V223, P1, DOI 10.1016/S0022-5193(03)00035-3; Alberts MJ, 2008, INT J STROKE, V3, P16, DOI 10.1111/j.1747-4949.2008.00174.x; Ay Ferhat, 2008, Comput Syst Bioinformatics Conf, V7, P237, DOI 10.1142/9781848162648_0021; Ay Ferhat, 2009, Journal of Bioinformatics and Computational Biology, V7, P389, DOI 10.1142/S0219720009004163; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Bornholdt S, 2008, J R SOC INTERFACE, V5, pS85, DOI 10.1098/rsif.2008.0132.focus; BUYLLA EA, 2008, PLOS ONE, V3, pE3626; Davidich MI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001672; DEMONGEOT J, 2008, C P ADV INF NET APP, P782; Devloo V, 2003, B MATH BIOL, V65, P1025, DOI 10.1016/S0092-8240(03)00061-2; FANGTING L, 2004, P NATL ACAD SCI USA, V101, P4781; GARG A, 2007, C P IEEE ENG MED BIO, P1398; Garg A, 2008, BIOINFORMATICS, V24, P1917, DOI 10.1093/bioinformatics/btn336; Garg A, 2007, LECT NOTES COMPUT SC, V4453, P62; Hachtel GD, 1996, IEEE T COMPUT AID D, V15, P1479, DOI 10.1109/43.552081; Hirose O, 2008, BIOINFORMATICS, V24, P932, DOI 10.1093/bioinformatics/btm639; Hupp TR, 2000, BIOCHEM J, V352, P1, DOI 10.1042/0264-6021:3520001; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karlebach G, 2008, NAT REV MOL CELL BIO, V9, P770, DOI 10.1038/nrm2503; KAUFFMAN S, 1969, NATURE, V224, P177, DOI 10.1038/224177a0; Lane DP, 1999, BRIT J CANCER, V80, P1; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Mendoza L, 1999, BIOINFORMATICS, V15, P593, DOI 10.1093/bioinformatics/15.7.593; Mendoza L, 2006, BIOSYSTEMS, V84, P101, DOI 10.1016/j.biosystems.2005.10.004; Mendoza L, 2006, THEOR BIOL MED MODEL, V3, DOI 10.1186/1742-4682-3-13; NIELSEN J, 2006, BUDDY BINARY DECISIO; Obayashi T, 2008, NUCLEIC ACIDS RES, V36, pD77, DOI 10.1093/nar/gkm840; Oldham MC, 2006, P NATL ACAD SCI USA, V103, P17973, DOI 10.1073/pnas.0605938103; OSAMU H, 2005, LECT NOTES COMPUT SC, V3482, P349; Ostergaard S, 2000, NAT BIOTECHNOL, V18, P1283, DOI 10.1038/82400; Saez-Rodriguez J, 2007, PLOS COMPUT BIOL, V3, P1580, DOI 10.1371/journal.pcbi.0030163; SATORU M, 2003, C P COMP MET SYS BIO, P207; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Schaub MA, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-4; Segal E, 2005, J MACH LEARN RES, V6, P557; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Shlomi T, 2005, P NATL ACAD SCI USA, V102, P7695, DOI 10.1073/pnas.0406346102; Shmulevich I, 2002, BIOINFORMATICS, V18, P261, DOI 10.1093/bioinformatics/18.2.261; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; TATSUYA A, 1999, C P PAC S BIOC, V4, P17; TATSUYA A, 2003, THEOR COMPUT SCI, V298, P235; Tyson JJ, 2002, BIOESSAYS, V24, P1095, DOI 10.1002/bies.10191; Tyson JJ, 2001, NAT REV MOL CELL BIO, V2, P908, DOI 10.1038/35103078; Wong SL, 2004, P NATL ACAD SCI USA, V101, P15682, DOI 10.1073/pnas.0406614101; Wu YL, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000442; Zotenko E, 2006, ALGORITHM MOL BIOL, V1, DOI 10.1186/1748-7188-1-7	46	50	50	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2009	4	12							e7992	10.1371/journal.pone.0007992	http://dx.doi.org/10.1371/journal.pone.0007992			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MT	19956604	Green Published, gold, Green Submitted			2022-12-25	WOS:000272828700003
J	Aguilar, S; Scotton, CJ; McNulty, K; Nye, E; Stamp, G; Laurent, G; Bonnet, D; Janes, SM				Aguilar, Susana; Scotton, Chris J.; McNulty, Katrina; Nye, Emma; Stamp, Gordon; Laurent, Geoff; Bonnet, Dominique; Janes, Sam M.			Bone Marrow Stem Cells Expressing Keratinocyte Growth Factor via an Inducible Lentivirus Protects against Bleomycin-Induced Pulmonary Fibrosis	PLOS ONE			English	Article							INDUCED LUNG INJURY; IN-VIVO; EPITHELIAL PROLIFERATION; MULTIPLE MECHANISMS; PROGENITOR CELLS; GENE-EXPRESSION; II CELLS; MICE; MODEL; ENGRAFTMENT	Many common diseases of the gas exchange surface of the lung have no specific treatment but cause serious morbidity and mortality. Idiopathic Pulmonary Fibrosis (IPF) is characterized by alveolar epithelial cell injury, interstitial inflammation, fibroblast proliferation and collagen accumulation within the lung parenchyma. Keratinocyte Growth Factor (KGF, also known as FGF-7) is a critical mediator of pulmonary epithelial repair through stimulation of epithelial cell proliferation. During repair, the lung not only uses resident cells after injury but also recruits circulating bone marrow-derived cells (BMDC). Several groups have used Mesenchymal Stromal Cells (MSCs) as therapeutic vectors, but little is known about the potential of Hematopoietic Stem cells (HSCs). Using an inducible lentiviral vector (Tet-On) expressing KGF, we were able to efficiently transduce both MSCs and HSCs, and demonstrated that KGF expression is induced in a regulated manner both in vitro and in vivo. We used the in vivo bleomycin-induced lung fibrosis model to assess the potential therapeutic effect of MSCs and HSCs. While both populations reduced the collagen accumulation associated with bleomycin-induced lung fibrosis, only transplantation of transduced HSCs greatly attenuated the histological damage. Using double immunohistochemistry, we show that the reduced lung damage likely occurs through endogenous type II pneumocyte proliferation induced by KGF. Taken together, our data indicates that bone marrow transplantation of lentivirus-transduced HSCs can attenuate lung damage, and shows for the first time the potential of using an inducible Tet-On system for cell based gene therapy in the lung.	[Aguilar, Susana; Scotton, Chris J.; McNulty, Katrina; Laurent, Geoff; Janes, Sam M.] UCL, Rayne Inst, Ctr Resp Res, London, England; [Aguilar, Susana; Bonnet, Dominique] Canc Res UK, London Res Inst, Hematopoiet Stem Cell Lab, London, England; [Nye, Emma; Stamp, Gordon] Canc Res UK, London Res Inst, Expt Pathol Lab, London, England; [Nye, Emma; Stamp, Gordon] Univ London Imperial Coll Sci Technol & Med, Dept Histopathol, London, England	University of London; King's College London; University College London; Cancer Research UK; Cancer Research UK; Imperial College London	Aguilar, S (corresponding author), UCL, Rayne Inst, Ctr Resp Res, London, England.	d.bonnet@cancer.org.uk; s.janes@ucl.ac.uk		Scotton, Chris/0000-0002-9671-9057	Johnson and Johnso; Department of Health's NIHR Biomedical Research Centres funding scheme; Internal Cancer Research UK; Medical Research Council [G108/596, G0800340, G0900380] Funding Source: researchfish; MRC [G0900380, G108/596, G0800340] Funding Source: UKRI	Johnson and Johnso; Department of Health's NIHR Biomedical Research Centres funding scheme(National Institute for Health Research (NIHR)); Internal Cancer Research UK; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. DB is a Cancer Research UK principle Investigator. SJ was an MRC Clinician Scientist. This work was in part funded by a Johnson and Johnson "Focussed Giving Grant'' to SJ and partly undertaken at UCLH/UCL who received a proportion of funding from the Department of Health's NIHR Biomedical Research Centres funding scheme (SJ) and by internal Cancer Research UK funding (DB).	Anjos-Afonso F, 2004, J CELL SCI, V117, P5655, DOI 10.1242/jcs.01488; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Atzori L, 2004, THORAX, V59, P217, DOI 10.1136/thx.2003.008979; Barde I, 2006, MOL THER, V13, P382, DOI 10.1016/j.ymthe.2005.09.012; Bigger BW, 2006, GENE THER, V13, P117, DOI 10.1038/sj.gt.3302638; BOWDEN DH, 1984, LAB INVEST, V50, P487; Brazelton TR, 2000, SCIENCE, V290, P1775, DOI 10.1126/science.290.5497.1775; Bruscia EM, 2006, P NATL ACAD SCI USA, V103, P2965, DOI 10.1073/pnas.0510758103; Chapman HA, 2004, J CLIN INVEST, V113, P148, DOI 10.1172/JCI200420729; Charafeddine L, 1999, AM J PHYSIOL-LUNG C, V276, pL105, DOI 10.1152/ajplung.1999.276.1.L105; Chua F, 2005, AM J RESP CELL MOL, V33, P9, DOI 10.1165/rcmb.2005-0062TR; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Emoto H, 1997, J BIOL CHEM, V272, P23191, DOI 10.1074/jbc.272.37.23191; Frank MH, 2004, LANCET, V363, P1411, DOI 10.1016/S0140-6736(04)16134-5; Grove JE, 2002, AM J RESP CELL MOL, V27, P645, DOI 10.1165/rcmb.2002-0056RC; Guo J, 1998, AM J PHYSIOL-LUNG C, V275, pL800, DOI 10.1152/ajplung.1998.275.4.L800; HARRISON JH, 1987, J PHARMACOL EXP THER, V243, P1185; Horwitz EM, 1999, NAT MED, V5, P309, DOI 10.1038/6529; Howell DCJ, 2005, AM J PATHOL, V166, P1353, DOI 10.1016/S0002-9440(10)62354-1; Ishizawa K, 2004, FEBS LETT, V556, P249, DOI 10.1016/S0014-5793(03)01399-1; Koc ON, 2002, BONE MARROW TRANSPL, V30, P215, DOI 10.1038/sj.bmt.1703650; Kotton DN, 2001, DEVELOPMENT, V128, P5181; Kotton DN, 2005, AM J RESP CELL MOL, V33, P328, DOI 10.1165/rcmb.2005-0175RC; Krampera M, 2006, STEM CELLS, V24, P386, DOI 10.1634/stemcells.2005-0008; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; Laurent Geoffrey J, 2008, Proc Am Thorac Soc, V5, P311, DOI 10.1513/pats.200710-159DR; Le Blanc K, 2003, CYTOTHERAPY, V5, P485, DOI 10.1080/14653240310003611; Liebler JM, 2008, AM J PHYSIOL-LUNG C, V295, pL285, DOI 10.1152/ajplung.00222.2007; Maher TM, 2007, EUR RESPIR J, V30, P835, DOI 10.1183/09031936.00069307; MARCHESE C, 1995, J EXP MED, V182, P1369, DOI 10.1084/jem.182.5.1369; Mason CM, 1996, CRIT CARE MED, V24, P925, DOI 10.1097/00003246-199606000-00009; McCarter SD, 2007, AM J RESP CRIT CARE, V175, P1014, DOI 10.1164/rccm.200609-1370OC; Mei SHJ, 2007, PLOS MED, V4, P1525, DOI 10.1371/journal.pmed.0040269; Moeller A, 2008, INT J BIOCHEM CELL B, V40, P362, DOI 10.1016/j.biocel.2007.08.011; Morikawa O, 2000, AM J RESP CELL MOL, V23, P626, DOI 10.1165/ajrcmb.23.5.4178; Okamoto R, 2002, NAT MED, V8, P1011, DOI 10.1038/nm755; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Ortiz LA, 2003, P NATL ACAD SCI USA, V100, P8407, DOI 10.1073/pnas.1432929100; Ortiz LA, 2007, P NATL ACAD SCI USA, V104, P11002, DOI 10.1073/pnas.0704421104; PANOS RJ, 1993, J CLIN INVEST, V92, P969, DOI 10.1172/JCI116673; Peister A, 2004, BLOOD, V103, P1662, DOI 10.1182/blood-2003-09-3070; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Ray P, 2003, P NATL ACAD SCI USA, V100, P6098, DOI 10.1073/pnas.1031851100; Rojas M, 2005, AM J RESP CELL MOL, V33, P145, DOI 10.1165/rcmb.2004-0330OC; RUBIN JS, 1989, P NATL ACAD SCI USA, V86, P802, DOI 10.1073/pnas.86.3.802; Scotton CJ, 2007, CHEST, V132, P1311, DOI 10.1378/chest.06-2568; Spees JL, 2007, AM J RESP CRIT CARE, V176, P385, DOI 10.1164/rccm.200607-1004OC; Sugahara K, 1998, J PATHOL, V186, P90; Theise ND, 2002, EXP HEMATOL, V30, P1333, DOI 10.1016/S0301-472X(02)00931-1; ULICH TR, 1994, AM J PATHOL, V144, P862; Ware LB, 2002, AM J PHYSIOL-LUNG C, V282, pL924, DOI 10.1152/ajplung.00439.2001; Waters CM, 1999, J CELL PHYSIOL, V181, P424, DOI 10.1002/(SICI)1097-4652(199912)181:3<424::AID-JCP6>3.0.CO;2-Z; Yamada M, 2004, J IMMUNOL, V172, P1266, DOI 10.4049/jimmunol.172.2.1266; Yano T, 2000, AM J PHYSIOL-LUNG C, V279, pL1146, DOI 10.1152/ajplung.2000.279.6.L1146; YI ES, 1994, AM J PATHOL, V145, P80; Zhang X, 2008, CANCER GENE THER, V15, P73, DOI 10.1038/sj.cgt.7701108; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	57	125	136	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2009	4	11							e8013	10.1371/journal.pone.0008013	http://dx.doi.org/10.1371/journal.pone.0008013			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MH	19956603	Green Published, gold, Green Submitted			2022-12-25	WOS:000272827500035
J	Fischer, BJ; Anderson, CH; Pena, JL				Fischer, Brian J.; Anderson, Charles H.; Pena, Jose Luis			Multiplicative Auditory Spatial Receptive Fields Created by a Hierarchy of Population Codes	PLOS ONE			English	Article							INTERAURAL TIME DIFFERENCE; OWLS INFERIOR COLLICULUS; SPACE-SPECIFIC NEURONS; BARN OWL; SOUND-LOCALIZATION; OPTIC TECTUM; BRAIN-STEM; NUCLEUS LAMINARIS; CROSS-CORRELATION; COCHLEAR NUCLEUS	A multiplicative combination of tuning to interaural time difference (ITD) and interaural level difference (ILD) contributes to the generation of spatially selective auditory neurons in the owl's midbrain. Previous analyses of multiplicative responses in the owl have not taken into consideration the frequency-dependence of ITD and ILD cues that occur under natural listening conditions. Here, we present a model for the responses of ITD- and ILD-sensitive neurons in the barn owl's inferior colliculus which satisfies constraints raised by experimental data on frequency convergence, multiplicative interaction of ITD and ILD, and response properties of afferent neurons. We propose that multiplication between ITD- and ILD-dependent signals occurs only within frequency channels and that frequency integration occurs using a linear-threshold mechanism. The model reproduces the experimentally observed nonlinear responses to ITD and ILD in the inferior colliculus, with greater accuracy than previous models. We show that linear-threshold frequency integration allows the system to represent multiple sound sources with natural sound localization cues, whereas multiplicative frequency integration does not. Nonlinear responses in the owl's inferior colliculus can thus be generated using a combination of cellular and network mechanisms, showing that multiple elements of previous theories can be combined in a single system.	[Fischer, Brian J.] Occidental Coll, Dept Math, Los Angeles, CA 90041 USA; [Fischer, Brian J.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Fischer, Brian J.; Anderson, Charles H.] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; [Pena, Jose Luis] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10467 USA	Occidental College; California Institute of Technology; Washington University (WUSTL); Yeshiva University; Albert Einstein College of Medicine	Fischer, BJ (corresponding author), Occidental Coll, Dept Math, Los Angeles, CA 90041 USA.	Brian.Fischer@ens.fr		Pena, Jose/0000-0001-6773-5640	NIH [DC007690]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007690] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	NIH grant DC007690. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADOLPHS R, 1993, J NEUROSCI, V13, P3647; Arthur BJ, 2005, J COMP NEUROL, V492, P110, DOI 10.1002/cne.20726; ATWAL GS, 2004, SOFT MATTER, V70; BRAINARD MS, 1992, J ACOUST SOC AM, V91, P1015, DOI 10.1121/1.402627; BROZOVIC M, 2008, J COMPUT NEUROSCI; CARR CE, 1990, J NEUROSCI, V10, P3227; Chichilnisky EJ, 2001, NETWORK-COMP NEURAL, V12, P199, DOI 10.1088/0954-898X/12/2/306; Colburn HS, 1996, AUDITORY COMPUTATION, P332; COLES RB, 1988, J COMP PHYSIOL A, V163, P117, DOI 10.1007/BF00612002; Eliasmith C, 2003, NEURAL ENG; Euston DR, 2002, J NEUROSCI, V22, P284, DOI 10.1523/JNEUROSCI.22-01-00284.2002; EUSTON DR, 2000, THESIS U OREGON; Fischer BJ, 2008, J NEUROSCI, V28, P8107, DOI 10.1523/JNEUROSCI.1969-08.2008; Fischer BJ, 2007, J NEUROPHYSIOL, V98, P1181, DOI 10.1152/jn.00370.2007; GELFLAND JJ, 1988, 3 IEEE INT S INT CON, V3, P147; Gold JI, 2000, J NEUROSCI, V20, P862, DOI 10.1523/JNEUROSCI.20-02-00862.2000; GRASSI E, 2001, P C INF SCI SYST, P344; Kardar M, 2002, P NATL ACAD SCI USA, V99, P15894, DOI 10.1073/pnas.252472699; Keller CH, 2005, J NEUROSCI, V25, P10446, DOI 10.1523/JNEUROSCI.2093-05.2005; Keller CH, 1998, HEARING RES, V118, P13, DOI 10.1016/S0378-5955(98)00014-8; KNUDSEN EI, 1978, SCIENCE, V200, P795, DOI 10.1126/science.644324; KNUDSEN EI, 1987, ANNU REV NEUROSCI, V10, P41, DOI 10.1146/annurev.ne.10.030187.000353; KNUDSEN EI, 1983, J COMP NEUROL, V218, P174, DOI 10.1002/cne.902180205; KNUDSEN EI, 1993, J NEUROSCI, V13, P2837; KNUDSEN EI, 1979, J COMP PHYSIOL, V133, P1, DOI 10.1007/BF00663105; Konishi M, 2003, ANNU REV NEUROSCI, V26, P31, DOI 10.1146/annurev.neuro.26.041002.131123; Koppl C, 1999, J NEUROSCI, V19, P9674; Koppl C, 1997, J NEUROPHYSIOL, V77, P364, DOI 10.1152/jn.1997.77.1.364; MARTIN KD, 1995, THESIS MIT; MAZER JA, 1995, THESIS CALTECH; MEL BW, 1993, J NEUROPHYSIOL, V70, P1086, DOI 10.1152/jn.1993.70.3.1086; MEL BW, 1990, 6 CNS CALTECH; MOISEFF A, 1983, J NEUROSCI, V3, P2553; MOISEFF A, 1981, J NEUROSCI, V1, P40, DOI 10.1523/JNEUROSCI.01-01-00040.1981; MOISEFF A, 1989, J COMP PHYSIOL A, V164, P637, DOI 10.1007/BF00614506; MOISEFF A, 1989, J COMP PHYSIOL A, V164, P629, DOI 10.1007/BF00614505; Mori K, 1997, HEARING RES, V111, P22, DOI 10.1016/S0378-5955(97)00090-7; Murphy BK, 2003, J NEUROSCI, V23, P10040; Mysore SP, 2005, IEEE IJCNN, P2766; OLSEN JF, 1989, J NEUROSCI, V9, P2591; PATTERSON RD, 1992, ADV BIOSCI, V83, P429; Pena JL, 1996, J NEUROSCI, V16, P7046; Pena JL, 2002, J NEUROSCI, V22, P5652; Pena JL, 2001, SCIENCE, V292, P249, DOI 10.1126/science.1059201; Pena JL, 2000, P NATL ACAD SCI USA, V97, P11787, DOI 10.1073/pnas.97.22.11787; Perez ML, 2006, J NEUROPHYSIOL, V95, P783, DOI 10.1152/jn.00833.2005; Poganiatz I, 2001, JARO, V2, P1; POGGIO T, 1990, COLD SPRING HARB SYM, V55, P899; Poirazi P, 2003, NEURON, V37, P989, DOI 10.1016/S0896-6273(03)00149-1; Pouget A, 1997, J COGNITIVE NEUROSCI, V9, P222, DOI 10.1162/jocn.1997.9.2.222; Pouget A, 2003, ANNU REV NEUROSCI, V26, P381, DOI 10.1146/annurev.neuro.26.041002.131112; POUGET A, 1995, ADV NEURAL INFORM PR, V7; ROSEN DJ, 1994, ADV NEURAL INFORM PR, V6; Rucci M, 1997, J NEUROSCI, V17, P334, DOI 10.1523/JNEUROSCI.17-01-00334.1997; Rucci M, 1999, NEURAL NETWORKS, V12, P31, DOI 10.1016/S0893-6080(98)00107-5; Salinas E, 1996, P NATL ACAD SCI USA, V93, P11956, DOI 10.1073/pnas.93.21.11956; SPENCE CD, 1989, ADV IN NEURAL INFORM, V1; Spezio ML, 2003, J NEUROSCI, V23, P4677; Suarez H, 1989, NEURAL COMPUT, V1, P318, DOI 10.1162/neco.1989.1.3.318; SULLIVAN WE, 1984, J NEUROSCI, V4, P1787; TAKAHASHI T, 1984, J NEUROSCI, V4, P1781; TAKAHASHI T, 1986, J NEUROSCI, V6, P3413; TAKAHASHI TT, 1994, J NEUROSCI, V14, P4780; TAKAHASHI TT, 1988, J COMP NEUROL, V274, P190, DOI 10.1002/cne.902740206; TAKAHASHI TT, 1989, J COMP NEUROL, V281, P545, DOI 10.1002/cne.902810405; Viete S, 1997, J NEUROSCI, V17, P1815; WAGNER H, 1992, J COMP PHYSIOL A, V170, P3; WAGNER H, 1987, J NEUROSCI, V7, P3105; WAGNER H, 1993, J NEUROSCI, V13, P371; Witten IB, 2008, J NEUROPHYSIOL, V100, P1067, DOI 10.1152/jn.00013.2008	70	19	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2009	4	11							e8015	10.1371/journal.pone.0008015	http://dx.doi.org/10.1371/journal.pone.0008015			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MH	19956693	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000272827500037
J	Grigoryev, YA; Kurian, SM; Nakorchevskiy, AA; Burke, JP; Campbell, D; Head, SR; Deng, J; Kantor, AB; Yates, JR; Salomon, DR				Grigoryev, Yevgeniy A.; Kurian, Sunil M.; Nakorchevskiy, Aleksey A.; Burke, John P.; Campbell, Daniel; Head, Steve R.; Deng, Jun; Kantor, Aaron B.; Yates, John R., III; Salomon, Daniel R.			Genome-Wide Analysis of Immune Activation in Human T and B Cells Reveals Distinct Classes of Alternatively Spliced Genes	PLOS ONE			English	Article							PROTEIN IDENTIFICATION TECHNOLOGY; PERIPHERAL-BLOOD LYMPHOCYTES; EXON EXPRESSION ARRAYS; MESSENGER-RNA DECAY; MICROARRAY ANALYSIS; AFFYMETRIX EXON; GLOBAL ANALYSIS; HUMAN TRANSCRIPTOME; SHOTGUN PROTEOMICS; DNA MICROARRAY	Alternative splicing of pre-mRNA is a mechanism that increases the protein diversity of a single gene by differential exon inclusion/exclusion during post-transcriptional processing. While alternative splicing is established to occur during lymphocyte activation, little is known about the role it plays during the immune response. Our study is among the first reports of a systematic genome-wide analysis of activated human T and B lymphocytes using whole exon DNA microarrays integrating alternative splicing and differential gene expression. Purified human CD2(+) T or CD19(+) B cells were activated using protocols to model the early events in post-transplant allograft immunity and sampled as a function of time during the process of immune activation. Here we show that 3 distinct classes of alternatively spliced and/or differentially expressed genes change in an ordered manner as a function of immune activation. We mapped our results to function-based canonical pathways and demonstrated that some are populated by only one class of genes, like integrin signaling, while other pathways, such as purine metabolism and T cell receptor signaling, are populated by all three classes of genes. Our studies augment the current view of T and B cell activation in immunity that has been based exclusively upon differential gene expression by providing evidence for a large number of molecular networks populated as a function of time and activation by alternatively spliced genes, many of which are constitutively expressed.			Grigoryev, YA (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	dsalomon@scripps.edu	Salomon, Daniel/E-9380-2012; Kurian, Sunil/C-4493-2008	Kurian, Sunil/0000-0002-7782-7263	NIAID NIH HHS [U19 AI063603] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI063603] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abdueva D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000913; Argyropoulos C, 2004, GENES IMMUN, V5, P16, DOI 10.1038/sj.gene.6364034; Baron U, 2007, EUR J IMMUNOL, V37, P2378, DOI 10.1002/eji.200737594; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Baumgarth N, 2000, IMMUNOL REV, V176, P171; Ben-Dov C, 2008, J BIOL CHEM, V283, P1229, DOI 10.1074/jbc.R700033200; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Blumerman SL, 2007, MOL IMMUNOL, V44, P2023, DOI 10.1016/j.molimm.2006.09.020; Bunting K, 2007, J IMMUNOL, V178, P7097, DOI 10.4049/jimmunol.178.11.7097; Chambers CA, 1999, CURR OPIN CELL BIOL, V11, P203, DOI 10.1016/S0955-0674(99)80027-1; Chambers CA, 2001, TRENDS IMMUNOL, V22, P217, DOI 10.1016/S1471-4906(01)01868-3; Cheung HC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-216; Chtanova T, 2005, J IMMUNOL, V175, P7837, DOI 10.4049/jimmunol.175.12.7837; Clark TA, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r64; Du ZY, 2003, ACTA PHARMACOL SIN, V24, P864; Erickson LM, 2002, TRANSPLANT P, V34, P1385, DOI 10.1016/S0041-1345(02)02896-8; Ferrando AA, 2002, CANCER CELL, V1, P75, DOI 10.1016/S1535-6108(02)00018-1; Flechner SM, 2004, AM J TRANSPLANT, V4, P1475, DOI 10.1111/j.1600-6143.2004.00526.x; French PJ, 2007, CANCER RES, V67, P5635, DOI 10.1158/0008-5472.CAN-06-2869; Gardina PJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-325; Hansel NN, 2005, J LAB CLIN MED, V145, P263, DOI 10.1016/j.lab.2005.02.010; Hess K, 2004, INT IMMUNOL, V16, P1711, DOI 10.1093/intimm/dxh172; Holm AM, 2004, CLIN EXP IMMUNOL, V138, P278, DOI 10.1111/j.1365-2249.2004.02630.x; Huang RS, 2007, P NATL ACAD SCI USA, V104, P9758, DOI 10.1073/pnas.0703736104; Huang RS, 2008, PHARMACOGENET GENOM, V18, P545, DOI 10.1097/FPC.0b013e3282fe1745; Hutton JJ, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-82; Ip JY, 2007, RNA, V13, P563, DOI 10.1261/rna.457207; ITOH K, 1994, CELL IMMUNOL, V157, P478, DOI 10.1006/cimm.1994.1243; Johnson MB, 2009, NEURON, V62, P494, DOI 10.1016/j.neuron.2009.03.027; Joshi T, 2004, P ANN INT IEEE EMBS, V26, P2881; Kapur K, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r82; Kindler V, 1997, J IMMUNOL, V159, P2085; KINDLER V, 1995, EUR J IMMUNOL, V25, P1239, DOI 10.1002/eji.1830250516; Kwan T, 2007, GENOME RES, V17, P1210, DOI 10.1101/gr.6281007; LANE P, 1992, EUR J IMMUNOL, V22, P2573, DOI 10.1002/eji.1830221016; Lee BPL, 2005, J IMMUNOL, V174, P4535, DOI 10.4049/jimmunol.174.8.4535; Li XD, 2001, GENES IMMUN, V2, P88, DOI 10.1038/sj.gene.6363743; Li YF, 2006, INT J MOL MED, V18, P1127; Lin ZS, 2003, LAB INVEST, V83, P765, DOI 10.1097/01.LAB.0000073130.58435.E5; Lu BF, 2004, P NATL ACAD SCI USA, V101, P3023, DOI 10.1073/pnas.0307743100; Lynch KW, 2004, NAT REV IMMUNOL, V4, P931, DOI 10.1038/nri1497; Manfredini R, 2005, STEM CELLS, V23, P496, DOI 10.1634/stemcells.2004-0265; Mao XY, 2007, GENE CHROMOSOME CANC, V46, P675, DOI 10.1002/gcc.20452; Marrack P, 2000, CURR OPIN IMMUNOL, V12, P206, DOI 10.1016/S0952-7915(99)00075-8; McCormack AL, 1997, ANAL CHEM, V69, P767, DOI 10.1021/ac960799q; Modrek B, 2001, NUCLEIC ACIDS RES, V29, P2850, DOI 10.1093/nar/29.13.2850; Moore MJ, 2008, RNA, V14, P197, DOI 10.1261/rna.868008; NONOYAMA S, 1993, J EXP MED, V178, P1097, DOI 10.1084/jem.178.3.1097; Oberdoerffer S, 2008, SCIENCE, V321, P686, DOI 10.1126/science.1157610; Okoniewski MJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r79; Okoniewski MJ, 2007, BIOTECHNIQUES, V42, P181, DOI 10.2144/000112315; Pan Q, 2006, GENE DEV, V20, P153, DOI 10.1101/gad.1382806; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Raghavan A, 2002, NUCLEIC ACIDS RES, V30, P5529, DOI 10.1093/nar/gkf682; Rothrock CR, 2005, EMBO J, V24, P2792, DOI 10.1038/sj.emboj.7600745; ROUSSET F, 1995, INT IMMUNOL, V7, P1243, DOI 10.1093/intimm/7.8.1243; Sadygov RG, 2002, J PROTEOME RES, V1, P211, DOI 10.1021/pr015514r; SCHILIZZI BM, 1997, IMMUNOLOGY; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; THORSEN K, 2008, MOL CELL PROTEOMICS; Vinuesa CG, 2002, ANN NY ACAD SCI, V975, P33, DOI 10.1111/j.1749-6632.2002.tb05939.x; Wang ET, 2008, NATURE; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Wolters DA, 2001, ANAL CHEM, V73, P5683, DOI 10.1021/ac010617e; XI L, 2008, NUCL ACIDS RES; Xing Y, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000088; Xing Y, 2007, MOL BIOL EVOL, V24, P1283, DOI 10.1093/molbev/msm061; Xu Q, 2002, NUCLEIC ACIDS RES, V30, P3754, DOI 10.1093/nar/gkf492; Yoshida Ryo, 2006, Genome Inform, V17, P88; Zhang J, 2002, J IMMUNOL, V169, P2236, DOI 10.4049/jimmunol.169.5.2236; Zhang XS, 2002, LIFE SCI, V71, P3005, DOI 10.1016/S0024-3205(02)02164-1	72	31	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2009	4	11							e7906	10.1371/journal.pone.0007906	http://dx.doi.org/10.1371/journal.pone.0007906			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522NJ	19936255	Green Submitted, Green Published, gold			2022-12-25	WOS:000272004600010
J	Ke, YD; Delerue, F; Gladbach, A; Gotz, J; Ittner, LM				Ke, Yazi D.; Delerue, Fabien; Gladbach, Amadeus; Goetz, Juergen; Ittner, Lars M.			Experimental Diabetes Mellitus Exacerbates Tau Pathology in a Transgenic Mouse Model of Alzheimer's Disease	PLOS ONE			English	Article							ANIMAL-MODELS; NEUROFIBRILLARY TANGLES; IN-VIVO; INSULIN; PHOSPHORYLATION; BRAIN; ASSOCIATION; TAUOPATHY; DEMENTIA; BEHAVIOR	Diabetes mellitus (DM) is characterized by hyperglycemia caused by a lack of insulin, insulin resistance, or both. There is increasing evidence that insulin also plays a role in Alzheimer's disease (AD) as it is involved in the metabolism of beta-amyloid (A beta) and tau, two proteins that form A beta plaques and neurofibrillary tangles (NFTs), respectively, the hallmark lesions in AD. Here, we examined the effects of experimental DM on a pre-existing tau pathology in the pR5 transgenic mouse strain that is characterized by NFTs. pR5 mice express P301L mutant human tau that is associated with dementia. Experimental DM was induced by administration of streptozotocin (STZ), which causes insulin deficiency. We determined phosphorylation of tau, using immunohistochemistry and Western blotting. Solubility of tau was determined upon extraction with sarkosyl and formic acid, and Gallyas silver staining was employed to reveal NFTs. Insulin depletion by STZ administration in six months-old non-transgenic mice causes increased tau phosphorylation, without its deposition or NFT formation. In contrast, in pR5 mice this results in massive deposition of hyperphosphorylated, insoluble tau. Furthermore, they develop a pronounced tau-histopathology, including NFTs at this early age, while the pathology in sham-treated pR5 mice is moderate. Whereas experimental DM did not result in deposition of hyperphosphorylated tau in non-transgenic mice, a predisposition to develop a tau pathology in young pR5 mice was both sufficient and necessary to exacerbate tau deposition and NFT formation. Hence, DM can accelerate onset and increase severity of disease in individuals with a predisposition to developing tau pathology.			Ke, YD (corresponding author), Univ Sydney, Brain & Mind Res Inst, Alzheimers & Parkinsons Dis Lab, Sydney, NSW 2006, Australia.	Iittner@med.usyd.edu.au	Götz, Jürgen/C-2448-2014; Ke, Yazi/ABC-3052-2020	Götz, Jürgen/0000-0001-8501-7896; Ke, Yazi/0000-0002-1423-0451; Ittner, Lars/0000-0001-6738-3825; Delerue, Fabien/0000-0001-7944-2108				Am Diabetes Assoc, 2006, DIABETES CARE, V29, pS4; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Cairns NJ, 2007, ACTA NEUROPATHOL, V114, P5, DOI 10.1007/s00401-007-0237-2; Chen F, 2004, CURR DRUG TARGETS, V5, P503, DOI 10.2174/1389450043345236; CLAVAGUERA F, 2009, NAT CELL BIOL; Clodfelder-Miller BJ, 2006, DIABETES, V55, P3320, DOI 10.2337/db06-0485; Craft S, 1998, NEUROLOGY, V50, P164, DOI 10.1212/WNL.50.1.164; David DC, 2006, PROTEOMICS, V6, P6566, DOI 10.1002/pmic.200600634; Deters N, 2008, EUR J NEUROSCI, V28, P137, DOI 10.1111/j.1460-9568.2008.06318.x; Dickey C, 2009, AM J PATHOL, V174, P228, DOI 10.2353/ajpath.2009.080764; Ferrari A, 2003, J BIOL CHEM, V278, P40162, DOI 10.1074/jbc.M308243200; Frost B, 2009, J BIOL CHEM, V284, P3546, DOI 10.1074/jbc.M805627200; Gasparini L, 2002, TRENDS PHARMACOL SCI, V23, P288, DOI 10.1016/S0165-6147(02)02037-0; Gispen WH, 2000, TRENDS NEUROSCI, V23, P542, DOI 10.1016/S0166-2236(00)01656-8; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Gotz J, 2009, CELL MOL LIFE SCI, V66, P1321, DOI 10.1007/s00018-009-9070-1; Gotz J, 2004, MOL PSYCHIATR, V9, P664, DOI 10.1038/sj.mp.4001508; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; Gotz J, 2001, J BIOL CHEM, V276, P529, DOI 10.1074/jbc.M006531200; Gotz J, 2008, NAT REV NEUROSCI, V9, P532, DOI 10.1038/nrn2420; Hong M, 1997, J BIOL CHEM, V272, P19547, DOI 10.1074/jbc.272.31.19547; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Ittner LM, 2008, P NATL ACAD SCI USA, V105, P15997, DOI 10.1073/pnas.0808084105; Ittner LM, 2007, NAT PROTOC, V2, P1206, DOI 10.1038/nprot.2007.145; Ittner Lars M, 2005, J Biol, V4, P11, DOI 10.1186/jbiol29; Ittner LM, 2005, BIOCHEMISTRY-US, V44, P5749, DOI 10.1021/bi048111o; Jolivalt CG, 2008, J NEUROSCI RES, V86, P3265, DOI 10.1002/jnr.21787; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Mosconi Lisa, 2005, Eur J Nucl Med Mol Imaging, V32, P486, DOI 10.1007/s00259-005-1762-7; Pennanen L, 2006, GENES BRAIN BEHAV, V5, P369, DOI 10.1111/j.1601-183X.2005.00165.x; Planel E, 2007, J NEUROSCI, V27, P13635, DOI 10.1523/JNEUROSCI.3949-07.2007; Planel E, 2009, FASEB J, V23, P2595, DOI 10.1096/fj.08-122424; Probst A, 2000, ACTA NEUROPATHOL, V99, P469, DOI 10.1007/s004010051148; Rees DA, 2005, DIABETIC MED, V22, P359, DOI 10.1111/j.1464-5491.2005.01499.x; Rivera EJ, 2005, J ALZHEIMERS DIS, V8, P247; Selkoe DJ, 1997, SCIENCE, V275, P630, DOI 10.1126/science.275.5300.630; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P7737, DOI 10.1073/pnas.95.13.7737; van Eersel J, 2009, J NEURAL TRANSM, V116, P1243, DOI 10.1007/s00702-009-0293-y; Wang YP, 2007, P NATL ACAD SCI USA, V104, P10252, DOI 10.1073/pnas.0703676104; Wurdak H, 2005, GENE DEV, V19, P530, DOI 10.1101/gad.317405	40	146	151	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2009	4	11							e7917	10.1371/journal.pone.0007917	http://dx.doi.org/10.1371/journal.pone.0007917			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522NJ	19936237	gold, Green Published, Green Submitted			2022-12-25	WOS:000272004600019
J	Averette, KM; Pratt, MR; Yang, YA; Bassilian, S; Whitelegge, JP; Loo, JA; Muir, TW; Bradley, KA				Averette, Kathleen M.; Pratt, Matthew R.; Yang, Yanan; Bassilian, Sara; Whitelegge, Julian P.; Loo, Joseph A.; Muir, Tom W.; Bradley, Kenneth A.			Anthrax Lethal Toxin Induced Lysosomal Membrane Permeabilization and Cytosolic Cathepsin Release Is Nlrp1b/Nalp1b-Dependent	PLOS ONE			English	Article							INNATE IMMUNE-RESPONSE; NOD-LIKE RECEPTORS; CELL-DEATH; CASPASE-1 ACTIVATION; INDUCED APOPTOSIS; NALP3 INFLAMMASOME; TRANSCRIPTIONAL RESPONSES; MURINE MACROPHAGES; PROTEIN; PATHWAY	NOD-like receptors (NLRs) are a group of cytoplasmic molecules that recognize microbial invasion or 'danger signals'. Activation of NLRs can induce rapid caspase-1 dependent cell death termed pyroptosis, or a caspase-1 independent cell death termed pyronecrosis. Bacillus anthracis lethal toxin (LT), is recognized by a subset of alleles of the NLR protein Nlrp1b, resulting in pyroptotic cell death of macrophages and dendritic cells. Here we show that LT induces lysosomal membrane permeabilization (LMP). The presentation of LMP requires expression of an LT-responsive allele of Nlrp1b, and is blocked by proteasome inhibitors and heat shock, both of which prevent LT-mediated pyroptosis. Further the lysosomal protease cathepsin B is released into the cell cytosol and cathepsin inhibitors block LT-mediated cell death. These data reveal a role for lysosomal membrane permeabilization in the cellular response to bacterial pathogens and demonstrate a shared requirement for cytosolic relocalization of cathepsins in pyroptosis and pyronecrosis.			Averette, KM (corresponding author), Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA.	kbradley@microbio.ucla.edu	Muir, Tom/AHD-0860-2022	Muir, Tom/0000-0001-9635-0344	NATIONAL CANCER INSTITUTE [P30CA016042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057870, P30AI028697, T32AI007323, R56AI077791, R01AI077791] Funding Source: NIH RePORTER; NCI NIH HHS [CA16042, P30 CA016042] Funding Source: Medline; NIAID NIH HHS [R01 AI077791, AI077791, AI28697, R56 AI077791, R01 AI057870, AI057870, P30 AI028697, T32 AI007323] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alileche A, 2006, CELL CYCLE, V5, P100, DOI 10.4161/cc.5.1.2283; Artal-Sanz M, 2006, J CELL BIOL, V173, P231, DOI 10.1083/jcb.200511103; Bampton ETW, 2005, AUTOPHAGY, V1, P23, DOI 10.4161/auto.1.1.1495; Banks David J., 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406010714; Bardwell AJ, 2004, BIOCHEM J, V378, P569, DOI 10.1042/BJ20031382; BEALL FA, 1962, J BACTERIOL, V83, P1274, DOI 10.1128/JB.83.6.1274-1280.1962; Benchoua A, 2004, J CEREBR BLOOD F MET, V24, P1272, DOI 10.1097/01.WCB.0000140272.54583.FB; Bergman NH, 2005, INFECT IMMUN, V73, P1069, DOI 10.1128/IAI.73.2.1069-1080.2005; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Bivik C, 2007, CARCINOGENESIS, V28, P537, DOI 10.1093/carcin/bgl152; Blomgran R, 2007, J LEUKOCYTE BIOL, V81, P1213, DOI 10.1189/jlb.0506359; Boya P, 2008, ONCOGENE, V27, P6434, DOI 10.1038/onc.2008.310; Boyden ED, 2006, NAT GENET, V38, P240, DOI 10.1038/ng1724; Bradley KA, 2001, NATURE, V414, P225, DOI 10.1038/n35101999; Brunk UT, 1997, FREE RADICAL BIO MED, V23, P616, DOI 10.1016/S0891-5849(97)00007-5; Brunk UT, 2001, REDOX REP, V6, P91, DOI 10.1179/135100001101536094; Case CL, 2009, INFECT IMMUN, V77, P1981, DOI 10.1128/IAI.01382-08; Cervantes J, 2008, CELL MICROBIOL, V10, P41, DOI 10.1111/j.1462-5822.2007.01012.x; Chandra H, 2005, BBA-PROTEINS PROTEOM, V1747, P151, DOI 10.1016/j.bbapap.2004.10.012; Cheung NS, 2007, NEUROPHARMACOLOGY, V53, P505, DOI 10.1016/j.neuropharm.2007.06.014; Chopra AP, 2003, J BIOL CHEM, V278, P9402, DOI 10.1074/jbc.M211262200; Cirman T, 2004, J BIOL CHEM, V279, P3578, DOI 10.1074/jbc.M308347200; Comer JE, 2005, INFECT IMMUN, V73, P1879, DOI 10.1128/IAI.73.3.1879-1885.2005; Conus S, 2008, BIOCHEM PHARMACOL, V76, P1374, DOI 10.1016/j.bcp.2008.07.041; Cordoba-Rodriguez R, 2004, J BIOL CHEM, V279, P20563, DOI 10.1074/jbc.C300539200; De Milito A, 2007, CANCER RES, V67, P5408, DOI 10.1158/0008-5472.CAN-06-4095; Droga-Mazovec G, 2008, J BIOL CHEM, V283, P19140, DOI 10.1074/jbc.M802513200; Drysdale M, 2007, INFECT IMMUN, V75, P1757, DOI 10.1128/IAI.01712-06; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; Faustin B, 2007, MOL CELL, V25, P713, DOI 10.1016/j.molcel.2007.01.032; Fink SL, 2008, P NATL ACAD SCI USA, V105, P4312, DOI 10.1073/pnas.0707370105; Foghsgaard L, 2001, J CELL BIOL, V153, P999, DOI 10.1083/jcb.153.5.999; Franchi L, 2007, EUR J IMMUNOL, V37, P3030, DOI 10.1002/eji.200737532; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Franchi L, 2009, IMMUNOL REV, V227, P106, DOI 10.1111/j.1600-065X.2008.00734.x; Gehring U, 2004, EMBO REP, V5, P148, DOI 10.1038/sj.embor.7400083; Giammarioli AM, 2008, CANCER RES, V68, P5291, DOI 10.1158/0008-5472.CAN-08-0222; Gotoh T, 2004, CELL DEATH DIFFER, V11, P390, DOI 10.1038/sj.cdd.4401369; Gotoh T, 2001, CELL DEATH DIFFER, V8, P357, DOI 10.1038/sj.cdd.4400829; Guegan C, 2002, MOL CELL NEUROSCI, V20, P553, DOI 10.1006/mcne.2002.1136; Guicciardi ME, 2004, ONCOGENE, V23, P2881, DOI 10.1038/sj.onc.1207512; Gyrd-Hansen M, 2004, CELL CYCLE, V3, P1484, DOI 10.4161/cc.3.12.1287; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hammond SE, 1998, INFECT IMMUN, V66, P2374, DOI 10.1128/IAI.66.5.2374-2378.1998; Hayashi MAF, 2008, TOXICON, V52, P508, DOI 10.1016/j.toxicon.2008.06.029; Hentze H, 2003, CELL DEATH DIFFER, V10, P956, DOI 10.1038/sj.cdd.4401264; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Jaattela M, 2004, CELL DEATH DIFFER, V11, P135, DOI 10.1038/sj.cdd.4401333; Kagedal K, 2001, BIOCHEM J, V359, P335, DOI 10.1042/0264-6021:3590335; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Kim J, 2008, ARCH BIOCHEM BIOPHYS, V472, P58, DOI 10.1016/j.abb.2008.01.020; Kim R, 2005, CANCER BIOL THER, V4, P924, DOI 10.4161/cbt.4.9.2101; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Kuhn JF, 2006, ELECTROPHORESIS, V27, P1584, DOI 10.1002/elps.200500747; Labbe K, 2008, CELL DEATH DIFFER, V15, P1339, DOI 10.1038/cdd.2008.91; LEVIN TC, 2008, CELL MICROBIOL; Li N, 2007, CANCER RES, V67, P11176, DOI 10.1158/0008-5472.CAN-07-2333; Liton PB, 2008, INVEST OPHTH VIS SCI, V49, P3961, DOI 10.1167/iovs.08-1915; Maldonado-Arocho FJ, 2009, INFECT IMMUN, V77, P2036, DOI 10.1128/IAI.01329-08; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; MCINTIRE CR, 2009, INFLAMMASOMES INFECT; MILNE JC, 1994, J BIOL CHEM, V269, P20607; Muehlbauer SM, 2007, CELL CYCLE, V6, P758, DOI 10.4161/cc.6.6.3991; Newman ZL, 2009, INFECT IMMUN, V77, P4327, DOI 10.1128/IAI.00730-09; Nour AM, 2009, INFECT IMMUN, V77, P1262, DOI 10.1128/IAI.01032-08; Nylandsted J, 2004, J EXP MED, V200, P425, DOI 10.1084/jem.20040531; Pelegrin P, 2008, J IMMUNOL, V180, P7147, DOI 10.4049/jimmunol.180.11.7147; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Pratt MR, 2009, CHEM BIOL, V16, P1001, DOI 10.1016/j.chembiol.2009.07.011; Salles II, 2003, P NATL ACAD SCI USA, V100, P12426, DOI 10.1073/pnas.2134042100; Sandes E, 2007, INT J MOL MED, V20, P823; Sapra R, 2006, MICROB PATHOGENESIS, V41, P157, DOI 10.1016/j.micpath.2006.07.002; Scobie HM, 2003, P NATL ACAD SCI USA, V100, P5170, DOI 10.1073/pnas.0431098100; Shao W, 2007, J BIOL CHEM, V282, P36321, DOI 10.1074/jbc.M708182200; Shin S, 1999, CELL BIOL TOXICOL, V15, P19, DOI 10.1023/A:1007546505528; Squires RC, 2007, J BIOL CHEM, V282, P34260, DOI 10.1074/jbc.M705687200; Stankiewicz AR, 2005, J BIOL CHEM, V280, P38729, DOI 10.1074/jbc.M509497200; Suzuki T, 2007, PLOS PATHOG, V3, P1082, DOI 10.1371/journal.ppat.0030111; Syntichaki P, 2005, CURR BIOL, V15, P1249, DOI 10.1016/j.cub.2005.05.057; Tang GQ, 1999, INFECT IMMUN, V67, P3055, DOI 10.1128/IAI.67.6.3055-3060.1999; Ting JPY, 2008, NAT REV IMMUNOL, V8, P372, DOI 10.1038/nri2296; Tucker AE, 2003, CELL MICROBIOL, V5, P523, DOI 10.1046/j.1462-5822.2003.00298.x; Vitale G, 1998, BIOCHEM BIOPH RES CO, V248, P706, DOI 10.1006/bbrc.1998.9040; WEI YQ, 1995, CANCER IMMUNOL IMMUN, V40, P73, DOI 10.1007/s002620050146; WEI YQ, 1994, CANCER RES, V54, P4952; Werneburg NW, 2002, AM J PHYSIOL-GASTR L, V283, pG947, DOI 10.1152/ajpgi.00151.2002; Wickliffe KE, 2008, CELL MICROBIOL, V10, P332, DOI 10.1111/j.1462-5822.2007.01044.x; Windelborn JA, 2008, J NEUROCHEM, V106, P56, DOI 10.1111/j.1471-4159.2008.05349.x; Xu LX, 2008, J IMMUNOL, V180, P4139, DOI 10.4049/jimmunol.180.6.4139; Young JAT, 2007, ANNU REV BIOCHEM, V76, P243, DOI 10.1146/annurev.biochem.75.103004.142728; Yu HB, 2008, CELL HOST MICROBE, V4, P198, DOI 10.1016/j.chom.2008.08.007; Yuan XM, 2002, P NATL ACAD SCI USA, V99, P6286, DOI 10.1073/pnas.092135599; Zang Y, 2001, CELL DEATH DIFFER, V8, P477, DOI 10.1038/sj.cdd.4400843; Zeiss CJ, 2003, VET PATHOL, V40, P481, DOI 10.1354/vp.40-5-481; Zhao M, 2001, FEBS LETT, V509, P399, DOI 10.1016/S0014-5793(01)03184-2	98	43	44	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2009	4	11							e7913	10.1371/journal.pone.0007913	http://dx.doi.org/10.1371/journal.pone.0007913			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521QH	19924255	Green Published, Green Submitted, gold			2022-12-25	WOS:000271936700028
J	Prashar, V; Bihani, S; Das, A; Ferrer, JL; Hosur, M				Prashar, Vishal; Bihani, Subhash; Das, Amit; Ferrer, Jean-Luc; Hosur, Madhusoodan			Catalytic Water Co-Existing with a Product Peptide in the Active Site of HIV-1 Protease Revealed by X-Ray Structure Analysis	PLOS ONE			English	Article							IMMUNODEFICIENCY VIRUS-1 PROTEASE; BARRIER HYDROGEN-BOND; CRYSTAL-STRUCTURES; MECHANISM; COMPLEX; RESOLUTION; INHIBITOR; SUBSTRATE; CRYSTALLOGRAPHY; AIDS	Background: It is known that HIV-1 protease is an important target for design of antiviral compounds in the treatment of Acquired Immuno Deficiency Syndrome (AIDS). In this context, understanding the catalytic mechanism of the enzyme is of crucial importance as transition state structure directs inhibitor design. Most mechanistic proposals invoke nucleophilic attack on the scissile peptide bond by a water molecule. But such a water molecule coexisting with any ligand in the active site has not been found so far in the crystal structures. Principal Findings: We report here the first observation of the coexistence in the active site, of a water molecule WAT1, along with the carboxyl terminal product (Q product) peptide. The product peptide has been generated in situ through cleavage of the full-length substrate. The N-terminal product (P product) has diffused out and is replaced by a set of water molecules while the Q product is still held in the active site through hydrogen bonds. The position of WAT1, which hydrogen bonds to both the catalytic aspartates, is different from when there is no substrate bound in the active site. We propose WAT1 to be the position from where catalytic water attacks the scissile peptide bond. Comparison of structures of HIV-1 protease complexed with the same oligopeptide substrate, but at pH 2.0 and at pH 7.0 shows interesting changes in the conformation and hydrogen bonding interactions from the catalytic aspartates. Conclusions/Significance: The structure is suggestive of the repositioning, during substrate binding, of the catalytic water for activation and subsequent nucleophilic attack. The structure could be a snap shot of the enzyme active site primed for the next round of catalysis. This structure further suggests that to achieve the goal of designing inhibitors mimicking the transition-state, the hydrogen-bonding pattern between WAT1 and the enzyme should be replicated.			Prashar, V (corresponding author), Bhabha Atom Res Ctr, Div Solid State Phys, Bombay 400085, Maharashtra, India.	hosur@barc.gov.in	Bihani, Subhash Chandra/G-1255-2010	Bihani, Subhash Chandra/0000-0002-0724-4919; Hosur, Madhusoodan/0000-0003-1012-0906				Adachi M, 2009, P NATL ACAD SCI USA, V106, P4641, DOI 10.1073/pnas.0809400106; Anderson VE, 2006, CHEM REV, V106, P3236, DOI 10.1021/cr050281z; BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bihani S, 2009, PROTEINS, V74, P594, DOI 10.1002/prot.22174; Brik A, 2003, ORG BIOMOL CHEM, V1, P5, DOI 10.1039/b208248a; Brunger A.T., 2001, CRYSTALLOGRAPHY NMR; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHATFIELD DC, 1995, J AM CHEM SOC, V117, P5561, DOI 10.1021/ja00125a018; CHENG YSE, 1990, P NATL ACAD SCI USA, V87, P9660, DOI 10.1073/pnas.87.24.9660; Das A, 2006, P NATL ACAD SCI USA, V103, P18464, DOI 10.1073/pnas.0605809103; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dunn BM, 2002, CHEM REV, V102, P4431, DOI 10.1021/cr010167q; GALLO RC, 1984, SCIENCE, V224, P500, DOI 10.1126/science.6200936; Hine J, 1978, ADV PHYS ORG CHEM, V15, P1; HYLAND LJ, 1991, BIOCHEMISTRY-US, V30, P8454, DOI 10.1021/bi00098a024; HYLAND LJ, 1991, BIOCHEMISTRY-US, V30, P8441, DOI 10.1021/bi00098a023; JAMES MNG, 1992, BIOCHEMISTRY-US, V31, P3872, DOI 10.1021/bi00130a019; JASKOLSKI M, 1991, BIOCHEMISTRY-US, V30, P1600, DOI 10.1021/bi00220a023; Johnson ECB, 2007, J MOL BIOL, V373, P573, DOI 10.1016/j.jmb.2007.07.054; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KOHL NE, 1988, P NATL ACAD SCI USA, V85, P4686, DOI 10.1073/pnas.85.13.4686; Kovalevsky AY, 2007, BIOCHEMISTRY-US, V46, P14854, DOI 10.1021/bi700822g; Kumar M, 2005, BIOCHEM J, V389, P365, DOI 10.1042/BJ20041804; Kumar M, 2002, BIOCHEM BIOPH RES CO, V294, P395, DOI 10.1016/S0006-291X(02)00482-5; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Northrop DB, 2001, ACCOUNTS CHEM RES, V34, P790, DOI 10.1021/ar000184m; Okimoto N, 1999, J AM CHEM SOC, V121, P7349, DOI 10.1021/ja9841106; Piana S, 2004, J PHYS CHEM B, V108, P11139, DOI 10.1021/jp037651c; Pillai B, 2001, PROTEINS, V43, P57, DOI 10.1002/1097-0134(20010401)43:1<57::AID-PROT1017>3.0.CO;2-D; Prabu-Jeyabalan M, 2002, STRUCTURE, V10, P369, DOI 10.1016/S0969-2126(02)00720-7; Rose RB, 1996, BIOCHEMISTRY-US, V35, P12933, DOI 10.1021/bi9612733; Roth M, 2002, ACTA CRYSTALLOGR D, V58, P805, DOI 10.1107/S0907444902003943; Sepkowitz KA, 2001, NEW ENGL J MED, V344, P1764, DOI 10.1056/NEJM200106073442306; Silva AM, 1996, J MOL BIOL, V255, P321, DOI 10.1006/jmbi.1996.0026; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Torbeev VY, 2008, BIOORG MED CHEM LETT, V18, P4554, DOI 10.1016/j.bmcl.2008.07.039; Trylska J, 2004, PROTEIN SCI, V13, P513, DOI 10.1110/ps.03372304; Tyndall JDA, 2008, BIOCHEMISTRY-US, V47, P3736, DOI 10.1021/bi7023157; YUNFENG T, 2004, J MOL BIOL, V338, P341	42	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2009	4	11							e7860	10.1371/journal.pone.0007860	http://dx.doi.org/10.1371/journal.pone.0007860			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520OG	19924250	gold, Green Published, Green Submitted			2022-12-25	WOS:000271854200008
J	Owczarek, S; Kiryushko, D; Larsen, MH; Kastrup, JS; Gajhede, M; Sandi, C; Berezin, V; Bock, E; Soroka, V				Owczarek, Sylwia; Kiryushko, Darya; Larsen, Marianne Hald; Kastrup, Jette Sandholm; Gajhede, Michael; Sandi, Carmen; Berezin, Vladimir; Bock, Elisabeth; Soroka, Vladislav			Neuroplastin-55 binds to and signals through the fibroblast growth factor receptor	FASEB JOURNAL			English	Article						hippocampal; cell adhesion molecule; mimetic peptide; synaptic plasticity	CELL-ADHESION MOLECULE; LONG-TERM POTENTIATION; IMMUNOGLOBULIN-SUPERFAMILY MEMBERS; SYNAPTIC GLYCOPROTEIN NEUROPLASTIN; SYNTHETIC PEPTIDE LIGAND; FGF-RECEPTOR; NEURITE OUTGROWTH; CRYSTAL-STRUCTURE; PRESYNAPTIC FUNCTION; HOMOPHILIC ADHESION	Neuroplastin (Np) is a glycoprotein belonging to the immunoglobulin superfamily of cell adhesion molecules (CAMs) and existing in two isoforms, Np55 and Np65, named according to their molecular weights. The extracellular part of Np65 contains three immunoglobulin (Ig)-like modules (Ig1, Ig2, and Ig3), whereas Np55 lacks the Ig1 module. Of these two isoforms, only Np65 is involved in homophilic interactions resulting in cell adhesion, whereas the role of Np55 is poorly understood. The present study reports for the first time the crystal structure of the ectodomain of Np55 at 1.95-angstrom resolution and demonstrates that Np55 binds to and activates the fibroblast growth factor receptor 1 (FGFR1). Furthermore, we identify a sequence motif in the Ig2 module of Np55 interacting with FGFR1 and show that a synthetic peptide encompassing this motif, termed narpin, binds to and activates FGFR1. We show that both Np55 and the narpin peptide induce neurite outgrowth through FGFR1 activation and that Np55 increases synaptic calcium concentration in an FGFR1-dependent manner. Moreover, we demonstrate that narpin has an antidepressive-like effect in rats subjected to the forced swim test, suggesting that Np55-induced signaling may be involved in synaptic plasticity in vivo. Owczarek, S., Kiryushko, D., Larsen, M. H., Kastrup, J. S., Gajhede, M., Sandi, C., Berezin, V., Bock, E., Soroka, V. Neuroplastin-55 binds to and signals through the fibroblast growth factor receptor. FASEB J. 24, 1139-1150 (2010). www.fasebj.org	[Owczarek, Sylwia] Univ Copenhagen, Panum Inst, Dept Neurosci & Pharmacol, Prot Lab, DK-2200 Copenhagen, Denmark; [Kastrup, Jette Sandholm; Gajhede, Michael] Univ Copenhagen, Fac Pharmaceut Sci, Dept Med Chem, DK-2200 Copenhagen, Denmark; [Larsen, Marianne Hald; Sandi, Carmen] Ecole Polytech Fed Lausanne, Brain Mind Inst, Lausanne, Switzerland; [Soroka, Vladislav] Enkam Pharmaceut AS, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Owczarek, S (corresponding author), Univ Copenhagen, Panum Inst, Dept Neurosci & Pharmacol, Prot Lab, Blegdamsvej 3C,Bldg 24-2, DK-2200 Copenhagen, Denmark.	sylwia@sund.ku.dk		Kastrup, Jette Sandholm/0000-0003-2654-1510; Gajhede, Michael/0000-0001-9864-2287; Sandi, Carmen/0000-0001-7713-8321	Seventh Framework Programme (FP7) [HEALTH-F2M-2007201600]; Swiss National Science Foundation [3100A0-108102]; Alfred Benzon Foundation (Denmark), Neurocluster; Copenhagen University; Lundbeck Foundation; Danish Research Councils	Seventh Framework Programme (FP7)(European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Alfred Benzon Foundation (Denmark), Neurocluster; Copenhagen University; Lundbeck Foundation(Lundbeckfonden); Danish Research Councils(Det Frie Forskningsrad (DFF))	The authors thank Gregoire Parchet and beamline scientists at the European Molecular Biology Laboratory (DESY, Hamburg, Germany) and ESRF (Grenoble, France) for skillful technical assistance. This study was supported by a Seventh Framework Programme (FP7) grant (HEALTH- F2M-2007201600; MemStick to C.S.), the Swiss National Science Foundation (3100A0-108102), the Alfred Benzon Foundation (Denmark), Neurocluster, Copenhagen University, the Lundbeck Foundation, and the Danish Research Councils.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aonurm-Helm A, 2008, EUR J NEUROSCI, V28, P1618, DOI 10.1111/j.1460-9568.2008.06471.x; Archer FR, 1999, EUR J NEUROSCI, V11, P3565, DOI 10.1046/j.1460-9568.1999.00773.x; Belton RJ, 2008, J BIOL CHEM, V283, P17805, DOI 10.1074/jbc.M801876200; Bernstein HG, 2007, BRAIN RES, V1134, P107, DOI 10.1016/j.brainres.2006.11.090; Bukalo O, 2004, J NEUROSCI, V24, P1565, DOI 10.1523/JNEUROSCI.3298-03.2004; Cambon K, 2004, J NEUROSCI, V24, P4197, DOI 10.1523/JNEUROSCI.0436-04.2004; Casasnovas JM, 1998, P NATL ACAD SCI USA, V95, P4134, DOI 10.1073/pnas.95.8.4134; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Einat H, 2003, J NEUROSCI, V23, P7311; Empson RM, 2006, J NEUROCHEM, V99, P850, DOI 10.1111/j.1471-4159.2006.04123.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans SJ, 2004, P NATL ACAD SCI USA, V101, P15506, DOI 10.1073/pnas.0406788101; Garcia-Maya M, 2006, J CELL PHYSIOL, V206, P386, DOI 10.1002/jcp.20483; Hansen SM, 2008, CELL MOL LIFE SCI, V65, P3809, DOI 10.1007/s00018-008-8290-0; Jacobsen J, 2008, NEUROCHEM RES, V33, P2532, DOI 10.1007/s11064-008-9680-2; Juliano RL, 2002, ANNU REV PHARMACOL, V42, P283, DOI 10.1146/annurev.pharmtox.42.090401.151133; Kiryushko D, 2006, MOL BIOL CELL, V17, P2278, DOI 10.1091/mbc.E05-10-0987; Kiryushko D, 2003, J BIOL CHEM, V278, P12325, DOI 10.1074/jbc.M211628200; Kiselyov VV, 2006, PROTEIN SCI, V15, P2318, DOI 10.1110/ps.062206106; Kiselyov VV, 2003, STRUCTURE, V11, P691, DOI 10.1016/S0969-2126(03)00096-0; Kleywegt GJ, 1996, STRUCTURE, V4, P1395, DOI 10.1016/S0969-2126(96)00147-5; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kulahin N, 2008, MOL CELL NEUROSCI, V37, P528, DOI 10.1016/j.mcn.2007.12.001; Langnaese K, 1998, FEBS LETT, V429, P284, DOI 10.1016/S0014-5793(98)00616-4; Langnaese K, 1997, J BIOL CHEM, V272, P821, DOI 10.1074/jbc.272.2.821; Laskowski RA, 2009, NUCLEIC ACIDS RES, V37, pD355, DOI 10.1093/nar/gkn860; LUTHL A, 1994, NATURE, V22, P777; Marzban H, 2003, J COMP NEUROL, V462, P286, DOI 10.1002/cne.10719; Mohammadi M, 2005, CYTOKINE GROWTH F R, V16, P107, DOI 10.1016/j.cytogfr.2005.01.008; Neiiendam JL, 2004, J NEUROCHEM, V91, P920, DOI 10.1111/j.1471-4159.2004.02779.x; Olsen SK, 2004, P NATL ACAD SCI USA, V101, P935, DOI 10.1073/pnas.0307287101; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PORSOLT RD, 1978, EUR J PHARMACOL, V47, P379, DOI 10.1016/0014-2999(78)90118-8; Porter NM, 1997, J NEUROSCI, V17, P5629; Powell HR, 1999, ACTA CRYSTALLOGR D, V55, P1690, DOI 10.1107/S0907444999009506; Reuss B, 2003, CELL TISSUE RES, V313, P139, DOI 10.1007/s00441-003-0756-7; Ronn LCB, 2000, J NEUROCHEM, V75, P665, DOI 10.1046/j.1471-4159.2000.0750665.x; Rosenthal R, 2001, FASEB J, V15, P970, DOI 10.1096/fj.00-0188com; Saffell JL, 1997, NEURON, V18, P231, DOI 10.1016/S0896-6273(00)80264-0; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Smalla KH, 2000, P NATL ACAD SCI USA, V97, P4327, DOI 10.1073/pnas.080389297; Soroka V, 2003, STRUCTURE, V11, P1291, DOI 10.1016/j.str.2003.09.006; Tang LX, 1998, NEURON, V20, P1165, DOI 10.1016/S0896-6273(00)80497-3; TSANG M, 2004, SCI STKE, V228, P17; Turner CA, 2008, BRAIN RES, V1224, P63, DOI 10.1016/j.brainres.2008.05.088; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Wong ESM, 2002, EMBO J, V21, P4796, DOI 10.1093/emboj/cdf493; Xing J, 1998, MOL CELL BIOL, V18, P1946, DOI 10.1128/MCB.18.4.1946; Yu XL, 2008, J BIOL CHEM, V283, P18056, DOI 10.1074/jbc.M802694200; Yurchenko V, 2006, IMMUNOLOGY, V117, P301, DOI 10.1111/j.1365-2567.2005.02316.x	54	41	43	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	APR	2010	24	4					1139	1150		10.1096/fj.09-140509	http://dx.doi.org/10.1096/fj.09-140509			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	580PV	19952283				2022-12-25	WOS:000276462300021
J	Lenferink, AEG; Cantin, C; Nantel, A; Wang, E; Durocher, Y; Banville, M; Paul-Roc, B; Marcil, A; Wilson, MR; O'Connor-McCourt, MD				Lenferink, A. E. G.; Cantin, C.; Nantel, A.; Wang, E.; Durocher, Y.; Banville, M.; Paul-Roc, B.; Marcil, A.; Wilson, M. R.; O'Connor-McCourt, M. D.			Transcriptome profiling of a TGF-beta-induced epithelial-to-mesenchymal transition reveals extracellular clusterin as a target for therapeutic antibodies	ONCOGENE			English	Article						TGF-beta; clusterin; EMT; invasion; breast cancer	GROWTH-FACTOR-BETA; BREAST-CANCER METASTASIS; NECROSIS-FACTOR-ALPHA; RENAL-CELL CARCINOMA; MOUSE MAMMARY-TUMOR; RETE TESTIS FLUID; PROSTATE-CANCER; GENE-EXPRESSION; CLUSTERIN/APOLIPOPROTEIN-J; ANTISENSE OLIGONUCLEOTIDE	Transforming growth factor (TGF)-beta plays a dual role in tumorigenesis, switching from acting as a growth inhibitory tumor suppressor early in the process, to a tumor promoter in late-stage disease. Since TGF-beta's prometastatic role may be linked to its ability to induce tumor cell epithelial-to-mesenchymal transition (EMT), we explored TGF-beta's EMT-promoting pathways by analysing the transcriptome changes occurring in BRI-JM01 mammary tumor epithelial cells undergoing a TGF-beta-induced EMT. We found the clusterin gene to be the most highly upregulated throughout most of the TGF-beta time course, and showed that this results in an increase of the secreted form of clusterin. By monitoring several hallmark features of EMT, we demonstrated that antibodies targeting secreted clusterin inhibit the TGF-beta-induced EMT of BRI-JM01 cells, as well as the invasive phenotype of several other breast and prostate tumor cell lines (4T1, NMuMG, MDA-MB231LM2 and PC3), without affecting the proliferation of these cells. These results indicate that secreted clusterin is a functionally important EMT mediator that lies downstream within TGF-beta's EMT-promoting transcriptional cascade, but not within its growth-inhibitory pathways. To further investigate the role played by secreted clusterin in tumor metastasis, we assessed the effect of several anti-clusterin monoclonal antibodies in vivo using a 4T1 syngeneic mouse breast cancer model and found that these antibodies significantly reduce lung metastasis. Taken together, our results reveal a role for secreted clusterin as an important extracellular promoter of EMT, and suggest that antibodies targeting clusterin may inhibit tumor metastasis without reducing the beneficial growth inhibitory effects of TGF-beta. Oncogene (2010) 29, 831-844; doi:10.1038/onc.2009.399; published online 23 November 2009	[Lenferink, A. E. G.; Cantin, C.; Banville, M.; Paul-Roc, B.; O'Connor-McCourt, M. D.] Natl Res Council Canada, Receptor Signaling & Prote Grp, Biotechnol Res Inst, Montreal, PQ H4P 2R2, Canada; [Nantel, A.; Marcil, A.] Natl Res Council Canada, Biotechnol Res Inst, Genet Grp, Montreal, PQ H4P 2R2, Canada; [Wang, E.] Natl Res Council Canada, Biotechnol Res Inst, Computat Chem & Biol Grp, Montreal, PQ H4P 2R2, Canada; [Durocher, Y.] Natl Res Council Canada, Biotechnol Res Inst, Anim Cell Culture Technol Grp, Montreal, PQ H4P 2R2, Canada; [Wilson, M. R.] Univ Wollongong, Sch Biol Sci, Wollongong, NSW, Australia	National Research Council Canada; National Research Council Canada; National Research Council Canada; National Research Council Canada; University of Wollongong	Lenferink, AEG (corresponding author), Natl Res Council Canada, Receptor Signaling & Prote Grp, Biotechnol Res Inst, 6100 Royalmount Ave, Montreal, PQ H4P 2R2, Canada.	anne.lenferink@cnrc-nrc.gc.ca	Wilson, Mark R/B-3254-2018; Wang, Edwin/Y-1553-2019; Durocher, Yves/K-8709-2019	Wilson, Mark R/0000-0002-9551-7445; Marcil, Anne/0000-0002-4111-1781				Al Moustafa AE, 1999, BIOTECHNIQUES, V27, P60; Ammar H, 2008, J BIOL CHEM, V283, P12851, DOI 10.1074/jbc.M800403200; Andersen CL, 2007, MOL CELL PROTEOMICS, V6, P1039, DOI 10.1074/mcp.M600261-MCP200; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Bates RC, 2003, MOL BIOL CELL, V14, P1790, DOI 10.1091/mbc.E02-09-0583; BLASCHUK O, 1983, J BIOL CHEM, V258, P7714; Brabletz T, 2001, P NATL ACAD SCI USA, V98, P10356, DOI 10.1073/pnas.171610498; Buijs JT, 2007, CLIN EXP METASTAS, V24, P609, DOI 10.1007/s10585-007-9118-2; Buijs JT, 2007, CANCER RES, V67, P8742, DOI 10.1158/0008-5472.CAN-06-2490; Chi KN, 2005, J NATL CANCER I, V97, P1287, DOI 10.1093/jnci/dji252; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Chou TY, 2009, CELL SIGNAL, V21, P704, DOI 10.1016/j.cellsig.2009.01.008; Cochrane DR, 2007, J BIOL CHEM, V282, P2278, DOI 10.1074/jbc.M608162200; DALAL BI, 1993, AM J PATHOL, V143, P381; Dumon N, 2003, J BIOL CHEM, V278, P3275, DOI 10.1074/jbc.M204623200; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Enjalbert B, 2003, MOL BIOL CELL, V14, P1460, DOI 10.1091/mbc.E02-08-0546; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; FRITZ IB, 1983, BIOL REPROD, V28, P1173, DOI 10.1095/biolreprod28.5.1173; Gleave ME, 2001, UROLOGY, V58, P39, DOI 10.1016/S0090-4295(01)01241-9; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Hay ED, 2005, DEV DYNAM, V233, P706, DOI 10.1002/dvdy.20345; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; Humphreys DT, 1999, J BIOL CHEM, V274, P6875, DOI 10.1074/jbc.274.11.6875; Hunakova L, 2009, NEOPLASMA, V56, P548, DOI 10.4149/neo_2009_06_548; Jin G, 1997, J BIOL CHEM, V272, P26620, DOI 10.1074/jbc.272.42.26620; Jin G, 1999, EUR J BIOCHEM, V263, P534, DOI 10.1046/j.1432-1327.1999.00533.x; Jo H, 2008, MOL CELL BIOL, V28, P4285, DOI 10.1128/MCB.01240-07; Jo M, 2009, J BIOL CHEM, V284, P22825, DOI 10.1074/jbc.M109.023960; Lakins JN, 2002, BIOCHEMISTRY-US, V41, P282, DOI 10.1021/bi0157666; Lau SH, 2006, ONCOGENE, V25, P1242, DOI 10.1038/sj.onc.1209141; Lee KB, 2008, BIOCHEM BIOPH RES CO, V366, P905, DOI 10.1016/j.bbrc.2007.12.033; Lelekakis M, 1999, CLIN EXP METASTAS, V17, P163, DOI 10.1023/A:1006689719505; Lenferink AE, 2004, BREAST CANCER RES, V6, pR514, DOI 10.1186/bcr907; Leskov KS, 2003, J BIOL CHEM, V278, P11590, DOI 10.1074/jbc.M209233200; Lou YM, 2008, DEV DYNAM, V237, P2755, DOI 10.1002/dvdy.21658; MATSUBARA M, 1991, INVEST OPHTH VIS SCI, V32, P3221; MATSUBARA M, 1991, DEV BIOL, V147, P425, DOI 10.1016/0012-1606(91)90300-R; MIETTINEN PJ, 1994, J CELL BIOL, V127, P2021, DOI 10.1083/jcb.127.6.2021; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Miyake H, 2000, CANCER RES, V60, P2547; Miyake H, 2002, J UROLOGY, V167, P2203, DOI 10.1016/S0022-5347(05)65129-4; Miyake H, 2002, J UROLOGY, V167, P703, DOI 10.1016/S0022-5347(01)69130-4; Moretti RM, 2007, CANCER RES, V67, P10325, DOI 10.1158/0008-5472.CAN-07-0516; Moustakas A, 2007, CANCER SCI, V98, P1512, DOI 10.1111/j.1349-7006.2007.00550.x; Nam JS, 2008, CANCER RES, V68, P3915, DOI 10.1158/0008-5472.CAN-08-0206; Nam JS, 2006, CANCER RES, V66, P6327, DOI 10.1158/0008-5472.CAN-06-0068; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nguyen DX, 2007, NAT REV GENET, V8, P341, DOI 10.1038/nrg2101; Oft M, 1996, GENE DEV, V10, P2462, DOI 10.1101/gad.10.19.2462; Pardali K, 2007, BBA-REV CANCER, V1775, P21, DOI 10.1016/j.bbcan.2006.06.004; Park DC, 2008, NEOPLASIA, V10, P964, DOI 10.1593/neo.08604; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Poon S, 2002, FEBS LETT, V513, P259, DOI 10.1016/S0014-5793(02)02326-8; Reddy KB, 1996, BIOCHEMISTRY-US, V35, P309, DOI 10.1021/bi951880a; Redondo M, 2000, AM J PATHOL, V157, P393, DOI 10.1016/S0002-9440(10)64552-X; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Santilli G, 2003, J BIOL CHEM, V278, P38214, DOI 10.1074/jbc.C300252200; Scaltriti M, 2004, BRIT J CANCER, V91, P1842, DOI 10.1038/sj.bjc.6602193; Scheel C, 2007, CANCER RES, V67, P11476, DOI 10.1158/0008-5472.CAN-07-1653; Shannan B, 2006, CELL DEATH DIFFER, V13, P12, DOI 10.1038/sj.cdd.4401779; Shook D, 2003, MECH DEVELOP, V120, P1351, DOI 10.1016/j.mod.2003.06.005; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Sintich SM, 1999, PROSTATE, V39, P87; So A, 2005, MOL CANCER THER, V4, P1837, DOI 10.1158/1535-7163.MCT-05-0178; So A, 2005, CURR OPIN UROL, V15, P320, DOI 10.1097/01.mou.0000175572.46986.2c; So A, 2005, WORLD J UROL, V23, P1, DOI 10.1007/s00345-004-0473-1; Steinberg J, 1997, CLIN CANCER RES, V3, P1707; Tarin D, 2005, CANCER RES, V65, P5996, DOI 10.1158/0008-5472.CAN-05-0699; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; THOMPSON EW, 1992, J CELL PHYSIOL, V150, P534, DOI 10.1002/jcp.1041500314; TOM R, 2007, METHODS EXPRESS EXPR, P203; Trougakos IP, 2009, CANCER RES, V69, P403, DOI 10.1158/0008-5472.CAN-08-2912; Trougakos IP, 2002, INT J BIOCHEM CELL B, V34, P1430, DOI 10.1016/S1357-2725(02)00041-9; Trougakos IP, 2005, FREE RADICAL BIO MED, V38, P436, DOI 10.1016/j.freeradbiomed.2004.10.038; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Valcourt U, 2005, MOL BIOL CELL, V16, P1987, DOI 10.1091/mbc.e04-08-0658; Wakefield LM, 2002, CURR OPIN GENET DEV, V12, P22, DOI 10.1016/S0959-437X(01)00259-3; Wegrowski Y, 1999, EXP CELL RES, V247, P475, DOI 10.1006/excr.1998.4378; WILSON MR, 1992, BIOCHIM BIOPHYS ACTA, V1159, P319, DOI 10.1016/0167-4838(92)90062-I; Wilson MR, 2000, TRENDS BIOCHEM SCI, V25, P95, DOI 10.1016/S0968-0004(99)01534-0; Xie L, 2003, BREAST CANCER RES, V5, pR187, DOI 10.1186/bcr640; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691; Yu L, 2002, EMBO J, V21, P3749, DOI 10.1093/emboj/cdf366; Zellweger T, 2001, J PHARMACOL EXP THER, V298, P934	87	75	86	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	FEB 11	2010	29	6					831	844		10.1038/onc.2009.399	http://dx.doi.org/10.1038/onc.2009.399			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	553WP	19935703				2022-12-25	WOS:000274397800006
J	Basi, GS; Feinberg, H; Oshidari, F; Anderson, J; Barbour, R; Baker, J; Comery, TA; Diep, L; Gill, D; Johnson-Wood, K; Goel, A; Grantcharova, K; Lee, M; Li, JZ; Partridge, A; Griswold-Prenner, I; Piot, N; Walker, D; Widom, A; Pangalos, MN; Seubert, P; Jacobsen, JS; Schenk, D; Weis, WI				Basi, Guriqbal S.; Feinberg, Hadar; Oshidari, Farshid; Anderson, John; Barbour, Robin; Baker, Jeanne; Comery, Thomas A.; Diep, Linnea; Gill, Davinder; Johnson-Wood, Kelly; Goel, Amita; Grantcharova, Katerina; Lee, Mike; Li, Jingzhi; Partridge, Anthony; Griswold-Prenner, Irene; Piot, Nicolas; Walker, Don; Widom, Angela; Pangalos, Menelas N.; Seubert, Peter; Jacobsen, J. Steven; Schenk, Dale; Weis, William I.			Structural Correlates of Antibodies Associated with Acute Reversal of Amyloid beta-related Behavioral Deficits in a Mouse Model of Alzheimer Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A-BETA; MOLECULAR-BASIS; PASSIVE IMMUNOTHERAPY; LEARNING-DEFICITS; COGNITIVE DECLINE; KINETIC-ANALYSIS; MEMORY DEFICITS; TRANSGENIC MICE; PEPTIDE; IMMUNIZATION	Immunotherapy targeting of amyloid beta (A beta) peptide in transgenic mouse models of Alzheimer disease (AD) has been widely demonstrated to resolve amyloid deposition as well as associated neuronal, glial, and inflammatory pathologies. These successes have provided the basis for ongoing clinical trials of immunotherapy for treatment of AD in humans. Acute as well as chronic A beta-targeted immunotherapy has also been demonstrated to reverse A beta-related behavioral deficits assessing memory in AD transgenic mouse models. We observe that three antibodies targeting the same linear epitope of A beta, A beta(3-7), differ in their ability to reverse contextual fear deficits in Tg2576 mice in an acute testing paradigm. Reversal of contextual fear deficit by the antibodies does not correlate with in vitro recognition of A beta in a consistent or correlative manner. To better define differences in antigen recognition at the atomic level, we determined crystal structures of Fab fragments in complex with A beta. The conformation of the A beta peptide recognized by all three antibodies was highly related and is also remarkably similar to that observed in independently reported A beta: antibody crystal structures. Sequence and structural differences between the antibodies, particularly in CDR3 of the heavy chain variable region, are proposed to account for differing in vivo properties of the antibodies under study. These findings provide a structural basis for immunotherapeutic strategies targeting A beta species postulated to underlie cognitive deficits in AD.	[Basi, Guriqbal S.; Oshidari, Farshid; Anderson, John; Barbour, Robin; Baker, Jeanne; Diep, Linnea; Johnson-Wood, Kelly; Goel, Amita; Grantcharova, Katerina; Lee, Mike; Partridge, Anthony; Griswold-Prenner, Irene; Piot, Nicolas; Walker, Don; Seubert, Peter; Schenk, Dale] Elan Pharmaceut Inc, San Francisco, CA 94080 USA; [Barbour, Robin; Baker, Jeanne; Seubert, Peter; Schenk, Dale] Janssen Alzheimers Immunotherapy Res & Dev, San Francisco, CA 94080 USA; [Feinberg, Hadar; Li, Jingzhi; Weis, William I.] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; [Feinberg, Hadar; Li, Jingzhi; Weis, William I.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Comery, Thomas A.; Pangalos, Menelas N.; Jacobsen, J. Steven] Wyeth Res, Discovery Neurosci, Princeton, NJ 08543 USA; [Gill, Davinder; Widom, Angela] Wyeth Res, Biol Technol, Cambridge, MA 02140 USA	Johnson & Johnson; Johnson & Johnson USA; Stanford University; Stanford University; Pfizer; Pfizer	Basi, GS (corresponding author), Elan Pharmaceut Inc, 700 Gateway Blvd, San Francisco, CA 94080 USA.	guriq.basi@elan.com	Weis, William I/G-1437-2011	Weis, William I/0000-0002-5583-6150				Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Backskai BJ, 2001, NAT MED, V7, P369, DOI 10.1038/85525; Bacskai BJ, 2002, J NEUROSCI, V22, P7873; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Bard F, 2003, P NATL ACAD SCI USA, V100, P2023, DOI 10.1073/pnas.0436286100; Bayer AJ, 2005, NEUROLOGY, V64, P94, DOI 10.1212/01.WNL.0000148604.77591.67; Bombois S, 2007, ARCH NEUROL-CHICAGO, V64, P583, DOI 10.1001/archneur.64.4.583; Brody DL, 2008, ANNU REV NEUROSCI, V31, P175, DOI 10.1146/annurev.neuro.31.060407.125529; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen GQ, 2007, J NEUROSCI, V27, P2654, DOI 10.1523/JNEUROSCI.3710-06.2007; Cheng IH, 2007, J BIOL CHEM, V282, P23818, DOI 10.1074/jbc.M701078200; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Comery TA, 2005, J NEUROSCI, V25, P8898, DOI 10.1523/JNEUROSCI.2693-05.2005; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; Dineley KT, 2002, J BIOL CHEM, V277, P22768, DOI 10.1074/jbc.M200164200; Dodart JC, 2002, NAT NEUROSCI, V5, P452, DOI 10.1038/nn842; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; Gardberg AS, 2007, P NATL ACAD SCI USA, V104, P15659, DOI 10.1073/pnas.0705888104; Gilman S, 2005, NEUROLOGY, V64, P1553, DOI 10.1212/01.WNL.0000159740.16984.3C; Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100; Hartman RE, 2005, J NEUROSCI, V25, P6213, DOI 10.1523/JNEUROSCI.0664-05.2005; Hock C, 2003, NEURON, V38, P547, DOI 10.1016/S0896-6273(03)00294-0; Holmes C, 2008, LANCET, V372, P216, DOI 10.1016/S0140-6736(08)61075-2; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Jacobsen JS, 2006, P NATL ACAD SCI USA, V103, P5161, DOI 10.1073/pnas.0600948103; Janus C, 2000, NATURE, V408, P979, DOI 10.1038/35050110; Jogl G, 2001, ACTA CRYSTALLOGR D, V57, P1127, DOI 10.1107/S0907444901006783; JONES ST, 1991, BIO-TECHNOL, V9, P88, DOI 10.1038/nbt0191-88; KARLSSON R, 1991, J IMMUNOL METHODS, V145, P229, DOI 10.1016/0022-1759(91)90331-9; Karlsson R, 1997, J IMMUNOL METHODS, V200, P121, DOI 10.1016/S0022-1759(96)00195-0; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kobayashi DT, 2005, GENES BRAIN BEHAV, V4, P173, DOI 10.1111/j.1601-183X.2005.00124.x; Kotilinek LA, 2002, J NEUROSCI, V22, P6331; Kuo YM, 1997, BIOCHEM BIOPH RES CO, V237, P188, DOI 10.1006/bbrc.1997.7083; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; Lee M, 2005, ANN NEUROL, V58, P430, DOI 10.1002/ana.20592; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Masliah E, 2005, NEUROLOGY, V64, P129, DOI 10.1212/01.WNL.0000148590.39911.DF; Miles LA, 2008, J MOL BIOL, V377, P181, DOI 10.1016/j.jmb.2007.12.036; Morgan D, 2000, NATURE, V408, P982, DOI 10.1038/35050116; Myszyka DG, 1999, J MOL RECOGNIT, V12, P279, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<279::AID-JMR473>3.0.CO;2-3; Nemazee D, 2006, NAT REV IMMUNOL, V6, P728, DOI 10.1038/nri1939; Nicoll JAR, 2006, J NEUROPATH EXP NEUR, V65, P1040, DOI 10.1097/01.jnen.0000240466.10758.ce; Nicoll JAR, 2003, NAT MED, V9, P448, DOI 10.1038/nm840; Oddo S, 2006, J BIOL CHEM, V281, P39413, DOI 10.1074/jbc.M608485200; ROHER AE, 1993, J BIOL CHEM, V268, P3072; Schenk D, 2004, CURR OPIN IMMUNOL, V16, P599, DOI 10.1016/j.coi.2004.07.012; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Shimizu T, 2000, ARCH BIOCHEM BIOPHYS, V381, P225, DOI 10.1006/abbi.2000.1955; Townsend M, 2006, J PHYSIOL-LONDON, V572, P477, DOI 10.1113/jphysiol.2005.103754; Walsh DM, 2004, NEURON, V44, P181, DOI 10.1016/j.neuron.2004.09.010; Walsh DM, 2000, BIOCHEMISTRY-US, V39, P10831, DOI 10.1021/bi001048s; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Westerman MA, 2002, J NEUROSCI, V22, P1858, DOI 10.1523/JNEUROSCI.22-05-01858.2002; Wilcock DM, 2003, J NEUROSCI, V23, P3745, DOI 10.1523/jneurosci.23-09-03745.2003; Zirah S, 2006, J BIOL CHEM, V281, P2151, DOI 10.1074/jbc.M504454200	60	37	43	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5					3417	3427		10.1074/jbc.M109.045187	http://dx.doi.org/10.1074/jbc.M109.045187			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19923222	Green Published, hybrid			2022-12-25	WOS:000273829000056
J	Choe, KS; Ujhelly, O; Wontakal, SN; Skoultchi, AI				Choe, Kevin S.; Ujhelly, Olga; Wontakal, Sandeep N.; Skoultchi, Arthur I.			PU.1 Directly Regulates cdk6 Gene Expression, Linking the Cell Proliferation and Differentiation Programs in Erythroid Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR PU.1; CYCLIN-DEPENDENT KINASES; TERMINAL DIFFERENTIATION; ERYTHROLEUKEMIA-CELLS; C-MYC; DEREGULATED EXPRESSION; C/EBP-ALPHA; GATA-1; MACROPHAGE; BINDING	Cell proliferation and differentiation are highly coordinated processes during normal development. Most leukemia cells are blocked from undergoing terminal differentiation and also exhibit uncontrolled proliferation. Dysregulated expression of transcription factor PU.1 is strongly associated with Friend virus-induced erythroleukemia. PU.1 inhibits erythroid differentiation by binding to and inhibiting GATA-1. PU.1 also may be involved in controlling proliferation of erythroid cells. We reported previously that the G(1) phase-specific cyclin-dependent kinase 6 (CDK6) also blocks erythroid differentiation. We now report that PU.1 directly stimulates transcription of the cdk6 gene in both normal erythroid progenitors and erythroleukemia cells, as well as in macrophages. We propose that PU.1 coordinates proliferation and differentiation in immature erythroid cells by inhibiting the GATA-1-mediated gene expression program and also by regulating expression of genes that control progression through the G(1) phase of the cell cycle, the period during which the decision to differentiate is made.	[Choe, Kevin S.; Ujhelly, Olga; Wontakal, Sandeep N.; Skoultchi, Arthur I.] Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Skoultchi, AI (corresponding author), Albert Einstein Coll Med, Dept Cell Biol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	arthur.skoultchi@einstein.yu.edu			National Institutes of Health [HL078381, 5T32GM07288]; National Cancer Institute Cancer Center [2P30CA13330]; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078381] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007288] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant HL078381.; Supported by National Institutes of Health Medical Scientist Training Program Grant 5T32GM07288.; Supported by National Cancer Institute Cancer Center Grant 2P30CA13330.	Atar O, 2005, BIOCHEM BIOPH RES CO, V329, P1288, DOI 10.1016/j.bbrc.2005.02.109; Back J, 2004, BLOOD, V103, P3615, DOI 10.1182/blood-2003-11-4089; Buttitta LA, 2007, CURR OPIN CELL BIOL, V19, P697, DOI 10.1016/j.ceb.2007.10.004; Carotta S, 2004, BLOOD, V104, P1873, DOI 10.1182/blood-2004-02-0570; CARROLL M, 1995, P NATL ACAD SCI USA, V92, P2869, DOI 10.1073/pnas.92.7.2869; Celada A, 1996, J EXP MED, V184, P61, DOI 10.1084/jem.184.1.61; Choe KS, 2003, CANCER RES, V63, P6363; COPPOLA JA, 1986, NATURE, V320, P760, DOI 10.1038/320760a0; DeKoter RP, 1998, EMBO J, V17, P4456, DOI 10.1093/emboj/17.15.4456; DMITROVSKY E, 1986, NATURE, V322, P748, DOI 10.1038/322748a0; Dolznig H, 2004, METH MOLEC MED, V105, P323; Fisher RC, 1998, STEM CELLS, V16, P25, DOI 10.1002/stem.160025; Fisher RC, 2004, LEUKEMIA RES, V28, P83, DOI 10.1016/S0145-2126(03)00178-4; Fujimoto T, 2007, EMBO J, V26, P2361, DOI 10.1038/sj.emboj.7601675; Himmelmann A, 1997, BLOOD, V90, P3984, DOI 10.1182/blood.V90.10.3984; HOHAUS S, 1995, MOL CELL BIOL, V15, P5830; KLEMSZ MJ, 1990, CELL, V61, P113, DOI 10.1016/0092-8674(90)90219-5; Koschmieder S, 2005, INT J HEMATOL, V81, P368, DOI 10.1532/IJH97.05051; LACHMAN HM, 1986, P NATL ACAD SCI USA, V83, P6480, DOI 10.1073/pnas.83.17.6480; Loose M, 2007, CURR OPIN HEMATOL, V14, P307, DOI 10.1097/MOH.0b013e3281900eee; Matushansky I, 2000, BLOOD, V96, P2755, DOI 10.1182/blood.V96.8.2755.h8002755_2755_2764; Matushansky I, 2003, ONCOGENE, V22, P4143, DOI 10.1038/sj.onc.1206484; Matushansky I, 2000, P NATL ACAD SCI USA, V97, P14317, DOI 10.1073/pnas.250488697; Migliaccio AR, 2005, ANN NY ACAD SCI, V1044, P142, DOI 10.1196/annals.1349.019; MOREAUGACHELIN F, 1988, NATURE, V331, P277, DOI 10.1038/331277a0; MOULTON KS, 1994, MOL CELL BIOL, V14, P4408, DOI 10.1128/MCB.14.7.4408; Nerlov C, 2000, BLOOD, V95, P2543, DOI 10.1182/blood.V95.8.2543.008k19_2543_2551; Nerlov C, 1998, GENE DEV, V12, P2403, DOI 10.1101/gad.12.15.2403; Ogasawara T, 2004, MOL CELL BIOL, V24, P6560, DOI 10.1128/mcb.24.15.6560-6568.2004; Ohneda K, 2002, ACTA HAEMATOL-BASEL, V108, P237, DOI 10.1159/000065660; Orkin S H, 1998, Stem Cells, V16 Suppl 2, P79; Orkin SH, 2000, NAT REV GENET, V1, P57, DOI 10.1038/35049577; PAHL HL, 1993, J BIOL CHEM, V268, P5014; Papetti M, 2007, MOL CANCER RES, V5, P1053, DOI 10.1158/1541-7786.MCR-07-0145; Pesu M, 2003, EUR J IMMUNOL, V33, P1727, DOI 10.1002/eji.200323680; PROCHOWNIK EV, 1986, NATURE, V322, P848, DOI 10.1038/322848a0; Rao G, 1997, ONCOGENE, V14, P123, DOI 10.1038/sj.onc.1200807; Rekhtman N, 1999, GENE DEV, V13, P1398, DOI 10.1101/gad.13.11.1398; Rekhtman N, 2003, MOL CELL BIOL, V23, P7460, DOI 10.1128/MCB.23.21.7460-7474.2003; Rhodes J, 2005, DEV CELL, V8, P97, DOI 10.1016/j.devcel.2004.11.014; Rylski M, 2003, MOL CELL BIOL, V23, P5031, DOI 10.1128/MCB.23.14.5031-5042.2003; SHIN MK, 1993, GENE DEV, V7, P2006, DOI 10.1101/gad.7.10.2006; Sieweke MH, 1998, CURR OPIN GENET DEV, V8, P545, DOI 10.1016/S0959-437X(98)80009-9; Steinman RA, 2002, ONCOGENE, V21, P3403, DOI 10.1038/sj.onc.1205325; Stopka T, 2005, EMBO J, V24, P3712, DOI 10.1038/sj.emboj.7600834; Zeng WL, 2000, J CELL BIOCHEM, V78, P519, DOI 10.1002/1097-4644(20000915)78:4<519::AID-JCB1>3.0.CO;2-V; Zhang P, 1999, P NATL ACAD SCI USA, V96, P8705, DOI 10.1073/pnas.96.15.8705; Zhu L, 2001, CURR OPIN GENET DEV, V11, P91, DOI 10.1016/S0959-437X(00)00162-3	48	26	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5							3044	10.1074/jbc.M109.077727	http://dx.doi.org/10.1074/jbc.M109.077727			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19955566	Green Published, hybrid			2022-12-25	WOS:000273829000020
J	Kariya, Y; Kawamura, C; Tabei, T; Gu, JG				Kariya, Yoshinobu; Kawamura, Chihiro; Tabei, Toshiki; Gu, Jianguo			Bisecting GlcNAc Residues on Laminin-332 Down-regulate Galectin-3-dependent Keratinocyte Motility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-ACETYLGLUCOSAMINYLTRANSFERASE-III; JUNCTIONAL EPIDERMOLYSIS-BULLOSA; BASEMENT-MEMBRANE ADHESION; EPIDERMAL-GROWTH-FACTOR; MEDIATED CELL-ADHESION; BREAST-CARCINOMA CELLS; BETA-PROPELLER DOMAIN; ALPHA-3-BETA-1 INTEGRIN; LIPID RAFTS; EXTRACELLULAR-MATRIX	Laminin-332 (Lm332; formerly laminin-5) is a basement membrane protein in the skin, which promotes cell motility in wound healing and cancer invasion. In a previous study, we reported that the introduction of bisecting GlcNAc into Lm332 (GnT-III-Lm332), catalyzed by N-acetylglucosaminyltransferase III (GnT-III), reduced cell migration (Kariya, Y., Kato, R., Itoh, S., Fukuda, T., Shibukawa, Y., Sanzen, N., Sekiguchi, K., Wada, Y., Kawasaki, N., and Gu, J. (2008) J. Biol. Chem. 283, 3303633045). However, the underlying molecular mechanism by which GnT-III-Lm332 suppresses the normal biological functions of Lm332 remains to be elucidated. In this study, we show that galectin-3, which is a beta-galactoside-binding protein, strongly bound to unmodified Lm332 but not to GnT-III-Lm332 and that binding of galectin-3 was completely blocked by lactose. Exogenous galectin-3 significantly enhanced keratinocyte cell motility on control Lm332 but not on GnT-III-Lm332. A functional blocking antibody against galectin-3 inhibited Lm332-induced alpha 3 beta 1 and alpha 6 beta 4 integrin clustering and focal contact formation. Co-immunoprecipitation revealed that galectin-3 associated with both beta 4 integrin and epidermal growth factor receptor, thereby cross-linking the two molecules. The associations were inhibited by either the presence of lactose or expression of GnT-III. Moreover, galectin-3 consistently enhanced ERK activation. Taken together, the results of this study are the first to clearly identify the molecular mechanism responsible for the inhibitory effects of GnT-III on extracellular matrix-integrin-meditated cell adhesion, migration, and signal transduction. The findings presented herein shed light on the importance of N-glycosylation-mediated supramolecular complex formation on the cell surface.	[Kariya, Yoshinobu; Kawamura, Chihiro; Tabei, Toshiki; Gu, Jianguo] Tohoku Pharmaceut Univ, Div Regulatory Glycobiol, Inst Mol Biomembrane & Glycobiol, Aoba Ku, Sendai, Miyagi 9818558, Japan	Tohoku Medical & Pharmaceutical University	Gu, JG (corresponding author), Tohoku Pharmaceut Univ, Div Regulatory Glycobiol, Inst Mol Biomembrane & Glycobiol, Aoba Ku, 4-4-1 Komatsushima, Sendai, Miyagi 9818558, Japan.	jgu@tohoku-pharm.ac.jp	Gu, Jianguo/ABC-9257-2020		Core Research for Evolutional Science and Technology; Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Science [21370059]	Core Research for Evolutional Science and Technology(Core Research for Evolutional Science and Technology (CREST)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Core Research for Evolutional Science and Technology, the Japan Science and Technology Agency, the Academic Frontier Project for Private Universities from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and Grant-in-aid for Scientific Research 21370059 from Japan Society for the Promotion of Science.	ABERDAM D, 1994, NAT GENET, V6, P299, DOI 10.1038/ng0394-299; ADAMS JC, 1993, DEVELOPMENT, V117, P1183; Akama R, 2008, PROTEOMICS, V8, P3221, DOI 10.1002/pmic.200800038; Cao ZY, 2002, J BIOL CHEM, V277, P42299, DOI 10.1074/jbc.M200981200; CARTER BZ, 1991, LAB INVEST, V65, P610; Colognato H, 2000, DEV DYNAM, V218, P213, DOI 10.1002/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO;2-R; CUMMINGS RD, 1982, J BIOL CHEM, V257, P13421; Dajee M, 2003, NATURE, V421, P639, DOI 10.1038/nature01283; DENNIS JW, 1989, CANCER RES, V49, P945; Dumic J, 2006, BBA-GEN SUBJECTS, V1760, P616, DOI 10.1016/j.bbagen.2005.12.020; Elola MT, 2007, CELL MOL LIFE SCI, V64, P1679, DOI 10.1007/s00018-007-7044-8; FUJIWARA S, 1988, BIOCHEM J, V252, P453, DOI 10.1042/bj2520453; Fukushi J, 2004, MOL BIOL CELL, V15, P3580, DOI 10.1091/mbc.E04-03-0236; Furtak V, 2001, BIOCHEM BIOPH RES CO, V289, P845, DOI 10.1006/bbrc.2001.6064; Gagnoux-Palacios L, 2003, J CELL BIOL, V162, P1189, DOI 10.1083/jcb.200305006; Giancotti FG, 2007, TRENDS PHARMACOL SCI, V28, P506, DOI 10.1016/j.tips.2007.08.004; Granovsky M, 2000, NAT MED, V6, P306; Gu JG, 2004, GLYCOBIOLOGY, V14, P177, DOI 10.1093/glycob/cwh016; Gu JG, 2008, CELL ADHES MIGR, V2, P243, DOI 10.4161/cam.2.4.6748; Gu J, 2009, J PROTEOME RES, V8, P431, DOI 10.1021/pr800674g; Guo HB, 2003, J BIOL CHEM, V278, P52412, DOI 10.1074/jbc.M308837200; Guo HB, 2002, CANCER RES, V62, P6837; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P225, DOI 10.1073/pnas.012540899; Hirohashi S, 1998, AM J PATHOL, V153, P333, DOI 10.1016/S0002-9440(10)65575-7; Hittelet A, 2003, INT J CANCER, V103, P370, DOI 10.1002/ijc.10843; Hodivala-Dilke KM, 1998, J CELL BIOL, V142, P1357, DOI 10.1083/jcb.142.5.1357; Hsu DK, 2009, J INVEST DERMATOL, V129, P573, DOI 10.1038/jid.2008.276; Iijima J, 2006, J BIOL CHEM, V281, P13038, DOI 10.1074/jbc.M601961200; Isaji T, 2004, J BIOL CHEM, V279, P19747, DOI 10.1074/jbc.M311627200; Isaji T, 2006, J BIOL CHEM, V281, P33258, DOI 10.1074/jbc.M607771200; Kapucuoglu N, 2009, PATHOL RES PRACT, V205, P97, DOI 10.1016/j.prp.2008.09.001; Kariya Y, 2003, J CELL BIOCHEM, V88, P506, DOI 10.1002/jcb.10350; Kariya Y, 2004, EXP CELL RES, V297, P508, DOI 10.1016/j.yexcr.2004.03.044; Kariya Y, 2008, J BIOL CHEM, V283, P33036, DOI 10.1074/jbc.M804526200; LeMarer N, 1996, J CELL PHYSIOL, V168, P51, DOI 10.1002/(SICI)1097-4652(199607)168:1<51::AID-JCP7>3.0.CO;2-7; Marinkovich MP, 2007, NAT REV CANCER, V7, P370, DOI 10.1038/nrc2089; Mariotti A, 2001, J CELL BIOL, V155, P447, DOI 10.1083/jcb.200105017; Matarrese P, 2000, INT J CANCER, V85, P545, DOI 10.1002/(SICI)1097-0215(20000215)85:4<545::AID-IJC17>3.0.CO;2-N; Miyazaki K, 2006, CANCER SCI, V97, P91, DOI 10.1111/j.1349-7006.2006.00150.x; Nguyen BP, 2000, J BIOL CHEM, V275, P31896, DOI 10.1074/jbc.M006379200; Ochieng J, 1998, BIOCHEM BIOPH RES CO, V246, P788, DOI 10.1006/bbrc.1998.8708; Okamoto O, 2003, J BIOL CHEM, V278, P44168, DOI 10.1074/jbc.M300726200; Paret C, 2005, INT J CANCER, V115, P724, DOI 10.1002/ijc.20977; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Pike LJ, 2005, BBA-MOL CELL RES, V1746, P260, DOI 10.1016/j.bbamcr.2005.05.005; Pochec E, 2003, BBA-MOL CELL RES, V1643, P113, DOI 10.1016/j.bbamcr.2003.10.004; PULKKINEN L, 1994, GENOMICS, V24, P357, DOI 10.1006/geno.1994.1627; Rabinovich GA, 2007, CURR OPIN STRUC BIOL, V17, P513, DOI 10.1016/j.sbi.2007.09.002; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; ROUSSELLE P, 1991, J CELL BIOL, V114, P567, DOI 10.1083/jcb.114.3.567; Russell AJ, 2003, J CELL SCI, V116, P3543, DOI 10.1242/jcs.00663; RYAN MC, 1994, J BIOL CHEM, V269, P22779; SATO S, 1992, J BIOL CHEM, V267, P6983; Sato Y, 2009, J BIOL CHEM, V284, P11873, DOI 10.1074/jbc.M807660200; SCHACHTER H, 1986, BIOCHEM CELL BIOL, V64, P163, DOI 10.1139/o86-026; SHOREIBAH M, 1993, J BIOL CHEM, V268, P15381; SONNENBERG A, 1991, J CELL BIOL, V113, P907, DOI 10.1083/jcb.113.4.907; Utani A, 2001, J BIOL CHEM, V276, P28779, DOI 10.1074/jbc.M101420200; Yang XW, 2004, J CELL BIOL, V167, P1231, DOI 10.1083/jcb.200404100; Yoon SJ, 2006, P NATL ACAD SCI USA, V103, P18987, DOI 10.1073/pnas.0609281103; Yoshimura M, 1996, J BIOL CHEM, V271, P13811, DOI 10.1074/jbc.271.23.13811; YOSHIMURA M, 1995, P NATL ACAD SCI USA, V92, P8754, DOI 10.1073/pnas.92.19.8754; Zhao YY, 2006, J BIOL CHEM, V281, P32122, DOI 10.1074/jbc.M607274200; Zhuo Y, 2008, J BIOL CHEM, V283, P22177, DOI 10.1074/jbc.M8000015200	64	53	59	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5					3330	3340		10.1074/jbc.M109.038836	http://dx.doi.org/10.1074/jbc.M109.038836			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19940114	Green Published, hybrid			2022-12-25	WOS:000273829000048
J	Yego, ECK; Mohr, S				Yego, E. Chepchumba K.; Mohr, Susanne			siah-1 Protein Is Necessary for High Glucose-induced Glyceraldehyde-3-phosphate Dehydrogenase Nuclear Accumulation and Cell Death in Muller Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINAL GLIAL-CELLS; UBIQUITIN LIGASE; PROTEASOME PATHWAY; DIABETIC-RETINOPATHY; INDUCED APOPTOSIS; ELEVATED GLUCOSE; ALPHA-SYNUCLEIN; RAT RETINA; SINA GENE; DEGRADATION	The translocation and accumulation of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) in the nucleus has closely been associated with cell death induction. However, the mechanism of this process has not been completely understood. The E3 ubiquitin ligase siah-1 (seven in absentia homolog 1) has recently been identified as a potential shuttle protein to transport GAPDH from the cytosol to the nucleus. Previously, we have demonstrated that elevated glucose levels induce GAPDH nuclear accumulation in retinal Muller cells. Therefore, this study investigated the role of siah-1 in high glucose-induced GAPDH nuclear translocation and subsequent cell death in retinal Muller cells. High glucose significantly increased siah-1 expression within 12 h. Under hyperglycemic conditions, siah-1 formed a complex with GAPDH and was predominantly localized in the nucleus of Muller cells. siah-1 knockdown using 50 nM siah-1 small interfering RNA significantly decreased high glucose-induced GAPDH nuclear accumulation at 24 h by 43.8 +/- 4.0%. Further, knockdown of siah-1 prevented high glucose-induced cell death of Muller cells potentially by inhibiting p53 phosphorylation consistent with previous observations, indicating that nuclear GAPDH induces cell death via p53 activation. Therefore, inhibition of GAPDH nuclear translocation and accumulation by targeting siah-1 promotes Muller cell survival under hyperglycemic conditions.	[Mohr, Susanne] Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA; [Yego, E. Chepchumba K.; Mohr, Susanne] Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Cleveland, OH 44106 USA	Michigan State University; Case Western Reserve University	Mohr, S (corresponding author), Michigan State Univ, Dept Physiol, 3175 Biomed Phys Sci, E Lansing, MI 48824 USA.	mohrs@msu.edu			National Institutes of Health [2T32EY007157, 1F31EY018075, EY-014380, EY-017206]; Visual Science Research Center Core [2P30EY011373]; American Diabetes Association [7-06-RA-95]; NATIONAL EYE INSTITUTE [F31EY018075, R01EY017206, R03EY014380, T32EY007157, P30EY011373] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Visual Science Research Center Core; American Diabetes Association(American Diabetes Association); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Training Grants 2T32EY007157 and 1F31EY018075 (to E.Y.) and Research Grants: EY-014380 and EY-017206 (to S.M.). This work was also supported by Visual Science Research Center Core Grant 2P30EY011373 (to E.Y. and S. M.) and by American Diabetes Association Grant 7-06-RA-95 (to S.M.).	Adachi-Uehara N, 2006, EXP EYE RES, V83, P849, DOI 10.1016/j.exer.2006.04.012; Brown VM, 2004, J BIOL CHEM, V279, P5984, DOI 10.1074/jbc.M307071200; Bruzzoni-Giovanelli H, 1999, ONCOGENE, V18, P7101, DOI 10.1038/sj.onc.1203187; Cahuana GM, 2004, EXP CELL RES, V293, P22, DOI 10.1016/j.yexcr.2003.10.004; CARTHEW RW, 1990, CELL, V63, P561, DOI 10.1016/0092-8674(90)90452-K; Chuang DM, 2005, ANNU REV PHARMACOL, V45, P269, DOI 10.1146/annurev.pharmtox.45.120403.095902; Chuang DM, 1996, NAT MED, V2, P609, DOI 10.1038/nm0696-609; DELLA NG, 1993, DEVELOPMENT, V117, P1333; Distler C, 1996, VISION RES, V36, P2381, DOI 10.1016/0042-6989(96)00005-3; Du YP, 2004, AM J PHYSIOL-REG I, V287, pR735, DOI 10.1152/ajpregu.00080.2003; Du ZX, 2007, ENDOCRINOLOGY, V148, P4352, DOI 10.1210/en.2006-1511; Feit-Leichman RA, 2005, INVEST OPHTH VIS SCI, V46, P4281, DOI 10.1167/iovs.04-1361; Fiucci G, 2004, P NATL ACAD SCI USA, V101, P3510, DOI 10.1073/pnas.0400177101; Fukuba H, 2007, BIOCHEM BIOPH RES CO, V353, P324, DOI 10.1016/j.bbrc.2006.12.051; Germani A, 2003, ONCOGENE, V22, P8845, DOI 10.1038/sj.onc.1206994; Germani A, 2000, ONCOGENE, V19, P5997, DOI 10.1038/sj.onc.1204002; Groenman F, 2007, J HISTOCHEM CYTOCHEM, V55, P355, DOI 10.1369/jhc.6A7129.2006; Hara MR, 2006, CELL MOL NEUROBIOL, V26, P527, DOI 10.1007/s10571-006-9011-6; Hara MR, 2006, P NATL ACAD SCI USA, V103, P3887, DOI 10.1073/pnas.0511321103; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; House CM, 2006, STRUCTURE, V14, P695, DOI 10.1016/j.str.2005.12.013; House CM, 2003, P NATL ACAD SCI USA, V100, P3101, DOI 10.1073/pnas.0534783100; Hu G, 1997, GENOMICS, V46, P103, DOI 10.1006/geno.1997.4997; Hu G, 1997, GENE DEV, V11, P2701, DOI 10.1101/gad.11.20.2701; Kannan R, 1999, EXP EYE RES, V68, P609, DOI 10.1006/exer.1998.0639; Kanwar M, 2009, DIABETES, V58, P227, DOI 10.2337/db08-1025; Kodama R, 2005, GENES CELLS, V10, P1211, DOI 10.1111/j.1365-2443.2005.00911.x; Kusner LL, 2004, INVEST OPHTH VIS SCI, V45, P1553, DOI 10.1167/iovs.03-1294; Lee JT, 2008, HUM MOL GENET, V17, P906, DOI 10.1093/hmg/ddm363; Li Q, 2002, INVEST OPHTH VIS SCI, V43, P3109; Liani E, 2004, P NATL ACAD SCI USA, V101, P5500, DOI 10.1073/pnas.0401081101; Lieth E, 2000, CLIN EXP OPHTHALMOL, V28, P3, DOI 10.1046/j.1442-9071.2000.00222.x; Liu J, 2001, MOL CELL, V7, P927, DOI 10.1016/S1097-2765(01)00241-6; Martin PM, 2004, INVEST OPHTH VIS SCI, V45, P3330, DOI 10.1167/iovs.04-0247; Mazzola JL, 2003, J NEUROSCI RES, V71, P279, DOI 10.1002/jnr.10484; MILLER RF, 1970, J NEUROPHYSIOL, V33, P323, DOI 10.1152/jn.1970.33.3.323; Mohr S, 2002, DIABETES, V51, P1172, DOI 10.2337/diabetes.51.4.1172; MOHR S, 2000, ASS RES VIS OPHTH AN; Moriyoshi K, 2004, P NATL ACAD SCI USA, V101, P8614, DOI 10.1073/pnas.0403042101; Nagano Y, 2003, J BIOL CHEM, V278, P51504, DOI 10.1074/jbc.M306347200; Nemani M, 1996, P NATL ACAD SCI USA, V93, P9039, DOI 10.1073/pnas.93.17.9039; NEWMAN EA, 1984, SCIENCE, V225, P1174, DOI 10.1126/science.6474173; Park SH, 2003, DIABETOLOGIA, V46, P1260, DOI 10.1007/s00125-003-1177-6; Podesta F, 2000, AM J PATHOL, V156, P1025, DOI 10.1016/S0002-9440(10)64970-X; Polekhina G, 2002, NAT STRUCT BIOL, V9, P68, DOI 10.1038/nsb743; PURO DG, 1991, J NEUROSCI, V11, P1873; REICHENBACH A, 1993, J CHEM NEUROANAT, V6, P201, DOI 10.1016/0891-0618(93)90042-3; Sarthy V P, 2000, Arch Soc Esp Oftalmol, V75, P367; Sarthy VP, 1998, INVEST OPHTH VIS SCI, V39, P212; Saunders PA, 1999, J NEUROCHEM, V72, P925, DOI 10.1046/j.1471-4159.1999.0720925.x; Schutte M, 1998, NEUROSCI LETT, V246, P53, DOI 10.1016/S0304-3940(98)00229-8; Sen N, 2008, NAT CELL BIOL, V10, P866, DOI 10.1038/ncb1747; Sirover MA, 2005, J CELL BIOCHEM, V95, P45, DOI 10.1002/jcb.20399; Sirover MA, 1999, BBA-PROTEIN STRUCT M, V1432, P159, DOI 10.1016/S0167-4838(99)00119-3; Sugiyama T, 2004, INVEST OPHTH VIS SCI, V45, P1026, DOI 10.1167/iovs.03-1062; SUNAGA K, 1995, NEUROSCI LETT, V200, P133, DOI 10.1016/0304-3940(95)12098-O; Susini L, 2001, P NATL ACAD SCI USA, V98, P15067, DOI 10.1073/pnas.261571998; Tang AH, 1997, CELL, V90, P459, DOI 10.1016/S0092-8674(00)80506-1; Tatton WG, 2000, ADV RES NEURODEGENER, V8, P77; Tsuchiya K, 2004, LIFE SCI, V74, P3245, DOI 10.1016/j.lfs.2003.11.029; Vincent JA, 2007, DIABETES, V56, P224, DOI 10.2337/db06-0427; Ward MM, 2005, DIABETOLOGIA, V48, P351, DOI 10.1007/s00125-004-1639-5; Winter M, 2008, NAT CELL BIOL, V10, P812, DOI 10.1038/ncb1743; Xi X, 2005, BIOCHEM BIOPH RES CO, V326, P548, DOI 10.1016/j.bbrc.2004.11.064; Yego ECK, 2009, INVEST OPHTH VIS SCI, V50, P1920, DOI 10.1167/iovs.08-2082	65	43	47	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5					3181	3190		10.1074/jbc.M109.083907	http://dx.doi.org/10.1074/jbc.M109.083907			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19940145	Green Published, hybrid			2022-12-25	WOS:000273829000033
J	Das, S; Ghosh, D; Basu, A				Das, Sulagna; Ghosh, Debapriya; Basu, Anirban			Japanese Encephalitis Virus Induce Immuno-Competency in Neural Stem/Progenitor Cells	PLOS ONE			English	Article							STEM-CELLS; CLASS-I; PROGENITOR CELLS; AUTOIMMUNE ENCEPHALOMYELITIS; COSTIMULATORY MOLECULES; INFLAMMATORY CYTOKINES; RESIST DESTRUCTION; NEURONAL DEATH; T-LYMPHOCYTES; EXPRESSION	Background: The low immunogenicity of neural stem/progenitor cells (NSPCs) coupled with negligible expression of MHC antigens has popularized their use in transplantation medicine. However, in an inflammatory environment, the NSPCs express costimulatory molecules and MHC antigens, and also exhibit certain immunomodulatory functions. Since NSPCs are the cellular targets in a number of virus infections both during postnatal and adult stages, we wanted to investigate the immunological properties of these stem cells in response to viral pathogen. Methodology/Principal Findings: We utilized both in vivo mouse model and in vitro neurosphere model of Japanese encephalitis virus (JEV) infection for the study. The NSPCs residing in the subventricular zone of the infected brains showed prominent expression of MHC-I and costimulatory molecules CD40, CD80, and CD86. Using Flow cytometry and fluorescence microscopy, we observed increased surface expression of co-stimulatory molecule and MHC class I antigen in NSPCs upon progressive JEV infection in vitro. Moreover, significant production of pro-inflammatory cyto/chemokines was detected in JEV infected NSPCs by Cytokine Bead Array analysis. Interestingly, NSPCs were capable of providing functional costimulation to allogenic T cells and JEV infection resulted in increased proliferation of allogenic T cells, as detected by Mixed Lymphocyte reaction and CFSE experiments. We also report IL-2 production by NSPCs upon JEV infection, which possibly provides mitogenic signals to T cells and trigger their proliferation. Conclusion/Significance: The in vivo and in vitro findings clearly indicate the development of immunogenicity in NSPCs following progressive JEV infection, in our case, JEV infection. Following a neurotropic virus infection, NSPCs possibly behave as immunogenic cells and contribute to both the innate and adaptive immune axes. The newly discovered immunological properties of NSPCs may have implications in assigning a new role of these cells as non-professional antigen presenting cells in the central nervous system.	[Das, Sulagna; Ghosh, Debapriya; Basu, Anirban] Natl Brain Res Ctr, Manesar, Haryana, India	Department of Biotechnology (DBT) India; National Brain Research Centre (NBRC)	Das, S (corresponding author), Natl Brain Res Ctr, Manesar, Haryana, India.	anirban@nbrc.ac.in		Das, Sulagna/0000-0002-8495-3153; Ghosh, Debapriya/0000-0002-8251-6945; Basu, Anirban/0000-0002-5200-2054	Department of Biotechnology [BT/PR8682/Med/14/1273/2007]; Senior Research Fellowship from University	Department of Biotechnology; Senior Research Fellowship from University	This work was supported by grant awarded to AB from the Department of Biotechnology, Award #BT/PR8682/Med/14/1273/2007. SD is a recipient of a Senior Research Fellowship from University Grants Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AK, 2003, AUTOIMMUN REV, V2, P115, DOI 10.1016/S1568-9972(03)00028-4; Abraham SA, 2006, VIRUS RES, V119, P216, DOI 10.1016/j.virusres.2006.03.006; Aloisi F, 2001, GLIA, V36, P165, DOI 10.1002/glia.1106; Ben-Hur T, 2008, J NEUROL SCI, V265, P102, DOI 10.1016/j.jns.2007.05.007; Bhowmick S, 2007, NEUROSCI LETT, V414, P45, DOI 10.1016/j.neulet.2006.11.070; Cummings BJ, 2005, P NATL ACAD SCI USA, V102, P14069, DOI 10.1073/pnas.0507063102; Das S, 2008, J NEUROCHEM, V106, P1624, DOI 10.1111/j.1471-4159.2008.05511.x; Dong YS, 2001, GLIA, V36, P180, DOI 10.1002/glia.1107; Dutta K, 2009, J NEUROIMMUNE PHARM, V4, P328, DOI 10.1007/s11481-009-9158-2; Einstein O, 2008, ARCH NEUROL-CHICAGO, V65, P452, DOI 10.1001/archneur.65.4.452; Einstein O, 2007, ANN NEUROL, V61, P209, DOI 10.1002/ana.21033; Foster JA, 2002, J NEUROIMMUNOL, V131, P83, DOI 10.1016/S0165-5728(02)00258-8; Gendelman HE, 2009, J NEUROIMMUNE PHARM, V4, P47, DOI 10.1007/s11481-008-9135-1; Ghoshal A, 2007, GLIA, V55, P483, DOI 10.1002/glia.20474; Griffin DE, 2003, NAT REV IMMUNOL, V3, P493, DOI 10.1038/nri1105; Hori J, 2003, STEM CELLS, V21, P405, DOI 10.1634/stemcells.21-4-405; Hori J, 2007, OCUL IMMUNOL INFLAMM, V15, P261, DOI 10.1080/09273940701382242; Huh GS, 2000, SCIENCE, V290, P2155, DOI 10.1126/science.290.5499.2155; Imitola J, 2004, AM J PATHOL, V164, P1615, DOI 10.1016/S0002-9440(10)63720-0; Issazadeh S, 1998, J IMMUNOL, V161, P1104; Johansson S, 2008, STEM CELLS, V26, P2444, DOI 10.1634/stemcells.2008-0116; Kelly S, 2004, P NATL ACAD SCI USA, V101, P11839, DOI 10.1073/pnas.0404474101; Kim SY, 2009, J NEUROSCI RES, V87, P2264, DOI 10.1002/jnr.22050; Mammolenti M, 2004, STEM CELLS, V22, P1101, DOI 10.1634/stemcells.22-6-1101; Martino G, 2007, NAT CELL BIOL, V9, P1031, DOI 10.1038/ncb0907-1031; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Miralves J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001354; NEUMANN H, 1995, SCIENCE, V269, P549, DOI 10.1126/science.7624779; Neumann H, 2001, GLIA, V36, P191, DOI 10.1002/glia.1108; Odeberg J, 2005, J NEUROIMMUNOL, V161, P1, DOI 10.1016/j.jneuroim.2004.11.016; Ourednik J, 2002, NAT BIOTECHNOL, V20, P1103, DOI 10.1038/nbt750; Park KI, 2002, NAT BIOTECHNOL, V20, P1111, DOI 10.1038/nbt751; Pechhold K, 1997, J IMMUNOL, V158, P4921; Pluchino S, 2005, BRAIN RES REV, V48, P211, DOI 10.1016/j.brainresrev.2004.12.011; Pluchino S, 2005, NATURE, V436, P266, DOI 10.1038/nature03889; Romanko MJ, 2004, PROG NEUROBIOL, V74, P77, DOI 10.1016/j.pneurobio.2004.07.001; Sheng WS, 2005, J LEUKOCYTE BIOL, V78, P1233, DOI 10.1189/jlb.0405221; Swarup V, 2007, J NEUROCHEM, V103, P771, DOI 10.1111/j.1471-4159.2007.04790.x; Tai P, 2008, J CELL PHYSIOL, V214, P456, DOI 10.1002/jcp.21221; TAUB DD, 1995, J CLIN INVEST, V95, P1370, DOI 10.1172/JCI117788; Thams S, 2008, BRAIN RES REV, V57, P265, DOI 10.1016/j.brainresrev.2007.06.016; Ubiali F, 2007, INT IMMUNOL, V19, P1063, DOI 10.1093/intimm/dxm079; Vrati S, 1999, J GEN VIROL, V80, P1665, DOI 10.1099/0022-1317-80-7-1665	43	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2009	4	12							e8134	10.1371/journal.pone.0008134	http://dx.doi.org/10.1371/journal.pone.0008134			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MU	19956550	Green Submitted, gold, Green Published			2022-12-25	WOS:000272828800025
J	Kolachalama, VB; Levine, EG; Edelman, ER				Kolachalama, Vijaya B.; Levine, Evan G.; Edelman, Elazer R.			Luminal Flow Amplifies Stent-Based Drug Deposition in Arterial Bifurcations	PLOS ONE			English	Article							PACLITAXEL-ELUTING STENTS; LEFT MAIN; DELIVERY; LESIONS; TRIAL; IMPLANTATION; THROMBOSIS; PROTEINS; DISEASE; UPDATE	Background: Treatment of arterial bifurcation lesions using drug-eluting stents (DES) is now common clinical practice and yet the mechanisms governing drug distribution in these complex morphologies are incompletely understood. It is still not evident how to efficiently determine the efficacy of local drug delivery and quantify zones of excessive drug that are harbingers of vascular toxicity and thrombosis, and areas of depletion that are associated with tissue overgrowth and luminal re-narrowing. Methods and Results: We constructed two-phase computational models of stent-deployed arterial bifurcations simulating blood flow and drug transport to investigate the factors modulating drug distribution when the main-branch (MB) was treated using a DES. Simulations predicted extensive flow-mediated drug delivery in bifurcated vascular beds where the drug distribution patterns are heterogeneous and sensitive to relative stent position and luminal flow. A single DES in the MB coupled with large retrograde luminal flow on the lateral wall of the side-branch (SB) can provide drug deposition on the SB lumen-wall interface, except when the MB stent is downstream of the SB flow divider. In an even more dramatic fashion, the presence of the SB affects drug distribution in the stented MB. Here fluid mechanic effects play an even greater role than in the SB especially when the DES is across and downstream to the flow divider and in a manner dependent upon the Reynolds number. Conclusions: The flow effects on drug deposition and subsequent uptake from endovascular DES are amplified in bifurcation lesions. When only one branch is stented, a complex interplay occurs - drug deposition in the stented MB is altered by the flow divider imposed by the SB and in the SB by the presence of a DES in the MB. The use of DES in arterial bifurcations requires a complex calculus that balances vascular and stent geometry as well as luminal flow.	[Kolachalama, Vijaya B.; Levine, Evan G.; Edelman, Elazer R.] MIT, Ctr Biomed Engn, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Edelman, Elazer R.] Harvard Univ, Brigham & Womens Hosp, Div Cardiovasc, Sch Med, Boston, MA 02115 USA	Harvard University; Massachusetts Institute of Technology (MIT); Harvard University; Brigham & Women's Hospital; Harvard Medical School	Kolachalama, VB (corresponding author), MIT, Ctr Biomed Engn, Harvard Mit Div Hlth Sci & Technol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	vbk@mit.edu	Kolachalama, Vijaya B./AAH-3528-2020	Kolachalama, Vijaya B./0000-0002-5312-8644; Edelman, Elazer/0000-0002-7832-7156	NIH [R01 GM-49039]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported in part by a grant from the NIH (R01 GM-49039) to ERE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balakrishnan B, 2005, CIRCULATION, V111, P2958, DOI 10.1161/CIRCULATIONAHA.104.512475; Balakrishnan B, 2007, J CONTROL RELEASE, V123, P100, DOI 10.1016/j.jconrel.2007.06.025; Balakrishnan B, 2008, J CONTROL RELEASE, V131, P173, DOI 10.1016/j.jconrel.2008.07.027; CHIEN S, 1966, J APPL PHYSIOL, V21, P81, DOI 10.1152/jappl.1966.21.1.81; Colombo A, 2004, CIRCULATION, V109, P1244, DOI 10.1161/01.CIR.0000118474.71662.E3; Colombo A, 2007, CIRCULATION, V116, P1424, DOI 10.1161/CIRCULATIONAHA.106.621359; Creel CJ, 2000, CIRC RES, V86, P879, DOI 10.1161/01.RES.86.8.879; *FDA, 2007, KEY FDA CRIT PATH AC; Finn AV, 2005, CIRCULATION, V112, P270, DOI 10.1161/CIRCULATIONAHA.104.508937; Food and Drug Administration [FDA], 2008, GUID IND COR DRUG EL; Grube E, 2003, CIRCULATION, V107, P38, DOI 10.1161/01.CIR.0000047700.58683.A1; Hitt E, 2002, NAT MED, V8, P544, DOI 10.1038/nm0602-544a; Hoi YM, 2004, J NEUROSURG, V101, P676, DOI 10.3171/jns.2004.101.4.0676; Hwang Chao-Wei, 2003, Int J Cardiovasc Intervent, V5, P7; Hwang CW, 2001, CIRCULATION, V104, P600, DOI 10.1161/hc3101.092214; Iakovou I, 2005, JAMA-J AM MED ASSOC, V293, P2126, DOI 10.1001/jama.293.17.2126; Joner M, 2006, J AM COLL CARDIOL, V48, P193, DOI 10.1016/j.jacc.2006.03.042; Kolachalama VB, 2007, BIOMED ENG ONLINE, V6, DOI 10.1186/1475-925X-6-47; Kolachalama VB, 2009, J CONTROL RELEASE, V133, P24, DOI 10.1016/j.jconrel.2008.09.075; Latib A, 2009, HEART, V95, P495, DOI 10.1136/hrt.2008.150391; Lemos PA, 2003, CIRCULATION, V107, P3003, DOI 10.1161/01.CIR.0000078025.19258.28; Lovich MA, 2001, J PHARM SCI, V90, P1324, DOI 10.1002/jps.1085; Mauri L, 2007, NEW ENGL J MED, V356, P1020, DOI 10.1056/NEJMoa067731; Richter Y, 2004, J CLIN INVEST, V113, P1607, DOI 10.1172/JCI200421007; Richter Y, 2006, CIRCULATION, V113, P2679, DOI 10.1161/CIRCULATIONAHA.106.632687; Serruys P., 2002, HDB CORONARY STENTS; Sheiban I, 2009, J INTERV CARDIOL, V22, P150, DOI 10.1111/j.1540-8183.2009.00444.x; Sheiban I, 2009, CATHETER CARDIO INTE, V73, P25, DOI 10.1002/ccd.21759; Stone GW, 2007, NEW ENGL J MED, V356, P998, DOI 10.1056/NEJMoa067193; Tada S, 2001, ANN BIOMED ENG, V29, P456, DOI 10.1114/1.1376410; Tanabe K, 2003, CIRCULATION, V107, P559, DOI 10.1161/01.CIR.0000048184.96491.8A; Tanabe K, 2004, CIRCULATION, V109, P196, DOI 10.1161/01.CIR.0000109137.51122.49; Wentzel JJ, 2001, CIRCULATION, V103, P1740, DOI 10.1161/01.CIR.103.13.1740	33	44	47	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2009	4	12							e8105	10.1371/journal.pone.0008105	http://dx.doi.org/10.1371/journal.pone.0008105			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MU	19956555	Green Published, gold, Green Submitted			2022-12-25	WOS:000272828800009
J	Ochola, R; Sande, C; Fegan, G; Scott, PD; Medley, GF; Cane, PA; Nokes, DJ				Ochola, Rachel; Sande, Charles; Fegan, Gregory; Scott, Paul D.; Medley, Graham F.; Cane, Patricia A.; Nokes, D. James			The Level and Duration of RSV-Specific Maternal IgG in Infants in Kilifi Kenya	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; RURAL AREA; INFECTION; ANTIBODIES; AGE; EPIDEMIOLOGY; PREVALENCE; DISTRICT; MEASLES; BIRTH	Background: Respiratory syncytial virus (RSV) is the major cause of lower respiratory tract infection in infants. The rate of decay of RSV-specific maternal antibodies (RSV-matAb), the factors affecting cord blood levels, and the relationship between these levels and protection from infection are poorly defined. Methods: A birth cohort (n = 635) in rural Kenya, was studied intensively to monitor infections and describe age-related serological characteristics. RSV specific IgG antibody (Ab) in serum was measured by the enzyme linked immunosorbent assay (ELISA) in cord blood, consecutive samples taken 3 monthly, and in paired acute and convalescent samples. A linear regression model was used to calculate the rate of RSV-matAb decline. The effect of risk factors on cord blood titres was investigated. Results: The half-life of matAb in the Kenyan cohort was calculated to be 79 days (95% confidence limits (CL): 76-81 days). Ninety seven percent of infants were born with RSV-matAb. Infants who subsequently experienced an infection in early life had significantly lower cord titres of anti-RSV Ab in comparison to infants who did not have any incident infection in the first 6 months (P = 0.011). RSV infections were shown to have no effect on the rate of decay of RSV-matAb. Conclusion: Maternal-specific RSV Ab decline rapidly following birth. However, we provide evidence of protection against severe disease by RSV-matAb during the first 6-7 months. This suggests that boosting maternal-specific Ab by RSV vaccination may be a useful strategy to consider.	[Ochola, Rachel; Sande, Charles; Fegan, Gregory; Nokes, D. James] Kenya Govt Med Res Ctr, Ctr Geog Med Res Coast, Kilifi, Kenya; [Fegan, Gregory] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England; [Scott, Paul D.; Medley, Graham F.; Nokes, D. James] Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England; [Cane, Patricia A.] Hlth Protect Agcy, London, England	Kenya Medical Research Institute; University of London; London School of Hygiene & Tropical Medicine; University of Warwick; Health Protection Agency	Ochola, R (corresponding author), Kenya Govt Med Res Ctr, Ctr Geog Med Res Coast, Kilifi, Kenya.	rachel.opiyo@gmail.com	Medley, Graham/B-7289-2008; Fegan, Greg W/O-8079-2018	Medley, Graham/0000-0002-0030-7278; Fegan, Greg W/0000-0002-2663-2765; Sande, Charles/0000-0002-8364-6063	The Wellcome Trust [061584, 076278]	The Wellcome Trust(Wellcome TrustEuropean Commission)	Financial support was provided by The Wellcome Trust (http://www.wellcome.ac.uk/; 061584 and 076278). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boeck K D, 1996, Monaldi Arch Chest Dis, V51, P210; Brandenburg AH, 1997, J MED VIROL, V52, P97, DOI 10.1002/(SICI)1096-9071(199705)52:1&lt;97::AID-JMV16&gt;3.0.CO;2-Y; Caceres VM, 2000, CLIN INFECT DIS, V31, P110, DOI 10.1086/313926; Connor E, 1997, PEDIATRICS, V99, P93; Cox MJ, 1998, J MED VIROL, V55, P234, DOI 10.1002/(SICI)1096-9071(199807)55:3&lt;234::AID-JMV9&gt;3.0.CO;2-2; Ebihara T, 2004, J MED VIROL, V72, P304, DOI 10.1002/jmv.10572; Englund J, 1998, VACCINE, V16, P1456, DOI 10.1016/S0264-410X(98)00108-X; GLEZEN WP, 1986, AM J DIS CHILD, V140, P543, DOI 10.1001/archpedi.1986.02140200053026; GLEZEN WP, 1981, J PEDIATR-US, V98, P708, DOI 10.1016/S0022-3476(81)80829-3; Hacimustafaoglu M, 2004, ARCH DIS CHILD, V89, P52, DOI 10.1136/adc.2002.017780; HALL CB, 1979, NEW ENGL J MED, V300, P393, DOI 10.1056/NEJM197902223000803; LAMPRECHT CL, 1976, J INFECT DIS, V134, P211, DOI 10.1093/infdis/134.3.211; Lee DH, 2001, ORG LETT, V3, P5, DOI 10.1021/ol006690t; Loscertales MP, 2002, PEDIATR INFECT DIS J, V21, P148, DOI 10.1097/00006454-200202000-00013; *MIN FIN PLANN, 2002, AN REP POP PROJ, V2; Munoz FM, 2003, VACCINE, V21, P3465, DOI 10.1016/S0264-410X(03)00352-9; NANDAPALAN N, 1986, J MED VIROL, V20, P79, DOI 10.1002/jmv.1890200110; NELIGAN GA, 1970, BMJ-BRIT MED J, V3, P146, DOI 10.1136/bmj.3.5715.146; Nokes DJ, 2008, CLIN INFECT DIS, V46, P50, DOI 10.1086/524019; Nokes DJ, 2004, J INFECT DIS, V190, P1828, DOI 10.1086/425040; Null D, 1998, PEDIATRICS, V102, P531, DOI 10.1542/peds.102.3.531; OGILVIE MM, 1981, J MED VIROL, V7, P263, DOI 10.1002/jmv.1890070403; Roca A, 2003, J MED VIROL, V69, P579, DOI 10.1002/jmv.10348; Roca A, 2002, J MED VIROL, V67, P616, DOI 10.1002/jmv.10148; SATO H, 1979, AM J DIS CHILD, V133, P1240, DOI 10.1001/archpedi.1979.02130120032005; Stensballe LG, 2009, J PEDIATR-US, V154, P296, DOI 10.1016/j.jpeds.2008.07.053; WARD KA, 1983, J GEN VIROL, V64, P1867, DOI 10.1099/0022-1317-64-9-1867; Wilson SD, 2000, J MED VIROL, V61, P81, DOI 10.1002/(SICI)1096-9071(200005)61:1&lt;81::AID-JMV13&gt;3.0.CO;2-O; Zambon MC, 2001, LANCET, V358, P1410, DOI 10.1016/S0140-6736(01)06528-X	29	108	109	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2009	4	12							e8088	10.1371/journal.pone.0008088	http://dx.doi.org/10.1371/journal.pone.0008088			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MU	19956576	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000272828800008
J	Kaushik, JK; Kumar, A; Duary, RK; Mohanty, AK; Grover, S; Batish, VK				Kaushik, Jai K.; Kumar, Ashutosh; Duary, Raj K.; Mohanty, Ashok K.; Grover, Sunita; Batish, Virender K.			Functional and Probiotic Attributes of an Indigenous Isolate of Lactobacillus plantarum	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; COMPLETE GENOME SEQUENCE; HUMAN INTESTINAL-MUCOSA; BILE-SALT HYDROLASE; IN-VITRO; GASTROINTESTINAL-TRACT; LACTOCOCCUS-LACTIS; ADHESION; STRAINS; IDENTIFICATION	Background: Probiotic microorganisms favorably alter the intestinal microflora balance, promote intestinal integrity and mobility, inhibit the growth of harmful bacteria and increase resistance to infection. Probiotics are increasingly used in nutraceuticals, functional foods or in microbial interference treatment. However, the effectiveness of probiotic organism is considered to be population-specific due to variation in gut microflora, food habits and specific host-microbial interactions. Most of the probiotic strains available in the market are of western or European origin, and a strong need for exploring new indigenous probiotic organisms is felt. Methods and Findings: An indigenous isolate Lp9 identified as Lactobacillus plantarum by molecular-typing methods was studied extensively for its functional and probiotic attributes, viz., acid and bile salt tolerance, cell surface hydrophobicity, autoaggregation and Caco-2 cell-binding as well as antibacterial and antioxidative activities. Lp9 isolate could survive 2 h incubation at pH 1.5-2.0 and toxicity of 1.5-2.0% oxgall bile. Lp9 could deconjugate major bile salts like glycocholate and deoxytaurocholate, indicating its potential to cause hypocholesterolemia. The isolate exhibited cell-surface hydrophobicity of similar to 37% and autoaggregation of similar to 31%. Presence of putative probiotic marker genes like mucus-binding protein (mub), fibronectin-binding protein (fbp) and bile salt hydrolase (bsh) were confirmed by PCR. Presence of these genes suggested the possibility of specific interaction and colonization potential of Lp9 isolate in the gut, which was also suggested by a good adhesion ratio of 7.4 +/- 1.3% with Caco-2 cell line. The isolate demonstrated higher free radical scavenging activity than standard probiotics L. johnsonii LA1 and L. acidophilus LA7. Lp9 also exhibited antibacterial activity against E. coli, L. monocytogenes, S. typhi, S. aureus and B. cereus. Conclusion: The indigenous Lactobacillus plantarum Lp9 exhibited high resistance against low pH and bile and possessed antibacterial, antioxidative and cholesterol lowering properties with a potential for exploitation in the development of indigenous functional food or nutraceuticals.	[Kaushik, Jai K.; Mohanty, Ashok K.] Natl Dairy Res Inst, Anim Biotechnol Ctr, Karnal, India; [Kumar, Ashutosh; Duary, Raj K.; Grover, Sunita; Batish, Virender K.] Natl Dairy Res Inst, Dairy Microbiol Div, Mol Biol Unit, Karnal, India	Indian Council of Agricultural Research (ICAR); ICAR - National Dairy Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - National Dairy Research Institute	Kaushik, JK (corresponding author), Natl Dairy Res Inst, Anim Biotechnol Ctr, Karnal, India.	Jaikr1@gmail.com; vkbatish@gmail.com	DUARY, RAJ KUMAR/U-8465-2017	DUARY, RAJ KUMAR/0000-0002-1186-6999; Kaushik, Jai/0000-0002-8872-0066	Indian Council of Agricultural Research	Indian Council of Agricultural Research(Indian Council of Agricultural Research (ICAR))	The running funds of the department were used to purchase the chemicals. AK and RKD acknowledge the Indian Council of Agricultural Research for providing Junior Research Fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlerberth I, 1996, APPL ENVIRON MICROB, V62, P2244, DOI 10.1128/AEM.62.7.2244-2251.1996; Ahrne S, 1998, J APPL MICROBIOL, V85, P88; Mariutti LRB, 2008, BRAZ ARCH BIOL TECHN, V51, P1225, DOI 10.1590/S1516-89132008000600018; Bengmark S, 1998, GUT, V42, P2, DOI 10.1136/gut.42.1.2; Bianchi MA, 2004, LETT APPL MICROBIOL, V39, P301, DOI 10.1111/j.1472-765X.2004.01589.x; Boekhorst J, 2006, MICROBIOL-SGM, V152, P273, DOI 10.1099/mic.0.28415-0; Boekhorst J, 2006, MICROBIOL-SGM, V152, P3175, DOI 10.1099/mic.0.29217-0; Bolotin A, 2001, GENOME RES, V11, P731, DOI 10.1101/gr.GR-1697R; Bron PA, 2004, J BACTERIOL, V186, P5721, DOI 10.1128/JB.186.17.5721-5729.2004; Carey CM, 2008, J MICROBIOL METH, V73, P125, DOI 10.1016/j.mimet.2008.01.014; Cataloluk O, 2004, FEMS MICROBIOL LETT, V236, P7, DOI 10.1016/j.femsle.2004.05.010; Cesena C, 2001, J DAIRY SCI, V84, P1001, DOI 10.3168/jds.S0022-0302(01)74559-6; Christie J, 2002, MICROBIOL-SGM, V148, P1615, DOI 10.1099/00221287-148-6-1615; Collado MC, 2007, J FOOD SCI, V72, pM89, DOI 10.1111/j.1750-3841.2007.00294.x; Collado MC, 2006, J FOOD PROTECT, V69, P1675, DOI 10.4315/0362-028X-69.7.1675; Crittenden R, 2002, J SCI FOOD AGR, V82, P781, DOI 10.1002/jsfa.1095; van de Guchte M, 2006, P NATL ACAD SCI USA, V103, P9274, DOI 10.1073/pnas.0603024103; de Vries MC, 2006, INT DAIRY J, V16, P1018, DOI 10.1016/j.idairyj.2005.09.003; Del Re B, 2000, LETT APPL MICROBIOL, V31, P438, DOI 10.1046/j.1365-2672.2000.00845.x; DESMET I, 1994, MICROB ECOL HEALTH D, V7, P315, DOI 10.3109/08910609409141371; Donnet-Hughes A, 1999, J DAIRY SCI, V82, P863, DOI 10.3168/jds.S0022-0302(99)75304-X; Draksler D, 2004, REPROD NUTR DEV, V44, P397, DOI 10.1051/rnd:2004046; du Toit M, 1998, INT J FOOD MICROBIOL, V40, P93, DOI 10.1016/S0168-1605(98)00024-5; Dubernet S, 2002, FEMS MICROBIOL LETT, V214, P271, DOI [10.1111/j.1574-6968.2002.tb11358.x, 10.1016/S0378-1097(02)00895-9]; Dunne C, 1999, ANTON LEEUW INT J G, V76, P279, DOI 10.1023/A:1002065931997; Falagas ME, 2007, CLIN MICROBIOL INFEC, V13, P657, DOI 10.1111/j.1469-0691.2007.01688.x; Falagas ME, 2006, J ANTIMICROB CHEMOTH, V58, P266, DOI 10.1093/jac/dkl246; FLOCH MH, 1972, AM J CLIN NUTR, V25, P1418; Food and Agriculture Organization of the United Nations World Health Organization, 2002, GUIDELINES EVALUATIO; GILLILAND SE, 2001, HLTH NUTR PROPERTIES; Hernandez-Ledesma B, 2005, J SCI FOOD AGR, V85, P1041, DOI 10.1002/jsfa.2063; Hugo AA, 2008, LETT APPL MICROBIOL, V46, P613, DOI 10.1111/j.1472-765X.2008.02363.x; Jacobsen CN, 1999, APPL ENVIRON MICROB, V65, P4949; JENCKS WP, 1969, MCGRAWHILL SERIES AD, P555; JOHANSSON ML, 1993, APPL ENVIRON MICROB, V59, P15, DOI 10.1128/AEM.59.1.15-20.1993; KAIZU H, 1993, J DAIRY SCI, V76, P2493, DOI 10.3168/jds.S0022-0302(93)77584-0; Klaenhammer T. R., 1993, BACTERIOCINS LACTIC, P151; Klaenhammer TR, 2005, FEMS MICROBIOL REV, V29, P393, DOI 10.1016/j.femsre.2005.04.007; Kleerebezem M, 2003, P NATL ACAD SCI USA, V100, P1990, DOI 10.1073/pnas.0337704100; Kmet V, 1997, FEMS IMMUNOL MED MIC, V19, P111, DOI 10.1016/S0928-8244(97)00075-8; Kos B, 2003, J APPL MICROBIOL, V94, P981, DOI 10.1046/j.1365-2672.2003.01915.x; Kullisaar T, 2002, INT J FOOD MICROBIOL, V72, P215, DOI 10.1016/S0168-1605(01)00674-2; Lam EKY, 2007, EUR J PHARMACOL, V565, P171, DOI 10.1016/j.ejphar.2007.02.050; Lambert JM, 2008, APPL ENVIRON MICROB, V74, P4719, DOI 10.1128/AEM.00137-08; Lankaputhra W. E. V., 1995, Cultured Dairy Products Journal, V30, P2; Lim Hyeong-Jun, 2004, J Vet Sci, V5, P391; Lin MY, 1999, J AGR FOOD CHEM, V47, P1460, DOI 10.1021/jf981149l; LINDGREN SE, 1990, FEMS MICROBIOL LETT, V87, P149, DOI 10.1111/j.1574-6968.1990.tb04885.x; Makarova K, 2006, P NATL ACAD SCI USA, V103, P15611, DOI 10.1073/pnas.0607117103; Marco ML, 2007, APPL ENVIRON MICROB, V73, P124, DOI 10.1128/AEM.01475-06; MARTEAU P, 1993, FEMS MICROBIOL REV, V12, P207, DOI [10.1016/0168-6445(93)90064-G, 10.1111/j.1574-6976.1993.tb00019.x]; Minelli EB, 2004, INT DAIRY J, V14, P723, DOI 10.1016/j.idairyj.2004.01.007; Molenaar D, 2005, J BACTERIOL, V187, P6119, DOI 10.1128/JB.187.17.6119-6127.2005; Neeser JR, 2000, GLYCOBIOLOGY, V10, P1193, DOI 10.1093/glycob/10.11.1193; Nollet Lode J.A., 1999, Microbial Ecology in Health and Disease, V11, P13, DOI 10.1080/089106099435871; Ocana Virginia S, 2002, Br J Biomed Sci, V59, P183; ODUNFA SA, 1996, TRADITIONAL FERMENTE, P27; Pellegrini N, 1999, METHOD ENZYMOL, V299, P379; Pena JA, 2005, INFECT IMMUN, V73, P912, DOI 10.1128/IAI.73.2.912-920.2005; Pereira DIA, 2003, APPL ENVIRON MICROB, V69, P4743, DOI 10.1128/AEM.69.8.4743-4752.2003; POSPIECH A, 1995, TRENDS GENET, V11, P217, DOI 10.1016/S0168-9525(00)89052-6; Prakash R, 1997, INDIAN J DAIRY SCI, V10, P43; Pretzer G, 2005, J BACTERIOL, V187, P6128, DOI 10.1128/JB.187.17.6128-6136.2005; Pridmore RD, 2004, P NATL ACAD SCI USA, V101, P2512, DOI 10.1073/pnas.0307327101; Ramiah K, 2007, INT J FOOD MICROBIOL, V116, P405, DOI 10.1016/j.ijfoodmicro.2007.02.011; Reid G, 1999, APPL ENVIRON MICROB, V65, P3763; RENZIK SR, 1993, MIKROBIOLZ, V55, P81; Rickard AH, 2003, TRENDS MICROBIOL, V11, P94, DOI 10.1016/S0966-842X(02)00034-3; RIJNAARTS HHM, 1993, APPL ENVIRON MICROB, V59, P3255, DOI 10.1128/AEM.59.10.3255-3265.1993; Roos S, 2002, MICROBIOL-SGM, V148, P433, DOI 10.1099/00221287-148-2-433; ROSENBERG M, 1980, FEMS MICROBIOL LETT, V9, P29, DOI 10.1016/0378-1097(80)90106-8; Schar-Zammaretti P, 2003, BIOPHYS J, V85, P4076, DOI 10.1016/S0006-3495(03)74820-6; Schiffrin EJ, 1997, AM J CLIN NUTR, V66, P515, DOI 10.1093/ajcn/66.2.515S; Schillinger U, 2005, INT DAIRY J, V15, P1289, DOI 10.1016/j.idairyj.2004.12.008; Song YL, 2000, FEMS MICROBIOL LETT, V187, P167, DOI 10.1016/S0378-1097(00)00196-8; Tomas MSJ, 2005, J APPL MICROBIOL, V99, P1383, DOI 10.1111/j.1365-2672.2005.02726.x; Troost FJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-374; Tuomola E, 2001, AM J CLIN NUTR, V73, p393S, DOI 10.1093/ajcn/73.2.393s; Tuomola EM, 1998, INT J FOOD MICROBIOL, V41, P45, DOI 10.1016/S0168-1605(98)00033-6; van Baarlen P, 2009, P NATL ACAD SCI USA, V106, P2371, DOI 10.1073/pnas.0809919106; Vanderhoof JA, 1998, J PEDIATR GASTR NUTR, V27, P323, DOI 10.1097/00005176-199809000-00011; VANDEVOORDE L, 1992, J APPL BACTERIOL, V72, P214, DOI 10.1111/j.1365-2672.1992.tb01826.x; VELDMAN A, 1992, TIJDSCHR DIERGENEESK, V117, P345; Vitini E, 2000, BIOCELL, V24, P223; Vouloumanou EK, 2009, INT J ANTIMICROB AG, V34, DOI 10.1016/j.ijantimicag.2008.11.005; Wilson AR, 2005, J APPL MICROBIOL, V99, P1516, DOI 10.1111/j.1365-2672.2005.02725.x; Woodmansey EJ, 2007, J APPL MICROBIOL, V102, P1178, DOI 10.1111/j.1365-2672.2007.03400.x; Yadav H, 2006, BIOSCI BIOTECH BIOCH, V70, P1255, DOI 10.1271/bbb.70.1255	88	197	208	5	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2009	4	12							e8099	10.1371/journal.pone.0008099	http://dx.doi.org/10.1371/journal.pone.0008099			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MT	19956615	Green Submitted, Green Published, gold			2022-12-25	WOS:000272828700012
J	Mito, JK; Riedel, RF; Dodd, L; Lahat, G; Lazar, AJ; Dodd, RD; Stangenberg, L; Eward, WC; Hornicek, FJ; Yoon, SS; Brigman, BE; Jacks, T; Lev, D; Mukherjee, S; Kirsch, DG				Mito, Jeffrey K.; Riedel, Richard F.; Dodd, Leslie; Lahat, Guy; Lazar, Alexander J.; Dodd, Rebecca D.; Stangenberg, Lars; Eward, William C.; Hornicek, Francis J.; Yoon, Sam S.; Brigman, Brian E.; Jacks, Tyler; Lev, Dina; Mukherjee, Sayan; Kirsch, David G.			Cross Species Genomic Analysis Identifies a Mouse Model as Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma	PLOS ONE			English	Article							SOFT-TISSUE SARCOMA; GENE-EXPRESSION; H-RAS; NORMALIZATION; MUTATIONS; INSIGHTS	Undifferentiated pleomorphic sarcoma/Malignant Fibrous Histiocytoma (MFH) is one of the most common subtypes of human soft tissue sarcoma. Using cross species genomic analysis, we define a geneset from the LSL-Kras(G12D); Trp53(Flox/Flox) mouse model of soft tissue sarcoma that is highly enriched in human MFH. With this mouse geneset as a filter, we identify expression of the RAS target FOXM1 in human MFH. Expression of Foxm1 is elevated in mouse sarcomas that metastasize to the lung and tissue microarray analysis of human MFH correlates overexpression of FOXM1 with metastasis. These results suggest that genomic alterations present in human MFH are conserved in the LSL-Kras(G12D); p53(Flox/Flox) mouse model of soft tissue sarcoma and demonstrate the utility of this pre-clinical model.	[Mito, Jeffrey K.; Kirsch, David G.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Riedel, Richard F.] Duke Univ, Med Ctr, Dept Med, Div Med Oncol, Durham, NC 27710 USA; [Dodd, Leslie; Lev, Dina] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Lahat, Guy] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA; [Lazar, Alexander J.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Dodd, Rebecca D.; Kirsch, David G.] Duke Univ, Med Ctr, Dept Radiat Oncol, Durham, NC USA; [Stangenberg, Lars; Hornicek, Francis J.; Yoon, Sam S.] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; [Stangenberg, Lars; Hornicek, Francis J.; Yoon, Sam S.] Harvard Univ, Sch Med, Boston, MA USA; [Eward, William C.; Brigman, Brian E.] Duke Univ, Med Ctr, Dept Surg, Div Orthopaed Surg, Durham, NC 27710 USA; [Jacks, Tyler] MIT, Ctr Canc Res, Cambridge, MA 02139 USA; [Jacks, Tyler] Howard Hughes Med Inst, Chevy Chase, MD USA; [Mukherjee, Sayan] Duke Univ, Dept Stat Sci, Durham, NC USA; [Mukherjee, Sayan] Duke Univ, Med Ctr, Inst Genome Sci & Policy, Durham, NC USA	Duke University; Duke University; Duke University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Duke University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Duke University; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Duke University; Duke University	Mito, JK (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA.	david.kirsch@duke.edu	Riedel, Richard/HHM-4275-2022; Lazar, Alexander J/A-3416-2008	Lazar, Alexander J/0000-0002-6395-4499; Dodd, Rebecca/0000-0001-7295-1882; Stangenberg, Lars/0000-0002-9432-0683; Mukherjee, Sayan/0000-0002-6715-3920	Howard Hughes Medical Institute [KO8 CA 114176, RO1 CA 138265, T32 GM- 07171]; Maria Garcia-Estrada Foundation; NATIONAL CANCER INSTITUTE [R01CA138265, K08CA114176] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007171] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Maria Garcia-Estrada Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the Howard Hughes Medical Institute (TJ) and by KO8 CA 114176 and RO1 CA 138265 (DGK), T32 GM- 07171 (JM), and the Maria Garcia-Estrada Foundation (RR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird K, 2005, CANCER RES, V65, P9226, DOI 10.1158/0008-5472.CAN-05-1699; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Detwiller KY, 2005, CANCER RES, V65, P5881, DOI 10.1158/0008-5472.CAN-04-4078; Fletcher CDM, 2001, J CLIN ONCOL, V19, P3045, DOI 10.1200/JCO.2001.19.12.3045; FLETCHER CDM, 1992, AM J SURG PATHOL, V16, P213, DOI 10.1097/00000478-199203000-00001; Haldar M, 2007, CANCER CELL, V11, P375, DOI 10.1016/j.ccr.2007.01.016; HOLLOWOOD K, 1995, SEMIN DIAGN PATHOL, V12, P210; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kirsch DG, 2007, NAT MED, V13, P992, DOI 10.1038/nm1602; LEACH FS, 1993, CANCER RES, V53, P2231; Liu MG, 2006, CANCER RES, V66, P3593, DOI 10.1158/0008-5472.CAN-05-2912; Ma RYM, 2005, J CELL SCI, V118, P795, DOI 10.1242/jcs.01657; Nakayama R, 2007, MODERN PATHOL, V20, P749, DOI 10.1038/modpathol.3800794; OZZELLO L, 1963, CANCER-AM CANCER SOC, V16, P331, DOI 10.1002/1097-0142(196303)16:3<331::AID-CNCR2820160307>3.0.CO;2-F; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Wang IC, 2008, J BIOL CHEM, V283, P20770, DOI 10.1074/jbc.M709892200; Yoo J, 1999, CANCER, V86, P58, DOI 10.1002/(SICI)1097-0142(19990701)86:1<58::AID-CNCR10>3.3.CO;2-J; Yoo JY, 1999, MODERN PATHOL, V12, P775	20	52	54	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2009	4	11							e8075	10.1371/journal.pone.0008075	http://dx.doi.org/10.1371/journal.pone.0008075			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MQ	19956606	Green Published, Green Submitted, gold			2022-12-25	WOS:000272828400022
J	Moffitt, H; McPhail, GD; Woodman, B; Hobbs, C; Bates, GP				Moffitt, Hilary; McPhail, Graham D.; Woodman, Ben; Hobbs, Carl; Bates, Gillian P.			Formation of Polyglutamine Inclusions in a Wide Range of Non-CNS Tissues in the HdhQ150 Knock-In Mouse Model of Huntington's Disease	PLOS ONE			English	Article							NEURONAL INTRANUCLEAR INCLUSIONS; EXPANDED CAG REPEAT; HD TRANSGENIC MICE; R6/2 MOUSE; SKELETAL-MUSCLE; GENE-EXPRESSION; DIABETES-MELLITUS; WEIGHT-LOSS; MUTATION; ABNORMALITIES	Background: Huntington's disease (HD) is an inherited progressive neurodegenerative disorder caused by a CAG repeat expansion in the ubiquitously expressed HD gene resulting in an abnormally long polyglutamine repeat in the huntingtin protein. Polyglutamine inclusions are a hallmark of the neuropathology of HD. We have previously shown that inclusion pathology is also present in the peripheral tissues of the R6/2 mouse model of HD which expresses a small N-terminal fragment of mutant huntingtin. To determine whether this peripheral pathology is a consequence of the aberrant expression of this N-terminal fragment, we extend this analysis to the genetically precise knock-in mouse model of HD, HdhQ150, which expresses mutant mouse huntingtin. Methodology/Principal Findings: We have previously standardized the CAG repeat size and strain background of the R6/2 and HdhQ150 knock-in mouse models and found that they develop a comparable and widespread neuropathology. To determine whether HdhQ150 knock-in mice also develop peripheral inclusion pathology, homozygous Hdh(Q150/Q150) mice were perfusion fixed at 22 months of age, and tissues were processed for histology and immunohistochemistry with the anti-huntingtin antibody S830. The peripheral inclusion pathology was almost identical to that found in R6/2 mice at 12 weeks of age with minor differences in inclusion abundance. Conclusions/Significance: The highly comparable peripheral inclusion pathology that is present in both the R6/2 and HdhQ150 knock-in models of HD indicates that the presence of peripheral inclusions in R6/2 mice is not a consequence of the aberrant expression of an N-terminal huntingtin protein. It remains to be determined whether peripheral inclusions are a pathological feature of the human disease. Both mouse models carry CAG repeats that cause childhood disease in humans, and therefore, inclusion pathology may be a feature of the childhood rather than the adult forms of HD. It is important to establish the extent to which peripheral pathology causes the peripheral symptoms of HD from the perspective of a mechanistic understanding and future treatment options.	[Moffitt, Hilary; Woodman, Ben; Bates, Gillian P.] Kings Coll London, Sch Med, Dept Med & Mol Genet, London WC2R 2LS, England; [McPhail, Graham D.] Royal London Hosp, Barts & London NHS Trust, Div Cellular Pathol, London E1 1BB, England; [Hobbs, Carl] Kings Coll London, Sch Med, Wolfson Ctr Age Related Dis, London WC2R 2LS, England	University of London; King's College London; Barts Health NHS Trust; Royal London Hospital; University of London; King's College London	Moffitt, H (corresponding author), Kings Coll London, Sch Med, Dept Med & Mol Genet, London WC2R 2LS, England.	gillian.bates@kcl.ac.uk	Longo, Kenneth A/A-5631-2010; Bates, Gillian P/E-1146-2012	Bates, Gillian P/0000-0002-4041-6305	Medical Research Council [G9800001]; Wellcome Trust [066270]; CHDI Foundation; Huntington's Disease Society of America Coalition; MRC [G9800001] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); CHDI Foundation; Huntington's Disease Society of America Coalition; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from Medical Research Council (G9800001), Wellcome Trust (066270), CHDI Foundation, and Huntington's Disease Society of America Coalition for the Cure to GPB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreassen OA, 2002, NEUROBIOL DIS, V11, P410, DOI 10.1006/nbdi.2002.0562; Aziz NA, 2008, NEUROLOGY, V71, P1506, DOI 10.1212/01.wnl.0000334276.09729.0e; Aziz NA, 2007, REV NEUROSCIENCE, V18, P223; Bacos K, 2008, HISTOCHEM CELL BIOL, V129, P623, DOI 10.1007/s00418-008-0393-z; Bancroft J., 2007, THEORY PRACTICE HIST, V6 ed; BATES G, 2002, HUNTINGTONS DIS; Bjorkqvist M, 2006, HUM MOL GENET, V15, P1713, DOI 10.1093/hmg/ddl094; Bjorkqvist M, 2005, HUM MOL GENET, V14, P565, DOI 10.1093/hmg/ddi053; Bjorkqvist M, 2008, J EXP MED, V205, P1869, DOI 10.1084/jem.20080178; Busse ME, 2008, J NEUROL, V255, P1534, DOI 10.1007/s00415-008-0964-x; Chaturvedi RK, 2009, HUM MOL GENET, V18, P3048, DOI 10.1093/hmg/ddp243; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Djousse L, 2002, NEUROLOGY, V59, P1325, DOI 10.1212/01.WNL.0000031791.10922.CF; Duan WZ, 2003, P NATL ACAD SCI USA, V100, P2911, DOI 10.1073/pnas.0536856100; Fain JN, 2001, HUM MOL GENET, V10, P145, DOI 10.1093/hmg/10.2.145; Goodman AOG, 2008, EXP NEUROL, V210, P691, DOI 10.1016/j.expneurol.2007.12.026; Gutekunst CA, 1999, J NEUROSCI, V19, P2522; Hayat M.A., 2000, PRINCIPALS TECHNIQUE; Henley SMD, 2009, MOVEMENT DISORD, V24, P932, DOI 10.1002/mds.22485; Hockly E, 2003, BRAIN RES BULL, V61, P469, DOI 10.1016/S0361-9230(03)00185-0; Hunt MJ, 2005, EXP BRAIN RES, V166, P220, DOI 10.1007/s00221-005-2357-z; Hurlbert MS, 1999, DIABETES, V48, P649, DOI 10.2337/diabetes.48.3.649; Josefsen K, 2008, J NEUROENDOCRINOL, V20, P165, DOI 10.1111/j.1365-2826.2007.01629.x; Kloppel S, 2009, NEUROSCIENCE, V164, P205, DOI 10.1016/j.neuroscience.2009.01.045; Kosinski CM, 2007, MOVEMENT DISORD, V22, P1637, DOI 10.1002/mds.21550; Kuhn A, 2007, HUM MOL GENET, V16, P1845, DOI 10.1093/hmg/ddm133; Lalic NM, 2008, ARCH NEUROL-CHICAGO, V65, P476, DOI 10.1001/archneur.65.4.476; LANSKA DJ, 1988, NEUROLOGY, V38, P769, DOI 10.1212/WNL.38.5.769; Lin CH, 2001, HUM MOL GENET, V10, P137, DOI 10.1093/hmg/10.2.137; Lodi R, 2000, ANN NEUROL, V48, P72; Luesse HG, 2001, BEHAV BRAIN RES, V126, P185, DOI 10.1016/S0166-4328(01)00261-3; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Markianos M, 2005, ANN NEUROL, V57, P520, DOI 10.1002/ana.20428; Martin B, 2009, DIABETES, V58, P318, DOI 10.2337/db08-0799; Menalled L, 2009, NEUROBIOL DIS, V35, P319, DOI 10.1016/j.nbd.2009.05.007; Mihm MJ, 2007, NEUROBIOL DIS, V25, P297, DOI 10.1016/j.nbd.2006.09.016; Myers Richard H, 2004, NeuroRx, V1, P255, DOI 10.1007/BF03206609; Panov AV, 2002, NAT NEUROSCI, V5, P731, DOI 10.1038/nn884; Papalexi E, 2005, EUR J NEUROSCI, V22, P1541, DOI 10.1111/j.1460-9568.2005.04324.x; Pattison JS, 2008, CIRCULATION, V117, P2743, DOI 10.1161/CIRCULATIONAHA.107.750232; Petersen A, 2005, HUM MOL GENET, V14, P39, DOI 10.1093/hmg/ddi004; Petersen A, 2006, EUR J NEUROSCI, V24, P961, DOI 10.1111/j.1460-9568.2006.04985.x; Phan J, 2009, HUM MOL GENET, V18, P1006, DOI 10.1093/hmg/ddn428; Powley TL, 2005, AM J PHYSIOL-REG I, V289, pR563, DOI 10.1152/ajpregu.00167.2005; Ribchester RR, 2004, EUR J NEUROSCI, V20, P3092, DOI 10.1111/j.1460-9568.2004.03783.x; Rubinsztein DC, 1996, AM J HUM GENET, V59, P16; Saft C, 2005, MOVEMENT DISORD, V20, P674, DOI 10.1002/mds.20373; Saleh N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004962; SANBERG PR, 1981, MED J AUSTRALIA, V1, P407, DOI 10.5694/j.1326-5377.1981.tb135681.x; Sathasivam K, 1999, HUM MOL GENET, V8, P813, DOI 10.1093/hmg/8.5.813; Sathasivam K, 2001, HUM MOL GENET, V10, P2425, DOI 10.1093/hmg/10.21.2425; SATHASIVAM K, 2009, HUM MOL GEN IN PRESS; Schilling G, 1999, HUM MOL GENET, V8, P397, DOI 10.1093/hmg/8.3.397; Schilling G, 1999, HUM MOL GENET, V8, P943; SEWRY CA, 2001, DISORDERS VOLUNTARY; SORENSEN SA, 1992, J MED GENET, V29, P911, DOI 10.1136/jmg.29.12.911; Squitieri F, 2006, MECH AGEING DEV, V127, P217, DOI 10.1016/j.mad.2005.09.010; Strand AD, 2005, HUM MOL GENET, V14, P1863, DOI 10.1093/hmg/ddi192; van der Burg JMM, 2008, NEUROBIOL DIS, V29, P41, DOI 10.1016/j.nbd.2007.07.029; Van Raamsdonk JM, 2007, NEUROBIOL DIS, V26, P512, DOI 10.1016/j.nbd.2007.01.006; Weydt P, 2006, CELL METAB, V4, P349, DOI 10.1016/j.cmet.2006.10.004; Woodman B, 2007, BRAIN RES BULL, V72, P83, DOI 10.1016/j.brainresbull.2006.11.004	64	108	108	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2009	4	11							e8025	10.1371/journal.pone.0008025	http://dx.doi.org/10.1371/journal.pone.0008025			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MQ	19956633	Green Published, gold, Green Submitted			2022-12-25	WOS:000272828400004
J	Wu, YJ; Wang, CX; Sun, H; LeRoith, D; Yakar, S				Wu, Yingjie; Wang, Chunxin; Sun, Hui; LeRoith, Derek; Yakar, Shoshana			High-Efficient FLPo Deleter Mice in C57BL/6J Background	PLOS ONE			English	Article							TRANSGENIC MICE; CRE RECOMBINASE; MAMMALIAN-CELLS; EXPRESSION; GENE; WIDESPREAD; MOUSE	Conditional gene manipulation in mice becomes a routine for genetic studies of mammalian gene functions. Additional site-specific recombinases such as FLP or phi 31 provide one more level of gene manipulation flexibility. The recombination activity of the currently available FLP deleter mice remains low. We generated a new FLP deleter mouse line with the mouse codon-optimized FLPo gene in C57BJ/6 background, which showed superior recombination efficacy in comparison to FLPe deleter mice. 100% complete removal of FRT-flanked Neo cassette was observed in all F1 progeny mice carrying both FLPo and Neo cassette, which can be transmitted to F2 generation independent of FLPo activity. Our new FLPo transgenic mice (on pure C57BJ/6 background) will largely facilitate the gene targeting process and is valuable for conditional gene manipulation.	[Wu, Yingjie; Sun, Hui; LeRoith, Derek; Yakar, Shoshana] Mt Sinai Sch Med, Endocrinol Diabet & Bone Dis Div, New York, NY USA; [Wang, Chunxin] NINDS, Biochem Sect, SNB, NIH, Bethesda, MD 20892 USA	Icahn School of Medicine at Mount Sinai; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Wu, YJ (corresponding author), Mt Sinai Sch Med, Endocrinol Diabet & Bone Dis Div, New York, NY USA.	shoshana.yakar@mssm.edu	Wang, Chunxin/B-9312-2016	Wang, Chunxin/0000-0001-6015-6806	NIH [AR054919, AR055141]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054919, R01AR055141] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work is funded by the NIH grants AR054919, AR055141 to S.Y. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreas S, 2002, NUCLEIC ACIDS RES, V30, P2299, DOI 10.1093/nar/30.11.2299; Buchholz F, 1998, NAT BIOTECHNOL, V16, P657, DOI 10.1038/nbt0798-657; Dymecki SM, 1996, P NATL ACAD SCI USA, V93, P6191, DOI 10.1073/pnas.93.12.6191; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; FIERING S, 1995, GENE DEV, V9, P2203, DOI 10.1101/gad.9.18.2203; Kanki H, 2006, EXP ANIM TOKYO, V55, P137, DOI 10.1538/expanim.55.137; Kondo S, 2009, J MOL BIOL, V390, P221, DOI 10.1016/j.jmb.2009.04.057; MCBURNEY MW, 1994, DEV DYNAM, V200, P278, DOI 10.1002/aja.1002000403; Meyers EN, 1998, NAT GENET, V18, P136, DOI 10.1038/ng0298-136; Mishina M, 2007, NEUROSCI RES, V58, P105, DOI 10.1016/j.neures.2007.01.004; Nagy A, 2000, GENESIS, V26, P99, DOI 10.1002/(SICI)1526-968X(200002)26:2<99::AID-GENE1>3.0.CO;2-B; Nagy Andras, 2009, V530, P365, DOI 10.1007/978-1-59745-471-1_19; Raymond CS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000162; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Schaft J, 2001, GENESIS, V31, P6, DOI 10.1002/gene.1076; Takeuchi T, 2002, BIOCHEM BIOPH RES CO, V293, P953, DOI 10.1016/S0006-291X(02)00321-2; Testa G, 2004, GENESIS, V38, P151, DOI 10.1002/gene.20012; Vooijs M, 1998, ONCOGENE, V17, P1, DOI 10.1038/sj.onc.1202169	18	54	55	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2009	4	11							e8054	10.1371/journal.pone.0008054	http://dx.doi.org/10.1371/journal.pone.0008054			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MN	19956655	Green Submitted, Green Published, gold			2022-12-25	WOS:000272828100010
J	Jeong, JH; Song, HR; Ko, JH; Jeong, YM; Kwon, YE; Seol, JH; Amasino, RM; Noh, B; Noh, YS				Jeong, Ju-Hee; Song, Hae-Ryong; Ko, Jong-Hyun; Jeong, Young-Min; Kwon, Young Eun; Seol, Jae Hong; Amasino, Richard M.; Noh, Bosl; Noh, Yoo-Sun			Repression of FLOWERING LOCUS T Chromatin by Functionally Redundant Histone H3 Lysine 4 Demethylases in Arabidopsis	PLOS ONE			English	Article							MADS DOMAIN PROTEIN; FLORAL INDUCTION; HETEROCHROMATIN PROTEIN1; EXPRESSION ANALYSIS; TARGET GENES; JMJC DOMAIN; TIME; CONSTANS; ENCODES; THALIANA	FLOWERING LOCUS T (FT) plays a key role as a mobile floral induction signal that initiates the floral transition. Therefore, precise control of FT expression is critical for the reproductive success of flowering plants. Coexistence of bivalent histone H3 lysine 27 trimethylation (H3K27me3) and H3K4me3 marks at the FT locus and the role of H3K27me3 as a strong FT repression mechanism in Arabidopsis have been reported. However, the role of an active mark, H3K4me3, in FT regulation has not been addressed, nor have the components affecting this mark been identified. Mutations in Arabidopsis thaliana Jumonji4 (AtJmj4) and EARLY FLOWERING6 (ELF6), two Arabidopsis genes encoding Jumonji (Jmj) family proteins, caused FT-dependent, additive early flowering correlated with increased expression of FT mRNA and increased H3K4me3 levels within FT chromatin. Purified recombinant AtJmj4 protein possesses specific demethylase activity for mono-, di-, and trimethylated H3K4. Tagged AtJmj4 and ELF6 proteins associate directly with the FT transcription initiation region, a region where the H3K4me3 levels were increased most significantly in the mutants. Thus, our study demonstrates the roles of AtJmj4 and ELF6 as H3K4 demethylases directly repressing FT chromatin and preventing precocious flowering in Arabidopsis.	[Jeong, Ju-Hee; Song, Hae-Ryong; Ko, Jong-Hyun; Jeong, Young-Min; Amasino, Richard M.; Noh, Bosl; Noh, Yoo-Sun] Seoul Natl Univ, Global Res Lab Floral Regulatory Signaling, Seoul, South Korea; [Jeong, Ju-Hee; Song, Hae-Ryong; Ko, Jong-Hyun; Jeong, Young-Min; Kwon, Young Eun; Seol, Jae Hong; Noh, Yoo-Sun] Seoul Natl Univ, Sch Biol Sci, Seoul, South Korea; [Noh, Bosl] Gyeongsang Natl Univ, Environm Biotechnol Natl Core Res Ctr, Jinju, South Korea; [Jeong, Young-Min; Amasino, Richard M.] Univ Wisconsin, Dept Biochem, Madison, WI 53705 USA	Seoul National University (SNU); Seoul National University (SNU); Gyeongsang National University; University of Wisconsin System; University of Wisconsin Madison	Noh, B (corresponding author), Seoul Natl Univ, Global Res Lab Floral Regulatory Signaling, Seoul, South Korea.	bnoh2003@yahoo.co.kr; ysnoh@snu.ac.kr		Jeong, Young-Min/0000-0001-6849-0067	Ministry of Education, Science, and Technology [R15-2003-012-01001-0]; Korea Research Foundation [KRF-2007-313-C00703, KRF-2008-314-C00359]; BK21 Program	Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea Research Foundation(National Research Foundation of Korea); BK21 Program(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	This work was supported by the Global Research Laboratory Program of the Ministry of Education, Science, and Technology, by the Plant Diversity Research Center, and by the Bio-Green21 Program of the Rural Development Administration. B.N. was supported by a grant from the Ministry of Education, Science, and Technology to the Environmental Biotechnology National Core Research Center (R15-2003-012-01001-0) and by grants from the Korea Research Foundation (KRF-2007-313-C00703 and KRF-2008-314-C00359). J.-H. J and H.-R. S. were supported by the BK21 Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2005, SCIENCE, V309, P1052, DOI 10.1126/science.1115983; Adamczyk BJ, 2007, PLANT J, V50, P1007, DOI 10.1111/j.1365-313X.2007.03105.x; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Ausin I, 2004, NAT GENET, V36, P162, DOI 10.1038/ng1295; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Castillejo C, 2008, CURR BIOL, V18, P1338, DOI 10.1016/j.cub.2008.07.075; Chang BS, 2007, SCIENCE, V318, P444, DOI 10.1126/science.1145801; Choi K, 2005, PLANT CELL, V17, P2647, DOI 10.1105/tpc.105.035485; Christensen J, 2007, CELL, V128, P1063, DOI 10.1016/j.cell.2007.02.003; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; Farrona S, 2008, SEMIN CELL DEV BIOL, V19, P560, DOI 10.1016/j.semcdb.2008.07.015; Fowler S, 1999, EMBO J, V18, P4679, DOI 10.1093/emboj/18.17.4679; Han SK, 2007, PLANT J, V49, P103, DOI 10.1111/j.1365-313X.2006.02939.x; Hartmann U, 2000, PLANT J, V21, P351, DOI 10.1046/j.1365-313x.2000.00682.x; He YH, 2003, SCIENCE, V302, P1751, DOI 10.1126/science.1091109; Hong EH, 2009, MOL CELLS, V27, P481, DOI 10.1007/s10059-009-0054-7; Jiang DH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003404; Jung JH, 2007, PLANT CELL, V19, P2736, DOI 10.1105/tpc.107.054528; Kang BH, 2001, PLANT PHYSIOL, V126, P47, DOI 10.1104/pp.126.1.47; Kardailsky I, 1999, SCIENCE, V286, P1962, DOI 10.1126/science.286.5446.1962; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Klose RJ, 2006, NATURE, V442, P312, DOI 10.1038/nature04853; Kobayashi Y, 1999, SCIENCE, V286, P1960, DOI 10.1126/science.286.5446.1960; KOORNNEEF M, 1994, PLANT J, V6, P911, DOI 10.1046/j.1365-313X.1994.6060911.x; KOORNNEEF M, 1991, MOL GEN GENET, V229, P57, DOI 10.1007/BF00264213; Kotake T, 2003, PLANT CELL PHYSIOL, V44, P555, DOI 10.1093/pcp/pcg091; Larsson AS, 1998, GENETICS, V149, P597; Lee H, 2000, GENE DEV, V14, P2366, DOI 10.1101/gad.813600; LEE I, 1994, PLANT J, V6, P903, DOI 10.1046/j.1365-313X.1994.6060903.x; Lee JH, 2007, BBA-GENE STRUCT EXPR, V1769, P455, DOI 10.1016/j.bbaexp.2007.05.001; Lee MG, 2007, CELL, V128, P877, DOI 10.1016/j.cell.2007.02.004; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li D, 2008, DEV CELL, V15, P110, DOI 10.1016/j.devcel.2008.05.002; Liu HT, 2008, SCIENCE, V322, P1535, DOI 10.1126/science.1163927; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Michaels SD, 2001, PLANT CELL, V13, P935, DOI 10.1105/tpc.13.4.935; Mylne JS, 2006, P NATL ACAD SCI USA, V103, P5012, DOI 10.1073/pnas.0507427103; Niwa Y, 1999, PLANT J, V18, P455, DOI 10.1046/j.1365-313X.1999.00464.x; Noh B, 2004, PLANT CELL, V16, P2601, DOI 10.1105/tpc.104.025353; Noh YS, 2003, PLANT CELL, V15, P1671, DOI 10.1105/tpc.012161; Park DH, 1999, SCIENCE, V285, P1579, DOI 10.1126/science.285.5433.1579; Pasini D, 2008, GENE DEV, V22, P1345, DOI 10.1101/gad.470008; PUTTERILL J, 1995, CELL, V80, P847, DOI 10.1016/0092-8674(95)90288-0; Samach A, 2000, SCIENCE, V288, P1613, DOI 10.1126/science.288.5471.1613; Saze H, 2008, SCIENCE, V319, P462, DOI 10.1126/science.1150987; Schatlowski N, 2008, SEMIN CELL DEV BIOL, V19, P547, DOI 10.1016/j.semcdb.2008.07.019; Schmid M, 2003, DEVELOPMENT, V130, P6001, DOI 10.1242/dev.00842; Schomburg FM, 2001, PLANT CELL, V13, P1427, DOI 10.1105/tpc.13.6.1427; Sheldon CC, 1999, PLANT CELL, V11, P445, DOI 10.1105/tpc.11.3.445; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Sung SB, 2004, NATURE, V427, P159, DOI 10.1038/nature02195; Takada S, 2003, PLANT CELL, V15, P2856, DOI 10.1105/tpc.016345; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Turck F, 2007, PLOS GENET, V3, P855, DOI 10.1371/journal.pgen.0030086; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016; Wenkel S, 2006, PLANT CELL, V18, P2971, DOI 10.1105/tpc.106.043299; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Wigge PA, 2005, SCIENCE, V309, P1056, DOI 10.1126/science.1114358; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Yoo SK, 2005, PLANT PHYSIOL, V139, P770, DOI 10.1104/pp.105.066928; Zhang X, 2007, NAT STRUCT MOL BIOL, V14, P869, DOI 10.1038/nsmb1283	63	114	123	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2009	4	11							e8033	10.1371/journal.pone.0008033	http://dx.doi.org/10.1371/journal.pone.0008033			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MK	19946624	Green Published, Green Submitted, gold			2022-12-25	WOS:000272827800020
J	Delihas, N				Delihas, Nicholas			Stem Loop Sequences Specific to Transposable Element IS605 Are Found Linked to Lipoprotein Genes in Borrelia Plasmids	PLOS ONE			English	Article							DNA INSERTION SEQUENCES; LYME-DISEASE SPIROCHETE; FUNCTIONAL-PROPERTIES; SMALL RNA; BURGDORFERI; ORGANIZATION; REPEATS; GENOME; NEISSERIAE; ACTIVATION	Background: Plasmids of Borrelia species are dynamic structures that contain a large number of repetitive genes, gene fragments, and gene fusions. In addition, the transposable element IS605/200 family, as well as degenerate forms of this IS element, are prevalent. In Helicobacter pylori, flanking regions of the IS605 transposase gene contain sequences that fold into identical small stem loops. These function in transposition at the single-stranded DNA level. Methodology/Principal Findings: In work reported here, bioinformatics techniques were used to scan Borrelia plasmid genomes for IS605 transposable element specific stem loop sequences. Two variant stem loop motifs are found in the left and right flanking regions of the transposase gene. Both motifs appear to have dispersed in plasmid genomes and are found "free-standing'' and phylogenetically conserved without the associated IS605 transposase gene or the adjacent flanking sequence. Importantly, IS605 specific stem loop sequences are also found at the 3' ends of lipoprotein genes (PFam12 and PFam60), however the left and right sequences appear to develop their own evolutionary patterns. The lipoprotein gene-linked left stem loop sequences maintain the IS605 stem loop motif in orthologs but only at the RNA level. These show mutations whereby variants fold into phylogenetically conserved RNA-type stem loops that contain the wobble non-Watson-Crick G-U base-pairing. The right flanking sequence is associated with the family lipoprotein-1 genes. A comparison of homologs shows that the IS605 stem loop motif rapidly dissipates, but a more elaborate secondary structure appears to develop in its place. Conclusions/Significance: Stem loop sequences specific to the transposable element IS605 are present in plasmid regions devoid of a transposase gene and significantly, are found linked to lipoprotein genes in Borrelia plasmids. These sequences are evolutionarily conserved and/or structurally developed in an RNA format. The findings show that IS605 stem loop sequences are multifaceted and are selectively conserved during evolution when the transposable element dissipates.			Delihas, N (corresponding author), SUNY Stony Brook, Sch Med, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA.	Nicholas.delihas@sunysb.edu		Delihas, Nicholas/0000-0002-1704-2587				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barabas O, 2008, CELL, V132, P208, DOI 10.1016/j.cell.2007.12.029; Casjens S, 2000, MOL MICROBIOL, V35, P490, DOI 10.1046/j.1365-2958.2000.01698.x; Chen Y, 2008, GENETICS, V179, P2291, DOI 10.1534/genetics.108.089995; De Gregorio E, 2005, J BACTERIOL, V187, P7945, DOI 10.1128/JB.187.23.7945-7954.2005; De Gregorio E, 2002, BBA-GENE STRUCT EXPR, V1576, P39, DOI 10.1016/S0167-4781(02)00290-7; De Gregorio E, 2006, J BACTERIOL, V188, P7876, DOI 10.1128/JB.00942-06; Delihas N, 2007, GENE REGUL SYST BIO, V1, P191; Delihas N, 2008, MOL MICROBIOL, V67, P475, DOI 10.1111/j.1365-2958.2007.06068.x; Delihas N, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-101; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Guynet C, 2008, MOL CELL, V29, P302, DOI 10.1016/j.molcel.2007.12.008; Labarga A, 2007, NUCLEIC ACIDS RES, V35, pW6, DOI 10.1093/nar/gkm291; Lybecker MC, 2007, MOL MICROBIOL, V64, P1075, DOI 10.1111/j.1365-2958.2007.05716.x; Mazzone M, 2001, GENE, V278, P211, DOI 10.1016/S0378-1119(01)00725-9; Mcmanus CJ, 2007, RNA, V13, P2252, DOI 10.1261/rna.699907; Ostberg Y, 2004, J BACTERIOL, V186, P8472, DOI 10.1128/JB.186.24.8472-8477.2004; Ronning DR, 2005, MOL CELL, V20, P143, DOI 10.1016/j.molcel.2005.07.026; SantaLucia J, 1998, P NATL ACAD SCI USA, V95, P1460, DOI 10.1073/pnas.95.4.1460; Schmitz M, 2004, NUCLEIC ACIDS RES, V32, P6358, DOI 10.1093/nar/gkh961; Sittka A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000163; Snyder LAS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-70; Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01; Treangen TJ, 2009, FEMS MICROBIOL REV, V33, P539, DOI 10.1111/j.1574-6976.2009.00169.x; Zhou F, 2008, BIOCHEM BIOPH RES CO, V365, P790, DOI 10.1016/j.bbrc.2007.11.038; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	26	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2009	4	11							e7941	10.1371/journal.pone.0007941	http://dx.doi.org/10.1371/journal.pone.0007941			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522NL	19936201	gold, Green Published, Green Submitted			2022-12-25	WOS:000272004800018
J	Lowenstein, JH; Amato, G; Kolokotronis, SO				Lowenstein, Jacob H.; Amato, George; Kolokotronis, Sergios-Orestis			The Real maccoyii: Identifying Tuna Sushi with DNA Barcodes - Contrasting Characteristic Attributes and Genetic Distances	PLOS ONE			English	Article							ATLANTIC BLUEFIN TUNA; MITOCHONDRIAL-DNA; PHYLOGENETIC-RELATIONSHIPS; SPECIES IDENTIFICATION; FISH; TAXONOMY; DELIMITATION; SUBSTITUTION; MUSCLE; MARKET	Background: The use of DNA barcodes for the identification of described species is one of the least controversial and most promising applications of barcoding. There is no consensus, however, as to what constitutes an appropriate identification standard and most barcoding efforts simply attempt to pair a query sequence with reference sequences and deem identification successful if it falls within the bounds of some pre-established cutoffs using genetic distance. Since the Renaissance, however, most biological classification schemes have relied on the use of diagnostic characters to identify and place species. Methodology/Principal Findings: Here we developed a cytochrome c oxidase subunit 1 character-based key for the identification of all tuna species of the genus Thunnus, and compared its performance with distance-based measures for identification of 68 samples of tuna sushi purchased from 31 restaurants in Manhattan (New York City) and Denver, Colorado. Both the character-based key and GenBank BLAST successfully identified 100% of the tuna samples, while the Barcode of Life Database (BOLD) as well as genetic distance thresholds, and neighbor-joining phylogenetic tree building performed poorly in terms of species identification. A piece of tuna sushi has the potential to be an endangered species, a fraud, or a health hazard. All three of these cases were uncovered in this study. Nineteen restaurant establishments were unable to clarify or misrepresented what species they sold. Five out of nine samples sold as a variant of "white tuna'' were not albacore (T. alalunga), but escolar (Lepidocybium flavorunneum), a gempylid species banned for sale in Italy and Japan due to health concerns. Nineteen samples were northern bluefin tuna (T. thynnus) or the critically endangered southern bluefin tuna (T. maccoyii), though nine restaurants that sold these species did not state these species on their menus. Conclusions/Significance: The Convention on International Trade Endangered Species (CITES) requires that listed species must be identifiable in trade. This research fulfills this requirement for tuna, and supports the nomination of northern bluefin tuna for CITES listing in 2010.			Lowenstein, JH (corresponding author), Amer Museum Nat Hist, Div Vertebrate Zool, New York, NY 10024 USA.	jlowenstein@amnh.org; koloko@amnh.org	Kolokotronis, Sergios-Orestis/A-1910-2009; 赵, 鹏/B-8401-2009; Kolokotronis, Sergios-Orestis/GWM-5773-2022	Kolokotronis, Sergios-Orestis/0000-0003-3309-8465; Kolokotronis, Sergios-Orestis/0000-0003-3309-8465				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amato G, 1999, ANIM CONSERV, V2, P1, DOI 10.1111/j.1469-1795.1999.tb00042.x; Atanassova V, 2008, J FOOD PROTECT, V71, P860, DOI 10.4315/0362-028X-71.4.860; Backeljau T, 1996, MOL BIOL EVOL, V13, P309, DOI 10.1093/oxfordjournals.molbev.a025590; Baker CS, 2008, MOL ECOL, V17, P3985, DOI 10.1111/j.1365-294X.2008.03867.x; Besansky NJ, 2003, TRENDS PARASITOL, V19, P545, DOI 10.1016/j.pt.2003.09.015; Block BA, 2001, SCIENCE, V293, P1310, DOI 10.1126/science.1061197; BOSE S, 1996, MARINE RESOURCE EC, V11, P143, DOI DOI 10.1086/MRE.11.3.42629157; Brower AVZ, 2006, SYST BIODIVERS, V4, P127, DOI 10.1017/S147720000500191X; *BUR RUR SCI, 2008, FISH STAT REP 2007 S; CATARCI C, 2005, WORLD TUNA IND ANAL, P279; Chow S, 2006, J FISH BIOL, V68, P24, DOI 10.1111/j.0022-1112.2006.00945.x; Chow S, 1995, J MOL EVOL, V41, P741, DOI 10.1007/BF00173154; COLLETTE BB, 1999, MACKERELS MOL MORPHO, P149; COLLETTE BB, 1979, PHYSL ECOLOGY TUNAS, P7; Collette Bruce B., 2001, Fish Physiology, V19, P1; *COMM CONS SO BLU, 2008, 13 M SCI COMM ROT NZ; *COMM CONS SO BLU, 2008, REP PERF REV; *COMM CONS SO BLUE, 2008, REP IND EXP; CORSON T, 2007, ZEN FISH STORY SUSHI; DAVIS JI, 1992, SYST BIOL, V41, P421, DOI 10.2307/2992584; de Carvalho MR, 2008, EVOL BIOL, V35, P150, DOI 10.1007/s11692-008-9018-7; DeSalle R, 2005, PHILOS T R SOC B, V360, P1905, DOI 10.1098/rstb.2005.1722; DeSalle R, 2006, J BIOMED INFORM, V39, P6, DOI 10.1016/j.jbi.2005.11.002; DeSalle R, 2004, NAT REV GENET, V5, P702, DOI 10.1038/nrg1425; DeSalle R, 1996, NATURE, V381, P197, DOI 10.1038/381197a0; DeSalle R, 2006, CONSERV BIOL, V20, P1545, DOI 10.1111/j.1523-1739.2006.00543.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elias M, 2007, P ROY SOC B-BIOL SCI, V274, P2881, DOI 10.1098/rspb.2007.1035; ELLIS R, 2008, TUNA LOVE STORY; *EUR FOOD SAF AUTH, 2004, EFSA J, V92, P1; FARRIS J S, 1985, Cladistics, V1, P67, DOI 10.1111/j.1096-0031.1985.tb00411.x; Farris JS, 1996, CLADISTICS, V12, P99, DOI 10.1111/j.1096-0031.1996.tb00196.x; FARWELL CJ, 2001, TUNA PHYSL ECOLOGY E, P391; Ferguson JWH, 2002, BIOL J LINN SOC, V75, P509, DOI 10.1046/j.1095-8312.2002.00042.x; FOX D, 2008, CONSERVATION MAGAZIN; FROESE R, 2008, FISHBASE; Godfray HCJ, 2004, PHILOS T R SOC B, V359, P559, DOI 10.1098/rstb.2003.1457; Goldstein PZ, 2000, CONSERV BIOL, V14, P120, DOI 10.1046/j.1523-1739.2000.98122.x; Hamilton A, 2008, ISIS, V99, P331, DOI 10.1086/588691; HEARNSHAW JB, 1986, ANAL STARLIGHT 150 Y; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hickerson MJ, 2006, SYST BIOL, V55, P729, DOI 10.1080/10635150600969898; Holst-Jensen A, 2004, NEW PHYTOL, V161, P11, DOI 10.1111/j.1469-8137.2004.00961.x; Hsieh YHP, 1998, J FOOD QUALITY, V21, P1, DOI 10.1111/j.1745-4557.1998.tb00499.x; HSIEH YHP, 1995, J FOOD QUALITY, V18, P131, DOI 10.1111/j.1745-4557.1995.tb00368.x; HURRY GD, 2008, REPORT INDEPENDENT R; *INT GAM FISH ASS, 2006, WORLD REC GAM FISH; ISSENBERG S, 2007, SUSHI EC GLOBALIZATI; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Jacquet JL, 2008, MAR POLICY, V32, P309, DOI 10.1016/j.marpol.2007.06.007; Janzen DH, 2004, PHILOS T R SOC B, V359, P731, DOI 10.1098/rstb.2003.1444; Kelly RP, 2007, MOL ECOL NOTES, V7, P177, DOI 10.1111/j.1471-8286.2006.01641.x; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kitagawa T, 2007, FISH OCEANOGR, V16, P409, DOI 10.1111/j.1365-2419.2007.00441.x; Kochzius M, 2008, MAR BIOTECHNOL, V10, P207, DOI 10.1007/s10126-007-9068-3; Lefebure T, 2006, MOL PHYLOGENET EVOL, V40, P435, DOI 10.1016/j.ympev.2006.03.014; Lipp EK, 1997, REV SCI TECH OIE, V16, P620, DOI 10.20506/rst.16.2.1048; Little DP, 2007, CLADISTICS, V23, P1, DOI 10.1111/j.1096-0031.2006.00126.x; Logan CA, 2008, BIOL CONSERV, V141, P1591, DOI 10.1016/j.biocon.2008.04.007; Majkowski J., 2007, FAO FISH TECH PAP, V483, P1; Marcinek DJ, 2001, MAR BIOL, V138, P869, DOI 10.1007/s002270000492; Marko PB, 2004, NATURE, V430, P309, DOI 10.1038/430309b; Mayr E., 1982, GROWTH BIOL THOUGHT; MEDITERRANEAN WWF, 2008, LIFTING LID ITALYS B; Meier R, 2008, SYST BIOL, V57, P809, DOI 10.1080/10635150802406343; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; MESSING J, 1983, METHOD ENZYMOL, V101, P20; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; *MONT BAY AQ, 2008, SUSH GUID; MORENO JIL, 2005, STATUS TUNA STOCKS W, P58; Nakagawa R, 1997, CHEMOSPHERE, V35, P2909, DOI 10.1016/S0045-6535(97)00351-2; OSHIMA T, 1987, PARASITOL TODAY, V3, P44, DOI 10.1016/0169-4758(87)90212-2; Paine MA, 2008, ICHTHYOL RES, V55, P7, DOI 10.1007/s10228-007-0003-4; Paine MA, 2007, B MAR SCI, V80, P353; POLACHECK T, 2007, IMPLICATIONS JAPANES, P16; Porch CE, 2005, B MAR SCI, V76, P363; Prendini L, 2005, CAN J ZOOL, V83, P498, DOI 10.1139/Z05-025; PUNT A, 1996, THUNNUS MACCOYII; QUAMMEN D, 2000, BOILERPLATE RHINO NA; Rach J, 2008, P ROY SOC B-BIOL SCI, V275, P237, DOI 10.1098/rspb.2007.1290; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Rooker JR, 2008, MAR ECOL PROG SER, V368, P231, DOI 10.3354/meps07602; Rooker JR, 2008, SCIENCE, V322, P742, DOI 10.1126/science.1161473; Ross HA, 2008, SYST BIOL, V57, P216, DOI 10.1080/10635150802032990; Rubinoff D, 2006, J HERED, V97, P581, DOI 10.1093/jhered/esl036; Rubinoff D, 2006, CONSERV BIOL, V20, P1548, DOI 10.1111/j.1523-1739.2006.00542.x; SAFINA C, 1993, CONSERV BIOL, V7, P229, DOI 10.1046/j.1523-1739.1993.07020229.x; SAFINA C, 1998, SONG BLUE OCEAN ENCO; SAFINA C, 2001, TUNA PHYSL ECOLOGY E, P413; Safina C, 2008, CONSERV BIOL, V22, P243, DOI 10.1111/j.1523-1739.2008.00901.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sarkar IN, 2002, MOL PHYLOGENET EVOL, V24, P388; Sarkar IN, 2008, MOL ECOL RESOUR, V8, P1256, DOI 10.1111/j.1755-0998.2008.02235.x; SCHWARTZ J, 2008, NY TIMES        0822; SHADBOLT C, 2002, COMMUNICABLE DIS INT, V26, P3; SOKAL R. R., 1963, Principles of numerical taxonomy., P359; SOUTHERLAND B, 2008, NEWSWEEK        0707; Takezaki N, 1998, MOL BIOL EVOL, V15, P727, DOI 10.1093/oxfordjournals.molbev.a025976; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Teisl MF, 2002, J ENVIRON ECON MANAG, V43, P339, DOI 10.1006/jeem.2000.1186; Teletchea F, 2005, TRENDS BIOTECHNOL, V23, P359, DOI 10.1016/j.tibtech.2005.05.006; Vilgalys R, 2003, NEW PHYTOL, V160, P4, DOI 10.1046/j.1469-8137.2003.00894.x; WALT V, 2008, TIME            1128; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; WARDLE CS, 1989, J FISH BIOL, V35, P129, DOI 10.1111/j.1095-8649.1989.tb03399.x; Wheeler QD, 2005, CLADISTICS, V21, P405, DOI 10.1111/j.1096-0031.2005.00075.x; Will KW, 2005, SYST BIOL, V54, P844, DOI 10.1080/10635150500354878; Will KW, 2004, CLADISTICS, V20, P47, DOI 10.1111/j.1096-0031.2003.00008.x; Wong EHK, 2008, FOOD RES INT, V41, P828, DOI 10.1016/j.foodres.2008.07.005; *WWF, 2008, 1000 JOIN BLUEF TUN; *WWF, 2008, TUN COMM COM DISG NO; Yancy HF, 2008, J FOOD PROTECT, V71, P210, DOI 10.4315/0362-028X-71.1.210; 2008, TELEGRAPH       0926; 2008, ECONOMIST       1127	117	124	135	2	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2009	4	11							e7866	10.1371/journal.pone.0007866	http://dx.doi.org/10.1371/journal.pone.0007866			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521QH	19924239	Green Published, gold			2022-12-25	WOS:000271936700009
J	Robert, G; Ben Sahra, I; Puissant, A; Colosetti, P; Belhacene, N; Gounon, P; Hofman, P; Bost, F; Cassuto, JP; Auberger, P				Robert, Guillaume; Ben Sahra, Issam; Puissant, Alexandre; Colosetti, Pascal; Belhacene, Nathalie; Gounon, Pierre; Hofman, Paul; Bost, Frederic; Cassuto, Jill-Patrice; Auberger, Patrick			Acadesine Kills Chronic Myelogenous Leukemia (CML) Cells through PKC-Dependent Induction of Autophagic Cell Death	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; ACUTE LYMPHOBLASTIC-LEUKEMIA; ABL TYROSINE KINASE; BCR-ABL; 5-AMINOIMIDAZOLE-4-CARBOXAMIDE RIBOSIDE; MYELOID-LEUKEMIA; BLAST-CRISIS; STEM-CELLS; IN-VITRO; APOPTOSIS	CML is an hematopoietic stem cell disease characterized by the t(9;22) (q34;q11) translocation encoding the oncoprotein p210BCR-ABL. The effect of acadesine (AICAR, 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside) a compound with known antileukemic effect on B cell chronic lymphoblastic leukemia (B-CLL) was investigated in different CML cell lines. Acadesine triggered loss of cell metabolism in K562, LAMA-84 and JURL-MK1 and was also effective in killing imatinib-resistant K562 cells and Ba/F3 cells carrying the T315I-BCR-ABL mutation. The anti-leukemic effect of acadesine did not involve apoptosis but required rather induction of autophagic cell death. AMPK knock-down by Sh-RNA failed to prevent the effect of acadesine, indicating an AMPK-independent mechanism. The effect of acadesine was abrogated by GF109203X and Ro-32-0432, both inhibitor of classical and new PKCs and accordingly, acadesine triggered relocation and activation of several PKC isoforms in K562 cells. In addition, this compound exhibited a potent anti-leukemic effect in clonogenic assays of CML cells in methyl cellulose and in a xenograft model of K562 cells in nude mice. In conclusion, our work identifies an original and unexpected mechanism by which acadesine triggers autophagic cell death through PKC activation. Therefore, in addition to its promising effects in B-CLL, acadesine might also be beneficial for Imatinib-resistant CML patients.			Robert, G (corresponding author), Fac Med Nice, INSERM, UMR 895, Team Cell Death Differentiat & Canc 2, U210, F-06034 Nice, France.	auberger@unice.fr	Hofman, Paul/P-7654-2018; robert, guillaume/O-1935-2017; AUBERGER, Patrick/G-1491-2013; BOST, Frederic/AAN-4691-2020; Colosetti, Pascal/ABH-4585-2020; Puissant, Alexandre/AAF-3875-2021; PUISSANT, ALEXANDRE/O-9575-2016	Hofman, Paul/0000-0003-0431-9353; robert, guillaume/0000-0002-6350-2222; AUBERGER, Patrick/0000-0002-2481-8275; BOST, Frederic/0000-0003-4509-4701; Puissant, Alexandre/0000-0002-3997-9282; PUISSANT, ALEXANDRE/0000-0002-3997-9282				Bellodi C, 2009, J CLIN INVEST, V119, P1109, DOI 10.1172/JCI35660; Ben Sahra I, 2008, ONCOGENE, V27, P3576, DOI 10.1038/sj.onc.1211024; Broker LE, 2005, CLIN CANCER RES, V11, P3155, DOI 10.1158/1078-0432.CCR-04-2223; BUCHDUNGER E, 1995, P NATL ACAD SCI USA, V92, P2558, DOI 10.1073/pnas.92.7.2558; Bursch W, 2001, CELL DEATH DIFFER, V8, P569, DOI 10.1038/sj.cdd.4400852; Campas C, 2003, BLOOD, V101, P3674, DOI 10.1182/blood-2002-07-2339; Campas C, 2005, LEUKEMIA, V19, P292, DOI 10.1038/sj.leu.2403593; Colosetti P, 2009, AUTOPHAGY, V5, P1092, DOI 10.4161/auto.5.8.9889; Conus S, 2008, BIOCHEM PHARMACOL, V76, P1374, DOI 10.1016/j.bcp.2008.07.041; Dan S, 1998, CELL DEATH DIFFER, V5, P710, DOI 10.1038/sj.cdd.4400400; Deininger MWN, 2000, BLOOD, V96, P3343, DOI 10.1182/blood.V96.10.3343; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; Fang GF, 2000, BLOOD, V96, P2246, DOI 10.1182/blood.V96.6.2246.h8002246_2246_2253; Galluzzi L, 2008, CURR MOL MED, V8, P78; GROFFEN J, 1984, CELL, V36, P93, DOI 10.1016/0092-8674(84)90077-1; Guigas B, 2006, DIABETES, V55, P865, DOI 10.2337/diabetes.55.04.06.db05-1178; Heinrich MC, 2000, BLOOD, V96, P925, DOI 10.1182/blood.V96.3.925.015k50_925_932; Herrant M, 2004, ONCOGENE, V23, P7863, DOI 10.1038/sj.onc.1208069; Herrant M, 2002, ONCOGENE, V21, P4957, DOI 10.1038/sj.onc.1205689; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Jacobs RL, 2007, J BIOL CHEM, V282, P4516, DOI 10.1074/jbc.M605702200; Jacquel A, 2007, ONCOGENE, V26, P2445, DOI 10.1038/sj.onc.1210034; Jacquel A, 2006, ONCOGENE, V25, P781, DOI 10.1038/sj.onc.1209119; Jacquel A, 2003, FASEB J, V17, P2160, DOI 10.1096/fj.03-0322fje; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kim YM, 2007, ANN NY ACAD SCI, V1095, P496, DOI 10.1196/annals.1397.053; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Koschmieder S, 2005, BLOOD, V105, P324, DOI 10.1182/blood-2003-12-4369; Kuo CL, 2008, J CELL BIOCHEM, V103, P931, DOI 10.1002/jcb.21466; Larocca MC, 2002, CELL SIGNAL, V14, P641, DOI 10.1016/S0898-6568(02)00003-7; Long YC, 2006, J CLIN INVEST, V116, P1776, DOI 10.1172/JCI29044; Mari B, 1997, FASEB J, V11, P869, DOI 10.1096/fasebj.11.11.9285485; Motoshima H, 2006, J PHYSIOL-LONDON, V574, P63, DOI 10.1113/jphysiol.2006.108324; Neering SJ, 2007, BLOOD, V110, P2578, DOI 10.1182/blood-2007-02-073031; Nishino Y, 2004, CARDIOVASC RES, V61, P610, DOI 10.1016/j.cardiores.2003.10.022; Puissant A, 2008, FASEB J, V22, P1894, DOI 10.1096/fj.07-101394; Rattan R, 2005, J BIOL CHEM, V280, P39582, DOI 10.1074/jbc.M507443200; Ren RB, 2002, ONCOGENE, V21, P8629, DOI 10.1038/sj.onc.1206090; Schaefer M, 2001, FASEB J, V15, P1634, DOI 10.1096/fj.00-0824fje; Sengupta TK, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-46; Steelman LS, 2004, LEUKEMIA, V18, P189, DOI 10.1038/sj.leu.2403241; Su RY, 2007, MOL CANCER THER, V6, P1562, DOI 10.1158/1535-7163.MCT-06-0800; Swinnen JV, 2005, CANCER RES, V65, P2441, DOI 10.1158/0008-5472.CAN-04-3025; Tanimura A, 2002, J BIOL CHEM, V277, P29054, DOI 10.1074/jbc.M201130200; DRUGS R D, V9, P169	45	73	79	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2009	4	11							e7889	10.1371/journal.pone.0007889	http://dx.doi.org/10.1371/journal.pone.0007889			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521QH	19924252	Green Submitted, gold, Green Published			2022-12-25	WOS:000271936700021
J	Ishikawa, F; Miyoshi, H; Nose, K; Shibanuma, M				Ishikawa, F.; Miyoshi, H.; Nose, K.; Shibanuma, M.			Transcriptional induction of MMP-10 by TGF-beta, mediated by activation of MEF2A and downregulation of class IIa HDACs	ONCOGENE			English	Article						TGF-beta; MMP-10; MEF2A; class IIa HDACs	GROWTH-FACTOR-BETA; EPITHELIAL-MESENCHYMAL TRANSITION; MATRIX METALLOPROTEINASES; MYOGENIC DIFFERENTIATION; CELL CARCINOMA; EXPRESSION; CANCER; PROTEIN; GENE; REPRESSES	Transforming growth factor (TGF)-beta regulates the expression of matrix metalloproteinases (MMPs) and components of the extracellular matrix, thereby profoundly affecting the microenvironment of cells including cancerous ones. We studied MMP-10 induction by TGF-beta in mammary epithelial cells and found that the induction was dependent on the myocyte enhancer factor (MEF)-2 transcription factor. TGF-beta upregulated the gene promoter through the MEF2 site, and knockdown of the MEF2A transcription factor negatively affected MMP-10 induction, whereas its overexpression had a positive effect on the induction. In response to TGF-beta, acetylation and concomitant binding of MEF2A to the promoter region increased, thus suggesting a critical role of MEF2A in transactivation of MMP-10 by TGF-beta. Consistent with the fact that class IIa histone deacetylases (HDACs) interact with MEF2 and suppress transcription, knockdown of HDACs increased and their overexpression inhibited MMP-10 expression. Intriguingly, TGF-beta promoted proteasome-dependent degradation of HDACs. Consistent with this, acetylation of core histones was increased around the MEF2 site of the MMP-10 promoter by TGF-beta and alleviated by overexpression of HDACs. Collectively, it is possible that TGF-beta transcriptionally upregulated MMP-10 through activation of MEF2A, concomitant with acetylation of core histones increasing around the promoter, as a consequence of degradation of the class IIa HDACs. Oncogene (2010) 29, 909-919; doi:10.1038/onc.2009.387; published online 23 November 2009	[Ishikawa, F.; Nose, K.; Shibanuma, M.] Showa Univ, Sch Pharm, Dept Canc Cell Biol, Shinagawa Ku, Tokyo 1428555, Japan; [Miyoshi, H.] RIKEN BioResource Ctr, Subteam Manipulat Cell Fate, Tsukuba, Ibaraki, Japan	Showa University; RIKEN	Shibanuma, M (corresponding author), Showa Univ, Sch Pharm, Dept Canc Cell Biol, Shinagawa Ku, Tokyo 1428555, Japan.	smotoko@pharm.showa-u.ac.jp	Miyoshi, Hiroyuki/G-9808-2013		Ministry for Education, Culture Sports, Science and Technology (MEXT) of Japan [19570185]	Ministry for Education, Culture Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank Dr Eric N Olson (University of Texas Southwestern Medical School, Dallas, TX, USA) for his generous gift of the MMP-10 promoter luciferase constructs. We also thank Ms E Kaneko and Ms T Kaneko for contributing to this work as a project for their bachelor's degree. This work was supported in part by a Grant-in-Aid for Scientific Research (C) (19570185) and the High-Technology Research Center Project from the Ministry for Education, Culture Sports, Science and Technology (MEXT) of Japan, and also by the High-Tech Research Centre Project for Private Universities: a matching fund subsidy from MEXT, 2007-2009.	Angelelli C, 2008, NUCLEIC ACIDS RES, V36, P915, DOI 10.1093/nar/gkm1114; Aung PP, 2006, ONCOGENE, V25, P2546, DOI 10.1038/sj.onc.1209279; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Chakraborti S, 2003, MOL CELL BIOCHEM, V253, P269, DOI 10.1023/A:1026028303196; Chang SR, 2006, CELL, V126, P321, DOI 10.1016/j.cell.2006.05.040; Cho NH, 2004, ONCOGENE, V23, P845, DOI 10.1038/sj.onc.1207140; Clark IA, 2008, INT J BIOCHEM CELL B, V40, P1362, DOI 10.1016/j.biocel.2007.12.006; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Derynck R, 1998, CELL, V95, P737, DOI 10.1016/S0092-8674(00)81696-7; Gill JH, 2004, NEOPLASIA, V6, P777, DOI 10.1593/neo.04283; Impola U, 2004, J PATHOL, V202, P14, DOI 10.1002/path.1479; Inoue Y, 2008, CANCER SCI, V99, P2107, DOI 10.1111/j.1349-7006.2008.00925.x; Ishikawa F, 2008, EXP CELL RES, V314, P2131, DOI 10.1016/j.yexcr.2008.03.013; Izzi L, 2004, ONCOGENE, V23, P2071, DOI 10.1038/sj.onc.1207412; Jakowlew SB, 2006, CANCER METAST REV, V25, P435, DOI 10.1007/s10555-006-9006-2; Kang JS, 2005, EMBO J, V24, P2543, DOI 10.1038/sj.emboj.7600729; Kanome T, 2007, ONCOGENE, V26, P5991, DOI 10.1038/sj.onc.1210423; Kato Y, 2000, J BIOL CHEM, V275, P18534, DOI 10.1074/jbc.M001573200; Kerkela E, 2001, BRIT J CANCER, V84, P659, DOI 10.1054/bjoc.2000.1634; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Lemercier C, 2000, J BIOL CHEM, V275, P15594, DOI 10.1074/jbc.M908437199; Levy L, 2005, MOL CELL BIOL, V25, P8108, DOI 10.1128/MCB.25.18.8108-8125.2005; Liu D, 2004, EMBO J, V23, P1557, DOI 10.1038/sj.emboj.7600179; Ma KW, 2005, MOL CELL BIOL, V25, P3575, DOI 10.1128/MCB.25.9.3575-3582.2005; Massague J, 2006, FEBS LETT, V580, P2811, DOI 10.1016/j.febslet.2006.04.033; Mathew R, 2002, CANCER DETECT PREV, V26, P222, DOI 10.1016/S0361-090X(02)00035-1; McKinsey TA, 2002, TRENDS BIOCHEM SCI, V27, P40, DOI 10.1016/S0968-0004(01)02031-X; Miska EA, 1999, EMBO J, V18, P5099, DOI 10.1093/emboj/18.18.5099; Miyata Y, 2007, EUR UROL, V52, P791, DOI 10.1016/j.eururo.2006.12.028; Mori K, 2006, J BIOL CHEM, V281, P22048, DOI 10.1074/jbc.M513111200; Muraoka-Cook RS, 2004, CANCER RES, V64, P9002, DOI 10.1158/0008-5472.CAN-04-2111; Nakamura H, 1998, EUR J BIOCHEM, V253, P67, DOI 10.1046/j.1432-1327.1998.2530067.x; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Ornatsky OI, 1999, NUCLEIC ACIDS RES, V27, P2646, DOI 10.1093/nar/27.13.2646; Pardali K, 2007, BBA-REV CANCER, V1775, P21, DOI 10.1016/j.bbcan.2006.06.004; Piek E, 2001, J BIOL CHEM, V276, P19945, DOI 10.1074/jbc.M102382200; Quinn ZA, 2001, NUCLEIC ACIDS RES, V29, P732, DOI 10.1093/nar/29.3.732; Ramos-DeSimone N, 1999, J BIOL CHEM, V274, P13066, DOI 10.1074/jbc.274.19.13066; Shalizi A, 2006, SCIENCE, V311, P1012, DOI 10.1126/science.1122513; Sparrow DB, 1999, EMBO J, V18, P5085, DOI 10.1093/emboj/18.18.5085; Thuault S, 2006, J CELL BIOL, V174, P175, DOI 10.1083/jcb.200512110; Weeks BH, 2001, CANCER RES, V61, P7435; WINDSOR LJ, 1993, J BIOL CHEM, V268, P17341; Yang SH, 1999, MOL CELL BIOL, V19, P4028; Zhao M, 1999, MOL CELL BIOL, V19, P21	45	32	32	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 11	2010	29	6					909	919		10.1038/onc.2009.387	http://dx.doi.org/10.1038/onc.2009.387			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	553WP	19935709				2022-12-25	WOS:000274397800013
J	Leffler, J; Herbert, AP; Norstrom, E; Schmidt, CQ; Barlow, PN; Blom, AM; Martin, M				Leffler, Jonatan; Herbert, Andrew P.; Norstrom, Eva; Schmidt, Christoph Q.; Barlow, Paul N.; Blom, Anna M.; Martin, Myriam			Annexin-II, DNA, and Histones Serve as Factor H Ligands on the Surface of Apoptotic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PATHWAY COMPLEMENT ACTIVATION; CYTOSOLIC PHOSPHOLIPASE A(2); BINDING LECTIN ENGAGEMENT; HEMOLYTIC-UREMIC SYNDROME; DISEASE-ASSOCIATED FORM; DEPENDENT PROTEIN-S; C4B-BINDING PROTEIN; NECROTIC CELLS; ALTERNATIVE PATHWAY; MACULAR DEGENERATION	Apoptotic cells are opsonized by complement components such as C1q and C3b, which increases their susceptibility to phagocytosis. Soluble complement inhibitors such as factor H (fH) also recognize apoptotic cells to minimize the pro-inflammatory effects of downstream complement activation. We used four radiolabeled protein constructs that span different regions of the 20 complement control protein (CCP) modules that make up fH and found that fragments comprising CCPs 6-8, CCPs 8-15, and CCPs 19-20 but not CCPs 1-4, bound to apoptotic Jurkat T cells. There are four possible ligand types on apoptotic cells that could recruit fH: proteins, carbohydrates, lipids, and DNA. We found that CCPs 6-8 of fH bind to annexin-II, a trypsin-insensitive protein that becomes exposed on surfaces of apoptotic cells. The second ligand of fH, which interacts with CCPs 6-8 and 19-20, is DNA. Confocal microscopy showed co-localization of fH with antibodies specific for DNA. fH also binds to histones devoid of DNA, and CCPs 1-4, 6-8, and 8-15 mediate this interaction. Treatment of apoptotic cells with neuraminidase, chondroitinase, heparitinase, and heparinase did not change fH binding. Treatment of apoptotic cells with phospholipase A(2) dramatically increased both binding of fH and cell-surface DNA. We also excluded the possibility that fH interacts with lysophospholipids using surface plasmon resonance and flow cytometry with lipid-coated beads. Identification of annexin-II as one of the fH ligands on apoptotic cells together with the fact that autoantibodies against annexin-II are found in systemic lupus erythematosus provides further insight into understanding the pathogenesis of this disease.	[Blom, Anna M.] Lund Univ, Malmo Univ Hosp, Dept Lab Med, Div Med Prot Chem,Wallenberg Lab, S-20502 Malmo, Sweden; [Herbert, Andrew P.; Schmidt, Christoph Q.; Barlow, Paul N.] Univ Edinburgh, Edinburgh Biol NMR Unit, Edinburgh EH9 3JJ, Midlothian, Scotland	Lund University; Skane University Hospital; University of Edinburgh	Blom, AM (corresponding author), Lund Univ, Malmo Univ Hosp, Dept Lab Med, Div Med Prot Chem,Wallenberg Lab, Entrance 46,Floor 4, S-20502 Malmo, Sweden.	Anna.Blom@med.lu.se	Leffler, Jonatan/A-8748-2018; Herbert, Andrew P/C-4755-2008; Blom, Anna/B-9607-2009; Leffler, Jonatan/D-4630-2011; Herbert, Andy P/F-6693-2010; Barlow, Paul N/G-2853-2011; Blom, Anna/AFS-7369-2022	Leffler, Jonatan/0000-0001-5674-8462; Herbert, Andrew P/0000-0002-4549-6965; Blom, Anna/0000-0002-1348-1734; Leffler, Jonatan/0000-0001-5674-8462; Herbert, Andy P/0000-0002-4549-6965; Martin, Myriam/0000-0003-1526-8678	Swedish Research Council; Swedish Foundation for Strategic Research; Foundations of Osterlund, Kock, King Gustav V's 80th Anniversary; Knut; Alice Wallenberg; IngaBritt; Arne Lundberg; University Hospital in Malmo; Wellcome Trust; MRC [G0001089] Funding Source: UKRI; Medical Research Council [G0001089] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Foundations of Osterlund, Kock, King Gustav V's 80th Anniversary; Knut; Alice Wallenberg(Knut & Alice Wallenberg Foundation); IngaBritt; Arne Lundberg; University Hospital in Malmo; Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Swedish Research Council, the Swedish Foundation for Strategic Research, the Foundations of Osterlund, Kock, King Gustav V's 80th Anniversary, Knut and Alice Wallenberg, and IngaBritt and Arne Lundberg, and research grants from the University Hospital in Malmo. Work in Edinburgh was supported by the Wellcome Trust.	Atsumi G, 1998, J BIOL CHEM, V273, P13870, DOI 10.1074/jbc.273.22.13870; Blom AM, 2003, MOL IMMUNOL, V39, P547, DOI 10.1016/S0161-5890(02)00213-4; Clark SJ, 2006, J BIOL CHEM, V281, P24713, DOI 10.1074/jbc.M605083200; COLEMAN K, 2008, 22 INT COMPL WORKSH, P411; Cummings BS, 2000, J PHARMACOL EXP THER, V294, P793; DAHLBACK B, 1983, BIOCHEM J, V209, P847, DOI 10.1042/bj2090847; de Cordoba SR, 2004, MOL IMMUNOL, V41, P355, DOI 10.1016/j.molimm.2004.02.005; Fadeel B, 2003, CELL MOL LIFE SCI, V60, P2575, DOI 10.1007/s00018-003-3145-1; Fan XX, 2004, MOL BIOL CELL, V15, P2863, DOI 10.1091/mbc.E03-09-0670; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Gormally E, 2007, MUTAT RES-REV MUTAT, V635, P105, DOI 10.1016/j.mrrev.2006.11.002; Happonen KE, 2009, J IMMUNOL, V182, P1518, DOI 10.4049/jimmunol.182.3.1518; Herbert AP, 2006, J BIOL CHEM, V281, P16512, DOI 10.1074/jbc.M513611200; Hinkovska-Galcheva V, 1998, BLOOD, V91, P4761, DOI 10.1182/blood.V91.12.4761.412k24_4761_4769; Hocking HG, 2008, J BIOL CHEM, V283, P9475, DOI 10.1074/jbc.M709587200; Jones AL, 2005, J BIOL CHEM, V280, P35733, DOI 10.1074/jbc.M504384200; Jozsi M, 2008, TRENDS IMMUNOL, V29, P380, DOI 10.1016/j.it.2008.04.008; Jozsi M, 2007, BLOOD, V110, P1516, DOI 10.1182/blood-2007-02-071472; Kemper C, 2008, P NATL ACAD SCI USA, V105, P9023, DOI 10.1073/pnas.0801015105; Kim SJ, 2002, J EXP MED, V196, P655, DOI 10.1084/jem.20020542; Lehmann PV, 1996, NEPHROL DIAL TRANSPL, V11, P953; Ma KY, 2000, J BIOL CHEM, V275, P15541, DOI 10.1074/jbc.275.20.15541; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Manuelian T, 2003, J CLIN INVEST, V111, P1181, DOI 10.1172/JCI200316651; MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545; MERI S, 1990, P NATL ACAD SCI USA, V87, P3982, DOI 10.1073/pnas.87.10.3982; MERI S, 1994, BIOCHEM BIOPH RES CO, V198, P52, DOI 10.1006/bbrc.1994.1008; Nauta AJ, 2002, EUR J IMMUNOL, V32, P1726, DOI 10.1002/1521-4141(200206)32:6<1726::AID-IMMU1726>3.0.CO;2-R; Nauta AJ, 2003, EUR J IMMUNOL, V33, P2853, DOI 10.1002/eji.200323888; Ogden CA, 2001, J EXP MED, V194, P781, DOI 10.1084/jem.194.6.781; Oppermann M, 2006, CLIN EXP IMMUNOL, V144, P342, DOI 10.1111/j.1365-2249.2006.03071.x; Oslakovic C, 2009, J BIOL CHEM, V284, P5896, DOI 10.1074/jbc.M807286200; PULIDO R, 1989, J IMMUNOL, V143, P1930; Radic M, 2004, J IMMUNOL, V172, P6692, DOI 10.4049/jimmunol.172.11.6692; Salle V, 2008, J CLIN IMMUNOL, V28, P291, DOI 10.1007/s10875-008-9188-1; Schmidt CQ, 2008, J IMMUNOL, V181, P2610, DOI 10.4049/jimmunol.181.4.2610; Sjoberg AP, 2009, TRENDS IMMUNOL, V30, P83, DOI 10.1016/j.it.2008.11.003; Sjoberg AP, 2007, J BIOL CHEM, V282, P10894, DOI 10.1074/jbc.M610256200; Sjoberg AP, 2009, MOL IMMUNOL, V46, P830, DOI 10.1016/j.molimm.2008.09.018; Sorice M, 2000, CLIN EXP IMMUNOL, V122, P277, DOI 10.1046/j.1365-2249.2000.01353.x; Sorice M, 2004, CELL DEATH DIFFER, V11, P1133, DOI 10.1038/sj.cdd.4401457; Tepper AD, 2000, J CELL BIOL, V150, P155, DOI 10.1083/jcb.150.1.155; Trouw LA, 2005, J EXP MED, V201, P1937, DOI 10.1084/jem.20050189; Trouw LA, 2007, J BIOL CHEM, V282, P28540, DOI 10.1074/jbc.M704354200; WAISMAN DM, 1995, MOL CELL BIOCHEM, V149, P301, DOI 10.1007/BF01076592; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; Webb JH, 2002, J IMMUNOL, V169, P2580, DOI 10.4049/jimmunol.169.5.2580; Wissing D, 1997, P NATL ACAD SCI USA, V94, P5073, DOI 10.1073/pnas.94.10.5073; WOODIN AM, 1966, BIOCHEM J, V99, P493, DOI 10.1042/bj0990493; Xu W, 2008, J IMMUNOL, V180, P7613, DOI 10.4049/jimmunol.180.11.7613	51	50	56	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3766	3776		10.1074/jbc.M109.045427	http://dx.doi.org/10.1074/jbc.M109.045427			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19951950	Green Published, hybrid			2022-12-25	WOS:000275254000029
J	Krudysz-Amblo, J; Jennings, ME; Mann, KG; Butenas, S				Krudysz-Amblo, Jolanta; Jennings, Mark E., II; Mann, Kenneth G.; Butenas, Saulius			Carbohydrates and Activity of Natural and Recombinant Tissue Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MASS-SPECTROMETRIC CHARACTERIZATION; FACTOR PROCOAGULANT ACTIVITY; FACTOR PATHWAY INHIBITOR; HUMAN FACTOR-VIIA; HUMAN FACTOR-IX; ANTITHROMBIN-III; POSTTRANSLATIONAL MODIFICATIONS; ACTIVATION PEPTIDE; FACTOR-X; LC MS	The effect of glycosylation on tissue factor (TF) activity was evaluated, and site-specific glycosylation of full-length recombinant TF (rTF) and that of natural TF from human placenta (pTF) were studied by liquid chromatography-tandem mass spectrometry. The amidolytic activity of the TF.factor VIIa (FVIIa) complex toward a fluorogenic substrate showed that the catalytic efficiency (V-max) of the complex increased in the order rTF(1-243) (Escherichia coli) < rTF(1-263) (Sf9 insect cells) < pTF for the glycosylated and deglycosylated forms. Substrate hydrolysis was unaltered by deglycosylation. In FXase, the K-m of FX for rTF(1-263)-FVIIa remained unchanged after deglycosylation, whereas the k(cat) decreased slightly. A pronounced decrease, 4-fold, in k(cat) was observed for pTF.FVIIa upon deglycosylation, whereas the K-m was minimally altered. The parameters of FX activation by both rTF(1-263D)-FVIIa and pTF(D)-FVIIa were identical and similar to those for rTF(1-243)-FVIIa. In conclusion, carbohydrates significantly influence the activity of TF proteins. Carbohydrate analysis revealed glycosylation on asparagines 11, 124, and 137 in both rTF1-263 and pTF. The carbohydrates of rTF(1-263) contain high mannose, hybrid, and fucosylated glycans. Natural pTF contains no high mannose glycans but is modified with hybrid, highly fucosylated, and sialylated sugars.	Univ Vermont, Dept Biochem, Burlington, VT 05405 USA; [Jennings, Mark E., II] Univ Vermont, Dept Med Cardiol, Burlington, VT 05405 USA	University of Vermont; University of Vermont	Butenas, S (corresponding author), Univ Vermont, Dept Biochem, 208 S Pk Dr,Rm 235A, Colchester, VT 05446 USA.	sbutenas@uvm.edu			National Institutes of Health [P01HL46703]; National Center for Research Resources [P20RR16462]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016462] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL046703] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant P01HL46703 (Project 2). This work was presented in part at the XXII Congress of the International Society on Thrombosis and Haemostasis, July 11-16, 2009, Boston, MA.; We thank Dr. Dwight E. Matthews for helpful analysis and discussion. The LC/MS instrumentation and the materials used for LC/MS analysis were provided by support made possible by Vermont Genetics Network Grant P20RR16462 from the IDeA Networks of Biomedical Research Excellence Program of the National Center for Research Resources, a component of the National Institutes of Health.	AGARWALA KL, 1994, BIOCHEMISTRY-US, V33, P5167, DOI 10.1021/bi00183a021; Ashline D, 2005, ANAL CHEM, V77, P6250, DOI 10.1021/ac050724z; ASTRUP T, 1965, THROMB DIATH HAEMOST, V14, P401; BACH R, 1990, P NATL ACAD SCI USA, V87, P6995, DOI 10.1073/pnas.87.18.6995; BAJAJ SP, 1981, J BIOL CHEM, V256, P253; Belting M, 2004, NAT MED, V10, P502, DOI 10.1038/nm1037; BONA R, 1987, THROMB RES, V48, P487, DOI 10.1016/0049-3848(87)90405-1; BROZE GJ, 1982, J CLIN INVEST, V70, P526, DOI 10.1172/JCI110644; BUTENAS S, 1993, BIOCHEMISTRY-US, V32, P6531, DOI 10.1021/bi00077a006; BUTENAS S, 1994, BIOCHEMISTRY-US, V33, P3449, DOI 10.1021/bi00177a039; Demain AL, 2009, BIOTECHNOL ADV, V27, P297, DOI 10.1016/j.biotechadv.2009.01.008; Dietzen DJ, 2004, BLOOD, V103, P3038, DOI 10.1182/blood-2003-07-2399; Dorfleutner A, 2003, BLOOD, V102, P3998, DOI 10.1182/blood-2003-04-1149; DRAKE TA, 1989, AM J PATHOL, V134, P1087; Egorina EM, 2008, THROMB RES, V122, P831, DOI 10.1016/j.thromres.2007.11.004; Fenaille F, 2008, GLYCOCONJUGATE J, V25, P827, DOI 10.1007/s10719-008-9143-7; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Go EP, 2008, J PROTEOME RES, V7, P1660, DOI 10.1021/pr7006957; GUZZETTA AW, 1993, ANAL CHEM, V65, P2953, DOI 10.1021/ac00069a004; HANSEN L, 1988, J BIOL CHEM, V263, P15713; HARLOS K, 1994, NATURE, V370, P662, DOI 10.1038/370662a0; Harvey DJ, 1997, J MASS SPECTROM, V32, P167, DOI 10.1002/(SICI)1096-9888(199702)32:2<167::AID-JMS472>3.0.CO;2-Q; HUDDLESTON MJ, 1993, ANAL CHEM, V65, P877, DOI 10.1021/ac00055a009; Iacob RE, 2008, J AM SOC MASS SPECTR, V19, P428, DOI 10.1016/j.jasms.2007.11.022; Irungu J, 2008, J AM SOC MASS SPECTR, V19, P1209, DOI 10.1016/j.jasms.2008.05.010; Jiang H, 2004, J AM SOC MASS SPECTR, V15, P750, DOI 10.1016/j.jasms.2004.01.009; Klammer AA, 2006, J PROTEOME RES, V5, P695, DOI 10.1021/pr050315j; KOMIYAMA Y, 1990, BIOCHEMISTRY-US, V29, P9418, DOI 10.1021/bi00492a016; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; KRISHNASWAMY S, 1992, J BIOL CHEM, V267, P26110; LAWSON JH, 1992, J BIOL CHEM, V267, P4834; Link AJ, 1999, NAT BIOTECHNOL, V17, P676, DOI 10.1038/10890; Mackman N, 2006, BLOOD CELL MOL DIS, V36, P104, DOI 10.1016/j.bcmd.2005.12.008; Mann M, 2003, CHEST, V124, P70, DOI 10.1378/chest.124.1.70; Marchal I, 2001, BIOL CHEM, V382, P151, DOI 10.1515/BC.2001.023; MARTIN DMA, 1995, FASEB J, V9, P852, DOI 10.1096/fasebj.9.10.7615155; Mody RS, 1997, BIOCHEMISTRY-US, V36, P7869, DOI 10.1021/bi9701235; Mori Y, 2009, J THROMB HAEMOST, V7, P111, DOI 10.1111/j.1538-7836.2008.03222.x; Munzert E, 1997, BIOTECHNOL BIOENG, V56, P441, DOI 10.1002/(SICI)1097-0290(19971120)56:4<441::AID-BIT9>3.0.CO;2-O; Osterud B, 2000, THROMB HAEMOSTASIS, V83, P861, DOI 10.1055/s-0037-1613934; PABORSKY LR, 1989, BIOCHEMISTRY-US, V28, P8072, DOI 10.1021/bi00446a016; PABORSKY LR, 1991, J BIOL CHEM, V266, P21911; PABORSKY LR, 1990, THROMB RES, V60, P367, DOI 10.1016/0049-3848(90)90219-3; Parhami-Seren B, 2006, J THROMB HAEMOST, V4, P1747, DOI 10.1111/j.1538-7836.2006.02000.x; Pendurthi UR, 2007, BLOOD, V110, P3900, DOI 10.1182/blood-2007-07-101469; Peter-Katalinic J, 2005, METHOD ENZYMOL, V405, P139, DOI 10.1016/S0076-6879(05)05007-X; PETERSON CB, 1985, J BIOL CHEM, V260, P610; PITLICK FA, 1975, J CLIN INVEST, V55, P175, DOI 10.1172/JCI107908; PLUMMER TH, 1984, J BIOL CHEM, V259, P700; REHEMTULLA A, 1991, J BIOL CHEM, V266, P10294; Reinhardt C, 2008, J CLIN INVEST, V118, P1110, DOI 10.1172/JCI32376; REINHOLD VN, 1995, ANAL CHEM, V67, P1772, DOI 10.1021/ac00107a005; RUDD PM, 1995, BBA-PROTEIN STRUCT M, V1248, P1, DOI 10.1016/0167-4838(94)00230-E; SCHULLEK JR, 1994, J BIOL CHEM, V269, P19399; SHANDS JW, 1985, BLOOD, V65, P169; Silveira JR, 2002, BIOCHEMISTRY-US, V41, P1672, DOI 10.1021/bi011304g; SPICER EK, 1987, P NATL ACAD SCI USA, V84, P5148, DOI 10.1073/pnas.84.15.5148; STONE MJ, 1995, BIOCHEM J, V310, P605, DOI 10.1042/bj3100605; TOOMEY JR, 1991, J BIOL CHEM, V266, P19198; TRIMBLE RB, 1991, J BIOL CHEM, V266, P1646; Valmu L, 2006, GLYCOBIOLOGY, V16, P1207, DOI 10.1093/glycob/cwl034; Valnickova Z, 2006, BIOCHEMISTRY-US, V45, P1525, DOI 10.1021/bi051956v; VANDENBESSELAAR AMHP, 1984, THROMB HAEMOSTASIS, V52, P192; vantVeer C, 1997, J BIOL CHEM, V272, P4367, DOI 10.1074/jbc.272.7.4367; Wang YH, 2006, BIOTECHNOL PROGR, V22, P873, DOI 10.1021/bp060005l; WAXMAN E, 1992, BIOCHEMISTRY-US, V31, P3998, DOI 10.1021/bi00131a015; Weiskopf AS, 1998, ANAL CHEM, V70, P4441, DOI 10.1021/ac980289r; Wuhrer M, 2005, ANAL CHEM, V77, P886, DOI 10.1021/ac048619x; Yang L, 2009, J THROMB HAEMOST, V7, P1696, DOI 10.1111/j.1538-7836.2009.03578.x; YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020	70	31	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5					3371	3382		10.1074/jbc.M109.055178	http://dx.doi.org/10.1074/jbc.M109.055178			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19955571	Green Published, hybrid			2022-12-25	WOS:000273829000052
J	Kaczocha, M; Glaser, ST; Chae, J; Brown, DA; Deutsch, DG				Kaczocha, Martin; Glaser, Sherrye T.; Chae, Janiper; Brown, Deborah A.; Deutsch, Dale G.			Lipid Droplets Are Novel Sites of N-Acylethanolamine Inactivation by Fatty Acid Amide Hydrolase-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR CHARACTERIZATION; TRANSMEMBRANE DOMAIN; ANANDAMIDE UPTAKE; DEGRADATION; IDENTIFICATION; PROTEINS; PALMITOYLETHANOLAMIDE; TRIGLYCERIDE; HYDROLYSIS; ADIPOSOMES	Anandamide (AEA) and other bioactive N-acylethanolamines (NAEs) are primarily inactivated by the enzyme fatty acid amide hydrolase (FAAH). Recently, FAAH-2 was discovered in humans, suggesting an additional enzyme can mediate NAE inactivation in higher mammals. Here, we performed a biochemical characterization of FAAH-2 and explored its capacity to hydrolyze NAEs in cells. In homogenate activity assays, FAAH-2 hydrolyzed AEA and palmitoylethanolamide (PEA) with activities similar to 6 and similar to 20% those of FAAH, respectively. In contrast, FAAH-2 hydrolyzed AEA and PEA in intact cells with rates similar to 30-40% those of FAAH, highlighting a potentially greater contribution toward NAE catabolism in vivo than previously appreciated. In contrast to endoplasmic reticulum-localized FAAH, immunofluorescence revealed FAAH-2 was localized on lipid droplets. Supporting this distribution pattern, the putative N-terminal hydrophobic region of FAAH-2 was identified as a functional lipid droplet localization sequence. Lipid droplet localization was essential for FAAH-2 activity as chimeras excluded from lipid droplets lacked activity and/or were poorly expressed. Lipid droplets represent novel sites of NAE inactivation. Therefore, we examined substrate delivery to these organelles. AEA was readily trafficked to lipid droplets, confirming that lipid droplets constitute functional sites of NAE inactivation. Collectively, these results establish FAAH-2 as a bone fide NAE-catabolizing enzyme and suggest that NAE inactivation is spatially separated in cells of higher mammals.	[Kaczocha, Martin; Chae, Janiper; Brown, Deborah A.; Deutsch, Dale G.] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Glaser, Sherrye T.] SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Kaczocha, M (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Life Sci Bldg,Room 450, Stony Brook, NY 11794 USA.	MKaczoch@notes.sunysb.edu		Kaczocha, Martin/0000-0002-2527-1398	National Institutes of Health [DA9374, DA16419]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016419, R01DA009374] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants DA9374 and DA16419.	Ahn K, 2008, CHEM REV, V108, P1687, DOI 10.1021/cr0782067; Arreaza G, 1999, FEBS LETT, V454, P57, DOI 10.1016/S0014-5793(99)00774-7; Bartz R, 2007, J LIPID RES, V48, P837, DOI 10.1194/jlr.M600413-JLR200; Batkai S, 2007, AM J PHYSIOL-HEART C, V293, pH909, DOI 10.1152/ajpheart.00373.2007; Bisogno T, 1997, J BIOL CHEM, V272, P3315, DOI 10.1074/jbc.272.6.3315; Brown DA, 2001, CURR BIOL, V11, pR446, DOI 10.1016/S0960-9822(01)00257-3; Chebrou H, 1996, BBA-PROTEIN STRUCT M, V1298, P285, DOI 10.1016/S0167-4838(96)00145-8; Cravatt BF, 1996, NATURE, V384, P83, DOI 10.1038/384083a0; Cravatt BF, 2001, P NATL ACAD SCI USA, V98, P9371, DOI 10.1073/pnas.161191698; Cravatt BF, 2004, P NATL ACAD SCI USA, V101, P10821, DOI 10.1073/pnas.0401292101; Day TA, 2001, MOL PHARMACOL, V59, P1369, DOI 10.1124/mol.59.6.1369; DEUTSCH DG, 1993, BIOCHEM PHARMACOL, V46, P791, DOI 10.1016/0006-2952(93)90486-G; Deutsch DG, 2001, J BIOL CHEM, V276, P6967, DOI 10.1074/jbc.M003161200; Giang DK, 1997, P NATL ACAD SCI USA, V94, P2238, DOI 10.1073/pnas.94.6.2238; Glaser ST, 2003, P NATL ACAD SCI USA, V100, P4269, DOI 10.1073/pnas.0730816100; Gulyas AI, 2004, EUR J NEUROSCI, V20, P441, DOI 10.1111/j.1460-9568.2004.03428.x; Jacobsson SOP, 2001, BRIT J PHARMACOL, V132, P1743, DOI 10.1038/sj.bjp.0704029; Kaczocha M, 2006, J BIOL CHEM, V281, P9066, DOI 10.1074/jbc.M509721200; Kaczocha M, 2009, P NATL ACAD SCI USA, V106, P6375, DOI 10.1073/pnas.0901515106; Lambert DM, 2005, J MED CHEM, V48, P5059, DOI 10.1021/jm058183t; Listenberger LL, 2007, J LIPID RES, V48, P2751, DOI 10.1194/jlr.M700359-JLR200; McKinney MK, 2005, ANNU REV BIOCHEM, V74, P411, DOI 10.1146/annurev.biochem.74.082803.133450; Oddi S, 2005, CELL MOL LIFE SCI, V62, P386, DOI 10.1007/s00018-004-4446-8; Oddi S, 2008, CELL MOL LIFE SCI, V65, P840, DOI 10.1007/s00018-008-7494-7; Oddi S, 2009, CHEM BIOL, V16, P624, DOI 10.1016/j.chembiol.2009.05.004; Olofsson SO, 2008, CURR OPIN LIPIDOL, V19, P441, DOI 10.1097/MOL.0b013e32830dd09b; Olofsson SO, 2009, BBA-MOL CELL BIOL L, V1791, P448, DOI 10.1016/j.bbalip.2008.08.001; OMEIR RL, 1995, LIFE SCI, V56, P1999, DOI 10.1016/0024-3205(95)00181-5; Patricelli MP, 1998, BIOCHEMISTRY-US, V37, P15177, DOI 10.1021/bi981733n; Smirnova E, 2006, EMBO REP, V7, P106, DOI 10.1038/sj.embor.7400559; Sun YX, 2005, BBA-MOL CELL BIOL L, V1736, P211, DOI 10.1016/j.bbalip.2005.08.010; Tauchi-Sato K, 2002, J BIOL CHEM, V277, P44507, DOI 10.1074/jbc.M207712200; Thiele C, 2008, CURR OPIN CELL BIOL, V20, P378, DOI 10.1016/j.ceb.2008.05.009; Tsuboi K, 2005, J BIOL CHEM, V280, P11082, DOI 10.1074/jbc.M413473200; Walker JM, 2002, CHEM PHYS LIPIDS, V121, P159, DOI 10.1016/S0009-3084(02)00152-4; Wei BQQ, 2006, J BIOL CHEM, V281, P36569, DOI 10.1074/jbc.M606646200; Zehmer JK, 2008, J CELL SCI, V121, P1852, DOI 10.1242/jcs.012013; Zehmer JK, 2009, PROTEOMICS, V9, P914, DOI 10.1002/pmic.200800584	38	70	73	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2796	2806		10.1074/jbc.M109.058461	http://dx.doi.org/10.1074/jbc.M109.058461			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19926788	Green Published, hybrid			2022-12-25	WOS:000273697800056
J	Vicent, GP; Zaurin, R; Nacht, AS; Font-Mateu, J; Le Dily, F; Beato, M				Pablo Vicent, Guillermo; Zaurin, Roser; Silvina Nacht, A.; Font-Mateu, Jofre; Le Dily, Francois; Beato, Miguel			Nuclear Factor 1 Synergizes with Progesterone Receptor on the Mouse Mammary Tumor Virus Promoter Wrapped around a Histone H3/H4 Tetramer by Facilitating Access to the Central Hormone-responsive Elements	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN-REMODELING COMPLEX; YEAST SWI/SNF COMPLEX; MMTV PROMOTER; TRANSCRIPTIONAL ACTIVATION; REGULATORY ELEMENT; H1 PHOSPHORYLATION; BAF COMPLEX; CROSS-TALK; IN-VIVO; NUCLEOSOME	Steroid hormones induce transcription of their responsive genes by complex mechanisms including synergism between the hormone receptors and other transcription factors. On the mouse mammary tumor virus (MMTV) promoter progesterone induction is mediated by the reciprocal synergism between progesterone receptor (PR) and the ubiquitous transcription factor nuclear factor 1 (NF1). PR binding mediates ATP-dependent displacement of histone H2A and H2B, enabling NF1 access to its target site. In minichromosomes assembled in vitro NF1 binding facilitates access of PR to the hormone-responsive elements (HREs) by precluding reforming of the histone octamer, but the function of NF1 in living cells remains unclear. Here we show that depleting NF1 by small interfering RNAs or mutating the NF1-binding site significantly compromises transcription of the MMTV promoter. The central HREs 2 and 3 are not needed for ATP-dependent H2A/H2B displacement or NF1 binding but are critical for full PR binding and MMTV transactivation. We found that NF1 binding to the MMTV promoter on a H3/H4 histone tetramer particle exposes the central HREs and facilitates their binding by PR, suggesting a possible mechanism for the reciprocal synergism between PR and NF1.	[Pablo Vicent, Guillermo; Zaurin, Roser; Silvina Nacht, A.; Font-Mateu, Jofre; Le Dily, Francois; Beato, Miguel] Univ Pompeu Fabra, Ctr Regulacio Genom, E-08003 Barcelona, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG)	Vicent, GP (corresponding author), Univ Pompeu Fabra, Ctr Regulacio Genom, Parc Recerca Biomed,Dr Aiguader 88, E-08003 Barcelona, Spain.	guillermo.vicent@crg.es; miguel.beato@crg.es	Vicent, Guillermo P./K-5432-2015; Beato, Miguel/B-5564-2015; Le Dily, François/J-9448-2015; Le Dily, François/GNH-3646-2022; Font-Mateu, Jofre/AAE-9801-2019; Font-Mateu, Jofre/K-5492-2015	Vicent, Guillermo P./0000-0002-0554-2226; Beato, Miguel/0000-0002-2878-2222; Le Dily, François/0000-0002-8324-7927; Le Dily, François/0000-0002-8324-7927; Font-Mateu, Jofre/0000-0001-9983-9647	Department d'Innovacio Universitat i Empresa, Ministerio de Ciencia e Innovacion [BMC 200302902, CSD2006-00049]; Fondo de Investigacion Sanitaria, [PI0411605, CP04/00087]; European Union	Department d'Innovacio Universitat i Empresa, Ministerio de Ciencia e Innovacion; Fondo de Investigacion Sanitaria,(Instituto de Salud Carlos III); European Union(European Commission)	This work was supported by grants from the Department d'Innovacio Universitat i Empresa, Ministerio de Ciencia e Innovacion Grant BMC 200302902, Consolider (CSD2006-00049), and Fondo de Investigacion Sanitaria Grant PI0411605 and CP04/00087, as well as by European Union Integrated Project HEROIC.	Aalfs JD, 2000, TRENDS BIOCHEM SCI, V25, P548, DOI 10.1016/S0968-0004(00)01689-3; BEATO M, 1995, CELL, V83, P851, DOI 10.1016/0092-8674(95)90201-5; Bhattacharjee RN, 2006, VIROLOGY, V346, P1, DOI 10.1016/j.virol.2005.12.034; Bhattacharjee RN, 2001, MOL CELL BIOL, V21, P5417, DOI 10.1128/MCB.21.16.5417-5425.2001; Boyer LA, 2000, J BIOL CHEM, V275, P11545, DOI 10.1074/jbc.275.16.11545; BRESNICK EH, 1992, NUCLEIC ACIDS RES, V20, P273, DOI 10.1093/nar/20.2.273; Bruno M, 2003, MOL CELL, V12, P1599, DOI 10.1016/S1097-2765(03)00499-4; Cairns BR, 1999, MOL CELL, V4, P715, DOI 10.1016/S1097-2765(00)80382-2; Cairns BR, 1996, GENE DEV, V10, P2131, DOI 10.1101/gad.10.17.2131; CAIRNS BR, 1994, P NATL ACAD SCI USA, V91, P1950, DOI 10.1073/pnas.91.5.1950; Candau R, 1996, J STEROID BIOCHEM, V57, P19, DOI 10.1016/0960-0760(96)00262-2; CHALEPAKIS G, 1988, CELL, V53, P371, DOI 10.1016/0092-8674(88)90157-2; Corona DFV, 1999, MOL CELL, V3, P239, DOI 10.1016/S1097-2765(00)80314-7; Di Croce L, 1999, MOL CELL, V4, P45, DOI 10.1016/S1097-2765(00)80186-0; Eisfeld K, 1997, NUCLEIC ACIDS RES, V25, P3733, DOI 10.1093/nar/25.18.3733; Flaus A, 2004, CURR OPIN GENET DEV, V14, P165, DOI 10.1016/j.gde.2004.01.007; Hebbar PB, 2003, MOL CELL BIOL, V23, P887, DOI 10.1128/MCB.23.3.887-898.2003; Hsiao PW, 2003, MOL CELL BIOL, V23, P6210, DOI 10.1128/MCB.23.17.6210-6220.2003; Koop R, 2003, EMBO J, V22, P588, DOI 10.1093/emboj/cdg052; Krajewski WA, 1998, P NATL ACAD SCI USA, V95, P1540, DOI 10.1073/pnas.95.4.1540; Langst G, 1999, CELL, V97, P843, DOI 10.1016/S0092-8674(00)80797-7; Liu R, 2001, CELL, V106, P309, DOI 10.1016/S0092-8674(01)00446-9; Logie C, 1999, METHOD ENZYMOL, V304, P726; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Martens JA, 2003, CURR OPIN GENET DEV, V13, P136, DOI 10.1016/S0959-437X(03)00022-4; Migliaccio A, 1998, EMBO J, V17, P2008, DOI 10.1093/emboj/17.7.2008; MUCHARDT C, 1993, EMBO J, V12, P4279, DOI 10.1002/j.1460-2075.1993.tb06112.x; Narayanan R, 2005, MOL CELL BIOL, V25, P264, DOI 10.1128/MCB.25.1.264-277.2005; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Nie ZQ, 2000, MOL CELL BIOL, V20, P8879, DOI 10.1128/MCB.20.23.8879-8888.2000; Vicent GP, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000567; PINA B, 1990, CELL, V60, P719, DOI 10.1016/0092-8674(90)90087-U; RICHARDFOY H, 1987, EMBO J, V6, P2321, DOI 10.1002/j.1460-2075.1987.tb02507.x; Roberts CWM, 2004, NAT REV CANCER, V4, P133, DOI 10.1038/nrc1273; SCHEIDEREIT C, 1984, P NATL ACAD SCI-BIOL, V81, P3029, DOI 10.1073/pnas.81.10.3029; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Spangenberg C, 1998, J MOL BIOL, V278, P725, DOI 10.1006/jmbi.1998.1718; Strutt H, 1999, METH MOL B, V119, P455; TRUSS M, 1995, EMBO J, V14, P1737, DOI 10.1002/j.1460-2075.1995.tb07163.x; Venditti P, 1998, NUCLEIC ACIDS RES, V26, P3657, DOI 10.1093/nar/26.16.3657; Vicent GP, 2004, MOL CELL, V16, P439, DOI 10.1016/j.molcel.2004.10.025; Vicent GP, 2002, J STEROID BIOCHEM, V83, P15, DOI 10.1016/S0960-0760(02)00253-4; Vicent GP, 2002, J MOL BIOL, V324, P501, DOI 10.1016/S0022-2836(02)01101-4; Vicent GP, 2006, ANN NY ACAD SCI, V1089, P59, DOI 10.1196/annals.1386.025; Vicent GP, 2006, MOL CELL, V24, P367, DOI 10.1016/j.molcel.2006.10.011; Wang W, 2003, CURR TOP MICROBIOL, V274, P143; Yang CY, 2007, XENOTRANSPLANTATION, V14, P547; Zhao LH, 2005, ACTA BIOCH BIOPH SIN, V37, P440, DOI 10.1111/j.1745-7270.2005.00061.x	48	20	24	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2622	2631		10.1074/jbc.M109.060848	http://dx.doi.org/10.1074/jbc.M109.060848			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19940123	hybrid, Green Published			2022-12-25	WOS:000273697800041
J	Jacks, KA; Koch, CA				Jacks, Kellie A.; Koch, C. Anne			Differential Regulation of Mitogen- and Stress-activated Protein Kinase-1 and-2 (MSK1 and MSK2) by CK2 following UV Radiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; INDUCED PHOSPHORYLATION; P38 MAPK; COMPLEX; FAMILY; CREB; P65; INFLAMMATION; EXPRESSION; SUBUNIT	Mitogen- and stress-activated protein kinases, MSK1 and the closely related isoform MSK2, are nuclear kinases that are activated following mitogen stimulation or cellular stress, including UV radiation, by the ERK1/2 and p38 MAPK signaling cascades, respectively. However, factors that differentially regulate MSK1 and MSK2 have not been well characterized. Here we report that the CK2 protein kinase, which contributes to NF-kappa B activation following UV radiation in a p38-dependent manner, physically interacts with MSK2 but not MSK1 and that CK2 inhibition specifically impairs UV-induced MSK2 kinase activation. A putative site of CK2 phosphorylation was mapped to MSK2 residue Ser(324) and when substituted to alanine (S324A) also compromised MSK2 activity. RNA interference-mediated depletion of MSK2 in human MDA-MB-231 cells, but not MSK1 depletion, resulted in impaired UV-induced phosphorylation of NF-kappa B p65 at Ser(276) in vivo, which was restored by the ectopic expression of MSK2 but not by MSK2-S324A. Furthermore, UV radiation led to the activation of NF-kappa B-responsive gene expression in MDA-MB-231 cells and induced p65 transactivation capacity that was dependent on MSK2, MSK2 residue Ser(324), and p65-Ser(276). These results suggest that MSK1 and MSK2 are differentially regulated by CK2 during the UV response and that MSK2 is the major protein kinase responsible for the UV-induced phosphorylation of p65 at Ser(276) that positively regulates NF-kappa B activity in MDA-MB-231 cells.	[Koch, C. Anne] Princess Margaret Hosp, Radiat Med Program, UHN, Toronto, ON M5G 2M9, Canada; [Jacks, Kellie A.; Koch, C. Anne] Princess Margaret Hosp, Ontario Canc Inst, UHN, Toronto, ON M5G 2M9, Canada; [Jacks, Kellie A.; Koch, C. Anne] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto	Koch, CA (corresponding author), Princess Margaret Hosp, Radiat Med Program, UHN, 610 Univ Ave, Toronto, ON M5G 2M9, Canada.	anne.koch@rmp.uhn.on.ca			Princess Margaret Hospital Foundation	Princess Margaret Hospital Foundation	This work was supported by the Princess Margaret Hospital Foundation (to C. A. K.).	Bibby AC, 2005, INT J BIOL SCI, V1, P67; Campbell KJ, 2004, MOL CELL, V13, P853, DOI 10.1016/S1097-2765(04)00131-5; Canton DA, 2001, BIOCHEM J, V358, P87, DOI 10.1042/0264-6021:3580087; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Hauge C, 2006, J CELL SCI, V119, P3021, DOI 10.1242/jcs.02950; Herrlich P, 2008, MOL CELL, V29, P279, DOI 10.1016/j.molcel.2008.01.001; Hildesheim J, 2005, J BIOL CHEM, V280, P17221, DOI 10.1074/jbc.M410440200; Kato T, 2003, MOL CELL, V12, P829, DOI 10.1016/S1097-2765(03)00358-7; Keller DM, 2002, J BIOL CHEM, V277, P50206, DOI 10.1074/jbc.M209820200; Keller DM, 2001, MOL CELL, V7, P283, DOI 10.1016/S1097-2765(01)00176-9; Kittler R, 2005, NAT METHODS, V2, P779, DOI 10.1038/nmeth1005-779; Koch CA, 2004, EMBO J, V23, P3874, DOI 10.1038/sj.emboj.7600375; Li YP, 2005, J BIOL CHEM, V280, P11869, DOI 10.1074/jbc.M413944200; Macrae CJ, 2008, DNA REPAIR, V7, P292, DOI 10.1016/j.dnarep.2007.10.008; McCoy CE, 2005, BIOCHEM J, V387, P507, DOI 10.1042/BJ20041501; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Niefind K, 2001, EMBO J, V20, P5320, DOI 10.1093/emboj/20.19.5320; Okazaki T, 2003, BIOCHEM BIOPH RES CO, V300, P807, DOI 10.1016/S0006-291X(02)02932-7; Pierrat B, 1998, J BIOL CHEM, V273, P29661, DOI 10.1074/jbc.273.45.29661; Pinna LA, 2002, J CELL SCI, V115, P3873, DOI 10.1242/jcs.00074; Reber L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004393; Ritt DA, 2007, CURR BIOL, V17, P179, DOI 10.1016/j.cub.2006.11.061; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Sayed M, 2000, J BIOL CHEM, V275, P16569, DOI 10.1074/jbc.M000312200; Singh S, 2007, MOL CANCER THER, V6, P1973, DOI 10.1158/1535-7163.MCT-07-0063; Soloaga A, 2003, EMBO J, V22, P2788, DOI 10.1093/emboj/cdg273; Tomas-Zuber M, 2000, J BIOL CHEM, V275, P23549, DOI 10.1074/jbc.M002586200; Vermeulen L, 2003, EMBO J, V22, P1313, DOI 10.1093/emboj/cdg139; Viatour P, 2005, TRENDS BIOCHEM SCI, V30, P43, DOI 10.1016/j.tibs.2004.11.009; Wiggin GR, 2002, MOL CELL BIOL, V22, P2871, DOI 10.1128/MCB.22.8.2871-2881.2002	31	18	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2010	285	3					1661	1670		10.1074/jbc.M109.083808	http://dx.doi.org/10.1074/jbc.M109.083808			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	541PJ	19933278	Green Published, hybrid			2022-12-25	WOS:000273429100012
J	Bischoff, K; Ballew, AC; Simon, MA; O'Reilly, AM				Bischoff, Kara; Ballew, Anna C.; Simon, Michael A.; O'Reilly, Alana M.			Wing Defects in Drosophila xenicid Mutant Clones Are Caused by C-Terminal Deletion of Additional Sex Combs (Asx)	PLOS ONE			English	Article							POLYCOMB GROUP GENES; BITHORAX COMPLEX; ENGRAILED EXPRESSION; PS INTEGRINS; CONTRABITHORAX MUTATIONS; SIGNALING PATHWAY; GENOME PROJECT; HOMEOTIC LOCI; MELANOGASTER; MORPHOGENESIS	Background: The coordinated action of genes that control patterning, cell fate determination, cell size, and cell adhesion is required for proper wing formation in Drosophila. Defects in any of these basic processes can lead to wing aberrations, including blisters. The xenicid mutation was originally identified in a screen designed to uncover regulators of adhesion between wing surfaces [1]. Principal Findings: Here, we demonstrate that expression of the beta PS integrin or the patterning protein Engrailed are not affected in developing wing imaginal discs in xenicid mutants. Instead, expression of the homeotic protein Ultrabithorax (Ubx) is strongly increased in xenicid mutant cells. Conclusion: Our results suggest that upregulation of Ubx transforms cells from a wing blade fate to a haltere fate, and that the presence of haltere cells within the wing blade is the primary defect leading to the adult wing phenotypes observed.	[Bischoff, Kara; Ballew, Anna C.; Simon, Michael A.; O'Reilly, Alana M.] Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; [O'Reilly, Alana M.] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA	Stanford University; Fox Chase Cancer Center	Bischoff, K (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	Alana.OReilly@fccc.edu			NIH R01; Ruth L. Kirschstein NRSA; Stanford University Undergraduate Research	NIH R01(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford University Undergraduate Research(Stanford University)	This study was supported by an NIH R01 (MAS), a Ruth L. Kirschstein NRSA (AOR) and a Stanford University Undergraduate Research Programs (URO) grant (KB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azpiazu N, 2000, DEVELOPMENT, V127, P2685; Bokel C, 2005, J CELL SCI, V118, P633, DOI 10.1242/jcs.01619; Brabant MC, 1996, DEVELOPMENT, V122, P3307; BREEN TR, 1995, MECH DEVELOP, V52, P89, DOI 10.1016/0925-4773(95)00393-F; BREEN TR, 1986, DEV BIOL, V118, P442, DOI 10.1016/0012-1606(86)90015-1; Brower DL, 2003, CURR OPIN CELL BIOL, V15, P607, DOI 10.1016/S0955-0674(03)00102-9; BROWER DL, 1984, P NATL ACAD SCI-BIOL, V81, P7485, DOI 10.1073/pnas.81.23.7485; BROWER DL, 1989, NATURE, V342, P285, DOI 10.1038/342285a0; Brown NH, 2000, DEV BIOL, V223, P1, DOI 10.1006/dbio.2000.9711; Brown NH, 2002, DEV CELL, V3, P569, DOI 10.1016/S1534-5807(02)00290-3; Brumby A, 2004, GENETICS, V168, P227, DOI 10.1534/genetics.104.026617; BUNCH TA, 1992, DEVELOPMENT, V116, P239; BUSTURIA A, 1988, DEVELOPMENT, V104, P713; CASANOVA J, 1985, CELL, V42, P663, DOI 10.1016/0092-8674(85)90123-0; Casares F, 2000, DEVELOPMENT, V127, P1499; Clark KA, 2003, DEVELOPMENT, V130, P2611, DOI 10.1242/dev.00492; Alonso AGD, 2007, GENETICS, V176, P2099, DOI 10.1534/genetics.107.075739; Dominguez-Gimenez P, 2007, J CELL SCI, V120, P1061, DOI 10.1242/jcs.03404; FRISTROM D, 1993, DEVELOPMENT, V117, P509; FRISTROM D, 1994, DEVELOPMENT, V120, P2661; Fristrom DF, 1993, METAMORPHIC DEV ADUL; Goberdhan DCI, 1999, GENE DEV, V13, P3244, DOI 10.1101/gad.13.24.3244; GONZALEZGAITAN MA, 1990, GENETICS, V126, P139; Grimaud C, 2006, CHROMOSOME RES, V14, P363, DOI 10.1007/s10577-006-1069-y; JURGENS G, 1985, NATURE, V316, P153, DOI 10.1038/316153a0; KERRIDGE S, 1982, J EMBRYOL EXP MORPH, V68, P211; Lewis E B, 1982, Prog Clin Biol Res, V85 Pt A, P269; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; LEWIS EB, 1955, AM NAT, V89, P73, DOI 10.1086/281867; LEWIS EB, 1963, AM ZOOL, V3, P33; MCKEON J, 1994, MOL GEN GENET, V244, P474, DOI 10.1007/BF00583898; MCKEON J, 1991, ROUX ARCH DEV BIOL, V199, P387, DOI 10.1007/BF01705848; MICOL JL, 1988, P NATL ACAD SCI USA, V85, P1146, DOI 10.1073/pnas.85.4.1146; Milne TA, 1999, MOL GEN GENET, V261, P753, DOI 10.1007/s004380050018; MOAZED D, 1992, DEVELOPMENT, V116, P805; Montagne J, 1996, DEVELOPMENT, V122, P2589; MORATA G, 1981, NATURE, V290, P778, DOI 10.1038/290778a0; MORATA G, 1976, ROUX ARCH DEV BIOL, V179, P125, DOI 10.1007/BF00848298; MORATA G, 1975, NATURE, V255, P614, DOI 10.1038/255614a0; Muller M, 1999, GENETICS, V153, P1333; Nabel-Rosen H, 2002, DEV CELL, V2, P183, DOI 10.1016/S1534-5807(01)00118-6; Petruk S, 2008, DEVELOPMENT, V135, P2383, DOI 10.1242/dev.023275; Prout M, 1997, GENETICS, V146, P275; Radimerski T, 2002, NAT CELL BIOL, V4, P251, DOI 10.1038/ncb763; Randsholt NB, 2000, MECH DEVELOP, V95, P89, DOI 10.1016/S0925-4773(00)00342-7; Roch F, 2000, DEVELOPMENT, V127, P97; SIMON J, 1992, DEVELOPMENT, V114, P493; Sinclair DAR, 1998, DEVELOPMENT, V125, P1207; SPRADLING AC, 1995, P NATL ACAD SCI USA, V92, P10824, DOI 10.1073/pnas.92.24.10824; Spradling AC, 1999, GENETICS, V153, P135; Steinberg AG, 1944, P NATL ACAD SCI USA, V30, P5, DOI 10.1073/pnas.30.1.5; Torgler CN, 2004, DEV CELL, V6, P357, DOI 10.1016/S1534-5807(04)00055-3; Walsh EP, 1998, GENETICS, V150, P791; WHITE RAH, 1984, CELL, V39, P163, DOI 10.1016/0092-8674(84)90202-2; WILCOX M, 1989, DEVELOPMENT, V107, P891; Wolpert L., 1998, PRINCIPLES DEV; ZIMM GG, 1951, J EXP ZOOL, V116, P289, DOI 10.1002/jez.1401160205; ZUSMAN S, 1990, DEVELOPMENT, V108, P391	58	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2009	4	12							e8106	10.1371/journal.pone.0008106	http://dx.doi.org/10.1371/journal.pone.0008106			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MT	19956620	Green Published, Green Submitted, gold			2022-12-25	WOS:000272828700017
J	Leite, NR; Krogh, R; Xu, W; Ishida, Y; Iulek, J; Leal, WS; Oliva, G				Leite, Ney Ribeiro; Krogh, Renata; Xu, Wei; Ishida, Yuko; Iulek, Jorge; Leal, Walter S.; Oliva, Glaucius			Structure of an Odorant-Binding Protein from the Mosquito Aedes aegypti Suggests a Binding Pocket Covered by a pH-Sensitive "Lid"	PLOS ONE			English	Article							YELLOW-FEVER MOSQUITO; APIS-MELLIFERA L; PHEROMONE-BINDING; BOMBYX-MORI; NMR STRUCTURE; OLFACTORY PROTEINS; ANOPHELES-GAMBIAE; CRYSTAL-STRUCTURE; LIGAND RELEASE; MOTH	Background: The yellow fever mosquito, Aedes aegypti, is the primary vector for the viruses that cause yellow fever, mostly in tropical regions of Africa and in parts of South America, and human dengue, which infects 100 million people yearly in the tropics and subtropics. A better understanding of the structural biology of olfactory proteins may pave the way for the development of environmentally-friendly mosquito attractants and repellents, which may ultimately contribute to reduction of mosquito biting and disease transmission. Methodology: Previously, we isolated and cloned a major, female-enriched odorant-binding protein (OBP) from the yellow fever mosquito, AaegOBP1, which was later inadvertently renamed AaegOBP39. We prepared recombinant samples of AaegOBP1 by using an expression system that allows proper formation of disulfide bridges and generates functional OBPs, which are indistinguishable from native OBPs. We crystallized AaegOBP1 and determined its three-dimensional structure at 1.85 angstrom resolution by molecular replacement based on the structure of the malaria mosquito OBP, AgamOBP1, the only mosquito OBP structure known to date. Conclusion: The structure of AaegOBP1 (= AaegOBP39) shares the common fold of insect OBPs with six alpha-helices knitted by three disulfide bonds. A long molecule of polyethylene glycol (PEG) was built into the electron-density maps identified in a long tunnel formed by a crystallographic dimer of AaegOBP1. Circular dichroism analysis indicated that delipidated AaegOBP1 undergoes a pH-dependent conformational change, which may lead to release of odorant at low pH (as in the environment in the vicinity of odorant receptors). A C-terminal loop covers the binding cavity and this "lid" may be opened by disruption of an array of acid-labile hydrogen bonds thus explaining reduced or no binding affinity at low pH.	[Leite, Ney Ribeiro; Krogh, Renata; Oliva, Glaucius] Univ Sao Paulo, Inst Fis Sao Carlos, Ctr Biotecnol Mol Estrutural, Sao Paulo, Brazil; [Xu, Wei; Ishida, Yuko; Leal, Walter S.] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA; [Iulek, Jorge] Univ Estadual Ponta Grossa, Dept Quim, Ponta Grossa, Parana, Brazil	Universidade de Sao Paulo; University of California System; University of California Davis; Universidade Estadual de Ponta Grossa	Leite, NR (corresponding author), Univ Sao Paulo, Inst Fis Sao Carlos, Ctr Biotecnol Mol Estrutural, Sao Paulo, Brazil.	wsleal@ucdavis.edu	4, INCT/H-4499-2013; Inbeqmedi, Inct/I-1929-2013; Iulek, Jorge/G-4356-2019; Xu, Wei/G-4709-2010; Leal, Walter/ABC-6940-2021; Oliva, Glaucius/B-9059-2012	Iulek, Jorge/0000-0002-2293-4950; Oliva, Glaucius/0000-0003-2719-0302; Leal Filho, Walter/0000-0002-1241-5225; Leal, Walter/0000-0002-6800-1240; Xu, Wei/0000-0003-4019-5140	National Science Foundation [0918177]; National Institutes of Health NIAID; Brazilian National Institutes of Science and Technology;  [573607/2008-7];  [08/57910-0]	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Brazilian National Institutes of Science and Technology; ; 	This work was supported in part by the National Science Foundation (0918177 to W. S. L), the National Institutes of Health NIAID (to W. S. L.), and by the Brazilian National Institutes of Science and Technology (INCT, a consortium of CNPq, FAPESP, and the Ministry of Health, 573607/2008-7 and 08/57910-0 to G. O.), but the funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Biessmann H, 2002, INSECT MOL BIOL, V11, P123, DOI 10.1046/j.1365-2583.2002.00316.x; Damberger F, 2000, PROTEIN SCI, V9, P1038, DOI 10.1110/ps.9.5.1038; Damberger FF, 2007, J MOL BIOL, V373, P811, DOI 10.1016/j.jmb.2007.07.078; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hildebrand J.G., 1980, RECEPTORS NEUROTRANS, P261; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Horst R, 2001, P NATL ACAD SCI USA, V98, P14374, DOI 10.1073/pnas.251532998; Ishida Y, 2004, NATURWISSENSCHAFTEN, V91, P426, DOI 10.1007/s00114-004-0551-7; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KEIL TA, 1987, ANN NY ACAD SCI, V510, P403; KEIL TA, 1984, TISSUE CELL, V16, P705, DOI 10.1016/0040-8166(84)90004-1; Krieger J, 1996, INSECT BIOCHEM MOLEC, V26, P297, DOI 10.1016/0965-1748(95)00096-8; KRISSINEL E, 2007, PISA SERVER; Kruse SW, 2003, NAT STRUCT BIOL, V10, P694, DOI 10.1038/nsb960; Lartigue A, 2004, J BIOL CHEM, V279, P4459, DOI 10.1074/jbc.M311212200; Lartigue A, 2003, ACTA CRYSTALLOGR D, V59, P919, DOI 10.1107/S090744490300413X; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lautenschlager C, 2005, BIOCHEM BIOPH RES CO, V335, P1044, DOI 10.1016/j.bbrc.2005.07.176; Lautenschlager C, 2007, STRUCTURE, V15, P1148, DOI 10.1016/j.str.2007.07.013; Leal WS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007235; Leal WS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003045; Leal WS, 2005, J CHEM ECOL, V31, P2493, DOI 10.1007/s10886-005-7458-4; Leal WS, 2000, BIOCHEM BIOPH RES CO, V268, P521, DOI 10.1006/bbrc.2000.2158; Leal WS, 2005, P NATL ACAD SCI USA, V102, P5386, DOI 10.1073/pnas.0501447102; Leal WS, 2005, TOP CURR CHEM, V240, P1, DOI 10.1007/b98314; Leal WS, 2007, INSECT REPELLENTS PR, P229; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mohanty S, 2004, J MOL BIOL, V338, P1037, DOI 10.1016/j.jmb.2004.03.052; Mohanty S, 2004, J MOL BIOL, V337, P443, DOI 10.1016/j.jmb.2004.01.009; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pelletier J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006237; Pesenti ME, 2009, J MOL BIOL, V390, P981, DOI 10.1016/j.jmb.2009.05.067; Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7; Sandler BH, 2000, CHEM BIOL, V7, P143, DOI 10.1016/S1074-5521(00)00078-8; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; VOGT RG, 1981, NATURE, V293, P161, DOI 10.1038/293161a0; Wogulis M, 2006, BIOCHEM BIOPH RES CO, V339, P157, DOI 10.1016/j.bbrc.2005.10.191; Wojtasek H, 1999, J BIOL CHEM, V274, P30950, DOI 10.1074/jbc.274.43.30950; Zhou JJ, 2008, INSECT MOL BIOL, V17, P147, DOI 10.1111/j.1365-2583.2007.00789.x; Zhou JJ, 2008, INSECT MOL BIOL, V17, P445	43	91	97	5	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2009	4	11							e8006	10.1371/journal.pone.0008006	http://dx.doi.org/10.1371/journal.pone.0008006			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MN	19956631	Green Published, gold, Green Submitted			2022-12-25	WOS:000272828100003
J	Stefflova, K; Dulik, MC; Pai, AA; Walker, AH; Zeigler-Johnson, CM; Gueye, SM; Schurr, TG; Rebbeck, TR				Stefflova, Klara; Dulik, Matthew C.; Pai, Athma A.; Walker, Amy H.; Zeigler-Johnson, Charnita M.; Gueye, Serigne M.; Schurr, Theodore G.; Rebbeck, Timothy R.			Evaluation of Group Genetic Ancestry of Populations from Philadelphia and Dakar in the Context of Sex-Biased Admixture in the Americas	PLOS ONE			English	Article							SUB-SAHARAN POPULATIONS; Y-CHROMOSOME; MITOCHONDRIAL-DNA; BRAZILIAN POPULATIONS; PARENTAL POPULATIONS; HUMAN MIGRATIONS; CONTROL REGION; UNITED-STATES; MALE LINEAGES; NEAR-EASTERN	Background: Population history can be reflected in group genetic ancestry, where genomic variation captured by the mitochondrial DNA (mtDNA) and non-recombining portion of the Y chromosome (NRY) can separate female-and male-specific admixture processes. Genetic ancestry may influence genetic association studies due to differences in individual admixture within recently admixed populations like African Americans. Principal Findings: We evaluated the genetic ancestry of Senegalese as well as European Americans and African Americans from Philadelphia. Senegalese mtDNA consisted of similar to 12% U haplotypes (U6 and U5b1b haplotypes, common in North Africa) while the NRY haplotypes belonged solely to haplogroup E. In Philadelphia, we observed varying degrees of admixture. While African Americans have 9-10% mtDNAs and similar to 31% NRYs of European origin, these results are not mirrored in the mtDNA/NRY pools of European Americans: they have less than 7% mtDNAs and less than 2% NRYs from non-European sources. Additionally, there is < 2% Native American contribution to Philadelphian African American ancestry and the admixture from combined mtDNA/NRY estimates is consistent with the admixture derived from autosomal genetic data. To further dissect these estimates, we have analyzed our samples in the context of different demographic groups in the Americas. Conclusions: We found that sex-biased admixture in African-derived populations is present throughout the Americas, with continual influence of European males, while Native American females contribute mainly to populations of the Caribbean and South America. The high non-European female contribution to the pool of European-derived populations is consistently characteristic of Iberian colonization. These data suggest that genomic data correlate well with historical records of colonization in the Americas.	[Stefflova, Klara; Walker, Amy H.; Zeigler-Johnson, Charnita M.; Rebbeck, Timothy R.] Univ Penn, Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Dulik, Matthew C.; Pai, Athma A.; Schurr, Theodore G.] Univ Penn, Dept Anthropol, Philadelphia, PA 19104 USA; [Gueye, Serigne M.] Hop Gen Grand Yoff, Dakar, Senegal; [Gueye, Serigne M.] Univ Cheikh Anta Diop, Dakar, Senegal; [Rebbeck, Timothy R.] Univ Penn, Sch Med, Abramson Canc Ctr, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University Cheikh Anta Diop Dakar; University of Pennsylvania; Pennsylvania Medicine	Stefflova, K (corresponding author), Univ Penn, Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA.	Klara.Stefflova@cancer.org.uk	Rebbeck, Timothy/GLU-8348-2022	Rebbeck, Timothy/0000-0002-4799-1900; Pai, Athma/0000-0002-7995-9948; Zeigler-Johnson, Charnita/0000-0003-2641-7755; Barsi, Klara/0000-0001-9338-0468	Public Health Service [R29-ES08031, R01-CA85074, P50-CA105641]; Penn; NATIONAL CANCER INSTITUTE [R01CA085074, P50CA105641] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R29ES008031] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Penn; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by grants from the Public Health Service (R29-ES08031, R01-CA85074, and P50-CA105641) to TRR and Faculty Research Funds from Penn to TGS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe-Sandes K, 2004, HUM BIOL, V76, P77, DOI 10.1353/hub.2004.0014; Achilli A, 2005, AM J HUM GENET, V76, P883, DOI 10.1086/430073; Allard MW, 2005, FORENSIC SCI INT, V148, P169, DOI 10.1016/j.forsciint.2004.06.001; Alves-Silva J, 2000, AM J HUM GENET, V67, P444, DOI 10.1086/303004; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Berniell-Lee G, 2009, MOL BIOL EVOL, V26, P1581, DOI 10.1093/molbev/msp069; Bortolini MC, 1997, HUM BIOL, V69, P141; Brion M, 2005, ELECTROPHORESIS, V26, P4411, DOI 10.1002/elps.200500293; Ribeiro-dos-Santos AKC, 2007, FORENSIC SCI INT, V167, P77, DOI 10.1016/j.forsciint.2005.12.033; Destro-Bisol G, 2004, MOL BIOL EVOL, V21, P1673, DOI 10.1093/molbev/msh186; Dupanloup I, 2001, MOL BIOL EVOL, V18, P672, DOI 10.1093/oxfordjournals.molbev.a003847; Ellis N, 2002, GENOME RES, V12, P339; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fagundes NJR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003157; Goncalves VF, 2007, GENET MOL RES, V6, P256; Goncalves VF, 2008, HUM HERED, V65, P23, DOI 10.1159/000106059; Guerreiro V, 2009, GENET MOL BIOL, V32, P1, DOI 10.1590/S1415-47572009005000001; Halder I, 2008, HUM MUTAT, V29, P648, DOI 10.1002/humu.20695; Hammer MF, 2006, FORENSIC SCI INT, V164, P45, DOI 10.1016/j.forsciint.2005.11.013; Hunemeier T, 2007, AM J PHYS ANTHROPOL, V133, P854, DOI 10.1002/ajpa.20604; Jackson BA, 2005, AM J PHYS ANTHROPOL, V128, P156, DOI 10.1002/ajpa.20040; Karafet TM, 2008, GENOME RES, V18, P830, DOI 10.1101/gr.7172008; Kivisild T, 2002, MOL BIOL EVOL, V19, P1737, DOI 10.1093/oxfordjournals.molbev.a003996; Lind JM, 2007, HUM GENET, V120, P713, DOI 10.1007/s00439-006-0261-7; Luis JR, 2004, AM J HUM GENET, V74, P532, DOI 10.1086/382286; Mendizabal I, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-213; Olivieri A, 2006, SCIENCE, V314, P1767, DOI 10.1126/science.1135566; Parra EJ, 2001, AM J PHYS ANTHROPOL, V114, P18, DOI 10.1002/1096-8644(200101)114:1<18::AID-AJPA1002>3.0.CO;2-2; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; Pimenta JR, 2006, HUM HERED, V62, P190, DOI 10.1159/000096872; Quintana-Murci L, 2008, P NATL ACAD SCI USA, V105, DOI 10.1073/pnas.0711467105; Rando JC, 1998, ANN HUM GENET, V62, P531, DOI 10.1046/j.1469-1809.1998.6260531.x; Rawley J, 2005, TRANSATLANTIC SLAVE; RICHARDS B, 1993, HUM MOL GENET, V2, P159, DOI 10.1093/hmg/2.2.159; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Rosa A, 2004, ANN HUM GENET, V68, P340, DOI 10.1046/j.1529-8817.2004.00100.x; Rosa A, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-124; Salas A, 2008, AM J HUM BIOL, V20, P584, DOI 10.1002/ajhb.20783; Salas A, 2005, AM J PHYS ANTHROPOL, V128, P855, DOI 10.1002/ajpa.20117; Sans M, 2002, AM J PHYS ANTHROPOL, V118, P33, DOI 10.1002/ajpa.10071; Silva WA, 2006, HUM BIOL, V78, P29, DOI 10.1353/hub.2006.0028; SLATKIN M, 1995, GENETICS, V139, P457; Smith GD, 1998, LANCET, V351, P934, DOI 10.1016/S0140-6736(05)60603-4; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Thomas DC, 2002, CANCER EPIDEM BIOMAR, V11, P505; Torres JB, 2007, ANN HUM GENET, V71, P782, DOI 10.1111/j.1469-1809.2007.00380.x; Underhill PA, 2007, ANNU REV GENET, V41, P539, DOI 10.1146/annurev.genet.41.110306.130407; Walker AH, 1999, ENVIRON HEALTH PERSP, V107, P517, DOI 10.2307/3434392; Wang S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000037; Watson E, 1997, AM J HUM GENET, V61, P691, DOI 10.1086/515503; Wood ET, 2005, EUR J HUM GENET, V13, P867, DOI 10.1038/sj.ejhg.5201408; Yaeger R, 2008, CANCER EPIDEM BIOMAR, V17, P1329, DOI 10.1158/1055-9965.EPI-07-2505; Zerjal T, 2003, AM J HUM GENET, V72, P717, DOI 10.1086/367774	54	24	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2009	4	11							e7842	10.1371/journal.pone.0007842	http://dx.doi.org/10.1371/journal.pone.0007842			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	533MK	19946364	Green Submitted, Green Published, gold			2022-12-25	WOS:000272827800005
J	Bomphrey, RJ; Walker, SM; Taylor, GK				Bomphrey, Richard J.; Walker, Simon M.; Taylor, Graham K.			The Typical Flight Performance of Blowflies: Measuring the Normal Performance Envelope of Calliphora vicina Using a Novel Corner-Cube Arena	PLOS ONE			English	Article							LOCUST SCHISTOCERCA-GREGARIA; VISUAL CONTROL; INTERCEPTION; HONEYBEES; BEHAVIOR; PURSUIT; FLY	Despite a wealth of evidence demonstrating extraordinary maximal performance, little is known about the routine flight performance of insects. We present a set of techniques for benchmarking performance characteristics of insects in free flight, demonstrated using a model species, and comment on the significance of the performance observed. Free-flying blowflies (Calliphora vicina) were filmed inside a novel mirrored arena comprising a large (1.6 m x 1.6 m x 1.6 m) corner-cube reflector using a single high-speed digital video camera (250 or 500 fps). This arrangement permitted accurate reconstruction of the flies' 3-dimensional trajectories without the need for synchronisation hardware, by virtue of the multiple reflections of a subject within the arena. Image sequences were analysed using custom-written automated tracking software, and processed using a self-calibrating bundle adjustment procedure to determine the subject's instantaneous 3-dimensional position. We illustrate our method by using these trajectory data to benchmark the routine flight performance envelope of our flies. Flight speeds were most commonly observed between 1.2 ms(-1) and 2.3 ms(-1), with a maximum of 2.5 ms(-1). Our flies tended to dive faster than they climbed, with a maximum descent rate (22.4 ms(-1)) almost double the maximum climb rate (1.2 ms(-1)). Modal turn rate was around 240 degrees s(-1), with maximal rates in excess of 1700 degrees s(-1). We used the maximal flight performance we observed during normal flight to construct notional physical limits on the blowfly flight envelope, and used the distribution of observations within that notional envelope to postulate behavioural preferences or physiological and anatomical constraints. The flight trajectories we recorded were never steady: rather they were constantly accelerating or decelerating, with maximum tangential accelerations and maximum centripetal accelerations on the order of 3 g.			Bomphrey, RJ (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	graham.taylor@zoo.ox.ac.uk	Taylor, Graham/A-5041-2010; Bomphrey, Richard/I-6272-2013	Bomphrey, Richard/0000-0002-4748-0510	EPSRC [EP/H004025/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/H004025/1] Funding Source: researchfish; Biotechnology and Biological Sciences Research Council [BBC5185731, BB/C518573/1] Funding Source: Medline; European Research Council [204513] Funding Source: Medline	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Research Council(European Research Council (ERC)European Commission)		Challis JH, 1999, J APPL BIOMECH, V15, P303, DOI 10.1123/jab.15.3.303; COLLETT TS, 1978, J COMP PHYSIOL, V125, P191, DOI 10.1007/BF00656597; COLLETT TS, 1975, J COMP PHYSIOL, V99, P1, DOI 10.1007/BF01464710; COOPER M, 2003, CLOSE RANGE PHOTOGRA, P9; DAHMEN HJ, 1984, PROC R SOC SER B-BIO, V222, P107, DOI 10.1098/rspb.1984.0051; Fry SN, 2000, J NEUROSCI METH, V101, P59, DOI 10.1016/S0165-0270(00)00253-3; Kern R, 2006, J EXP BIOL, V209, P1251, DOI 10.1242/jeb.02127; LAND MF, 1993, J COMP PHYSIOL A, V173, P595; LYNN P, 2000, INTRO SIGNAL PROCESS; Muller P, 2001, J EXP BIOL, V204, P1039; NACHTIGALL W, 1983, J COMP PHYSIOL, V150, P251, DOI 10.1007/BF00606375; Olberg RM, 2000, J COMP PHYSIOL A, V186, P155, DOI 10.1007/s003590050015; Riley JR, 2005, NATURE, V435, P205, DOI 10.1038/nature03526; Riley JR, 2003, P ROY SOC B-BIOL SCI, V270, P2421, DOI 10.1098/rspb.2003.2542; Schilstra C, 1999, J EXP BIOL, V202, P1481; SCHILSTRA C, 1999, INSECT FLIGHT EYE MO; Taylor GK, 2003, J EXP BIOL, V206, P2803, DOI 10.1242/jeb.00501; Thomas ALR, 2004, J EXP BIOL, V207, P4299, DOI 10.1242/jeb.01262; WEISFOGH T, 1956, PHILOS T ROY SOC B, V239, P459, DOI 10.1098/rstb.1956.0008; WILKERSON RC, 1984, ANN ENTOMOL SOC AM, V77, P293, DOI 10.1093/aesa/77.3.293	20	25	25	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2009	4	11							e7852	10.1371/journal.pone.0007852	http://dx.doi.org/10.1371/journal.pone.0007852			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521QH	19924228	Green Published, gold, Green Submitted			2022-12-25	WOS:000271936700007
J	Dasgupta, N; Mandl, KD; Brownstein, JS				Dasgupta, Nabarun; Mandl, Kenneth D.; Brownstein, John S.			Breaking the News or Fueling the Epidemic? Temporal Association between News Media Report Volume and Opioid-Related Mortality	PLOS ONE			English	Article							ILLICIT DRUGS; PRINT MEDIA; COVERAGE; SURVEILLANCE; CONSTRUCTION; BEHAVIOR; DEATHS; IMPACT	Background: Historical studies of news media have suggested an association between reporting and increased drug abuse. Period effects for substance use have been documented for different classes of legal and illicit substances, with the suspicion that media publicity may have played major roles in their emergence. Previous analyses have drawn primarily from qualitative evidence; the temporal relationship between media reporting volume and adverse health consequences has not been quantified nationally. We set out to explore whether we could find a quantitative relationship between media reports about prescription opioid abuse and overdose mortality associated with these drugs. We assessed whether increases in news media reports occurred before or after increases in overdose deaths. Methodology/Principal Findings: Our ecological study compared a monthly time series of unintentional poisoning deaths involving short-acting prescription opioid substances, from 1999 to 2005 using multiple cause-of-death data published by the National Center for Health Statistics, to monthly counts of English-language news articles mentioning generic and branded names of prescription opioids obtained from Google News Archives from 1999 to 2005. We estimated the association between media volume and mortality rates by time-lagged regression analyses. There were 24,272 articles and 30,916 deaths involving prescription opioids during the seven-year study period. Nationally, the number of articles mentioning prescription opioids increased dramatically starting in early 2001, following prominent coverage about the nonmedical use of OxyContin. We found a significant association between news reports and deaths, with media reporting preceding fatal opioid poisonings by two to six months and explaining 88% (p<0.0001, df 78) of the variation in mortality. Conclusions/Significance: While availability, structural, and individual predispositions are key factors influencing substance use, news reporting may enhance the popularity of psychoactive substances. Albeit ecological in nature, our finding suggests the need for further evaluation of the influence of news media on health. Reporting on prescription opioids conforms to historical patterns of news reporting on other psychoactive substances.			Dasgupta, N (corresponding author), Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27515 USA.	john_brownstein@harvard.edu	Brownstein, John S/A-1438-2011	Dasgupta, Nabarun/0000-0002-4098-605X	NATIONAL LIBRARY OF MEDICINE [R21LM009263] Funding Source: NIH RePORTER; CIHR Funding Source: Medline; NLM NIH HHS [R21LM009263-01, R21 LM009263] Funding Source: Medline	NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); CIHR(Canadian Institutes of Health Research (CIHR)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		[Anonymous], 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000051; Barbour V, 2008, PLOS MED, V5, P681, DOI 10.1371/journal.pmed.0050118; BEAN P, 1994, COCAINE CRACK SUPPLY; Blendon RJ, 1998, JAMA-J AM MED ASSOC, V279, P827, DOI 10.1001/jama.279.11.827; Boyd S., 2002, INT J DRUG POLICY, V13, P397, DOI DOI 10.1016/S0955-3959(02)00079-8; BRECHER EM, 1972, LICIT ILLICIT DRUGS, pR15; Brown S L, 2001, J Long Term Eff Med Implants, V11, P1; Brown SL, 1998, PUBLIC HEALTH REP, V113, P535; BROWNSTEIN HH, 1991, SOCIAL JUSTICE, V18, P85; Brownstein JS, 2008, PLOS MED, V5, P1019, DOI 10.1371/journal.pmed.0050151; Brushwood David B, 2004, J Am Pharm Assoc (2003), V44, P439, DOI 10.1331/1544345041475779; Caburnay CA, 2003, HEALTH EDUC BEHAV, V30, P709, DOI 10.1177/1090198103255456; CASE P, 2005, HIST METHAMPHETAMINE; CATLIN P, 1989, NEWSLETTER JOURNALIS, V1, P7; Dasgupta N, 2008, GEOGRAPHY DRUG ADDIC; DAVIES JB, 1990, BRIT J ADDICT, V85, P811; DEQUINCEY T, 1924, T DEQUINCEYS CONFESS; FAN DP, 1994, INT J PUBLIC OPIN R, V6, P139, DOI 10.1093/ijpor/6.2.139; Fan DP, 1996, SUBST USE MISUSE, V31, P1413, DOI 10.3109/10826089609063984; Food and Drug Administration, 2007, FDA PUBL HLTH ADV ME; Food and Drug Administration, 2007, FDA PUBL HLTH ADV IM; Goldney R D, 2001, Crisis, V22, P173, DOI 10.1027//0227-5910.22.4.173; Hartman DM, 1999, J PSYCHOACTIVE DRUGS, V31, P423, DOI 10.1080/02791072.1999.10471772; Hawton K, 1999, BRIT MED J, V318, P972, DOI 10.1136/bmj.318.7189.972; Jauncey ME, 2005, DRUG ALCOHOL REV, V24, P401, DOI 10.1080/09595230500286021; JENKINS P, 1999, SYNTHETIC PANICS SYM, pR11; LESKOVEC J, 2009, KDD IN PRESS; Mayor S, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a742; McAdams M, 2008, PHARMACOEPIDEM DR S, V17, P229, DOI 10.1002/pds.1535; MERRIAM J, 1989, COMMUNICATION CAMPAI; MEYER CR, 1992, MINN MED, V75, P7; Miroff N, 2008, WASH POST; MUSTO DF, 1973, AM DIS ORIGINS NARCO, pR13; NEPON J, 2009, CAN J PSYCHIAT; Nicholson B, 2007, SOUTH MED J, V100, P1028, DOI 10.1097/SMJ.0b013e3180f626ff; NIEDERKROTENTHA.T, 2009, EUR J PUBLIC HLTH; O'Carroll P W, 1994, MMWR Recomm Rep, V43, P9; O'Carroll P W, 1994, MMWR Recomm Rep, V43, P1; ORCUTT JD, 1993, SOC PROBL, V40, P190, DOI 10.1525/sp.1993.40.2.03x0325m; PATTERSON SJ, 1994, J DRUG EDUC, V24, P351, DOI 10.2190/GPW5-MEVU-1CTB-9RJ0; Paulozzi LJ, 2006, PHARMACOEPIDEM DR S, V15, P618, DOI 10.1002/pds.1276; POCHNA P, 2000, NEW DRUG CHOICE SWEE, P1; *PRES COM LAW ENF, 1967, REP TASK FORC NARC D; Reese S. D., 1989, COMMUNICATION CAMPAI; REINARMAN C, 1997, CRACK AM DEMON DRUGS, pR16; Rosenbaum M, 2002, J PSYCHOACTIVE DRUGS, V34, P137, DOI 10.1080/02791072.2002.10399947; SHAFER J, 2006, PHAR FETCHED PHARM P; Sisask Merike, 2005, Arch Suicide Res, V9, P87, DOI 10.1080/13811110590512985; Stack S, 2002, INJ PREV, V8, pIV30, DOI 10.1136/ip.8.suppl_4.iv30; STOCKDALE JE, 2001, LEARNING DRINKING; *SUBST AB MENT HLT, 2007, PATT TRENDS NONM PRE; SZALAVITZ M, 2004, ACCIDENTAL ADDICT; Taylor S, 2008, PROBAT J, V55, P369, DOI 10.1177/0264550508096493; Tousignant M, 2005, SOC SCI MED, V60, P1919, DOI 10.1016/j.socscimed.2004.08.054; Wysowski DK, 2007, DRUG SAFETY, V30, P533, DOI 10.2165/00002018-200730060-00007; Yanovitzky I, 2002, J STUD ALCOHOL, V63, P342, DOI 10.15288/jsa.2002.63.342; 1962, NEWSWEEK        0813, P42	57	54	54	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2009	4	11							e7758	10.1371/journal.pone.0007758	http://dx.doi.org/10.1371/journal.pone.0007758			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	521QH	19924221	Green Published, gold, Green Submitted			2022-12-25	WOS:000271936700002
J	Mielgo, A; Torres, VA; Schmid, MC; Graf, R; Zeitlin, SG; Lee, P; Shields, DJ; Barbero, S; Jamora, C; Stupack, DG				Mielgo, Ainhoa; Torres, Vicente A.; Schmid, Michael C.; Graf, Ryon; Zeitlin, Samantha G.; Lee, Pedro; Shields, David J.; Barbero, Simone; Jamora, Colin; Stupack, Dwayne G.			The Death Effector Domains of Caspase-8 Induce Terminal Differentiation	PLOS ONE			English	Article							NF-KAPPA-B; TRANSFECTED TUMORIGENIC CLONES; SMALL-CELL; CANCER; ACTIVATION; EXPRESSION; GROWTH; HACAT; ASSOCIATION; METASTASIS	The differentiation and senescence programs of metazoans play key roles in regulating normal development and preventing aberrant cell proliferation, such as cancer. These programs are intimately associated with both the mitotic and apoptotic pathways. Caspase-8 is an apical apoptotic initiator that has recently been appreciated to coordinate non-apoptotic roles in the cell. Most of these functions are attributed to the catalytic domain, however, the amino-terminal death effector domains (DED)s, which belong to the death domain superfamily of proteins, can also play key roles during development. Here we describe a novel role for caspase-8 DEDs in regulating cell differentiation and senescence. Caspase-8 DEDs accumulate during terminal differentiation and senescence of epithelial, endothelial and myeloid cells; genetic deletion or shRNA suppression of caspase-8 disrupts cell differentiation, while re-expression of DEDs rescues this phenotype. Among caspase-8 deficient neuroblastoma cells, DED expression attenuated tumor growth in vivo and proliferation in vitro via disruption of mitosis and cytokinesis, resulting in upregulation of p53 and induction of differentiation markers. These events occur independent of caspase-8 catalytic activity, but require a critical lysine (K156) in a microtubule-binding motif in the second DED domain. The results demonstrate a new function for the DEDs of caspase-8, and describe an unexpected mechanism that contributes to cell differentiation and senescence.			Mielgo, A (corresponding author), Univ Calif San Diego, Sch Med, Dept Pathol, La Jolla, CA 92093 USA.	dstupack@ucsd.edu	Torres, Vicente/I-2437-2013	Mielgo, Ainhoa/0000-0002-4159-5931; Torres, Vicente A/0000-0002-5973-7248; Schmid, Michael/0000-0002-3445-0013	NATIONAL CANCER INSTITUTE [R01CA107263] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053185] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA107263, CA107263] Funding Source: Medline; NIAMS NIH HHS [R01 AR053185, AR053185] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Al-Bassam J, 2002, J CELL BIOL, V157, P1187, DOI 10.1083/jcb.200201048; Bao JJ, 2005, J BIOL CHEM, V280, P19594, DOI 10.1074/jbc.M501573200; Barbero S., 2008, J BIOL CHEM; Barbero S, 2009, CANCER RES, V69, P3755, DOI 10.1158/0008-5472.CAN-08-3937; Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Blumenschein GR, 2008, J CLIN ONCOL, V26, P1879, DOI 10.1200/JCO.2007.12.2689; BREITKREUTZ D, 1991, CANCER RES, V51, P4402; Campisi J, 2005, SCIENCE, V309, P886, DOI 10.1126/science.1116801; Campisi J, 2008, AGING CELL, V7, P281, DOI 10.1111/j.1474-9726.2008.00383.x; Chang BD, 2002, P NATL ACAD SCI USA, V99, P389, DOI 10.1073/pnas.012602599; Dufner A, 2006, P NATL ACAD SCI USA, V103, P988, DOI 10.1073/pnas.0510380103; FINLAY D, 2009, CANC RES; Finlay D, 2007, CANCER RES, V67, P11704, DOI 10.1158/0008-5472.CAN-07-1906; Finlay D, 2009, CANCER RES, V69, P5023, DOI 10.1158/0008-5472.CAN-08-3731; Gniadecki R, 2003, EXP DERMATOL, V12, P453, DOI 10.1034/j.1600-0625.2003.00013.x; Helfer B, 2006, CANCER RES, V66, P4273, DOI 10.1158/0008-5472.CAN-05-4183; Joseph B, 1999, BIOCHEM BIOPH RES CO, V262, P381, DOI 10.1006/bbrc.1999.1191; Kang TB, 2004, J IMMUNOL, V173, P2976, DOI 10.4049/jimmunol.173.5.2976; LaCasse EC, 2008, ONCOGENE, V27, P6252, DOI 10.1038/onc.2008.302; Lavrik IN, 2007, J BIOL CHEM, V282, P13664, DOI 10.1074/jbc.M700434200; Lechler T, 2007, J CELL BIOL, V176, P147, DOI 10.1083/jcb.200609109; Lee KH, 2006, EMBO J, V25, P1009, DOI 10.1038/sj.emboj.7601016; Lee P, 2009, NATURE, V458, P519, DOI 10.1038/nature07687; McDonald ER, 2004, P NATL ACAD SCI USA, V101, P6170, DOI 10.1073/pnas.0307459101; Medema JP, 1997, EMBO J, V16, P2794, DOI 10.1093/emboj/16.10.2794; Mielgo A, 2009, ONCOGENE, V28, P3551, DOI 10.1038/onc.2009.210; Ogawa T, 2004, CELL, V116, P591, DOI 10.1016/S0092-8674(04)00129-1; Pellegrini M, 2005, BLOOD, V106, P1581, DOI 10.1182/blood-2005-01-0284; Rebe C, 2007, BLOOD, V109, P1442, DOI 10.1182/blood-2006-03-011585; RYLE CM, 1989, DIFFERENTIATION, V40, P42, DOI 10.1111/j.1432-0436.1989.tb00812.x; Sachs L, 1996, P NATL ACAD SCI USA, V93, P4742, DOI 10.1073/pnas.93.10.4742; Siegel RM, 1998, J CELL BIOL, V141, P1243, DOI 10.1083/jcb.141.5.1243; Stupack DG, 2006, NATURE, V439, P95, DOI 10.1038/nature04323; Su H, 2005, SCIENCE, V307, P1465, DOI 10.1126/science.1104765; Teitz T, 2001, J MOL MED, V79, P428, DOI 10.1007/s001090100233; Tibbetts MD, 2003, NAT IMMUNOL, V4, P404, DOI 10.1038/ni0503-404; Torres VA, 2008, J BIOL CHEM, V283, P36280, DOI 10.1074/jbc.M805878200; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3	38	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2009	4	11							e7879	10.1371/journal.pone.0007879	http://dx.doi.org/10.1371/journal.pone.0007879			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521QH	19924290	Green Submitted, Green Published, gold			2022-12-25	WOS:000271936700013
J	Mestdagh, P; Fredlund, E; Pattyn, F; Schulte, JH; Muth, D; Vermeulen, J; Kumps, C; Schlierf, S; De Preter, K; Van Roy, N; Noguera, R; Laureys, G; Schramm, A; Eggert, A; Westermann, F; Speleman, F; Vandesompele, J				Mestdagh, P.; Fredlund, E.; Pattyn, F.; Schulte, J. H.; Muth, D.; Vermeulen, J.; Kumps, C.; Schlierf, S.; De Preter, K.; Van Roy, N.; Noguera, R.; Laureys, G.; Schramm, A.; Eggert, A.; Westermann, F.; Speleman, F.; Vandesompele, J.			MYCN/c-MYC-induced microRNAs repress coding gene networks associated with poor outcome in MYCN/c-MYC-activated tumors	ONCOGENE			English	Article						MYCN; c-MYC; microRNA; neuroblastoma	B-CELL LYMPHOMAS; C-MYC; N-MYC; TRANSCRIPTIONAL REPRESSION; EXPRESSION SIGNATURES; PATHWAY DEREGULATION; NEUROBLASTOMA; DIFFERENTIATION; TARGET; GROWTH	Increased activity of MYC protein-family members is a common feature in many cancers. Using neuroblastoma as a tumor model, we established a microRNA (miRNA) signature for activated MYCN/c-MYC signaling in two independent primary neuroblastoma tumor cohorts and provide evidence that c-MYC and MYCN have overlapping functions. On the basis of an integrated approach including miRNA and messenger RNA (mRNA) gene expression data we show that miRNA activation contributes to widespread mRNA repression, both in c-MYC- and MYCN-activated tumors. c-MYC/MYCN-induced miRNA activation was shown to be dependent on c-MYC/MYCN promoter binding as evidenced by chromatin immunoprecipitation. Finally, we show that pathways, repressed through c-MYC/MYCN miRNA activation, are highly correlated to tumor aggressiveness and are conserved across different tumor entities suggesting that c-MYC/MYCN activate a core set of miRNAs for cooperative repression of common transcriptional programs related to disease aggressiveness. Our results uncover a widespread correlation between miRNA activation and c-MYC/MYCN-mediated coding gene expression modulation and further substantiate the overlapping functions of c-MYC and MYCN in the process of tumorigenesis. Oncogene (2010) 29, 1394-1404; doi:10.1038/onc.2009.429; published online 30 November 2009	[Vandesompele, J.] Ghent Univ Hosp, Ctr Med Genet, MRB, B-9000 Ghent, Belgium; [Schulte, J. H.; Schlierf, S.; Schramm, A.; Eggert, A.] Univ Childrens Hosp, Essen, Germany; [Muth, D.; Westermann, F.] German Canc Res Ctr, Dept Tumour Genet, D-6900 Heidelberg, Germany; [Noguera, R.] Med Sch Valencia, Valencia, Spain	Ghent University; Ghent University Hospital; University of Duisburg Essen; University of Hamburg; University Medical Center Hamburg-Eppendorf; Helmholtz Association; German Cancer Research Center (DKFZ)	Vandesompele, J (corresponding author), Ghent Univ Hosp, Ctr Med Genet, MRB, Pintelaan 185, B-9000 Ghent, Belgium.	Joke.Vandesompele@UGent.be	Schulte, Johannes H/G-3981-2010; Schulte, Johannes H./V-2474-2018; speleman, frank/AAR-5184-2020; Vandesompele, Jo/W-3411-2018; Westermann, Frank/F-7509-2013; De Preter, Katleen/I-7135-2013; Pattyn, Filip/A-4164-2015; laureys, genevieve/AAG-2390-2021; Eggert, Angelika/AAE-6907-2022; Schramm, Alexander/G-5688-2010	speleman, frank/0000-0002-6628-8559; Vandesompele, Jo/0000-0001-6274-0184; De Preter, Katleen/0000-0002-7726-5096; Pattyn, Filip/0000-0003-0858-6651; Eggert, Angelika/0000-0003-3476-8184; Schramm, Alexander/0000-0001-7670-7529; Mestdagh, Pieter/0000-0001-7821-9684; Schulte, Johannes Hubertus/0000-0003-0671-1201	Gent University [BOF 01D31406, BOF 01F07207, BOF 01Z09407]; Fondation pour la recherche Nuovo-Soldati; RTICC/ISCIII [RD06/0020/0102]; Fund for Scientific Research [G.0198.08, 31511809]; Belgian Kid's Fund; Stichting tegen Kanker; European Community [037260]	Gent University; Fondation pour la recherche Nuovo-Soldati(Fondation pour la Recherche Medicale); RTICC/ISCIII(Instituto de Salud Carlos III); Fund for Scientific Research; Belgian Kid's Fund; Stichting tegen Kanker; European Community(European Commission)	We acknowledge Q Wang and J Maris for providing the neuroblastoma microarray data set. This research was funded by the Gent University Research Fund (BOF 01D31406 to PM, BOF 01F07207 to FP, BOF 01Z09407 to J Vandesompele), the Fondation pour la recherche Nuovo-Soldati (J Vermeulen), RD06/0020/0102 from RTICC/ISCIII to RN, the Fund for Scientific Research (grant number: G.0198.08 and 31511809), the Belgian Kid's Fund and the Stichting tegen Kanker. KDP is a post-doctoral researcher with the Fund for Scientific Research-Flanders. We acknowledge the support of the European Community under the FP6 (project: STREP: EET-pipeline, number: 037260).	Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Cappellen D, 2007, EMBO REP, V8, P70, DOI 10.1038/sj.embor.7400849; Chang CC, 2000, AM J CLIN PATHOL, V113, P512, DOI 10.1309/YHFE-R65B-D3LK-3GGV; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Chen YX, 2007, CANCER RES, V67, P976, DOI 10.1158/0008-5472.CAN-06-3667; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Fontana L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002236; Fredlund E, 2008, P NATL ACAD SCI USA, V105, P14094, DOI 10.1073/pnas.0804455105; Gartel AL, 2006, ONCOGENE, V25, P1989, DOI 10.1038/sj.onc.1209101; Jiang MR, 2008, BBA-MOL CELL RES, V1783, P1055, DOI 10.1016/j.bbamcr.2008.02.007; Kleine-Kohlbrecher D, 2006, CURR TOP MICROBIOL, V302, P51; Kramer MHH, 1998, BLOOD, V92, P3152, DOI 10.1182/blood.V92.9.3152.421a07_3152_3162; Landais S, 2007, CANCER RES, V67, P5699, DOI 10.1158/0008-5472.CAN-06-4478; Lee Y, 2008, NAT NEUROSCI, V11, P1137, DOI 10.1038/nn.2183; Lenz G, 2008, NEW ENGL J MED, V359, P2313, DOI 10.1056/NEJMoa0802885; Liu YC, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r77; Malynn BA, 2000, GENE DEV, V14, P1390; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Mestdagh P, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn725; Northcott PA, 2009, CANCER RES, V69, P3249, DOI 10.1158/0008-5472.CAN-08-4710; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Oberthuer A, 2006, J CLIN ONCOL, V24, P5070, DOI 10.1200/JCO.2006.06.1879; Park DS, 2001, BIOCHEMISTRY-US, V40, P3354, DOI 10.1021/bi002787b; Peterson S, 2004, ONCOGENE, V23, P213, DOI 10.1038/sj.onc.1206980; Saito-Ohara F, 2003, CANCER RES, V63, P1876; Sampson VB, 2007, CANCER RES, V67, P9762, DOI 10.1158/0008-5472.CAN-07-2462; Sander S, 2008, BLOOD, V112, P4202, DOI 10.1182/blood-2008-03-147645; Schulte JH, 2008, INT J CANCER, V122, P699, DOI 10.1002/ijc.23153; SEEGER RC, 1985, NEW ENGL J MED, V313, P1111, DOI 10.1056/NEJM198510313131802; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Stupack DG, 2006, NATURE, V439, P95, DOI 10.1038/nature04323; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun Y, 2009, BREAST CANCER RES TR, V118, P185, DOI 10.1007/s10549-008-0171-6; Tan LP, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp715; Van Roy N, 2006, GENE CHROMOSOME CANC, V45, P107, DOI 10.1002/gcc.20272; Vandesompele J, 2003, ONCOGENE, V22, P456, DOI 10.1038/sj.onc.1206148; VANROY N, 1994, GENE CHROMOSOME CANC, V10, P103, DOI 10.1002/gcc.2870100205; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang Q, 2006, CANCER RES, V66, P6050, DOI 10.1158/0008-5472.CAN-05-4618; Watters JW, 2006, MOL CANCER THER, V5, P2444, DOI 10.1158/1535-7163.MCT-06-0340; Westermann F, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r150; Zeller KI, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r69	45	96	98	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 4	2010	29	9					1394	1404		10.1038/onc.2009.429	http://dx.doi.org/10.1038/onc.2009.429			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	563XJ	19946337				2022-12-25	WOS:000275170600014
J	Feng, YM; Hartig, SM; Bechill, JE; Blanchard, EG; Caudell, E; Corey, SJ				Feng, Yanming; Hartig, Sean M.; Bechill, John E.; Blanchard, Elisabeth G.; Caudell, Eva; Corey, Seth J.			The Cdc42-interacting Protein-4 (CIP4) Gene Knock-out Mouse Reveals Delayed and Decreased Endocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN CYTOSKELETON; MEMBRANE INVAGINATION; MEDIATED ENDOCYTOSIS; PLASMA-MEMBRANE; PCH PROTEINS; N-WASP; BAR; DOMAIN; GLUT4; CELLS	The newly described F-BAR (Fer/CIP4 and Bin, amphiphysin, Rvs) family of proteins includes Cdc42-interacting protein-4 (CIP4), formin-binding protein-17 (FBP-17) and transactivator of cytoskeletal assembly-1 (Toca-1), and drives membrane deformation and invagination. Membrane remodeling affects endocytosis, vesicle budding, and cargo selection. The F-BAR family presents a novel family of proteins, which little is known about their in vivo function. We investigated the physiological role of CIP4, by creating Cip4-null mice through homologous recombination. Compared with their wild-type littermates, the Cip4-null mice displayed lower early post-prandial glucose levels. Adipocytes isolated from Cip4-null mice exhibited increased [C-14]2-deoxyglucose uptake compared with cells from wild-type mice. The enhanced insulin sensitivity was not due to higher levels of insulin or phospho-Akt, a critical player in insulin signaling. However, higher glucose transporter 4 (GLUT4) levels were detected in muscle membrane fractions in Cip4-null mice under insulin stimulation. Mouse embryonic fibroblasts from Cip4-null mice demonstrated decreased transferrin uptake, fluorescein isothiocyanate-dextran, and horseradish peroxidase uptake, indicating that CIP4 affects multiple modes of endocytosis. These studies demonstrate a physiological role for CIP4 in endocytosis leading to a whole animal phenotype.	[Feng, Yanming; Bechill, John E.; Corey, Seth J.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Feng, Yanming; Bechill, John E.; Corey, Seth J.] Northwestern Univ, Dept Pediat, Chicago, IL 60611 USA; [Feng, Yanming; Bechill, John E.; Corey, Seth J.] Northwestern Univ, Dept Cellular & Mol Biol, Chicago, IL 60611 USA; [Feng, Yanming; Hartig, Sean M.; Blanchard, Elisabeth G.; Caudell, Eva; Corey, Seth J.] Univ Texas MD Anderson Canc Ctr, Div Pediat, Houston, TX 77030 USA; [Hartig, Sean M.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; Northwestern University; Northwestern University; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine	Corey, SJ (corresponding author), Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Lurie 5-107,303 E Super St, Chicago, IL 60611 USA.	s-corey@northwestern.edu			National Institutes of Health [RO1HL080052]; American Heart Association; Charlotte Geyer Foundation; University of Texas M.D. Anderson Cancer Center Odyssey Fellowship; Tennessee Law Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080052] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Charlotte Geyer Foundation; University of Texas M.D. Anderson Cancer Center Odyssey Fellowship; Tennessee Law Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1HL080052 (to S. J. C.). This work was also supported by a grant-in-aid from the American Heart Association, Charlotte Geyer Foundation, and grants from the University of Texas M.D. Anderson Cancer Center Odyssey Fellowship and the Tennessee Law Foundation (to S. M. H.).	Aspenstrom P, 1997, CURR BIOL, V7, P479, DOI 10.1016/S0960-9822(06)00219-3; Bryant DM, 2007, J CELL SCI, V120, P1818, DOI 10.1242/jcs.000653; Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; Bu WY, 2009, J BIOL CHEM, V284, P11622, DOI 10.1074/jbc.M805940200; Chang L, 2002, P NATL ACAD SCI USA, V99, P12835, DOI 10.1073/pnas.202495599; Chitu V, 2007, TRENDS CELL BIOL, V17, P145, DOI 10.1016/j.tcb.2007.01.003; Dawson JC, 2006, TRENDS CELL BIOL, V16, P493, DOI 10.1016/j.tcb.2006.08.004; Dombrosky-Ferlan P, 2003, BLOOD, V101, P2804, DOI 10.1182/blood-2002-03-0851; Frost A, 2008, CELL, V132, P807, DOI 10.1016/j.cell.2007.12.041; Hartig SM, 2009, J CELL SCI, V122, P2283, DOI 10.1242/jcs.041343; Henne WM, 2007, STRUCTURE, V15, P839, DOI 10.1016/j.str.2007.05.002; Ho HYH, 2004, CELL, V118, P203, DOI 10.1016/j.cell.2004.06.027; Hou JCQ, 2007, CURR OPIN CELL BIOL, V19, P466, DOI 10.1016/j.ceb.2007.04.018; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Itoh T, 2006, BBA-MOL CELL BIOL L, V1761, P897, DOI 10.1016/j.bbalip.2006.06.015; Kamioka Y, 2004, J BIOL CHEM, V279, P40091, DOI 10.1074/jbc.M404899200; Kruth HS, 2005, J BIOL CHEM, V280, P2352, DOI 10.1074/jbc.M407167200; Lamaze C, 1997, J BIOL CHEM, V272, P20332, DOI 10.1074/jbc.272.33.20332; Moyers JS, 1996, J BIOL CHEM, V271, P23111, DOI 10.1074/jbc.271.38.23111; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; Schlunck G, 2004, MOL BIOL CELL, V15, P256, DOI 10.1091/mbc.E03-01-0019; Shimada A, 2007, CELL, V129, P761, DOI 10.1016/j.cell.2007.03.040; Tengholm A, 2002, CURR BIOL, V12, P1871, DOI 10.1016/S0960-9822(02)01223-X; Tian L, 2000, J BIOL CHEM, V275, P7854, DOI 10.1074/jbc.275.11.7854; Tsujita K, 2006, J CELL BIOL, V172, P269, DOI 10.1083/jcb.200508091; Wang L, 2002, BIOCHEM BIOPH RES CO, V293, P1426, DOI 10.1016/S0006-291X(02)00398-4; Yang CM, 2001, J CLIN INVEST, V107, P1311, DOI 10.1172/JCI12274; Yarar D, 2007, DEV CELL, V13, P43, DOI 10.1016/j.devcel.2007.04.014; Zhou M, 1998, AM J PHYSIOL-ENDOC M, V275, pE187, DOI 10.1152/ajpendo.1998.275.2.E187	29	40	40	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4348	4354		10.1074/jbc.M109.041038	http://dx.doi.org/10.1074/jbc.M109.041038			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	19920150	Green Published, hybrid			2022-12-25	WOS:000275274800011
J	Suzuki, S; Zhou, Y; Refaat, A; Takasaki, I; Koizumi, K; Yamaoka, S; Tabuchi, Y; Saiki, I; Sakurai, H				Suzuki, Shunsuke; Zhou, Yue; Refaat, Alaa; Takasaki, Ichiro; Koizumi, Keiichi; Yamaoka, Shoji; Tabuchi, Yoshiaki; Saiki, Ikuo; Sakurai, Hiroaki			Human T Cell Lymphotropic Virus 1 Manipulates Interferon Regulatory Signals by Controlling the TAK1-IRF3 and IRF4 Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TRANSCRIPTION FACTORS; GENE INDUCTION; FACTOR FAMILY; RNA HELICASE; KINASE TAK1; HTLV-1 TAX; RIG-I; ACTIVATION; LEUKEMIA	We previously reported that human T cell lymphotropic virus 1 (HTLV-1) Tax oncoprotein constitutively activates transforming growth factor-beta-activated kinase 1 (TAK1). Here, we established Tax-positive HuT-102 cells stably transfected with a short hairpin RNA vector (HuT-shTAK1 cells) and investigated the physiological function of TAK1. Microarray analysis demonstrated that several interferon (IFN)-inducible genes, including chemokines such as CXCL10 and CCL5, were significantly down-regulated in HuT-shTAK1 cells. In contrast, Tax-mediated constitutive activation of nuclear factor-kappa B (NF-kappa B) was intact in HuT-shTAK1 cells. IFN-regulatory factor 3 (IRF3), a critical transcription factor in innate immunity to viral infection, was constitutively activated in a Tax-dependent manner. Activation of IRF3 and IRF3-dependent gene expressions was dependent on TAK1 and TANK-binding kinase 1 (TBK1). On the other hand, IRF4, another member in the IRF family of transcription factors overexpressed in a Tax-independent manner, negatively regulated TAK1-dependent IRF3 transcriptional activity. Together, HTLV-1 manipulates IFN signaling by regulating both positive and negative IRFs.	[Suzuki, Shunsuke; Zhou, Yue; Refaat, Alaa; Koizumi, Keiichi; Saiki, Ikuo; Sakurai, Hiroaki] Toyama Univ, Inst Nat Med, Div Pathogen Biochem, Toyama 9300194, Japan; [Takasaki, Ichiro; Tabuchi, Yoshiaki] Toyama Univ, Div Mol Genet Res, Life Sci Res Ctr, Toyama 9300194, Japan; [Yamaoka, Shoji] Tokyo Med & Dent Univ, Grad Sch Med, Dept Mol Virol, Tokyo 1138519, Japan	University of Toyama; University of Toyama; Tokyo Medical & Dental University (TMDU)	Sakurai, H (corresponding author), Toyama Univ, Inst Nat Med, Div Pathogen Biochem, 2630 Sugitani, Toyama 9300194, Japan.	hsakurai@inm.u-toyama.ac.jp	Refaat, Alaa/F-3596-2018; Sakurai, Hiroaki/AAE-4294-2019; Koizumi, Keiichi/AAG-6915-2019	Refaat, Alaa/0000-0002-7821-2500; Sakurai, Hiroaki/0000-0003-0657-9570; Zhou, Yue/0000-0002-1335-5703; Tabuchi, Yoshiaki/0000-0002-6007-6176	Ministry of Education, Culture, Sports, Science, and Technology, Japan [C 19590063, 20890078]; Takeda Science Foundation	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported in part by Grants-in-aid for Scientific Research (C 19590063), Young Scientists Start-up Grant 20890078, a grant for the Cooperative Link of Unique Science and Technology for Economy Revitalization from the Ministry of Education, Culture, Sports, Science, and Technology, Japan, and a grant from Takeda Science Foundation.	Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Grassmann R, 2005, ONCOGENE, V24, P5976, DOI 10.1038/sj.onc.1208978; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Imaizumi Y, 2001, JPN J CANCER RES, V92, P1284, DOI 10.1111/j.1349-7006.2001.tb02151.x; Jin DY, 1999, J BIOL CHEM, V274, P17402, DOI 10.1074/jbc.274.25.17402; Kang DC, 2002, P NATL ACAD SCI USA, V99, P637, DOI 10.1073/pnas.022637199; Kawai T, 2007, J BIOCHEM, V141, P137, DOI 10.1093/jb/mvm032; Matsuoka M, 2007, NAT REV CANCER, V7, P270, DOI 10.1038/nrc2111; Miura H, 2005, EXP CELL RES, V308, P29, DOI 10.1016/j.yexcr.2005.04.005; Negishi H, 2005, P NATL ACAD SCI USA, V102, P15989, DOI 10.1073/pnas.0508327102; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Ramos JC, 2007, BLOOD, V109, P3060, DOI 10.1182/blood-2006-07-036368; Sakurai H, 2003, J BIOL CHEM, V278, P36916, DOI 10.1074/jbc.M301598200; Sakurai H, 1999, J BIOL CHEM, V274, P10641, DOI 10.1074/jbc.274.15.10641; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Sharma S, 2002, J IMMUNOL, V169, P3120, DOI 10.4049/jimmunol.169.6.3120; Sharma S, 2000, AIDS RES HUM RETROV, V16, P1613, DOI 10.1089/08892220050193047; Singhirunnusorn P, 2005, J BIOL CHEM, V280, P7359, DOI 10.1074/jbc.M407537200; Sun SC, 2005, ONCOGENE, V24, P5952, DOI 10.1038/sj.onc.1208969; Suzuki S, 2007, J BIOL CHEM, V282, P25177, DOI 10.1074/jbc.C700065200; Takasaki I, 2007, J CELL BIOCHEM, V102, P1472, DOI 10.1002/jcb.21369; Wu XF, 2007, EMBO REP, V8, P510, DOI 10.1038/sj.embor.7400931; Yamagata T, 1996, MOL CELL BIOL, V16, P1283; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoneyama M, 2008, IMMUNITY, V29, P178, DOI 10.1016/j.immuni.2008.07.009; Yoshida R, 2008, J BIOL CHEM, V283, P36211, DOI 10.1074/jbc.M806576200; Zhang BH, 2009, CELL RES, V19, P412, DOI 10.1038/cr.2009.8; Zhang J, 2008, VIROLOGY, V379, P306, DOI 10.1016/j.virol.2008.06.035; Zhao TJ, 2007, NAT IMMUNOL, V8, P592, DOI 10.1038/ni1465	31	25	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4441	4446		10.1074/jbc.M109.031476	http://dx.doi.org/10.1074/jbc.M109.031476			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	19955181	hybrid, Green Published			2022-12-25	WOS:000275274800021
J	Zhang, XJ; Skiba, NP; Cote, RH				Zhang, Xiu-Jun; Skiba, Nikolai P.; Cote, Rick H.			Structural Requirements of the Photoreceptor Phosphodiesterase gamma-Subunit for Inhibition of Rod PDE6 Holoenzyme and for Its Activation by Transducin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC-GMP PHOSPHODIESTERASE; RETINAL CGMP-PHOSPHODIESTERASE; ALPHA-SUBUNIT; CATALYTIC SUBUNITS; BINDING-SITES; G-PROTEIN; GAF DOMAINS; ALLOSTERIC REGULATION; CARBOXYL-TERMINUS; PURIFICATION	The central enzyme of the visual transduction cascade, cGMP phosphodiesterase (PDE6), is regulated by its gamma-subunit (P gamma), whose inhibitory constraint is released upon binding of activated transducin. It is generally believed that the last four or five C-terminal amino acid residues of P gamma are responsible for blocking catalysis. In this paper, we showed that the last 10 C-terminal residues (P gamma 78-87) are the minimum required to completely block catalysis. The kinetic mechanism of inhibition by the P gamma C terminus depends on which substrate is undergoing catalysis. We also discovered a second mechanism of P gamma inhibition that does not require this C-terminal region and that is capable of inhibiting up to 80% of the maximal cGMP hydrolytic rate. Furthermore, amino acids 63-70 and/or the intact alpha 2 helix of P gamma stabilize binding of C-terminal P gamma peptides by 100-fold. When PDE6 catalytic subunits were reconstituted with portions of the P gamma molecule and tested for activation by transducin, we found that the C-terminal region (P gamma 63-87) by itself could not be displaced but that transducin could relieve inhibition of certain P gamma truncation mutants. Our results are consistent with two distinct mechanisms of P gamma inhibition of PDE6. One involves direct interaction of the C-terminal residues with the catalytic site. A second regulatory mechanism may involve binding of other regions of P gamma to the catalytic domain, thereby allosterically reducing the catalytic rate. Transducin activation of PDE6 appears to require interaction with both the C terminus and other regions of P gamma to effectively relieve its inhibitory constraint.	[Zhang, Xiu-Jun; Cote, Rick H.] Univ New Hampshire, Dept Mol Cellular & Biomed Sci, Durham, NH 03824 USA; [Skiba, Nikolai P.] Duke Univ, Med Ctr, Dept Ophthalmol, Durham, NC 27710 USA	University System Of New Hampshire; University of New Hampshire; Duke University	Cote, RH (corresponding author), Univ New Hampshire, Dept Mol Cellular & Biomed Sci, Durham, NH 03824 USA.	rick.cote@unh.edu	Cote, Rick H/G-3363-2013	Cote, Rick H/0000-0002-1573-6526	National Institutes of Health [EY-05798]; NATIONAL EYE INSTITUTE [P30EY005722, R01EY005798] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant EY-05798.	Arshavsky VY, 2002, ANNU REV PHYSIOL, V64, P153, DOI 10.1146/annurev.physiol.64.082701.102229; Artemyev NO, 1996, P NATL ACAD SCI USA, V93, P5407, DOI 10.1073/pnas.93.11.5407; ARTEMYEV NO, 1992, BIOCHEM J, V283, P273, DOI 10.1042/bj2830273; ARTEMYEV NO, 1992, J BIOL CHEM, V267, P25067; ARTEMYEV NO, 1993, J BIOL CHEM, V268, P23611; Artemyev NO, 1997, BIOCHEMISTRY-US, V36, P4188, DOI 10.1021/bi963002y; Artemyev NO, 1998, METHODS, V14, P93, DOI 10.1006/meth.1997.0568; Barren B, 2009, EMBO J, V28, P3613, DOI 10.1038/emboj.2009.284; BROWN NG, 1992, EUR J BIOCHEM, V208, P659, DOI 10.1111/j.1432-1033.1992.tb17232.x; BROWN RL, 1992, BIOCHEMISTRY-US, V31, P5918, DOI 10.1021/bi00140a031; Corbin JD, 2009, CELL SIGNAL, V21, P1768, DOI 10.1016/j.cellsig.2009.07.012; Cote R.H., 2006, CYCLIC NUCLEOTIDE PH, DOI DOI 10.1201/9781420020847.CH8; Cote R. H., 2008, VISUAL TRANSDUCTION, P141; Cote RH, 2000, METHOD ENZYMOL, V315, P646; Cote Rick H., 2005, V307, P141; D'Amours MR, 1999, MOL PHARMACOL, V55, P508; Dryja TP, 1996, NAT GENET, V13, P358, DOI 10.1038/ng0796-358; Farber DB, 2003, FRONT BIOSCI, V8, pS666, DOI 10.2741/1111; Fu YB, 2007, PFLUG ARCH EUR J PHY, V454, P805, DOI 10.1007/s00424-006-0194-y; GILLESPIE PG, 1989, MOL PHARMACOL, V36, P773; Granovsky AE, 1997, J BIOL CHEM, V272, P11686, DOI 10.1074/jbc.272.18.11686; Grant JE, 2006, J BIOL CHEM, V281, P6194, DOI 10.1074/jbc.M509511200; Guo LW, 2008, CURR PROTEIN PEPT SC, V9, P611, DOI 10.2174/138920308786733930; Hebert MC, 1998, J BIOL CHEM, V273, P5557, DOI 10.1074/jbc.273.10.5557; HURLEY JB, 1982, J BIOL CHEM, V257, P1094; Jungbauer A, 2001, J CLIN LIGAND ASSAY, V24, P270; KLEUSS C, 1987, J CHROMATOGR, V407, P281, DOI 10.1016/S0021-9673(01)92625-1; LIPKIN VM, 1988, FEBS LETT, V234, P287, DOI 10.1016/0014-5793(88)80100-5; LIPKIN VM, 1993, BIOCHIM BIOPHYS ACTA, V1176, P250, DOI 10.1016/0167-4889(93)90052-Q; MORRISON DF, 1989, J BIOL CHEM, V264, P11671; Mou HM, 1999, J BIOL CHEM, V274, P18813, DOI 10.1074/jbc.274.26.18813; Mou HM, 2001, J BIOL CHEM, V276, P27527, DOI 10.1074/jbc.M103316200; Moussaif M, 2006, J NEUROSCI, V26, P6863, DOI 10.1523/JNEUROSCI.1322-06.2006; Muradov KG, 2000, J BIOL CHEM, V275, P6969, DOI 10.1074/jbc.275.10.6969; Natochin M, 1996, J BIOL CHEM, V271, P19964, DOI 10.1074/jbc.271.33.19964; Pandit J, 2009, P NATL ACAD SCI USA, V106, P18225, DOI 10.1073/pnas.0907635106; Pentia Dana C., 2005, V307, P125; Pugh E.N., 2000, HDB BIOL PHYS, V3, P183, DOI DOI 10.1016/S1383-8121(00)80008-1; Salchow DJ, 1999, INVEST OPHTH VIS SCI, V40, P3262; SKIBA NP, 1995, J BIOL CHEM, V270, P13210, DOI 10.1074/jbc.270.22.13210; Skiba NP, 1996, J BIOL CHEM, V271, P413, DOI 10.1074/jbc.271.1.413; Slep KC, 2001, NATURE, V409, P1071, DOI 10.1038/35059138; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Song J, 2008, P NATL ACAD SCI USA, V105, P1505, DOI 10.1073/pnas.0709558105; TAKEMOTO DJ, 1992, BIOCHEM J, V281, P637, DOI 10.1042/bj2810637; Tsang SH, 1998, SCIENCE, V282, P117, DOI 10.1126/science.282.5386.117; Tsang SH, 2002, VISION RES, V42, P439, DOI 10.1016/S0042-6989(01)00213-9; Tsang SH, 2001, BIOCHEM J, V353, P467, DOI 10.1042/0264-6021:3530467; Uversky VN, 2002, J PROTEOME RES, V1, P149, DOI 10.1021/pr0155127; Wensel TG, 2008, VISION RES, V48, P2052, DOI 10.1016/j.visres.2008.03.010; Wensel Theodore G., 2005, V307, P289; Yamazaki M, 2002, J BIOL CHEM, V277, P40675, DOI 10.1074/jbc.M203469200; Zhang XJ, 2008, J BIOL CHEM, V283, P29699, DOI 10.1074/jbc.M803948200; Zhang XJ, 2005, INVEST OPHTH VIS SCI, V46, P3060, DOI 10.1167/iovs.05-0257	54	13	13	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4455	4463		10.1074/jbc.M109.057406	http://dx.doi.org/10.1074/jbc.M109.057406			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	19948718	Green Published, hybrid			2022-12-25	WOS:000275274800023
J	Behrendt, M; Polaina, J; Naim, HY				Behrendt, Marc; Polaina, Julio; Naim, Hassan Y.			Structural Hierarchy of Regulatory Elements in the Folding and Transport of an Intestinal Multidomain Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LACTASE-PHLORHIZIN HYDROLASE; BETA-GLUCOSIDASE; PHLORIZIN HYDROLASE; INTRACELLULAR-TRANSPORT; CRYSTAL-STRUCTURE; EPITHELIAL-CELLS; MEMBRANE; ENZYME; EXPRESSION; BIOSYNTHESIS	Human intestinal lactase-phlorizin hydrolase, LPH, encompasses four homologous domains, which presumably have evolved from two subsequent duplications of one ancestral gene. The profragment, LPH alpha, comprises homologous domains I and II and functions as an intramolecular chaperone in the context of the brush-border LPH beta region of LPH. Here, we analyze the inter-relationship between homologous domains III and IV of LPH beta and their implication in the overall structure, function, and trafficking of LPH. In silico analyses revealed potential domain boundaries for these domains as a basis for loop-out mutagenesis and construction of deletion or individual domain forms of LPH. Removal of domain IV, which contains lactase, results in a diminished phlorizin hydrolase activity, lack of dimerization in the endoplasmic reticulum (ER), but accelerated transport kinetics from the ER to the Golgi apparatus. By contrast, deletion of domain III, which harbors phlorizin hydrolase, generates a malfolded protein that is blocked in the ER. Interestingly, homologous domain III is transport-competent per se and sorted to the apical membrane in polarized Madin-Darby canine kidney cells. Nevertheless, it neither dimerizes nor acquires complete phlorizin hydrolase activity. Our data present a hierarchical model of LPH in which the homologous domain III constitutes (i) a fully autonomous core domain within LPH and (ii) another intramolecular chaperone besides the profragment LPH alpha. Nevertheless, the regulation of the trafficking kinetics and activity of domain III and entire LPH including elevation of the enzymatic activities require the correct dimerization of LPH in the ER, an event that is accomplished by the non-autonomous domain IV.	[Naim, Hassan Y.] Univ Vet Med Hannover, Dept Physiol Chem, D-30559 Hannover, Germany; [Polaina, Julio] Univ Valencia, CSIC, Inst Agroquim & Tecnol Alimentos, E-46100 Valencia, Spain	University of Veterinary Medicine Hannover, Foundation; Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Agroquimica y Tecnologia de los Alimentos (IATA); University of Valencia	Naim, HY (corresponding author), Univ Vet Med Hannover, Dept Physiol Chem, Bunteweg 17, D-30559 Hannover, Germany.	Hassan.Naim@tiho-hannover.de	Polaina, Julio/H-4498-2012	Polaina, Julio/0000-0001-9912-0640	German Research Foundation Deutsche Forschungsgemeinschaft [Na 331/1-5]; Sonderforschungsbereich [621]	German Research Foundation Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Sonderforschungsbereich(German Research Foundation (DFG))	This work was supported by grants from the German Research Foundation Deutsche Forschungsgemeinschaft (Grant Na 331/1-5) and Sonderforschungsbereich (Grant 621) (to H. Y. N.).	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Arribas JCD, 2000, EUR J BIOCHEM, V267, P6996, DOI 10.1046/j.1432-1327.2000.01784.x; BARR PJ, 1991, CELL, V66, P1, DOI 10.1016/0092-8674(91)90129-M; Behrendt M, 2009, GASTROENTEROLOGY, V136, P2295, DOI 10.1053/j.gastro.2009.01.041; BULLER HA, 1990, ANNU REV MED, V41, P141; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chuenchor W, 2008, J MOL BIOL, V377, P1200, DOI 10.1016/j.jmb.2008.01.076; Coutinho Pedro M., 1999, Journal of Molecular Microbiology and Biotechnology, V1, P307; DANIELSEN EM, 1984, BIOCHEM BIOPH RES CO, V122, P82; DIGEON B, 1986, Digestive Diseases, V4, P139, DOI 10.1159/000171144; HARVEY CB, 1995, EUR J HUM GENET, V3, P27; HAURI HP, 1985, J CELL BIOL, V101, P838, DOI 10.1083/jcb.101.3.838; Hayashi Y, 2007, J BIOL CHEM, V282, P30889, DOI 10.1074/jbc.M700832200; Isorna P, 2007, J MOL BIOL, V371, P1204, DOI 10.1016/j.jmb.2007.05.082; Jacob R, 1996, EUR J BIOCHEM, V236, P789, DOI 10.1111/j.1432-1033.1996.t01-1-00789.x; Jacob R, 2000, J BIOL CHEM, V275, P10630, DOI 10.1074/jbc.275.14.10630; Jacob R, 2002, J BIOL CHEM, V277, P8217, DOI 10.1074/jbc.M111500200; Jacob R, 2001, CURR BIOL, V11, P1444, DOI 10.1016/S0960-9822(01)00446-8; JACOB R, 1994, J BIOL CHEM, V269, P2712; MAIURI L, 1991, GASTROENTEROLOGY, V100, P359, DOI 10.1016/0016-5085(91)90203-W; MANTEI N, 1988, EMBO J, V7, P2705, DOI 10.1002/j.1460-2075.1988.tb03124.x; McGuffin LJ, 2003, BIOINFORMATICS, V19, P874, DOI 10.1093/bioinformatics/btg097; NAIM HY, 1987, BIOCHEM J, V241, P427, DOI 10.1042/bj2410427; NAIM HY, 1991, J BIOL CHEM, V266, P12313; NAIM HY, 1994, J BIOL CHEM, V269, P26933; Naim HY, 1996, EUR J CELL BIOL, V70, P198; Naim HY, 2001, HISTOL HISTOPATHOL, V16, P553, DOI 10.14670/HH-16.553; Nijikken Y, 2007, FEBS LETT, V581, P1514, DOI 10.1016/j.febslet.2007.03.009; OBERHOLZER T, 1993, FEBS LETT, V333, P127, DOI 10.1016/0014-5793(93)80389-C; Ouwendijk J, 1998, J BIOL CHEM, V273, P6650, DOI 10.1074/jbc.273.12.6650; Panzer P, 1998, J BIOL CHEM, V273, P13861, DOI 10.1074/jbc.273.22.13861; PHILLIPS T, 1978, P NUTR SOC, V37, pA24; Sanz-Aparicio J, 1998, J MOL BIOL, V275, P491, DOI 10.1006/jmbi.1997.1467; STEINER DF, 1984, J CELL BIOCHEM, V24, P121, DOI 10.1002/jcb.240240204; WANG YX, 1995, HUM MOL GENET, V4, P657, DOI 10.1093/hmg/4.4.657; Wuthrich M, 1996, ARCH BIOCHEM BIOPHYS, V336, P27, DOI 10.1006/abbi.1996.0528; YEH KY, 1991, AM J PHYSIOL, V260, pG379, DOI 10.1152/ajpgi.1991.260.3.G379; Zecca L, 1998, FEBS LETT, V435, P225, DOI 10.1016/S0014-5793(98)01076-X	38	10	10	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					4143	4152		10.1074/jbc.M109.060780	http://dx.doi.org/10.1074/jbc.M109.060780			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19955176	Green Published, hybrid			2022-12-25	WOS:000275254000066
J	Bom, APDA; Freitas, MS; Moreira, FS; Ferraz, D; Sanches, D; Gomes, AMO; Valente, AP; Cordeiro, Y; Silva, JL				Ano Bom, Ana Paula D.; Freitas, Monica S.; Moreira, Flavia S.; Ferraz, Danielly; Sanches, Daniel; Gomes, Andre M. O.; Valente, Ana Paula; Cordeiro, Yraima; Silva, Jerson L.			The p53 Core Domain Is a Molten Globule at Low pH FUNCTIONAL IMPLICATIONS OF A PARTIALLY UNFOLDED STRUCTURE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR P53; DNA-BINDING DOMAIN; THERMODYNAMIC STABILITY; ALPHA-LACTALBUMIN; NMR-SPECTROSCOPY; ARC REPRESSOR; CELL-DEATH; WILD-TYPE; PROTEIN; STATE	p53 is a transcription factor that maintains genome integrity, and its function is lost in 50% of human cancers. The majority of p53 mutations are clustered within the core domain. Here, we investigate the effects of low pH on the structure of the wild-type (wt) p53 core domain (p53C) and the R248Q mutant. At low pH, the tryptophan residue is partially exposed to the solvent, suggesting a fluctuating tertiary structure. On the other hand, the secondary structure increases, as determined by circular dichroism. Binding of the probe bis-ANS (bis-8-anilinonaphthalene-1-sulfonate) indicates that there is an increase in the exposure of hydrophobic pockets for both wt and mutant p53C at low pH. This behavior is accompanied by a lack of cooperativity under urea denaturation and decreased stability under pressure when p53C is in acidic pH. Together, these results indicate that p53C acquires a partially unfolded conformation (molten-globule state) at low pH (5.0). The hydrodynamic properties of this conformation are intermediate between the native and denatured conformation. H-1-N-15 HSQC NMR spectroscopy confirms that the protein has a typical molten-globule structure at acidic pH when compared with pH 7.2. Human breast cells in culture (MCF-7) transfected with p53-GFP revealed localization of p53 in acidic vesicles, suggesting that the low pH conformation is present in the cell. Low pH stress also tends to favor high levels of p53 in the cells. Taken together, all of these data suggest that p53 may play physiological or pathological roles in acidic microenvironments.	[Ano Bom, Ana Paula D.; Freitas, Monica S.; Moreira, Flavia S.; Ferraz, Danielly; Sanches, Daniel; Gomes, Andre M. O.; Valente, Ana Paula; Silva, Jerson L.] Univ Fed Rio de Janeiro, Inst Bioquim Med, Ctr Nacl Ressonancia Magnet Nucl Macromol, BR-21941590 Rio De Janeiro, Brazil; [Cordeiro, Yraima] Univ Fed Rio de Janeiro, Fac Farm, BR-21941590 Rio De Janeiro, Brazil; [Ano Bom, Ana Paula D.; Freitas, Monica S.; Ferraz, Danielly; Sanches, Daniel; Gomes, Andre M. O.; Valente, Ana Paula; Cordeiro, Yraima; Silva, Jerson L.] Univ Fed Rio de Janeiro, Inst Nacl Ciencia & Tecnol Biol Estructural & Bio, BR-21941590 Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Silva, JL (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med, Ctr Nacl Ressonancia Magnet Nucl Macromol, Bloco E Sala 10,Cidade Univ, BR-21941590 Rio De Janeiro, Brazil.	jerson@bioqmed.ufrj.br	Valente, Ana Paula/J-3010-2017; de Freitas, Mônica Santos/E-8540-2015; Cordeiro, Yraima/J-7619-2012; Gomes, Andre M.O./C-4009-2014; Silva, Jerson/J-8984-2014; SILVA, JERSON Lima/GRF-1442-2022	Valente, Ana Paula/0000-0001-7219-1123; de Freitas, Mônica Santos/0000-0003-3105-7918; Cordeiro, Yraima/0000-0003-4278-212X; Gomes, Andre M.O./0000-0003-1052-8004; Silva, Jerson/0000-0001-9523-9441; SILVA, JERSON Lima/0000-0001-9523-9441	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Financiadora de Estudos e Projetos (FINEP); Fundacao Universitaria Jose Bonifacio (FUJB) of Brazil	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Financiadora de Estudos e Projetos (FINEP)(Financiadora de Inovacao e Pesquisa (Finep)); Fundacao Universitaria Jose Bonifacio (FUJB) of Brazil	This work was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), CNPq Millennium and National Insitute Programs, Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Financiadora de Estudos e Projetos (FINEP), and Fundacao Universitaria Jose Bonifacio (FUJB) of Brazil.	Arai M, 2000, ADV PROTEIN CHEM, V53, P209; BALEJA JD, 1994, BIOCHEM CELL BIOL, V72, P95, DOI 10.1139/o94-016; BOCHKAREVA ES, 1988, NATURE, V336, P254, DOI 10.1038/336254a0; Buchhop S, 1997, NUCLEIC ACIDS RES, V25, P3868, DOI 10.1093/nar/25.19.3868; Bullock AN, 2000, ONCOGENE, V19, P1245, DOI 10.1038/sj.onc.1203434; Bullock AN, 1997, P NATL ACAD SCI USA, V94, P14338, DOI 10.1073/pnas.94.26.14338; BURGERING MJM, 1995, BIOPOLYMERS, V35, P217, DOI 10.1002/bip.360350210; Caramelo JJ, 2003, P NATL ACAD SCI USA, V100, P86, DOI 10.1073/pnas.262661199; Chai YL, 1999, ONCOGENE, V18, P263, DOI 10.1038/sj.onc.1202323; Choi EK, 2004, INT J RADIAT ONCOL, V60, P1264, DOI 10.1016/j.ijrobp.2004.04.043; CHRISTENSEN H, 1991, EUR BIOPHYS J, V19, P221, DOI 10.1007/BF00183530; Chung CM, 2005, BIOPHYS J, V88, P4232, DOI 10.1529/biophysj.105.061317; Cordeiro Y, 2004, J BIOL CHEM, V279, P32354, DOI 10.1074/jbc.M404295200; Creighton TE, 1997, TRENDS BIOCHEM SCI, V22, P6, DOI 10.1016/S0968-0004(96)20030-1; Cremades N, 2008, J BIOL CHEM, V283, P2883, DOI 10.1074/jbc.M705677200; DAPOIAN AT, 1995, BIOCHEMISTRY-US, V34, P2672, DOI 10.1021/bi00008a034; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dial R, 2003, BIOCHEMISTRY-US, V42, P9937, DOI 10.1021/bi034989o; DiGiammarino EL, 2002, NAT STRUCT BIOL, V9, P12, DOI 10.1038/nsb730; Ditaranto K, 2001, NEUROBIOL DIS, V8, P19, DOI 10.1006/nbdi.2000.0364; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Engel R, 2008, J BIOL CHEM, V283, P27383, DOI 10.1074/jbc.M802393200; FINK AL, 1995, ANNU REV BIOPH BIOM, V24, P495, DOI 10.1146/annurev.bb.24.060195.002431; FINK AL, 1993, PROTEIN SCI, V2, P1155, DOI 10.1002/pro.5560020710; FINLAY CA, 1989, CELL, V57, P1083, DOI 10.1016/0092-8674(89)90045-7; Foguel B, 2004, BIOCHEMISTRY-US, V43, P11361; Foguel D, 2003, P NATL ACAD SCI USA, V100, P9831, DOI 10.1073/pnas.1734009100; Gerber R, 2007, J BIOL CHEM, V282, P6300, DOI 10.1074/jbc.M608926200; Gillespie JR, 2000, BBA-PROTEIN STRUCT M, V1480, P41, DOI 10.1016/S0167-4838(00)00104-7; Glover JNM, 2004, TRENDS BIOCHEM SCI, V29, P579, DOI 10.1016/j.tibs.2004.09.010; Hansson LO, 2002, P NATL ACAD SCI USA, V99, P10305, DOI 10.1073/pnas.122347199; Hawe A, 2008, PHARM RES-DORDR, V25, P1487, DOI 10.1007/s11095-007-9516-9; Herczenik E, 2008, FASEB J, V22, P2115, DOI 10.1096/fj.07-099671; Hollstein M, 1999, MUTAT RES-FUND MOL M, V431, P199, DOI 10.1016/S0027-5107(99)00162-1; Ishimaru D, 2004, BIOPHYS J, V87, P2691, DOI 10.1529/biophysj.104.044685; Ishimaru D, 2003, J MOL BIOL, V333, P443, DOI 10.1016/j.jmb.2003.08.026; Ishimaru D, 2003, BIOCHEMISTRY-US, V42, P9022, DOI 10.1021/bi034218k; Ishimaru D, 2009, BIOCHEMISTRY-US, V48, P6126, DOI 10.1021/bi9003028; Iwabuchi K, 1998, J BIOL CHEM, V273, P26061, DOI 10.1074/jbc.273.40.26061; Ji ZS, 2006, J BIOL CHEM, V281, P2683, DOI 10.1074/jbc.M506646200; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kamatari YO, 2004, METHODS, V34, P133, DOI 10.1016/j.ymeth.2004.03.010; KIM PS, 1990, ANNU REV BIOCHEM, V59, P631, DOI 10.1146/annurev.biochem.59.1.631; Kim S, 1999, J MOL BIOL, V294, P551, DOI 10.1006/jmbi.1999.3250; Klein C, 2001, J BIOL CHEM, V276, P37390, DOI 10.1074/jbc.M103801200; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; KUWAJIMA K, 1989, PROTEINS, V6, P87, DOI 10.1002/prot.340060202; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE, V3rd, P278; Laptenko O, 2006, CELL DEATH DIFFER, V13, P951, DOI 10.1038/sj.cdd.4401916; Levesque AA, 2007, CARCINOGENESIS, V28, P13, DOI 10.1093/carcin/bgl214; Lo MC, 1998, P NATL ACAD SCI USA, V95, P8455, DOI 10.1073/pnas.95.15.8455; MartinezZaguilan R, 1996, CLIN EXP METASTAS, V14, P176, DOI 10.1007/BF00121214; Meek DW, 2004, DNA REPAIR, V3, P1049, DOI 10.1016/j.dnarep.2004.03.027; Mihara Motohiro, 2003, Methods Mol Biol, V234, P203; MILLA ME, 1995, BIOCHEMISTRY-US, V34, P3344, DOI 10.1021/bi00010a025; MILNER J, 1995, TRENDS BIOCHEM SCI, V20, P49, DOI 10.1016/S0968-0004(00)88954-9; Nam GH, 2002, EUR J BIOCHEM, V269, P5280, DOI 10.1046/j.1432-1033.2002.03242.x; NOZAKA M, 1978, BIOCHEMISTRY-US, V17, P3753, DOI 10.1021/bi00611a013; OHGUSHI M, 1983, FEBS LETT, V164, P21, DOI 10.1016/0014-5793(83)80010-6; Ohtsubo T, 1997, CANCER RES, V57, P3910; Pace C N, 1986, Methods Enzymol, V131, P266; Petros AM, 2004, FEBS LETT, V559, P171, DOI 10.1016/s0014-5793(04)00059-6; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Ptitsyn OB, 1995, ADV PROTEIN CHEM, V47, P83, DOI 10.1016/S0065-3233(08)60546-X; Rawat U, 1998, J BIOL CHEM, V273, P9415, DOI 10.1074/jbc.273.16.9415; Rippin TM, 2002, J MOL BIOL, V319, P351, DOI 10.1016/S0022-2836(02)00326-1; ROSEN CG, 1969, BIOCHEMISTRY-US, V8, P3915, DOI 10.1021/bi00838a006; Silva JL, 2006, BBA-PROTEINS PROTEOM, V1764, P443, DOI 10.1016/j.bbapap.2005.11.012; Silva JL, 2002, BBA-PROTEIN STRUCT M, V1595, P250, DOI 10.1016/S0167-4838(01)00348-X; SILVA JL, 1992, J MOL BIOL, V223, P545, DOI 10.1016/0022-2836(92)90669-B; Soussi T, 2006, NAT REV CANCER, V6, P83, DOI 10.1038/nrc1783; Sutovsky H, 2004, J BIOL CHEM, V279, P17190, DOI 10.1074/jbc.M311225200; Svensson M, 1999, J BIOL CHEM, V274, P6388, DOI 10.1074/jbc.274.10.6388; Twigg PD, 2001, P NATL ACAD SCI USA, V98, P11259, DOI 10.1073/pnas.191354798; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; Vassilenko KS, 2002, BBA-PROTEIN STRUCT M, V1594, P168, DOI 10.1016/S0167-4838(01)00303-X; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Williams AC, 1999, ONCOGENE, V18, P3199, DOI 10.1038/sj.onc.1202660; Wong KB, 1999, P NATL ACAD SCI USA, V96, P8438, DOI 10.1073/pnas.96.15.8438; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Xu L, 2002, J BIOL CHEM, V277, P11368, DOI 10.1074/jbc.M108347200; Xu L, 2000, CANCER RES, V60, P4610; Yuan XM, 2002, P NATL ACAD SCI USA, V99, P6286, DOI 10.1073/pnas.092135599; Zhang B, 1996, J BIOL CHEM, V271, P28734, DOI 10.1074/jbc.271.46.28734	84	50	51	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2857	2866		10.1074/jbc.M109.075861	http://dx.doi.org/10.1074/jbc.M109.075861			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19933157	hybrid, Green Published			2022-12-25	WOS:000273697800061
J	Cole, JG; Jerse, AE				Cole, Jessica G.; Jerse, Ann E.			Functional Characterization of Antibodies against Neisseria gonorrhoeae Opacity Protein Loops	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEIN; SEXUALLY-TRANSMITTED-DISEASES; SEROVAR-SPECIFIC IMMUNITY; OPA PROTEINS; GONOCOCCAL SALPINGITIS; ANTIGENIC VARIATION; SERUM RESISTANCE; TRACT INFECTION; IMMUNIZATION; EXPRESSION	Background: The development of a gonorrhea vaccine is challenged by the lack of correlates of protection. The antigenically variable neisserial opacity (Opa) proteins are expressed during infection and have a semivariable (SV) and highly conserved (4L) loop that could be targeted in a vaccine. Here we compared antibodies to linear (Ab(linear)) and cyclic (Ab(cyclic)) peptides that correspond to the SV and 4L loops and selected hypervariable (HV(2)) loops for surface-binding and protective activity in vitro and in vivo. Methods/Findings: Ab(SV) (cyclic) bound a greater number of different Opa variants than Ab(SV linear), including variants that differed by seven amino acids. Antibodies to the 4L peptide did not bind Opa-expressing bacteria. Ab(SV cyclic) and Ab(HV2) (cyclic), but not Ab(SV linear) or Ab(HV2 linear) agglutinated homologous Opa variants, and Ab(HV2BD) (cyclic) but not Ab(HV2BD) (linear) blocked the association of OpaB variants with human endocervical cells. Only Ab(HV2BD linear) were bactericidal against the serum resistant parent strain. Consistent with host restrictions in the complement cascade, the bactericidal activity of Ab(HV2BD linear) was increased 8-fold when rabbit complement was used. None of the antibodies was protective when administered vaginally to mice. Antibody duration in the vagina was short-lived, however, with <50% of the antibodies recovered 3 hrs post-administration. Conclusions: We conclude that an SV loop-specific cyclic peptide can be used to induce antibodies that recognize a broad spectrum of antigenically distinct Opa variants and have agglutination abilities. HV(2) loop-specific cyclic peptides elicited antibodies with agglutination and adherence blocking abilities. The use of human complement when testing the bactericidal activity of vaccine-induced antibodies against serum resistant gonococci is also important.	[Cole, Jessica G.; Jerse, Ann E.] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Dept Microbiol & Immunol, Bethesda, MD 20814 USA	Uniformed Services University of the Health Sciences - USA	Cole, JG (corresponding author), Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Dept Microbiol & Immunol, Bethesda, MD 20814 USA.	ajerse@usuhs.mil			NIH/NIAID STI-TM-CRC [U19 AI31496]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI031496] Funding Source: NIH RePORTER	NIH/NIAID STI-TM-CRC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was funded by NIH/NIAID STI-TM-CRC grant U19 AI31496. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonina G, 2006, INFECT IMMUN, V74, P2224, DOI 10.1128/IAI.74.4.2224-2232.2006; BHAT KS, 1991, MOL MICROBIOL, V5, P1889, DOI 10.1111/j.1365-2958.1991.tb00813.x; Bos MP, 1997, INFECT IMMUN, V65, P645, DOI 10.1128/IAI.65.2.645-650.1997; Bos MP, 2002, INFECT IMMUN, V70, P1715, DOI 10.1128/IAI.70.4.1715-1723.2002; Boulton IC, 2002, NAT IMMUNOL, V3, P229, DOI 10.1038/ni769; BUCHANAN TM, 1980, AM J OBSTET GYNECOL, V138, P978, DOI 10.1016/0002-9378(80)91091-1; Chesson HW, 2004, PERSPECT SEX REPRO H, V36, P11, DOI 10.1363/3601104; CHRISTODOULIDES M, 1993, J GEN MICROBIOL, V139, P1729, DOI 10.1099/00221287-139-8-1729; Cohen MS, 1997, LANCET, V349, P1868, DOI 10.1016/S0140-6736(97)02190-9; de Jonge MI, 2004, VACCINE, V22, P4021, DOI 10.1016/j.vaccine.2004.03.047; de Jonge MI, 2003, INFECT IMMUN, V71, P2331, DOI 10.1128/IAI.71.5.2331-2340.2003; Dehio C, 1998, TRENDS MICROBIOL, V6, P489, DOI 10.1016/S0966-842X(98)01365-1; del Rio C., 2007, Morbidity and Mortality Weekly Report, V56, P332; DEMPSEY JAF, 1991, J BACTERIOL, V173, P5476, DOI 10.1128/jb.173.17.5476-5486.1991; DEREE JM, 1986, J CLIN MICROBIOL, V24, P121, DOI 10.1128/JCM.24.1.121-125.1986; FARUKI H, 1985, NEW ENGL J MED, V313, P607, DOI 10.1056/NEJM198509053131004; Fox KK, 1999, AM J EPIDEMIOL, V149, P353, DOI 10.1093/oxfordjournals.aje.a009820; Garvin LE, 2008, INFECT IMMUN, V76, P3700, DOI 10.1128/IAI.00265-08; Gerbase AC, 1998, SEX TRANSM INFECT, V74, pS12; Han E, 2001, BIOCHEM J, V355, P417, DOI 10.1042/0264-6021:3550417; Harvey HA, 2001, MOL MICROBIOL, V42, P659, DOI 10.1046/j.1365-2958.2001.02666.x; Hobbs MM, 1999, J INFECT DIS, V179, P371, DOI 10.1086/314608; Hook E. W., 1999, SEXU LLY TRANSMITTED, P451; JAMES JF, 1978, INFECT IMMUN, V19, P332, DOI 10.1128/IAI.19.1.332-340.1978; JERSE AE, 1994, J EXP MED, V179, P911, DOI 10.1084/jem.179.3.911; Jerse AE, 1999, INFECT IMMUN, V67, P5699, DOI 10.1128/IAI.67.11.5699-5708.1999; KELLOGG DS, 1963, J BACTERIOL, V85, P1274, DOI 10.1128/JB.85.6.1274-1279.1963; LAMMEL CJ, 1985, J INFECT DIS, V152, P990, DOI 10.1093/infdis/152.5.990; Malorny B, 1998, J BACTERIOL, V180, P1323, DOI 10.1128/JB.180.5.1323-1330.1998; McNabb Scott J N, 2008, MMWR Morb Mortal Wkly Rep, V55, P1; MURPHY GL, 1989, CELL, V56, P539, DOI 10.1016/0092-8674(89)90577-1; Ngampasutadol J, 2005, P NATL ACAD SCI USA, V102, P17142, DOI 10.1073/pnas.0506471102; Ngampasutadol J, 2008, J IMMUNOL, V180, P3426, DOI 10.4049/jimmunol.180.5.3426; Pal S, 1997, VACCINE, V15, P575, DOI 10.1016/S0264-410X(97)00206-5; Pantelic M, 2005, INFECT IMMUN, V73, P4171, DOI 10.1128/IAI.73.7.4171-4179.2005; Parr EL, 1997, J VIROL, V71, P8109, DOI 10.1128/JVI.71.11.8109-8115.1997; PLUMMER FA, 1989, J CLIN INVEST, V83, P1472, DOI 10.1172/JCI114040; PLUMMER FA, 1994, J CLIN INVEST, V93, P1748, DOI 10.1172/JCI117159; Ram S, 2001, J EXP MED, V193, P281, DOI 10.1084/jem.193.3.281; Ram S, 1999, MOL IMMUNOL, V36, P915, DOI 10.1016/S0161-5890(99)00114-5; Sherwood JK, 1996, BIOL REPROD, V54, P264, DOI 10.1095/biolreprod54.1.264; Simms AN, 2006, INFECT IMMUN, V74, P2965, DOI 10.1128/IAI.74.5.2965-2974.2006; Song W, 2008, VACCINE; STERN A, 1986, CELL, V47, P61, DOI 10.1016/0092-8674(86)90366-1; SWANSON J, 1988, J EXP MED, V168, P2121, DOI 10.1084/jem.168.6.2121; Tapsall JW, 2005, CLIN INFECT DIS, V41, pS263, DOI 10.1086/430787; Veazey RS, 2003, NAT MED, V9, P343, DOI 10.1038/nm833; Villullas S, 2007, CELL MICROBIOL, V9, P329, DOI 10.1111/j.1462-5822.2006.00789.x; WHALEY KJ, 1994, J INFECT DIS, V169, P647, DOI 10.1093/infdis/169.3.647; ZAK K, 1984, J INFECT DIS, V149, P166, DOI 10.1093/infdis/149.2.166	50	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2009	4	12							e8108	10.1371/journal.pone.0008108	http://dx.doi.org/10.1371/journal.pone.0008108			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MT	19956622	gold, Green Published, Green Submitted			2022-12-25	WOS:000272828700019
J	Manabe, T; Katayama, T; Tohyama, M				Manabe, Takayuki; Katayama, Taiichi; Tohyama, Masaya			HMGA1a Recognition Candidate DNA Sequences in Humans	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; MOBILITY GROUP-I(Y) PROTEIN; GENE-EXPRESSION; BREAST-CANCER; CYCLIN D3; BINDING; TRANSCRIPTION; I(Y); RNA; INDUCTION	High mobility group protein A1a (HMGA1a) acts as an architectural transcription factor and influences a diverse array of normal biological processes. It binds AT-rich sequences, and previous reports have demonstrated HMGA1a binding to the authentic promoters of various genes. However, the precise sequences that HMGA1a binds to remain to be clarified. Therefore, in this study, we searched for the sequences with the highest affinity for human HMGA1a using an existing SELEX method, and then compared the identified sequences with known human promoter sequences. Based on our results, we propose the sequences "-(G/A)-G-(A/T)-(A/T)-A-T-T-T-'' as HMGA1a-binding candidate sequences. Furthermore, these candidate sequences bound native human HMGA1a from SK-N-SH cells. When candidate sequences were analyzed by performing FASTAs against all known human promoter sequences, 500-900 sequences were hit by each one. Some of the extracted genes have already been proven or suggested as HMGA1a-binding promoters. The candidate sequences presented here represent important information for research into the various roles of HMGA1a, including cell differentiation, death, growth, proliferation, and the pathogenesis of cancer.	[Manabe, Takayuki] Fujita Hlth Univ, Inst Comprehens Med Sci, Div Gene Express Mech, Aichi, Japan; [Tohyama, Masaya] Osaka Univ, Dept Anat & Neurosci, Grad Sch Med, Osaka, Japan; [Katayama, Taiichi; Tohyama, Masaya] Kanazawa Univ, Dept Child Dev, United Grad Sch Child Dev, Osaka Univ, Osaka, Japan; [Katayama, Taiichi; Tohyama, Masaya] Hamamatsu Univ Sch Med, Osaka, Japan	Fujita Health University; Osaka University; Kanazawa University; Osaka University; Hamamatsu University School of Medicine	Manabe, T (corresponding author), Fujita Hlth Univ, Inst Comprehens Med Sci, Div Gene Express Mech, Aichi, Japan.	manabe@fujita-hu.ac.jp						ABDULKADIR SA, 1995, J EXP MED, V182, P487, DOI 10.1084/jem.182.2.487; Adair JE, 2007, CANCER RES, V67, P6044, DOI 10.1158/0008-5472.CAN-06-1689; Bai ZL, 2009, ARCH PHARM, V342, P133, DOI 10.1002/ardp.200800174; Baldassarre G, 1999, J CLIN INVEST, V104, P865, DOI 10.1172/JCI6443; Baran B, 2009, EUR J CELL BIOL, V88, P743, DOI 10.1016/j.ejcb.2009.08.002; Bonnefoy E, 1999, MOL CELL BIOL, V19, P2803; Chase MB, 1999, AM J HEMATOL, V60, P27, DOI 10.1002/(SICI)1096-8652(199901)60:1<27::AID-AJH6>3.0.CO;2-0; Chau KY, 2005, INT IMMUNOL, V17, P297, DOI 10.1093/intimm/dxh209; Chau KY, 2000, J NEUROSCI, V20, P7317; Chiappetta G, 2004, CLIN CANCER RES, V10, P7637, DOI 10.1158/1078-0432.CCR-04-0291; Chin MT, 1998, J BIOL CHEM, V273, P9755, DOI 10.1074/jbc.273.16.9755; Choi Dongseok, 2008, J Ocul Biol Dis Infor, V1, P37, DOI 10.1007/s12177-008-9007-1; CHUVPILO S, 1993, NUCLEIC ACIDS RES, V21, P5694, DOI 10.1093/nar/21.24.5694; DEMARTINO I, 2009, RE CANC S, V69, P1844; Duncan B, 2007, DNA CELL BIOL, V26, P745, DOI 10.1089/dna.2007.0629; Ebert MPA, 2001, J CANCER RES CLIN, V127, P449, DOI 10.1007/s004320100235; Fay J, 2009, J MED VIROL, V81, P897, DOI 10.1002/jmv.21406; Fedele M, 2006, CANCER RES, V66, P2536, DOI 10.1158/0008-5472.CAN-05-1889; Foster LC, 2000, FASEB J, V14, P368, DOI 10.1096/fasebj.14.2.368; Gorla L, 2006, CELL SIGNAL, V18, P2272, DOI 10.1016/j.cellsig.2006.05.016; Gotte M, 2006, CANCER RES, V66, P10233, DOI 10.1158/0008-5472.CAN-06-1464; Heaney AP, 1999, NAT MED, V5, P1317, DOI 10.1038/15275; Himes SR, 1996, IMMUNITY, V5, P479, DOI 10.1016/S1074-7613(00)80503-8; Ji YS, 1998, CIRC RES, V83, P295, DOI 10.1161/01.RES.83.3.295; Kappeler L, 2003, J NEUROENDOCRINOL, V15, P592, DOI 10.1046/j.1365-2826.2003.01039.x; Kim ES, 2001, CURR OPIN ONCOL, V13, P506, DOI 10.1097/00001622-200111000-00014; Kondo T, 2007, CLIN CANCER RES, V13, P4713, DOI 10.1158/1078-0432.CCR-07-0618; Liau SS, 2008, CANCER-AM CANCER SOC, V113, P302, DOI 10.1002/cncr.23560; Lin SC, 2006, MOL IMMUNOL, V43, P1325, DOI 10.1016/j.molimm.2005.09.007; Long JL, 2009, LARYNGOSCOPE, V119, P89, DOI 10.1002/lary.20062; Manabe T, 2003, CELL DEATH DIFFER, V10, P698, DOI 10.1038/sj.cdd.4401221; Manabe T, 2007, GENES CELLS, V12, P1179, DOI 10.1111/j.1365-2443.2007.01123.x; Mandal M, 2001, J BIOL CHEM, V276, P9699, DOI 10.1074/jbc.M008514200; Mayer IA, 2009, CLIN BREAST CANCER, V9, pS50, DOI 10.3816/CBC.2009.s.005; Miyake K, 2008, PANCREAS, V36, pE1, DOI 10.1097/MPA.0b013e31815f2c2a; Najy AJ, 2008, J BIOL CHEM, V283, P18393, DOI 10.1074/jbc.M801329200; Oh KB, 2007, ONCOGENE, V26, P5950, DOI 10.1038/sj.onc.1210401; Okuda H, 2006, MOL CELL NEUROSCI, V33, P81, DOI 10.1016/j.mcn.2006.06.009; Onguru O, 2004, MODERN PATHOL, V17, P772, DOI 10.1038/modpathol.3800118; Perrella MA, 1999, J BIOL CHEM, V274, P9045, DOI 10.1074/jbc.274.13.9045; Reeves R, 2001, BBA-GENE STRUCT EXPR, V1519, P13, DOI 10.1016/S0167-4781(01)00215-9; Reeves R, 2001, GENE, V277, P63, DOI 10.1016/S0378-1119(01)00689-8; Russell A, 1999, ONCOGENE, V18, P1983, DOI 10.1038/sj.onc.1202511; Saeger W, 2001, ENDOCR PATHOL, V12, P39, DOI 10.1385/EP:12:1:39; Sansone P, 2007, J CLIN INVEST, V117, P3988, DOI 10.1172/JCI32533; Sasaki M, 2001, CANCER RES, V61, P4809; Sawai H, 2001, PANCREAS, V23, P399, DOI 10.1097/00006676-200111000-00011; Schmutzler C, 2007, BIOL CHEM, V388, P1053, DOI 10.1515/BC.2007.122; Takamiya R, 2008, FEBS LETT, V582, P810, DOI 10.1016/j.febslet.2008.02.008; Tesfaye A, 2007, CANCER RES, V67, P3998, DOI 10.1158/0008-5472.CAN-05-1684; Treff NR, 2004, ONCOGENE, V23, P8557, DOI 10.1038/sj.onc.1207926; Treff NR, 2004, ONCOGENE, V23, P777, DOI 10.1038/sj.onc.1207167; Wascher RA, 2001, BRIT J CANCER, V85, P1340, DOI 10.1054/bjoc.2001.2079; Yanagita T, 2005, NEUROSCI LETT, V374, P47, DOI 10.1016/j.neulet.2004.10.039; Zhou RY, 2010, INT J CANCER, V126, P395, DOI 10.1002/ijc.24744	55	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2009	4	11							e8004	10.1371/journal.pone.0008004	http://dx.doi.org/10.1371/journal.pone.0008004			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MH	19956671	gold, Green Published, Green Submitted			2022-12-25	WOS:000272827500028
J	Rajaram, MVS; Butchar, JP; Parsa, KVL; Cremer, TJ; Amer, A; Schlesinger, LS; Tridandapani, S				Rajaram, Murugesan V. S.; Butchar, Jonathan P.; Parsa, Kishore V. L.; Cremer, Thomas J.; Amer, Amal; Schlesinger, Larry S.; Tridandapani, Susheela			Akt and SHIP Modulate Francisella Escape from the Phagosome and Induction of the Fas-Mediated Death Pathway	PLOS ONE			English	Article							MACROPHAGE INFLAMMATORY RESPONSE; MURINE MACROPHAGES; LIGAND INTERACTIONS; HUMAN MONOCYTES; T-LYMPHOCYTES; TULARENSIS; ACTIVATION; APOPTOSIS; CELLS; EXPRESSION	Francisella tularensis infects macrophages and escapes phago-lysosomal fusion to replicate within the host cytosol, resulting in host cell apoptosis. Here we show that the Fas-mediated death pathway is activated in infected cells and correlates with escape of the bacterium from the phagosome and the bacterial burden. Our studies also demonstrate that constitutive activation of Akt, or deletion of SHIP, promotes phago-lysosomal fusion and limits bacterial burden in the host cytosol, and the subsequent induction of Fas expression and cell death. Finally, we show that phagosomal escape/intracellular bacterial burden regulate activation of the transcription factors sp1/sp3, leading to Fas expression and cell death. These data identify for the first time host cell signaling pathways that regulate the phagosomal escape of Francisella, leading to the induction of Fas and subsequent host cell death.			Rajaram, MVS (corresponding author), Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA.	tridandapani.2@osu.edu	Butchar, Jonathan/E-2825-2011; Amer, Amal/E-2643-2011; Rajaram, Murugesan/E-5203-2013; Tridandapani, Susheela/E-4209-2011	Parsa, Kishore/0000-0001-7883-2534; Rajaram, Murugesan/0000-0002-1515-1122	NCI NIH HHS [P01 CA095426] Funding Source: Medline; NHLBI NIH HHS [R01 HL094586-01A1, R01 HL094586] Funding Source: Medline; NIAID NIH HHS [U54 AI057153, R01 AI059406, R21 AI083871-01, 1-U54-AI-057153, R21 AI083871] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA095426] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI083871, R01AI059406, U54AI057153] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ANTHONY LSD, 1989, MICROB PATHOGENESIS, V7, P421, DOI 10.1016/0882-4010(89)90022-3; Baran J, 2001, INFECT IMMUN, V69, P1287, DOI 10.1128/IAI.69.3.1287-1297.2001; Barbieri MA, 1998, J BIOL CHEM, V273, P19367, DOI 10.1074/jbc.273.31.19367; Baumler CB, 1996, BLOOD, V88, P1741; Bolger CE, 2005, J LEUKOCYTE BIOL, V77, P893, DOI 10.1189/jlb.1104637; Butchar JP, 2007, J IMMUNOL, V178, P4445, DOI 10.4049/jimmunol.178.7.4445; Butchar JP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002924; Chanteux H, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-71; Checroun C, 2006, P NATL ACAD SCI USA, V103, P14578, DOI 10.1073/pnas.0601838103; CHEN Q, J IMMUNOL, V170, P5302; Chong A, 2008, INFECT IMMUN, V76, P5488, DOI 10.1128/IAI.00682-08; Clemens DL, 2007, ANN NY ACAD SCI, V1105, P160, DOI 10.1196/annals.1409.001; DEBATIN KM, 1994, BLOOD, V83, P3101, DOI 10.1182/blood.V83.10.3101a.3101a; Drecktrah D, 2004, INFECT IMMUN, V72, P4331, DOI 10.1128/IAI.72.8.4331-4335.2004; Fang HQ, 2004, J IMMUNOL, V173, P360, DOI 10.4049/jimmunol.173.1.360; Fortier A H, 1994, Immunol Ser, V60, P349; Ganesan LP, 2004, J BIOL CHEM, V279, P54416, DOI 10.1074/jbc.M408188200; Ganesan LP, 2003, J BIOL CHEM, V278, P35710, DOI 10.1074/jbc.M305078200; Gavrilin MA, 2006, P NATL ACAD SCI USA, V103, P141, DOI 10.1073/pnas.0504271103; Golovliov I, 1996, FEMS IMMUNOL MED MIC, V13, P239, DOI 10.1111/j.1574-695X.1996.tb00244.x; Gutierrez MG, 2008, J IMMUNOL, V181, P2651, DOI 10.4049/jimmunol.181.4.2651; Hoyal CR, 2003, P NATL ACAD SCI USA, V100, P5130, DOI 10.1073/pnas.1031526100; KATSIKIS PD, 1995, J EXP MED, V181, P2029, DOI 10.1084/jem.181.6.2029; Kieffer TL, 2003, MICROBES INFECT, V5, P397, DOI 10.1016/S1286-4579(03)00052-2; KISCHKEL FC, 1995, EMBO J, V14, P5579, DOI 10.1002/j.1460-2075.1995.tb00245.x; Krammer PH, 2000, NATURE, V407, P789, DOI 10.1038/35037728; Lai XH, 2001, INFECT IMMUN, V69, P4691, DOI 10.1128/IAI.69.7.4691-4694.2001; Lai XH, 2003, INFECT IMMUN, V71, P4642, DOI 10.1128/IAI.71.8.4642-4646.2003; Lai XH, 2004, MICROB PATHOGENESIS, V37, P225, DOI 10.1016/j.micpath.2004.07.002; Lauriano CM, 2004, P NATL ACAD SCI USA, V101, P4246, DOI 10.1073/pnas.0307690101; Lindgren H, 2004, J MED MICROBIOL, V53, P953, DOI 10.1099/jmm.0.45685-0; Mariathasan S, 2005, J EXP MED, V202, P1043, DOI 10.1084/jem.20050977; MCLEAN IW, 1974, J HISTOCHEM CYTOCHEM, V22, P1077, DOI 10.1177/22.12.1077; McLendon MK, 2006, ANNU REV MICROBIOL, V60, P167, DOI 10.1146/annurev.micro.60.080805.142126; Pang HL, 1998, BIOCHEM J, V333, P209, DOI 10.1042/bj3330209; Parsa KVL, 2006, PLOS PATHOG, V2, P681, DOI 10.1371/journal.ppat.0020071; PARSA KV, 2008, MOL IMMUNOL; Rajaram MVS, 2006, J IMMUNOL, V177, P6317, DOI 10.4049/jimmunol.177.9.6317; Rudi J, 1998, J CLIN INVEST, V102, P1506, DOI 10.1172/JCI2808; Rupper AC, 2001, J CELL SCI, V114, P1283; Santic M, 2005, CELL MICROBIOL, V7, P969, DOI 10.1111/j.1462-5822.2005.00526.x; Santic M, 2005, CELL MICROBIOL, V7, P957, DOI 10.1111/j.1462-5822.2005.00529.x; Santic M, 2006, TRENDS MICROBIOL, V14, P37, DOI 10.1016/j.tim.2005.11.008; Scott CC, 2002, J BIOL CHEM, V277, P12770, DOI 10.1074/jbc.M110399200; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; SWANSON MS, 1995, INFECT IMMUN, V63, P3609, DOI 10.1128/IAI.63.9.3609-3620.1995; Telepnev M, 2005, MICROB PATHOGENESIS, V38, P239, DOI 10.1016/j.micpath.2005.02.003; Vieira OV, 2001, J CELL BIOL, V155, P19, DOI 10.1083/jcb.200107069; Wang JD, 2000, INFECT IMMUN, V68, P4303, DOI 10.1128/IAI.68.7.4303-4311.2000; WICKSTRUM JR, 2009, INFECT IMMUN	51	28	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2009	4	11							e7919	10.1371/journal.pone.0007919	http://dx.doi.org/10.1371/journal.pone.0007919			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522NL	19936232	gold, Green Submitted, Green Published			2022-12-25	WOS:000272004800004
J	Ghelli, A; Porcelli, AM; Zanna, C; Vidoni, S; Mattioli, S; Barbieri, A; Iommarini, L; Pala, M; Achilli, A; Torroni, A; Rugolo, M; Carelli, V				Ghelli, Anna; Porcelli, Anna Maria; Zanna, Claudia; Vidoni, Sara; Mattioli, Stefano; Barbieri, Anna; Iommarini, Luisa; Pala, Maria; Achilli, Alessandro; Torroni, Antonio; Rugolo, Michela; Carelli, Valerio			The Background of Mitochondrial DNA Haplogroup J Increases the Sensitivity of Leber's Hereditary Optic Neuropathy Cells to 2,5-Hexanedione Toxicity	PLOS ONE			English	Article							N-HEXANE; PARKINSONS-DISEASE; APOPTOTIC DEATH; ORGANIC-SOLVENT; EXPRESSION; MUTATIONS; EXPOSURE; TOLUENE; ALCOHOL; CYBRIDS	Leber's hereditary optic neuropathy (LHON) is a maternally inherited blinding disease due to mitochondrial DNA (mtDNA) point mutations in complex I subunit genes, whose incomplete penetrance has been attributed to both genetic and environmental factors. Indeed, the mtDNA background defined as haplogroup J is known to increase the penetrance of the 11778/ND4 and 14484/ND6 mutations. Recently it was also documented that the professional exposure to n-hexane might act as an exogenous trigger for LHON. Therefore, we here investigate the effect of the n-hexane neurotoxic metabolite 2,5-hexanedione (2,5-HD) on cell viability and mitochondrial function of different cell models (cybrids and fibroblasts) carrying the LHON mutations on different mtDNA haplogroups. The viability of control and LHON cybrids and fibroblasts, whose mtDNAs were completely sequenced, was assessed using the MTT assay. Mitochondrial ATP synthesis rate driven by complex I substrates was determined with the luciferine/luciferase method. Incubation with 2,5-HD caused the maximal loss of viability in control and LHON cells. The toxic effect of this compound was similar in control cells irrespective of the mtDNA background. On the contrary, sensitivity to 2,5-HD induced cell death was greatly increased in LHON cells carrying the 11778/ND4 or the 14484/ND6 mutation on haplogroup J, whereas the 11778/ND4 mutation in association with haplogroups U and H significantly improved cell survival. The 11778/ND4 mutation on haplogroup U was also more resistant to inhibition of complex I dependent ATP synthesis by 2,5-HD. In conclusion, this study shows that mtDNA haplogroups modulate the response of LHON cells to 2,5-HD. In particular, haplogroup J makes cells more sensitive to its toxic effect. This is the first evidence that an mtDNA background plays a role by interacting with an environmental factor and that 2,5-HD may be a risk element for visual loss in LHON. This proof of principle has broad implications for other neurodegenerative disorders such as Parkinson's disease.			Ghelli, A (corresponding author), Univ Bologna, Dipartimento Biol Evoluzionist Sperimentale, Bologna, Italy.	annamaria.ghelli@unibo.it	Zanna, Claudia/GVT-1932-2022; Rugolo, Michela/AAY-8640-2020; Torroni, Antonio/E-1557-2011; Achilli, Alessandro/I-9236-2012; Iommarini, Luisa/J-2328-2018	Torroni, Antonio/0000-0002-4163-4478; Achilli, Alessandro/0000-0001-6871-3451; Iommarini, Luisa/0000-0002-6804-7302; Barbieri, Anna/0000-0001-8839-294X; Rugolo, Michela/0000-0002-4597-0452; Porcelli, Anna Maria/0000-0002-6209-0692; GHELLI, ANNA MARIA/0000-0003-0830-0000; Mattioli, Stefano/0000-0002-9639-7430; Pala, Maria/0000-0001-9202-8331; CARELLI, VALERIO/0000-0003-4923-6404	Telethon [GGP06233] Funding Source: Medline	Telethon(Fondazione Telethon)		Acin-Perez R, 2004, MOL CELL, V13, P805, DOI 10.1016/S1097-2765(04)00124-8; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Blier PU, 2001, TRENDS GENET, V17, P400, DOI 10.1016/S0168-9525(01)02338-1; Bonetta L, 2002, NAT MED, V8, P1050, DOI 10.1038/nm1002-1050; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Canton M, 1996, BBA-BIOENERGETICS, V1274, P39, DOI 10.1016/0005-2728(96)00008-4; Carelli V, 2002, BBA-MOL BASIS DIS, V1588, P7, DOI 10.1016/S0925-4439(02)00097-2; Carelli V, 2006, AM J HUM GENET, V78, P564, DOI 10.1086/501236; Carelli V, 2003, TRENDS GENET, V19, P257, DOI 10.1016/S0168-9525(03)00072-6; Carelli V, 2004, PROG RETIN EYE RES, V23, P53, DOI 10.1016/j.preteyeres.2003.10.003; Carelli V, 2002, NEUROCHEM INT, V40, P573, DOI 10.1016/S0197-0186(01)00129-2; Carelli V, 2007, ENVIRON HEALTH PERSP, V115, P113, DOI 10.1289/ehp.9245; CULLOM ME, 1993, ARCH OPHTHALMOL-CHIC, V111, P1482, DOI 10.1001/archopht.1993.01090110048021; Danielson SR, 2005, BRAIN, V128, P1026, DOI 10.1093/brain/awh447; Floreani M, 2005, FEBS J, V272, P1124, DOI 10.1111/j.1742-4658.2004.04542.x; Ghelli A, 2003, J BIOL CHEM, V278, P4145, DOI 10.1074/jbc.M210285200; Ghelli A, 2008, INVEST OPHTH VIS SCI, V49, P671, DOI 10.1167/iovs.07-0880; Ghezzi D, 2005, EUR J HUM GENET, V13, P748, DOI 10.1038/sj.ejhg.5201425; Gobba F, 2003, NEUROTOXICOLOGY, V24, P693, DOI 10.1016/S0161-813X(03)00037-8; Hudson G, 2005, AM J HUM GENET, V77, P1086, DOI 10.1086/498176; Hudson G, 2007, AM J HUM GENET, V81, P228, DOI 10.1086/519394; Kerrison JB, 2000, AM J OPHTHALMOL, V130, P803, DOI 10.1016/S0002-9394(00)00603-6; King M P, 1996, Methods Enzymol, V264, P304, DOI 10.1016/S0076-6879(96)64029-4; Kirkman MA, 2009, BRAIN, V132, P2317, DOI 10.1093/brain/awp158; Kiyokawa M, 1999, JPN J OPHTHALMOL, V43, P438, DOI 10.1016/S0021-5155(99)00102-1; La Morgia C, 2008, NEUROLOGY, V70, P762, DOI 10.1212/01.wnl.0000295505.74234.d0; LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561; Man PYW, 2002, J MED GENET, V39, P162, DOI 10.1136/jmg.39.3.162; Manfredi G, 2002, METHODS, V26, P317, DOI 10.1016/S1046-2023(02)00037-3; Maruff P, 1998, BRAIN, V121, P1903, DOI 10.1093/brain/121.10.1903; McDermott C, 2007, TOXICOL IN VITRO, V21, P116, DOI 10.1016/j.tiv.2006.08.002; Meadows R, 1996, SOUTHERN MED J, V89, P455, DOI 10.1097/00007611-199605000-00001; MEDRANO CJ, 1989, NEUROTOXICOLOGY, V10, P249; Mishra DP, 2006, J BIOL CHEM, V281, P2133, DOI 10.1074/jbc.M508648200; Moreno-Loshuertos R, 2006, NAT GENET, V38, P1261, DOI 10.1038/ng1897; OGAWA Y, 1988, IND HEALTH, V26, P239, DOI 10.2486/indhealth.26.239; Pello R, 2008, HUM MOL GENET, V17, P4001, DOI 10.1093/hmg/ddn303; PERBELLINI L, 1982, INT ARCH OCC ENV HEA, V50, P351, DOI 10.1007/BF00377831; RAITTA C, 1978, A GRAEF ARCH KLIN EX, V209, P99, DOI 10.1007/BF00407843; RAMSAY RR, 1986, BIOCHEM BIOPH RES CO, V135, P269, DOI 10.1016/0006-291X(86)90972-1; Roubertoux PL, 2003, NAT GENET, V35, P65, DOI 10.1038/ng1230; Sadun AA, 2003, AM J OPHTHALMOL, V136, P231, DOI 10.1016/S0002-9394(03)00099-0; Sanchez RN, 2006, J NEURO-OPHTHALMOL, V26, P268, DOI 10.1097/01.wno.0000249320.27110.ab; Shankar SP, 2008, OPHTHALMIC GENET, V29, P17, DOI 10.1080/13816810701867607; SPENCER PS, 1978, ENVIRON HEALTH PERSP, V26, P97, DOI 10.2307/3428829; SPENCER PS, 1985, SCAND J WORK ENV HEA, V11, P53; Suissa S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000474; TAKEUCHI Y, 1993, INT ARCH OCC ENV HEA, V65, pS227, DOI 10.1007/BF00381347; Torroni A, 1997, AM J HUM GENET, V60, P1107; Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0; Tsao K, 1999, BRIT J OPHTHALMOL, V83, P577, DOI 10.1136/bjo.83.5.577; van der Walt JM, 2003, AM J HUM GENET, V72, P804, DOI 10.1086/373937; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wallace DC, 2008, GENETICS, V179, P727, DOI 10.1534/genetics.104.91769; WILLIAMS DML, 1988, J OTOLARYNGOL, V17, P321; Zanna C, 2005, APOPTOSIS, V10, P997, DOI 10.1007/s10495-005-0742-5; Zhao WY, 1998, NEUROCHEM RES, V23, P837, DOI 10.1023/A:1022402810695	58	63	65	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2009	4	11							e7922	10.1371/journal.pone.0007922	http://dx.doi.org/10.1371/journal.pone.0007922			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522NJ	19936068	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000272004600020
J	Graham, SP; Hassan, HK; Burkett-Cadena, ND; Guyer, C; Unnasch, TR				Graham, Sean P.; Hassan, Hassan K.; Burkett-Cadena, Nathan D.; Guyer, Craig; Unnasch, Thomas R.			Nestedness of Ectoparasite-Vertebrate Host Networks	PLOS ONE			English	Article							EMERGING INFECTIOUS-DISEASES; ANIMAL MUTUALISTIC NETWORKS; WEST-NILE-VIRUS; COEVOLUTIONARY NETWORKS; SPECIES RICHNESS; BRIDGE VECTOR; MARINE FISH; PARASITE; ECOLOGY; COMMUNITIES	Determining the structure of ectoparasite-host networks will enable disease ecologists to better understand and predict the spread of vector-borne diseases. If these networks have consistent properties, then studying the structure of well-understood networks could lead to extrapolation of these properties to others, including those that support emerging pathogens. Borrowing a quantitative measure of network structure from studies of mutualistic relationships between plants and their pollinators, we analyzed 29 ectoparasite-vertebrate host networks-including three derived from molecular bloodmeal analysis of mosquito feeding patterns-using measures of nestedness to identify non-random interactions among species. We found significant nestedness in ectoparasite-vertebrate host lists for habitats ranging from tropical rainforests to polar environments. These networks showed non-random patterns of nesting, and did not differ significantly from published estimates of nestedness from mutualistic networks. Mutualistic and antagonistic networks appear to be organized similarly, with generalized ectoparasites interacting with hosts that attract many ectoparasites and more specialized ectoparasites usually interacting with these same "generalized'' hosts. This finding has implications for understanding the network dynamics of vector-born pathogens. We suggest that nestedness (rather than random ectoparasite-host associations) can allow rapid transfer of pathogens throughout a network, and expand upon such concepts as the dilution effect, bridge vectors, and host switching in the context of nested ectoparasite-vertebrate host networks.			Graham, SP (corresponding author), Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA.	grahasp@auburn.edu		Burkett-Cadena, Nathan/0000-0001-6168-1637	PHS HHS [R01-A149724] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Allan BF, 2003, CONSERV BIOL, V17, P267, DOI 10.1046/j.1523-1739.2003.01260.x; ALLRED DM, 1966, BRIGHAM YOUNG U SCI; Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; Anderson PK, 2004, TRENDS ECOL EVOL, V19, P535, DOI 10.1016/j.tree.2004.07.021; ANTONOVICS J, 1995, AM NAT, V145, P661, DOI 10.1086/285761; ATMAR W, 1993, OECOLOGIA, V96, P373, DOI 10.1007/BF00317508; Baker Anne S., 2003, Systematic and Applied Acarology Special Publications, V14, P1; Barros-Battesti DM, 2000, J MED ENTOMOL, V37, P820, DOI 10.1603/0022-2585-37.6.820; Barros-Battesti DM, 1998, MEM I OSWALDO CRUZ, V93, P719, DOI 10.1590/S0074-02761998000600003; Bascompte J, 2006, SCIENCE, V312, P431, DOI 10.1126/science.1123412; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bascompte J, 2007, ANNU REV ECOL EVOL S, V38, P567, DOI 10.1146/annurev.ecolsys.38.091206.095818; Bersier LF, 2002, ECOLOGY, V83, P2394, DOI 10.1890/0012-9658(2002)083[2394:QDOFWM]2.0.CO;2; Bezerra ELS, 2009, J ANIM ECOL, V78, P1096, DOI 10.1111/j.1365-2656.2009.01567.x; Bittencourt EB, 2003, MEM I OSWALDO CRUZ, V98, P793, DOI 10.1590/S0074-02762003000600015; Blick R, 2009, PERSPECT PLANT ECOL, V11, P41, DOI 10.1016/j.ppees.2008.10.002; Brennan J. M., 1955, Great Basin Naturalist, V15, P1; Burkett-Cadena ND, 2008, AM J TROP MED HYG, V79, P809, DOI 10.4269/ajtmh.2008.79.809; BUSENBERG S, 1990, J MATH BIOL, V28, P257, DOI 10.1007/BF00178776; CHOE JC, 1987, CAN J ZOOL, V65, P2998, DOI 10.1139/z87-454; Clausen PH, 1998, MED VET ENTOMOL, V12, P169, DOI 10.1046/j.1365-2915.1998.00097.x; Collinge SK, 2006, DIS ECOLOGY COMMUNIT; Cupp EW, 2004, AM J TROP MED HYG, V71, P272, DOI 10.4269/ajtmh.2004.71.272; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Lyra-Neves Rachel M. de, 2003, Rev. Bras. Zool., V20, P481, DOI 10.1590/S0101-81752003000300019; Dick CW, 2007, INT J PARASITOL, V37, P871, DOI 10.1016/j.ijpara.2007.02.004; Dick CW, 2005, J PARASITOL, V91, P1015, DOI 10.1645/GE-536R.1; DUMROW R, 1985, AUST J ZOOL S, V114, P1; DUNNET GM, 1974, AUSTR J ZOOLOGY S, V30, P1; EDMUNDS LAFE R., 1951, PAN PACIFIC ENT, V27, P23; Fauci AS, 2004, JAMA-J AM MED ASSOC, V292, P1887, DOI 10.1001/jama.292.15.1887; Fischer J, 2002, OIKOS, V99, P193, DOI 10.1034/j.1600-0706.2002.990121.x; Ford P. L., 2004, FLEAS LICE MAMMALS N; GILOT B, 1990, EUR J EPIDEMIOL, V6, P357, DOI 10.1007/BF00151708; Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x; Guegan JF, 1996, PARASITOL TODAY, V12, P367, DOI 10.1016/0169-4758(96)10054-5; GUEGAN JF, 1994, OECOLOGIA, V100, P184, DOI 10.1007/BF00317145; Guimaraes PR, 2007, CURR BIOL, V17, P1797, DOI 10.1016/j.cub.2007.09.059; Guimaraes PR, 2007, BIOL LETTERS, V3, P51, DOI 10.1098/rsbl.2006.0562; GUIMARAES PR, 2006, ENVIRON MODELL SOFTW, V21, P1521; Haas Glenn E., 2005, Journal of the Entomological Society of British Columbia, V102, P65; HAFNER MS, 1995, PHILOS T R SOC B, V349, P77, DOI 10.1098/rstb.1995.0093; Hamer GL, 2008, J MED ENTOMOL, V45, P125, DOI 10.1603/0022-2585(2008)45[125:CPDCAB]2.0.CO;2; Hassan HK, 2003, AM J TROP MED HYG, V69, P641, DOI 10.4269/ajtmh.2003.69.641; HEATH A C G, 1977, Tuatara, V23, P26; HORAK IG, 1991, ONDERSTEPOORT J VET, V58, P125; Jordano P, 2003, ECOL LETT, V6, P69, DOI 10.1046/j.1461-0248.2003.00403.x; Kilpatrick AM, 2006, PLOS BIOL, V4, P606, DOI 10.1371/journal.pbio.0040082; Kilpatrick AM, 2005, EMERG INFECT DIS, V11, P425, DOI 10.3201/eid1103.040364; Krasnov BR, 2006, J ANIM ECOL, V75, P1330, DOI 10.1111/j.1365-2656.2006.01156.x; Labruna MB, 2007, EXP APPL ACAROL, V43, P147, DOI 10.1007/s10493-007-9106-x; LoGiudice K, 2003, P NATL ACAD SCI USA, V100, P567, DOI 10.1073/pnas.0233733100; Lowenberg-Neto P, 2008, J TROP ECOL, V24, P575, DOI 10.1017/S0266467408005348; MAA T C, 1971, Pacific Insects Monograph, V(28, P1; MALMQVIST B, 2004, P ROY SOC LOND B BIO, V271, P152; Martins-Hatano F, 2002, J PARASITOL, V88, P36, DOI 10.1645/0022-3395(2002)088[0036:EAHSOL]2.0.CO;2; MATTHYSSE JG, 1990, EXP AP ARACOL, V8, P221; McCoy KD, 2001, J EVOLUTION BIOL, V14, P395, DOI 10.1046/j.1420-9101.2001.00290.x; Morand S, 2002, PARASITOLOGY, V124, pS57, DOI 10.1017/S0031182002001464; Murrell BP, 2003, J MED ENTOMOL, V40, P682, DOI 10.1603/0022-2585-40.5.682; MUZAFFAR SSB, 2000, THESIS MEMORIAL U NE; Nelder MP, 2005, VET PARASITOL, V129, P313, DOI 10.1016/j.vetpar.2004.02.029; Nielsen A, 2007, J ECOL, V95, P1134, DOI 10.1111/j.1365-2745.2007.01271.x; Olesen JM, 2007, P NATL ACAD SCI USA, V104, P19891, DOI 10.1073/pnas.0706375104; Olesen JM, 2006, J THEOR BIOL, V240, P270, DOI 10.1016/j.jtbi.2005.09.014; OLLERTON J, 2007, P R SOC B, V217, P591; Ostfeld R, 2000, CAN J ZOOL, V78, P2061, DOI 10.1139/cjz-78-12-2061; PARKER DD, 1959, J PARASITOL, V45, P597, DOI 10.2307/3274808; PHILIP CORNELIUS B., 1938, JOUR PARASITOL, V24, P483, DOI 10.2307/3272274; Poulin R, 2000, INT J PARASITOL, V30, P1147, DOI 10.1016/S0020-7519(00)00102-8; POULIN R, 1995, ECOL MONOGR, V65, P283, DOI 10.2307/2937061; Poulin R, 1997, ANNU REV ECOL SYST, V28, P341, DOI 10.1146/annurev.ecolsys.28.1.341; Poulin R, 2001, INT J PARASITOL, V31, P1194, DOI 10.1016/S0020-7519(01)00262-4; PRICE MA, 1997, TECHNICAL B USDA, V1849; Rezende EL, 2007, NATURE, V448, P925, DOI 10.1038/nature05956; RHODE K, 1995, INT J PARASITOL, V25, P945; Ricklefs RE, 2002, P ROY SOC B-BIOL SCI, V269, P885, DOI 10.1098/rspb.2001.1940; Roberts F.H.S., 1970, AUSTR TICKS; Rohde K, 1998, INT J PARASITOL, V28, P461, DOI 10.1016/S0020-7519(97)00209-9; Simkova A, 2002, BIOL J LINN SOC, V76, P125, DOI 10.1046/j.1095-8312.2002.00056.x; Stanko M, 2002, OECOLOGIA, V131, P289, DOI 10.1007/s00442-002-0889-5; STARK HE, 1958, SIPHONAPTERA UTAH; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; Tenquist JD, 2001, J ROY SOC NEW ZEAL, V31, P481, DOI 10.1080/03014223.2001.9517666; Thebault E, 2008, OIKOS, V117, P555, DOI 10.1111/j.0030-1299.2008.16485.x; THOMPSON G. B., 1939, TRANS SOC BRIT ENT, V6, P1; Thompson GB, 1935, J ANIM ECOL, V4, P192, DOI 10.2307/1008; Thompson JN, 2006, SCIENCE, V312, P372, DOI 10.1126/science.1126904; UILENGBERG G, 1979, TICKS MADAGASCAR IXO; Unnasch RS, 2006, ECOL MODEL, V192, P425, DOI 10.1016/j.ecolmodel.2005.07.011; Vacher C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001740; VANEWRIGHT RI, 1991, BIOL CONSERV, V55, P235, DOI 10.1016/0006-3207(91)90030-D; Vazquez DP, 2009, ANN BOT-LONDON, V103, P1445, DOI 10.1093/aob/mcp057; Vazquez DP, 2005, J ANIM ECOL, V74, P946, DOI 10.1111/j.1365-2656.2005.00992.x; VAZQUEZ DP, 2008, INTERACTION WEB DATA; Verdu M, 2008, AM NAT, V172, P751, DOI 10.1086/593003; Wenzel RL., 1966, ECTOPARASITES PANAMA, DOI [10.5962/bhl.title.2633, DOI 10.5962/BHL.TITLE.2633]; Whitaker J. O, 1982, ECTOPARASITES MAMMAL; Wikel SK, 1999, BIOSCIENCE, V49, P311, DOI 10.2307/1313614; Wikel SK, 2001, VET PARASITOL, V101, P275, DOI 10.1016/S0304-4017(01)00556-8; Wilson N, 2003, J BIOGEOGR, V30, P1207, DOI 10.1046/j.1365-2699.2003.00894.x; Worthen WB, 1996, OIKOS, V75, P471, DOI 10.2307/3545888; Yates TL, 2002, BIOSCIENCE, V52, P989, DOI 10.1641/0006-3568(2002)052[0989:TEAEHO]2.0.CO;2; Zar J. H., 1996, BIOSTATISTICAL ANAL	104	56	56	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2009	4	11							e7873	10.1371/journal.pone.0007873	http://dx.doi.org/10.1371/journal.pone.0007873			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521QH	19924299	Green Published, Green Submitted, gold			2022-12-25	WOS:000271936700010
J	Dunn, TA; Storm, DR; Feller, MB				Dunn, Timothy A.; Storm, Daniel R.; Feller, Marla B.			Calcium-Dependent Increases in Protein Kinase-A Activity in Mouse Retinal Ganglion Cells Are Mediated by Multiple Adenylate Cyclases	PLOS ONE			English	Article							BARREL MAP DEVELOPMENT; ELECTRICAL-ACTIVITY; SUBCELLULAR DYNAMICS; RETINOTOPIC MAP; SPERM-MOTILITY; CYCLIC-AMP; RAT RETINA; GROWTH; REFINEMENT; CAMP	Neurons undergo long term, activity dependent changes that are mediated by activation of second messenger cascades. In particular, calcium-dependent activation of the cyclic-AMP/Protein kinase A signaling cascade has been implicated in several developmental processes including cell survival, axonal outgrowth, and axonal refinement. The biochemical link between calcium influx and the activation of the cAMP/PKA pathway is primarily mediated through adenylate cyclases. Here, dual imaging of intracellular calcium concentration and PKA activity was used to assay the role of different classes of calcium-dependent adenylate cyclases (ACs) in the activation of the cAMP/PKA pathway in retinal ganglion cells (RGCs). Surprisingly, depolarization-induced calcium-dependent PKA transients persist in barrelless mice lacking AC1, the predominant calcium-dependent adenylate cyclase in RGCs, as well as in double knockout mice lacking both AC1 and AC8. Furthermore, in a subset of RGCs, depolarization-induced PKA transients persist during the inhibition of all transmembrane adenylate cyclases. These results are consistent with the existence of a soluble adenylate cyclase that plays a role in calcium-dependent activation of the cAMP/PKA cascade in neurons.			Dunn, TA (corresponding author), Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA.	mfeller@berkeley.edu			NEI NIH HHS [R21 EY016417, R21 EY016417-02, R01EY013528, R01 EY013528, R01 EY013528-09] Funding Source: Medline; NIEHS NIH HHS [R01 ES015594, R01ES015594] Funding Source: Medline; NIMH NIH HHS [MH 073601, R01 MH073601] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY013528, R21EY016417] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073601] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abdel-Majid RM, 2002, MOL BRAIN RES, V101, P62, DOI 10.1016/S0169-328X(02)00163-8; Allen MD, 2006, BIOCHEM BIOPH RES CO, V348, P716, DOI 10.1016/j.bbrc.2006.07.136; BORODINSKY LN, 2006, SCI STKE, pPE22; Chan GCK, 2005, J NEUROSCI, V25, P9913, DOI 10.1523/JNEUROSCI.2376-05.2005; Chandrasekaran AR, 2005, J NEUROSCI, V25, P6929, DOI 10.1523/JNEUROSCI.1470-05.2005; CHOI EJ, 1992, BIOCHEMISTRY-US, V31, P6492, DOI 10.1021/bi00143a019; DiPilato LM, 2004, P NATL ACAD SCI USA, V101, P16513, DOI 10.1073/pnas.0405973101; Dunn TA, 2006, J NEUROSCI, V26, P12807, DOI 10.1523/JNEUROSCI.3238-06.2006; Esposito G, 2004, P NATL ACAD SCI USA, V101, P2993, DOI 10.1073/pnas.0400050101; Farrell J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003251; Feller MB, 1996, SCIENCE, V272, P1182, DOI 10.1126/science.272.5265.1182; Feller MB, 1999, NEURON, V22, P653, DOI 10.1016/S0896-6273(00)80724-2; Ferguson GD, 2004, PHYSIOLOGY, V19, P271, DOI 10.1152/physiol.00010.2004; Goldberg JL, 2002, NEURON, V33, P689, DOI 10.1016/S0896-6273(02)00602-5; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HARBECK MC, 2006, SCI STKE, pPL6; KAIN K, 2005, TRANSIENT ADHESION M; Koulen P, 1999, J NEUROSCI RES, V56, P397; Landa LR, 2005, J BIOL CHEM, V280, P31294, DOI 10.1074/jbc.M505657200; Lu HC, 2006, J NEUROSCI, V26, P2692, DOI 10.1523/JNEUROSCI.3956-05.2006; Lu HC, 2003, NAT NEUROSCI, V6, P939, DOI 10.1038/nn1106; Maas JW, 2005, J NEUROSCI, V25, P4118, DOI 10.1523/JNEUROSCI.4273-04.2005; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; Ming GL, 2001, NEURON, V29, P441, DOI 10.1016/S0896-6273(01)00217-3; Moore SW, 2008, J NEUROSCI, V28, P3920, DOI 10.1523/JNEUROSCI.0547-08.2008; Myhr KL, 2001, J NEUROSCI, V21, P8664, DOI 10.1523/JNEUROSCI.21-21-08664.2001; Nicol X, 2006, J NEUROSCI, V26, P862, DOI 10.1523/JNEUROSCI.3385-05.2006; Nicol X, 2005, J COMP NEUROL, V486, P281, DOI 10.1002/cne.20528; Nicol X, 2007, NAT NEUROSCI, V10, P340, DOI 10.1038/nn1842; Nicol X, 2006, EUR J NEUROSCI, V24, P3401, DOI 10.1111/j.1460-9568.2006.05227.x; Plas DT, 2004, VISION RES, V44, P3357, DOI 10.1016/j.visres.2004.09.036; Qu J, 2008, DEV NEUROBIOL, V68, P1196, DOI 10.1002/dneu.20653; Santone R, 2006, J NEUROSCI RES, V84, P1020, DOI 10.1002/jnr.21009; Saucerman JJ, 2006, P NATL ACAD SCI USA, V103, P12923, DOI 10.1073/pnas.0600137103; SCHAMBRA B, 1994, NEUROSCIENCE, V62, P65, DOI 10.1016/0306-4522(94)90315-8; Schuh SM, 2006, BIOL REPROD, V74, P492, DOI 10.1095/biolreprod.105.047837; Sinclair ML, 2000, MOL REPROD DEV, V56, P6, DOI 10.1002/(SICI)1098-2795(200005)56:1&lt;6::AID-MRD2&gt;3.0.CO;2-M; Spitzer NC, 2006, NATURE, V444, P707, DOI 10.1038/nature05300; Stellwagen D, 1999, NEURON, V24, P673, DOI 10.1016/S0896-6273(00)81121-6; Stessin AM, 2006, J BIOL CHEM, V281, P17253, DOI 10.1074/jbc.M603500200; Torborg CL, 2005, PROG NEUROBIOL, V76, P213, DOI 10.1016/j.pneurobio.2005.09.002; Violin JD, 2003, J CELL BIOL, V161, P899, DOI 10.1083/jcb.200302125; Wang GY, 1997, J NEUROPHYSIOL, V78, P2895, DOI 10.1152/jn.1997.78.6.2895; Wang Y, 2005, AM J PHYSIOL-CELL PH, V289, pC1145, DOI 10.1152/ajpcell.00627.2004; WAYMAN GA, 1995, J BIOL CHEM, V270, P21480, DOI 10.1074/jbc.270.37.21480; Willoughby D, 2006, J CELL SCI, V119, P828, DOI 10.1242/jcs.02812; Wong ST, 1999, NEURON, V23, P787, DOI 10.1016/S0896-6273(01)80036-2; Wong ST, 2001, J BIOL CHEM, V276, P34206, DOI 10.1074/jbc.M103923200; Wu KY, 2006, NAT NEUROSCI, V9, P1257, DOI 10.1038/nn1767; Zhang J, 2005, NATURE, V437, P569, DOI 10.1038/nature04140; Zhang J, 2001, P NATL ACAD SCI USA, V98, P14997, DOI 10.1073/pnas.211566798; Zhong HN, 2009, NEURON, V62, P363, DOI 10.1016/j.neuron.2009.03.013	52	39	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2009	4	11							e7877	10.1371/journal.pone.0007877	http://dx.doi.org/10.1371/journal.pone.0007877			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520OG	19924297	gold, Green Published, Green Submitted			2022-12-25	WOS:000271854200022
J	Badea, TC; Hua, ZL; Smallwood, PM; Williams, J; Rotolo, T; Ye, X; Nathans, J				Badea, Tudor C.; Hua, Zhong L.; Smallwood, Philip M.; Williams, John; Rotolo, Thomas; Ye, Xin; Nathans, Jeremy			New Mouse Lines for the Analysis of Neuronal Morphology Using CreER(T)/loxP-Directed Sparse Labeling	PLOS ONE			English	Article							SITE-SPECIFIC RECOMBINATION; CRE-MEDIATED RECOMBINATION; DOPAMINERGIC AMACRINE CELL; TYROSINE-HYDROXYLASE; RABBIT RETINA; RAT-BRAIN; QUANTITATIVE-ANALYSIS; GENE-EXPRESSION; MONKEY RETINA; MICE	Background: Pharmacologic control of Cre-mediated recombination using tamoxifen-dependent activation of a Cre-estrogen receptor ligand binding domain fusion protein [CreER(T)] is widely used to modify and/or visualize cells in the mouse. Methods and Findings: We describe here two new mouse lines, constructed by gene targeting to the Rosa26 locus to facilitate Cre-mediated cell modification. These lines should prove particularly useful in the context of sparse labeling experiments. The R26rtTACreER line provides ubiquitous expression of CreER under transcriptional control by the tetracycline reverse transactivator (rtTA); dual control by doxycycline and tamoxifen provides an extended dynamic range of Cre-mediated recombination activity. The R26IAP line provides high efficiency Cre-mediated activation of human placental alkaline phosphatase (hPLAP), complementing the widely used, but low efficiency, Z/AP line. By crossing with mouse lines that direct cell-type specific CreER expression, the R26IAP line has been used to produce atlases of labeled cholinergic and catecholaminergic neurons in the mouse brain. The R26IAP line has also been used to visualize the full morphologies of retinal dopaminergic amacrine cells, among the largest neurons in the mammalian retina. Conclusions: The two new mouse lines described here expand the repertoire of genetically engineered mice available for controlled in vivo recombination and cell labeling using the Cre-lox system.			Badea, TC (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.	tbadea@mail.jhmi.edu; jnathans@jhmi.edu	Hua, Zhong/J-8149-2014; Badea, Tudor Constantin/B-1654-2018	Badea, Tudor Constantin/0000-0003-3086-6713; Nathans, Jeremy/0000-0001-8106-5460	Howard Hughes Medical Institute Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY018637] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Backman CM, 2009, J NEUROSCI METH, V176, P16, DOI 10.1016/j.jneumeth.2008.08.024; Badea TC, 2003, J NEUROSCI, V23, P2314; Badea TC, 2004, J COMP NEUROL, V480, P331, DOI 10.1002/cne.20304; Badea TC, 2009, NEURON, V61, P852, DOI 10.1016/j.neuron.2009.01.020; Baldridge WH, 1998, SEMIN CELL DEV BIOL, V9, P311, DOI 10.1006/scdb.1998.0235; Baron U, 2000, METHOD ENZYMOL, V327, P401, DOI 10.1016/S0076-6879(00)27292-3; Lin B, 2006, J COMP NEUROL, V499, P797, DOI 10.1002/cne.21126; Branda CS, 2004, DEV CELL, V6, P7, DOI 10.1016/S1534-5807(03)00399-X; Butcher Larry L., 1995, P1003; Cameron MA, 2009, EUR J NEUROSCI, V29, P761, DOI 10.1111/j.1460-9568.2009.06631.x; CASINI G, 1992, J COMP NEUROL, V326, P302, DOI 10.1002/cne.903260211; DACEY DM, 1990, J COMP NEUROL, V301, P461, DOI 10.1002/cne.903010310; DACEY DM, 1989, J COMP NEUROL, V284, P275, DOI 10.1002/cne.902840210; Feil R, 1996, P NATL ACAD SCI USA, V93, P10887, DOI 10.1073/pnas.93.20.10887; Forster A, 2005, NAT METHODS, V2, P27, DOI 10.1038/NMETH727; FOSTER GA, 1985, BRAIN RES, V330, P183, DOI 10.1016/0006-8993(85)90025-3; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; Gelman DM, 2003, GENESIS, V36, P196, DOI 10.1002/gene.10217; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Gong SC, 2007, J NEUROSCI, V27, P9817, DOI 10.1523/JNEUROSCI.2707-07.2007; Gustincich S, 1997, NEURON, V18, P723, DOI 10.1016/S0896-6273(00)80313-X; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Heimer L., 1995, P579; HOKFELT T, 1977, MED BIOL, V55, P21; HOKFELT T, 1976, MED BIOL, V54, P427; KOLB H, 1990, J NEUROCYTOL, V19, P343, DOI 10.1007/BF01188404; Lin CX, 2009, GENESIS, V47, P352, DOI 10.1002/dvg.20506; Lin Q, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-25; Liu C, 2008, J NEUROSCI, V28, P5641, DOI 10.1523/JNEUROSCI.1056-08.2008; Lobe CG, 1999, DEV BIOL, V208, P281, DOI 10.1006/dbio.1999.9209; Long MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005435; Macneil MA, 1999, J COMP NEUROL, V413, P305; MARIANI AP, 1988, J COMP NEUROL, V276, P81, DOI 10.1002/cne.902760106; Matthews BJ, 2007, CELL, V129, P593, DOI 10.1016/j.cell.2007.04.013; Millard SS, 2007, NATURE, V447, P720, DOI 10.1038/nature05855; MITROFANIS J, 1988, J COMP NEUROL, V276, P343, DOI 10.1002/cne.902760303; OLDFIELD BJ, 1995, RAT NERVOUS SYSTEM, P1003; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Poche RA, 2009, DEVELOPMENT, V136, P2141, DOI 10.1242/dev.033175; Que JW, 2008, P NATL ACAD SCI USA, V105, P16626, DOI 10.1073/pnas.0808649105; Rao PC, 2009, DEV NEUROBIOL, V69, P401, DOI 10.1002/dneu.20714; Rotolo T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004099; Schonig K, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf134; Storch KF, 2007, CELL, V130, P730, DOI 10.1016/j.cell.2007.06.045; STRATFORD TR, 1990, BRAIN RES, V511, P173, DOI 10.1016/0006-8993(90)90239-8; TAUCHI M, 1990, J COMP NEUROL, V293, P178, DOI 10.1002/cne.902930203; TRULSON ME, 1985, BRAIN RES BULL, V15, P229, DOI 10.1016/0361-9230(85)90142-X; VERSAUXBOTTERI C, 1986, J COMP NEUROL, V243, P422, DOI 10.1002/cne.902430311; Vooijs M, 2001, EMBO REP, V2, P292, DOI 10.1093/embo-reports/kve064; WULLE I, 1989, DEV BRAIN RES, V48, P59, DOI 10.1016/0165-3806(89)90093-X; Zhang DQ, 2008, P NATL ACAD SCI USA, V105, P14181, DOI 10.1073/pnas.0803893105; Zhang DQ, 2007, J NEUROSCI, V27, P692, DOI 10.1523/JNEUROSCI.4478-06.2007; Zhang DQ, 2004, NEUROREPORT, V15, P1761, DOI 10.1097/01.wnr.0000135699.75775.41; Zhu PX, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000533	54	61	61	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2009	4	11							e7859	10.1371/journal.pone.0007859	http://dx.doi.org/10.1371/journal.pone.0007859			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520NG	19924248	Green Published, Green Submitted, gold			2022-12-25	WOS:000271851000013
J	King, GJ; Chen, KE; Robin, G; Forwood, JK; Heras, B; Thakur, AS; Kobe, B; Blomberg, SP; Martin, JL				King, Gordon J.; Chen, Kai-En; Robin, Gautier; Forwood, Jade K.; Heras, Begona; Thakur, Anil S.; Kobe, Bostjan; Blomberg, Simon P.; Martin, Jennifer L.			Interaction between Plate Make and Protein in Protein Crystallisation Screening	PLOS ONE			English	Article							HETEROGENEOUS NUCLEATION; WATER EQUILIBRATION; CRYSTALS; SURFACES	Background: Protein crystallisation screening involves the parallel testing of large numbers of candidate conditions with the aim of identifying conditions suitable as a starting point for the production of diffraction quality crystals. Generally, condition screening is performed in 96-well plates. While previous studies have examined the effects of protein construct, protein purity, or crystallisation condition ingredients on protein crystallisation, few have examined the effect of the crystallisation plate. Methodology/Principal Findings: We performed a statistically rigorous examination of protein crystallisation, and evaluated interactions between crystallisation success and plate row/column, different plates of same make, different plate makes and different proteins. From our analysis of protein crystallisation, we found a significant interaction between plate make and the specific protein being crystallised. Conclusions/Significance: Protein crystal structure determination is the principal method for determining protein structure but is limited by the need to produce crystals of the protein under study. Many important proteins are difficult to crystallise, so that identification of factors that assist crystallisation could open up the structure determination of these more challenging targets. Our findings suggest that protein crystallisation success may be improved by matching a protein with its optimal plate make.			King, GJ (corresponding author), Univ Queensland, Div Chem & Struct Biol, Inst Mol Biosci, Brisbane, Qld, Australia.	S.Blomberg1@uq.edu.au; j.martin@imb.uq.edu.au	Blomberg, Simone P/B-7613-2008; King, Gordon/J-8718-2014; Forwood, Jade K/K-4123-2014; Chen, Kai-En/T-8516-2019; Heras, Begona/H-8686-2014; Kobe, Bostjan/D-1292-2009; Chen, Kevin Kai-En/D-2133-2017; Martin, Jennifer L./A-6039-2010	Blomberg, Simone P/0000-0003-1062-0839; Forwood, Jade K/0000-0003-3267-9997; Chen, Kai-En/0000-0003-1106-1629; Heras, Begona/0000-0003-3469-7988; Kobe, Bostjan/0000-0001-9413-9166; Chen, Kevin Kai-En/0000-0003-1106-1629; Martin, Jennifer L./0000-0002-9225-8863				Aagaard A, 2005, STRUCTURE, V13, P309, DOI 10.1016/j.str.2004.12.013; ARAKALI SV, 1994, ACTA CRYSTALLOGR D, V50, P472, DOI 10.1107/S0907444994001770; Bergfors T, 2003, J STRUCT BIOL, V142, P66, DOI 10.1016/S1047-8477(03)00039-X; Bergfors T., 1999, PROTEIN CRYSTALLIZAT; BLOW DM, 1994, PROTEIN SCI, V3, P1638, DOI 10.1002/pro.5560031003; Box G.E.P., 2005, STAT EXPT DESIGN INN, V2nd ed.; BOX GEP, 1951, J R STAT SOC B, V13, P1, DOI 10.1111/j.2517-6161.1951.tb00067.x; Chayen NE, 2006, P NATL ACAD SCI USA, V103, P597, DOI 10.1073/pnas.0504860102; CUDNEY R, 1994, ACTA CRYSTALLOGR D, V50, P414; Dai B., 2008, IME4 LINEAR MIXED EF; DETITTA GT, 1995, ACTA CRYSTALLOGR D, V51, P786, DOI 10.1107/S090744499500299X; Gelman A., 2004, BAYESIAN DATA ANAL; Georgieva DG, 2007, ACTA CRYSTALLOGR D, V63, P564, DOI 10.1107/S0907444907007810; Heras B, 2004, P NATL ACAD SCI USA, V101, P8876, DOI 10.1073/pnas.0402769101; Martins PM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001998; MCPHERSON A, 1988, SCIENCE, V239, P385, DOI 10.1126/science.239.4838.385; Pinheiro J, 2001, MIXED EFFECTS MODELS; R Core Team, 2022, R LANG ENV STAT COMP; Tang L, 2005, ACTA CRYSTALLOGR D, V61, P53, DOI 10.1107/S0907444904026009; Thakur AS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001091; Tickle I, 2004, CHEM SOC REV, V33, P558, DOI 10.1039/b314510g; Tosi G, 2008, ACTA CRYSTALLOGR D, V64, P1054, DOI 10.1107/S0907444908025079; Walter TS, 2005, ACTA CRYSTALLOGR D, V61, P651, DOI 10.1107/S0907444905007808	23	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2009	4	11							e7851	10.1371/journal.pone.0007851	http://dx.doi.org/10.1371/journal.pone.0007851			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520NG	19924245	Green Submitted, Green Published, gold			2022-12-25	WOS:000271851000009
J	Moise, AR; Lobo, GP; Erokwu, B; Wilson, DL; Peck, D; Alvarez, S; Dominguez, M; Alvarez, R; Flask, CA; de Lera, AR; von Lintig, J; Palczewski, K				Moise, Alexander R.; Lobo, Glenn P.; Erokwu, Bernadette; Wilson, David L.; Peck, David; Alvarez, Susana; Dominguez, Marta; Alvarez, Rosana; Flask, Chris A.; de Lera, Angel R.; von Lintig, Johannes; Palczewski, Krzysztof			Increased adiposity in the retinol saturase-knockout mouse	FASEB JOURNAL			English	Article						retinoic acid; dihydroretinol; retinol-binding proteins; retinoic acid receptor	VITAMIN-A SUPPLEMENTATION; ACTIVATED RECEPTOR-GAMMA; PPAR-GAMMA; IN-VITRO; LEPTIN EXPRESSION; REGULATES OBESITY; GENE-EXPRESSION; ACID RECEPTOR; MAP KINASE; TISSUE	The enzyme retinol saturase (RetSat) catalyzes the saturation of all-trans-retinol to produce (R)-all-trans-13,14-dihydroretinol. As a peroxisome proliferator-activated receptor (PPAR) gamma target, RetSat was shown to be required for adipocyte differentiation in the 3T3-L1 cell culture model. To understand the mechanism involved in this putative proadipogenic effect of RetSat, we studied the consequences of ablating RetSat expression on retinoid metabolism and adipose tissue differentiation in RetSat-null mice. Here, we report that RetSat-null mice have normal levels of retinol and retinyl palmitate in liver, serum, and adipose tissue, but, in contrast to wild-type mice, are deficient in the production of all-trans-13,14-dihydroretinol from dietary vitamin A. Despite accumulating more fat, RetSat-null mice maintained on either low-fat or high-fat diets gain weight and have similar rates of food intake as age-and gender-matched wildtype control littermates. This increased adiposity of RetSat-null mice is associated with up-regulation of PPAR gamma, a key transcriptional regulator of adipogenesis, and also its downstream target, fatty acid-binding protein 4 (FABP4/aP2). On the basis of these results, we propose that dihydroretinoids produced by RetSat control physiological processes that influence PPAR gamma activity and regulate lipid accumulation in mice.-Moise, A. R., Lobo, G. P., Erokwu, B., Wilson, D. L., Peck, D., Alvarez, S., Dom nguez, M., Alvarez, R., Flask, C. A., de Lera, A. R., von Lintig, J., Palczewski, K. Increased adiposity in the retinol saturase-knockout mouse. FASEB J. 24, 1261-1270 (2010). www.fasebj.org	[Moise, Alexander R.; Lobo, Glenn P.; Peck, David; von Lintig, Johannes; Palczewski, Krzysztof] Case Western Reserve Univ, Dept Pharmacol, Case Sch Med, Cleveland, OH 44106 USA; [Erokwu, Bernadette; Wilson, David L.; Flask, Chris A.] Case Western Reserve Univ, Dept Radiol, Cleveland, OH 44106 USA; [Erokwu, Bernadette; Wilson, David L.; Flask, Chris A.] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA; [Alvarez, Susana; Dominguez, Marta; Alvarez, Rosana; de Lera, Angel R.] Univ Vigo, Fac Quim, Dept Quim Organ, Vigo 36310, Spain	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Universidade de Vigo	Moise, AR (corresponding author), Univ Kansas, Dept Pharmacol & Toxicol, Lawrence, KS 66045 USA.	alexmoise@ku.edu	Moise, Alexander R/C-9498-2009; alvarez, susana/L-9941-2015; AR, Moise/P-2474-2019; Dominguez, Marta/AAA-2084-2019; Lobo, Glenn P./AAI-9736-2020; Rodríguez, Rosana Alvarez/AAA-1998-2019	Moise, Alexander R/0000-0003-2307-6035; alvarez, susana/0000-0003-2420-4721; AR, Moise/0000-0003-2307-6035; Rodríguez, Rosana Alvarez/0000-0001-5608-7561; Rodriguez de Lera, Angel/0000-0001-6896-9078; Flask, Chris/0000-0002-1066-333X; Wilson, David/0000-0001-9763-1463; Dominguez Seoane, Marta/0000-0003-4569-8011; von Lintig, Johannes/0000-0002-2079-2143	National Eye Institute (National Institutes of Health, Bethesda, MD, USA) [EY01730, EY019478, EY015399, EY08061, SAF 2007-63880-FEDER, PGIDIT07PXIBIB3174174PR]; NATIONAL EYE INSTITUTE [R01EY008061, R29EY008061, R01EY019478, P30EY001730, R03EY015399] Funding Source: NIH RePORTER	National Eye Institute (National Institutes of Health, Bethesda, MD, USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The authors thank members of the K. P. and J.V. laboratories and Dr. Leslie Webster Jr. for critical reading of the manuscript. This research was supported in part by U.S. Public Health Service grants EY01730, EY019478, EY015399, and EY08061 from the National Eye Institute (National Institutes of Health, Bethesda, MD, USA) to K. P., and grants SAF 2007-63880-FEDER and PGIDIT07PXIBIB3174174PR to A. R. D. and R. A.	Amengual J, 2008, OBESITY, V16, P585, DOI 10.1038/oby.2007.104; Anghel SI, 2007, J BIOL CHEM, V282, P29946, DOI 10.1074/jbc.M702490200; Berry DC, 2009, MOL CELL BIOL, V29, P3286, DOI 10.1128/MCB.01742-08; Bonet ML, 2003, CELL MOL LIFE SCI, V60, P1311, DOI 10.1007/s00018-003-2290-x; Bost F, 2005, DIABETES, V54, P402, DOI 10.2337/diabetes.54.2.402; Camp HS, 1997, J BIOL CHEM, V272, P10811; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Felipe F, 2005, BBA-MOL BASIS DIS, V1740, P258, DOI 10.1016/j.bbadis.2004.11.014; GIGUERE V, 1987, NATURE, V330, P624, DOI 10.1038/330624a0; Hessel S, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706763200; Hollung K, 2004, J CELL BIOCHEM, V92, P307, DOI 10.1002/jcb.20047; Hu ED, 1996, SCIENCE, V274, P2100, DOI 10.1126/science.274.5295.2100; Jeyakumar SM, 2008, BIOCHEM BIOPH RES CO, V370, P243, DOI 10.1016/j.bbrc.2008.03.073; Jeyakumar SM, 2006, OBESITY, V14, P52, DOI 10.1038/oby.2006.7; Johnson DH, 2008, J MAGN RESON IMAGING, V28, P915, DOI 10.1002/jmri.21481; Kane MA, 2005, BIOCHEM J, V388, P363, DOI 10.1042/BJ20041867; Kane MA, 2008, ANAL CHEM, V80, P1702, DOI 10.1021/ac702030f; KURIHARCUCH W, 1982, DIFFERENTIATION, V23, P164, DOI 10.1111/j.1432-0436.1982.tb01279.x; Lillie RD, 1976, HISTOPATHOLOGIC TECH, V4th; Lopez IP, 2004, BIOCHEM BIOPH RES CO, V318, P234, DOI 10.1016/j.bbrc.2004.04.018; Lopez IP, 2005, MOL CELL BIOCHEM, V275, P109, DOI 10.1007/s11010-005-1082-z; Mercader J, 2007, CELL PHYSIOL BIOCHEM, V20, P1061, DOI 10.1159/000110717; Mercader J, 2006, ENDOCRINOLOGY, V147, P5325, DOI 10.1210/en.2006-0760; Moise AR, 2008, J AM CHEM SOC, V130, P1154, DOI 10.1021/ja710487q; Moise AR, 2007, BIOCHEMISTRY-US, V46, P1811, DOI 10.1021/bi062147u; Moise AR, 2009, MOL PHARMACOL, V76, P1228, DOI 10.1124/mol.109.060038; Moise AR, 2005, J BIOL CHEM, V280, P27815, DOI 10.1074/jbc.M503520200; Moise AR, 2004, J BIOL CHEM, V279, P50230, DOI 10.1074/jbc.M409130200; MURRAY T, 1980, J SUPRAMOL STR CELL, V14, P255, DOI 10.1002/jss.400140214; PETKOVICH M, 1987, NATURE, V330, P444, DOI 10.1038/330444a0; Ribot J, 2001, OBES RES, V9, P500, DOI 10.1038/oby.2001.65; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Ross SA, 2000, PHYSIOL REV, V80, P1021, DOI 10.1152/physrev.2000.80.3.1021; SAFONOVA I, 1994, MOL CELL ENDOCRINOL, V104, P201, DOI 10.1016/0303-7207(94)90123-6; SALE EM, 1995, EMBO J, V14, P674, DOI 10.1002/j.1460-2075.1995.tb07046.x; Schupp M, 2009, P NATL ACAD SCI USA, V106, P1105, DOI 10.1073/pnas.0812065106; Schwarz EJ, 1997, MOL CELL BIOL, V17, P1552, DOI 10.1128/MCB.17.3.1552; Shin DJ, 1997, J NUTR, V127, P1274, DOI 10.1093/jn/127.7.1274; Strom K, 2009, FASEB J, V23, P2307, DOI 10.1096/fj.08-120923; Trujillo ME, 2006, ENDOCR REV, V27, P798, DOI 10.1210/er.2006-0033; TSUTSUMI C, 1992, J BIOL CHEM, V267, P1805; Xue JC, 1996, MOL CELL BIOL, V16, P1567; Yu HZ, 2008, MAGN RESON MED, V60, P1122, DOI 10.1002/mrm.21737; Zhang M, 2007, FASEB J, V21, P2886, DOI 10.1096/fj.06-7964com; Ziouzenkova O, 2008, FEBS LETT, V582, P32, DOI 10.1016/j.febslet.2007.11.081; Ziouzenkova O, 2007, NAT MED, V13, P695, DOI 10.1038/nm1587	46	40	42	0	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	APR	2010	24	4					1261	1270		10.1096/fj.09-147207	http://dx.doi.org/10.1096/fj.09-147207			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	580PV	19940255	Green Published			2022-12-25	WOS:000276462300032
J	Roidl, A; Foo, P; Wong, W; Mann, C; Bechtold, S; Berger, HJ; Streit, S; Ruhe, JE; Hart, S; Ullrich, A; Ho, HK				Roidl, A.; Foo, P.; Wong, W.; Mann, C.; Bechtold, S.; Berger, H. J.; Streit, S.; Ruhe, J. E.; Hart, S.; Ullrich, A.; Ho, H. K.			The FGFR4 Y367C mutant is a dominant oncogene in MDA-MB453 breast cancer cells	ONCOGENE			English	Article						cancer; FGFR4; mutation; oncogenesis; proliferation	FACTOR RECEPTOR 4; GROWTH-FACTOR RECEPTOR-3; KINASE GENE FAMILY; PROSTATE-CANCER; ARG388 ALLELE; PROGRESSION; MUTATIONS; EXPRESSION; PROLIFERATION; POLYMORPHISM	Mutational analysis of oncogenes is critical for our understanding of cancer development. Oncogenome screening has identified a fibroblast growth factor receptor 4 (FGFR4) Y367C mutation in the human breast cancer cell line MDA-MB453. Here, we investigate the consequence of this missense mutation in cancer cells. We show that MDA-MB453 cells harbouring the mutation are insensitive to FGFR4-specific ligand stimulation or inhibition with an antagonistic antibody. Furthermore, the FGFR4 mutant elicits constitutive phosphorylation leading to an activation of the mitogen-activated protein kinase cascade as shown by an enhanced Erk1/2 phosphorylation. Cloning and ectopic expression of the FGFR4 Y367C mutant in HEK293 cells revealed high pErk levels and enhanced cell proliferation. Based on these findings, we propose that FGFR4 may be a driver of tumour growth, particularly when highly expressed or stabilized and constitutively activated through genetic alterations. As such, FGFR4 presents an option for further mutational screening in tumours and is an attractive cancer target with the therapeutic potential. Oncogene (2010) 29, 1543-1552; doi:10.1038/onc.2009.432; published online 30 November 2009	[Ho, H. K.] ASTAR, Inst Med Biol, Singapore OncoGenome Programme, Singapore 138648, Singapore; [Roidl, A.; Mann, C.; Bechtold, S.; Berger, H. J.; Ullrich, A.] Max Planck Inst Biochem, Dept Mol Biol, D-82152 Martinsried, Germany	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); Max Planck Society	Ho, HK (corresponding author), ASTAR, Inst Med Biol, Singapore OncoGenome Programme, 8A Biomed Grove,06-06 Immunos, Singapore 138648, Singapore.	hankiat.ho@imb.a-star.edu.sg			National Genome Research Network 2/CancerNet [01GS0435]; Agency for Science Technology and Research (A*STAR), Singapore	National Genome Research Network 2/CancerNet; Agency for Science Technology and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR))	We thank Heike Stubbe for excellent technical support and Dr Peter Czernilofsky for critically reading the manuscript. This work was supported by the National Genome Research Network 2/CancerNet, Grant Number: NGFN2/CancerNet no. 01GS0435, and the Agency for Science Technology and Research (A*STAR), Singapore.	Andrea R, 2003, AM J MED GENET A, V121A, P41, DOI 10.1002/ajmg.a.20101; Ansell A, 2009, ORAL ONCOL, V45, P23, DOI 10.1016/j.oraloncology.2008.03.007; Bange J, 2002, CANCER RES, V62, P840; Bardelli A, 2003, SCIENCE, V300, P949, DOI 10.1126/science.1082596; Bignell G, 2006, GENE CHROMOSOME CANC, V45, P42, DOI 10.1002/gcc.20265; Chesi M, 2001, BLOOD, V97, P729, DOI 10.1182/blood.V97.3.729; d'Avis PY, 1998, CELL GROWTH DIFFER, V9, P71; Dailey L, 2005, CYTOKINE GROWTH F R, V16, P233, DOI 10.1016/j.cytogfr.2005.01.007; Elbashir SM, 2002, METHODS, V26, P199, DOI 10.1016/S1046-2023(02)00023-3; Ercolino T, 2008, CLIN ENDOCRINOL, V69, P253, DOI 10.1111/j.1365-2265.2008.03197.x; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Fishman DA, 2001, CANCER RES, V61, P3194; Giri D, 1999, CLIN CANCER RES, V5, P1063; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Ho HK, 2009, J HEPATOL, V50, P118, DOI 10.1016/j.jhep.2008.08.015; Itoh N, 2004, TRENDS GENET, V20, P563, DOI 10.1016/j.tig.2004.08.007; Koziczak M, 2004, ONCOGENE, V23, P3501, DOI 10.1038/sj.onc.1207331; Ma ZY, 2008, INT J CANCER, V123, P2574, DOI 10.1002/ijc.23578; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Roidl A, 2009, CLIN CANCER RES, V15, P2058, DOI 10.1158/1078-0432.CCR-08-0890; Rousseau F, 1996, HUM MOL GENET, V5, P509, DOI 10.1093/hmg/5.4.509; Ruhe JE, 2007, CANCER RES, V67, P11368, DOI 10.1158/0008-5472.CAN-07-2703; Sasaki H, 2008, ONCOL REP, V20, P1125, DOI 10.3892/or_00000119; SHAOUL E, 1995, ONCOGENE, V10, P1553; Stephens P, 2005, NAT GENET, V37, P590, DOI 10.1038/ng1571; Stephens P, 2004, NATURE, V431, P525, DOI 10.1038/431525b; Streit S, 2006, BRIT J CANCER, V94, P1879, DOI 10.1038/sj.bjc.6603181; Streit S, 2004, INT J CANCER, V111, P213, DOI 10.1002/ijc.20204; Thomas RK, 2007, NAT GENET, V39, P347, DOI 10.1038/ng1975; Thussbas C, 2006, J CLIN ONCOL, V24, P3747, DOI 10.1200/JCO.2005.04.8587; Wang JH, 2008, NEOPLASIA, V10, P847, DOI 10.1593/neo.08450; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; White KE, 2005, AM J HUM GENET, V76, P361, DOI 10.1086/427956; Wilkie AOM, 2005, CYTOKINE GROWTH F R, V16, P187, DOI 10.1016/j.cytogfr.2005.03.001; YAMAGUCHI F, 1994, P NATL ACAD SCI USA, V91, P484, DOI 10.1073/pnas.91.2.484	35	49	61	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2010	29	10					1543	1552		10.1038/onc.2009.432	http://dx.doi.org/10.1038/onc.2009.432			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	566SD	19946327				2022-12-25	WOS:000275392400012
J	Bai, J; Zhang, J; Wu, J; Shen, L; Zeng, J; Ding, J; Wu, Y; Gong, Z; Li, A; Xu, S; Zhou, J; Li, G				Bai, J.; Zhang, J.; Wu, J.; Shen, L.; Zeng, J.; Ding, J.; Wu, Y.; Gong, Z.; Li, A.; Xu, S.; Zhou, J.; Li, G.			JWA regulates melanoma metastasis by integrin alpha(V)beta(3) signaling	ONCOGENE			English	Article						JWA; melanoma; metastasis; integrin	V BETA 3; CANCER-CELLS; ALPHA-V-BETA-3 INTEGRIN; VITRONECTIN RECEPTOR; MALIGNANT-MELANOMA; ARSENIC TRIOXIDE; PC12 CELLS; EXPRESSION; PROTEIN; ADHESION	JWA, a newly identified novel microtubule-associated protein (MAP), was recently demonstrated to be indispensable for the rearrangement of actin cytoskeleton and activation of MAPK cascades induced by arsenic trioxide (As2O3) and phorbol ester (PMA). JWA depletion blocked the inhibitory effect of As2O3 on HeLa cell migration, but enhanced cell migration after PMA treatment. As cancer cell migration is a hallmark of tumor metastasis and the functional role of JWA in cancer metastasis is not understood, here we show that JWA has an important role in melanoma metastasis. Our data demonstrated that JWA knockdown increased the adhesion and invasion abilities of melanoma cells. Furthermore, JWA knockdown in B16-F10 and A375 melanoma cells significantly promoted the formation and growth of metastatic colonies in vivo. Moreover, in the tumor biopsies from human melanoma patients, JWA expression was significantly decreased in malignant melanoma compared with normal nevi. In addition, we found that JWA knockdown could intensify tumor integrin alpha(V)beta(3) signaling by regulating nuclear factor Sp1. These findings suggest that JWA suppresses melanoma metastasis and may serve a potential therapeutic target for human melanoma. Oncogene (2010) 29, 1227-1237; doi: 10.1038/onc.2009.408; published online 30 November 2009	[Bai, J.; Zhang, J.; Wu, J.; Shen, L.; Zeng, J.; Ding, J.; Wu, Y.; Gong, Z.; Li, A.; Xu, S.; Zhou, J.] Nanjing Med Univ, Sch Publ Hlth, Dept Mol Cell Biol & Toxicol, Ctr Canc, Nanjing 210029, Peoples R China; [Bai, J.; Li, G.] Univ British Columbia, Dept Dermatol & Skin Sci, Jack Bell Res Ctr, Vancouver Coastal Hlth Res Inst, Vancouver, BC V5Z 1M9, Canada; [Zhang, J.] Nantong Canc Hosp, Dept Pathol, Nantong, Jiangsu Prov, Peoples R China	Nanjing Medical University; University of British Columbia; Vancouver Coastal Health Research Institute	Zhou, J (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Dept Mol Cell Biol & Toxicol, Ctr Canc, Nanjing 210029, Peoples R China.	jwzhou@njmu.edu.cn	Li, Gang/A-8257-2011	gong, zhenghua/0000-0002-4363-1043	Key Basic Research Project of Department of Education, Jiangsu Province [06KJA33023]; National Natural Science Foundation of China [30771829, 30930080]; Doctoral Training Program of Education Ministry [200803120001]; Jiangsu Provincial Graduate Students Innovation Project [CX08B-181Z]; Canadian Institutes of Health Research [MOP-84559, MOP-93810]; Cancer Research Society; Canadian Dermatology Foundation	Key Basic Research Project of Department of Education, Jiangsu Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Training Program of Education Ministry; Jiangsu Provincial Graduate Students Innovation Project; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Cancer Research Society; Canadian Dermatology Foundation	This study was partially supported by the grants of Key Basic Research Project of Department of Education, Jiangsu Province (06KJA33023), the National Natural Science Foundation of China (30771829, 30930080), the Doctoral Training Program of Education Ministry (200803120001) to JZ and the Jiangsu Provincial Graduate Students Innovation Project (CX08B-181Z) to JB; and Canadian Institutes of Health Research (MOP-84559 and MOP-93810), Cancer Research Society and Canadian Dermatology Foundation to GL.	ALBELDA SM, 1990, CANCER RES, V50, P6757; Balch CM, 2001, J CLIN ONCOL, V19, P3635, DOI 10.1200/JCO.2001.19.16.3635; Becker JC, 2000, CLIN EXP DERMATOL, V25, P503, DOI 10.1046/j.1365-2230.2000.00690.x; Brooks PC, 1996, CELL, V85, P683, DOI 10.1016/S0092-8674(00)81235-0; Butchbach MER, 2002, GENE, V292, P81, DOI 10.1016/S0378-1119(02)00669-8; Cao HX, 2002, CHINESE SCI BULL, V47, P834, DOI 10.1360/02tb9188; Chen HR, 2007, CELL SIGNAL, V19, P1315, DOI 10.1016/j.cellsig.2007.01.007; Chen HR, 2004, CHINESE SCI BULL, V49, P467, DOI 10.1360/03wc0398; Chen R, 2007, FREE RADICAL BIO MED, V42, P1704, DOI 10.1016/j.freeradbiomed.2007.02.018; Cheng CM, 2009, J BIOL CHEM, V284, P8786, DOI 10.1074/jbc.M806144200; Cooper CR, 2002, NEOPLASIA, V4, P191, DOI 10.1038/sj.neo.7900224; Felding-Habermann B, 2003, CLIN EXP METASTAS, V20, P203, DOI 10.1023/A:1022983000355; FELDINGHABERMANN B, 1992, J CLIN INVEST, V89, P2018, DOI 10.1172/JCI115811; GLADSON CL, 1991, J CLIN INVEST, V88, P1924, DOI 10.1172/JCI115516; Horton MA, 1997, INT J BIOCHEM CELL B, V29, P721, DOI 10.1016/S1357-2725(96)00155-0; Hsu MY, 1998, AM J PATHOL, V153, P1435, DOI 10.1016/S0002-9440(10)65730-6; Huang S, 2006, BIOCHEM BIOPH RES CO, V341, P440, DOI 10.1016/j.bbrc.2005.12.197; Hynes RO, 2003, CELL, V113, P821, DOI 10.1016/S0092-8674(03)00468-9; Ingley E, 1999, FEBS LETT, V459, P69, DOI 10.1016/S0014-5793(99)01188-6; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Li AQ, 2003, CHINESE SCI BULL, V48, P1828, DOI 10.1360/03wc0032; Li XW, 2001, J CELL SCI, V114, P2665; Lossner D, 2009, J CELL PHYSIOL, V220, P367, DOI 10.1002/jcp.21774; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; MONTGOMERY AMP, 1994, P NATL ACAD SCI USA, V91, P8856, DOI 10.1073/pnas.91.19.8856; Moretti S, 1997, MELANOMA RES, V7, P313, DOI 10.1097/00008390-199708000-00006; NIP J, 1995, CANCER METAST REV, V14, P241, DOI 10.1007/BF00690295; Pechkovsky DV, 2008, J BIOL CHEM, V283, P12898, DOI 10.1074/jbc.M708226200; REMMELE W, 1987, PATHOLOGE, V8, P138; Rothhammer T, 2004, CELL MOL LIFE SCI, V61, P118, DOI 10.1007/s00018-003-3337-8; Sampsel JW, 2004, NEW ENGL J MED, V351, P2770; Schweneker M, 2005, FEBS LETT, V579, P1751, DOI 10.1016/j.febslet.2005.02.037; Seftor REB, 1999, CANCER METAST REV, V18, P359, DOI 10.1023/A:1006317125454; Sinanan ACM, 2008, BIOL CELL, V100, P465, DOI 10.1042/BC20070115; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Tajima A, 2000, BBA-GENE STRUCT EXPR, V1492, P377, DOI 10.1016/S0167-4781(00)00121-4; van Nimwegen MJ, 2007, BIOCHEM PHARMACOL, V73, P597, DOI 10.1016/j.bcp.2006.08.011; Voura EB, 2001, MOL BIOL CELL, V12, P2699, DOI 10.1091/mbc.12.9.2699; Wang SY, 2009, NUCLEIC ACIDS RES, V37, P1936, DOI 10.1093/nar/gkp054; Zhou H, 2005, J BIOL CHEM, V280, P10624, DOI 10.1074/jbc.M411900200; Zhou JH, 2008, TOXICOL APPL PHARM, V230, P33, DOI 10.1016/j.taap.2008.01.041; Zhou JW, 1999, INVESTIGATION CELL M, P110	42	64	66	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	FEB 25	2010	29	8					1227	1237		10.1038/onc.2009.408	http://dx.doi.org/10.1038/onc.2009.408			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	560ON	19946336				2022-12-25	WOS:000274912100013
J	Dang, YK; Green, BR				Dang, Yunkun; Green, Beverley R.			Long Transcripts from Dinoflagellate Chloroplast Minicircles Suggest "Rolling Circle" Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DERIVATIVE-CONTAINING PLASTIDS; TRANSFER-RNA GENES; MESSENGER-RNA; AMPHIDINIUM-OPERCULATUM; CERATIUM-HORRIDUM; SEPARATE ORIGINS; RIBOSOMAL-RNA; GAPDH GENE; GENOME; DNA	The chloroplast genome of a dinoflagellate consists of a group of small circular DNA molecules (minicircles), most of which carry a single gene. With RT-PCR, primer extension, and Northern analyses, we show that the entire minicircle is transcribed and that some minicircles can produce RNAs larger than themselves. Using an RNA ligase-mediated rapid amplification of cDNA ends method, we were able to detect large processed precursors that are generated by endonucleolytic cleavage of an even longer molecule. This cleavage produces the mature mRNA 3'-end and at the same time the 5'-end of the precursor. The tRNAs encoded by the petD and psbE minicircles appear to be processed in the same way. We propose a "rolling circle" model for chloroplast transcription in which transcription would proceed continuously around the minicircular DNA to produce transcripts larger than the minicircle itself. These transcripts would be further processed into discrete mature mRNAs and tRNAs.	[Dang, Yunkun; Green, Beverley R.] Univ British Columbia, Dept Bot, Vancouver, BC V6T 1Z4, Canada	University of British Columbia	Green, BR (corresponding author), Univ British Columbia, Dept Bot, 6270 Univ Blvd, Vancouver, BC V6T 1Z4, Canada.	brgreen@interchange.ubc.ca	Green, Beverley R./AAJ-5199-2021	Green, Beverley R./0000-0002-4021-9387	Natural Sciences and Engineering Research Council of Canada [54688]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by Natural Sciences and Engineering Research Council of Canada Grant 54688.	Bachvaroff TR, 2004, PROTIST, V155, P65, DOI 10.1078/1434461000165; Barbrook AC, 2000, MOL GEN GENET, V263, P152, DOI 10.1007/s004380050042; Barbrook AC, 2001, MOL GENET GENOMICS, V266, P632, DOI 10.1007/s004380100582; Barbrook AC, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-297; Bensing BA, 1996, P NATL ACAD SCI USA, V93, P7794, DOI 10.1073/pnas.93.15.7794; Canino G, 2009, PLANT PHYSIOL, V150, P1494, DOI 10.1104/pp.109.137950; Ceballos-Chavez M, 2005, J BIOL CHEM, V280, P33461, DOI 10.1074/jbc.M504691200; Dang Y, 2009, GENE, V442, P73, DOI 10.1016/j.gene.2009.04.006; DAUBENDIEK SL, 1995, J AM CHEM SOC, V117, P7818, DOI 10.1021/ja00134a032; Diegelman AM, 1998, NUCLEIC ACIDS RES, V26, P3235, DOI 10.1093/nar/26.13.3235; GRAHAM LE, 2000, ALGAE, P198; Green BR, 2004, PROTIST, V155, P23, DOI 10.1078/1434461000161; Hackett JD, 2004, CURR BIOL, V14, P213, DOI 10.1016/j.cub.2004.01.032; Hayes R, 1996, EMBO J, V15, P1132, DOI 10.1002/j.1460-2075.1996.tb00451.x; Herrin DL, 2004, PHOTOSYNTH RES, V82, P301, DOI 10.1007/s11120-004-2741-8; Hiller RG, 2001, FEBS LETT, V505, P449, DOI 10.1016/S0014-5793(01)02871-X; HOHFELD I, 1992, J PHYCOL, V28, P82, DOI 10.1111/j.0022-3646.1992.00082.x; Laatsch T, 2004, MOL BIOL EVOL, V21, P1318, DOI 10.1093/molbev/msh127; LaJeunesse TC, 2005, J PHYCOL, V41, P880, DOI 10.1111/j.0022-3646.2005.04231.x; Leung SK, 2009, NUCLEIC ACIDS RES, V37, P1991, DOI 10.1093/nar/gkp063; Monde RA, 2000, BIOCHIMIE, V82, P573, DOI 10.1016/S0300-9084(00)00606-4; Morl M, 2001, EMBO REP, V2, P17, DOI 10.1093/embo-reports/kve006; Nelson MJ, 2007, GENE, V392, P291, DOI 10.1016/j.gene.2007.01.018; Nelson MJ, 2005, GENE, V358, P102, DOI 10.1016/j.gene.2005.05.024; Nisbet RER, 2008, PROTIST, V159, P31, DOI 10.1016/j.protis.2007.07.002; Sambrook J., 2002, MOL CLONING LAB MANU; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Schiffer S, 2002, EMBO J, V21, P2769, DOI 10.1093/emboj/21.11.2769; STERN DB, 1987, CELL, V51, P1145, DOI 10.1016/0092-8674(87)90600-3; Swiatecka-Hagenbruch M, 2007, MOL GENET GENOMICS, V277, P725, DOI 10.1007/s00438-007-0222-4; Takishita K, 2005, PHYCOLOGIA, V44, P26, DOI 10.2216/0031-8884(2005)44[26:POTPGC]2.0.CO;2; Takishita K, 2004, PROTIST, V155, P447, DOI 10.1078/1434461042650325; Takishita K, 2003, PROTIST, V154, P443, DOI 10.1078/143446103322454176; Wang YL, 2006, NUCLEIC ACIDS RES, V34, P613, DOI 10.1093/nar/gkj438; WESTHOFF P, 1988, EUR J BIOCHEM, V171, P551, DOI 10.1111/j.1432-1033.1988.tb13824.x; Zauner S, 2004, FEBS LETT, V577, P535, DOI 10.1016/j.febslet.2004.10.060; Zhang ZD, 2002, MOL BIOL EVOL, V19, P489, DOI 10.1093/oxfordjournals.molbev.a004104; Zhang ZD, 1999, NATURE, V400, P155, DOI 10.1038/22099	38	21	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5196	5203		10.1074/jbc.M109.058545	http://dx.doi.org/10.1074/jbc.M109.058545			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	19948728	Green Published, hybrid			2022-12-25	WOS:000275327200012
J	Valli, A; Rosner, M; Fuchs, C; Siegel, N; Bishop, CE; Dolznig, H; Madel, U; Feichtinger, W; Atala, A; Hengstschlager, M				Valli, A.; Rosner, M.; Fuchs, C.; Siegel, N.; Bishop, C. E.; Dolznig, H.; Maedel, U.; Feichtinger, W.; Atala, A.; Hengstschlaeger, M.			Embryoid body formation of human amniotic fluid stem cells depends on mTOR	ONCOGENE			English	Article						amniotic fluid; stem cell; EB; mTOR	DIFFERENTIATION; MOUSE; BODIES; ACTIVATION; PLURIPOTENCY; DISRUPTION; GROWTH; RICTOR; OCT-4; GENE	Human amniotic fluid stem cells (hAFSCs) harbor high proliferative capacity and high differentiation potential and do not raise the ethical concerns associated with human embryonic stem cells. The formation of three-dimensional aggregates known as embryoid bodies (EBs) is the principal step in the differentiation of pluripotent embryonic stem cells. Using c-Kit-positive hAFSC lines, we show here that these stem cells harbor the potential to form EBs. As part of the two kinase complexes, mTORC1 and mTORC2, mammalian target of rapamycin (mTOR) is the key component of an important signaling pathway, which is involved in the regulation of cell proliferation, growth, tumor development and differentiation. Blocking intracellular mTOR activity through the inhibitor rapamycin or through specific small interfering RNA approaches revealed hAFSC EB formation to depend on mTORC1 and mTORC2. These findings demonstrate hAFSCs to be a new and powerful biological system to recapitulate the three-dimensional and tissue level contexts of in vivo development and identify the mTOR pathway to be essential for this process. Oncogene (2010) 29, 966-977; doi:10.1038/onc.2009.405; published online 23 November 2009	[Valli, A.; Rosner, M.; Fuchs, C.; Siegel, N.; Dolznig, H.; Hengstschlaeger, M.] Med Univ Vienna, Dept Med Genet, A-1090 Vienna, Austria; [Bishop, C. E.; Atala, A.] Wake Forest Univ, Bowman Gray Sch Med, Dept Urol, Winston Salem, NC 27103 USA; [Bishop, C. E.; Atala, A.] Wake Forest Univ, Bowman Gray Sch Med, Wake Forest Inst Regenerat Med, Winston Salem, NC 27103 USA; [Maedel, U.; Feichtinger, W.] Wunschbabyzentrum, Vienna, Austria	Medical University of Vienna; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center	Hengstschlager, M (corresponding author), Med Univ Vienna, Dept Med Genet, Wahringer Gurtel 18-20, A-1090 Vienna, Austria.	markus.hengstschlaeger@meduniwien.ac.at	Dolznig, Helmut/L-7005-2015	Dolznig, Helmut/0000-0002-6063-3585; Atala, Anthony/0000-0001-8186-2160; Fuchs, Christiane/0000-0002-5052-3198	FWF Austrian Science Fund [P18894-B12]; Herzfelder'sche Familienstiftung; European Community [FP6 036097-2]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD060097] Funding Source: NIH RePORTER	FWF Austrian Science Fund(Austrian Science Fund (FWF)); Herzfelder'sche Familienstiftung; European Community(European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Research in our laboratory is supported by the FWF Austrian Science Fund (P18894-B12), by the Herzfelder'sche Familienstiftung and by the Research Training Network 'Developing a stem cell based therapy to replace nephrons lost through reflux nephropathy' (http://www.kidstem.org) funded by the European Community as part of the Framework program 6 (FP6 036097-2).	Aboushwareb T, 2008, NAT CLIN PRACT UROL, V5, P621, DOI 10.1038/ncpuro1228; Besser D, 2004, J BIOL CHEM, V279, P45076, DOI 10.1074/jbc.M404979200; Blazquez C, 2006, CELL RES, V16, P93, DOI 10.1038/sj.cr.7310012; Bossolasco P, 2006, CELL RES, V16, P329, DOI 10.1038/sj.cr.7310043; Cananzi M, 2009, REPROD BIOMED ONLINE, V18, P17, DOI 10.1016/S1472-6483(10)60111-3; Dann SG, 2007, TRENDS MOL MED, V13, P252, DOI 10.1016/j.molmed.2007.04.002; De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Ditadi A, 2009, BLOOD, V113, P3953, DOI 10.1182/blood-2008-10-182105; Gangloff YG, 2004, MOL CELL BIOL, V24, P9508, DOI 10.1128/MCB.24.21.9508-9516.2004; GUALANDRIS A, 2008, FASEB J, V23, P1; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hengstschlager M, 2005, AM J MED GENET A, V133A, P48, DOI 10.1002/ajmg.a.30520; in 'tAnker PS, 2003, BLOOD, V102, P1548, DOI 10.1182/blood-2003-04-1291; Itskovitz-Eldor J, 2000, MOL MED, V6, P88, DOI 10.1007/BF03401776; Karlmark KR, 2005, INT J MOL MED, V16, P987; Kim GD, 2008, TOXICOL LETT, V180, P166, DOI 10.1016/j.toxlet.2008.05.023; Kim J, 2007, CELL PROLIFERAT, V40, P75; Koike M, 2007, J BIOSCI BIOENG, V104, P294, DOI 10.1263/jbb.104.294; Kolambkar YM, 2007, J MOL HISTOL, V38, P405, DOI 10.1007/s10735-007-9118-1; Kurosawa H, 2007, J BIOSCI BIOENG, V103, P389, DOI 10.1263/jbb.103.389; Lim SM, 2009, STEM CELLS, V27, P363, DOI 10.1634/stemcells.2008-1008; Maherali N, 2008, COLD SH Q B, V73, P157, DOI 10.1101/sqb.2008.73.017; Narita N, 1997, DEVELOPMENT, V124, P3755; Ng ES, 2005, BLOOD, V106, P1601, DOI 10.1182/blood-2005-03-0987; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Pennings G, 2007, REPROD BIOMED ONLINE, V14, P92, DOI 10.1016/S1472-6483(10)60737-7; Perin L, 2007, CELL PROLIFERAT, V40, P936, DOI 10.1111/j.1365-2184.2007.00478.x; Perin L, 2008, METHOD CELL BIOL, V86, P85, DOI 10.1016/S0091-679X(08)00005-8; Pesce M, 2001, STEM CELLS, V19, P271, DOI 10.1634/stemcells.19-4-271; Prusa AR, 2004, AM J OBSTET GYNECOL, V191, P309, DOI 10.1016/j.ajog.2003.12.014; Prusa AR, 2003, HUM REPROD, V18, P1489, DOI 10.1093/humrep/deg279; Rosner M, 2003, ONCOGENE, V22, P4786, DOI 10.1038/sj.onc.1206776; Rosner M, 2008, MUTAT RES-REV MUTAT, V659, P284, DOI 10.1016/j.mrrev.2008.06.001; Rosner M, 2008, HUM MOL GENET, V17, P2934, DOI 10.1093/hmg/ddn192; Rosner M, 2007, HUM MOL GENET, V16, P1541, DOI 10.1093/hmg/ddm103; Sampath P, 2008, CELL STEM CELL, V2, P448, DOI 10.1016/j.stem.2008.03.013; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Shiota C, 2006, DEV CELL, V11, P583, DOI 10.1016/j.devcel.2006.08.013; Siegel N, 2007, STEM CELL REV, V3, P256, DOI 10.1007/s12015-007-9003-z; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Trounson A, 2007, NAT BIOTECHNOL, V25, P62, DOI 10.1038/nbt0107-62; Tsai MS, 2006, BIOL REPROD, V74, P545, DOI 10.1095/biolreprod.105.046029; Tsai MS, 2004, HUM REPROD, V19, P1450, DOI 10.1093/humrep/deh279; Ungrin MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001565; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Yamashita J, 2000, NATURE, V408, P92, DOI 10.1038/35040568; Yang Q, 2007, CELL RES, V17, P666, DOI 10.1038/cr.2007.64	50	61	64	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 18	2010	29	7					966	977		10.1038/onc.2009.405	http://dx.doi.org/10.1038/onc.2009.405			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	556PV	19935716	Green Accepted			2022-12-25	WOS:000274604400004
J	Tsutsui, K; Manabe, R; Yamada, T; Nakano, I; Oguri, Y; Keene, DR; Sengle, G; Sakai, LY; Sekiguchi, K				Tsutsui, Ko; Manabe, Ri-ichiroh; Yamada, Tomiko; Nakano, Itsuko; Oguri, Yasuko; Keene, Douglas R.; Sengle, Gerhard; Sakai, Lynn Y.; Sekiguchi, Kiyotoshi			ADAMTSL-6 Is a Novel Extracellular Matrix Protein That Binds to Fibrillin-1 and Promotes Fibrillin-1 Fibril Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WEILL-MARCHESANI-SYNDROME; MARFAN-SYNDROME; PROTEOLYTIC ACTIVITIES; MICROFIBRILS; GLYCOPROTEIN; ORGANIZATION; DEPOSITION; DOMAIN; SITES; GENE	ADAMTS (A disintegrin and metalloproteinase with thrombospondin motifs)-like (ADAMTSL) proteins, a subgroup of the ADAMTS superfamily, share several domains with ADAMTS proteinases, including thrombospondin type I repeats, a cysteine-rich domain, and an ADAMTS spacer, but lack a catalytic domain. We identified two new members of ADAMTSL proteins, ADAMTSL-6 alpha and -6 alpha, that differ in their N-terminal amino acid sequences but have common C-terminal regions. When transfected into MG63 osteosarcoma cells, both isoforms were secreted and deposited into pericellular matrices, although ADAMTSL-6 alpha, in contrast to -6 beta, was barely detectable in the conditioned medium. Immunolabeling at the light and electron microscopic levels showed their close association with fibrillin-1-rich microfibrils in elastic connective tissues. Surface plasmon resonance analyses demonstrated that ADAMTSL-6 beta binds to the N-terminal half of fibrillin-1 with a dissociation constant of similar to 80 nM. When MG63 cells were transfected or exogenously supplemented with ADAMTSL-6, fibrillin-1 matrix assembly was promoted in the early but not the late stage of the assembly process. Furthermore, ADAMTSL-6 transgenic mice exhibited excessive fibrillin-1 fibril formation in tissues where ADAMTSL-6 was overexpressed. All together, these results indicated that ADAMTSL-6 is a novel microfibril-associated protein that binds directly to fibrillin-1 and promotes fibrillin-1 matrix assembly.	[Tsutsui, Ko; Manabe, Ri-ichiroh; Nakano, Itsuko; Sekiguchi, Kiyotoshi] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; [Tsutsui, Ko; Manabe, Ri-ichiroh; Yamada, Tomiko; Nakano, Itsuko; Oguri, Yasuko; Sekiguchi, Kiyotoshi] Aichi Med Univ, Japan Sci & Technol Agcy, Sekiguchi Biomatrix Signaling Project, Aichi 4801195, Japan; [Keene, Douglas R.; Sakai, Lynn Y.] Oregon Hlth & Sci Univ, Shriners Hosp Children, Portland, OR 97239 USA; [Sengle, Gerhard; Sakai, Lynn Y.] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA	Osaka University; Aichi Medical University; Japan Science & Technology Agency (JST); Oregon Health & Science University; Oregon Health & Science University	Sekiguchi, K (corresponding author), Osaka Univ, Inst Prot Res, 3-2 Yamadaoka, Suita, Osaka 5650871, Japan.	sekiguch@protein.osaka-u.ac.jp		Tsutsui, Ko/0000-0003-0729-5975	National Institutes of Health [P01AR049698]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [17082005, 20370046]; Shriners Hospitals for Children; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR049698] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Shriners Hospitals for Children; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant P01AR049698 (to L. Y. S.). This work was also supported by Grants-in-aid for Scientific Research 17082005 and 20370046 (to K. S.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and from the Shriners Hospitals for Children (to D. R. K. and to L. Y. S.).	Ahram D, 2009, AM J HUM GENET, V84, P274, DOI 10.1016/j.ajhg.2009.01.007; AOYAMA T, 1994, J CLIN INVEST, V94, P130, DOI 10.1172/JCI117298; Ashworth JL, 1999, J CELL SCI, V112, P3549; Baldock C, 2001, J CELL BIOL, V152, P1045, DOI 10.1083/jcb.152.5.1045; Buchner DA, 2003, GENE, V307, P23, DOI 10.1016/S0378-1119(03)00423-2; Cain SA, 2005, J BIOL CHEM, V280, P30526, DOI 10.1074/jbc.M501390200; Cain SA, 2008, J BIOL CHEM, V283, P27017, DOI 10.1074/jbc.M803373200; Charbonneau NL, 2003, J BIOL CHEM, V278, P2740, DOI 10.1074/jbc.M209201200; Charbonneau Noe L, 2004, Birth Defects Res C Embryo Today, V72, P37, DOI 10.1002/bdrc.20000; Chaudhry SS, 2007, J CELL BIOL, V176, P355, DOI 10.1083/jcb.200608167; Dzamba BJ, 2001, J INVEST DERMATOL, V117, P1612, DOI 10.1046/j.0022-202x.2001.01588.x; El-Hallous E, 2007, J BIOL CHEM, V282, P8935, DOI 10.1074/jbc.M608204200; Faivre L, 2002, HUM GENET, V110, P366, DOI 10.1007/s00439-002-0689-3; Faivre L, 2003, J MED GENET, V40, P34, DOI 10.1136/jmg.40.1.34; Gendron C, 2007, J BIOL CHEM, V282, P18294, DOI 10.1074/jbc.M701523200; GODFREY M, 1995, AM J PATHOL, V146, P1414; Hall NG, 2003, MATRIX BIOL, V22, P501, DOI 10.1016/S0945-053X(03)00075-1; Handford PA, 2000, MATRIX BIOL, V19, P457, DOI 10.1016/S0945-053X(00)00100-1; Handford PA, 2000, BBA-MOL CELL RES, V1498, P84, DOI 10.1016/S0167-4889(00)00085-9; Hashimoto G, 2004, J BIOL CHEM, V279, P32483, DOI 10.1074/jbc.M314216200; Hileman RE, 1998, BIOESSAYS, V20, P156, DOI 10.1002/(SICI)1521-1878(199802)20:2<156::AID-BIES8>3.3.CO;2-#; Hirohata S, 2002, J BIOL CHEM, V277, P12182, DOI 10.1074/jbc.M109665200; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Hubmacher D, 2008, P NATL ACAD SCI USA, V105, P6548, DOI 10.1073/pnas.0706335105; Isogai Z, 2003, J BIOL CHEM, V278, P2750, DOI 10.1074/jbc.M209256200; Jensen SA, 2001, J BIOL CHEM, V276, P39661, DOI 10.1074/jbc.M104533200; Kashiwagi M, 2004, J BIOL CHEM, V279, P10109, DOI 10.1074/jbc.M312123200; Kielty CM, 2002, J CELL SCI, V115, P2817; Kinsey R, 2008, J CELL SCI, V121, P2696, DOI 10.1242/jcs.029819; KOFF A, 1992, SCIENCE, V257, P1689, DOI 10.1126/science.1388288; Koo BH, 2007, MATRIX BIOL, V26, P431, DOI 10.1016/j.matbio.2007.03.003; Kuno K, 1998, J BIOL CHEM, V273, P13912, DOI 10.1074/jbc.273.22.13912; Kuo CL, 2007, J BIOL CHEM, V282, P4007, DOI 10.1074/jbc.M606370200; Le Goff C, 2008, NAT GENET, V40, P1119, DOI 10.1038/ng.199; Lee SSJ, 2004, STRUCTURE, V12, P717, DOI 10.1016/j.str.2004.02.023; Lin GQ, 2002, J BIOL CHEM, V277, P50795, DOI 10.1074/jbc.M210611200; Manabe RI, 2008, P NATL ACAD SCI USA, V105, P12849, DOI 10.1073/pnas.0803640105; Marson A, 2005, J BIOL CHEM, V280, P5013, DOI 10.1074/jbc.M409029200; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Ono RN, 2009, J BIOL CHEM, V284, P16872, DOI 10.1074/jbc.M809348200; Pearson WR, 1997, GENOMICS, V46, P24, DOI 10.1006/geno.1997.4995; Penner AS, 2002, J BIOL CHEM, V277, P35044, DOI 10.1074/jbc.M206363200; Pereira L, 1997, NAT GENET, V17, P218, DOI 10.1038/ng1097-218; Porter S, 2005, BIOCHEM J, V386, P15, DOI 10.1042/BJ20040424; Reinhardt DP, 2000, J BIOL CHEM, V275, P2205, DOI 10.1074/jbc.275.3.2205; Reinhardt DP, 1996, J MOL BIOL, V258, P104, DOI 10.1006/jmbi.1996.0237; Rifkin DB, 2005, J BIOL CHEM, V280, P7409, DOI 10.1074/jbc.R400029200; Ritty TM, 2003, BIOCHEM J, V375, P425, DOI 10.1042/BJ20030649; Robinson PN, 2006, J MED GENET, V43, P769, DOI 10.1136/jmg.2005.039669; Sabatier L, 2009, MOL BIOL CELL, V20, P846, DOI 10.1091/mbc.E08-08-0830; SAKAI LY, 1994, METHOD ENZYMOL, V245, P29; SAKAI LY, 1991, J BIOL CHEM, V266, P14763; SAKAI LY, 1986, J CELL BIOL, V103, P2499, DOI 10.1083/jcb.103.6.2499; Somerville RPT, 2003, J BIOL CHEM, V278, P9503, DOI 10.1074/jbc.M211009200; Tan KM, 2002, J CELL BIOL, V159, P373, DOI 10.1083/jcb.200206062; Tiedemann K, 2001, J BIOL CHEM, V276, P36035, DOI 10.1074/jbc.M104985200; Tortorella M, 2000, J BIOL CHEM, V275, P25791, DOI 10.1074/jbc.M001065200; Trask TM, 1999, BIOCHEM J, V340, P693, DOI 10.1042/0264-6021:3400693; Tsumaki N, 1999, J CELL BIOL, V144, P161, DOI 10.1083/jcb.144.1.161	60	69	72	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4870	4882		10.1074/jbc.M109.076919	http://dx.doi.org/10.1074/jbc.M109.076919			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	19940141	Green Published, hybrid			2022-12-25	WOS:000275274800065
J	Peuhu, E; Rivero-Muller, A; Stykki, H; Torvaldson, E; Holmbom, T; Eklund, P; Unkila, M; Sjoholm, R; Eriksson, JE				Peuhu, E.; Rivero-Muller, A.; Stykki, H.; Torvaldson, E.; Holmbom, T.; Eklund, P.; Unkila, M.; Sjoholm, R.; Eriksson, J. E.			Inhibition of Akt signaling by the lignan matairesinol sensitizes prostate cancer cells to TRAIL-induced apoptosis	ONCOGENE			English	Article						matairesinol; lignans; apoptosis; TRAIL	MAMMALIAN LIGNANS; SECOISOLARICIRESINOL DIGLYCOSIDE; BCL-2 FAMILY; DEATH; RECEPTOR; PROTEIN; LIGAND; GROWTH; LNCAP; RESISTANCE	Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) has been shown to be selectively pro-apoptotic in cancer cells, with minimal toxicity to normal tissues. Although this feature makes TRAIL a promising anticancer agent, not all cancer cell types are sensitive to TRAIL-induced apoptosis despite abundant expression of TRAIL receptors. Thus, combinatorial treatments to sensitize tumor cells to TRAIL-induced apoptosis have been in the focus of extensive research. Dietary lignans have shown cancer preventive and antitumorigenic activity, but the mechanisms behind these effects are poorly known. Here we observed that of the three tested lignan molecules, matairesinol (MAT) was the most effective as a death receptor-sensitizing agent. MAT sensitized the androgen-dependent LNCaP cells to TRAIL-induced apoptosis both in the presence and absence of androgens. Treatment with MAT markedly decreased Akt activity, which has been implicated as a key signaling mechanism in the TRAIL resistance of LNCaP prostate cancer cells. The involvement of the pathway in the MAT-mediated sensitization was shown in rescue experiments using ectopic expression of constitutively active Akt. Owing to the high activity of phosphatidylinositol 3-kinase/Akt signaling in cancer, targeting this survival pathway with MAT could markedly benefit TRAIL-based tumor therapies, including those aimed at prostate cancer. Oncogene (2010) 29, 898-908; doi:10.1038/onc.2009.386; published online 23 November 2009	[Peuhu, E.; Stykki, H.; Torvaldson, E.; Eriksson, J. E.] Abo Akad Univ, Dept Biol, Turku 20520, Finland; [Peuhu, E.; Rivero-Muller, A.; Stykki, H.; Torvaldson, E.; Eriksson, J. E.] Univ Turku, Turku Ctr Biotechnol, Turku, Finland; [Rivero-Muller, A.] Univ Turku, Inst Biomed, Turku, Finland; [Holmbom, T.] Abo Akad Univ, Lab Fiber & Cellulose Technol, Turku 20520, Finland; [Eklund, P.; Sjoholm, R.] Abo Akad Univ, Organ Chem Lab, Turku 20520, Finland; [Unkila, M.] Hormos Med Ltd, Turku, Finland	Abo Akademi University; University of Turku; University of Turku; Abo Akademi University; Abo Akademi University	Eriksson, JE (corresponding author), Abo Akad Univ, Dept Biol, Tykistokatu 6B, Turku 20520, Finland.	john.eriksson@abo.fi	Rivero-Muller, Adolfo/A-5120-2008	Rivero-Muller, Adolfo/0000-0002-9794-802X; Peuhu, Emilia/0000-0003-4945-3046; Torvaldson, Elin/0000-0002-7175-6396	Academy of Finland; Sigrid Juselius Foundation; Research Institute of the Abo Akademi University; Foundation of the Abo Akademi University; K Albin Johansson Foundation; Liv och Halsa Foundation; Magnus Ehrnrooth Foundation	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Research Institute of the Abo Akademi University; Foundation of the Abo Akademi University; K Albin Johansson Foundation; Liv och Halsa Foundation; Magnus Ehrnrooth Foundation	We thank Henning Walczak for providing the recombinant izTRAIL, Julian Downward for the ca-Akt construct and Perttu Terho for technical assistance in flow cytometry. We also thank Cecilia Sahlgren and all the members of our laboratory for critical comments on the paper and technical help during the course of this study. This work was supported by the Academy of Finland, the Sigrid Juselius Foundation, the Research Institute of the Abo Akademi University, the Foundation of the Abo Akademi University, K Albin Johansson Foundation, Liv och Halsa Foundation and Magnus Ehrnrooth Foundation.	ADLERCREUTZ H, 1993, J STEROID BIOCHEM, V44, P147, DOI 10.1016/0960-0760(93)90022-O; Adlercreutz H, 2007, CRIT REV CL LAB SCI, V44, P483, DOI 10.1080/10408360701612942; Aslan JE, 2009, MOL CELL, V34, P497, DOI 10.1016/j.molcel.2009.04.011; AXELSON M, 1982, NATURE, V298, P659, DOI 10.1038/298659a0; Bucur O, 2006, FRONT BIOSCI-LANDMRK, V11, P1549, DOI 10.2741/1903; Bylund A, 2005, EXP BIOL MED, V230, P217; Chen LH, 2007, MOL CANCER THER, V6, P2581, DOI 10.1158/1535-7163.MCT-07-0220; Chen LH, 2009, J NUTR, V139, P653, DOI 10.3945/jn.108.101832; Chen XF, 2001, ONCOGENE, V20, P6073, DOI 10.1038/sj.onc.1204736; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Fulda S, 2004, CURR OPIN PHARMACOL, V4, P327, DOI 10.1016/j.coph.2004.02.005; Hausott B, 2003, J CANCER RES CLIN, V129, P569, DOI 10.1007/s00432-003-0461-7; Huang HJ, 2004, ONCOGENE, V23, P2161, DOI 10.1038/sj.onc.1207326; Jemal A, 2008, JNCI-J NATL CANCER I, V100, P1672, DOI 10.1093/jnci/djn389; Jin ZY, 2004, J BIOL CHEM, V279, P35829, DOI 10.1074/jbc.M405538200; Kim KM, 2005, J BIOL CHEM, V280, P41047, DOI 10.1074/jbc.M503713200; KISCHKEL FC, 1995, EMBO J, V14, P5579, DOI 10.1002/j.1460-2075.1995.tb00245.x; Kitts DD, 1999, MOL CELL BIOCHEM, V202, P91, DOI 10.1023/A:1007022329660; Koschny R, 2007, J MOL MED, V85, P923, DOI 10.1007/s00109-007-0194-1; Li DH, 1999, CANCER LETT, V142, P91, DOI 10.1016/S0304-3835(99)00158-5; Lin X, 2001, ANTICANCER RES, V21, P3995; Mahalingam D, 2009, CANCER TREAT REV, V35, P280, DOI 10.1016/j.ctrv.2008.11.006; McCann MJ, 2008, MOL NUTR FOOD RES, V52, P567, DOI 10.1002/mnfr.200700052; McCann MJ, 2005, NUTR CANCER, V52, P1, DOI 10.1207/s15327914nc5201_1; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Nesterov A, 2001, J BIOL CHEM, V276, P10767, DOI 10.1074/jbc.M005196200; OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0; Pan GH, 1997, SCIENCE, V277, P815, DOI 10.1126/science.277.5327.815; Raja SM, 2008, MOL CANCER THER, V7, P2212, DOI 10.1158/1535-7163.MCT-07-2409; Ray S, 2005, APOPTOSIS, V10, P1411, DOI 10.1007/s10495-005-2490-y; Rokhlin OW, 2002, CANCER BIOL THER, V1, P631, DOI 10.4161/cbt.311; Rokhlin OW, 2005, ONCOGENE, V24, P6773, DOI 10.1038/sj.onc.1208833; Saarinen NM, 2008, INT J CANCER, V123, P1196, DOI 10.1002/ijc.23614; Schaefer U, 2007, FRONT BIOSCI, V12, P3813, DOI 10.2741/2354; Sheridan JP, 1997, SCIENCE, V277, P818, DOI 10.1126/science.277.5327.818; Sprick MR, 2004, BBA-MOL CELL RES, V1644, P125, DOI 10.1016/j.bbamcr.2003.11.002; Thakkar H, 2001, J BIOL CHEM, V276, P38361, DOI 10.1074/jbc.M103321200; Thompson LU, 1996, NUTR CANCER, V26, P159, DOI 10.1080/01635589609514472; Vincenz C, 1997, J BIOL CHEM, V272, P6578, DOI 10.1074/jbc.272.10.6578; Vlietstra RJ, 1998, CANCER RES, V58, P2720; Yokoyama T, 2003, BIOL PHARM BULL, V26, P371, DOI 10.1248/bpb.26.371	41	36	39	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 11	2010	29	6					898	908		10.1038/onc.2009.386	http://dx.doi.org/10.1038/onc.2009.386			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	553WP	19935713				2022-12-25	WOS:000274397800012
J	Luo, WB; Zhong, J; Chang, R; Hu, HX; Pandey, A; Semenza, GL				Luo, Weibo; Zhong, Jun; Chang, Ryan; Hu, Hongxia; Pandey, Akhilesh; Semenza, Gregg L.			Hsp70 and CHIP Selectively Mediate Ubiquitination and Degradation of Hypoxia-inducible Factor (HIF)-1 alpha but Not HIF-2 alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR PROTEIN; CANCER-THERAPY; CELL-CULTURE; AMINO-ACIDS; HIF-ALPHA; HIF-1-ALPHA; EXPRESSION; BINDING; PROMOTES; PATHWAY	Hypoxia-inducible factors (HIFs) are transcription factors that mediate adaptive responses to reduced oxygen availability. HIF-alpha subunits are stabilized under conditions of acute hypoxia. However, prolonged hypoxia leads to decay of HIF-1 alpha but not HIF-2 alpha protein levels by unknown mechanisms. Here, we identify Hsp70 and CHIP (carboxyl terminus of Hsc70-interacting protein) as HIF-1 alpha-interacting proteins. Hsp70, through recruiting the ubiquitin ligase CHIP, promotes the ubiquitination and proteasomal degradation of HIF-1 alpha but not HIF-2 alpha, thereby inhibiting HIF-1-dependent gene expression. Disruption of Hsp70-CHIP interaction blocks HIF-1 alpha degradation mediated by Hsp70 and CHIP. Inhibition of Hsp70 or CHIP synthesis by RNA interference increases protein levels of HIF-1 alpha but not HIF-2 alpha and attenuates the decay of HIF-1 alpha levels during prolonged hypoxia. Thus, Hsp70- and CHIP-dependent ubiquitination represents a molecular mechanism by which prolonged hypoxia selectively reduces the levels of HIF-1 alpha but not HIF-2 alpha protein.	[Luo, Weibo; Chang, Ryan; Hu, Hongxia; Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Vasc Program, Baltimore, MD 21205 USA; [Luo, Weibo; Chang, Ryan; Hu, Hongxia; Pandey, Akhilesh; Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Zhong, Jun; Pandey, Akhilesh; Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Pandey, Akhilesh; Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Pandey, Akhilesh] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Radiat Oncol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Semenza, GL (corresponding author), 733 N Broadway,Ste 671, Baltimore, MD 21205 USA.	gsemenza@jhmi.edu	Hu, Hongxia/Q-7765-2016; Pandey, Akhilesh/B-4127-2009; 高, 雨莉/HGU-8187-2022; Zhong, Jun/D-1662-2010	Pandey, Akhilesh/0000-0001-9943-6127; Zhong, Jun/0000-0003-3148-4143; Luo, Weibo/0000-0002-1992-0320	NHLBI [N01-HV28180, U54 RR020839]; DIVISION OF HEART AND VASCULAR DISEASES [N01HV028180] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020839] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grant N01-HV28180 from NHLBI and Roadmap Grant U54 RR020839.	Arany Z, 1996, P NATL ACAD SCI USA, V93, P12969, DOI 10.1073/pnas.93.23.12969; Cockman ME, 2000, J BIOL CHEM, V275, P25733, DOI 10.1074/jbc.M002740200; Covello KL, 2006, GENE DEV, V20, P557, DOI 10.1101/gad.1399906; Cui Y, 2002, BLOOD, V99, P399, DOI 10.1182/blood.V99.2.399; D'Angelo G, 2003, J BIOL CHEM, V278, P38183, DOI 10.1074/jbc.M302244200; Ema M, 1997, P NATL ACAD SCI USA, V94, P4273, DOI 10.1073/pnas.94.9.4273; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Ginouves A, 2008, P NATL ACAD SCI USA, V105, P4745, DOI 10.1073/pnas.0705680105; Gu YZ, 1998, GENE EXPRESSION, V7, P205; Harsha HC, 2008, NAT PROTOC, V3, P505, DOI 10.1038/nprot.2008.2; Holmquist-Mengelbier L, 2006, CANCER CELL, V10, P413, DOI 10.1016/j.ccr.2006.08.026; Hu CJ, 2007, MOL BIOL CELL, V18, P4528, DOI 10.1091/mbc.E06-05-0419; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jiang BH, 1996, J BIOL CHEM, V271, P17771, DOI 10.1074/jbc.271.30.17771; Jiang JH, 2001, J BIOL CHEM, V276, P42938, DOI 10.1074/jbc.M101968200; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Koh MY, 2008, MOL CELL BIOL, V28, P7081, DOI 10.1128/MCB.00773-08; Kong XG, 2006, MOL CELL BIOL, V26, P2019, DOI 10.1128/MCB.26.6.2019-2028.2006; Liu YV, 2007, J BIOL CHEM, V282, P37064, DOI 10.1074/jbc.M705015200; Liu YV, 2007, MOL CELL, V25, P207, DOI 10.1016/j.molcel.2007.01.001; Luo WB, 2007, J BIOL CHEM, V282, P30246, DOI 10.1074/jbc.M703205200; Mastrogiannaki M, 2009, J CLIN INVEST, V119, P1159, DOI 10.1172/JCI38499; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Melillo G, 2007, CANCER METAST REV, V26, P341, DOI 10.1007/s10555-007-9059-x; Nakayama K, 2004, CELL, V117, P941, DOI 10.1016/j.cell.2004.06.001; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Raval RR, 2005, MOL CELL BIOL, V25, P5675, DOI 10.1128/MCB.25.13.5675-5686.2005; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Semenza GL, 2009, PHYSIOLOGY, V24, P97, DOI 10.1152/physiol.00045.2008; Taylor CT, 2008, BIOCHEM J, V409, P19, DOI 10.1042/BJ20071249; Uchida T, 2004, J BIOL CHEM, V279, P14871, DOI 10.1074/jbc.M400461200; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wiesener MS, 2002, FASEB J, V16, P271, DOI 10.1096/fj.02-0445fje; Xu WP, 2002, P NATL ACAD SCI USA, V99, P12847, DOI 10.1073/pnas.202365899	37	164	173	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3651	3663		10.1074/jbc.M109.068577	http://dx.doi.org/10.1074/jbc.M109.068577			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19940151	Green Published, hybrid			2022-12-25	WOS:000275254000017
J	Brull, F; Mensink, RP; van den Hurk, K; Duijvestijn, A; Plat, J				Brull, Florence; Mensink, Ronald P.; van den Hurk, Karin; Duijvestijn, Adriaan; Plat, Jogchum			TLR2 Activation Is Essential to Induce a Th1 Shift in Human Peripheral Blood Mononuclear Cells by Plant Stanols and Plant Sterols	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE-RECEPTORS; REGULATORY T-CELLS; IMMUNE-RESPONSE; BETA-SITOSTEROL; TH1/TH2 BALANCE; CYTOKINE; DISEASE; PHYTOSTEROLS; MICE; TARGET	Plant sterols may induce a Th1 shift in humans. However, whether plant stanols have similar effects as well as the underlying mechanism are unknown. We have now shown that ( like sitosterol) sitostanol, both 4-desmethylsterols, induces a Th1 shift when added in vitro at physiological concentrations to human PBMCs. This conclusion was based on a higher IFN gamma production, with no change in the production of IL-4 and IL-10. alpha-Amyrin, a 4.4-dimethylsterol, had comparable effects. Because 4.4-dimethylsterols cannot activate transcription factor LXR, this finding indicates that LXR activation was not involved. Sitosterol and sitostanol did not alter the production of IL-12 and IL-18 in PBMCs as well as in monocyte-derived U937 cells, suggesting that plant sterols directly affect T-helper cells, without activating APCs. However, in PBMCs treated with a TLR2 blocker (T2.5), IFN gamma production was completely inhibited, whereas blocking TLR4 with HTA125 had no such effect. To confirm these findings, PBMCs from TLR2(-/-) mice were cultured in the presence of sitosterol and sitostanol. In these cells, no Th1 shift was observed. Our results, therefore, indicate that TLR2 activation is essential to induce a Th1 shift in human PBMCs by plant stanols and plant sterols.	[Brull, Florence; Mensink, Ronald P.; van den Hurk, Karin; Plat, Jogchum] Maastricht Univ, Dept Human Biol, NL-6229 ER Maastricht, Netherlands; [Brull, Florence; Mensink, Ronald P.; van den Hurk, Karin; Plat, Jogchum] Maastricht Univ, Sch Nutr Toxicol & Metab NUTRIM, NL-6229 ER Maastricht, Netherlands; [Duijvestijn, Adriaan] Maastricht Univ, Dept Immunol, NL-6229 ER Maastricht, Netherlands; [Duijvestijn, Adriaan] Maastricht Univ, Sch Cardiovasc Dis CARIM, NL-6229 ER Maastricht, Netherlands	Maastricht University; Maastricht University; Maastricht University; Maastricht University	Plat, J (corresponding author), POB 616, NL-6200 MD Maastricht, Netherlands.	j.plat@hb.unimaas.nl						Albers R, 2005, BRIT J NUTR, V94, P452, DOI 10.1079/BJN20051469; Awad AB, 2004, PROSTAG LEUKOTR ESS, V70, P511, DOI 10.1016/j.plefa.2003.11.005; Benfield T, 2007, DIABETOLOGIA, V50, P549, DOI 10.1007/s00125-006-0570-3; Bouic PJD, 2001, CURR OPIN CLIN NUTR, V4, P471, DOI 10.1097/00075197-200111000-00001; Bouic PJD, 1996, INT J IMMUNOPHARMACO, V18, P693, DOI 10.1016/S0192-0561(97)85551-8; Bouic PJD, 2002, DRUG DISCOV TODAY, V7, P775, DOI 10.1016/S1359-6446(02)02343-7; Breytenbach U, 2001, CELL BIOL INT, V25, P43, DOI 10.1006/cbir.2000.0676; Calpe-Berdiel L, 2007, ATHEROSCLEROSIS, V195, P210, DOI 10.1016/j.atherosclerosis.2006.11.042; Calpe-Berdiel L, 2007, LIFE SCI, V80, P1951, DOI 10.1016/j.lfs.2007.02.032; Chan YM, 2006, NUTR REV, V64, P385, DOI [10.1301/nr.2006.sept.385-402, 10.1111/j.1753-4887.2006.tb00224.x]; Desai F, 2009, INT IMMUNOPHARMACOL, V9, P153, DOI 10.1016/j.intimp.2008.10.019; Eigenmann PA, 2008, CLIN EXP IMMUNOL, V151, P546, DOI 10.1111/j.1365-2249.2007.03582.x; Fransen HP, 2007, J NUTR, V137, P1301, DOI 10.1093/jn/137.5.1301; Frossard CP, 2007, J ALLERGY CLIN IMMUN, V119, P952, DOI 10.1016/j.jaci.2006.12.615; Joseph SB, 2004, CELL, V119, P299, DOI 10.1016/j.cell.2004.09.032; Kawai T, 2005, CURR OPIN IMMUNOL, V17, P338, DOI 10.1016/j.coi.2005.02.007; Kew S, 2004, AM J CLIN NUTR, V79, P674; Kidd Parris, 2003, Altern Med Rev, V8, P223; Lee JH, 2007, VACCINE, V25, P3834, DOI 10.1016/j.vaccine.2007.01.108; Lesourd B, 2006, P NUTR SOC, V65, P319, DOI 10.1079/PNS2006507; Mizoguchi E, 2000, INT IMMUNOL, V12, P597, DOI 10.1093/intimm/12.5.597; Moghadasian MH, 2000, LIFE SCI, V67, P605, DOI 10.1016/S0024-3205(00)00665-2; Nashed B, 2005, J NUTR, V135, P2438, DOI 10.1093/jn/135.10.2438; Naumann E, 2003, J NUTR, V133, P2741, DOI 10.1093/jn/133.9.2741; Nembrini C, 2006, J IMMUNOL, V176, P7180, DOI 10.4049/jimmunol.176.12.7180; Normen AL, 2001, AM J CLIN NUTR, V74, P141; O'Garra A, 2003, NAT IMMUNOL, V4, P304, DOI 10.1038/ni0403-304; O'Garra A, 1998, IMMUNITY, V8, P275, DOI 10.1016/S1074-7613(00)80533-6; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; Ostlund RE, 2002, AM J PHYSIOL-ENDOC M, V282, pE911, DOI 10.1152/ajpendo.00328.2001; Plat J, 2001, NUTR METAB CARDIOVAS, V11, P31; Plat J, 2005, J LIPID RES, V46, P2468, DOI 10.1194/jlr.M500272-JLR200; Plat J, 2005, CURR OPIN LIPIDOL, V16, P31, DOI 10.1097/00041433-200502000-00007; ROITT I, 2000, IMMUNOLOGIE; Sato M, 1999, IMMUNOL LETT, V70, P29, DOI 10.1016/S0165-2478(99)00122-4; Shearer GM, 1998, AIDS RES HUM RETROV, V14, pS149; Sutmuller R, 2007, ANN RHEUM DIS, V66, P91, DOI 10.1136/ard.2007.078535; Sutmuller RPM, 2006, TRENDS IMMUNOL, V27, P387, DOI 10.1016/j.it.2006.06.005; Sutmuller RPM, 2006, J CLIN INVEST, V116, P485, DOI 10.1172/JCI25439; Tammi A, 2001, J NUTR, V131, P1942, DOI 10.1093/jn/131.7.1942; Watanabe T, 2004, NAT IMMUNOL, V5, P800, DOI 10.1038/ni1092; Weststrate JA, 1998, EUR J CLIN NUTR, V52, P334, DOI 10.1038/sj.ejcn.1600559; Yang CD, 2004, J CLIN INVEST, V114, P813, DOI 10.1172/JCI200422186; Zhang P, 2005, J NUTR, V135, P1745, DOI 10.1093/jn/135.7.1745	44	42	42	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5							2951	10.1074/jbc.M109.036343	http://dx.doi.org/10.1074/jbc.M109.036343			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19948716	hybrid, Green Published			2022-12-25	WOS:000273829000009
J	Daniels, R; Mellroth, P; Bernsel, A; Neiers, F; Normark, S; von Heijne, G; Henriques-Normark, B				Daniels, Robert; Mellroth, Peter; Bernsel, Andreas; Neiers, Fabrice; Normark, Staffan; von Heijne, Gunnar; Henriques-Normark, Birgitta			Disulfide Bond Formation and Cysteine Exclusion in Gram-positive Bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STAPHYLOCOCCUS-AUREUS DSBA; ESCHERICHIA-COLI; PROTEIN SECRETION; BETA-LACTAMASE; BACILLUS-SUBTILIS; CRYSTAL-STRUCTURE; OUTER-MEMBRANE; CYTOPLASMIC MEMBRANE; SIGNAL PEPTIDES; OXIDOREDUCTASES	Most secretion pathways in bacteria and eukaryotic cells are challenged by the requirement for their substrate proteins to mature after they traverse a membrane barrier and enter a reactive oxidizing environment. For Gram-positive bacteria, the mechanisms that protect their exported proteins from misoxidation during their post-translocation maturation are poorly understood. To address this, we separated numerous bacterial species according to their tolerance for oxygen and divided their proteomes based on the predicted subcellular localization of their proteins. We then applied a previously established computational approach that utilizes cysteine incorporation patterns in proteins as an indicator of enzymatic systems that may exist in each species. The Sec-dependent exported proteins from aerobic Gram-positive Actinobacteria were found to encode cysteines in an even-biased pattern indicative of a functional disulfide bond formation system. In contrast, aerobic Gram-positive Firmicutes favor the exclusion of cysteines from both their cytoplasmic proteins and their substantially longer exported proteins. Supporting these findings, we show that Firmicutes, but not Actinobacteria, tolerate growth in reductant. We further demonstrate that the actinobacterium Corynebacterium glutamicum possesses disulfide-bonded proteins and two dimeric Dsb-like enzymes that can efficiently catalyze the formation of disulfide bonds. Our results suggest that cysteine exclusion is an important adaptive strategy against the challenges presented by oxidative environments.	[Bernsel, Andreas; von Heijne, Gunnar] Stockholm Univ, Dept Biochem & Biophys, Ctr Biomembrane Res, SE-10691 Stockholm, Sweden; [Henriques-Normark, Birgitta] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, SE-17177 Stockholm, Sweden; [Daniels, Robert; Mellroth, Peter; Neiers, Fabrice; Normark, Staffan; Henriques-Normark, Birgitta] Swedish Inst Infect Dis Control, S-17182 Solna, Sweden	Stockholm University; Karolinska Institutet; Swedish Institute for Infectious Disease Control	von Heijne, G (corresponding author), Stockholm Univ, Dept Biochem & Biophys, Ctr Biomembrane Res, Svante Arrhenius Vag 16, SE-10691 Stockholm, Sweden.	gunnar@dbb.su.se; birgitta.henriques@smi.se	von Heijne, Gunnar/AAH-9389-2019; Neiers, Fabrice/AAM-1637-2021; von Heijne, Gunnar/F-5576-2011	Neiers, Fabrice/0000-0002-8965-4929; von Heijne, Gunnar/0000-0002-4490-8569; Mellroth, Peter/0000-0002-3518-1054; daniels, Robert/0000-0002-5988-2920	Wenner-Gren Foundation; Swedish Research Council; Torsten and Ragnar Soderbergs Foundation; Swedish Royal Academy of Sciences; Swedish Foundation for Strategic Research	Wenner-Gren Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Torsten and Ragnar Soderbergs Foundation; Swedish Royal Academy of Sciences; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research)	This work was supported by a postdoctoral fellowship from the Wenner-Gren Foundation (to R.D.) and the Swedish Research Council, the Torsten and Ragnar Soderbergs Foundation, the Swedish Royal Academy of Sciences, and the Swedish Foundation for Strategic Research.	Apperizeller-Herzog C, 2008, BBA-MOL CELL RES, V1783, P535, DOI 10.1016/j.bbamcr.2007.11.010; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Berndt C, 2008, BBA-MOL CELL RES, V1783, P641, DOI 10.1016/j.bbamcr.2008.02.003; Bernsel A, 2008, P NATL ACAD SCI USA, V105, P7177, DOI 10.1073/pnas.0711151105; Bessette PH, 1999, J BIOL CHEM, V274, P7784, DOI 10.1074/jbc.274.12.7784; Bolhuis A, 1999, J BIOL CHEM, V274, P24531, DOI 10.1074/jbc.274.35.24531; Carmel-Harel O, 2000, ANNU REV MICROBIOL, V54, P439, DOI 10.1146/annurev.micro.54.1.439; Chen SL, 2006, P NATL ACAD SCI USA, V103, P5977, DOI 10.1073/pnas.0600938103; CHEN W, 1995, P NATL ACAD SCI USA, V92, P6229, DOI 10.1073/pnas.92.14.6229; Cross BCS, 2009, NAT REV MOL CELL BIO, V10, P255, DOI 10.1038/nrm2657; Depuydt M, 2009, SCIENCE, V326, P1109, DOI 10.1126/science.1179557; Dorenbos R, 2002, J BIOL CHEM, V277, P16682, DOI 10.1074/jbc.M201158200; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; Dumoulin A, 2005, ARCH MICROBIOL, V184, P117, DOI 10.1007/s00203-005-0024-1; Dutton RJ, 2008, P NATL ACAD SCI USA, V105, P11933, DOI 10.1073/pnas.0804621105; Giles NM, 2003, BIOCHEM BIOPH RES CO, V300, P1, DOI 10.1016/S0006-291X(02)02770-5; Goulding CW, 2004, J BIOL CHEM, V279, P3516, DOI 10.1074/jbc.M311833200; Harwood CR, 2008, TRENDS MICROBIOL, V16, P73, DOI 10.1016/j.tim.2007.12.001; Heras B, 2008, J BIOL CHEM, V283, P4261, DOI 10.1074/jbc.M707838200; Heras B, 2009, NAT REV MICROBIOL, V7, P215, DOI 10.1038/nrmicro2087; HERZBERG O, 1991, J MOL BIOL, V217, P701, DOI 10.1016/0022-2836(91)90527-D; Hoffmann C, 2008, P NATL ACAD SCI USA, V105, P3963, DOI 10.1073/pnas.0709530105; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; Holmgren A, 2000, ANTIOXID REDOX SIGN, V2, P811, DOI 10.1089/ars.2000.2.4-811; Inaba K, 2008, BBA-MOL CELL RES, V1783, P520, DOI 10.1016/j.bbamcr.2007.11.006; Inaba K, 2006, CELL, V127, P789, DOI 10.1016/j.cell.2006.10.034; JELSCH C, 1993, PROTEINS, V16, P364, DOI 10.1002/prot.340160406; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Kadokura H, 2004, SCIENCE, V303, P534, DOI 10.1126/science.1091724; Kadokura H, 2003, ANNU REV BIOCHEM, V72, P111, DOI 10.1146/annurev.biochem.72.121801.161459; Kadokura H, 2009, CELL, V138, P1164, DOI 10.1016/j.cell.2009.07.030; Kang HJ, 2007, SCIENCE, V318, P1625, DOI 10.1126/science.1145806; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Kouwen TRHM, 2007, MOL MICROBIOL, V64, P984, DOI 10.1111/j.1365-2958.2007.05707.x; Kouwen TRHM, 2009, TRENDS MICROBIOL, V17, P6, DOI 10.1016/j.tim.2008.10.003; Kuzin AP, 1999, BIOCHEMISTRY-US, V38, P5720, DOI 10.1021/bi990136d; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lim D, 2001, BIOCHEMISTRY-US, V40, P395, DOI 10.1021/bi001653v; LYLES MM, 1991, BIOCHEMISTRY-US, V30, P619, DOI 10.1021/bi00217a005; Mainathambika BS, 2008, ANNU REV CELL DEV BI, V24, P211, DOI 10.1146/annurev.cellbio.24.110707.175333; Mallick P, 2002, P NATL ACAD SCI USA, V99, P9679, DOI 10.1073/pnas.142310499; Matias VRF, 2007, MOL MICROBIOL, V64, P195, DOI 10.1111/j.1365-2958.2007.05634.x; Meima R, 2002, J BIOL CHEM, V277, P6994, DOI 10.1074/jbc.M111380200; Nakamoto H, 2004, BBA-MOL CELL RES, V1694, P111, DOI 10.1016/j.bbamcr.2004.02.012; Paetzel M, 2002, CHEM REV, V102, P4549, DOI 10.1021/cr010166y; Papanikou E, 2007, NAT REV MICROBIOL, V5, P839, DOI 10.1038/nrmicro1771; Pericone CD, 2003, J BACTERIOL, V185, P6815, DOI 10.1128/JB.185.23.6815-6825.2003; Petersen MTN, 1999, PROTEIN ENG, V12, P535, DOI 10.1093/protein/12.7.535; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Reid E, 2001, BIOCHEM J, V355, P51, DOI 10.1042/0264-6021:3550051; Rosch J, 2004, SCIENCE, V304, P1513, DOI 10.1126/science.1097404; Ruiz N, 2006, NAT REV MICROBIOL, V4, P57, DOI 10.1038/nrmicro1322; SANKARAN K, 1994, J BIOL CHEM, V269, P19701; Sarvas M, 2004, BBA-MOL CELL RES, V1694, P311, DOI 10.1016/j.bbamcr.2004.04.009; Schnell DJ, 2003, CELL, V112, P491, DOI 10.1016/S0092-8674(03)00110-7; Sevier CS, 2002, NAT REV MOL CELL BIO, V3, P836, DOI 10.1038/nrm954; Singh AK, 2008, J BIOL CHEM, V283, P15762, DOI 10.1074/jbc.M800982200; Stewart EJ, 1999, EMBO J, V18, P5963, DOI 10.1093/emboj/18.21.5963; Thanassi DG, 2000, CURR OPIN CELL BIOL, V12, P420, DOI 10.1016/S0955-0674(00)00111-3; Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85; Xie K, 2008, NAT REV MICROBIOL, V6, P234, DOI 10.1038/nrmicro3595	62	68	68	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5					3300	3309		10.1074/jbc.M109.081398	http://dx.doi.org/10.1074/jbc.M109.081398			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19940132	Green Published, hybrid			2022-12-25	WOS:000273829000045
J	Walker, VE; Wong, MJH; Atanasiu, R; Hantouche, C; Young, JC; Shrier, A				Walker, Valerie E.; Wong, Michael J. H.; Atanasiu, Roxana; Hantouche, Christine; Young, Jason C.; Shrier, Alvin			Hsp40 Chaperones Promote Degradation of the hERG Potassium Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG QT SYNDROME; TRANSMEMBRANE CONDUCTANCE REGULATOR; UBIQUITIN-PROTEASOME PATHWAY; INHERITED CARDIAC-ARRHYTHMIA; MOLECULAR CHAPERONES; QUALITY-CONTROL; CYSTIC-FIBROSIS; HEAT-SHOCK; HSP70 CHAPERONES; PROTEIN	Loss of function mutations in the hERG (human ether-ago-go related gene or KCNH2) potassium channel underlie the proarrhythmic cardiac long QT syndrome type 2. Most often this is a consequence of defective trafficking of hERG mutants to the cell surface, with channel retention and degradation at the endoplasmic reticulum. Here, we identify the Hsp40 type 1 chaperones DJA1 (DNAJA1/Hdj2) and DJA2 (DNAJA2) as key modulators of hERG degradation. Overexpression of the DJAs reduces hERG trafficking efficiency, an effect eliminated by the proteasomal inhibitor lactacystin or with DJA mutants lacking their J domains essential for Hsc70/Hsp70 activation. Both DJA1 and DJA2 cause a decrease in the amount of hERG complexed with Hsc70, indicating a preferential degradation of the complex. Similar effects were observed with the E3 ubiquitin ligase CHIP. Both the DJAs and CHIP reduce hERG stability and act differentially on folding intermediates of hERG and the disease-related trafficking mutant G601S. We propose a novel role for the DJA proteins in regulating degradation and suggest that they act at a critical point in secretory pathway quality control.	[Shrier, Alvin] McGill Univ, Dept Physiol, Montreal, PQ H3G 1Y6, Canada; [Wong, Michael J. H.; Young, Jason C.] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada	McGill University; McGill University		jason.young2@mcgill.ca; alvin.shrier@mcgill.ca			Canadian Institutes of Health Research [MOP-86589, MOP-68825]; Canadian Foundation for Innovation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation)	This work was supported by Canadian Institutes of Health Research Grants MOP-86589 and MOP-68825 and by the Canadian Foundation for Innovation.	Akhavan A, 2005, J CELL SCI, V118, P2803, DOI 10.1242/jcs.02423; Akhavan A, 2003, J BIOL CHEM, V278, P40105, DOI 10.1074/jbc.M307837200; Alberti S, 2004, MOL BIOL CELL, V15, P4003, DOI 10.1091/mbc.E04-04-0293; Anderson CL, 2006, CIRCULATION, V113, P365, DOI 10.1161/CIRCULATIONAHA.105.570200; Arndt V, 2005, MOL BIOL CELL, V16, P5891, DOI 10.1091/mbc.E05-07-0660; Bhangoo MK, 2007, MOL BIOL CELL, V18, P3414, DOI 10.1091/mbc.E07-01-0088; Cintron NS, 2006, J BIOL CHEM, V281, P26235, DOI 10.1074/jbc.M605417200; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; CYR DM, 1994, TRENDS BIOCHEM SCI, V19, P176, DOI 10.1016/0968-0004(94)90281-X; Dai Q, 2005, J BIOL CHEM, V280, P38673, DOI 10.1074/jbc.M507986200; Delisle BP, 2003, J BIOL CHEM, V278, P35749, DOI 10.1074/jbc.M305787200; Demand J, 2001, CURR BIOL, V11, P1569, DOI 10.1016/S0960-9822(01)00487-0; Edlich F, 2007, J BIOL CHEM, V282, P15341, DOI 10.1074/jbc.M611594200; Enoki S, 2004, BIOCHEMISTRY-US, V43, P14238, DOI 10.1021/bi048733+; Ficker E, 2004, MOL PHARMACOL, V66, P33, DOI 10.1124/mol.66.1.33; Ficker E, 2003, CIRC RES, V92, pE87, DOI 10.1161/01.RES.0000079028.31393.15; Ficker E, 2002, J BIOL CHEM, V277, P4989, DOI 10.1074/jbc.M107345200; Ficker E, 2000, J MOL CELL CARDIOL, V32, P2327, DOI 10.1006/jmcc.2000.1263; Furutani M, 1999, CIRCULATION, V99, P2290, DOI 10.1161/01.CIR.99.17.2290; Gong QM, 2005, J BIOL CHEM, V280, P19419, DOI 10.1074/jbc.M502327200; Hernandez MP, 2002, J BIOL CHEM, V277, P11873, DOI 10.1074/jbc.M111445200; Hohfeld J, 2001, EMBO REP, V2, P885, DOI 10.1093/embo-reports/kve206; Luders J, 2000, J BIOL CHEM, V275, P4613, DOI 10.1074/jbc.275.7.4613; Marques C, 2006, FASEB J, V20, P741, DOI 10.1096/fj.05-5080fje; MATSUMOTO A, 1990, P NATL ACAD SCI USA, V87, P9133, DOI 10.1073/pnas.87.23.9133; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; McDonough H, 2003, CELL STRESS CHAPERON, V8, P303, DOI 10.1379/1466-1268(2003)008<0303:CALBTC>2.0.CO;2; Meacham GC, 1999, EMBO J, V18, P1492, DOI 10.1093/emboj/18.6.1492; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Qiu XB, 2006, CELL MOL LIFE SCI, V63, P2560, DOI 10.1007/s00018-006-6192-6; Rajamani S, 2002, CIRCULATION, V105, P2830, DOI 10.1161/01.CIR.0000019513.50928.74; Riordan JR, 2008, ANNU REV BIOCHEM, V77, P701, DOI 10.1146/annurev.biochem.75.103004.142532; Riordan JR, 2005, ANNU REV PHYSIOL, V67, P701, DOI 10.1146/annurev.physiol.67.032003.154107; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; Sanguinetti MC, 1996, P NATL ACAD SCI USA, V93, P2208, DOI 10.1073/pnas.93.5.2208; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Sharma M, 2004, J CELL BIOL, V164, P923, DOI 10.1083/jcb.200312018; Stenoien DL, 1999, HUM MOL GENET, V8, P731, DOI 10.1093/hmg/8.5.731; Terada K, 2000, J BIOL CHEM, V275, P24728, DOI 10.1074/jbc.M002021200; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; Tzankov S, 2008, J BIOL CHEM, V283, P27100, DOI 10.1074/jbc.M803923200; Walker VE, 2007, J BIOL CHEM, V282, P23509, DOI 10.1074/jbc.M701006200; Wang XD, 2008, TRAFFIC, V9, P1878, DOI 10.1111/j.1600-0854.2008.00806.x; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; WARMKE JW, 1994, P NATL ACAD SCI USA, V91, P3438, DOI 10.1073/pnas.91.8.3438; White SM, 2004, AM J PHYSIOL-HEART C, V286, pH823, DOI 10.1152/ajpheart.00986.2003; Wickner S, 1999, SCIENCE, V286, P1888, DOI 10.1126/science.286.5446.1888; Wyttenbach A, 2000, P NATL ACAD SCI USA, V97, P2898, DOI 10.1073/pnas.97.6.2898; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041; Younger JM, 2004, J CELL BIOL, V167, P1075, DOI 10.1083/jcb.200410065; Zhou ZF, 1998, J BIOL CHEM, V273, P21061, DOI 10.1074/jbc.273.33.21061	55	61	62	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5					3319	3329		10.1074/jbc.M109.024000	http://dx.doi.org/10.1074/jbc.M109.024000			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19940115	Green Published, hybrid			2022-12-25	WOS:000273829000047
J	Zee, BM; Levin, RS; Xu, B; LeRoy, G; Wingreen, NS; Garcia, BA				Zee, Barry M.; Levin, Rebecca S.; Xu, Bo; LeRoy, Gary; Wingreen, Ned S.; Garcia, Benjamin A.			In Vivo Residue-specific Histone Methylation Dynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSINE METHYLATION; KINETIC MECHANISM; H3 LYSINE-9; CHROMATIN; IDENTIFICATION; TRANSCRIPTION; ACETYLATION; ACTIVATION; PATTERNS; STATES	Methylation of specific histone residues is capable of both gene activation and silencing. Despite vast work on the function of methylation, most studies either present a static snapshot of methylation or fail to assign kinetic information to specific residues. Using liquid chromatography-tandem mass spectrometry on a high-resolution mass spectrometer and heavy methyl-SILAC labeling, we studied site-specific histone lysine and arginine methylation dynamics. The detection of labeled intermediates within a methylation state revealed that mono-, di-, and trimethylated residues generally have progressively slower rates of formation. Furthermore, methylations associated with active genes have faster rates than methylations associated with silent genes. Finally, the presence of both an active and silencing mark on the same peptide results in a slower rate of methylation than the presence of either mark alone. Here we show that quantitative proteomic approaches such as this can determine the dynamics of multiple methylated residues, an understudied portion of histone biology.	[Zee, Barry M.; Xu, Bo; LeRoy, Gary; Wingreen, Ned S.; Garcia, Benjamin A.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Levin, Rebecca S.; Garcia, Benjamin A.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA	Princeton University; Princeton University	Garcia, BA (corresponding author), Princeton Univ, Dept Mol Biol, 415 Schultz Lab, Princeton, NJ 08544 USA.	bagarcia@princeton.edu		Zee, Barry/0000-0002-3123-8375	Princeton University; National Science Foundation [CBET-0941143]; Waters Corporation	Princeton University(Princeton University); National Science Foundation(National Science Foundation (NSF)); Waters Corporation	This work was supported by Princeton University, the National Science Foundation Grant CBET-0941143, and an American Society for Mass Spectrometry research award sponsored by the Waters Corporation (to B.A.G.).	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Beisel C, 2002, NATURE, V419, P857, DOI 10.1038/nature01126; Bell O, 2007, EMBO J, V26, P4974, DOI 10.1038/sj.emboj.7601926; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyne MT, 2009, J PROTEOME RES, V8, P374, DOI 10.1021/pr800635m; BYVOET P, 1972, ARCH BIOCHEM BIOPHYS, V148, P558, DOI 10.1016/0003-9861(72)90174-9; Chin HG, 2006, BIOCHEMISTRY-US, V45, P3272, DOI 10.1021/bi051997r; DJONDJUROV LP, 1983, BIOCHEMISTRY-US, V22, P4095; Fischle W, 2003, NATURE, V425, P475, DOI 10.1038/nature02017; FODOR BD, 2009, GENE DEV, V20, P1557; Forneris F, 2006, J BIOL CHEM, V281, P35289, DOI 10.1074/jbc.M607411200; Garcia BA, 2007, NAT PROTOC, V2, P933, DOI 10.1038/nprot.2007.106; Garcia BA, 2007, NAT METHODS, V4, P487, DOI 10.1038/nmeth1052; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kirmizis A, 2009, NAT STRUCT MOL BIOL, V16, P449, DOI 10.1038/nsmb.1569; Klose RJ, 2006, NATURE, V442, P312, DOI 10.1038/nature04853; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kurdistani SK, 2004, CELL, V117, P721, DOI 10.1016/j.cell.2004.05.023; Lan F, 2009, SCI CHINA SER C, V52, P311, DOI 10.1007/s11427-009-0054-z; Lee BM, 2009, J CELL BIOCHEM, V108, P22, DOI 10.1002/jcb.22250; Leroy G, 2009, MOL CELL PROTEOMICS, V8, P2432, DOI 10.1074/mcp.M900160-MCP200; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; McManus KJ, 2006, J BIOL CHEM, V281, P8888, DOI 10.1074/jbc.M505323200; Misteli T, 2000, NATURE, V408, P877, DOI 10.1038/35048610; Mito Y, 2007, SCIENCE, V315, P1408, DOI 10.1126/science.1134004; Morillon A, 2005, MOL CELL, V18, P723, DOI 10.1016/j.molcel.2005.05.009; Noma K, 2001, SCIENCE, V293, P1150, DOI 10.1126/science.1064150; Oda Y, 1999, P NATL ACAD SCI USA, V96, P6591, DOI 10.1073/pnas.96.12.6591; Ong SE, 2004, NAT METHODS, V1, P119, DOI 10.1038/NMETH715; OSLEY MA, 1991, ANNU REV BIOCHEM, V60, P827, DOI 10.1146/annurev.biochem.60.1.827; Patnaik D, 2004, J BIOL CHEM, V279, P53248, DOI 10.1074/jbc.M409604200; Pesavento JJ, 2008, MOL CELL BIOL, V28, P468, DOI 10.1128/MCB.01517-07; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Rice JC, 2003, MOL CELL, V12, P1591, DOI 10.1016/S1097-2765(03)00479-9; SCHARF AN, 2009, NUCLEIC ACIDS RES, P1; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Shi Y, 2007, MOL CELL, V25, P1, DOI 10.1016/j.molcel.2006.12.010; SIROTKIN AM, 1995, P NATL ACAD SCI USA, V92, P6434, DOI 10.1073/pnas.92.14.6434; Steger DJ, 2008, MOL CELL BIOL, V28, P2825, DOI 10.1128/MCB.02076-07; Tamaru H, 2003, NAT GENET, V34, P75, DOI 10.1038/ng1143; THOMAS G, 1975, EUR J BIOCHEM, V51, P609, DOI 10.1111/j.1432-1033.1975.tb03963.x; Trievel RC, 2002, CELL, V111, P91, DOI 10.1016/S0092-8674(02)01000-0; Trojer P, 2007, CELL, V129, P915, DOI 10.1016/j.cell.2007.03.048; Wang HB, 2001, SCIENCE, V293, P853, DOI 10.1126/science.1060781; WATERBORG JH, 1993, J BIOL CHEM, V268, P4918; WORCEL A, 1978, CELL, V15, P969, DOI 10.1016/0092-8674(78)90280-5; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027	49	189	194	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5					3341	3350		10.1074/jbc.M109.063784	http://dx.doi.org/10.1074/jbc.M109.063784			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19940157	Green Published, hybrid			2022-12-25	WOS:000273829000049
J	Eudes, A; Kunji, ERS; Noiriel, A; Klaus, SMJ; Vickers, TJ; Beverley, SM; Gregory, JF; Hanson, AD				Eudes, Aymerick; Kunji, Edmund R. S.; Noiriel, Alexandre; Klaus, Sebastian M. J.; Vickers, Tim J.; Beverley, Stephen M.; Gregory, Jesse F., III; Hanson, Andrew D.			Identification of Transport-critical Residues in a Folate Transporter from the Folate-Biopterin Transporter (FBT) Family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARASITE LEISHMANIA-MAJOR; P-AMINOBENZOYL-GLUTAMATE; ESCHERICHIA-COLI; METHOTREXATE RESISTANCE; MEMBRANE-TRANSPORT; LACTOSE PERMEASE; FOLIC-ACID; PROTEIN; METABOLISM; ARABIDOPSIS	The Synechocystis Slr0642 protein and its plastidial Arabidopsis (Arabidopsis thaliana) ortholog At2g32040 belong to the folate-biopterin transporter (FBT) family within the major facilitator superfamily. Both proteins transport folates when expressed in Escherichia coli. Because the structural requirements for transport activity are not known for any FBT protein, we applied mutational analysis to identify residues that are critical to transport and interpreted the results using a comparative structural model based on E. coli lactose permease. Folate transport was assessed via the growth of an E. coli pabA abgT strain, which cannot synthesize or take up folates or p-aminobenzoylglutamate. In total, 47 residues were replaced with Cys or Ala. Mutations at 22 positions abolished folate uptake without affecting Slr0642 expression in membranes, whereas other mutations had no effect. Residues important for function mostly line the predicted central cavity and are concentrated in the core alpha-helices H1, H4, H7, and H10. The essential residue locations are consistent with a folate-binding site lying roughly equidistant from both faces of the transporter. Arabidopsis has eight FBT proteins besides At2g32040, often lacking conserved critical residues. When six of these proteins were expressed in E. coli or in Leishmania folate or pterin transporter mutants, none showed evidence of folate or pterin transport activity, and only At2g32040 was isolated by functional screening of Arabidopsis cDNA libraries in E. coli. Such negative data could reflect roles in transport of other substrates. These studies provide the first insights into the native structure and catalytic mechanism of FBT family carriers.	[Eudes, Aymerick; Noiriel, Alexandre; Klaus, Sebastian M. J.; Hanson, Andrew D.] Univ Florida, Dept Hort Sci, Gainesville, FL 32611 USA; [Gregory, Jesse F., III] Univ Florida, Dept Food Sci & Human Nutr, Gainesville, FL 32611 USA; [Kunji, Edmund R. S.] MRC, Mitochondrial Biol Unit, Cambridge CB2 0XY, England; [Vickers, Tim J.; Beverley, Stephen M.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Washington University (WUSTL)	Hanson, AD (corresponding author), Univ Florida, Dept Hort Sci, POB 110690, Gainesville, FL 32611 USA.	adha@ufl.edu	Eudes, Aymerick/AAH-4909-2021; Kunji, Edmund/AAH-2362-2020	Eudes, Aymerick/0000-0002-1387-6111; Kunji, Edmund/0000-0002-0610-4500; Gregory, Jesse/0000-0002-9976-2085; Beverley, Stephen/0000-0001-5319-0811	National Institutes of Health [R01 GM071382, AI21903]; Medical Research Council UK; European Molecular Biology Organization [ALTF 106-2005]; C. V. Griffin, Sr. Foundation; MRC [MC_U105663139] Funding Source: UKRI; Medical Research Council [MC_U105663139] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI031078, R37AI021903, R01AI021903] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071382] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); C. V. Griffin, Sr. Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM071382 and AI21903, by the Medical Research Council UK, by European Molecular Biology Organization Fellowship ALTF 106-2005, and by an endowment from the C. V. Griffin, Sr. Foundation.	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Abramson J, 2004, CURR OPIN STRUC BIOL, V14, P413, DOI 10.1016/j.sbi.2004.07.005; ARFMAN N, 1992, J BACTERIOL, V174, P7370, DOI 10.1128/jb.174.22.7370-7378.1992; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Baldwin JM, 1997, J MOL BIOL, V272, P144, DOI 10.1006/jmbi.1997.1240; Bedhomme M, 2005, J BIOL CHEM, V280, P34823, DOI 10.1074/jbc.M506045200; Bekaert S, 2008, TRENDS PLANT SCI, V13, P28, DOI 10.1016/j.tplants.2007.11.001; BELLO AR, 1994, P NATL ACAD SCI USA, V91, P11442, DOI 10.1073/pnas.91.24.11442; Bibi E, 1998, METHOD ENZYMOL, V292, P370; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Cappello AR, 2007, J MOL BIOL, V369, P400, DOI 10.1016/j.jmb.2007.03.048; Carter EL, 2007, J BACTERIOL, V189, P3329, DOI 10.1128/JB.01940-06; CROSTI P, 1993, PLANT SCI, V88, P97, DOI 10.1016/0168-9452(93)90114-F; Cunningham ML, 2001, MOL BIOCHEM PARASIT, V113, P199, DOI 10.1016/S0166-6851(01)00213-4; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; de Crecy-Lagard V, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-245; DeLano WL, 2002, CURR OPIN STRUC BIOL, V12, P14, DOI 10.1016/S0959-440X(02)00283-X; Dridi L, 2010, BIOCHEM PHARMACOL, V79, P30, DOI 10.1016/j.bcp.2009.07.019; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; GREEN JM, 2002, CHEM BIOL PTERIDINES, P631; Ha DS, 1996, MOL BIOCHEM PARASIT, V77, P57, DOI 10.1016/0166-6851(96)02580-7; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Hussein MJ, 1998, J BACTERIOL, V180, P6260; Jabrin S, 2003, PLANT PHYSIOL, V131, P1431, DOI 10.1104/pp.016915; KAPLER GM, 1990, MOL CELL BIOL, V10, P1084, DOI 10.1128/MCB.10.3.1084; KIEBER JJ, 1993, CELL, V72, P427, DOI 10.1016/0092-8674(93)90119-B; Klaus SMJ, 2005, J BIOL CHEM, V280, P38457, DOI 10.1074/jbc.M507432200; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Lemley C, 1999, MOL BIOCHEM PARASIT, V104, P93, DOI 10.1016/S0166-6851(99)00132-2; Lolkema JS, 1998, MOL MEMBR BIOL, V15, P33, DOI 10.3109/09687689809027516; Lucock M, 2000, MOL GENET METAB, V71, P121, DOI 10.1006/mgme.2000.3027; MARGER MD, 1993, TRENDS BIOCHEM SCI, V18, P13, DOI 10.1016/0968-0004(93)90081-W; Massimine KM, 2005, MOL BIOCHEM PARASIT, V144, P44, DOI 10.1016/j.molbiopara.2005.07.006; Matherly LH, 2003, VITAM HORM, V66, P403, DOI 10.1016/S0083-6729(03)01012-4; Orsomando G, 2005, J BIOL CHEM, V280, P28877, DOI 10.1074/jbc.M504306200; Ouellette M, 2002, INT J PARASITOL, V32, P385, DOI 10.1016/S0020-7519(01)00346-0; Prabhu V, 1998, PLANT PHYSIOL, V116, P137, DOI 10.1104/pp.116.1.137; Qiu AD, 2006, CELL, V127, P917, DOI 10.1016/j.cell.2006.09.041; Richard D, 2004, J BIOL CHEM, V279, P54494, DOI 10.1074/jbc.M409264200; Rodionov DA, 2009, J BACTERIOL, V191, P42, DOI 10.1128/JB.01208-08; Saier MH, 2006, NUCLEIC ACIDS RES, V34, pD181, DOI 10.1093/nar/gkj001; Scott J, 2000, J SCI FOOD AGR, V80, P795, DOI [10.1002/(SICI)1097-0010(20000515)80:7&lt;795::AID-JSFA599&gt;3.0.CO;2-K, 10.1002/(SICI)1097-0010(20000515)80:7<795::AID-JSFA599>3.0.CO;2-K]; Titus SA, 2000, J BIOL CHEM, V275, P36811, DOI 10.1074/jbc.M005163200; Yin Y, 2006, SCIENCE, V312, P741, DOI 10.1126/science.1125629	47	17	19	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2867	2875		10.1074/jbc.M109.063651	http://dx.doi.org/10.1074/jbc.M109.063651			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19923217	Green Published, hybrid			2022-12-25	WOS:000273697800062
J	Fujiwara, I; Remmert, K; Hammer, JA				Fujiwara, Ikuko; Remmert, Kirsten; Hammer, John A., III			Direct Observation of the Uncapping of Capping Protein-capped Actin Filaments by CARMIL Homology Domain 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BARBED END; ARP2/3 COMPLEX; BINDING; DYNAMICS; MOTILITY; YEAST; POLYMERIZATION; IDENTIFICATION; NUCLEATION; MECHANISM	Bulk solution assays have shown that the isolated CARMIL homology 3 (CAH3) domain from mouse and Acanthamoeba CARMIL rapidly and potently restores actin polymerization when added to actin filaments previously capped with capping protein (CP). To demonstrate this putative uncapping activity directly, we used total internal reflection microscopy to observe single, CP-capped actin filaments before and after the addition of the CAH3 domain from mouse CARMIL-1 (mCAH3). The addition of mCAH3 rapidly restored the polymerization of individual capped filaments, consistent with uncapping. To verify uncapping, filaments were capped with recombinant mouse CP tagged with monomeric green fluorescent protein (mGFP-CP). Restoration of polymerization upon the addition of mCAH3 was immediately preceded by the complete dissociation of mGFP-CP from the filament end, confirming the CAH3-driven uncapping mechanism. Quantitative analyses showed that the percentage of capped filaments that uncapped increased as the concentration of mCAH3 was increased, reaching a maximum of similar to 90% at similar to 250 nM mCAH3. Moreover, the time interval between mCAH3 addition and uncapping decreased as the concentration of mCAH3 increased, with the half-time of CP at the barbed end decreasing from similar to 30 min without mCAH3 to similar to 10 s with a saturating amount of mCAH3. Finally, using mCAH3 tagged with mGFP, we obtained direct evidence that the complex of CP and mCAH3 has a small but measurable affinity for the barbed end, as inferred from previous studies and kinetic modeling. We conclude that the isolated CAH3 domain of CARMIL (and presumably the intact molecule as well) possesses the ability to uncap CP-capped actin filaments.	[Fujiwara, Ikuko; Remmert, Kirsten; Hammer, John A., III] NHLBI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Hammer, JA (corresponding author), NHLBI, Cell Biol Lab, NIH, Bldg 50,Rm 2523,9000 Rockville Pike, Bethesda, MD 20892 USA.	hammerj@nhlbi.nih.gov	Fujiwara, Ikuko/H-5717-2016	Fujiwara, Ikuko/0000-0002-9361-636X; Hammer, John/0000-0002-2496-5179	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006120] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Akin O, 2008, CELL, V133, P841, DOI 10.1016/j.cell.2008.04.011; AMATRUDA JF, 1990, NATURE, V344, P352, DOI 10.1038/344352a0; AMATRUDA JF, 1992, J CELL BIOL, V119, P1151, DOI 10.1083/jcb.119.5.1151; Bhattacharya N, 2006, J BIOL CHEM, V281, P31021, DOI 10.1074/jbc.M606278200; Bruck S, 2006, J BIOL CHEM, V281, P19196, DOI 10.1074/jbc.M600166200; Canton DA, 2006, J BIOL CHEM, V281, P36347, DOI 10.1074/jbc.M607595200; COOPER JA, 1983, J MUSCLE RES CELL M, V4, P253, DOI 10.1007/BF00712034; Cooper JA, 2008, INT REV CEL MOL BIO, V267, P183, DOI 10.1016/S1937-6448(08)00604-7; Fujiwara I, 2002, NAT CELL BIOL, V4, P666, DOI 10.1038/ncb841; HOUK TW, 1974, ANAL BIOCHEM, V62, P66, DOI 10.1016/0003-2697(74)90367-4; HUG C, 1995, CELL, V81, P591, DOI 10.1016/0092-8674(95)90080-2; Iwasa JH, 2007, CURR BIOL, V17, P395, DOI 10.1016/j.cub.2007.02.012; Jung G, 2001, J CELL BIOL, V153, P1479, DOI 10.1083/jcb.153.7.1479; KIELLEY WW, 1960, BIOCHIM BIOPHYS ACTA, V41, P401; Kim K, 2004, J CELL BIOL, V164, P567, DOI 10.1083/jcb.200308061; Kim K, 2007, J BIOL CHEM, V282, P5871, DOI 10.1074/jbc.M609850200; KOUYAMA T, 1980, EUR J BIOCHEM, V105, P279, DOI 10.1111/j.1432-1033.1980.tb04499.x; Kuhn JR, 2007, J BIOL CHEM, V282, P28014, DOI 10.1074/jbc.M705287200; Kuhn JR, 2005, BIOPHYS J, V88, P1387, DOI 10.1529/biophysj.104.047399; Loisel TP, 1999, NATURE, V401, P613, DOI 10.1038/44183; Matsuzaka Y, 2004, GENE, V343, P291, DOI 10.1016/j.gene.2004.09.004; Mejillano MR, 2004, CELL, V118, P363, DOI 10.1016/j.cell.2004.07.019; Miyoshi T, 2006, J CELL BIOL, V175, P947, DOI 10.1083/jcb.200604176; Mogilner A, 2002, BIOPHYS J, V83, P1237, DOI 10.1016/S0006-3495(02)73897-6; Palmgren S, 2001, J CELL BIOL, V155, P251, DOI 10.1083/jcb.200106157; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; Remmert K, 2004, J BIOL CHEM, V279, P3068, DOI 10.1074/jbc.M308829200; Remmert K, 2009, PROTEIN EXPRES PURIF, V67, P113, DOI 10.1016/j.pep.2009.05.002; Rogers SL, 2003, J CELL BIOL, V162, P1079, DOI 10.1083/jcb.200303023; Schafer DA, 1996, J CELL BIOL, V135, P169, DOI 10.1083/jcb.135.1.169; Sizonenko GI, 1996, MOL BIOL CELL, V7, P1; Uruno T, 2006, J BIOL CHEM, V281, P10635, DOI 10.1074/jbc.M513186200; Vanderzalm PJ, 2009, DEVELOPMENT, V136, P1201, DOI 10.1242/dev.026666; Wear MA, 2003, CURR BIOL, V13, P1531, DOI 10.1016/S0960-9822(03)00559-1; Wear MA, 2004, TRENDS BIOCHEM SCI, V29, P418, DOI 10.1016/j.tibs.2004.06.003; Wu XF, 2006, FEBS LETT, V580, P5863, DOI 10.1016/j.febslet.2006.09.047; Xu P, 1997, P NATL ACAD SCI USA, V94, P3685, DOI 10.1073/pnas.94.8.3685; Yang CS, 2005, DEV CELL, V9, P209, DOI 10.1016/j.devcel.2005.06.008	39	42	42	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2707	2720		10.1074/jbc.M109.031203	http://dx.doi.org/10.1074/jbc.M109.031203			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19926785	Green Published, hybrid			2022-12-25	WOS:000273697800049
J	Kobayashi, K; Kato, K; Sugi, T; Takemae, H; Pandey, K; Gong, HY; Tohya, Y; Akashi, H				Kobayashi, Kyousuke; Kato, Kentaro; Sugi, Tatsuki; Takemae, Hitoshi; Pandey, Kishor; Gong, Haiyan; Tohya, Yukinobu; Akashi, Hiroomi			Plasmodium falciparum BAEBL Binds to Heparan Sulfate Proteoglycans on the Human Erythrocyte Surface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HERPES-SIMPLEX-VIRUS; RED-BLOOD-CELLS; MEMBRANE PROTEIN-1 PFEMP1; MALARIA PARASITE; RECEPTOR SPECIFICITY; PSEUDORABIES VIRUS; ENDOTHELIAL-CELLS; MAMMALIAN-CELLS; GLYCOPHORIN-C; INVASION	Erythrocyte invasion is critical to the pathogenesis and survival of the malarial parasite, Plasmodium falciparum. This process is partly mediated by proteins that belong to the Duffy binding-like family, which are expressed on the merozoite surface. One of these proteins, BAEBL (also known as EBA-140), is thought to bind to glycophorin C in a sialic acid-dependent manner. In this report, by the binding assay between recombinant BAEBL protein and enzyme-treated erythrocytes, we show that the binding of BAEBL to erythrocytes is mediated primarily by sialic acid and partially through heparan sulfate (HS). Because BAEBL binds to several kinds of HS proteoglycans or purified HS, the BAEBL-HS binding was found to be independent of the HS proteoglycan peptide backbone and the presence of sialic acid moieties. Furthermore, both the sialic acid-and HS-dependent binding were disrupted by the addition of soluble heparin. This inhibition may be the result of binding between BAEBL and heparin. Invasion assays demonstrated that HS-dependent binding was related to the efficiency of merozoite invasion. These results suggest that HS functions as a factor that promotes the binding of BAEBL and merozoite invasion. Moreover, these findings may explain the invasion inhibition mechanisms observed following the addition of heparin and other sulfated glycoconjugates.	[Kobayashi, Kyousuke; Kato, Kentaro; Sugi, Tatsuki; Takemae, Hitoshi; Pandey, Kishor; Gong, Haiyan; Tohya, Yukinobu; Akashi, Hiroomi] Univ Tokyo, Dept Vet Microbiol, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan	University of Tokyo	Kato, K (corresponding author), Univ Tokyo, Dept Vet Microbiol, Grad Sch Agr & Life Sci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	akkato@mail.ecc.u-tokyo.ac.jp	Sugi, Tatsuki/A-9110-2012; Takemae, Hitoshi/AEP-5503-2022	Kobayashi, Kyousuke/0000-0001-5501-8396	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Bio-Oriented Technology Research Advancement Institution	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Bio-Oriented Technology Research Advancement Institution	This work was supported by a grant-in-aid for young scientists from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and the Bio-Oriented Technology Research Advancement Institution.	Adams JH, 2001, TRENDS PARASITOL, V17, P297, DOI 10.1016/S1471-4922(01)01948-1; Akhouri RR, 2004, BIOCHEM J, V379, P815, DOI 10.1042/BJ20031500; BANFIELD BW, 1995, J VIROL, V69, P3290, DOI 10.1128/JVI.69.6.3290-3298.1995; Barragan A, 2000, BLOOD, V95, P3594, DOI 10.1182/blood.V95.11.3594.011k21_3594_3599; Baum J, 2009, INT J PARASITOL, V39, P371, DOI 10.1016/j.ijpara.2008.10.006; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; BUTCHER GA, 1988, T ROY SOC TROP MED H, V82, P558, DOI 10.1016/0035-9203(88)90504-4; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; Chen Q, 1998, J EXP MED, V187, P15, DOI 10.1084/jem.187.1.15; Clark DL, 1997, GLYCOCONJUGATE J, V14, P473, DOI 10.1023/A:1018551518610; Coppi A, 2007, CELL HOST MICROBE, V2, P316, DOI 10.1016/j.chom.2007.10.002; Crandall IE, 2007, BIOCHEM PHARMACOL, V73, P632, DOI 10.1016/j.bcp.2006.10.030; Dinglasan RR, 2007, P NATL ACAD SCI USA, V104, P13461, DOI 10.1073/pnas.0702239104; DOLAN SA, 1990, J CLIN INVEST, V86, P618, DOI 10.1172/JCI114753; Drzeniek Z, 1999, BLOOD, V93, P2884; DVORAK JA, 1975, SCIENCE, V187, P748, DOI 10.1126/science.803712; Flynn SJ, 1996, J VIROL, V70, P1355, DOI 10.1128/JVI.70.3.1355-1364.1996; GALLAGHER JT, 1985, BIOCHEM J, V230, P665, DOI 10.1042/bj2300665; GRUENHEID S, 1993, J VIROL, V67, P93, DOI 10.1128/JVI.67.1.93-100.1993; Hans D, 2005, MOL MICROBIOL, V55, P1423, DOI 10.1111/j.1365-2958.2005.04484.x; HORIO T, 1995, THEORY PRACTICE ENZY, P436; Kaneko O, 1999, EXP PARASITOL, V93, P116, DOI 10.1006/expr.1999.4441; Kato K, 2005, P NATL ACAD SCI USA, V102, P5552, DOI 10.1073/pnas.0501594102; Kato K, 2001, J GEN VIROL, V82, P1457, DOI 10.1099/0022-1317-82-6-1457; Kisilevsky R, 2002, ANTIMICROB AGENTS CH, V46, P2619, DOI 10.1128/AAC.46.8.2619-2626.2002; Kobayashi K, 2009, ANAL BIOCHEM, V389, P80, DOI 10.1016/j.ab.2009.03.008; KUHN S, 1995, GENE, V162, P225, DOI 10.1016/0378-1119(95)00360-I; KULANE A, 1992, AM J TROP MED HYG, V46, P589, DOI 10.4269/ajtmh.1992.46.589; Lobo CA, 2003, BLOOD, V101, P4628, DOI 10.1182/blood-2002-10-3076; Maier AG, 2003, NAT MED, V9, P87, DOI 10.1038/nm807; Maier AG, 2009, INFECT IMMUN, V77, P1689, DOI 10.1128/IAI.01331-08; Matuschewski K, 2002, EMBO J, V21, P1597, DOI 10.1093/emboj/21.7.1597; Mayer DCG, 2002, J EXP MED, V196, P1523, DOI 10.1084/jem.20020750; Mayer DCG, 2001, P NATL ACAD SCI USA, V98, P5222, DOI 10.1073/pnas.081075398; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Narum DL, 2002, MOL BIOCHEM PARASIT, V119, P159, DOI 10.1016/S0166-6851(01)00428-5; Onishi M, 1996, EXP HEMATOL, V24, P324; Park PW, 2000, J BIOL CHEM, V275, P29923, DOI 10.1074/jbc.R000008200; Pasvol G, 2003, TRENDS PARASITOL, V19, P430, DOI 10.1016/j.pt.2003.08.005; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SHIEH MT, 1992, J CELL BIOL, V116, P1273, DOI 10.1083/jcb.116.5.1273; Shimojima M, 2004, SCIENCE, V303, P1192, DOI 10.1126/science.1092124; Shimojima M, 2007, J INFECT DIS, V196, pS259, DOI 10.1086/520594; SIM BKL, 1994, SCIENCE, V264, P1941, DOI 10.1126/science.8009226; Sinnis P, 2007, J BIOL CHEM, V282, P25376, DOI 10.1074/jbc.M704698200; Spear PG, 2004, CELL MICROBIOL, V6, P401, DOI 10.1111/j.1462-5822.2004.00389.x; Thompson JK, 2001, MOL MICROBIOL, V41, P47, DOI 10.1046/j.1365-2958.2001.02484.x; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Trybala E, 1998, J BIOL CHEM, V273, P5047, DOI 10.1074/jbc.273.9.5047; Vogt AM, 2004, BIOCHEM J, V381, P593, DOI 10.1042/BJ20040762; Vogt AM, 2003, BLOOD, V101, P2405, DOI 10.1182/blood-2002-07-2016; Vogt AM, 2006, PLOS PATHOG, V2, P853, DOI 10.1371/journal.ppat.0020100; Xiao LH, 1996, INFECT IMMUN, V64, P1373, DOI 10.1128/IAI.64.4.1373-1378.1996; Yoon M, 2003, J VIROL, V77, P9221, DOI 10.1128/JVI.77.17.9221-9231.2003	54	38	43	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2010	285	3					1716	1725		10.1074/jbc.M109.021576	http://dx.doi.org/10.1074/jbc.M109.021576			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	541PJ	19940142	Green Published, hybrid			2022-12-25	WOS:000273429100017
J	Rush, JS; Alaimo, C; Robbiani, R; Wacker, M; Waechter, CJ				Rush, Jeffrey S.; Alaimo, Cristina; Robbiani, Riccardo; Wacker, Michael; Waechter, Charles J.			A Novel Epimerase That Converts GlcNAc-P-P-undecaprenol to GalNAc-P-P-undecaprenol in Escherichia coli O157	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINKED PROTEIN GLYCOSYLATION; ANTIGEN GENE-CLUSTER; O-ANTIGEN; CAMPYLOBACTER-JEJUNI; N-ACETYLGLUCOSAMINE; FUNCTIONAL-ANALYSIS; COLI; LIPOPOLYSACCHARIDE; BIOSYNTHESIS; POLYSACCHARIDES	Escherichia coli strain O157 produces an O-antigen with the repeating tetrasaccharide unit alpha-D-PerNAc-alpha-L-Fuc-beta-D-Glc-alpha-D-GalNAc, preassembled on undecaprenyl pyrophosphate (Und-P-P). These studies were conducted to determine whether the biosynthesis of the lipid-linked repeating tetrasaccharide was initiated by the formation of GalNAc-P-P-Und by WecA. When membrane fractions from E. coli strains K12, O157, and PR4019, a WecA-overexpressing strain, were incubated with UDP-[H-3] GalNAc, neither the enzymatic synthesis of [H-3]GlcNAcP-P-Und nor [H-3] GalNAc-P-P-Und was detected. However, when membrane fractions from strain O157 were incubated with UDP-[H-3] GlcNAc, two enzymatically labeled products were observed with the chemical and chromatographic properties of [H-3] GlcNAc-P-P-Und and [H-3] GalNAc-P-P-Und, suggesting that strain O157 contained an epimerase capable of interconverting GlcNAc-P-P-Und and GalNAc-P-P-Und. The presence of a novel epimerase was demonstrated by showing that exogenous [H-3] GlcNAc-P-P-Und was converted to [H-3] GalNAc-P-P-Und when incubated with membranes from strain O157. When strain O157 was metabolically labeled with [H-3] GlcNAc, both [H-3] GlcNAc-P-P-Und and [H-3] GalNAc-P-P-Und were detected. Transformation of E. coli strain 21546 with the Z3206 gene enabled these cells to synthesize GalNAc-P-P-Und in vivo and in vitro. The reversibility of the epimerase reaction was demonstrated by showing that [H-3] GlcNAc-P-P-Und was reformed when membranes from strain O157 were incubated with exogenous [H-3] GalNAc-P-P-Und. The inability of Z3206 to complement the loss of the gne gene in the expression of the Campylobacter jejuni N-glycosylation system in E. coli indicated that it does not function as a UDP-GlcNAc/UDPGalNAc epimerase. Based on these results, GalNAc-P-P-Und is synthesized reversibly by a novel GlcNAc-P-P-Und epimerase after the formation of GlcNAc-P-P-Und by WecA in E. coli O157.	[Waechter, Charles J.] Univ Kentucky, Dept Mol & Cellular Biochem, Coll Med, BBSRB, Lexington, KY 40536 USA; [Alaimo, Cristina; Robbiani, Riccardo; Wacker, Michael] GlycoVaxyn AG, CH-8952 Schlieren, Switzerland	University of Kentucky	Waechter, CJ (corresponding author), Univ Kentucky, Dept Mol & Cellular Biochem, Coll Med, BBSRB, 741 S Limestone St, Lexington, KY 40536 USA.	waechte@uky.edu			National Institutes of Health [GM36065]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036065] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM36065 (to C. J. W.).	Aebi M, 1996, GLYCOBIOLOGY, V6, P439, DOI 10.1093/glycob/6.4.439; ALEXANDER DC, 1994, J BACTERIOL, V176, P7079, DOI 10.1128/JB.176.22.7079-7084.1994; Allard STM, 2001, CELL MOL LIFE SCI, V58, P1650, DOI 10.1007/PL00000803; Amor PA, 1997, MOL MICROBIOL, V26, P145, DOI 10.1046/j.1365-2958.1997.5631930.x; Bernatchez S, 2005, J BIOL CHEM, V280, P4792, DOI 10.1074/jbc.M407767200; CARDINI CE, 1957, J BIOL CHEM, V225, P317; DUNPHY PJ, 1967, BIOCHIM BIOPHYS ACTA, V136, P136, DOI 10.1016/0304-4165(67)90329-7; Feldman MF, 2005, P NATL ACAD SCI USA, V102, P3016, DOI 10.1073/pnas.0500044102; Field RA, 2003, BIOCHEMISTRY-US, V42, P7637, DOI 10.1021/bi0345079; GORDON HT, 1956, ANAL CHEM, V28, P849, DOI 10.1021/ac60113a020; Guan ZQ, 2005, ANAL BIOCHEM, V345, P336, DOI 10.1016/j.ab.2005.07.002; Guo HJ, 2007, BIOCHEM BIOPH RES CO, V356, P604, DOI 10.1016/j.bbrc.2007.03.015; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; KEAN EL, 1966, J LIPID RES, V7, P449; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Law D, 2000, J APPL MICROBIOL, V88, P729, DOI 10.1046/j.1365-2672.2000.01031.x; Lefebre MD, 2002, APPL ENVIRON MICROB, V68, P5956, DOI 10.1128/AEM.68.12.5956-5964.2002; Linton D, 2005, MOL MICROBIOL, V55, P1695, DOI 10.1111/j.1365-2958.2005.04519.x; Liu B, 2008, FEMS MICROBIOL REV, V32, P627, DOI 10.1111/j.1574-6976.2008.00114.x; MEIERDIETER U, 1990, J BIOL CHEM, V265, P13490; Mikusova K, 2005, J BACTERIOL, V187, P8020, DOI 10.1128/JB.187.23.8020-8025.2005; PERRY MB, 1986, BIOCHEM CELL BIOL, V64, P21, DOI 10.1139/o86-004; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Reeves PR, 1996, TRENDS MICROBIOL, V4, P495, DOI 10.1016/S0966-842X(97)82912-5; Rush JS, 1997, GLYCOBIOLOGY, V7, P315, DOI 10.1093/glycob/7.2.315; Samuel G, 2003, CARBOHYD RES, V338, P2503, DOI 10.1016/j.carres.2003.07.009; SCHWIMMER S, 1956, SCIENCE, V123, P543, DOI 10.1126/science.123.3196.543; Spears KJ, 2006, FEMS MICROBIOL LETT, V255, P187, DOI 10.1111/j.1574-6968.2006.00119.x; Stenutz R, 2006, FEMS MICROBIOL REV, V30, P382, DOI 10.1111/j.1574-6976.2006.00016.x; Stephan R, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-10; STEVENSON G, 1994, J BACTERIOL, V176, P4144, DOI 10.1128/JB.176.13.4144-4156.1994; Wacker M, 2002, SCIENCE, V298, P1790, DOI 10.1126/science.298.5599.1790; WAECHTER CJ, 1976, ARCH BIOCHEM BIOPHYS, V174, P726, DOI 10.1016/0003-9861(76)90403-3; WAECHTER CJ, 1977, ARCH BIOCHEM BIOPHYS, V181, P185, DOI 10.1016/0003-9861(77)90497-0; Wang L, 2002, J BACTERIOL, V184, P2620, DOI 10.1128/JB.184.10.2620-2625.2002; Wang L, 1998, INFECT IMMUN, V66, P3545, DOI 10.1128/IAI.66.8.3545-3551.1998; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; Zhang LJ, 1997, MOL MICROBIOL, V23, P63, DOI 10.1046/j.1365-2958.1997.1871558.x	38	61	68	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2010	285	3					1671	1680		10.1074/jbc.M109.061630	http://dx.doi.org/10.1074/jbc.M109.061630			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	541PJ	19923219	Green Published, hybrid			2022-12-25	WOS:000273429100013
J	Arenas, A; Fernandez, VM; Farina, WM				Arenas, Andres; Fernandez, Vanesa M.; Farina, Walter M.			Associative Learning during Early Adulthood Enhances Later Memory Retention in Honeybees	PLOS ONE			English	Article							APIS-MELLIFERA; FLORAL ODORS; DISCRIMINATION; INSECT; RATS; HIVE; AGE; REPRESENTATIONS; DEPRIVATION; FORAGERS	Background: Cognitive experiences during the early stages of life play an important role in shaping the future behavior in mammals but also in insects, in which precocious learning can directly modify behaviors later in life depending on both the timing and the rearing environment. However, whether olfactory associative learning acquired early in the adult stage of insects affect memorizing of new learning events has not been studied yet. Methodology: Groups of adult honeybee workers that experienced an odor paired with a sucrose solution 5 to 8 days or 9 to 12 days after emergence were previously exposed to (i) a rewarded experience through the offering of scented food, or (ii) a non-rewarded experience with a pure volatile compound in the rearing environment. Principal Findings: Early rewarded experiences (either at 1-4 or 5-8 days of adult age) enhanced retention performance in 9-12-day-conditioned bees when they were tested at 17 days of age. The highest retention levels at this age, which could not be improved with prior rewarded experiences, were found for memories established at 5-8 days of adult age. Associative memories acquired at 9-12 days of age showed a weak effect on retention for some pure pre-exposed volatile compounds; whereas the sole exposure of an odor at any younger age did not promote long-term effects on learning performance. Conclusions: The associative learning events that occurred a few days after adult emergence improved memorizing in middle-aged bees. In addition, both the timing and the nature of early sensory inputs interact to enhance retention of new learning events acquired later in life, an important matter in the social life of honeybees.	[Arenas, Andres; Fernandez, Vanesa M.; Farina, Walter M.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Grp Estudio Insectos Sociales, IFIBYNE CONICET,Dept Biodiversidad & Biol Expt, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Arenas, A (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Grp Estudio Insectos Sociales, IFIBYNE CONICET,Dept Biodiversidad & Biol Expt, Pabellon 2, Buenos Aires, DF, Argentina.	walter@fbmc.fcen.uba.ar	Arenas, Andres/ABC-4886-2021	Farina, Walter/0000-0001-6411-489X	ANPCYT [01-1155]; University of Buenos Aires [X 077]; CONICET [PIP 112-200801-00150]	ANPCYT(ANPCyT); University of Buenos Aires(University of Buenos Aires); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	ANPCYT (01-1155), University of Buenos Aires (X 077), CONICET (PIP 112-200801-00150) and Guggenheim fellowship to WMF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Arenas A, 2009, EUR J NEUROSCI, V30, P1498, DOI 10.1111/j.1460-9568.2009.06940.x; Arenas A, 2008, APIDOLOGIE, V39, P714, DOI 10.1051/apido:2008053; Arenas A, 2008, J COMP PHYSIOL A, V194, P629, DOI 10.1007/s00359-008-0337-z; Behrends A, 2009, ANIM COGN, V12, P249, DOI 10.1007/s10071-008-0187-7; Bialystok E., 2001, BILINGUALISM DEV LAN, DOI [10.1017/CBO9780511605963, DOI 10.1017/CBO9780511605963]; BITTERMAN ME, 1983, J COMP PSYCHOL, V97, P107, DOI 10.1037/0735-7036.97.2.107; CAUBET Y, 1991, ANIM BEHAV, V42, P977, DOI 10.1016/S0003-3472(05)80150-2; Chandra SBC, 2000, J COMP PSYCHOL, V114, P86, DOI 10.1037//0735-7036.114.1.86; Daly KC, 2004, P NATL ACAD SCI USA, V101, P10476, DOI 10.1073/pnas.0401902101; Daly KC, 2001, J INSECT PHYSIOL, V47, P375, DOI 10.1016/S0022-1910(00)00117-7; Faber T, 1999, NAT NEUROSCI, V2, P74, DOI 10.1038/4576; Farina WM, 2007, NATURWISSENSCHAFTEN, V94, P55, DOI 10.1007/s00114-006-0157-3; Farina WM, 2005, P ROY SOC B-BIOL SCI, V272, P1923, DOI 10.1098/rspb.2005.3172; Farris SM, 2001, J NEUROSCI, V21, P6395, DOI 10.1523/JNEUROSCI.21-16-06395.2001; Ferguson HJ, 2001, ANIM BEHAV, V61, P527, DOI 10.1006/anbe.2000.1635; Fernandez VM, 2009, J COMP PHYSIOL A, V195, P759, DOI 10.1007/s00359-009-0453-4; FREE JB, 1969, NATURE, V222, P778, DOI 10.1038/222778a0; Garelick MG, 2005, P NATL ACAD SCI USA, V102, P9091, DOI 10.1073/pnas.0504017102; Gil M, 2005, J EXP BIOL, V208, P671, DOI 10.1242/jeb.01474; Holldobler B., 1980, Evolution of social behaviour: hypotheses and empirical tests, P35; Ichikawa N, 2003, APPL ENTOMOL ZOOL, V38, P203, DOI 10.1303/aez.2003.203; Iso H, 2007, BEHAV BRAIN RES, V179, P90, DOI 10.1016/j.bbr.2007.01.025; Laloi D, 2004, J INSECT BEHAV, V17, P385, DOI 10.1023/B:JOIR.0000031538.15346.e1; LINDAUER M, 1952, Z VERGL PHYSIOL, V34, P299, DOI 10.1007/BF00298048; Lodge DJ, 2003, BEHAV BRAIN RES, V141, P113, DOI 10.1016/S0166-4328(02)00328-5; LORENZ K., 1935, Journal fur Ornithologie, V83, P137, DOI 10.1007/BF01905355; LUNNEY GH, 1970, J EDUC MEAS, V7, P263, DOI 10.1111/j.1745-3984.1970.tb00727.x; Maleszka R, 2001, HORM BEHAV, V40, P403, DOI 10.1006/hbeh.2001.1705; MASSON C, 1993, APIDOLOGIE, V24, P169, DOI 10.1051/apido:19930302; NEAL WR, 1972, CHILD YOUTH CARE Q, V1, P157, DOI 10.1007/BF01543431; Oitzl MS, 2000, EUR J NEUROSCI, V12, P3771, DOI 10.1046/j.1460-9568.2000.00231.x; ROBINSON GE, 1992, ANNU REV ENTOMOL, V37, P637, DOI 10.1146/annurev.en.37.010192.003225; Rosch G.A, 1925, Z VERGL PHYSIOL, V2, P571; SAHAKIAN BJ, 1975, BRAIN RES, V84, P195, DOI 10.1016/0006-8993(75)90975-0; Sandoz JC, 2000, ANIM BEHAV, V59, P1025, DOI 10.1006/anbe.2000.1395; SEELEY TD, 1982, BEHAV ECOL SOCIOBIOL, V11, P287, DOI 10.1007/BF00299306; TAKEDA K, 1961, J INSECT PHYSIOL, V6, P168, DOI 10.1016/0022-1910(61)90060-9; Vergoz V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000288; Wilson E.O., 1971, INSECT SOC; Winnington AP, 1996, J COMP NEUROL, V365, P479, DOI 10.1002/(SICI)1096-9861(19960212)365:3<479::AID-CNE10>3.0.CO;2-M	40	18	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2009	4	12							e8046	10.1371/journal.pone.0008046	http://dx.doi.org/10.1371/journal.pone.0008046			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	533MU	19956575	Green Published, gold, Green Submitted			2022-12-25	WOS:000272828800006
J	Basso, M; Samengo, G; Nardo, G; Massignan, T; D'Alessandro, G; Tartari, S; Cantoni, L; Marino, M; Cheroni, C; De Biasi, S; Giordana, MT; Strong, MJ; Estevez, AG; Salmona, M; Bendotti, C; Bonetto, V				Basso, Manuela; Samengo, Giuseppina; Nardo, Giovanni; Massignan, Tania; D'Alessandro, Giuseppina; Tartari, Silvia; Cantoni, Lavinia; Marino, Marianna; Cheroni, Cristina; De Biasi, Silvia; Giordana, Maria Teresa; Strong, Michael J.; Estevez, Alvaro G.; Salmona, Mario; Bendotti, Caterina; Bonetto, Valentina			Characterization of Detergent-Insoluble Proteins in ALS Indicates a Causal Link between Nitrative Stress and Aggregation in Pathogenesis	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; NITRIC-OXIDE SYNTHASE; SOD1 TRANSGENIC MICE; SUPEROXIDE-DISMUTASE PROTEINS; MOTOR-NEURON DEGENERATION; MOUSE MODEL; SPINAL-CORD; HYALINE INCLUSIONS; CU,ZN-SUPEROXIDE DISMUTASE; DISEASE PROGRESSION	Background: Amyotrophic lateral sclerosis (ALS) is a progressive and fatal motor neuron disease, and protein aggregation has been proposed as a possible pathogenetic mechanism. However, the aggregate protein constituents are poorly characterized so knowledge on the role of aggregation in pathogenesis is limited. Methodology/Principal Findings: We carried out a proteomic analysis of the protein composition of the insoluble fraction, as a model of protein aggregates, from familial ALS (fALS) mouse model at different disease stages. We identified several proteins enriched in the detergent-insoluble fraction already at a preclinical stage, including intermediate filaments, chaperones and mitochondrial proteins. Aconitase, HSC70 and cyclophilin A were also significantly enriched in the insoluble fraction of spinal cords of ALS patients. Moreover, we found that the majority of proteins in mice and HSP90 in patients were tyrosine-nitrated. We therefore investigated the role of nitrative stress in aggregate formation in fALS- like murine motor neuron-neuroblastoma (NSC-34) cell lines. By inhibiting nitric oxide synthesis the amount of insoluble proteins, particularly aconitase, HSC70, cyclophilin A and SOD1 can be substantially reduced. Conclusion/Significance: Analysis of the insoluble fractions from cellular/mouse models and human tissues revealed novel aggregation-prone proteins and suggests that nitrative stress contribute to protein aggregate formation in ALS.	[Estevez, Alvaro G.] Cornell Univ, Coll Med, Burke Med Res Inst, White Plains, NY 10605 USA; [Basso, Manuela; Samengo, Giuseppina; Nardo, Giovanni; Massignan, Tania; Bonetto, Valentina] Dulbecco Telethon Inst, Milan, Italy; [Basso, Manuela; Samengo, Giuseppina; Nardo, Giovanni; Massignan, Tania; D'Alessandro, Giuseppina; Tartari, Silvia; Cantoni, Lavinia; Salmona, Mario; Bonetto, Valentina] Mario Negri Inst Pharmacol Res, Dept Mol Biochem & Pharmacol, I-20157 Milan, Italy; [Marino, Marianna; Cheroni, Cristina; Bendotti, Caterina] Mario Negri Inst Pharmacol Res, Dept Neurosci, I-20157 Milan, Italy; [De Biasi, Silvia] Univ Milan, Dept Biomol Sci & Biotechnol, Milan, Italy; [Giordana, Maria Teresa] Univ Turin, Dept Neurosci, Turin, Italy; [Strong, Michael J.] Univ Western Ontario, Robarts Res Inst, London, ON, Canada; [Strong, Michael J.] Univ Western Ontario, Dept Clin Neurol Sci, London, ON, Canada	Cornell University; Fondazione Telethon; Dulbecco Telethon Institute (DTI); Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Milan; University of Turin; Western University (University of Western Ontario); Western University (University of Western Ontario)	Basso, M (corresponding author), Cornell Univ, Coll Med, Burke Med Res Inst, White Plains, NY 10605 USA.	valentina.bonetto@marionegri.it	Nardo, Giovanni/C-1406-2014; D'ALESSANDRO, GIUSEPPINA/L-6726-2019; D'Alessandro, Giuseppina/K-7825-2016; Cheroni, Cristina/AAO-2316-2020; Bendotti, Caterina/AAB-2273-2020; salmona, mario/AAA-7116-2020; Basso, Manuela/AAA-9147-2020; salmona, mario/ABI-4066-2020; Bonetto, Valentina/ABB-6383-2020; Bonetto, Valentina/I-4694-2018; Strong, Michael/AAU-5699-2020; Strong, Michael J/H-9689-2012	Nardo, Giovanni/0000-0002-1803-1484; D'ALESSANDRO, GIUSEPPINA/0000-0001-7220-6065; D'Alessandro, Giuseppina/0000-0001-7220-6065; Bendotti, Caterina/0000-0003-1055-1271; salmona, mario/0000-0002-9098-9873; Basso, Manuela/0000-0002-9278-8960; Bonetto, Valentina/0000-0003-0456-2054; Bonetto, Valentina/0000-0003-0456-2054; Strong, Michael/0000-0003-1988-6262; Cheroni, Cristina/0000-0002-0832-2333; massignan, tania/0000-0002-6176-2696	Telethon Foundation; Cariplo Foundation; Compagnia San Paolo Foundation; MIUR [RBIN04J58W]	Telethon Foundation(Fondazione Telethon); Cariplo Foundation(Fondazione Cariplo); Compagnia San Paolo Foundation(Compagnia di San Paolo); MIUR(Ministry of Education, Universities and Research (MIUR))	This work was supported by grants from the Telethon Foundation (www.telethon.it) (to V.B., C.B. and S.D.B), the Cariplo Foundation (http://www.fondazionecariplo.it) (to V.B., M.S. and C.B.), Compagnia San Paolo Foundation (http://www.compagnia.torino.it) (to V.B.) and MIUR (FIRB Protocol RBIN04J58W)(to L.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babetto E, 2005, MOL BRAIN RES, V140, P63, DOI 10.1016/j.molbrainres.2005.07.010; Basso M, 2006, J BIOL CHEM, V281, P33325, DOI 10.1074/jbc.M603489200; BECKMAN JS, 1993, NATURE, V364, P584, DOI 10.1038/364584a0; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bendotti C, 2004, J NEUROPATH EXP NEUR, V63, P113, DOI 10.1093/jnen/63.2.113; Bendotti C, 2001, J NEUROL SCI, V191, P25, DOI 10.1016/S0022-510X(01)00627-X; Biasini E, 2006, PROTEOMICS, V6, P2823, DOI 10.1002/pmic.200500620; Bruening W, 1999, J NEUROCHEM, V72, P693, DOI 10.1046/j.1471-4159.1999.0720693.x; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; Bulteau AL, 2003, BIOCHEMISTRY-US, V42, P14846, DOI 10.1021/bi0353979; Casoni F, 2005, J BIOL CHEM, V280, P16295, DOI 10.1074/jbc.M413111200; Cheroni C, 2005, NEUROBIOL DIS, V18, P509, DOI 10.1016/j.nbd.2004.12.007; Chi L, 2007, NEUROSCIENCE, V144, P991, DOI 10.1016/j.neuroscience.2006.09.064; Crow JP, 1997, J NEUROCHEM, V69, P1945; Deng HX, 2006, P NATL ACAD SCI USA, V103, P7142, DOI 10.1073/pnas.0602046103; Durham HD, 1997, J NEUROPATH EXP NEUR, V56, P523, DOI 10.1097/00005072-199705000-00008; Estevez AG, 1998, J NEUROSCI, V18, P923; Estevez AG, 1999, SCIENCE, V286, P2498, DOI 10.1126/science.286.5449.2498; Facchinetti F, 1999, NEUROSCIENCE, V90, P1483, DOI 10.1016/S0306-4522(98)00492-8; Fujita K, 1998, NEUROCHEM RES, V23, P169, DOI 10.1023/A:1022476724381; Fujiwara N, 2007, J BIOL CHEM, V282, P35933, DOI 10.1074/jbc.M702941200; Furukawa Y, 2006, P NATL ACAD SCI USA, V103, P7148, DOI 10.1073/pnas.0602048103; GARDNER PR, 1994, P NATL ACAD SCI USA, V91, P12248, DOI 10.1073/pnas.91.25.12248; Ghezzi P, 2006, PROTEOMICS, V6, P817, DOI 10.1002/pmic.200500177; Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985; Goldner FM, 1996, J COMP NEUROL, V372, P283; Grune T, 1997, FASEB J, V11, P526, DOI 10.1096/fasebj.11.7.9212076; Harraz MM, 2008, J CLIN INVEST, V118, P659, DOI 10.1172/JCI34060; Hodara R, 2004, J BIOL CHEM, V279, P47746, DOI 10.1074/jbc.M408906200; Horiguchi T, 2003, AM J PATHOL, V163, P1021, DOI 10.1016/S0002-9440(10)63462-1; Hyun DH, 2003, J NEUROCHEM, V86, P363, DOI 10.1046/j.1471-4159.2003.01841.x; Ikeda K, 1998, J NEUROL SCI, V160, P9, DOI 10.1016/S0022-510X(98)00224-X; Johnston JA, 2000, P NATL ACAD SCI USA, V97, P12571, DOI 10.1073/pnas.220417997; Karch CM, 2008, J BIOL CHEM, V283, P13528, DOI 10.1074/jbc.M800564200; Kawamoto Y, 2004, ACTA NEUROPATHOL, V108, P531, DOI 10.1007/s00401-004-0923-2; Kikuchi H, 2006, P NATL ACAD SCI USA, V103, P6025, DOI 10.1073/pnas.0509227103; Ligon LA, 2005, NEUROREPORT, V16, P533, DOI 10.1097/00001756-200504250-00002; Liu J, 2005, J NEUROCHEM, V93, P875, DOI 10.1111/j.1471-4159.2005.03054.x; Manzerra P, 1997, J CELL PHYSIOL, V170, P130, DOI 10.1002/(SICI)1097-4652(199702)170:2<130::AID-JCP4>3.0.CO;2-P; Martin LJ, 2007, J COMP NEUROL, V500, P20, DOI 10.1002/cne.21160; Mattiazzi M, 2002, J BIOL CHEM, V277, P29626, DOI 10.1074/jbc.M203065200; MURAYAMA S, 1989, ACTA NEUROPATHOL, V78, P143, DOI 10.1007/BF00688202; Nardo G, 2009, ANTIOXID REDOX SIGN, V11, P1559, DOI [10.1089/ars.2009.2548, 10.1089/ARS.2009.2548]; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; PAPPIN DJC, 1993, CURR BIOL, V3, P327, DOI 10.1016/0960-9822(93)90195-T; Pasinelli P, 2004, NEURON, V43, P19, DOI 10.1016/j.neuron.2004.06.021; Robertson J, 2007, NEUROSCI LETT, V420, P128, DOI 10.1016/j.neulet.2007.03.066; Ross CA, 2005, NAT REV MOL CELL BIO, V6, P891, DOI 10.1038/nrm1742; Rotig A, 1997, NAT GENET, V17, P215, DOI 10.1038/ng1097-215; Salazar M, 2006, J BIOL CHEM, V281, P14841, DOI 10.1074/jbc.M513737200; Shaw BF, 2008, J BIOL CHEM, V283, P8340, DOI 10.1074/jbc.M707751200; Shibata N, 1998, ACTA NEUROPATHOL, V95, P136, DOI 10.1007/s004010050777; Shinder GA, 2001, J BIOL CHEM, V276, P12791, DOI 10.1074/jbc.M010759200; Stieber A, 2000, J NEUROL SCI, V177, P114, DOI 10.1016/S0022-510X(00)00351-8; Strong MJ, 2005, J NEUROPATH EXP NEUR, V64, P649, DOI 10.1097/01.jnen.0000173889.71434.ea; Strong MJ, 1998, BIOCHEM BIOPH RES CO, V248, P157, DOI 10.1006/bbrc.1998.8930; Tartari S, 2009, FEBS J, V276, P2861, DOI 10.1111/j.1742-4658.2009.07010.x; Tortarolo M, 2003, MOL CELL NEUROSCI, V23, P180, DOI 10.1016/S1044-7431(03)00022-8; Tummala H, 2005, J BIOL CHEM, V280, P17725, DOI 10.1074/jbc.M501705200; Upton-Rice MN, 1999, ANN NEUROL, V45, P413, DOI 10.1002/1531-8249(199903)45:3<413::AID-ANA24>3.0.CO;2-5; Vijayvergiya C, 2005, J NEUROSCI, V25, P2463, DOI 10.1523/JNEUROSCI.4385-04.2005; Wang Q, 2005, FASEB J, V19, P869, DOI 10.1096/fj.04-3210fje; Watanabe M, 2001, NEUROBIOL DIS, V8, P933, DOI 10.1006/nbdi.2001.0443; Wood JD, 2003, NEUROPATH APPL NEURO, V29, P529, DOI 10.1046/j.0305-1846.2003.00518.x; Yamin G, 2003, FEBS LETT, V542, P147, DOI 10.1016/S0014-5793(03)00367-3; Yan LJ, 1997, P NATL ACAD SCI USA, V94, P11168, DOI 10.1073/pnas.94.21.11168; Ye YZ, 2007, J BIOL CHEM, V282, P6324, DOI 10.1074/jbc.M610800200; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218	68	85	89	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2009	4	12							e8130	10.1371/journal.pone.0008130	http://dx.doi.org/10.1371/journal.pone.0008130			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MU	19956584	Green Published, gold			2022-12-25	WOS:000272828800022
J	Kfutwah, A; Mary, JY; Lemen, B; Leke, R; Rousset, D; Barre-Sinoussi, F; Nerrienet, E; Menu, E; Ayouba, A				Kfutwah, Anfumbom; Mary, Jean Yves; Lemen, Brigitte; Leke, Robert; Rousset, Dominique; Barre-Sinoussi, Francoise; Nerrienet, Eric; Menu, Elisabeth; Ayouba, Ahidjo		ANRS 1267 Study Team	Plasmodium falciparum Infection Significantly Impairs Placental Cytokine Profile in HIV Infected Cameroonian Women	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; TO-CHILD TRANSMISSION; NECROSIS-FACTOR-ALPHA; CHONDROITIN SULFATE; PREGNANT-WOMEN; TH2 CYTOKINES; BIRTH-WEIGHT; EXPRESSION; MALARIA; MOTHER	Background: Placental cytokines play crucial roles in the establishment and maintenance of pregnancy as well as protecting the foetus from infections. Previous studies have suggested the implication of infections such as P. falciparum and HIV in the stimulation of placental cytokines. This study assessed the impact of P. falciparum on placental cytokine profiles between HIV-1 positive and negative women. Materials and Methods: P. falciparum infection was checked in peripheral and placental blood of HIV-1 negative and positive women by the thick blood smear test. Cytokines proteins and messenger RNAs were quantified by ELISA and real time PCR, respectively. Non-parametric tests were used for statistical analyses. Results: Placental and peripheral P. falciparum infections were not significantly associated with HIV-1 infection (OR: 1.4; 95% confidence interval (95% CI): 0.5-4.2; p = 0.50 and OR: 0.6; 95% CI: 0.3-1.4; p = 0.26, respectively). Conversely, placental P. falciparum parasitemia was significantly higher in the HIV-1 positive group (p = 0.04). We observed an increase of TNF-alpha mRNA median levels (p = 0.02) and a trend towards a decrease of IL-10 mRNA (p = 0.07) in placenta from HIV-1 positive women compared to the HIV negative ones leading to a median TNF-alpha/IL-10 mRNA ratio significantly higher among HIV-1 positive than among HIV-1 negative placenta (p = 0.004; 1.5 and 0.8, respectively). Significant decrease in median secreted cytokine levels were observed in placenta from HIV-1 positive women as compared to the HIV negative however these results are somewhat indicative since it appears that differences in cytokine levels (protein or mRNA) between HIV-1 positive and negative women depend greatly on P. falciparum infection. Within the HIV-1 positive group, TNF-alpha was the only cytokine significantly associated with clinical parameters linked with HIV-1 MTCT such as premature rupture of membranes, CD4 T-cell number, plasma viral load and delay of NVP intake before delivery. Conclusions: These results show that P. falciparum infection profoundly modifies the placenta cytokine environment and acts as a confounding factor, masking the impact of HIV-1 in co-infected women. This interplay between the two infections might have implications in the in utero MTCT of HIV-1 in areas where HIV-1 and P. falciparum co-circulate.	[Kfutwah, Anfumbom; Rousset, Dominique; Nerrienet, Eric; Ayouba, Ahidjo] Ctr Pasteur Cameroun, Virol Lab, Yaounde, Cameroon; [Mary, Jean Yves] Univ Paris 07, INSERM, Hop St Louis, U717, Paris, France; [Lemen, Brigitte] CASS, Yaounde, Cameroon; [Leke, Robert] Maternite Principale Hop Cent, Yaounde, Cameroon; [Barre-Sinoussi, Francoise; Menu, Elisabeth; Ayouba, Ahidjo] Inst Pasteur, Unit Regulat Infect Retrovirales, Paris, France	Centre Pasteur du Cameroun; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Kfutwah, A (corresponding author), Ctr Pasteur Cameroun, Virol Lab, Yaounde, Cameroon.	ahidjo.ayouba@mpl.ird.fr	Ayouba, Ahidjo/G-8775-2017; Rousset, Dominique/S-5400-2019; Barre-Sinoussi, Françoise/G-8355-2011; MENU, Elisabeth/B-2886-2010	Ayouba, Ahidjo/0000-0002-5081-1632; Rousset, Dominique/0000-0002-1473-3147; MENU, Elisabeth/0000-0001-8844-9328	ANRS [1267]; Centre Pasteur du Cameroun, Institut Pasteur Paris; International Network of Institut Pasteur, INSERM; French Ministry of Foreign affairs (MAE)	ANRS(ANRSFrench National Research Agency (ANR)); Centre Pasteur du Cameroun, Institut Pasteur Paris; International Network of Institut Pasteur, INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)); French Ministry of Foreign affairs (MAE)	ANRS (grant #1267), Centre Pasteur du Cameroun, Institut Pasteur Paris, the International Network of Institut Pasteur, INSERM. AK received a grant from the French Ministry of Foreign affairs (MAE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayouba A, 2003, JAIDS-J ACQ IMM DEF, V34, P274, DOI 10.1097/00126334-200311010-00003; Ayouba A, 2003, AM J TROP MED HYG, V69, P447, DOI 10.4269/ajtmh.2003.69.447; Barin F, 2006, J INFECT DIS, V193, P1504, DOI 10.1086/503778; Behbahani H, 2000, AM J PATHOL, V157, P1811, DOI 10.1016/S0002-9440(10)64819-5; Biswas P, 2003, BLOOD, V101, P4452, DOI 10.1182/blood-2002-10-3056; Bodkin C, 2006, J CLIN NURS, V15, P735, DOI 10.1111/j.1365-2702.2006.01438.x; BOURINBAIAR AS, 1992, FEMS MICROBIOL LETT, V96, P27, DOI 10.1111/j.1574-6968.1992.tb05388.x; Chaisavaneeyakorn S, 2003, CLIN DIAGN LAB IMMUN, V10, P631, DOI 10.1128/CDLI.10.4.631-636.2003; Chaouat G, 1999, AM J REPROD IMMUNOL, V42, P1; Coulomb-L'Hermine A, 2000, AIDS RES HUM RETROV, V16, P1097, DOI 10.1089/08892220050075372; Duffy PE, 2003, INFECT IMMUN, V71, P6620, DOI 10.1128/IAI.71.11.6620-6623.2003; Faye A, 2007, CLIN EXP IMMUNOL, V149, P430, DOI 10.1111/j.1365-2249.2007.03411.x; Fievet N, 2001, J INFECT DIS, V183, P1530, DOI 10.1086/320201; Foli A, 1997, AIDS RES HUM RETROV, V13, P829, DOI 10.1089/aid.1997.13.829; Fox H., 1997, PATHOLOGY PLACENTA; Fried M, 1998, J IMMUNOL, V160, P2523; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; GAVIN L, 2006, J ADOLESC HLTH, V39; ISRAEL N, 1989, J IMMUNOL, V143, P3956; Kedzierska Katherine, 2001, Antiviral Chemistry and Chemotherapy, V12, P133; Kfutwah AKW, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-36; Lacroix MC, 2005, ENDOCRINOLOGY, V146, P2434, DOI 10.1210/en.2004-1550; Lane BR, 1999, J IMMUNOL, V163, P3653; Lee BN, 1997, J VIROL, V71, P3628, DOI 10.1128/JVI.71.5.3628-3635.1997; McGowan I, 2004, JAIDS-J ACQ IMM DEF, V37, P1228, DOI 10.1097/01.qai.0000131846.12453.29; Menu E, 1997, Early Pregnancy, V3, P245; Moore JM, 2004, INFECT IMMUN, V72, P7022, DOI 10.1128/IAI.72.12.7022-7029.2004; Moormann AM, 1999, J INFECT DIS, V180, P1987, DOI 10.1086/315135; Moussa M, 1999, AM J REPROD IMMUNOL, V41, P312; Ng SC, 2002, AM J REPROD IMMUNOL, V48, P77, DOI 10.1034/j.1600-0897.2002.01105.x; O'Brien ME, 2005, JAIDS-J ACQ IMM DEF, V40, P219, DOI 10.1097/01.qai.0000166374.16222.a2; O'Neil-Dunne I, 2001, INFECT IMMUN, V69, P7487, DOI 10.1128/IAI.69.12.7487-7492.2001; Patterson BK, 2001, J CLIN INVEST, V107, P287, DOI 10.1172/JCI11481; Pedroza-Martins L, 2006, AIDS, V20, P939, DOI 10.1097/01.aids.0000218563.12897.ba; Pornprasert S, 2006, PLACENTA, V27, P989, DOI 10.1016/j.placenta.2005.10.010; Pornprasert S, 2009, CURR HIV RES, V7, P211, DOI 10.2174/157016209787581472; Rogerson SJ, 2003, INFECT IMMUN, V71, P267, DOI 10.1128/IAI.71.1.267-270.2003; Saito S, 2000, J REPROD IMMUNOL, V47, P87, DOI 10.1016/S0165-0378(00)00060-7; Salanti A, 2004, J EXP MED, V200, P1197, DOI 10.1084/jem.20041579; Salmen S, 2004, CLIN EXP IMMUNOL, V137, P166, DOI 10.1111/j.1365-2249.2004.02503.x; Shearer WT, 1997, ACTA PAEDIATR, V86, P33; Skinner-Adams TS, 2008, TRENDS PARASITOL, V24, P264, DOI 10.1016/j.pt.2008.03.008; Soumelis V, 2002, HUM IMMUNOL, V63, P1206, DOI 10.1016/S0198-8859(02)00760-7; Staalsoe T, 2004, LANCET, V363, P283, DOI 10.1016/S0140-6736(03)15386-X; STORY CM, 1994, J EXP MED, V180, P2377, DOI 10.1084/jem.180.6.2377; Suguitan AL, 2003, AM J TROP MED HYG, V69, P574, DOI 10.4269/ajtmh.2003.69.574; Suguitan AL, 2003, J INFECT DIS, V188, P1074, DOI 10.1086/378500; Tako EA, 2005, AM J TROP MED HYG, V72, P236, DOI 10.4269/ajtmh.2005.72.236; Taupin JL, 1997, CYTOKINE, V9, P112, DOI 10.1006/cyto.1996.0144; Tkachuk AN, 2001, J INFECT DIS, V183, P967, DOI 10.1086/319248; Velez DR, 2008, HUM REPROD, V23, P1902, DOI 10.1093/humrep/den170; VYAKARNAM A, 1990, AIDS, V4, P21, DOI 10.1097/00002030-199001000-00003; WEISSMAN D, 1994, AIDS RES HUM RETROV, V10, P1199, DOI 10.1089/aid.1994.10.1199; Zachar V, 2002, AIDS RES HUM RETROV, V18, P839, DOI 10.1089/08892220260190317	54	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2009	4	12							e8114	10.1371/journal.pone.0008114	http://dx.doi.org/10.1371/journal.pone.0008114			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MU	19956547	Green Submitted, Green Published, gold			2022-12-25	WOS:000272828800012
J	He, X; Chen, CC; Hong, F; Fang, F; Sinha, S; Ng, HH; Zhong, S				He, Xin; Chen, Chieh-Chun; Hong, Feng; Fang, Fang; Sinha, Saurabh; Ng, Huck-Hui; Zhong, Sheng			A Biophysical Model for Analysis of Transcription Factor Interaction and Binding Site Arrangement from Genome-Wide Binding Data	PLOS ONE			English	Article							CIS-REGULATORY MODULES; DNA-BINDING; COOPERATIVE BINDING; GENE-EXPRESSION; DROSOPHILA; EVOLUTION; NETWORK; MOTIFS; PLURIPOTENCY; SEQUENCE	Background: How transcription factors (TFs) interact with cis-regulatory sequences and interact with each other is a fundamental, but not well understood, aspect of gene regulation. Methodology/Principal Findings: We present a computational method to address this question, relying on the established biophysical principles. This method, STAP (sequence to affinity prediction), takes into account all combinations and configurations of strong and weak binding sites to analyze large scale transcription factor (TF)-DNA binding data to discover cooperative interactions among TFs, infer sequence rules of interaction and predict TF target genes in new conditions with no TF-DNA binding data. The distinctions between STAP and other statistical approaches for analyzing cis-regulatory sequences include the utility of physical principles and the treatment of the DNA binding data as quantitative representation of binding strengths. Applying this method to the ChIP-seq data of 12 TFs in mouse embryonic stem (ES) cells, we found that the strength of TF-DNA binding could be significantly modulated by cooperative interactions among TFs with adjacent binding sites. However, further analysis on five putatively interacting TF pairs suggests that such interactions may be relatively insensitive to the distance and orientation of binding sites. Testing a set of putative Nanog motifs, STAP showed that a novel Nanog motif could better explain the ChIP-seq data than previously published ones. We then experimentally tested and verified the new Nanog motif. A series of comparisons showed that STAP has more predictive power than several state-of-the-art methods for cis-regulatory sequence analysis. We took advantage of this power to study the evolution of TF-target relationship in Drosophila. By learning the TF-DNA interaction models from the ChIP-chip data of D. melanogaster (Mel) and applying them to the genome of D. pseudoobscura (Pse), we found that only about half of the sequences strongly bound by TFs in Mel have high binding affinities in Pse. We show that prediction of functional TF targets from ChIP-chip data can be improved by using the conservation of STAP predicted affinities as an additional filter. Conclusions/Significance: STAP is an effective method to analyze binding site arrangements, TF cooperativity, and TF target genes from genome-wide TF-DNA binding data.	[He, Xin; Sinha, Saurabh; Zhong, Sheng] Univ Illinois, Dept Comp Sci, Champaign, IL 61820 USA; [Chen, Chieh-Chun; Zhong, Sheng] Univ Illinois, Dept Bioengn, Champaign, IL 61820 USA; [Hong, Feng; Zhong, Sheng] Univ Illinois, Dept Stat, Champaign, IL 61820 USA; [Fang, Fang; Ng, Huck-Hui] Genome Inst Singapore, Gene Regulat Lab, Singapore, Singapore	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS)	He, X (corresponding author), Univ Illinois, Dept Comp Sci, Champaign, IL 61820 USA.	szhong@illinois.edu	Ng, Huck Hui/A-1135-2009; Fang, Fang/G-7679-2016	NG, HUCK HUI/0000-0001-6352-8417; Fang, Fang/0000-0002-5272-302X	National Science Foundation [DBI08-45823]; NSF [DBI-0746303]	National Science Foundation(National Science Foundation (NSF)); NSF(National Science Foundation (NSF))	Funding was provided by the National Science Foundation (http://www.nsf. gov/) DBI08-45823 (to SZ) and by an NSF Career Grant DBI-0746303 (to SS). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andolfatto P, 2005, NATURE, V437, P1149, DOI 10.1038/nature04107; Arnosti DN, 2005, J CELL BIOCHEM, V94, P890, DOI 10.1002/jcb.20352; BAILEY TL, 1994, P 2 INT C INT SYST M, P28; Barski A, 2009, J CELL BIOCHEM, V107, P11, DOI 10.1002/jcb.22077; Beer MA, 2004, CELL, V117, P185, DOI 10.1016/S0092-8674(04)00304-6; BERG OG, 1988, TRENDS BIOCHEM SCI, V13, P207, DOI 10.1016/0968-0004(88)90085-0; Bergman CM, 2005, BIOINFORMATICS, V21, P1747, DOI 10.1093/bioinformatics/bti173; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Blackwood EM, 1998, SCIENCE, V281, P60, DOI 10.1126/science.281.5373.60; Borneman AR, 2007, SCIENCE, V317, P815, DOI 10.1126/science.1140748; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brown CD, 2007, SCIENCE, V317, P1557, DOI 10.1126/science.1145893; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Buchler NE, 2003, P NATL ACAD SCI USA, V100, P5136, DOI 10.1073/pnas.0930314100; Bulyk ML, 2006, CURR OPIN BIOTECH, V17, P422, DOI 10.1016/j.copbio.2006.06.015; CHEN X, 2008, COLD SPRING HARB S Q; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Crocker J, 2008, PLOS BIOL, V6, P2576, DOI 10.1371/journal.pbio.0060263; Datta D, 2008, BIOINFORMATICS, V24, P545, DOI 10.1093/bioinformatics/btm523; Davidson EH, 2006, REG GEN GEN REG; Dermitzakis ET, 2003, MOL BIOL EVOL, V20, P703, DOI 10.1093/molbev/msg077; Down TA, 2005, NUCLEIC ACIDS RES, V33, P1445, DOI 10.1093/nar/gki282; Foat BC, 2006, BIOINFORMATICS, V22, pE141, DOI 10.1093/bioinformatics/btl223; Frith MC, 2004, NUCLEIC ACIDS RES, V32, P1372, DOI 10.1093/nar/gkh299; Frith MC, 2003, NUCLEIC ACIDS RES, V31, P3666, DOI 10.1093/nar/gkg540; Gertz J, 2009, NATURE, V457, P215, DOI 10.1038/nature07521; GINIGER E, 1988, P NATL ACAD SCI USA, V85, P382, DOI 10.1073/pnas.85.2.382; Halfon MS, 2008, NUCLEIC ACIDS RES, V36, pD594, DOI 10.1093/nar/gkm876; Hermsen R, 2006, PLOS COMPUT BIOL, V2, P1552, DOI 10.1371/journal.pcbi.0020164; HOCHSCHILD A, 1986, CELL, V44, P681, DOI 10.1016/0092-8674(86)90833-0; Howard ML, 2004, DEV BIOL, V271, P109, DOI 10.1016/j.ydbio.2004.03.031; Huang W, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r225; Janssens H, 2006, NAT GENET, V38, P1159, DOI 10.1038/ng1886; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Jin VX, 2006, GENOME RES, V16, P1585, DOI 10.1101/gr.5520206; Kinoshita K, 2007, BIOCHEM BIOPH RES CO, V353, P686, DOI 10.1016/j.bbrc.2006.12.071; Kuhn RM, 2009, NUCLEIC ACIDS RES, V37, pD755, DOI 10.1093/nar/gkn875; Li XY, 2008, PLOS BIOL, V6, P365, DOI 10.1371/journal.pbio.0060027; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Ludwig MZ, 1998, DEVELOPMENT, V125, P949; Ludwig MZ, 2000, NATURE, V403, P564, DOI 10.1038/35000615; Makeev VJ, 2003, NUCLEIC ACIDS RES, V31, P6016, DOI 10.1093/nar/gkg799; Matsumura I, 2003, CELL CYCLE, V2, P333, DOI 10.4161/cc.2.4.428; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Moses AM, 2006, PLOS COMPUT BIOL, V2, P1219, DOI 10.1371/journal.pcbi.0020130; Noyes MB, 2008, NUCLEIC ACIDS RES, V36, P2547, DOI 10.1093/nar/gkn048; Press W. H., 1992, ART SCI COMPUTING; Roider HG, 2007, BIOINFORMATICS, V23, P134, DOI 10.1093/bioinformatics/btl565; Saiz L, 2005, P NATL ACAD SCI USA, V102, P17642, DOI 10.1073/pnas.0505693102; Segal E, 2008, NATURE, V451, P535, DOI 10.1038/nature06496; Sene KH, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-85; SHEA MA, 1985, J MOL BIOL, V181, P211, DOI 10.1016/0022-2836(85)90086-5; Shirokawa JM, 1997, MOL CELL BIOL, V17, P3345, DOI 10.1128/MCB.17.6.3345; Sinha S, 2006, BIOINFORMATICS, V22, pE454, DOI 10.1093/bioinformatics/btl227; Smith AD, 2005, P NATL ACAD SCI USA, V102, P1560, DOI 10.1073/pnas.0406123102; Smith DR, 2005, WORD IMAGE, V21, P1, DOI 10.1080/0266628052000307175; Stormo GD, 2000, BIOINFORMATICS, V16, P16, DOI 10.1093/bioinformatics/16.1.16; Struhl K, 2001, SCIENCE, V293, P1054, DOI 10.1126/science.1064050; Tanay A, 2006, GENOME RES, V16, P962, DOI 10.1101/gr.5113606; Teif VB, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm268; Thompson WA, 2007, NUCLEIC ACIDS RES, V35, pW232, DOI 10.1093/nar/gkm265; Valouev A, 2008, NAT METHODS, V5, P829, DOI 10.1038/NMETH.1246; van den Berg DLC, 2008, MOL CELL BIOL, V28, P5986, DOI 10.1128/MCB.00301-08; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Zhang ZDD, 2007, GENOME RES, V17, P787, DOI 10.1101/gr.5573107; Zhou Q, 2008, NUCLEIC ACIDS RES, V36, P4137, DOI 10.1093/nar/gkn361; Zhou Q, 2007, P NATL ACAD SCI USA, V104, P16438, DOI 10.1073/pnas.0701014104; Zinzen RP, 2007, PLOS COMPUT BIOL, V3, P826, DOI 10.1371/journal.pcbi.0030084; Zinzen RP, 2006, CURR BIOL, V16, P1358, DOI 10.1016/j.cub.2006.05.044	70	42	42	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2009	4	12							e8155	10.1371/journal.pone.0008155	http://dx.doi.org/10.1371/journal.pone.0008155			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MT	19956545	gold, Green Published, Green Submitted			2022-12-25	WOS:000272828700023
J	Yesilaltay, A; Daniels, K; Pal, R; Krieger, M; Kocher, O				Yesilaltay, Ayce; Daniels, Kathleen; Pal, Rinku; Krieger, Monty; Kocher, Olivier			Loss of PDZK1 Causes Coronary Artery Occlusion and Myocardial Infarction in Paigen Diet-Fed Apolipoprotein E Deficient Mice	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; RECEPTOR CLASS-B; SCAVENGER RECEPTOR; SR-BI; HEART-DISEASE; TARGETED DISRUPTION; CARDIAC DYSFUNCTION; HEPATIC EXPRESSION; LIPID-METABOLISM; PREMATURE DEATH	Background: PDZK1 is a four PDZ-domain containing protein that binds to the carboxy terminus of the HDL receptor, scavenger receptor class B type I (SR-BI), and regulates its expression, localization and function in a tissue-specific manner. PDZK1 knockout (KO) mice are characterized by a marked reduction of SR-BI protein expression (similar to 95%) in the liver (lesser or no reduction in other organs) with a concomitant 1.7 fold increase in plasma cholesterol. PDZK1 has been shown to be atheroprotective using the high fat/high cholesterol ('Western') diet-fed murine apolipoprotein E ( apoE) KO model of atherosclerosis, presumably because of its role in promoting reverse cholesterol transport via SR-BI. Principal Findings: Here, we have examined the effects of PDZK1 deficiency in apoE KO mice fed with the atherogenic 'Paigen' diet for three months. Relative to apoE KO, PDZK1/apoE double KO (dKO) mice showed increased plasma lipids (33% increase in total cholesterol; 49% increase in unesterified cholesterol; and 36% increase in phospholipids) and a 26% increase in aortic root lesions. Compared to apoE KO, dKO mice exhibited substantial occlusive coronary artery disease: 375% increase in severe occlusions. Myocardial infarctions, not observed in apoE KO mice (although occasional minimal fibrosis was noted), were seen in 7 of 8 dKO mice, resulting in 12 times greater area of fibrosis in dKO cardiac muscle. Conclusions: These results show that Paigen-diet fed PDZK1/apoE dKO mice represent a new animal model useful for studying coronary heart disease and suggest that PDZK1 may represent a valuable target for therapeutic intervention.	[Yesilaltay, Ayce; Krieger, Monty] MIT, Dept Biol, Cambridge, MA 02139 USA; [Daniels, Kathleen; Pal, Rinku; Kocher, Olivier] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; [Daniels, Kathleen; Pal, Rinku; Kocher, Olivier] Beth Israel Deaconess Med Ctr, Vasc Biol Res Ctr, Boston, MA 02215 USA; [Daniels, Kathleen; Pal, Rinku; Kocher, Olivier] Harvard Univ, Sch Med, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Yesilaltay, A (corresponding author), MIT, Dept Biol, Cambridge, MA 02139 USA.	okocher@bidmc.harvard.edu			National Institutes of Health [HL-52212, HL66105, HL077780]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077780, P01HL066105, R01HL052212] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by grants from the National Institutes of Health HL-52212 and HL66105 (MK), HL077780 (OK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; ACTON SL, 1994, J BIOL CHEM, V269, P21003; Arai T, 1999, J BIOL CHEM, V274, P2366, DOI 10.1074/jbc.274.4.2366; Assanasen C, 2005, J CLIN INVEST, V115, P969, DOI 10.1172/JCI23858; BARR DP, 1951, AM J MED, V11, P480, DOI 10.1016/0002-9343(51)90183-0; Braun A, 2003, P NATL ACAD SCI USA, V100, P7283, DOI 10.1073/pnas.1237725100; Braun A, 2002, CIRC RES, V90, P270, DOI 10.1161/hh0302.104462; Braun A, 2008, ATHEROSCLEROSIS, V198, P77, DOI 10.1016/j.atherosclerosis.2007.10.012; Caligiuri G, 1999, P NATL ACAD SCI USA, V96, P6920, DOI 10.1073/pnas.96.12.6920; Chase A, 2007, CRIT CARE MED, V35, P2344, DOI 10.1097/01.CCM.0000282085.63409.FB; Covey SD, 2003, ARTERIOSCL THROM VAS, V23, P1589, DOI 10.1161/01.ATV.0000083343.19940.A0; GLOMSET JA, 1968, J LIPID RES, V9, P155; Herrera VLM, 1999, NAT MED, V5, P1383, DOI 10.1038/70956; Huszar D, 2000, ARTERIOSCL THROM VAS, V20, P1068, DOI 10.1161/01.ATV.20.4.1068; Ikemoto M, 2000, P NATL ACAD SCI USA, V97, P6538, DOI 10.1073/pnas.100114397; KANNEL WB, 1961, ANN INTERN MED, V55, P33, DOI 10.7326/0003-4819-55-1-33; KARACKATTU S, 2006, THESIS MIT; KARACKATTU S, 2006, ARTERIOSCLER THROMB, P548; Kocher O, 1998, LAB INVEST, V78, P117; Kocher O, 2003, J BIOL CHEM, V278, P52820, DOI 10.1074/jbc.M310482200; Kocher O, 2003, MOL CELL BIOL, V23, P1175, DOI 10.1128/MCB.23.4.1175-1180.2003; Kocher O, 2008, BBA-MOL BASIS DIS, V1782, P310, DOI 10.1016/j.bbadis.2008.02.004; Kozarsky KF, 2000, ARTERIOSCL THROM VAS, V20, P721, DOI 10.1161/01.ATV.20.3.721; Krieger M, 1999, ANNU REV BIOCHEM, V68, P523, DOI 10.1146/annurev.biochem.68.1.523; Kumar V., 2005, ROBBINS COTRAN PATHO, P516; Landschulz KT, 1996, J CLIN INVEST, V98, P984, DOI 10.1172/JCI118883; MILLER GJ, 1975, LANCET, V1, P16; Mineo C, 2006, CIRC RES, V98, P1352, DOI 10.1161/01.RES.0000225982.01988.93; NAKASHIMA Y, 1994, ARTERIOSCLER THROMB, V14, P133, DOI 10.1161/01.ATV.14.1.133; PAIGEN B, 1985, ATHEROSCLEROSIS, V57, P65, DOI 10.1016/0021-9150(85)90138-8; PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G; Reardon CA, 2001, CURR OPIN LIPIDOL, V12, P167, DOI 10.1097/00041433-200104000-00010; Rigotti A, 2003, ENDOCR REV, V24, P357, DOI 10.1210/er.2001-0037; Rigotti A, 1997, P NATL ACAD SCI USA, V94, P12610, DOI 10.1073/pnas.94.23.12610; Trigatti B, 1999, P NATL ACAD SCI USA, V96, P9322, DOI 10.1073/pnas.96.16.9322; Ueda Y, 2000, J BIOL CHEM, V275, P20368, DOI 10.1074/jbc.M000730200; Van Eck M, 2003, J BIOL CHEM, V278, P23699, DOI 10.1074/jbc.M211233200; Webb NR, 1998, J BIOL CHEM, V273, P15241, DOI 10.1074/jbc.273.24.15241; Yesilaltay A, 2006, ENDOCRINOLOGY, V147, P1577, DOI 10.1210/en.2005-1286; Yesilaltay A, 2005, CURR OPIN LIPIDOL, V16, P147, DOI 10.1097/01.mol.0000162319.54795.e5; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543; ZHANG SH, 1994, J CLIN INVEST, V94, P937, DOI 10.1172/JCI117460; Zhang SW, 2005, CIRCULATION, V111, P3457, DOI 10.1161/CIRCULATIONAHA.104.523563; Zhang YZ, 2005, J CLIN INVEST, V115, P2870, DOI 10.1172/JCI25327; Zhu WF, 2008, CIRC RES, V102, P480, DOI 10.1161/CIRCRESAHA.107.159079; Zuliani G, 1999, ARTERIOSCL THROM VAS, V19, P802, DOI 10.1161/01.ATV.19.3.802	46	31	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2009	4	12							e8103	10.1371/journal.pone.0008103	http://dx.doi.org/10.1371/journal.pone.0008103			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MT	19956623	Green Published, gold, Green Submitted			2022-12-25	WOS:000272828700015
J	Kwong, JC; Li, P; Redelmeier, DA				Kwong, Jeffrey C.; Li, Ping; Redelmeier, Donald A.			Influenza Morbidity and Mortality in Elderly Patients Receiving Statins: A Cohort Study	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; POPULATION-BASED COHORT; C-REACTIVE PROTEIN; CYTOKINE PRODUCTION; RISK; THERAPY; BIAS; ATORVASTATIN; OUTCOMES; RELEASE	Background: Statins possess immunomodulatory properties and have been proposed for reducing morbidity during an influenza pandemic. We sought to evaluate the effect of statins on hospitalizations and deaths related to seasonal influenza outbreaks. Methodology/Principal Findings: We conducted a population-based cohort study over 10 influenza seasons (1996 to 2006) using linked administrative databases in Ontario, Canada. We identified all adults older than 65 years who had received an influenza vaccination prior to the start of influenza season and distinguished those also prescribed statins (23%) from those not also prescribed statins (77%). Propensity-based matching, which accounted for each individual's likelihood of receiving a statin, yielded a final cohort of 2,240,638 patients, exactly half of whom received statins. Statins were associated with small protective effects against pneumonia hospitalization (odds ratio [OR] 0.92; 95% CI 0.89-0.95), 30-day pneumonia mortality (0.84; 95% CI 0.77-0.91), and all-cause mortality (0.87; 95% CI 0.84-0.89). These protective effects attenuated substantially after multivariate adjustment and when we excluded multiple observations for each individual, declined over time, differed across propensity score quintiles and risk groups, and were unchanged during post-influenza season periods. The main limitations of this study were the observational study design, the non-specific outcomes, and the lack of information on medications while hospitalized. Conclusions/Significance: Statin use is associated with a statistically significant but minimal protective effect against influenza morbidity that can easily be attributed to residual confounding. Public health officials and clinicians should focus on other measures to reduce morbidity and mortality from the next influenza pandemic.	[Kwong, Jeffrey C.; Li, Ping; Redelmeier, Donald A.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Kwong, Jeffrey C.] Univ Toronto, Dept Family, Toronto, ON, Canada; [Kwong, Jeffrey C.] Univ Toronto, Dept Community Med, Toronto, ON, Canada; [Redelmeier, Donald A.] Univ Toronto, Dept Med & Hlth Policy, Toronto, ON, Canada; [Redelmeier, Donald A.] Univ Toronto, Dept Management, Toronto, ON, Canada; [Redelmeier, Donald A.] Univ Toronto, Dept Evaluat, Toronto, ON, Canada; [Kwong, Jeffrey C.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto	Kwong, JC (corresponding author), Inst Clin Evaluat Sci, Toronto, ON, Canada.	jeff.kwong@utoronto.ca	Li, Ping/GYV-4914-2022		Canadian Institutes of Health Research (CIHR); CIHR Fellowship Award; Ontario Ministry of Health and Long-Term Care (MOHLTC); University of Toronto Department of Family; Community Medicine Research Scholar Award; Institute for Clinical Evaluative Sciences (ICES)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR Fellowship Award(Canadian Institutes of Health Research (CIHR)); Ontario Ministry of Health and Long-Term Care (MOHLTC)(Ministry of Health and Long-Term Care, Ontario); University of Toronto Department of Family(University of Toronto); Community Medicine Research Scholar Award; Institute for Clinical Evaluative Sciences (ICES)(University of Toronto)	This study was supported by an operating grant from the Canadian Institutes of Health Research (CIHR) (www.cihr.ca). Dr. Kwong was supported by a CIHR Fellowship Award, an Ontario Ministry of Health and Long-Term Care (MOHLTC) Career Scientist Award, a University of Toronto Department of Family and Community Medicine Research Scholar Award, and the Institute for Clinical Evaluative Sciences (ICES). Dr. Redelmeier was supported by a Canadian Research Chair in Medical Decision Science. This work was made possible with the support of ICES which is funded in part by the Ontario MOHLTC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almog Y, 2004, CIRCULATION, V110, P880, DOI 10.1161/01.CIR.0000138932.17956.F1; [Anonymous], 2006, CAN IMM GUID; Ascer E, 2004, ATHEROSCLEROSIS, V177, P161, DOI 10.1016/j.atherosclerosis.2004.07.003; Bessler H, 2005, CLIN IMMUNOL, V117, P73, DOI 10.1016/j.clim.2005.06.014; Chalmers JD, 2008, AM J MED, V121, P1002, DOI 10.1016/j.amjmed.2008.06.030; Chan B., 1999, SUPPLY PHYS SERVICES; DE BN, 1998, ATHEROSCLEROSIS, V139, P147; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Dormuth CR, 2009, CIRCULATION, V119, P2051, DOI 10.1161/CIRCULATIONAHA.108.824151; Dublin S, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b2137; Fedson DS, 2008, LANCET INFECT DIS, V8, P571, DOI 10.1016/S1473-3099(08)70070-7; Hackam DG, 2006, LANCET, V367, P413, DOI 10.1016/S0140-6736(06)68041-0; Hall R, 2001, CAN J AGING, V20, P175, DOI 10.1017/S0714980800012964; Hux JE, 2002, DIABETES CARE, V25, P512, DOI 10.2337/diacare.25.3.512; Iron K, 2008, LIVING DYING ONTARIO; Jackson LA, 2006, INT J EPIDEMIOL, V35, P337, DOI 10.1093/ije/dyi274; Jialal I, 2001, CIRCULATION, V103, P1933; Jialal I, 2007, J CLIN ENDOCR METAB, V92, P3136, DOI 10.1210/jc.2007-0453; Ko DT, 2004, JAMA-J AM MED ASSOC, V291, P1864, DOI 10.1001/jama.291.15.1864; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; Kwong JC, 2007, VACCINE, V25, P1270, DOI 10.1016/j.vaccine.2006.10.004; Lee N, 2007, CLIN INFECT DIS, V45, P723, DOI 10.1086/520981; Levy Adrian R, 2003, Can J Clin Pharmacol, V10, P67; Levy AR, 1999, CAN J CARDIOL, V15, P1277; Li JJ, 2003, CORONARY ARTERY DIS, V14, P329, DOI 10.1097/01.mca.0000078062.22445.60; Liappis AP, 2001, CLIN INFECT DIS, V33, P1352, DOI 10.1086/323334; Majumdar SR, 2006, BMJ-BRIT MED J, V333, P999, DOI 10.1136/BMJ.38992.565972.7C; Mortensen EM, 2008, EUR RESPIR J, V31, P611, DOI 10.1183/09031936.00162006; Mortensen EM, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-82; Murray CJL, 2006, LANCET, V368, P2211, DOI 10.1016/S0140-6736(06)69895-4; Naylor CD, 1999, CARDIOVASCULAR HLTH; Okopien B, 2005, J CARDIOVASC PHARM, V46, P377, DOI 10.1097/01.fjc.0000175455.46245.c8; Pan American Health Organization [PAHO], 2004, 16 M VACC PREV DIS P; Peiris JSM, 2007, CLIN MICROBIOL REV, V20, P243, DOI 10.1128/CMR.00037-06; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; Rosenson RS, 1999, LANCET, V353, P983, DOI 10.1016/S0140-6736(98)05917-0; Schlienger RG, 2007, PHARMACOTHERAPY, V27, P325, DOI 10.1592/phco.27.3.325; STARFIELD B, 1991, HEALTH SERV RES, V26, P53; Stukel TA, 2007, JAMA-J AM MED ASSOC, V297, P278, DOI 10.1001/jama.297.3.278; Thomsen RW, 2008, ARCH INTERN MED, V168, P2081, DOI 10.1001/archinte.168.19.2081; Tousoulis D, 2005, EUR J HEART FAIL, V7, P1126, DOI 10.1016/j.ejheart.2005.03.007; van de Garde EMW, 2006, THORAX, V61, P957, DOI 10.1136/thx.2006.062885; *WHO, 2009, CUM NUMB CONF HUM CA	43	74	76	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2009	4	11							e8087	10.1371/journal.pone.0008087	http://dx.doi.org/10.1371/journal.pone.0008087			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MQ	19956645	gold, Green Published, Green Submitted			2022-12-25	WOS:000272828400028
J	Parast, MM; Yu, H; Ciric, A; Salata, MW; Davis, V; Milstone, DS				Parast, Mana M.; Yu, Heather; Ciric, Aleksandar; Salata, Mark W.; Davis, Vannessa; Milstone, David S.			PPAR gamma Regulates Trophoblast Proliferation and Promotes Labyrinthine Trilineage Differentiation	PLOS ONE			English	Article							STEM-CELLS; PLACENTAL MORPHOLOGY; ALPHA HETERODIMERS; INSULIN-RESISTANCE; EXPRESSION DATA; GIANT-CELLS; GENE; TRANSCRIPTION; MICE; PROTEIN	Background: Abnormal trophoblast differentiation and function is the basis of many placenta-based pregnancy disorders, including pre-eclampsia and fetal growth restriction. PPAR gamma, a ligand-activated nuclear receptor, plays essential roles in placental development; null murine embryos die at midgestation due to abnormalities in all placental layers, in particular, small labyrinth and expanded giant cell layer. Previous studies have focused mostly on the role of PPAR gamma in trophoblast invasion. Based on the previously reported role of PPAR gamma in preadipocyte differentiation, we hypothesized that PPAR gamma also plays a pivotal role in trophoblast differentiation. To test this hypothesis, we report derivation of wild-type and PPAR gamma-null trophoblast stem (TS) cells. Methodology/Principal Findings: PPAR gamma-null TS cells showed defects in both proliferation and differentiation, specifically into labyrinthine trophoblast. Detailed marker analysis and functional studies revealed reduced differentiation of all three labyrinthine lineages, and enhanced giant cell differentiation, particularly the invasive subtypes. In addition, rosiglitazone, a specific PPAR gamma agonist, reduced giant cell differentiation, while inducing Gcm1, a key regulator in labyrinth. Finally, reintroducing PPAR gamma into null TS cells, using an adenovirus, normalized invasion and partially reversed defective labyrinthine differentiation, as assessed both by morphology and marker analysis. Conclusions/Significance: In addition to regulating trophoblast invasion, PPAR gamma plays a predominant role in differentiation of labyrinthine trophoblast lineages, which, along with fetal endothelium, form the vascular exchange interface with maternal blood. Elucidating cellular and molecular mechanisms mediating PPAR gamma action will help determine if modulating PPAR gamma activity, for which clinical pharmacologic agonists already exist, might modify the course of pregnancy disorders associated with placental dysfunction.	[Parast, Mana M.; Ciric, Aleksandar; Salata, Mark W.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Parast, Mana M.; Yu, Heather; Davis, Vannessa; Milstone, David S.] Brigham & Womens Hosp, Dept Pathol, Div Vasc Res, Ctr Excellence Vasc Biol, Boston, MA 02115 USA	University of California System; University of California San Diego; Harvard University; Brigham & Women's Hospital	Parast, MM (corresponding author), Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA.	mparast@ucsd.edu; milstone@rascal.med.harvard.edu			National Institute of Child Health and Human Development [R01HD040895]; Department of Pathology at UCSD; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD040895] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Department of Pathology at UCSD; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by R01HD040895 (D. S. M.) from the National Institute of Child Health and Human Development, as well as funds from the Department of Pathology at UCSD (M. M. P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama TE, 2002, MOL CELL BIOL, V22, P2607, DOI 10.1128/MCB.22.8.2607-2619.2002; Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; Barak Y, 2008, PPAR RES, V2008, DOI 10.1155/2008/142082; Basyuk E, 1999, DEV DYNAM, V214, P303, DOI 10.1002/(SICI)1097-0177(199904)214:4<303::AID-AJA3>3.3.CO;2-2; Dahl KDC, 2005, MOL CELL BIOL, V25, P10479, DOI 10.1128/MCB.25.23.10479-10491.2005; Duan SZ, 2007, J CLIN INVEST, V117, P812, DOI 10.1172/JCI28859; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Glass CK, 2006, J CLIN INVEST, V116, P556, DOI 10.1172/JCI27913; Hemberger M, 2004, DEV BIOL, V271, P362, DOI 10.1016/j.ydbio.2004.03.040; HU ED, 1995, P NATL ACAD SCI USA, V92, P9856, DOI 10.1073/pnas.92.21.9856; Hughes M, 2004, DEV BIOL, V271, P26, DOI 10.1016/j.ydbio.2004.03.029; Huppertz B, 2006, PLACENTA, V27, pS3, DOI 10.1016/j.placenta.2006.01.007; Kibschull M, 2004, DEV BIOL, V273, P63, DOI 10.1016/j.ydbio.2004.04.037; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maltepe E, 2005, DEVELOPMENT, V132, P3393, DOI 10.1242/dev.01923; MINAMIDE LS, 1990, ANAL BIOCHEM, V190, P66, DOI 10.1016/0003-2697(90)90134-U; Nadra K, 2006, MOL CELL BIOL, V26, P3266, DOI 10.1128/MCB.26.8.3266-3281.2006; Nakachi Y, 2008, BIOCHEM BIOPH RES CO, V372, P362, DOI 10.1016/j.bbrc.2008.05.037; Schaiff WT, 2007, ENDOCRINOLOGY, V148, P3625, DOI 10.1210/en.2007-0211; Shalom-Barak T, 2004, MOL CELL BIOL, V24, P10661, DOI 10.1128/MCB.24.24.10661-10669.2004; Simmons DG, 2008, DEVELOPMENT, V135, P2083, DOI 10.1242/dev.020099; Simmons DG, 2007, DEV BIOL, V304, P567, DOI 10.1016/j.ydbio.2007.01.009; Straus DS, 2007, TRENDS IMMUNOL, V28, P551, DOI 10.1016/j.it.2007.09.003; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Tarrade A, 2001, J CLIN ENDOCR METAB, V86, P5017, DOI 10.1210/jc.86.10.5017; Tarrade A, 2001, ENDOCRINOLOGY, V142, P4504, DOI 10.1210/en.142.10.4504; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; Yoon JC, 2000, MOL CELL BIOL, V20, P5343, DOI 10.1128/MCB.20.14.5343-5349.2000	29	72	72	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2009	4	11							e8055	10.1371/journal.pone.0008055	http://dx.doi.org/10.1371/journal.pone.0008055			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MQ	19956639	Green Submitted, Green Published, gold			2022-12-25	WOS:000272828400012
J	Zhou, LQ; Ma, XT; Arbeitman, MN; Sun, FZ				Zhou, Linqi; Ma, Xiaotu; Arbeitman, Michelle N.; Sun, Fengzhu			Chromatin Regulation and Gene Centrality Are Essential for Controlling Fitness Pleiotropy in Yeast	PLOS ONE			English	Article							PROTEIN-INTERACTION NETWORKS; TRANSPORT	Background: There are a wide range of phenotypes that are due to loss-of-function or null mutations. Previously, the functions of gene products that distinguish essential from nonessential genes were characterized. However, the functions of products of non-essential genes that contribute to fitness remain minimally understood. Principal Findings: Using data from Saccharomyces cerevisiae, we investigated several gene characteristics, which we are able to measure, that are significantly associated with a gene's fitness pleiotropy. Fitness pleiotropy is a measurement of the gene's importance to fitness. These characteristics include: 1) whether the gene's product functions in chromatin regulation, 2) whether the regulation of the gene is influenced by chromatin state, measured by chromatin regulation effect (CRE), 3) whether the gene's product functions as a transcription factor (TF) and the number of genes a TF regulates, 4) whether the gene contains TATA-box, and 5) whether the gene's product is central in a protein interaction network. Partial correlation analysis was used to study how these characteristics interact to influence fitness pleiotropy. We show that all five characteristics that were measured are statistically significantly associated with fitness pleiotropy. However, fitness pleiotropy is not associated with the presence of TATA-box when CRE is controlled. In particular, two characteristics: 1) whether the regulation of a gene is more likely to be influenced by chromatin state, and 2) whether the gene product is central in a protein interaction network measured by the number of protein interactions were found to play the most important roles affecting a gene's fitness pleiotropy. Conclusions: These findings highlight the significance of both epigenetic gene regulation and protein interaction networks in influencing the fitness pleiotropy.	[Zhou, Linqi; Arbeitman, Michelle N.; Sun, Fengzhu] Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA; [Ma, Xiaotu] Univ Texas Dallas, Dept Mol & Cell Biol, Richardson, TX 75083 USA; [Sun, Fengzhu] Tsinghua Univ, TNLIST Dept Automat, MOE Key Lab Bioinformat & Bioinformat Div, Beijing 100084, Peoples R China	University of Southern California; University of Texas System; University of Texas Dallas; Tsinghua University	Zhou, LQ (corresponding author), Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA.	fsun@usc.edu	Sun, Fengzhu/G-4373-2010	Sun, Fengzhu/0000-0002-8552-043X; Arbeitman, Michelle/0000-0002-2437-4352	National Institutes of Health (NIH) [R21AG032743]; NIH Centers for Excellence in Genomic Sciences [P50 HG 002790]; Natural Science Foundation of China [60928007, 60805010]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073039] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG032743] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Centers for Excellence in Genomic Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work is partly supported by the National Institutes of Health (NIH) R21AG032743 and NIH Centers for Excellence in Genomic Sciences P50 HG 002790. FS is also partially supported by Natural Science Foundation of China 60928007 and 60805010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; Batada NN, 2006, PLOS COMPUT BIOL, V2, P748, DOI 10.1371/journal.pcbi.0020088; Batagelj V., 1998, CONNECTIONS, V21, P47, DOI DOI 10.1017/CB09780511996368; Brown JA, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100043; Chen Y, 2005, BIOINFORMATICS, V21, P575, DOI 10.1093/bioinformatics/bti058; Choi JK, 2008, NAT GENET, V40, P141, DOI 10.1038/ng.2007.58; Coulomb S, 2005, P ROY SOC B-BIOL SCI, V272, P1721, DOI 10.1098/rspb.2005.3128; Deane CM, 2002, MOL CELL PROTEOMICS, V1, P349, DOI 10.1074/mcp.M100037-MCP200; Deckert J, 2001, MOL CELL BIOL, V21, P2726, DOI 10.1128/MCB.21.8.2726-2735.2001; DENG MH, 2003, PAC S BIOCOMPUT, P197; Dhasarathy A, 2005, MOL CELL BIOL, V25, P2698, DOI 10.1128/MCB.25.7.2698-2707.2005; Felice MR, 2005, J BIOL CHEM, V280, P22181, DOI 10.1074/jbc.M414663200; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Hakes L, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-131; Hakes L, 2008, NAT BIOTECHNOL, V26, P69, DOI 10.1038/nbt0108-69; He XL, 2006, GENETICS, V173, P1885, DOI 10.1534/genetics.106.060269; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Hu ZZ, 2007, NAT GENET, V39, P683, DOI 10.1038/ng2012; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Landry CR, 2007, SCIENCE, V317, P118, DOI 10.1126/science.1140247; Mewes HW, 2004, NUCLEIC ACIDS RES, V32, pD41, DOI 10.1093/nar/gkh092; Parsons AB, 2006, CELL, V126, P611, DOI 10.1016/j.cell.2006.06.040; Radisky D, 1999, J BIOL CHEM, V274, P4481, DOI 10.1074/jbc.274.8.4481; Robinson MD, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-35; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Steinfeld I, 2007, NAT GENET, V39, P303, DOI 10.1038/ng1965; Tirosh I, 2006, NAT GENET, V38, P830, DOI 10.1038/ng1819; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Yu HY, 2007, PLOS COMPUT BIOL, V3, P713, DOI 10.1371/journal.pcbi.0030059; Zhou LQ, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-54	34	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2009	4	11							e8086	10.1371/journal.pone.0008086	http://dx.doi.org/10.1371/journal.pone.0008086			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MQ	19956643	Green Published, Green Submitted, gold			2022-12-25	WOS:000272828400027
J	van Dellen, E; Douw, L; Baayen, JC; Heimans, JJ; Ponten, SC; Vandertop, WP; Velis, DN; Stam, CJ; Reijneveld, JC				van Dellen, Edwin; Douw, Linda; Baayen, Johannes C.; Heimans, Jan J.; Ponten, Sophie C.; Vandertop, W. Peter; Velis, Demetrios N.; Stam, Cornelis J.; Reijneveld, Jaap C.			Long-Term Effects of Temporal Lobe Epilepsy on Local Neural Networks: A Graph Theoretical Analysis of Corticography Recordings	PLOS ONE			English	Article							DISTURBED FUNCTIONAL CONNECTIVITY; SMALL-WORLD NETWORKS; BRAIN NETWORKS; TOPOLOGY; EEG; EPILEPTOGENESIS; PROGRESSION; TRANSITION; CLUSTERS; SURGERY	Purpose: Pharmaco-resistant temporal lobe epilepsy (TLE) is often treated with surgical intervention at some point. As epilepsy surgery is considered a last resort by most physicians, a long history of epileptic seizures prior to surgery is not uncommon. Little is known about the effects of ongoing TLE on neural functioning. A better understanding of these effects might influence the moment of surgical intervention. Functional connectivity (interaction between spatially distributed brain areas) and network structure (integration and segregation of information processing) are thought to be essential for optimal brain functioning. We report on the impact of TLE duration on temporal lobe functional connectivity and network characteristics. Methods: Functional connectivity of the temporal lobe at the time of surgery was assessed by means of interictal electrocorticography (ECoG) recordings of 27 TLE patients by using the phase lag index (PLI). Graphs (abstract network representations) were reconstructed from the PLI matrix and characterized by the clustering coefficient C (local clustering), the path length L (overall network interconnectedness), and the "small world index'' S (network configuration). Results: Functional connectivity (average PLI), clustering coefficients, and the small world index were negatively correlated with TLE duration in the broad frequency band (0.5-48 Hz). Discussion: Temporal lobe functional connectivity is lower in patients with longer TLE history, and longer TLE duration is correlated with more random network configuration. Our findings suggest that the neural networks of TLE patients become more pathological over time, possibly due to temporal lobe changes associated with long-standing lesional epilepsy.	[van Dellen, Edwin; Douw, Linda; Heimans, Jan J.; Ponten, Sophie C.; Reijneveld, Jaap C.] Vrije Univ Amsterdam, Dept Neurol, Med Ctr, Amsterdam, Netherlands; [Baayen, Johannes C.; Vandertop, W. Peter] Vrije Univ Amsterdam, Dept Neurosurg, Neurosurg Ctr Amsterdam, Med Ctr, Amsterdam, Netherlands; [Velis, Demetrios N.] Dutch Epilepsy Clin Fdn, Dept Clin Neurophysiol, Heemstede, Netherlands; [Velis, Demetrios N.] Dutch Epilepsy Clin Fdn, Epilepsy Monitoring Unit, Heemstede, Netherlands; [Ponten, Sophie C.; Stam, Cornelis J.] Vrije Univ Amsterdam, Dept Clin Neurophysiol, Med Ctr, Amsterdam, Netherlands; [Reijneveld, Jaap C.] Univ Amsterdam, Acad Med Ctr, Dept Neurol, NL-1105 AZ Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	van Dellen, E (corresponding author), Vrije Univ Amsterdam, Dept Neurol, Med Ctr, Amsterdam, Netherlands.	E.vanDellen@vumc.nl	van Dellen, Edwin/AAL-6605-2020; van Dellen, Edwin/ABC-1501-2020; van Dellen, Edwin/AAU-6245-2020	van Dellen, Edwin/0000-0003-1828-5959; van Dellen, Edwin/0000-0003-1828-5959; Stam, Cornelis/0000-0001-9163-7274; Douw, Linda/0000-0001-7058-4062; Vandertop, William/0000-0001-5417-0265	National Epilepsy Foundation of the Netherlands	National Epilepsy Foundation of the Netherlands	This study was supported by the National Epilepsy Foundation of the Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartolomei F, 2008, NEUROCHIRURGIE, V54, P174, DOI 10.1016/j.neuchi.2008.02.013; Bartolomei F, 2006, ANN NEUROL, V59, P128, DOI 10.1002/ana.20710; Bartolomei F, 2004, EPILEPSY RES, V61, P89, DOI 10.1016/j.eplepsyres.2004.06.006; Bartolomei F, 2008, BRAIN, V131, P1818, DOI 10.1093/brain/awn111; Bartolomei F, 2006, CLIN NEUROPHYSIOL, V117, P2039, DOI 10.1016/j.clinph.2006.05.018; Ben-Ari Yehezkel, 2008, Epilepsy Curr, V8, P68, DOI 10.1111/j.1535-7511.2008.00241.x; Berg AT, 2004, CNS SPECTRUMS, V9, P136, DOI 10.1017/S109285290000849X; Berg AT, 2003, NEUROLOGY, V60, P186, DOI 10.1212/01.WNL.0000031792.89992.EC; Bernasconi N, 2005, NEUROLOGY, V65, P223, DOI 10.1212/01.wnl.0000169066.46912.fa; BETTUS G, 2008, HUM BRAIN MAPP; Blume WT, 2006, EPILEPSIA, V47, P71, DOI 10.1111/j.1528-1167.2006.00665.x; Bosma Ingeborg, 2009, Nonlinear Biomed Phys, V3, P9, DOI 10.1186/1753-4631-3-9; Bragin A, 2000, EPILEPSIA, V41, pS144, DOI 10.1111/j.1528-1157.2000.tb01573.x; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; da Silva FL, 2003, EPILEPSIA, V44, P72, DOI 10.1111/j.0013-9580.2003.12005.x; Dyhrfjeld-Johnsen J, 2007, J NEUROPHYSIOL, V97, P1566, DOI 10.1152/jn.00950.2006; Elger CE, 2004, LANCET NEUROL, V3, P663, DOI 10.1016/S1474-4422(04)00906-8; Engel J, 1993, SURG TREATMENT EPILE, P609; FRENCH JA, 1993, ANN NEUROL, V34, P774, DOI 10.1002/ana.410340604; Humphries MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002051; Kramer MA, 2008, EPILEPSY RES, V79, P173, DOI 10.1016/j.eplepsyres.2008.02.002; Le Van Quyen M, 2005, CLIN NEUROPHYSIOL, V116, P559, DOI 10.1016/j.clinph.2004.10.014; Marchiori M, 2000, PHYSICA A, V285, P539, DOI 10.1016/S0378-4371(00)00311-3; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Mathern GW, 2002, PROG BRAIN RES, V135, P237; Micheloyannis S, 2005, NEUROSCI LETT, V373, P212, DOI 10.1016/j.neulet.2004.10.005; Micheloyannis S, 2006, SCHIZOPHR RES, V87, P60, DOI 10.1016/j.schres.2006.06.028; Montez T, 2006, NEUROIMAGE, V33, P1117, DOI 10.1016/j.neuroimage.2006.06.066; Morgan RJ, 2008, P NATL ACAD SCI USA, V105, P6179, DOI 10.1073/pnas.0801372105; Netoff TI, 2004, J NEUROSCI, V24, P8075, DOI 10.1523/JNEUROSCI.1509-04.2004; Ortega GJ, 2008, EPILEPSIA, V49, P269, DOI 10.1111/j.1528-1167.2007.01266.x; Ortega GJ, 2008, NEUROSCI LETT, V447, P129, DOI 10.1016/j.neulet.2008.09.080; Percha B, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.031909; Pitkanen A, 2002, LANCET NEUROL, V1, P173, DOI 10.1016/S1474-4422(02)00073-X; Ponten SC, 2007, CLIN NEUROPHYSIOL, V118, P918, DOI 10.1016/j.clinph.2006.12.002; Rampil IJ, 1998, ANESTHESIOLOGY, V89, P980, DOI 10.1097/00000542-199810000-00023; Ryvlin P, 2003, EPILEPSIA, V44, P23, DOI 10.1046/j.1528-1157.44.s.5.4.x; Schindler KA, 2008, CHAOS, V18, DOI 10.1063/1.2966112; Srinivas KV, 2007, EUR J NEUROSCI, V25, P3276, DOI 10.1111/j.1460-9568.2007.05559.x; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Stam CJ, 2007, HUM BRAIN MAPP, V28, P1178, DOI 10.1002/hbm.20346; Stam Cornelis J, 2007, Nonlinear Biomed Phys, V1, P3, DOI 10.1186/1753-4631-1-3; van den Heuvel MP, 2009, J NEUROSCI, V29, P7619, DOI 10.1523/JNEUROSCI.1443-09.2009; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wendling F, 2005, J CLIN NEUROPHYSIOL, V22, P343; Wiebe S, 2001, NEW ENGL J MED, V345, P311, DOI 10.1056/NEJM200108023450501	46	108	110	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2009	4	11							e8081	10.1371/journal.pone.0008081	http://dx.doi.org/10.1371/journal.pone.0008081			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MN	19956634	Green Published, gold, Green Submitted			2022-12-25	WOS:000272828100018
J	La Scola, B; Raoult, D				La Scola, Bernard; Raoult, Didier			Direct Identification of Bacteria in Positive Blood Culture Bottles by Matrix-Assisted Laser Desorption Ionisation Time-of-Flight Mass Spectrometry	PLOS ONE			English	Article							INITIAL ANTIMICROBIAL THERAPY; GRAM-NEGATIVE BACILLI; RAPID IDENTIFICATION; STAPHYLOCOCCUS-AUREUS; STREAM INFECTIONS; PATHOGENS; PCR; DESORPTION/IONIZATION; PNEUMONIA; FUNGEMIA	Background: With long delays observed between sampling and availability of results, the usefulness of blood cultures in the context of emergency infectious diseases has recently been questioned. Among methods that allow quicker bacterial identification from growing colonies, matrix-assisted laser desorption ionisation time-of-flight (MALDI-TOF) mass spectrometry was demonstrated to accurately identify bacteria routinely isolated in a clinical biology laboratory. In order to speed up the identification process, in the present work we attempted bacterial identification directly from blood culture bottles detected positive by the automate. Methodology/Principal Findings: We prospectively analysed routine MALDI-TOF identification of bacteria detected in blood culture by two different protocols involving successive centrifugations and then lysis by trifluoroacetic acid or formic acid. Of the 562 blood culture broths detected as positive by the automate and containing one bacterial species, 370 (66%) were correctly identified. Changing the protocol from trifluoroacetic acid to formic acid improved identification of Staphylococci, and overall correct identification increased from 59% to 76%. Lack of identification was observed mostly with viridans streptococci, and only one false positive was observed. In the 22 positive blood culture broths that contained two or more different species, only one of the species was identified in 18 samples, no species were identified in two samples and false species identifications were obtained in two cases. The positive predictive value of bacterial identification using this procedure was 99.2%. Conclusions/Significance: MALDI-TOF MS is an efficient method for direct routine identification of bacterial isolates in blood culture, with the exception of polymicrobial samples and viridans streptococci. It may replace routine identification performed on colonies, provided improvement for the specificity of blood culture broths growing viridans streptococci is obtained in the near future.	[La Scola, Bernard] Univ Mediterranee, Fac Med, Assistance Publ Hop Marseille, Marseille, France; Univ Mediterranee, Fac Med, IFR48, IRD 6236,CNRS,URMITE, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD)	La Scola, B (corresponding author), Univ Mediterranee, Fac Med, Assistance Publ Hop Marseille, Marseille, France.	bernard.lascola@univmed.fr	RAOULT, Didier/A-8434-2008; LA SCOLA, Bernard/P-6477-2016	RAOULT, Didier/0000-0002-0633-5974; LA SCOLA, Bernard/0000-0001-8006-7704				Abe T, 2009, J INFECT CHEMOTHER, V15, P180, DOI 10.1007/s10156-009-0682-z; ANHALT JP, 1975, ANAL CHEM, V47, P219, DOI 10.1021/ac60352a007; Annane D, 2005, LANCET, V365, P63, DOI 10.1016/S0140-6736(04)17667-8; Camara JE, 2007, ANAL BIOANAL CHEM, V389, P1633, DOI 10.1007/s00216-007-1558-7; Carbonnelle E, 2007, J CLIN MICROBIOL, V45, P2156, DOI 10.1128/JCM.02405-06; Chapin KC, 2003, J CLIN MICROBIOL, V41, P4751, DOI 10.1128/JCM.41.10.4751-4754.2003; Cleven BEE, 2006, J CLIN MICROBIOL, V44, P2389, DOI 10.1128/JCM.02291-05; Corbo J, 2004, EMERG MED J, V21, P446, DOI 10.1136/emj.2003.005306; COYLE MB, 1984, J CLIN MICROBIOL, V20, P473, DOI 10.1128/JCM.20.3.473-477.1984; de Cueto M, 2004, J CLIN MICROBIOL, V42, P3734, DOI [10.1128/JCM.42.8.3734-3738.2004, 10.1128/jcm.42.8.3734-3738.2004]; Degand N, 2008, J CLIN MICROBIOL, V46, P3361, DOI 10.1128/JCM.00569-08; Du ZM, 2002, ANAL CHEM, V74, P5487, DOI 10.1021/ac020109k; Eigner U, 2005, J CLIN MICROBIOL, V43, P5256, DOI 10.1128/JCM.43.10.5256-5262.2005; Funke G, 2004, J CLIN MICROBIOL, V42, P1466, DOI 10.1128/JCM.42.4.1466-1470.2004; Gebert S, 2008, J INFECTION, V57, P307, DOI 10.1016/j.jinf.2008.07.013; Gescher DM, 2008, INT J ANTIMICROB AG, V32, pS51, DOI 10.1016/j.ijantimicag.2008.06.007; Harbarth S, 2003, AM J MED, V115, P529, DOI 10.1016/j.amjmed.2003.07.005; Jansen GJ, 2000, J CLIN MICROBIOL, V38, P814, DOI 10.1128/JCM.38.2.814-817.2000; Kang CI, 2005, ANTIMICROB AGENTS CH, V49, P760, DOI 10.1128/AAC.49.2.760-766.2005; Kempf VAJ, 2000, J CLIN MICROBIOL, V38, P830, DOI 10.1128/JCM.38.2.830-838.2000; Kristensen B, 2001, APMIS, V109, P284, DOI 10.1034/j.1600-0463.2001.d01-121.x; Micek ST, 2005, ANTIMICROB AGENTS CH, V49, P1306, DOI 10.1128/AAC.49.4.1306-1311.2005; Peters RPH, 2004, LANCET INFECT DIS, V4, P751, DOI 10.1016/S1473-3099(04)01205-8; Seng P, 2009, CLIN INFECT DIS, V49, P543, DOI 10.1086/600885; Shapiro NI, 2008, J EMERG MED, V35, P255, DOI 10.1016/j.jemermed.2008.04.001; Speers DJ, 1998, J CLIN MICROBIOL, V36, P1032, DOI 10.1128/JCM.36.4.1032-1034.1998; WALLET F, 2009, CLIN MICROBIOL  0818; WEINSTEIN MP, 1995, J CLIN MICROBIOL, V33, P978, DOI 10.1128/JCM.33.4.978-981.1995; Wellinghausen N, 2004, DIAGN MICR INFEC DIS, V48, P229, DOI 10.1016/j.diagmicrobio.2003.11.005; Westh H, 2009, CLIN MICROBIOL INFEC, V15, P544, DOI 10.1111/j.1469-0691.2009.02736.x; WILSON ML, 1995, J CLIN MICROBIOL, V33, P2265, DOI 10.1128/JCM.33.9.2265-2270.1995; Wolk DM, 2009, J CLIN MICROBIOL, V47, P823, DOI 10.1128/JCM.01884-08	32	271	275	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2009	4	11							e8041	10.1371/journal.pone.0008041	http://dx.doi.org/10.1371/journal.pone.0008041			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MK	19946369	gold, Green Submitted, Green Published			2022-12-25	WOS:000272827800024
J	Reef, R; Kaniewska, P; Hoegh-Guldberg, O				Reef, Ruth; Kaniewska, Paulina; Hoegh-Guldberg, Ove			Coral Skeletons Defend against Ultraviolet Radiation	PLOS ONE			English	Article							INDUCED DNA-DAMAGE; HUMIC-ACID BANDS; TRACE MATERIALS; PORITES-LUTEA; LIGHT; FLUORESCENT; REEF; PHOTOSYNTHESIS; REPAIR; ZOOXANTHELLAE	Background: Many coral reef organisms are photosynthetic or have evolved in tight symbiosis with photosynthetic symbionts. As such, the tissues of reef organisms are often exposed to intense solar radiation in clear tropical waters and have adapted to trap and harness photosynthetically active radiation (PAR). High levels of ultraviolet radiation (UVR) associated with sunlight, however, represent a potential problem in terms of tissue damage. Methodology/Principal Findings: By measuring UVR and PAR reflectance from intact and ground bare coral skeletons we show that the property of calcium carbonate skeletons to absorb downwelling UVR to a significant extent, while reflecting PAR back to the overlying tissue, has biological advantages. We placed cnidarians on top of bare skeletons and a UVR reflective substrate and showed that under ambient UVR levels, UVR transmitted through the tissues of cnidarians placed on top of bare skeletons were four times lower compared to their counterparts placed on a UVR reflective white substrate. In accordance with the lower levels of UVR measured in cnidarians on top of coral skeletons, a similar drop in UVR damage to their DNA was detected. The skeletons emitted absorbed UVR as yellow fluorescence, which allows for safe dissipation of the otherwise harmful radiation. Conclusions/Significance: Our study presents a novel defensive role for coral skeletons and reveals that the strong UVR absorbance by the skeleton can contribute to the ability of corals, and potentially other calcifiers, to thrive under UVR levels that are detrimental to most marine life.	[Reef, Ruth] Univ Queensland, Ctr Marine Studies, St Lucia, Qld, Australia; Univ Queensland, Ctr Excellence Coral Reef Studies, ARC, St Lucia, Qld, Australia	University of Queensland; University of Queensland	Reef, R (corresponding author), Univ Queensland, Ctr Marine Studies, St Lucia, Qld, Australia.	r.reef@uq.edu.au	Hoegh-Guldberg, Ove/ABA-5420-2020; Hoegh-Guldberg, Ove/H-6169-2011	Hoegh-Guldberg, Ove/0000-0001-7510-6713; Hoegh-Guldberg, Ove/0000-0001-7510-6713; Reef, Ruth/0000-0001-6639-520X	Australian Research Council Centre of Excellence for Coral Reefs Studies	Australian Research Council Centre of Excellence for Coral Reefs Studies(Australian Research Council)	The Australian Research Council Centre of Excellence for Coral Reefs Studies http://www.coralcoe.org.au/funded this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allemand D, 2004, CR PALEVOL, V3, P453, DOI 10.1016/j.crpv.2004.07.011; Andrews K, 2007, BIOL LETTERS, V3, P265, DOI 10.1098/rsbl.2007.0016; Anthony KRN, 2005, FUNCT ECOL, V19, P17, DOI 10.1111/j.0269-8463.2005.00925.x; Anthony KRN, 2003, FUNCT ECOL, V17, P246, DOI 10.1046/j.1365-2435.2003.00731.x; Apprill AM, 2007, CORAL REEFS, V26, P387, DOI 10.1007/s00338-007-0209-y; Barnes DJ, 2005, J EXP MAR BIOL ECOL, V322, P135, DOI 10.1016/j.jembe.2005.02.008; Barnes DJ, 1995, J EXP MAR BIOL ECOL, V194, P251, DOI 10.1016/0022-0981(95)00091-7; Britt AB, 1996, ANNU REV PLANT PHYS, V47, P75, DOI 10.1146/annurev.arplant.47.1.75; BROWN BE, 1991, CORAL REEFS, V10, P211, DOI 10.1007/BF00336776; Cockell CS, 1998, BIOL J LINN SOC, V63, P449, DOI 10.1006/bijl.1997.0201; CROSSLAND CJ, 1991, CORAL REEFS, V10, P55, DOI 10.1007/BF00571824; DEVILLIERS S, 1995, SCIENCE, V269, P1247, DOI 10.1126/science.269.5228.1247; DUNLAP WC, 1986, CORAL REEFS, V5, P155, DOI 10.1007/BF00298182; Dunlap WC, 1998, J PHYCOL, V34, P418, DOI 10.1046/j.1529-8817.1998.340418.x; Enriquez S, 2005, LIMNOL OCEANOGR, V50, P1025, DOI 10.4319/lo.2005.50.4.1025; FALKOWSKI PG, 1984, BIOSCIENCE, V34, P705, DOI 10.2307/1309663; Fallon SJ, 2003, CORAL REEFS, V22, P389, DOI 10.1007/s00338-003-0322-5; FANG LS, 1992, CORAL REEFS, V11, P187, DOI 10.1007/BF00301991; Fasel A, 1997, J PHOTOCH PHOTOBIO B, V39, P96, DOI 10.1016/S1011-1344(96)00016-4; Frost LM., 2001, SCORPIONS 2001 MEMOR, P363; Gaft M., 2005, MODERN LUMINESCENCE; Heller J., 1961, CATCH 22; ISDALE P, 1984, NATURE, V310, P578, DOI 10.1038/310578a0; ISHAY JS, 1988, J LUMIN, V40-1, P221, DOI 10.1016/0022-2313(88)90164-0; JOKIEL PL, 1980, SCIENCE, V207, P1069, DOI 10.1126/science.207.4435.1069; Kaniewska P, 2008, MAR BIOL, V155, P649, DOI 10.1007/s00227-008-1061-5; KUHL M, 1995, MAR ECOL PROG SER, V117, P159, DOI 10.3354/meps117159; LAWRENCE R. F., 1954, JOUR ENT SOC S AFRICA, V17, P167; LIVINGSTON HD, 1971, LIMNOL OCEANOGR, V16, P786, DOI 10.4319/lo.1971.16.5.0786; Matthews BJH, 1996, MAR CHEM, V55, P317, DOI 10.1016/S0304-4203(96)00039-4; Mayer B, 2005, ATMOS CHEM PHYS, V5, P1855, DOI 10.5194/acp-5-1855-2005; Mazel CH, 2004, SCIENCE, V303, P51, DOI 10.1126/science.1089803; MILNE PJ, 1994, APPL SPECTROSC, V48, P1282, DOI 10.1366/0003702944027453; MORI T, 1991, PHOTOCHEM PHOTOBIOL, V54, P225, DOI 10.1111/j.1751-1097.1991.tb02010.x; Muscatine L, 2005, P NATL ACAD SCI USA, V102, P1525, DOI 10.1073/pnas.0408921102; MUSCATINE L, 1981, LIMNOL OCEANOGR, V26, P601, DOI 10.4319/lo.1981.26.4.0601; OLSON JM, 1986, PHOTOSYNTH RES, V9, P251, DOI 10.1007/BF00029748; Pingitore NE, 2002, MICROCHEM J, V71, P205, DOI 10.1016/S0026-265X(02)00012-7; RAVEN JA, 1991, J PHOTOCH PHOTOBIO B, V9, P239, DOI 10.1016/1011-1344(91)80158-E; Reef R, 2009, J EXP BIOL, V212, P2760, DOI 10.1242/jeb.031286; Richter DK, 2003, MINER PETROL, V79, P127, DOI 10.1007/s00710-003-0237-4; SCOFFIN TP, 1989, CORAL REEFS, V7, P169, DOI 10.1007/BF00301595; SCOFFIN TP, 1992, CORAL REEFS, V11, P1, DOI 10.1007/BF00291929; SHIBATA K, 1969, PLANT CELL PHYSIOL, V10, P325; Shirai K, 2008, GEOCHIM COSMOCHIM AC, V72, P5386, DOI 10.1016/j.gca.2008.07.026; Sinha RP, 2002, PHOTOCH PHOTOBIO SCI, V1, P225, DOI 10.1039/b201230h; Stambler N, 2005, CORAL REEFS, V24, P1, DOI 10.1007/s00338-004-0452-4; Stanley GD, 2006, SCIENCE, V312, P857, DOI 10.1126/science.1123701; SUSIC M, 1991, MAR CHEM, V33, P91, DOI 10.1016/0304-4203(91)90059-6; TAYLOR RB, 1995, J EXP MAR BIOL ECOL, V185, P255, DOI 10.1016/0022-0981(94)00155-7; Vink AA, 2001, J PHOTOCH PHOTOBIO B, V65, P101, DOI 10.1016/S1011-1344(01)00245-7; Weis VM, 2008, TRENDS ECOL EVOL, V23, P369, DOI 10.1016/j.tree.2008.03.004; Wild FJ, 2000, CORAL REEFS, V19, P132, DOI 10.1007/s003380000084; [No title captured]; [No title captured]; [No title captured]	57	34	35	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2009	4	11							e7995	10.1371/journal.pone.0007995	http://dx.doi.org/10.1371/journal.pone.0007995			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MK	19946361	Green Published, gold, Green Submitted			2022-12-25	WOS:000272827800010
J	Tiede, BJ; Owens, LA; Li, F; DeCoste, C; Kang, YB				Tiede, Benjamin J.; Owens, Leah A.; Li, Feng; DeCoste, Christina; Kang, Yibin			A Novel Mouse Model for Non-Invasive Single Marker Tracking of Mammary Stem Cells In Vivo Reveals Stem Cell Dynamics throughout Pregnancy	PLOS ONE			English	Article							BREAST-CANCER; GLAND; DIFFERENTIATION; COMMITMENT	Mammary stem cells (MaSCs) play essential roles for the development of the mammary gland and its remodeling during pregnancy. However, the precise localization of MaSCs in the mammary gland and their regulation during pregnancy is unknown. Here we report a transgenic mouse model for luciferase-based single marker detection of MaSCs in vivo that we used to address these issues. Single transgene expressing mammary epithelial cells were shown to reconstitute mammary glands in vivo while immunohistochemical staining identified MaSCs in basal and luminal locations, with preponderance towards the basal position. By quantifying luciferase expression using bioluminescent imaging, we were able to track MaSCs non-invasively in individual mice over time. Using this model to monitor MaSC dynamics throughout pregnancy, we found that MaSCs expand in both total number and percentage during pregnancy and then drop down to or below baseline levels after weaning. However, in a second round of pregnancy, this expansion was not as extensive. These findings validate a powerful system for the analysis of MaSC dynamics in vivo, which will facilitate future characterization of MaSCs during mammary gland development and breast cancer.	[Tiede, Benjamin J.; Owens, Leah A.; Li, Feng; DeCoste, Christina; Kang, Yibin] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University	Tiede, BJ (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	ykang@princeton.edu		Kang, Yibin/0000-0002-1626-6730; Owens, Leah/0000-0002-4232-3516	Department of Defense Era of Hope Scholar Award; NIH; New Jersey Commission on Cancer Research; Department of Defense Breast Cancer Research	Department of Defense Era of Hope Scholar Award(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New Jersey Commission on Cancer Research; Department of Defense Breast Cancer Research(United States Department of Defense)	YK was funded by a Department of Defense Era of Hope Scholar Award. BT is supported by an NIH training grant and by pre-doctoral fellowships from the New Jersey Commission on Cancer Research and the Department of Defense Breast Cancer Research Program. The funders had no role in study, data collection and analysis, decision to publish, or preparation of the manuscript.	Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; Asselin-Labat ML, 2006, J NATL CANCER I, V98, P1011, DOI 10.1093/jnci/djj267; Bouras T, 2008, CELL STEM CELL, V3, P429, DOI 10.1016/j.stem.2008.08.001; Britt K, 2007, ENDOCR-RELAT CANCER, V14, P907, DOI 10.1677/ERC-07-0137; Britt KL, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2245; Cao YA, 2005, TRANSPLANTATION, V80, P134, DOI 10.1097/01.TP.0000164347.50559.A3; DEOME KB, 1959, CANCER RES, V19, P515; Lindvall C, 2006, J BIOL CHEM, V281, P35081, DOI 10.1074/jbc.M607571200; Raouf A, 2008, CELL STEM CELL, V3, P109, DOI 10.1016/j.stem.2008.05.018; Richert MM, 2000, J MAMMARY GLAND BIOL, V5, P227, DOI 10.1023/A:1026499523505; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Siwko SK, 2008, STEM CELLS, V26, P3205, DOI 10.1634/stemcells.2008-0103; Sleeman KE, 2007, J CELL BIOL, V176, P19, DOI 10.1083/jcb.200604065; Smalley M, 2003, NAT REV CANCER, V3, P832, DOI 10.1038/nrc1212; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Taddei I, 2008, NAT CELL BIOL, V10, P716, DOI 10.1038/ncb1734; Welm Bryan E, 2008, Cell Stem Cell, V2, P90, DOI 10.1016/j.stem.2007.10.002	17	20	23	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2009	4	11							e8035	10.1371/journal.pone.0008035	http://dx.doi.org/10.1371/journal.pone.0008035			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MK	19946375	gold, Green Submitted, Green Published			2022-12-25	WOS:000272827800022
J	Choi, J; Oh, S; Lee, D; Oh, HJ; Park, JY; Lee, SB; Lim, DS				Choi, Juhyun; Oh, Sangphil; Lee, Dongjun; Oh, Hyun Jung; Park, Jik Young; Lee, Sean Bong; Lim, Dae-Sik			Mst1-FoxO Signaling Protects Naive T Lymphocytes from Cellular Oxidative Stress in Mice	PLOS ONE			English	Article							KINASE MST1; HISTONE H2B; CELLS; APOPTOSIS; PHOSPHORYLATION; PROLIFERATION; ACTIVATION; SURVIVAL; GROWTH; HIPPO	Background: The Ste-20 family kinase Hippo restricts cell proliferation and promotes apoptosis for proper organ development in Drosophila. In C. elegans, Hippo homolog also regulates longevity. The mammalian Ste20-like protein kinase, Mst1, plays a role in apoptosis induced by various types of apoptotic stress. Mst1 also regulates peripheral naive T cell trafficking and proliferation in mice. However, its functions in mammals are not fully understood. Methodology/Principal Findings: Here, we report that the Mst1-FoxO signaling pathway plays a crucial role in survival, but not apoptosis, of naive T cells. In Mst1(-/-) mice, peripheral T cells showed impaired FoxO1/3 activation and decreased FoxO protein levels. Consistently, the FoxO targets, Sod2 and catalase, were significantly down-regulated in Mst1(-/-) T cells, thereby resulting in elevated levels of intracellular reactive oxygen species (ROS) and induction of apoptosis. Expression of constitutively active FoxO3a restored Mst1(-/-) T cell survival. Crossing Mst1 transgenic mice (Mst1 Tg) with Mst1(-/-) mice reduced ROS levels and restored normal numbers of peripheral naive T cells in Mst1 Tg; Mst1(-/-) progeny. Interestingly, peripheral T cells from Mst1(-/-) mice were hypersensitive to gamma-irradiation and paraquat-induced oxidative stresses, whereas those from Mst1 Tg mice were resistant. Conclusions/Significance: These data support the hypothesis that tolerance to increased levels of intracellular ROS provided by the Mst1-FoxOs signaling pathway is crucial for the maintenance of naive T cell homeostasis in the periphery.	[Choi, Juhyun; Oh, Sangphil; Lee, Dongjun; Oh, Hyun Jung; Lim, Dae-Sik] Korea Adv Inst Sci & Technol, Natl Res Lab Mol Genet, Dept Biol Sci, Biomed Res Ctr, Taejon 305701, South Korea; [Park, Jik Young; Lee, Sean Bong] NIDDKD, Genet Dev & Dis Branch, NIH, Bethesda, MD 20892 USA	Korea Advanced Institute of Science & Technology (KAIST); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Choi, J (corresponding author), Korea Adv Inst Sci & Technol, Natl Res Lab Mol Genet, Dept Biol Sci, Biomed Res Ctr, Taejon 305701, South Korea.	daesiklim@kaist.ac.kr	Lim, Dae-Sik/C-1599-2011; Lee, Dongjun/ABF-4381-2021	Lim, Dae-Sik/0000-0003-2356-7555; Lee, Dongjun/0000-0001-6828-401X; Lee, Sean/0000-0001-6211-3498	NRL (National Research Laboratory) Program; Nuclear Research Grant; 21st Century Frontier Functional Human Genome Project	NRL (National Research Laboratory) Program(Korea Science and Engineering Foundation); Nuclear Research Grant; 21st Century Frontier Functional Human Genome Project(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This study was supported by grants from the NRL (National Research Laboratory) Program, a Nuclear Research Grant, and the 21<SUP>st</SUP> Century Frontier Functional Human Genome Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SH, 2005, CELL, V120, P25, DOI 10.1016/j.cell.2004.11.016; Cemek M, 2006, PHOTOCHEM PHOTOBIOL, V82, P1691, DOI [10.1562/2006-06-15-RA-924, 10.1111/j.1751-1097.2006.tb09832.x]; Cheung WL, 2003, CELL, V113, P507, DOI 10.1016/S0092-8674(03)00355-6; Cinar B, 2007, EMBO J, V26, P4523, DOI 10.1038/sj.emboj.7601872; DHEIN J, 1995, NATURE, V373, P438, DOI 10.1038/373438a0; DONG Y, 2009, J IMMUNOL, V19, P19; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Hildeman DA, 1999, IMMUNITY, V10, P735, DOI 10.1016/S1074-7613(00)80072-2; ISHII N, 1990, MUTAT RES, V237, P165, DOI 10.1016/0921-8734(90)90022-J; Jang SW, 2007, J BIOL CHEM, V282, P30836, DOI 10.1074/jbc.M704542200; Karanjawala ZE, 2002, CURR BIOL, V12, P397, DOI 10.1016/S0960-9822(02)00684-X; Katagiri K, 2004, NAT IMMUNOL, V5, P1045, DOI 10.1038/ni1111; Katagiri K, 2006, NAT IMMUNOL, V7, P919, DOI 10.1038/ni1374; Katagiri K, 2009, EMBO J, V28, P1319, DOI 10.1038/emboj.2009.82; Kerdiles YM, 2009, NAT IMMUNOL, V10, P176, DOI 10.1038/ni.1689; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Lee JH, 2008, EMBO J, V27, P1231, DOI 10.1038/emboj.2008.63; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; Mueller P, 2008, NAT IMMUNOL, V9, P424, DOI 10.1038/ni1570; Murali-Krishna K, 1999, SCIENCE, V286, P1377, DOI 10.1126/science.286.5443.1377; Nakashima I, 2002, ANTIOXID REDOX SIGN, V4, P353, DOI 10.1089/15230860260196155; Nemoto S, 2002, SCIENCE, V295, P2450, DOI 10.1126/science.1069004; OH S, 2009, MOL CELL BIOL; Ouyang WM, 2009, IMMUNITY, V30, P358, DOI 10.1016/j.immuni.2009.02.003; Pan DJ, 2007, GENE DEV, V21, P886, DOI 10.1101/gad.1536007; Polic B, 2001, P NATL ACAD SCI USA, V98, P8744, DOI 10.1073/pnas.141218898; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Schwaller J, 2001, BLOOD, V97, P3910, DOI 10.1182/blood.V97.12.3910; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167; Wojciechowski S, 2007, J EXP MED, V204, P1665, DOI 10.1084/jem.20070618; Yuan ZQ, 2009, J BIOL CHEM, V284, P11285, DOI 10.1074/jbc.M900461200; ZHENG LX, 1995, NATURE, V377, P348, DOI 10.1038/377348a0; Zhou DW, 2008, P NATL ACAD SCI USA, V105, P20321, DOI 10.1073/pnas.0810773105	33	90	93	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2009	4	11							e8011	10.1371/journal.pone.0008011	http://dx.doi.org/10.1371/journal.pone.0008011			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MH	19956688	Green Published, Green Submitted, gold			2022-12-25	WOS:000272827500034
J	Schrader, KA; Gorbatcheva, B; Senz, J; Heravi-Moussavi, A; Melnyk, N; Salamanca, C; Maines-Bandiera, S; Cooke, SL; Leung, P; Brenton, JD; Gilks, CB; Monahan, J; Huntsman, DG				Schrader, Kasmintan A.; Gorbatcheva, Bella; Senz, Janine; Heravi-Moussavi, Alireza; Melnyk, Nataliya; Salamanca, Clara; Maines-Bandiera, Sarah; Cooke, Susanna L.; Leung, Peter; Brenton, James D.; Gilks, C. Blake; Monahan, John; Huntsman, David G.			The Specificity of the FOXL2 c.402C > G Somatic Mutation: A Survey of Solid Tumors	PLOS ONE			English	Article							TRANSCRIPTION FACTOR FOXL2; GRANULOSA-CELL TUMOR; MELTING ANALYSIS; OVARY; AGGREGATION	Background: A somatic mutation in the FOXL2 gene is reported to be present in almost all (97%; 86/89) morphologically defined, adult-type, granulosa-cell tumors (A-GCTs). This FOXL2 c.402C>G mutation changes a highly conserved cysteine residue to a tryptophan (p.C134W). It was also found in a minority of other ovarian malignant stromal tumors, but not in benign ovarian stromal tumors or unrelated ovarian tumors or breast cancers. Methodology/Principal Findings: Herein we studied other cancers and cell lines for the presence of this mutation. We screened DNA from 752 tumors of epithelial and mesenchymal origin and 28 ovarian cancer cell lines and 52 other cancer cell lines of varied origin. We found the FOXL2 c>402C.G mutation in an unreported A-GCT case and the A-GCT-derived cell line KGN. All other tumors and cell lines analyzed were mutation negative. Conclusions/Significance: In addition to proving that the KGN cell line is a useful model to study A-GCTs, these data show that the c.402C>G mutation in FOXL2 is not commonly found in a wide variety of other cancers and therefore it is likely pathognomonic for A-GCTs and closely related tumors.	[Schrader, Kasmintan A.; Senz, Janine; Heravi-Moussavi, Alireza; Melnyk, Nataliya; Salamanca, Clara; Maines-Bandiera, Sarah; Huntsman, David G.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada; [Schrader, Kasmintan A.; Senz, Janine; Melnyk, Nataliya; Monahan, John] British Columbia Canc Agcy, Ctr Translat & Appl Genom, Vancouver, BC V5Z 4E6, Canada; [Gorbatcheva, Bella; Huntsman, David G.] Novartis Inst Biomed Res, Cambridge, MA USA; [Cooke, Susanna L.; Brenton, James D.] Cambridge Res Inst, Cambridge, England; [Leung, Peter] Univ British Columbia, Child & Family Res Inst, Dept Obstet & Gynecol, Vancouver, BC V5Z 1M9, Canada; [Gilks, C. Blake; Huntsman, David G.] Vancouver Gen Hosp, Genet Pathol & Evaluat Ctr, Vancouver, BC, Canada	University of British Columbia; British Columbia Cancer Agency; Novartis; CRUK Cambridge Institute; University of Cambridge; Child & Family Research Institute; University of British Columbia; University of British Columbia	Schrader, KA (corresponding author), Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada.	dhuntsma@bccancer.bc.ca	Brenton, James D/B-3174-2008; Huntsman, David/ABE-6082-2020	Brenton, James D/0000-0002-5738-6683; Schrader, Kasmintan/0000-0002-7413-4314; Leung, Peter/0000-0003-3152-3800; Monahan, John/0000-0002-3125-8704	Canadian Institutes of Health Research [MOP 97735]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant from the Canadian Institutes of Health Research MOP 97735. CIHR had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The high resolution melt assay used to screen the solid tumors was internally funded and performed at the Novartis Institutes for BioMedical Research. John Monahan and Bella Gorbatcheva of the Novartis Institutes for BioMedical Research designed this portion of the study, collected and analysed the resulting data. The decision to publish and preparation of the manuscript was done in collaboration with John Monahan and Bella Gorbatcheva.	Batista F, 2007, P NATL ACAD SCI USA, V104, P3330, DOI 10.1073/pnas.0611326104; Benayoun BA, 2009, HUM MOL GENET, V18, P632, DOI 10.1093/hmg/ddn389; Beysen D, 2008, HUM MOL GENET, V17, P2030, DOI 10.1093/hmg/ddn100; Beysen D, 2008, HUM MUTAT, V29, pE205, DOI 10.1002/humu.20819; Crisponi L, 2001, NAT GENET, V27, P159, DOI 10.1038/84781; Herrmann MG, 2007, CLIN CHEM, V53, P1544, DOI 10.1373/clinchem.2007.088120; Kalfa N, 2008, J UROLOGY, V180, P1810, DOI 10.1016/j.juro.2008.03.097; Koukourakis GV, 2008, INTEGR CANCER THER, V7, P204, DOI 10.1177/1534735408322845; Lie BL, 1996, MOL CELL ENDOCRINOL, V120, P169, DOI 10.1016/0303-7207(96)03835-X; Mayr D, 2008, PATHOL RES PRACT, V204, P823, DOI 10.1016/j.prp.2008.07.009; Moumne L, 2008, HUM MOL GENET, V17, P1010, DOI 10.1093/hmg/ddm373; Nishi Y, 2001, ENDOCRINOLOGY, V142, P437, DOI 10.1210/en.142.1.437; Reed GH, 2004, CLIN CHEM, V50, P1748, DOI 10.1373/clinchem.2003.029751; Schmidt D, 2004, DEVELOPMENT, V131, P933, DOI 10.1242/dev.00969; SHAH SP, 2009, N ENGL J MED	15	74	77	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2009	4	11							e7988	10.1371/journal.pone.0007988	http://dx.doi.org/10.1371/journal.pone.0007988			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MH	19956657	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000272827500018
J	Abplanalp, AL; Morris, IR; Parida, BK; Teale, JM; Berton, MT				Abplanalp, Allison L.; Morris, Ian R.; Parida, Bijaya K.; Teale, Judy M.; Berton, Michael T.			TLR-Dependent Control of Francisella tularensis Infection and Host Inflammatory Responses	PLOS ONE			English	Article							LIVE VACCINE STRAIN; TOLL-LIKE RECEPTOR-2; IMMUNE-RESPONSE; CUTTING EDGE; PROTECTIVE IMMUNITY; GAMMA-INTERFERON; DENDRITIC CELLS; INNATE IMMUNITY; INTRACELLULAR BACTERIUM; INTRANASAL VACCINATION	Background: Francisella tularensis is the causative agent of tularemia and is classified as a Category A select agent. Recent studies have implicated TLR2 as a critical element in the host protective response to F. tularensis infection, but questions remain about whether TLR2 signaling dominates the response in all circumstances and with all species of Francisella and whether F. tularensis PAMPs are predominantly recognized by TLR2/TLR1 or TLR2/TLR6. To address these questions, we have explored the role of Toll-like receptors (TLRs) in the host response to infections with F. tularensis Live Vaccine Strain (LVS) and F. tularensis subspecies (subsp.) novicida in vivo. Methodology/Principal Findings: C57BL/6 (B6) control mice and TLR-or MyD88-deficient mice were infected intranasally (i.n.) or intradermally (i.d.) with F. tularensis LVS or with F. tularensis subsp. novicida. B6 mice survived >21 days following infection with LVS by both routes and survival of TLR1(-/-), TLR4(-/-), and TLR6(-/-) mice infected i.n. with LVS was equivalent to controls. Survival of TLR2(-/-) and MyD88(-/-) mice, however, was significantly reduced compared to B6 mice, regardless of the route of infection or the subspecies of F. tularensis. TLR2(-/-) and MyD88(-/-) mice also showed increased bacterial burdens in lungs, liver, and spleen compared to controls following i.n. infection. Primary macrophages from MyD88(-/-) and TLR2(-/-) mice were significantly impaired in the ability to secrete TNF and other pro-inflammatory cytokines upon ex vivo infection with LVS. TNF expression was also impaired in vivo as demonstrated by analysis of bronchoalveolar lavage fluid and by in situ immunofluorescent staining. Conclusions/Significance: We conclude from these studies that TLR2 and MyD88, but not TLR4, play critical roles in the innate immune response to F. tularensis infection regardless of the route of infection or the subspecies. Moreover, signaling through TLR2 does not depend exclusively on TLR1 or TLR6 during F. tularensis LVS infection.			Abplanalp, AL (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA.	berton@uthscsa.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007271, P01AI057986] Funding Source: NIH RePORTER; NIAID NIH HHS [T32AI7271, P01 AI057986, AI057986, T32 AI007271] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Aliprantis AO, 1999, SCIENCE, V285, P736, DOI 10.1126/science.285.5428.736; Ancuta P, 1996, INFECT IMMUN, V64, P2041, DOI 10.1128/IAI.64.6.2041-2046.1996; ANTHONY LSD, 1991, INFECT IMMUN, V59, P3291, DOI 10.1128/IAI.59.9.3291-3296.1991; Archer KA, 2006, INFECT IMMUN, V74, P3325, DOI 10.1128/IAI.02049-05; Ben Nasr A, 2006, J LEUKOCYTE BIOL, V80, P774, DOI 10.1189/jlb.1205755; Bosio CM, 2005, J IMMUNOL, V175, P6792, DOI 10.4049/jimmunol.175.10.6792; Burns E, 2006, J IMMUNOL, V177, P8296, DOI 10.4049/jimmunol.177.12.8296; Checroun C, 2006, P NATL ACAD SCI USA, V103, P14578, DOI 10.1073/pnas.0601838103; Chen WX, 2005, IMMUNOL LETT, V97, P151, DOI 10.1016/j.imlet.2004.10.001; Chen WX, 2004, MICROB PATHOGENESIS, V37, P185, DOI 10.1016/j.micpath.2004.06.010; Chen WX, 2004, MICROB PATHOGENESIS, V36, P311, DOI 10.1016/j.micpath.2004.02.003; Clemens DL, 2004, INFECT IMMUN, V72, P3204, DOI 10.1128/IAI.72.6.3204-3217.2004; Cole LE, 2007, INFECT IMMUN, V75, P4127, DOI 10.1128/IAI.01868-06; Collazo CM, 2006, MICROBES INFECT, V8, P779, DOI 10.1016/j.micinf.2005.09.014; Collazo CM, 2009, INFECT IMMUN, V77, P2010, DOI 10.1128/IAI.01322-08; Conlan JW, 2002, MICROB PATHOGENESIS, V32, P127, DOI 10.1006/mpat.2001.0489; De Pascalis R, 2008, INFECT IMMUN, V76, P4311, DOI 10.1128/IAI.00514-08; Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; Duckett NS, 2005, INFECT IMMUN, V73, P2306, DOI 10.1128/IAI.73.4.2306-2311.2005; Echchannaoui H, 2002, J INFECT DIS, V186, P798, DOI 10.1086/342845; EIGELSBACH H, 1961, J IMMUNOL, V87, P415; Elkins KL, 2007, ANN NY ACAD SCI, V1105, P284, DOI 10.1196/annals.1409.014; ELKINS KL, 1992, MICROB PATHOGENESIS, V13, P417, DOI 10.1016/0882-4010(92)90085-3; ELKINS KL, 1993, INFECT IMMUN, V61, P823, DOI 10.1128/IAI.61.3.823-829.1993; Elkins KL, 1996, INFECT IMMUN, V64, P3288, DOI 10.1128/IAI.64.8.3288-3293.1996; Ellis J, 2002, CLIN MICROBIOL REV, V15, P631, DOI 10.1128/CMR.15.4.631-646.2002; Erridge C, 2004, J MED MICROBIOL, V53, P735, DOI 10.1099/jmm.0.45598-0; Forestal CA, 2008, MICROB PATHOGENESIS, V44, P512, DOI 10.1016/j.micpath.2008.01.003; FORTIER AH, 1991, INFECT IMMUN, V59, P2922, DOI 10.1128/IAI.59.9.2922-2928.1991; Golovliov I, 2003, INFECT IMMUN, V71, P5940, DOI 10.1128/IAI.71.10.5940-5950.2003; Griffin KF, 2007, FEMS IMMUNOL MED MIC, V49, P315, DOI 10.1111/j.1574-695X.2007.00219.x; Hajjar AM, 2006, INFECT IMMUN, V74, P6730, DOI 10.1128/IAI.00934-06; Hajjar AM, 2001, J IMMUNOL, V166, P15, DOI 10.4049/jimmunol.166.1.15; Hall JD, 2008, INFECT IMMUN, V76, P5843, DOI 10.1128/IAI.01176-08; Hall JD, 2007, INFECT IMMUN, V75, P1034, DOI 10.1128/IAI.01254-06; Hawn TR, 2006, J INFECT DIS, V193, P1693, DOI 10.1086/504525; HOLLIS DG, 1989, J CLIN MICROBIOL, V27, P1601, DOI 10.1128/JCM.27.7.1601-1608.1989; Hong KJ, 2007, INFECT IMMUN, V75, P5338, DOI 10.1128/IAI.00561-07; Hoshino K, 1999, J IMMUNOL, V162, P3749; Kanistanon D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040024; Katz J, 2006, INFECT IMMUN, V74, P2809, DOI 10.1128/IAI.74.5.2809-2816.2006; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kieffer TL, 2003, MICROBES INFECT, V5, P397, DOI 10.1016/S1286-4579(03)00052-2; Larson CL, 1955, PUBLIC HEALTH REP, V70, P253, DOI 10.2307/4589039; Lauriano CM, 2004, P NATL ACAD SCI USA, V101, P4246, DOI 10.1073/pnas.0307690101; LEIBY DA, 1992, INFECT IMMUN, V60, P84, DOI 10.1128/IAI.60.1.84-89.1992; Li HF, 2006, J LEUKOCYTE BIOL, V80, P766, DOI 10.1189/jlb.0406294; Lien E, 1999, J BIOL CHEM, V274, P33419, DOI 10.1074/jbc.274.47.33419; Lopez MC, 2004, CELL IMMUNOL, V232, P75, DOI 10.1016/j.cellimm.2005.02.001; Macela A, 1996, FEMS IMMUNOL MED MIC, V13, P235, DOI 10.1111/j.1574-695X.1996.tb00243.x; Malik M, 2006, INFECT IMMUN, V74, P3657, DOI 10.1128/IAI.02030-05; Mandell L, 2004, INFECT IMMUN, V72, P6446, DOI 10.1128/IAI.72.11.6446-6454.2004; Mares CA, 2008, INFECT IMMUN, V76, P3001, DOI 10.1128/IAI.00215-08; Mariathasan S, 2005, J EXP MED, V202, P1043, DOI 10.1084/jem.20050977; Massari P, 2006, J IMMUNOL, V176, P2373, DOI 10.4049/jimmunol.176.4.2373; McCaffrey RL, 2006, J LEUKOCYTE BIOL, V80, P1224, DOI 10.1189/jlb.0406287; MCCRUMB FR, 1961, BACTERIOL REV, V25, P262, DOI 10.1128/MMBR.25.3.262-267.1961; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Michelsen KS, 2001, J BIOL CHEM, V276, P25680, DOI 10.1074/jbc.M011615200; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Pammit MA, 2006, INFECT IMMUN, V74, P2063, DOI 10.1128/IAI.74.4.2063-2071.2006; SANDSTROM G, 1992, FEMS MICROBIOL IMMUN, V105, P201, DOI 10.1111/j.1574-6968.1992.tb05902.x; Sjostedt A, 2006, MICROBES INFECT, V8, P561, DOI 10.1016/j.micinf.2005.08.001; Takeuchi O, 2000, J IMMUNOL, V165, P5392, DOI 10.4049/jimmunol.165.10.5392; Takeuchi O, 2002, J IMMUNOL, V169, P10, DOI 10.4049/jimmunol.169.1.10; Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Telepnev M, 2003, CELL MICROBIOL, V5, P41, DOI 10.1046/j.1462-5822.2003.00251.x; Thakran S, 2008, J BIOL CHEM, V283, P3751, DOI 10.1074/jbc.M706854200; Wu TH, 2005, INFECT IMMUN, V73, P2644, DOI 10.1128/IAI.73.5.2644-2654.2005; Wyllie DH, 2000, J IMMUNOL, V165, P7125, DOI 10.4049/jimmunol.165.12.7125	73	42	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2009	4	11							e7920	10.1371/journal.pone.0007920	http://dx.doi.org/10.1371/journal.pone.0007920			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522NL	19936231	Green Published, gold, Green Submitted			2022-12-25	WOS:000272004800005
J	Choi, HY; Dieckmann, M; Herz, J; Niemeier, A				Choi, Hong Y.; Dieckmann, Marco; Herz, Joachim; Niemeier, Andreas			Lrp4, a Novel Receptor for Dickkopf 1 and Sclerostin, Is Expressed by Osteoblasts and Regulates Bone Growth and Turnover In Vivo	PLOS ONE			English	Article							VAN-BUCHEM-DISEASE; MINERAL DENSITY; VASCULAR WALL; DKK1-MEDIATED INHIBITION; CARTILAGE DEVELOPMENT; WNT PATHWAY; SOST GENE; MASS; DKK1; ANTAGONIST	Lrp4 is a multifunctional member of the low density lipoprotein-receptor gene family and a modulator of extracellular cell signaling pathways in development. For example, Lrp4 binds Wise, a secreted Wnt modulator and BMP antagonist. Lrp4 shares structural elements within the extracellular ligand binding domain with Lrp5 and Lrp6, two established Wnt co-receptors with important roles in osteogenesis. Sclerostin is a potent osteocyte secreted inhibitor of bone formation that directly binds Lrp5 and Lrp6 and modulates both BMP and Wnt signaling. The anti-osteogenic effect of sclerostin is thought to be mediated mainly by inhibition of Wnt signaling through Lrp5/6 within osteoblasts. Dickkopf1 (Dkk1) is another potent soluble Wnt inhibitor that binds to Lrp5 and Lrp6, can displace Lrp5-bound sclerostin and is itself regulated by BMPs. In a recent genome-wide association study of bone mineral density a significant modifier locus was detected near the SOST gene at 17q21, which encodes sclerostin. In addition, nonsynonymous SNPs in the LRP4 gene were suggestively associated with bone mineral density. Here we show that Lrp4 is expressed in bone and cultured osteoblasts and binds Dkk1 and sclerostin in vitro. MicroCT analysis of Lrp4 deficient mutant mice revealed shortened total femur length, reduced cortical femoral perimeter, and reduced total femur bone mineral content (BMC) and bone mineral density (BMD). Lumbar spine trabecular bone volume per total volume (BV/TV) was significantly reduced in the mutants and the serum and urinary bone turnover markers alkaline phosphatase, osteocalcin and desoxypyridinoline were increased. We conclude that Lrp4 is a novel osteoblast expressed Dkk1 and sclerostin receptor with a physiological role in the regulation of bone growth and turnover, which is likely mediated through its function as an integrator of Wnt and BMP signaling pathways.			Choi, HY (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA.	Joachim.Herz@UTSouthwestern.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL063762] Funding Source: NIH RePORTER; NHLBI NIH HHS [R37 HL063762] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ai M, 2005, MOL CELL BIOL, V25, P4946, DOI 10.1128/MCB.25.12.4946-4955.2005; Bafico A, 2001, NAT CELL BIOL, V3, P683, DOI 10.1038/35083081; Balemans W, 1999, AM J HUM GENET, V64, P1661, DOI 10.1086/302416; Balemans W, 2002, J MED GENET, V39, P91, DOI 10.1136/jmg.39.2.91; Balemans W, 2001, HUM MOL GENET, V10, P537, DOI 10.1093/hmg/10.5.537; Balemans W, 2008, CALCIFIED TISSUE INT, V82, P445, DOI 10.1007/s00223-008-9130-9; Balemans W, 2007, ENDOCRINOLOGY, V148, P2622, DOI 10.1210/en.2006-1352; Balemans W, 2007, J BONE MINER RES, V22, P708, DOI 10.1359/JBMR.070211; Baron R, 2007, ENDOCRINOLOGY, V148, P2635, DOI 10.1210/en.2007-0270; Bhat BM, 2007, GENE, V391, P103, DOI 10.1016/j.gene.2006.12.014; Boucher P, 2003, SCIENCE, V300, P329, DOI 10.1126/science.1082095; Boucher P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000448; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Brunkow ME, 2001, AM J HUM GENET, V68, P577, DOI 10.1086/318811; Chen M, 2008, J CELL SCI, V121, P1455, DOI 10.1242/jcs.020362; Deal C, 2009, NAT CLIN PRACT RHEUM, V5, P20, DOI 10.1038/ncprheum0977; Drogemuller C, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-5; Ducy P, 2000, CELL, V100, P197, DOI 10.1016/S0092-8674(00)81558-5; Ellies DL, 2006, J BONE MINER RES, V21, P1738, DOI 10.1359/JBMR.060810; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Grotewold L, 2002, EMBO J, V21, P966, DOI 10.1093/emboj/21.5.966; Herz J, 2009, J LIPID RES, V50, pS287, DOI 10.1194/jlr.R800077-JLR200; Hoeppner LH, 2009, EXPERT OPIN THER TAR, V13, P485, DOI [10.1517/14728220902841961, 10.1517/14728220902841961 ]; Johnson EB, 2005, HUM MOL GENET, V14, P3523, DOI 10.1093/hmg/ddi381; Kamiya N, 2008, DEVELOPMENT, V135, P3801, DOI 10.1242/dev.025825; Kanis JA, 2007, OSTEOPOROSIS INT, V18, P1033, DOI 10.1007/s00198-007-0343-y; Kim N, 2008, CELL, V135, P334, DOI 10.1016/j.cell.2008.10.002; Kobayashi T, 2005, P NATL ACAD SCI USA, V102, P18023, DOI 10.1073/pnas.0503617102; Kusu N, 2003, J BIOL CHEM, V278, P24113, DOI 10.1074/jbc.M301716200; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Li XF, 2005, J BIOL CHEM, V280, P19883, DOI 10.1074/jbc.M413274200; Li XD, 2008, J BONE MINER RES, V23, P860, DOI 10.1359/JBMR.080216; Loots GG, 2005, GENOME RES, V15, P928, DOI 10.1101/gr.3437105; MacDonald BT, 2007, BONE, V41, P331, DOI 10.1016/j.bone.2007.05.009; MacDonald BT, 2004, DEVELOPMENT, V131, P2543, DOI 10.1242/dev.01126; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; McClung Michael R, 2005, Curr Osteoporos Rep, V3, P57, DOI 10.1007/s11914-005-0005-y; Mukhopadhyay M, 2001, DEV CELL, V1, P423, DOI 10.1016/S1534-5807(01)00041-7; Nagayama M, 2008, J DENT RES, V87, P244, DOI 10.1177/154405910808700309; Ohazama A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004092; Perry MJ, 2008, BONE, V42, P216, DOI 10.1016/j.bone.2007.09.053; Piters E, 2008, ARCH BIOCHEM BIOPHYS, V473, P112, DOI 10.1016/j.abb.2008.03.006; Simon-Chazottes D, 2006, GENOMICS, V87, P673, DOI 10.1016/j.ygeno.2006.01.007; Sims AM, 2008, J BONE MINER RES, V23, P499, DOI 10.1359/JBMR.071113; Strickland DK, 2002, TRENDS ENDOCRIN MET, V13, P66, DOI 10.1016/S1043-2760(01)00526-4; Styrkarsdottir U, 2008, NEW ENGL J MED, V358, P2355, DOI 10.1056/NEJMoa0801197; Styrkarsdottir U, 2009, NAT GENET, V41, P15, DOI 10.1038/ng.284; Tomita Y, 1998, J BIOCHEM-TOKYO, V124, P784, DOI 10.1093/oxfordjournals.jbchem.a022180; Uitterlinden AG, 2004, AM J HUM GENET, V75, P1032, DOI 10.1086/426458; van Bezooijen RL, 2007, J BONE MINER RES, V22, P19, DOI 10.1359/JBMR.061002; Wang K, 2008, J BIOL CHEM, V283, P23371, DOI 10.1074/jbc.M802376200; Weatherbee SD, 2006, DEVELOPMENT, V133, P4993, DOI 10.1242/dev.02696; Williams BO, 2009, J BONE MINER RES, V24, P171, DOI [10.1359/JBMR.081235, 10.1359/jbmr.081235]; Willnow TE, 1999, NAT CELL BIOL, V1, pE157, DOI 10.1038/14109; WILLNOW TE, 1994, SCIENCE, V264, P1471, DOI 10.1126/science.7515194; Winkler DG, 2005, J BIOL CHEM, V280, P2498, DOI 10.1074/jbc.M400524200; Winkler DG, 2003, EMBO J, V22, P6267, DOI 10.1093/emboj/cdg599; Yamaguchi YL, 2006, GENE EXPR PATTERNS, V6, P607, DOI 10.1016/j.modgep.2005.11.013; Zhang B, 2008, NEURON, V60, P285, DOI 10.1016/j.neuron.2008.10.006; Zhou L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006922	61	156	166	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2009	4	11							e7930	10.1371/journal.pone.0007930	http://dx.doi.org/10.1371/journal.pone.0007930			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522NL	19936252	Green Published, Green Submitted, gold			2022-12-25	WOS:000272004800011
J	Teyssier, C; Gallet, M; Rabier, B; Monfoulet, L; Dine, J; Macari, C; Espallergues, J; Horard, B; Giguere, V; Cohen-Solal, M; Chassande, O; Vanacker, JM				Teyssier, Catherine; Gallet, Marlene; Rabier, Benedicte; Monfoulet, Laurent; Dine, Julien; Macari, Claire; Espallergues, Julie; Horard, Beatrice; Giguere, Vincent; Cohen-Solal, Martine; Chassande, Olivier; Vanacker, Jean-Marc			Absence of ERR alpha in Female Mice Confers Resistance to Bone Loss Induced by Age or Estrogen-Deficiency	PLOS ONE			English	Article							RECEPTOR-RELATED RECEPTORS; OSTEOBLAST DIFFERENTIATION; TRANSCRIPTIONAL ACTIVATOR; OSTEOPONTIN DEFICIENCY; MINERAL CRYSTALLINITY; ORPHAN RECEPTOR; MOUSE BONE; RESORPTION; OSTEOPROTEGERIN; EXPRESSION	Background: ERR alpha is an orphan member of the nuclear hormone receptor superfamily, which acts as a transcription factor and is involved in various metabolic processes. ERR alpha is also highly expressed in ossification zones during mouse development as well as in human bones and cell lines. Previous data have shown that this receptor up-modulates the expression of osteopontin, which acts as an inhibitor of bone mineralization and whose absence results in resistance to ovariectomy-induced bone loss. Altogether this suggests that ERR alpha may negatively regulate bone mass and could impact on bone fragility that occurs in the absence of estrogens. Methods/Principal Findings: In this report, we have determined the in vivo effect of ERR alpha on bone, using knock-out mice. Relative to wild type animals, female ERR alpha KO bones do not age and are resistant to bone loss induced by estrogen-withdrawal. Strikingly male ERR alpha KO mice are indistinguishable from their wild type counterparts, both at the unchallenged or gonadectomized state. Using primary cell cultures originating from ERR alpha KO bone marrow, we also show that ERR alpha acts as an inhibitor of osteoblast differentiation. Conclusion/Significance: Down-regulating ERR alpha could thus be beneficial against osteoporosis.	[Teyssier, Catherine; Gallet, Marlene; Macari, Claire; Chassande, Olivier; Vanacker, Jean-Marc] Univ Lyon 1, Inst Genom Fonct Lyon, CNRS, Ecole Normale Super Lyon,Inst Natl Rech Agron, F-69365 Lyon, France; [Rabier, Benedicte; Monfoulet, Laurent; Dine, Julien; Chassande, Olivier] Univ Bordeaux 2, U577, INSERM, Bordeaux, France; [Espallergues, Julie] Univ Montpellier 2, U710, INSERM, Montpellier, France; [Horard, Beatrice] Ecole Normale Super Lyon, UMRS239, CNRS, Lab Biol Mol Cellule, Villeurbanne, France; [Giguere, Vincent] Rosalind & Morris Goodman Canc Ctr, Montreal, PQ, Canada; [Cohen-Solal, Martine] Hop Lariboisiere, U606, INSERM, Paris, France	INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Teyssier, C (corresponding author), Univ Lyon 1, Inst Genom Fonct Lyon, CNRS, Ecole Normale Super Lyon,Inst Natl Rech Agron, F-69365 Lyon, France.	jean-marc.vanacker@ens-lyon.fr	Monfoulet, Laurent-Emmanuel/O-6508-2016; Teyssier, Catherine/AAC-2395-2020; Chassande, Olivier/J-3582-2015; Cohen-Solal, Martine/P-7808-2017	Monfoulet, Laurent-Emmanuel/0000-0001-9836-0255; Teyssier, Catherine/0000-0003-4937-6503; Cohen-Solal, Martine/0000-0002-8582-8258; Giguere, Vincent/0000-0001-9567-3694				Ariazi EA, 2006, CURR TOP MED CHEM, V6, P203, DOI 10.2174/1568026610606030203; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Bianco S, 2009, J BIOL CHEM, V284, P23286, DOI 10.1074/jbc.M109.028191; Bonnelye E, 1997, MOL ENDOCRINOL, V11, P905, DOI 10.1210/me.11.7.905; Bonnelye E, 1997, MECH DEVELOP, V65, P71, DOI 10.1016/S0925-4773(97)00059-2; Bonnelye E, 2001, J CELL BIOL, V153, P971, DOI 10.1083/jcb.153.5.971; Boskey AL, 2002, CALCIFIED TISSUE INT, V71, P145, DOI 10.1007/s00223-001-1121-z; Boyce BF, 2008, ARCH BIOCHEM BIOPHYS, V473, P139, DOI 10.1016/j.abb.2008.03.018; Delhon I, 2009, ENDOCRINOLOGY, V150, P4463, DOI 10.1210/en.2009-0121; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; GIGUERE V, 1988, NATURE, V331, P91, DOI 10.1038/331091a0; Giguere V, 1999, ENDOCR REV, V20, P689, DOI 10.1210/er.20.5.689; Giguere V, 2008, ENDOCR REV, V29, P677, DOI 10.1210/er.2008-0017; Horard B, 2003, J MOL ENDOCRINOL, V31, P349, DOI 10.1677/jme.0.0310349; Ishijima M, 2001, J EXP MED, V193, P399, DOI 10.1084/jem.193.3.399; Jeong BC, 2009, J BIOL CHEM, V284, P14211, DOI 10.1074/jbc.M808345200; Kavukcuoglu NB, 2007, J BIOMED MATER RES A, V83A, P136, DOI 10.1002/jbm.a.31081; Komori T, 2006, J CELL BIOCHEM, V99, P1233, DOI 10.1002/jcb.20958; Kostenuik PJ, 2005, CURR OPIN PHARMACOL, V5, P618, DOI 10.1016/j.coph.2005.06.005; Laflamme N, 2005, J BONE MINER RES, V20, P938, DOI 10.1359/JBMR.050203; LAUDET V, 2002, NUCL RECEPTOR FACTBO; Luo JM, 2003, MOL CELL BIOL, V23, P7947, DOI 10.1128/MCB.23.22.7947-7956.2003; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; NODA M, 2002, PRINCIPLES BONE BIOL, V1, P239; Raisz LG, 2005, J CLIN INVEST, V115, P3318, DOI 10.1172/JCI27071; REINHOLT FP, 1990, P NATL ACAD SCI USA, V87, P4473, DOI 10.1073/pnas.87.12.4473; ROSS FP, 1993, J BIOL CHEM, V268, P9901; Schreiber SN, 2004, P NATL ACAD SCI USA, V101, P6472, DOI 10.1073/pnas.0308686101; Shapses SA, 2003, CALCIFIED TISSUE INT, V73, P86, DOI 10.1007/s00223-002-1090-x; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Syed F, 2005, BIOCHEM BIOPH RES CO, V328, P688, DOI 10.1016/j.bbrc.2004.11.097; Tremblay Annie M, 2007, Nucl Recept Signal, V5, pe009, DOI 10.1621/nrs.05009; Vanacker JM, 1998, CELL GROWTH DIFFER, V9, P1007; Vanacker JM, 1999, EMBO J, V18, P4270, DOI 10.1093/emboj/18.15.4270; Villena JA, 2008, TRENDS ENDOCRIN MET, V19, P269, DOI 10.1016/j.tem.2008.07.005; Wada T, 2006, TRENDS MOL MED, V12, P17, DOI 10.1016/j.molmed.2005.11.007; Xing LP, 2005, IMMUNOL REV, V208, P19, DOI 10.1111/j.0105-2896.2005.00336.x; Yoshitake H, 1999, P NATL ACAD SCI USA, V96, P8156, DOI 10.1073/pnas.96.14.8156; Zirngibl RA, 2008, J MOL ENDOCRINOL, V40, P61, DOI 10.1677/JME-07-0114	39	31	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2009	4	11							e7942	10.1371/journal.pone.0007942	http://dx.doi.org/10.1371/journal.pone.0007942			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522NL	19936213	Green Published, gold, Green Submitted			2022-12-25	WOS:000272004800019
J	Willuweit, A; Velden, J; Godemann, R; Manook, A; Jetzek, F; Tintrup, H; Kauselmann, G; Zevnik, B; Henriksen, G; Drzezga, A; Pohlner, J; Schoor, M; Kemp, JA; von der Kammer, H				Willuweit, Antje; Velden, Joachim; Godemann, Robert; Manook, Andre; Jetzek, Fritz; Tintrup, Hartmut; Kauselmann, Gunther; Zevnik, Branko; Henriksen, Gjermund; Drzezga, Alexander; Pohlner, Johannes; Schoor, Michael; Kemp, John A.; von der Kammer, Heinz			Early-Onset and Robust Amyloid Pathology in a New Homozygous Mouse Model of Alzheimer's Disease	PLOS ONE			English	Article							A-BETA-DEPOSITION; TRANSGENIC MICE; PRECURSOR-PROTEIN; COGNITIVE DEFICITS; MUTANT PRESENILIN-1; IN-VIVO; PLAQUES; BRAIN; SENILE; NEUROPATHOLOGY	Background: Transgenic mice expressing mutated amyloid precursor protein (APP) and presenilin (PS)-1 or -2 have been successfully used to model cerebral beta-amyloidosis, one of the characteristic hallmarks of Alzheimer's disease (AD) pathology. However, the use of many transgenic lines is limited by premature death, low breeding efficiencies and late onset and high inter-animal variability of the pathology, creating a need for improved animal models. Here we describe the detailed characterization of a new homozygous double-transgenic mouse line that addresses most of these issues. Methodology/Principal Findings: The transgenic mouse line (ARTE10) was generated by co-integration of two transgenes carrying the K670N/M671L mutated amyloid precursor protein (APP(swe)) and the M146V mutated presenilin 1 (PS1) both under control of a neuron-specific promoter. Mice, hemi-as well as homozygous for both transgenes, are viable and fertile with good breeding capabilities and a low rate of premature death. They develop robust AD-like cerebral beta-amyloid plaque pathology with glial inflammation, signs of neuritic dystrophy and cerebral amyloid angiopathy. Using our novel image analysis algorithm for semi-automatic quantification of plaque burden, we demonstrate an early onset and progressive plaque deposition starting at 3 months of age in homozygous mice with low inter-animal variability and 100%-penetrance of the phenotype. The plaques are readily detected in vivo by PiB, the standard human PET tracer for AD. In addition, ARTE10 mice display early loss of synaptic markers and age-related cognitive deficits. By applying a gamma-secretase inhibitor we show a dose dependent reduction of soluble amyloid beta levels in the brain. Conclusions: ARTE10 mice develop a cerebral beta-amyloidosis closely resembling the beta-amyloid-related aspects of human AD neuropathology. Unifying several advantages of previous transgenic models, this line particularly qualifies for the use in target validation and for evaluating potential diagnostic or therapeutic agents targeting the amyloid pathology of AD.			Willuweit, A (corresponding author), Evotec Neurosci GmbH, Hamburg, Germany.	antje.willuweit@evotec.com; heinz.vonderkammer@evotec.com	Zevnik, Branko/AAB-7853-2020	Zevnik, Branko/0000-0001-7845-9522; Willuweit, Antje/0000-0002-6725-0755; Drzezga, Alexander/0000-0001-6018-716X				Arnold SE, 1991, CEREB CORTEX, V1, P103, DOI 10.1093/cercor/1.1.103; BANCHER C, 1991, BRAIN RES, V539, P11, DOI 10.1016/0006-8993(91)90681-K; Bondolfi L, 2002, J NEUROSCI, V22, P515, DOI 10.1523/JNEUROSCI.22-02-00515.2002; Callahan MJ, 2001, AM J PATHOL, V158, P1173, DOI 10.1016/S0002-9440(10)64064-3; Chishti MA, 2001, J BIOL CHEM, V276, P21562, DOI 10.1074/jbc.M100710200; Chubb C, 2006, NEUROBIOL AGING, V27, P1462, DOI 10.1016/j.neurobiolaging.2005.08.023; Churcher I, 2006, BIOORG MED CHEM LETT, V16, P280, DOI 10.1016/j.bmcl.2005.10.009; Coleman PD, 2003, NEUROBIOL AGING, V24, P1023, DOI 10.1016/j.neurobiolaging.2003.09.001; Corder EH, 2000, EXP GERONTOL, V35, P851, DOI 10.1016/S0531-5565(00)00147-9; Counts SE, 2006, J NEUROPATH EXP NEUR, V65, P592, DOI 10.1097/00005072-200606000-00007; Cummings BJ, 2002, NEUROBIOL AGING, V23, P161, DOI 10.1016/S0197-4580(01)00316-5; Dodart JC, 1999, BEHAV NEUROSCI, V113, P982, DOI 10.1037/0735-7044.113.5.982; Dong HX, 2007, J COMP NEUROL, V500, P311, DOI 10.1002/cne.21176; DUYCKAERTS C, 1999, ALZHEIMERS DIS RELAT; Franklin KBJ, 2008, MOUSE BRAIN STEREOTA, V3rd; Freude S, 2009, FASEB J, V23, P3315, DOI 10.1096/fj.09-132043; Garcia-Alloza M, 2006, NEUROBIOL DIS, V24, P516, DOI 10.1016/j.nbd.2006.08.017; Gordon MN, 2002, EXP NEUROL, V173, P183, DOI 10.1006/exnr.2001.7754; Gordon MN, 2001, NEUROBIOL AGING, V22, P377, DOI 10.1016/S0197-4580(00)00249-9; Gouras GK, 2000, AM J PATHOL, V156, P15, DOI 10.1016/S0002-9440(10)64700-1; Gylys KH, 2004, AM J PATHOL, V165, P1809, DOI 10.1016/S0002-9440(10)63436-0; Harigaya Y, 1996, J NEUROSCI RES, V43, P87, DOI 10.1002/jnr.490430111; Hatanpaa K, 1999, J NEUROPATH EXP NEUR, V58, P637, DOI 10.1097/00005072-199906000-00008; Herzig MC, 2004, NAT NEUROSCI, V7, P954, DOI 10.1038/nn1302; Hogan B, 1994, MANIPULATING MOUSE E; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; Horgan J, 2007, J ALZHEIMERS DIS, V12, P115; Howlett DR, 2008, HISTOL HISTOPATHOL, V23, P67, DOI 10.14670/HH-23.67; Howlett DR, 2004, BRAIN RES, V1017, P130, DOI 10.1016/j.brainres.2004.05.029; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Hwang DY, 2005, CELL MOL NEUROBIOL, V25, P881, DOI 10.1007/s10571-005-4950-x; Hyde LA, 2005, BEHAV BRAIN RES, V160, P344, DOI 10.1016/j.bbr.2004.12.017; Ingelsson M, 2004, NEUROLOGY, V62, P925, DOI 10.1212/01.WNL.0000115115.98960.37; Jacobsen JS, 2006, P NATL ACAD SCI USA, V103, P5161, DOI 10.1073/pnas.0600948103; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; King DL, 1999, BEHAV BRAIN RES, V103, P145, DOI 10.1016/S0166-4328(99)00037-6; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Kuo YM, 2001, MOL MED, V7, P609, DOI 10.1007/BF03401867; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Luthi A, 1997, J NEUROSCI, V17, P4688; Maeda J, 2007, J NEUROSCI, V27, P10957, DOI 10.1523/JNEUROSCI.0673-07.2007; MANN DMA, 1989, ANN MED, V21, P133, DOI 10.3109/07853898909149200; MASLIAH E, 1991, EXP NEUROL, V113, P131, DOI 10.1016/0014-4886(91)90169-D; McConlogue L, 2007, J BIOL CHEM, V282, P26326, DOI 10.1074/jbc.M611687200; McGowan E, 1999, NEUROBIOL DIS, V6, P231, DOI 10.1006/nbdi.1999.0243; McGowan E, 2006, TRENDS GENET, V22, P281, DOI 10.1016/j.tig.2006.03.007; McLean CA, 2001, J ALZHEIMERS DIS, V3, P305, DOI 10.3233/JAD-2001-3305; Metsaars WP, 2003, NEUROBIOL AGING, V24, P563, DOI 10.1016/S0197-4580(02)00134-3; Moechars D, 1999, J BIOL CHEM, V274, P6483, DOI 10.1074/jbc.274.10.6483; Ozmen L, 2009, NEURODEGENER DIS, V6, P29, DOI 10.1159/000170884; PRICE JL, 1991, NEUROBIOL AGING, V12, P295, DOI 10.1016/0197-4580(91)90006-6; PUCHTLER H, 1965, J HISTOCHEM CYTOCHEM, V13, P693, DOI 10.1177/13.8.693; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; Richards JG, 2003, J NEUROSCI, V23, P8989; Rouleau I, 1996, BRAIN COGNITION, V31, P17, DOI 10.1006/brcg.1996.0022; RUDELLI RD, 1984, ACTA NEUROPATHOL, V64, P273, DOI 10.1007/BF00690393; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Selkoe DJ, 2005, ARCH NEUROL-CHICAGO, V62, P192, DOI 10.1001/archneur.62.2.192; Sigurdsson EM, 2004, J NEUROSCI, V24, P6277, DOI 10.1523/JNEUROSCI.1344-04.2004; Spires TL, 2005, J NEUROSCI, V25, P7278, DOI 10.1523/JNEUROSCI.1879-05.2005; SturchlerPierrat C, 1997, P NATL ACAD SCI USA, V94, P13287, DOI 10.1073/pnas.94.24.13287; Sze CI, 1997, J NEUROPATH EXP NEUR, V56, P933, DOI 10.1097/00005072-199708000-00011; Takeuchi A, 2000, AM J PATHOL, V157, P331, DOI 10.1016/S0002-9440(10)64544-0; Tsai J, 2004, NAT NEUROSCI, V7, P1181, DOI 10.1038/nn1335; Wang J, 2003, NEUROBIOL DIS, V14, P318, DOI 10.1016/j.nbd.2003.08.009; Wolfer DP, 2001, PHYSIOL BEHAV, V73, P745, DOI 10.1016/S0031-9384(01)00531-5	69	40	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2009	4	11							e7931	10.1371/journal.pone.0007931	http://dx.doi.org/10.1371/journal.pone.0007931			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522NL	19936202	Green Published, Green Submitted, gold			2022-12-25	WOS:000272004800012
J	Baqri, RM; Turner, BA; Rheuben, MB; Hammond, BD; Kaguni, LS; Miller, KE				Baqri, Rehan M.; Turner, Brittany A.; Rheuben, Mary B.; Hammond, Bradley D.; Kaguni, Laurie S.; Miller, Kyle E.			Disruption of Mitochondrial DNA Replication in Drosophila Increases Mitochondrial Fast Axonal Transport In Vivo	PLOS ONE			English	Article							MARIE-TOOTH-DISEASE; POLYMERASE-GAMMA; OXIDATIVE-PHOSPHORYLATION; CATALYTIC SUBUNIT; ACCESSORY SUBUNIT; ALPERS-SYNDROME; POLG MUTATIONS; KINESIN; NEURONS; MELANOGASTER	Mutations in mitochondrial DNA polymerase (pol gamma) cause several progressive human diseases including Parkinson's disease, Alper's syndrome, and progressive external ophthalmoplegia. At the cellular level, disruption of pol gamma leads to depletion of mtDNA, disrupts the mitochondrial respiratory chain, and increases susceptibility to oxidative stress. Although recent studies have intensified focus on the role of mtDNA in neuronal diseases, the changes that take place in mitochondrial biogenesis and mitochondrial axonal transport when mtDNA replication is disrupted are unknown. Using high-speed confocal microscopy, electron microscopy and biochemical approaches, we report that mutations in pol gamma deplete mtDNA levels and lead to an increase in mitochondrial density in Drosophila proximal nerves and muscles, without a noticeable increase in mitochondrial fragmentation. Furthermore, there is a rise in flux of bidirectional mitochondrial axonal transport, albeit with slower kinesin-based anterograde transport. In contrast, flux of synaptic vesicle precursors was modestly decreased in pol gamma-alpha mutants. Our data indicate that disruption of mtDNA replication does not hinder mitochondrial biogenesis, increases mitochondrial axonal transport, and raises the question of whether high levels of circulating mtDNA-deficient mitochondria are beneficial or deleterious in mtDNA diseases.			Baqri, RM (corresponding author), Michigan State Univ, Dept Zool, E Lansing, MI 48824 USA.	kmiller@msu.edu		Miller, Kyle/0000-0003-0401-4736	NIGMS NIH HHS [GM45295, R01 GM045295] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045295] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adan C, 2008, J BIOL CHEM, V283, P12333, DOI 10.1074/jbc.M801342200; Amiri M, 2008, DEV NEUROBIOL, V68, P1348, DOI 10.1002/dneu.20668; Ashley N, 2005, EXP CELL RES, V303, P432, DOI 10.1016/j.yexcr.2004.10.013; Atlante A, 2005, BBA-BIOENERGETICS, V1708, P50, DOI 10.1016/j.bbabio.2005.01.009; Baloh RH, 2007, J NEUROSCI, V27, P422, DOI 10.1523/JNEUROSCI.4798-06.2007; Beal MF, 2005, ANN NEUROL, V58, P495, DOI 10.1002/ana.20624; Betts J, 2004, NEUROCHEM RES, V29, P505, DOI 10.1023/B:NERE.0000014821.07269.8d; BRADY ST, 1985, NATURE, V317, P73, DOI 10.1038/317073a0; Chang DTW, 2006, NEUROBIOL DIS, V22, P388, DOI 10.1016/j.nbd.2005.12.007; Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831; Davis AF, 1996, J CELL BIOL, V135, P883, DOI 10.1083/jcb.135.4.883; De Vos KJ, 2007, HUM MOL GENET, V16, P2720, DOI 10.1093/hmg/ddm226; DIMAURO S, 1987, J INHERIT METAB DIS, V10, P113, DOI 10.1007/BF01812852; Ebneth A, 1998, J CELL BIOL, V143, P777, DOI 10.1083/jcb.143.3.777; Escobar-Khondiker M, 2007, J NEUROSCI, V27, P7827, DOI 10.1523/JNEUROSCI.1644-07.2007; Ferreirinha F, 2004, J CLIN INVEST, V113, P231, DOI 10.1172/JCI200420138; Fisher ME, 2001, P NATL ACAD SCI USA, V98, P7748, DOI 10.1073/pnas.141080498; FRIEDE RL, 1977, J PHYSIOL-LONDON, V265, P507, DOI 10.1113/jphysiol.1977.sp011727; Gajewski CD, 2003, MOL BIOL CELL, V14, P3628, DOI 10.1091/mbc.E02-12-0796; GODDARD JM, 1978, P NATL ACAD SCI USA, V75, P3886, DOI 10.1073/pnas.75.8.3886; Goldstein AYN, 2008, CURR OPIN NEUROBIOL, V18, P495, DOI 10.1016/j.conb.2008.10.003; Goldstein LSB, 2003, NEURON, V40, P415, DOI 10.1016/S0896-6273(03)00630-5; GOTT AL, 1990, HUM REPROD, V5, P104, DOI 10.1093/oxfordjournals.humrep.a137028; Hansson A, 2004, P NATL ACAD SCI USA, V101, P3136, DOI 10.1073/pnas.0308710100; Harrower T, 2008, ARCH NEUROL-CHICAGO, V65, P133, DOI 10.1001/archneurol.2007.4; Heddi A, 1999, J BIOL CHEM, V274, P22968, DOI 10.1074/jbc.274.33.22968; Hirokawa N, 2008, PHYSIOL REV, V88, P1089, DOI 10.1152/physrev.00023.2007; HOLLENBECK PJ, 1985, CELL BIOL INT REP, V9, P193, DOI 10.1016/0309-1651(85)90094-3; Iyengar B, 1999, GENETICS, V153, P1809; Iyengar B, 2002, P NATL ACAD SCI USA, V99, P4483, DOI 10.1073/pnas.072664899; Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Klopfenstein DR, 2004, MOL BIOL CELL, V15, P3729, DOI 10.1091/mbc.E04-04-0326; Knott AB, 2008, NAT REV NEUROSCI, V9, P505, DOI 10.1038/nrn2417; Kundu M, 2005, CELL DEATH DIFFER, V12, P1484, DOI 10.1038/sj.cdd.4401780; Legros F, 2004, J CELL SCI, V117, P2653, DOI 10.1242/jcs.01134; Lewis DL, 1996, J BIOL CHEM, V271, P23389, DOI 10.1074/jbc.271.38.23389; Lewis W, 2003, NAT REV DRUG DISCOV, V2, P812, DOI 10.1038/nrd1201; Liu D, 2006, NEUROMOL MED, V8, P389, DOI 10.1385/NMM:8:3:389; Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303; Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3; Luoma PT, 2007, NEUROLOGY, V69, P1152, DOI 10.1212/01.wnl.0000276955.23735.eb; Mansouri A, 2003, HEPATOLOGY, V38, P715, DOI 10.1053/jhep.2003.50353; MARTINEZAZORIN F, 2007, J NEUROCHEM; McKenzie M, 2007, J BIOL CHEM, V282, P36845, DOI 10.1074/jbc.M704158200; Miller KE, 2004, J CELL SCI, V117, P2791, DOI 10.1242/jcs.01130; Miller KE, 2005, CURR BIOL, V15, P684, DOI 10.1016/j.cub.2005.02.061; Mironov SL, 2007, BIOPHYS J, V92, P2944, DOI 10.1529/biophysj.106.092981; Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079; Naviaux RK, 1999, ANN NEUROL, V45, P54, DOI 10.1002/1531-8249(199901)45:1<54::AID-ART10>3.0.CO;2-B; OCHS S, 1971, J NEUROCHEM, V18, P107, DOI 10.1111/j.1471-4159.1971.tb00172.x; PASCHAL BM, 1987, J CELL BIOL, V105, P1273, DOI 10.1083/jcb.105.3.1273; Piccioni F, 2002, FASEB J, V16, P1418, DOI 10.1096/fj.01-1035fje; PILLING AD, 2006, MOL BIOL CELL; Samuels DC, 2006, IUBMB LIFE, V58, P403, DOI 10.1080/15216540600791571; Sanyal S, 2009, GENE EXPR PATTERNS, V9, P371, DOI 10.1016/j.gep.2009.01.002; SENIOR AE, 1988, PHYSIOL REV, V68, P177, DOI 10.1152/physrev.1988.68.1.177; SHOFFNER JM, 1994, ANNU REV NUTR, V14, P535, DOI 10.1146/annurev.nu.14.070194.002535; Smeitink JA, 2006, CELL METAB, V3, P9, DOI 10.1016/j.cmet.2005.12.001; Sweeney ST, 2002, NEURON, V36, P403, DOI 10.1016/S0896-6273(02)01014-0; VALE RD, 1985, CELL, V42, P39, DOI 10.1016/S0092-8674(85)80099-4; Verburg J, 2008, J NEUROSCI, V28, P8306, DOI 10.1523/JNEUROSCI.2614-08.2008; Wang YX, 1997, J BIOL CHEM, V272, P13640, DOI 10.1074/jbc.272.21.13640	63	30	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2009	4	11							e7874	10.1371/journal.pone.0007874	http://dx.doi.org/10.1371/journal.pone.0007874			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520OG	19924234	Green Submitted, gold, Green Published			2022-12-25	WOS:000271854200020
J	Lee, MJ; Chang, CP; Lee, YH; Wu, YC; Tseng, HW; Tung, YY; Wu, MT; Chen, YH; Kuo, LT; Stephenson, D; Hung, SI; Wu, JY; Chang, C; Chen, YT; Chern, YJ				Lee, Ming-Jen; Chang, Ching-Pang; Lee, Yi-Hsin; Wu, Yi-Chih; Tseng, Hsu-Wen; Tung, Yu-Ying; Wu, Min-Tzu; Chen, Yen-Hui; Kuo, Lu-Ting; Stephenson, Dennis; Hung, Shuen-Iu; Wu, Jer-Yuarn; Chang, Chen; Chen, Yuan-Tsong; Chern, Yijuang			Longitudinal Evaluation of an N-Ethyl-N-Nitrosourea-Created Murine Model with Normal Pressure Hydrocephalus	PLOS ONE			English	Article							CONGENITAL HYDROCEPHALUS; MICROGLIAL ACTIVATION; COGNITIVE IMPAIRMENT; FLUID PRESSURE; MOUSE; DEFICIENCY; MUTATION; DISEASE; DAMAGE; GENES	Background: Normal-pressure hydrocephalus (NPH) is a neurodegenerative disorder that usually occurs late in adult life. Clinically, the cardinal features include gait disturbances, urinary incontinence, and cognitive decline. Methodology/Principal Findings: Herein we report the characterization of a novel mouse model of NPH (designated p23-ST1), created by N-ethyl-N-nitrosourea (ENU)-induced mutagenesis. The ventricular size in the brain was measured by 3-dimensional micro-magnetic resonance imaging (3D-MRI) and was found to be enlarged. Intracranial pressure was measured and was found to fall within a normal range. A histological assessment and tracer flow study revealed that the cerebral spinal fluid (CSF) pathway of p23-ST1 mice was normal without obstruction. Motor functions were assessed using a rotarod apparatus and a CatWalk gait automatic analyzer. Mutant mice showed poor rotarod performance and gait disturbances. Cognitive function was evaluated using auditory fear-conditioned responses with the mutant displaying both short-and long-term memory deficits. With an increase in urination frequency and volume, the mutant showed features of incontinence. Nissl substance staining and cell-type-specific markers were used to examine the brain pathology. These studies revealed concurrent glial activation and neuronal loss in the periventricular regions of mutant animals. In particular, chronically activated microglia were found in septal areas at a relatively young age, implying that microglial activation might contribute to the pathogenesis of NPH. These defects were transmitted in an autosomal dominant mode with reduced penetrance. Using a whole-genome scan employing 287 single-nucleotide polymorphic (SNP) markers and further refinement using six additional SNP markers and four microsatellite markers, the causative mutation was mapped to a 5.3-cM region on chromosome 4. Conclusions/Significance: Our results collectively demonstrate that the p23-ST1 mouse is a novel mouse model of human NPH. Clinical observations suggest that dysfunctions and alterations in the brains of patients with NPH might occur much earlier than the appearance of clinical signs. p23-ST1 mice provide a unique opportunity to characterize molecular changes and the pathogenic mechanism of NPH.			Lee, MJ (corresponding author), Natl Taiwan Univ, Natl Taiwan Univ Hosp, Coll Med, Dept Neurol, Taipei 10764, Taiwan.	bmychern@ibms.sinica.edu.tw	Wu, Jer-Yuarn/S-7010-2018; Kuo, Lu-Ting/AAU-3205-2021; Chang, Chen/B-5079-2009; Hung, Shuen-Iu/HHS-9012-2022; chern, yijuang/S-7013-2018; Hung, Shuen-Iu/ABB-2139-2021	chern, yijuang/0000-0002-5842-5429; Hung, Shuen-Iu/0000-0001-6531-5538; Lee, Ming-Jen/0000-0001-8732-2448; Kuo, Lu-Ting/0000-0002-1405-8700				ADAMS RD, 1965, NEW ENGL J MED, V273, P117, DOI 10.1056/NEJM196507152730301; Azzi GM, 1999, ACTA NEUROPATHOL, V98, P245, DOI 10.1007/s004010051076; BRONSON RT, 1990, DEV BRAIN RES, V54, P131, DOI 10.1016/0165-3806(90)90073-8; Chalmers RM, 1999, J NEUROL NEUROSUR PS, V67, P410, DOI 10.1136/jnnp.67.3.410; CHAPMAN PH, 1990, NEUROSURGERY, V26, P181, DOI 10.1227/00006123-199002000-00001; Chiang MC, 2007, HUM MOL GENET, V16, P483, DOI 10.1093/hmg/ddl481; Chizhikov V, 2006, MAMM GENOME, V17, P1025, DOI 10.1007/s00335-006-0033-7; Chou SY, 2005, J NEUROCHEM, V93, P310, DOI 10.1111/j.1471-4159.2005.03029.x; Chwang WB, 2007, J NEUROSCI, V27, P12732, DOI 10.1523/JNEUROSCI.2522-07.2007; Clark FH, 1932, P NATL ACAD SCI USA, V18, P654, DOI 10.1073/pnas.18.11.654; Del Bigio MR, 1998, EXP NEUROL, V154, P157, DOI 10.1006/exnr.1998.6922; DELBIGIO MR, 1993, ACTA NEUROPATHOL, V85, P573, DOI 10.1007/BF00334666; Factora R, 2006, CLIN GERIATR MED, V22, P645, DOI 10.1016/j.cger.2006.05.001; Fukumizu M, 1996, BRAIN DEV-JPN, V18, P40, DOI 10.1016/0387-7604(95)00103-4; GRAFFRADFORD NR, 1989, NEUROLOGY, V39, P1596, DOI 10.1212/WNL.39.12.1596; Gruneberg H, 1943, J GENET, V45, P22, DOI 10.1007/BF02982771; Gruneberg H, 1943, J GENET, V45, P1, DOI 10.1007/BF02982770; HAAN J, 1987, EUR NEUROL, V27, P216, DOI 10.1159/000116159; Hellstrom P, 2008, NEUROSURGERY, V63, P527, DOI 10.1227/01.NEU.0000325258.16934.BB; Iddon JL, 1999, J NEUROL NEUROSUR PS, V67, P723, DOI 10.1136/jnnp.67.6.723; Jones HC, 2004, EXP NEUROL, V190, P79, DOI 10.1016/j.expneurol.2004.06.019; Justice MJ, 1999, HUM MOL GENET, V8, P1955, DOI 10.1093/hmg/8.10.1955; Kazui Hiroaki, 2008, Brain and Nerve (Tokyo), V60, P225; Klinge P, 2002, ACTA NEUROCHIR SUPPL, V81, P51; Krauss JK, 1997, MOVEMENT DISORD, V12, P53, DOI 10.1002/mds.870120110; Krefft TA, 2004, ALZ DIS ASSOC DIS, V18, P35, DOI 10.1097/00002093-200401000-00007; Kuba H, 2002, J CLIN NEUROSCI, V9, P33, DOI 10.1054/jocn.2001.1010; Kume T, 2000, DEVELOPMENT, V127, P1387; Kume T, 1998, CELL, V93, P985, DOI 10.1016/S0092-8674(00)81204-0; Lee WT, 2004, PROG NEUROBIOL, V72, P87, DOI 10.1016/j.pneurobio.2004.02.002; Lin CY, 2009, NEUROIMAGE, V45, P824, DOI 10.1016/j.neuroimage.2008.12.030; Ma MH, 2001, EXP NEUROL, V169, P239, DOI 10.1006/exnr.2001.7679; MAEDA M, 1988, Neurological Research, V10, P93; Mangano FT, 1998, NEUROL RES, V20, P697; MCHUGH PR, 1964, Q J MED, V33, P297; Miller Janet M, 2007, Cerebrospinal Fluid Res, V4, P5, DOI 10.1186/1743-8454-4-5; MORI A, 1968, BRAIN NERVE (TOKYO), V20, P695; Rice R, 2003, DEV BIOL, V262, P75, DOI 10.1016/S0012-1606(03)00355-5; Robinson ML, 2002, MAMM GENOME, V13, P625, DOI 10.1007/s00335-002-2201-8; ROSENTHAL A, 1992, NAT GENET, V2, P107, DOI 10.1038/ng1092-107; Sakakibara Ryuji, 2008, Brain and Nerve (Tokyo), V60, P233; Schutz C, 2006, CRIT CARE MED, V34, P492, DOI 10.1097/01.CCM.0000198326.32049.7F; Shapiro LA, 2008, EPILEPSIA, V49, P33, DOI 10.1111/j.1528-1167.2008.01491.x; Shinoda M, 1997, INT J NEUROSCI, V92, P9, DOI 10.3109/00207459708986386; Streit WJ, 1999, PROG NEUROBIOL, V57, P563, DOI 10.1016/S0301-0082(98)00069-0; Tai YF, 2007, BRAIN RES BULL, V72, P148, DOI 10.1016/j.brainresbull.2006.10.029; Tarkowski E, 2003, NEUROBIOL AGING, V24, P707, DOI 10.1016/S0197-4580(02)00187-2; Ulfig N, 2004, BRAIN DEV-JPN, V26, P307, DOI 10.1016/S0387-7604(03)00172-4; VARADI V, 1988, AM J MED GENET, V29, P305, DOI 10.1002/ajmg.1320290209; Wodarczyk C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007137; Wu JY, 2004, J CLIN INVEST, V113, P434, DOI 10.1172/JCI200419574; Zweckberger K, 2003, J NEUROTRAUM, V20, P1307, DOI 10.1089/089771503322686102	52	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2009	4	11							e7868	10.1371/journal.pone.0007868	http://dx.doi.org/10.1371/journal.pone.0007868			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520OG	19924295	gold, Green Published, Green Submitted			2022-12-25	WOS:000271854200015
J	Thurlings, RM; Wijbrandts, CA; Bennink, RJ; Dohmen, SE; Voermans, C; Wouters, D; Izmailova, ES; Gerlag, DM; van Eck-Smit, BLF; Tak, PP				Thurlings, Rogier M.; Wijbrandts, Carla A.; Bennink, Roelof J.; Dohmen, Serge E.; Voermans, Carlijn; Wouters, Diana; Izmailova, Elena S.; Gerlag, Danielle M.; van Eck-Smit, Berthe L. F.; Tak, Paul P.			Monocyte Scintigraphy in Rheumatoid Arthritis: The Dynamics of Monocyte Migration in Immune-Mediated Inflammatory Disease	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; SYNOVIAL CELL INFILTRATE; MONOCLONAL-ANTIBODY; PERIPHERAL-BLOOD; TISSUE; MACROPHAGES; BLOCKADE; JOINTS; INITIATION; REDUCTION	Background: Macrophages are principal drivers of synovial inflammation in rheumatoid arthritis (RA), a prototype immune-mediated inflammatory disease. Conceivably, synovial macrophages are continuously replaced by circulating monocytes in RA. Animal studies from the 1960s suggested that macrophage replacement by monocytes is a slow process in chronic inflammatory lesions. Translation of these data into the human condition has been hampered by the lack of available techniques to analyze monocyte migration in man. Methods/Principal Findings: We developed a technique that enabled us to analyze the migration of labelled autologous monocytes in RA patients using single photon emission computer tomography (SPECT). We isolated CD14+ monocytes by CliniMACS in 8 patients and labeled these with technetium-99m (Tc-99m-HMPAO). Monocytes were re-infused into the same patient. Using SPECT we calculated that a very small but specific fraction of 3.4x10(-3) (0.95-5.1x10(-3)) % of re-infused monocytes migrated to the inflamed joints, being detectable within one hour after re-infusion. Conclusions/Significance: The results indicate monocytes migrate continuously into the inflamed synovial tissue of RA patients, but at a slow macrophage-replacement rate. This suggests that the rapid decrease in synovial macrophages that occurs after antirheumatic treatment might rather be explained by an alteration in macrophage retention than in monocyte influx and that RA might be particularly sensitive to treatments targeting inflammatory cell retention.			Thurlings, RM (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Clin Immunol & Rheumatol, Meibergdreef 9, NL-1105 AZ Amsterdam, Noord Holland, Netherlands.	p.p.tak@amc.uva.nl	Thurlings, R.M./L-4689-2015; Voermans, Carlijn/GPP-3405-2022	Izmailova, Elena/0000-0002-7150-1748				ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bartholome B, 2004, FASEB J, V18, P70, DOI 10.1096/fj.03-0328com; Bennink RJ, 2008, J NUCL MED, V49, P1380, DOI 10.2967/jnumed.108.051755; Braakman E, 2008, CYTOTHERAPY, V10, P83, DOI 10.1080/14653240701787650; Burman A, 2005, JOINT BONE SPINE, V72, P10, DOI 10.1016/j.jbspin.2004.03.009; Chacko M, 2007, DERMATOL THER, V20, P265, DOI 10.1111/j.1529-8019.2007.00139.x; Gerlag DM, 2004, ARTHRITIS RHEUM, V50, P3783, DOI 10.1002/art.20664; Goodin DS, 2008, NEUROLOGY, V71, P766, DOI 10.1212/01.wnl.0000320512.21919.d2; Haringman JJ, 2005, ARTHRITIS RES THER, V7, pR862, DOI 10.1186/ar1757; Haringman JJ, 2005, ANN RHEUM DIS, V64, P834, DOI 10.1136/ard.2004.029751; Haringman JJ, 2003, ANN RHEUM DIS, V62, P715, DOI 10.1136/ard.62.8.715; Kinne RW, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2333; Kraan MC, 2002, ARTHRITIS RHEUM-US, V46, P2034, DOI 10.1002/art.10556; LOEWI G, 1969, IMMUNOLOGY, V17, P489; McQueen FM, 2007, BEST PRACT RES CL RH, V21, P841, DOI 10.1016/j.berh.2007.05.001; Polzer K, 2008, ANN RHEUM DIS, V67, P1610, DOI 10.1136/ard.2007.083394; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Saravanan Vadivelu, 2002, Expert Opin Pharmacother, V3, P845; Smeets TJM, 2003, ARTHRITIS RHEUM-US, V48, P2155, DOI 10.1002/art.11098; Smeets TJM, 2003, ANN RHEUM DIS, V62, P635, DOI 10.1136/ard.62.7.635; SPECTOR WG, 1967, J PATHOL BACTERIOL, V93, P101, DOI 10.1002/path.1700930109; SPECTOR WG, 1969, J PATH BAC, V92, P163; Szekanecz Z, 2007, CURR OPIN RHEUMATOL, V19, P289, DOI 10.1097/BOR.0b013e32805e87ae; Tak PP, 2006, BEST PRACT RES CL RH, V20, P929, DOI 10.1016/j.berh.2006.06.001; Tak PP, 1997, ARTHRITIS RHEUM, V40, P217, DOI 10.1002/art.1780400206; TAK PP, 1995, ARTHRITIS RHEUM, V38, P1457, DOI 10.1002/art.1780381012; Taylor PC, 2000, ARTHRITIS RHEUM-US, V43, P38, DOI 10.1002/1529-0131(200001)43:1<38::AID-ANR6>3.0.CO;2-L; van Hemert FJ, 2005, ANN NUCL MED, V19, P345, DOI 10.1007/BF02984631; Van Hemert FJ, 2007, NUCL MED BIOL, V34, P933, DOI 10.1016/j.nucmedbio.2007.07.008; VANFURTH R, 1981, SCAND J RHEUMATOL, P13; Wijbrandts CA, 2008, ARTHRITIS RHEUM, V58, P3330, DOI 10.1002/art.23989; Wijbrandts CA, 2007, ARTHRITIS RHEUM, V56, P3869, DOI 10.1002/art.22964; WOLBINK GJ, 1993, J IMMUNOL METHODS, V163, P67, DOI 10.1016/0022-1759(93)90240-8	33	47	49	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2009	4	11							e7865	10.1371/journal.pone.0007865	http://dx.doi.org/10.1371/journal.pone.0007865			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520OG	19924229	Green Published, Green Submitted, gold			2022-12-25	WOS:000271854200013
J	Bray, I; Bryan, K; Prenter, S; Buckley, PG; Foley, NH; Murphy, DM; Alcock, L; Mestdagh, P; Vandesompele, J; Speleman, F; London, WB; McGrady, PW; Higgins, DG; O'Meara, A; O'Sullivan, M; Stallings, RL				Bray, Isabella; Bryan, Kenneth; Prenter, Suzanne; Buckley, Patrick G.; Foley, Niamh H.; Murphy, Derek M.; Alcock, Leah; Mestdagh, Pieter; Vandesompele, Jo; Speleman, Frank; London, Wendy B.; McGrady, Patrick W.; Higgins, Desmond G.; O'Meara, Anne; O'Sullivan, Maureen; Stallings, Raymond L.			Widespread Dysregulation of MiRNAs by MYCN Amplification and Chromosomal Imbalances in Neuroblastoma: Association of miRNA Expression with Survival	PLOS ONE			English	Article							MICRORNA EXPRESSION; TUMOR-SUPPRESSOR; 11Q; DELETIONS; THERAPY; 3P	MiRNAs regulate gene expression at a post-transcriptional level and their dysregulation can play major roles in the pathogenesis of many different forms of cancer, including neuroblastoma, an often fatal paediatric cancer originating from precursor cells of the sympathetic nervous system. We have analyzed a set of neuroblastoma (n = 145) that is broadly representative of the genetic subtypes of this disease for miRNA expression (430 loci by stem-loop RT qPCR) and for DNA copy number alterations (array CGH) to assess miRNA involvement in disease pathogenesis. The tumors were stratified and then randomly split into a training set (n = 96) and a validation set (n = 49) for data analysis. Thirty-seven miRNAs were significantly over-or under-expressed in MYCN amplified tumors relative to MYCN single copy tumors, indicating a potential role for the MYCN transcription factor in either the direct or indirect dysregulation of these loci. In addition, we also determined that there was a highly significant correlation between miRNA expression levels and DNA copy number, indicating a role for large-scale genomic imbalances in the dysregulation of miRNA expression. In order to directly assess whether miRNA expression was predictive of clinical outcome, we used the Random Forest classifier to identify miRNAs that were most significantly associated with poor overall patient survival and developed a 15 miRNA signature that was predictive of overall survival with 72.7% sensitivity and 86.5% specificity in the validation set of tumors. We conclude that there is widespread dysregulation of miRNA expression in neuroblastoma tumors caused by both over-expression of the MYCN transcription factor and by large-scale chromosomal imbalances. MiRNA expression patterns are also predicative of clinical outcome, highlighting the potential for miRNA mediated diagnostics and therapeutics.	[Bray, Isabella; Bryan, Kenneth; Prenter, Suzanne; Buckley, Patrick G.; Foley, Niamh H.; Murphy, Derek M.; Alcock, Leah; Stallings, Raymond L.] Royal Coll Surgeons Ireland, Dept Canc Genet, Dublin 2, Ireland; [Bray, Isabella; Bryan, Kenneth; Prenter, Suzanne; Buckley, Patrick G.; Foley, Niamh H.; Murphy, Derek M.; Alcock, Leah; O'Sullivan, Maureen; Stallings, Raymond L.] Our Ladys Childrens Hosp Crumlin, Childrens Res Ctr, Dublin, Ireland; [Mestdagh, Pieter; Vandesompele, Jo; Speleman, Frank] Ghent Univ Hosp, Ctr Med Genet, Ghent, Belgium; [London, Wendy B.; McGrady, Patrick W.] Univ Florida, Childrens Oncol Grp Stat & Data Ctr, Gainesville, FL USA; [Higgins, Desmond G.] Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin, Ireland; [O'Meara, Anne; O'Sullivan, Maureen] Our Ladys Childrens Hosp Crumlin, Dept Oncol, Dublin, Ireland; [O'Meara, Anne; O'Sullivan, Maureen] Our Ladys Childrens Hosp Crumlin, Dept Pathol, Dublin, Ireland	Royal College of Surgeons - Ireland; National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin; Ghent University; Ghent University Hospital; Children's Oncology Group (COG); State University System of Florida; University of Florida; University College Dublin; National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin; National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin	Bray, I (corresponding author), Royal Coll Surgeons Ireland, Dept Canc Genet, Dublin 2, Ireland.	rstallings@rcsi.ie	Stallings, Raymond/A-7213-2008; Murphy, Derek/B-1285-2013; Higgins, des g/J-6314-2012; Vandesompele, Jo/W-3411-2018; Bray, Isabella/D-6179-2012; speleman, frank/AAR-5184-2020; London, Wendy/ABD-4624-2021; London, Wendy Beth/ABA-8948-2021	Vandesompele, Jo/0000-0001-6274-0184; speleman, frank/0000-0002-6628-8559; London, Wendy Beth/0000-0003-3571-6538; Mestdagh, Pieter/0000-0001-7821-9684; Higgins, Des/0000-0002-3952-3285; Bryan, Kenneth/0000-0002-9550-8354; O'Sullivan, Maureen/0000-0001-5838-1609	NATIONAL CANCER INSTITUTE [R01CA127496] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Attiyeh EF, 2005, NEW ENGL J MED, V353, P2243, DOI 10.1056/NEJMoa052399; Breen CJ, 2000, CANCER GENET CYTOGEN, V120, P44, DOI 10.1016/S0165-4608(99)00252-6; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Chen YX, 2007, CANCER RES, V67, P976, DOI 10.1158/0008-5472.CAN-06-3667; Cole KA, 2008, MOL CANCER RES, V6, P735, DOI 10.1158/1541-7786.MCR-07-2102; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fontana L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002236; Glazov EA, 2008, MOL BIOL EVOL, V25, P939, DOI 10.1093/molbev/msn045; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Mestdagh P, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn725; Miska EA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r68; Schulte JH, 2008, INT J CANCER, V122, P699, DOI 10.1002/ijc.23153; Selzer RR, 2005, GENE CHROMOSOME CANC, V44, P305, DOI 10.1002/gcc.20243; Spitz R, 2003, CLIN CANCER RES, V9, P52; Vandesompele J, 2005, J CLIN ONCOL, V23, P2280, DOI 10.1200/JCO.2005.06.104; Vandesompele J, 1998, GENE CHROMOSOME CANC, V23, P141, DOI 10.1002/(SICI)1098-2264(199810)23:2<141::AID-GCC7>3.0.CO;2-2; Wei JS, 2008, ONCOGENE, V27, P5204, DOI 10.1038/onc.2008.154; Wei JS, 2009, CLIN CANCER RES, V15, P5560, DOI 10.1158/1078-0432.CCR-08-3287; Welch C, 2007, ONCOGENE, V26, P5017, DOI 10.1038/sj.onc.1210293; Xu H, 2009, CANCER RES, V69, P6275, DOI 10.1158/0008-5472.CAN-08-4517; Zhang L, 2008, P NATL ACAD SCI USA, V105, P7004, DOI 10.1073/pnas.0801615105	24	95	100	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2009	4	11							e7850	10.1371/journal.pone.0007850	http://dx.doi.org/10.1371/journal.pone.0007850			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520NG	19924232	Green Published, gold, Green Submitted			2022-12-25	WOS:000271851000008
J	Ludes-Meyers, JH; Kil, H; Parker-Thornburg, J; Kusewitt, DF; Bedford, MT; Aldaz, CM				Ludes-Meyers, John H.; Kil, Hyunsuk; Parker-Thornburg, Jan; Kusewitt, Donna F.; Bedford, Mark T.; Aldaz, C. Marcelo			Generation and Characterization of Mice Carrying a Conditional Allele of the Wwox Tumor Suppressor Gene	PLOS ONE			English	Article							CHROMOSOMAL FRAGILE SITE; IN-VIVO; LETHAL DWARFISM; CANCER; PROTEIN; FRA16D; COMMON; CELLS; IDENTIFICATION; EXPRESSION	WWOX, the gene that spans the second most common human chromosomal fragile site, FRA16D, is inactivated in multiple human cancers and behaves as a suppressor of tumor growth. Since we are interested in understanding WWOX function in both normal and cancer tissues we generated mice harboring a conditional Wwox allele by flanking Exon 1 of the Wwox gene with LoxP sites. Wwox knockout (KO) mice were developed by breeding with transgenic mice carrying the Cre-recombinase gene under the control of the adenovirus EIIA promoter. We found that Wwox KO mice suffered from severe metabolic defect(s) resulting in growth retardation and all mice died by 3 wk of age. All Wwox KO mice displayed significant hypocapnia suggesting a state of metabolic acidosis. This finding and the known high expression of Wwox in kidney tubules suggest a role for Wwox in acid/base balance. Importantly, Wwox KO mice displayed histopathological and hematological signs of impaired hematopoeisis, leukopenia, and splenic atrophy. Impaired hematopoeisis can also be a contributing factor to metabolic acidosis and death. Hypoglycemia and hypocalcemia was also observed affecting the KO mice. In addition, bone metabolic defects were evident in Wwox KO mice. Bones were smaller and thinner having reduced bone volume as a consequence of a defect in mineralization. No evidence of spontaneous neoplasia was observed in Wwox KO mice. We have generated a new mouse model to inactivate the Wwox tumor suppressor gene conditionally. This will greatly facilitate the functional analysis of Wwox in adult mice and will allow investigating neoplastic transformation in specific target tissues.			Ludes-Meyers, JH (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Carcinogenesis, Div Sci Pk Res, Smithville, TX USA.	maaldaz@mdanderson.org	Kusewitt, Donna F/E-8107-2011; Aldaz, C. Marcelo/E-7868-2011; Bedford, Mark T/E-7856-2011	Aldaz, C. Marcelo/0000-0002-2453-2939; 	NCI NIH HHS [R01 CA102444-04, R01 CA102444-06A1, R01 CA102444-02, R01 CA102444-03, R01 CA102444, R01 CA102444-07, R01 CA102444-05, R01 CA102444-01] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA102444] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aqeilan RI, 2008, J BIOL CHEM, V283, P21629, DOI 10.1074/jbc.M800855200; Aqeilan RI, 2007, J CELL PHYSIOL, V212, P307, DOI 10.1002/jcp.21099; Aqeilan RI, 2007, P NATL ACAD SCI USA, V104, P3949, DOI 10.1073/pnas.0609783104; Aqeilan RI, 2005, CANCER RES, V65, P6764, DOI 10.1158/0008-5472.CAN-05-1150; Aqeilan RI, 2004, P NATL ACAD SCI USA, V101, P4401, DOI 10.1073/pnas.0400805101; Aqeilan RI, 2004, CANCER RES, V64, P8256, DOI 10.1158/0008-5472.CAN-04-2055; Bednarek AK, 2000, CANCER RES, V60, P2140; Bednarek AK, 2001, CANCER RES, V61, P8068; Fabbri M, 2005, P NATL ACAD SCI USA, V102, P15611, DOI 10.1073/pnas.0505485102; Gourley C, 2009, CANCER RES, V69, P4835, DOI 10.1158/0008-5472.CAN-08-2974; Jin CJ, 2006, BIOCHEM BIOPH RES CO, V341, P784, DOI 10.1016/j.bbrc.2006.01.023; Kallberg Y, 2002, PROTEIN SCI, V11, P636, DOI 10.1110/ps.26902; Krummel KA, 2000, GENOMICS, V69, P37, DOI 10.1006/geno.2000.6321; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Ludes-Meyers JH, 2004, ONCOGENE, V23, P5049, DOI 10.1038/sj.onc.1207680; Ludes-Meyers JH, 2003, CYTOGENET GENOME RES, V100, P101, DOI 10.1159/000072844; Ludes-Meyers JH, 2007, GENE CHROMOSOME CANC, V46, P1129, DOI 10.1002/gcc.20497; Matteucci E, 2009, CARCINOGENESIS, V30, P937, DOI 10.1093/carcin/bgp080; MCCARRICK JW, 1993, TRANSGENIC RES, V2, P183, DOI 10.1007/BF01977348; Nunez MI, 2006, J MOL HISTOL, V37, P115, DOI 10.1007/s10735-006-9046-5; Paige AJW, 2001, P NATL ACAD SCI USA, V98, P11417, DOI 10.1073/pnas.191175898; Qin HR, 2006, CANCER RES, V66, P6477, DOI 10.1158/0008-5472.CAN-06-0956; Ramos D, 2006, ADV EXP MED BIOL, V587, P149; Ried K, 2000, HUM MOL GENET, V9, P1651, DOI 10.1093/hmg/9.11.1651; Sun X, 2000, NAT GENET, V25, P83, DOI 10.1038/75644; Suzuki H, 2009, GENES BRAIN BEHAV, V8, P650, DOI 10.1111/j.1601-183X.2009.00502.x; Suzuki H, 2007, COMPARATIVE MED, V57, P360; Wu XQ, 2007, MOL CELL ENDOCRINOL, V265, P71, DOI 10.1016/j.mce.2006.12.006	28	54	55	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2009	4	11							e7775	10.1371/journal.pone.0007775	http://dx.doi.org/10.1371/journal.pone.0007775			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	517ZU	19936220	Green Published, Green Submitted, gold			2022-12-25	WOS:000271658800012
J	Nakamura, K; Salomonis, N; Tomoda, K; Yamanaka, S; Conklin, BR				Nakamura, Kenta; Salomonis, Nathan; Tomoda, Kiichiro; Yamanaka, Shinya; Conklin, Bruce R.			G(i)-Coupled GPCR Signaling Controls the Formation and Organization of Human Pluripotent Colonies	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; ISLET-ACTIVATING PROTEIN; STRESS FIBER FORMATION; STEM-CELLS; TRANSDUCTION PATHWAYS; ADENYLATE-CYCLASE; ADP-RIBOSYLATION; PERTUSSIS TOXIN; SURVIVAL; LINES	Background: Reprogramming adult human somatic cells to create human induced pluripotent stem (hiPS) cell colonies involves a dramatic morphological and organizational transition. These colonies are morphologically indistinguishable from those of pluripotent human embryonic stem (hES) cells. G protein-coupled receptors (GPCRs) are required in diverse developmental processes, but their role in pluripotent colony morphology and organization is unknown. We tested the hypothesis that G(i)-coupled GPCR signaling contributes to the characteristic morphology and organization of human pluripotent colonies. Methodology/Principal Findings: Specific and irreversible inhibition of G(i)-coupled GPCR signaling by pertussis toxin markedly altered pluripotent colony morphology. Wild-type hES and hiPS cells formed monolayer colonies, but colonies treated with pertussis toxin retracted inward, adopting a dense, multi-layered conformation. The treated colonies were unable to reform after a scratch wound insult, whereas control colonies healed completely within 48 h. In contrast, activation of an alternative GPCR pathway, G(s)-coupled signaling, with cholera toxin did not affect colony morphology or the healing response. Pertussis toxin did not alter the proliferation, apoptosis or pluripotency of pluripotent stem cells. Conclusions/Significance: Experiments with pertussis toxin suggest that G(i) signaling plays a critical role in the morphology and organization of pluripotent colonies. These results may be explained by a G(i)-mediated density-sensing mechanism that propels the cells radially outward. GPCRs are a promising target for modulating the formation and organization of hiPS and hES cell colonies and may be important for understanding somatic cell reprogramming and for engineering pluripotent stem cells for therapeutic applications.			Nakamura, K (corresponding author), Gladstone Inst Cardiovasc Dis, San Francisco, CA USA.	kenta.nakamura@ucsf.edu	Conklin, Bruce/E-4738-2019	Conklin, Bruce/0000-0003-1463-6061	NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018928] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060664] Funding Source: NIH RePORTER; NCRR NIH HHS [RR18928-01, C06 RR018928] Funding Source: Medline; NHLBI NIH HHS [R01 HL060664, R01 HL-60664] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bajpai R, 2008, MOL REPROD DEV, V75, P818, DOI 10.1002/mrd.20809; Bakthavatsalam D, 2007, CURR BIOL, V17, P892, DOI 10.1016/j.cub.2007.04.029; Boguslawski G, 2000, BIOCHEM BIOPH RES CO, V272, P603, DOI 10.1006/bbrc.2000.2822; BUHL AM, 1995, J BIOL CHEM, V270, P24631, DOI 10.1074/jbc.270.42.24631; Chen T, 2007, STEM CELLS, V25, P392, DOI 10.1634/stemcells.2006-0145; Cotton M, 2009, CELL SIGNAL, V21, P1045, DOI 10.1016/j.cellsig.2009.02.008; Coward P, 1998, P NATL ACAD SCI USA, V95, P352, DOI 10.1073/pnas.95.1.352; Daley GQ, 2009, CELL STEM CELL, V4, P200, DOI 10.1016/j.stem.2009.02.009; DANIELLO C, 2009, CIRC RES; Deery WJ, 2002, J BIOL CHEM, V277, P31972, DOI 10.1074/jbc.M204539200; FREDERICH RC, 1995, NAT MED, V1, P1311, DOI 10.1038/nm1295-1311; Guo Y, 2005, STEM CELLS, V23, P1324, DOI 10.1634/stemcells.2005-0085; Harb N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003001; Hashimoto Y, 2005, INT J MOL MED, V16, P787; Jiang SX, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000641; KASLOW HR, 1992, FASEB J, V6, P2684, DOI 10.1096/fasebj.6.9.1612292; KATADA T, 1982, P NATL ACAD SCI-BIOL, V79, P3129, DOI 10.1073/pnas.79.10.3129; Katoh H, 1998, J BIOL CHEM, V273, P28700, DOI 10.1074/jbc.273.44.28700; Kemp CR, 2007, DEV DYNAM, V236, P2011, DOI 10.1002/dvdy.21198; Kita-Matsuo H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005046; Kristiansen K, 2004, PHARMACOL THERAPEUT, V103, P21, DOI 10.1016/j.pharmthera.2004.05.002; Larue L, 1996, DEVELOPMENT, V122, P3185; Li XY, 2009, HUM REPROD, V24, P580, DOI 10.1093/humrep/den404; Maherali N, 2008, CELL STEM CELL, V3, P595, DOI 10.1016/j.stem.2008.11.008; Majumdar M, 1998, J BIOL CHEM, V273, P10099, DOI 10.1074/jbc.273.17.10099; Malbon CC, 2005, NAT REV MOL CELL BIO, V6, P689, DOI 10.1038/nrm1716; Masaki H, 2008, STEM CELL RES, V1, P105, DOI 10.1016/j.scr.2008.01.001; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; MURAYAMA T, 1983, J BIOL CHEM, V258, P3319; Nelson TJ, 2008, STEM CELLS, V26, P1464, DOI 10.1634/stemcells.2007-0808; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Pebay A, 2005, STEM CELLS, V23, P1541, DOI 10.1634/stemcells.2004-0338; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; POLLARD KS, 2002, METHOD IDENTIFY SIGN; Regard JB, 2007, J CLIN INVEST, V117, P4034, DOI 10.1172/JCI32994; RIDLEY AJ, 1994, EMBO J, V13, P2600, DOI 10.1002/j.1460-2075.1994.tb06550.x; Salomonis N, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000553; Scott IC, 2007, DEV CELL, V12, P403, DOI 10.1016/j.devcel.2007.01.012; Seitz G, 2005, ANN NY ACAD SCI, V1044, P84, DOI 10.1196/annals.1349.011; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; van der Laan MJ, 2003, J STAT PLAN INFER, V117, P275, DOI 10.1016/S0378-3758(02)00388-9; Vogt S, 2003, J BIOL CHEM, V278, P28743, DOI 10.1074/jbc.M304570200; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; Xiong YM, 2004, P NATL ACAD SCI USA, V101, P1045, DOI 10.1073/pnas.2637002100; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	49	23	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2009	4	11							e7780	10.1371/journal.pone.0007780	http://dx.doi.org/10.1371/journal.pone.0007780			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	517ZU	19936228	Green Published, gold, Green Submitted			2022-12-25	WOS:000271658800015
J	Lin, Z; Yin, P; Reierstad, S; O'Halloran, M; Coon, JS; Pearson, EK; Mutlu, GM; Bulun, SE				Lin, Z.; Yin, P.; Reierstad, S.; O'Halloran, M.; Coon, J. S.; Pearson, E. K.; Mutlu, G. M.; Bulun, S. E.			Adenosine A1 receptor, a target and regulator of estrogen receptor-alpha action, mediates the proliferative effects of estradiol in breast cancer	ONCOGENE			English	Article						Adora1; ER alpha; estradiol; breast cancer; G protein-coupled receptors; cell proliferation	ADENOSINE A(1) RECEPTORS; CELL-PROLIFERATION; ENDOCRINE THERAPY; EXPRESSION; TRANSCRIPTION; ACTIVATION; INHIBITION; REVEALS; BINDING; PHOSPHORYLATION	Estrogen receptor-alpha (ER alpha) and its ligand estradiol (E2) has critical roles in breast cancer growth and are key therapeutic targets. In this study, we report a novel dual role of the adenosine A1 receptor (Adora1) as an E2/ER alpha target and a regulator of ER alpha transcriptional activity. In ER alpha-positive breast cancer cells, E2 upregulated Adora1 messenger RNA (mRNA) and protein levels, an effect that was reversed by the E2 antagonist ICI 182 780. Small interference RNA ablation of Adora1 in ER alpha-positive cells reduced basal and E2-dependent proliferation, whereas Adora1 over-expression in an ER alpha-negative cell line induced proliferation. The selective Adora1 antagonist, DPCPX, reduced proliferation, establishing Adora1 as a mediator of E2/ER alpha-dependent breast cancer growth. Intriguingly, Adora1 ablation decreased both mRNA and protein levels of ER alpha and, consequently, estrogen-responsive element-dependent ER alpha transcriptional activity. Moreover, Adora1 ablation decreased binding activity of ER alpha to the promoter of its target gene TFF1 and led to reduced TFF1 promoter activity and mRNA levels, suggesting that Adora1 is required for full transcriptional activity of ER alpha on E2 stimulation. Taken together, we showed a short feed-forward loop involving E2, ER alpha and Adora1 that favors breast cancer growth. These data suggest that Adora1 may represent an important target for therapeutic intervention in hormone-dependent breast cancer. Oncogene (2010) 29, 1114-1122; doi: 10.1038/onc.2009.409; published online 23 November 2009	[Lin, Z.; Yin, P.; Reierstad, S.; O'Halloran, M.; Coon, J. S.; Pearson, E. K.; Bulun, S. E.] Northwestern Univ, Dept Obstet & Gynecol, Feinberg Sch Med, Chicago, IL 60611 USA; [Mutlu, G. M.] Northwestern Univ, Dept Med, Feinberg Sch Med, Div Pulm & Crit Care Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Bulun, SE (corresponding author), Northwestern Univ, Dept Obstet & Gynecol, Feinberg Sch Med, Chicago, IL 60611 USA.	s-bulun@northwestern.edu			NIH [R01CA067167]; AVON Foundation; Lynn Sage Foundation; Northwestern Memorial Foundation; NATIONAL CANCER INSTITUTE [R01CA067167] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AVON Foundation; Lynn Sage Foundation; Northwestern Memorial Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by grants from the NIH (R01CA067167), AVON Foundation, Lynn Sage Foundation, and Northwestern Memorial Foundation. We thank Megha Reddi for expert technical assistance.	AITKEN SC, 1982, CANCER RES, V42, P1727; Alao JP, 2004, CLIN CANCER RES, V10, P8094, DOI 10.1158/1078-0432.CCR-04-1023; Albasanz JL, 2007, EUR J NEUROSCI, V26, P3501, DOI 10.1111/j.1460-9568.2007.05965.x; Altucci L, 1996, ONCOGENE, V12, P2315; Boulay A, 2005, CLIN CANCER RES, V11, P5319, DOI 10.1158/1078-0432.CCR-04-2402; Bourguignon LYW, 2005, J BIOL CHEM, V280, P11961, DOI 10.1074/jbc.M411985200; Brunsden AM, 1999, J PHYSIOL-LONDON, V521, P517, DOI 10.1111/j.1469-7793.1999.00517.x; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; CHALBOS D, 1982, J CLIN ENDOCR METAB, V55, P276, DOI 10.1210/jcem-55-2-276; DeNardo DG, 2005, MOL ENDOCRINOL, V19, P362, DOI 10.1210/me.2004-0267; Factor P, 2007, P NATL ACAD SCI USA, V104, P4083, DOI 10.1073/pnas.0601117104; Fan S, 1999, SCIENCE, V284, P1354, DOI 10.1126/science.284.5418.1354; Fu HJ, 2006, CANCER BIOL THER, V5, P842, DOI 10.4161/cbt.5.7.2840; HALEEN SJ, 1987, LIFE SCI, V40, P555, DOI 10.1016/0024-3205(87)90369-9; Hayashi S, 2005, CANCER CHEMOTH PHARM, V56, pS27, DOI 10.1007/s00280-005-0096-2; Howell A, 2005, J STEROID BIOCHEM, V93, P237, DOI 10.1016/j.jsbmb.2005.02.004; Huang Y, 2006, J BIOL CHEM, V281, P19055, DOI 10.1074/jbc.M600910200; Ilie A, 2009, NEUROSCIENCE, V159, P1070, DOI 10.1016/j.neuroscience.2009.01.025; Kenealy MR, 2000, ENDOCRINOLOGY, V141, P2805, DOI 10.1210/en.141.8.2805; Keshamouni VG, 2002, J BIOL CHEM, V277, P22558, DOI 10.1074/jbc.M202351200; Kochanek PM, 2006, J CEREBR BLOOD F MET, V26, P565, DOI 10.1038/sj.jcbfm.9600218; Kun Y, 2003, HUM MOL GENET, V12, P3245, DOI 10.1093/hmg/ddg347; Kuske B, 2006, ENDOCR-RELAT CANCER, V13, P1121, DOI 10.1677/erc.1.01257; Laganiere J, 2005, P NATL ACAD SCI USA, V102, P11651, DOI 10.1073/pnas.0505575102; Landis SH, 1999, CA-CANCER J CLIN, V49, P8, DOI 10.3322/canjclin.49.1.8; Lin ZH, 2007, CANCER RES, V67, P5017, DOI 10.1158/0008-5472.CAN-06-3696; Lu J, 2003, CANCER RES, V63, P6413; McPherson LA, 1997, P NATL ACAD SCI USA, V94, P4342, DOI 10.1073/pnas.94.9.4342; McPherson LA, 2007, J SURG RES, V138, P71, DOI 10.1016/j.jss.2006.07.002; Merighi S, 2003, PHARMACOL THERAPEUT, V100, P31, DOI 10.1016/S0163-7258(03)00084-6; Mirza A, 2005, CANCER BIOL THER, V4, P1355, DOI 10.4161/cbt.4.12.2196; Moosavi SMS, 2009, NEPHROLOGY, V14, P179, DOI 10.1111/j.1440-1797.2008.01024.x; Morrison RR, 2006, AM J PHYSIOL-HEART C, V291, pH1875, DOI 10.1152/ajpheart.00158.2005; Namba R, 2005, BREAST CANCER RES, V7, pR881, DOI 10.1186/bcr1317; Nonclercq D, 2007, J MOL ENDOCRINOL, V39, P105, DOI 10.1677/JME-07-0040; NUNEZ AM, 1989, EMBO J, V8, P823, DOI 10.1002/j.1460-2075.1989.tb03443.x; Osborne CK, 2005, J CLIN ONCOL, V23, P1616, DOI 10.1200/JCO.2005.10.036; Pettersson K, 2001, ANNU REV PHYSIOL, V63, P165, DOI 10.1146/annurev.physiol.63.1.165; Prest SJ, 2002, FASEB J, V16, P592, DOI 10.1096/fj.01-0498fje; Reid G, 2002, CELL MOL LIFE SCI, V59, P821, DOI 10.1007/s00018-002-8470-2; Shen Y, 2008, J NATL CANCER I, V100, P1448, DOI 10.1093/jnci/djn320; Snoj N, 2008, CURR OPIN ONCOL, V20, P627, DOI 10.1097/CCO.0b013e3283136770; Wendler CC, 2007, P NATL ACAD SCI USA, V104, P9697, DOI 10.1073/pnas.0703557104	43	44	48	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 25	2010	29	8					1114	1122		10.1038/onc.2009.409	http://dx.doi.org/10.1038/onc.2009.409			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	560ON	19935720	Green Accepted			2022-12-25	WOS:000274912100003
J	Merkhofer, EC; Cogswell, P; Baldwin, AS				Merkhofer, E. C.; Cogswell, P.; Baldwin, A. S.			Her2 activates NF-kappa B and induces invasion through the canonical pathway involving IKK alpha	ONCOGENE			English	Article						Her2; IKKalpha; NF-KappaB	HUMAN-BREAST-CANCER; UP-REGULATION; PLASMINOGEN-ACTIVATOR; MONOCLONAL-ANTIBODY; SIGNALING NETWORK; GENE-EXPRESSION; KINASE-ACTIVITY; PHASE-II; CELLS; INHIBITOR	The membrane bound receptor tyrosine kinase Her2 is overexpressed in approximately 30% of human breast cancers, which correlates with poor prognosis. Her2-induced signaling pathways include MAPK and PI3K/Akt, of which the latter has been shown to be critical for Her2(+) breast cancer cell growth and survival. In addition, the NF-kappa B pathway has been shown to be activated downstream of Her2 overexpression; however, the mechanisms leading to this activation are not currently clear. Using Her2(+)/ER- breast cancer cells, we show that Her2 activates NF-kappa B through the canonical pathway which, surprisingly, involves IKK alpha. Knockdown of IKK alpha led to a significant decrease in transcription levels of multiple NF-kappa B-regulated cytokine and chemokine genes. siRNA-mediated knockdown of IKK alpha resulted in a decrease in cancer cell invasion, but had no effect on cell proliferation. Inhibition of the PI3K/Akt pathway had no effect on NF-kappa B activation, but significantly inhibited cell proliferation. Our study suggests different roles for the NF-kappa B and PI3K pathways downstream of Her2, leading to changes in invasion and proliferation of breast cancer cells. In addition this work indicates the importance of IKK alpha as a mediator of Her2-induced tumor progression. Oncogene ( 2010) 29, 1238-1248; doi: 10.1038/onc.2009.410; published online 30 November 2009	[Merkhofer, E. C.; Cogswell, P.; Baldwin, A. S.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Merkhofer, E. C.; Baldwin, A. S.] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; [Baldwin, A. S.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Baldwin, AS (corresponding author), Univ N Carolina, Lineberger Canc Ctr, CB 7295, Chapel Hill, NC 27599 USA.	albert_baldwin@med.unc.edu			NIH [RO1CA73756, RO1CA75080]; Department of Defense [BC074027]; Samuel Waxman Cancer Research Foundation; NATIONAL CANCER INSTITUTE [R01CA073756, R01CA138937, R01CA075080] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI035098] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Samuel Waxman Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank William Comb for his assistance in the preparation of this paper, as well as Dr H Shelton Earp and Dr Carolyn Sartor for generously providing reagents. This work is funded by NIH RO1CA73756 and RO1CA75080, and Department of Defense Grant BC074027. Support is also provided by the Samuel Waxman Cancer Research Foundation.	Arihiro K, 2000, Breast Cancer, V7, P221, DOI 10.1007/BF02967464; Arora P, 2008, ONCOGENE, V27, P4434, DOI 10.1038/onc.2008.84; Baselga J, 1999, SEMIN ONCOL, V26, P78; Basseres DS, 2006, ONCOGENE, V25, P6817, DOI 10.1038/sj.onc.1209942; Belguise K, 2007, J CLIN INVEST, V117, P4009, DOI 10.1172/JCI32424; Bhaumik D, 2008, ONCOGENE, V27, P5643, DOI 10.1038/onc.2008.171; Biswas DK, 2004, P NATL ACAD SCI USA, V101, P10137, DOI 10.1073/pnas.0403621101; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Cao YX, 2007, P NATL ACAD SCI USA, V104, P15852, DOI 10.1073/pnas.0706728104; Chavey C, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1648; Chen DY, 2003, ONCOGENE, V22, P4348, DOI 10.1038/sj.onc.1206532; Cogswell PC, 2000, ONCOGENE, V19, P1123, DOI 10.1038/sj.onc.1203412; Dan HC, 2008, GENE DEV, V22, P1490, DOI 10.1101/gad.1662308; Dillon RL, 2007, ONCOGENE, V26, P1338, DOI 10.1038/sj.onc.1210202; ETHIER SP, 1993, CANCER RES, V53, P627; Galang CK, 1996, J BIOL CHEM, V271, P7992, DOI 10.1074/jbc.271.14.7992; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; GUM R, 1995, ANTICANCER RES, V15, P1167; Habib AA, 2001, J BIOL CHEM, V276, P8865, DOI 10.1074/jbc.M008458200; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hegde PS, 2007, MOL CANCER THER, V6, P1629, DOI 10.1158/1535-7163.MCT-05-0399; HYNES NE, 1994, BBA-REV CANCER, V1198, P165, DOI 10.1016/0304-419X(94)90012-4; Klapper LN, 2000, ADV CANCER RES, V77, P25; Knuefermann C, 2003, ONCOGENE, V22, P3205, DOI 10.1038/sj.onc.1206394; Lam LT, 2008, P NATL ACAD SCI USA, V105, P20798, DOI 10.1073/pnas.0806491106; Li YM, 2004, CANCER CELL, V6, P459, DOI 10.1016/j.ccr.2004.09.027; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Makino K, 2004, ONCOGENE, V23, P3883, DOI 10.1038/sj.onc.1207485; Mayo MW, 1997, SCIENCE, V278, P1812, DOI 10.1126/science.278.5344.1812; Papa S, 2006, CELL DEATH DIFFER, V13, P712, DOI 10.1038/sj.cdd.4401865; Pegram MD, 1998, J CLIN ONCOL, V16, P2659, DOI 10.1200/JCO.1998.16.8.2659; Pianetti S, 2001, ONCOGENE, V20, P1287, DOI 10.1038/sj.onc.1204257; Sakurai H, 1999, J BIOL CHEM, V274, P30353, DOI 10.1074/jbc.274.43.30353; She QB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003065; Singh S, 2007, MOL CANCER THER, V6, P1973, DOI 10.1158/1535-7163.MCT-07-0063; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Solt LA, 2008, IMMUNOL RES, V42, P3, DOI 10.1007/s12026-008-8025-1; Steinbrecher KA, 2005, MOL CELL BIOL, V25, P8444, DOI 10.1128/MCB.25.19.8444-8455.2005; Vazquez-Martin A, 2008, ADV EXP MED BIOL, V617, P311, DOI 10.1007/978-0-387-69080-3_29; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; Wang WX, 1999, ONCOGENE, V18, P4554, DOI 10.1038/sj.onc.1202833; Weih F, 2003, IMMUNOL REV, V195, P91, DOI 10.1034/j.1600-065X.2003.00064.x; Wilson W, 2008, CANCER RES, V68, P8156, DOI 10.1158/0008-5472.CAN-08-1061; Xia WL, 2002, ONCOGENE, V21, P6255, DOI 10.1038/sj.onc.1205794; Zhou H, 2004, INT J RADIAT ONCOL, V58, P344, DOI 10.1016/j.ijrobp.2003.09.046	48	104	107	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 25	2010	29	8					1238	1248		10.1038/onc.2009.410	http://dx.doi.org/10.1038/onc.2009.410			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	560ON	19946332	Green Accepted, Green Submitted			2022-12-25	WOS:000274912100014
J	Kofoed, EM; Guerbadot, M; Schaufele, F				Kofoed, Eric M.; Guerbadot, Martin; Schaufele, Fred			Structure, Affinity, and Availability of Estrogen Receptor Complexes in the Cellular Environment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; ENTREZS 3D-STRUCTURE DATABASE; GREEN FLUORESCENT PROTEIN; NUCLEAR RECEPTOR; LIVING CELLS; SELECTIVE INTERACTIONS; COACTIVATOR BINDING; ALPHA; SRC-1; TRANSCRIPTION	An ability to measure the biochemical parameters and structures of protein complexes at defined locations within the cellular environment would improve our understanding of cellular function. Wedescribe widely applicable, calibrated Forster resonance energy transfer methods that quantify structural and biochemical parameters for interaction of the human estrogen receptor alpha-isoform (ER alpha) with the receptor interacting domains (RIDs) of three cofactors (SRC1, SRC2, SRC3) in living cells. The interactions of ER alpha with all three SRC-RIDs, measured throughout the cell nucleus, transitioned from structurally similar, high affinity complexes containing two ER alpha s at low free SRC-RID concentrations (<2 nM) to lower affinity complexes with an ER alpha monomer at higher SRC-RID concentrations (similar to 10 nM). The methods also showed that only a sub-population of ER alpha was available to form complexes with the SRC-RIDs in the cell. These methods represent a template for extracting unprecedented details of the biochemistry and structure of any complex that is capable of being measured by Forster resonance energy transfer in the cellular environment.	[Kofoed, Eric M.; Guerbadot, Martin; Schaufele, Fred] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; [Schaufele, Fred] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Schaufele, F (corresponding author), S1230,513 Parnassus, San Francisco, CA 94143 USA.	freds@diabetes.ucsf.edu			Congressionally Directed Medical Research [PC040777]; National Institutes of Health [R01 DK54345, P30 DK63720]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720, R01DK054345] Funding Source: NIH RePORTER	Congressionally Directed Medical Research(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Congressionally Directed Medical Research Programs (Grant PC040777) and by the National Institutes of Health (Grant R01 DK54345) with infrastructure support from the National Institutes of Health (Grant P30 DK63720).	Acevedo ML, 2004, ESSAYS BIOCHEM, V40, P73, DOI 10.1042/bse0400073; Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; Bai YL, 2003, MOL ENDOCRINOL, V17, P589, DOI 10.1210/me.2002-0351; Becker M, 2002, EMBO REP, V3, P1188, DOI 10.1093/embo-reports/kvf244; Bramlett KS, 2001, MOL ENDOCRINOL, V15, P909, DOI 10.1210/me.15.6.909; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; Carpenter AE, 2007, NAT CHEM BIOL, V3, P461, DOI 10.1038/nchembio.2007.15; Chen H, 2006, BIOPHYS J, V91, pL39, DOI 10.1529/biophysj.106.088773; Chen HM, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2799171; Chen J, 2003, NUCLEIC ACIDS RES, V31, P474, DOI 10.1093/nar/gkg086; Cheskis BJ, 2003, J BIOL CHEM, V278, P13271, DOI 10.1074/jbc.M211031200; Day RN, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2939093; Day RN, 2005, MOL ENDOCRINOL, V19, P1675, DOI 10.1210/me.2005-0028; Ding XF, 1998, MOL ENDOCRINOL, V12, P302, DOI 10.1210/me.12.2.302; Feng WJ, 1998, SCIENCE, V280, P1747, DOI 10.1126/science.280.5370.1747; FORSTER T, 1959, DISCUSS FARADAY SOC, V27, P1; Forster T., 1948, ANN PHYS, V6, P54; Gehin M, 2002, MOL CELL BIOL, V22, P5923, DOI 10.1128/MCB.22.16.5923-5937.2002; Giuliano KA, 2006, METHOD ENZYMOL, V414, P601, DOI 10.1016/S0076-6879(06)14031-8; Glass CK, 1997, CURR OPIN CELL BIOL, V9, P222, DOI 10.1016/S0955-0674(97)80066-X; Gordon GW, 1998, BIOPHYS J, V74, P2702, DOI 10.1016/S0006-3495(98)77976-7; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Hoppe A, 2002, BIOPHYS J, V83, P3652, DOI 10.1016/S0006-3495(02)75365-4; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Kofoed EM, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2940366; Koushik SV, 2006, BIOPHYS J, V91, pL99, DOI 10.1529/biophysj.106.096206; List HJ, 2001, BREAST CANCER RES TR, V68, P21, DOI 10.1023/A:1017910924390; Liu AP, 2009, NAT REV MOL CELL BIO, V10, P644, DOI 10.1038/nrm2746; Llopis J, 2000, P NATL ACAD SCI USA, V97, P4363, DOI 10.1073/pnas.97.8.4363; Lonard DM, 2007, MOL CELL, V27, P691, DOI 10.1016/j.molcel.2007.08.012; Margeat E, 2001, J MOL BIOL, V306, P433, DOI 10.1006/jmbi.2000.4418; McKenna NJ, 2009, MOL ENDOCRINOL, V23, P740, DOI 10.1210/me.2009-0135; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Miyawaki A, 2000, METHOD ENZYMOL, V327, P472, DOI 10.1016/S0076-6879(00)27297-2; Osborne CK, 2003, J NATL CANCER I, V95, P353, DOI 10.1093/jnci/95.5.353; Padron A, 2007, MOL ENDOCRINOL, V21, P49, DOI 10.1210/me.2006-0075; Patterson GH, 2000, ANAL BIOCHEM, V284, P438, DOI 10.1006/abio.2000.4708; Pearce ST, 2004, CRIT REV ONCOL HEMAT, V50, P3, DOI 10.1016/j.critrevonc.2003.09.003; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; STRYER L, 1967, P NATL ACAD SCI USA, V58, P719, DOI 10.1073/pnas.58.2.719; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsien RY, 2003, NAT REV MOL CELL BIO, pSS16, DOI 10.1038/nrm1196; Valentine JE, 2000, J BIOL CHEM, V275, P25322, DOI 10.1074/jbc.M002497200; Wang YL, 2007, NUCLEIC ACIDS RES, V35, pD298, DOI 10.1093/nar/gkl952; Warnmark A, 2002, J BIOL CHEM, V277, P21862, DOI 10.1074/jbc.M200764200; Weatherman RV, 2002, MOL ENDOCRINOL, V16, P487, DOI 10.1210/me.16.3.487; Xu JM, 2003, MOL ENDOCRINOL, V17, P1681, DOI 10.1210/me.2003-0116; Xu JM, 2000, P NATL ACAD SCI USA, V97, P6379, DOI 10.1073/pnas.120166297; Xu JM, 1998, SCIENCE, V279, P1922, DOI 10.1126/science.279.5358.1922; You X, 2006, P NATL ACAD SCI USA, V103, P18458, DOI 10.1073/pnas.0605422103	51	10	10	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2428	2437		10.1074/jbc.M109.045203	http://dx.doi.org/10.1074/jbc.M109.045203			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19926790	Green Published, hybrid			2022-12-25	WOS:000273697800022
J	Zhang, WJ; Urban, A; Mihara, H; Leimkuhler, S; Kurihara, T; Esaki, N				Zhang, Wanjiao; Urban, Alexander; Mihara, Hisaaki; Leimkuehler, Silke; Kurihara, Tatsuo; Esaki, Nobuyoshi			IscS Functions as a Primary Sulfur-donating Enzyme by Interacting Specifically with MoeB and MoaD in the Biosynthesis of Molybdopterin in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FE-S CLUSTER; MOLYBDENUM COFACTOR BIOSYNTHESIS; IN-VITRO BIOSYNTHESIS; CYSTEINE DESULFURASE; TRANSFER-RNA; SELENOCYSTEINE LYASE; STRUCTURAL-CHARACTERIZATION; UBIQUITIN ACTIVATION; GENE CLONING; MECHANISM	The persulfide sulfur formed on an active site cysteine residue of pyridoxal 5'-phosphate-dependent cysteine desulfurases is subsequently incorporated into the biosynthetic pathways of a variety of sulfur-containing cofactors and thionucleosides. In molybdenum cofactor biosynthesis, MoeB activates the C terminus of the MoaD subunit of molybdopterin (MPT) synthase to form MoaD-adenylate, which is subsequently converted to a thiocarboxylate for the generation of the dithiolene group of MPT. It has been shown that three cysteine desulfurases (CsdA, SufS, and IscS) of Escherichia coli can transfer sulfur from L-cysteine to the thiocarboxylate of MoaD in vitro. Here, we demonstrate by surface plasmon resonance analyses that IscS, but not CsdA or SufS, interacts with MoeB and MoaD. MoeB and MoaD can stimulate the IscS activity up to 1.6-fold. Analysis of the sulfuration level of MoaD isolated from strains defective in cysteine desulfurases shows a largely decreased sulfuration level of the protein in an iscS deletion strain but not in a csdA/sufS deletion strain. We also show that another iscS deletion strain of E. coli accumulates compound Z, a direct oxidation product of the immediate precursor of MPT, to the same extent as an MPT synthase-deficient strain. In contrast, analysis of the content of compound Z in Delta csdA and Delta sufS strains revealed no such accumulation. These findings indicate that IscS is the primary physiological sulfur-donating enzyme for the generation of the thiocarboxylate of MPT synthase in MPT biosynthesis.	[Zhang, Wanjiao; Kurihara, Tatsuo; Esaki, Nobuyoshi] Kyoto Univ, Inst Chem Res, Kyoto 6110011, Japan; [Mihara, Hisaaki] Ritsumeikan Univ, Coll Life Sci, Dept Biotechnol, Inst Sci & Engn, Shiga 5258577, Japan; [Urban, Alexander; Leimkuehler, Silke] Univ Potsdam, Inst Biochem & Biol, D-14476 Potsdam, Germany	Kyoto University; Ritsumeikan University; University of Potsdam	Esaki, N (corresponding author), Kyoto Univ, Inst Chem Res, Kyoto 6110011, Japan.	esakin@scl.kyoto-u.ac.jp	Mihara, Hisaaki/F-2172-2010	Mihara, Hisaaki/0000-0002-5153-4403; Leimkuhler, Silke/0000-0003-3238-2122	Ministry of Education, Culture, Sports, Science, and Technology of Japan [17370037]; Japan Society for the Promotion of Science [18780073]; Deutsche Forschungsgemeinschaft [LE1171/5]; Fonds der Chemischen Industrie	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	This work was supported in part by a Grant-in-aid for Scientific Research on Priority Areas (B) 17370037 (to N. E.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, by Grant-in-aid for Encouragement of Young Scientists 18780073 (to H. M.) from the Japan Society for the Promotion of Science, by the National Project on Protein Structural and Functional Analyses, by a Grant-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (21st Century COE on Kyoto University Alliance for Chemistry), and by Deutsche Forschungsgemeinschaft Grant LE1171/5, and the Fonds der Chemischen Industrie (to S. L.).	Behshad E, 2004, BIOCHEMISTRY-US, V43, P12220, DOI 10.1021/bi049143e; Bittner F, 2010, PLANT CELL MONOGR, V17, P119, DOI [10.1016/j.bbamcr.2006.03.013, 10.1007/978-3-642-10613-2_6]; Fonknechten N, 2009, J BACTERIOL, V191, P3162, DOI 10.1128/JB.01777-08; Hille R, 1998, FEMS MICROBIOL REV, V22, P489; Hille R, 2002, TRENDS BIOCHEM SCI, V27, P360, DOI 10.1016/S0968-0004(02)02107-2; Ikeuchi Y, 2006, MOL CELL, V21, P97, DOI 10.1016/j.molcel.2005.11.001; JOHNSON JL, 1984, J BIOL CHEM, V259, P5414; JOHNSON JL, 1989, J BIOL CHEM, V264, P13440; Kambampati R, 2000, J BIOL CHEM, V275, P10727, DOI 10.1074/jbc.275.15.10727; Kambampati R, 1999, BIOCHEMISTRY-US, V38, P16561, DOI 10.1021/bi991119r; Kato S, 2002, P NATL ACAD SCI USA, V99, P5948, DOI 10.1073/pnas.082123599; Kessler D, 2006, FEMS MICROBIOL REV, V30, P825, DOI 10.1111/j.1574-6976.2006.00036.x; KLUGER R, 1987, CHEM REV, V87, P863, DOI 10.1021/cr00081a001; KNOWLES JR, 1989, ANNU REV BIOCHEM, V58, P195, DOI 10.1146/annurev.bi.58.070189.001211; Kurihara T, 2003, BBA-PROTEINS PROTEOM, V1647, P303, DOI 10.1016/S1570-9639(03)00078-5; Lake MW, 2001, NATURE, V414, P325, DOI 10.1038/35104586; Lauhon CT, 2000, J BIOL CHEM, V275, P20096, DOI 10.1074/jbc.M002680200; Lauhon CT, 2002, J BACTERIOL, V184, P6820, DOI 10.1128/JB.184.24.6820-6829.2002; Layer G, 2007, J BIOL CHEM, V282, P13342, DOI 10.1074/jbc.M608555200; Leimkuhler S, 2001, J BIOL CHEM, V276, P1837, DOI 10.1074/jbc.M007304200; Leimkuhler S, 2001, J BIOL CHEM, V276, P34695, DOI 10.1074/jbc.M102787200; Leimkuhler S, 2001, J BIOL CHEM, V276, P22024, DOI 10.1074/jbc.M102072200; Loiseau L, 2005, J BIOL CHEM, V280, P26760, DOI 10.1074/jbc.M504067200; Loiseau L, 2003, J BIOL CHEM, V278, P38352, DOI 10.1074/jbc.M305953200; Marelja Z, 2008, J BIOL CHEM, V283, P25178, DOI 10.1074/jbc.M804064200; Mihara H, 2000, J BIOCHEM-TOKYO, V127, P559, DOI 10.1093/oxfordjournals.jbchem.a022641; Mihara H, 2002, APPL MICROBIOL BIOT, V60, P12, DOI 10.1007/s00253-002-1107-4; Mihara H, 2002, P NATL ACAD SCI USA, V99, P6679, DOI 10.1073/pnas.102176099; Mihara H, 1997, J BIOL CHEM, V272, P22417, DOI 10.1074/jbc.272.36.22417; Mihara H, 1999, J BIOL CHEM, V274, P14768, DOI 10.1074/jbc.274.21.14768; Mueller EG, 2006, NAT CHEM BIOL, V2, P185, DOI 10.1038/nchembio779; Nilsson K, 2002, J BACTERIOL, V184, P6830, DOI 10.1128/JB.184.24.6830-6835.2002; Ollagnier-De-Choudens S, 2003, FEBS LETT, V555, P263, DOI 10.1016/S0014-5793(03)01244-4; Outten FW, 2004, MOL MICROBIOL, V52, P861, DOI 10.1111/j.1365-2958.2004.04025.x; Outten FW, 2003, J BIOL CHEM, V278, P45713, DOI 10.1074/jbc.M308004200; RAMABHADRAN TV, 1976, J BACTERIOL, V128, P671, DOI 10.1128/JB.128.2.671-672.1976; ROGERS KC, 1995, BIOCHIMIE, V77, P66, DOI 10.1016/0300-9084(96)88106-5; Rudolph MJ, 2001, NAT STRUCT BIOL, V8, P42; Schwartz CJ, 2000, P NATL ACAD SCI USA, V97, P9009, DOI 10.1073/pnas.160261497; Schwarz G, 2006, ANNU REV PLANT BIOL, V57, P623, DOI 10.1146/annurev.arplant.57.032905.105437; SEN GC, 1976, NUCLEIC ACIDS RES, V3, P523, DOI 10.1093/nar/3.3.523; Smith AD, 2001, J AM CHEM SOC, V123, P11103, DOI 10.1021/ja016757n; Takahashi Y, 2002, J BIOL CHEM, V277, P28380, DOI 10.1074/jbc.C200365200; Taylor SV, 1998, J BIOL CHEM, V273, P16555, DOI 10.1074/jbc.273.26.16555; Tokumoto U, 2001, J BIOCHEM, V130, P63, DOI 10.1093/oxfordjournals.jbchem.a002963; Urbina HD, 2001, J BIOL CHEM, V276, P44521, DOI 10.1074/jbc.M106907200; WUEBBENS MM, 1993, J BIOL CHEM, V268, P13493; Wuebbens MM, 2003, J BIOL CHEM, V278, P14523, DOI 10.1074/jbc.M300453200; YOKOYAMA S, 1985, P NATL ACAD SCI USA, V82, P4905, DOI 10.1073/pnas.82.15.4905	49	51	53	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2302	2308		10.1074/jbc.M109.082172	http://dx.doi.org/10.1074/jbc.M109.082172			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19946146	hybrid, Green Published			2022-12-25	WOS:000273697800009
J	Anthonisen, EH; Berven, L; Holm, S; Nygard, M; Nebb, HI; Gronning-Wang, LM				Anthonisen, Elin Holter; Berven, Lise; Holm, Sverre; Nygard, Maria; Nebb, Hilde I.; Gronning-Wang, Line M.			Nuclear Receptor Liver X Receptor Is O-GlcNAc-modified in Response to Glucose	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEIN-1C EXPRESSION; N-ACETYLGLUCOSAMINE; GENE-EXPRESSION; FATTY-ACID; LXR-ALPHA; ACTIVATION; PHOSPHORYLATION; GLYCOSYLATION; TRANSCRIPTION; INDUCTION	Post-translational modification of nucleocytoplasmic proteins by O-linked beta-N-acetylglucosamine (O-GlcNAc) has for the last 25 years emerged as an essential glucose-sensing mechanism. The liver X receptors (LXRs) function as nutritional sensors for cholesterol-regulating lipid metabolism, glucose homeostasis, and inflammation. LXRs are shown to be posttranslationally modified by phosphorylation, acetylation, and sumoylation, affecting their target gene specificity, stability, and transactivating and transrepressional activity, respectively. In the present study, we show for the first time that LXR alpha and LXR beta are targets for glucose-hexosamine-derived O-GlcNAc modification in human Huh7 cells. Furthermore, we observed increased hepatic LXR alpha O-GlcNAcylation in vivo in refed mice and in streptozotocin-induced refed diabetic mice. Importantly, induction of LXR alpha O-GlcNAcylation in both mouse models was concomitant with increased expression of the lipogenic gene SREBP-1c (sterol regulatory element-binding protein 1c). Furthermore, glucose increased LXR/retinoic acid receptor-dependent activation of luciferase reporter activity driven by the mouse SREBP-1c promoter via the hexosamine biosynthetic pathway in Huh7 cells. Altogether, our results suggest that O-GlcNAcylation of LXR is a novel mechanism by which LXR acts as a glucose sensor affecting LXR-dependent gene expression, substantiating the crucial role of LXR as a nutritional sensor in lipid and glucose metabolism.	[Anthonisen, Elin Holter; Berven, Lise; Holm, Sverre; Nygard, Maria; Nebb, Hilde I.; Gronning-Wang, Line M.] Univ Oslo, Dept Nutr, Inst Basic Med Sci, N-0316 Oslo, Norway	University of Oslo	Nebb, HI (corresponding author), Univ Oslo, Dept Nutr, Inst Basic Med Sci, POB 1046, N-0316 Oslo, Norway.	h.i.nebb@medisin.uio.no; l.m.gronning-wang@medisin.uio.no	Center, Norwegian Transgenic/T-2512-2018	Holm, Sverre/0000-0003-1064-3926	Norwegian Research Council; Novo Nordic Foundation; Anders Jahres Foundation; Joh H. Andresens Medical Foundation; Aktieselskabet Freia Chocolade Fabriks Medical Foundation; Johan Throne Holst Foundation; European Union	Norwegian Research Council(Research Council of NorwayEuropean Commission); Novo Nordic Foundation(Novo Nordisk Foundation); Anders Jahres Foundation; Joh H. Andresens Medical Foundation; Aktieselskabet Freia Chocolade Fabriks Medical Foundation; Johan Throne Holst Foundation; European Union(European Commission)	This work was supported by the Norwegian Research Council, the Novo Nordic Foundation, Anders Jahres Foundation, Joh H. Andresens Medical Foundation, Aktieselskabet Freia Chocolade Fabriks Medical Foundation, Johan Throne Holst Foundation, and the European Union-granted project 6th framework, CRESCENDO.	APFEL R, 1994, MOL CELL BIOL, V14, P7025, DOI 10.1128/MCB.14.10.7025; Bavner A, 2005, NUCLEIC ACIDS RES, V33, P3561, DOI 10.1093/nar/gki667; Chen GX, 2004, P NATL ACAD SCI USA, V101, P11245, DOI 10.1073/pnas.0404297101; Chen MY, 2006, FEBS LETT, V580, P4835, DOI 10.1016/j.febslet.2006.07.074; Comer FI, 2001, ANAL BIOCHEM, V293, P169, DOI 10.1006/abio.2001.5132; Denechaud PD, 2008, J CLIN INVEST, V118, P956, DOI 10.1172/JCI34314; Ghisletti S, 2007, MOL CELL, V25, P57, DOI 10.1016/j.molcel.2006.11.022; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hasty AH, 2000, J BIOL CHEM, V275, P31069, DOI 10.1074/jbc.M003335200; Housley MP, 2008, J BIOL CHEM, V283, P16283, DOI 10.1074/jbc.M802240200; Issad T, 2008, TRENDS ENDOCRIN MET, V19, P380, DOI 10.1016/j.tem.2008.09.001; Jakobsson T, 2009, MOL CELL, V34, P510, DOI 10.1016/j.molcel.2009.05.006; Janowski BA, 1999, P NATL ACAD SCI USA, V96, P266, DOI 10.1073/pnas.96.1.266; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Joseph SB, 2002, J BIOL CHEM, V277, P11019, DOI 10.1074/jbc.M111041200; Kuo M, 2008, FEBS LETT, V582, P829, DOI 10.1016/j.febslet.2008.02.010; Lazar MA, 2007, CELL METAB, V5, P159, DOI 10.1016/j.cmet.2007.02.001; Li X, 2007, MOL CELL, V28, P91, DOI 10.1016/j.molcel.2007.07.032; Liang GS, 2002, J BIOL CHEM, V277, P9520, DOI 10.1074/jbc.M111421200; Love, 2005, SCI STKE, V2005, DOI DOI 10.1126/STKE.3122005RE13; Matsuzaka T, 2004, DIABETES, V53, P560, DOI 10.2337/diabetes.53.3.560; Mitro N, 2007, NATURE, V445, P219, DOI 10.1038/nature05449; MONSIGNY M, 1980, EUR J BIOCHEM, V104, P147, DOI 10.1111/j.1432-1033.1980.tb04410.x; Myhre AE, 2008, SHOCK, V29, P468, DOI 10.1097/SHK.0b013e31815073cb; Oberkofler H, 2004, BIOCHEM J, V381, P357, DOI 10.1042/BJ20040173; Peet DJ, 1998, CURR OPIN GENET DEV, V8, P571, DOI 10.1016/S0959-437X(98)80013-0; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; Shiota M, 2008, J CLIN INVEST, V118, P841, DOI 10.1172/JCI35137; STARR CM, 1990, J BIOL CHEM, V265, P6868; TEBOUL M, 1995, P NATL ACAD SCI USA, V92, P2096, DOI 10.1073/pnas.92.6.2096; Tobin KAR, 2002, J BIOL CHEM, V277, P10691, DOI 10.1074/jbc.M109771200; Torra IP, 2008, MOL CELL BIOL, V28, P2626, DOI 10.1128/MCB.01575-07; Walcher D, 2006, ARTERIOSCL THROM VAS, V26, P1022, DOI 10.1161/01.ATV.0000210278.67076.8f; Williams S, 2003, J BIOL CHEM, V278, P27138, DOI 10.1074/jbc.M302260200; Yamamoto T, 2007, J BIOL CHEM, V282, P11687, DOI 10.1074/jbc.M611911200; Yang WH, 2008, P NATL ACAD SCI USA, V105, P17345, DOI 10.1073/pnas.0806198105; Yang WH, 2006, NAT CELL BIOL, V8, P1074, DOI 10.1038/ncb1470; Yoshikawa T, 2002, J BIOL CHEM, V277, P1705, DOI 10.1074/jbc.M105711200; Yoshikawa T, 2001, MOL CELL BIOL, V21, P2991, DOI 10.1128/MCB.21.9.2991-3000.2001	41	73	76	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2010	285	3					1607	1615		10.1074/jbc.M109.082685	http://dx.doi.org/10.1074/jbc.M109.082685			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	541PJ	19933273	hybrid, Green Published			2022-12-25	WOS:000273429100006
J	Shen, A; Lupardus, PJ; Morell, M; Ponder, EL; Sadaghiani, AM; Garcia, KC; Bogyo, M				Shen, Aimee; Lupardus, Patrick J.; Morell, Montse; Ponder, Elizabeth L.; Sadaghiani, A. Masoud; Garcia, K. Christopher; Bogyo, Matthew			Simplified, Enhanced Protein Purification Using an Inducible, Autoprocessing Enzyme Tag	PLOS ONE			English	Article							RECOMBINANT PROTEINS; RTX TOXIN; EXPRESSION; DOMAIN; FUSION; ACTIVATION	We introduce a new method for purifying recombinant proteins expressed in bacteria using a highly specific, inducible, self-cleaving protease tag. This tag is comprised of the Vibrio cholerae MARTX toxin cysteine protease domain (CPD), an autoprocessing enzyme that cleaves exclusively after a leucine residue within the target protein-CPD junction. Importantly, V. cholerae CPD is specifically activated by inositol hexakisphosphate (InsP(6)), a eukaryotic-specific small molecule that is absent from the bacterial cytosol. As a result, when His(6)-tagged CPD is fused to the C-terminus of target proteins and expressed in Escherichia coli, the full-length fusion protein can be purified from bacterial lysates using metal ion affinity chromatography. Subsequent addition of InsP(6) to the immobilized fusion protein induces CPD-mediated cleavage at the target protein-CPD junction, releasing untagged target protein into the supernatant. This method condenses affinity chromatography and fusion tag cleavage into a single step, obviating the need for exogenous protease addition to remove the fusion tag(s) and increasing the efficiency of tag separation. Furthermore, in addition to being timesaving, versatile, and inexpensive, our results indicate that the CPD purification system can enhance the expression, integrity, and solubility of intractable proteins from diverse organisms.	[Shen, Aimee; Morell, Montse; Ponder, Elizabeth L.; Bogyo, Matthew] Stanford Sch Med, Dept Pathol, Stanford, CA USA; [Lupardus, Patrick J.; Garcia, K. Christopher] Stanford Sch Med, Dept Mol & Cellular Physiol, Stanford, CA USA; [Sadaghiani, A. Masoud] Stanford Sch Med, Dept Syst & Chem Biol, Stanford, CA USA; [Garcia, K. Christopher] Stanford Sch Med, Howard Hughes Inst, Stanford, CA USA	Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Shen, A (corresponding author), Stanford Sch Med, Dept Pathol, Stanford, CA USA.	mbogyo@stanford.edu	Ponder, Elizabeth/E-5147-2011	Shen, Aimee/0000-0002-9786-5742; Bogyo, Matthew/0000-0003-3753-4412	Burroughs Wellcome Foundation; NIH [R01 AI078947, R01 EB005011]; Damon Runyon Cancer Research Fellowship; Keck Foundation; Howard Hughes Medical Institute; Stanford Dean's Fellowship; Beautriu de Pinos of Agaur Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078947, T32AI007328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB005011] Funding Source: NIH RePORTER	Burroughs Wellcome Foundation(Burroughs Wellcome Fund); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Cancer Research Fellowship; Keck Foundation(W.M. Keck Foundation); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Stanford Dean's Fellowship; Beautriu de Pinos of Agaur Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by a Burroughs Wellcome Foundation grant and NIH grants R01 AI078947 and R01 EB005011 to M. B., the Damon Runyon Cancer Research Fellowship to P.J.L., a Keck Foundation and Howard Hughes Medical Institute grant to K.C.G., a Stanford Dean's Fellowship to A. S., and a Beautriu de Pinos of Agaur Fellowship to M.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnau J, 2006, PROTEIN EXPRES PURIF, V48, P1, DOI 10.1016/j.pep.2005.12.002; Banki MR, 2005, NAT METHODS, V2, P659, DOI 10.1038/nmeth787; Butt TR, 2005, PROTEIN EXPRES PURIF, V43, P1, DOI 10.1016/j.pep.2005.03.016; Graslund S, 2008, NAT METHODS, V5, P135, DOI 10.1038/nmeth.f.202; HIBI M, 1990, CELL, V63, P1149, DOI 10.1016/0092-8674(90)90411-7; Lupardus PJ, 2008, SCIENCE, V322, P265, DOI 10.1126/science.1162403; Mao HY, 2004, PROTEIN EXPRES PURIF, V37, P253, DOI 10.1016/j.pep.2004.06.013; Mehlin C, 2006, MOL BIOCHEM PARASIT, V148, P144, DOI 10.1016/j.molbiopara.2006.03.011; Michell RH, 2008, NAT REV MOL CELL BIO, V9, P151, DOI 10.1038/nrm2334; O'Callaghan CA, 1999, ANAL BIOCHEM, V266, P9, DOI 10.1006/abio.1998.2930; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Parkar AA, 2000, PROTEIN EXPRES PURIF, V20, P152, DOI 10.1006/prep.2000.1280; PONDER EL, 2009, NAT CHEM BI IN PRESS; Prochazkova K, 2008, J BIOL CHEM, V283, P23656, DOI 10.1074/jbc.M803334200; Raboy V, 2003, PHYTOCHEMISTRY, V64, P1033, DOI 10.1016/S0031-9422(03)00446-1; Sheahan KL, 2007, EMBO J, V26, P2552, DOI 10.1038/sj.emboj.7601700; Shen A, 2009, NAT CHEM BIOL, V5, P469, DOI 10.1038/nchembio.178; Skiniotis G, 2008, MOL CELL, V31, P737, DOI 10.1016/j.molcel.2008.08.011; Zhang AH, 2001, GENE, V275, P241, DOI 10.1016/S0378-1119(01)00663-1	19	65	69	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2009	4	12							e8119	10.1371/journal.pone.0008119	http://dx.doi.org/10.1371/journal.pone.0008119			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MU	19956581	Green Published, gold			2022-12-25	WOS:000272828800015
J	McCormick, PJ; Segarra, M; Gasperini, P; Gulino, AV; Tosato, G				McCormick, Peter J.; Segarra, Marta; Gasperini, Paola; Gulino, A. Virginia; Tosato, Giovanna			Impaired Recruitment of Grk6 and beta-Arrestin2 Causes Delayed Internalization and Desensitization of a WHIM Syndrome-Associated CXCR4 Mutant Receptor	PLOS ONE			English	Article							HEMATOPOIETIC PROGENITOR CELLS; BONE-MARROW; BETA-ARRESTIN; FACTOR-I; G-CSF; NEUTROPHIL HOMEOSTASIS; EXTRACELLULAR SIGNAL; MYELOID CELLS; STEM-CELLS; CXCL12	WHIM (warts, hypogammaglobulinemia, infections, and myelokatexis) syndrome is a rare immunodeficiency syndrome linked to heterozygous mutations of the chemokine receptor CXCR4 resulting in truncations of its cytoplasmic tail. Leukocytes from patients with WHIM syndrome display impaired CXCR4 internalization and enhanced chemotaxis in response to its unique ligand SDF-1/CXCL12, which likely contribute to the clinical manifestations. Here, we investigated the biochemical mechanisms underlying CXCR4 deficiency in WHIM syndrome. We report that after ligand activation, WHIM-associated mutant CXCR4 receptors lacking the carboxy-terminal 19 residues internalize and activate Erk 1/2 slower than wild-type (WT) receptors, while utilizing the same trafficking endocytic pathway. Recruitment of beta-Arrestin 2, but not beta-Arrestin 1, to the active WHIM-mutant receptor is delayed compared to the WT CXCR4 receptor. In addition, while both kinases Grk3 and Grk6 bind to WT CXCR4 and are critical to its trafficking to the lysosomes, Grk6 fails to associate with the WHIM-mutant receptor whereas Grk3 associates normally. Since beta-Arrestins and Grks play critical roles in phosphorylation and internalization of agonist-activated G protein-coupled receptors, these results provide a molecular basis for CXCR4 dysfunction in WHIM syndrome.	[McCormick, Peter J.; Segarra, Marta; Gasperini, Paola; Gulino, A. Virginia; Tosato, Giovanna] NCI, Cellular Oncol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	McCormick, PJ (corresponding author), NCI, Cellular Oncol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	mccormpe@mail.nih.gov	Segarra, Marta/ABE-2312-2020; McCormick, Peter/E-7387-2012	McCormick, Peter/0000-0002-2225-5181; Gulino, Virginia/0000-0003-1724-4450; Gasperini, Paola/0000-0002-3016-9742; Tosato, Giovanna/0000-0003-1663-3227	National Institutes of Health; National Cancer Institute; Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010782] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balabanian K, 2005, BLOOD, V105, P2449, DOI 10.1182/blood-2004-06-2289; Balabanian K, 2008, J CLIN INVEST, V118, P1074, DOI 10.1172/JCI33187; Bhandari D, 2007, J BIOL CHEM, V282, P36971, DOI 10.1074/jbc.M705085200; Busillo JM, 2007, BBA-BIOMEMBRANES, V1768, P952, DOI 10.1016/j.bbamem.2006.11.002; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Cheng ZJ, 2000, J BIOL CHEM, V275, P2479, DOI 10.1074/jbc.275.4.2479; Contento RL, 2008, P NATL ACAD SCI USA, V105, P10101, DOI 10.1073/pnas.0804286105; Diaz GA, 2005, IMMUNOL REV, V203, P235, DOI 10.1111/j.0105-2896.2005.00226.x; Eash KJ, 2009, BLOOD, V113, P4711, DOI 10.1182/blood-2008-09-177287; Fong AM, 2002, P NATL ACAD SCI USA, V99, P7478, DOI 10.1073/pnas.112198299; Gorlin RJ, 2000, AM J MED GENET, V91, P368, DOI 10.1002/(SICI)1096-8628(20000424)91:5<368::AID-AJMG10>3.0.CO;2-9; Gulino AV, 2003, CURR OPIN ALLERGY CL, V3, P443, DOI 10.1097/01.all.0000104449.09202.d8; Gulino AV, 2004, BLOOD, V104, P444, DOI 10.1182/blood-2003-10-3532; Hernandez PA, 2003, NAT GENET, V34, P70, DOI 10.1038/ng1149; Imai K, 1999, BRIT J HAEMATOL, V106, P905, DOI 10.1046/j.1365-2141.1999.01644.x; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kim HK, 2006, BLOOD, V108, P812, DOI 10.1182/blood-2005-10-4162; Lagane B, 2008, BLOOD, V112, P34, DOI 10.1182/blood-2007-07-102103; Laporte SA, 1999, P NATL ACAD SCI USA, V96, P3712, DOI 10.1073/pnas.96.7.3712; Levoye A, 2009, BLOOD, V113, P6085, DOI 10.1182/blood-2008-12-196618; Lin FT, 1999, J BIOL CHEM, V274, P15971, DOI 10.1074/jbc.274.23.15971; Link DC, 2005, IMMUNOL RES, V32, P169, DOI 10.1385/IR:32:1-3:169; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Ma Q, 1999, IMMUNITY, V10, P463, DOI 10.1016/S1074-7613(00)80046-1; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Marchese A, 2003, DEV CELL, V5, P709, DOI 10.1016/S1534-5807(03)00321-6; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; Martin C, 2003, IMMUNITY, V19, P583, DOI 10.1016/S1074-7613(03)00263-2; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Nobles KN, 2007, J BIOL CHEM, V282, P21370, DOI 10.1074/jbc.M611483200; Orsini MJ, 1999, J BIOL CHEM, V274, P31076, DOI 10.1074/jbc.274.43.31076; Patrussi L, 2008, IMMUNOL LETT, V115, P75, DOI 10.1016/j.imlet.2007.10.012; Peng SB, 2005, MOL CANCER RES, V3, P227; Ponomaryov T, 2000, J CLIN INVEST, V106, P1331, DOI 10.1172/JCI10329; Raaijmakers MHGP, 2008, CURR OPIN HEMATOL, V15, P301, DOI 10.1097/MOH.0b013e328303e14c; Rey M, 2007, J CELL SCI, V120, P1126, DOI 10.1242/jcs.03415; Ribas C, 2007, BBA-BIOMEMBRANES, V1768, P913, DOI 10.1016/j.bbamem.2006.09.019; Salvucci O, 2002, BLOOD, V99, P2703, DOI 10.1182/blood.V99.8.2703; Schwartz V, 2009, FEBS LETT, V583, P2749, DOI 10.1016/j.febslet.2009.07.058; Semerad CL, 2005, BLOOD, V106, P3020, DOI 10.1182/blood-2004-01-0272; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Shenoy Sudha K, 2005, Sci STKE, V2005, pcm10, DOI 10.1126/stke.2005/308/cm10; Sierra MDLL, 2007, BLOOD, V110, P2276, DOI 10.1182/blood-2007-03-081448; Sipkins DA, 2005, NATURE, V435, P969, DOI 10.1038/nature03703; Suratt BT, 2004, BLOOD, V104, P565, DOI 10.1182/blood-2003-10-3638; TASHIRO K, 1993, SCIENCE, V261, P600, DOI 10.1126/science.8342023; Tokoyoda K, 2004, IMMUNITY, V20, P707, DOI 10.1016/j.immuni.2004.05.001; Uchida DE, 2004, LAB INVEST, V84, P1538, DOI 10.1038/labinvest.3700190; van Buul JD, 2003, J BIOL CHEM, V278, P30302, DOI 10.1074/jbc.M304764200; Violin JD, 2007, TRENDS PHARMACOL SCI, V28, P416, DOI 10.1016/j.tips.2007.06.006; Vroon A, 2004, J LEUKOCYTE BIOL, V75, P698, DOI 10.1189/jlb.0703320; Wang JH, 2001, J BIOL CHEM, V276, P49236, DOI 10.1074/jbc.M108523200; Yao L, 2003, BLOOD, V102, P3900, DOI 10.1182/blood-2003-02-0641; Zhang YY, 2004, STEM CELLS, V22, P1015, DOI 10.1634/stemcells.22-6-1015; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	56	52	59	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2009	4	12							e8102	10.1371/journal.pone.0008102	http://dx.doi.org/10.1371/journal.pone.0008102			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MT	19956569	Green Submitted, Green Published, gold			2022-12-25	WOS:000272828700014
J	Zhang, JG; Li, J; Deng, HW				Zhang, Jigang; Li, Jian; Deng, Hong-Wen			Identifying Gene Interaction Enrichment for Gene Expression Data	PLOS ONE			English	Article							SET ENRICHMENT; MICROARRAY DATA; GLOBAL TEST; P53; LOCI; DISCOVERY; FRAMEWORK; PROTEIN; GROWTH; CANCER	Gene set analysis allows the inclusion of knowledge from established gene sets, such as gene pathways, and potentially improves the power of detecting differentially expressed genes. However, conventional methods of gene set analysis focus on gene marginal effects in a gene set, and ignore gene interactions which may contribute to complex human diseases. In this study, we propose a method of gene interaction enrichment analysis, which incorporates knowledge of predefined gene sets (e.g. gene pathways) to identify enriched gene interaction effects on a phenotype of interest. In our proposed method, we also discuss the reduction of irrelevant genes and the extraction of a core set of gene interactions for an identified gene set, which contribute to the statistical variation of a phenotype of interest. The utility of our method is demonstrated through analyses on two publicly available microarray datasets. The results show that our method can identify gene sets that show strong gene interaction enrichments. The enriched gene interactions identified by our method may provide clues to new gene regulation mechanisms related to the studied phenotypes. In summary, our method offers a powerful tool for researchers to exhaustively examine the large numbers of gene interactions associated with complex human diseases, and can be a useful complement to classical gene set analyses which only considers single genes in a gene set.	[Zhang, Jigang; Li, Jian; Deng, Hong-Wen] Univ Missouri, Sch Med, Kansas City, MO 64108 USA; [Deng, Hong-Wen] Xi An Jiao Tong Univ, Sch Life Sci & Technol, Xian 710049, Shaanxi, Peoples R China; [Deng, Hong-Wen] Shanghai Univ Sci & Technol, Systemat Biomed Res Ctr, Shanghai 201800, Peoples R China	University of Missouri System; University of Missouri Kansas City; Xi'an Jiaotong University; University of Shanghai for Science & Technology	Zhang, JG (corresponding author), Univ Missouri, Sch Med, Kansas City, MO 64108 USA.	dengh@umkc.edu	Li, Jian/G-4445-2015	Deng, Hong-Wen/0000-0002-0387-8818	National Institutes of Health [R01 AR050496, R21 AG027110, R01 AG026564, R21 AA015973, P50 AR055081]; Missouri Life Sciences Research Board Center [09-1101]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR055081, R01AR050496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG027110, R01AG026564] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA015973] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Missouri Life Sciences Research Board Center; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	The investigators of this work were partially supported by grants from National Institutes of Health (R01 AR050496, R21 AG027110, R01 AG026564, R21 AA015973, and P50 AR055081) and Missouri Life Sciences Research Board center (Missouri State Funding 09-1101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-47; Aston CE, 2005, HUM GENET, V116, P208, DOI 10.1007/s00439-004-1206-7; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BLEEKER FE, 2008, ONCOGENE; Broberg P, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-6-r41; Brock MV, 2008, NEW ENGL J MED, V358, P1118, DOI 10.1056/NEJMoa0706550; Cohen J., 2003, APPL MULTIPLE REGRES; Cox NJ, 1999, NAT GENET, V21, P213, DOI 10.1038/6002; Dinu I, 2009, BRIEF BIOINFORM, V10, P24, DOI 10.1093/bib/bbn042; Efron B, 2007, ANN APPL STAT, V1, P107, DOI 10.1214/07-AOAS101; Fabian Z, 2006, J CELL BIOCHEM, V99, P1431, DOI 10.1002/jcb.21019; Goeman JJ, 2007, BIOINFORMATICS, V23, P980, DOI 10.1093/bioinformatics/btm051; Goeman JJ, 2004, BIOINFORMATICS, V20, P93, DOI 10.1093/bioinformatics/btg382; Gottlieb TM, 1996, BBA-REV CANCER, V1287, P77, DOI 10.1016/0304-419X(95)00019-C; Gulati AP, 2006, MOL CARCINOGEN, V45, P26, DOI 10.1002/mc.20149; Hoh J, 2003, NAT REV GENET, V4, P701, DOI 10.1038/nrg1155; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Liu Q, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-431; Mansmann U, 2005, METHOD INFORM MED, V44, P449; Marchini J, 2005, NAT GENET, V37, P413, DOI 10.1038/ng1537; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Rougemont J, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-15; Roy S, 2008, FREE RADICAL BIO MED, V44, P180, DOI 10.1016/j.freeradbiomed.2007.01.025; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tsai CA, 2009, BIOINFORMATICS, V25, P897, DOI 10.1093/bioinformatics/btp098; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wu XS, 2008, EUR J HUM GENET, V16, P644, DOI 10.1038/sj.ejhg.5202004; Yan XT, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-362; Zhang JX, 2007, BIOINFORMATICS, V23, P2903, DOI 10.1093/bioinformatics/btm482; Zhang JG, 2008, AM J HUM GENET, V83, P269, DOI 10.1016/j.ajhg.2008.07.009	32	19	19	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2009	4	11							e8064	10.1371/journal.pone.0008064	http://dx.doi.org/10.1371/journal.pone.0008064			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MQ	19956614	Green Published, Green Submitted, gold			2022-12-25	WOS:000272828400018
J	Rodder, D; Schmidtlein, S; Veith, M; Lotters, S				Roedder, Dennis; Schmidtlein, Sebastian; Veith, Michael; Loetters, Stefan			Alien Invasive Slider Turtle in Unpredicted Habitat: A Matter of Niche Shift or of Predictors Studied?	PLOS ONE			English	Article							TRACHEMYS-SCRIPTA-ELEGANS; RED-EARED SLIDER; CLIMATE-CHANGE; SPECIES DISTRIBUTIONS; TEMPERATURE; PERFORMANCE; MODELS; ECOLOGY; SPACE	Background: Species Distribution Models (SDMs) aim on the characterization of a species' ecological niche and project it into geographic space. The result is a map of the species' potential distribution, which is, for instance, helpful to predict the capability of alien invasive species. With regard to alien invasive species, recently several authors observed a mismatch between potential distributions of native and invasive ranges derived from SDMs and, as an explanation, ecological niche shift during biological invasion has been suggested. We studied the physiologically well known Slider turtle from North America which today is widely distributed over the globe and address the issue of ecological niche shift versus choice of ecological predictors used for model building, i.e., by deriving SDMs using multiple sets of climatic predictor. Principal Findings: In one SDM, predictors were used aiming to mirror the physiological limits of the Slider turtle. It was compared to numerous other models based on various sets of ecological predictors or predictors aiming at comprehensiveness. The SDM focusing on the study species' physiological limits depicts the target species' worldwide potential distribution better than any of the other approaches. Conclusion: These results suggest that a natural history-driven understanding is crucial in developing statistical models of ecological niches (as SDMs) while "comprehensive'' or "standard'' sets of ecological predictors may be of limited use.	[Roedder, Dennis; Veith, Michael; Loetters, Stefan] Univ Trier, Biogeog Dept, Trier, Germany; [Schmidtlein, Sebastian] Univ Bonn, Dept Geog, Sebastian Schmidtlein, D-5300 Bonn, Germany	Universitat Trier; University of Bonn	Rodder, D (corresponding author), Univ Trier, Biogeog Dept, Trier, Germany.	loetters@uni-trier.de	Schmidtlein, Sebastian/Q-2919-2016; Rödder, Dennis/A-7043-2010; Rödder, Dennis/AAT-8644-2021	Rödder, Dennis/0000-0002-6108-1639; Schmidtlein, Sebastian/0000-0003-1888-1865	'Graduiertenforderung des Landes Nordrhein-Westfalen'; Ministry of Education, Science, Youth and Culture of the Rhineland-Palatinate state of Germany	'Graduiertenforderung des Landes Nordrhein-Westfalen'; Ministry of Education, Science, Youth and Culture of the Rhineland-Palatinate state of Germany	This work has been supported by grants from the 'Graduiertenforderung des Landes Nordrhein-Westfalen' and the Ministry of Education, Science, Youth and Culture of the Rhineland-Palatinate state of Germany ('Die Folgen des Global Change fur Bioressourcen, Gesetzgebung und Standardsetzung'). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BACCARI GC, 1993, J ANAT, V183, P21; BAILEY JR, 1995, J COMP PHYSIOL B, V164, P622, DOI 10.1007/BF00389803; Broennimann O, 2007, ECOL LETT, V10, P701, DOI 10.1111/j.1461-0248.2007.01060.x; Busby JR, 1991, NATURE CONSERVATION, P64, DOI DOI 10.1046/J.1365-294X.2001.01244.X; CREWS D, 1994, DEV GENET, V15, P297, DOI 10.1002/dvg.1020150310; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Ficetola GF, 2007, DIVERS DISTRIB, V13, P476, DOI 10.1111/j.1472-4642.2007.00377.x; Ficetola GF, 2009, DIVERS DISTRIB, V15, P108, DOI 10.1111/j.1472-4642.2008.00516.x; Fitzpatrick MC, 2007, GLOBAL ECOL BIOGEOGR, V16, P24, DOI 10.1111/j.1466-8238.2006.00258.x; GARSTKA WR, 1991, COMP BIOCHEM PHYS A, V98, P271, DOI 10.1016/0300-9629(91)90532-H; Giovanelli JGR, 2008, BIOL INVASIONS, V10, P585, DOI 10.1007/s10530-007-9154-5; Hijmans R.J., 2001, DIVA GIS VERSION 1 4; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, 2006, GLOBAL CHANGE BIOL, V12, P2272, DOI 10.1111/j.1365-2486.2006.01256.x; Holt RD, 2005, SPECIES INVASIONS: INSIGHTS INTO ECOLOGY, EVOLUTION, AND BIOGEORGRAPHY, P259; Hutchinson G.E., 1978, INTRO POPULATION ECO; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Hutchison V.H., 1979, P207; HUTCHISON VICTOR H., 1966, HERPETOLOGIA, V22, P32; Jeschke JM, 2008, ANN NY ACAD SCI, V1134, P1, DOI 10.1196/annals.1439.002; Kearney M, 2004, ECOLOGY, V85, P3119, DOI 10.1890/03-0820; Kearney M, 2008, ECOGRAPHY, V31, P423, DOI 10.1111/j.0906-7590.2008.05457.x; LAMB T, 1995, ECOTOXICOLOGY, V4, P5, DOI 10.1007/BF00350647; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Lowe S., 2000, ENCY BIOL INVASIONS; Malcolm JR, 2006, CONSERV BIOL, V20, P538, DOI 10.1111/j.1523-1739.2006.00364.x; Nix H. A., 1986, ATLAS ELAPID SNAKES, V7, P4; Ota Hidetoshi, 2004, Global Environmental Research, V8, P133; Packard GC, 1997, COPEIA, P339, DOI 10.2307/1447753; PARMENTER RR, 1980, COPEIA, P503, DOI 10.2307/1444528; Pearce J, 2000, ECOL MODEL, V133, P225, DOI 10.1016/S0304-3800(00)00322-7; Pearman PB, 2008, TRENDS ECOL EVOL, V23, P149, DOI 10.1016/j.tree.2007.11.005; Perry Gad, 2007, APPLIED HERPETOLOGY, V4, P88, DOI 10.1163/157075407779766723; Peterson AT, 2008, GLOBAL ECOL BIOGEOGR, V17, P135, DOI 10.1111/j.1466-8238.2007.00347.x; Peterson AT, 2008, EVOLUTION, V62, P173, DOI 10.1111/j.1558-5646.2007.00258.x; Peterson AT, 2001, BIOSCIENCE, V51, P363, DOI 10.1641/0006-3568(2001)051[0363:PSIUEN]2.0.CO;2; Peterson AT, 2003, Q REV BIOL, V78, P419, DOI 10.1086/378926; Peterson AT, 2001, CONDOR, V103, P599, DOI 10.1650/0010-5422(2001)103[0599:PSGDBO]2.0.CO;2; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pulliam HR, 2000, ECOL LETT, V3, P349, DOI 10.1046/j.1461-0248.2000.00143.x; Ramsay Neil F., 2007, V2, P161; RODDER D, 2009, CLIMATE CHANGE ECOLO; Rodder D, 2009, J NAT HIST, V43, P2525, DOI 10.1080/00222930903100550; Rodder D, 2009, NORTH-WEST J ZOOL, V5, P16; Rodder D, 2008, NORTH-WEST J ZOOL, V4, P236; Sax DF, 2007, TRENDS ECOL EVOL, V22, P465, DOI 10.1016/j.tree.2007.06.009; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Telecky Teresa M., 2001, Turtle and Tortoise Newsletter, V4, P8; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Tucker JK, 1998, J HERPETOL, V32, P431, DOI 10.2307/1565459; Tucker JK, 1998, J HERPETOL, V32, P124, DOI 10.2307/1565492; Welk E, 2002, DIVERS DISTRIB, V8, P219, DOI 10.1046/j.1472-4642.2002.00144.x; WIBBELS T, 1991, J EXP ZOOL, V260, P371, DOI 10.1002/jez.1402600311; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x	56	149	157	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2009	4	11							e7843	10.1371/journal.pone.0007843	http://dx.doi.org/10.1371/journal.pone.0007843			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MH	19956684	Green Submitted, gold, Green Published			2022-12-25	WOS:000272827500001
J	De Biase, I; Chutake, YK; Rindler, PM; Bidichandani, SI				De Biase, Irene; Chutake, Yogesh K.; Rindler, Paul M.; Bidichandani, Sanjay I.			Epigenetic Silencing in Friedreich Ataxia Is Associated with Depletion of CTCF (CCCTC-Binding Factor) and Antisense Transcription	PLOS ONE			English	Article							TRIPLET-REPEAT EXPANSION; DOT-TTC REPEATS; HUMAN PROMOTERS; HUMAN-CELLS; GENE; RNA; CHROMATIN; HETEROCHROMATIN; COHESIN; DNA	Background: Over 15 inherited diseases are caused by expansion of triplet-repeats. Friedreich ataxia (FRDA) patients are homozygous for an expanded GAA triplet-repeat sequence in intron 1 of the FXN gene. The expanded GAA triplet-repeat results in deficiency of FXN gene transcription, which is reversed via administration of histone deacetylase inhibitors indicating that transcriptional silencing is at least partially due to an epigenetic abnormality. Methodology/Principal Findings: We found a severe depletion of the chromatin insulator protein CTCF (CCCTC-binding factor) in the 5'UTR of the FXN gene in FRDA, and coincident heterochromatin formation involving the +1 nucleosome via enrichment of H3K9me3 and recruitment of heterochromatin protein 1. We identified FAST-1 (FXN Antisense Transcript - 1), a novel antisense transcript that overlaps the CTCF binding site in the 5'UTR, which was expressed at higher levels in FRDA. The reciprocal relationship of deficient FXN transcript and higher levels of FAST-1 seen in FRDA was reproduced in normal cells via knockdown of CTCF. Conclusions/Significance: CTCF depletion constitutes an epigenetic switch that results in increased antisense transcription, heterochromatin formation and transcriptional deficiency in FRDA. These findings provide a mechanistic basis for the transcriptional silencing of the FXN gene in FRDA, and broaden our understanding of disease pathogenesis in triplet-repeat diseases.			De Biase, I (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73190 USA.	Sanjay-Bidichandani@ouhsc.edu		Bidichandani, Sanjay/0000-0001-6191-6475				Al-Mahdawi S, 2008, HUM MOL GENET, V17, P735, DOI 10.1093/hmg/ddm346; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bidichandani SI, 1998, AM J HUM GENET, V62, P111, DOI 10.1086/301680; Burnett R, 2006, P NATL ACAD SCI USA, V103, P11497, DOI 10.1073/pnas.0604939103; Bushey AM, 2008, MOL CELL, V32, P1, DOI 10.1016/j.molcel.2008.08.017; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Cho DH, 2005, MOL CELL, V20, P483, DOI 10.1016/j.molcel.2005.09.002; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Dahl JA, 2008, NAT PROTOC, V3, P1032, DOI 10.1038/nprot.2008.68; Dennis JH, 2007, GENOME RES, V17, P928, DOI 10.1101/gr.5636607; Filippova GN, 2008, CURR TOP DEV BIOL, V80, P337, DOI 10.1016/S0070-2153(07)80009-3; Gaszner M, 2006, NAT REV GENET, V7, P703, DOI 10.1038/nrg1925; Greene E, 2007, NUCLEIC ACIDS RES, V35, P3383, DOI 10.1093/nar/gkm271; Grewal SIS, 2007, NATURE, V447, P399, DOI 10.1038/nature05914; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Gupta S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000134; Han J, 2007, P NATL ACAD SCI USA, V104, P12422, DOI 10.1073/pnas.0701635104; He YP, 2008, SCIENCE, V322, P1855, DOI 10.1126/science.1163853; Herman D, 2006, NAT CHEM BIOL, V2, P551, DOI 10.1038/nchembio815; Iida T, 2008, MOL CELL, V31, P178, DOI 10.1016/j.molcel.2008.07.003; Jiang CZ, 2009, NAT REV GENET, V10, P161, DOI 10.1038/nrg2522; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Kim DH, 2008, P NATL ACAD SCI USA, V105, P16230, DOI 10.1073/pnas.0808830105; Lefevre P, 2008, MOL CELL, V32, P129, DOI 10.1016/j.molcel.2008.07.023; Lunyak VV, 2008, CURR OPIN CELL BIOL, V20, P281, DOI 10.1016/j.ceb.2008.03.018; Ohshima K, 1998, J BIOL CHEM, V273, P14588, DOI 10.1074/jbc.273.23.14588; Ozsolak F, 2007, NAT BIOTECHNOL, V25, P244, DOI 10.1038/nbt1279; Pandolfo M, 2008, ARCH NEUROL-CHICAGO, V65, P1296, DOI 10.1001/archneur.65.10.1296; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Peters JM, 2008, GENE DEV, V22, P3089, DOI 10.1101/gad.1724308; Pianese L, 2004, J NEUROL NEUROSUR PS, V75, P1061, DOI 10.1136/jnnp.2003.028605; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; Renaud S, 2007, NUCLEIC ACIDS RES, V35, P7372, DOI 10.1093/nar/gkm896; Rubio ED, 2008, P NATL ACAD SCI USA, V105, P8309, DOI 10.1073/pnas.0801273105; Sakamoto N, 1999, MOL CELL, V3, P465, DOI 10.1016/S1097-2765(00)80474-8; Saveliev A, 2003, NATURE, V422, P909, DOI 10.1038/nature01596; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Tufarelli C, 2003, NAT GENET, V34, P157, DOI 10.1038/ng1157; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Yu WQ, 2008, NATURE, V451, P202, DOI 10.1038/nature06468	41	87	89	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2009	4	11							e7914	10.1371/journal.pone.0007914	http://dx.doi.org/10.1371/journal.pone.0007914			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522NJ	19956589	gold, Green Published, Green Submitted			2022-12-25	WOS:000272004600017
J	Hancock, WW; Ozkaynak, E				Hancock, Wayne W.; Oezkaynak, Engin			Three Distinct Domains Contribute to Nuclear Transport of Murine Foxp3	PLOS ONE			English	Article							T-CELL FUNCTION; IMMUNE DYSREGULATION; POLYENDOCRINOPATHY; ENTEROPATHY; BINDING; IPEX; LOCALIZATION; ACTIVATION; EXPRESSION; MUTATIONS	Foxp3, a 47-kDa transcription factor, is necessary for the function of CD4+CD25+regulatory T cells (Tregs), with an essential role in the control of self-reactive T cells and in preventing autoimmunity. Activation of Tregs by TCR engagement results in upregulation of Foxp3 expression, followed by its rapid nuclear transport and binding to chromatin. Here, we identify three distinct Foxp3 domains that contribute to nuclear transport. The first domain (Domain 1) comprises the C-terminal 12 amino acids. The second domain (Domain 2) is located immediately N-terminal to the forkhead domain (FHD), recently reported to be a binding site for the runt-related transcription factor 1/acute myeloid leukemia 1 (Runx1/AML1). The third domain (Domain 3) is located within the N-terminal first 51 amino acids. Unlike the known nuclear localization signals (NLSs), none of these three regions are rich in basic residues and do not bear any similarity to known monopartite or bipartite NLSs that have one or more clusters of basic amino acids. The basic arginine-lysine-lysine-arginine (RKKR) sequence, located 12-aa from the C-terminal end of Foxp3 was previously reported to be a nuclear localization signal (NLS) for several proteins, including for a GFP-Foxp3 hybrid. Evidence is provided here that in the full-length native Foxp3 RKKR does not function as an NLS. The data reported in this study indicates that Foxp3 achieves nuclear transport by binding to other nuclear factors and co-transporting with them to the nucleus.			Hancock, WW (corresponding author), Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Div Transplant Immunol, Philadelphia, PA 19104 USA.	ozkaynak@email.chop.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI072420] Funding Source: NIH RePORTER; NIAID NIH HHS [R21 AI072420, 1R21AI72420-01A1] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Allan SE, 2008, MOL THER, V16, P194, DOI 10.1038/sj.mt.6300341; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Bettelli E, 2005, P NATL ACAD SCI USA, V102, P5138, DOI 10.1073/pnas.0501675102; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Chen CX, 2006, J BIOL CHEM, V281, P36828, DOI 10.1074/jbc.M608848200; de Zoeten EF, 2009, J BIOL CHEM, V284, P5709, DOI 10.1074/jbc.M807322200; Du JG, 2008, J IMMUNOL, V180, P4785, DOI 10.4049/jimmunol.180.7.4785; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Gambineri E, 2003, CURR OPIN RHEUMATOL, V15, P430, DOI 10.1097/00002281-200307000-00010; KALDERON D, 1984, NATURE, V311, P33, DOI 10.1038/311033a0; Kirito K, 2004, MOL CELL BIOL, V24, P6751, DOI 10.1128/MCB.24.15.6751-6762.2004; KLEINSCHMIDT JA, 1988, EMBO J, V7, P1605, DOI 10.1002/j.1460-2075.1988.tb02986.x; Kong M, 2000, EMBO J, V19, P1378, DOI 10.1093/emboj/19.6.1378; Lee SM, 2008, BLOOD, V111, P3599, DOI 10.1182/blood-2007-09-115014; Li B, 2007, INT IMMUNOL, V19, P825, DOI 10.1093/intimm/dxm043; Li B, 2007, P NATL ACAD SCI USA, V104, P4571, DOI 10.1073/pnas.0700298104; Lopes JE, 2006, J IMMUNOL, V177, P3133, DOI 10.4049/jimmunol.177.5.3133; Mikami Y, 2005, MOL CELL BIOL, V25, P1958, DOI 10.1128/MCB.25.5.1958-1970.2005; MORELAND RB, 1987, MOL CELL BIOL, V7, P4048, DOI 10.1128/MCB.7.11.4048; Nilsson I, 1998, J MOL BIOL, V284, P1185, DOI 10.1006/jmbi.1998.2219; Ono M, 2007, NATURE, V446, P685, DOI 10.1038/nature05673; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Song JH, 2006, J BIOL CHEM, V281, P15361, DOI 10.1074/jbc.M600749200; Tieleman DP, 2001, PROTEINS, V44, P63, DOI 10.1002/prot.1073; Wildin RS, 2002, J MED GENET, V39, P537, DOI 10.1136/jmg.39.8.537; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Zhou ZC, 2008, IMMUNOL RES, V42, P19, DOI 10.1007/s12026-008-8029-x	28	31	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2009	4	11							e7890	10.1371/journal.pone.0007890	http://dx.doi.org/10.1371/journal.pone.0007890			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521QH	19924293	Green Submitted, Green Published, gold			2022-12-25	WOS:000271936700022
J	Poh, YC; Na, S; Chowdhury, F; Ouyang, MX; Wang, YX; Wang, N				Poh, Yeh-Chuin; Na, Sungsoo; Chowdhury, Farhan; Ouyang, Mingxing; Wang, Yingxiao; Wang, Ning			Rapid Activation of Rac GTPase in Living Cells by Force Is Independent of Src	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION; IN-VIVO; MEMBRANE; MECHANOTRANSDUCTION; DYNAMICS	It is well known that mechanical forces are crucial in regulating functions of every tissue and organ in a human body. However, it remains unclear how mechanical forces are transduced into biochemical activities and biological responses at the cellular and molecular level. Using the magnetic twisting cytometry technique, we applied local mechanical stresses to living human airway smooth muscle cells with a magnetic bead bound to the cell surface via transmembrane adhesion molecule integrins. The temporal and spatial activation of Rac, a small guanosine triphosphatase, was quantified using a fluorescent resonance energy transfer (FRET) method that measures changes in Rac activity in response to mechanical stresses by quantifying intensity ratios of ECFP (enhanced cyan fluorescent protein as a donor) and YPet (a variant yellow fluorescent protein as an acceptor) of the Rac biosensor. The applied stress induced rapid activation (less than 300 ms) of Rac at the cell periphery. In contrast, platelet derived growth factor (PDGF) induced Rac activation at a much later time (>30 sec). There was no stress-induced Rac activation when a mutant form of the Rac biosensor (RacN17) was transfected or when the magnetic bead was coated with transferrin or with poly-L-lysine. It is known that PDGF-induced Rac activation depends on Src activity. Surprisingly, pre-treatment of the cells with specific Src inhibitor PP1 or knocking-out Src gene had no effects on stress-induced Rac activation. In addition, eliminating lipid rafts through extraction of cholesterol from the plasma membrane did not prevent stress-induced Rac activation, suggesting a raft-independent mechanism in governing the Rac activation upon mechanical stimulation. Further evidence indicates that Rac activation by stress depends on the magnitudes of the applied stress and cytoskeletal integrity. Our results suggest that Rac activation by mechanical forces is rapid, direct and does not depend on Src activation. These findings suggest that signaling pathways of mechanical forces via integrins might be fundamentally different from those of growth factors.			Poh, YC (corresponding author), Univ Illinois, Dept Mech Sci & Engn, Urbana, IL 61801 USA.	yingxiao@illinois.edu; nwangrw@illinois.edu	Ouyang, Mingxing/AAF-5896-2019; Ouyang, Mingxing/C-9130-2011; Ouyang, Mingxing/F-8907-2019; Wang, Ning/B-6966-2008; Ouyang, Mingxing/J-4529-2013; Chowdhury, Farhan/D-1496-2009	Ouyang, Mingxing/0000-0002-2910-0713; Chowdhury, Farhan/0000-0003-1527-2677	NCI NIH HHS [R21 CA139272-01, CA139272, R21 CA139272] Funding Source: Medline; NIGMS NIH HHS [R01 GM072744, GM 072744] Funding Source: Medline; NINDS NIH HHS [R01 NS063405, NS063405] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R21CA139272] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072744] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063405] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Baumer AT, 2008, J BIOL CHEM, V283, P7864, DOI 10.1074/jbc.M704997200; Chowdhury F, 2010, NAT MATER, V9, P82, DOI [10.1038/NMAT2563, 10.1038/nmat2563]; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Eckes B, 1998, J CELL SCI, V111, P1897; Fabry B, 2001, J APPL PHYSIOL, V91, P986, DOI 10.1152/jappl.2001.91.2.986; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Hayakawa K, 2008, J CELL SCI, V121, P496, DOI 10.1242/jcs.022053; Hu SH, 2004, AM J PHYSIOL-CELL PH, V287, pC1184, DOI 10.1152/ajpcell.00224.2004; Hu SH, 2003, AM J PHYSIOL-CELL PH, V285, pC1082, DOI 10.1152/ajpcell.00159.2003; Ingber DE, 2006, FASEB J, V20, P811, DOI 10.1096/fj.05-5424rev; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; Katsumi A, 2002, J CELL BIOL, V158, P153, DOI 10.1083/jcb.200201105; Kural C, 2005, SCIENCE, V308, P1469, DOI 10.1126/science.1108408; Moissoglu K, 2006, MOL BIOL CELL, V17, P2770, DOI 10.1091/mbc.E06-01-0005; Na S, 2008, P NATL ACAD SCI USA, V105, P6626, DOI 10.1073/pnas.0711704105; Na SS, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.134pl1; Ouyang MX, 2008, P NATL ACAD SCI USA, V105, P14353, DOI 10.1073/pnas.0807537105; PANETTIERI RA, 1989, AM J PHYSIOL, V256, pC329, DOI 10.1152/ajpcell.1989.256.2.C329; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; WANG N, 1993, SCIENCE, V260, P1124, DOI 10.1126/science.7684161; Wang N, 1995, BIOCHEM CELL BIOL, V73, P327, DOI 10.1139/o95-041; Wang YX, 2009, INTEGR BIOL-UK, V1, P565, DOI 10.1039/b913093b; Wang YX, 2005, NATURE, V434, P1040, DOI 10.1038/nature03469	25	60	61	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2009	4	11							e7886	10.1371/journal.pone.0007886	http://dx.doi.org/10.1371/journal.pone.0007886			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521QH	19924282	Green Submitted, Green Published, gold			2022-12-25	WOS:000271936700018
J	Uemura, K; Lill, CM; Li, XJ; Peters, JA; Ivanov, A; Fan, ZY; DeStrooper, B; Bacskai, BJ; Hyman, BT; Berezovska, O				Uemura, Kengo; Lill, Christina M.; Li, Xuejing; Peters, Jessica A.; Ivanov, Alexander; Fan, Zhanyun; DeStrooper, Bart; Bacskai, Brian J.; Hyman, Bradley T.; Berezovska, Oksana			Allosteric Modulation of PS1/gamma-Secretase Conformation Correlates with Amyloid beta(42/40) Ratio	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; GAMMA-SECRETASE ACTIVITY; PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; IN-VIVO; CATALYTIC PORE; BETA-PROTEIN; PRESENILIN; NOTCH; APP	Background: Presenilin 1(PS1) is the catalytic subunit of gamma-secretase, the enzyme responsible for the A beta C-terminal cleavage site, which results in the production of A beta peptides of various lengths. Production of longer forms of the A beta peptide occur in patients with autosomal dominant Alzheimer disease (AD) due to mutations in presenilin. Many modulators of gamma-secretase function have been described. We hypothesize that these modulators act by a common mechanism by allosterically modifying the structure of presenilin. Methodology/Principal Findings: To test this hypothesis we generated a genetically encoded GFP-PS1-RFP (G-PS1-R) FRET probe that allows monitoring of the conformation of the PS1 molecule in its native environment in live cells. We show that G-PS1-R can be incorporated into the gamma-secretase complex, reconstituting its activity in PS1/2 deficient cells. Using Forster resonance energy transfer (FRET)-based approaches we show that various pharmacological and genetic manipulations that target either gamma-secretase components (PS1, Pen2, Aph1) or gamma-secretase substrate (amyloid precursor protein, APP) and are known to change A beta(42) production are associated with a consistent conformational change in PS1. Conclusions/ Significance: These results strongly support the hypothesis that allosteric changes in PS1 conformation underlie changes in the A beta(42/40) ratio. Direct measurement of physiological and pathological changes in the conformation of PS1/gamma-secretase may provide insight into molecular mechanism of A beta(42) generation, which could be exploited therapeutically.			Uemura, K (corresponding author), Massachusetts Gen Hosp, MassGeneral Inst Neurodegenerat Dis, Alzheimer Res Unit, Charlestown, MA 02129 USA.	oberezovska@partners.org	Lill, Christina/J-9449-2015; Lill, Christina M/GSI-4054-2022; De Strooper, Bart/F-6507-2012; Bacskai, Brian/AAE-9583-2021	Lill, Christina/0000-0002-2805-1307; De Strooper, Bart/0000-0001-5455-5819; 	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG015379, R01AG026593] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG026593, AG 15379, AG026593, P01 AG015379] Funding Source: Medline; NIBIB NIH HHS [EB000768, R01 EB000768] Funding Source: Medline	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		Annaert WG, 2001, NEURON, V32, P579, DOI 10.1016/S0896-6273(01)00512-8; Beher D, 2004, J BIOL CHEM, V279, P43419, DOI 10.1074/jbc.M404937200; Berezovska O, 2005, J NEUROSCI, V25, P3009, DOI 10.1523/JNEUROSCI.0364-05.2005; Bitan G, 2003, J BIOL CHEM, V278, P34882, DOI 10.1074/jbc.M300825200; Bittner T, 2009, J NEUROSCI, V29, P10405, DOI 10.1523/JNEUROSCI.2288-09.2009; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; Cervantes S, 2001, FEBS LETT, V505, P81, DOI 10.1016/S0014-5793(01)02785-5; [陈启宏 CHEN Qihong], 2006, [华中师范大学学报. 自然科学版, Journal of Central China Normal University. Natural Sciences edition], V40, P42; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Eriksen JL, 2003, J CLIN INVEST, V112, P440, DOI 10.1172/JCI200318162; Francis R, 2002, DEV CELL, V3, P85, DOI 10.1016/S1534-5807(02)00189-2; Geling A, 2002, EMBO REP, V3, P688, DOI 10.1093/embo-reports/kvf124; Goutte C, 2002, P NATL ACAD SCI USA, V99, P775, DOI 10.1073/pnas.022523499; Herl L, 2006, BIOCHEM BIOPH RES CO, V340, P668, DOI 10.1016/j.bbrc.2005.12.063; Herl L, 2009, MOL CELL NEUROSCI, V41, P166, DOI 10.1016/j.mcn.2009.02.008; Herreman A, 2000, NAT CELL BIOL, V2, P461, DOI 10.1038/35017105; Isoo N, 2007, J BIOL CHEM, V282, P12388, DOI 10.1074/jbc.M611549200; Kukar T, 2005, NAT MED, V11, P545, DOI 10.1038/nm1235; Kukar TL, 2008, NATURE, V453, P925, DOI 10.1038/nature07055; Lazarov VK, 2006, P NATL ACAD SCI USA, V103, P6889, DOI 10.1073/pnas.0602321103; Lee SF, 2002, J BIOL CHEM, V277, P45013, DOI 10.1074/jbc.M208164200; Lleo A, 2004, NAT MED, V10, P1065, DOI 10.1038/nm1112; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; Saffarian S, 2008, BIOPHYS J, V94, P2333, DOI 10.1529/biophysj.107.117234; Sato C, 2008, J NEUROSCI, V28, P6264, DOI 10.1523/JNEUROSCI.1163-08.2008; Schroeter EH, 2003, P NATL ACAD SCI USA, V100, P13075, DOI 10.1073/pnas.1735338100; SELKOE DJ, 1988, P NATL ACAD SCI USA, V85, P7341, DOI 10.1073/pnas.85.19.7341; Serneels L, 2009, SCIENCE, V324, P639, DOI 10.1126/science.1171176; Steiner H, 2002, J BIOL CHEM, V277, P39062, DOI 10.1074/jbc.C200469200; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Tesco G, 2005, J NEUROCHEM, V95, P446, DOI 10.1111/j.1471-4159.2005.03381.x; Tolia A, 2008, J BIOL CHEM, V283, P19793, DOI 10.1074/jbc.M802461200; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Weggen S, 2003, J BIOL CHEM, V278, P31831, DOI 10.1074/jbc.M303592200; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Xia WM, 1997, J BIOL CHEM, V272, P7977, DOI 10.1074/jbc.272.12.7977; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009	38	70	79	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2009	4	11							e7893	10.1371/journal.pone.0007893	http://dx.doi.org/10.1371/journal.pone.0007893			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521QH	19924286	Green Published, gold, Green Submitted			2022-12-25	WOS:000271936700023
J	Kulkarni, S; Reddy, KB; Esteva, FJ; Moore, HCF; Budd, GT; Tubbs, RR				Kulkarni, S.; Reddy, K. B.; Esteva, F. J.; Moore, H. C. F.; Budd, G. T.; Tubbs, R. R.			Calpain regulates sensitivity to trastuzumab and survival in HER2-positive breast cancer	ONCOGENE			English	Article						HER2; AKT1; survival; resistance; calpain	GROWTH-FACTOR-RECEPTOR; MONOCLONAL-ANTIBODY; FACTOR-BETA; CELLS; RESISTANCE; KINASE; INTEGRIN; ACTIVATION; ERBB2; HER2	Resistance to anti-HER2 (human epithelial growth factor receptor 2) trastuzumab therapy occurs commonly in HER2-positive breast cancer and involves overactivation of HER2 and/or AKT1. Using the model of trastuzumab-sensitive or trastuzumab-resistant HER2-positive cells with wild-type PTEN, negative regulator of AKT1, we explore the involvement of cysteine protease calpain in mechanisms of trastuzumab resistance. Overexpression of calpain1 or activation of endogenous calpain during adhesion or trastuzumab treatment of trastuzumab-sensitive cells induces cleavage of cytoplasmic domains of HER2/phospho-HER2; cleavage occurs in HER2-positive tumors. Expression of the catalytically inactive mutant of calpain1 reduces the cleavage to enhance the activity of HER2, inactivates PTEN to enhance the activation of AKT1, induces desensitization to trastuzumab and promotes survival of trastuzumab-sensitive cells. In the model of trastuzumab resistance, constitutive overactivation of HER2 and AKT1 correlates with reduced activation of calpain. Moreover, inhibitors of the catalytic site of calpain reduce the increase in constitutive activity of AKT1 and survival of trastuzumab-resistant cells selectively. Together, by regulating the activation of HER2 and PTEN/AKT1, calpain regulates trastuzumab sensitivity and survival, and the deregulation of the activation of calpain promotes trastuzumab resistance. Trastuzumab-resistant cells activate AKT1 in a mechanism dependent on the residual calpain activity, inhibition of which restores trastuzumab sensitivity and rescues resistance. These data identify calpain as a new therapeutic target in HER2-positive breast cancer. Oncogene (2010) 29, 1339-1350; doi:10.1038/onc.2009.422; published online 30 November 2009	[Kulkarni, S.; Tubbs, R. R.] Cleveland Clin, Dept Mol Pathol, Pathol & Lab Med Inst, Cleveland, OH 44195 USA; [Reddy, K. B.] Cleveland Clin, Dept Mol Cardiol, Cleveland, OH 44106 USA; [Esteva, F. J.] Univ Texas Houston, MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA; [Moore, H. C. F.; Budd, G. T.] Cleveland Clin, Taussig Canc Ctr, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; Cleveland Clinic Foundation	Kulkarni, S (corresponding author), Cleveland Clin, Dept Mol Pathol, Pathol & Lab Med Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA.	kulkars@ccf.org						Anastasi S, 2005, ONCOGENE, V24, P4540, DOI 10.1038/sj.onc.1208658; Anido J, 2006, EMBO J, V25, P3234, DOI 10.1038/sj.emboj.7601191; Arthur JSC, 2000, MOL CELL BIOL, V20, P4474, DOI 10.1128/MCB.20.12.4474-4481.2000; Berns K, 2007, CANCER CELL, V12, P395, DOI 10.1016/j.ccr.2007.08.030; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Chan CT, 2005, BREAST CANCER RES TR, V91, P187, DOI 10.1007/s10549-004-7715-1; Clark AS, 2002, MOL CANCER THER, V1, P707; Edelstein CL, 2000, METH MOL B, V144, P233; FOX JEB, 1993, J CELL BIOL, V120, P1501, DOI 10.1083/jcb.120.6.1501; Gericke A, 2006, GENE, V374, P1, DOI 10.1016/j.gene.2006.02.024; Glading A, 2004, MOL CELL BIOL, V24, P2499, DOI 10.1128/MCB.24.6.2499-2512.2004; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; GREGORIOU M, 1994, EUR J BIOCHEM, V223, P455, DOI 10.1111/j.1432-1033.1994.tb19013.x; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Ishizawar RC, 2007, ONCOGENE, V26, P3503, DOI 10.1038/sj.onc.1210138; Kulkarni S, 1999, J BIOL CHEM, V274, P21265, DOI 10.1074/jbc.274.30.21265; Kulkarni S, 2002, J BIOL CHEM, V277, P24435, DOI 10.1074/jbc.M203457200; Lacroix M, 2004, BREAST CANCER RES TR, V83, P249, DOI 10.1023/B:BREA.0000014042.54925.cc; Lawlor MA, 2001, J CELL SCI, V114, P2903; Libertini SJ, 2007, CANCER RES, V67, P9001, DOI 10.1158/0008-5472.CAN-07-1072; Mlynarczuk-Bialy I, 2006, CANCER RES, V66, P7598, DOI 10.1158/0008-5472.CAN-05-2614; Molina MA, 2001, CANCER RES, V61, P4744; Nagata Y, 2004, CANCER CELL, V6, P117, DOI 10.1016/j.ccr.2004.06.022; Nahta R, 2005, CANCER RES, V65, P11118, DOI 10.1158/0008-5472.CAN-04-3841; Nahta R, 2004, CANCER CHEMOTH PHARM, V53, P186, DOI 10.1007/s00280-003-0728-3; Perrin BJ, 2006, MOL BIOL CELL, V17, P239, DOI 10.1091/mbc.e05-06-0488; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; Raynaud F, 2003, EUR J BIOCHEM, V270, P4662, DOI 10.1046/j.1432-1033.2003.03859.x; Ritter CA, 2007, CLIN CANCER RES, V13, P4909, DOI 10.1158/1078-0432.CCR-07-0701; Shattuck DL, 2008, CANCER RES, V68, P1471, DOI 10.1158/0008-5472.CAN-07-5962; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Stemke-Hale K, 2008, CANCER RES, V68, P6084, DOI 10.1158/0008-5472.CAN-07-6854; Tan M, 2005, CANCER RES, V65, P1858, DOI 10.1158/0008-5472.CAN-04-2353; Tan Y, 2006, J BIOL CHEM, V281, P17689, DOI 10.1074/jbc.M601978200; Tao Y, 2007, NAT CLIN PRACT ONCOL, V4, P591, DOI 10.1038/ncponc0934; Troussard AA, 2006, CANCER RES, V66, P393, DOI 10.1158/0008-5472.CAN-05-2304; Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.2002.20.3.719; Wang SZE, 2006, CANCER RES, V66, P9591, DOI 10.1158/0008-5472.CAN-06-2071; Wang SE, 2009, CANCER RES, V69, P475, DOI 10.1158/0008-5472.CAN-08-2649; Yakes FM, 2002, CANCER RES, V62, P4132; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zhu HB, 2004, MOL THER, V9, P666, DOI 10.1016/j.ymthe.2004.02.007; Zito CI, 2008, GENE CHROMOSOME CANC, V47, P633, DOI 10.1002/gcc.20566; Zutter MM, 2007, ADV EXP MED BIOL, V608, P87	44	35	37	1	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR 4	2010	29	9					1339	1350		10.1038/onc.2009.422	http://dx.doi.org/10.1038/onc.2009.422			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	563XJ	19946330				2022-12-25	WOS:000275170600009
J	Ramakrishnan, V; Timm, M; Haug, JL; Kimlinger, TK; Wellik, LE; Witzig, TE; Rajkumar, SV; Adjei, AA; Kumar, S				Ramakrishnan, V.; Timm, M.; Haug, J. L.; Kimlinger, T. K.; Wellik, L. E.; Witzig, T. E.; Rajkumar, S. V.; Adjei, A. A.; Kumar, S.			Sorafenib, a dual Raf kinase/vascular endothelial growth factor receptor inhibitor has significant anti-myeloma activity and synergizes with common anti-myeloma drugs	ONCOGENE			English	Article						vascular endothelial growth factor; myeloma; angiogenesis; proliferation; apoptosis; microenvironment	BONE-MARROW ANGIOGENESIS; MULTIPLE-MYELOMA; K-RAS; ACTIVATING MUTATIONS; DISEASE PROGRESSION; DOWN-REGULATION; PLASMA-CELLS; TUMOR-CELLS; N-RAS; KINASE	Multiple myeloma is characterized by increased bone marrow neovascularization driven in part by vascular endothelial growth factor (VEGF). In addition, the Ras/Raf/MEK/ERK pathway is critical for the proliferation of myeloma cells and is often upregulated. Sorafenib (Nexavar) is a novel multi-kinase inhibitor that acts predominantly through inhibition of Raf-kinase and VEGF receptor 2, offering the potential for targeting two important aspects of disease biology. In in vitro studies, sorafenib-induced cytotoxicity in MM cell lines as well as freshly isolated patient myeloma cells. It retained its activity against MM cells in co-culture with stromal cells or with interleukin-6, VEGF or IGF; conditions mimicking tumor microenvironment. Examination of cellular signaling pathways showed downregulation of Mcl1 as well as decreased phosphorylation of the STAT3 and MEK/ERK, as potential mechanisms of its anti-tumor effect. Sorafenib induces reciprocal upregulation of Akt phosphorylation; and simultaneous inhibition of downstream mTOR with rapamycin leads to synergistic effects. Sorafenib also synergizes with drugs such as proteasome inhibitors and steroids. In a human in vitro angiogenesis assay, sorafenib showed potent anti-angiogenic activity. Sorafenib, through multiple mechanisms exerts potent anti-myeloma activity and these results favor further clinical evaluation and development of novel sorafenib combinations. Oncogene (2010) 29, 1190-1202; doi: 10.1038/onc.2009.403; published online 23 November 2009	[Ramakrishnan, V.; Timm, M.; Haug, J. L.; Kimlinger, T. K.; Wellik, L. E.; Witzig, T. E.; Rajkumar, S. V.; Kumar, S.] Mayo Clin, Div Hematol, Rochester, MN USA; [Adjei, A. A.] Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USA	Mayo Clinic; Roswell Park Cancer Institute	Kumar, S (corresponding author), Mayo Clin & Mayo Fdn, Div Hematol, 200 1st St SW, Rochester, MN 55905 USA.	kumar.shaji@mayo.edu	Kumar, Shaji K/A-9853-2008; Rajkumar, S. Vincent/AAV-1834-2021	Kumar, Shaji K/0000-0001-5392-9284; Rajkumar, S. Vincent/0000-0002-5862-1833	Mayo Foundation; Lymphoma SPORE; Bayer Pharmaceuticals; NATIONAL CANCER INSTITUTE [P50CA097274, R01CA127433] Funding Source: NIH RePORTER	Mayo Foundation; Lymphoma SPORE; Bayer Pharmaceuticals(Bayer AG); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We acknowledge Roberta DeGoey and Christy Finke for their assistance with processing of tumor cells and all of the patients who provided us with the tumor samples. This work was supported by Mayo Clinic Hematologic Malignancies Program, CR20 Award from Mayo Foundation and Career Development Award from Lymphoma SPORE. Sorafenib was provided through CTEP drug evaluation program by Bayer Pharmaceuticals.	Bezieau S, 2001, HUM MUTAT, V18, P212, DOI 10.1002/humu.1177; BROWN RD, 1994, LEUKEMIA LYMPHOMA, V16, P147, DOI 10.3109/10428199409114152; Catlett-Falcone R, 1999, IMMUNITY, V10, P105, DOI 10.1016/S1074-7613(00)80011-4; Catlett-Falcone Robyn, 1999, Current Opinion in Oncology, V11, P490, DOI 10.1097/00001622-199911000-00010; Chatterjee M, 2004, BLOOD, V104, P3712, DOI 10.1182/blood-2004-04-1670; Chatterjee M, 2002, BLOOD, V100, P3311, DOI 10.1182/blood-2002-01-0102; CORRADINI P, 1993, BRIT J HAEMATOL, V83, P672, DOI 10.1111/j.1365-2141.1993.tb04711.x; Dai Y, 2002, BLOOD, V100, P3333, DOI 10.1182/blood-2002-03-0940; Ferlin M, 2000, BRIT J HAEMATOL, V111, P626, DOI 10.1046/j.1365-2141.2000.02364.x; Frassanito MA, 2002, BRIT J HAEMATOL, V118, P157, DOI 10.1046/j.1365-2141.2002.03559.x; Giuliani N, 2004, LEUKEMIA, V18, P628, DOI 10.1038/sj.leu.2403269; Gupta D, 2001, LEUKEMIA, V15, P1950, DOI 10.1038/sj.leu.2402295; Hideshima T, 2001, ONCOGENE, V20, P5991, DOI 10.1038/sj.onc.1204833; Hideshima T, 2006, BLOOD, V107, P4053, DOI 10.1182/blood-2005-08-3434; Hsu JH, 2004, ONCOGENE, V23, P3368, DOI 10.1038/sj.onc.1207459; Kimlinger T, 2006, HAEMATOLOGICA, V91, P1033; Kumar S, 2005, LEUKEMIA, V19, P1466, DOI 10.1038/sj.leu.2403823; Kumar S, 2005, LEUKEMIA, V19, P1253, DOI 10.1038/sj.leu.2403776; Kumar S, 2004, BLOOD, V104, P1159, DOI 10.1182/blood-2003-11-3811; Kumar S, 2004, BONE MARROW TRANSPL, V34, P235, DOI 10.1038/sj.bmt.1704555; Le Gouill S, 2004, BLOOD, V104, P2886, DOI 10.1182/blood-2004-05-1760; Lentzsch S, 2003, BLOOD, V101, P3568, DOI 10.1182/blood-2002-08-2383; Liu M, 2006, J BIOL CHEM, V281, P18090, DOI 10.1074/jbc.M601324200; Liu PC, 1996, BLOOD, V88, P2699, DOI 10.1182/blood.V88.7.2699.bloodjournal8872699; NERI A, 1989, J EXP MED, V170, P1715, DOI 10.1084/jem.170.5.1715; PAQUETTE RL, 1990, ONCOGENE, V5, P1659; Podar K, 2001, BLOOD, V98, P428, DOI 10.1182/blood.V98.2.428; Pope B, 1997, LEUKEMIA LYMPHOMA, V25, P545, DOI 10.3109/10428199709039043; PORTIER M, 1992, ONCOGENE, V7, P2539; Puthier D, 1999, EUR J IMMUNOL, V29, P3945, DOI 10.1002/(SICI)1521-4141(199912)29:12<3945::AID-IMMU3945>3.0.CO;2-O; Rahmani M, 2005, J BIOL CHEM, V280, P35217, DOI 10.1074/jbc.M506551200; Raje N, 2004, BLOOD, V104, P4188, DOI 10.1182/blood-2004-06-2281; Rajkumar SV, 2002, CLIN CANCER RES, V8, P2210; Rowley M, 2002, ONCOGENE, V21, P8769, DOI 10.1038/sj.onc.1205387; Shi YY, 2002, J BIOL CHEM, V277, P15712, DOI 10.1074/jbc.M200043200; Strumberg D, 2005, ONKOLOGIE, V28, P101, DOI 10.1159/000083373; Strumberg D, 2005, DRUGS TODAY, V41, P773, DOI 10.1358/dot.2005.41.12.937959; Strumberg D, 2005, J CLIN ONCOL, V23, P965, DOI 10.1200/JCO.2005.06.124; UCHIYAMA H, 1993, BLOOD, V82, P3712; VACCA A, 1994, BRIT J HAEMATOL, V87, P503, DOI 10.1111/j.1365-2141.1994.tb08304.x; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; Yu CR, 2005, ONCOGENE, V24, P6861, DOI 10.1038/sj.onc.1208841; Zhang B, 2002, J CELL PHYSIOL, V193, P42, DOI 10.1002/jcp.10148	43	74	77	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 25	2010	29	8					1190	1202		10.1038/onc.2009.403	http://dx.doi.org/10.1038/onc.2009.403			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	560ON	19935717	Green Accepted			2022-12-25	WOS:000274912100010
J	Lev, S; Zeevi, DA; Frumkin, A; Offen-Glasner, V; Bach, G; Minke, B				Lev, Shaya; Zeevi, David A.; Frumkin, Ayala; Offen-Glasner, Vered; Bach, Gideon; Minke, Baruch			Constitutive Activity of the Human TRPML2 Channel Induces Cell Degeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUCOLIPIDOSIS TYPE-IV; CATION CHANNEL; HAIR-CELLS; MUTATIONS; TRAFFICKING; MECHANISM; DEAFNESS; GENE; PH; EXPRESSION	The mucolipin (TRPML) ion channel proteins represent a distinct subfamily of channel proteins within the transient receptor potential (TRP) superfamily of cation channels. Mucolipin 1, 2, and 3 (TRPML1, -2, and -3, respectively) are channel proteins that share high sequence homology with each other and homology in the transmembrane domain with other TRPs. Mutations in the TRPML1 protein are implicated in mucolipidosis type IV, whereas mutations in TRPML3 are found in the varitint-waddler mouse. The properties of the wild type TRPML2 channel are not well known. Here we show functional expression of the wild type human TRPML2 channel (h-TRPML2). The channel is functional at the plasma membrane and characterized by a significant inward rectification similar to other constitutively active TRPML mutant isoforms. The h-TRPML2 channel displays nonselective cation permeability, which is Ca2+-permeable and inhibited by low extracytosolic pH but not Ca2+ regulated. In addition, constitutively active h-TRPML2 leads to cell death by causing Ca2+ overload. Furthermore, we demonstrate by functional mutation analysis that h-TRPML2 shares similar characteristics and structural similarities with other TRPML channels that regulate the channel in a similar manner. Hence, in addition to overall structure, all three TRPML channels also share common modes of regulation.	[Lev, Shaya; Minke, Baruch] Hebrew Univ Jerusalem, Fac Med, Dept Med Neurobiol, IL-91120 Jerusalem, Israel; [Lev, Shaya; Minke, Baruch] Hebrew Univ Jerusalem, Fac Med, Kuhne Minerva Ctr Studies Visual Transduct, IL-91120 Jerusalem, Israel; [Zeevi, David A.; Frumkin, Ayala; Offen-Glasner, Vered; Bach, Gideon] Hadassah Hebrew Univ Hosp, Dept Human Genet, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hadassah University Medical Center	Minke, B (corresponding author), Hebrew Univ Jerusalem, Fac Med, Dept Med Neurobiol, POB 12272, IL-91120 Jerusalem, Israel.	baruchm@ekmd.huji.ac.il			National Institutes of Health [RO1 EY 03529]; Israel Science Foundation; United States-Israel Binational Science Foundation; Moscona Foundation; Minerva Foundation; Rita Altura foundation; NATIONAL EYE INSTITUTE [R01EY003529] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Israel Science Foundation(Israel Science Foundation); United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation); Moscona Foundation; Minerva Foundation; Rita Altura foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 EY 03529 (to B. M.). This work was also supported by the Israel Science Foundation (to B. M. and G. B.), the United States-Israel Binational Science Foundation (to B. M.), the Moscona Foundation (to B. M.), the Minerva Foundation (to B. M.), and the Rita Altura foundation (to G. B.).	Agam K, 2000, J NEUROSCI, V20, P5748, DOI 10.1523/JNEUROSCI.20-15-05748.2000; Altarescu G, 2002, NEUROLOGY, V59, P306, DOI 10.1212/WNL.59.3.306; Bach G, 2001, MOL GENET METAB, V73, P197, DOI 10.1006/mgme.2001.3195; Bach G, 2005, PFLUG ARCH EUR J PHY, V451, P313, DOI 10.1007/s00424-004-1361-7; Bautista DM, 2007, NATURE, V448, P204, DOI 10.1038/nature05910; Bezzerides VJ, 2004, NAT CELL BIOL, V6, P709, DOI 10.1038/ncb1150; Cable J, 1998, HEARING RES, V123, P125, DOI 10.1016/S0378-5955(98)00107-5; Cantiello HF, 2005, PFLUG ARCH EUR J PHY, V451, P304, DOI 10.1007/s00424-005-1448-9; Chyb S, 1999, NATURE, V397, P255, DOI 10.1038/16703; Curcio-Morelli C, 2010, J CELL PHYSIOL, V222, P328, DOI 10.1002/jcp.21956; Damann N, 2008, CURR BIOL, V18, pR880, DOI 10.1016/j.cub.2008.07.063; Di Palma F, 2002, P NATL ACAD SCI USA, V99, P14994, DOI 10.1073/pnas.222425399; Dong XP, 2008, NATURE, V455, P992, DOI 10.1038/nature07311; Dong XP, 2009, J BIOL CHEM, V284, P32040, DOI 10.1074/jbc.M109.037184; Grimm C, 2007, P NATL ACAD SCI USA, V104, P19583, DOI 10.1073/pnas.0709846104; Grimm C, 2009, J BIOL CHEM, V284, P13823, DOI 10.1074/jbc.M809045200; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hu HZ, 2006, J CELL PHYSIOL, V208, P201, DOI 10.1002/jcp.20648; Karacsonyi C, 2007, TRAFFIC, V8, P1404, DOI 10.1111/j.1600-0854.2007.00619.x; Kim HJ, 2008, EMBO J, V27, P1197, DOI 10.1038/emboj.2008.56; Kim HJ, 2007, J BIOL CHEM, V282, P36138, DOI 10.1074/jbc.C700190200; Kim HJ, 2009, TRAFFIC, V10, P1157, DOI 10.1111/j.1600-0854.2009.00924.x; Kiselyov K, 2005, J BIOL CHEM, V280, P43218, DOI 10.1074/jbc.M508210200; Lindvall JM, 2005, CELL IMMUNOL, V235, P46, DOI 10.1016/j.cellimm.2005.07.001; Lindvall JM, 2004, EUR J IMMUNOL, V34, P1981, DOI 10.1002/eji.200324051; Lucas P, 2003, NEURON, V40, P551, DOI 10.1016/S0896-6273(03)00675-5; Manzoni M, 2004, FEBS LETT, V567, P219, DOI 10.1016/j.febslet.2004.04.080; Martina JA, 2009, TRAFFIC, V10, P1143, DOI 10.1111/j.1600-0854.2009.00935.x; MINKE B, 1975, NATURE, V258, P84, DOI 10.1038/258084a0; Minke B, 2006, CELL CALCIUM, V40, P261, DOI 10.1016/j.ceca.2006.05.002; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; Nagata K, 2008, P NATL ACAD SCI USA, V105, P353, DOI 10.1073/pnas.0707963105; Parnas M, 2007, J GEN PHYSIOL, V129, P17, DOI 10.1085/jgp.200609659; Parnas M, 2009, J NEUROSCI, V29, P2371, DOI 10.1523/JNEUROSCI.4280-08.2009; Pryor PR, 2006, TRAFFIC, V7, P1388, DOI 10.1111/j.1600-0854.2006.00475.x; Puertollano R, 2009, AM J PHYSIOL-RENAL, V296, pF1245, DOI 10.1152/ajprenal.90522.2008; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Raychowdhury MK, 2004, HUM MOL GENET, V13, P617, DOI 10.1093/hmg/ddh067; Samie MA, 2009, PFLUG ARCH EUR J PHY, V459, P79, DOI 10.1007/s00424-009-0716-5; Schaefer M, 2005, PFLUG ARCH EUR J PHY, V451, P35, DOI 10.1007/s00424-005-1467-6; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Slaugenhaupt Susan A., 2002, Current Molecular Medicine (Hilversum), V2, P445, DOI 10.2174/1566524023362276; Soyombo AA, 2006, J BIOL CHEM, V281, P7294, DOI 10.1074/jbc.M508211200; Spassova MA, 2006, P NATL ACAD SCI USA, V103, P16586, DOI 10.1073/pnas.0606894103; Strubing C, 2001, NEURON, V29, P645, DOI 10.1016/S0896-6273(01)00240-9; Sun M, 2000, HUM MOL GENET, V9, P2471, DOI 10.1093/hmg/9.17.2471; Topala CN, 2007, CELL CALCIUM, V41, P513, DOI 10.1016/j.ceca.2006.10.003; van Aken AFJ, 2008, J PHYSIOL-LONDON, V586, P5403, DOI 10.1113/jphysiol.2008.156992; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Venkatachalam K, 2006, J BIOL CHEM, V281, P17517, DOI 10.1074/jbc.M600807200; Vergarajauregui S, 2006, TRAFFIC, V7, P337, DOI 10.1111/j.1600-0854.2006.00387.x; Xu HX, 2007, P NATL ACAD SCI USA, V104, P18321, DOI 10.1073/pnas.0709096104; Xu XL, 2019, J CELL MOL MED, V23, P7449, DOI 10.1111/jcmm.14613; Yoon J, 2000, J NEUROSCI, V20, P649, DOI 10.1523/JNEUROSCI.20-02-00649.2000; Zeevi DA, 2007, BBA-MOL BASIS DIS, V1772, P851, DOI 10.1016/j.bbadis.2007.01.004; Zeevi DA, 2009, J PATHOL, V219, P153, DOI 10.1002/path.2587; Zhang P, 2009, HUM MOL GENET, V18, P1238, DOI 10.1093/hmg/ddp024	58	34	34	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2771	2782		10.1074/jbc.M109.046508	http://dx.doi.org/10.1074/jbc.M109.046508			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19940139	Green Published, hybrid			2022-12-25	WOS:000273697800054
J	Matsuda, JJ; Filali, MS; Collins, MM; Volk, KA; Lamb, FS				Matsuda, James J.; Filali, Mohammed S.; Collins, Malia M.; Volk, Kenneth A.; Lamb, Fred S.			The ClC-3 Cl-/H+ Antiporter Becomes Uncoupled at Low Extracellular pH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLORIDE CHANNEL; SIGNALING ENDOSOMES; PROKARYOTIC HOMOLOG; PLASMA-MEMBRANE; CELLS; ACIDIFICATION; CURRENTS; TRANSPORTERS; SELECTIVITY; ACTIVATION	Adenovirus expressing ClC-3 (Ad-ClC-3) induces Cl-/H+ antiportcurrent (IClC-3) in HEK293 cells. The outward rectification and time dependence of IClC-3 closely resemble an endogenous HEK293 cell acid-activated Cl- current (IClacid) seen at extracellular pH <= 5.5. IClacid was present in smooth muscle cells from wildtype but not ClC-3 null mice. We therefore sought to determine whether these currents were related. IClacid was larger in cells expressing Ad-ClC-3. Protons shifted the reversal potential (E-rev) of IClC-3 between pH 8.2 and 6.2, but not pH 6.2 and 5.2, suggesting that Cl- and H+ transport become uncoupled at low pH. At pH 4.0 E-rev was completely Cl- dependent (55.8 +/- 2.3 mV/decade). Several findings linked ClC-3 with native IClacid; 1) RNA interference directed at ClC-3 message reduced native IClacid; 2) removal of the extracellular "fast gate" (E224A) produced large currents that were pH-insensitive; and 3) wild-type IClC-3 and IClacid were both inhibited by (2-sulfonatoethyl) methanethiosulfonate (MTSES; 10-500 mu M)-induced alkanethiolation at exposed cysteine residues. However, a ClC-3 mutant lacking four extracellular cysteine residues (C103_P130del) was completely resistant to MTSES. C103_P130del currents were still acid-activated, but could be distinguished from wild-type IClC-3 and from native IClacid by a much slower response to low pH. Thus, ClC-3 currents are activated by protons and ClC-3 protein may account for native IClacid. Low pH uncouples Cl-/H+ transport so that at pH 4.0 ClC-3 behaves as an anion-selective channel. These findings have important implications for the biology of Cl-/H+ antiporters and perhaps for pH regulation in highly acidic intracellular compartments.	[Matsuda, James J.; Filali, Mohammed S.; Collins, Malia M.; Volk, Kenneth A.; Lamb, Fred S.] Univ Iowa, Dept Pediat, Childrens Hosp, Iowa City, IA 52242 USA	University of Iowa	Lamb, FS (corresponding author), Univ Iowa, Dept Pediat, 7770-F JPP, Iowa City, IA 52242 USA.	fred-lamb@uiowa.edu		Lamb, Fred/0000-0003-2955-5133	National Institutes of Health [R01 HL62483, T32 DK07690-15]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062483] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007690] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL62483 (to F. S. L.) and T32 DK07690-15 (to J. J. M.).	Accardi A, 2005, J GEN PHYSIOL, V126, P563, DOI 10.1085/jgp.200509417; Accardi A, 2004, J GEN PHYSIOL, V123, P109, DOI 10.1085/jgp.200308935; Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; Alekov AK, 2009, J GEN PHYSIOL, V133, P485, DOI 10.1085/jgp.200810155; Auzanneau C, 2003, J BIOL CHEM, V278, P19230, DOI 10.1074/jbc.M301096200; Barg S, 2001, J CELL SCI, V114, P2145; Chen MF, 2001, J GEN PHYSIOL, V118, P23, DOI 10.1085/jgp.118.1.23; Chen SF, 1997, J MEMBRANE BIOL, V155, P11, DOI 10.1007/s002329900154; Duan D, 1997, NATURE, V390, P417, DOI 10.1038/37151; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Dutzler R, 2003, SCIENCE, V300, P108, DOI 10.1126/science.1082708; Faundez Victor, 2004, Sci STKE, V2004, pre8, DOI 10.1126/stke.2332004re8; Friedrich T, 1999, J BIOL CHEM, V274, P896, DOI 10.1074/jbc.274.2.896; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hara-Chikuma M, 2005, J BIOL CHEM, V280, P1241, DOI 10.1074/jbc.M407030200; Hayashi M, 2002, J NEUROCHEM, V82, P698, DOI 10.1046/j.1471-4159.2002.01025.x; HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145; Huang P, 2001, J BIOL CHEM, V276, P20093, DOI 10.1074/jbc.M009376200; Jayaram H, 2008, P NATL ACAD SCI USA, V105, P11194, DOI 10.1073/pnas.0804503105; Jentsch TJ, 2008, CRIT REV BIOCHEM MOL, V43, P3, DOI [10.1080/10409230701829110, 10.1080/10409230701829110 ]; Jentsch TJ, 2007, J PHYSIOL-LONDON, V578, P633, DOI 10.1113/jphysiol.2006.124719; Jentsch TJ, 2005, CURR OPIN NEUROBIOL, V15, P319, DOI 10.1016/j.conb.2005.05.002; Jentsch TJ, 2005, ANNU REV PHYSIOL, V67, P779, DOI 10.1146/annurev.physiol.67.032003.153245; JENTSCH TJ, 1995, J PHYSIOL-LONDON, V482, P19; Jordan PA, 2006, ANTIOXID REDOX SIGN, V8, P312, DOI 10.1089/ars.2006.8.312; Lamb FS, 2009, ANTIOXID REDOX SIGN, V11, P1335, DOI [10.1089/ars.2008.2448, 10.1089/ARS.2009.2448]; Lambert S, 2005, J PHYSIOL-LONDON, V567, P191, DOI 10.1113/jphysiol.2005.089888; Li XH, 2002, AM J PHYSIOL-CELL PH, V282, pC1483, DOI 10.1152/ajpcell.00504.2001; Li XH, 2000, J BIOL CHEM, V275, P35994, DOI 10.1074/jbc.M002712200; Lisal J, 2008, NAT STRUCT MOL BIOL, V15, P805, DOI 10.1038/nsmb.1466; Lisal J, 2009, PHILOS T R SOC B, V364, P181, DOI 10.1098/rstb.2008.0123; Ma ZY, 2008, BIOCHEM BIOPH RES CO, V371, P437, DOI 10.1016/j.bbrc.2008.04.090; Maritzen T, 2008, J NEUROSCI, V28, P10587, DOI 10.1523/JNEUROSCI.3750-08.2008; Matsuda JJ, 2008, AM J PHYSIOL-CELL PH, V294, pC251, DOI 10.1152/ajpcell.00338.2007; MELLMAN I, 1986, ANNU REV BIOCHEM, V55, P663, DOI 10.1146/annurev.biochem.55.1.663; Miller FJ, 2007, CIRC RES, V101, P663, DOI 10.1161/CIRCRESAHA.107.151076; Moreland JG, 2006, J BIOL CHEM, V281, P12277, DOI 10.1074/jbc.M511030200; Nguitragool W, 2006, J MOL BIOL, V362, P682, DOI 10.1016/j.jmb.2006.07.006; Nobles M, 2004, AM J PHYSIOL-CELL PH, V287, pC1426, DOI 10.1152/ajpcell.00549.2002; Picollo A, 2005, NATURE, V436, P420, DOI 10.1038/nature03720; Robinson NC, 2004, J PHYSIOL-LONDON, V556, P353, DOI 10.1113/jphysiol.2003.058032; Rychkov GY, 1996, J PHYSIOL-LONDON, V497, P423, DOI 10.1113/jphysiol.1996.sp021778; Scheel O, 2005, NATURE, V436, P424, DOI [10.1038/nature03860, 10.1038/nature0386O]; SchmidtRose T, 1997, P NATL ACAD SCI USA, V94, P7633, DOI 10.1073/pnas.94.14.7633; Schwiebert EM, 1998, P NATL ACAD SCI USA, V95, P3879, DOI 10.1073/pnas.95.7.3879; Sile S, 2006, CURR OPIN NEPHROL HY, V15, P511, DOI 10.1097/01.mnh.0000242177.36953.be; Stobrawa SM, 2001, NEURON, V29, P185, DOI 10.1016/S0896-6273(01)00189-1; Vanoye CG, 2002, J PHYSIOL-LONDON, V539, P373, DOI 10.1113/jphysiol.2001.013115; Weng TX, 2002, AM J PHYSIOL-CELL PH, V283, pC839, DOI 10.1152/ajpcell.00445.2001; Weylandt KH, 2001, J BIOL CHEM, V276, P17461, DOI 10.1074/jbc.M011667200; Yamamoto S, 2006, AM J PHYSIOL-HEART C, V290, pH1905, DOI 10.1152/ajpheart.00965.2005; Zdebik AA, 2008, J BIOL CHEM, V283, P4219, DOI 10.1074/jbc.M708368200; Zhang YY, 2006, BIOPHYS J, V91, P2901, DOI 10.1529/biophysj.106.087700; Zhao ZF, 2007, J BIOL CHEM, V282, P29022, DOI 10.1074/jbc.M703506200; Zifarelli G, 2009, EMBO J, V28, P175, DOI 10.1038/emboj.2008.284	55	55	55	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2569	2579		10.1074/jbc.M109.018002	http://dx.doi.org/10.1074/jbc.M109.018002			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19926787	Green Published, hybrid			2022-12-25	WOS:000273697800036
J	Alchanati, I; Teicher, C; Cohen, G; Shemesh, V; Barr, HM; Nakache, P; Ben-Avraham, D; Idelevich, A; Angel, I; Livnah, N; Tuvia, S; Reiss, Y; Taglicht, D; Erez, O				Alchanati, Iris; Teicher, Carmit; Cohen, Galit; Shemesh, Vivian; Barr, Haim M.; Nakache, Philippe; Ben-Avraham, Danny; Idelevich, Anna; Angel, Itzchak; Livnah, Nurit; Tuvia, Shmuel; Reiss, Yuval; Taglicht, Daniel; Erez, Omri			The E3 Ubiquitin-Ligase Bmi1/Ring1A Controls the Proteasomal Degradation of Top2 alpha Cleavage Complex - A Potentially New Drug Target	PLOS ONE			English	Article							POLYCOMB-GROUP PROTEINS; TOPOISOMERASE-II-ALPHA; HEMATOPOIETIC STEM-CELLS; MYC TRANSGENIC MICE; H2A UBIQUITYLATION; SELF-RENEWAL; CANCER-CELLS; IN-VITRO; DNA; BMI-1	Background: The topoisomerases Top1, Top2 alpha and Top2 beta are important molecular targets for antitumor drugs, which specifically poison Top1 or Top2 isomers. While it was previously demonstrated that poisoned Top1 and Top2 beta are subject to proteasomal degradation, this phenomena was not demonstrated for Top2 alpha. Methodology/Principal Findings: We show here that Top2 alpha is subject to drug induced proteasomal degradation as well, although at a lower rate than Top2 beta. Using an siRNA screen we identified Bmi1 and Ring1A as subunits of an E3 ubiquitin ligase involved in this process. We show that silencing of Bmi1 inhibits drug-induced Top2 alpha degradation, increases the persistence of Top2 alpha-DNA cleavage complex, and increases Top2 drug efficacy. The Bmi1/Ring1A ligase ubiquitinates Top2 alpha in-vitro and cellular overexpression of Bmi1 increases drug induced Top2a ubiquitination. A small-molecular weight compound, identified in a screen for inhibitors of Bmi1/Ring1A ubiquitination activity, also prevents Top2 alpha ubiquitination and drug-induced Top2 alpha degradation. This ubiquitination inhibitor increases the efficacy of topoisomerase 2 poisons in a synergistic manner. Conclusions/Significance: The discovery that poisoned Top2 alpha is undergoing proteasomal degradation combined with the involvement of Bmi1/Ring1A, allowed us to identify a small molecule that inhibits the degradation process. The Bmi1/Ring1A inhibitor sensitizes cells to Top2 drugs, suggesting that this type of drug combination will have a beneficial therapeutic outcome. As Bmi1 is also a known oncogene, elevated in numerous types of cancer, the identified Bmi1/Ring1A ubiquitin ligase inhibitors can also be potentially used to directly target the oncogenic properties of Bmi1.	[Alchanati, Iris; Teicher, Carmit; Cohen, Galit; Shemesh, Vivian; Barr, Haim M.; Nakache, Philippe; Ben-Avraham, Danny; Idelevich, Anna; Angel, Itzchak; Livnah, Nurit; Tuvia, Shmuel; Reiss, Yuval; Taglicht, Daniel; Erez, Omri] Proteologics Ltd, Rehovot, Israel		Alchanati, I (corresponding author), Proteologics Ltd, Rehovot, Israel.	omri@proteologics.com	Ben-Avraham, Dan/H-2971-2013		Proteologics Ltd (PRL)	Proteologics Ltd (PRL)	Proteologics Ltd (PRL) provided funding for this research, and employed all authors for this manuscript. PRL therefore played a role in study design, data collection and analysis, decision to publish, and preparation and approval of the manuscript. PRL gave permission and full support for the publication this manuscript.	Albert TK, 2002, EMBO J, V21, P355, DOI 10.1093/emboj/21.3.355; Bandele OJ, 2008, BIOCHEMISTRY-US, V47, P11900, DOI 10.1021/bi800981j; Ben-Saadon R, 2006, MOL CELL, V24, P701, DOI 10.1016/j.molcel.2006.10.022; Bracken AP, 2009, NAT REV CANCER, V9, P773, DOI 10.1038/nrc2736; Brown JM, 1999, CANCER RES, V59, P5863; Brzovic PS, 2003, P NATL ACAD SCI USA, V100, P5646, DOI 10.1073/pnas.0836054100; Buchwald G, 2006, EMBO J, V25, P2465, DOI 10.1038/sj.emboj.7601144; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; CIECHANOVER A, 1982, J BIOL CHEM, V257, P2537; Dahiya A, 2001, MOL CELL, V8, P557, DOI 10.1016/S1097-2765(01)00346-X; Francis NJ, 2009, CELL, V137, P110, DOI 10.1016/j.cell.2009.02.017; Glinsky GV, 2008, J CLIN ONCOL, V26, P2846, DOI 10.1200/JCO.2008.17.0266; HAUPT Y, 1991, CELL, V65, P753, DOI 10.1016/0092-8674(91)90383-A; Hernandez-Munoz I, 2005, MOL CELL BIOL, V25, P11047, DOI 10.1128/MCB.25.24.11047-11058.2005; Holden Joseph A., 2001, Current Medicinal Chemistry - Anti-Cancer Agents, V1, P1, DOI 10.2174/1568011013354859; Iwama A, 2004, IMMUNITY, V21, P843, DOI 10.1016/j.immuni.2004.11.004; Kim HD, 1999, J CELL PHYSIOL, V180, P97, DOI 10.1002/(SICI)1097-4652(199907)180:1<97::AID-JCP11>3.0.CO;2-Y; Lennon G, 1996, GENOMICS, V33, P151, DOI 10.1006/geno.1996.0177; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Li ZZ, 2006, J BIOL CHEM, V281, P20643, DOI 10.1074/jbc.M602461200; Liu L, 2006, ONCOGENE, V25, P4370, DOI 10.1038/sj.onc.1209454; Lou ZK, 2005, NAT STRUCT MOL BIOL, V12, P589, DOI 10.1038/nsmb953; Mao Y, 2001, J BIOL CHEM, V276, P40652, DOI 10.1074/jbc.M104009200; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Nayak MS, 2007, CANCER RES, V67, P5831, DOI 10.1158/0008-5472.CAN-06-4533; Ogiso Y, 2000, CANCER RES, V60, P2429; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Rajasekhar VK, 2007, STEM CELLS, V25, P2498, DOI 10.1634/stemcells.2006-0608; Sanchez-Beato M, 2006, MODERN PATHOL, V19, P684, DOI 10.1038/modpathol.3800577; Satijn DPE, 1999, MOL CELL BIOL, V19, P57; Schwartz YB, 2008, CURR OPIN CELL BIOL, V20, P266, DOI 10.1016/j.ceb.2008.03.002; Shinagawa H, 2008, ANTIOXID REDOX SIGN, V10, P939, DOI 10.1089/ars.2007.1851; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Simon JA, 2008, MUTAT RES-FUND MOL M, V647, P21, DOI 10.1016/j.mrfmmm.2008.07.010; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; VANLOHUIZEN M, 1991, CELL, V65, P737, DOI 10.1016/0092-8674(91)90382-9; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Wei JH, 2006, J BIOL CHEM, V281, P22537, DOI 10.1074/jbc.M600826200; Xiao H, 2005, ONCOGENE, V24, P8105, DOI 10.1038/sj.onc.1208958; Xiao H, 2003, P NATL ACAD SCI USA, V100, P3239, DOI 10.1073/pnas.0736401100; Yun J, 1995, ONCOL RES, V7, P583; Yun JS, 2004, J BIOL CHEM, V279, P31296, DOI 10.1074/jbc.M401411200; Zhang HF, 2004, CANCER RES, V64, P1114, DOI 10.1158/0008-5472.CAN-03-2858; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	46	58	59	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2009	4	12							e8104	10.1371/journal.pone.0008104	http://dx.doi.org/10.1371/journal.pone.0008104			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MT	19956605	Green Submitted, Green Published, gold			2022-12-25	WOS:000272828700016
J	Zhang, J; Niyogi, P; McPeek, MS				Zhang, Jun; Niyogi, Partha; McPeek, Mary Sara			Laplacian Eigenfunctions Learn Population Structure	PLOS ONE			English	Article							GENETIC ASSOCIATION; COMPLEX TRAITS; STRATIFICATION; MODEL	Principal components analysis has been used for decades to summarize genetic variation across geographic regions and to infer population migration history. More recently, with the advent of genome-wide association studies of complex traits, it has become a commonly-used tool for detection and correction of confounding due to population structure. However, principal components are generally sensitive to outliers. Recently there has also been concern about its interpretation. Motivated from geometric learning, we describe a method based on spectral graph theory. Regarding each study subject as a node with suitably defined weights for its edges to close neighbors, one can form a weighted graph. We suggest using the spectrum of the associated graph Laplacian operator, namely, Laplacian eigenfunctions, to infer population structure. In simulations and real data on a ring species of birds, Laplacian eigenfunctions reveal more meaningful and less noisy structure of the underlying population, compared with principal components. The proposed approach is simple and computationally fast. It is expected to become a promising and basic method for population genetics and disease association studies.	[Zhang, Jun] Univ Chicago, Dept Radiol, Chicago, IL 60637 USA; [Niyogi, Partha; McPeek, Mary Sara] Univ Chicago, Dept Stat, Chicago, IL 60637 USA; [Niyogi, Partha] Univ Chicago, Dept Comp Sci, Chicago, IL 60637 USA; [McPeek, Mary Sara] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago	Zhang, J (corresponding author), Univ Chicago, Dept Radiol, Chicago, IL 60637 USA.	junzhang@galton.uchicago.edu	zhang, jun/B-5061-2012		NIH [R01 HG001645]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG001645] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Support from NIH grant R01 HG001645 (to M.S.M.) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belkin M, 2003, NEURAL COMPUT, V15, P1373, DOI 10.1162/089976603321780317; CAVALLISFORZA L, GENETICS TODAY, V3; Chen HS, 2003, ANN HUM GENET, V67, P250, DOI 10.1046/j.1469-1809.2003.00036.x; Chung F., 1997, SPECTRAL GRAPH THEOR; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Felsenstein J., 2002, MODERN DEV THEORETIC, P118; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Irwin DE, 2005, SCIENCE, V307, P414, DOI 10.1126/science.1105201; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; LEE A, 2009, GENETIC EPIDEMIOLOGY, V33; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; MENOZZI P, 1978, SCIENCE, V201, P786, DOI 10.1126/science.356262; Nelson MR, 2008, AM J HUM GENET, V83, P347, DOI 10.1016/j.ajhg.2008.08.005; Novembre J, 2008, NAT GENET, V40, P646, DOI 10.1038/ng.139; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; Pritchard JK, 2000, GENETICS, V155, P945; Reich D, 2008, NAT GENET, V40, P491, DOI 10.1038/ng0508-491; Rosenberg S., 1997, LONDON MATH SOC STUD, DOI DOI 10.1017/CBO9780511623783; von Luxburg U, 2007, STAT COMPUT, V17, P395, DOI 10.1007/s11222-007-9033-z; ZHANG J, 2009, BMC P IN PRESS; Zhu XF, 2002, GENET EPIDEMIOL, V23, P181, DOI 10.1002/gepi.210	23	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2009	4	12							e7928	10.1371/journal.pone.0007928	http://dx.doi.org/10.1371/journal.pone.0007928			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MT	19956572	gold, Green Submitted, Green Published			2022-12-25	WOS:000272828700001
J	Meda, SA; Stevens, MC; Folley, BS; Calhoun, VD; Pearlson, GD				Meda, Shashwath A.; Stevens, Michael C.; Folley, Bradley S.; Calhoun, Vince D.; Pearlson, Godfrey D.			Evidence for Anomalous Network Connectivity during Working Memory Encoding in Schizophrenia: An ICA Based Analysis	PLOS ONE			English	Article							DORSOLATERAL PREFRONTAL CORTEX; FUNCTIONAL CONNECTIVITY; 1ST-DEGREE RELATIVES; BASAL GANGLIA; NEURAL BASIS; FMRI; ACTIVATION; ENDOPHENOTYPE; RECOGNITION; MAINTENANCE	Background: Numerous neuroimaging studies report abnormal regional brain activity during working memory performance in schizophrenia, but few have examined brain network integration as determined by "functional connectivity" analyses. Methodology/Principal Findings: We used independent component analysis (ICA) to identify and characterize dysfunctional spatiotemporal networks in schizophrenia engaged during the different stages (encoding and recognition) of a Sternberg working memory fMRI paradigm. 37 chronic schizophrenia and 54 healthy age/gender-matched participants performed a modified Sternberg Item Recognition fMRI task. Time series images preprocessed with SPM2 were analyzed using ICA. Schizophrenia patients showed relatively less engagement of several distinct "normal" encoding-related working memory networks compared to controls. These encoding networks comprised 1) left posterior parietal-left dorsal/ventrolateral prefrontal cortex, cingulate, basal ganglia, 2) right posterior parietal, right dorsolateral prefrontal cortex and 3) default mode network. In addition, the left fronto-parietal network demonstrated a load-dependent functional response during encoding. Network engagement that differed between groups during recognition comprised the posterior cingulate, cuneus and hippocampus/parahippocampus. As expected, working memory task accuracy differed between groups (p < 0.0001) and was associated with degree of network engagement. Functional connectivity within all three encoding-associated functional networks correlated significantly with task accuracy, which further underscores the relevance of abnormal network integration to well-described schizophrenia working memory impairment. No network was significantly associated with task accuracy during the recognition phase. Conclusions/Significance: This study extends the results of numerous previous schizophrenia studies that identified isolated dysfunctional brain regions by providing evidence of disrupted schizophrenia functional connectivity using ICA within widely-distributed neural networks engaged for working memory cognition.			Meda, SA (corresponding author), Hartford Hosp, Inst Living, Olin Neuropsychiat Res Ctr, Hartford, CT 06115 USA.	smeda01@harthosp.org	Stevens, Michael C/M-7678-2017; Calhoun, Vince D./ACN-9399-2022	Stevens, Michael C/0000-0002-3799-5465; Calhoun, Vince D./0000-0001-9058-0747	NIBIB NIH HHS [1R01EB000840, R01 EB000840] Funding Source: Medline; NIMH NIH HHS [R01 MH052886, MH60504, R01 MH060504, L30 MH081244-01, MH52886, R37 MH043775, L30 MH081244, MH43775, R01 MH043775] Funding Source: Medline; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000840] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH052886, R37MH043775, R01MH060504, R01MH043775] Funding Source: NIH RePORTER	NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abe M, 2007, J NEUROSCI, V27, P3429, DOI 10.1523/JNEUROSCI.4273-06.2007; Babiloni C, 2004, BEHAV NEUROSCI, V118, P687, DOI 10.1037/0735-7044.118.4.687; Barch DM, 2007, AM J PSYCHIAT, V164, P1090, DOI 10.1176/appi.ajp.164.7.1090; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Bunge SA, 2000, P NATL ACAD SCI USA, V97, P3573, DOI 10.1073/pnas.050583797; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; CALHOUN VD, 2008, NEUROIMAGE; Chang C, 2007, NEUROIMAGE, V34, P1253, DOI 10.1016/j.neuroimage.2006.08.056; Cohen JD, 1999, J ABNORM PSYCHOL, V108, P120, DOI 10.1037/0021-843X.108.1.120; Conklin HM, 2000, AM J PSYCHIAT, V157, P275, DOI 10.1176/appi.ajp.157.2.275; Das P, 2007, SCHIZOPHR RES, V90, P284, DOI 10.1016/j.schres.2006.11.023; DESPOSITO M, 1995, NATURE, V378, P279, DOI 10.1038/378279a0; First MB, 2002, PSYCHOPATHOLOGY, V35, P67, DOI 10.1159/000065121; Freire L, 2002, IEEE T MED IMAGING, V21, P470, DOI 10.1109/TMI.2002.1009383; FRISTON KJ, 1995, CLIN NEUROSCI, V3, P89; Garrity AG, 2007, AM J PSYCHIAT, V164, P450, DOI 10.1176/appi.ajp.164.3.450; Glahn DC, 2003, BIOL PSYCHIAT, V53, P624, DOI 10.1016/S0006-3223(02)01641-4; Gruber O, 2006, NEUROSCI LETT, V405, P24, DOI 10.1016/j.neulet.2006.06.062; Haenschel C, 2007, ARCH GEN PSYCHIAT, V64, P1229, DOI 10.1001/archpsyc.64.11.1229; Heckers S, 1998, NAT NEUROSCI, V1, P318, DOI 10.1038/1137; Jessen F, 2003, AM J PSYCHIAT, V160, P1305, DOI 10.1176/appi.ajp.160.7.1305; Johnson MR, 2006, BIOL PSYCHIAT, V60, P11, DOI 10.1016/j.biopsych.2005.11.012; Kondo H, 2004, NEUROIMAGE, V21, P2, DOI 10.1016/j.neuroimage.2003.09.046; Manoach DS, 2000, BIOL PSYCHIAT, V48, P99, DOI 10.1016/S0006-3223(00)00227-4; Meyer-Lindenberg A, 2001, AM J PSYCHIAT, V158, P1809, DOI 10.1176/appi.ajp.158.11.1809; Pomarol-Clotet E, 2008, PSYCHOL MED, V38, P1185, DOI 10.1017/S0033291708003565; Quintana J, 2003, BIOL PSYCHIAT, V53, P12, DOI 10.1016/S0006-3223(02)01435-X; Ragland JD, 2001, AM J PSYCHIAT, V158, P1114, DOI 10.1176/appi.ajp.158.7.1114; Scheibel RS, 2004, CORTEX, V40, P218, DOI 10.1016/S0010-9452(08)70957-2; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; Stephan KE, 2001, PSYCHOL MED, V31, P1065, DOI 10.1017/S0033291701004330; STERNBERG S, 1966, SCIENCE, V153, P652, DOI 10.1126/science.153.3736.652; STEVENS MC, 2007, HUM BRAIN MAPP; Tan HY, 2005, AM J PSYCHIAT, V162, P1849, DOI 10.1176/appi.ajp.162.10.1849; Tekin S, 2002, J PSYCHOSOM RES, V53, P647, DOI 10.1016/S0022-3999(02)00428-2; Wager TD, 2003, COGN AFFECT BEHAV NE, V3, P255, DOI 10.3758/CABN.3.4.255; Wexler BE, 1998, ARCH GEN PSYCHIAT, V55, P1093, DOI 10.1001/archpsyc.55.12.1093; White T, 2022, HUM BRAIN MAPP, V43, P278, DOI 10.1002/hbm.25120; Whitfield-Gabrieli S, 2009, P NATL ACAD SCI USA, V106, P1279, DOI 10.1073/pnas.0809141106; Woodward TS, 2006, NEUROSCIENCE, V139, P317, DOI 10.1016/j.neuroscience.2005.05.043; Zhou Y, 2007, NEUROSCI LETT, V417, P297, DOI 10.1016/j.neulet.2007.02.081	43	89	90	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2009	4	11							e7911	10.1371/journal.pone.0007911	http://dx.doi.org/10.1371/journal.pone.0007911			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	522NJ	19936244	Green Submitted, Green Published, gold			2022-12-25	WOS:000272004600015
J	Garcia-Pichel, F; Wojciechowski, MF				Garcia-Pichel, Ferran; Wojciechowski, Martin F.			The Evolution of a Capacity to Build Supra-Cellular Ropes Enabled Filamentous Cyanobacteria to Colonize Highly Erodible Substrates	PLOS ONE			English	Article							BIOLOGICAL SOIL CRUSTS; STABILIZATION	Background: Several motile, filamentous cyanobacteria display the ability to self-assemble into tightly woven or twisted groups of filaments that form macroscopic yarns or ropes, and that are often centimeters long and 50-200 mu m in diameter. Traditionally, this trait has been the basis for taxonomic definition of several genera, notably Microcoleus and Hydrocoleum, but the trait has not been associated with any plausible function. Method and Findings: Through the use of phylogenetic reconstruction, we demonstrate that pedigreed, rope-building cyanobacteria from various habitats do not form a monophyletic group. This is consistent with the hypothesis that rope-building ability was fixed independently in several discrete clades, likely through processes of convergent evolution or lateral transfer. Because rope-building cyanobacteria share the ability to colonize geologically unstable sedimentary substrates, such as subtidal and intertidal marine sediments and non-vegetated soils, it is also likely that this supracellular differentiation capacity imparts a particular fitness advantage in such habitats. The physics of sediment and soil erosion in fact predict that threads in the 50-200 mu m size range will attain optimal characteristics to stabilize such substrates on contact. Conclusions: Rope building is a supracellular morphological adaptation in filamentous cyanobacteria that allows them to colonize physically unstable sedimentary environments, and to act as successful pioneers in the biostabilization process.			Garcia-Pichel, F (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	ferran@asu.edu						Abed RMM, 2003, J PHYCOL, V39, P862, DOI 10.1046/j.1529-8817.2003.02180.x; BELNAP J, 1993, GREAT BASIN NAT, V53, P40; Belnap J, 1998, J ARID ENVIRON, V39, P133, DOI 10.1006/jare.1998.0388; Boyer SL, 2002, J PHYCOL, V38, P1222, DOI 10.1046/j.1529-8817.2002.01168.x; Castenholz RW, 1989, BERGEYS MANUAL SYSTE, V3, p[1771, 1780, 1794]; Garcia-Pichel F, 2001, APPL ENVIRON MICROB, V67, P1902, DOI 10.1128/AEM.67.4.1902-1910.2001; Garcia-Pichel F., 2002, ENCY ENV MICROBIOLOG, P1019; GarciaPichel F, 1996, APPL ENVIRON MICROB, V62, P3284, DOI 10.1128/AEM.62.9.3284-3291.1996; GarciaPichel F, 1996, SCI MAR, V60, P73; GARCIAPICHEL F, 2000, ENCY MICROBIOLOGY; Geitler L, 1932, CYANOPHYCEAE; GRANT J, 1987, NATURE, V330, P244, DOI 10.1038/330244a0; Greeley R., 1985, WIND GEOLOGICAL PROC, P333, DOI DOI 10.1017/CBO9780511573071; Hu CX, 2002, J APPL PHYCOL, V14, P281, DOI 10.1023/A:1021128530086; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; LANGE OL, 1992, FUNCT ECOL, V6, P519, DOI 10.2307/2390048; Lick W, 2004, J HYDRAUL ENG-ASCE, V130, P755, DOI 10.1061/(ASCE)0733-9429(2004)130:8(755); LIVINGSTONE I, 1996, AEOLIAN GEOMORPHOLOG, P221; Lodders N, 2005, ENVIRON MICROBIOL, V7, P434, DOI 10.1111/j.1462-2920.2005.00730.x; LORNE J, 2006, FEMS MICROBIOLOGY LE, V189; McKenna H. A, 2004, HDB FIBER ROPE TECHN; Paterson DM, 1999, ADV ECOL RES, V29, P155; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Reid RP, 2000, NATURE, V406, P989, DOI 10.1038/35023158; Schulz HN, 2001, ANNU REV MICROBIOL, V55, P105, DOI 10.1146/annurev.micro.55.1.105; Stal LJ, 2003, GEOMICROBIOL J, V20, P463, DOI 10.1080/713851126; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; WIEGESMUND MA, 2008, J PHYCOL, V44, P1572; Wojciechowski MF, 2004, AM J BOT, V91, P1846, DOI 10.3732/ajb.91.11.1846; YALLOP ML, 1994, ESTUAR COAST SHELF S, V39, P565, DOI 10.1016/S0272-7714(06)80010-7	30	108	112	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2009	4	11							e7801	10.1371/journal.pone.0007801	http://dx.doi.org/10.1371/journal.pone.0007801			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520OG	19924246	Green Submitted, Green Published, gold			2022-12-25	WOS:000271854200003
J	Shen, J; Ma, JP; Wang, QH				Shen, Jun; Ma, Jianpeng; Wang, Qinghua			Evolutionary Trends of A(H1N1) Influenza Virus Hemagglutinin Since 1918	PLOS ONE			English	Article							AMINO-ACID SITES; RECEPTOR-BINDING PROPERTIES; A H1N1 VIRUSES; DETECTING POSITIVE SELECTION; CODON-SUBSTITUTION MODELS; SWINE INFLUENZA; MAXIMUM-LIKELIHOOD; PANDEMIC INFLUENZA; UNITED-STATES; PHYLOGENETIC ANALYSIS	The Pandemic (H1N1) 2009 is spreading to numerous countries and causing many human deaths. Although the symptoms in humans are mild at present, fears are that further mutations in the virus could lead to a potentially more dangerous outbreak in subsequent months. As the primary immunity-eliciting antigen, hemagglutinin (HA) is the major agent for host-driven antigenic drift in A(H3N2) virus. However, whether and how the evolution of HA is influenced by existing immunity is poorly understood for A(H1N1). Here, by analyzing hundreds of A(H1N1) HA sequences since 1918, we show the first evidence that host selections are indeed present in A(H1N1) HAs. Among a subgroup of human A(H1N1) HAs between 1918 similar to 2008, we found strong diversifying (positive) selection at HA(1) 156 and 190. We also analyzed the evolutionary trends at HA(1) 190 and 225 that are critical determinants for receptor-binding specificity of A(H1N1) HA. Different A(H1N1) viruses appeared to favor one of these two sites in host-driven antigenic drift: epidemic A(H1N1) HAs favor HA(1) 190 while the 1918 pandemic and swine HAs favor HA(1) 225. Thus, our results highlight the urgency to understand the interplay between antigenic drift and receptor binding in HA evolution, and provide molecular signatures for monitoring future antigenically drifted 2009 pandemic and seasonal A(H1N1) influenza viruses.			Shen, J (corresponding author), Rice Univ, Dept Bioengn, Houston, TX 77251 USA.	jpma@bcm.tmc.edu; qinghuaw@bcm.tmc.edu			NIAID NIH HHS [R01 AI067839, R01-AI067839] Funding Source: Medline; NIGMS NIH HHS [R01-GM067801, R01 GM067801, R01 GM067801-07] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067801] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anisimova M, 2003, GENETICS, V164, P1229; Anisimova M, 2009, MOL BIOL EVOL, V26, P255, DOI 10.1093/molbev/msn232; Brown IH, 1997, J GEN VIROL, V78, P553, DOI 10.1099/0022-1317-78-3-553; Brown IH, 2000, VET MICROBIOL, V74, P29, DOI 10.1016/S0378-1135(00)00164-4; Brown IH, 1998, J GEN VIROL, V79, P2947, DOI 10.1099/0022-1317-79-12-2947; Bush RM, 1999, MOL BIOL EVOL, V16, P1457, DOI 10.1093/oxfordjournals.molbev.a026057; Bush RM, 1999, SCIENCE, V286, P1921, DOI 10.1126/science.286.5446.1921; CATON AJ, 1982, CELL, V31, P417, DOI 10.1016/0092-8674(82)90135-0; COLLINS SD, 1951, PUBLIC HEALTH REP, V66, P1487, DOI 10.2307/4587915; DANIELS RS, 1984, VIROLOGY, V138, P174, DOI 10.1016/0042-6822(84)90158-2; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Delport W, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000242; Delport W, 2009, BRIEF BIOINFORM, V10, P97, DOI 10.1093/bib/bbn049; DONATELLI I, 1991, J MED VIROL, V34, P248, DOI 10.1002/jmv.1890340410; Dunham EJ, 2009, J VIROL, V83, P5485, DOI 10.1128/JVI.02565-08; Finkelman BS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001296; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Gambaryan AS, 1999, VIROLOGY, V258, P232, DOI 10.1006/viro.1999.9732; Gambaryan AS, 1997, VIROLOGY, V232, P345, DOI 10.1006/viro.1997.8572; Gamblin SJ, 2004, SCIENCE, V303, P1838, DOI 10.1126/science.1093155; Garten RJ, 2009, SCIENCE; GERHARD W, 1981, NATURE, V290, P713, DOI 10.1038/290713a0; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Heath L, 2006, J VIROL, V80, P11827, DOI 10.1128/JVI.01100-06; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; ISAACS A, 1952, Bull World Health Organ, V6, P287; KENDAL AP, 1978, VIROLOGY, V89, P632, DOI 10.1016/0042-6822(78)90207-6; Kilbourne ED, 2002, P NATL ACAD SCI USA, V99, P10748, DOI 10.1073/pnas.162366899; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lemey P, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P1; LOGAN W P D, 1951, Lancet, V1, P264; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Matrosovich MN, 1997, VIROLOGY, V233, P224, DOI 10.1006/viro.1997.8580; Morens DM, 2009, NEW ENGL J MED, V361, P225, DOI 10.1056/NEJMp0904819; MUNSTER VJ, 2009, SCIENCE; NAKAJIMA K, 1978, NATURE, V274, P334, DOI 10.1038/274334a0; Nelson MI, 2007, NAT REV GENET, V8, P196, DOI 10.1038/nrg2053; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Newman AP, 2008, EMERG INFECT DIS, V14, P1470, DOI 10.3201/eid1409.080305; Nielsen R, 1998, GENETICS, V148, P929; NOBUSAWA E, 1987, VIROLOGY, V159, P10, DOI 10.1016/0042-6822(87)90342-4; Olsen CW, 2002, VIRUS RES, V85, P199, DOI 10.1016/S0168-1702(02)00027-8; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Peiris JSM, 2009, J CLIN VIROL, V45, P169, DOI 10.1016/j.jcv.2009.06.006; PENSAERT M, 1981, B WORLD HEALTH ORGAN, V59, P75; Pond SLK, 2008, MOL BIOL EVOL, V25, P1809, DOI 10.1093/molbev/msn123; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; RASMUSSEN AF, 1948, AM J HYG, V47, P142, DOI 10.1093/oxfordjournals.aje.a119191; Reid AH, 2004, J VIROL, V78, P12462, DOI 10.1128/JVI.78.22.12462-12470.2004; Reid AH, 2003, EMERG INFECT DIS, V9, P1249; ROBERTSON JS, 1987, VIROLOGY, V160, P31, DOI 10.1016/0042-6822(87)90040-7; ROGERS GN, 1989, VIROLOGY, V173, P317, DOI 10.1016/0042-6822(89)90249-3; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SALK JE, 1949, AM J PUBLIC HEALTH, V39, P345; SARTWELL PE, 1948, AM J HYG, V47, P135, DOI 10.1093/oxfordjournals.aje.a119190; SCHOLTISSEK C, 1978, VIROLOGY, V89, P613, DOI 10.1016/0042-6822(78)90203-9; SCHOLTISSEK C, 1978, VIROLOGY, V87, P13, DOI 10.1016/0042-6822(78)90153-8; Seoighe C, 2007, MOL BIOL EVOL, V24, P1025, DOI 10.1093/molbev/msm021; SHEERAR MG, 1989, J GEN VIROL, V70, P3297, DOI 10.1099/0022-1317-70-12-3297; Shen J, 2009, J MED VIROL, V81, P114, DOI 10.1002/jmv.21335; Shi WF, 2008, SCI CHINA SER C, V51, P987, DOI 10.1007/s11427-008-0131-8; Shinde V, 2009, NEW ENGL J MED, V360, P2616, DOI 10.1056/NEJMoa0903812; Shope RE, 1931, SCIENCE, V73, P214, DOI 10.1126/science.73.1886.214; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; SOLOVYOV A, 2009, EURO SURVEILL, V14; Srinivasan A, 2008, P NATL ACAD SCI USA, V105, P2800, DOI 10.1073/pnas.0711963105; Stevens J, 2006, J MOL BIOL, V355, P1143, DOI 10.1016/j.jmb.2005.11.002; Taubenberger JK, 2001, PHILOS T ROY SOC B, V356, P1829, DOI 10.1098/rstb.2001.1020; Tumpey TM, 2007, SCIENCE, V315, P655, DOI 10.1126/science.1136212; Viboud C, 2006, EMERG INFECT DIS, V12, P661, DOI 10.3201/eid1204.050695; Viboud C, 2006, VACCINE, V24, P6701, DOI 10.1016/j.vaccine.2006.05.067; Wang TT, 2009, CELL, V137, P983, DOI 10.1016/j.cell.2009.05.032; Webby RJ, 2000, J VIROL, V74, P8243, DOI 10.1128/JVI.74.18.8243-8251.2000; WILEY DC, 1981, NATURE, V289, P373, DOI 10.1038/289373a0; Wolf YI, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-34; XU XY, 1993, VIRUS RES, V28, P37; Yang Z., 2006, COMPUTATIONAL MOL EV, DOI DOI 10.1093/ACPROF:OSO/9780198567028.001.0001; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Yang ZH, 2000, J MOL EVOL, V51, P423, DOI 10.1007/s002390010105; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 1998, J MOL EVOL, V46, P409, DOI 10.1007/PL00006320; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; MMWR MORB MORTAL WKL, V58, P521	87	59	62	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2009	4	11							e7789	10.1371/journal.pone.0007789	http://dx.doi.org/10.1371/journal.pone.0007789			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520OG	19924230	Green Published, gold, Green Submitted			2022-12-25	WOS:000271854200002
J	Post, SM; Quintas-Cardama, A; Terzian, T; Smith, C; Eischen, CM; Lozano, G				Post, S. M.; Quintas-Cardama, A.; Terzian, T.; Smith, C.; Eischen, C. M.; Lozano, G.			p53-dependent senescence delays E mu-myc-induced B-cell lymphomagenesis	ONCOGENE			English	Article						p53; apoptosis; senescence; lymphoma; mouse model	CYCLIN-DEPENDENT KINASES; IN-VIVO; TUMOR-SUPPRESSOR; HUMAN FIBROBLASTS; ONCOGENIC RAS; P53; P21; P21(CIP1/WAF1); P16(INK4A); INHIBITOR	The effect of p53-dependent cell-cycle arrest and senescence on E mu-myc-induced B-cell lymphoma development remains controversial. To address this question, we crossed E mu-myc mice with the p53(515C) mutant mouse, encoding the mutant p53R172P protein that retains the ability to activate the cell-cycle inhibitor and senescence activator p21. Importantly, this mutant lacks the ability to activate p53-dependent apoptotic genes. Hence, E mu-myc mice that harbor two p53(515C) alleles are completely defective for p53-dependent apoptosis. Both E mu-myc::p53(515C/515C) and E mu-myc::p53(515C/+) mice survive significantly longer than E mu-myc::p53(+/-) mice, indicating the importance of the p53-dependent non-apoptotic pathways in B-cell lymphomagenesis. In addition, the p53(515C) allele is deleted in several E mu-myc::p53(515C/+) lymphomas, further emphasizing the functionality of p53R172P in tumor inhibition. Lymphomas from both E mu-myc:: p53(515C/515C) and E mu-myc::p53(515C/+) mice retain the ability to upregulate p21, resulting in cellular senescence. Senescence-associated beta-galactosidase (SA beta-gal) activity was observed in lymphomas from E mu-myc::p53(+/+), E mu-myc::p53(515C/515C) and E mu-myc::p53(515C /+) mice but not in lymphomas isolated from E mu-myc::p53(+/-) mice. Thus, in the absence of p53-dependent apoptosis, the ability of p53R172P to induce senescence leads to a significant delay in B-cell lymphoma development. Oncogene (2010) 29, 1260-1269; doi:10.1038/onc.2009.423; published online 23 November 2009	[Lozano, G.] Univ Texas MD Anderson Canc Ctr, Dept Genet, Unit 1010, Houston, TX 77030 USA; [Quintas-Cardama, A.] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA; [Smith, C.] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Eischen, C. M.] Vanderbilt Univ, Sch Med, Dept Pathol, Nashville, TN 37212 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Vanderbilt University	Lozano, G (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genet, Unit 1010, 1515 Holcombe Blvd, Houston, TX 77030 USA.	gglozano@mdanderson.org			NCI Cancer Center [CA16672]; Ruth L Kirschstein NRSA fellowship [F32CA119616]; Dowdy P Hawn postdoctoral fellowship; NIH [CA82577]; NATIONAL CANCER INSTITUTE [F32CA119616, P30CA016672, R01CA082577] Funding Source: NIH RePORTER	NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ruth L Kirschstein NRSA fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dowdy P Hawn postdoctoral fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Tomoo Iwakuma, Arlette Audiffred and Kristina Castro for helpful discussions and technical assistance, and Dr Clifton Stephens for pathological analysis. We thank Drs Jim Jackson and Vinod Pant for review of this paper. Veterinary support and DNA sequencing core facilities were supported by NCI Cancer Center Support Grant CA16672. SMP is supported by a Ruth L Kirschstein NRSA fellowship F32CA119616 and is a recipient of the Dowdy P Hawn postdoctoral fellowship. This study was supported by NIH Grant CA82577 (to GL).	ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; BANDARA LR, 1991, NATURE, V351, P494, DOI 10.1038/351494a0; Barboza JA, 2006, P NATL ACAD SCI USA, V103, P19842, DOI 10.1073/pnas.0606343104; BEENKEN SW, 1991, NUCLEIC ACIDS RES, V19, P4747, DOI 10.1093/nar/19.17.4747; Brown JP, 1997, SCIENCE, V277, P831, DOI 10.1126/science.277.5327.831; DEIRY WS, 1993, CELL, V75, P817; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Eischen CM, 1999, GENE DEV, V13, P2658, DOI 10.1101/gad.13.20.2658; Eischen CM, 2001, MOL CELL BIOL, V21, P7653, DOI 10.1128/MCB.21.22.7653-7662.2001; Feldser DM, 2007, CANCER CELL, V11, P461, DOI 10.1016/j.ccr.2007.02.026; GU Y, 1993, NATURE, V366, P707, DOI 10.1038/366707a0; HARPER JW, 1993, CELL, V75, P805; HSU B, 1995, ONCOGENE, V11, P175; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; KULJU KS, 1995, EXP CELL RES, V217, P336, DOI 10.1006/excr.1995.1095; Liu G, 2004, NAT GENET, V36, P63, DOI 10.1038/ng1282; Ludwig RL, 1996, MOL CELL BIOL, V16, P4952; Martins CP, 2002, EMBO J, V21, P3739, DOI 10.1093/emboj/cdf364; Missero C, 1996, GENE DEV, V10, P3065, DOI 10.1101/gad.10.23.3065; NODA A, 1994, EXP CELL RES, V211, P90, DOI 10.1006/excr.1994.1063; Pantoja C, 1999, ONCOGENE, V18, P4974, DOI 10.1038/sj.onc.1202880; Rowan S, 1996, EMBO J, V15, P827, DOI 10.1002/j.1460-2075.1996.tb00418.x; Schmitt CA, 1999, GENE DEV, V13, P2670, DOI 10.1101/gad.13.20.2670; Schmitt CA, 2002, CANCER CELL, V1, P289, DOI 10.1016/S1535-6108(02)00047-8; Schmitt CA, 2002, CELL, V109, P335, DOI 10.1016/S0092-8674(02)00734-1; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; Sherr CJ, 2005, COLD SH Q B, V70, P129, DOI 10.1101/sqb.2005.70.004; SHIOHARA M, 1994, BLOOD, V84, P3781, DOI 10.1182/blood.V84.11.3781.bloodjournal84113781; TAHARA H, 1995, ONCOGENE, V10, P835; Terzian T, 2008, GENE DEV, V22, P1337, DOI 10.1101/gad.1662908; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; WAGA S, 1994, NATURE, V369, P574, DOI 10.1038/369574a0; Weinberg WC, 1997, ONCOGENE, V15, P685, DOI 10.1038/sj.onc.1201230; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0	36	49	50	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 4	2010	29	9					1260	1269		10.1038/onc.2009.423	http://dx.doi.org/10.1038/onc.2009.423			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	563XJ	19935700	Green Accepted			2022-12-25	WOS:000275170600002
J	Oh, SM; Liu, Z; Okada, M; Jang, SW; Liu, X; Chan, CB; Luo, H; Ye, K				Oh, S-M; Liu, Z.; Okada, M.; Jang, S-W; Liu, X.; Chan, C-B; Luo, H.; Ye, K.			Ebp1 sumoylation, regulated by TLS/FUS E3 ligase, is required for its anti-proliferative activity	ONCOGENE			English	Article						Ebp1; TLS/FUS; sumoylation; cell proliferation	HUMAN MYELOID-LEUKEMIA; BINDING-PROTEIN EBP1; ONCOGENIC TRANSFORMATION; DNA-DAMAGE; TRANSCRIPTIONAL ACTIVATION; CHROMOSOMAL TRANSLOCATION; SUBCELLULAR-LOCALIZATION; CELL-PROLIFERATION; GENOMIC STRUCTURE; CHIMERIC PROTEIN	Ebp1, an ErbB3 receptor-binding protein, inhibits cell proliferation and acts as a putative tumor suppressor. Ebp1 translocates into the nucleus and functions as a transcription co-repressor for E2F-1. Here, we show that Ebp1 p42 isoform can be sumoylated on both K93 and K298 residues, which mediate its nuclear translocation and are required for its anti-proliferative activity. We find that translocation in liposarcoma (TLS)/FUS, an RNA-binding nuclear protein that is involved in pre-mRNA processing and nucleocytoplasmic shuttling, has Sumo1 E3 ligase activity for Ebp1 p42. Ebp1 directly binds TLS/FUS, which is regulated by genotoxic stress-triggered phosphorylation on Ebp1. Ebp1 sumoylation facilitates its nucleolar distribution and protein stability. Overexpression of TLS enhances Ebp1 sumoylation, whereas depletion of TLS abolishes Ebp1 sumoylation. Moreover, unsumoylated Ebp1 mutants fail to suppress E2F-1-regulated transcription, resulting in loss of its anti-proliferation activity. Hence, TLS-mediated sumoylation is required for Ebp1 transcriptional repressive activity. Oncogene (2010) 29, 1017-1030; doi:10.1038/onc.2009.411; published online 30 November 2009	[Oh, S-M; Liu, Z.; Okada, M.; Jang, S-W; Liu, X.; Chan, C-B; Ye, K.] Emory Univ, Dept Pathol & Lab Med, Sch Med, Atlanta, GA 30322 USA; [Luo, H.] Harvard Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA USA; [Luo, H.] Childrens Hosp, Boston, MA 02115 USA	Emory University; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Ye, K (corresponding author), Emory Univ, Dept Pathol & Lab Med, Sch Med, Room 145,Whitehead Bldg,615 Michael St, Atlanta, GA 30322 USA.	kye@emory.edu			National Institute of Health [CA127119]; NATIONAL CANCER INSTITUTE [R01CA127119] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by grants from the National Institute of Health (RO1, CA127119) to K Ye. We thank Dr Yang Liu at Medical Research Service (VA Puget Sound Health Care System, Seattle, WA, USA) for TLS constructs.	Ahn JY, 2006, EMBO J, V25, P2083, DOI 10.1038/sj.emboj.7601111; Aman P, 1996, GENOMICS, V37, P1, DOI 10.1006/geno.1996.0513; Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Bae SH, 2004, BIOCHEM BIOPH RES CO, V324, P394, DOI 10.1016/j.bbrc.2004.09.068; Bossis G, 2005, MOL CELL BIOL, V25, P6964, DOI 10.1128/MCB.25.16.6964-6979.2005; CROZAT A, 1993, NATURE, V363, P640, DOI 10.1038/363640a0; Falini B, 2007, HAEMATOLOGICA, V92, P519, DOI 10.3324/haematol.11007; Gill G, 2005, CURR OPIN GENET DEV, V15, P536, DOI 10.1016/j.gde.2005.07.004; Grisendi S, 2005, NATURE, V437, P147, DOI 10.1038/nature03915; Hay RT, 2001, TRENDS BIOCHEM SCI, V26, P332, DOI 10.1016/S0968-0004(01)01849-7; Hicks GG, 2000, NAT GENET, V24, P175, DOI 10.1038/72842; Hochstrasser M, 2001, CELL, V107, P5, DOI 10.1016/S0092-8674(01)00519-0; Huen MS, 2008, CELL RES, V18, P8, DOI 10.1038/cr.2007.109; Inoue Y, 2007, EMBO J, V26, P2083, DOI 10.1038/sj.emboj.7601652; Jackson PK, 2001, GENE DEV, V15, P3053, DOI 10.1101/gad.955501; Kuroda M, 1997, AM J PATHOL, V151, P735; Kuroda M, 2000, EMBO J, V19, P453, DOI 10.1093/emboj/19.3.453; Lee CD, 2008, PROTEIN SCI, V17, P1241, DOI 10.1110/ps.035188.108; Liu X, 2007, P NATL ACAD SCI USA, V104, P9679, DOI 10.1073/pnas.0701806104; Liu ZX, 2006, P NATL ACAD SCI USA, V103, P10917, DOI 10.1073/pnas.0602923103; Meek DW, 1998, CELL SIGNAL, V10, P159, DOI 10.1016/S0898-6568(97)00119-8; Morohoshi F, 1998, GENE, V221, P191, DOI 10.1016/S0378-1119(98)00463-6; Muller S, 2001, NAT REV MOL CELL BIO, V2, P202, DOI 10.1038/35056591; Nakagawa K, 1997, J HISTOCHEM CYTOCHEM, V45, P41, DOI 10.1177/002215549704500106; Okada M, 2007, J BIOL CHEM, V282, P36744, DOI 10.1074/jbc.M706169200; PANAKHOVA KG, 1995, BIOL MEMBRANY, V12, P16; Perrotti D, 2000, MOL CELL BIOL, V20, P6159, DOI 10.1128/MCB.20.16.6159-6169.2000; PRASAD DDK, 1994, ONCOGENE, V9, P3717; RABBITTS TH, 1993, NAT GENET, V4, P175, DOI 10.1038/ng0693-175; RADOMSKI N, 1995, EXP CELL RES, V220, P434, DOI 10.1006/excr.1995.1335; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Ron D, 1997, CURR TOP MICROBIOL, V220, P131; SANCHEZGARCIA I, 1994, P NATL ACAD SCI USA, V91, P7869, DOI 10.1073/pnas.91.17.7869; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; SHIMIZU K, 1993, P NATL ACAD SCI USA, V90, P10280, DOI 10.1073/pnas.90.21.10280; Squatrito M, 2004, ONCOGENE, V23, P4454, DOI 10.1038/sj.onc.1207579; Watts FZ, 2006, DNA REPAIR, V5, P399, DOI 10.1016/j.dnarep.2005.11.002; Wei F, 2007, J BIOL CHEM, V282, P21551, DOI 10.1074/jbc.M611041200; Xia XM, 2001, J CELL PHYSIOL, V187, P209, DOI 10.1002/jcp.1075; Yoo JY, 2000, BRIT J CANCER, V82, P683; Yu YC, 2007, INT J CANCER, V120, P1909, DOI 10.1002/ijc.22541; Zhang YX, 2005, P NATL ACAD SCI USA, V102, P9890, DOI 10.1073/pnas.0503829102; Zhang YX, 2003, NUCLEIC ACIDS RES, V31, P2168, DOI 10.1093/nar/gkg318; ZINSZNER H, 1994, GENE DEV, V8, P2513, DOI 10.1101/gad.8.21.2513; Zinszner H, 1997, ONCOGENE, V14, P451, DOI 10.1038/sj.onc.1200854; Zinszner H, 1997, J CELL SCI, V110, P1741	46	31	33	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 18	2010	29	7					1017	1030		10.1038/onc.2009.411	http://dx.doi.org/10.1038/onc.2009.411			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	556PV	19946338	Green Accepted, Green Submitted			2022-12-25	WOS:000274604400008
J	Saugar, I; Irigoyen, N; Luque, D; Carrascosa, JL; Rodriguez, JF; Caston, JR				Saugar, Irene; Irigoyen, Nerea; Luque, Daniel; Carrascosa, Jose L.; Rodriguez, Jose F.; Caston, Jose R.			Electrostatic Interactions between Capsid and Scaffolding Proteins Mediate the Structural Polymorphism of a Double-stranded RNA Virus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BURSAL-DISEASE-VIRUS; PANCREATIC NECROSIS VIRUS; CRYSTAL-STRUCTURE; NONENVELOPED VIRUS; MOLECULAR SWITCH; CATALYTIC DYAD; VP3; POLYMERASE; MATURATION; MECHANISM	Capsid proteins that adopt distinct conformations constitute a paradigm of the structural polymorphism of macromolecular assemblies. We show the molecular basis of the flexibility mechanism of VP2, the capsid protein of the double-stranded RNA virus infectious bursal disease virus. The initial assembly, a procapsid-like structure, is built by the protein precursor pVP2 and requires VP3, the other infectious bursal disease virus major structural protein, which acts as a scaffold. The pVP2 C-terminal region, which is proteolyzed during virus maturation, contains an amphipathic alpha-helix that acts as a molecular switch. In the absence of VP3, efficient virus-like particle assembly occurs when the structural unit is a VP2-based chimeric protein with an N-terminal-fused His(6) tag. The His tag has a positively charged N terminus and a negatively charged C terminus, both important for virion-like structure assembly. The charge distributions of the VP3 C terminus and His tag are similar. We tested whether the His tag emulates the role of VP3 and found that the presence of a VP3 C-terminal peptide in VP2-based chimeric proteins resulted in the assembly of virus-like particles. We analyzed the electrostatic interactions between these two charged morphogenetic peptides, in which a single residue was mutated to impede the predicted interaction, followed by a compensatory double mutation to rescue electrostatic interactions. The effects of these mutations were monitored by following the virus-like and/or virus-related assemblies. Our results suggest that the basic face of the pVP2 amphipathic alpha-helix interacts with the acidic region of the VP3 C terminus and that this interaction is essential for VP2 acquisition of competent conformations for capsid assembly.	[Saugar, Irene; Luque, Daniel; Carrascosa, Jose L.; Caston, Jose R.] CSIC, Ctr Nacl Biotecnol, Dept Struct Macromol, Madrid 28049, Spain; [Irigoyen, Nerea; Rodriguez, Jose F.] CSIC, Ctr Nacl Biotecnol, Dept Mol & Cellular Biol, Madrid 28049, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Caston, JR (corresponding author), CSIC, Ctr Nacl Biotecnol, Dept Struct Macromol, Darwin 3,Cantoblanco, Madrid 28049, Spain.	jrcaston@cnb.csic.es	Irigoyen, Nerea/CAJ-2485-2022; Caston, Jose/AAB-8825-2021; Rodríguez, José F/T-8500-2017; Luque, Daniel/I-6467-2015; Irigoyen, Nerea/A-7925-2017; Caston, Jose R/L-5896-2014	Irigoyen, Nerea/0000-0001-6346-3369; Caston, Jose/0000-0003-2350-9048; Rodríguez, José F/0000-0001-7944-5341; Luque, Daniel/0000-0002-0151-6020; Irigoyen, Nerea/0000-0001-6346-3369; Caston, Jose R/0000-0003-2350-9048; Saugar, Irene/0000-0002-5576-5786	Spanish Ministry of Science and Innovation [BFU 2008-02328/BMC, S-0505-Mat-0238, BIO2006-09407, BIO2008-02361]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by Spanish Ministry of Science and Innovation Grants BFU 2008-02328/BMC and S-0505-Mat-0238 (to J. L. C.), BIO2006-09407 (to J. F. R.), and BIO2008-02361 (to J. R. C.).	Birghan C, 2000, EMBO J, V19, P114, DOI 10.1093/emboj/19.1.114; Bottcher B, 1997, J VIROL, V71, P325; Cardone G, 2009, NATURE, V457, P694, DOI 10.1038/nature07724; Casanas A, 2008, STRUCTURE, V16, P29, DOI 10.1016/j.str.2007.10.023; Caston J R, 2008, SEGMENTED DOUBLE STR; Caston JR, 2001, J VIROL, V75, P10815, DOI 10.1128/JVI.75.22.10815-10828.2001; Chevalier C, 2005, J VIROL, V79, P12253, DOI 10.1128/JVI.79.19.12253-12263.2005; Chevalier C, 2004, J VIROL, V78, P3296, DOI 10.1128/JVI.78.7.3296-3303.2004; Coulibaly F, 2005, CELL, V120, P761, DOI 10.1016/j.cell.2005.01.009; Da Costa B, 2002, J VIROL, V76, P2393, DOI 10.1128/JVI.76.5.2393-2402.2002; DELMAS B, 2005, VIRUS TAXONOMY, P561; Dokland T, 2000, STRUCTURE, V8, pR157, DOI 10.1016/S0969-2126(00)00181-7; DRYDEN KA, 1993, J CELL BIOL, V122, P1023, DOI 10.1083/jcb.122.5.1023; EARL PL, 1993, CURRENT PROTOCOLS MO; Fane BA, 2003, ADV PROTEIN CHEM, V64, P259; Feldman AR, 2006, J MOL BIOL, V358, P1378, DOI 10.1016/j.jmb.2006.02.045; Galloux M, 2007, J BIOL CHEM, V282, P20774, DOI 10.1074/jbc.M701048200; Garriga D, 2007, P NATL ACAD SCI USA, V104, P20540, DOI 10.1073/pnas.0704447104; Garriga D, 2006, J VIROL, V80, P6895, DOI 10.1128/JVI.00368-06; Gertsman I, 2009, NATURE, V458, P646, DOI 10.1038/nature07686; Hjalmarsson A, 1999, J VIROL, V73, P3484, DOI 10.1128/JVI.73.4.3484-3490.1999; Irigoyen N, 2009, J BIOL CHEM, V284, P8064, DOI 10.1074/jbc.M808942200; Johnson JE, 2008, J STRUCT BIOL, V163, P246, DOI 10.1016/j.jsb.2008.03.013; Kochan G, 2003, ARCH VIROL, V148, P723, DOI 10.1007/s00705-002-0949-5; Lee CC, 2006, J STRUCT BIOL, V155, P74, DOI 10.1016/j.jsb.2006.02.014; Lombardo E, 1999, J VIROL, V73, P6973, DOI 10.1128/JVI.73.8.6973-6983.1999; Luque D, 2007, J VIROL, V81, P6869, DOI 10.1128/JVI.00077-07; Luque D, 2009, J MOL BIOL, V386, P891, DOI 10.1016/j.jmb.2008.11.029; Luque D, 2009, P NATL ACAD SCI USA, V106, P2148, DOI 10.1073/pnas.0808498106; Maraver A, 2003, J VIROL, V77, P6438, DOI 10.1128/JVI.77.11.6438-6449.2003; Maraver A, 2003, J VIROL, V77, P2459, DOI 10.1128/JVI.77.4.2459-2468.2003; Martinez-Torrecuadrada JL, 2000, VIROLOGY, V278, P322, DOI 10.1006/viro.2000.0559; Ona A, 2004, VIROLOGY, V322, P135, DOI 10.1016/j.virol.2004.01.025; Pan JH, 2007, P NATL ACAD SCI USA, V104, P7385, DOI 10.1073/pnas.0611599104; Parent KN, 2005, VIROLOGY, V340, P33, DOI 10.1016/j.virol.2005.06.018; Parker MH, 2001, BIOCHEMISTRY-US, V40, P8962, DOI 10.1021/bi0026167; Pedersen T, 2007, J VIROL, V81, P6652, DOI 10.1128/JVI.02831-06; Sanchez AB, 1999, VIROLOGY, V262, P190, DOI 10.1006/viro.1999.9910; Saugar I, 2005, STRUCTURE, V13, P1007, DOI 10.1016/j.str.2005.04.012; Steven AC, 2005, CURR OPIN STRUC BIOL, V15, P227, DOI 10.1016/j.sbi.2005.03.008; Villanueva RA, 2004, J VIROL, V78, P13829, DOI 10.1128/JVI.78.24.13829-13838.2004; von Einem UI, 2004, J GEN VIROL, V85, P2221, DOI 10.1099/vir.0.19772-0; WARD GA, 1995, P NATL ACAD SCI USA, V92, P6773, DOI 10.1073/pnas.92.15.6773; Zlotnick A, 2005, J MOL RECOGNIT, V18, P479, DOI 10.1002/jmr.754; Zlotnick A, 2007, NAT PROTOC, V2, P490, DOI 10.1038/nprot.2007.60	45	20	20	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3643	3650		10.1074/jbc.M109.075994	http://dx.doi.org/10.1074/jbc.M109.075994			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19933276	hybrid, Green Published			2022-12-25	WOS:000275254000016
J	Gastebois, A; Mouyna, I; Simenel, C; Clavaud, C; Coddeville, B; Delepierre, M; Latge, JP; Fontaine, T				Gastebois, Amandine; Mouyna, Isabelle; Simenel, Catherine; Clavaud, Cecile; Coddeville, Bernadette; Delepierre, Muriel; Latge, Jean-Paul; Fontaine, Thierry			Characterization of a New beta(1-3)-Glucan Branching Activity of Aspergillus fumigatus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-WALL; SACCHAROMYCES-CEREVISIAE; FUNGAL CELL; SPECTROSCOPY; SEQUENCE; ASSAY; ACID; GENE; NMR	A new HPLC method was developed to separate linear from beta(1-6)-branched beta(1-3)-glucooligosaccharides. This methodology has permitted the isolation of the first fungal beta(1-6)/beta(1-3)-glucan branching transglycosidase using a cell wall autolysate of Aspergillus fumigatus (Af). The encoding gene, AfBGT2 is an ortholog of AfBGT1, another transglycosidase of A. fumigatus previously analyzed (Mouyna, I., Hartland, R. P., Fontaine, T., Diaquin, M., Simenel, C., Delepierre, M., Henrissat, B., and Latge, J.P. (1998) Microbiology 144, 3171-3180). Both enzymes release laminaribiose from the reducing end of a beta(1-3)-linked oligosaccharide and transfer the remaining chain to another molecule of the original substrate. The AfBgt1p transfer occurs at C-6 of the non-reducing end group of the acceptor, creating a kinked beta(1-3; 1-6) linear molecule. The AfBgt2p transfer takes place at the C-6 of an internal group of the acceptor, resulting in a beta(1-3)-linked product with a beta(1-6)-linked side branch. The single Afbgt2 mutant and the double Afbgt1/Afbgt2 mutant in A. fumigatus did not display any cell wall phenotype showing that these activities were not responsible for the construction of the branched beta(1-3)-glucans of the cell wall.	[Gastebois, Amandine; Mouyna, Isabelle; Clavaud, Cecile; Latge, Jean-Paul; Fontaine, Thierry] Inst Pasteur, Unite Aspergillus, F-75015 Paris, France; [Simenel, Catherine; Delepierre, Muriel] Inst Pasteur, Unite Resonance Magnet Nucl Biomol, CNRS, URA 2185, F-75724 Paris 15, France; [Coddeville, Bernadette] Univ Sci & Tech Lille Flandres Artois, UMR 8576, CNRS, Lab Glycobiol Struct & Fonct, F-59655 Villeneuve Dascq, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille	Fontaine, T (corresponding author), Inst Pasteur, Unite Aspergillus, 25 Rue Docteur Roux, F-75015 Paris, France.	tfontain@pasteur.fr	Mouyna, Isabelle/O-7697-2018; mouyna, isabelle/F-3578-2011; Fontaine, thierry/Q-2201-2018; Latge, Jean Paul/C-9846-2014; Fontaine, Thierry/F-8227-2011	Mouyna, Isabelle/0000-0003-3140-5927; Fontaine, thierry/0000-0002-8184-789X; 				Aimanianda V, 2009, J BIOL CHEM, V284, P13401, DOI 10.1074/jbc.M807667200; BEAUVAIS A, 1993, J GEN MICROBIOL, V139, P3071, DOI 10.1099/00221287-139-12-3071; Beauvais A, 1997, J BIOL CHEM, V272, P6238, DOI 10.1074/jbc.272.10.6238; Bhagwat AA, 1996, J BACTERIOL, V178, P4635, DOI 10.1128/jb.178.15.4635-4642.1996; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; COVE DJ, 1966, BIOCHIM BIOPHYS ACTA, V113, P51, DOI 10.1016/S0926-6593(66)80120-0; DESAI NN, 1983, BIOCHEM J, V211, P273, DOI 10.1042/bj2110273; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Ferreira MED, 2006, EUKARYOT CELL, V5, P207, DOI 10.1128/EC.5.1.207-211.2006; Fontaine T, 2000, J BIOL CHEM, V275, P27594; Fontaine T, 2009, CARBOHYD RES, V344, P1960, DOI 10.1016/j.carres.2009.07.012; GIRARDIN H, 1993, J CLIN MICROBIOL, V31, P1547, DOI 10.1128/JCM.31.6.1547-1554.1993; GOLDMAN RC, 1995, EUR J BIOCHEM, V227, P372, DOI 10.1111/j.1432-1033.1995.tb20399.x; Hartland RP, 1996, J BIOL CHEM, V271, P26843, DOI 10.1074/jbc.271.43.26843; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; Hurtado-Guerrero R, 2009, J BIOL CHEM, V284, P8461, DOI 10.1074/jbc.M807990200; JOHNSON AR, 1971, ANAL BIOCHEM, V44, P628, DOI 10.1016/0003-2697(71)90252-1; KESSLER H, 1987, J AM CHEM SOC, V109, P607, DOI 10.1021/ja00236a063; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lamarre C, 2007, FUNGAL GENET BIOL, V44, P682, DOI 10.1016/j.fgb.2007.01.009; Latge JP, 2007, MOL MICROBIOL, V66, P279, DOI 10.1111/j.1365-2958.2007.05872.x; Leitao EA, 2003, GLYCOBIOLOGY, V13, P681, DOI 10.1093/glycob/cwg089; Martin-Cuadrado AB, 2008, MOL MICROBIOL, V69, P188, DOI 10.1111/j.1365-2958.2008.06275.x; Mattern I.E., 1988, FUNGAL GENET NEWSL, V35, P25, DOI DOI 10.4148/1941-4765.1533; Mouyna I, 2005, MOL MICROBIOL, V56, P1675, DOI 10.1111/j.1365-2958.2005.04654.x; Mouyna I, 2000, J BIOL CHEM, V275, P14882, DOI 10.1074/jbc.275.20.14882; Mouyna I, 1998, MICROBIOL-SGM, V144, P3171, DOI 10.1099/00221287-144-11-3171; Mouyna I, 2000, BIOCHEM J, V347, P741, DOI 10.1042/0264-6021:3470741; Popolo L, 1999, BBA-GEN SUBJECTS, V1426, P385, DOI 10.1016/S0304-4165(98)00138-X; PUNT PJ, 1987, GENE, V56, P117, DOI 10.1016/0378-1119(87)90164-8; Receveur-Brechot V, 2006, PROTEINS, V63, P235, DOI 10.1002/prot.20876; S~anchez O, 1996, FUNGAL GENET REP, V43, P21; SAWARDEKER JS, 1965, ANAL CHEM, V37, P1602, DOI 10.1021/ac60231a048; Sestak S, 2004, MICROBIOL-SGM, V150, P3197, DOI 10.1099/mic.0.27293-0; STYNEN D, 1995, J CLIN MICROBIOL, V33, P497, DOI 10.1128/JCM.33.2.497-500.1995; Teparic R, 2007, YEAST, V24, P259, DOI 10.1002/yea.1463; VARGHESE JN, 1994, P NATL ACAD SCI USA, V91, P2785, DOI 10.1073/pnas.91.7.2785; WILLKER W, 1993, MAGN RESON CHEM, V31, P287, DOI 10.1002/mrc.1260310315; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Zverlov VV, 1997, MICROBIOL-SGM, V143, P1701, DOI 10.1099/00221287-143-5-1701	40	53	65	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2386	2396		10.1074/jbc.M109.077545	http://dx.doi.org/10.1074/jbc.M109.077545			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19948732	Green Published, hybrid			2022-12-25	WOS:000273697800019
J	Lee, TV; Johnson, LJ; Johnson, RD; Koulman, A; Lane, GA; Lott, JS; Arcus, VL				Lee, T. Verne; Johnson, Linda J.; Johnson, Richard D.; Koulman, Albert; Lane, Geoffrey A.; Lott, J. Shaun; Arcus, Vickery L.			Structure of a Eukaryotic Nonribosomal Peptide Synthetase Adenylation Domain That Activates a Large Hydroxamate Amino Acid in Siderophore Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACYL-COA SYNTHETASE; CRYSTAL-STRUCTURE; SUBSTRATE-SPECIFICITY; DENSITY MODIFICATION; FIREFLY LUCIFERASE; PROTEIN-PRODUCTION; BINDING; MODEL; SELECTION; MODULE	Nonribosomal peptide synthetases (NRPSs) are large, multidomain proteins that are involved in the biosynthesis of an array of secondary metabolites. We report the structure of the third adenylation domain from the siderophore-synthesizing NRPS, SidN, from the endophytic fungus Neotyphodium lolii. This is the first structure of a eukaryotic NRPS domain, and it reveals a large binding pocket required to accommodate the unusual amino acid substrate, N-delta-cis-anhydromevalonyl-N-delta-hydroxy-L-ornithine (cis-AMHO). The specific activation of cis-AMHO was confirmed biochemically, and an AMHO moiety was unambiguously identified as a component of the fungal siderophore using mass spectroscopy. The protein structure shows that the substrate binding pocket is defined by 17 amino acid residues, in contrast to both prokaryotic adenylation domains and to previous predictions based on modeling. Existing substrate prediction methods for NRPS adenylation domains fail for domains from eukaryotes due to the divergence of their signature sequences from those of prokaryotes. Thus, this new structure will provide a basis for improving prediction methods for eukaryotic NRPS enzymes that play important and diverse roles in the biology of fungi.	[Arcus, Vickery L.] Univ Waikato, Dept Biol Sci, Hamilton 3240, New Zealand; [Johnson, Linda J.; Johnson, Richard D.; Koulman, Albert; Lane, Geoffrey A.] AgResearch Ltd, Grasslands Res Ctr, Palmerston North 4442, New Zealand; [Lee, T. Verne; Lott, J. Shaun; Arcus, Vickery L.] Univ Auckland, Sch Biol Sci, AgRes Struct Biol Lab, Auckland 1142, New Zealand	University of Waikato; AgResearch - New Zealand; University of Auckland	Arcus, VL (corresponding author), Univ Waikato, Dept Biol Sci, Private Bag 3105, Hamilton 3240, New Zealand.	varcus@waikato.ac.nz	Lee, Verne/M-6283-2014; Koulman, Albert/B-2967-2009	Lee, Verne/0000-0002-5768-2781; Koulman, Albert/0000-0001-9998-051X; Johnson, Richard/0000-0003-2100-6658; Johnson, linda/0000-0002-3779-0902; Lott, Shaun/0000-0003-3660-452X	New Zealand Foundation for Research Science and Technology [CX10X0203]; Agricultural and Marketing Research and Development Trust; University of Auckland; MRC [MC_EX_G0800783] Funding Source: UKRI; Medical Research Council [MC_EX_G0800783] Funding Source: researchfish	New Zealand Foundation for Research Science and Technology(New Zealand Foundation for Research, Science and Technology); Agricultural and Marketing Research and Development Trust; University of Auckland; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by the New Zealand Foundation for Research Science and Technology Contract CX10X0203.; Supported by an Agricultural and Marketing Research and Development Trust doctoral scholarship and a University of Auckland doctoral scholarship.	Afonine PV, 2005, CCP4 NEWSL, V42; Arora P, 2009, NAT CHEM BIOL, V5, P166, DOI 10.1038/nchembio.143; Bains J, 2007, J MOL BIOL, V373, P965, DOI 10.1016/j.jmb.2007.08.008; Bushley KE, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-328; Challis GL, 2000, CHEM BIOL, V7, P211, DOI 10.1016/S1074-5521(00)00091-0; Cole JC, 2005, VIRTUAL SCREENING IN DRUG DISCOVERY, P379; CONNOLLY ML, 1983, J APPL CRYSTALLOGR, V16, P548, DOI 10.1107/S0021889883010985; Conti E, 1997, EMBO J, V16, P4174, DOI 10.1093/emboj/16.14.4174; Conti E, 1996, STRUCTURE, V4, P287, DOI 10.1016/S0969-2126(96)00033-0; DIEKMANN H, 1967, EUR J BIOCHEM, V3, P213, DOI 10.1111/j.1432-1033.1967.tb19518.x; Du LQ, 2008, BIOCHEMISTRY-US, V47, P11473, DOI 10.1021/bi801363b; Eisendle M, 2003, MOL MICROBIOL, V49, P359, DOI 10.1046/j.1365-2958.2003.03586.x; Eldridge MD, 1997, J COMPUT AID MOL DES, V11, P425, DOI 10.1023/A:1007996124545; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Finking R, 2004, ANNU REV MICROBIOL, V58, P453, DOI 10.1146/annurev.micro.58.030603.123615; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Fleetwood DJ, 2007, APPL ENVIRON MICROB, V73, P2571, DOI 10.1128/AEM.00257-07; Franks NP, 1998, BIOPHYS J, V75, P2205, DOI 10.1016/S0006-3495(98)77664-7; Gimenez C, 2007, CURR ORG CHEM, V11, P707, DOI 10.2174/138527207780598765; Gulick AM, 2004, BIOCHEMISTRY-US, V43, P8670, DOI 10.1021/bi049384m; Gulick AM, 2003, BIOCHEMISTRY-US, V42, P2866, DOI 10.1021/bi0271603; Hisanaga Y, 2004, J BIOL CHEM, V279, P31717, DOI 10.1074/jbc.M400100200; Jogl G, 2004, BIOCHEMISTRY-US, V43, P1425, DOI 10.1021/bi035911a; Johnson L, 2008, MYCOL RES, V112, P170, DOI 10.1016/j.mycres.2007.11.012; Kochan G, 2009, J MOL BIOL, V388, P997, DOI 10.1016/j.jmb.2009.03.064; LARSEN IK, 1988, ACTA CRYSTALLOGR B, V44, P527, DOI 10.1107/S0108768188003556; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Luo LS, 2001, J AM CHEM SOC, V123, P11208, DOI 10.1021/ja0166646; MANTLE PG, 1976, J GEN MICROBIOL, V93, P321, DOI 10.1099/00221287-93-2-321; May JJ, 2002, P NATL ACAD SCI USA, V99, P12120, DOI 10.1073/pnas.182156699; McCormack P, 2003, ANAL CHEM, V75, P2647, DOI 10.1021/ac0340105; Meekhof AE, 1998, J MOL BIOL, V282, P181, DOI 10.1006/jmbi.1998.2019; Moreland N, 2005, ACTA CRYSTALLOGR D, V61, P1378, DOI 10.1107/S090744905023590; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nakatsu T, 2006, NATURE, V440, P372, DOI 10.1038/nature04542; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Rausch C, 2005, NUCLEIC ACIDS RES, V33, P5799, DOI 10.1093/nar/gki885; Reger AS, 2008, BIOCHEMISTRY-US, V47, P8016, DOI 10.1021/bi800696y; Reger AS, 2007, BIOCHEMISTRY-US, V46, P6536, DOI 10.1021/bi6026506; Rodriguez R, 2008, J EXP BOT, V59, P1109, DOI 10.1093/jxb/erm342; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; Schwecke T, 2006, CHEMBIOCHEM, V7, P612, DOI 10.1002/cbic.200500301; SCOTTCRAIG JS, 1992, J BIOL CHEM, V267, P26044; Shah MB, 2009, PROTEINS, V77, P685, DOI 10.1002/prot.22482; Sieber SA, 2005, CHEM REV, V105, P715, DOI 10.1021/cr0301191; Stachelhaus T, 1999, CHEM BIOL, V6, P493, DOI 10.1016/S1074-5521(99)80082-9; Stack D, 2007, MICROBIOL-SGM, V153, P1297, DOI 10.1099/mic.0.2006/006908-0; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tanovic A, 2008, SCIENCE, V321, P659, DOI 10.1126/science.1159850; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P1174, DOI 10.1107/S0907444903009922; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Upson RH, 1996, ANAL BIOCHEM, V243, P41, DOI 10.1006/abio.1996.0479; Villiers BRM, 2009, CHEMBIOCHEM, V10, P671, DOI 10.1002/cbic.200800553; von Dohren H, 2009, FUNGAL GENET BIOL, V46, pS45, DOI 10.1016/j.fgb.2008.08.008; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Yonus H, 2008, J BIOL CHEM, V283, P32484, DOI 10.1074/jbc.M800557200	58	43	46	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2415	2427		10.1074/jbc.M109.071324	http://dx.doi.org/10.1074/jbc.M109.071324			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19923209	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000273697800021
J	White, GF; Schermann, SM; Bradley, J; Roberts, A; Greene, NP; Berks, BC; Thomson, AJ				White, Gaye F.; Schermann, Sonya M.; Bradley, Justin; Roberts, Andrew; Greene, Nicholas P.; Berks, Ben C.; Thomson, Andrew J.			Subunit Organization in the TatA Complex of the Twin Arginine Protein Translocase A SITE-DIRECTED EPR SPIN LABELING STUDY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEC-INDEPENDENT PROTEIN; ESCHERICHIA-COLI; TRANSPORT SYSTEM; MEMBRANE-PROTEINS; SIGNAL PEPTIDE; EXPORT PATHWAY; COMPONENT; RESONANCE; DYNAMICS; DISTINCT	The Tat system is used to transport folded proteins across the cytoplasmic membrane in bacteria and archaea and across the thylakoid membrane of plant chloroplasts. Multimers of the integral membrane TatA protein are thought to form the protein-conducting element of the Tat pathway. Nitroxide radicals were introduced at selected positions within the transmembrane helix of Escherichia coli TatA and used to probe the structure of detergent-solubilized TatA complexes by EPR spectroscopy. A comparison of spin label mobilities allowed classification of individual residues as buried within the TatA complex or exposed at the surface and suggested that residues Ile(12) and Val(14) are involved in interactions between helices. Analysis of inter-spin distances suggested that the transmembrane helices of TatA subunits are arranged as a single-walled ring containing a contact interface between Ile(12) on one subunit and Val(14) on an adjacent subunit. Experiments in which labeled and unlabeled TatA samples were mixed demonstrate that TatA subunits are exchanged between TatA complexes. This observation is consistent with the TatA dynamic polymerization model for the mechanism of Tat transport.	[Schermann, Sonya M.; Roberts, Andrew; Greene, Nicholas P.; Berks, Ben C.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [White, Gaye F.; Bradley, Justin; Thomson, Andrew J.] Univ E Anglia, Sch Chem, Norwich NR4 7TJ, Norfolk, England	University of Oxford; University of East Anglia	Berks, BC (corresponding author), Univ Oxford, Dept Biochem, S Parks Rd, Oxford OX1 3QU, England.	ben.berks@bioch.ox.ac.uk; a.thomson@uea.ac.uk		Berks, Ben/0000-0001-9685-4067; Greene, Nicholas/0000-0002-3631-0380	Biotechnology and Biological Sciences Research Council [BBS/B/03637, BB/D012074/1, BB/D004578/1]; Engineering and Physical Sciences Research Council [GR/S57402/01]; National Research Council Canada Fellowship; Wellcome Trust; BBSRC [BB/D004578/1, BB/D012074/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Research Council Canada Fellowship; Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Grants BBS/B/03637, BB/D012074/1, and BB/D004578/1 from the Biotechnology and Biological Sciences Research Council, and Grant GR/S57402/01 from the Engineering and Physical Sciences Research Council, by a National Research Council Canada Fellowship (to S. M. S.), and by an equipment grant from the Wellcome Trust.	Alami M, 2003, MOL CELL, V12, P937, DOI 10.1016/S1097-2765(03)00398-8; BARTON LL, 2005, STRUCTURAL FUNCTIONA, P45; Berks BC, 2005, CURR OPIN MICROBIOL, V8, P174, DOI 10.1016/j.mib.2005.02.010; Berks BC, 2003, ADV MICROB PHYSIOL, V47, P187, DOI 10.1016/S0065-2911(03)47004-5; Berks BC, 1996, MOL MICROBIOL, V22, P393, DOI 10.1046/j.1365-2958.1996.00114.x; BERLINER LJ, 1983, ANN NY ACAD SCI, V414, P153, DOI 10.1111/j.1749-6632.1983.tb31681.x; Bogsch EG, 1998, J BIOL CHEM, V273, P18003, DOI 10.1074/jbc.273.29.18003; Bolhuis A, 2001, J BIOL CHEM, V276, P20213, DOI 10.1074/jbc.M100682200; Borbat PP, 2001, SCIENCE, V291, P266, DOI 10.1126/science.291.5502.266; BORDIGNON E, 2007, MEMBRANE PROTEIN STR, P129; CARL P, 2003, BRUKER BIOSPIN APPL; CHADDOCK AM, 1995, EMBO J, V14, P2715, DOI 10.1002/j.1460-2075.1995.tb07272.x; Cline K, 2001, J CELL BIOL, V154, P719, DOI 10.1083/jcb.200105149; CLINE K, 2007, ENZYMES MOL MACHINES, V25, P455; Columbus L, 2002, TRENDS BIOCHEM SCI, V27, P288, DOI 10.1016/S0968-0004(02)02095-9; Dabney-Smith C, 2006, J BIOL CHEM, V281, P5476, DOI 10.1074/jbc.M512453200; Dabney-Smith C, 2009, MOL BIOL CELL, V20, P2060, DOI 10.1091/mbc.E08-12-1189; FEIX JB, 1998, BIO MAGN RE, V14, P251; Gohlke U, 2005, P NATL ACAD SCI USA, V102, P10482, DOI 10.1073/pnas.0503558102; Gouffi K, 2004, J BIOL CHEM, V279, P11608, DOI 10.1074/jbc.M313187200; Greene NP, 2007, J BIOL CHEM, V282, P23937, DOI 10.1074/jbc.M702972200; HUBBELL WL, 1994, CURR OPIN STRUC BIOL, V4, P566, DOI 10.1016/S0959-440X(94)90219-4; Hubbell WL, 2000, NAT STRUCT BIOL, V7, P735, DOI 10.1038/78956; Hubbell WL, 1998, CURR OPIN STRUC BIOL, V8, P649, DOI 10.1016/S0959-440X(98)80158-9; Hubbell WL, 1996, STRUCTURE, V4, P779, DOI 10.1016/S0969-2126(96)00085-8; HUBBELL WL, 1994, MEMBRANE PROTEIN STR, P00224; Leake MC, 2008, P NATL ACAD SCI USA, V105, P15376, DOI 10.1073/pnas.0806338105; Lee PA, 2006, ANNU REV MICROBIOL, V60, P373, DOI 10.1146/annurev.micro.60.080805.142212; Mchaourab HS, 1996, BIOCHEMISTRY-US, V35, P7692, DOI 10.1021/bi960482k; MILES AJ, 2005, ESSAYS BIOINFORMATIC, V368, P96; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Mori H, 2002, J CELL BIOL, V157, P205, DOI 10.1083/jcb.200202048; MOULD RM, 1991, J BIOL CHEM, V266, P12189; Muller SD, 2007, BBA-BIOMEMBRANES, V1768, P3071, DOI 10.1016/j.bbamem.2007.09.008; Natale P, 2008, BBA-BIOMEMBRANES, V1778, P1735, DOI 10.1016/j.bbamem.2007.07.015; Oates J, 2005, J MOL BIOL, V346, P295, DOI 10.1016/j.jmb.2004.11.047; Perozo E, 2002, NATURE, V418, P942, DOI 10.1038/nature00992; Persson M, 2001, BIOPHYS J, V80, P2886, DOI 10.1016/S0006-3495(01)76254-6; Porcelli I, 2002, BIOCHEMISTRY-US, V41, P13690, DOI 10.1021/bi026142i; Radzwill N, 2001, BIOPHYS J, V80, P2856, DOI 10.1016/S0006-3495(01)76252-2; Ridder ANJA, 2009, J BACTERIOL, V191, P4410, DOI 10.1128/JB.00215-09; Sargent F, 1998, EMBO J, V17, P3640, DOI 10.1093/emboj/17.13.3640; Sargent F, 1999, J BIOL CHEM, V274, P36073, DOI 10.1074/jbc.274.51.36073; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Steinhoff HJ, 1997, BIOPHYS J, V73, P3287, DOI 10.1016/S0006-3495(97)78353-X; Tarry MJ, 2009, P NATL ACAD SCI USA, V106, P13284, DOI 10.1073/pnas.0901566106; Weiner JH, 1998, CELL, V93, P93, DOI 10.1016/S0092-8674(00)81149-6	47	19	20	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2294	2301		10.1074/jbc.M109.065458	http://dx.doi.org/10.1074/jbc.M109.065458			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19920142	Green Published, hybrid			2022-12-25	WOS:000273697800008
J	Lluis, JM; Llacuna, L; von Montfort, C; Barcena, C; Enrich, C; Morales, A; Fernandez-Checa, JC				Lluis, Josep M.; Llacuna, Laura; von Montfort, Claudia; Barcena, Cristina; Enrich, Carlos; Morales, Albert; Fernandez-Checa, Jose C.			GD3 Synthase Overexpression Sensitizes Hepatocarcinoma Cells to Hypoxia and Reduces Tumor Growth by Suppressing the cSrc/NF-kappa B Survival Pathway	PLOS ONE			English	Article							MITOCHONDRIAL PERMEABILITY TRANSITION; T-CELLS; INDUCIBLE FACTORS; GANGLIOSIDE GD3; HEPATOMA-CELLS; HUMAN-LIVER; APOPTOSIS; ACTIVATION; PHOSPHORYLATION; CHEMOTHERAPY	Background: Hypoxia-mediated HIF-1 alpha stabilization and NF-kappa B activation play a key role in carcinogenesis by fostering cancer cell survival, angiogenesis and tumor invasion. Gangliosides are integral components of biological membranes with an increasingly recognized role as signaling intermediates. In particular, ganglioside GD3 has been characterized as a proapoptotic lipid effector by promoting cell death signaling and suppression of survival pathways. Thus, our aim was to analyze the role of GD3 in hypoxia susceptibility of hepatocarcinoma cells and in vivo tumor growth. Methodology/Principal Findings: We generated and characterized a human hepatocarcinoma cell line stably expressing GD3 synthase (Hep3B-GD3), which catalyzes the synthesis of GD3 from GM3. Despite increased GD3 levels (2-3 fold), no significant changes in cell morphology or growth were observed in Hep3B-GD3 cells compared to wild type Hep3B cells under normoxia. However, exposure of Hep3B-GD3 cells to hypoxia (2% O-2) enhanced reactive oxygen species (ROS) generation, resulting in decreased cell survival, with similar findings observed in Hep3B cells exposed to increasing doses of exogenous GD3. In addition, hypoxia-induced c-Src phosphorylation at tyrosine residues, NF-kappa B activation and subsequent expression of Mn-SOD were observed in Hep3B cells but not in Hep3B-GD3 cells. Moreover, MnTBAP, an antioxidant with predominant SOD mimetic activity, reduced ROS generation, protecting Hep3B-GD3 cells from hypoxia-induced death. Finally, lower tumor growth, higher cell death and reduced Mn-SOD expression were observed in Hep3B-GD3 compared to Hep3B tumor xenografts. Conclusion: These findings underscore a role for GD3 in hypoxia susceptibility by disabling the c-Src/NF-kappa B survival pathway resulting in lower Mn-SOD expression, which may be of relevance in hepatocellular carcinoma therapy.	[Lluis, Josep M.; Llacuna, Laura; von Montfort, Claudia; Barcena, Cristina; Morales, Albert; Fernandez-Checa, Jose C.] IIBB CSIC, Dept Cell Death & Proliferat, Barcelona, Spain; [Lluis, Josep M.; Llacuna, Laura; von Montfort, Claudia; Barcena, Cristina; Morales, Albert; Fernandez-Checa, Jose C.] CIBEREHD, IDIBAPS CIBEK, Hosp Clin, Liver Unit, Barcelona, Spain; [Lluis, Josep M.; Enrich, Carlos] Univ Barcelona, Fac Med, Dept Cellular Biol, Barcelona 7, Spain; [Fernandez-Checa, Jose C.] Univ So Calif, Keck Sch Med, Res Ctr Alcohol Liver & Pancreat Dis, Los Angeles, CA 90033 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas de Barcelona (IIBB); University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; University of Southern California	Lluis, JM (corresponding author), IIBB CSIC, Dept Cell Death & Proliferat, Barcelona, Spain.	amorales@clinic.ub.es; checa229@yahoo.com	Fernández-Checa, José Carlos/L-8342-2014; Morales, Albert/E-2988-2013	Fernández-Checa, José Carlos/0000-0003-3422-2990; Morales, Albert/0000-0001-8702-2269; Barcena, Cristina/0000-0002-9640-5568; Enrich, Carlos/0000-0003-0382-2993	CIBEREHD; Instituto de Salud Carlos III [FIS06/0395, FIS07/1039, SAF2006-06789, SAF2008-02199]; Ministry of Science and Innovation from Spain; Research Center for Liver and Pancreatic Diseases; US National Institute on Alcohol Abuse and Alcoholism [P50-AA-11999]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA011999] Funding Source: NIH RePORTER	CIBEREHD; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Ministry of Science and Innovation from Spain(Spanish Government); Research Center for Liver and Pancreatic Diseases; US National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Grant support: CIBEREHD and grants FIS06/0395, FIS07/1039, SAF2006-06789 and SAF2008-02199 by Instituto de Salud Carlos III and Ministry of Science and Innovation from Spain, and from the Research Center for Liver and Pancreatic Diseases, P50-AA-11999 funded by the US National Institute on Alcohol Abuse and Alcoholism. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batinic-Haberle I, 2009, FREE RADICAL BIO MED, V46, P192, DOI 10.1016/j.freeradbiomed.2008.09.042; Bennewith KL, 2002, CANCER RES, V62, P6827; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Birkle S, 1999, J NEUROCHEM, V72, P954, DOI 10.1046/j.1471-4159.1999.0720954.x; Brunelle JK, 2005, CELL METAB, V1, P409, DOI 10.1016/j.cmet.2005.05.002; Colell A, 2004, FEBS LETT, V560, P63, DOI 10.1016/S0014-5793(04)00071-7; Colell Anna, 2001, FASEB Journal, V15, P1068; DeMaria R, 1997, SCIENCE, V277, P1652, DOI 10.1126/science.277.5332.1652; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; Fernandez A, 2009, J NEUROSCI, V29, P6394, DOI 10.1523/JNEUROSCI.4909-08.2009; Garcia-Ruiz C, 2000, FASEB J, V14, P847, DOI 10.1096/fasebj.14.7.847; Garcia-Ruiz C, 2002, J BIOL CHEM, V277, P36443, DOI 10.1074/jbc.M206021200; Garofalo T, 2005, CELL DEATH DIFFER, V12, P1378, DOI 10.1038/sj.cdd.4401672; Guzy RD, 2005, CELL METAB, V1, P401, DOI 10.1016/j.cmet.2005.05.001; Hakomori S, 2001, ADV EXP MED BIOL, V491, P369; Hummel I, 2005, FEBS LETT, V579, P3381, DOI 10.1016/j.febslet.2005.05.003; HYNDS DL, 1995, J NEUROCHEM, V65, P2251; Kasahara K, 1997, J BIOL CHEM, V272, P29947, DOI 10.1074/jbc.272.47.29947; Kniep B, 2006, INT J CANCER, V119, P67, DOI 10.1002/ijc.21788; Lluis JM, 2007, CANCER RES, V67, P7368, DOI 10.1158/0008-5472.CAN-07-0515; Malisan F, 2005, IUBMB LIFE, V57, P477, DOI 10.1080/15216540500167179; Malisan F, 2002, J EXP MED, V196, P1535, DOI 10.1084/jem.20020960; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Melov S, 1998, NAT GENET, V18, P159, DOI 10.1038/ng0298-159; Montero J, 2008, CANCER RES, V68, P5246, DOI 10.1158/0008-5472.CAN-07-6161; Moon SK, 2006, FASEB J, V20, P1387, DOI 10.1096/fj.05-4618com; Morales A, 2007, ONCOGENE, V26, P905, DOI 10.1038/sj.onc.1209834; Morales A, 2004, GLYCOCONJUGATE J, V20, P579; NILSSON O, 1982, J LIPID RES, V23, P327; Paris R, 2002, J BIOL CHEM, V277, P49870, DOI 10.1074/jbc.M208303200; Prinetti A, 2001, J NEUROCHEM, V78, P1162, DOI 10.1046/j.1471-4159.2001.00515.x; Rankin EB, 2008, CELL DEATH DIFFER, V15, P678, DOI 10.1038/cdd.2008.21; Rippo MR, 2000, FASEB J, V14, P2047, DOI 10.1096/fj.99-1028com; RUCKHABERLE E, 2009, J CANC RES CLIN ONCO; Sa G, 2009, CANCER RES, V69, P3095, DOI 10.1158/0008-5472.CAN-08-3776; Saqr HE, 2006, J NEUROCHEM, V96, P1301, DOI 10.1111/j.1471-4159.2005.03640.x; SPITALNIK PF, 1989, ARCH BIOCHEM BIOPHYS, V273, P578, DOI 10.1016/0003-9861(89)90518-3; TANNO M, 1987, JPN J MED, V26, P147, DOI 10.2169/internalmedicine1962.26.147; Tettamanti G, 2003, GLYCOCONJUGATE J, V20, P301, DOI 10.1023/B:GLYC.0000033627.02765.cc; Uzzo RG, 1999, J CLIN INVEST, V104, P769, DOI 10.1172/JCI6775; Wang XQ, 2002, J BIOL CHEM, V277, P40410, DOI 10.1074/jbc.M207117200; Yeo EJ, 2003, J NATL CANCER I, V95, P516, DOI 10.1093/jnci/95.7.516; Zhong H, 1999, CANCER RES, V59, P5830	43	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2009	4	11							e8059	10.1371/journal.pone.0008059	http://dx.doi.org/10.1371/journal.pone.0008059			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MN	19956670	Green Submitted, Green Published, gold			2022-12-25	WOS:000272828100011
J	Trousson, A; Makoukji, J; Petit, PX; Bernard, S; Slomianny, C; Schumacher, M; Massaad, C				Trousson, Amalia; Makoukji, Joelle; Petit, Patrice X.; Bernard, Sophie; Slomianny, Christian; Schumacher, Michael; Massaad, Charbel			Cross-Talk between Oxysterols and Glucocorticoids: Differential Regulation of Secreted Phopholipase A2 and Impact on Oligodendrocyte Death	PLOS ONE			English	Article							LIVER-X-RECEPTOR; SMOOTH-MUSCLE-CELLS; MULTIPLE-SCLEROSIS; PHOSPHOLIPASE A(2); P160 COACTIVATORS; SCHWANN-CELLS; LXR-ALPHA; CHOLESTEROL; 24S-HYDROXYCHOLESTEROL; PROLIFERATION	Background: Oxysterols are oxidized forms of cholesterol. They have been shown to be implicated in cholesterol turnover, inflammation and in neurodegenerative diseases such as Alzheimer's disease and multiple sclerosis. Glial cells are targets of oxysterols: they inhibit astrocyte proliferation after brain injury, and we have previously shown that 25-hydroxycholesterol (25OH) provokes oligodendrocyte apoptosis and stimulates the expression of sPLA2 type IIA (sPLA2-IIA), which has a protective effect. Methodology/Principal Findings: As glucocorticoids are well-known for their anti-inflammatory effects, our aim was to understand their direct effects on oxysterol-induced responses in oligodendrocytes (sPLA2-IIA stimulation and apoptosis). We demonstrate that the synthetic glucocorticoid dexamethasone (Dex) abolishes the stimulation of sPLA2-IIA by 25-hydroxycholesterol (25-OH). This inhibition is mediated by the glucocorticoid receptor (GR), which decreases the expression of the oxysterol receptor Pregnane X Receptor (PXR) and interferes with oxysterol signaling by recruiting a common limiting coactivator PGC1 alpha. Consistent with the finding that sPLA2-IIA can partially protect oligodendrocytes against oxysterol-triggered apoptosis, we demonstrate here that the inhibition of sPLA2-IIA by Dex accelerates the apoptotic phenomenon, leading to a shift towards necrosis. We have shown by atomic force microscopy and electron microscopy that 25-OH and Dex alters oligodendrocyte shape and disorganizes the cytoplasm. Conclusions/Significance: Our results provide a new understanding of the cross-talk between oxysterol and glucocorticoid signaling pathways and their respective roles in apoptosis and oligodendrocyte functions.	[Trousson, Amalia; Schumacher, Michael; Massaad, Charbel] INSERM, UMR788, Le Kremlin Bicetre, France; [Trousson, Amalia; Schumacher, Michael; Massaad, Charbel] Univ Paris 11, IFR 93, Le Kremlin Bicetre, France; [Trousson, Amalia; Makoukji, Joelle; Bernard, Sophie; Massaad, Charbel] CNRS, UPR 2228, Paris, France; [Trousson, Amalia; Makoukji, Joelle; Bernard, Sophie; Massaad, Charbel] Univ Paris 05, IFR95, Paris, France; [Petit, Patrice X.] Inst Cochin, CNRS, UMR8104, Canc Apoptosis & Mitochondria Team, Paris, France; [Slomianny, Christian] INSERM, U800, Villeneuve Dascq, France; [Slomianny, Christian] Univ Lille 1, F-59655 Villeneuve Dascq, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille	Trousson, A (corresponding author), INSERM, UMR788, Le Kremlin Bicetre, France.	charbel.massaad@parisdescartes.fr	Schumacher, Michael/G-3581-2013; Petit, patrice/AAF-6774-2020; Petit, Patrice X./A-3692-2009; Slomianny, Christian/L-8285-2018	Schumacher, Michael/0000-0001-6117-5371; Petit, Patrice X./0000-0002-5038-9101; BERNARD, Sophie/0000-0001-8039-1301	Inserm; CNRS; University Paris-Sud; University Paris Descartes	Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); University Paris-Sud; University Paris Descartes	This article has been prepared with financial support from Inserm, CNRS, University Paris-Sud, and University Paris Descartes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen L Klembt, 2005, Eur Cell Mater, V10, P61; Antonio V, 2003, BIOCHEM J, V376, P351, DOI 10.1042/BJ20030098; Arioka M, 2005, FEBS LETT, V579, P2693, DOI 10.1016/j.febslet.2005.03.092; Bhalla S, 2004, J BIOL CHEM, V279, P45139, DOI 10.1074/jbc.M405423200; Bjorkhem I, 2001, J LIPID RES, V42, P366; BOCHELEN D, 1995, J NEUROCHEM, V65, P2194; Cummins CL, 2006, J CLIN INVEST, V116, P1902, DOI 10.1172/JCI28400; Dietschy JM, 2001, CURR OPIN LIPIDOL, V12, P105, DOI 10.1097/00041433-200104000-00003; Feutz AC, 2001, GLIA, V34, P241, DOI 10.1002/glia.1058; Greger DL, 2007, J ANIM PHYSIOL AN N, V91, P62, DOI 10.1111/j.1439-0396.2006.00642.x; Grenier J, 2006, MOL ENDOCRINOL, V20, P254, DOI 10.1210/me.2005-0061; Grenier J, 2004, MOL ENDOCRINOL, V18, P2866, DOI 10.1210/me.2004-0241; Huuskonen J, 2004, ARTERIOSCL THROM VAS, V24, P703, DOI 10.1161/01.ATV.0000121202.72593.da; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Jaulmes A, 2005, ARTERIOSCL THROM VAS, V25, P1161, DOI 10.1161/01.ATV.0000164310.67356.a9; Leoni V, 2002, NEUROSCI LETT, V331, P163, DOI 10.1016/S0304-3940(02)00887-X; Liu YJ, 2006, ENDOCRINOLOGY, V147, P5061, DOI 10.1210/en.2006-0243; Lutjohann D, 2000, J LIPID RES, V41, P195; Massaad C, 2000, BIOCHEM J, V350, P123, DOI 10.1042/0264-6021:3500123; McNally HA, 2004, J NEUROCYTOL, V33, P251, DOI 10.1023/B:NEUR.0000030700.48612.0b; Mitro N, 2007, FEBS LETT, V581, P1721, DOI 10.1016/j.febslet.2007.03.047; Moses GSD, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-28; Oberkofler H, 2003, BIOCHEM J, V371, P89, DOI 10.1042/BJ20021665; Papassotiropoulos A, 2002, J PSYCHIAT RES, V36, P27, DOI 10.1016/S0022-3956(01)00050-4; Pascual-Le Tallec L, 2003, MOL ENDOCRINOL, V17, P2529, DOI 10.1210/me.2003-0299; Rufini S, 1999, AM J PHYSIOL-CELL PH, V277, pC814, DOI 10.1152/ajpcell.1999.277.4.C814; Russell DW, 2000, BBA-MOL CELL BIOL L, V1529, P126, DOI 10.1016/S1388-1981(00)00142-6; Saegusa J, 2008, J BIOL CHEM, V283, P26107, DOI 10.1074/jbc.M804835200; Schmidt A, 1999, MOL CELL ENDOCRINOL, V155, P51, DOI 10.1016/S0303-7207(99)00115-X; Shenoy SD, 2004, DRUG METAB DISPOS, V32, P66, DOI 10.1124/dmd.32.1.66; Specty O, 2001, FEBS LETT, V490, P88, DOI 10.1016/S0014-5793(00)02414-5; Steffensen KR, 2003, BIOCHEM BIOPH RES CO, V312, P716, DOI 10.1016/j.bbrc.2003.10.174; Stulnig TM, 2002, DIABETES, V51, P2426, DOI 10.2337/diabetes.51.8.2426; Sun GY, 2005, MOL NEUROBIOL, V31, P27, DOI 10.1385/MN:31:1-3:027; Teunissen CE, 2003, NEUROSCI LETT, V347, P159, DOI 10.1016/S0304-3940(03)00667-0; Touqui Lhousseine, 2001, Current Molecular Medicine (Hilversum), V1, P739, DOI 10.2174/1566524013363258; TROUSSON A, 2009, J NEUROCHEM; Yagami T, 2002, MOL PHARMACOL, V61, P114, DOI 10.1124/mol.61.1.114	38	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2009	4	11							e8080	10.1371/journal.pone.0008080	http://dx.doi.org/10.1371/journal.pone.0008080			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MN	19956653	gold, Green Submitted, Green Published			2022-12-25	WOS:000272828100017
J	Xu, Y; Mori, T; Qin, XM; Yan, HP; Egli, M; Johnson, CH				Xu, Yao; Mori, Tetsuya; Qin, Ximing; Yan, Heping; Egli, Martin; Johnson, Carl Hirschie			Intramolecular Regulation of Phosphorylation Status of the Circadian Clock Protein KaiC	PLOS ONE			English	Article							SYNECHOCOCCUS-ELONGATUS; IN-VITRO; CYANOBACTERIA; SYSTEM; RHYTHM; OSCILLATION; EXPRESSION; INSIGHTS; FEEDBACK; BINDING	Background: KaiC, a central clock protein in cyanobacteria, undergoes circadian oscillations between hypophosphorylated and hyperphosphorylated forms in vivo and in vitro. Structural analyses of KaiC crystals have identified threonine and serine residues in KaiC at three residues (T426, S431, and T432) as potential sites at which KaiC is phosphorylated; mutation of any of these three sites to alanine abolishes rhythmicity, revealing an essential clock role for each residue separately and for KaiC phosphorylation in general. Mass spectrometry studies confirmed that the S431 and T432 residues are key phosphorylation sites, however, the role of the threonine residue at position 426 was not clear from the mass spectrometry measurements. Methodology and Principal Findings: Mutational approaches and biochemical analyses of KaiC support a key role for T426 in control of the KaiC phosphorylation status in vivo and in vitro and demonstrates that alternative amino acids at residue 426 dramatically affect KaiC's properties in vivo and in vitro, especially genetic dominance/recessive relationships, KaiC dephosphorylation, and the formation of complexes of KaiC with KaiA and KaiB. These mutations alter key circadian properties, including period, amplitude, robustness, and temperature compensation. Crystallographic analyses indicate that the T426 site is phosphorylatible under some conditions, and in vitro phosphorylation assays of KaiC demonstrate labile phosphorylation of KaiC when the primary S431 and T432 sites are blocked. Conclusions and Significance: T426 is a crucial site that regulates KaiC phosphorylation status in vivo and in vitro and these studies underscore the importance of KaiC phosphorylation status in the essential cyanobacterial circadian functions. The regulatory roles of these phosphorylation sites-including T426-within KaiC enhance our understanding of the molecular mechanism underlying circadian rhythm generation in cyanobacteria.	[Xu, Yao; Mori, Tetsuya; Qin, Ximing; Yan, Heping; Johnson, Carl Hirschie] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA; [Egli, Martin] Vanderbilt Univ, Dept Biochem, Med Ctr, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Johnson, CH (corresponding author), Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA.	carl.h.johnson@vanderbilt.edu	Johnson, Carl H/I-4655-2014; Qin, Ximing/J-6485-2012	Mori, Tetsuya/0000-0001-6036-5261	National Institute of General Medical Sciences [GM067152, GM073845]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073845, R01GM067152] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institute of General Medical Sciences (GM067152 to CHJ and GM073845 to ME). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ditty JL, 2009, BACTERIAL CIRCADIAN; Hitomi K, 2005, J BIOL CHEM, V280, P19127, DOI 10.1074/jbc.M411284200; Ishiura M, 1998, SCIENCE, V281, P1519, DOI 10.1126/science.281.5382.1519; Ito H, 2007, NAT STRUCT MOL BIOL, V14, P1084, DOI 10.1038/nsmb1312; Iwasaki H, 2002, P NATL ACAD SCI USA, V99, P15788, DOI 10.1073/pnas.222467299; Iwasaki H, 1999, EMBO J, V18, P1137, DOI 10.1093/emboj/18.5.1137; Johnson CH, 2008, SCIENCE, V322, P697, DOI 10.1126/science.1150451; Kageyama H, 2003, J BIOL CHEM, V278, P2388, DOI 10.1074/jbc.M208899200; Kageyama H, 2006, MOL CELL, V23, P161, DOI 10.1016/j.molcel.2006.05.039; Kim YI, 2008, P NATL ACAD SCI USA, V105, P12825, DOI 10.1073/pnas.0800526105; Kitayama Y, 2008, GENE DEV, V22, P1513, DOI 10.1101/gad.1661808; LIU Y, 1995, GENE DEV, V9, P1469, DOI 10.1101/gad.9.12.1469; Mori T, 2001, SEMIN CELL DEV BIOL, V12, P271, DOI 10.1006/scdb.2001.0254; Mori T, 2007, PLOS BIOL, V5, P841, DOI 10.1371/journal.pbio.0050093; Nakajima M, 2005, SCIENCE, V308, P414, DOI 10.1126/science.1108451; Nishiwaki T, 2004, P NATL ACAD SCI USA, V101, P13927, DOI 10.1073/pnas.0403906101; Nishiwaki T, 2000, P NATL ACAD SCI USA, V97, P495, DOI 10.1073/pnas.97.1.495; Nishiwaki T, 2007, EMBO J, V26, P4029, DOI 10.1038/sj.emboj.7601832; Pattanayek R, 2004, MOL CELL, V15, P375, DOI 10.1016/j.molcel.2004.07.013; PATTANAYEK R, 2009, PLOS ONE IN PRESS; Rust MJ, 2007, SCIENCE, V318, P809, DOI 10.1126/science.1148596; Smith RM, 2006, P NATL ACAD SCI USA, V103, P8564, DOI 10.1073/pnas.0508696103; Takai N, 2006, P NATL ACAD SCI USA, V103, P12109, DOI 10.1073/pnas.0602955103; Taniguchi Y, 2001, FEBS LETT, V496, P86, DOI 10.1016/S0014-5793(01)02408-5; Tomita J, 2005, SCIENCE, V307, P251, DOI 10.1126/science.1102540; Woelfle MA, 2007, P NATL ACAD SCI USA, V104, P18819, DOI 10.1073/pnas.0706069104; Xu Y, 1999, P NATL ACAD SCI USA, V96, P151, DOI 10.1073/pnas.96.1.151; Xu Y, 2004, P NATL ACAD SCI USA, V101, P13933, DOI 10.1073/pnas.0404768101; Xu Y, 2003, EMBO J, V22, P2117, DOI 10.1093/emboj/cdg168	29	27	27	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2009	4	11							e7509	10.1371/journal.pone.0007509	http://dx.doi.org/10.1371/journal.pone.0007509			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MK	19946629	Green Published, Green Submitted, gold			2022-12-25	WOS:000272827800001
J	You, S; Poulton, L; Cobbold, S; Liu, CP; Rosenzweig, M; Ringler, D; Lee, WH; Segovia, B; Bach, JF; Waldmann, H; Chatenoud, L				You, Sylvaine; Poulton, Lynn; Cobbold, Steve; Liu, Chih-Pin; Rosenzweig, Michael; Ringler, Douglas; Lee, Wen-Hui; Segovia, Berta; Bach, Jean-Francois; Waldmann, Herman; Chatenoud, Lucienne			Key Role of the GITR/GITRLigand Pathway in the Development of Murine Autoimmune Diabetes: A Potential Therapeutic Target	PLOS ONE			English	Article							INDUCED TNF RECEPTOR; REGULATORY T-CELLS; IMMUNOLOGICAL SELF-TOLERANCE; COLLAGEN-INDUCED ARTHRITIS; COSTIMULATORY RECEPTOR; ANTITUMOR IMMUNITY; LIGAND GITRL; CUTTING EDGE; ACTIVATION; INSULIN	Background: The cross-talk between pathogenic T lymphocytes and regulatory T cells (Tregs) plays a major role in the progression of autoimmune diseases. Our objective is to identify molecules and/or pathways involved in this interaction and representing potential targets for innovative therapies. Glucocorticoid-induced tumor necrosis factor receptor (GITR) and its ligand are key players in the T effector/Treg interaction. GITR is expressed at low levels on resting T cells and is significantly up-regulated upon activation. Constitutive high expression of GITR is detected only on Tregs. GITR interacts with its ligand mainly expressed on antigen presenting cells and endothelial cells. It has been suggested that GITR triggering activates effector T lymphocytes while inhibiting Tregs thus contributing to the amplification of immune responses. In this study, we examined the role of GITR/GITRLigand interaction in the progression of autoimmune diabetes. Methods and Findings: Treatment of 10-day-old non-obese diabetic (NOD) mice, which spontaneously develop diabetes, with an agonistic GITR-specific antibody induced a significant acceleration of disease onset (80% at 12 weeks of age). This activity was not due to a decline in the numbers or functional capacity of CD4(+)CD25(+)Foxp3(+) Tregs but rather to a major activation of 'diabetogenic' T cells. This conclusion was supported by results showing that anti-GITR antibody exacerbates diabetes also in CD28(-/-) NOD mice, which lack Tregs. In addition, treatment of NOD mice, infused with the diabetogenic CD4(+)BDC2.5 T cell clone, with GITR-specific antibody substantially increased their migration, proliferation and activation within the pancreatic islets and draining lymph nodes. As a mirror image, blockade of the GITR/GITRLigand pathway using a neutralizing GITRLigand-specific antibody significantly protected from diabetes even at late stages of disease progression. Experiments using the BDC2.5 T cell transfer model suggested that the GITRLigand antibody acted by limiting the homing and proliferation of pathogenic T cells in pancreatic lymph nodes. Conclusion: GITR triggering plays an important costimulatory role on diabetogenic T cells contributing to the development of autoimmune responses. Therefore, blockade of the GITR/GITRLigand pathway appears as a novel promising clinically oriented strategy as GITRLigand-specific antibody applied at an advanced stage of disease progression can prevent overt diabetes.			You, S (corresponding author), Univ Paris 05, Paris, France.	sylvaine.you@inserm.fr	You, Sylvaine/AAF-5600-2021; waldmann, herman/F-7412-2011; waldmann, herman/W-8051-2019; Lee, Wen Hwa/G-1250-2013	You, Sylvaine/0000-0002-1578-5205; Lee, Wen Hwa/0000-0002-4098-5225; Cobbold, Stephen/0000-0003-1206-4880; Waldmann, Herman/0000-0001-7519-6720	Medical Research Council [G7904009] Funding Source: Medline; MRC [G7904009] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Alyanakian MA, 2003, P NATL ACAD SCI USA, V100, P15806, DOI 10.1073/pnas.2636971100; BACH JF, 1994, ENDOCR REV, V15, P516, DOI 10.1210/er.15.4.516; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; BAE EM, 2007, MOL IMMUNOL; Battaglia M, 2006, J IMMUNOL, V177, P8338, DOI 10.4049/jimmunol.177.12.8338; Belghith M, 2003, NAT MED, V9, P1202, DOI 10.1038/nm924; BERGMAN B, 1994, DIABETES, V43, P197, DOI 10.2337/diabetes.43.2.197; Bisikirska B, 2005, J CLIN INVEST, V115, P2904, DOI 10.1172/JCI23961; Bluestone JA, 2003, NAT REV IMMUNOL, V3, P253, DOI 10.1038/nri1032; Bot A, 2001, J IMMUNOL, V167, P2950, DOI 10.4049/jimmunol.167.5.2950; Cobbold SP, 2004, J IMMUNOL, V172, P6003, DOI 10.4049/jimmunol.172.10.6003; Cohen AD, 2006, CANCER RES, V66, P4904, DOI 10.1158/0008-5472.CAN-05-2813; Cuzzocrea S, 2005, FASEB J, V19, P1253, DOI 10.1096/fj.04-3556com; Cuzzocrea S, 2007, FASEB J, V21, P117, DOI 10.1096/fj.06-6611com; Dittmer U, 2004, IMMUNITY, V20, P293, DOI 10.1016/S1074-7613(04)00054-8; Esparza EM, 2005, J IMMUNOL, V174, P7875, DOI 10.4049/jimmunol.174.12.7875; Esparza EM, 2005, J IMMUNOL, V174, P7869, DOI 10.4049/jimmunol.174.12.7869; Grohmann U, 2007, NAT MED, V13, P579, DOI 10.1038/nm1563; Hanabuchi S, 2006, BLOOD, V107, P3617, DOI 10.1182/blood-2005-08-3419; Harjutsalo V, 2008, LANCET, V371, P1777, DOI 10.1016/S0140-6736(08)60765-5; HASKINS K, 1990, SCIENCE, V249, P1433, DOI 10.1126/science.2205920; Herold KC, 2002, NEW ENGL J MED, V346, P1692, DOI 10.1056/NEJMoa012864; Hoglund P, 1999, J EXP MED, V189, P331, DOI 10.1084/jem.189.2.331; Ji HB, 2004, J IMMUNOL, V172, P5823, DOI 10.4049/jimmunol.172.10.5823; Judkowski V, 2001, J IMMUNOL, V166, P908, DOI 10.4049/jimmunol.166.2.908; Kamimura Y, 2009, J IMMUNOL, V182, P2708, DOI 10.4049/jimmunol.0803704; Kanamaru F, 2004, J IMMUNOL, V172, P7306, DOI 10.4049/jimmunol.172.12.7306; KATZ JD, 1993, CELL, V74, P1089, DOI 10.1016/0092-8674(93)90730-E; Keymeulen B, 2005, NEW ENGL J MED, V352, P2598, DOI 10.1056/NEJMoa043980; Kim JD, 2003, GENES IMMUN, V4, P564, DOI 10.1038/sj.gene.6364026; Ko K, 2005, J EXP MED, V202, P885, DOI 10.1084/jem.20050940; Kohm AP, 2004, J IMMUNOL, V172, P4686, DOI 10.4049/jimmunol.172.8.4686; Lenschow DJ, 1996, IMMUNITY, V5, P285, DOI 10.1016/S1074-7613(00)80323-4; Lepault F, 2000, J IMMUNOL, V164, P240, DOI 10.4049/jimmunol.164.1.240; Ludvigsson J, 2008, NEW ENGL J MED, V359, P1909, DOI 10.1056/NEJMoa0804328; MAKINO S, 1980, Experimental Animals (Tokyo), V29, P1; McHugh RS, 2002, IMMUNITY, V16, P311, DOI 10.1016/S1074-7613(02)00280-7; Patel M, 2005, EUR J IMMUNOL, V35, P3581, DOI 10.1002/eji.200535421; Patterson CC, 2009, LANCET, V373, P2027, DOI 10.1016/S0140-6736(09)60568-7; PETERSON JD, 1995, IMMUNOLOGY, V85, P455; Piao J, 2009, IMMUNOLOGY, V127, P489, DOI 10.1111/j.1365-2567.2008.03036.x; Ramirez-Montagut T, 2006, J IMMUNOL, V176, P6434, DOI 10.4049/jimmunol.176.11.6434; Ronchetti S, 2002, BLOOD, V100, P350, DOI 10.1182/blood-2001-12-0276; Ronchetti S, 2004, EUR J IMMUNOL, V34, P613, DOI 10.1002/eji.200324804; Ronchetti S, 2007, J IMMUNOL, V179, P5916, DOI 10.4049/jimmunol.179.9.5916; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Santucci L, 2007, GUT, V56, P52, DOI 10.1136/gut.2006.091181; Shimizu J, 2002, NAT IMMUNOL, V3, P135, DOI 10.1038/ni759; Shin HH, 2002, FEBS LETT, V514, P275, DOI 10.1016/S0014-5793(02)02379-7; Skyler JS, 2002, NEW ENGL J MED, V346, P1685; Stephens GL, 2004, J IMMUNOL, V173, P5008, DOI 10.4049/jimmunol.173.8.5008; Tian JD, 1996, J EXP MED, V183, P1561, DOI 10.1084/jem.183.4.1561; Tisch R, 1999, J IMMUNOL, V163, P1178; Tone M, 2003, P NATL ACAD SCI USA, V100, P15059, DOI 10.1073/pnas.2334901100; Tuyaerts S, 2007, J LEUKOCYTE BIOL, V82, P93, DOI 10.1189/jlb.0906568; You S, 2005, DIABETES, V54, P1415, DOI 10.2337/diabetes.54.5.1415; You S, 2003, J IMMUNOL, V170, P4011, DOI 10.4049/jimmunol.170.8.4011	59	35	38	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2009	4	11							e7848	10.1371/journal.pone.0007848	http://dx.doi.org/10.1371/journal.pone.0007848			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522NL	19936238	gold, Green Submitted, Green Published			2022-12-25	WOS:000272004800002
J	Morimoto, H; Kanatsu-Shinohara, M; Takashima, S; Chuma, S; Nakatsuji, N; Takehashi, M; Shinohara, T				Morimoto, Hiroko; Kanatsu-Shinohara, Mito; Takashima, Seiji; Chuma, Shinichiro; Nakatsuji, Norio; Takehashi, Masanori; Shinohara, Takashi			Phenotypic Plasticity of Mouse Spermatogonial Stem Cells	PLOS ONE			English	Article							LONG-TERM CULTURE; C-KIT; SELF-RENEWAL; TYROSINE KINASE; IN-VITRO; PROLIFERATION; SPERMATOGENESIS; DIFFERENTIATION; TRANSPLANTATION; TESTIS	Background: Spermatogonial stem cells (SSCs) continuously undergo self-renewal division to support spermatogenesis. SSCs are thought to have a fixed phenotype, and development of a germ cell transplantation technique facilitated their characterization and prospective isolation in a deterministic manner; however, our in vitro SSC culture experiments indicated heterogeneity of cultured cells and suggested that they might not follow deterministic fate commitment in vitro. Methodology and Principal Findings: In this study, we report phenotypic plasticity of SSCs. Although c-kit tyrosine kinase receptor (Kit) is not expressed in SSCs in vivo, it was upregulated when SSCs were cultured on laminin in vitro. Both Kit(-) and Kit(+) cells in culture showed comparable levels of SSC activity after germ cell transplantation. Unlike differentiating spermatogonia that depend on Kit for survival and proliferation, Kit expressed on SSCs did not play any role in SSC self-renewal. Moreover, Kit expression on SSCs changed dynamically once proliferation began after germ cell transplantation in vivo. Conclusions/Significance: These results indicate that SSCs can change their phenotype according to their microenvironment and stochastically express Kit. Our results also suggest that activated and non-activated SSCs show distinct phenotypes.			Morimoto, H (corresponding author), Kyoto Univ, Grad Sch Med, Dept Mol Genet, Kyoto, Japan.	tshinoha@virus.kyoto-u.ac.jp	Takashima, Seiji/I-4993-2019	Takashima, Seiji/0000-0002-9176-3139				Barroca V, 2009, NAT CELL BIOL, V11, P190, DOI 10.1038/ncb1826; BRANNAN CI, 1991, P NATL ACAD SCI USA, V88, P4671, DOI 10.1073/pnas.88.11.4671; Brawley C, 2004, SCIENCE, V304, P1331, DOI 10.1126/science.1097676; Braydich-Stolle L, 2007, DEV BIOL, V304, P34, DOI 10.1016/j.ydbio.2006.12.013; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11298, DOI 10.1073/pnas.91.24.11298; CHIBA S, 1991, BLOOD, V78, P2261; Chuma S, 2001, DEV BIOL, V229, P468, DOI 10.1006/dbio.2000.9989; CLERMONT Y, 1968, AM J ANAT, V122, P237, DOI 10.1002/aja.1001220205; De Rooij DG, 2000, J ANDROL, V21, P776; DYM M, 1970, AM J ANAT, V128, P265, DOI 10.1002/aja.1001280302; Hamra FK, 2005, P NATL ACAD SCI USA, V102, P17430, DOI 10.1073/pnas.0508780102; He ZP, 2007, BIOL REPROD, V77, P723, DOI 10.1095/biolreprod.107.062513; Kanatsu-Shinohara M, 2005, DEVELOPMENT, V132, P4155, DOI 10.1242/dev.02004; Kanatsu-Shinohara M, 2003, BIOL REPROD, V68, P167, DOI 10.1095/biolreprod.102.008516; Kanatsu-Shinohara M, 2005, BIOL REPROD, V72, P236, DOI 10.1095/biolreprod.104.035659; Kanatsu-Shinohara M, 2003, BIOL REPROD, V69, P612, DOI 10.1095/biolreprod.103.017012; Kanatsu-Shinohara M, 2005, BIOL REPROD, V72, P985, DOI 10.1095/biolreprod.104.036400; Kanatsu-Shinohara M, 2003, BIOL REPROD, V68, P1801, DOI 10.1095/biolreprod.102.012575; Kanatsu-Shinohara M, 2008, CELL STEM CELL, V3, P533, DOI 10.1016/j.stem.2008.08.002; Kanatsu-Shinohara M, 2008, BIOL REPROD, V78, P611, DOI 10.1095/biolreprod.107.065615; Kanatsu-Shinohara M, 2006, P NATL ACAD SCI USA, V103, P8018, DOI 10.1073/pnas.0601139103; KITAYAMA H, 1995, BLOOD, V85, P790, DOI 10.1182/blood.V85.3.790.bloodjournal853790; Lee J, 2007, DEVELOPMENT, V134, P1853, DOI 10.1242/dev.003004; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Meistrich ML, 1993, CELL MOL BIOL TESTIS, P266; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Nagano M, 1999, BIOL REPROD, V60, P1429, DOI 10.1095/biolreprod60.6.1429; Nakagawa T, 2007, DEV CELL, V12, P195, DOI 10.1016/j.devcel.2007.01.002; Oatley JA, 2008, ANNU REV CELL DEV BI, V24, P263, DOI 10.1146/annurev.cellbio.24.110707.175355; Ohta H, 2000, DEVELOPMENT, V127, P2125; Schrans-Stassen BHGJ, 1999, ENDOCRINOLOGY, V140, P5894, DOI 10.1210/en.140.12.5894; Shinohara T, 2000, DEV BIOL, V220, P401, DOI 10.1006/dbio.2000.9655; Shinohara T, 2000, P NATL ACAD SCI USA, V97, P8346, DOI 10.1073/pnas.97.15.8346; Tadokoro Y, 2002, MECH DEVELOP, V113, P29, DOI 10.1016/S0925-4773(02)00004-7; YOSHINAGA K, 1991, DEVELOPMENT, V113, P689	35	69	73	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2009	4	11							e7909	10.1371/journal.pone.0007909	http://dx.doi.org/10.1371/journal.pone.0007909			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522NJ	19936070	Green Published, Green Submitted, gold			2022-12-25	WOS:000272004600013
J	Li, MH; Valimaki, K; Piha, M; Pakkala, T; Merila, J				Li, Meng-Hua; Valimaki, Kaisa; Piha, Markus; Pakkala, Timo; Merila, Juha			Extrapair Paternity and Maternity in the Three-Toed Woodpecker, Picoides tridactylus: Insights from Microsatellite-Based Parentage Analysis	PLOS ONE			English	Article							PAIR PATERNITY; MATING SYSTEM; FOREST; BIRDS; PARASITISM; INFERENCE; SUCCESS; QUALITY	Molecular techniques have revealed that avian mating systems are more diverse and complex than previously thought. We used microsatellite markers to determine genetic parentage, the prevalence of extrapair paternity and quasi-parasitism (i.e. situations where a male's extrapair mate lay in his nest) in a socially monogamous population of three-toed woodpeckers (Picoides tridactylus) in southern Finland. A total of 129 adults and nestlings, representing 5-9 families annually from 20042007, were genotyped at up to ten microsatellite loci. The results of genetic assignment tests confirmed that monogamous parentage characterized the majority (84.6%, 22/26) of broods, and that most (93.8%, 75/80) nestlings were the offspring of their social parents. Two of 80 nestlings (2.5%) in two of 26 broods (7.7%) were sired by extrapair males and quasi-parasitism occurred in 3.8% (3/80) of nestlings and 7.7% (2/26) of broods. Hence, the levels of extrapair parentage were low, possibly because both genetic polygyny and polyandry are constrained by the high paternal effort required for parental care. The co-occurrence of low levels of extrapair paternity and quasi-parasitism are discussed in light of ecological and behavioural factors characterizing the species biology.			Li, MH (corresponding author), Univ Helsinki, Dept Biol & Environm Sci, Ecol Genet Res Unit, Helsinki, Finland.	menghua.li@helsinki.fi	Merila, Juha/A-4061-2008	Merila, Juha/0000-0001-9614-0072; Piha, Markus/0000-0002-8482-6162				Alves MAS, 1998, ANIM BEHAV, V56, P1323, DOI 10.1006/anbe.1998.0910; Bennett P. M., 2002, OX ECOL EV; Blomqvist D, 2002, NATURE, V419, P613, DOI 10.1038/nature01104; Fridolfsson AK, 1999, J AVIAN BIOL, V30, P116, DOI 10.2307/3677252; Griffith SC, 2002, MOL ECOL, V11, P2195, DOI 10.1046/j.1365-294X.2002.01613.x; Griffith SC, 2004, BEHAV ECOL SOCIOBIOL, V56, P191, DOI 10.1007/s00265-004-0766-9; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Hill CE, 2005, J FIELD ORNITHOL, V76, P119, DOI 10.1648/0273-8570-76.2.119; Hoyt JS, 2002, CAN J FOREST RES, V32, P1881, DOI [10.1139/x02-109, 10.1139/X02-109]; Hughes JM, 2003, MOL ECOL, V12, P3441, DOI 10.1046/j.1365-294X.2003.01997.x; Jones AG, 2003, MOL ECOL, V12, P2511, DOI 10.1046/j.1365-294X.2003.01928.x; KEMPENAERS B, 1992, NATURE, V357, P494, DOI 10.1038/357494a0; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; McRae SB, 1999, BEHAV ECOL SOCIOBIOL, V47, P104, DOI 10.1007/s002650050655; Nei M., 1987, MOL EVOLUTIONARY GEN; Owens IPF, 1998, P ROY SOC B-BIOL SCI, V265, P397, DOI 10.1098/rspb.1998.0308; Pakkala T, 2002, SILVA FENN, V36, P279, DOI 10.14214/sf.563; Pakkala T, 2006, ANN ZOOL FENN, V43, P137; Pechacek P, 2005, BEHAVIOUR, V142, P1093, DOI 10.1163/156853905774405281; Pechacek P, 2004, J WILDLIFE MANAGE, V68, P683, DOI 10.2193/0022-541X(2004)068[0683:CDOAAY]2.0.CO;2; Pechacek P, 2006, ANN ZOOL FENN, V43, P165; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Richardson DS, 2001, MOL ECOL, V10, P2263, DOI 10.1046/j.0962-1083.2001.01355.x; Ruge K., 1971, Ornithologische Beobachter, V68, P256; SABRINA ST, 2008, J AVIAN BIOL, V39, P579; Slate J, 2000, MOL ECOL, V9, P801, DOI 10.1046/j.1365-294x.2000.00930.x; Valimaki K, 2008, MOL ECOL RESOUR, V8, P1152, DOI 10.1111/j.1755-0998.2008.02209.x; WEATHERHEAD PJ, 1995, BEHAV ECOL SOCIOBIOL, V37, P81, DOI 10.1007/s0026550370081; Webster MS, 2001, BEHAV ECOL, V12, P439, DOI 10.1093/beheco/12.4.439; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Westneat DF, 2003, ANNU REV ECOL EVOL S, V34, P365, DOI 10.1146/annurev.ecolsys.34.011802.132439; Westneat DF, 1997, BEHAV ECOL SOCIOBIOL, V41, P205, DOI 10.1007/s002650050381; Wiktander U, 2000, J AVIAN BIOL, V31, P447, DOI 10.1034/j.1600-048X.2000.310003.x; WINKLER H., 2002, HDB BIRDS WORLD, VVII, P296	34	14	14	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2009	4	11							e7895	10.1371/journal.pone.0007895	http://dx.doi.org/10.1371/journal.pone.0007895			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521QH	19924300	Green Published, Green Submitted, gold			2022-12-25	WOS:000271936700025
J	Ote, I; Lebrun, M; Vandevenne, P; Bontems, S; Medina-Palazon, C; Manet, E; Piette, J; Sadzot-Delvaux, C				Ote, Isabelle; Lebrun, Marielle; Vandevenne, Patricia; Bontems, Sebastien; Medina-Palazon, Cahora; Manet, Evelyne; Piette, Jacques; Sadzot-Delvaux, Catherine			Varicella-Zoster Virus IE4 Protein Interacts with SR Proteins and Exports mRNAs through the TAP/NXF1 Pathway	PLOS ONE			English	Article							IMMEDIATE-EARLY PROTEIN; NUCLEAR EXPORT; SPLICING FACTORS; NUCLEOCYTOPLASMIC EXPORT; TRANSACTIVATOR PROTEIN; VIRAL REPLICATION; UNSPLICED RNA; TREX COMPLEX; ICP27; BINDING	Available data suggest that the Varicella-Zoster virus (VZV) IE4 protein acts as an important regulator on VZV and cellular genes expression and could exert its functions at post-transcriptional level. However, the molecular mechanisms supported by this protein are not yet fully characterized. In the present study, we have attempted to clarify this IE4-mediated gene regulation and identify some cellular partners of IE4. By yeast two-hybrid and immunoprecipitation analysis, we showed that IE4 interacts with three shuttling SR proteins, namely ASF/SF2, 9G8 and SRp20. We positioned the binding domain in the IE4 RbRc region and we showed that these interactions are not bridged by RNA. We demonstrated also that IE4 strongly interacts with the main SR protein kinase, SRPK1, and is phosphorylated in in vitro kinase assay on residue Ser-136 contained in the Rb domain. By Northwestern analysis, we showed that IE4 is able to bind RNA through its arginine-rich region and in immunoprecipitation experiments the presence of RNA stabilizes complexes containing IE4 and the cellular export factors TAP/NXF1 and Aly/REF since the interactions are RNase-sensitive. Finally, we determined that IE4 influences the export of reporter mRNAs and clearly showed, by TAP/NXF1 knockdown, that VZV infection requires the TAP/NXF1 export pathway to express some viral transcripts. We thus highlighted a new example of viral mRNA export factor and proposed a model of IE4-mediated viral mRNAs export.			Ote, I (corresponding author), Univ Liege, GIGA R, Lab Virol & Immunol, Liege, Belgium.	csadzot@ulg.ac.be	MANET, Evelyne/G-5644-2019; Lebrun, Marielle/GVT-8895-2022	MANET, Evelyne/0000-0001-7619-9982; 				Bachi A, 2000, RNA, V6, P136, DOI 10.1017/S1355838200991994; Batisse J, 2005, J VIROL, V79, P14102, DOI 10.1128/JVI.79.22.14102-14111.2005; Baudoux L, 2000, J BIOL CHEM, V275, P32822, DOI 10.1074/jbc.M001444200; Bell I, 2007, J VIROL, V81, P5437, DOI 10.1128/JVI.02609-06; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Boyne JR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000194; Chen IHB, 2005, J VIROL, V79, P3949, DOI 10.1128/JVI.79.7.3949-3961.2005; Cheng H, 2006, CELL, V127, P1389, DOI 10.1016/j.cell.2006.10.044; Cohen JI, 2005, J VIROL, V79, P6969, DOI 10.1128/JVI.79.11.6969-6975.2005; Cohrs RJ, 2002, J VIROL, V76, P7228, DOI 10.1128/JVI.76.14.7228-7238.2002; DEBRUS S, 1995, J VIROL, V69, P3240, DOI 10.1128/JVI.69.5.3240-3245.1995; Defechereux P, 1997, J VIROL, V71, P7073, DOI 10.1128/JVI.71.9.7073-7079.1997; DEFECHEREUX P, 1993, J VIROL, V67, P4379, DOI 10.1128/JVI.67.7.4379-4385.1993; Fukuhara T, 2006, P NATL ACAD SCI USA, V103, P11329, DOI 10.1073/pnas.0604616103; Gatfield D, 2002, J CELL BIOL, V159, P579, DOI 10.1083/jcb.200207128; Guang SH, 2005, MOL CELL BIOL, V25, P6303, DOI 10.1128/MCB.25.15.6303-6313.2005; GUI JF, 1994, P NATL ACAD SCI USA, V91, P10824, DOI 10.1073/pnas.91.23.10824; Hargous Y, 2006, EMBO J, V25, P5126, DOI 10.1038/sj.emboj.7601385; Hiriart E, 2003, J BIOL CHEM, V278, P37790, DOI 10.1074/jbc.M305925200; Hiriart E, 2003, J BIOL CHEM, V278, P335, DOI 10.1074/jbc.M208656200; HOPE TJ, 1991, J VIROL, V65, P6001, DOI 10.1128/JVI.65.11.6001-6007.1991; Huang YQ, 2004, P NATL ACAD SCI USA, V101, P9666, DOI 10.1073/pnas.0403533101; Huang YQ, 2003, MOL CELL, V11, P837, DOI 10.1016/S1097-2765(03)00089-3; Huang YQ, 2001, MOL CELL, V7, P899, DOI 10.1016/S1097-2765(01)00233-7; Jacquenet S, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-33; Johnson LA, 2009, J VIROL, V83, P6335, DOI 10.1128/JVI.00375-09; Kennedy PGE, 2001, VIROLOGY, V289, P218, DOI 10.1006/viro.2001.1173; Lai MC, 2004, J BIOL CHEM, V279, P31745, DOI 10.1074/jbc.C400173200; Le Hir H, 2001, EMBO J, V20, P4987, DOI 10.1093/emboj/20.17.4987; Lindberg A, 2002, VIROLOGY, V294, P189, DOI 10.1006/viro.2001.1301; Lischka P, 2006, MOL CELL BIOL, V26, P1631, DOI 10.1128/MCB.26.5.1631-1643.2006; Longman D, 2003, RNA, V9, P881, DOI 10.1261/rna.5420503; Luo MJ, 2001, NATURE, V413, P644, DOI 10.1038/35098106; Masuda S, 2005, GENE DEV, V19, P1512, DOI 10.1101/gad.1302205; Mears WE, 1996, J VIROL, V70, P7445, DOI 10.1128/JVI.70.11.7445-7453.1996; MORIUCHI M, 1995, VIROLOGY, V208, P376, DOI 10.1006/viro.1995.1164; Nolen B, 2001, NAT STRUCT BIOL, V8, P176, DOI 10.1038/84178; PERERA LP, 1994, J VIROL, V68, P2468, DOI 10.1128/JVI.68.4.2468-2477.1994; Rodrigues JP, 2001, P NATL ACAD SCI USA, V98, P1030, DOI 10.1073/pnas.98.3.1030; RODRIGUEZ PL, 1994, BIOTECHNIQUES, V17, P702; Sandri-Goldin RM, 1998, GENE DEV, V12, P868, DOI 10.1101/gad.12.6.868; Sato B, 2003, J VIROL, V77, P12369, DOI 10.1128/JVI.77.22.12369-12372.2003; Sciabica KS, 2003, EMBO J, V22, P1608, DOI 10.1093/emboj/cdg166; Souki SK, 2009, J VIROL, V83, P8970, DOI 10.1128/JVI.00801-09; Strasser K, 2002, NATURE, V417, P304, DOI 10.1038/nature746; Stutz F, 2000, RNA, V6, P638, DOI 10.1017/S1355838200000078; Toth Z, 2006, NUCLEIC ACIDS RES, V34, P1237, DOI 10.1093/nar/gkl007; Toth Z, 2008, FRONT BIOSCI-LANDMRK, V13, P2939, DOI 10.2741/2899; Zhang Z, 2007, J VIROL, V81, P9024, DOI 10.1128/JVI.02666-06	49	26	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2009	4	11							e7882	10.1371/journal.pone.0007882	http://dx.doi.org/10.1371/journal.pone.0007882			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521QH	19924249	gold, Green Published, Green Submitted			2022-12-25	WOS:000271936700015
J	Ploemen, IHJ; Prudencio, M; Douradinha, BG; Ramesar, J; Fonager, J; van Gemert, GJ; Luty, AJF; Hermsen, CC; Sauerwein, RW; Baptista, FG; Mota, MM; Waters, AP; Que, I; Lowik, CWGM; Khan, SM; Janse, CJ; Franke-Fayard, BMD				Ploemen, Ivo H. J.; Prudencio, Miguel; Douradinha, Bruno G.; Ramesar, Jai; Fonager, Jannik; van Gemert, Geert-Jan; Luty, Adrian J. F.; Hermsen, Cornelus C.; Sauerwein, Robert W.; Baptista, Fernanda G.; Mota, Maria M.; Waters, Andrew P.; Que, Ivo; Lowik, Clemens W. G. M.; Khan, Shahid M.; Janse, Chris J.; Franke-Fayard, Blandine M. D.			Visualisation and Quantitative Analysis of the Rodent Malaria Liver Stage by Real Time Imaging	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; HIGH-EFFICIENCY TRANSFECTION; IN-VIVO; EXOERYTHROCYTIC STAGES; DRUG DISCOVERY; BLOOD STAGES; PARASITES; BERGHEI; INFECTION; MICE	The quantitative analysis of Plasmodium development in the liver in laboratory animals in cultured cells is hampered by low parasite infection rates and the complicated methods required to monitor intracellular development. As a consequence, this important phase of the parasite's life cycle has been poorly studied compared to blood stages, for example in screening antimalarial drugs. Here we report the use of a transgenic P. berghei parasite, PbGFP-Luc(CON), expressing the bioluminescent reporter protein luciferase to visualize and quantify parasite development in liver cells both in culture and in live mice using real-time luminescence imaging. The reporter-parasite based quantification in cultured hepatocytes by real-time imaging or using a microplate reader correlates very well with established quantitative RT-PCR methods. For the first time the liver stage of Plasmodium is visualized in whole bodies of live mice and we were able to discriminate as few as 1-5 infected hepatocytes per liver in mice using 2D-imaging and to identify individual infected hepatocytes by 3D-imaging. The analysis of liver infections by whole body imaging shows a good correlation with quantitative RT-PCR analysis of extracted livers. The luminescence-based analysis of the effects of various drugs on in vitro hepatocyte infection shows that this method can effectively be used for in vitro screening of compounds targeting Plasmodium liver stages. Furthermore, by analysing the effect of primaquine and tafenoquine in vivo we demonstrate the applicability of real time imaging to assess parasite drug sensitivity in the liver. The simplicity and speed of quantitative analysis of liver-stage development by real-time imaging compared to the PCR methodologies, as well as the possibility to analyse liver development in live mice without surgery, opens up new possibilities for research on Plasmodium liver infections and for validating the effect of drugs and vaccines on the liver stage of Plasmodium.			Ploemen, IHJ (corresponding author), RUNMC, Dept Med Microbiol, Nijmegen, Netherlands.	bfranke@lumc.nl	Mota, Maria/AAF-2048-2019; Douradinha, Bruno/H-6945-2012; Prudêncio, Miguel/D-2032-2012; Prudêncio, Miguel/ABD-9282-2021; Luty, Adrian/CAH-2547-2022; Douradinha, Bruno/R-5832-2017; Hermsen, C.C./L-4368-2015; Fonager, Jannik/AAJ-8292-2020; Sauerwein, Robert/C-8519-2013; Waters, Andy P/C-9377-2009	Prudêncio, Miguel/0000-0003-1746-6029; Prudêncio, Miguel/0000-0003-1746-6029; Waters, Andy P/0000-0001-8900-2982; Luty, Adrian John Frederick/0000-0001-8830-3425; Fonager, Jannik/0000-0003-1688-1482; Mota, Maria Manuel/0000-0002-2858-1041; Douradinha, Bruno/0000-0002-9980-4505; Khan, Shahid/0000-0002-0533-4670; , Blandine/0000-0001-6041-4182; Janse, Chris J/0000-0002-6410-6205	Wellcome Trust [083811] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Adak T, 2001, CLIN DIAGN LAB IMMUN, V8, P891, DOI 10.1128/CDLI.8.5.891-894.2001; Amino R, 2005, CURR OPIN MICROBIOL, V8, P407, DOI 10.1016/j.mib.2005.06.019; Baer K, 2007, PLOS PATHOG, V3, P1651, DOI 10.1371/journal.ppat.0030171; Baird J Kevin, 2007, Curr Infect Dis Rep, V9, P39, DOI 10.1007/s11908-007-0021-4; Baniecki ML, 2007, ANTIMICROB AGENTS CH, V51, P716, DOI 10.1128/AAC.01144-06; BATES MD, 1990, AM J TROP MED HYG, V42, P532, DOI 10.4269/ajtmh.1990.42.532; Bruna-Romero O, 2001, INT J PARASITOL, V31, P1499, DOI 10.1016/S0020-7519(01)00265-X; Carraz M, 2008, BIOORGAN MED CHEM, V16, P6186, DOI 10.1016/j.bmc.2008.04.033; Craft JC, 2008, CURR OPIN MICROBIOL, V11, P428, DOI 10.1016/j.mib.2008.09.003; Cui Liwang, 2009, V470, P263, DOI 10.1007/978-1-59745-204-5_18; Cunha-Rodrigues Margarida, 2006, BMC Microbiol, V6, P73, DOI 10.1186/1471-2180-6-73; Cunha-Rodrigues M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002732; Evers A, 2008, BIOL CHEM, V389, P1523, DOI 10.1515/BC.2008.167; Fidock DA, 2004, NAT REV DRUG DISCOV, V3, P509, DOI 10.1038/nrd1416; FISK TL, 1989, AM J TROP MED HYG, V40, P235, DOI 10.4269/ajtmh.1989.40.235; Francois G, 1997, INT J PARASITOL, V27, P29, DOI 10.1016/S0020-7519(96)00171-3; Franke-Fayard B, 2008, INT J PARASITOL, V38, P1651, DOI 10.1016/j.ijpara.2008.05.012; Franke-Fayard B, 2005, P NATL ACAD SCI USA, V102, P11468, DOI 10.1073/pnas.0503386102; Franke-Fayard B, 2004, MOL BIOCHEM PARASIT, V137, P23, DOI 10.1016/j.molbiopara.2004.04.007; Franke-Fayard B, 2006, NAT PROTOC, V1, P476, DOI 10.1038/nprot.2006.69; Gego A, 2006, ANTIMICROB AGENTS CH, V50, P1586, DOI 10.1128/AAC.50.4.1586-1589.2006; Greenwood BM, 2008, J CLIN INVEST, V118, P1266, DOI 10.1172/JCI33996; Henriquez NV, 2007, CLIN EXP METASTAS, V24, P699, DOI 10.1007/s10585-007-9115-5; Heussler V, 2006, TRENDS PARASITOL, V22, P192, DOI 10.1016/j.pt.2006.03.001; Hobbs CV, 2009, J INFECT DIS, V199, P134, DOI 10.1086/594369; Imwong M, 2007, J INFECT DIS, V195, P927, DOI 10.1086/512241; Janse CJ, 2006, NAT PROTOC, V1, P346, DOI 10.1038/nprot.2006.53; Janse CJ, 2006, MOL BIOCHEM PARASIT, V145, P60, DOI 10.1016/j.molbiopara.2005.09.007; KOK P, 2007, P SOC PHOTO-OPT INS, V6509, P1; Kumar KA, 2004, J IMMUNOL METHODS, V292, P157, DOI 10.1016/j.jim.2004.06.017; Kuo C, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2717898; Lalloo DG, 2007, J INFECTION, V54, P111, DOI 10.1016/j.jinf.2006.12.003; Lanteri Charlotte A, 2007, Recent Pat Antiinfect Drug Discov, V2, P95, DOI 10.2174/157489107780832640; Lasonder E, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000195; LI J, 1991, EXP PARASITOL, V72, P450, DOI 10.1016/0014-4894(91)90091-A; Matuschewski K, 2007, CELL MOL LIFE SCI, V64, P3007, DOI 10.1007/s00018-007-7263-z; Menard R, 2007, B ACAD NAT MED PARIS, V191, P1261, DOI 10.1016/S0001-4079(19)32945-0; Mikolajczak SA, 2006, MOL MICROBIOL, V62, P1499, DOI 10.1111/j.1365-2958.2006.05470.x; MOST H, 1975, AM J TROP MED HYG, V24, P179, DOI 10.4269/ajtmh.1975.24.179; Mota MM, 2002, BIOESSAYS, V24, P149, DOI 10.1002/bies.10050; Parvanova I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005078; PETERS W, 1993, ANN TROP MED PARASIT, V87, P547, DOI 10.1080/00034983.1993.11812809; Price RN, 2007, AM J TROP MED HYG, V77, P79, DOI 10.4269/ajtmh.2007.77.79; Prudencio M, 2008, CELL MICROBIOL, V10, P218, DOI 10.1111/j.1462-5822.2007.01032.x; Prudencio M, 2006, NAT REV MICROBIOL, V4, P849, DOI 10.1038/nrmicro1529; Rettig GR, 2006, ANAL BIOCHEM, V355, P90, DOI 10.1016/j.ab.2006.04.026; Sadikot Ruxana T, 2005, Proc Am Thorac Soc, V2, P537, DOI 10.1513/pats.200507-067DS; SCHOFIELD L, 1987, J IMMUNOL, V139, P2020; Shanks GD, 2001, CLIN INFECT DIS, V33, P1968, DOI 10.1086/324081; Sharrock WW, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-94; Siau A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000121; Silvie O, 2006, CELL MICROBIOL, V8, P1134, DOI 10.1111/j.1462-5822.2006.00697.x; Sturm A, 2009, PROTIST, V160, P51, DOI 10.1016/j.protis.2008.08.002; Sturm A, 2006, SCIENCE, V313, P1287, DOI 10.1126/science.1129720; Tarun AS, 2006, INT J PARASITOL, V36, P1283, DOI 10.1016/j.ijpara.2006.06.009; Thiberge S, 2007, NAT PROTOC, V2, P1811, DOI 10.1038/nprot.2007.257; Vinkenoog R, 1998, MOL BIOCHEM PARASIT, V94, P1, DOI 10.1016/S0166-6851(98)00035-8; Walsh DS, 2004, J INFECT DIS, V190, P1456, DOI 10.1086/424468; Waters AP, 2005, SCIENCE, V307, P528, DOI 10.1126/science.1108598; Weisman JL, 2006, CHEM BIOL DRUG DES, V67, P409, DOI 10.1111/j.1747-0285.2006.00391.x; Welsh DK, 2005, CURR OPIN BIOTECH, V16, P73, DOI 10.1016/j.copbio.2004.12.006	61	180	182	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2009	4	11							e7881	10.1371/journal.pone.0007881	http://dx.doi.org/10.1371/journal.pone.0007881			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521QH	19924309	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000271936700014
J	Binder, H; Fasold, M; Glomb, T				Binder, Hans; Fasold, Mario; Glomb, Torsten			Mismatch and G-Stack Modulated Probe Signals on SNP Microarrays	PLOS ONE			English	Article							LIGHT-DIRECTED SYNTHESIS; HIGH-DENSITY; OLIGONUCLEOTIDE PROBES; GENECHIP-MICROARRAYS; DNA MICROARRAYS; NONSPECIFIC HYBRIDIZATION; HOOK-CALIBRATION; THERMODYNAMICS; STABILITY; DUPLEXES	Background: Single nucleotide polymorphism (SNP) arrays are important tools widely used for genotyping and copy number estimation. This technology utilizes the specific affinity of fragmented DNA for binding to surface-attached oligonucleotide DNA probes. We analyze the variability of the probe signals of Affymetrix GeneChip SNP arrays as a function of the probe sequence to identify relevant sequence motifs which potentially cause systematic biases of genotyping and copy number estimates. Methodology/Principal Findings: The probe design of GeneChip SNP arrays enables us to disentangle different sources of intensity modulations such as the number of mismatches per duplex, matched and mismatched base pairings including nearest and next-nearest neighbors and their position along the probe sequence. The effect of probe sequence was estimated in terms of triple-motifs with central matches and mismatches which include all 256 combinations of possible base pairings. The probe/target interactions on the chip can be decomposed into nearest neighbor contributions which correlate well with free energy terms of DNA/DNA-interactions in solution. The effect of mismatches is about twice as large as that of canonical pairings. Runs of guanines (G) and the particular type of mismatched pairings formed in cross-allelic probe/target duplexes constitute sources of systematic biases of the probe signals with consequences for genotyping and copy number estimates. The poly-G effect seems to be related to the crowded arrangement of probes which facilitates complex formation of neighboring probes with at minimum three adjacent G's in their sequence. Conclusions: The applied method of "triple-averaging'' represents a model-free approach to estimate the mean intensity contributions of different sequence motifs which can be applied in calibration algorithms to correct signal values for sequence effects. Rules for appropriate sequence corrections are suggested.			Binder, H (corresponding author), Univ Leipzig, Interdisciplinary Ctr Bioinformat, Leipzig, Germany.	binder@izbi.uni-leipzig.de	Binder, Hans/U-5519-2018	Binder, Hans/0000-0002-2242-4678				Bhasi K, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl520; Binder H, 2006, Bioinformatics of Genome Regulation and Structure II, P451, DOI 10.1007/0-387-29455-4_43; Binder H, 2005, LANGMUIR, V21, P9287, DOI 10.1021/la051231s; Binder H, 2005, BIOPHYS J, V89, P337, DOI 10.1529/biophysj.104.055343; Binder H, 2004, J PHYS CHEM B, V108, P18015, DOI 10.1021/jp049592o; Binder H, 2004, J PHYS CHEM B, V108, P18003, DOI 10.1021/jp049593g; Binder H, 2006, J PHYS-CONDENS MAT, V18, pS491, DOI 10.1088/0953-8984/18/18/S02; Binder H, 2006, J PHYS-CONDENS MAT, V18, pS537, DOI 10.1088/0953-8984/18/18/S04; Binder H, 2009, J PHYS CHEM B, V113, P2874, DOI 10.1021/jp808118m; Binder H, 2008, ALGORITHM MOL BIOL, V3, DOI 10.1186/1748-7188-3-11; Binder H, 2008, ALGORITHM MOL BIOL, V3, DOI 10.1186/1748-7188-3-12; BRUUN CM, 2007, NUCL ACIDS RES, V3; BURDEN C, 2009, PHYSICOCHEMICA UNPUB; Burden C.J., 2004, STAT APPL GENET MOL, V3, DOI [10.2202/1544-6115.1095, DOI 10.2202/1544-6115.1095]; Burden CJ, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/1/016004; Carvalho B, 2007, BIOSTATISTICS, V8, P485, DOI 10.1093/biostatistics/kxl042; DEUTSCH JM, 2004, ARXIVQBIOBM0406039V1; DI X, 2005, BIOINFORMATICS; FASOLD M, 2009, GGG BIAS GENEC UNPUB; Ferrantini A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-3; Fish DJ, 2007, NUCLEIC ACIDS RES, V35, P7197, DOI 10.1093/nar/gkm865; Hacia JG, 1999, NAT GENET, V21, P42, DOI 10.1038/4469; Halperin A, 2006, J PHYS-CONDENS MAT, V18, pS463, DOI 10.1088/0953-8984/18/18/S01; Heim T, 2006, J PHYS-CONDENS MAT, V18, pS525, DOI 10.1088/0953-8984/18/18/S03; Held GA, 2003, P NATL ACAD SCI USA, V100, P7575, DOI 10.1073/pnas.0832500100; Hooyberghs J, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp109; IKUTA S, 1987, NUCLEIC ACIDS RES, V15, P797, DOI 10.1093/nar/15.2.797; LaFramboise T, 2005, PLOS COMPUT BIOL, V1, P507, DOI 10.1371/journal.pcbi.0010065; LAFRAMBOISE T, 2006, HARVARD U BIOSTATIST, V44, P1; Langdon WB, 2009, BRIEF BIOINFORM, V10, P259, DOI 10.1093/bib/bbp018; Lee I, 2004, NUCLEIC ACIDS RES, V32, P681, DOI 10.1093/nar/gkh196; Marcelino LA, 2006, P NATL ACAD SCI USA, V103, P13629, DOI 10.1073/pnas.0601476103; Matveeva OV, 2003, NUCLEIC ACIDS RES, V31, P4211, DOI 10.1093/nar/gkg476; McGall G, 1996, P NATL ACAD SCI USA, V93, P13555, DOI 10.1073/pnas.93.24.13555; McGall GH, 1997, J AM CHEM SOC, V119, P5081, DOI 10.1021/ja964427a; Mei R, 2003, P NATL ACAD SCI USA, V100, P11237, DOI 10.1073/pnas.1534744100; Naef F, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.011906; Naiser T, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.218301; Naiser T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-509; Naiser T, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-48; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; Peyret N, 1999, BIOCHEMISTRY-US, V38, P3468, DOI 10.1021/bi9825091; Pirrung MC, 1998, J ORG CHEM, V63, P241, DOI 10.1021/jo970872s; Pozhitkov A, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl133; Rachwal PA, 2007, BIOCHEMISTRY-US, V46, P3036, DOI 10.1021/bi062118j; SantaLucia J, 2004, ANNU REV BIOPH BIOM, V33, P415, DOI 10.1146/annurev.biophys.32.110601.141800; SantaLucia J, 1998, P NATL ACAD SCI USA, V95, P1460, DOI 10.1073/pnas.95.4.1460; Seringhaus M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-635; Sharp AJ, 2007, HUM MOL GENET, V16, P2770, DOI 10.1093/hmg/ddm234; Shen F, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-27; SUGIMOTO N, 1995, BIOCHEMISTRY-US, V34, P11211, DOI 10.1021/bi00035a029; Suhnel J, 2001, BIOPOLYMERS, V61, P32, DOI 10.1002/1097-0282(2001)61:1<32::AID-BIP10063>3.0.CO;2-B; Suzuki S, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-373; Upton GJG, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-613; Vetterling W.T., 1989, NUMERICAL RECIPES; Weinberg RA, 1996, SCI AM, V275, P62, DOI 10.1038/scientificamerican0996-62; Wick LM, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj024; Wu CL, 2007, BIOINFORMATICS, V23, P2566, DOI 10.1093/bioinformatics/btm271; Zhang L, 2003, NAT BIOTECHNOL, V21, P818, DOI 10.1038/nbt836	59	7	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2009	4	11							e7862	10.1371/journal.pone.0007862	http://dx.doi.org/10.1371/journal.pone.0007862			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520OG	19924253	gold, Green Published, Green Submitted			2022-12-25	WOS:000271854200010
J	Gurvitz, A				Gurvitz, Aner			A C. elegans Model for Mitochondrial Fatty Acid Synthase II: The Longevity-Associated Gene W09H1.5/mecr-1 Encodes a 2-trans-Enoyl-Thioester Reductase	PLOS ONE			English	Article							ACYL CARRIER PROTEIN; 2-ENOYL THIOESTER REDUCTASES; SACCHAROMYCES-CEREVISIAE; LIPOIC ACID; ESCHERICHIA-COLI; CAENORHABDITIS-ELEGANS; PEROXISOME PROLIFERATION; TRYPANOSOMA-BRUCEI; YEAST MITOCHONDRIA; RNAI SCREEN	Our recognition of the mitochondria as being important sites of fatty acid biosynthesis is continuously unfolding, especially in light of new data becoming available on compromised fatty acid synthase type 2 (FASII) in mammals. For example, perturbed regulation of murine 17 beta-HSD8 encoding a component of the mitochondrial FASII enzyme 3-oxoacyl-thioester reductase is implicated in polycystic kidney disease. In addition, over-expression in mice of the Mecr gene coding for 2-trans-enoyl-thioester reductase, also of mitochondrial FASII, leads to impaired heart function. However, mouse knockouts for mitochondrial FASII have hitherto not been reported and, hence, there is a need to develop alternate metazoan models such as nematodes or fruit flies. Here, the identification of Caenorhabditis elegans W09H1.5/MECR-1 as a 2-trans-enoyl-thioester reductase of mitochondrial FASII is reported. To identify MECR-1, Saccharomyces cerevisiae etr1 Delta mutant cells were employed that are devoid of mitochondrial 2-trans-enoyl-thioester reductase Etr1p. These yeast mutants fail to synthesize sufficient levels of lipoic acid or form cytochrome complexes, and cannot respire or grow on non-fermentable carbon sources. A mutant yeast strain ectopically expressing nematode mecr-1 was shown to contain reductase activity and resemble the self-complemented mutant strain for these phenotype characteristics. Since MECR-1 was not intentionally targeted for compartmentalization using a yeast mitochondrial leader sequence, this inferred that the protein represented a physiologically functional mitochondrial 2-trans-enoyl-thioester reductase. In accordance with published findings, RNAi-mediated knockdown of mecr-1 in C. elegans resulted in life span extension, presumably due to mitochondrial dysfunction. Moreover, old mecr-1(RNAi) worms had better internal organ appearance and were more mobile than control worms, indicating a reduced physiological age. This is the first report on RNAi work dedicated specifically to curtailing mitochondrial FASII in metazoans. The availability of affected survivors will help to position C. elegans as an excellent model for future pursuits in the emerging field of mitochondrial FASII research.			Gurvitz, A (corresponding author), Med Univ Vienna, Inst Physiol, Ctr Physiol Pathophysiol & Immunol, Sect Physiol Lipid Metab, Vienna, Austria.	aner.gurvitz@meduniwien.ac.at			Austrian Science Fund FWF [P 20764] Funding Source: Medline	Austrian Science Fund FWF(Austrian Science Fund (FWF))		Ausubel F. M., 1988, CURRENT PROTOCOLS MO; Autio KJ, 2008, FEBS LETT, V582, P729, DOI 10.1016/j.febslet.2008.01.051; Autio KJ, 2008, FASEB J, V22, P569, DOI 10.1096/fj.07-8986; BOKERSCHMITT E, 1982, J BACTERIOL, V151, P303; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brody S, 1997, FEBS LETT, V408, P217, DOI 10.1016/S0014-5793(97)00428-6; Burnell AM, 2005, EXP GERONTOL, V40, P850, DOI 10.1016/j.exger.2005.09.006; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; CHEN DC, 1992, CURR GENET, V21, P83, DOI 10.1007/BF00318659; Chen Y, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-12; Chen ZJ, 2009, FASEB J, V23, P3682, DOI 10.1096/fj.09-133587; Chen ZJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005589; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Cronan JE, 2005, FEBS LETT, V579, P4892, DOI 10.1016/j.febslet.2005.07.077; Curran SP, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030056; DOMMES V, 1984, J BIOL CHEM, V259, P1781; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; FILIPITS M, 1993, GENE, V132, P49, DOI 10.1016/0378-1119(93)90513-3; FILPPULA SA, 1995, J BIOL CHEM, V270, P27453, DOI 10.1074/jbc.270.46.27453; GOLDMAN P, 1961, J BIOL CHEM, V236, P2620; Guler JL, 2008, MOL MICROBIOL, V67, P1125, DOI 10.1111/j.1365-2958.2008.06112.x; Gurvitz A, 1997, J BIOL CHEM, V272, P22140, DOI 10.1074/jbc.272.35.22140; Gurvitz A, 2008, APPL ENVIRON MICROB, V74, P5078, DOI 10.1128/AEM.00655-08; Gurvitz A, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/235868; Hamilton B, 2005, GENE DEV, V19, P1544, DOI 10.1101/gad.1308205; Hansen M, 2005, PLOS GENET, V1, P119, DOI 10.1371/journal.pgen.0010017; HARINGTON A, 1993, MOL MICROBIOL, V9, P545, DOI 10.1111/j.1365-2958.1993.tb01715.x; HAYDEN MA, 1993, BIOCHEMISTRY-US, V32, P3778, DOI 10.1021/bi00065a033; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; Hiltunen JK, 2009, J BIOL CHEM, V284, P9011, DOI 10.1074/jbc.R800068200; Hiltunen JK, 2005, BIOCHEM SOC T, V33, P1162, DOI 10.1042/BST0331162; HOLLINGSWORTH MJ, 1986, MOL CELL BIOL, V6, P1058, DOI 10.1128/MCB.6.4.1058; JONES EW, 1977, GENETICS, V85, P23; Kastaniotis AJ, 2004, MOL MICROBIOL, V53, P1407, DOI 10.1111/j.1365-2958.2004.04191.x; Miinalainen IJ, 2003, J BIOL CHEM, V278, P20154, DOI 10.1074/jbc.M302851200; Rea SL, 2007, PLOS BIOL, V5, P2312, DOI 10.1371/journal.pbio.0050259; Rock CO, 1996, BBA-LIPID LIPID MET, V1302, P1, DOI 10.1016/0005-2760(96)00056-2; Rose MD., 1990, METHODS YEAST GENETI; Rottensteiner H, 1996, EMBO J, V15, P2924, DOI 10.1002/j.1460-2075.1996.tb00655.x; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schneider R, 1995, CURR GENET, V29, P10, DOI 10.1007/BF00313188; Schneider R, 1997, CURR GENET, V32, P384, DOI 10.1007/s002940050292; Schonauer MS, 2008, MOL CELL BIOL, V28, P6646, DOI 10.1128/MCB.01162-08; Schonauer MS, 2009, J BIOL CHEM, V284, P23234, DOI 10.1074/jbc.M109.015594; Stephens JL, 2007, J BIOL CHEM, V282, P4427, DOI 10.1074/jbc.M609037200; STUMPF PK, 1963, BIOCHIM BIOPHYS ACTA, V70, P20, DOI 10.1016/0006-3002(63)90715-7; Torkko JM, 2003, J BIOL CHEM, V278, P41213, DOI 10.1074/jbc.M307664200; Torkko JM, 2001, MOL CELL BIOL, V21, P6243, DOI 10.1128/MCB.21.18.6243-6253.2001; WADSWORTH WG, 1989, DEV BIOL, V132, P167, DOI 10.1016/0012-1606(89)90214-5; Waller RF, 1998, P NATL ACAD SCI USA, V95, P12352, DOI 10.1073/pnas.95.21.12352; YAMAZOE M, 1994, J BIOL CHEM, V269, P15244; Yi XW, 2005, MOL CELL BIOL, V25, P8387, DOI 10.1128/MCB.25.18.8387-8392.2005; Yoneda T, 2004, J CELL SCI, V117, P4055, DOI 10.1242/jcs.01275; Zhang L, 2005, J BIOL CHEM, V280, P12422, DOI 10.1074/jbc.M413686200; Zhang L, 2003, J BIOL CHEM, V278, P40067, DOI 10.1074/jbc.M306121200	55	2	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2009	4	11							e7791	10.1371/journal.pone.0007791	http://dx.doi.org/10.1371/journal.pone.0007791			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520NG	19924289	Green Published, Green Submitted, gold			2022-12-25	WOS:000271851000002
J	Adler, ED; Chen, VC; Bystrup, A; Kaplan, AD; Giovannone, S; Briley-Saebo, K; Young, W; Kattman, S; Mani, V; Laflamme, M; Zhu, WZ; Fayad, Z; Keller, G				Adler, Eric D.; Chen, Vincent C.; Bystrup, Anne; Kaplan, Aaron D.; Giovannone, Steven; Briley-Saebo, Karen; Young, Wilson; Kattman, Steve; Mani, Venkatesh; Laflamme, Michael; Zhu, Wei-Zhong; Fayad, Zahi; Keller, Gordon			The cardiomyocyte lineage is critical for optimization of stem cell therapy in a mouse model of myocardial infarction	FASEB JOURNAL			English	Article						cardiac regeneration; cadiomyopathy; embryonic stem cells	CARDIOVASCULAR PROGENITOR CELLS; MARROW-DERIVED ANGIOBLASTS; CARDIAC-FUNCTION; SMOOTH-MUSCLE; REPAIR; NEOVASCULARIZATION; HEARTS; MICE	We recently described a murine embryonic stem cell (ESC) line engineered to express the activated Notch 4 receptor in a tetracycline (doxcycline; Dox) regulated fashion (tet-notch4 ESCs). Notch 4 induction in Flk1(+) hematopoietic and vascular progenitors from this line respecified them to a cardiovascular fate. We reasoned that these cells would be ideal for evaluating the contribution of the cardiomyocyte and vascular lineages to the functional improvement noted following stem cell transplantation in infarcted hearts. Flk-1(+) Tet-notch4 cells from d 3 embryoid bodies exposed to doxycycline (Dox(+)) were compared to uninduced (Dox(+)) Flk-1(+) cells. Mice underwent transplantation of 5 x 10(5) Dox(+) cells, Dox(-) cells, or an equal volume of serum-free medium after surgically induced myocardial infarction. The mean ejection fraction was 59 +/- 15, 46 +/- 17, and 39 +/- 13% in the Dox(+), Dox(-), and serum-free medium groups, respectively (P<0.05 for the differences among all 3 groups). Immunohistochemistry of hearts injected with Dox(+) grafts expressed myocardial and vascular markers, whereas grafts of Dox(-) cells expressed primarily vascular markers. We conclude that cardiovascular progenitors are more effective than vascular progenitors in improving function after myocardial infarction. The transplantation of appropriate cell types is critical for maximizing the benefit of cardiovascular cell therapy.-Adler, E. D., Chen, V. C., Bystrup, A., Kaplan, A. D., Giovannone, S., Briley-Saebo, K., Young, W., Kattman, S., Mani, V., Laflamme, M., Zhu, W.-Z., Fayad, Z., Keller, G. The cardiomyocyte lineage is critical for optimization of stem cell therapy in a mouse model of myocardial infarction. FASEB J. 24, 1073-1081 (2010). www.fasebj.org	[Adler, Eric D.; Bystrup, Anne; Kaplan, Aaron D.; Briley-Saebo, Karen; Young, Wilson; Mani, Venkatesh; Fayad, Zahi] Mt Sinai Hosp, New York, NY 10029 USA; [Chen, Vincent C.] City Hope Hosp, Pasadena, CA USA; [Giovannone, Steven] New York Univ Hosp, New York, NY USA; [Kattman, Steve; Keller, Gordon] Univ Hlth Networks, Toronto, ON, Canada; [Laflamme, Michael; Zhu, Wei-Zhong] Univ Washington, Med Ctr, Seattle, WA 98195 USA	Icahn School of Medicine at Mount Sinai; New York University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Washington; University of Washington Seattle	Adler, ED (corresponding author), Oregon Hlth & Sci Univ, 3181 SW Sam Jackson Pk Rd,Mail Code UN-62, Portland, OR 97239 USA.	adler@ohsu.edu; gkeller@uhnresearch.ca	Zhu, Wei-Zhong/G-4919-2011; Fayad, Zahi/Z-3272-2019; Laflamme, Michael/AAV-6791-2021; Mani, Venkatesh/B-8939-2011	Fayad, Zahi/0000-0002-3439-7347; Laflamme, Michael/0000-0001-5908-880X; Mani, Venkatesh/0000-0002-0432-2918; Briley, Karen/0000-0001-5402-8779; Keller, Gordon/0000-0001-9309-9297	The Glorney Raisbeck Fellowship in Cardiovascular Disease; U.S. National Institutes of Health [R01 HL71800, RO1 HL48834, R01 HL071021, R01 HL078667]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078667, T32HL007824, R01HL071021, R01HL048834, R01HL071800] Funding Source: NIH RePORTER	The Glorney Raisbeck Fellowship in Cardiovascular Disease; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This investigation was partially supported by The Glorney Raisbeck Fellowship in Cardiovascular Disease (E.A.) and U.S. National Institutes of Health grants R01 HL71800 and RO1 HL48834 (G.K.) and R01 HL071021 and R01 HL078667 (Z.A.F.) The authors do not have any disclosures.	Abdel-Latif A, 2007, ARCH INTERN MED, V167, P989, DOI 10.1001/archinte.167.10.989; ADLER E, 2006, KEYST S MOL MECH CAR, P101; Ahlgren U, 1997, NATURE, V385, P257, DOI 10.1038/385257a0; Albert J, 2003, ACTA ANAESTH SCAND, V47, P407, DOI 10.1034/j.1399-6576.2003.00059.x; Chaudhry HW, 2004, J BIOL CHEM, V279, P35858, DOI 10.1074/jbc.M404975200; Chen VC, 2008, NAT BIOTECHNOL, V26, P1169, DOI 10.1038/nbt.1497; Herreros J, 2003, EUR HEART J, V24, P2012, DOI 10.1016/j.ehj.2003.09.012; Heubach JF, 2004, J PHYSIOL-LONDON, V554, P659, DOI 10.1113/jphysiol.2003.055806; Houghton FD, 1999, DEV GENET, V24, P5, DOI 10.1002/(SICI)1520-6408(1999)24:1/2&lt;5::AID-DVG2&gt;3.0.CO;2-F; Itescu S, 2002, ANN HEMATOL, V81, pS21; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Kehat I, 2004, NAT BIOTECHNOL, V22, P1282, DOI 10.1038/nbt1014; Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498; Kolossov E, 2006, J EXP MED, V203, P2315, DOI 10.1084/jem.20061469; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Levkau B, 2008, CIRCULATION, V117, P1583, DOI 10.1161/CIRCULATIONAHA.107.734160; Mangi AA, 2003, NAT MED, V9, P1195, DOI 10.1038/nm912; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Mummery C L, 2006, Ned Tijdschr Geneeskd, V150, P943; Murry CE, 2004, NATURE, V428, P664, DOI 10.1038/nature02446; O'Connell Timothy D, 2007, Methods Mol Biol, V357, P271; Orlic D, 2001, ANN NY ACAD SCI, V938, P221; Penn MS, 2002, PROG CARDIOVASC DIS, V45, P21, DOI 10.1053/pcad.2002.123466; Rubart M, 2006, ANN NY ACAD SCI, V1080, P34, DOI 10.1196/annals.1380.004; Smith RR, 2007, CIRCULATION, V115, P896, DOI 10.1161/CIRCULATIONAHA.106.655209; Taylor DA, 2001, CURR CONTR TRIALS C, V2, P208, DOI 10.1186/CVM-2-5-208; Valiunas V, 2004, J PHYSIOL-LONDON, V555, P617, DOI 10.1113/jphysiol.2003.058719; van Laake LW, 2007, STEM CELL RES, V1, P9, DOI 10.1016/j.scr.2007.06.001; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Yuasa Shinsuke, 2008, Circ J, V72 Suppl A, pA49, DOI 10.1253/circj.CJ-08-0378	30	15	16	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	APR	2010	24	4					1073	1081		10.1096/fj.09-135426	http://dx.doi.org/10.1096/fj.09-135426			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	580PV	19940262	Green Published			2022-12-25	WOS:000276462300015
J	Kalyanasundaram, A; Bal, NC; Franzini-Armstrong, C; Knollmann, BC; Periasamy, M				Kalyanasundaram, Anuradha; Bal, Naresh C.; Franzini-Armstrong, Clara; Knollmann, Bjoern C.; Periasamy, Muthu			The Calsequestrin Mutation CASQ2(D307H) Does Not Affect Protein Stability and Targeting to the Junctional Sarcoplasmic Reticulum but Compromises Its Dynamic Regulation of Calcium Buffering	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMORPHIC VENTRICULAR-TACHYCARDIA; HUMAN CARDIAC CALSEQUESTRIN; CHAIN GENE PROMOTER; RYANODINE RECEPTOR; MISSENSE MUTATION; BEDOUIN FAMILIES; RELEASE CHANNEL; CASQ2; SKELETAL; TRIADIN	Mutations in cardiac ryanodine receptor (RYR2) and cardiac calsequestrin (CASQ2) genes are linked to catecholaminergic polymorphic ventricular tachycardia, a life-threatening genetic disease. They predispose young individuals to cardiac arrhythmia in the absence of structural abnormalities. One such mutation that changes an aspartic residue to histidine at position 307 in CASQ2 has been linked to catecholaminergic polymorphic ventricular tachycardia. In this study we made a transgenic mouse model expressing the mutant CASQ2(D307H) protein in a CASQ2 null background and investigated if the disease is caused by accelerated degradation of the mutant protein. Our data suggest that the mutant protein can be expressed, is relatively stable, and targets appropriately to the junctional sarcoplasmic reticulum. Moreover, it partially normalizes the ultrastructure of the sarcoplasmic reticulum, which was altered in the CASQ2 null background. In addition, overexpression of the mutant protein does not cause any pathology and/or structural changes in the myocardium. We further demonstrate, using purified protein, that the mutant protein is very stable under chemical and thermal denaturation but shows abnormal Ca2+ buffering characteristics at high calcium concentrations. In addition, trypsin digestion studies reveal that the mutant protein is more susceptible to protease activity only in the presence of high Ca2+. These studies collectively suggest that the D307H mutation can compromise the dynamic behavior of CASQ2 including supramolecular rearrangement upon Ca2+ activation.	[Kalyanasundaram, Anuradha; Bal, Naresh C.; Periasamy, Muthu] Ohio State Univ, Dept Physiol & Cell Biol, Coll Med, Columbus, OH 43210 USA; [Franzini-Armstrong, Clara] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Knollmann, Bjoern C.] Vanderbilt Univ, Div Clin Pharmacol, Dept Med, Nashville, TN 37232 USA; [Knollmann, Bjoern C.] Vanderbilt Univ, Div Clin Pharmacol, Dept Pharmacol, Nashville, TN 37232 USA	Ohio State University; University of Pennsylvania; Vanderbilt University; Vanderbilt University	Periasamy, M (corresponding author), 304 Hamilton Hall,1645 Neil Ave, Columbus, OH 43210 USA.	periasamy.1@osu.edu		Periasamy, Muthu/0000-0001-8834-5975; Knollmann, Bjorn/0000-0003-4956-9735	National Institutes of Health [R0-1 HL64014]; American Heart Association pre-doctoral fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088635] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association pre-doctoral fellowship(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R0-1 HL64014 (to M. P.) and an American Heart Association pre-doctoral fellowship (to A. K.).	Babu GJ, 2005, CARDIOVASC RES, V65, P177, DOI 10.1016/j.cardiores.2004.08.012; Beard NA, 2004, PROG BIOPHYS MOL BIO, V85, P33, DOI 10.1016/j.pbiomolbio.2003.07.001; di Barletta MR, 2006, CIRCULATION, V114, P1012, DOI 10.1161/CIRCULATIONAHA.106.623793; Dirksen WP, 2007, CARDIOVASC RES, V75, P69, DOI 10.1016/j.cardiores.2007.03.002; Eldar M, 2003, TRENDS CARDIOVAS MED, V13, P148, DOI 10.1016/S1050-1738(03)00025-2; Glover L, 2001, BBA-BIOMEMBRANES, V1515, P120, DOI 10.1016/S0005-2736(01)00406-0; GULICK J, 1991, J BIOL CHEM, V266, P9180; GUO W, 1995, J BIOL CHEM, V270, P9027, DOI 10.1074/jbc.270.16.9027; Gyorke I, 2004, BIOPHYS J, V86, P2121, DOI 10.1016/S0006-3495(04)74271-X; Gyorke S, 2004, BIOL RES, V37, P603, DOI 10.4067/s0716-97602004000400014; Houle TD, 2004, CARDIOVASC RES, V64, P227, DOI 10.1016/j.cardiores.2004.09.009; IKEMOTO N, 1974, J BIOL CHEM, V249, P2357; Jones LR, 1998, J CLIN INVEST, V101, P1385, DOI 10.1172/JCI1362; Kang ChulHee, 2002, Methods Mol Biol, V172, P281; Kim E, 2007, J MOL BIOL, V373, P1047, DOI 10.1016/j.jmb.2007.08.055; Knollmann BC, 2006, J CLIN INVEST, V116, P2510, DOI 10.1172/JCI29128; Lahat H, 2004, ANN MED, V36, P87, DOI 10.1080/17431380410032517; Lahat H, 2001, AM J HUM GENET, V69, P1378, DOI 10.1086/324565; Lahat H, 2001, CIRCULATION, V103, P2822; MacLennan DH, 2002, J MOL CELL CARDIOL, V34, P897, DOI 10.1006/jmcc.2002.2031; MITCHELL RD, 1988, J BIOL CHEM, V263, P1376; Postma AV, 2002, CIRC RES, V91, pE21, DOI 10.1161/01.RES.0000038886.18992.6B; Rizzi N, 2008, CIRC RES, V103, P298, DOI 10.1161/CIRCRESAHA.108.171660; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Shen XH, 2004, J CHEM NEUROANAT, V28, P79, DOI 10.1016/j.jchemneu.2004.02.006; Song L, 2007, J CLIN INVEST, V117, P1814, DOI 10.1172/JCI31080; SUBRAMANIAM A, 1993, J BIOL CHEM, V268, P4331; SUBRAMANIAM A, 1991, J BIOL CHEM, V266, P24613; Terentyev D, 2003, P NATL ACAD SCI USA, V100, P11759, DOI 10.1073/pnas.1932318100; Terentyev D, 2006, CIRC RES, V98, P1151, DOI 10.1161/01.RES.0000220647.93982.08; Valle G, 2008, BIOCHEM J, V413, P291, DOI 10.1042/BJ20080163; Viatchenko-Karpinski S, 2004, CIRC RES, V94, P471, DOI 10.1161/01.RES.0000115944.10681.EB; Wang SR, 1998, NAT STRUCT BIOL, V5, P476, DOI 10.1038/nsb0698-476; Zhang L, 1997, J BIOL CHEM, V272, P23389, DOI 10.1074/jbc.272.37.23389; Zhang L, 2001, J MOL CELL CARDIOL, V33, P233, DOI 10.1006/jmcc.2000.1295	35	24	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5							3076	10.1074/jbc.M109.053892	http://dx.doi.org/10.1074/jbc.M109.053892			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19920148	Green Published, hybrid			2022-12-25	WOS:000273829000023
J	Lewis, EM; Sergeant, S; Ledford, B; Stull, N; Dinauer, MC; Mcphail, LC				Lewis, Eric M.; Sergeant, Susan; Ledford, Bill; Stull, Natalie; Dinauer, Mary C.; Mcphail, Linda C.			Phosphorylation of p22(phox) on Threonine 147 Enhances NADPH Oxidase Activity by Promoting p47(phox) Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; HUMAN POLYMORPHONUCLEAR LEUKOCYTES; CHRONIC GRANULOMATOUS-DISEASE; NEUTROPHIL CYTOCHROME-B; TANDEM SH3 DOMAINS; FLAVOCYTOCHROME B(558); RESPIRATORY BURST; REACTIVE OXYGEN; PHORBOL ESTER; LIGHT-CHAIN	NADPH oxidase comprises both cytosolic and membrane-bound subunits, which, when assembled and activated, initiate the transfer of electrons from NADPH to molecular oxygen to form superoxide. This activity, known as the respiratory burst, is extremely important in the innate immune response as indicated by the disorder chronic granulomatous disease. The regulation of this enzyme complex involves protein-protein and protein-lipid interactions as well as phosphorylation events. Previously, our laboratory demonstrated that the small membrane subunit of the oxidase complex, p22(phox), is phosphorylated in neutrophils and that its phosphorylation correlates with NADPH oxidase activity. In this study, we utilized site-directed mutagenesis in a Chinese hamster ovarian cell system to determine the phosphorylation sites within p22(phox). We also explored the mechanism by which p22(phox) phosphorylation affects NADPH oxidase activity. We found that mutation of threonine 147 to alanine inhibited superoxide production in vivo by more than 70%. This mutation also blocked phosphorylation of p22(phox) in vitro by both protein kinase C-alpha and -delta. Moreover, this mutation blocked the p22(phox)-p47(phox) interaction in intact cells. When phosphorylation was mimicked in vivo through mutation of Thr-147 to an aspartyl residue, NADPH oxidase activity was recovered, and the p22(phox)-p47(phox) interaction in the membrane was restored. Maturation of gp91(phox) was not affected by the alanine mutation, and phosphorylation of the cytosolic component p47(phox) still occurred. This study directly implicates threonine 147 of p22(phox) as a critical residue for efficient NADPH oxidase complex formation and resultant enzyme activity.	[Stull, Natalie; Dinauer, Mary C.] Indiana Univ, Sch Med, Riley Hosp Children, Herman B Wells Ctr Pediat Res,Dept Pediat, Indianapolis, IN 46202 USA; Wake Forest Univ, Dept Biochem, Sch Med, Winston Salem, NC 27157 USA	Indiana University System; Indiana University-Purdue University Indianapolis; James Whitcomb Riley Hospital Children; Wake Forest University		lmcphail@wfubmc.edu	McPhail, Linda C/D-9505-2013	McPhail, Linda C/0000-0002-8670-306X	National Institutes of Health [R01 AI 22564, R01 HL 045635, T32 GM-063485]; March of Dimes Research Foundation [MOD 1-FY02-191]; Wake Forest University Graduate School of Arts and Sciences; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL045635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI022564] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM063485] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes Research Foundation(March of Dimes); Wake Forest University Graduate School of Arts and Sciences; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AI 22564 (to L. C. M.) and R01 HL 045635 (to M. C. D.). This work was also supported by March of Dimes Research Foundation Grant MOD 1-FY02-191 (to L. C. M.).; Supported by National Institutes of Health Training Grant T32 GM-063485 and a graduate fellowship from the Wake Forest University Graduate School of Arts and Sciences.	Ambasta RK, 2004, J BIOL CHEM, V279, P45935, DOI 10.1074/jbc.M406486200; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Biberstine-Kinkade KJ, 2002, J BIOL CHEM, V277, P30368, DOI 10.1074/jbc.M203993200; Biberstine-Kinkade KJ, 2001, J BIOL CHEM, V276, P31105, DOI 10.1074/jbc.M103327200; BURRITT JB, 1995, J BIOL CHEM, V270, P16974, DOI 10.1074/jbc.270.28.16974; CALDWELL SE, 1988, J CLIN INVEST, V81, P1485, DOI 10.1172/JCI113480; Cave AC, 2006, ANTIOXID REDOX SIGN, V8, P691, DOI 10.1089/ars.2006.8.691; Cheng GJ, 2001, GENE, V269, P131, DOI 10.1016/S0378-1119(01)00449-8; COX JA, 1985, J CLIN INVEST, V76, P1932, DOI 10.1172/JCI112190; CROSS AR, 1986, BIOCHEM J, V237, P111, DOI 10.1042/bj2370111; Dang PMC, 2001, J IMMUNOL, V166, P1206, DOI 10.4049/jimmunol.166.2.1206; DECHATELET LR, 1976, BLOOD, V47, P545; DeCoursey TE, 2005, CELL MOL LIFE SCI, V62, P2173, DOI 10.1007/s00018-005-5177-1; DEMENDEZ I, 1995, BLOOD, V85, P1104, DOI 10.1182/blood.V85.4.1104.bloodjournal8541104; ELLIS JA, 1989, BIOCHEM J, V262, P575, DOI 10.1042/bj2620575; GARCIA RC, 1988, BIOCHEM J, V252, P901, DOI 10.1042/bj2520901; Greaves DR, 2000, MICROBES INFECT, V2, P331, DOI 10.1016/S1286-4579(00)00293-8; Groemping Y, 2005, BIOCHEM J, V386, P401, DOI 10.1042/BJ20041835; Heyworth PG, 2003, CURR OPIN IMMUNOL, V15, P578, DOI 10.1016/S0952-7915(03)00109-2; Infanger DW, 2006, ANTIOXID REDOX SIGN, V8, P1583, DOI 10.1089/ars.2006.8.1583; JESAITIS AJ, 1991, NEW BIOL, V3, P651; Kawahara T, 2005, J BIOL CHEM, V280, P31859, DOI 10.1074/jbc.M501882200; Kobayashi SD, 2005, ARCH IMMUNOL THER EX, V53, P505; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Leto TL, 2006, ANTIOXID REDOX SIGN, V8, P1549, DOI 10.1089/ars.2006.8.1549; LETO TL, 1991, J BIOL CHEM, V266, P19812; LEUSEN JHW, 1994, J EXP MED, V180, P2329, DOI 10.1084/jem.180.6.2329; LIGHT DR, 1981, BIOCHEMISTRY-US, V20, P1468, DOI 10.1021/bi00509a010; LU DJ, 1993, BLOOD CELLS, V19, P343; LYNCH RE, 1983, TOP CURR CHEM, V108, P35; McCall C E, 1985, Trans Assoc Am Physicians, V98, P253; MCPHAIL LC, 1993, EUR J HAEMATOL, V51, P294; MCPHAIL LC, 1993, NATURAL IMMUNE SYSTE, P63; Nauseef WM, 2004, HISTOCHEM CELL BIOL, V122, P277, DOI 10.1007/s00418-004-0679-8; Nobuhisa I, 2006, BIOCHEM J, V396, P183, DOI 10.1042/BJ20051899; PARKOS CA, 1988, P NATL ACAD SCI USA, V85, P3319, DOI 10.1073/pnas.85.10.3319; Perisic O, 2004, ADV ENZYME REGUL, V44, P279, DOI 10.1016/j.advenzreg.2003.11.003; PONTREMOLI S, 1986, ITAL J BIOCHEM, V35, P368; Price MO, 2002, BLOOD, V99, P2653, DOI 10.1182/blood.V99.8.2653; Quinn MT, 2006, CLIN SCI, V111, P1, DOI 10.1042/cs20060059; Rask-Madsen C, 2007, NAT CLIN PRACT ENDOC, V3, P46, DOI 10.1038/ncpendmet0366; Reeves EP, 1999, BIOCHEM J, V344, P859, DOI 10.1042/0264-6021:3440859; Regier DS, 2000, J BIOL CHEM, V275, P28406, DOI 10.1074/jbc.M004703200; Regier DS, 1999, J BIOL CHEM, V274, P36601, DOI 10.1074/jbc.274.51.36601; Roos D, 2003, MICROBES INFECT, V5, P1307, DOI 10.1016/j.micinf.2003.09.009; ROTROSEN D, 1992, SCIENCE, V256, P1459, DOI 10.1126/science.1318579; SCHALL TJ, 1994, CURR OPIN IMMUNOL, V6, P865, DOI 10.1016/0952-7915(94)90006-X; Selvatici R, 2006, EUR J PHARMACOL, V534, P1, DOI 10.1016/j.ejphar.2006.01.034; Sheppard FR, 2005, J LEUKOCYTE BIOL, V78, P1025, DOI 10.1189/jlb.0804442; Sumimoto H, 1996, J BIOL CHEM, V271, P22152, DOI 10.1074/jbc.271.36.22152; Takeya R, 2003, J BIOL CHEM, V278, P25234, DOI 10.1074/jbc.M212856200; Takeya R, 2006, ANTIOXID REDOX SIGN, V8, P1523, DOI 10.1089/ars.2006.8.1523; TAUBER AI, 1982, BLOOD, V60, P333; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Ueno N, 2005, J BIOL CHEM, V280, P23328, DOI 10.1074/jbc.M414548200; Vignais PV, 2002, CELL MOL LIFE SCI, V59, P1428, DOI 10.1007/s00018-002-8520-9; Waki K, 2006, FREE RADICAL RES, V40, P359, DOI 10.1080/10715760500539121; WIERNIK PH, 1985, MEDIGUIDE ONCOL, V1, P1; Wu WS, 2006, CANCER METAST REV, V25, P695, DOI 10.1007/s10555-006-9037-8; Yuzawa S, 2004, GENES CELLS, V9, P443, DOI 10.1111/j.1356-9597.2004.00733.x; Zhu YM, 2006, J BIOL CHEM, V281, P30336, DOI 10.1074/jbc.M607191200	62	31	33	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5							2959	10.1074/jbc.M109.030643	http://dx.doi.org/10.1074/jbc.M109.030643			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19948736	Green Published, hybrid			2022-12-25	WOS:000273829000010
J	Tsai, JY; Kienesberger, PC; Pulinilkunnil, T; Sailors, MH; Durgan, DJ; Villegas-Montoya, C; Jahoor, A; Gonzalez, R; Garvey, ME; Boland, B; Blasier, Z; McElfresh, TA; Nannegari, V; Chow, CW; Heird, WC; Chandler, MP; Dyck, JRB; Bray, MS; Young, ME				Tsai, Ju-Yun; Kienesberger, Petra C.; Pulinilkunnil, Thomas; Sailors, Mary H.; Durgan, David J.; Villegas-Montoya, Carolina; Jahoor, Anil; Gonzalez, Raquel; Garvey, Merissa E.; Boland, Brandon; Blasier, Zachary; McElfresh, Tracy A.; Nannegari, Vijayalakshmi; Chow, Chi-Wing; Heird, William C.; Chandler, Margaret P.; Dyck, Jason R. B.; Bray, Molly S.; Young, Martin E.			Direct Regulation of Myocardial Triglyceride Metabolism by the Cardiomyocyte Circadian Clock	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONTRACTILE FUNCTION; RHYTHMS; HEART; MICE; TRANSCRIPTION; DISRUPTION; BMAL1; LIVER	Maintenance of circadian alignment between an organism and its environment is essential to ensure metabolic homeostasis. Synchrony is achieved by cell autonomous circadian clocks. Despite a growing appreciation of the integral relation between clocks and metabolism, little is known regarding the direct influence of a peripheral clock on cellular responses to fatty acids. To address this important issue, we utilized a genetic model of disrupted clock function specifically in cardiomyocytes in vivo (termed cardiomyocyte clock mutant (CCM)). CCM mice exhibited altered myocardial response to chronic high fat feeding at the levels of the transcriptome and lipidome as well as metabolic fluxes, providing evidence that the cardiomyocyte clock regulates myocardial triglyceride metabolism. Time-of-day-dependent oscillations in myocardial triglyceride levels, net triglyceride synthesis, and lipolysis were markedly attenuated in CCM hearts. Analysis of key proteins influencing triglyceride turnover suggest that the cardiomyocyte clock inactivates hormone-sensitive lipase during the active/awake phase both at transcriptional and post-translational (via AMP-activated protein kinase) levels. Consistent with increased net triglyceride synthesis during the end of the active/awake phase, high fat feeding at this time resulted in marked cardiac steatosis. These data provide evidence for direct regulation of triglyceride turnover by a peripheral clock and reveal a potential mechanistic explanation for accelerated metabolic pathologies after prevalent circadian misalignment in Western society.	[Durgan, David J.; Young, Martin E.] Univ Alabama Birmingham, Div Cardiovasc Dis, Dept Med, Birmingham, AL 35294 USA; [Villegas-Montoya, Carolina; Jahoor, Anil; Gonzalez, Raquel; Garvey, Merissa E.; Boland, Brandon; Blasier, Zachary] Baylor Coll Med, Dept Pediat, USDA ARS, Childrens Nutr Res Ctr, Houston, TX 77030 USA; [Kienesberger, Petra C.; Pulinilkunnil, Thomas; Dyck, Jason R. B.] Univ Alberta, Dept Pediat, Fac Med & Dent, Cardiovasc Res Ctr, Edmonton, AB T6G 2S2, Canada; [Bray, Molly S.] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL 35294 USA; [McElfresh, Tracy A.; Chandler, Margaret P.] Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Cleveland, OH 44106 USA; [Chow, Chi-Wing] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA	University of Alabama System; University of Alabama Birmingham; Baylor College of Medicine; United States Department of Agriculture (USDA); University of Alberta; University of Alabama System; University of Alabama Birmingham; Case Western Reserve University; Yeshiva University; Albert Einstein College of Medicine	Young, ME (corresponding author), Univ Alabama Birmingham, Div Cardiovasc Dis, Dept Med, 703 19th St S,ZRB 308, Birmingham, AL 35294 USA.	meyoung@uab.edu	Pulinilkunnil, Thomas C/L-5511-2016; Pulinilkunnil, Thomas/H-4387-2019	Pulinilkunnil, Thomas C/0000-0003-1228-893X; Pulinilkunnil, Thomas/0000-0003-1228-893X; Boland, Brandon/0000-0003-1280-9547; Dyck, Jason/0000-0002-7045-2884; Kienesberger, Petra/0000-0001-9643-8338	National Institutes of Health [HL-074259]; DeBakey Heart Fund; National Science Foundation [GK-12]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074259] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DeBakey Heart Fund; National Science Foundation(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL-074259 (NHLBI).; Supported by the DeBakey Heart Fund at Baylor College of Medicine.; Supported by a National Science Foundation GK-12 fellowship.	Barger PM, 2000, TRENDS CARDIOVAS MED, V10, P238, DOI 10.1016/S1050-1738(00)00077-3; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bray MS, 2008, AM J PHYSIOL-HEART C, V294, pH1036, DOI 10.1152/ajpheart.01291.2007; Bunger MK, 2005, GENESIS, V41, P122, DOI 10.1002/gene.20102; CARSON FL, 1997, HISTOTECHNOLOGY SELF, P159; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Donsmark M, 2004, BIOCHEM BIOPH RES CO, V316, P867, DOI 10.1016/j.bbrc.2004.02.140; Durgan DJ, 2007, AM J PHYSIOL-HEART C, V293, pH2385, DOI 10.1152/ajpheart.01361.2006; Durgan DJ, 2006, J BIOL CHEM, V281, P24254, DOI 10.1074/jbc.M601704200; Edery I, 2000, PHYSIOL GENOMICS, V3, P59, DOI 10.1152/physiolgenomics.2000.3.2.59; Gibson UEM, 1996, GENOME RES, V6, P995, DOI 10.1101/gr.6.10.995; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Hardin PE, 2004, J BIOL RHYTHM, V19, P348, DOI 10.1177/0748730404268052; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Kudo T, 2007, J BIOL RHYTHM, V22, P312, DOI 10.1177/0748730407302625; Kudo Takashi, 2009, J Circadian Rhythms, V7, P4, DOI 10.1186/1740-3391-7-4; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Lockridge JB, 2008, J LIPID RES, V49, P1395, DOI 10.1194/jlr.M700517-JLR200; Martino T, 2004, J MOL MED, V82, P256, DOI 10.1007/s00109-003-0520-1; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; MORRISON WR, 1964, J LIPID RES, V5, P600; Pan XY, 2009, J LIPID RES, V50, P1800, DOI 10.1194/jlr.M900085-JLR200; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; SADDIK M, 1991, J BIOL CHEM, V266, P8162; Shimba S, 2005, P NATL ACAD SCI USA, V102, P12071, DOI 10.1073/pnas.0502383102; Szczepaniak LS, 2007, CIRC RES, V101, P759, DOI 10.1161/CIRCRESAHA.107.160457; Taegtmeyer H, 2000, J AM COLL CARDIOL, V36, P1386, DOI 10.1016/S0735-1097(00)00870-6; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; van den Buuse M, 1999, PHYSIOL BEHAV, V68, P9, DOI 10.1016/S0031-9384(99)00148-1; Wilson CR, 2007, BIOCHEM J, V406, P457, DOI 10.1042/BJ20070392; Young ME, 2007, SLEEP MED, V8, P656, DOI 10.1016/j.sleep.2006.12.010; Young ME, 2001, CIRC RES, V89, P1199, DOI 10.1161/hh2401.100741	34	72	75	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5							2918	10.1074/jbc.M109.077800	http://dx.doi.org/10.1074/jbc.M109.077800			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19940111	hybrid, Green Published			2022-12-25	WOS:000273829000006
J	Herz, K; Rimon, A; Olkhova, E; Kozachkov, L; Padan, E				Herz, Katia; Rimon, Abraham; Olkhova, Elena; Kozachkov, Lena; Padan, Etana			Transmembrane Segment II of NhaA Na+/H+ Antiporter Lines the Cation Passage, and Asp(65) Is Critical for pH Activation of the Antiporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT CONFORMATIONAL-CHANGE; SITE-DIRECTED MUTAGENESIS; LOOP-VIII-IX; ESCHERICHIA-COLI; ELECTRON-TRANSFER; STRUCTURAL INTERACTIONS; PHYSIOLOGICAL PH; ION-TRANSPORT; PROTEIN; PROTON	The crystal structure of Escherichia coli NhaA determined at pH 4 has provided insights into the mechanism of activity of a pH-regulated Na+/H+ antiporter. However, because NhaA is activated at physiological pH (pH 5.5-8.5), many questions related to the active state of NhaA have remained elusive. Our experimental results at physiological pH and computational analyses reveal that amino acid residues in transmembrane segment II contribute to the cation pathway of NhaA and its pH regulation: 1) transmembrane segment II is a highly conserved helix and the conserved amino acid residues are located on one side of the helix facing either the cytoplasmic or periplasmic funnels of NhaA structure. 2) Cys replacements of the conserved residues and measuring their antiporter activity in everted membrane vesicles showed that D65C, L67C, E78C, and E82C increased the apparent K-m to Na+ and Li+ and changed the pH response of the antiporter. 3) Introduced Cys replacements, L60C, N64C, F71C, F72C, and E78C, were significantly alkylated by [C-14]N-ethylmaleimide implying the presence of water-filled cavities in NhaA. 4) Several Cys replacements were modified by MTSES and/or MTSET, membrane impermeant, negatively and positively charged reagents, respectively, that could reach Cys replacements from the periplasm only via water-filled funnel(s). Remarkably, the reactivity of D65C to MTSES increased with increasing pH and chemical modification by MTSES but not by MTSET, decreased the apparent Km of the antiporter at pH 7.5 (10-fold) but not at pH 8.5, implying the importance of Asp(65) negative charge for pH activation of the antiporter.	[Herz, Katia; Rimon, Abraham; Padan, Etana] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel; [Olkhova, Elena] Max Planck Inst Biophys, Dept Mol Membrane Biol, D-60438 Frankfurt, Germany	Hebrew University of Jerusalem; Max Planck Society	Padan, E (corresponding author), Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel.	etana@vms.huji.ac.il			USA-Israel Binational Science Foundation [501/03-16.2]; European Union [FP 7]; Max-Planck-Gesellschaft	USA-Israel Binational Science Foundation(US-Israel Binational Science Foundation); European Union(European Commission); Max-Planck-Gesellschaft(Max Planck Society)	This work was supported by USA-Israel Binational Science Foundation Grant 501/03-16.2 and European Union European Drug Initiative on Channels and Transporters Grant FP 7 (to E. P.) and a grant from the Max-Planck-Gesellschaft (to E.O.).	AKABAS MH, 1994, NEURON, V13, P919, DOI 10.1016/0896-6273(94)90257-7; AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; Alexov EG, 1999, BIOCHEMISTRY-US, V38, P8253, DOI 10.1021/bi982700a; Alexov EG, 1997, BIOPHYS J, V72, P2075, DOI 10.1016/S0006-3495(97)78851-9; Appel M, 2009, J MOL BIOL, V386, P351, DOI 10.1016/j.jmb.2008.12.042; BEROZA P, 1995, BIOPHYS J, V68, P2233, DOI 10.1016/S0006-3495(95)80406-6; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brett CL, 2005, AM J PHYSIOL-CELL PH, V288, pC223, DOI 10.1152/ajpcell.00360.2004; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; DAVIS BD, 1950, J BACTERIOL, V60, P17, DOI 10.1128/JB.60.1.17-28.1950; Fisher CL, 1997, BIOTECHNIQUES, V23, P570, DOI 10.2144/97234bm01; Fliegel L, 2008, J MOL CELL CARDIOL, V44, P228, DOI 10.1016/j.yjmcc.2007.11.016; Galili L, 2004, J BIOL CHEM, V279, P23104, DOI 10.1074/jbc.M400288200; Galili L, 2002, BIOCHEMISTRY-US, V41, P609, DOI 10.1021/bi011655v; Gerchman Y, 1999, J BIOL CHEM, V274, P24617, DOI 10.1074/jbc.274.35.24617; GERCHMAN Y, 1993, P NATL ACAD SCI USA, V90, P1212, DOI 10.1073/pnas.90.4.1212; GOLDBERG EB, 1987, P NATL ACAD SCI USA, V84, P2615, DOI 10.1073/pnas.84.9.2615; Gunner MR, 2000, BBA-BIOENERGETICS, V1458, P63, DOI 10.1016/S0005-2728(00)00060-8; Herz K, 2009, J BIOL CHEM, V284, P6337, DOI 10.1074/jbc.M807720200; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; KARPEL R, 1988, J BIOL CHEM, V263, P10408; Kozachkov L, 2007, BIOCHEMISTRY-US, V46, P2419, DOI 10.1021/bi602393s; Landau M, 2007, J BIOL CHEM, V282, P37854, DOI 10.1074/jbc.M705460200; NICHOLLS A, 1991, J COMPUT CHEM, V12, P435, DOI 10.1002/jcc.540120405; Ninio S, 2004, FEBS LETT, V562, P193, DOI 10.1016/S0014-5793(04)00240-6; Olami Y, 1997, J BIOL CHEM, V272, P1761, DOI 10.1074/jbc.272.3.1761; Olkhova E, 2006, P NATL ACAD SCI USA, V103, P2629, DOI 10.1073/pnas.0510914103; Olkhova E, 2007, BIOPHYS J, V92, P3784, DOI 10.1529/biophysj.106.098269; Orlowski J, 2004, PFLUG ARCH EUR J PHY, V447, P549, DOI 10.1007/s00424-003-1110-3; Orlowski J, 2003, SODIUM-HYDROGEN EXCHANGER: FROM MOLECULE TO ITS ROLE IN DISEASE, P17; Padan E, 2005, BBA-BIOMEMBRANES, V1717, P67, DOI 10.1016/j.bbamem.2005.09.010; PADAN E, 1989, J BIOL CHEM, V264, P20297; Padan E, 2001, BBA-BIOENERGETICS, V1505, P144, DOI 10.1016/S0005-2728(00)00284-X; Padan E, 2008, TRENDS BIOCHEM SCI, V33, P435, DOI 10.1016/j.tibs.2008.06.007; PINNER E, 1993, J BIOL CHEM, V268, P1729; Putney LK, 2002, ANNU REV PHARMACOL, V42, P527, DOI 10.1146/annurev.pharmtox.42.092001.143801; Rimon A, 2002, BIOCHEMISTRY-US, V41, P14897, DOI 10.1021/bi0261342; Rimon A, 1998, J BIOL CHEM, V273, P26470, DOI 10.1074/jbc.273.41.26470; ROSEN BP, 1986, METHOD ENZYMOL, V125, P328; Rothman A, 1996, J BIOL CHEM, V271, P32288, DOI 10.1074/jbc.271.50.32288; SCHULDINER S, 1978, BIOCHEMISTRY-US, V17, P706, DOI 10.1021/bi00597a023; SITKOFF D, 1994, BIOPHYS J, V67, P2251, DOI 10.1016/S0006-3495(94)80709-X; TAGLICHT D, 1991, J BIOL CHEM, V266, P11289; TAGLICHT D, 1993, J BIOL CHEM, V268, P5382; Tsuboi Y, 2003, J BIOL CHEM, V278, P21467, DOI 10.1074/jbc.M301932200; Tzubery T, 2004, J BIOL CHEM, V279, P3265, DOI 10.1074/jbc.M309021200; Tzubery T, 2008, J BIOL CHEM, V283, P15975, DOI 10.1074/jbc.M800482200; Venturi M, 2000, J BIOL CHEM, V275, P4734, DOI 10.1074/jbc.275.7.4734; Wakabayashi S, 2003, J BIOL CHEM, V278, P43580, DOI 10.1074/jbc.M306690200	50	33	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2010	285	3					2211	2220		10.1074/jbc.M109.047134	http://dx.doi.org/10.1074/jbc.M109.047134			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	541PJ	19923224	Green Published, hybrid			2022-12-25	WOS:000273429100065
J	Freeman, E; Verghese, P				Freeman, Elliot; Verghese, Preeti			Peeling Plaids Apart: Context Counteracts Cross-Orientation Contrast Masking	PLOS ONE			English	Article							PRIMARY VISUAL-CORTEX; HUMAN-VISION; SPATIAL DISCRIMINATIONS; SPEED DISCRIMINATION; PERCEIVED CONTRAST; SURROUND CONTRAST; MOTION PERCEPTION; ATTENTION; UNCERTAINTY; SEGMENTATION	Background: Contrast discrimination for an image is usually harder if another image is superimposed on top. We asked whether such contrast masking may be enhanced or relieved depending on cues promoting integration of both images as a single pattern, versus segmentation into two independent components. Methodology & Principal Findings: Contrast discrimination thresholds for a foveal test grating were sharply elevated in the presence of a perfectly overlapping orthogonally-oriented mask grating. However thresholds returned to the unmasked baseline when a surround grating was added, having the same orientation and phase of either the test or mask grating. Both such masking and 'unmasking' effects were much stronger for moving than static stimuli. Conclusions & Significance: Our results suggest that common-fate motion reinforces the perception of a single coherent plaid pattern, while the surround helps to identify each component independently, thus peeling the plaid apart again. These results challenge current models of early vision, suggesting that higher-level surface organization influences contrast encoding, determining whether the contrast of a grating may be recovered independently from that of its mask.	[Freeman, Elliot] City Univ London, Dept Psychol, London EC1V 0HB, England; [Verghese, Preeti] Smith Kettlewell Eye Res Inst, San Francisco, CA 94115 USA	City University London; The Smith-Kettlewell Eye Research Institute	Freeman, E (corresponding author), City Univ London, Dept Psychol, London EC1V 0HB, England.	elliot.freeman@city.ac.uk		Freeman, Elliot/0000-0001-7234-824X	UK Biotechnology and Biological Sciences Research Council [S20366]; Brunel Research Initiative and Enterprise Fund; City University research fund; NSF [0347051, 0642728]; Biotechnology and Biological Sciences Research Council [S20366] Funding Source: researchfish	UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Brunel Research Initiative and Enterprise Fund; City University research fund; NSF(National Science Foundation (NSF)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was supported by Smith-Kettlewell Eye Research Institute funds to EF (Rachel C Atkinson Fellowship) and to PV. Additional support came from the UK Biotechnology and Biological Sciences Research Council grant S20366 (EF), the Brunel Research Initiative and Enterprise Fund (EF), City University research fund (EF), and NSF grants 0347051 and 0642728 (PV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADELSON EH, 1982, NATURE, V300, P523, DOI 10.1038/300523a0; ALBRIGHT TD, 1995, P NATL ACAD SCI USA, V92, P2433, DOI 10.1073/pnas.92.7.2433; Arabzadeh E, 2008, PSYCHOL SCI, V19, P635, DOI 10.1111/j.1467-9280.2008.02134.x; BALL K, 1987, VISION RES, V27, P953, DOI 10.1016/0042-6989(87)90011-3; Bonneh Y, 1998, VISION RES, V38, P3541, DOI 10.1016/S0042-6989(98)00045-5; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BURR DC, 1982, VISION RES, V22, P479, DOI 10.1016/0042-6989(82)90196-1; Carandini M, 1997, J NEUROSCI, V17, P8621; Carrasco M, 2000, VISION RES, V40, P1203, DOI 10.1016/S0042-6989(00)00024-9; Cheng EM, 2008, PARKINSONISM RELAT D, V14, P8, DOI 10.1016/j.parkreldis.2007.05.001; Foley JM, 1997, VISION RES, V37, P2781; Foley JM, 1998, J OPT SOC AM A, V15, P1036, DOI 10.1364/JOSAA.15.001036; FOLEY JM, 1994, J OPT SOC AM A, V11, P1710, DOI 10.1364/JOSAA.11.001710; Freeman E, 2001, NAT NEUROSCI, V4, P1032, DOI 10.1038/nn728; Georgeson MA, 1997, VISION RES, V37, P3255, DOI 10.1016/S0042-6989(97)00124-7; Grossberg S, 2001, VISION RES, V41, P2521, DOI 10.1016/S0042-6989(01)00131-6; Grossberg S, 2000, VISION RES, V40, P1413, DOI 10.1016/S0042-6989(99)00229-1; LEGGE GE, 1980, J OPT SOC AM, V70, P1458, DOI 10.1364/JOSA.70.001458; Mareschal I, 2001, VISION RES, V41, P1915, DOI 10.1016/S0042-6989(01)00082-7; Matthews N, 1999, VISION RES, V39, P2205, DOI 10.1016/S0042-6989(98)00300-9; Meese TS, 2007, J VISION, V7, DOI 10.1167/7.4.7; Meese TS, 2004, J VISION, V4, P930, DOI 10.1167/4.10.8; NACHMIAS J, 1974, VISION RES, V14, P1039, DOI 10.1016/0042-6989(74)90175-8; Olzak LA, 2005, J OPT SOC AM A, V22, P2230, DOI 10.1364/JOSAA.22.002230; Pack CC, 2003, NEURON, V39, P671, DOI 10.1016/S0896-6273(03)00439-2; PALMER J, 1994, VISION RES, V34, P1703, DOI 10.1016/0042-6989(94)90128-7; PELLI DG, 1985, J OPT SOC AM A, V2, P1508, DOI 10.1364/JOSAA.2.001508; Petrov Y, 2006, J VISION, V6, P170, DOI 10.1167/6.2.8; Petrov Y, 2005, J NEUROSCI, V25, P8704, DOI 10.1523/JNEUROSCI.2871-05.2005; Qiu FTT, 2007, NAT NEUROSCI, V10, P283, DOI 10.1038/nn1853; Reynolds JH, 2009, NEURON, V61, P168, DOI 10.1016/j.neuron.2009.01.002; ROSS J, 1991, P ROY SOC B-BIOL SCI, V246, P61, DOI 10.1098/rspb.1991.0125; ROSS J, 1993, VISION RES, V33, P2051, DOI 10.1016/0042-6989(93)90003-F; Saenz M, 2002, NAT NEUROSCI, V5, P631, DOI 10.1038/nn876; Snowden RJ, 1998, VISION RES, V38, P1935, DOI 10.1016/S0042-6989(97)00379-9; SOLOMON JA, 1993, VISION RES, V33, P2671, DOI 10.1016/0042-6989(93)90227-N; STONER GR, 1990, NATURE, V344, P153, DOI 10.1038/344153a0; van der Smagt MJ, 2005, J NEUROPHYSIOL, V94, P576, DOI 10.1152/jn.00366.2004; Verghese P, 1996, NATURE, V381, P161, DOI 10.1038/381161a0; VOGELS R, 1988, PERCEPTION, V17, P565, DOI 10.1068/p170565; VONDERHEYDT R, 1984, SCIENCE, V224, P1260, DOI 10.1126/science.6539501; Weidenbacher U, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005909; WELCH L, 1989, NATURE, V337, P734, DOI 10.1038/337734a0; WELCH L, 1990, PERCEPTION, V19, P425, DOI 10.1068/p190425; Wuerger S, 1996, PERCEPTION, V25, P1317, DOI 10.1068/p251317; Xing J, 2001, VISION RES, V41, P571, DOI 10.1016/S0042-6989(00)00270-4; Xing J, 2000, VISION RES, V40, P3065, DOI 10.1016/S0042-6989(00)00152-8; Yazdanbakhsh A, 2004, NEURAL NETWORKS, V17, P707, DOI 10.1016/j.neunet.2004.06.005; Yu C, 2003, J VISION, V3, P527, DOI 10.1167/3.8.1; Yu C, 2002, J VISION, V2, DOI 10.1167/2.3.4	50	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2009	4	12							e8123	10.1371/journal.pone.0008123	http://dx.doi.org/10.1371/journal.pone.0008123			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	533MU	19956546	Green Published, Green Accepted, gold			2022-12-25	WOS:000272828800017
J	Steegers-Theunissen, RP; Obermann-Borst, SA; Kremer, D; Lindemans, J; Siebel, C; Steegers, EA; Slagboom, PE; Heijmans, BT				Steegers-Theunissen, Regine P.; Obermann-Borst, Sylvia A.; Kremer, Dennis; Lindemans, Jan; Siebel, Cissy; Steegers, Eric A.; Slagboom, P. Eline; Heijmans, Bastiaan T.			Periconceptional Maternal Folic Acid Use of 400 mu g per Day Is Related to Increased Methylation of the IGF2 Gene in the Very Young Child	PLOS ONE			English	Article							NEURAL-TUBE DEFECTS; DNA METHYLATION; BECKWITH-WIEDEMANN; FETAL-GROWTH; FORTIFICATION; CANCER; SUPPLEMENTATION; HOMOCYSTEINE; ASSOCIATION; PREVALENCE	Background: Countries worldwide recommend women planning pregnancy to use daily 400 mg of synthetic folic acid in the periconceptional period to prevent birth defects in children. The underlying mechanisms of this preventive effect are not clear, however, epigenetic modulation of growth processes by folic acid is hypothesized. Here, we investigated whether periconceptional maternal folic acid use and markers of global DNA methylation potential (S-adenosylmethionine and S-adenosylhomocysteine blood levels) in mothers and children affect methylation of the insulin-like growth factor 2 gene differentially methylation region (IGF2 DMR) in the child. Moreover, we tested whether the methylation of the IGF2 DMR was independently associated with birth weight. Methodology/Principal Findings: IGF2 DMR methylation in 120 children aged 17 months (SD 0.3) of whom 86 mothers had used and 34 had not used folic acid periconceptionally were studied. Methylation was measured of 5 CpG dinucleotides covering the DMR using a mass spectrometry-based method. Children of mother who used folic acid had a 4.5% higher methylation of the IGF2 DMR than children who were not exposed to folic acid (49.5% vs. 47.4%; p = 0.014). IGF2 DMR methylation of the children also was associated with the S-adenosylmethionine blood level of the mother but not of the child (+1.7% methylation per SD S-adenosylmethionine; p = 0.037). Finally, we observed an inverse independent association between IGF2 DMR methylation and birth weight (21.7% methylation per SD birthweight; p = 0.034). Conclusions: Periconceptional folic acid use is associated with epigenetic changes in IGF2 in the child that may affect intrauterine programming of growth and development with consequences for health and disease throughout life. These results indicate plasticity of IGF2 methylation by periconceptional folic acid use.			Steegers-Theunissen, RP (corresponding author), Univ Med Ctr, Erasmus MC, Div Obstet & Prenatal Med, Rotterdam, Netherlands.	r.steegers@erasmusmc.nl	Slagboom, P. Eline/R-4790-2016	Slagboom, P. Eline/0000-0002-2875-4723				[Anonymous], 1992, MMWR Recomm Rep, V41, P1; AROSIO M, 1995, J ENDOCRINOL INVEST, V18, P346, DOI 10.1007/BF03347836; Cui HM, 2003, SCIENCE, V299, P1753, DOI 10.1126/science.1080902; De Wals P, 2003, BIRTH DEFECTS RES A, V67, P919, DOI 10.1002/bdra.10124; DeBaun MR, 2002, AM J HUM GENET, V70, P604, DOI 10.1086/338934; Eggenschwiler J, 1997, GENE DEV, V11, P3128, DOI 10.1101/gad.11.23.3128; Fawzi WW, 2007, NEW ENGL J MED, V356, P1423, DOI 10.1056/NEJMoa064868; Friso S, 2002, J NUTR, V132, p2382S, DOI 10.1093/jn/132.8.2382S; Gluckman PD, 2003, J NUTR, V133, p1741S, DOI 10.1093/jn/133.5.1741S; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Godwin KA, 2008, CAN J PUBLIC HEALTH, V99, P271, DOI 10.1007/BF03403753; Heijmans BT, 2008, P NATL ACAD SCI USA, V105, P17046, DOI 10.1073/pnas.0806560105; Heijmans BT, 2007, HUM MOL GENET, V16, P547, DOI 10.1093/hmg/ddm010; Honein MA, 2001, JAMA-J AM MED ASSOC, V285, P2981, DOI 10.1001/jama.285.23.2981; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Lillycrop KA, 2008, BRIT J NUTR, V100, P278, DOI 10.1017/S0007114507894438; Lumley J, 2001, BRIT J OBSTET GYNAEC, V108, P937, DOI 10.1111/j.1471-0528.2001.00228.x; Mason JB, 2007, CANCER EPIDEM BIOMAR, V16, P1325, DOI 10.1158/1055-9965.EPI-07-0329; Nurk E, 2004, AM J CLIN NUTR, V79, P812; Ray JG, 2003, J PEDIATR-US, V143, P805, DOI 10.1067/S0022-3476(03)00495-5; Roberfroid D, 2008, AM J CLIN NUTR, V88, P1330, DOI 10.3945/ajcn.2008.26296; Sayed AR, 2008, BIRTH DEFECTS RES A, V82, P211, DOI 10.1002/bdra.20442; Scholl TO, 1996, AM J CLIN NUTR, V63, P520, DOI 10.1093/ajcn/63.4.520; Sinclair K D, 2007, Soc Reprod Fertil Suppl, V64, P425; Sinclair KD, 2007, P NATL ACAD SCI USA, V104, P19351, DOI 10.1073/pnas.0707258104; Smith AD, 2008, AM J CLIN NUTR, V87, P517; Trollmann R, 1996, EUR J PEDIATR SURG, V6, P42; van Driel LMJW, 2008, OBSTET GYNECOL, V112, P277, DOI 10.1097/AOG.0b013e31817dd058; Verkleij-Hagoort AC, 2006, BJOG-INT J OBSTET GY, V113, P1412, DOI 10.1111/j.1471-0528.2006.01109.x; Waterland RA, 2003, J NUTR, V133, P238, DOI 10.1093/jn/133.1.238; Waterland RA, 2006, GENESIS, V44, P401, DOI 10.1002/dvg.20230; WILLET W, 1998, NUTR EPIDEMIOLOGY, P38; Yajnik CS, 2008, REV ENDOCR METAB DIS, V9, P203, DOI 10.1007/s11154-008-9087-z; Yi P, 2000, J BIOL CHEM, V275, P29318, DOI 10.1074/jbc.M002725200	34	331	343	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2009	4	11							e7845	10.1371/journal.pone.0007845	http://dx.doi.org/10.1371/journal.pone.0007845			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520NG	19924280	Green Published, Green Submitted, gold			2022-12-25	WOS:000271851000005
J	Meng, Y; Eshghi, S; Li, YJ; Schmidt, R; Schaffer, DV; Healy, KE				Meng, Ying; Eshghi, Shawdee; Li, Ying J.; Schmidt, Ray; Schaffer, David V.; Healy, Kevin E.			Characterization of integrin engagement during defined human embryonic stem cell culture	FASEB JOURNAL			English	Article						extracellular matrix; Matrigel; peptide; microenvironment; biointerface; cell adhesion; feeder-free cell culture	LAMININ ALPHA-1 CHAIN; SELF-RENEWAL; UNDIFFERENTIATED GROWTH; VITRONECTIN RECEPTOR; SYNTHETIC PEPTIDES; HUMAN BLASTOCYSTS; IN-VITRO; G-DOMAIN; DIFFERENTIATION; ADHESION	Human embryonic stem (hES) cells are pluripotent, capable of differentiating into any cell type of the body, and therefore have the ability to provide insights into mechanisms of human development and disease, as well as to provide a potentially unlimited supply of cells for cell-based therapy and diagnostics. Knowledge of the adhesion receptors that hES cells employ to engage extracellular matrix (ECM) proteins is of basic biological interest and can enhance the design of cell culture and implantation systems to enable these biomedical applications. Although hES cells express a variety of cell surface receptors, little is known about which integrins are involved during subculture and passage. Matrigel is broadly used as a cell adhesive matrix for hES cell culture. Here, we sought to identify which integrins hES cells exploit for adhesion to Matrigel-coated surfaces in defined medium conditions. Using RT-PCR, flow cytometry, and fluorescence immunochemistry, we found that numerous integrins were expressed by H1 hES cells; however, antibody blocking assays indicated that only alpha(v)beta(3), alpha(6), beta(1), and alpha(2)beta(1) played a significant role in the initial adhesion of the hES cells to Matrigel in defined medium conditions. We subsequently identified a cohort of synthetic peptides that, when adsorbed to the culture surface, promoted H1 hES cell attachment and proliferation, as well as maintained a pluripotent phenotype. Peptides designed to engage with alpha(v)beta(3), alpha(6), beta(1), and alpha(2)beta(1) integrins and syndecan-1 were tested both individually and in various combinations. A combination of two integrin-engaging peptides (AG-10, C-16) and one syndecan-engaging peptide (AG-73) was sufficient to promote hES cell adhesion, maintenance, and proliferation. We propose that a specific integrin "fingerprint" is necessary for maintenance of hES cell self-renewal, and synthetic culture systems must capture this engagement profile for hES cells to remain undifferentiated.-Meng, Y., Eshghi, S., Li, Y. J., Schmidt, R., Schaffer, D. V., Healy, K. E. Characterization of integrin engagement during defined human embryonic stem cell culture. FASEB J. 24, 1056-1065 (2010). www.fasebj.org	[Schaffer, David V.; Healy, Kevin E.] Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA; [Meng, Ying; Eshghi, Shawdee; Li, Ying J.; Schmidt, Ray; Schaffer, David V.; Healy, Kevin E.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Eshghi, Shawdee; Schaffer, David V.] Univ Calif Berkeley, Dept Chem Engn, Berkeley, CA 94720 USA; [Schaffer, David V.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Healy, KE (corresponding author), Univ Calif Berkeley, Dept Mat Sci & Engn, 370 Hearst Mem Min Bldg 1760, Berkeley, CA 94720 USA.	kehealy@berkeley.edu			University of California Discovery [bio06-10597]; U.S. National Institutes of Health; NIH [R21DE18044, R21DE018044, R01GM085754]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE018044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085754] Funding Source: NIH RePORTER	University of California Discovery(University of California System); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the University of California Discovery Grant program (bio06-10597) and Geron Corporation (Menlo Park, CA, USA), as well as by U.S. National Institutes of Health grants NIH R21DE18044, R21DE018044, and R01GM085754.The authors thank Elizabeth Irwin and Eric Jabart (University of California-Berkeley) for their critical reading of the manuscript.The authors thank Kiichiro Tomoda and Shinya Yamanaka (Gladstone Institute of Cardiovascular Disease, San Francisco, CA, USA) for the pluripotency and germ layer marker PCR primers and reaction conditions.Y.M., S.E., and Y.J.L.were responsible for collection and/or assembly of data, data analysis and interpretation, and manuscript writing.R.S.was responsible for collection and/or assembly of data, and manuscript writing. D.V.S.was responsible for conception and design, financial support, data analysis and interpretation, and manuscript writing.K.E.H.was responsible for conception and design, financial support, data analysis and interpretation, manuscript writing, and final approval of manuscript.	Adjaye J, 2005, STEM CELLS, V23, P1514, DOI 10.1634/stemcells.2005-0113; Beattie GM, 2005, STEM CELLS, V23, P489, DOI 10.1634/stemcells.2004-0279; Brandenberger R, 2004, NAT BIOTECHNOL, V22, P707, DOI 10.1038/nbt971; Chase LG, 2007, CURR OPIN CHEM BIOL, V11, P367, DOI 10.1016/j.cbpa.2007.06.421; Cheng LZ, 2003, STEM CELLS, V21, P131, DOI 10.1634/stemcells.21-2-131; COOPER HM, 1991, J CELL BIOL, V115, P843, DOI 10.1083/jcb.115.3.843; Derda R, 2007, ACS CHEM BIOL, V2, P347, DOI 10.1021/cb700032u; FASSLER R, 1995, J CELL BIOL, V128, P979, DOI 10.1083/jcb.128.5.979; Fletcher JM, 2006, CLONING STEM CELLS, V8, P319, DOI 10.1089/clo.2006.8.319; Genbacev O, 2005, FERTIL STERIL, V83, P1517, DOI 10.1016/j.fertnstert.2005.01.086; Hansen KC, 2009, MOL CELL PROTEOMICS, V8, P1648, DOI 10.1074/mcp.M900039-MCP200; Hayashi Y, 2007, STEM CELLS, V25, P3005, DOI 10.1634/stemcells.2007-0103; HIERCK BP, 1993, CELL ADHES COMMUN, V1, P1; Hoffman MP, 1998, J BIOL CHEM, V273, P28633, DOI 10.1074/jbc.273.44.28633; Hoffman MP, 2001, J BIOL CHEM, V276, P22077, DOI 10.1074/jbc.M100774200; HOGERVORST F, 1993, J CELL BIOL, V121, P179, DOI 10.1083/jcb.121.1.179; HORTON M, 1990, INT J EXP PATHOL, V71, P741; Ilic D, 1998, J CELL BIOL, V143, P547; Ingber DE, 2003, J CELL SCI, V116, P1397, DOI 10.1242/jcs.00360; KLEINMAN HK, 1979, J SUPRAMOL STR CELL, V11, P69, DOI 10.1002/jss.400110108; KLEINMAN HK, 1982, BIOCHEMISTRY-US, V21, P6188, DOI 10.1021/bi00267a025; Leahy A, 1999, J EXP ZOOL, V284, P67, DOI 10.1002/(SICI)1097-010X(19990615)284:1&lt;67::AID-JEZ10&gt;3.0.CO;2-O; Li XJ, 2006, METH MOL B, V331, P169; Li Y, 2005, BIOTECHNOL BIOENG, V91, P688, DOI 10.1002/bit.20536; Li YJ, 2006, J BIOMED MATER RES A, V79A, P1, DOI 10.1002/jbm.a.30732; Liu YX, 2006, BIOCHEM BIOPH RES CO, V346, P131, DOI 10.1016/j.bbrc.2006.05.086; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; Martin MJ, 2005, NAT MED, V11, P228, DOI 10.1038/nm1181; Miura T, 2004, STEM CELLS DEV, V13, P694, DOI 10.1089/scd.2004.13.694; Nakahara H, 1996, J BIOL CHEM, V271, P27221, DOI 10.1074/jbc.271.44.27221; NOMIZU M, 1995, J BIOL CHEM, V270, P20583, DOI 10.1074/jbc.270.35.20583; Ponce ML, 2001, FASEB J, V15, P1389, DOI 10.1096/fj.00-0736com; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Rezania A, 1999, J ORTHOPAED RES, V17, P615, DOI 10.1002/jor.1100170423; Richards M, 2002, NAT BIOTECHNOL, V20, P933, DOI 10.1038/nbt726; RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619; SMITH JW, 1990, J BIOL CHEM, V265, P2168; STAATZ WD, 1990, J BIOL CHEM, V265, P4778; STEPHENS LE, 1995, GENE DEV, V9, P1883, DOI 10.1101/gad.9.15.1883; Stupack DG, 2001, J CELL BIOL, V155, P459, DOI 10.1083/jcb.200106070; Stupack DG, 2002, J CELL SCI, V115, P3729, DOI 10.1242/jcs.00071; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; TAMURA RN, 1991, P NATL ACAD SCI USA, V88, P10183, DOI 10.1073/pnas.88.22.10183; Tanentzapf G, 2007, NAT CELL BIOL, V9, P1413, DOI 10.1038/ncb1660; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; WANG N, 1993, SCIENCE, V260, P1124, DOI 10.1126/science.7684161; Xiao L, 2006, STEM CELLS, V24, P1476, DOI 10.1634/stemcells.2005-0299; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Yao S, 2006, P NATL ACAD SCI USA, V103, P6907, DOI 10.1073/pnas.0602280103	50	84	90	0	32	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2010	24	4					1056	1065		10.1096/fj.08-126821	http://dx.doi.org/10.1096/fj.08-126821			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	580PV	19933311	Green Published			2022-12-25	WOS:000276462300013
J	Powers, GL; Ellison-Zelski, SJ; Casa, AJ; Lee, AV; Alarid, ET				Powers, G. L.; Ellison-Zelski, S. J.; Casa, A. J.; Lee, A. V.; Alarid, E. T.			Proteasome inhibition represses ER alpha gene expression in ER plus cells: a new link between proteasome activity and estrogen signaling in breast cancer	ONCOGENE			English	Article						nuclear receptor; proteolysis; hormone-dependent cancer; bortezomib; transcription	RECEPTOR-ALPHA; ANTIESTROGEN ICI-182780; BORTEZOMIB PS-341; PURE ANTIESTROGEN; OVARIAN-CANCER; PHASE-II; PROTEIN; DEGRADATION; THERAPY; GROWTH	Estrogen receptor-alpha (ER alpha) is a major therapeutic target of hormonal therapies in breast cancer, and its expression in tumors is predictive of clinical response. Protein levels of ER alpha are tightly controlled by the 26S proteasome; yet, how the clinical proteasome inhibitor, bortezomib, affects ER alpha regulation has not been studied. Bortezomib selectively inhibits the chymotrypsin-like activity of the proteasome. Unlike other laboratory proteasome inhibitors, bortezomib failed to stabilize ER alpha protein at a dose exceeding 90% inhibition of the chymotrypsin-like activity. Unexpectedly, however, chronic bortezomib exposure caused a reduction of ER alpha levels in multiple ER+ breast cancer cell lines. This response can be explained by the fact that bortezomib induced a dramatic decrease in ER alpha mRNA because of direct transcriptional inhibition and loss of RNA polymerase II recruitment on the ER alpha gene promoter. Bortezomib treatment resulted in promoter-specific changes in estrogen-induced gene transcription that related with occupancy of ER alpha and RNA polymerase II (PolII) on endogenous promoters. In addition, bortezomib inhibited estrogen-dependent growth in soft agar. These results reveal a novel link between proteasome activity and expression of ER alpha in breast cancer and uncover distinct roles of the chymotrypsin-like activity of the proteasome in the regulation of the ER alpha pathway. Oncogene (2010) 29, 1509-1518; doi:10.1038/onc.2009.434; published online 30 November 2009	[Alarid, E. T.] Univ Wisconsin, Dept Oncol, Wisconsin Inst Med Res 6151, Madison, WI 53705 USA; [Casa, A. J.; Lee, A. V.] Baylor Coll Med, Lester & Sue Smith Breast Ctr, Houston, TX 77030 USA; [Casa, A. J.; Lee, A. V.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	University of Wisconsin System; University of Wisconsin Madison; Baylor College of Medicine; Baylor College of Medicine	Alarid, ET (corresponding author), Univ Wisconsin, Dept Oncol, Wisconsin Inst Med Res 6151, 1111 Highland Ave, Madison, WI 53705 USA.	alarid@oncology.wisc.edu		Lee, Adrian/0000-0001-9917-514X	NIH [DK64034, DAMD-17-02-1-0286, T32CA009135, T32GM08688, W81XWH-06-1-0714]; NATIONAL CANCER INSTITUTE [T32CA009135, R01CA104708] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008688] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Grants NIH DK64034 (ETA), DAMD-17-02-1-0286 (AVL), T32CA009135 (GLP), T32GM08688 (GLP) and W81XWH-06-1-0714 (AJC). We thank Drs Shigeki Miyamoto and Michael Fritsch for reagents.	Adams BD, 2007, MOL ENDOCRINOL, V21, P1132, DOI 10.1210/me.2007-0022; Alarid ET, 2006, MOL ENDOCRINOL, V20, P1972, DOI 10.1210/me.2005-0481; Alarid ET, 1999, MOL ENDOCRINOL, V13, P1522, DOI 10.1210/me.13.9.1522; Bazzaro M, 2006, CANCER RES, V66, P3754, DOI 10.1158/0008-5472.CAN-05-2321; Bossola M, 2003, ANN SURG, V237, P384, DOI 10.1097/00000658-200303000-00013; Cardoso F, 2006, MOL CANCER THER, V5, P3042, DOI 10.1158/1535-7163.MCT-06-0104; Chen L, 2005, CANCER RES, V65, P5599, DOI 10.1158/0008-5472.CAN-05-0201; Chia S, 2008, J CLIN ONCOL, V26, P1664, DOI 10.1200/JCO.2007.13.5822; Clarke RB, 1997, CANCER RES, V57, P4987; Coates AS, 2007, J CLIN ONCOL, V25, P486, DOI 10.1200/JCO.2006.08.8617; Codony-Servat J, 2006, MOL CANCER THER, V5, P665, DOI 10.1158/1535-7163.MCT-05-0147; DAUVOIS S, 1993, J CELL SCI, V106, P1377; DEFRIEND DJ, 1994, BRIT J CANCER, V70, P204, DOI 10.1038/bjc.1994.281; DeNardo DG, 2007, MOL CELL ENDOCRINOL, V277, P13, DOI 10.1016/j.mce.2007.07.006; Denger S, 2001, MOL ENDOCRINOL, V15, P2064, DOI 10.1210/me.15.12.2064; Dhasarathy A, 2007, MOL ENDOCRINOL, V21, P2907, DOI 10.1210/me.2007-0293; DOWSETT M, 1985, BRIT J CANCER, V52, P31, DOI 10.1038/bjc.1985.144; El Khissiin A, 1999, FEBS LETT, V448, P160, DOI 10.1016/S0014-5793(99)00343-9; Ellison-Zelski SJ, 2009, MOL CELL BIOL, V29, P4949, DOI 10.1128/MCB.00383-09; Engel RH, 2007, CANCER INVEST, V25, P733, DOI 10.1080/07357900701506573; FABRIS G, 1987, J STEROID BIOCHEM, V27, P171, DOI 10.1016/0022-4731(87)90307-4; Fan MY, 2004, MOL ENDOCRINOL, V18, P2603, DOI 10.1210/me.2004-0164; Feng Y, 2007, P NATL ACAD SCI USA, V104, P14718, DOI 10.1073/pnas.0706933104; Fowler AM, 2006, MOL ENDOCRINOL, V20, P291, DOI 10.1210/me.2005-0288; Han YQ, 2008, MOL CANCER RES, V6, P1347, DOI 10.1158/1541-7786.MCR-07-2179; Harrell JC, 2007, CANCER RES, V67, P10582, DOI 10.1158/0008-5472.CAN-07-1655; Heinemeyer W, 1997, J BIOL CHEM, V272, P25200, DOI 10.1074/jbc.272.40.25200; Hui R, 2002, CANCER RES, V62, P6916; JORDAN VC, 1976, CANCER TREAT REP, V60, P1409; Khan SA, 1999, CANCER EPIDEM BIOMAR, V8, P867; Kisselev AF, 2006, J BIOL CHEM, V281, P8582, DOI 10.1074/jbc.M509043200; Kondo N, 2008, CANCER RES, V68, P5004, DOI 10.1158/0008-5472.CAN-08-0180; Kos M, 2001, MOL ENDOCRINOL, V15, P2057, DOI 10.1210/me.15.12.2057; KUMATORI A, 1990, P NATL ACAD SCI USA, V87, P7071, DOI 10.1073/pnas.87.18.7071; Lee S, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1367; Lee S, 2007, AM J PATHOL, V171, P252, DOI 10.2353/ajpath.2007.061010; Liedtke C, 2009, ANN ONCOL; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lonard DM, 2000, MOL CELL, V5, P939, DOI 10.1016/S1097-2765(00)80259-2; Maki CG, 1996, CANCER RES, V56, P2649; Marx C, 2007, MOL PHARMACOL, V71, P1525, DOI 10.1124/mol.107.034090; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Nawaz Z, 1999, P NATL ACAD SCI USA, V96, P1858, DOI 10.1073/pnas.96.5.1858; NOMURA Y, 1985, CANCER, V55, P546, DOI 10.1002/1097-0142(19850201)55:3<546::AID-CNCR2820550313>3.0.CO;2-V; O'Donnell AJM, 2005, ENDOCR-RELAT CANCER, V12, P851, DOI 10.1677/erc.1.01039; Oesterreich S, 2001, CANCER RES, V61, P5771; ORLOWSKI M, 1981, BIOCHEM BIOPH RES CO, V101, P814; Pandey DP, 2009, MOL CELL BIOL, V29, P3783, DOI 10.1128/MCB.01875-08; PARKER MG, 1993, BREAST CANCER RES TR, V26, P131, DOI 10.1007/BF00689686; Qin CH, 2002, MOL ENDOCRINOL, V16, P1793, DOI 10.1210/me.2002-0006; Reid G, 2003, MOL CELL, V11, P695, DOI 10.1016/S1097-2765(03)00090-X; Richardson PG, 2006, ANNU REV MED, V57, P33, DOI 10.1146/annurev.med.57.042905.122625; Robertson JFR, 2009, J CLIN ONCOL, V27, P4530, DOI 10.1200/JCO.2008.21.1136; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Shaaban AM, 2002, AM J PATHOL, V160, P597, DOI 10.1016/S0002-9440(10)64879-1; Shah MH, 2004, CLIN CANCER RES, V10, P6111, DOI 10.1158/1078-0432.CCR-04-0422; Shoker BS, 1999, AM J PATHOL, V155, P1811, DOI 10.1016/S0002-9440(10)65498-3; Taggart CC, 2002, J BIOL CHEM, V277, P33648, DOI 10.1074/jbc.M203710200; Teicher BA, 1999, CLIN CANCER RES, V5, P2638; Valley CC, 2005, MOL CELL BIOL, V25, P5417, DOI 10.1128/MCB.25.13.5417-5428.2005; Valley CC, 2008, J MOL ENDOCRINOL, V40, P23, DOI 10.1677/JME-07-0067; Viale G, 2007, J CLIN ONCOL, V25, P3846, DOI 10.1200/JCO.2007.11.9453; WAKELING AE, 1991, CANCER RES, V51, P3867; Wang XB, 2009, MOL CELL BIOL, V29, P3832, DOI 10.1128/MCB.00032-09; Wijayaratne AL, 2001, J BIOL CHEM, V276, P35684, DOI 10.1074/jbc.M101097200; Wong DJ, 2008, CANCER RES, V68, P369, DOI 10.1158/0008-5472.CAN-07-0382; Xu HM, 2008, BREAST CANCER RES TR, V107, P267, DOI 10.1007/s10549-007-9553-4; Yang CH, 2006, ANN ONCOL, V17, P813, DOI 10.1093/annonc/mdj131; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85	69	42	47	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2010	29	10					1509	1518		10.1038/onc.2009.434	http://dx.doi.org/10.1038/onc.2009.434			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	566SD	19946334	Green Accepted			2022-12-25	WOS:000275392400009
J	Campbell, S; Hazes, B; Kvansakul, M; Colman, P; Barry, M				Campbell, Stephanie; Hazes, Bart; Kvansakul, Marc; Colman, Peter; Barry, Michele			Vaccinia Virus F1L Interacts with Bak Using Highly Divergent Bcl-2 Homology Domains and Replaces the Function of Mcl-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C RELEASE; PROAPOPTOTIC PROTEIN BAK; BH3-ONLY PROTEINS; MYXOMA-VIRUS; GRANZYME-B; CELL-DEATH; BLOCKS APOPTOSIS; FOWLPOX VIRUS; E1B 19K; MITOCHONDRIAL-MEMBRANE	The Bcl-2 family regulates induction of apoptosis at the mitochondria. Essential to this regulation are the interactions between Bcl-2 family members, which are mediated by Bcl-2 homology (BH) domains. Vaccinia virus F1L is a unique inhibitor of apoptosis that lacks significant sequence similarity with the Bcl-2 family and does not contain obvious BH domains. Despite this, F1L inhibits cytochrome c release from mitochondria by preventing Bak and Bax activation. Although F1L constitutively interacts with Bak to prevent Bak activation, the precise mechanism of this interaction remains elusive. We have identified highly divergent BH domains in F1L that were verified by the recent crystal structure of F1L (Kvansakul, M., Yang, H., Fairlie, W. D., Czabotar, P. E., Fischer, S. F., Perugini, M. A., Huang, D. C., and Colman, P. M. (2008) Cell Death Differ. 15, 1564-1571). Here we show that F1L required these BH domains to interact with ectopically expressed and endogenous Bak. The interaction between F1L and Bak was conserved across species, and both F1L and the cellular antiapoptotic protein Mcl-1 required the Bak BH3 domain for interaction. Moreover, F1L replaced Mcl-1 during infection, as the Bak.Mcl-1 complex was disrupted during vaccinia virus infection. In contrast to UV irradiation, vaccinia virus infection did not result in rapid degradation of Mcl-1, consistent with our observation that vaccinia virus did not initiate a DNA damage response. Additionally, Mcl-1 expression prevented Bak activation and apoptosis during infection with a proapoptotic vaccinia virus devoid of F1L. Our data suggest that F1L replaces the antiapoptotic activity of Mcl-1 during vaccinia virus infection by interacting with Bak using highly divergent BH domains.	[Campbell, Stephanie; Hazes, Bart; Barry, Michele] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB T6G 2S2, Canada; [Kvansakul, Marc; Colman, Peter] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia	University of Alberta; Walter & Eliza Hall Institute	Barry, M (corresponding author), Univ Alberta, Dept Med Microbiol & Immunol, 621 HMRC, Edmonton, AB T6G 2S2, Canada.	michele.barry@ualberta.ca	Kvansakul, Marc/AAF-2453-2019	Kvansakul, Marc/0000-0003-2639-2498	Canadian Institutes of Health Research; Howard Hughes Medical Institute	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was supported by grants from the Canadian Institutes of Health Research and the Howard Hughes Medical Institute (to M. B.).	Afonso CL, 2000, J VIROL, V74, P3815, DOI 10.1128/JVI.74.8.3815-3831.2000; Antonsson B, 2001, J BIOL CHEM, V276, P11615, DOI 10.1074/jbc.M010810200; Banadyga L, 2007, J VIROL, V81, P11032, DOI 10.1128/JVI.00734-07; Banadyga L, 2009, J VIROL, V83, P7085, DOI 10.1128/JVI.00437-09; Barry M, 2000, MOL CELL BIOL, V20, P3781, DOI 10.1128/MCB.20.11.3781-3794.2000; Barry M, 2004, PROG MOL SUBCELL BIO, V36, P19; Benedict CA, 2002, NAT IMMUNOL, V3, P1013, DOI 10.1038/ni1102-1013; Boya P, 2004, BBA-BIOENERGETICS, V1659, P178, DOI 10.1016/j.bbabio.2004.08.007; BOYD JM, 1995, ONCOGENE, V11, P1921; Cheng EHY, 1997, P NATL ACAD SCI USA, V94, P690, DOI 10.1073/pnas.94.2.690; CHITTENDEN T, 1995, EMBO J, V14, P5589, DOI 10.1002/j.1460-2075.1995.tb00246.x; Clohessy JG, 2006, J BIOL CHEM, V281, P5750, DOI 10.1074/jbc.M505688200; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Cuconati A, 2003, GENE DEV, V17, P2922, DOI 10.1101/gad.1156903; Cuconati A, 2002, GENE DEV, V16, P2465, DOI 10.1101/gad.1012702; Degenhardt K, 2002, J BIOL CHEM, V277, P14127, DOI 10.1074/jbc.M109939200; Douglas AE, 2007, PROTEIN SCI, V16, P695, DOI 10.1110/ps.062720107; Earl PL, 1998, CURRENT PROTOCOLS MO; Everett H, 2000, J EXP MED, V191, P1487, DOI 10.1084/jem.191.9.1487; Fischer SF, 2006, CELL DEATH DIFFER, V13, P109, DOI 10.1038/sj.cdd.4401718; Galluzzi L, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000018; Griffiths GJ, 2001, ONCOGENE, V20, P7668, DOI 10.1038/sj.onc.1204995; Griffiths GJ, 1999, J CELL BIOL, V144, P903, DOI 10.1083/jcb.144.5.903; Han J, 2005, J BIOL CHEM, V280, P16383, DOI 10.1074/jbc.M411377200; Han J, 2004, J BIOL CHEM, V279, P22020, DOI 10.1074/jbc.M313234200; Han J, 1996, MOL CELL BIOL, V16, P5857; Han JH, 1996, GENE DEV, V10, P461, DOI 10.1101/gad.10.4.461; Han JH, 1998, ONCOGENE, V17, P2993, DOI 10.1038/sj.onc.1202215; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Hsu YT, 1997, J BIOL CHEM, V272, P13829, DOI 10.1074/jbc.272.21.13829; Huang QL, 2002, P NATL ACAD SCI USA, V99, P3428, DOI 10.1073/pnas.062525799; Khanim F, 1997, J GEN VIROL, V78, P2987, DOI 10.1099/0022-1317-78-11-2987; KOO GC, 1984, HYBRIDOMA, V3, P301, DOI 10.1089/hyb.1984.3.301; Kvansakul M, 2008, CELL DEATH DIFFER, V15, P1564, DOI 10.1038/cdd.2008.83; Kvansakul M, 2007, MOL CELL, V25, P933, DOI 10.1016/j.molcel.2007.02.004; Langland JO, 2006, J VIROL, V80, P10083, DOI 10.1128/JVI.00607-06; Leu JIJ, 2004, NAT CELL BIOL, V6, P443, DOI 10.1038/ncb1123; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Marsden VS, 2003, ANNU REV IMMUNOL, V21, P71, DOI 10.1146/annurev.immunol.21.120601.141029; Mei YD, 2005, ONCOGENE, V24, P7224, DOI 10.1038/sj.onc.1208873; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Nijhawan D, 2003, GENE DEV, V17, P1475, DOI 10.1101/gad.1093903; Petros AM, 2004, BBA-MOL CELL RES, V1644, P83, DOI 10.1016/j.bbamcr.2003.08.012; Postigo A, 2006, CELL DEATH DIFFER, V13, P1651, DOI 10.1038/sj.cdd.4401853; Revilla Y, 1997, VIROLOGY, V228, P400, DOI 10.1006/viro.1996.8395; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Roulston A, 1999, ANNU REV MICROBIOL, V53, P577, DOI 10.1146/annurev.micro.53.1.577; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Shimazu T, 2007, GENE DEV, V21, P929, DOI 10.1101/gad.1522007; Stewart TL, 2005, J VIROL, V79, P1084, DOI 10.1128/JVI.79.2.1084-1098.2005; STUART D, 1991, J VIROL, V65, P61, DOI 10.1128/JVI.65.1.61-70.1991; Su J, 2006, J VIROL, V80, P1140, DOI 10.1128/JVI.80.3.1140-1151.2006; Taylor JM, 2006, VIROLOGY, V344, P139, DOI 10.1016/j.virol.2005.09.032; Taylor JM, 2006, J BIOL CHEM, V281, P39728, DOI 10.1074/jbc.M607465200; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tulman ER, 2004, J VIROL, V78, P353, DOI 10.1128/JVI.78.1.353-366.2004; Ulrich E, 1997, GENOMICS, V44, P195, DOI 10.1006/geno.1997.4858; van Buuren N, 2008, J VIROL, V82, P9917, DOI 10.1128/JVI.00953-08; Wang G, 2004, J VIROL, V78, P7097, DOI 10.1128/JVI.78.13.7097-7111.2004; Wang GQ, 2001, J EXP MED, V194, P1325, DOI 10.1084/jem.194.9.1325; Wang XD, 2001, GENE DEV, V15, P2922; Wasilenko ST, 2003, P NATL ACAD SCI USA, V100, P14345, DOI 10.1073/pnas.2235583100; Wasilenko ST, 2005, J VIROL, V79, P14031, DOI 10.1128/JVI.79.22.14031-14043.2005; Wasilenko ST, 2001, J VIROL, V75, P11437, DOI 10.1128/JVI.75.23.11437-11448.2001; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei MC, 2000, GENE DEV, V14, P2060; Westphal D, 2007, J VIROL, V81, P7178, DOI 10.1128/JVI.00404-07; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Willis SN, 2005, CURR OPIN CELL BIOL, V17, P617, DOI 10.1016/j.ceb.2005.10.001; YIN XM, 1994, NATURE, V369, P321, DOI 10.1038/369321a0; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhai DY, 2008, J BIOL CHEM, V283, P9580, DOI 10.1074/jbc.M708426200	74	26	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4695	4708		10.1074/jbc.M109.053769	http://dx.doi.org/10.1074/jbc.M109.053769			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	19955184	hybrid, Green Published			2022-12-25	WOS:000275274800047
J	Porten, E; Seliger, B; Schneider, VA; Woll, S; Stangel, D; Ramseger, R; Kroger, S				Porten, Elmar; Seliger, Beate; Schneider, Verena A.; Woell, Stefan; Stangel, Daniela; Ramseger, Rene; Kroeger, Stephan			The Process-inducing Activity of Transmembrane Agrin Requires Follistatin-like Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE PROTEOGLYCAN; CALCIUM-BINDING PROTEIN; NEOCORTEX IN-VIVO; DENDRITIC FILOPODIA; HIPPOCAMPAL-NEURONS; SYNAPSE FORMATION; DEFICIENT MICE; NEURITE OUTGROWTH; AVIAN RETINA; LIPID RAFTS	Clustering or overexpression of the transmembrane form of the extracellular matrix proteoglycan agrin in neurons results in the formation of numerous highly motile filopodia-like processes extending from axons and dendrites. Here we show that similar processes can be induced by overexpression of transmembrane-agrin in several non-neuronal cell lines. Mapping of the process-inducing activity in neurons and non-neuronal cells demonstrates that the cytoplasmic part of transmembrane agrin is dispensable and that the extracellular region is necessary for process formation. Site-directed mutagenesis reveals an essential role for the loop between beta-sheets 3 and 4 within the Kazal subdomain of the seventh follistatin-like domain of TM-agrin. An aspartic acid residue within this loop is critical for process formation. The seventh follistatin-like domain could be functionally replaced by the first and sixth but not by the eighth follistatin-like domain, demonstrating a functional redundancy among some follistatin-like domains of agrin. Moreover, a critical distance of the seventh follistatin-like domain to the plasma membrane appears to be required for process formation. These results demonstrate that different regions within the agrin protein are responsible for synapse formation at the neuromuscular junction and for process formation in central nervous system neurons and suggest a role for agrin's follistatin-like domains in the developing central nervous system.	[Kroeger, Stephan] Johannes Gutenberg Univ Mainz, Dept Physiol Chem, D-55128 Mainz, Germany; [Seliger, Beate; Schneider, Verena A.; Stangel, Daniela; Kroeger, Stephan] Univ Munich, Dept Physiol, D-80336 Munich, Germany	Johannes Gutenberg University of Mainz; University of Munich	Kroger, S (corresponding author), Johannes Gutenberg Univ Mainz, Dept Physiol Chem, D-55128 Mainz, Germany.	skroeger@lmu.de		Kroger, Stephan/0000-0002-4626-1690	Deutsche Forschungsgemeinschaft [KR 1039/7, KR 1039/9]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Supported by the Deutsche Forschungsgemeinschaft (DFG Grant KR 1039/7) and the DFG Priority Program 1086 (Grant KR 1039/9).	Adams JC, 2000, J CELL BIOL, V150, P807, DOI 10.1083/jcb.150.4.807; Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; Annies M, 2006, MOL CELL NEUROSCI, V31, P515, DOI 10.1016/j.mcn.2005.11.005; Annies M, 2002, MOL CELL NEUROSCI, V20, P525, DOI 10.1006/mcne.2002.1125; Baerwald-De La Torre K, 2004, J NEUROCHEM, V90, P50, DOI 10.1111/j.1471-4159.2004.02454.x; Bezakova G, 2003, NAT REV MOL CELL BIO, V4, P295, DOI 10.1038/nrm1074; Bork P, 1996, Q REV BIOPHYS, V29, P119, DOI 10.1017/S0033583500005783; Bose CM, 2000, J NEUROSCI, V20, P9086; BOWE MA, 1994, NEURON, V12, P1173, DOI 10.1016/0896-6273(94)90324-7; Burgess RW, 2000, J CELL BIOL, V151, P41, DOI 10.1083/jcb.151.1.41; Dailey ME, 1996, J NEUROSCI, V16, P2983; Denzer AJ, 1997, J CELL BIOL, V137, P671, DOI 10.1083/jcb.137.3.671; Denzer AJ, 1998, EMBO J, V17, P335, DOI 10.1093/emboj/17.2.335; Dityateva G, 2003, J NEUROSCI METH, V130, P65, DOI 10.1016/S0165-0270(03)00202-4; Ferreira A, 1999, J CELL SCI, V112, P4729; Fiala JC, 1998, J NEUROSCI, V18, P8900; Frischknecht R, 2008, J NEUROSCI, V28, P1568, DOI 10.1523/JNEUROSCI.3398-07.2008; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; Gesemann M, 1998, J BIOL CHEM, V273, P600, DOI 10.1074/jbc.273.1.600; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Hilgenberg LGW, 2006, CELL, V125, P359, DOI 10.1016/j.cell.2006.01.052; Hohenester E, 1997, EMBO J, V16, P3778, DOI 10.1093/emboj/16.13.3778; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Hopf C, 1996, J BIOL CHEM, V271, P5231; Innis CA, 2003, J BIOL CHEM, V278, P39969, DOI 10.1074/jbc.M211284200; INOUYE S, 1991, BIOCHEM BIOPH RES CO, V179, P352, DOI 10.1016/0006-291X(91)91377-O; Kim MJ, 2003, J NEUROBIOL, V55, P261, DOI 10.1002/neu.10213; Kim N, 2008, CELL, V135, P334, DOI 10.1016/j.cell.2008.10.002; Knott G, 2008, BRAIN RES REV, V58, P282, DOI 10.1016/j.brainresrev.2008.01.002; Knott GW, 2006, NAT NEUROSCI, V9, P1117, DOI 10.1038/nn1747; Kroger S, 2009, FUTUR NEUROL, V4, P67, DOI 10.2217/14796708.4.1.67; Kroger S, 2002, NEWS PHYSIOL SCI, V17, P207, DOI 10.1152/01390.2002; Kroger S, 1996, J NEUROBIOL, V29, P165; Kroger S, 1997, MOL CELL NEUROSCI, V10, P149, DOI 10.1006/mcne.1997.0651; Ksiazek I, 2007, J NEUROSCI, V27, P7183, DOI 10.1523/JNEUROSCI.1609-07.2007; Li Z, 1999, J NEUROBIOL, V39, P547, DOI 10.1002/(SICI)1097-4695(19990615)39:4<547::AID-NEU8>3.0.CO;2-C; Lin S, 2008, J NEUROSCI, V28, P3333, DOI 10.1523/JNEUROSCI.5590-07.2008; Lohmann C, 2008, NEURON, V59, P253, DOI 10.1016/j.neuron.2008.05.025; Matsumoto-Miyai K, 2009, CELL, V136, P1161, DOI 10.1016/j.cell.2009.02.034; McCroskery S, 2009, NEUROSCIENCE, V163, P168, DOI 10.1016/j.neuroscience.2009.06.012; McCroskery S, 2006, MOL CELL NEUROSCI, V33, P15, DOI 10.1016/j.mcn.2006.06.004; MURPHYULLRICH JE, 1995, J CELL BIOCHEM, V57, P341, DOI 10.1002/jcb.240570218; Neumann FR, 2001, MOL CELL NEUROSCI, V17, P208, DOI 10.1006/mcne.2000.0932; Parnass Z, 2000, HIPPOCAMPUS, V10, P561, DOI 10.1002/1098-1063(2000)10:5<561::AID-HIPO6>3.3.CO;2-O; Ramseger R, 2009, J BIOL CHEM, V284, P7697, DOI 10.1074/jbc.M806719200; Reif R, 2007, FASEB J, V21, P3468, DOI 10.1096/fj.07-8800com; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Serpinskaya AS, 1999, DEV BIOL, V205, P65, DOI 10.1006/dbio.1998.9112; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Stephan A, 2008, FASEB J, V22, P1861, DOI 10.1096/fj.07-100008; SUMITOMO S, 1995, BIOCHEM BIOPH RES CO, V208, P1, DOI 10.1006/bbrc.1995.1297; TSEN G, 1995, J BIOL CHEM, V270, P3392, DOI 10.1074/jbc.270.7.3392; Uchida T, 1999, BIOCHEM BIOPH RES CO, V266, P593, DOI 10.1006/bbrc.1999.1873; Uhm CS, 2001, J NEUROSCI, V21, P9678, DOI 10.1523/JNEUROSCI.21-24-09678.2001; Ullman CG, 1997, BIOCHEM J, V326, P939, DOI 10.1042/bj3260929v; Vannahme C, 2003, BIOCHEM J, V373, P805, DOI 10.1042/BJ20030532; Vannahme C, 2002, J BIOL CHEM, V277, P37977, DOI 10.1074/jbc.M203830200; Vannahme C, 1999, J NEUROCHEM, V73, P12, DOI 10.1046/j.1471-4159.1999.0730012.x; Wang QF, 2000, ENDOCRINOLOGY, V141, P3183, DOI 10.1210/en.141.9.3183; White R, 2008, J CELL BIOL, V181, P579, DOI 10.1083/jcb.200706164; Winzen U, 2003, J BIOL CHEM, V278, P30106, DOI 10.1074/jbc.M212676200; Yoneda A, 2003, MATRIX BIOL, V22, P25, DOI 10.1016/S0945-053X(03)00010-6; Yuste R, 2004, NAT REV NEUROSCI, V5, P24, DOI 10.1038/nrn1300; Zacharias U, 2002, MOL CELL NEUROSCI, V21, P626, DOI 10.1006/mcne.2002.1203; Zhang B, 2008, NEURON, V60, P285, DOI 10.1016/j.neuron.2008.10.006; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	66	12	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5					3114	3125		10.1074/jbc.M109.039420	http://dx.doi.org/10.1074/jbc.M109.039420			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19940118	hybrid, Green Published			2022-12-25	WOS:000273829000027
J	Earl, LA; Bi, SG; Baum, LG				Earl, Lesley A.; Bi, Shuguang; Baum, Linda G.			N- and O-Glycans Modulate Galectin-1 Binding, CD45 Signaling, and T Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYMIC EPITHELIAL-CELLS; TYROSINE-PHOSPHATASE; DIFFERENTIAL GLYCOSYLATION; ISOFORM EXPRESSION; ENDOGENOUS LECTIN; APOPTOSIS; THYMOCYTES; ACTIVATION; CD7; PHOSPHORYLATION	Galectin-1, a beta-galactoside-binding protein highly expressed in the thymus, induces apoptosis of specific thymocyte subsets and activated T cells. Galectin-1 binds to N- and O-glycans on several glycoprotein receptors, including CD7, CD43, and CD45. Here we show that galectin-1 signaling through CD45, which carries both N- and O-glycans, is regulated by CD45 isoform expression, core 2 O-glycan formation and the balance of N- glycan sialylation. Regulation of galectin-1 T cell death by O-glycans is mediated through CD45 phosphatase activity. While galectin-1 signaling in cells expressing low molecular weight isoforms of CD45 requires expression of core 2 O-glycans (high affinity ligands for galectin-1), galectin-1 signaling in cells expressing a high molecular weight isoform of CD45 does not require core 2 O-glycans, suggesting that a larger amount of core 1 O-glycans (low affinity ligands for galectin-1) is sufficient to overcome lack of core 2 O-glycans. Furthermore, regulation of galectin-1 signaling by alpha 2,6-sialylation of N-glycans is not solely dependent on CD45 phosphatase activity and can be modulated by the relative expression of enzymes that attach sialic acid in an alpha 2,6- or alpha 2,3-linkage. Thus, N- and O-glycans modulate galectin-1 T cell death by distinct mechanisms, and different glycosylation events can render thymocytes susceptible or resistant to galectin-1.	[Earl, Lesley A.; Bi, Shuguang; Baum, Linda G.] Univ Calif Los Angeles, Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Baum, LG (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Pathol & Lab Med, 10833 LeConte Ave, Los Angeles, CA 90095 USA.	lbaum@mednet.ucla.edu			National Institutes of Health [GM63281]; National Institutes of Health Training [T32 AI52031]; University of California, Cancer Research Coordinating Committee; NATIONAL CANCER INSTITUTE [P30CA016042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI028697, T32AI052031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063281, U54GM062116] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Training(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California, Cancer Research Coordinating Committee(University of California System); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM63281 (to L.G.B.) and National Institutes of Health Training Grant T32 AI52031 (to L.A.E.). This work was also supported by a grant from the University of California, Cancer Research Coordinating Committee (to L.G.B.).	Alexander DR, 2000, SEMIN IMMUNOL, V12, P349, DOI 10.1006/smim.2000.0218; Amano M, 2003, J BIOL CHEM, V278, P7469, DOI 10.1074/jbc.M209595200; Barran P, 1997, GLYCOBIOLOGY, V7, P129, DOI 10.1093/glycob/7.1.129; Baum LG, 1996, J BIOL CHEM, V271, P10793, DOI 10.1074/jbc.271.18.10793; BAUM LG, 1995, J EXP MED, V181, P877, DOI 10.1084/jem.181.3.877; Bi S, 2008, J BIOL CHEM, V283, P12248, DOI 10.1074/jbc.M800523200; Cabrera PV, 2006, BLOOD, V108, P2399, DOI 10.1182/blood-2006-04-018556; Daniels MA, 2002, NAT IMMUNOL, V3, P903, DOI 10.1038/ni1002-903; Dawes R, 2006, J IMMUNOL, V176, P3417, DOI 10.4049/jimmunol.176.6.3417; Di Virgilio S, 1999, GLYCOBIOLOGY, V9, P353, DOI 10.1093/glycob/9.4.353; Earl LA, 2008, IMMUNOL CELL BIOL, V86, P608, DOI 10.1038/icb.2008.46; Fortin M, 2002, J IMMUNOL, V168, P6084, DOI 10.4049/jimmunol.168.12.6084; Fouillit M, 2000, GLYCOBIOLOGY, V10, P413, DOI 10.1093/glycob/10.4.413; Furukawa K, 1998, EUR J BIOCHEM, V251, P288, DOI 10.1046/j.1432-1327.1998.2510288.x; Galvan M, 2000, J BIOL CHEM, V275, P16730, DOI 10.1074/jbc.M001117200; GILLESPIE W, 1993, J BIOL CHEM, V268, P3801; HATHCOCK KS, 1992, J IMMUNOL, V148, P19; Hermiston ML, 2003, ANNU REV IMMUNOL, V21, P107, DOI 10.1146/annurev.immunol.21.120601.140946; Hernandez JD, 2002, GLYCOBIOLOGY, V12, p127R, DOI 10.1093/glycob/cwf081; Hernandez JD, 2007, INT IMMUNOL, V19, P847, DOI 10.1093/intimm/dxm053; Hernandez JD, 2006, J IMMUNOL, V177, P5328, DOI 10.4049/jimmunol.177.8.5328; Hogquist KA, 2005, NAT REV IMMUNOL, V5, P772, DOI 10.1038/nri1707; HOLLADAY S, 1993, IMMUNOL INVEST, V22, P517, DOI 10.3109/08820139309084180; Irles C, 2003, NAT IMMUNOL, V4, P189, DOI 10.1038/ni877; JONES AT, 1994, J IMMUNOL, V153, P3426; KARASUYAMA H, 1990, J EXP MED, V172, P969, DOI 10.1084/jem.172.3.969; Lanteri M, 2003, GLYCOBIOLOGY, V13, P909, DOI 10.1093/glycob/cwg110; Leppanen A, 2005, J BIOL CHEM, V280, P5549, DOI 10.1074/jbc.m412019200; Liu SD, 2008, BLOOD, V112, P120, DOI 10.1182/blood-2007-09-114181; Liu SD, 2009, J IMMUNOL, V182, P5283, DOI 10.4049/jimmunol.0803811; Majeti R, 2000, CELL, V103, P1059, DOI 10.1016/S0092-8674(00)00209-9; Marino JH, 2008, GLYCOBIOLOGY, V18, P719, DOI 10.1093/glycob/cwn051; McNeill L, 2004, IMMUNOL LETT, V92, P125, DOI 10.1016/j.imlet.2003.10.018; McNeill L, 2007, IMMUNITY, V27, P425, DOI 10.1016/j.immuni.2007.07.015; Motran CC, 2008, EUR J IMMUNOL, V38, P3015, DOI 10.1002/eji.200838295; Nguyen JT, 2001, J IMMUNOL, V167, P5697, DOI 10.4049/jimmunol.167.10.5697; Pace KE, 1999, J IMMUNOL, V163, P3801; Pace KE, 2000, J IMMUNOL, V165, P2331, DOI 10.4049/jimmunol.165.5.2331; Pace KE, 2003, METHOD ENZYMOL, V363, P499; Pang MB, 2009, J IMMUNOL, V182, P7001, DOI 10.4049/jimmunol.0804329; PERILLO NL, 1995, NATURE, V378, P736, DOI 10.1038/378736a0; Perillo NL, 1997, J EXP MED, V185, P1851, DOI 10.1084/jem.185.10.1851; Priatel JJ, 2000, IMMUNITY, V12, P273, DOI 10.1016/S1074-7613(00)80180-6; REISNER Y, 1976, CELL IMMUNOL, V25, P129, DOI 10.1016/0008-8749(76)90103-9; Roberts AA, 2003, MODERN PATHOL, V16, P543, DOI 10.1097/01.MP.0000071840.84469.06; Sempowski GD, 1999, CRIT REV IMMUNOL, V19, P331; Stowell SR, 2008, J BIOL CHEM, V283, P10109, DOI 10.1074/jbc.M709545200; Tackenberg B, 2003, AUTOIMMUNITY, V36, P117, DOI 10.1080/0891693031000084369; THOMAS ML, 1987, P NATL ACAD SCI USA, V84, P5360, DOI 10.1073/pnas.84.15.5360; THOMAS ML, 1989, ANNU REV IMMUNOL, V7, P339, DOI 10.1146/annurev.immunol.7.1.339; Toscano MA, 2007, NAT IMMUNOL, V8, P825, DOI 10.1038/ni1482; TROWBRIDGE IS, 1994, ANNU REV IMMUNOL, V12, P85, DOI 10.1146/annurev.iy.12.040194.000505; Tsuboi S, 1998, J BIOL CHEM, V273, P30680, DOI 10.1074/jbc.273.46.30680; Vespa GNR, 1999, J IMMUNOL, V162, P799; Walzel H, 1999, IMMUNOL LETT, V67, P193, DOI 10.1016/S0165-2478(99)00012-7; Wang YN, 2005, J BIOL CHEM, V280, P14318, DOI 10.1074/jbc.M413265200; Windhagen A, 2007, CLIN EXP IMMUNOL, V150, P509, DOI 10.1111/j.1365-2249.2007.03508.x; Wu WY, 1996, J EXP MED, V184, P759, DOI 10.1084/jem.184.2.759; Xu Z, 2002, NAT IMMUNOL, V3, P764, DOI 10.1038/ni822; Zamoyska R, 2007, IMMUNITY, V27, P421, DOI 10.1016/j.immuni.2007.08.009	60	101	104	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2242	2254		10.1074/jbc.M109.066191	http://dx.doi.org/10.1074/jbc.M109.066191			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19920154	hybrid, Green Published			2022-12-25	WOS:000273697800004
J	Jedidi, I; Zhang, F; Qiu, HF; Stahl, SJ; Palmer, I; Kaufman, JD; Nadaud, PS; Mukherjee, S; Wingfield, PT; Jaroniec, CP; Hinnebusch, AG				Jedidi, Iness; Zhang, Fan; Qiu, Hongfang; Stahl, Stephen J.; Palmer, Ira; Kaufman, Joshua D.; Nadaud, Philippe S.; Mukherjee, Sujoy; Wingfield, Paul T.; Jaroniec, Christopher P.; Hinnebusch, Alan G.			Activator Gcn4 Employs Multiple Segments of Med15/Gal11, Including the KIX Domain, to Recruit Mediator to Target Genes in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; TATA-BINDING PROTEIN; TRANSCRIPTIONAL ACTIVATION; SACCHAROMYCES-CEREVISIAE; SRB MEDIATOR; AMINO-ACIDS; YEAST; HOLOENZYME; COMPLEX; ASSOCIATION	Mediator is a multisubunit coactivator required for initiation by RNA polymerase II. The Mediator tail subdomain, containing Med15/Gal11, is a target of the activator Gcn4 in vivo, critical for recruitment of native Mediator or the Mediator tail subdomain present in sin4 Delta cells. Although several Gal11 segments were previously shown to bind Gcn4 in vitro, the importance of these interactions for recruitment of Mediator and transcriptional activation by Gcn4 in cells was unknown. We show that interaction of Gcn4 with the Mediator tail in vitro and recruitment of this subcomplex and intact Mediator to the ARG1 promoter in vivo involve additive contributions from three different segments in the N terminus of Gal11. These include the KIX domain, which is a critical target of other activators, and a region that shares a conserved motif (B-box) with mammalian coactivator SRC-1, and we establish that B-box is a critical determinant of Mediator recruitment by Gcn4. We further demonstrate that Gcn4 binds to the Gal11 KIX domain directly and, by NMR chemical shift analysis combined with mutational studies, we identify the likely binding site for Gcn4 on the KIX surface. Gcn4 is distinctive in relying on comparable contributions from multiple segments of Gal11 for efficient recruitment of Mediator in vivo.	[Jedidi, Iness; Zhang, Fan; Qiu, Hongfang; Hinnebusch, Alan G.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Lab Gene Regulat & Dev, NIH, Bethesda, MD 20892 USA; [Stahl, Stephen J.; Palmer, Ira; Kaufman, Joshua D.; Wingfield, Paul T.] NIAMS, Prot Express Lab, NIH, Bethesda, MD 20892 USA; [Nadaud, Philippe S.; Mukherjee, Sujoy; Jaroniec, Christopher P.] Ohio State Univ, Dept Chem, Columbus, OH 43210 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); University System of Ohio; Ohio State University	Hinnebusch, AG (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Lab Gene Regulat & Dev, NIH, Bldg 6A,Rm B1A-13, Bethesda, MD 20892 USA.	ahinnebusch@nih.gov	Jaroniec, Christopher/A-4948-2008; Mukherjee, Sujoy/E-5708-2011	Jaroniec, Christopher/0000-0003-0364-2888; Wingfield, Paul/0000-0002-9515-4752; , Iness/0000-0001-8591-8782	National Institutes of Health; Ohio State University; Eli Lilly and Company; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008899] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ohio State University(Ohio State University); Eli Lilly and Company(Eli Lilly); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported in part by the Intramural Research Program of the National Institutes of Health.; Supported by a grant from the Ohio State University and a Young Investigator Award from Eli Lilly and Company.	ALANI E, 1987, GENETICS, V116, P541, DOI 10.1534/genetics.112.541.test; Balciunas D, 1999, P NATL ACAD SCI USA, V96, P376, DOI 10.1073/pnas.96.2.376; BARBERIS A, 1995, CELL, V81, P359, DOI 10.1016/0092-8674(95)90389-5; Beve J, 2005, J BIOL CHEM, V280, P41366, DOI 10.1074/jbc.M511181200; Bhoite LT, 2001, GENE DEV, V15, P2457, DOI 10.1101/gad.921601; Bourbon HM, 2004, MOL CELL, V14, P553, DOI 10.1016/j.molcel.2004.05.011; Chadick JZ, 2005, TRENDS BIOCHEM SCI, V30, P264, DOI 10.1016/j.tibs.2005.03.001; CIGAN AM, 1991, MOL CELL BIOL, V11, P3217, DOI 10.1128/MCB.11.6.3217; Cosma MP, 2001, MOL CELL, V7, P1213, DOI 10.1016/S1097-2765(01)00266-0; Cross FR, 1997, YEAST, V13, P647, DOI 10.1002/(SICI)1097-0061(19970615)13:7<647::AID-YEA115>3.0.CO;2-#; Davis JA, 2002, MOL CELL, V10, P409, DOI 10.1016/S1097-2765(02)00598-1; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dotson MR, 2000, P NATL ACAD SCI USA, V97, P14307, DOI 10.1073/pnas.260489497; Drysdale CM, 1998, MOL CELL BIOL, V18, P1711, DOI 10.1128/MCB.18.3.1711; DRYSDALE CM, 1995, MOL CELL BIOL, V15, P1220, DOI 10.1128/MCB.15.3.1220; Fishburn J, 2005, MOL CELL, V18, P369, DOI 10.1016/j.molcel.2005.03.029; Gaudreau L, 1997, CELL, V89, P55, DOI 10.1016/S0092-8674(00)80182-8; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Goddard TD, 1993, SPARKY 3; Govind CK, 2007, MOL CELL, V25, P31, DOI 10.1016/j.molcel.2006.11.020; Govind CK, 2005, MOL CELL BIOL, V25, P5626, DOI 10.1128/MCB.25.13.5626-5638.2005; Guglielmi B, 2004, NUCLEIC ACIDS RES, V32, P5379, DOI 10.1093/nar/gkh878; Gustafsson CM, 1998, J BIOL CHEM, V273, P30851, DOI 10.1074/jbc.273.47.30851; HENGARTNER CJ, 1995, GENE DEV, V9, P897, DOI 10.1101/gad.9.8.897; HINNEBUSCH AG, 1985, P NATL ACAD SCI USA, V82, P498, DOI 10.1073/pnas.82.2.498; Huth JR, 1997, PROTEIN SCI, V6, P2359; Jackson BM, 1996, MOL CELL BIOL, V16, P5557; JIANG YW, 1995, GENETICS, V140, P47; Kang JS, 2001, J BIOL CHEM, V276, P42003, DOI 10.1074/jbc.M105961200; Kim DH, 2008, MOL CELL BIOL, V28, P913, DOI 10.1128/MCB.01140-07; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; Koh SS, 1998, MOL CELL, V1, P895, DOI 10.1016/S1097-2765(00)80088-X; Kuras L, 2003, P NATL ACAD SCI USA, V100, P13887, DOI 10.1073/pnas.2036346100; Kuras L, 1999, NATURE, V399, P609, DOI 10.1038/21239; Lee YC, 1999, MOL CELL BIOL, V19, P2967; Lemieux K, 2004, EMBO J, V23, P4040, DOI 10.1038/sj.emboj.7600416; Li XY, 1999, NATURE, V399, P605, DOI 10.1038/21232; LI Y, 1995, P NATL ACAD SCI USA, V92, P10864, DOI 10.1073/pnas.92.24.10864; Liu Y, 2001, J BIOL CHEM, V276, P7169, DOI 10.1074/jbc.M009586200; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lu Z, 2002, P NATL ACAD SCI USA, V99, P8591, DOI 10.1073/pnas.092263499; MOEHLE CM, 1991, MOL CELL BIOL, V11, P2723, DOI 10.1128/MCB.11.5.2723; Myers LC, 1999, P NATL ACAD SCI USA, V96, P67, DOI 10.1073/pnas.96.1.67; Myers LC, 2000, ANNU REV BIOCHEM, V69, P729, DOI 10.1146/annurev.biochem.69.1.729; Nishizawa M, 2001, YEAST, V18, P1099, DOI 10.1002/yea.754; Park JM, 2001, MOL CELL, V8, P9, DOI 10.1016/S1097-2765(01)00296-9; Park JM, 2000, MOL CELL BIOL, V20, P8709, DOI 10.1128/MCB.20.23.8709-8719.2000; Qiu HF, 2005, MOL CELL BIOL, V25, P3461, DOI 10.1128/MCB.25.9.3461-3474.2005; Qiu HF, 2004, MOL CELL BIOL, V24, P4104, DOI 10.1128/MCB.24.10.4104-4117.2004; REID GA, 1982, J BIOL CHEM, V257, P3056; Takagi Y, 2006, J BIOL CHEM, V281, P80, DOI 10.1074/jbc.M508253200; Takagi Y, 2006, MOL CELL, V23, P355, DOI 10.1016/j.molcel.2006.06.007; Thakur JK, 2008, NATURE, V452, P604, DOI 10.1038/nature06836; Thakur JK, 2009, J BIOL CHEM, V284, P4422, DOI 10.1074/jbc.M808263200; THOMPSON CM, 1993, CELL, V73, P1361, DOI 10.1016/0092-8674(93)90362-T; THOMPSON CM, 1995, P NATL ACAD SCI USA, V92, P4587, DOI 10.1073/pnas.92.10.4587; WETLAUFER DB, 1962, ADV PROTEIN CHEM, V17, P303; Yamazaki T, 1996, PROTEIN SCI, V5, P495; YAMAZAKI T, 1994, J AM CHEM SOC, V116, P11655, DOI 10.1021/ja00105a005; Yang FJ, 2006, NATURE, V442, P700, DOI 10.1038/nature04942; Yoon S, 2003, MOL CELL BIOL, V23, P8829, DOI 10.1128/MCB.23.23.8829-9945.2003; Zhang F, 2004, MOL CELL BIOL, V24, P6871, DOI 10.1128/mcb.24.15.6871-6886.2004; Zhang F, 2008, MOL CELL BIOL, V28, P6796, DOI 10.1128/MCB.00800-08	63	50	50	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2438	2455		10.1074/jbc.M109.071589	http://dx.doi.org/10.1074/jbc.M109.071589			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19940160	hybrid, Green Published			2022-12-25	WOS:000273697800023
J	Tori, K; Dassa, B; Johnson, MA; Southworth, MW; Brace, LE; Ishino, Y; Pietrokovski, S; Perler, FB				Tori, Kazuo; Dassa, Bareket; Johnson, Margaret A.; Southworth, Maurice W.; Brace, Lear E.; Ishino, Yoshizumi; Pietrokovski, Shmuel; Perler, Francine B.			Splicing of the Mycobacteriophage Bethlehem DnaB Intein IDENTIFICATION OF A NEW MECHANISTIC CLASS OF INTEINS THAT CONTAIN AN OBLIGATE BLOCK F NUCLEOPHILE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; SWISS-MODEL; PROTEINS; SEQUENCES; PRECURSOR; GLUTAMINE; PROFILES; HOMOLOGY	Inteins are single turnover enzymes that splice out of protein precursors during maturation of the host protein (extein). The Cys or Ser at the N terminus of most inteins initiates a four-step protein splicing reaction by forming a (thio) ester bond at the N-terminal splice junction. Several recently identified inteins cannot perform this acyl rearrangement because they do not begin with Cys, Thr, or Ser. This study analyzes one of these, the mycobacteriophage Bethlehem DnaB intein, which we describe here as the prototype for a new class of inteins based on sequence comparisons, reactivity, and mechanism. These Class 3 inteins are characterized by a non-nucleophilic N-terminal residue that co-varies with a non-contiguous Trp, Cys, Thr triplet (WCT) and a Thr or Ser as the first C-extein residue. Several mechanistic differences were observed when compared with standard inteins or previously studied atypical KlbA Ala(1) inteins: (a) cleavage at the N-terminal splice junction in the absence of all standard N- and C-terminal splice junction nucleophiles, (b) activation of the N-terminal splice junction by a variant Block B motif that includes the WCT triplet Trp, (c) decay of the branched intermediate by thiols or Cys despite an ester linkage at the C-extein branch point, and (d) an absolute requirement for the WCT triplet Block F Cys. Based on biochemical data and confirmed by molecular modeling, we propose roles for these newly identified conserved residues, a novel protein splicing mechanism that includes a second branched intermediate, and an intein classification with three mechanistic categories.	[Tori, Kazuo; Southworth, Maurice W.; Brace, Lear E.; Perler, Francine B.] New England Biolabs Inc, Ipswich, MA 01938 USA; [Tori, Kazuo; Ishino, Yoshizumi] Kyushu Univ, Fukuoka 8128581, Japan; [Dassa, Bareket; Pietrokovski, Shmuel] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; [Johnson, Margaret A.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	New England Biolabs; Kyushu University; Weizmann Institute of Science; Scripps Research Institute	Perler, FB (corresponding author), New England Biolabs Inc, 240 Cty Rd, Ipswich, MA 01938 USA.	perler@neb.com		Pietrokovski, Shmuel/0000-0001-8573-5863; Brace, Lear/0000-0001-6961-9758; Ishino, Yoshizumi/0000-0001-9419-0826	Israel Science Foundation [626/03]	Israel Science Foundation(Israel Science Foundation)	This work was supported in part by Israel Science Foundation Grant 626/03 (to S. P.).	Amitai G, 2004, J BIOL CHEM, V279, P3121, DOI 10.1074/jbc.M311343200; Ding Y, 2003, J BIOL CHEM, V278, P39133, DOI 10.1074/jbc.M306197200; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hall TMT, 1997, CELL, V91, P85, DOI 10.1016/S0092-8674(01)80011-8; Hatfull GF, 2006, PLOS GENET, V2, P835, DOI 10.1371/journal.pgen.0020092; HENIKOFF S, 1994, J MOL BIOL, V243, P574, DOI 10.1016/0022-2836(94)90032-9; HODGES RA, 1992, NUCLEIC ACIDS RES, V20, P6153, DOI 10.1093/nar/20.23.6153; Johnson MA, 2007, PROTEIN SCI, V16, P1316, DOI 10.1110/ps.072816707; Kass I, 2002, PROTEINS, V48, P611, DOI 10.1002/prot.10180; Martin DD, 2001, BIOCHEMISTRY-US, V40, P1393, DOI 10.1021/bi001786g; Melo F, 1998, J MOL BIOL, V277, P1141, DOI 10.1006/jmbi.1998.1665; Mills KV, 2005, PROTEIN PEPTIDE LETT, V12, P751, DOI 10.2174/0929866054864337; Mills KV, 2004, J BIOL CHEM, V279, P20685, DOI 10.1074/jbc.M400887200; Mizutani R, 2002, J MOL BIOL, V316, P919, DOI 10.1006/jmbi.2001.5357; Pearl EJ, 2007, FEBS LETT, V581, P3000, DOI 10.1016/j.febslet.2007.05.060; Perler FB, 2005, IUBMB LIFE, V57, P469, DOI 10.1080/15216540500163343; Perler FB, 2002, NUCLEIC ACIDS RES, V30, P383, DOI 10.1093/nar/30.1.383; Perler FB, 1997, NUCLEIC ACIDS RES, V25, P1087, DOI 10.1093/nar/25.6.1087; Pietrokovski S, 1998, PROTEIN SCI, V7, P64, DOI 10.1002/pro.5560070106; PIETROKOVSKI S, 1994, PROTEIN SCI, V3, P2340, DOI 10.1002/pro.5560031218; Romanelli A, 2004, P NATL ACAD SCI USA, V101, P6397, DOI 10.1073/pnas.0306616101; Rychlewski L, 2000, PROTEIN SCI, V9, P232, DOI 10.1110/ps.9.2.232; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Southworth MW, 2000, EMBO J, V19, P5019, DOI 10.1093/emboj/19.18.5019; Southworth MW, 1999, BIOTECHNIQUES, V27, P110, DOI 10.2144/99271st04; Van Roey P, 2007, J MOL BIOL, V367, P162, DOI 10.1016/j.jmb.2006.12.050; Xu MQ, 1996, EMBO J, V15, P5146, DOI 10.1002/j.1460-2075.1996.tb00898.x	28	65	67	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2515	2526		10.1074/jbc.M109.069567	http://dx.doi.org/10.1074/jbc.M109.069567			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19940146	Green Published, hybrid			2022-12-25	WOS:000273697800030
J	Weis, MA; Hudson, DM; Kim, L; Scott, M; Wu, JJ; Eyre, DR				Weis, Mary Ann; Hudson, David M.; Kim, Lammy; Scott, Melissa; Wu, Jiann-Jiu; Eyre, David R.			Location of 3-Hydroxyproline Residues in Collagen Types I, II, III, and V/XI Implies a Role in Fibril Supramolecular Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYANOGEN-BROMIDE PEPTIDES; AMINO-ACID-SEQUENCE; RECESSIVE OSTEOGENESIS IMPERFECTA; BASEMENT-MEMBRANE COLLAGEN; HIGHER-ORDER STRUCTURES; TRIPLE-HELIX; CARTILAGE COLLAGEN; COVALENT STRUCTURE; PROLYL 3-HYDROXYLATION; ARTICULAR-CARTILAGE	Collagen triple helices are stabilized by 4-hydroxyproline residues. No function is known for the much less common 3-hydroxyproline (3Hyp), although genetic defects inhibiting its formation cause recessive osteogenesis imperfecta. To help understand the pathogenesis, we used mass spectrometry to identify the sites and local sequence motifs of 3Hyp residues in fibril-forming collagens from normal human and bovine tissues. The results confirm a single, essentially fully occupied 3Hyp site (A1) at Pro(986) in A-clade chains alpha 1(I), alpha 1(II), and alpha 2(V). Two partially modified sites (A2 and A3) were found at Pro(944) in alpha 1(II) and alpha 2(V) and Pro(707) in alpha 2(I) and alpha 2(V), which differed from A1 in sequence motif. Significantly, the distance between sites 2 and 3, 237 residues, is close to the collagen D-period (234 residues). A search for additional D-periodic 3Hyp sites revealed a fourth site (A4) at Pro(470) in alpha 2(V), 237 residues N-terminal to site 3. In contrast, human and bovine type III collagen contained no 3Hyp at any site, despite a candidate proline residue and recognizable A1 sequence motif. A conserved histidine in mammalian alpha 1(III) at A1 may have prevented 3-hydroxylation because this site in chicken type III was fully hydroxylated, and tyrosine replaced histidine. All three B-clade type V/XI collagen chains revealed the same three sites of 3Hyp but at different loci and sequence contexts from those in A-clade collagen chains. Two of these B-clade sites were spaced apart by 231 residues. From these and other observations we propose a fundamental role for 3Hyp residues in the ordered self-assembly of collagen supramolecular structures.	[Weis, Mary Ann; Hudson, David M.; Kim, Lammy; Scott, Melissa; Wu, Jiann-Jiu; Eyre, David R.] Univ Washington, Orthopaed Res Labs, Dept Orthopaed & Sports Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Eyre, DR (corresponding author), 1959 NE Pacific St,HSB BB1052,Box 356500, Seattle, WA 98195 USA.	deyre@u.washington.edu			National Institutes of Health [AR37318, AR36794]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR036794, R37AR036794, R01AR037318, R37AR037318] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR37318 and AR36794.	Baldridge D, 2008, HUM MUTAT, V29, P1435, DOI 10.1002/humu.20799; Barnes AM, 2006, NEW ENGL J MED, V355, P2757, DOI 10.1056/NEJMoa063804; BERG RA, 1973, BIOCHEM BIOPH RES CO, V52, P115, DOI 10.1016/0006-291X(73)90961-3; Berisio R, 2009, J PEPT SCI, V15, P131, DOI 10.1002/psc.1082; Burger C, 2008, BIOPHYS J, V95, P1985, DOI 10.1529/biophysj.107.128355; BURGESON RE, 1976, P NATL ACAD SCI USA, V73, P2579, DOI 10.1073/pnas.73.8.2579; BUTLER WT, 1967, BIOCHEMISTRY-US, V6, P3771, DOI 10.1021/bi00864a022; Cabral WA, 2007, NAT GENET, V39, P359, DOI 10.1038/ng1968; Capellini TD, 2008, GENESIS, V46, P683, DOI 10.1002/dvg.20406; CLICK EM, 1970, BIOCHEMISTRY-US, V9, P4699; DOYLE BB, 1974, PROC R SOC SER B-BIO, V187, P37, DOI 10.1098/rspb.1974.0059; Dunn MP, 2009, DEV BIOL, V328, P561, DOI 10.1016/j.ydbio.2009.02.007; EYRE D, 1987, METHOD ENZYMOL, V144, P115; Eyre DR, 2008, METHODS, V45, P65, DOI 10.1016/j.ymeth.2008.01.002; Eyre DR, 2006, EUR CELLS MATER, V12, P57, DOI 10.22203/eCM.v012a07; EYRE DR, 1984, ANNU REV BIOCHEM, V53, P717, DOI 10.1146/annurev.bi.53.070184.003441; EYRE DR, 1983, FEBS LETT, V158, P265, DOI 10.1016/0014-5793(83)80592-4; EYRE DR, 1975, BIOCHEM J, V151, P595, DOI 10.1042/bj1510595; FIETZEK PP, 1972, EUR J BIOCHEM, V30, P163, DOI 10.1111/j.1432-1033.1972.tb02083.x; FLEISCHMAJER R, 1990, J STRUCT BIOL, V105, P162, DOI 10.1016/1047-8477(90)90110-X; Garrone R., 1985, NATO ASI (Advanced Science Institutes) Series Series A Life Sciences, V93, P157; GRYDER RM, 1975, J BIOL CHEM, V250, P2470; Hanna SL, 2000, MICROBIOL-UK, V146, P2495, DOI 10.1099/00221287-146-10-2495; HOJIMA Y, 1994, ANAL BIOCHEM, V223, P173, DOI 10.1006/abio.1994.1569; Ishikawa Y, 2009, J BIOL CHEM, V284, P17641, DOI 10.1074/jbc.M109.007070; Jenkins CL, 2003, J AM CHEM SOC, V125, P6422, DOI 10.1021/ja034015j; Kar K, 2006, J BIOL CHEM, V281, P33283, DOI 10.1074/jbc.M605747200; Kar K, 2009, BIOCHEMISTRY-US, V48, P7959, DOI 10.1021/bi900496m; Kramer RZ, 2001, J MOL BIOL, V311, P131, DOI 10.1006/jmbi.2001.4849; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Marini JC, 2007, CELL CYCLE, V6, P1675, DOI 10.4161/cc.6.14.4474; MILLER EJ, 1972, BIOCHEMISTRY-US, V11, P4903, DOI 10.1021/bi00776a005; MILLER EJ, 1973, BIOCHEMISTRY-US, V12, P3153, DOI 10.1021/bi00741a003; Mizuno K, 2008, FEBS J, V275, P5830, DOI 10.1111/j.1742-4658.2008.06704.x; Morello R, 2006, CELL, V127, P291, DOI 10.1016/j.cell.2006.08.039; OGLE JD, 1962, J BIOL CHEM, V237, P3667; Okuyama K, 2009, BIOPOLYMERS, V91, P361, DOI 10.1002/bip.21138; Orgel JPRO, 2006, P NATL ACAD SCI USA, V103, P9001, DOI 10.1073/pnas.0502718103; PIEZ KA, 1963, BIOCHEMISTRY-US, V2, P58, DOI 10.1021/bi00901a012; Polishchuk EV, 2003, MOL BIOL CELL, V14, P4470, DOI 10.1091/mbc.E03-01-0033; RHODES RK, 1979, J BIOL CHEM, V254, P2084; Schumacher MA, 2006, J BIOL CHEM, V281, P27566, DOI 10.1074/jbc.M602797200; SCHUPPAN D, 1982, EUR J BIOCHEM, V123, P505; SEYER JM, 1981, BIOCHEMISTRY-US, V20, P2621, DOI 10.1021/bi00512a040; Tiainen P, 2008, J BIOL CHEM, V283, P19432, DOI 10.1074/jbc.M802973200; Vranka JA, 2004, J BIOL CHEM, V279, P23615, DOI 10.1074/jbc.M312807200; Vranka J, 2009, CELL STRUCT FUNCT, V34, P97, DOI 10.1247/csf.09002; WOODHEADGALLOWAY J, 1980, PROC R SOC SER B-BIO, V209, P275, DOI 10.1098/rspb.1980.0095; Wu JJ, 2009, J BIOL CHEM, V284, P5539, DOI 10.1074/jbc.M806369200; Young RD, 2000, J HISTOCHEM CYTOCHEM, V48, P423, DOI 10.1177/002215540004800312; Zhang XM, 2007, J BIOL CHEM, V282, P6792, DOI 10.1074/jbc.M607528200	51	102	103	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2580	2590		10.1074/jbc.M109.068726	http://dx.doi.org/10.1074/jbc.M109.068726			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19940144	Green Published, hybrid			2022-12-25	WOS:000273697800037
J	Wong, YY; Moon, A; Duffin, R; Barthet-Barateig, A; Meijer, HA; Clemens, MJ; de Moor, CH				Wong, Ying Ying; Moon, Alice; Duffin, Ruth; Barthet-Barateig, Adeline; Meijer, Hedda A.; Clemens, Michael J.; de Moor, Cornelia H.			Cordycepin Inhibits Protein Synthesis and Cell Adhesion through Effects on Signal Transduction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN TARGET; TRANSLATION INITIATION; MESSENGER-RNAS; IN-VITRO; MTOR; KINASE; AKT; PHOSPHORYLATION; RAPAMYCIN; GROWTH	3'-Deoxyadenosine, also known as cordycepin, is a known polyadenylation inhibitor with a large spectrum of biological activities, including anti-proliferative, pro-apoptotic and antiinflammatory effects. In this study we confirm that cordycepin reduces the length of poly(A) tails, with some mRNAs being much more sensitive than others. The low doses of cordycepin that cause poly(A) changes also reduce the proliferation of NIH3T3 fibroblasts. At higher doses of the drug we observed inhibition of cell attachment and a reduction of focal adhesions. Furthermore, we observed a strong inhibition of total protein synthesis that correlates with an inhibition of mammalian target of rapamycin (mTOR) signaling, as observed by reductions in Akt kinase and 4E-binding protein (4EBP) phosphorylation. In 4EBP knock-out cells, the effect of cordycepin on translation is strongly reduced, confirming the role of this modification. In addition, the AMP-activated kinase (AMPK) was shown to be activated. Inhibition of AMPK prevented translation repression by cordycepin and abolished 4EBP1 dephosphorylation, indicating that the effect of cordycepin on mTOR signaling and protein synthesis is mediated by AMPK activation. We conclude that many of the reported biological effects of cordycepin are likely to be due to its effects on mTOR and AMPK signaling.	[Wong, Ying Ying; Moon, Alice; Duffin, Ruth; Barthet-Barateig, Adeline; Meijer, Hedda A.; de Moor, Cornelia H.] Univ Nottingham, Sch Pharm, Ctr Biomol Sci, Nottingham NG7 2RD, England; [Clemens, Michael J.] Univ Sussex, Dept Chem & Biochem, Sch Life Sci, Brighton BN1 9QG, Sussex, England	University of Nottingham; University of Sussex	de Moor, CH (corresponding author), Univ Nottingham, Sch Pharm, Ctr Biomol Sci, Univ Pk, Nottingham NG7 2RD, England.	cornelia.demoor@nottingham.ac.uk	de Moor, Cornelia/AAE-8043-2020	de Moor, Cornelia/0000-0001-8776-0085	Wellcome Trust [076179, 082609]; Biotechnology and Biological Sciences Research Council [BB/G001847/1]; BBSRC [BB/G001847/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Wellcome Trust (Grants 076179 and 082609) and the Biotechnology and Biological Sciences Research Council (Grant BB/G001847/1).	Amiri A, 2007, ONCOGENE, V26, P3027, DOI 10.1038/sj.onc.1210101; Bolster DR, 2002, J BIOL CHEM, V277, P23977, DOI 10.1074/jbc.C200171200; Browne GJ, 2004, MOL CELL BIOL, V24, P2986, DOI 10.1128/MCB.24.7.2986-2997.2004; Bushell M, 2006, MOL CELL, V23, P401, DOI 10.1016/j.molcel.2006.06.012; Chang W, 2008, EUR J PHARMACOL, V597, P64, DOI 10.1016/j.ejphar.2008.08.030; Chen LS, 2008, BRIT J HAEMATOL, V140, P682, DOI 10.1111/j.1365-2141.2007.06955.x; Cho HJ, 2007, J MICROBIOL BIOTECHN, V17, P1134; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Clemens MJ, 2005, SEMIN CELL DEV BIOL, V16, P13, DOI 10.1016/j.semcdb.2004.11.011; CRAIG N, 1973, J CELL PHYSIOL, V82, P133, DOI 10.1002/jcp.1040820202; di Penta A, 2009, J CELL BIOL, V184, P423, DOI 10.1083/jcb.200807033; Dowling RJO, 2007, CANCER RES, V67, P10804, DOI 10.1158/0008-5472.CAN-07-2310; Enomoto A, 2005, DEV CELL, V9, P389, DOI 10.1016/j.devcel.2005.08.001; Evans JR, 2003, ONCOGENE, V22, P8012, DOI 10.1038/sj.onc.1206645; Garcia-Echeverria C, 2008, ONCOGENE, V27, P5511, DOI 10.1038/onc.2008.246; Gingras AC, 2003, CURR TOP MICROBIOL, V279, P169; Groisman I, 2000, CELL, V103, P435, DOI 10.1016/S0092-8674(00)00135-5; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hahn-Windgassen A, 2005, J BIOL CHEM, V280, P32081, DOI 10.1074/jbc.M502876200; Hardie DG, 2008, MOL CELL, V30, P263, DOI 10.1016/j.molcel.2008.04.012; Harris TE, 2006, EMBO J, V25, P1659, DOI 10.1038/sj.emboj.7601047; Holbein S, 2008, NUCLEIC ACIDS RES, V36, P353, DOI 10.1093/nar/gkm990; Huang JX, 2009, BIOCHEM SOC T, V37, P217, DOI 10.1042/BST0370217; Huang X, 2008, BIOCHEM J, V412, P211, DOI 10.1042/BJ20080557; Ioannidis P, 1999, ONCOGENE, V18, P117, DOI 10.1038/sj.onc.1202255; JACKSON RJ, 1983, METHOD ENZYMOL, V96, P50; JAGGER DV, 1961, CANCER RES, V21, P216; Kim HG, 2006, EUR J PHARMACOL, V545, P192, DOI 10.1016/j.ejphar.2006.06.047; Le Bacquer O, 2007, J CLIN INVEST, V117, P387, DOI 10.1172/JCI29528; Loreni F, 2000, EUR J BIOCHEM, V267, P6594, DOI 10.1046/j.1432-1327.2000.01753.x; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Meijer HA, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm830; Memmott RM, 2009, CELL SIGNAL, V21, P656, DOI 10.1016/j.cellsig.2009.01.004; MULLER WEG, 1977, CANCER RES, V37, P3824; Nakamura K, 2006, ANTICANCER RES, V26, P43; Nakamura K, 2005, IN VIVO, V19, P137; Ng TB, 2005, J PHARM PHARMACOL, V57, P1509, DOI 10.1211/jpp.57.12.0001; Paterson RRM, 2008, PHYTOCHEMISTRY, V69, P1469, DOI 10.1016/j.phytochem.2008.01.027; Patursky-Polischuk I, 2009, MOL CELL BIOL, V29, P640, DOI 10.1128/MCB.00980-08; PENMAN S, 1970, P NATL ACAD SCI USA, V67, P1878, DOI 10.1073/pnas.67.4.1878; Rassa JC, 2000, VIROLOGY, V274, P438, DOI 10.1006/viro.2000.0494; Rattan R, 2005, J BIOL CHEM, V280, P39582, DOI 10.1074/jbc.M507443200; Raught B, 2004, EMBO J, V23, P1761, DOI 10.1038/sj.emboj.7600193; Rhoads RE, 2007, J MAMMARY GLAND BIOL, V12, P283, DOI 10.1007/s10911-007-9058-0; Scheuner D, 2006, J BIOL CHEM, V281, P21458, DOI 10.1074/jbc.M603784200; Sheng SJ, 2009, J CELL PHYSIOL, V218, P451, DOI 10.1002/jcp.21616; Shi P, 2008, METHOD FIND EXP CLIN, V30, P347, DOI 10.1358/mf.2008.30.5.1186085; Smolewski P, 2006, ANTI-CANCER DRUG, V17, P487, DOI 10.1097/00001813-200606000-00001; Thomadaki H, 2008, CANCER CHEMOTH PHARM, V61, P251, DOI 10.1007/s00280-007-0467-y; van Gorp AGM, 2009, ONCOGENE, V28, P95, DOI 10.1038/onc.2008.367; Wehbe-Janek H, 2007, ANTICANCER RES, V27, P3143; Wei HP, 2009, EUR J MED CHEM, V44, P665, DOI 10.1016/j.ejmech.2008.05.013; Woodard J, 2008, CLIN CANCER RES, V14, P4640, DOI 10.1158/1078-0432.CCR-07-5232; Woods A, 2003, J BIOL CHEM, V278, P28434, DOI 10.1074/jbc.M303946200; Wu WC, 2007, CANCER CHEMOTH PHARM, V60, P103, DOI 10.1007/s00280-006-0354-y; Yang FQ, 2008, J PHARMACEUT BIOMED, V48, P231, DOI 10.1016/j.jpba.2008.05.012; Yang Q, 2007, CELL RES, V17, P666, DOI 10.1038/cr.2007.64; Zearfoss NR, 2008, J NEUROSCI, V28, P8502, DOI 10.1523/JNEUROSCI.1756-08.2008	58	111	122	3	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2610	2621		10.1074/jbc.M109.071159	http://dx.doi.org/10.1074/jbc.M109.071159			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19940154	hybrid, Green Published, Green Accepted			2022-12-25	WOS:000273697800040
J	Yamakawa, H; Yagishita, S; Futai, E; Ishiura, S				Yamakawa, Hidekuni; Yagishita, Sosuke; Futai, Eugene; Ishiura, Shoichi			beta-Secretase Inhibitor Potency Is Decreased by Aberrant beta-Cleavage Location of the "Swedish Mutant" Amyloid Precursor Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; MEMORY DEFICITS; SYNAPTIC PLASTICITY; BACE1; APP; SORLA/LR11; REDUCTION; PHOSPHORYLATION; TRAFFICKING; METABOLISM	The amyloid-beta (A beta) peptide, widely known as the causative molecule of Alzheimer disease (AD), is generated by the sequential cleavage of amyloid precursor protein (APP) by the aspartyl proteases BACE1/beta-secretase and presenilin/gamma-secretase. Inhibition of BACE1, therefore, is a promising strategy for preventing the progression of AD. However, beta-secretase inhibitors (BSIs) exhibit unexpectedly low potency in cells expressing "Swedish mutant" APP (APPswe) and in the transgenic mouse Tg2576, an AD model overexpressing APPswe. The Swedish mutation dramatically accelerates beta-cleavage of APP and hence the generation of A beta; this acceleration has been assumed to underlie the poor inhibitory activity of BSI against APPswe processing. Here, we studied the mechanism by which the Swedish mutation causes this BSI potency decrease. Surprisingly, decreased BSI potency was not observed in an in vitro assay using purified BACE1 and substrates, indicating that the accelerated beta-cleavage resulting from the Swedish mutation is not its underlying cause. By focusing on differences between the cell-based and in vitro assays, we have demonstrated here that the potency decrease is caused by the aberrant subcellular localization of APPswe processing and not by accelerated beta-cleavage or the accumulation of the C-terminal fragment of beta-cleaved APP. Because most patients with sporadic AD express wild type APP, our findings suggest that the wild type mouse is superior to the Tg2576 mouse as a model for determining the effective dose of BSI for AD patients. This work provides novel insights into the potency decrease of BSI and valuable suggestions for its development as a disease-modifying agent.	[Yamakawa, Hidekuni; Yagishita, Sosuke; Futai, Eugene; Ishiura, Shoichi] Univ Tokyo, Dept Life Sci, Grad Sch Arts & Sci, Meguro Ku, Tokyo 1538902, Japan	University of Tokyo	Ishiura, S (corresponding author), 3-8-1 Komaba,Meguro Ku, Tokyo 1538902, Japan.	cishiura@mail.ecc.u-tokyo.ac.jp		Futai, Eugene/0000-0002-0879-6117				Asai M, 2006, J NEUROCHEM, V96, P533, DOI 10.1111/j.1471-4159.2005.03576.x; Borg JP, 1996, MOL CELL BIOL, V16, P6229; Cai ZY, 2009, NEUROCHEM RES, V34, P1226, DOI 10.1007/s11064-008-9899-y; Cam JA, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-8; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; Dodson SE, 2006, J NEUROPATH EXP NEUR, V65, P866, DOI 10.1097/01.jnen.0000228205.19915.20; HAASS C, 1995, NAT MED, V1, P1291, DOI 10.1038/nm1295-1291; Harada H, 2006, NEUROSCI RES, V54, P24, DOI 10.1016/j.neures.2005.10.001; He WX, 2004, NAT MED, V10, P959, DOI 10.1038/nm1088; Hong L, 2000, SCIENCE, V290, P150, DOI 10.1126/science.290.5489.150; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Hussain I, 2007, J NEUROCHEM, V100, P802, DOI 10.1111/j.1471-4159.2006.04260.x; King GD, 2003, NEUROSCIENCE, V120, P143, DOI 10.1016/S0306-4522(03)00284-7; Klyubin I, 2005, NAT MED, V11, P556, DOI 10.1038/nm1234; KOO EH, 1994, J BIOL CHEM, V269, P17386; Lee CM, 2006, BRIT J CANCER, V94, P863, DOI 10.1038/sj.bjc.6603010; Lee MS, 2003, J CELL BIOL, V163, P83, DOI 10.1083/jcb.200301115; Ma QL, 2009, ARCH NEUROL-CHICAGO, V66, P448, DOI 10.1001/archneurol.2009.22; Majercak J, 2006, P NATL ACAD SCI USA, V103, P17967, DOI 10.1073/pnas.0605461103; MALAMAS M, 2008, INT C ALZH DIS CHIC, V4, P515; Marzolo MP, 2009, SEMIN CELL DEV BIOL, V20, P191, DOI 10.1016/j.semcdb.2008.10.005; McConlogue L, 2007, J BIOL CHEM, V282, P26326, DOI 10.1074/jbc.M611687200; Meredith JE, 2008, J PHARMACOL EXP THER, V326, P502, DOI 10.1124/jpet.108.138974; Nishitomi K, 2006, J NEUROCHEM, V99, P1555, DOI 10.1111/j.1471-4159.2006.04178.x; Ohno M, 2004, NEURON, V41, P27, DOI 10.1016/S0896-6273(03)00810-9; Ohno M, 2007, NEUROBIOL DIS, V26, P134, DOI 10.1016/j.nbd.2006.12.008; Ono Y, 1997, J BIOCHEM-TOKYO, V121, P585; Perez RG, 1999, J BIOL CHEM, V274, P18851, DOI 10.1074/jbc.274.27.18851; Pietrak BL, 2005, ANAL BIOCHEM, V342, P144, DOI 10.1016/j.ab.2005.04.019; Rajendran L, 2008, SCIENCE, V320, P520, DOI 10.1126/science.1156609; RIDDELL D, 2009, INT C ALZH DIS VIENN; Sankaranarayanan S, 2008, J PHARMACOL EXP THER, V324, P957, DOI 10.1124/jpet.107.130039; Sankaranarayanan S, 2009, J PHARMACOL EXP THER, V328, P131, DOI 10.1124/jpet.108.143628; Sano Y, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000051; Schmidt V, 2007, J BIOL CHEM, V282, P32956, DOI 10.1074/jbc.M705073200; SELKOE DJ, 1987, SCIENCE, V235, P873, DOI 10.1126/science.3544219; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; SHITAKA Y, 2008, INT C ALZH DIS CHIC; SIMON SM, 1994, P NATL ACAD SCI USA, V91, P3497, DOI 10.1073/pnas.91.9.3497; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Spoelgen R, 2006, J NEUROSCI, V26, P418, DOI 10.1523/JNEUROSCI.3882-05.2006; Stachel SJ, 2009, BIOORG MED CHEM LETT, V19, P2977, DOI 10.1016/j.bmcl.2009.04.033; Steinhilb ML, 2002, J NEUROCHEM, V80, P1019, DOI 10.1046/j.0022-3042.2002.00764.x; Takahashi K, 2008, BIOCHEM BIOPH RES CO, V377, P544, DOI 10.1016/j.bbrc.2008.10.013; Thinakaran G, 1996, J BIOL CHEM, V271, P9390, DOI 10.1074/jbc.271.16.9390; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Yang LB, 2003, NAT MED, V9, P3, DOI 10.1038/nm0103-3; Yoon IS, 2005, J BIOL CHEM, V280, P20140, DOI 10.1074/jbc.M413729200	49	29	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2010	285	3					1634	1642		10.1074/jbc.M109.066753	http://dx.doi.org/10.1074/jbc.M109.066753			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	541PJ	19926793	Green Published, hybrid			2022-12-25	WOS:000273429100009
J	Izquierdo, E; Canete, JD; Celis, R; Santiago, B; Usategui, A; Sanmarti, R; del Rey, MJ; Pablos, JL				Izquierdo, Elena; Canete, Juan D.; Celis, Raquel; Santiago, Begona; Usategui, Alicia; Sanmarti, Raimon; del Rey, Manuel J.; Pablos, Jose L.			Immature Blood Vessels in Rheumatoid Synovium Are Selectively Depleted in Response to Anti-TNF Therapy	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; COLLAGEN-INDUCED ARTHRITIS; ANTITUMOR NECROSIS FACTOR; DISEASE-ACTIVITY; VASCULAR NORMALIZATION; ANGIOGENESIS; VEGF; RECRUITMENT; HYPOXIA; METHOTREXATE	Background: Angiogenesis is considered an important factor in the pathogenesis of Rheumatoid Arthritis (RA) where it has been proposed as a therapeutic target. In other settings, active angiogenesis is characterized by pathologic, immature vessels that lack periendothelial cells. We searched for the presence of immature vessels in RA synovium and analyzed the dynamics of synovial vasculature along the course of the disease, particularly after therapeutic response to TNF antagonists. Methodology/Principal Findings: Synovial arthroscopic biopsies from RA, osteoarthritis (OA) and normal controls were analyzed by double labeling of endothelium and pericytes/smooth muscle mural cells to identify and quantify mature/immature blood vessels. To analyze clinicopathological correlations, a cross-sectional study on 82 synovial biopsies from RA patients with variable disease duration and severity was performed. A longitudinal analysis was performed in 25 patients with active disease rebiopsied after anti-TNF-alpha therapy. We found that most RA synovial tissues contained a significant fraction of immature blood vessels lacking periendothelial coverage, whereas they were rare in OA, and inexistent in normal synovial tissues. Immature vessels were observed from the earliest phases of the disease but their presence or density was significantly increased in patients with longer disease duration, higher activity and severity, and stronger inflammatory cell infiltration. In patients that responded to anti-TNF-alpha therapy, immature vessels were selectively depleted. The mature vasculature was similarly expanded in early or late disease and unchanged by therapy. Conclusion/Significance: RA synovium contains a significant fraction of neoangiogenic, immature blood vessels. Progression of the disease increases the presence and density of immature but not mature vessels and only immature vessels are depleted in response to anti-TNF alpha therapy. The different dynamics of the mature and immature vascular fractions has important implications for the development of anti-angiogenic interventions in RA.	[Izquierdo, Elena; Santiago, Begona; Usategui, Alicia; del Rey, Manuel J.; Pablos, Jose L.] Hosp 12 Octubre, Serv Reumatol, Madrid, Spain; [Canete, Juan D.; Celis, Raquel; Sanmarti, Raimon] IDIBAPS, Unitat Artritis, Serv Reumatol, Hosp Clin Barcelona, Barcelona, Spain	Hospital Universitario 12 de Octubre; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Izquierdo, E (corresponding author), Hosp 12 Octubre, Serv Reumatol, Madrid, Spain.	jlpablos@h12o.es	Del Rey, Manuel/O-6114-2014; Izquierdo, Elena/Z-1861-2019; Celis, Raquel/K-5520-2017; Cañete, Juan D/AAV-8910-2021; Usategui, Alicia/O-6476-2014; crespillo, Juan D. cañete/M-4428-2017; Sanmarti, Raimon/M-4434-2017	Del Rey, Manuel/0000-0002-8180-1584; Izquierdo, Elena/0000-0002-3355-2798; Celis, Raquel/0000-0002-5096-4532; Cañete, Juan D/0000-0003-2606-0573; Usategui, Alicia/0000-0001-8874-9523; crespillo, Juan D. cañete/0000-0003-2606-0573; Sanmarti, Raimon/0000-0002-8864-3806	Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III [FIS 05/060, RD08/0075]; Fondo de Investigacion Sanitaria	Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III(Instituto de Salud Carlos III); Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III)	This work was supported by the Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III (FIS 05/060 and RETICS program, RD08/0075, RIER), Spain. EI was supported by predoctoral training program from Fondo de Investigacion Sanitaria. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afuwape AO, 2003, GENE THER, V10, P1950, DOI 10.1038/sj.gt.3302104; Ballara S, 2001, ARTHRITIS RHEUM, V44, P2055, DOI 10.1002/1529-0131(200109)44:9<2055::AID-ART355>3.0.CO;2-2; BALUK P, 2009, J CLIN INVEST; Baluk P, 2008, ANN NY ACAD SCI, V1131, P1, DOI 10.1196/annals.1413.001; Benjamin LE, 1999, J CLIN INVEST, V103, P159, DOI 10.1172/JCI5028; Brown AK, 2008, ARTHRITIS RHEUM-US, V58, P2958, DOI 10.1002/art.23945; Canete JD, 2009, ANN RHEUM DIS, V68, P751, DOI 10.1136/ard.2008.089284; Canete JD, 2004, ARTHRITIS RHEUM, V50, P1636, DOI 10.1002/art.20181; del Rey MJ, 2009, ARTHRITIS RHEUM-US, V60, P2926, DOI 10.1002/art.24844; Distler JHW, 2004, ARTHRITIS RHEUM-US, V50, P10, DOI 10.1002/art.11425; Ellis LM, 2008, NAT REV CANCER, V8, P579, DOI 10.1038/nrc2403; FAVA RA, 1994, J EXP MED, V180, P341, DOI 10.1084/jem.180.1.341; FITZGERALD O, 1991, ANN RHEUM DIS, V50, P792, DOI 10.1136/ard.50.11.792; Folkman J, 2006, ANNU REV MED, V57, P1, DOI 10.1146/annurev.med.57.121304.131306; Fransen J, 2005, CLIN EXP RHEUMATOL, V23, pS93; Giatromanolaki A, 2001, J PATHOL, V194, P101, DOI 10.1002/path.842; Goedkoop AY, 2004, ARTHRITIS RES THER, V6, pR326, DOI 10.1186/ar1182; Greenberg JI, 2008, NATURE, V456, P809, DOI 10.1038/nature07424; Grunewald M, 2006, CELL, V124, P175, DOI 10.1016/j.cell.2005.10.036; Hamzah J, 2008, NATURE, V453, P410, DOI 10.1038/nature06868; Hellstrom M, 1999, DEVELOPMENT, V126, P3047; Hitchon C, 2002, ARTHRITIS RHEUM, V46, P2587, DOI 10.1002/art.10520; Jain RK, 2007, CANCER RES, V67, P2729, DOI 10.1158/0008-5472.CAN-06-4102; KOCH AE, 1994, J IMMUNOL, V152, P4149; Lu J, 2000, J IMMUNOL, V164, P5922, DOI 10.4049/jimmunol.164.11.5922; Miotla J, 2000, LAB INVEST, V80, P1195, DOI 10.1038/labinvest.3780127; Murakami M, 2006, BLOOD, V108, P1849, DOI 10.1182/blood-2006-04-016030; Muz B, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2568; NAGASHIMA M, 1995, J RHEUMATOL, V22, P1624; Nakahara H, 2003, ARTHRITIS RHEUM-US, V48, P1521, DOI 10.1002/art.11143; Naredo E, 2008, ARTHRITIS RHEUM, V58, P2248, DOI 10.1002/art.23682; Okazaki T, 2009, AM J PATHOL, V174, P2388, DOI 10.2353/ajpath.2009.080949; Paleolog EM, 1998, ARTHRITIS RHEUM, V41, P1258, DOI 10.1002/1529-0131(199807)41:7<1258::AID-ART17>3.0.CO;2-1; Pessler F, 2008, ANN RHEUM DIS, V67, P1184, DOI 10.1136/ard.2008.087775; Saleem B, 2009, ARTHRITIS RHEUM-US, V60, P1915, DOI 10.1002/art.24596; Szekanecz Z, 2007, NAT CLIN PRACT RHEUM, V3, P635, DOI 10.1038/ncprheum0647; Taylor PC, 2005, RHEUMATOLOGY, V44, P721, DOI 10.1093/rheumatology/keh524; Walsh DA, 1998, AM J PATHOL, V152, P691; Willett CG, 2004, NAT MED, V10, P145, DOI 10.1038/nm988; Zittermann SI, 2006, J LEUKOCYTE BIOL, V80, P247, DOI 10.1189/jlb.1205718	40	62	67	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2009	4	12							e8131	10.1371/journal.pone.0008131	http://dx.doi.org/10.1371/journal.pone.0008131			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MU	19956574	Green Published, Green Submitted, gold			2022-12-25	WOS:000272828800023
J	Shimada, S				Shimada, Sotaro			Modulation of Motor Area Activity by the Outcome for a Player during Observation of a Baseball Game	PLOS ONE			English	Article							IMITATION; ACTIVATION; MECHANISMS; DANCERS; NIRS; FMRI	Background: Observing competitive games such as sports is a pervasive entertainment among humans. The inclination to watch others play may be based on our social-cognitive ability to understand the internal states of others. The mirror neuron system, which is activated when a subject observes the actions of others, as well as when they perform the same action themselves, seems to play a crucial role in this process. Our previous study showed that activity of the mirror neuron system was modulated by the outcome of the subject's favored player during observation of a simple competitive game (rock-paper-scissors). However, whether the mirror neuron system responds similarly in a more complex and naturalistic sports game has not yet been fully investigated. Methodology/Principal Findings: In the present study, we measured the activity of motor areas when the subjects, who were amateur baseball field players (non-pitchers), watched short movie clips of scenes in professional baseball games. The subjects were instructed to support either a batter or a pitcher when observing the movie clip. The results showed that activity in the motor area exhibited a strong interaction between the subject's supported side (batter or pitcher) and the outcome (a hit or an out). When the subject supported the batter, motor area activity was significantly higher when the batter made an out than when he made a hit. However, such modulation was not apparent when the subject supported the pitcher. Conclusions/Significance: This result indicates that mirror neuron system activity is modulated by the outcome for a particular player in a competitive game even when observing a complex and naturalistic sports game. We suggest that our inclination to watch competitive games is facilitated by this characteristic of the mirror neuron system.	Meiji Univ, Sch Sci & Technol, Dept Elect & Bioinformat, Kanagawa, Japan	Meiji University	Shimada, S (corresponding author), Meiji Univ, Sch Sci & Technol, Dept Elect & Bioinformat, Kanagawa, Japan.	sshimada@isc.meiji.ac.jp	Shimada, Sotaro/AAC-2484-2019		JSPS (Japan Society for the Promotion of Science) [19700249]	JSPS (Japan Society for the Promotion of Science)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was partially supported by a Grant-in-Aid for young scientists from JSPS (19700249). JSPS (Japan Society for the Promotion of Science) http://www.jsps.go.jp/english/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Calvo-Merino B, 2005, CEREB CORTEX, V15, P1243, DOI 10.1093/cercor/bhi007; Calvo-Merino B, 2006, CURR BIOL, V16, P1905, DOI 10.1016/j.cub.2006.07.065; Cross ES, 2006, NEUROIMAGE, V31, P1257, DOI 10.1016/j.neuroimage.2006.01.033; Decety J, 2003, TRENDS COGN SCI, V7, P527, DOI 10.1016/j.tics.2003.10.004; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608, DOI 10.1152/jn.1995.73.6.2608; Gallese V, 2003, PHILOS T R SOC B, V358, P517, DOI 10.1098/rstb.2002.1234; Hari R, 1998, P NATL ACAD SCI USA, V95, P15061, DOI 10.1073/pnas.95.25.15061; Hasson U, 2004, SCIENCE, V303, P1634, DOI 10.1126/science.1089506; Hoshi Y, 2001, J APPL PHYSIOL, V90, P1657, DOI 10.1152/jappl.2001.90.5.1657; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Kilner JM, 2006, SOC COGN AFFECT NEUR, V1, P143, DOI 10.1093/scan/nsl017; Koelewijn T, 2008, NEUROIMAGE, V40, P767, DOI 10.1016/j.neuroimage.2007.12.018; MELTZOFF AN, 1995, DEV PSYCHOL, V31, P838, DOI 10.1037/0012-1649.31.5.838; Okamoto M, 2004, NEUROIMAGE, V21, P99, DOI 10.1016/j.neuroimage.2003.08.026; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; Schroeter ML, 2004, NEUROIMAGE, V21, P283, DOI 10.1016/j.neuroimage.2003.09.054; Shimada S, 2009, NEUROREPORT, V20, P979, DOI 10.1097/WNR.0b013e32832d2d36; Shimada S, 2006, NEUROIMAGE, V32, P930, DOI 10.1016/j.neuroimage.2006.03.044; Singh AK, 2006, NEUROIMAGE, V33, P542, DOI 10.1016/j.neuroimage.2006.06.047; Strangman G, 2002, NEUROIMAGE, V17, P719, DOI 10.1006/nimg.2002.1227; van Schie HT, 2004, NAT NEUROSCI, V7, P549, DOI 10.1038/nn1239; Vogt S, 2007, NEUROIMAGE, V37, P1371, DOI 10.1016/j.neuroimage.2007.07.005	22	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2009	4	11							e8034	10.1371/journal.pone.0008034	http://dx.doi.org/10.1371/journal.pone.0008034			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MK	19946372	gold, Green Submitted, Green Published			2022-12-25	WOS:000272827800021
J	Liu, SM; Okada, T; Assmann, A; Soto, J; Liew, CW; Bugger, H; Shirihai, OS; Abel, ED; Kulkarni, RN				Liu, Siming; Okada, Terumasa; Assmann, Anke; Soto, Jamie; Liew, Chong Wee; Bugger, Heiko; Shirihai, Orian S.; Abel, E. Dale; Kulkarni, Rohit N.			Insulin Signaling Regulates Mitochondrial Function in Pancreatic beta-Cells	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; N-TERMINAL KINASE; INDUCED C-JUN; IGF-I; GLUCOSE-HOMEOSTASIS; INTERACTING PROTEIN; OXIDATIVE STRESS; DOWN-REGULATION; SURVIVAL; GLUCOKINASE	Insulin/IGF-I signaling regulates the metabolism of most mammalian tissues including pancreatic islets. To dissect the mechanisms linking insulin signaling with mitochondrial function, we first identified a mitochondria-tethering complex in beta-cells that included glucokinase (GK), and the pro-apoptotic protein, BAD(S). Mitochondria isolated from beta-cells derived from beta-cell specific insulin receptor knockout (beta IRKO) mice exhibited reduced BAD(S), GK and protein kinase A in the complex, and attenuated function. Similar alterations were evident in islets from patients with type 2 diabetes. Decreased mitochondrial GK activity in beta IRKOs could be explained, in part, by reduced expression and altered phosphorylation of BAD(S). The elevated phosphorylation of p70S6K and JNK1 was likely due to compensatory increase in IGF-1 receptor expression. Re-expression of insulin receptors in beta IRKO cells partially restored the stoichiometry of the complex and mitochondrial function. These data indicate that insulin signaling regulates mitochondrial function and have implications for beta-cell dysfunction in type 2 diabetes.	[Liu, Siming; Okada, Terumasa; Assmann, Anke; Liew, Chong Wee; Kulkarni, Rohit N.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Soto, Jamie; Bugger, Heiko; Abel, E. Dale] Univ Utah, Sch Med, Div Endocrinol Metab & Diabet, Salt Lake City, UT USA; [Soto, Jamie; Bugger, Heiko; Abel, E. Dale] Univ Utah, Sch Med, Program Mol Med, Salt Lake City, UT USA; [Shirihai, Orian S.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Liu, Siming; Okada, Terumasa; Assmann, Anke; Liew, Chong Wee; Kulkarni, Rohit N.] Harvard Univ, Sch Med, Joslin Diabet Ctr, Div Res, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Boston University; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.	Liu, SM (corresponding author), Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA.	Rohit.Kulkarni@joslin.harvard.edu	Bugger, Heiko/ABA-4180-2021	Shirihai, Orian/0000-0002-9502-2661; Liew, Chong Wee/0000-0001-9904-0958; Bugger, Heiko/0000-0002-3524-0405; Assmann, Anke/0000-0003-0298-3410; Abel, E. Dale/0000-0001-5290-0738	NIH [DK RO1 68721, DK RO1 67536, HL RO1 73167]; Joslin DERC [P30DK36836]; German Research Foundation DFG; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073167] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068721, R01DK056690, P30DK036836, R01DK067536, R01DK035914] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Joslin DERC; German Research Foundation DFG(German Research Foundation (DFG)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by grants from the NIH DK RO1 68721 (R. N. K.), NIH DK RO1 67536 (R. N. K.), NIH HL RO1 73167 (E. D. A.), and the Joslin DERC P30DK36836 (Specialized Assay and Advanced Microscopy Cores). HB was supported by a grant from the German Research Foundation DFG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel E. Dale, 2005, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V5, P219, DOI 10.2174/1568008054064869; Amiott EA, 2008, EXP NEUROL, V211, P115, DOI 10.1016/j.expneurol.2008.01.010; Anello M, 2005, DIABETOLOGIA, V48, P282, DOI 10.1007/s00125-004-1627-9; Aoki H, 2002, J BIOL CHEM, V277, P10244, DOI 10.1074/jbc.M112355200; Assmann A, 2009, PEDIATR DIABETES, V10, P14, DOI 10.1111/j.1399-5448.2008.00468.x; Assmann A, 2009, MOL CELL BIOL, V29, P3219, DOI 10.1128/MCB.01489-08; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Boudina S, 2009, CIRCULATION, V119, P1272, DOI 10.1161/CIRCULATIONAHA.108.792101; Bugger H, 2008, DIABETES, V57, P2924, DOI 10.2337/db08-0079; Che WY, 2002, CIRC RES, V90, P1222, DOI 10.1161/01.RES.0000021127.83364.7D; Danial NN, 2008, NAT MED, V14, P144, DOI 10.1038/nm1717; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Danial NN, 2003, NATURE, V424, P952, DOI 10.1038/nature01825; Datta SR, 2002, DEV CELL, V3, P631, DOI 10.1016/S1534-5807(02)00326-X; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Dickson LM, 2001, J BIOL CHEM, V276, P21110, DOI 10.1074/jbc.M101257200; Fernandez AM, 2001, GENE DEV, V15, P1926, DOI 10.1101/gad.908001; FERNANDEZ S, 2007, BIOCH BIOPHYS ACTA; Gollapudi S, 2003, INT J ONCOL, V22, P597; Harada H, 2001, P NATL ACAD SCI USA, V98, P9666, DOI 10.1073/pnas.171301998; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Heart E, 2006, AM J PHYSIOL-ENDOC M, V290, pE143, DOI 10.1152/ajpendo.00216.2005; Ichii H, 2005, AM J TRANSPLANT, V5, P21, DOI 10.1111/j.1600-6143.2005.00698.x; Kelekar A, 1997, MOL CELL BIOL, V17, P7040, DOI 10.1128/MCB.17.12.7040; Kim AS, 2000, NATURE, V404, P151, DOI 10.1038/35004513; Kim JJ, 2002, GROWTH HORM IGF RES, V12, P84, DOI 10.1054/ghir.2002.0265; Kim WH, 2005, DIABETES, V54, P2602, DOI 10.2337/diabetes.54.9.2602; Kulkarni RN, 2005, REV ENDOCR METAB DIS, V6, P199, DOI 10.1007/s11154-005-3051-y; Kulkarni RN, 2003, DIABETES, V52, P1528, DOI 10.2337/diabetes.52.6.1528; Kulkarni RN, 2002, NAT GENET, V31, P111, DOI 10.1038/ng872; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; Kulkarni RN, 1999, J CLIN INVEST, V104, pR69, DOI 10.1172/JCI8339; Kurmasheva RT, 2006, BBA-REV CANCER, V1766, P1, DOI 10.1016/j.bbcan.2006.05.003; Lee JW, 2009, CELL SIGNAL, V21, P69, DOI 10.1016/j.cellsig.2008.09.015; Lin Y, 2006, J BIOL CHEM, V281, P23525, DOI 10.1074/jbc.M601487200; Masters SC, 2001, MOL PHARMACOL, V60, P1325, DOI 10.1124/mol.60.6.1325; Matschinsky FM, 2006, DIABETES, V55, P1; Matschinsky FM, 1996, DIABETES, V45, P223, DOI 10.2337/diabetes.45.2.223; Niswender KD, 1997, J BIOL CHEM, V272, P22564, DOI 10.1074/jbc.272.36.22564; O'Neill BT, 2007, CELL METAB, V6, P294, DOI 10.1016/j.cmet.2007.09.001; Oberkofler H, 2006, ENDOCRINOLOGY, V147, P966, DOI 10.1210/en.2005-0817; Oberkofler H, 2009, J MOL MED, V87, P299, DOI 10.1007/s00109-008-0425-0; Okada T, 2007, P NATL ACAD SCI USA, V104, P8977, DOI 10.1073/pnas.0608703104; Otani K, 2004, AM J PHYSIOL-ENDOC M, V286, pE41, DOI 10.1152/ajpendo.00533.2001; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Pi JB, 2009, ENDOCRINOLOGY, V150, P3040, DOI 10.1210/en.2008-1642; Rosen ED, 2003, MOL CELL BIOL, V23, P7222, DOI 10.1128/MCB.23.20.7222-7229.2003; Shimamura A, 2000, CURR BIOL, V10, P127, DOI 10.1016/S0960-9822(00)00310-9; Smith FD, 2006, TRENDS BIOCHEM SCI, V31, P316, DOI 10.1016/j.tibs.2006.04.009; Ueki K, 2006, NAT GENET, V38, P583, DOI 10.1038/ng1787; Veluthakal R, 2005, APOPTOSIS, V10, P841, DOI 10.1007/s10495-005-0431-4; Wiederkehr A, 2006, ENDOCRINOLOGY, V147, P2643, DOI 10.1210/en.2006-0057; Wikstrom JD, 2007, DIABETES, V56, P2569, DOI 10.2337/db06-0757; Wiltshire C, 2004, BIOCHEM SOC T, V32, P1075, DOI 10.1042/BST0321075; Zhang CY, 2001, CELL, V105, P745, DOI 10.1016/S0092-8674(01)00378-6	55	51	52	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2009	4	11							e7983	10.1371/journal.pone.0007983	http://dx.doi.org/10.1371/journal.pone.0007983			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MH	19956695	gold, Green Published, Green Submitted			2022-12-25	WOS:000272827500013
J	Pennings, JLA; Koster, MPH; Rodenburg, W; Schielen, PCJI; de Vries, A				Pennings, Jeroen L. A.; Koster, Maria P. H.; Rodenburg, Wendy; Schielen, Peter C. J. I.; de Vries, Annemieke			Discovery of Novel Serum Biomarkers for Prenatal Down Syndrome Screening by Integrative Data Mining	PLOS ONE			English	Article							PLACENTAL GROWTH-HORMONE; MATERNAL SERUM; 2ND TRIMESTER; ACTIVIN-A; PROTEOMIC ANALYSIS; AMNIOTIC-FLUID; MOUSE MODEL; 1ST-TRIMESTER; PREGNANCIES; IDENTIFICATION	Background: To facilitate the experimental search for novel maternal serum biomarkers in prenatal Down Syndrome screening, we aimed to create a set of candidate biomarkers using a data mining approach. Methodology/Principal Findings: Because current screening markers are derived from either fetal liver or placental trophoblasts, we reasoned that new biomarkers can primarily be found to be derived from these two tissues. By applying a three-stage filtering strategy on publicly available data from different sources, we identified 49 potential blood-detectable protein biomarkers. Our set contains three biomarkers that are currently widely used in either first-or second-trimester screening (AFP, PAPP-A and f beta-hCG), as well as ten other proteins that are or have been examined as prenatal serum markers. This supports the effectiveness of our strategy and indicates the set contains other markers potentially applicable for screening. Conclusions/Significance: We anticipate the set will help support further experimental studies for the identification of new Down Syndrome screening markers in maternal blood.	[Pennings, Jeroen L. A.; Rodenburg, Wendy; de Vries, Annemieke] Natl Inst Publ Hlth & Environm RIVM, Lab Hlth Protect Res GBO, Bilthoven, Netherlands; [Koster, Maria P. H.; Schielen, Peter C. J. I.] Natl Inst Publ Hlth & Environm RIVM, Lab Infect Dis & Perinatal Screening LIS, Bilthoven, Netherlands	Netherlands National Institute for Public Health & the Environment; Netherlands National Institute for Public Health & the Environment	Pennings, JLA (corresponding author), Natl Inst Publ Hlth & Environm RIVM, Lab Hlth Protect Res GBO, Bilthoven, Netherlands.	Jeroen.Pennings@rivm.nl	Schielen, Peter/AAP-4539-2020	Pennings, Jeroen L.A./0000-0002-9188-6358				Anderson NL, 2004, MOL CELL PROTEOMICS, V3, P311, DOI 10.1074/mcp.M300127-MCP200; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BARKER EV, 1994, ENDOCRINOLOGY, V134, P982, DOI 10.1210/en.134.2.982; Baviera G, 2004, J Matern Fetal Neonatal Med, V16, P241; Cheng D, 2008, NUCLEIC ACIDS RES, V36, pW399, DOI 10.1093/nar/gkn296; Cho CKJ, 2007, MOL CELL PROTEOMICS, V6, P1406, DOI 10.1074/mcp.M700090-MCP200; Christiansen M, 2007, PRENATAL DIAG, V27, P1, DOI 10.1002/pd.1600; CUCKLE HS, 1987, BRIT J OBSTET GYNAEC, V94, P387, DOI 10.1111/j.1471-0528.1987.tb03115.x; Dalgliesh GL, 2001, PLACENTA, V22, P227, DOI 10.1053/plac.2000.0598; Donalson K, 2008, PRENATAL DIAG, V28, P904, DOI 10.1002/pd.2043; Jelier R, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-r96; Kahlem P, 2004, GENOME RES, V14, P1258, DOI 10.1101/gr.1951304; Kolialexi A, 2008, PRENATAL DIAG, V28, P691, DOI 10.1002/pd.2040; Koster MPH, 2009, PRENATAL DIAG, V29, P857, DOI 10.1002/pd.2294; KOSTER MP, 2009, PRENAT DIAG IN PRESS; Lambert-Messerlian G M, 1996, J Med Screen, V3, P58; Lambert-Messerlian GM, 1998, EUR J ENDOCRINOL, V138, P425, DOI 10.1530/eje.0.1380425; Lyle R, 2004, GENOME RES, V14, P1268, DOI 10.1101/gr.2090904; Lyle R, 2009, EUR J HUM GENET, V17, P454, DOI 10.1038/ejhg.2008.214; Malassine A, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-6; Moghadam S, 1998, FETAL DIAGN THER, V13, P291, DOI 10.1159/000020856; Nagalla SR, 2007, J PROTEOME RES, V6, P1245, DOI 10.1021/pr060539h; Newby D, 2000, PLACENTA, V21, P263, DOI 10.1053/plac.1999.0469; Oh JE, 2004, PROTEOMICS, V4, P1145, DOI 10.1002/pmic.200300654; Olson LE, 2004, SCIENCE, V306, P687, DOI 10.1126/science.1098992; Papadopoulou E, 2008, FETAL DIAGN THER, V23, P211, DOI 10.1159/000116743; Patterson D, 2005, NAT REV GENET, V6, P137, DOI 10.1038/nrg1525; Poon LCY, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.12.029; Pospisil P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105/7/354; R Development Core Team, 2009, R FDN STAT COMP; Rozovski U, 2007, HUM REPROD, V22, P2538, DOI 10.1093/humrep/dem214; Shapiro BL, 1997, HUM GENET, V99, P421, DOI 10.1007/s004390050383; Spencer K, 2008, PRENATAL DIAG, V28, P422, DOI 10.1002/pd.1994; Spencer K, 2008, PRENATAL DIAG, V28, P338, DOI 10.1002/pd.1978; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Su YN, 2002, PRENATAL DIAG, V22, P8, DOI 10.1002/pd.218; Tsangaris GT, 2006, PROTEOMICS, V6, P4410, DOI 10.1002/pmic.200600085; Wald NJ, 1997, PRENATAL DIAG, V17, P821, DOI 10.1002/(SICI)1097-0223(199709)17:9<821::AID-PD154>3.3.CO;2-X; WALD NJ, 1988, BRIT MED J, V297, P883, DOI 10.1136/bmj.297.6653.883; Wallace EM, 1999, CLIN ENDOCRINOL, V50, P669, DOI 10.1046/j.1365-2265.1999.00716.x; Wortelboer EJ, 2009, PRENATAL DIAG, V29, P866, DOI 10.1002/pd.2300; Wortelboer EJ, 2009, PRENATAL DIAG, V29, P588, DOI 10.1002/pd.2247; Wright A, 2004, AM J MED GENET A, V130A, P354, DOI 10.1002/ajmg.a.30254; Yang JH, 2008, CHILD NERV SYST, V24, P893, DOI 10.1007/s00381-008-0595-7	45	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2009	4	11							e8010	10.1371/journal.pone.0008010	http://dx.doi.org/10.1371/journal.pone.0008010			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MH	19956656	gold, Green Published, Green Submitted			2022-12-25	WOS:000272827500033
J	Mabon, ME; Scott, BA; Crowder, CM				Mabon, Meghann E.; Scott, Barbara A.; Crowder, C. Michael			Divergent Mechanisms Controlling Hypoxic Sensitivity and Lifespan by the DAF-2/Insulin/IGF-Receptor Pathway	PLOS ONE			English	Article							C-ELEGANS; DAF-16; TARGETS; LONGEVITY; GENES; IDENTIFICATION; EXPRESSION; SURVIVAL; SIGNALS; MEMBER	Organisms and their cells vary greatly in their tolerance of low oxygen environments (hypoxia). A delineation of the determinants of hypoxia tolerance is incomplete, despite intense interest for its implications in diseases such as stroke and myocardial infarction. The insulin/IGF-1 receptor (IGFR) signaling pathway controls survival of Caenorhabditis elegans from a variety of stressors including aging, hyperthermia, and hypoxia. daf-2 encodes a C. elegans IGFR homolog whose primary signaling pathway modulates the activity of the FOXO transcription factor DAF-16. DAF-16 regulates the transcription of a large number of genes, some of which have been shown to control aging. To identify genes that selectively regulate hypoxic sensitivity, we compared the whole-organismal transcriptomes of three daf-2 reduction-of-function alleles, all of which are hypoxia resistant, thermotolerant, and long lived, but differ in their rank of severities for these phenotypes. The transcript levels of 172 genes were increased in the most hypoxia resistant daf-2 allele, e1370, relative to the other alleles whereas transcripts from only 10 genes were decreased in abundance. RNAi knockdown of 6 of the 10 genes produced a significant increase in organismal survival after hypoxic exposure as would be expected if down regulation of these genes by the e1370 mutation was responsible for hypoxia resistance. However, RNAi knockdown of these genes did not prolong lifespan. These genes definitively separate the mechanisms of hypoxic sensitivity and lifespan and identify biological strategies to survive hypoxic injury.			Mabon, ME (corresponding author), Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA.	crowderm@morpheus.wustl.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045905] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS045905] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anderson LL, 2009, SCIENCE, V323, P630, DOI 10.1126/science.1166175; Apfeld J, 1999, NATURE, V402, P804, DOI 10.1038/45544; BRENNER S, 1974, GENETICS, V77, P71; Chen NS, 2005, P NATL ACAD SCI USA, V102, P146, DOI 10.1073/pnas.0408307102; Dasgupta N, 2007, CURR BIOL, V17, P1954, DOI 10.1016/j.cub.2007.10.017; Dong MQ, 2007, SCIENCE, V317, P660, DOI 10.1126/science.1139952; Gems D, 1998, GENETICS, V150, P129; Halaschek-Wiener J, 2005, GENOME RES, V15, P603, DOI 10.1101/gr.3274805; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Lamitina ST, 2005, AM J PHYSIOL-CELL PH, V288, pC467, DOI 10.1152/ajpcell.00451.2004; Lee RYN, 2001, CURR BIOL, V11, P1950, DOI 10.1016/S0960-9822(01)00595-4; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; MABON ME, 2009, GENETICS IN PRESS; McElwee J, 2003, AGING CELL, V2, P111, DOI 10.1046/j.1474-9728.2003.00043.x; Mendenhall AR, 2006, GENETICS, V174, P1173, DOI 10.1534/genetics.106.061390; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Oh SW, 2006, NAT GENET, V38, P251, DOI 10.1038/ng1723; Paradis S, 1998, GENE DEV, V12, P2488, DOI 10.1101/gad.12.16.2488; PINKSTONGOSSE J, 2007, NAT GENET; Reinke V, 2000, MOL CELL, V6, P605, DOI 10.1016/S1097-2765(00)00059-9; Riddle DL, 1997, C ELEGANS, P739; Samokhvalov V, 2008, AUTOPHAGY, V4, P1034, DOI 10.4161/auto.6994; Samuelson AV, 2007, GENE DEV, V21, P2976, DOI 10.1101/gad.1588907; Scott BA, 2002, SCIENCE, V296, P2388, DOI 10.1126/science.1072302; Timmons Lisa, 2006, V351, P119; Tops BBJ, 2006, COLD SPRING HARB SYM, V71, P189, DOI 10.1101/sqb.2006.71.035; Wicky C, 2004, MOL CELL BIOL, V24, P5016, DOI 10.1128/MCB.24.11.5016-5027.2004; Yu H, 2001, J MOL BIOL, V314, P1017, DOI 10.1006/jmbi.2000.5210; Yuan A, 2003, NEURON, V37, P765, DOI 10.1016/S0896-6273(03)00096-5	31	22	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2009	4	11							e7937	10.1371/journal.pone.0007937	http://dx.doi.org/10.1371/journal.pone.0007937			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522NL	19936206	gold, Green Published, Green Submitted			2022-12-25	WOS:000272004800016
J	Brunner, PC; Keller, N; McDonald, BA				Brunner, Patrick C.; Keller, Nicolas; McDonald, Bruce A.			Wheat Domestication Accelerated Evolution and Triggered Positive Selection in the beta-Xylosidase Enzyme of Mycosphaerella graminicola	PLOS ONE			English	Article							WALL-DEGRADING ENZYMES; IN-VITRO; DIVERSIFYING SELECTION; BOTRYTIS-CINEREA; PLANT DEFENSE; PROTEIN; XYLANASE; PATHOGENICITY; POPULATIONS; PATTERNS	Plant cell wall degrading enzymes (PCWDEs) of plant pathogens are receiving increasing interest for their potential to trigger plant defense reactions. In an antagonistic co-evolutionary arms race between host and pathogen, PCWDEs could be under strong selection. Here, we tested the hypothesis that PCWDEs in the fungal wheat pathogen Mycosphaerella graminicola have been positively selected by analyzing ratios of non-synonymous and synonymous nucleotide changes in the genes encoding these enzymes. Analyses of five PCWDEs demonstrated that one (beta-xylosidase) has been under strong positive selection and experienced an accelerated rate of evolution. In contrast, PCWDEs in the closest relatives of M. graminicola collected from wild grasses did not show evidence for selection or deviation from a molecular clock. Since the genealogical divergence of M. graminicola from these latter species coincided with the onset of agriculture, we hypothesize that the recent domestication of the host plant and/or agricultural practices triggered positive selection in beta-xylosidase and that this enzyme played a key role in the emergence of a host-specialized pathogen.			Brunner, PC (corresponding author), Swiss Fed Inst Technol, Plant Pathol Grp, Inst Integrat Biol, Zurich, Switzerland.	patrick.brunner@agrl.ethz.ch	Brunner, Patrick C/F-5400-2011; McDonald, Bruce A/A-2748-2008	McDonald, Bruce A/0000-0002-5332-2172				Banke S, 2005, MOL ECOL, V14, P1881, DOI 10.1111/j.1365-294X.2005.02536.x; Banke S, 2004, FUNGAL GENET BIOL, V41, P226, DOI 10.1016/j.fgb.2003.09.006; Belien T, 2006, MOL PLANT MICROBE IN, V19, P1072, DOI 10.1094/MPMI-19-1072; Bishop JG, 2005, MOL BIOL EVOL, V22, P1531, DOI 10.1093/molbev/msi146; COOPER RM, 1988, PHYSIOL MOL PLANT P, V32, P33, DOI 10.1016/S0885-5765(88)80004-3; COOPER RM, 1983, BIOCH PLANT PATHOLOG, P101; De Lorenzo G., 1997, MYCOTA PLANT RELATIO, P61; Debyser W, 1999, J CEREAL SCI, V30, P39, DOI 10.1006/jcrs.1999.0272; Di Matteo A, 2006, PHYTOCHEMISTRY, V67, P528, DOI 10.1016/j.phytochem.2005.12.025; Douaiher MN, 2007, PLANT PATHOL, V56, P79, DOI 10.1111/j.1365-3059.2006.01460.x; Douaiher MN, 2007, EUR J PLANT PATHOL, V117, P71, DOI 10.1007/s10658-006-9073-9; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Enkerli J, 1999, PLANT PHYSIOL, V121, P391, DOI 10.1104/pp.121.2.391; Esquerre-Tugaye MT, 2000, PLANT PHYSIOL BIOCH, V38, P157, DOI 10.1016/S0981-9428(00)00161-3; EYAL Z, 1985, PHYTOPATHOLOGY, V75, P1456, DOI 10.1094/Phyto-75-1456; EYAL Z, 1973, PHYTOPATHOLOGY, V63, P945; Fay JC, 2000, GENETICS, V155, P1405; Federici L, 2006, TRENDS PLANT SCI, V11, P65, DOI 10.1016/j.tplants.2005.12.005; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; GUTTMANN DS, 2006, MOL CELL, V5, P1003; Juge N, 2006, TRENDS PLANT SCI, V11, P359, DOI 10.1016/j.tplants.2006.05.006; Kang Z, 2000, J PHYTOPATHOL, V148, P263, DOI 10.1046/j.1439-0434.2000.00489.x; Kapat A, 1998, MYCOL RES, V102, P1017, DOI 10.1017/S0953756297006023; Kimura M., 1983, P208; Lalaoui F, 2000, PLANT PATHOL, V49, P727, DOI 10.1046/j.1365-3059.2000.00491.x; LEHTINEN U, 1993, PHYSIOL MOL PLANT P, V43, P121, DOI 10.1006/pmpp.1993.1045; Liu ZY, 2005, MOL BIOL EVOL, V22, P659, DOI 10.1093/molbev/msi049; Massingham T, 2005, GENETICS, V169, P1753, DOI 10.1534/genetics.104.032144; McDonald BA, 1999, SEPTORIA ON CEREALS: A STUDY OF PATHOSYSTEMS, P44; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; McLauchlan WR, 1999, BIOCHEM J, V338, P441, DOI 10.1042/0264-6021:3380441; Misas-Villamil JC, 2008, CURR OPIN PLANT BIOL, V11, P380, DOI 10.1016/j.pbi.2008.04.007; Nurnberger T, 2004, IMMUNOL REV, V198, P249, DOI 10.1111/j.0105-2896.2004.0119.x; Pilling E, 2003, CURR OPIN PLANT BIOL, V6, P611, DOI 10.1016/j.pbi.2003.09.004; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Rowe HC, 2007, MOL PLANT MICROBE IN, V20, P1126, DOI 10.1094/MPMI-20-9-1126; Schurch S, 2004, MOL PLANT MICROBE IN, V17, P1114, DOI 10.1094/MPMI.2004.17.10.1114; Stotz HU, 2000, PHYSIOL MOL PLANT P, V56, P117, DOI 10.1006/pmpp.2000.0258; Stukenbrock EH, 2008, ANNU REV PHYTOPATHOL, V46, P75, DOI 10.1146/annurev.phyto.010708.154114; Stukenbrock EH, 2007, MOL BIOL EVOL, V24, P398; Stukenbrock EH, 2007, MOL PLANT PATHOL, V8, P321, DOI 10.1111/J.1364-3703.2007.00396.X; TAJIMA F, 1989, GENETICS, V123, P585; Tiffin P, 2006, TRENDS GENET, V22, P662, DOI 10.1016/j.tig.2006.09.011; Vidal S, 1998, MOL PLANT MICROBE IN, V11, P23, DOI 10.1094/MPMI.1998.11.1.23; Wubben JP, 1999, APPL ENVIRON MICROB, V65, P1596; Zhang B, 2002, MOL PLANT MICROBE IN, V15, P963, DOI 10.1094/MPMI.2002.15.9.963; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	48	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2009	4	11							e7884	10.1371/journal.pone.0007884	http://dx.doi.org/10.1371/journal.pone.0007884			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521QH	19924304	Green Submitted, gold, Green Published			2022-12-25	WOS:000271936700017
J	Chen, C; Liu, CP				Chen, Cyndi; Liu, Chih-Pin			Regulatory Function of a Novel Population of Mouse Autoantigen-Specific Foxp3(-) Regulatory T Cells Depends on IFN-gamma, NO, and Contact with Target Cells	PLOS ONE			English	Article							NONOBESE DIABETIC MICE; RECEPTOR TRANSGENIC MICE; INTERFERON-GAMMA; NITRIC-OXIDE; IMMUNOLOGICAL-TOLERANCE; IMMUNE-RESPONSES; MECHANISMS; IDENTIFICATION; AUTOIMMUNITY; PROGRESSION	Background: Both naturally arising Foxp3(+) and antigen-induced Foxp3(-) regulatory T cells (Treg) play a critical role in regulating immune responses, as well as in preventing autoimmune diseases and graft rejection. It is known that antigen-specific Treg are more potent than polyclonal Treg in suppressing pathogenic immune responses that cause autoimmunity and inflammation. However, difficulty in identifying and isolating a sufficient number of antigen-specific Treg has limited their use in research to elucidate the mechanisms underlying their regulatory function and their potential role in therapy. Methodology/Principal Findings: Using a novel class II MHC tetramer, we have isolated a population of CD4(+) Foxp3(-) T cells specific for the autoantigen glutamic acid decarboxylase p286-300 peptide (NR286 T cells) from diabetes-resistant non-obese resistant (NOR) mice. These Foxp3(-) NR286 T cells functioned as Treg that were able to suppress target T cell proliferation in vitro and inhibit type 1 diabetes in animals. Unexpected results from mechanistic studies in vitro showed that their regulatory function was dependent on not only IFN-gamma and nitric oxide, but also on cell contact with target cells. In addition, separating NR286 Treg from target T cells in transwell assays abolished both production of NO and suppression of target T cells, regardless of whether IFN-gamma was produced in cell cultures. Therefore, production of NO, not IFN-gamma, was cell contact dependent, suggesting that NO may function downstream of IFN-gamma in mediating regulatory function of NR286 Treg. Conclusions/Significance: These studies identified a unique population of autoantigen-specific Foxp3(-) Treg that can exert their regulatory function dependent on not only IFN-gamma and NO but also cell contact with target cells.			Chen, C (corresponding author), Beckman Res Inst, Dept Immunol, Duarte, CA USA.	cpliu@coh.org						Bending D, 2009, J CLIN INVEST, V119, P565, DOI 10.1172/JCI37865; Billiau A, 1998, ANN NY ACAD SCI, V856, P22, DOI 10.1111/j.1749-6632.1998.tb08309.x; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Brusko TM, 2005, DIABETES, V54, P1407, DOI 10.2337/diabetes.54.5.1407; Chao CC, 1997, IMMUNOGENETICS, V46, P29, DOI 10.1007/s002510050238; Chen C, 2003, J IMMUNOL, V171, P733, DOI 10.4049/jimmunol.171.2.733; Chen C, 2006, J IMMUNOL, V176, P3449, DOI 10.4049/jimmunol.176.6.3449; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Hori S, 2002, P NATL ACAD SCI USA, V99, P8213, DOI 10.1073/pnas.122224799; Huang FP, 1998, EUR J IMMUNOL, V28, P4062, DOI 10.1002/(SICI)1521-4141(199812)28:12<4062::AID-IMMU4062>3.0.CO;2-K; Judkowski V, 2001, J IMMUNOL, V166, P908, DOI 10.4049/jimmunol.166.2.908; Kim SK, 2004, P NATL ACAD SCI USA, V101, P14204, DOI 10.1073/pnas.0405500101; Liu CP, 2000, P NATL ACAD SCI USA, V97, P14596, DOI 10.1073/pnas.250390997; Ludvigsson J, 2008, NEW ENGL J MED, V359, P1909, DOI 10.1056/NEJMoa0804328; Maloy KJ, 2001, NAT IMMUNOL, V2, P816, DOI 10.1038/ni0901-816; MARTINOROZCO N, EUR J IMMUNOL, V39, P216; Mazzoni A, 2002, J IMMUNOL, V168, P689, DOI 10.4049/jimmunol.168.2.689; Nishimura E, 2004, INT IMMUNOL, V16, P1189, DOI 10.1093/intimm/dxh122; O'Garra A, 2004, J CLIN INVEST, V114, P1372, DOI 10.1172/JCI200423215; O'Garra A, 2004, NAT MED, V10, P801, DOI 10.1038/nm0804-801; Piccirillo CA, 2004, SEMIN IMMUNOL, V16, P81, DOI 10.1016/j.smim.2003.12.003; Pop SM, 2005, J EXP MED, V201, P1333, DOI 10.1084/jem.20042398; PROCHAZKA M, 1992, DIABETES, V41, P98, DOI 10.2337/diabetes.41.1.98; Roncarolo MG, 2000, CURR OPIN IMMUNOL, V12, P676, DOI 10.1016/S0952-7915(00)00162-X; Rosloniec EF, 2002, ARTHRITIS RES, V4, P333, DOI 10.1186/ar432; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Schloot NC, 2002, DIABETES-METAB RES, V18, P64, DOI 10.1002/dmrr.256; SERREZE DV, 1994, J EXP MED, V180, P1553, DOI 10.1084/jem.180.4.1553; Shevach EM, 2004, ARTHRITIS RHEUM, V50, P2721, DOI 10.1002/art.20500; Steinman L, 2001, MULT SCLER, V7, P275, DOI 10.1177/135245850100700501; Szabo SJ, 2003, ANNU REV IMMUNOL, V21, P713, DOI 10.1146/annurev.immunol.21.120601.140942; Tang QZ, 2004, J EXP MED, V199, P1455, DOI 10.1084/jem.20040139; Tarbell KV, 2004, J EXP MED, V199, P1467, DOI 10.1084/jem.20040180; Tarbell KV, 2002, J EXP MED, V196, P481, DOI 10.1084/jem.20011845; van der Veen RC, 1999, CELL IMMUNOL, V193, P194, DOI 10.1006/cimm.1999.1471; von Boehmer H, 2005, NAT IMMUNOL, V6, P338, DOI 10.1038/ni1180; Wang B, 1997, P NATL ACAD SCI USA, V94, P13844, DOI 10.1073/pnas.94.25.13844; You S, 2005, DIABETES, V54, P1415, DOI 10.2337/diabetes.54.5.1415; You S, 2004, J IMMUNOL, V173, P6777, DOI 10.4049/jimmunol.173.11.6777; You S, 2003, J IMMUNOL, V170, P4011, DOI 10.4049/jimmunol.170.8.4011; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547	43	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2009	4	11							e7863	10.1371/journal.pone.0007863	http://dx.doi.org/10.1371/journal.pone.0007863			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520OG	19924236	gold, Green Submitted, Green Published			2022-12-25	WOS:000271854200011
J	Kurotani, A; Takagi, T; Toyama, M; Shirouzu, M; Yokoyama, S; Fukami, Y; Tokmakov, AA				Kurotani, Atsushi; Takagi, Tetsuo; Toyama, Mitsutoshi; Shirouzu, Mikako; Yokoyama, Shigeyuki; Fukami, Yasuo; Tokmakov, Alexander A.			Comprehensive bioinformatics analysis of cell-free protein synthesis: identification of multiple protein properties that correlate with successful expression	FASEB JOURNAL			English	Article						recombinant proteins; heterologous expression; rationalization; physicochemical protein properties; structural protein properties	STRUCTURAL GENOMICS; ESCHERICHIA-COLI; PROPENSITY; PREDICTION; SYSTEMS; CRYSTALLIZATION; OVEREXPRESSION; PURIFICATION; SEQUENCES; ELEGANS	High-throughput cell-free protein synthesis is being used increasingly in structural/functional genomics projects. However, the factors determining expression success are poorly understood. Here, we evaluated the expression of 3066 human proteins and their domains in a bacterial cell-free system and analyzed the correlation of protein expression with 39 physicochemical and structural properties of proteins. As a result of the bioinformatics analysis performed, we determined the 18 most influential features that affect protein amenability to cell-free expression. They include protein length; hydrophobicity; pI; content of charged, nonpolar, and aromatic residues;, cysteine content; solvent accessibility; presence of coiled coil; content of intrinsically disordered and structured (alpha-helix and beta-sheet) sequence; number of disulfide bonds and functional domains; presence of transmembrane regions; PEST motifs; and signaling sequences. This study represents the first comprehensive bioinformatics analysis of heterologous protein synthesis in a cell-free system. The rules and correlations revealed here provide a plethora of important insights into rationalization of cell-free protein production and can be of practical use for protein engineering with the aim of increasing expression success.-Kurotani, A., Takagi, T., Toyama, M., Shirouzu, M., Yokoyama, S., Fukami, Y., Tokmakov, A. A. Comprehensive bioinformatics analysis of cell- free protein synthesis: identification of multiple protein properties that correlate with successful expression. FASEB J. 24, 1095-1104 (2010). www.fasebj.org	[Kurotani, Atsushi; Takagi, Tetsuo; Toyama, Mitsutoshi; Shirouzu, Mikako; Yokoyama, Shigeyuki; Tokmakov, Alexander A.] RIKEN Syst & Struct Biol Ctr, Yokohama, Kanagawa, Japan; [Kurotani, Atsushi] Plant Sci Ctr, Yokohama, Kanagawa, Japan; [Yokoyama, Shigeyuki] Univ Tokyo, Grad Sch Sci, Tokyo 113, Japan; [Fukami, Yasuo; Tokmakov, Alexander A.] Kobe Univ, Grad Sch Sci, Nada, Japan; [Fukami, Yasuo; Tokmakov, Alexander A.] Kobe Univ, Res Ctr Environm Genom, Nada, Japan	RIKEN; University of Tokyo; Kobe University; Kobe University	Tokmakov, AA (corresponding author), Kobe Univ, Res Ctr Environm Genom, Nada Ku, Rokko Dai 1-1, Kobe, Hyogo 6578501, Japan.	tokmak@phoenix.kobe-u.ac.jp	Yokoyama, Shigeyuki/N-6911-2015; Shirouzu, Mikako/A-6521-2016	Yokoyama, Shigeyuki/0000-0003-3133-7338; 	RIKEN Structural Genomics/Proteomics; Ministry of Education, Culture, Sports, Science and Technology of Japan	RIKEN Structural Genomics/Proteomics; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the RIKEN Structural Genomics/Proteomics Initiative, the National Project on Protein Structural and Functional Analyses, Ministry of Education, Culture, Sports, Science and Technology of Japan.	Bertone P, 2001, NUCLEIC ACIDS RES, V29, P2884, DOI 10.1093/nar/29.13.2884; Braun P, 2002, P NATL ACAD SCI USA, V99, P2654, DOI 10.1073/pnas.042684199; Busso Didier, 2004, Journal of Structural and Functional Genomics, V5, P69, DOI 10.1023/B:JSFG.0000029197.44728.c5; Cheng JL, 2006, PROTEINS, V62, P617, DOI 10.1002/prot.20787; Chikayama E, 2004, BIOINFORMATICS, V20, P2836, DOI 10.1093/bioinformatics/bth276; Davis GD, 1999, BIOTECHNOL BIOENG, V65, P382, DOI 10.1002/(SICI)1097-0290(19991120)65:4<382::AID-BIT2>3.3.CO;2-9; Ding HT, 2002, ACTA CRYSTALLOGR D, V58, P2102, DOI 10.1107/S0907444902016359; Dyson MR, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-32; Ferre F, 2005, NUCLEIC ACIDS RES, V33, pW230, DOI 10.1093/nar/gki412; Finley JB, 2004, PROTEIN EXPRES PURIF, V34, P49, DOI 10.1016/j.pep.2003.11.026; Goerke AR, 2009, BIOTECHNOL BIOENG, V102, P400, DOI 10.1002/bit.22070; Goh CS, 2004, J MOL BIOL, V336, P115, DOI 10.1016/j.jmb.2003.11.053; Idicula-Thomas S, 2005, PROTEIN SCI, V14, P582, DOI 10.1110/ps.041009005; Idicula-Thomas S, 2006, BIOINFORMATICS, V22, P278, DOI 10.1093/bioinformatics/bti810; Idicula-Thomas Susan, 2007, In Silico Biology, V7, P225; Ishihara G, 2005, PROTEIN EXPRES PURIF, V41, P27, DOI 10.1016/j.pep.2005.01.013; Kantardjieff KA, 2004, BIOINFORMATICS, V20, P2162, DOI 10.1093/bioinformatics/bth066; Katzen F, 2005, TRENDS BIOTECHNOL, V23, P150, DOI 10.1016/j.tibtech.2005.01.003; KIGAWA T, 1991, J BIOCHEM-TOKYO, V110, P166, DOI 10.1093/oxfordjournals.jbchem.a123551; Kigawa T, 1999, FEBS LETT, V442, P15, DOI 10.1016/S0014-5793(98)01620-2; Kigawa Takanori, 2004, Journal of Structural and Functional Genomics, V5, P63, DOI 10.1023/B:JSFG.0000029204.57846.7d; Koschorreck M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-49; KUDLICKI W, 1992, ANAL BIOCHEM, V206, P389, DOI 10.1016/0003-2697(92)90383-I; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Luan CH, 2004, GENOME RES, V14, P2102, DOI 10.1101/gr.2520504; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Marsden Russell L., 2008, V426, P3, DOI 10.1007/978-1-60327-058-8_1; Niwa T, 2009, P NATL ACAD SCI USA, V106, P4201, DOI 10.1073/pnas.0811922106; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; Spirin AS, 2004, TRENDS BIOTECHNOL, V22, P538, DOI 10.1016/j.tibtech.2004.08.012; Suyama M, 2003, BIOINFORMATICS, V19, P673, DOI 10.1093/bioinformatics/btg031; WOOTTON JC, 1994, COMPUT CHEM, V18, P269, DOI 10.1016/0097-8485(94)85023-2; Wootton JC, 1996, METHOD ENZYMOL, V266, P554; Xie JM, 2005, METHODS, V36, P227, DOI 10.1016/j.ymeth.2005.04.010; Yabuki Takashi, 2007, Journal of Structural and Functional Genomics, V8, P173, DOI 10.1007/s10969-007-9038-z; Yokoyama S, 2003, CURR OPIN CHEM BIOL, V7, P39, DOI 10.1016/S1367-5931(02)00019-4; Yokoyama S, 2000, NAT STRUCT BIOL, V7, P943, DOI 10.1038/80712	37	18	18	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2010	24	4					1095	1104		10.1096/fj.09-139527	http://dx.doi.org/10.1096/fj.09-139527			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	580PV	19940260				2022-12-25	WOS:000276462300017
J	Giroud, C; Moreau, M; Mattioli, TA; Balland, V; Boucher, JL; Yun, XL; Stuehr, DJ; Santolini, J				Giroud, Claire; Moreau, Magali; Mattioli, Tony A.; Balland, Veronique; Boucher, Jean-Luc; Yun Xu-Li; Stuehr, Dennis J.; Santolini, Jerome			Role of Arginine Guanidinium Moiety in Nitric-oxide Synthase Mechanism of Oxygen Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-PROTEIN INTERACTIONS; ARYL N'-HYDROXYGUANIDINES; 2ND HALF-REACTION; NO-SYNTHASE; ELECTRON-TRANSFER; RESONANCE RAMAN; HEME ENVIRONMENT; STAPHYLOCOCCUS-AUREUS; SELECTIVE INHIBITOR; DIOXYGEN COMPLEXES	Nitric-oxide synthases (NOS) are highly regulated heme-thiolate enzymes that catalyze two oxidation reactions that sequentially convert the substrate L-Arg first to N-w-hydroxyl-L-arginine and then to L-citrulline and nitric oxide. Despite numerous investigations, the detailed molecular mechanism of NOS remains elusive and debatable. Much of the dispute in the various proposed mechanisms resides in the uncertainty concerning the number and sources of proton transfers. Although specific protonation events are key features in determining the specificity and efficiency of the two catalytic steps, little is known about the role and properties of protons from the substrate, cofactors, and H-bond network in the vicinity of the heme active site. In this study, we have investigated the role of the acidic proton from the L-Arg guanidinium moiety on the stability and reactivity of the ferrous heme-oxy complex intermediate by exploiting a series of L-Arg analogues exhibiting a wide range of guanidinium pK(a) values. Using electrochemical and vibrational spectroscopic techniques, we have analyzed the effects of the analogues on the heme, including characteristics of its proximal ligand, heme conformation, redox potential, and electrostatic properties of its distal environment. Our results indicate that the substrate guanidinium pK(a) value significantly affects the H-bond network near the heme distal pocket. Our results lead us to propose a new structural model where the properties of the guanidinium moiety finely control the proton transfer events in NOS and tune its oxidative chemistry. This model may account for the discrepancies found in previously proposed mechanisms of NOS oxidation processes.	[Mattioli, Tony A.; Santolini, Jerome] Commissariat Energie Atom Saclay, Inst Biol & Technol Saclay, Lab Stress Oxydants & Detoxicat, F-91191 Gif Sur Yvette, France; Univ Paris 05, CNRS, UMR 8601, F-75270 Paris, France; [Stuehr, Dennis J.] Lerner Res Fdn, Cleveland Clin, Cleveland, OH 44195 USA; [Balland, Veronique] Univ Paris Diderot, Electrochim Mol Lab, UMR7591, F-75205 Paris 13, France	CEA; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Cite; Cleveland Clinic Foundation; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Cite	Santolini, J (corresponding author), Commissariat Energie Atom Saclay, Inst Biol & Technol Saclay, Lab Stress Oxydants & Detoxicat, F-91191 Gif Sur Yvette, France.	jerome.santolini@cea.fr	Balland, Véronique/D-2479-2013; Balland, Véronique/AAD-7548-2022	Balland, Véronique/0000-0001-9534-9659; Santolini, Jerome/0000-0001-8919-112X				ABUSOUD HM, 1994, J BIOL CHEM, V269, P32318; ABUSOUD HM, 1993, P NATL ACAD SCI USA, V90, P10769, DOI 10.1073/pnas.90.22.10769; Adak S, 2000, J BIOL CHEM, V275, P17434, DOI 10.1074/jbc.M000846200; Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Babu BR, 1999, J BIOL CHEM, V274, P25218, DOI 10.1074/jbc.274.36.25218; Balland V, 2008, CHEM-EUR J, V14, P7186, DOI 10.1002/chem.200800368; BERNATOWICZ MS, 1993, TETRAHEDRON LETT, V34, P3389, DOI 10.1016/S0040-4039(00)79163-5; Bredt DS, 2003, J CELL SCI, V116, P9, DOI 10.1242/jcs.00183; BREDT DS, 1991, NATURE, V351, P714, DOI 10.1038/351714a0; Chartier FJM, 2006, J BIOL CHEM, V281, P9953, DOI 10.1074/jbc.M513893200; Chartier FJM, 2004, BIOPHYS J, V87, P1939, DOI 10.1529/biophysj.104.042119; Chartier FJM, 2007, J BIOL CHEM, V282, P20877, DOI 10.1074/jbc.M701800200; CHARTON M, 1965, J ORG CHEM, V30, P969, DOI 10.1021/jo01015a003; Cho KB, 2005, J PHYS CHEM B, V109, P23706, DOI 10.1021/jp054864o; Cho KB, 2007, J AM CHEM SOC, V129, P3182, DOI 10.1021/ja066662r; Cho KB, 2009, J PHYS CHEM B, V113, P336, DOI 10.1021/jp8073199; Collins JL, 1998, J MED CHEM, V41, P2858, DOI 10.1021/jm980072p; Crane BR, 2000, BIOCHEMISTRY-US, V39, P4608, DOI 10.1021/bi992409a; Crane BR, 1998, SCIENCE, V279, P2121, DOI 10.1126/science.279.5359.2121; Davydov R, 2002, BIOCHEMISTRY-US, V41, P10375, DOI 10.1021/bi0260637; Dawson VL, 1996, NEUROCHEM INT, V29, P97, DOI 10.1016/0197-0186(95)00149-2; de Visser SP, 2008, J AM CHEM SOC, V130, P12961, DOI 10.1021/ja8010995; Deng TJ, 1999, BIOCHEMISTRY-US, V38, P13699, DOI 10.1021/bi991287j; Dijols S, 2002, BIOCHEMISTRY-US, V41, P9286, DOI 10.1021/bi025691l; Fan BC, 1997, BIOCHEMISTRY-US, V36, P12660, DOI 10.1021/bi9715369; Forstermann U, 2006, BIOL CHEM, V387, P1521, DOI 10.1515/BC.2006.190; Forstermann U, 2006, CIRCULATION, V113, P1708, DOI 10.1161/CIRCULATIONAHA.105.602532; Garcin ED, 2004, J BIOL CHEM, V279, P37918, DOI 10.1074/jbc.M406204200; Garcin ED, 2008, NAT CHEM BIOL, V4, P700, DOI 10.1038/nchembio.115; Garvey EP, 1997, J BIOL CHEM, V272, P4959, DOI 10.1074/jbc.272.8.4959; Ghosh DK, 1999, EMBO J, V18, P6260, DOI 10.1093/emboj/18.22.6260; Ghosh DK, 2003, FRONT BIOSCI-LANDMRK, V8, pD193, DOI 10.2741/959; Gorren ACF, 2007, BBA-GEN SUBJECTS, V1770, P432, DOI 10.1016/j.bbagen.2006.08.019; Guix FX, 2005, PROG NEUROBIOL, V76, P126, DOI 10.1016/j.pneurobio.2005.06.001; Hammett LP, 1937, J AM CHEM SOC, V59, P96, DOI 10.1021/ja01280a022; HANSCH C, 1991, CHEM REV, V91, P165, DOI 10.1021/cr00002a004; Huang H, 2001, J AM CHEM SOC, V123, P2674, DOI 10.1021/ja005900u; Igarashi J, 2009, J MED CHEM, V52, P2060, DOI 10.1021/jm900007a; Ingledew WJ, 2002, BIOCHEMISTRY-US, V41, P8377, DOI 10.1021/bi012101v; Jung C, 1996, BIOCHEMISTRY-US, V35, P15088, DOI 10.1021/bi961507i; Jung C, 2000, BIOCHEMISTRY-US, V39, P10163, DOI 10.1021/bi0003792; JUNG C, 1992, BIOCHEMISTRY-US, V31, P12855, DOI 10.1021/bi00166a021; KNOWLES RG, 1994, BIOCHEM J, V298, P249, DOI 10.1042/bj2980249; Lefevre-Groboillot D, 2005, FEBS J, V272, P3172, DOI 10.1111/j.1742-4658.2005.04736.x; LEFFEK KT, 1989, CAN J CHEM, V67, P590, DOI 10.1139/v89-089; Li D, 2004, J BIOL CHEM, V279, P26489, DOI 10.1074/jbc.M400968200; Li D, 2007, J AM CHEM SOC, V129, P6943, DOI 10.1021/ja070683j; Li HY, 2006, J BIOL INORG CHEM, V11, P753, DOI 10.1007/s00775-006-0123-8; Li HY, 2002, BIOCHEMISTRY-US, V41, P13868, DOI 10.1021/bi020417c; Li HY, 2000, J INORG BIOCHEM, V81, P133, DOI 10.1016/S0162-0134(00)00099-4; Li HY, 2005, J INORG BIOCHEM, V99, P293, DOI 10.1016/j.jinorgbio.2004.10.016; Liaudet L, 2000, CRIT CARE MED, V28, pN37, DOI 10.1097/00003246-200004001-00005; Lipton SA, 1999, CELL DEATH DIFFER, V6, P943, DOI 10.1038/sj.cdd.4400580; Luzzi SD, 2005, BIOORG MED CHEM LETT, V15, P3934, DOI 10.1016/j.bmcl.2005.05.088; Malinski T, 2007, J ALZHEIMERS DIS, V11, P207; Mansuy D, 2004, FREE RADICAL BIO MED, V37, P1105, DOI 10.1016/j.freeradbiomed.2004.06.031; Marletta MA, 1998, CURR OPIN CHEM BIOL, V2, P656, DOI 10.1016/S1367-5931(98)80098-7; Martin NI, 2007, J AM CHEM SOC, V129, P12563, DOI 10.1021/ja0746159; Moreau M, 2006, BIOCHEMISTRY-US, V45, P3988, DOI 10.1021/bi051488p; MOREAU M, 2005, THESIS U PARIS DESCA; Mungrue IN, 2004, J CELL SCI, V117, P2627, DOI 10.1242/jcs.01187; Ost TWB, 2001, BIOCHEMISTRY-US, V40, P13421, DOI 10.1021/bi010716m; PACHER P, 2007, PHYSIOL REV, V315, P424; Pall ML, 2007, MED HYPOTHESES, V69, P821, DOI 10.1016/j.mehy.2007.01.070; Panda K, 2006, J BIOL CHEM, V281, P36819, DOI 10.1074/jbc.M606129200; Pant K, 2006, BIOCHEMISTRY-US, V45, P2537, DOI 10.1021/bi0518848; Patel RP, 1999, BBA-BIOENERGETICS, V1411, P385, DOI 10.1016/S0005-2728(99)00028-6; Perrin D.D., 1972, DISSOCIATION CONSTAN; POLLOCK JS, 1991, P NATL ACAD SCI USA, V88, P10480, DOI 10.1073/pnas.88.23.10480; Presta A, 1998, J AM CHEM SOC, V120, P9460, DOI 10.1021/ja9740374; Radi R, 2001, FREE RADICAL BIO MED, V30, P463, DOI 10.1016/S0891-5849(00)00373-7; Raman CS, 2001, BIOCHEMISTRY-US, V40, P13448, DOI 10.1021/bi010957u; RAY GB, 1994, J AM CHEM SOC, V116, P162, DOI 10.1021/ja00080a019; Renodon-Corniere A, 1999, BIOCHEMISTRY-US, V38, P4663, DOI 10.1021/bi982930p; Renodon-Corniere A, 2002, J MED CHEM, V45, P944, DOI 10.1021/jm011006h; Reynolds MR, 2007, BIOCHEMISTRY-US, V46, P7325, DOI 10.1021/bi700430y; Robinet JJ, 2008, J AM CHEM SOC, V130, P3328, DOI 10.1021/ja072650+; RodriguezCrespo I, 1997, BIOCHEMISTRY-US, V36, P8530, DOI 10.1021/bi970192j; Roman LJ, 2002, CHEM REV, V102, P1179, DOI 10.1021/cr000661e; Rousseau DL, 2005, J INORG BIOCHEM, V99, P306, DOI 10.1016/j.jinorgbio.2004.11.007; Santolini M, 2006, BIOCHEMISTRY-US, V45, P1480, DOI 10.1021/bi051710q; Schelvis JPM, 2002, BIOCHEMISTRY-US, V41, P5695, DOI 10.1021/bi0118456; Schulz E, 2008, ANTIOXID REDOX SIGN, V10, P1115, DOI 10.1089/ars.2007.1989; Sennequier N, 1996, BIOCHEMISTRY-US, V35, P5883, DOI 10.1021/bi952844e; SESSA WC, 1992, J BIOL CHEM, V267, P15274; Sessa WC, 2004, J CELL SCI, V117, P2427, DOI 10.1242/jcs.01165; Silverman RB, 2009, ACCOUNTS CHEM RES, V42, P439, DOI 10.1021/ar800201v; Spiro TG, 2005, J INORG BIOCHEM, V99, P34, DOI 10.1016/j.jinorgbio.2004.09.026; Stuehr D, 2001, J BIOL CHEM, V276, P14533, DOI 10.1074/jbc.R100011200; Stuehr D J, 1995, Adv Pharmacol, V34, P207; Stuehr DJ, 1999, BBA-BIOENERGETICS, V1411, P217, DOI 10.1016/S0005-2728(99)00016-X; STUEHR DJ, 1991, P NATL ACAD SCI USA, V88, P7773, DOI 10.1073/pnas.88.17.7773; STUEHR DJ, 1991, J BIOL CHEM, V266, P6259; Stuehr DJ, 2004, J BIOL CHEM, V279, P36167, DOI 10.1074/jbc.R400017200; STUEHR DJ, 1992, J BIOL CHEM, V267, P20547; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P662, DOI 10.1038/nrd2222; TAYLOR PJ, 1986, J CHEM SOC PERK T 2, P1765, DOI 10.1039/p29860001765; Tejero J, 2009, FEBS J, V276, P4505, DOI 10.1111/j.1742-4658.2009.07157.x; Tosha T, 2006, BIOCHEMISTRY-US, V45, P5631, DOI 10.1021/bi060094a; Trujillo M, 2008, ANTIOXID REDOX SIGN, V10, P1607, DOI 10.1089/ars.2008.2060; TSUBAKI M, 1986, BIOCHEMISTRY-US, V25, P3563, DOI 10.1021/bi00360a014; Vasquez-Vivar J, 2009, FREE RADICAL BIO MED, V47, P1108, DOI 10.1016/j.freeradbiomed.2009.07.024; WANG JL, 1995, BIOCHEMISTRY-US, V34, P7080, DOI 10.1021/bi00021a020; Wang JL, 1997, BIOCHEMISTRY-US, V36, P4595, DOI 10.1021/bi962309u; Wei CC, 2003, J BIOL CHEM, V278, P46668, DOI 10.1074/jbc.M307682200; Wei CC, 2002, J INORG BIOCHEM, V91, P618, DOI 10.1016/S0162-0134(02)00432-4; Wei CC, 2008, J BIOL CHEM, V283, P11734, DOI 10.1074/jbc.M709250200; WELLS AV, 1992, BIOCHEMISTRY-US, V31, P4384, DOI 10.1021/bi00133a002; Woodward JJ, 2009, J AM CHEM SOC, V131, P297, DOI 10.1021/ja807299t; XIE QW, 1992, SCIENCE, V256, P225, DOI 10.1126/science.1373522; YAMAMOTO Y, 1991, CHEM AMIDINES IMIDAT, V2, P485; Zhang L, 2006, PHARMACOL THERAPEUT, V109, P33, DOI 10.1016/j.pharmthera.2005.05.007; Zhu YQ, 2008, BIOCHEMISTRY-US, V47, P2231, DOI 10.1021/bi7023817	113	24	24	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7233	7245		10.1074/jbc.M109.038240	http://dx.doi.org/10.1074/jbc.M109.038240			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	19951943	hybrid, Green Published			2022-12-25	WOS:000275415600036
J	Levanon, K; Ng, V; Piao, HY; Zhang, Y; Chang, MC; Roh, MH; Kindelberger, DW; Hirsch, MS; Crum, CP; Marto, JA; Drapkin, R				Levanon, K.; Ng, V.; Piao, H. Y.; Zhang, Yi; Chang, M. C.; Roh, M. H.; Kindelberger, D. W.; Hirsch, M. S.; Crum, C. P.; Marto, J. A.; Drapkin, R.			Primary ex vivo cultures of human fallopian tube epithelium as a model for serous ovarian carcinogenesis	ONCOGENE			English	Article						ovarian cancer; fallopian tube; primary cell culture; cancer biomarkers; DNA damage and repair	CELL-CYCLE; IN-VITRO; CANCER; DIFFERENTIATION; CARCINOMA; HE-4; PATHOGENESIS; RECEPTOR; OVIDUCT; MARKERS	Recent studies suggest that some serous ovarian carcinomas (SOCs) arise from the fallopian tube (FT) epithelium rather than the ovarian surface epithelium. This hypothesis places emphasis on the FT secretory epithelial cell as a cell-of-origin. Herein, we report the development of a novel ex vivo primary human FT epithelium culture system that faithfully recapitulates the in vivo epithelium, as shown by morphological, ultrastructural and immunophenotypic analyses. Mass spectrometry-based proteomics reveal that these cultures secrete proteins previously identified as biomarkers for ovarian cancer. We also use this culture system to study the response of the FT epithelium to genotoxic stress and find that the secretory cells exhibit a distinct response to DNA damage when compared with neighboring ciliated cells. The secretory cells show a limited ability to resolve the damage over time, potentially leaving them more susceptible to accumulation of additional mutagenic injury. This divergent response is confirmed with in situ studies using tissue samples, further supporting the use of this ex vivo culture system to investigate FT epithelial pathobiology. We anticipate that this novel culture system will facilitate the study of SOC pathogenesis, and propose that similar culture systems could be developed for other organ site-specific epithelia. Oncogene (2010) 29, 1103-1113; doi: 10.1038/onc.2009.402; published online 23 November 2009	[Levanon, K.; Ng, V.; Piao, H. Y.; Drapkin, R.] Dana Farber Canc Inst, Dept Med Oncol, Ctr Mol Oncol Pathol, Boston, MA 02115 USA; [Zhang, Yi; Marto, J. A.] Dana Farber Canc Inst, Dept Canc Biol, Ctr Prote, Boston, MA 02115 USA; [Chang, M. C.; Roh, M. H.; Kindelberger, D. W.; Hirsch, M. S.; Crum, C. P.; Drapkin, R.] Brigham & Womens Hosp, Dept Pathol, Div Womens & Perinatal Pathol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital	Drapkin, R (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Ctr Mol Oncol Pathol, JF215D,44 Binney St, Boston, MA 02115 USA.	ronny_drapkin@dfci.harvard.edu	Chang, Martin/J-2329-2016; Drapkin, Ronny/E-9944-2016	Drapkin, Ronny/0000-0002-6912-6977; Levanon, Keren/0000-0002-5122-064X	National Cancer Institute [P50 CA105009, K08 CA108748, R21 CA124688]; Ovarian Cancer Research Fund; Phi Beta Psi Sorority Charitable Trust; Fannie E. Ripple Foundation; Robert and Deborah First Fund; Randi and Joel Cutler Ovarian Cancer Research Fund; Columbia Hospital for Women Research Foundation; Marsha Rivkin Foundation Scientific Scholar Award; AACR-George and Patricia Sehl Fellowship; American Physicians Fellowship; Emmanuel G Rosenblatt Foundation; NATIONAL CANCER INSTITUTE [P50CA105009, R21CA124688, K08CA108748] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ovarian Cancer Research Fund; Phi Beta Psi Sorority Charitable Trust; Fannie E. Ripple Foundation; Robert and Deborah First Fund; Randi and Joel Cutler Ovarian Cancer Research Fund; Columbia Hospital for Women Research Foundation; Marsha Rivkin Foundation Scientific Scholar Award; AACR-George and Patricia Sehl Fellowship; American Physicians Fellowship; Emmanuel G Rosenblatt Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Phil Karp, Thomas Moninger and Drs Paola Vermeer and Joseph Zabner (University of Iowa) for their enthusiastic support and assistance in establishing the FT ex vivo culture system, Drs Steve Cannistra, Glenn Dranoff and David Livingston for thoughtful suggestions and comments on the paper and Drs Tom Benjamin and Dawei Li for the Sall2 antibody. Special thanks goes to the faculty, technicians, residents and fellows of the division of Women's and Perinatal Pathology in the Department of Pathology at the Brigham and Women's Hospital, Boston, MA, for the allocation of tissues. This work was supported by the National Cancer Institute [P50 CA105009, K08 CA108748 and R21 CA124688], Ovarian Cancer Research Fund (Individual Investigator Award and Program Project Development Award), Phi Beta Psi Sorority Charitable Trust, Fannie E. Ripple Foundation, Robert and Deborah First Fund, Randi and Joel Cutler Ovarian Cancer Research Fund, the Columbia Hospital for Women Research Foundation, Marsha Rivkin Foundation Scientific Scholar Award, AACR-George and Patricia Sehl Fellowship for Cancer Genetics Research and the American Physicians Fellowship for Medicine in Israel-Claire and Emmanuel G Rosenblatt Foundation Grant.	Ando H, 2000, HUM REPROD, V15, P1597, DOI 10.1093/humrep/15.7.1597; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bast RC, 2005, INT J GYNECOL CANCER, V15, P274, DOI 10.1111/j.1525-1438.2005.00441.x; Bowen NJ, 2007, GYNECOL ONCOL, V104, P331, DOI 10.1016/j.ygyno.2006.08.052; Branzei D, 2008, NAT REV MOL CELL BIO, V9, P297, DOI 10.1038/nrm2351; Briton-Jones C, 2002, FERTIL STERIL, V77, P576, DOI 10.1016/S0015-0282(01)03216-2; Cannistra SA, 2004, NEW ENGL J MED, V351, P2519, DOI 10.1056/NEJMra041842; Comer MT, 1998, HUM REPROD, V13, P3114, DOI 10.1093/humrep/13.11.3114; CROW J, 1994, HUM REPROD, V9, P2224, DOI 10.1093/oxfordjournals.humrep.a138428; Crum CP, 2009, MOL ONCOL, V3, P165, DOI 10.1016/j.molonc.2009.01.004; Drapkin R, 2005, CANCER RES, V65, P2162, DOI 10.1158/0008-5472.CAN-04-3924; Folkins AK, 2009, GYNECOL ONCOL, V113, P391, DOI 10.1016/j.ygyno.2009.01.013; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Hellstrom I, 2003, CANCER RES, V63, P3695; HENRIKSEN T, 1990, HUM REPROD, V5, P25, DOI 10.1093/oxfordjournals.humrep.a137034; Huang KC, 2006, INT J CANCER, V118, P2433, DOI 10.1002/ijc.21671; Jarboe EA, 2008, HISTOPATHOLOGY, V53, P127, DOI 10.1111/j.1365-2559.2007.02938.x; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Karp Philip H, 2002, Methods Mol Biol, V188, P115; Keogh MC, 2006, NATURE, V439, P497, DOI 10.1038/nature04384; KERVANCIOGLU ME, 1994, BIOL CELL, V82, P103, DOI 10.1016/S0248-4900(94)80012-X; Kindelberger DW, 2007, AM J SURG PATHOL, V31, P161, DOI 10.1097/01.pas.0000213335.40358.47; Kozak KR, 2005, PROTEOMICS, V5, P4589, DOI 10.1002/pmic.200500093; Landen CN, 2008, J CLIN ONCOL, V26, P995, DOI 10.1200/JCO.2006.07.9970; Levanon K, 2008, J CLIN ONCOL, V26, P5284, DOI 10.1200/JCO.2008.18.1107; Li DW, 2004, MOL CELL BIOL, V24, P3885, DOI 10.1128/MCB.24.9.3885-3893.2004; Liu H, 2007, PLOS GENET, V3, P996, DOI 10.1371/journal.pgen.0030091; Moore RG, 2009, GYNECOL ONCOL, V112, P40, DOI 10.1016/j.ygyno.2008.08.031; Okada A, 2004, J MOL ENDOCRINOL, V32, P615, DOI 10.1677/jme.0.0320615; Piek JMJ, 2001, HISTOPATHOLOGY, V38, P481, DOI 10.1046/j.1365-2559.2001.1163c.x; Ponten F, 2008, J PATHOL, V216, P387, DOI 10.1002/path.2440; Rajagopal M, 2006, IN VITRO CELL DEV-AN, V42, P248; Rusiniak ME, 2000, CANCER RES, V60, P1824; Saridogan E, 1997, HUM REPROD, V12, P1500, DOI 10.1093/humrep/12.7.1500; Satir P, 2008, HISTOCHEM CELL BIOL, V129, P687, DOI 10.1007/s00418-008-0416-9; Seeley ES, 2009, CANCER RES, V69, P422, DOI 10.1158/0008-5472.CAN-08-1290; Vermeer PD, 2003, NATURE, V422, P322, DOI 10.1038/nature01440; You YJ, 2004, AM J PHYSIOL-LUNG C, V286, pL650, DOI 10.1152/ajplung.00170.2003; Yun MH, 2009, NATURE, V459, P460, DOI 10.1038/nature07955	39	153	166	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 25	2010	29	8					1103	1113		10.1038/onc.2009.402	http://dx.doi.org/10.1038/onc.2009.402			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	560ON	19935705	Green Accepted			2022-12-25	WOS:000274912100002
J	Challand, MR; Martins, FT; Roach, PL				Challand, Martin R.; Martins, Filipa T.; Roach, Peter L.			Catalytic Activity of the Anaerobic Tyrosine Lyase Required for Thiamine Biosynthesis in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RADICAL SAM SUPERFAMILY; S-ADENOSYLMETHIONINE; THIAZOLE SYNTHASE; BACILLUS-SUBTILIS; IN-VITRO; PROTEIN SUPERFAMILY; BIOTIN SYNTHASE; PRODUCT; IDENTIFICATION; COMPLEX	Thiazole synthase in Escherichia coli is an alpha beta heterodimer of ThiG and ThiH. ThiH is a tyrosine lyase that cleaves the C alpha-C beta bond of tyrosine, generating p-cresol as a by-product, to form dehydroglycine. This reactive intermediate acts as one of three substrates for the thiazole cyclization reaction catalyzed by ThiG. ThiH is a radical S-adenosylmethionine (AdoMet) enzyme that utilizes a [4Fe-4S](+) cluster to reductively cleave AdoMet, forming methionine and a 5'-deoxyadenosyl radical. Analysis of the time-dependent formation of the reaction products 5'-deoxyadenosine (DOA) and p-cresol has demonstrated catalytic behavior of the tyrosine lyase. The kinetics of product formation showed a pre-steady state burst phase, and the involvement of DOA in product inhibition was identified by the addition of 5'-methylthioadenosine/ S-adenosylhomocysteine nucleosidase to activity assays. This hydrolyzed the DOA and changed the rate-determining step but, in addition, substantially increased the uncoupled turnover of AdoMet. Addition of glyoxylate and ammonium inhibited the tyrosine cleavage reaction, but the reductive cleavage of AdoMet continued in an uncoupled manner. Tyrosine analogues were incubated with ThiGH, which showed a strong preference for phenolic substrates. 4-Hydroxyphenylpropionic acid analogues allowed uncoupled AdoMet cleavage but did not result in further reaction (C alpha-C beta bond cleavage). The results of the substrate analogue studies and the product inhibition can be explained by a mechanistic hypothesis involving two reaction pathways, a product-forming pathway and a futile cycle.	[Challand, Martin R.; Martins, Filipa T.; Roach, Peter L.] Univ Southampton, Sch Chem, Southampton SO17 1BJ, Hants, England	University of Southampton	Roach, PL (corresponding author), Univ Southampton, Sch Chem, Southampton SO17 1BJ, Hants, England.	plr2@soton.ac.uk	Challand, Martin/C-6395-2015; Roach, Peter/C-6248-2013; Roach, Peter/AAW-7071-2021	Challand, Martin/0000-0002-9685-3504; Roach, Peter/0000-0001-9880-2877	Biotechnology and Biological Sciences Research Council; Royal Society; University of Southampton	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society(Royal Society of London); University of Southampton	This work was supported by the Biotechnology and Biological Sciences Research Council, the Royal Society, and the University of Southampton.	Benjdia A, 2009, J AM CHEM SOC, V131, P8348, DOI 10.1021/ja901571p; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Challand MR, 2009, FEBS LETT, V583, P1358, DOI 10.1016/j.febslet.2009.03.044; Chatterjee A, 2008, NAT CHEM BIOL, V4, P758, DOI 10.1038/nchembio.121; Chatterjee A, 2006, ANGEW CHEM INT EDIT, V45, P3507, DOI 10.1002/anie.200504614; Cornell KA, 1998, BBA-GENE STRUCT EXPR, V1396, P8, DOI 10.1016/S0167-4781(97)00169-3; Dorrestein PC, 2004, J AM CHEM SOC, V126, P3091, DOI 10.1021/ja039616p; Duschene KS, 2009, CURR OPIN CHEM BIOL, V13, P74, DOI 10.1016/j.cbpa.2009.01.022; FISH WW, 1988, METHOD ENZYMOL, V158, P357, DOI 10.1016/0076-6879(88)58067-9; Fossey J, 1995, FREE RADICALS ORGANI; Grant BD, 1996, BIOCHEMISTRY-US, V35, P2022, DOI 10.1021/bi952144+; Grove TL, 2008, BIOCHEMISTRY-US, V47, P7523, DOI 10.1021/bi8004297; Hanes JW, 2007, J AM CHEM SOC, V129, P4860, DOI 10.1021/ja0679634; Hazra A, 2009, J AM CHEM SOC, V131, P3225, DOI 10.1021/ja806752h; Jurgenson CT, 2009, ANNU REV BIOCHEM, V78, P569, DOI 10.1146/annurev.biochem.78.072407.102340; Kriek M, 2007, ANGEW CHEM INT EDIT, V46, P9223, DOI 10.1002/anie.200702554; Kriek M, 2007, J BIOL CHEM, V282, P17413, DOI 10.1074/jbc.M700782200; Leonardi R, 2004, J BIOL CHEM, V279, P17054, DOI 10.1074/jbc.M312714200; Leonardi R, 2003, FEBS LETT, V539, P95, DOI 10.1016/S0014-5793(03)00204-7; Martinez-Gomez NC, 2008, BIOCHEMISTRY-US, V47, P9054, DOI 10.1021/bi8010253; Martinez-Gomez NC, 2004, J BIOL CHEM, V279, P40505, DOI 10.1074/jbc.M403985200; McCulloch KM, 2008, BIOCHEMISTRY-US, V47, P3810, DOI 10.1021/bi800041h; McIver L, 1998, EUR J BIOCHEM, V257, P577, DOI 10.1046/j.1432-1327.1998.2570577.x; Park JH, 2003, BIOCHEMISTRY-US, V42, P12430, DOI 10.1021/bi034902z; Pohl M, 2004, CURR OPIN BIOTECH, V15, P335, DOI 10.1016/j.copbio.2004.06.002; Segel I.H, 1993, ENZYME KINETICS; Settembre EC, 2003, BIOCHEMISTRY-US, V42, P2971, DOI 10.1021/bi026916v; Settembre EC, 2004, BIOCHEMISTRY-US, V43, P11647, DOI 10.1021/bi0488911; Sofia HJ, 2001, NUCLEIC ACIDS RES, V29, P1097, DOI 10.1093/nar/29.5.1097; Taylor AM, 2008, BIOCHEMISTRY-US, V47, P9309, DOI 10.1021/bi801035b; Ugulava NB, 2003, BIOCHEMISTRY-US, V42, P2708, DOI 10.1021/bi0261084; Wang SC, 2007, BIOCHEMISTRY-US, V46, P12889, DOI 10.1021/bi701745h; Wang SC, 2007, TRENDS BIOCHEM SCI, V32, P101, DOI 10.1016/j.tibs.2007.01.002	33	46	48	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5240	5248		10.1074/jbc.M109.056606	http://dx.doi.org/10.1074/jbc.M109.056606			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	19923213	Green Published, hybrid			2022-12-25	WOS:000275327200017
J	Groves, E; Rittinger, K; Amstutz, M; Berry, S; Holden, DW; Cornelis, GR; Caron, E				Groves, Eleanor; Rittinger, Katrin; Amstutz, Marlise; Berry, Sara; Holden, David W.; Cornelis, Guy R.; Caron, Emmanuelle			Sequestering of Rac by the Yersinia Effector YopO Blocks Fc gamma Receptor-mediated Phagocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-A; RHO-GTPASES; PLASMA-MEMBRANE; SER/THR KINASE; ACTIN-BINDING; INNER SURFACE; ACTIVATION; VIRULENCE; TARGET; IDENTIFICATION	Pathogenic Yersinia species neutralize innate immune mechanisms by injecting type three secretion effectors into immune cells, altering cell signaling. Our study elucidates how one of these effectors, YopO, blocks phagocytosis. We demonstrate using different phagocytic models that YopO specifically blocks Rac-dependent Fc gamma receptor internalization pathway but not complement receptor 3-dependent uptake, which is controlled by Rho activity. We show that YopO prevents Rac activation but does not affect Rac accumulation at the phagocytic cup. In addition, we show that plasma membrane localization and the guanine-nucleotide dissociation inhibitor (GDI)-like domain of YopO cooperate for maximal anti-phagocytosis. Although YopO has the same affinity for Rac1, Rac2, and RhoA in vitro, it selectively interacts with Rac isoforms in cells. This is due to the differential localization of the Rho family G proteins in resting cells; Rac isoforms partially exist as a GDI-free pool at the membrane of resting cells, whereas RhoA is trapped in the cytosol by RhoGDI alpha. We propose that YopO exploits this basic difference in localization and availability to selectively inhibit Rac-dependent phagocytosis.	[Caron, Emmanuelle] Univ London Imperial Coll Sci Technol & Med, Ctr Mol Microbiol & Infect, London SW7 2AZ, England; [Rittinger, Katrin] Natl Inst Med Res, Div Mol Struct, London NW7 1AA, England; [Amstutz, Marlise; Cornelis, Guy R.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland	Imperial College London; MRC National Institute for Medical Research; University of Basel	Groves, E (corresponding author), Univ London Imperial Coll Sci Technol & Med, CMMI2, Flowers Bldg, London SW15 3SH, England.	e.groves@imperial.ac.uk	Rittinger, Katrin/D-2586-2014; Rittinger, Katrin/N-3344-2019	Rittinger, Katrin/0000-0002-7698-4435; Rittinger, Katrin/0000-0002-7698-4435	Medical Research Council studentship; Medical Research Council and the Biotechnology and Biological Sciences Council; Medical Research Council [G0800148, MC_U117565398] Funding Source: researchfish; MRC [G0800148, MC_U117565398] Funding Source: UKRI	Medical Research Council studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council and the Biotechnology and Biological Sciences Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council studentship (to E. G.) and a core grant (to K. R.). Work in the Caron laboratory was funded by grants from the Medical Research Council and the Biotechnology and Biological Sciences Council.	ADAMSON P, 1992, J CELL BIOL, V119, P617, DOI 10.1083/jcb.119.3.617; Alrutz MA, 2001, MOL MICROBIOL, V42, P689, DOI 10.1046/j.1365-2958.2001.02676.x; Alto NM, 2006, CELL, V124, P133, DOI 10.1016/j.cell.2005.10.031; Barz C, 2000, FEBS LETT, V482, P139, DOI 10.1016/S0014-5793(00)02045-7; Bijlmakers MJJE, 1997, J CELL BIOL, V137, P1029, DOI 10.1083/jcb.137.5.1029; Booth JW, 2001, SEMIN IMMUNOL, V13, P357, DOI 10.1006/smim.2001.0332; Caron E, 1998, SCIENCE, V282, P1717, DOI 10.1126/science.282.5394.1717; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Cougoule C, 2006, J BIOL CHEM, V281, P8756, DOI 10.1074/jbc.M513731200; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; Dukuzumuremyi JM, 2000, J BIOL CHEM, V275, P35281, DOI 10.1074/jbc.M003009200; Finlay BB, 2005, CURR TOP MICROBIOL, V291, P1; Gorvel JP, 1998, FEBS LETT, V422, P269, DOI 10.1016/S0014-5793(98)00020-9; GRIFFIN FM, 1975, J EXP MED, V142, P1263, DOI 10.1084/jem.142.5.1263; Grosdent N, 2002, INFECT IMMUN, V70, P4165, DOI 10.1128/IAI.70.8.4165-4176.2002; Groves E, 2008, CELL MOL LIFE SCI, V65, P1957, DOI 10.1007/s00018-008-7578-4; Hakansson S, 1996, MOL MICROBIOL, V20, P593, DOI 10.1046/j.1365-2958.1996.5251051.x; Juris SJ, 2000, P NATL ACAD SCI USA, V97, P9431, DOI 10.1073/pnas.170281997; Letzelter M, 2006, EMBO J, V25, P3223, DOI 10.1038/sj.emboj.7601202; Marches O, 2008, CELL MICROBIOL, V10, P1104, DOI 10.1111/j.1462-5822.2007.01112.x; Marketon MM, 2005, SCIENCE, V309, P1739, DOI 10.1126/science.1114580; May RC, 2000, NAT CELL BIOL, V2, P246, DOI 10.1038/35008673; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; Navarro L, 2007, MOL CELL, V26, P465, DOI 10.1016/j.molcel.2007.04.025; Nejedlik L, 2004, YEAST, V21, P759, DOI 10.1002/yea.1135; Park H, 2007, J IMMUNOL, V178, P6426, DOI 10.4049/jimmunol.178.10.6426; Patel JC, 2000, METHOD ENZYMOL, V325, P462; Prehna G, 2006, CELL, V126, P869, DOI 10.1016/j.cell.2006.06.056; Reid T, 1996, J BIOL CHEM, V271, P13556, DOI 10.1074/jbc.271.23.13556; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Swanson JA, 2008, NAT REV MOL CELL BIO, V9, P639, DOI 10.1038/nrm2447; Thompson G, 1998, BIOCHEMISTRY-US, V37, P7885, DOI 10.1021/bi980140+; Trasak C, 2007, J BIOL CHEM, V282, P2268, DOI 10.1074/jbc.M610071200; Wheeler AP, 2006, J CELL SCI, V119, P2749, DOI 10.1242/jcs.03024; Wiedemann AS, 2006, J CELL BIOL, V172, P1069, DOI 10.1083/jcb.200508075; Wiley DJ, 2006, MICROB PATHOGENESIS, V40, P234, DOI 10.1016/j.micpath.2006.02.001; Yamauchi A, 2004, J IMMUNOL, V173, P5971, DOI 10.4049/jimmunol.173.10.5971; Yeung T, 2006, SCIENCE, V313, P347, DOI 10.1126/science.1129551	38	34	34	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					4087	4098		10.1074/jbc.M109.071035	http://dx.doi.org/10.1074/jbc.M109.071035			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19926792	Green Published, hybrid			2022-12-25	WOS:000275254000061
J	Hagn, F; Klein, C; Demmer, O; Marchenko, N; Vaseva, A; Moll, UM; Kessler, H				Hagn, Franz; Klein, Christian; Demmer, Oliver; Marchenko, Natasha; Vaseva, Angelina; Moll, Ute M.; Kessler, Horst			BclxL Changes Conformation upon Binding to Wild-type but Not Mutant p53 DNA Binding Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL-MEMBRANE PERMEABILIZATION; PROTEIN STRUCTURES; CELL-DEATH; IN-VIVO; NMR; BAX; APOPTOSIS; INHIBITOR; ALIGNMENT; LIGANDS	p53 can induce apoptosis through mitochondrial membrane permeabilization by interaction of its DNA binding region with the anti-apoptotic proteins BclxL and Bcl2. However, little is known about the action of p53 at the mitochondria in molecular detail. By using NMR spectroscopy and fluorescence polarization we characterized the binding of wildtype and mutant p53 DNA binding domains to BclxL and show that the wild-type p53 DNA binding domain leads to structural changes in the BH3 binding region of BclxL, whereas mutants fail to induce such effects due to reduced affinity. This was probed by induced chemical shift and residual dipolar coupling data. These data imply that p53 partly achieves its pro-apoptotic function at the mitochondria by facilitating interaction between BclxL and BH3-only proteins in an allosteric mode of action. Furthermore, we characterize for the first time the binding behavior of Pifithrin-mu, a specific small molecule inhibitor of the p53-BclxL interaction, and present a structural model of the protein-ligand complex. A rather unusual behavior is revealed whereby Pifithrin-mu binds to both sides of the protein-protein complex. These data should facilitate the rational design of more potent specific BclxL-p53 inhibitors.	[Hagn, Franz; Demmer, Oliver; Kessler, Horst] Tech Univ Munich, Inst Adv Study, D-85747 Garching, Germany; [Kessler, Horst] CIPSM, Dept Chem, D-85747 Garching, Germany; [Klein, Christian] Roche Diagnost GmbH, Discovery Oncol, D-82372 Penzberg, Germany; [Marchenko, Natasha; Vaseva, Angelina; Moll, Ute M.] SUNY Stony Brook, Dept Pathol, Stony Brook, NY 11794 USA	Technical University of Munich; Roche Holding; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Kessler, H (corresponding author), Lichtenbergstr 4, D-85747 Garching, Germany.	Horst.Kessler@ch.tum.de	Kessler, Horst/C-1178-2010; Hagn, Franz X/N-9553-2016; Klein, Christian/G-1336-2010	Hagn, Franz X/0000-0002-1315-459X; Klein, Christian/0000-0001-7594-7280	NCI [RO1 CA60664]; Center for Integrated Protein Science Munich; Deutsche Forschungsgemeinschaft [SFB594]; Elite-netzwerk Bayern, CompInt; NATIONAL CANCER INSTITUTE [R01CA060664] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Integrated Protein Science Munich; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Elite-netzwerk Bayern, CompInt; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 CA60664 from the NCI (to U. M. M.). This work was also supported by the Center for Integrated Protein Science Munich and Deutsche Forschungsgemeinschaft Grant SFB594 (to H. K.) and a grant from Elite-netzwerk Bayern, CompInt (to F. H.).	Battiste JL, 2000, BIOCHEMISTRY-US, V39, P5355, DOI 10.1021/bi000060h; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Canadillas JMP, 2006, P NATL ACAD SCI USA, V103, P2109, DOI 10.1073/pnas.0510941103; Carlson CB, 2007, ACS CHEM BIOL, V2, P119, DOI 10.1021/cb6003788; Chipuk JE, 2006, CELL DEATH DIFFER, V13, P1396, DOI 10.1038/sj.cdd.4401963; Chipuk JE, 2005, SCIENCE, V309, P1732, DOI 10.1126/science.1114297; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; CHITTENDEN T, 1995, EMBO J, V14, P5589, DOI 10.1002/j.1460-2075.1995.tb00246.x; DAVEY PG, 1987, J ANTIMICROB CHEMOTH, V20, P639, DOI 10.1093/jac/20.5.639; Dehner A, 2005, ANGEW CHEM INT EDIT, V44, P5247, DOI 10.1002/anie.200501887; Dehner A, 2003, CHEMBIOCHEM, V4, P870, DOI 10.1002/cbic.200300658; DeLano WL., 2020, PYMOL MOL GRAPHICS S; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Foster BA, 1999, SCIENCE, V286, P2507, DOI 10.1126/science.286.5449.2507; Fuster JJ, 2007, TRENDS MOL MED, V13, P192, DOI 10.1016/j.molmed.2007.03.002; Goddard T.D., 2004, SPARKY3; Hansen MR, 1998, NAT STRUCT BIOL, V5, P1065, DOI 10.1038/4176; JAHNKE W, 1995, J MAGN RESON SER B, V106, P86, DOI 10.1006/jmrb.1995.1015; Johnstone RW, 2002, CELL, V108, P153, DOI 10.1016/S0092-8674(02)00625-6; Jurgensmeier JM, 1998, P NATL ACAD SCI USA, V95, P4997, DOI 10.1073/pnas.95.9.4997; Kenakin TP., 1993, PHARM ANAL DRUG RECE, V2; Klein C, 2004, BIOL CHEM, V385, P95, DOI 10.1515/BC.2004.012; Kleywegt GJ, 1997, METHOD ENZYMOL, V277, P525, DOI 10.1016/S0076-6879(97)77029-0; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Mayer M, 2001, J AM CHEM SOC, V123, P6108, DOI 10.1021/ja0100120; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Petros AM, 2000, PROTEIN SCI, V9, P2528, DOI 10.1017/S096183680000331X; Petros AM, 2004, FEBS LETT, V559, P171, DOI 10.1016/s0014-5793(04)00059-6; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Privalov P L, 1979, Adv Protein Chem, V33, P167, DOI 10.1016/S0065-3233(08)60460-X; Romer L, 2006, ANGEW CHEM INT EDIT, V45, P6440, DOI 10.1002/anie.200600611; Ruckert M, 2000, J AM CHEM SOC, V122, P7793, DOI 10.1021/ja001068h; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Schottelius M, 2009, ACCOUNTS CHEM RES, V42, P969, DOI 10.1021/ar800243b; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Shuker SB, 1996, SCIENCE, V274, P1531, DOI 10.1126/science.274.5292.1531; Sot B, 2007, J BIOL CHEM, V282, P29193, DOI 10.1074/jbc.M705544200; Steele AJ, 2009, BLOOD, V114, P1217, DOI 10.1182/blood-2008-11-190587; Strom E, 2006, NAT CHEM BIOL, V2, P474, DOI 10.1038/nchembio809; Tomita Y, 2006, J BIOL CHEM, V281, P8600, DOI 10.1074/jbc.M507611200; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Wolff S, 2008, CELL RES, V18, P733, DOI 10.1038/cr.2008.62; Youle RJ, 2007, SCIENCE, V315, P776, DOI 10.1126/science.1138870; Zweckstetter M, 2000, J AM CHEM SOC, V122, P3791, DOI 10.1021/ja0000908	55	66	67	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5					3439	3450		10.1074/jbc.M109.065391	http://dx.doi.org/10.1074/jbc.M109.065391			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19955567	hybrid, Green Published			2022-12-25	WOS:000273829000058
J	Tan, M; Zhu, B; Zhou, XL; He, R; Chen, X; Eriani, G; Wang, ED				Tan, Min; Zhu, Bin; Zhou, Xiao-Long; He, Ran; Chen, Xin; Eriani, Gilbert; Wang, En-Duo			tRNA-dependent Pre-transfer Editing by Prokaryotic Leucyl-tRNA Synthetase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MISACTIVATED AMINO-ACIDS; ESCHERICHIA-COLI; PROTEIN-SYNTHESIS; AQUIFEX-AEOLICUS; STRUCTURAL BASIS; RATIONAL DESIGN; ACTIVE-SITE; ERRORS; DISCRIMINATION; TRANSLOCATION	To prevent genetic code ambiguity due to misincorporation of amino acids into proteins, aminoacyl-tRNA synthetases have evolved editing activities to eliminate intermediate or final non-cognate products. In this work we studied the different editing pathways of class Ia leucyl-tRNA synthetase (LeuRS). Different mutations and experimental conditions were used to decipher the editing mechanism, including the recently developed compound AN2690 that targets the post-transfer editing site of LeuRS. The study emphasizes the crucial importance of tRNA for the pre- and post-transfer editing catalysis. Both reactions have comparable efficiencies in prokaryotic Aquifex aeolicus and Escherichia coli LeuRSs, although the E. coli enzyme favors post-transfer editing, whereas the A. aeolicus enzyme favors pre-transfer editing. Our results also indicate that the entry of the CCA-acceptor end of tRNA in the editing domain is strictly required for tRNA-dependent pre-transfer editing. Surprisingly, this editing reaction was resistant to AN2690, which inactivates the enzyme by forming a covalent adduct with tRNALeu in the post-transfer editing site. Taken together, these data suggest that the binding of tRNA in the post-transfer editing conformation confers to the enzyme the capacity for pre-transfer editing catalysis, regardless of its capacity to catalyze post-transfer editing.	Chinese Acad Sci, Grad Sch, Shanghai Inst Biol Sci, State Key Lab Mol Biol,Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China; [Eriani, Gilbert] Univ Strasbourg, CNRS, Architecture & React ARN, UPR9002,Inst Biol Mol & Cellulaire, F-67084 Strasbourg, France	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg		edwang@sibs.ac.cn	Tan, Min/K-1780-2016	Eriani, Gilbert/0000-0002-8518-4675	Natural Science Foundation of China [30670463, 30930022]; National Key Basic Research Foundation of China [2006CB910301]; 973 Project of China [2005CB724600]; Committee of Science and Technology in Shanghai [09JC1415900]; CNRS [3606]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Foundation of China(National Basic Research Program of China); 973 Project of China(National Basic Research Program of China); Committee of Science and Technology in Shanghai(Shanghai Science & Technology Committee); CNRS(Centre National de la Recherche Scientifique (CNRS))	This work was supported by Natural Science Foundation of China Grants 30670463 and 30930022, National Key Basic Research Foundation of China Grant 2006CB910301, the 973 Project of China Grant 2005CB724600, Committee of Science and Technology in Shanghai Grant 09JC1415900, and the Exchange Program and Programme International de Cooperation Scientifique from CNRS Grant 3606.	BALDWIN AN, 1966, J BIOL CHEM, V241, P831; Bishop AC, 2003, P NATL ACAD SCI USA, V100, P490, DOI 10.1073/pnas.0237335100; Boniecki MT, 2008, P NATL ACAD SCI USA, V105, P19223, DOI 10.1073/pnas.0809336105; CARTER PJ, 1984, CELL, V38, P835, DOI 10.1016/0092-8674(84)90278-2; Chen JF, 2000, BIOCHEMISTRY-US, V39, P6726, DOI 10.1021/bi000108r; ENGLISCH S, 1986, NUCLEIC ACIDS RES, V14, P7529, DOI 10.1093/nar/14.19.7529; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; Francklyn CS, 2008, METHODS, V44, P100, DOI 10.1016/j.ymeth.2007.09.007; Fukai S, 2000, CELL, V103, P793, DOI 10.1016/S0092-8674(00)00182-3; Gruic-Sovulj I, 2005, J BIOL CHEM, V280, P23978, DOI 10.1074/jbc.M414260200; Gruic-Sovulj I, 2007, FEBS LETT, V581, P5110, DOI 10.1016/j.febslet.2007.09.058; Hati S, 2006, J BIOL CHEM, V281, P27862, DOI 10.1074/jbc.M605856200; Hendrickson TL, 2004, ANNU REV BIOCHEM, V73, P147, DOI 10.1146/annurev.biochem.73.012803.092429; Hendrickson TL, 2002, MOL CELL, V9, P353, DOI 10.1016/S1097-2765(02)00449-5; JAKUBOWSKI H, 1992, MICROBIOL REV, V56, P412, DOI 10.1128/MMBR.56.3.412-429.1992; Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096; Li Y, 1998, SCI CHINA SER C, V41, P225, DOI 10.1007/BF02895095; Lin L, 1996, NATURE, V384, P33, DOI 10.1038/384033b0; Lincecum TL, 2003, MOL CELL, V11, P951, DOI 10.1016/S1097-2765(03)00098-4; Ling JQ, 2009, ANNU REV MICROBIOL, V63, P61, DOI 10.1146/annurev.micro.091208.073210; LOFTFIELD RB, 1972, BIOCHEM J, V128, P1353, DOI 10.1042/bj1281353; Martinis S A, 1997, Nucleic Acids Symp Ser, V36, P125; Mascarenhas AP, 2009, FEBS LETT, V583, P3443, DOI 10.1016/j.febslet.2009.09.039; Mursinna RS, 2002, J AM CHEM SOC, V124, P7286, DOI 10.1021/ja025879s; Mursinna RS, 2001, BIOCHEMISTRY-US, V40, P5376, DOI 10.1021/bi002915w; Nangle LA, 2006, CHEM BIOL, V13, P1091, DOI 10.1016/j.chembiol.2006.08.011; Nomanbhoy TK, 1999, MOL CELL, V4, P519, DOI 10.1016/S1097-2765(00)80203-8; Nomanbhoy TK, 2000, P NATL ACAD SCI USA, V97, P5119, DOI 10.1073/pnas.090102197; Nordin BE, 2003, BIOCHEMISTRY-US, V42, P12989, DOI 10.1021/bi035052q; Rock FL, 2007, SCIENCE, V316, P1759, DOI 10.1126/science.1142189; SCHIMMEL P, 1987, ANNU REV BIOCHEM, V56, P125, DOI 10.1146/annurev.bi.56.070187.001013; SCHIMMEL P, 1995, TRENDS BIOCHEM SCI, V20, P1, DOI 10.1016/S0968-0004(00)88937-9; Seiradake E, 2009, J MOL BIOL, V390, P196, DOI 10.1016/j.jmb.2009.04.073; Silvian LF, 1999, SCIENCE, V285, P1074, DOI 10.1126/science.285.5430.1074; Tukalo M, 2005, NAT STRUCT MOL BIOL, V12, P923, DOI 10.1038/nsmb986; Woese CR, 2000, MICROBIOL MOL BIOL R, V64, P202, DOI 10.1128/MMBR.64.1.202-236.2000; Xu MG, 2004, BIOCHEM BIOPH RES CO, V318, P11, DOI 10.1016/j.bbrc.2004.03.180; Xu MG, 2002, J BIOL CHEM, V277, P41590, DOI 10.1074/jbc.M205126200; Yao P, 2008, J BIOL CHEM, V283, P22591, DOI 10.1074/jbc.M801181200; Zhao MW, 2005, EMBO J, V24, P1430, DOI 10.1038/sj.emboj.7600618; Zhu B, 2009, J BIOL CHEM, V284, P3418, DOI 10.1074/jbc.M806717200	41	43	47	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5					3235	3244		10.1074/jbc.M109.060616	http://dx.doi.org/10.1074/jbc.M109.060616			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19940155	Green Published, hybrid			2022-12-25	WOS:000273829000038
J	Kanchan, K; Linder, J; Winkler, K; Hantke, K; Schultz, A; Schultz, JE				Kanchan, Kajal; Linder, Juergen; Winkler, Karin; Hantke, Klaus; Schultz, Anita; Schultz, Joachim E.			Transmembrane Signaling in Chimeras of the Escherichia coli Aspartate and Serine Chemotaxis Receptors and Bacterial Class III Adenylyl Cyclases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUTATIONAL ANALYSIS; MYCOBACTERIUM-TUBERCULOSIS; CYTOPLASMIC DOMAIN; HISTIDINE KINASE; HAMP DOMAINS; CYCLIC-AMP; CHEMORECEPTOR; LINKER; BINDING; LIGAND	The Escherichia coli chemoreceptors for serine (Tsr) and aspartate (Tar) and several bacterial class III adenylyl cyclases (ACs) share a common molecular architecture; that is, a membrane anchor that is linked via a cytoplasmic HAMP domain to a C-terminal signal output unit. Functionality of both proteins requires homodimerization. The chemotaxis receptors are well characterized, whereas the typical hexahelical membrane anchor (6TM) of class III ACs, suggested to operate as a channel or transporter, has no known function beyond a membrane anchor. We joined the intramolecular networks of Tsr or Tar and two bacterial ACs, Rv3645 from Mycobacterium tuberculosis and CyaG from Arthrospira platensis, across their signal transmission sites, connecting the chemotaxis receptors via different HAMP domains to the catalytic AC domains. AC activity in the chimeras was inhibited by micromolar concentrations of L-serine or L-aspartate in vitro and in vivo. Single point mutations known to abolish ligand binding in Tar (R69E or T154I) or Tsr (R69E or T156K) abrogated AC regulation. Co-expression of mutant pairs, which functionally complement each other, restored regulation in vitro and in vivo. Taken together, these studies demonstrate chemotaxis receptor-mediated regulation of chimeric bacterial ACs and connect chemical sensing and AC regulation.	[Kanchan, Kajal; Linder, Juergen; Winkler, Karin; Hantke, Klaus; Schultz, Anita; Schultz, Joachim E.] Univ Tubingen, Inst Pharmazeut, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Schultz, JE (corresponding author), Univ Tubingen, Inst Pharmazeut, Morgenstelle 8, D-72076 Tubingen, Germany.	joachim.schultz@uni-tuebingen.de	Kanchan, Kajal/AAO-4013-2020	Kanchan, Kajal/0000-0003-4711-5588	Deutsche Forschungsgemeinschaft [SFB 766-B8]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (SFB 766-B8).	ADLER J, 1965, COLD SPRING HARB SYM, V30, P289, DOI 10.1101/SQB.1965.030.01.030; AMES P, 1994, J BACTERIOL, V176, P6340, DOI 10.1128/jb.176.20.6340-6348.1994; Ames P, 2008, J BACTERIOL, V190, P6676, DOI 10.1128/JB.00750-08; Appleman JA, 2003, J BACTERIOL, V185, P4872, DOI 10.1128/JB.185.16.4872-4882.2003; Appleman JA, 2003, J BACTERIOL, V185, P89, DOI 10.1128/JB.185.1.89-97.2003; Aravind L, 1999, FEMS MICROBIOL LETT, V176, P111, DOI 10.1016/S0378-1097(99)00197-4; BARZU O, 1994, PROG NUCLEIC ACID RE, V49, P241; Bettenbrock K, 2007, J BACTERIOL, V189, P6891, DOI 10.1128/JB.00819-07; BOYD A, 1983, NATURE, V301, P623, DOI 10.1038/301623a0; Falke JJ, 2001, TRENDS BIOCHEM SCI, V26, P257, DOI 10.1016/S0968-0004(00)01770-9; Gardina PJ, 1996, SCIENCE, V274, P425, DOI 10.1126/science.274.5286.425; Hazelbauer GL, 2008, TRENDS BIOCHEM SCI, V33, P9, DOI 10.1016/j.tibs.2007.09.014; Hulko M, 2006, CELL, V126, P929, DOI 10.1016/j.cell.2006.06.058; JIN T, 1994, J MOL BIOL, V244, P477, DOI 10.1006/jmbi.1994.1746; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Khursigara CM, 2008, P NATL ACAD SCI USA, V105, P16555, DOI 10.1073/pnas.0806401105; Kim KK, 1999, NATURE, V400, P787, DOI 10.1038/23512; Kim SH, 2002, P NATL ACAD SCI USA, V99, P11611, DOI 10.1073/pnas.132376499; KRUPINSKI J, 1989, SCIENCE, V244, P1558, DOI 10.1126/science.2472670; Linder JU, 2006, CELL MOL LIFE SCI, V63, P1736, DOI 10.1007/s00018-006-6072-0; Linder JU, 2004, EUR J BIOCHEM, V271, P2446, DOI 10.1111/j.1432-1033.2004.04172.x; Linder JU, 2003, CELL SIGNAL, V15, P1081, DOI 10.1016/S0898-6568(03)00130-X; Mason JM, 2004, CHEMBIOCHEM, V5, P170, DOI 10.1002/cbic.200300781; MATIN A, 1982, J BACTERIOL, V149, P801, DOI 10.1128/JB.149.3.801-807.1982; MESIBOV R, 1973, J GEN PHYSIOL, V62, P203, DOI 10.1085/jgp.62.2.203; MESIBOV R, 1972, J BACTERIOL, V112, P315, DOI 10.1128/JB.112.1.315-326.1972; MILBURN MV, 1991, SCIENCE, V254, P1342, DOI 10.1126/science.1660187; Miller JH., 1972, EXPT MOL GENETICS; MILLIGAN DL, 1988, J BIOL CHEM, V263, P6268; MOWBRAY SL, 1990, J BIOL CHEM, V265, P15638; PETERKOFSKY A, 1971, P NATL ACAD SCI USA, V68, P2794, DOI 10.1073/pnas.68.11.2794; SALOMON Y, 1974, ANAL BIOCHEM, V58, P541, DOI 10.1016/0003-2697(74)90222-X; Shenoy AR, 2004, FEBS LETT, V561, P11, DOI 10.1016/S0014-5793(04)00128-0; Shenoy AR, 2007, J MOL BIOL, V365, P211, DOI 10.1016/j.jmb.2006.10.005; SUTHERLAND E W, 1960, Acta Endocrinol Suppl (Copenh), V34(Suppl 50), P171; Tesmer JJG, 1997, SCIENCE, V278, P1907, DOI 10.1126/science.278.5345.1907; Tews I, 2005, SCIENCE, V308, P1020, DOI 10.1126/science.1107642; YANG Y, 1993, J MOL BIOL, V232, P493, DOI 10.1006/jmbi.1993.1405; Yoshida T, 2007, METHOD ENZYMOL, V423, P184, DOI 10.1016/S0076-6879(07)23008-3; Zhang GY, 1997, NATURE, V386, P247, DOI 10.1038/386247a0	40	20	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2010	285	3					2090	2099		10.1074/jbc.M109.051698	http://dx.doi.org/10.1074/jbc.M109.051698			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	541PJ	19923210	Green Published, hybrid			2022-12-25	WOS:000273429100053
J	Lepesheva, GI; Park, HW; Hargrove, TY; Vanhollebeke, B; Wawrzak, Z; Harp, JM; Sundaramoorthy, M; Nes, WD; Pays, E; Chaudhuri, M; Villalta, F; Waterman, MR				Lepesheva, Galina I.; Park, Hee-Won; Hargrove, Tatiana Y.; Vanhollebeke, Benoit; Wawrzak, Zdzislaw; Harp, Joel M.; Sundaramoorthy, Munirathinam; Nes, W. David; Pays, Etienne; Chaudhuri, Minu; Villalta, Fernando; Waterman, Michael R.			Crystal Structures of Trypanosoma brucei Sterol 14 alpha-Demethylase and Implications for Selective Treatment of Human Infections	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYCOBACTERIUM-TUBERCULOSIS; ACTIVE-SITE; CYP51; CRUZI; TARGETS; P450; INHIBITION; MECHANISMS	Sterol 14 alpha-demethylase (14DM, the CYP51 family of cytochrome P450) is an essential enzyme in sterol biosynthesis in eukaryotes. It serves as a major drug target for fungal diseases and can potentially become a target for treatment of human infections with protozoa. Here we present 1.9 angstrom resolution crystal structures of 14DM from the protozoan pathogen Trypanosoma brucei, ligand-free and complexed with a strong chemically selected inhibitor N-1-(2,4-dichlorophenyl)-2-(1H-imidazol-1-yl)ethyl)-4-(5-phenyl-1,3,4-oxadi-azol-2-yl)benzamide that we previously found to produce potent antiparasitic effects in Trypanosomatidae. This is the first structure of a eukaryotic microsomal 14DM that acts on sterol biosynthesis, and it differs profoundly from that of the water-soluble CYP51 family member from Mycobacterium tuberculosis, both in organization of the active site cavity and in the substrate access channel location. Inhibitor binding does not cause large scale conformational rearrangements, yet induces unanticipated local alterations in the active site, including formation of a hydrogen bond network that connects, via the inhibitor amide group fragment, two remote functionally essential protein segments and alters the heme environment. The inhibitor binding mode provides a possible explanation for both its functionally irreversible effect on the enzyme activity and its selectivity toward the 14DM from human pathogens versus the human 14DM ortholog. The structures shed new light on 14DM functional conservation and open an excellent opportunity for directed design of novel antiparasitic drugs.	[Lepesheva, Galina I.; Hargrove, Tatiana Y.; Harp, Joel M.; Sundaramoorthy, Munirathinam; Waterman, Michael R.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA; [Park, Hee-Won] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L5, Canada; [Park, Hee-Won] Univ Toronto, Dept Pharmacol, Toronto, ON M5G 1L5, Canada; [Vanhollebeke, Benoit; Pays, Etienne] Univ Libre Bruxelles, Mol Parasitol Lab, B-6041 Gosselies, Belgium; [Wawrzak, Zdzislaw] Northwestern Univ, Ctr Synchrotron Res, Life Sci Collaborat Access Team, Dept Biochem Mol Biol & Cell Biol, Argonne, IL 60439 USA; [Nes, W. David] Texas Tech Univ, Dept Chem & Biochem, Lubbock, TX 79409 USA; [Chaudhuri, Minu; Villalta, Fernando] Meharry Med Coll, Dept Microbiol & Immunol, Nashville, TN 37208 USA	Vanderbilt University; University of Toronto; Structural Genomics Consortium; University of Toronto; Universite Libre de Bruxelles; Northwestern University; Texas Tech University System; Texas Tech University; Meharry Medical College	Lepesheva, GI (corresponding author), Vanderbilt Univ, Dept Biochem, Nashville 622 RRB,23rd Pierce, Nashville, TN 37232 USA.	galina.i.lepesheva@vanderbilt.edu		Vanhollebeke, Benoit/0000-0002-0353-365X; Villalta, Fernando/0000-0002-6232-0574	National Institutes of Health [GM 067871, P30ES00267, AI 080580, GM 081146, WF D-1276]; American Heart Association [0535121N]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [SC1AI080580] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067871, SC1GM081146] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM 067871 (to M. R. W. and G. I. L.), P30ES00267 (to M. R. W.), AI 080580 (to F. V.), GM 081146 (to M. C.), and WF D-1276 (to W. D. N.). The work was also supported by American Heart Association Grant 0535121N (to G. I. L.).	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barrett MP, 2003, LANCET, V362, P1469, DOI 10.1016/S0140-6736(03)14694-6; Bellamine A, 2004, J LIPID RES, V45, P2000, DOI 10.1194/jlr.M400239-JLR200; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; BRUN R, 1977, Acta Tropica, V34, P21; Buckner F, 2003, P NATL ACAD SCI USA, V100, P15149, DOI 10.1073/pnas.2535442100; COMO JA, 1994, NEW ENGL J MED, V330, P263, DOI 10.1056/NEJM199401273300407; Coppens I, 2000, ANNU REV MICROBIOL, V54, P129, DOI 10.1146/annurev.micro.54.1.129; Croft SL, 2005, TRENDS PARASITOL, V21, P508, DOI 10.1016/j.pt.2005.08.026; Cruz AK, 2009, CURR DRUG TARGETS, V10, P178, DOI 10.2174/138945009787581177; Ekroos M, 2006, P NATL ACAD SCI USA, V103, P13682, DOI 10.1073/pnas.0603236103; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ghosh D, 2009, NATURE, V457, P219, DOI 10.1038/nature07614; GOODPASTURE HC, 1985, ARCH INTERN MED, V145, P879, DOI 10.1001/archinte.145.5.879; Guallar V, 2003, P NATL ACAD SCI USA, V100, P6998, DOI 10.1073/pnas.0732000100; HASEMANN CA, 1995, STRUCTURE, V3, P41, DOI 10.1016/S0969-2126(01)00134-4; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Konkle ME, 2009, J MED CHEM, V52, P2846, DOI 10.1021/jm801643b; Leoni V, 2005, J LIPID RES, V46, P191, DOI 10.1194/jlr.C400005-JLR200; Lepesheva GI, 2007, CHEM BIOL, V14, P1283, DOI 10.1016/j.chembiol.2007.10.011; Lepesheva GI, 2007, ARCH BIOCHEM BIOPHYS, V464, P221, DOI 10.1016/j.abb.2007.05.017; Lepesheva GI, 2007, BBA-GEN SUBJECTS, V1770, P467, DOI 10.1016/j.bbagen.2006.07.018; Lepesheva G, 2008, LIPIDS, V43, P1117, DOI 10.1007/s11745-008-3225-y; Lepesheva GI, 2006, J BIOL CHEM, V281, P3577, DOI 10.1074/jbc.M510317200; Lepesheva GI, 2003, BIOCHEMISTRY-US, V42, P9091, DOI 10.1021/bi034663f; Lepesheva GI, 2004, BIOCHEMISTRY-US, V43, P10789, DOI 10.1021/bi048967t; Lepesheva GI, 2001, J BIOL CHEM, V276, P28413, DOI 10.1074/jbc.M102767200; Luscher A, 2007, CURR PHARM DESIGN, V13, P555, DOI 10.2174/138161207780162809; Mast N, 2008, P NATL ACAD SCI USA, V105, P9546, DOI 10.1073/pnas.0803717105; Matsuura K, 2005, J BIOL CHEM, V280, P9088, DOI 10.1074/jbc.M413042200; McLean KJ, 2006, BIOCHEM SOC T, V34, P1178, DOI 10.1042/BST0341178; Myler PJ, 2008, ADV EXP MED BIOL, V625, P133, DOI 10.1007/978-0-387-77570-8_11; OTNINOWSKI Z, 1995, HKL MANUAL; Podust LM, 2001, P NATL ACAD SCI USA, V98, P3068, DOI 10.1073/pnas.061562898; Podust LM, 2004, STRUCTURE, V12, P1937, DOI 10.1016/j.str.2004.08.009; Poulos TL, 2007, DRUG METAB REV, V39, P557, DOI 10.1080/03602530701498240; Roberts CW, 2003, MOL BIOCHEM PARASIT, V126, P129, DOI 10.1016/S0166-6851(02)00280-3; Schlichting I, 2000, SCIENCE, V287, P1615, DOI 10.1126/science.287.5458.1615; Soeiro MNC, 2009, EXPERT OPIN THER TAR, V13, P105, DOI [10.1517/14728220802623881, 10.1517/14728220802623881 ]; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Thompson GR, 2009, CLIN CHEST MED, V30, P203, DOI 10.1016/j.ccm.2009.02.001; VANDEN BOSSCHE H, 1995, PHARMACOL THERAPEUT, V67, P79; Vanhollebeke B, 2008, SCIENCE, V320, P677, DOI 10.1126/science.1156296; vonWachenfeldt C, 1997, ARCH BIOCHEM BIOPHYS, V339, P107, DOI 10.1006/abbi.1996.9859; Williams D, 2000, PERFORM RES, V5, P131; Zhou WX, 2007, J LIPID RES, V48, P665, DOI 10.1194/jlr.M600404-JLR200	48	105	106	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2010	285	3					1773	1780		10.1074/jbc.M109.067470	http://dx.doi.org/10.1074/jbc.M109.067470			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	541PJ	19923211	Green Published, hybrid			2022-12-25	WOS:000273429100023
J	Lee, VJ; Yap, J; Ong, JBS; Chan, KP; Lin, RTP; Chan, SP; Goh, KT; Leo, YS; Chen, MIC				Lee, Vernon J.; Yap, Jonathan; Ong, Jimmy B. S.; Chan, Kwai-Peng; Lin, Raymond T. P.; Chan, Siew Pang; Goh, Kee Tai; Leo, Yee-Sin; Chen, Mark I-Cheng			Influenza Excess Mortality from 1950-2000 in Tropical Singapore	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; UNITED-STATES; PANDEMIC INFLUENZA; DENGUE EPIDEMIC; IMPACT; ENGLAND; WALES; POPULATION; INFECTIONS; PREVENTION	Introduction: Tropical regions have been shown to exhibit different influenza seasonal patterns compared to their temperate counterparts. However, there is little information about the burden of annual tropical influenza epidemics across time, and the relationship between tropical influenza epidemics compared with other regions. Methods: Data on monthly national mortality and population was obtained from 1947 to 2003 in Singapore. To determine excess mortality for each month, we used a moving average analysis for each month from 1950 to 2000. From 1972, influenza viral surveillance data was available. Before 1972, information was obtained from serial annual government reports, peer-reviewed journal articles and press articles. Results: The influenza pandemics of 1957 and 1968 resulted in substantial mortality. In addition, there were 20 other time points with significant excess mortality. Of the 12 periods with significant excess mortality post-1972, only one point (1988) did not correspond to a recorded influenza activity. For the 8 periods with significant excess mortality periods before 1972 excluding the pandemic years, 2 years (1951 and 1953) had newspaper reports of increased pneumonia deaths. Excess mortality could be observed in almost all periods with recorded influenza outbreaks but did not always exceed the 95% confidence limits of the baseline mortality rate. Conclusion: Influenza epidemics were the likely cause of most excess mortality periods in post-war tropical Singapore, although not every epidemic resulted in high mortality. It is therefore important to have good influenza surveillance systems in place to detect influenza activity.	[Lee, Vernon J.; Yap, Jonathan] Minist Def, Biodef Ctr, Singapore, Singapore; [Lee, Vernon J.; Ong, Jimmy B. S.; Chen, Mark I-Cheng] Tan Tock Seng Hosp, Dept Clin Epidemiol, Singapore, Singapore; [Lee, Vernon J.; Chen, Mark I-Cheng] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore 117595, Singapore; [Lee, Vernon J.] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia; [Chan, Kwai-Peng] Singapore Gen Hosp, Dept Pathol, Singapore 0316, Singapore; [Lin, Raymond T. P.; Goh, Kee Tai] Minist Hlth, Singapore, Singapore; [Chan, Siew Pang] SIM, Singapore, Singapore; [Leo, Yee-Sin] Tan Tock Seng Hosp, Dept Infect Dis, Singapore, Singapore; [Chen, Mark I-Cheng] Duke NUS Grad Med Sch, Singapore, Singapore	Tan Tock Seng Hospital; National University of Singapore; Australian National University; Singapore General Hospital; Ministry of Health-Singapore; Tan Tock Seng Hospital; National University of Singapore	Lee, VJ (corresponding author), Minist Def, Biodef Ctr, Singapore, Singapore.	vernonljm@hotmail.com	Chen, Mark/AGC-5338-2022; Chen, Mark/CAG-2949-2022; Yap, Jonathan/AAJ-7266-2020	Chen, Mark/0000-0001-9369-5830; Chen, Mark/0000-0001-9369-5830; Yap, Jonathan/0000-0002-5227-8536				ALLING DW, 1981, AM J EPIDEMIOL, V113, P30, DOI 10.1093/oxfordjournals.aje.a113063; AZOICAI D, BACTERIOL VIRUSOL PA, V39, P185; BARKER WH, 1980, AM J EPIDEMIOL, V112, P798, DOI 10.1093/oxfordjournals.aje.a113052; Besselaar TG, 1999, J MED VIROL, V59, P561, DOI 10.1002/(SICI)1096-9071(199912)59:4&lt;561::AID-JMV22&gt;3.0.CO;2-5; BRAMMER T, 2002, MORBIDITY MORTALITY, V51, pSS7; CHAPMAN L E, 1992, Morbidity and Mortality Weekly Report, V41, P35; Chew FT, 1998, EPIDEMIOL INFECT, V121, P121, DOI 10.1017/S0950268898008905; Chow A, 2006, EMERG INFECT DIS, V12, P114, DOI 10.3201/eid1201.050826; Claas E C, 1994, Ned Tijdschr Geneeskd, V138, P1966; CLIFFORD RE, 1977, INT J EPIDEMIOL, V6, P115, DOI 10.1093/ije/6.2.115; Curran M, 1998, Commun Dis Intell, V22, P69; *DEP PATH SING GEN, 2000, MED REP 1973 2000; DORAISINGHAM S, 1988, B WORLD HEALTH ORGAN, V66, P57; GILL PW, 1972, MED J AUSTRALIA, V2, P242, DOI 10.5694/j.1326-5377.1972.tb47264.x; GLEZEN WP, 1982, AM J EPIDEMIOL, V116, P589, DOI 10.1093/oxfordjournals.aje.a113441; GLEZEN WP, 1978, NEW ENGL J MED, V298, P587, DOI 10.1056/NEJM197803162981103; GLEZEN WP, 1982, EPIDEMIOL REV, V4, P25, DOI 10.1093/oxfordjournals.epirev.a036250; JENNINGS LC, 1978, J HYG-CAMBRIDGE, V81, P67, DOI 10.1017/S0022172400053778; Koh BKW, 2008, ANN ACAD MED SINGAP, V37, P538; Kuszewski K, 1999, Przegl Epidemiol, V53, P45; Lee VJ, 2007, EMERG INFECT DIS, V13, P1052, DOI 10.3201/eid1307.061313; Leo YS, 2009, LANCET INFECT DIS, V9, P457, DOI 10.1016/S1473-3099(09)70182-3; LUI KJ, 1985, AM J PUBLIC HEALTH, V77, P712; Morens DM, 2009, NEW ENGL J MED, V361, P225, DOI 10.1056/NEJMp0904819; Nicholson KG, 1996, EPIDEMIOL INFECT, V116, P51, DOI 10.1017/S0950268800058957; Ong A, 2007, INT J INFECT DIS, V11, P263, DOI 10.1016/j.ijid.2006.02.012; Ooi EE, 2006, EMERG INFECT DIS, V12, P887, DOI 10.3201/eid1206.051210; RAGONA G, 1978, J HYG-CAMBRIDGE, V80, P249, DOI 10.1017/S0022172400053602; Rao BL, 1997, INDIAN J MED RES, V106, P223; Rizzo C, 2007, EMERG INFECT DIS, V13, P694, DOI 10.3201/eid1305.061309; Rizzo C, 2006, VACCINE, V24, P6468, DOI 10.1016/j.vaccine.2006.06.052; Russell CA, 2008, SCIENCE, V320, P340, DOI 10.1126/science.1154137; Simonsen L, 1997, AM J PUBLIC HEALTH, V87, P1944, DOI 10.2105/AJPH.87.12.1944; SOUSA VO, 1974, B WORLD HEALTH ORGAN, V50, P475; TABER LH, 1981, J HYG-CAMBRIDGE, V86, P303, DOI 10.1017/S0022172400069059; Tangkanakul Waraluk, 2000, Journal of the Medical Association of Thailand, V83, P1005; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Viboud C, 2006, EMERG INFECT DIS, V12, P661, DOI 10.3201/eid1204.050695; Viboud C, 2006, VACCINE, V24, P6701, DOI 10.1016/j.vaccine.2006.05.067; Weber J M, 1994, Can Commun Dis Rep, V20, P177; Zgorzelska K, 1990, Przegl Epidemiol, V44, P299; 1953, STRAITS TIMES   0829, P4; 1953, STRAITS TIMES   0820, P7; 1951, STRAITS TIMES   0901, P4; 1951, STRAITS TIMES   0909, P5; 1951, STRAITS TIMES   0927, P7; 1951, STRAITS TIMES   0825, P4	47	49	49	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2009	4	12							e8096	10.1371/journal.pone.0008096	http://dx.doi.org/10.1371/journal.pone.0008096			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MT	19956611	Green Published, gold, Green Submitted			2022-12-25	WOS:000272828700010
J	Aghajanian, A; Wittchen, ES; Campbell, SL; Burridge, K				Aghajanian, Amir; Wittchen, Erika S.; Campbell, Sharon L.; Burridge, Keith			Direct Activation of RhoA by Reactive Oxygen Species Requires a Redox-Sensitive Motif	PLOS ONE			English	Article							GUANINE-NUCLEOTIDE EXCHANGE; PROTEIN-TYROSINE PHOSPHATASES; ACTIN STRESS FIBERS; HYDROGEN-PEROXIDE; SIGNAL-TRANSDUCTION; CELL-ADHESION; NADPH OXIDASES; S-NITROSATION; P115 RHOGEF; GTPASES	Background: Rho family GTPases are critical regulators of the cytoskeleton and affect cell migration, cell-cell adhesion, and cell-matrix adhesion. As with all GTPases, their activity is determined by their guanine nucleotide-bound state. Understanding how Rho proteins are activated and inactivated has largely focused on regulatory proteins such as guanine nucleotide exchange factors (GEFs) and GTPase activating proteins (GAPs). However, recent in vitro studies have indicated that GTPases may also be directly regulated by redox agents. We hypothesized that this redox-based mechanism occurs in cells and affects cytoskeletal dynamics, and in this report we conclude this is indeed a novel mechanism of regulating the GTPase RhoA. Methodology/Principal Findings: In this report, we show that RhoA can be directly activated by reactive oxygen species (ROS) in cells, and that this requires two critical cysteine residues located in a unique redox-sensitive motif within the phosphoryl binding loop. First, we show that ROS can reversibly activate RhoA and induce stress fiber formation, a well characterized readout of RhoA activity. To determine the role of cysteine residues in this mechanism of regulation, we generated cysteine to alanine RhoA mutants. Mutation of these cysteines abolishes ROS-mediated activation and stress fiber formation, indicating that these residues are critical for redox-regulation of RhoA. Importantly, these mutants maintain the ability to be activated by GEFs. Conclusions/Significance: Our findings identify a novel mechanism for the regulation of RhoA in cells by ROS, which is independent of classical regulatory proteins. This mechanism of regulation may be particularly relevant in pathological conditions where ROS are generated and the cellular redox-balance altered, such as in asthma and ischemia-reperfusion injury.	[Aghajanian, Amir; Wittchen, Erika S.; Burridge, Keith] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA; [Campbell, Sharon L.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Burridge, Keith] Univ N Carolina, UNC McAllister Heart Inst, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Aghajanian, A (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA.	amir@med.unc.edu		campbell, sharon/0000-0003-0311-409X; Aghajanian, Amir/0000-0002-3671-7957	NIH [GM029860, HL080166, HL045100, T32 GM008719]; North Carolina University Cancer Research Fund; NIH NRSA [1F30HL094063]; NATIONAL CANCER INSTITUTE [R01CA089614] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL045100, P01HL080166, F30HL094063] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008719, R01GM029860] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); North Carolina University Cancer Research Fund; NIH NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants GM029860 (KB), HL080166 (KB), HL045100 (KB and SLC) and a North Carolina University Cancer Research Fund Innovation Award (KB and SLC). AA received support from NIH Medical Scientist Training Program Grant T32 GM008719 and NIH NRSA 1F30HL094063. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKTORIES K, 1989, TRENDS PHARMACOL SCI, V10, P415, DOI 10.1016/0165-6147(89)90191-0; Andreadis AA, 2003, FREE RADICAL BIO MED, V35, P213, DOI 10.1016/S0891-5849(03)00278-8; Bae YS, 1997, J BIOL CHEM, V272, P217, DOI 10.1074/jbc.272.1.217; Bokoch GM, 2003, TRENDS BIOCHEM SCI, V28, P502, DOI 10.1016/S0968-0004(03)00194-4; BUHL AM, 1995, J BIOL CHEM, V270, P24631, DOI 10.1074/jbc.270.42.24631; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Carbajal JM, 2000, AM J PHYSIOL-CELL PH, V279, pC195; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; Chiarugi P, 2003, J CELL BIOL, V161, P933, DOI 10.1083/jcb.200211118; Dada LA, 2007, J CELL SCI, V120, P2214, DOI 10.1242/jcs.003038; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; DeYulia GJ, 2005, P NATL ACAD SCI USA, V102, P5044, DOI 10.1073/pnas.0501154102; DeYulia GJ, 2005, BIOCHEM BIOPH RES CO, V334, P38, DOI 10.1016/j.bbrc.2005.06.056; GARRELS JI, 1989, J BIOL CHEM, V264, P5299; Griendling KK, 2000, CIRC RES, V86, P494, DOI 10.1161/01.RES.86.5.494; HARRAZ MM, 2008, J CLIN INVEST; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; Heo J, 2005, J BIOL CHEM, V280, P31003, DOI 10.1074/jbc.M504768200; Heo JY, 2006, BIOCHEMISTRY-US, V45, P14481, DOI 10.1021/bi0610101; Heo JY, 2004, BIOCHEMISTRY-US, V43, P2314, DOI 10.1021/bi035275g; Hoffman DL, 2009, J BIOL CHEM, V284, P16236, DOI 10.1074/jbc.M809512200; Huot J, 1997, CIRC RES, V80, P383, DOI 10.1161/01.RES.80.3.383; Jin LM, 2004, AM J PHYSIOL-HEART C, V287, pH1495, DOI 10.1152/ajpheart.01006.2003; JOHNSON A, 1989, AM J PHYSIOL, V256, pH1012, DOI 10.1152/ajpheart.1989.256.4.H1012; Kheradmand F, 1998, SCIENCE, V280, P898, DOI 10.1126/science.280.5365.898; Kojima K, 2007, EUR J PHARMACOL, V556, P151, DOI 10.1016/j.ejphar.2006.11.007; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; LANDER HM, 1995, J BIOL CHEM, V270, P7017, DOI 10.1074/jbc.270.13.7017; Lander HM, 1996, NATURE, V381, P380, DOI 10.1038/381380a0; Leto TL, 2006, ANTIOXID REDOX SIGN, V8, P1549, DOI 10.1089/ars.2006.8.1549; LIU SM, 1995, EXP CELL RES, V217, P1, DOI 10.1006/excr.1995.1056; Maddox AS, 2003, J CELL BIOL, V160, P255, DOI 10.1083/jcb.200207130; Majumdar M, 1999, J BIOL CHEM, V274, P26815, DOI 10.1074/jbc.274.38.26815; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Niethammer P, 2009, NATURE, V459, P996, DOI 10.1038/nature08119; Nimnual AS, 2003, NAT CELL BIOL, V5, P236, DOI 10.1038/ncb938; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Noren NK, 2000, J CELL BIOL, V150, P567, DOI 10.1083/jcb.150.3.567; RABE KF, 1995, AM J PHYSIOL-LUNG C, V269, pL332, DOI 10.1152/ajplung.1995.269.3.L332; Raines KW, 2007, CARDIOVASC RES, V75, P229, DOI 10.1016/j.cardiores.2007.04.013; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; RUBIN EJ, 1988, MOL CELL BIOL, V8, P418, DOI 10.1128/MCB.8.1.418; Sander EE, 1999, J CELL BIOL, V147, P1009, DOI 10.1083/jcb.147.5.1009; Sander EE, 1998, J CELL BIOL, V143, P1385, DOI 10.1083/jcb.143.5.1385; SHASBY DM, 1985, BLOOD, V65, P605; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Sundaresan M, 1996, BIOCHEM J, V318, P379, DOI 10.1042/bj3180379; Tudor KSRS, 2001, CYTOKINE, V15, P196, DOI 10.1006/cyto.2001.0922; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016; Werner E, 2002, J CELL BIOL, V158, P357, DOI 10.1083/jcb.200111028; Wittchen ES, 2008, METHOD ENZYMOL, V443, P285, DOI 10.1016/S0076-6879(08)02014-4; Zhu LK, 2006, AM J PHYSIOL-HEART C, V290, pH365, DOI 10.1152/ajpheart.00812.2005; Zuckerbraun BS, 2007, AM J PHYSIOL-CELL PH, V292, pC824, DOI 10.1152/ajpcell.00592.2005; Zweier JL, 2006, CARDIOVASC RES, V70, P181, DOI 10.1016/j.cardiores.2006.02.025	57	149	153	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2009	4	11							e8045	10.1371/journal.pone.0008045	http://dx.doi.org/10.1371/journal.pone.0008045			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MN	19956681	Green Published, gold, Green Submitted			2022-12-25	WOS:000272828100007
J	Hobson, KA; Wunder, MB; Van Wilgenburg, SL; Clark, RG; Wassenaar, LI				Hobson, Keith A.; Wunder, Michael B.; Van Wilgenburg, Steven L.; Clark, Robert G.; Wassenaar, Leonard I.			A Method for Investigating Population Declines of Migratory Birds Using Stable Isotopes: Origins of Harvested Lesser Scaup in North America	PLOS ONE			English	Article							LONG-TERM POPULATION; AYTHYA-AFFINIS; BOREAL FOREST; SURVIVAL; FEATHERS; HYDROGEN; PINTAIL; FLYWAY	Background: Elucidating geographic locations from where migratory birds are recruited into adult breeding populations is a fundamental but largely elusive goal in conservation biology. This is especially true for species that breed in remote northern areas where field-based demographic assessments are logistically challenging. Methodology/Findings: Here we used hydrogen isotopes (delta D) to determine natal origins of migrating hatch-year lesser scaup (Aythya affinis) harvested by hunters in the United States from all North American flyways during the hunting seasons of 1999-2000 (n = 412) and 2000-2001 (n = 455). We combined geospatial, observational, and analytical data sources, including known scaup breeding range, delta D values of feathers from juveniles at natal sites, models of delta D for growing-season precipitation, and scaup band-recovery data to generate probabilistic natal origin landscapes for individual scaup. We then used Monte Carlo integration to model assignment uncertainty from among individual delta D variance estimates from birds of known molt origin and also from band-return data summarized at the flyway level. We compared the distribution of scaup natal origin with the distribution of breeding population counts obtained from systematic long-term surveys. Conclusions/Significance: Our analysis revealed that the proportion of young scaup produced in the northern (above 60 degrees N) versus the southern boreal and Prairie-Parkland region was inversely related to the proportions of breeding adults using these regions, suggesting that despite having a higher relative abundance of breeding adults, the northern boreal region was less productive for scaup recruitment into the harvest than more southern biomes. Our approach for evaluating population declines of migratory birds (particularly game birds) synthesizes all available distributional data and exploits the advantages of intrinsic isotopic markers that link individuals to geography.	[Hobson, Keith A.; Van Wilgenburg, Steven L.; Clark, Robert G.; Wassenaar, Leonard I.] Environm Canada, Saskatoon, SK, Canada; [Wunder, Michael B.] Univ Colorado, Dept Integrat Biol, Denver, CO 80202 USA	Environment & Climate Change Canada; University of Colorado System; University of Colorado Denver	Hobson, KA (corresponding author), Environm Canada, Saskatoon, SK, Canada.	Keith.Hobson@ec.gc.ca	Bond, Alexander L/A-3786-2010; Hobson, Keith/Q-9306-2019; Wassenaar, Leonard I/B-7508-2009; Wassenaar, Leonard/AAY-7081-2020	Wassenaar, Leonard/0000-0001-5532-0771; Van Wilgenburg, Steven/0000-0002-6742-4567	Environment Canada; U.S. Fish and Wildlife Service; Ducks Unlimited Canada	Environment Canada(CGIAR); U.S. Fish and Wildlife Service(US Fish & Wildlife Service); Ducks Unlimited Canada	Funding was provided through operating grants from Environment Canada to KAH, RGC and LIW and by the U.S. Fish and Wildlife Service (P. Padding, Robert Blohm) and Ducks Unlimited Canada (Michael G. Anderson). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afton AD, 2001, J WILDLIFE MANAGE, V65, P781, DOI 10.2307/3803028; Anteau MJ, 2006, CAN J ZOOL, V84, P779, DOI 10.1139/Z06-047; Anteau MJ, 2004, AUK, V121, P917, DOI 10.1642/0004-8038(2004)121[0917:NROLSA]2.0.CO;2; Austin JE, 2000, WILDLIFE SOC B, V28, P254; Austin JE, 2002, J WILDLIFE MANAGE, V66, P874, DOI 10.2307/3803152; AUSTIN JE, 1998, 338 BIRDS N AM; Badzinski SS, 2006, WILDLIFE SOC B, V34, P664, DOI 10.2193/0091-7648(2006)34[664:DOLAGS]2.0.CO;2; Bowen GJ, 2005, OECOLOGIA, V143, P337, DOI 10.1007/s00442-004-1813-y; Bowen GJ, 2003, WATER RESOUR RES, V39, DOI 10.1029/2003WR002086; Brook RW, 2005, WILDLIFE BIOL, V11, P3, DOI 10.2981/0909-6396(2005)11[3:EOSMCO]2.0.CO;2; Clark RG, 2006, CAN J ZOOL, V84, P1395, DOI 10.1139/Z06-135; Corcoran RM, 2007, J WILDLIFE MANAGE, V71, P127, DOI 10.2193/2005-534; Corcoran RM, 2009, HYDROBIOLOGIA, V620, P77, DOI 10.1007/s10750-008-9616-5; DeVink JM, 2008, AUK, V125, P291, DOI 10.1525/auk.2008.06171; Greenberg R, 1999, CONSERV BIOL, V13, P553, DOI 10.1046/j.1523-1739.1999.97478.x; Hebert CE, 2005, J WILDLIFE MANAGE, V69, P101, DOI 10.2193/0022-541X(2005)069&lt;0101:SIPEFP&gt;2.0.CO;2; Hobson KA, 2005, AUK, V122, P1037, DOI 10.1642/0004-8038(2005)122[1037:SIATDO]2.0.CO;2; Hobson KA, 1999, OECOLOGIA, V120, P314, DOI 10.1007/s004420050865; Hobson KA, 2008, TERR ECOL SER, V2, P1, DOI 10.1016/S1936-7961(07)00001-2; Hobson KA, 2006, WATERBIRDS, V29, P137, DOI 10.1675/1524-4695(2006)29[137:USHIAO]2.0.CO;2; Johnson Douglas H., 1992, P446; Koons DN, 2006, AVIAN CONSERV ECOL, V1; Legendre P., 1998, NUMERICAL ECOLOGY, V24; Newton I, 2006, J ORNITHOL, V147, P146, DOI 10.1007/s10336-006-0058-4; Quinlan R, 2005, GLOBAL CHANGE BIOL, V11, P1381, DOI 10.1111/j.1365-2486.2005.00981.x; Rotella JJ, 2003, CONDOR, V105, P336, DOI 10.1650/0010-5422(2003)105[0336:SOFLSE]2.0.CO;2; Rouse WR, 1997, HYDROL PROCESS, V11, P873, DOI 10.1002/(SICI)1099-1085(19970630)11:8<873::AID-HYP510>3.0.CO;2-6; Sauer J. R., 2004, N AM BREEDING BIRD S; Shannon JP, 2003, ISOT ENVIRON HEALT S, V39, P1, DOI 10.1080/1025601031000102215; Sillett TS, 2002, J ANIM ECOL, V71, P296, DOI 10.1046/j.1365-2656.2002.00599.x; Smith G.W., 1995, 5 NAT BIOL SERV; *US FISH WILDL SER, UNPUB; Walker J, 2005, J WILDLIFE MANAGE, V69, P592, DOI 10.2193/0022-541X(2005)069[0592:SOSDIT]2.0.CO;2; Walker J, 2005, J WILDLIFE MANAGE, V69, P582, DOI 10.2193/0022-541X(2005)069[0582:NSOSAO]2.0.CO;2; Walsh KA, 2006, HYDROBIOLOGIA, V567, P101, DOI 10.1007/s10750-006-0102-7; WEBSTER MS, 2005, BIRDS TWO WORLDS ECO, P119; Wunder MB, 2005, OECOLOGIA, V144, P607, DOI 10.1007/s00442-005-0071-y; WUNDER MB, 2009, ISOSCAPES U IN PRESS; Wunder MB, 2007, THESIS COLORADO STAT	40	96	101	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2009	4	11							e7915	10.1371/journal.pone.0007915	http://dx.doi.org/10.1371/journal.pone.0007915			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MK	19946360	gold, Green Published, Green Submitted			2022-12-25	WOS:000272827800007
J	Chan, AS; Jensen, KK; Skokos, D; Doty, S; Lederman, HK; Kaplan, RN; Rafii, S; Rivella, S; Lyden, D				Chan, April S.; Jensen, Kristian K.; Skokos, Dimitris; Doty, Stephen; Lederman, Hannah K.; Kaplan, Rosandra N.; Rafii, Shahin; Rivella, Stefano; Lyden, David			Id1 Represses Osteoclast-Dependent Transcription and Affects Bone Formation and Hematopoiesis	PLOS ONE			English	Article							RESISTANT ACID-PHOSPHATASE; RECEPTOR GENE-EXPRESSION; STEM-CELL NICHES; PROGENITOR CELLS; MARROW NICHE; PROTEINS; DIFFERENTIATION; CANCER; ANGIOGENESIS; METASTASIS	Background: The bone-bone marrow interface is an area of the bone marrow microenvironment in which both bone remodeling cells, osteoblasts and osteoclasts, and hematopoietic cells are anatomically juxtaposed. The close proximity of these cells naturally suggests that they interact with one another, but these interactions are just beginning to be characterized. Methodology/Principal Findings: An Id1(-/-) mouse model was used to assess the role of Id1 in the bone marrow microenvironment. Micro-computed tomography and fracture tests showed that Id1(-/-) mice have reduced bone mass and increased bone fragility, consistent with an osteoporotic phenotype. Osteoclastogenesis and pit formation assays revealed that loss of Id1 increased osteoclast differentiation and resorption activity, both in vivo and in vitro, suggesting a cell autonomous role for Id1 as a negative regulator of osteoclast differentiation. Examination by flow cytometry of the hematopoietic compartment of Id1(-/-) mice showed an increase in myeloid differentiation. Additionally, we found increased expression of osteoclast genes, TRAP, Oscar, and CTSK in the Id1(-/-) bone marrow microenvironment. Lastly, transplantation of wild-type bone marrow into Id1(-/-) mice repressed TRAP, Oscar, and CTSK expression and activity and rescued the hematopoietic and bone phenotype in these mice. Conclusions/Significance: In conclusion, we demonstrate an osteoporotic phenotype in Id1(-/-) mice and a mechanism for Id1 transcriptional control of osteoclast-associated genes. Our results identify Id1 as a principal player responsible for the dynamic cross-talk between bone and bone marrow hematopoietic cells.	[Chan, April S.; Jensen, Kristian K.; Lederman, Hannah K.; Kaplan, Rosandra N.; Rafii, Shahin; Lyden, David] Weill Cornell Med Coll, Dept Pediat, New York, NY USA; [Chan, April S.; Jensen, Kristian K.; Lederman, Hannah K.; Kaplan, Rosandra N.; Rafii, Shahin; Lyden, David] Weill Cornell Med Coll, Dept Cell & Dev Biol, New York, NY USA; [Chan, April S.; Jensen, Kristian K.; Lederman, Hannah K.; Kaplan, Rosandra N.; Rivella, Stefano; Lyden, David] Cornell Univ, Weill Med Coll, Childrens Canc & Blood Fdn Labs, Dept Pediat Hematol Oncol, New York, NY 10021 USA; [Skokos, Dimitris] Rockefeller Univ, Lab Mol Immunol, New York, NY 10021 USA; [Doty, Stephen] Hosp Special Surg, New York, NY 10021 USA; [Kaplan, Rosandra N.; Lyden, David] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Rafii, Shahin] Weill Cornell Med Coll, Dept Med Genet, New York, NY USA	Cornell University; Cornell University; Cornell University; Rockefeller University; Memorial Sloan Kettering Cancer Center; Cornell University	Chan, AS (corresponding author), Weill Cornell Med Coll, Dept Pediat, New York, NY USA.	str2010@med.cornell.edu; dcl2001@med.cornell.edu	Rivella, Stefano/A-1597-2010	Chan, April/0000-0002-4797-7009; Rivella, Stefano/0000-0002-0938-6558	National Cancer Institute [R01CA098234]; National Foundation for Cancer Research; Emerald Foundation; Malcolm Hewitt Wiener Foundation; Nancy C. and Daniel P. Paduano Foundation; American Hellenic Education Progressive Association; Charles and Meryl Witmer Family Foundation; Butler Foundation; Children's Cancer and Blood Foundation; NATIONAL CANCER INSTITUTE [R01CA098234, ZIABC011332] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Foundation for Cancer Research; Emerald Foundation; Malcolm Hewitt Wiener Foundation; Nancy C. and Daniel P. Paduano Foundation; American Hellenic Education Progressive Association; Charles and Meryl Witmer Family Foundation; Butler Foundation; Children's Cancer and Blood Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	National Cancer Institute (R01CA098234); Susan G. Komen for the Cure; National Foundation for Cancer Research; Emerald Foundation; Malcolm Hewitt Wiener Foundation; Nancy C. and Daniel P. Paduano Foundation; American Hellenic Education Progressive Association; Charles and Meryl Witmer Family Foundation; Butler Foundation and the Children's Cancer and Blood Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antin JH, 2001, BIOL BLOOD MARROW TR, V7, P473, DOI 10.1053/bbmt.2001.v7.pm11669214; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; BARKA T, 1962, J HISTOCHEM CYTOCHEM, V10, P741, DOI 10.1177/10.6.741; Benezra R, 2001, ONCOGENE, V20, P8334, DOI 10.1038/sj.onc.1205160; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Bruzzaniti A, 2006, REV ENDOCR METAB DIS, V7, P123, DOI 10.1007/s11154-006-9009-x; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Erben RG, 1997, J HISTOCHEM CYTOCHEM, V45, P307, DOI 10.1177/002215549704500215; Follenzi A, 2000, NAT GENET, V25, P217, DOI 10.1038/76095; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Gupta GP, 2007, P NATL ACAD SCI USA, V104, P19506, DOI 10.1073/pnas.0709185104; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Jankovic V, 2007, P NATL ACAD SCI USA, V104, P1260, DOI 10.1073/pnas.0607894104; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Kim K, 2005, J BIOL CHEM, V280, P35209, DOI 10.1074/jbc.M505815200; Kollet O, 2006, NAT MED, V12, P657, DOI 10.1038/nm1417; Lasorella A, 2001, ONCOGENE, V20, P8326, DOI 10.1038/sj.onc.1205093; Lee J, 2006, BLOOD, V107, P2686, DOI 10.1182/blood-2005-07-2798; LISTER J, 1995, J BIOL CHEM, V270, P17939, DOI 10.1074/jbc.270.30.17939; Luchin A, 2000, J BONE MINER RES, V15, P451, DOI 10.1359/jbmr.2000.15.3.451; Lyden D, 1999, NATURE, V401, P670, DOI 10.1038/44334; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Martin TJ, 2005, TRENDS MOL MED, V11, P76, DOI 10.1016/j.molmed.2004.12.004; Matsuo K, 2008, ARCH BIOCHEM BIOPHYS, V473, P201, DOI 10.1016/j.abb.2008.03.027; MINKIN C, 1982, CALCIFIED TISSUE INT, V34, P285, DOI 10.1007/BF02411252; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Motyckova G, 2001, P NATL ACAD SCI USA, V98, P5798, DOI 10.1073/pnas.091479298; Okaji Y, 2006, EUR J CANCER, V42, P668, DOI 10.1016/j.ejca.2005.11.016; Palacio S, 2001, EUR J ENDOCRINOL, V144, P431, DOI 10.1530/eje.0.1440431; Perry SS, 2007, BLOOD, V110, P2351, DOI 10.1182/blood-2007-01-069914; Phan TCA, 2004, HISTOL HISTOPATHOL, V19, P1325, DOI 10.14670/HH-19.1325; Reddy SV, 2004, CRIT REV EUKAR GENE, V14, P255, DOI 10.1615/CritRevEukaryotGeneExpr.v14.i4.20; Ruzinova MB, 2003, TRENDS CELL BIOL, V13, P410, DOI 10.1016/S0962-8924(03)00147-8; Sharma SM, 2007, J BIOL CHEM, V282, P15921, DOI 10.1074/jbc.M609723200; SHUNO Y, 2008, J SURG RES; So H, 2003, J BIOL CHEM, V278, P24209, DOI 10.1074/jbc.M302940200; Suda T, 2005, TRENDS IMMUNOL, V26, P426, DOI 10.1016/j.it.2005.06.006; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Tsuchiya T, 2005, CANCER SCI, V96, P784, DOI 10.1111/j.1349-7006.2005.00113.x; Visnjic D, 2004, BLOOD, V103, P3258, DOI 10.1182/blood-2003-11-4011; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779; Yan W, 1997, MOL CELL BIOL, V17, P7317, DOI 10.1128/MCB.17.12.7317; Yin T, 2006, J CLIN INVEST, V116, P1195, DOI 10.1172/JCI28568; Yokota Y, 2001, ONCOGENE, V20, P8290, DOI 10.1038/sj.onc.1205090; Zebedee Z, 2001, ONCOGENE, V20, P8317, DOI 10.1038/sj.onc.1205092; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	47	25	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2009	4	11							e7955	10.1371/journal.pone.0007955	http://dx.doi.org/10.1371/journal.pone.0007955			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MH	19956687	gold, Green Published, Green Submitted			2022-12-25	WOS:000272827500003
J	Volke, M; Gale, DP; Maegdefrau, U; Schley, G; Klanke, B; Bosserhoff, AK; Maxwell, PH; Eckardt, KU; Warnecke, C				Volke, Melanie; Gale, Daniel P.; Maegdefrau, Ulrike; Schley, Gunnar; Klanke, Bernd; Bosserhoff, Anja-Katrin; Maxwell, Patrick H.; Eckardt, Kai-Uwe; Warnecke, Christina			Evidence for a Lack of a Direct Transcriptional Suppression of the Iron Regulatory Peptide Hepcidin by Hypoxia-Inducible Factors	PLOS ONE			English	Article							HEREDITARY HEMOCHROMATOSIS PROTEIN; ANTIMICROBIAL PEPTIDE; GENE-EXPRESSION; FACTOR (HIF)-1-ALPHA; C/EBP-ALPHA; ERYTHROPOIETIN; HIF-2-ALPHA; ANEMIA; INFLAMMATION; MODULATION	Background: Hepcidin is a major regulator of iron metabolism and plays a key role in anemia of chronic disease, reducing intestinal iron uptake and release from body iron stores. Hypoxia and chemical stabilizers of the hypoxia-inducible transcription factor (HIF) have been shown to suppress hepcidin expression. We therefore investigated the role of HIF in hepcidin regulation. Methodology/Principal Findings: Hepcidin mRNA was down-regulated in hepatoma cells by chemical HIF stabilizers and iron chelators, respectively. In contrast, the response to hypoxia was variable. The decrease in hepcidin mRNA was not reversed by HIF-1 alpha or HIF-2 alpha knock-down or by depletion of the HIF and iron regulatory protein (IRP) target transferrin receptor 1 (TfR1). However, the response of hepcidin to hypoxia and chemical HIF inducers paralleled the regulation of transferrin receptor 2 (TfR2), one of the genes critical to hepcidin expression. Hepcidin expression was also markedly and rapidly decreased by serum deprivation, independent of transferrin-bound iron, and by the phosphatidylinositol 3 (PI3) kinase inhibitor LY294002, indicating that growth factors are required for hepcidin expression in vitro. Hepcidin promoter constructs mirrored the response of mRNA levels to interleukin-6 and bone morphogenetic proteins, but not consistently to hypoxia or HIF stabilizers, and deletion of the putative HIF binding motifs did not alter the response to different hypoxic stimuli. In mice exposed to carbon monoxide, hypoxia or the chemical HIF inducer N-oxalylglycine, liver hepcidin 1 mRNA was elevated rather than decreased. Conclusions/Significance: Taken together, these data indicate that hepcidin is neither a direct target of HIF, nor indirectly regulated by HIF through induction of TfR1 expression. Hepcidin mRNA expression in vitro is highly sensitive to the presence of serum factors and PI3 kinase inhibition and parallels TfR2 expression.			Volke, M (corresponding author), Univ Erlangen Nurnberg, Univ Hosp Erlangen, Dept Hypertens & Nephrol, Erlangen, Germany.	christina.warnecke@uk-erlangen.de	Gale, Daniel/D-5594-2013; Bosserhoff, Anja/GNH-4801-2022; Maxwell, Patrick H/C-5557-2008	Gale, Daniel/0000-0002-9170-1579; Maxwell, Patrick H/0000-0002-0338-2679; Bosserhoff, Anja/0000-0001-8147-394X; Schley, Gunnar/0000-0001-9929-5854	Medical Research Council [G0600420] Funding Source: Medline; National Institute for Health Research [NF-SI-0507-10315] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR))		Andriopoulos B, 2009, NAT GENET, V41, P482, DOI 10.1038/ng.335; Ashby DR, 2009, KIDNEY INT, V75, P976, DOI 10.1038/ki.2009.21; ASHBY DR, 2009, HAEMATOLOGICA   1014; Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Babitt JL, 2007, J CLIN INVEST, V117, P1933, DOI 10.1172/JCI31342; Bayele HK, 2006, BLOOD, V108, P4237, DOI 10.1182/blood-2005-07-027037; Belanger AJ, 2002, J MOL CELL CARDIOL, V34, P765, DOI 10.1006/jmcc.2002.2021; Beutler E, 2006, ANNU REV MED, V57, P331, DOI 10.1146/annurev.med.57.121304.131310; Braliou GG, 2008, J HEPATOL, V48, P801, DOI 10.1016/j.jhep.2007.12.021; Calzolari A, 2006, J CELL SCI, V119, P4486, DOI 10.1242/jcs.03228; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Choi SO, 2007, BIOCHEM BIOPH RES CO, V356, P312, DOI 10.1016/j.bbrc.2007.02.137; Courselaud B, 2002, J BIOL CHEM, V277, P41163, DOI 10.1074/jbc.M202653200; Courselaud B, 2004, BLOOD CELL MOL DIS, V32, P283, DOI 10.1016/j.bcmd.2003.11.003; Elbashir SM, 2002, METHODS, V26, P199, DOI 10.1016/S1046-2023(02)00023-3; Falzacappa MVV, 2008, J MOL MED, V86, P531, DOI 10.1007/s00109-008-0313-7; Falzacappa MVV, 2007, BLOOD, V109, P353, DOI 10.1182/blood-2006-07-033969; Ganz T, 2006, AM J PHYSIOL-GASTR L, V290, pG199, DOI 10.1152/ajpgi.00412.2005; Gao JW, 2009, CELL METAB, V9, P217, DOI 10.1016/j.cmet.2009.01.010; Gehrke SG, 2003, BLOOD, V102, P371, DOI 10.1182/blood-2002-11-3610; Goswami T, 2006, J BIOL CHEM, V281, P28494, DOI 10.1074/jbc.C600197200; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Krause A, 2000, FEBS LETT, V480, P147, DOI 10.1016/S0014-5793(00)01920-7; Lee MS, 2005, HUM VACCINES, V1, P6, DOI 10.4161/hv.1.1.1424; Mastrogiannaki M, 2009, J CLIN INVEST, V119, P1159, DOI 10.1172/JCI38499; Meynard D, 2009, NAT GENET, V41, P478, DOI 10.1038/ng.320; Nemeth E, 2003, BLOOD, V101, P2461, DOI 10.1182/blood-2002-10-3235; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Nemeth E, 2008, CURR OPIN HEMATOL, V15, P169, DOI 10.1097/MOH.0b013e3282f73335; Nicolas G, 2002, J CLIN INVEST, V110, P1037, DOI 10.1172/JCI200215686; Nicolas G, 2001, P NATL ACAD SCI USA, V98, P8780, DOI 10.1073/pnas.151179498; Pak M, 2006, BLOOD, V108, P3730, DOI 10.1182/blood-2006-06-028787; Park CH, 2001, J BIOL CHEM, V276, P7806, DOI 10.1074/jbc.M008922200; Peyssonnaux C, 2007, J CLIN INVEST, V117, P1926, DOI 10.1172/JCI31370; Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200; Pinto JP, 2008, BLOOD, V111, P5727, DOI 10.1182/blood-2007-08-106195; Rothhammer T, 2005, CANCER RES, V65, P448; Scharf JG, 2005, ENDOCRINOLOGY, V146, P5433, DOI 10.1210/en.2005-0948; SEMENIUK C, 2007, WETLANDS ECOL CONSER, V1, P1; Sowter HM, 2003, CANCER RES, V63, P6130; Tanno T, 2007, NAT MED, V13, P1096, DOI 10.1038/nm1629; Tazuke SI, 1998, P NATL ACAD SCI USA, V95, P10188, DOI 10.1073/pnas.95.17.10188; Vokurka M, 2006, PHYSIOL RES, V55, P667, DOI 10.33549/physiolres.930841; Wang J, 2004, MOL CELL BIOL, V24, P954, DOI 10.1128/MCB.24.3.954-965.2004; Wang RH, 2005, CELL METAB, V2, P399, DOI 10.1016/j.cmet.2005.10.010; Warnecke C, 2004, FASEB J, V18, P1462, DOI 10.1096/fj.04-1640fje; Warnecke C, 2008, EXP CELL RES, V314, P2016, DOI 10.1016/j.yexcr.2008.03.003; Wenger RH, 2002, FASEB J, V16, DOI 10.1096/fj.01-0944rev; Wrighting DM, 2006, BLOOD, V108, P3204, DOI 10.1182/blood-2006-06-027631	49	69	79	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2009	4	11							e7875	10.1371/journal.pone.0007875	http://dx.doi.org/10.1371/journal.pone.0007875			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521QH	19924283	Green Submitted, Green Published, gold			2022-12-25	WOS:000271936700011
J	Bocedi, A; Dawood, KF; Fabrini, R; Federici, G; Gradoni, L; Pedersen, JZ; Ricci, G				Bocedi, Alessio; Dawood, Kutayba F.; Fabrini, Raffaele; Federici, Giorgio; Gradoni, Luigi; Pedersen, Jens Z.; Ricci, Giorgio			Trypanothione efficiently intercepts nitric oxide as a harmless iron complex in trypanosomatid parasites	FASEB JOURNAL			English	Article						Leishmania infantum; Trypanosoma brucei; dinitrosyl-iron complex; trypanothione reductase	GLUTATHIONE TRANSFERASE SUPERFAMILY; IN-VIVO; S-TRANSFERASE; LEISHMANIA-DONOVANI; NO-CARRIERS; REDUCTASE; ENZYME; METABOLISM; STORAGE; INACTIVATION	Trypanosomatids are protozoan organisms that cause serious diseases, including African sleeping sickness, Chagas' disease, and leishmaniasis, affecting about 30 million people in the world. These parasites contain the unusual dithiol trypanothione [T(SH)(2)] instead of glutathione (GSH) as the main intracellular reductant, and they have replaced the otherwise ubiquitous GSH/glutathione reductase redox couple with a T(SH) 2/trypanothione reductase (TR) system. The reason for the existence of T(SH) 2 in parasitic organisms has remained an enigma. Here, we show that T(SH) 2 is able to intercept nitric oxide and labile iron and form a dinitrosyl-iron complex with at least 600 times higher affinity than GSH. Accumulation of the paramagnetic dinitrosyl-trypanothionyl iron complex in vivo was observed in Trypanosoma brucei and Leishmania infantum exposed to nitric oxide. While the analogous dinitrosyl-diglutathionyl iron complex formed in mammalian cells is a potent irreversible inhibitor of glutathione reductase (IC50 = 4 mu M), the T(SH) 2 complex does not inactivate TR even at millimolar levels. The peculiar capacity of T(SH) 2 to sequester NO and iron in a harmless stable complex could explain the predominance of this thiol in parasites regularly exposed to NO.-Bocedi, A., Dawood, K. F., Fabrini, R., Federici, G., Gradoni, L., Pedersen, J. Z., Ricci, G. Trypanothione efficiently intercepts nitric oxide as a harmless iron complex in trypanosomatid parasites. FASEB J. 24, 1035-1042 (2010). www.fasebj.org	[Dawood, Kutayba F.; Fabrini, Raffaele; Ricci, Giorgio] Univ Roma Tor Vergata, Dept Chem Sci & Technol, I-00133 Rome, Italy; [Bocedi, Alessio] Univ Rome Roma Tre, Dept Biol, Rome, Italy; [Pedersen, Jens Z.] Univ Roma Tor Vergata, Dept Biol, I-00133 Rome, Italy; [Federici, Giorgio] Childrens Hosp, Ist Ricovero & Cura Carattere Sci Bambin Gesu, Rome, Italy; [Gradoni, Luigi] Ist Super Sanita, Dept Infect Parasit & Immunomediated Dis, I-00161 Rome, Italy	University of Rome Tor Vergata; Roma Tre University; University of Rome Tor Vergata; IRCCS Bambino Gesu; Istituto Superiore di Sanita (ISS)	Ricci, G (corresponding author), Univ Roma Tor Vergata, Dept Chem Sci & Technol, Via Ric Sci 1, I-00133 Rome, Italy.	riccig@uniroma2.it	Dawood, Kutayba/E-1505-2019; Gradoni, Luigi/C-4962-2016	Dawood, Kutayba/0000-0002-0762-9632; Ricci, Giorgio/0000-0002-7108-2846	Italian Ministry for Education; University and Research; General Management for International Research	Italian Ministry for Education(Ministry of Education, Universities and Research (MIUR)); University and Research; General Management for International Research	The authors thank Paolo Ascenzi for helpful discussion. J.Z.P. was supported by the Italian Ministry for Education, University and Research, General Management for International Research.	Ariyanayagam MR, 2001, MOL BIOCHEM PARASIT, V115, P189, DOI 10.1016/S0166-6851(01)00285-7; Ariyanayagam MR, 2003, J BIOL CHEM, V278, P27612, DOI 10.1074/jbc.M302750200; Ascenzi P, 2003, IUBMB LIFE, V55, P573, DOI 10.1080/15216540310001639265; Becker K, 1998, NAT STRUCT BIOL, V5, P267, DOI 10.1038/nsb0498-267; Bocedi A, 2004, BIOCHEM BIOPH RES CO, V315, P710, DOI 10.1016/j.bbrc.2004.01.113; Cesareo E, 2005, J BIOL CHEM, V280, P42172, DOI 10.1074/jbc.M507916200; CUNNINGHAM ML, 1995, EUR J BIOCHEM, V230, P460, DOI 10.1111/j.1432-1033.1995.tb20583.x; De Maria F, 2003, J BIOL CHEM, V278, P42283, DOI 10.1074/jbc.M305568200; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V70, P82; FAIRLAMB AH, 1992, ANNU REV MICROBIOL, V46, P695, DOI 10.1146/annurev.micro.46.1.695; FAIRLAMB AH, 1985, SCIENCE, V227, P1485, DOI 10.1126/science.3883489; Giorgio S, 1998, INFECT IMMUN, V66, P807, DOI 10.1128/IAI.66.2.807-814.1998; Keese MA, 1997, BIOCHEM PHARMACOL, V54, P1307, DOI 10.1016/S0006-2952(97)00348-1; Krauth-Siegel RL, 2008, BBA-GEN SUBJECTS, V1780, P1236, DOI 10.1016/j.bbagen.2008.03.006; KRAUTHSIEGEL RL, 1987, EUR J BIOCHEM, V164, P123, DOI 10.1111/j.1432-1033.1987.tb11002.x; Lo Bello M, 2001, J BIOL CHEM, V276, P42138; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; Marquis JF, 2007, TRENDS MICROBIOL, V15, P93, DOI 10.1016/j.tim.2007.01.001; MOUTIEZ M, 1994, CHEM PHARM BULL, V42, P2641; Pedersen JZ, 2007, J BIOL CHEM, V282, P6364, DOI 10.1074/jbc.M609905200; Rauhala Pekka, 2005, Toxicol Appl Pharmacol, V207, P91, DOI 10.1016/j.taap.2005.02.028; Richardson DR, 2008, BBA-GEN SUBJECTS, V1780, P638, DOI 10.1016/j.bbagen.2007.12.009; Salvati L, 2001, BBA-PROTEIN STRUCT M, V1545, P357, DOI 10.1016/S0167-4838(00)00297-1; Singh SP, 1996, P NATL ACAD SCI USA, V93, P14428, DOI 10.1073/pnas.93.25.14428; Stella L, 2007, J BIOL CHEM, V282, P6372, DOI 10.1074/jbc.M609906200; Steverding D, 1998, PARASITOL RES, V84, P59, DOI 10.1007/s004360050357; Timoshin AA, 2007, NITRIC OXIDE-BIOL CH, V16, P286, DOI 10.1016/j.niox.2006.09.005; Toledo JC, 2008, J BIOL CHEM, V283, P28926, DOI 10.1074/jbc.M707862200; Tovar J, 1998, P NATL ACAD SCI USA, V95, P5311, DOI 10.1073/pnas.95.9.5311; Turella P, 2003, J BIOL CHEM, V278, P42294, DOI 10.1074/jbc.M305569200; Ueno T, 2000, JPN J PHARMACOL, V82, P95, DOI 10.1254/jjp.82.95; Vickers TJ, 2004, J BIOL CHEM, V279, P49003, DOI 10.1074/jbc.M407958200; Vickers TJ, 2004, J BIOL CHEM, V279, P27246, DOI 10.1074/jbc.M311039200; Vogt RN, 2003, BIOCHEM J, V371, P49, DOI 10.1042/BJ20021649; Wong ILK, 2006, MOL BIOCHEM PARASIT, V150, P278, DOI 10.1016/j.molbiopara.2006.08.014	35	48	48	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2010	24	4					1035	1042		10.1096/fj.09-146407	http://dx.doi.org/10.1096/fj.09-146407			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	580PV	19952282	Bronze			2022-12-25	WOS:000276462300011
J	Senapati, S; Rachagani, S; Chaudhary, K; Johansson, SL; Singh, RK; Batra, SK				Senapati, S.; Rachagani, S.; Chaudhary, K.; Johansson, S. L.; Singh, R. K.; Batra, S. K.			Overexpression of macrophage inhibitory cytokine-1 induces metastasis of human prostate cancer cells through the FAK-RhoA signaling pathway	ONCOGENE			English	Article						MIC-1; prostate; cancer; metastasis	TGF-BETA SUPERFAMILY; FOCAL-ADHESION KINASE; MORPHOGENETIC PROTEIN; BONE METASTASES; GROWTH-FACTOR; WEIGHT-LOSS; EXPRESSION; MEMBER; MIC-1; ACTIVATION	An elevated level of macrophage inhibitory cytokine-1 (MIC-1) is reported in the sera of patients with metastatic prostate cancer compared with that of benign diseases and healthy adults. We investigated the mechanistic role of MIC-1 overexpression in the metastasis of prostate cancer cells. Our study showed a progressive increase in secretory MIC-1 production correlated with the increase in the metastatic potential of PC-3 and LNPCa prostate cancer metastatic variants. Further, the in vitro studies using 'loss-' and 'gain'-of-function approaches showed that ectopic overexpression of MIC-1 (PC-3-MIC-1) and forced downregulation of MIC-1(PC-3M-siMIC-1) enhanced and reduced the motility and invasiveness of these cells, respectively. Supporting our in vitro observations, all the mice orthotopically implanted with PC-3-MIC-1 cells developed metastasis compared with none in the PC-3-vector group. Our results showed that MIC-1 overexpression was associated with apparent changes in actin organization. In addition, an enhanced phosphorylation of focal adhesion kinase (FAK) and guanosine-5'-triphosphate (GTP)-bound RhoA was also seen; however, no significant change was observed in total FAK and RhoA levels in the PC-3-MIC-1 cells. Altogether, our findings show that MIC-1 has a role in prostate cancer metastasis, in part, by promoting the motility of these cells. Activation of the FAK-RhoA signaling pathway is involved in MIC-1-mediated actin reorganization, and thus, leads to an increase in the motility of prostate cancer cells. Oncogene (2010) 29, 1293-1302; doi:10.1038/onc.2009.420; published online 30 November 2009	[Batra, S. K.] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center	Batra, SK (corresponding author), Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA.	sbatra@unmc.edu		Senapati, Shantibhusan/0000-0001-7108-8255	Department of Defense [PC040502, PC074289]; NCI Cancer Center [P30 CA36727]; NATIONAL CANCER INSTITUTE [P30CA036727, R01CA078590] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported, in part, by grants from the Department of Defense (PC040502 and PC074289). We thank Dr Ajay P Singh for reading the paper and for his valuable suggestions. We also thank Erik Moore for his technical assistance and Kristi LW Berger for editing the paper. We also acknowledge the NCI Cancer Center Support Grant (P30 CA36727) to UNMC.	Baek SJ, 2001, MOL PHARMACOL, V59, P901, DOI 10.1124/mol.59.4.901; Banyard J, 1998, CANCER METAST REV, V17, P449, DOI 10.1023/A:1006150007710; Barrack ER, 1997, PROSTATE, V31, P61; Bauskin AR, 2005, CANCER RES, V65, P2330, DOI 10.1158/0008-5472.CAN-04-3827; Bootcov MR, 1997, P NATL ACAD SCI USA, V94, P11514, DOI 10.1073/pnas.94.21.11514; Bottner M, 1999, CELL TISSUE RES, V297, P103, DOI 10.1007/s004410051337; Chen SJ, 2007, PROSTATE, V67, P557, DOI 10.1002/pros.20551; Chikumi H, 2002, J BIOL CHEM, V277, P12463, DOI 10.1074/jbc.M108504200; D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969; Fairlie WD, 1999, J LEUKOCYTE BIOL, V65, P2, DOI 10.1002/jlb.65.1.2; Hodge JC, 2003, CANCER RES, V63, P1359; Hromas R, 1997, BBA-GENE STRUCT EXPR, V1354, P40, DOI 10.1016/S0167-4781(97)00122-X; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Johnen H, 2007, NAT MED, V13, P1333, DOI 10.1038/nm1677; Karan D, 2003, BIOCHEM BIOPH RES CO, V305, P598, DOI 10.1016/S0006-291X(03)00823-4; Karan D, 2002, CARCINOGENESIS, V23, P967, DOI 10.1093/carcin/23.6.967; Karan D, 2009, CANCER RES, V69, P2, DOI 10.1158/0008-5472.CAN-08-1230; KOZLOWSKI JM, 1984, CANCER RES, V44, P3522; Lambert JR, 2006, J CELL PHYSIOL, V208, P566, DOI 10.1002/jcp.20692; Lawton LN, 1997, GENE, V203, P17, DOI 10.1016/S0378-1119(97)00485-X; Lee DH, 2003, CANCER RES, V63, P4648; Liu T, 2003, CANCER RES, V63, P5034; McLean GW, 2005, NAT REV CANCER, V5, P505, DOI 10.1038/nrc1647; Padua D, 2009, CELL RES, V19, P89, DOI 10.1038/cr.2008.316; Paralkar VM, 1998, J BIOL CHEM, V273, P13760, DOI 10.1074/jbc.273.22.13760; Patrikainen L, 2007, EUR J CLIN INVEST, V37, P126, DOI 10.1111/j.1365-2362.2007.01763.x; Pettaway CA, 1996, CLIN CANCER RES, V2, P1627; Robinson Victoria L, 2004, Cancer Treat Res, V118, P1; Schlaepfer DD, 2004, BBA-MOL CELL RES, V1692, P77, DOI 10.1016/j.bbamcr.2004.04.008; Selander KS, 2007, CANCER EPIDEM BIOMAR, V16, P532, DOI 10.1158/1055-9965.EPI-06-0841; Sieg DJ, 2000, NAT CELL BIOL, V2, P249, DOI 10.1038/35010517; Sporn MB, 1996, LANCET, V347, P1377, DOI 10.1016/S0140-6736(96)91015-6; Wakchoure S, 2009, PROSTATE, V69, P652, DOI 10.1002/pros.20913; Welsh JB, 2003, P NATL ACAD SCI USA, V100, P3410, DOI 10.1073/pnas.0530278100; Zhai JB, 2003, J BIOL CHEM, V278, P24865, DOI 10.1074/jbc.M302381200	35	94	104	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 4	2010	29	9					1293	1302		10.1038/onc.2009.420	http://dx.doi.org/10.1038/onc.2009.420			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	563XJ	19946339	Green Accepted			2022-12-25	WOS:000275170600005
J	Strickland, KC; Hoeferlin, LA; Oleinik, NV; Krupenko, NI; Krupenko, SA				Strickland, Kyle C.; Hoeferlin, L. Alexis; Oleinik, Natalia V.; Krupenko, Natalia I.; Krupenko, Sergey A.			Acyl Carrier Protein-specific 4 '-Phosphopantetheinyl Transferase Activates 10-Formyltetrahydrofolate Dehydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID SYNTHASE; CARBOXYL-TERMINAL DOMAIN; ALDEHYDE DEHYDROGENASE; CRYSTAL-STRUCTURES; ENZYME; RAT; MECHANISM; BINDING; TRANSFORMYLASE; IDENTIFICATION	4'-Phosphopantetheinyl transferases (PPTs) catalyze the transfer of 4'-phosphopantetheine (4-PP) from coenzyme A to a conserved serine residue of their protein substrates. In humans, the number of pathways utilizing the 4-PP posttranslational modification is limited and may only require a single broad specificity PPT for all phosphopantetheinylation reactions. Recently, we have shown that one of the enzymes of folate metabolism, 10-formyltetrahydrofolate dehydrogenase (FDH), requires a 4-PP prosthetic group for catalysis. This moiety acts as a swinging arm to couple the activities of the two catalytic domains of FDH and allows the conversion of 10-formyltetrahydrofolate to tetrahydrofolate and CO2. In the current study, we demonstrate that the broad specificity human PPT converts apo-FDH to holoenzyme and thus activates FDH catalysis. Silencing PPT by small interfering RNA in A549 cells prevents FDH modification, indicating the lack of alternative enzymes capable of accomplishing this transferase reaction. Interestingly, PPT-silenced cells demonstrate significantly reduced proliferation and undergo strong G(1) arrest, suggesting that the enzymatic function of PPT is essential and nonredundant. Our study identifies human PPT as the FDH-modifying enzyme and supports the hypothesis that mammals utilize a single enzyme for all phosphopantetheinylation reactions.	[Strickland, Kyle C.; Hoeferlin, L. Alexis; Oleinik, Natalia V.; Krupenko, Natalia I.; Krupenko, Sergey A.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA	Medical University of South Carolina	Krupenko, SA (corresponding author), Med Univ S Carolina, Dept Biochem & Mol Biol, 173 Ashley Ave, Charleston, SC 29425 USA.	krupenko@musc.edu	Strickland, Kyle/Q-7135-2019	Hoeferlin, L. Alexis/0000-0001-7569-8712; Strickland, Kyle/0000-0003-1636-5277	National Institutes of Health [DK54388]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054388] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK54388.	Anguera MC, 2006, J BIOL CHEM, V281, P18335, DOI 10.1074/jbc.M510623200; Anthony TE, 2007, J COMP NEUROL, V500, P368, DOI 10.1002/cne.21179; Boger DL, 1998, BIOORGAN MED CHEM, V6, P643, DOI 10.1016/S0968-0896(98)00040-6; Bunkoczi G, 2007, CHEM BIOL, V14, P1243, DOI 10.1016/j.chembiol.2007.10.013; CHAMPION KM, 1994, P NATL ACAD SCI USA, V91, P11338, DOI 10.1073/pnas.91.24.11338; Chirala SS, 2003, P NATL ACAD SCI USA, V100, P6358, DOI 10.1073/pnas.0931394100; Chirgadze NY, 2000, EMBO J, V19, P5281, DOI 10.1093/emboj/19.20.5281; Chumanevich AA, 2004, J BIOL CHEM, V279, P14355, DOI 10.1074/jbc.M313934200; Donato H, 2007, J BIOL CHEM, V282, P34159, DOI 10.1074/jbc.M707627200; ELOVSON J, 1968, J BIOL CHEM, V243, P3603; Fichtlscherer F, 2000, EUR J BIOCHEM, V267, P2666, DOI 10.1046/j.1432-1327.2000.01282.x; Fu TF, 1999, ARCH BIOCHEM BIOPHYS, V367, P161, DOI 10.1006/abbi.1999.1262; Gehring AM, 1997, CHEM BIOL, V4, P17, DOI 10.1016/S1074-5521(97)90233-7; JACKOWSKI S, 1983, J BIOL CHEM, V258, P5186; JOHLIN FC, 1989, MOL PHARMACOL, V35, P745; Joshi AK, 2003, J BIOL CHEM, V278, P33142, DOI 10.1074/jbc.M305459200; Kisliuk RL, 1999, CANC DRUG DISC DEV, P13; Knowles LM, 2004, J BIOL CHEM, V279, P30540, DOI 10.1074/jbc.M405061200; Knowles LM, 2008, J BIOL CHEM, V283, P31378, DOI 10.1074/jbc.M803384200; Krupenko SA, 1997, J BIOL CHEM, V272, P10266; Krupenko SA, 1997, J BIOL CHEM, V272, P10273; Krupenko SA, 2002, CELL GROWTH DIFFER, V13, P227; Krupenko SA, 2009, CHEM-BIOL INTERACT, V178, P84, DOI 10.1016/j.cbi.2008.09.007; La Clair JJ, 2004, CHEM BIOL, V11, P195, DOI 10.1016/j.chembiol.2004.02.010; Lambalot RH, 1996, CHEM BIOL, V3, P923, DOI 10.1016/S1074-5521(96)90181-7; Min H, 2005, ALCOHOL CLIN EXP RES, V29, P2188, DOI 10.1097/01.alc.0000191756.02856.a8; Mootz HD, 2001, J BIOL CHEM, V276, P37289, DOI 10.1074/jbc.M103556200; Mun Ju-Ae, 2008, Nutr Res Pract, V2, P195, DOI 10.4162/nrp.2008.2.4.195; Parris KD, 2000, STRUCT FOLD DES, V8, P883, DOI 10.1016/S0969-2126(00)00178-7; Perham RN, 2000, ANNU REV BIOCHEM, V69, P961, DOI 10.1146/annurev.biochem.69.1.961; Praphanphoj V, 2001, MOL GENET METAB, V72, P336, DOI 10.1006/mgme.2000.3138; Pumford NR, 1997, J PHARMACOL EXP THER, V280, P501; Reuland SN, 2006, PROTEIN SCI, V15, P1076, DOI 10.1110/ps.052062806; SCHIRCH D, 1994, J BIOL CHEM, V269, P24728; SMITH GK, 1981, BIOCHEMISTRY-US, V20, P4034, DOI 10.1021/bi00517a013; Tsybovsky Y, 2007, BIOCHEMISTRY-US, V46, P2917, DOI 10.1021/bi0619573; Wagner C, 1995, FOLATE HLTH DIS, P23; Walsh CT, 1997, CURR OPIN CHEM BIOL, V1, P309, DOI 10.1016/S1367-5931(97)80067-1	38	16	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2010	285	3					1627	1633		10.1074/jbc.M109.080556	http://dx.doi.org/10.1074/jbc.M109.080556			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	541PJ	19933275	hybrid, Green Published			2022-12-25	WOS:000273429100008
J	Yang, L; Olsson, B; Pfeifer, D; Jonsson, JI; Zhou, ZG; Jiang, X; Fredriksson, BA; Zhang, H; Sun, XF				Yang, L.; Olsson, B.; Pfeifer, D.; Jonsson, J.-I.; Zhou, Z-G; Jiang, X.; Fredriksson, B-A; Zhang, H.; Sun, X-F			Knockdown of peroxisome proliferator-activated receptor-beta induces less differentiation and enhances cell-fibronectin adhesion of colon cancer cells	ONCOGENE			English	Article						peroxisome proliferator-activated receptor; colon neoplasm; pathogenesis; RNA interference; differentiation	INTEGRIN-LINKED KINASE; PPAR-DELTA; COLORECTAL-CANCER; EXTRACELLULAR-MATRIX; METABOLIC SYNDROME; SIGNALING PATHWAY; EXPRESSION; CARCINOGENESIS; PROTEIN; GROWTH	The role of peroxisome proliferator-activated receptor-beta/delta (PPAR-beta/delta) in the pathogenesis of colon cancer remains highly controversial. This study specifically silenced the PPAR-beta expression in three colon cancer cell lines with different metastatic potentials. Although PPAR-beta knockdown resulted in more malignant morphological changes, bigger colony sizes and lower carcinoembryonic antigen (CEA) secretion, and enhanced the cell-fibronectin adhesion, cell invasion and migration were unaffected. These effects were stronger in poorly metastatic cell lines compared with highly metastatic ones. Simultaneously, PPAR-beta knockdown decreased the mRNAs encoding adipocyte differentiation-related protein and liver fatty acid binding protein, and increased the mRNA of ILK, whereas the mRNAs encoding integrin-beta 1 and angiopoietin-like 4 were unchanged. Using immunohistochemistry, we determined that the intensity of PPAR-beta expression was stronger in rectal cancers with better differentiation than in those with poor differentiation, and was stronger in early-stage tumors than in advanced ones. Together, these findings consistently indicate that PPAR-beta may facilitate differentiation and inhibit the cell-fibronectin adhesion of colon cancer, having a role as an inhibitor in the carcinogenesis and progression of colorectal cancer. Interestingly, PPAR-beta seems to have a more important role in poorly metastatic cells than in highly metastatic ones. Oncogene (2010) 29, 516-526; doi: 10.1038/onc.2009.370; published online 23 November 2009	[Yang, L.; Olsson, B.; Pfeifer, D.; Sun, X-F] Linkoping Univ, Div Oncol, Dept Clin & Expt Med, S-58185 Linkoping, Sweden; [Jonsson, J.-I.] Linkoping Univ, Div Expt Hematol, Dept Clin & Expt Med, S-58185 Linkoping, Sweden; [Yang, L.; Zhou, Z-G; Jiang, X.] Sichuan Univ, W China Hosp, State Key Lab Biotherapy, Chengdu, Sichuan Prov, Peoples R China; [Yang, L.; Zhou, Z-G; Jiang, X.] Sichuan Univ, Inst Digest Surg, Chengdu, Sichuan Prov, Peoples R China; [Fredriksson, B-A] Linkoping Univ, Div Expt Pathol, Dept Clin & Expt Med, S-58185 Linkoping, Sweden; [Zhang, H.] Univ Skovde, Div Biomed, Skovde, Sweden	Linkoping University; Linkoping University; Sichuan University; Sichuan University; Linkoping University; University of Skovde	Sun, XF (corresponding author), Linkoping Univ, Div Oncol, Dept Clin & Expt Med, S-58185 Linkoping, Sweden.	xiao-feng.sun@liu.se		Jonsson, Jan-Ingvar/0000-0003-4814-978X; , Zongguang/0000-0002-7616-1199	Swedish Cancer Foundation; Swedish Research Council; Health Research Council in the South-East of Sweden; Natural Science Foundation of China [30801332]; National Science Foundation [20070421149]	Swedish Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Health Research Council in the South-East of Sweden; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation(National Science Foundation (NSF))	We thank Petter Hammar (Linkoping University, Sweden) for his help in lentivirus construction, and thank Prof IJ Fidler (Anderson Cancer Center, Houston, TX) for offering KM12 cell lines. This study was financially supported by grants from the Swedish Cancer Foundation, Swedish Research Council and the Health Research Council in the South-East of Sweden, the Natural Science Foundation of China (Grant No. 30801332) and the National Science Foundation for post-doctoral Scientists of China (Grant No. 20070421149).	Alexandrova AY, 2008, BIOCHEMISTRY-MOSCOW+, V73, P733, DOI 10.1134/S0006297908070018; Aung CS, 2006, BIOCHEM BIOPH RES CO, V340, P656, DOI 10.1016/j.bbrc.2005.12.061; Barak Y, 2002, P NATL ACAD SCI USA, V99, P303, DOI 10.1073/pnas.012610299; Barish GD, 2006, J CLIN INVEST, V116, P590, DOI 10.1172/JCI27955; Bordonaro M, 2002, INT J CANCER, V97, P42, DOI 10.1002/ijc.1577; Burdick AD, 2006, CELL SIGNAL, V18, P9, DOI 10.1016/j.cellsig.2005.07.009; Camps J, 2004, INT J CANCER, V110, P869, DOI 10.1002/ijc.20195; Chen LC, 2004, CANCER RES, V64, P3694, DOI 10.1158/0008-5472.CAN-03-3264; Cheng LH, 2004, NAT MED, V10, P1245, DOI 10.1038/nm1116; Cordes N, 2003, BRIT J CANCER, V88, P1470, DOI 10.1038/sj.bjc.6600912; Di-Poi N, 2002, MOL CELL, V10, P721, DOI 10.1016/S1097-2765(02)00646-9; DOHERTY UO, 2000, J VIROL, V74, P10074; Galaup A, 2006, P NATL ACAD SCI USA, V103, P18721, DOI 10.1073/pnas.0609025103; Gupta RA, 2000, P NATL ACAD SCI USA, V97, P13275, DOI 10.1073/pnas.97.24.13275; Hannigan G, 2005, NAT REV CANCER, V5, P51, DOI 10.1038/nrc1524; Hannigan GE, 1996, NATURE, V379, P91, DOI 10.1038/379091a0; Harman FS, 2004, NAT MED, V10, P481, DOI 10.1038/nm1026; He TC, 1999, CELL, V99, P335, DOI 10.1016/S0092-8674(00)81664-5; Hinnebusch BF, 2002, J NUTR, V132, P1012, DOI 10.1093/jn/132.5.1012; Hollingshead HE, 2008, CARCINOGENESIS, V29, P169, DOI 10.1093/carcin/bgm209; JEFFREY MP, 2008, CLIN SCI, V115, P107; Kim DJ, 2006, CELL DEATH DIFFER, V13, P53, DOI 10.1038/sj.cdd.4401713; Kim DJ, 2004, J BIOL CHEM, V279, P23719, DOI 10.1074/jbc.M312063200; KLIEWER SA, 1994, P NATL ACAD SCI USA, V91, P7355, DOI 10.1073/pnas.91.15.7355; Lawrie LC, 2004, BRIT J CANCER, V90, P1955, DOI 10.1038/sj.bjc.6601828; MORIKAWA K, 1988, CANCER RES, V48, P6863; Orner GA, 2003, CARCINOGENESIS, V24, P263, DOI 10.1093/carcin/24.2.263; Ouyang N, 2006, CARCINOGENESIS, V27, P232, DOI 10.1093/carcin/bgi221; Park EY, 2005, CANCER RES, V65, P9923, DOI 10.1158/0008-5472.CAN-05-1604; Peraza MA, 2006, TOXICOL SCI, V90, P269, DOI 10.1093/toxsci/kfj062; Piqueras L, 2007, ARTERIOSCL THROM VAS, V27, P63, DOI 10.1161/01.ATV.0000250972.83623.61; Reddig PJ, 2005, CANCER METAST REV, V24, P425, DOI 10.1007/s10555-005-5134-3; Reed KR, 2004, ONCOGENE, V23, P8992, DOI 10.1038/sj.onc.1208143; Schmuth M, 2004, J INVEST DERMATOL, V122, P971, DOI 10.1111/j.0022-202X.2004.22412.x; Schroeder F, 2001, MOL CELL BIOCHEM, V219, P127, DOI 10.1023/A:1010851130136; Shao JY, 2002, CANCER RES, V62, P3282; Takahashi S, 2006, PHARMACOL RES, V53, P501, DOI 10.1016/j.phrs.2006.03.019; Targett-Adams P, 2005, BBA-GENE STRUCT EXPR, V1728, P95, DOI 10.1016/j.bbaexp.2005.01.017; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Worth DC, 2008, INT J BIOCHEM CELL B, V40, P2397, DOI 10.1016/j.biocel.2008.04.008; Wozniak MA, 2004, BBA-MOL CELL RES, V1692, P103, DOI 10.1016/j.bbamcr.2004.04.007; Yang L, 2008, DIS COLON RECTUM, V51, P318, DOI 10.1007/s10350-007-9145-8; Yang L, 2006, EJSO-EUR J SURG ONC, V32, P181, DOI 10.1016/j.ejso.2005.11.005; Yeatman TJ, 1996, CLIN EXP METASTAS, V14, P246	44	23	25	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2010	29	4					516	526		10.1038/onc.2009.370	http://dx.doi.org/10.1038/onc.2009.370			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	549WH	19935699				2022-12-25	WOS:000274084600005
J	De Marco, L; Gillio-Tos, A; Fiano, V; Ronco, G; Krogh, V; Palli, D; Panico, S; Tumino, R; Vineis, P; Merletti, F; Richiardi, L; Sacerdote, C				De Marco, Laura; Gillio-Tos, Anna; Fiano, Valentina; Ronco, Guglielmo; Krogh, Vittorio; Palli, Domenico; Panico, Salvatore; Tumino, Rosario; Vineis, Paolo; Merletti, Franco; Richiardi, Lorenzo; Sacerdote, Carlotta			Occult HCV Infection: An Unexpected Finding in a Population Unselected for Hepatic Disease	PLOS ONE			English	Article							C VIRUS-INFECTION; MOLECULAR EPIDEMIOLOGY PROJECT; BLOOD MONONUCLEAR-CELLS; HEPATOCELLULAR-CARCINOMA; MIXED CRYOGLOBULINEMIA; LEUKOCYTE-REDUCTION; PERSISTENCE; CANCER; RNA; ETIOLOGY	Background: Occult Hepatitis C virus (HCV) infection is a new pathological entity characterized by presence of liver disease and absence or very low levels of detectable HCV-RNA in serum. Abnormal values of liver enzymes and presence of replicative HCV-RNA in peripheral blood mononuclear cells are also observed. Aim of the study was to evaluate occult HCV occurrence in a population unselected for hepatic disease. Methodology/Principal Findings: We chose from previous epidemiological studies three series of subjects (n = 276, age range 40-65 years) unselected for hepatic disease. These subjects were tested for the presence of HCV antibodies and HCV-RNA in plasma and in the peripheral blood mononuclear cells (PBMCs) by using commercial systems. All subjects tested negative for HCV antibodies and plasma HCV-RNA and showed normal levels of liver enzymes; 9/276 patients (3.3%) were positive for HCV-RNA in PBMCs, identifying a subset of subjects with potential occult HCV infection. We could determine the HCV type for 8 of the 9 patients finding type 1a (3 patients), type 1b (2 patients), and type 2a (3 patients). Conclusions: The results of this study show evidence that occult HCV infection may occur in a population unselected for hepatic disease. A potential risk of HCV infection spread by subjects harbouring occult HCV infection should be considered. Design of prospective studies focusing on the frequency of infection in the general population and on the clinical evolution of occult HCV infection will be needed to verify this unexpected finding.	[De Marco, Laura; Gillio-Tos, Anna; Fiano, Valentina; Merletti, Franco; Richiardi, Lorenzo; Sacerdote, Carlotta] Univ Turin, Canc Epidemiol Unit, CERMS, Turin, Italy; [Ronco, Guglielmo; Merletti, Franco; Richiardi, Lorenzo] Univ Turin, Ctr Oncol Prevent, Turin, Italy; [Krogh, Vittorio] Natl Canc Inst, Epidemiol Unit, I-20133 Milan, Italy; [Palli, Domenico] ISPO, Mol & Nutr Epidemiol Unit, Canc Res & Prevent Inst, Florence, Italy; [Panico, Salvatore] Univ Naples Federico 2, Dept Clin & Expt Med, Naples, Italy; [Tumino, Rosario] Civile MP Arezzo Hosp, Canc Registry, Ragusa, Italy; [Vineis, Paolo] Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England	University of Turin; University of Turin; Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Naples Federico II; Civile M.P. Arezzo Hospital; Imperial College London	De Marco, L (corresponding author), Univ Turin, Canc Epidemiol Unit, CERMS, Turin, Italy.	gilliotos_demarco@yahoo.it	Panico, Salvatore/K-6506-2016; Krogh, Vittorio/K-2628-2016; Krogh, Vittorio/AAA-9171-2019; De Marco, Laura/J-7254-2016; richiardi, lorenzo/J-3480-2018	Panico, Salvatore/0000-0002-5498-8312; Krogh, Vittorio/0000-0003-0122-8624; Krogh, Vittorio/0000-0003-0122-8624; De Marco, Laura/0000-0003-2167-9270; richiardi, lorenzo/0000-0003-0316-9402; Sacerdote, Carlotta/0000-0002-8008-5096; tumino, rosario/0000-0003-2666-414X; Gillio-Tos, Anna/0000-0001-6553-5362; PALLI, Domenico/0000-0002-5558-2437; FIANO, VALENTINA/0000-0001-7978-372X	Italian Association for Cancer Research; Compagnia di San Paolo/FIRMS; Piedmont Region and the Italian Ministry of University and Research (MIUR); European Union; Italian Ministry of Health	Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); Compagnia di San Paolo/FIRMS(Compagnia di San Paolo); Piedmont Region and the Italian Ministry of University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); European Union(European Commission); Italian Ministry of Health(Ministry of Health, Italy)	This work was supported by the Italian Association for Cancer Research, the Compagnia di San Paolo/FIRMS, the Piedmont Region and the Italian Ministry of University and Research (MIUR), European Union, Italian Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansaldi F, 2005, J MED VIROL, V76, P327, DOI 10.1002/jmv.20376; Barril G, 2008, J AM SOC NEPHROL, V19, P2288, DOI 10.1681/ASN.2008030293; Bartolome J, 2007, J VIROL, V81, P7710, DOI 10.1128/JVI.02750-06; Berasain C, 2000, GUT, V47, P429, DOI 10.1136/gut.47.3.429; Carreno V, 2008, REV MED VIROL, V18, P139, DOI 10.1002/rmv.569; Carreno V, 2006, WORLD J GASTROENTERO, V12, P6922, DOI 10.3748/wjg.v12.i43.2000; Casato M, 2003, J VIRAL HEPATITIS, V10, P455, DOI 10.1046/j.1365-2893.2003.00462.x; Castillo I, 2004, J INFECT DIS, V189, P7, DOI 10.1086/380202; Castillo I, 2005, GUT, V54, P682, DOI 10.1136/gut.2004.057281; Chang TT, 1996, HEPATOLOGY, V23, P977; Clarke B, 1997, J GEN VIROL, V78, P2397, DOI 10.1099/0022-1317-78-10-2397; Colin C, 2001, J VIRAL HEPATITIS, V8, P87, DOI 10.1046/j.1365-2893.2001.00280.x; Comar M, 2006, J CLIN PATHOL, V59, P526, DOI 10.1136/jcp.2005.033050; CUYPERS HTM, 1992, J CLIN MICROBIOL, V30, P3220, DOI 10.1128/JCM.30.12.3220-3224.1992; Feld JJ, 2005, HEPATOLOGY, V41, P23, DOI 10.1002/hep.20561; FERAY C, 1992, J CLIN INVEST, V89, P1361, DOI 10.1172/JCI115723; Giannini C, 2006, HEPATOLOGY, V43, P1166, DOI 10.1002/hep.21132; Gordon SC, 2005, AM J GASTROENTEROL, V100, P1754, DOI 10.1111/j.1572-0241.2005.50483.x; Kopko PM, 2000, CURR OPIN HEMATOL, V7, P397, DOI 10.1097/00062752-200011000-00013; Laskus T, 2002, J INFECT DIS, V185, P417, DOI 10.1086/338635; Lerat H, 2004, J INFECT DIS, V189, P3, DOI 10.1086/380203; Lossos IS, 2003, LEUKEMIA, V17, P789, DOI 10.1038/sj.leu.2402880; Murphy MF, 1999, TRANSFUS MED REV, V13, P75, DOI 10.1016/S0887-7963(99)80001-7; Palli D, 2003, TUMORI, V89, P586, DOI 10.1177/030089160308900602; Palli D, 1999, ADV EXP MED BIOL, V472, P21; Pardo M, 2007, J VIRAL HEPATITIS, V14, P36, DOI 10.1111/j.1365-2893.2006.00783.x; Pardo M, 2006, ALIMENT PHARM THER, V23, P1153, DOI 10.1111/j.1365-2036.2006.02886.x; Pham TNQ, 2009, J VIRAL HEPATITIS, V16, P547, DOI 10.1111/j.1365-2893.2009.01092.x; Pham TNQ, 2004, J VIROL, V78, P5867, DOI 10.1128/JVI.78.11.5867-5874.2004; Pham TN, 2008, WORLD J GASTROENTERO, V14, P2789, DOI 10.3748/wjg.14.2789; Pham TNQ, 2008, GASTROENTEROLOGY, V134, P812, DOI 10.1053/j.gastro.2007.12.011; Radkowski M, 2005, HEPATOLOGY, V41, P106, DOI 10.1002/hep.20518; Radkowski M, 2005, J INFECT DIS, V191, P1730, DOI 10.1086/429834; Ronco G, 2006, JNCI-J NATL CANCER I, V98, P765, DOI 10.1093/jnci/djj209; Sacerdote C, 2007, MUTAGENESIS, V22, P281, DOI 10.1093/mutage/gem014; Sharma AD, 2000, ANESTH ANALG, V90, P1315, DOI 10.1097/00000539-200006000-00010; *STAT OFF, 2005, GUID UK TRANSF SERV; Welker MW, 2009, HEPATOLOGY, V49, P665, DOI 10.1002/hep.22706	38	62	63	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2009	4	12							e8128	10.1371/journal.pone.0008128	http://dx.doi.org/10.1371/journal.pone.0008128			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MU	19956542	Green Published, Green Submitted, gold			2022-12-25	WOS:000272828800021
J	Buscarlet, M; Hermann, R; Lo, R; Tang, YM; Joachim, K; Stifani, S				Buscarlet, Manuel; Hermann, Robert; Lo, Rita; Tang, Yeman; Joachim, Kerline; Stifani, Stefano			Cofactor-Activated Phosphorylation Is Required for Inhibition of Cortical Neuron Differentiation by Groucho/TLE1	PLOS ONE			English	Article							MEDIATED TRANSCRIPTIONAL REPRESSION; TRANSDUCIN-LIKE-ENHANCER; NERVOUS-SYSTEM; ASTROCYTE DIFFERENTIATION; PROMOTES NEUROGENESIS; DROSOPHILA GROUCHO; PROGENITOR CELLS; PROTEINS; SPLIT; LOOP	Background: Transcriptional co-repressors of the Groucho/transducin-like Enhancer of split (Gro/TLE) family regulate the expression of a variety of genes and are involved in numerous developmental processes in both invertebrate and vertebrate species. More specifically, Gro/TLE1 participates in mechanisms that inhibit/delay the differentiation of cerebral cortex neural progenitor cells into neurons during mammalian forebrain development. The anti-neurogenic function of Gro/TLE1 depends on the formation of protein complexes with specific DNA-binding transcription factors that engage Gro/TLE1 through WRP(W/Y) sequences. Interaction with those transcription partners results in Gro/TLE1 recruitment to selected DNA sites and causes increased Gro/TLE1 phosphorylation. The physiological significance of the latter event, termed "cofactor-activated phosphorylation," had not been determined. Therefore, this study aimed at clarifying the role of cofactor-activated phosphorylation in the anti-neurogenic function of Gro/TLE1. Methods and Principal Findings: A combination of site-directed mutagenesis, mass spectrometry, biochemistry, primary cell culture, and immunocytochemical assays was utilized to characterize point mutations of Ser-286, a residue that is phosphorylated in vivo and is located within the serine/proline-rich (SP) domain of Gro/TLE1. Mutation of Ser-286 to alanine or glutamic acid does not perturb the interaction of Gro/TLE1 with DNA-binding partners, including the basic helix-loophelix transcription factor Hes1, a prototypical anti-neurogenic WRP(W/Y) motif protein. Ser-286 mutations do not prevent the recruitment of Gro/TLE1 to DNA, but they impair cofactor-activated phosphorylation and weaken the interaction of Gro/TLE1 with chromatin. These effects are correlated with an impairment of the anti-neurogenic activity of Gro/TLE1. Similar results were obtained when mutations of Ser-289 and Ser-298, which are also located within the SP domain of Gro/TLE1, were analyzed. Conclusion: Based on the positive correlation between Gro/TLE1 cofactor-activated phosphorylation and ability to inhibit cortical neuron differentiation, we propose that hyperphosphorylation induced by cofactor binding plays a positive role in the regulation of Gro/TLE1 anti-neurogenic activity.	[Buscarlet, Manuel; Hermann, Robert; Lo, Rita; Tang, Yeman; Joachim, Kerline; Stifani, Stefano] McGill Univ, Montreal Neurol Inst, Ctr Neuronal Survival, Montreal, PQ, Canada	McGill University	Buscarlet, M (corresponding author), McGill Univ, Montreal Neurol Inst, Ctr Neuronal Survival, Montreal, PQ, Canada.	stefano.stifani@mcgill.ca		Stifani, Stefano/0000-0002-2376-7701	Canadian Institutes of Health Research [MOP-13957]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	These studies were supported by Operating Grant MOP-13957 awarded to S. S. by the Canadian Institutes of Health Research (www.cihr.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belanger-Jasmin S, 2007, J NEUROCHEM, V103, P2022, DOI 10.1111/j.1471-4159.2007.04902.x; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Buscarlet M, 2008, J BIOL CHEM, V283, P24881, DOI 10.1074/jbc.M800722200; Buscarlet M, 2007, TRENDS CELL BIOL, V17, P353, DOI 10.1016/j.tcb.2007.07.002; Choi CY, 2005, J BIOL CHEM, V280, P21427, DOI 10.1074/jbc.M500496200; Cinnamon E, 2008, DEVELOPMENT, V135, P829, DOI 10.1242/dev.015206; DEHNI G, 1995, MECH DEVELOP, V53, P369, DOI 10.1016/0925-4773(95)00452-1; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Eberhard D, 2000, EMBO J, V19, P2292, DOI 10.1093/emboj/19.10.2292; Fisher AL, 1996, MOL CELL BIOL, V16, P2670; Gasperowicz M, 2005, J CELL BIOCHEM, V95, P670, DOI 10.1002/jcb.20476; Ghosh MM, 1995, BIOREMED SER, V3, P15; Giagtzoglou N, 2003, DEVELOPMENT, V130, P259, DOI 10.1242/dev.00206; Gratton MO, 2003, MOL CELL BIOL, V23, P6922, DOI 10.1128/MCB.23.19.6922-6935.2003; Grbavec D, 1998, EUR J BIOCHEM, V258, P339, DOI 10.1046/j.1432-1327.1998.2580339.x; Hasson P, 2006, BRIT J CANCER, V94, P771, DOI 10.1038/sj.bjc.6603019; Heitzler P, 1996, DEVELOPMENT, V122, P161; Hirata H, 2000, J BIOL CHEM, V275, P19083, DOI 10.1074/jbc.M001075200; Hurlbut GD, 2007, CURR OPIN CELL BIOL, V19, P166, DOI 10.1016/j.ceb.2007.02.012; Husain J, 1996, BIOCHEM J, V317, P523, DOI 10.1042/bj3170523; ISHIBASHI M, 1994, EMBO J, V13, P1799, DOI 10.1002/j.1460-2075.1994.tb06448.x; Ishibashi M, 1995, GENE DEV, V9, P3136, DOI 10.1101/gad.9.24.3136; Javed A, 2000, J CELL SCI, V113, P2221; Jennings BH, 2008, EMBO REP, V9, P76, DOI 10.1038/sj.embor.7401122; Jennings BH, 2006, MOL CELL, V22, P645, DOI 10.1016/j.molcel.2006.04.024; Jennings BH, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-205; Jhas S, 2006, J NEUROSCI, V26, P11061, DOI 10.1523/JNEUROSCI.1358-06.2006; Ju BG, 2004, CELL, V119, P815, DOI 10.1016/j.cell.2004.11.017; Leon C, 1997, DEV DYNAM, V208, P11, DOI 10.1002/(SICI)1097-0177(199701)208:1<11::AID-AJA2>3.0.CO;2-4; Marcal N, 2005, MOL CELL BIOL, V25, P10916, DOI 10.1128/MCB.25.24.10916-10929.2005; McLarrent FW, 2001, J BIOL CHEM, V276, P1578, DOI 10.1074/jbc.M007629200; Muhr J, 2001, CELL, V104, P861, DOI 10.1016/S0092-8674(01)00283-5; Nuthall HN, 2004, MOL CELL BIOL, V24, P8395, DOI 10.1128/MCB.24.19.8395-8407.2004; Nuthall HN, 2002, MOL CELL BIOL, V22, P389, DOI 10.1128/MCB.22.2.389-399.2002; Ohtsuka T, 2001, J BIOL CHEM, V276, P30467, DOI 10.1074/jbc.M102420200; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; Palaparti A, 1997, J BIOL CHEM, V272, P26604, DOI 10.1074/jbc.272.42.26604; PAROUSH Z, 1994, CELL, V79, P805, DOI 10.1016/0092-8674(94)90070-1; Rinaldo C, 2007, BIOCHEM CELL BIOL, V85, P411, DOI 10.1139/O07-071; Shen Q, 2006, NAT NEUROSCI, V9, P743, DOI 10.1038/nn1694; STIFANI S, 1992, NAT GENET, V2, P119, DOI 10.1038/ng1092-119; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; Theriault FM, 2005, J NEUROSCI, V25, P2050, DOI 10.1523/JNEUROSCI.5108-04.2005; Yao J, 1998, DEV GROWTH DIFFER, V40, P133; Yao J, 2000, MECH DEVELOP, V93, P105, DOI 10.1016/S0925-4773(00)00278-1	45	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2009	4	12							e8107	10.1371/journal.pone.0008107	http://dx.doi.org/10.1371/journal.pone.0008107			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MT	19956621	Green Published, Green Submitted, gold			2022-12-25	WOS:000272828700018
J	Koh, KP; Sundrud, MS; Rao, A				Koh, Kian Peng; Sundrud, Mark S.; Rao, Anjana			Domain Requirements and Sequence Specificity of DNA Binding for the Forkhead Transcription Factor FOXP3	PLOS ONE			English	Article							REGULATORY T-CELLS; NF-KAPPA-B; IMMUNE DYSREGULATION; NUCLEAR FACTOR; HELIX PROTEIN; TARGET GENES; MUTATIONS; FAMILY; MOUSE; MICE	The forkhead, winged-helix transcription factor FOXP3 is preferentially expressed in T regulatory (Treg) cells and is critical for their immunosuppressive function. Mutations that abolish FOXP3 function lead to systemic autoimmunity in mice and humans. However, the manner by which FOXP3 recognizes cognate DNA elements is unclear. Here we identify an in vitro optimized DNA sequence to assess FOXP3 DNA binding by electrophoretic mobility shift assay (EMSA). The optimized sequence contains two tandem copies of a core DNA element resembling, but not identical to, the canonical forkhead (FKH) binding element. The tandem nature of this optimized FOXP3-binding oligonucleotide suggests a requirement for multimerization, and EMSA experiments confirm that both the DNA-binding FKH domain and an intact leucine-zipper domain, which mediates homo-multimerization of FOXP3, are required for DNA binding. These results establish a practical framework for understanding the molecular basis by which FOXP3 regulates gene transcription and programs Treg suppressive function.	[Koh, Kian Peng] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Immune Dis Inst, Boston, MA USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM)	Koh, KP (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA.	arao@idi.harvard.edu	Koh, Kian Peng/S-6279-2016	Koh, Kian Peng/0000-0003-2523-5175	NIH [ROI AI48213, R37 CA42471]; Cancer Research Institute; NATIONAL CANCER INSTITUTE [R37CA042471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048213] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by NIH grants to A. R. (ROI AI48213 and R37 CA42471). M. S. S was supported by the Irvington Institute fellowship program of the Cancer Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin RH, 2008, NAT IMMUNOL, V9, P613, DOI 10.1038/ni.1612; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Bettelli E, 2005, P NATL ACAD SCI USA, V102, P5138, DOI 10.1073/pnas.0501675102; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Chen CX, 2006, J BIOL CHEM, V281, P36828, DOI 10.1074/jbc.M608848200; Coffer PJ, 2004, NAT REV IMMUNOL, V4, P889, DOI 10.1038/nri1488; COSTA RH, 1989, MOL CELL BIOL, V9, P1415, DOI 10.1128/MCB.9.4.1415; Dengler HS, 2008, NAT IMMUNOL, V9, P1388, DOI 10.1038/ni.1667; Fisher SE, 2009, TRENDS GENET, V25, P166, DOI 10.1016/j.tig.2009.03.002; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, NAT IMMUNOL, V6, P331, DOI 10.1038/ni1179; Friedman JR, 2006, CELL MOL LIFE SCI, V63, P2317, DOI 10.1007/s00018-006-6095-6; Gambineri E, 2003, CURR OPIN RHEUMATOL, V15, P430, DOI 10.1097/00002281-200307000-00010; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; GODFREY VL, 1991, AM J PATHOL, V138, P1379; Gross DN, 2008, ONCOGENE, V27, P2320, DOI 10.1038/onc.2008.25; Hinman RM, 2009, INT IMMUNOL, V21, P831, DOI 10.1093/intimm/dxp049; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hu H, 2006, NAT IMMUNOL, V7, P819, DOI 10.1038/ni1358; Kaestner KH, 2000, GENE DEV, V14, P142; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Lee CS, 2005, NATURE, V435, P944, DOI 10.1038/nature03649; Lehmann OJ, 2003, TRENDS GENET, V19, P339, DOI 10.1016/S0168-9525(03)00111-2; LI C, 1993, P NATL ACAD SCI USA, V90, P11583, DOI 10.1073/pnas.90.24.11583; Lin L, 2004, IMMUNITY, V21, P203, DOI 10.1016/j.immuni.2004.06.016; Lin L, 2004, SCIENCE, V303, P1017, DOI 10.1126/science.1093889; Lopes JE, 2006, J IMMUNOL, V177, P3133, DOI 10.4049/jimmunol.177.5.3133; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; Nardone J, 2004, NAT IMMUNOL, V5, P768, DOI 10.1038/ni0804-768; NEHLS M, 1994, NATURE, V372, P103, DOI 10.1038/372103a0; Ochs HD, 2005, IMMUNOL REV, V203, P156, DOI 10.1111/j.0105-2896.2005.00231.x; Ono M, 2007, NATURE, V446, P685, DOI 10.1038/nature05673; Wang B, 2003, J BIOL CHEM, V278, P24259, DOI 10.1074/jbc.M207174200; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Yang T, 2007, AM J HUM GENET, V80, P1055, DOI 10.1086/518314; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674; Zhou ZC, 2008, IMMUNOL RES, V42, P19, DOI 10.1007/s12026-008-8029-x; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547	40	42	42	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2009	4	12							e8109	10.1371/journal.pone.0008109	http://dx.doi.org/10.1371/journal.pone.0008109			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MT	19956618	gold, Green Submitted, Green Published			2022-12-25	WOS:000272828700020
J	Kotevski, A; Cook, WD; Vaux, DL; Callus, BA				Kotevski, Aneta; Cook, Wendy D.; Vaux, David L.; Callus, Bernard A.			Identification of an Xiap-Like Pseudogene on Mouse Chromosome 7	PLOS ONE			English	Article							APOPTOSIS PROTEIN XIAP; NMR STRUCTURE; INHIBITOR; MUTAGENESIS	The most thoroughly characterized mammalian IAP is XIAP/BIRC4, which can inhibit caspases 9, 3 and 7, but may also regulate apoptosis through interactions with other proteins such as Smac/DIABLO, HtrA2/Omi, XAF1, TAK1, cIAP1, and cIAP2. High throughput sequencing of the mouse genome revealed the existence of a gene resembling Xiap/Birc4 on mouse chromosome 7. To confirm the existence of this gene, and to determine its functional significance, we performed Southern and Northern blot analysis. This showed the presence of the Xiap-like gene in both wild-type and Xiap gene knock-out mice, but the corresponding mRNA was not detected in any tissues examined by Northern blot. Analysis of the gene sequence in all three possible reading frames predicts that expression of this gene would not give rise to a full-length protein, but only non-functional truncated polypeptides. Because its nucleotide sequence is 92% identical to Xiap, but it has no introns corresponding to those of Xiap, we conclude that Xiap-ps1 is a pseudogene generated by retro- transposition of a spliced Xiap message to chromosome 7.	[Kotevski, Aneta; Cook, Wendy D.; Vaux, David L.; Callus, Bernard A.] La Trobe Univ, Dept Biochem, Bundoora, Vic 3083, Australia; [Callus, Bernard A.] Univ Western Australia, Western Australian Inst Med Res, Crawley, WA, Australia; [Callus, Bernard A.] Univ Western Australia, Sch Biomol Biomed & Chem Sci, Crawley, WA, Australia	La Trobe University; University of Western Australia; University of Western Australia	Kotevski, A (corresponding author), La Trobe Univ, Dept Biochem, Bundoora, Vic 3083, Australia.	D.Vaux@latrobe.edu.au	Vaux, David L/C-7249-2013; Cook, Wendy/N-7506-2019	Vaux, David L/0000-0003-2703-1651; 	National Health and Medical Research Council [433063, 461221]; Leukemia and Lymphoma Center Grant	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Leukemia and Lymphoma Center Grant	Funding was received from the National Health and Medical Research Council (433063, 461221) and a Leukemia and Lymphoma Center Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Deveraux QL, 1998, EMBO J, V17, P2215, DOI 10.1093/emboj/17.8.2215; Ekert PG, 2001, J CELL BIOL, V152, P483, DOI 10.1083/jcb.152.3.483; Harlin H, 2001, MOL CELL BIOL, V21, P3604, DOI 10.1128/MCB.21.10.3604-3608.2001; Hinds MG, 1999, NAT STRUCT BIOL, V6, P648; Lu Xuanyong, 2005, Int J Med Sci, V2, P30; Richter BWM, 2001, MOL CELL BIOL, V21, P4292, DOI 10.1128/MCB.21.13.4292-4301.2001; Rigaud S, 2006, NATURE, V444, P110, DOI 10.1038/nature05257; Sun CH, 2000, J BIOL CHEM, V275, P33777, DOI 10.1074/jbc.M006226200; Sun CH, 1999, NATURE, V401, P818, DOI 10.1038/44617; Wu G, 2000, NATURE, V408, P1008, DOI 10.1038/35050012	10	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2009	4	11							e8078	10.1371/journal.pone.0008078	http://dx.doi.org/10.1371/journal.pone.0008078			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MQ	19956646	Green Published, gold			2022-12-25	WOS:000272828400024
J	Guerrier, G; Zounoun, M; Delarosa, O; Defourny, I; Lacharite, M; Brown, V; Pedalino, B				Guerrier, Gilles; Zounoun, Malaika; Delarosa, Olimpia; Defourny, Isabelle; Lacharite, Michelo; Brown, Vincent; Pedalino, Biagio			Malnutrition and Mortality Patterns among Internally Displaced and Non-Displaced Population Living in a Camp, a Village or a Town in Eastern Chad	PLOS ONE			English	Article								Background: Certain population groups have been rendered vulnerable in Chad because of displacement of more than 200,000 people over the last three years as a result of mass violence against civilians in the east of the country. The objective of the study was to assess mortality and nutritional patterns among displaced and non-displaced population living in camps, villages and a town in the Ouddai and Salamat regions of Chad. Methodology: Between May and October 2007, two stage, 30-cluster household surveys were conducted among 43,900 internally displaced persons (IDPs) living in camps in Ouaddai region (n = 898 households), among 19,400 non-displaced persons (NDPs) living in 42 villages in Ouaddai region (n = 900 households) and among 17,000 NDPs living in a small town in Salamat region (n = 901 households). Data collection included anthropometric measurements, measles vaccination rates and retrospective mortality. Crude mortality rate (CMR), mortality rate among children younger than 5 years (U5MR), causes of death and the prevalence of wasting (weight-for-height z score <-2) among children aged 6 to 59 months were the main outcome measures. Conclusions: The CMR among the 4902 IDPs in Gozbeida camps, 4477 NDPs living in a village and 4073 NDPs living in a town surveyed was 1.8 (95% CI, 1.2-2.8), 0.3 (95% CI, 0.2-0.4), 0.3 (95% CI, 0.2-0.5) per 10,000 per day, respectively. The U5MR in a camp (n = 904), a village (n = 956) and a town (n = 901) was 4.1 (95% CI, 2.1-7.7), 0.5 (95% CI, 0.3-0.9) and 0.7 (95% CI, 0.4-1.4) per 10,000 per day, respectively. Diarrhoea was reported to be the main cause of death. Acute malnutrition rates (according to the WHO definition) among 904 IDP children, 956 NDPs children living in a village, 901 NDP children living in a town aged 6 to 59 months were 20.6% (95% CI, 17.9%-23.3%), 16.4% (95% CI, 14.0%-18.8%) and 10.1% (95% CI, 8.1%-12.2%) respectively. The study found a high mortality rate among IDPs and an elevated prevalence of wasting not only in IDP camps but also in villages located in the same region. The town-dweller population remains at risk of malnutrition. Appropriate contingency plans need to be made to ensure acceptable living standards for these populations.	[Guerrier, Gilles; Zounoun, Malaika; Brown, Vincent; Pedalino, Biagio] Epictr, Paris, France; [Delarosa, Olimpia] Med Sans Frontieres, Barcelona, Spain; [Defourny, Isabelle; Lacharite, Michelo] Med Sans Frontieres, Paris, France	Doctors Without Borders; Doctors Without Borders	Guerrier, G (corresponding author), Epictr, Paris, France.	guerriergilles@hotmail.com			Medecins sans Frontieres-France; Medecins sans Frontieres-Spain	Medecins sans Frontieres-France; Medecins sans Frontieres-Spain	This research was funded entirely by Medecins sans Frontieres-France and Medecins sans Frontieres-Spain. The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript.	Aaby P, 1999, BRIT MED J, V319, P878, DOI 10.1136/bmj.319.7214.878; Brown V, 2007, EMERG THEMES EPIDEMI, V4, DOI 10.1186/1742-7622-4-9; CHEDORGE D, 2009, REV EMERGENCY OPERAT; CHOTARD S, 2006, ASSESSMENT CHILD NUT; DUFFIELD A, 2004, ANAL SAVE CHILDREN U; *FEWS NET, 2008, NOV 24 SIT REP FAM E; *FEWS NET, 2007, OCT 17 SIT REP FAM E; Grandesso F, 2005, JAMA-J AM MED ASSOC, V293, P1490, DOI 10.1001/jama.293.12.1490; HENDERSON RH, 1982, B WORLD HEALTH ORGAN, V60, P253; Kaiser R, 2006, DISASTERS, V30, P199, DOI 10.1111/j.0361-3666.2006.00315.x; LOUTAN L, 1984, LANCET, V1, P945; Porignon D, 2000, J EPIDEMIOL COMMUN H, V54, P6, DOI 10.1136/jech.54.1.6; The Sphere Project, 2004, HUM CHART MIN STAND; *UN HIGH COM REF, 1999, HDB EM; United Nations High Commissioner for Refugees, 2007, STAT WORLDS REF; WOODRUFF BA, 2002, FIELD EXCHANGE, V17, P16; World Health Organization, 1999, WHO REC SURV STAND; *WORLD MED ASS, 2004, DECL HELS 2004	18	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2009	4	11							e8077	10.1371/journal.pone.0008077	http://dx.doi.org/10.1371/journal.pone.0008077			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MN	19956627	Green Published, gold			2022-12-25	WOS:000272828100015
J	Hagman, R; Ronnberg, E; Pejler, G				Hagman, Ragnvi; Ronnberg, Elin; Pejler, Gunnar			Canine Uterine Bacterial Infection Induces Upregulation of Proteolysis-Related Genes and Downregulation of Homeobox and Zinc Finger Factors	PLOS ONE			English	Article							INFLAMMATORY RESPONSE SYNDROME; NF-KAPPA-B; SERGLYCIN PROTEOGLYCAN; SEPSIS; EXPRESSION; PROTEIN; PYOMETRA; METABOLITE; BITCHES; DIAGNOSIS	Background: Bacterial infection with the severe complication of sepsis is a frequent and serious condition, being a major cause of death worldwide. To cope with the plethora of occurring bacterial infections there is therefore an urgent need to identify molecular mechanisms operating during the host response, in order both to identify potential targets for therapeutic intervention and to identify biomarkers for disease. Here we addressed this issue by studying global gene expression in uteri from female dogs suffering from spontaneously occurring uterine bacterial infection. Principal Findings: The analysis showed that almost 800 genes were significantly (p<0.05) upregulated (>2-fold) in the uteri of diseased animals. Among these were numerous chemokine and cytokine genes, as well as genes associated with inflammatory cell extravasation, anti-bacterial action, the complement system and innate immune responses, as well as proteoglycan-associated genes. There was also a striking representation of genes associated with proteolysis. Robust upregulation of immunoglobulin components and genes involved in antigen presentation was also evident, indicating elaboration of a strong adaptive immune response. The bacterial infection was also associated with a significant downregulation of almost 700 genes, of which various homeobox and zinc finger transcription factors were highly represented. Conclusions/Significance: Together, these finding outline the molecular patterns involved in bacterial infection of the uterus. The study identified altered expression of numerous genes not previously implicated in bacterial disease, and several of these may be evaluated for potential as biomarkers of disease or as therapeutic targets. Importantly, since humans and dogs show genetic similarity and develop diseases that share many characteristics, the molecular events identified here are likely to reflect the corresponding situation in humans afflicted by similar disease.	[Hagman, Ragnvi] Swedish Univ Agr Sci, Dept Clin Sci, Div Small Anim, Uppsala, Sweden; [Ronnberg, Elin; Pejler, Gunnar] Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, Uppsala, Sweden	Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences	Hagman, R (corresponding author), Swedish Univ Agr Sci, Dept Clin Sci, Div Small Anim, Uppsala, Sweden.	Ragnvi.Hagman@kv.slu.se; Gunnar.Pejler@afb.slu.se	Ronnberg, Elin/ABA-8898-2020	Ronnberg, Elin/0000-0002-4628-9968	Formas; Swedish Research Council; Torsten and Ragnar Soderberg Foundation; Michael Forsgren Foundation; Agria Insurance Co; Swedish Kennel Club Research Foundation	Formas(Swedish Research Council Formas); Swedish Research Council(Swedish Research CouncilEuropean Commission); Torsten and Ragnar Soderberg Foundation; Michael Forsgren Foundation; Agria Insurance Co; Swedish Kennel Club Research Foundation	This work was supported by grants from Formas (GP), The Swedish Research Council (GP), Torsten and Ragnar Soderberg Foundation (GP), Michael Forsgren Foundation (RH), Agria Insurance Co and Swedish Kennel Club Research Foundation (RH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arend WP, 2008, IMMUNOL REV, V223, P20, DOI 10.1111/j.1600-065X.2008.00624.x; Brady CA, 2001, VET CLIN N AM-SMALL, V31, P1147, DOI 10.1016/S0195-5616(01)50097-2; Calon A, 2007, GUT, V56, P1688, DOI 10.1136/gut.2007.125542; Canny G, 2008, TRENDS IMMUNOL, V29, P541, DOI 10.1016/j.it.2008.07.012; Ceron JJ, 2005, VET CLIN PATH, V34, P85, DOI 10.1111/j.1939-165X.2005.tb00019.x; Christensen KL, 2008, ADV CANCER RES, V101, P93, DOI 10.1016/S0065-230X(08)00405-3; Cole AM, 2001, J IMMUNOL, V167, P623, DOI 10.4049/jimmunol.167.2.623; Dyson A, 2009, CRIT CARE MED, V37, pS30, DOI 10.1097/CCM.0b013e3181922bd3; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Egenvall A, 2001, J VET INTERN MED, V15, P530, DOI 10.1892/0891-6640(2001)015&lt;0530:BROPII&gt;2.3.CO;2; Fransson BA, 2007, AM J VET RES, V68, P1281, DOI 10.2460/ajvr.68.12.1281; Godinez I, 2009, INFECT IMMUN, V77, P387, DOI 10.1128/IAI.00933-08; GRANSTROM E, 1982, METHOD ENZYMOL, V86, P320; Gupta S, 2008, EXPERT OPIN THER TAR, V12, P291, DOI 10.1517/14728222.12.3.291; Hagman R, 2006, THERIOGENOLOGY, V66, P198, DOI 10.1016/j.theriogenology.2005.11.002; Hagman R, 2006, ACTA VET SCAND, V47, P55, DOI 10.1186/1751-0147-47-55; Hagman R, 2005, VET REC, V157, P193, DOI 10.1136/vr.157.7.193; Hauptman JG, 1997, VET SURG, V26, P393, DOI 10.1111/j.1532-950X.1997.tb01699.x; Higgins MA, 2003, TOXICOL SCI, V74, P470, DOI 10.1093/toxsci/kfg142; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Hong JW, 2003, P NATL ACAD SCI USA, V100, P12301, DOI 10.1073/pnas.2133048100; Houston G, 2009, CLIN MICROBIOL INFEC, V15, P319, DOI 10.1111/j.1469-0691.2009.02751.x; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Johnson SB, 2007, ANN SURG, V245, P611, DOI 10.1097/01.sla.0000251619.10648.32; Kajiwara Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005071; Lakshmanan U, 2007, J IMMUNOL, V179, P8480, DOI 10.4049/jimmunol.179.12.8480; LeBlanc PM, 2008, CELL HOST MICROBE, V3, P146, DOI 10.1016/j.chom.2008.02.004; Li J, 2008, ONCOGENE, V27, P6194, DOI 10.1038/onc.2008.297; Lindahl U, 1999, HAEMOSTASIS, V29, P38; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Llewelyn M, 2001, INTENS CARE MED, V27, pS10, DOI 10.1007/PL00003792; Maelfait J, 2008, BIOCHEM PHARMACOL, V76, P1365, DOI 10.1016/j.bcp.2008.07.034; Maerki C, 2009, J IMMUNOL, V182, P507, DOI 10.4049/jimmunol.182.1.507; Marshall JC, 2009, CRIT CARE MED, V37, P2290, DOI 10.1097/CCM.0b013e3181a02afc; Martin CM, 2009, CRIT CARE MED, V37, P81, DOI 10.1097/CCM.0b013e31819285f0; Moroy T, 2008, IMMUNOBIOLOGY, V213, P341, DOI 10.1016/j.imbio.2007.11.004; Niemann CU, 2007, BLOOD, V109, P4478, DOI 10.1182/blood-2006-02-001719; Overall CM, 2002, BIOL CHEM, V383, P1059, DOI 10.1515/BC.2002.114; Parrillo J E, 1993, N Engl J Med, V328, P1471; Pejler G, 2009, BIOFACTORS, V35, P61, DOI 10.1002/biof.11; Poli-De-Figueiredo LF, 2008, SHOCK, V30, P53, DOI 10.1097/SHK.0b013e318181a343; Porter S, 2005, BIOCHEM J, V386, P15, DOI 10.1042/BJ20040424; Raymond WW, 2005, ARCH BIOCHEM BIOPHYS, V435, P311, DOI 10.1016/j.abb.2004.12.025; Schenck M, 2007, ARCH BIOCHEM BIOPHYS, V462, P171, DOI 10.1016/j.abb.2007.03.031; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Tang BMP, 2007, LANCET INFECT DIS, V7, P210, DOI 10.1016/S1473-3099(07)70052-X; Tang BMP, 2009, CRIT CARE MED, V37, P882, DOI 10.1097/CCM.0b013e31819b52fd; Trivedi CM, 2007, ATHEROSCLEROSIS, V195, pE50, DOI 10.1016/j.atherosclerosis.2007.04.055; Vandijck DM, 2008, DIMENS CRIT CARE NUR, V27, P244, DOI 10.1097/01.DCC.0000338868.31917.0e; Vasiljeva O, 2007, CURR PHARM DESIGN, V13, P387, DOI 10.2174/138161207780162962; Vincent JL, 2006, AM J RESP CRIT CARE, V173, P256, DOI 10.1164/rccm.200510-1604OE; Vincent JL, 2000, ACTA CLIN BELG, V55, P79, DOI 10.1080/17843286.2000.11754275; WENSMAN H, 2008, BREAST CANC RES TREA; Wong HR, 2009, CRIT CARE MED, V37, P1558, DOI 10.1097/CCM.0b013e31819fcc08; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	56	41	42	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2009	4	11							e8039	10.1371/journal.pone.0008039	http://dx.doi.org/10.1371/journal.pone.0008039			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MN	19956711	Green Published, gold, Green Submitted			2022-12-25	WOS:000272828100004
J	Ma, WX; Zhao, L; Fontainhas, AM; Fariss, RN; Wong, WT				Ma, Wenxin; Zhao, Lian; Fontainhas, Aurora M.; Fariss, Robert N.; Wong, Wai T.			Microglia in the Mouse Retina Alter the Structure and Function of Retinal Pigmented Epithelial Cells: A Potential Cellular Interaction Relevant to AMD	PLOS ONE			English	Article							MACULAR DEGENERATION; CHOROIDAL NEOVASCULARIZATION; SUBRETINAL MICROGLIA; FRACTALKINE RECEPTOR; UNITED-STATES; IMMUNE-SYSTEM; NITRIC-OXIDE; IN-VITRO; DRUSEN; INFLAMMATION	Background: Age-related macular degeneration (AMD) is a leading cause of legal blindness in the elderly in the industrialized word. While the immune system in the retina is likely to be important in AMD pathogenesis, the cell biology underlying the disease is incompletely understood. Clinical and basic science studies have implicated alterations in the retinal pigment epithelium (RPE) layer as a locus of early change. Also, retinal microglia, the resident immune cells of the retina, have been observed to translocate from their normal position in the inner retina to accumulate in the subretinal space close to the RPE layer in AMD eyes and in animal models of AMD. Methodology/Principal Findings: In this study, we examined the effects of retinal microglia on RPE cells using 1) an in vitro model where activated retinal microglia are co-cultured with primary RPE cells, and 2) an in vivo mouse model where retinal microglia are transplanted into the subretinal space. We found that retinal microglia induced in RPE cells 1) changes in RPE structure and distribution, 2) increased expression and secretion of pro-inflammatory, chemotactic, and pro-angiogenic molecules, and 3) increased extent of in vivo choroidal neovascularization in the subretinal space. Conclusions/Significance: These findings share similarities with important pathological features found in AMD and suggest the relevance of microglia-RPE interactions in AMD pathogenesis. We speculate that the migration of retinal microglia into the subretinal space in early stages of the disease induces significant changes in RPE cells that perpetuate further microglial accumulation, increase inflammation in the outer retina, and fosters an environment conducive for the formation of neovascular changes responsible for much of vision loss in advanced AMD.			Ma, WX (corresponding author), NEI, Unit Neuron Glia Interact Retinal Dis, NIH, Bethesda, MD 20892 USA.	wongw@nei.nih.gov	Fariss, Robert/ABI-1771-2020; Wong, Wai/B-6118-2017	Wong, Wai/0000-0003-0681-4016; Fariss, Robert/0000-0003-3227-7170	Intramural NIH HHS Funding Source: Medline; NATIONAL EYE INSTITUTE [ZIAEY000463, ZICEY000459] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Bok Dean, 2005, Retina, V25, pS61, DOI 10.1097/00006982-200512001-00028; BRESSLER NM, 1994, RETINA-J RET VIT DIS, V14, P130, DOI 10.1097/00006982-199414020-00006; Campochiaro P A, 1999, Mol Vis, V5, P34; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Checchin D, 2006, INVEST OPHTH VIS SCI, V47, P3595, DOI 10.1167/iovs.05-1522; Combadiere C, 2007, J CLIN INVEST, V117, P2920, DOI 10.1172/JCI31692; Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P477; Crabb JW, 2002, P NATL ACAD SCI USA, V99, P14682, DOI 10.1073/pnas.222551899; Ferris FL, 2005, ARCH OPHTHALMOL-CHIC, V123, P1570; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P532; GOUREAU O, 1992, BIOCHEM BIOPH RES CO, V186, P854, DOI 10.1016/0006-291X(92)90824-5; Green W R, 1977, Trans Am Ophthalmol Soc, V75, P180; Green W R, 1999, Mol Vis, V5, P27; Griffiths MR, 2009, J NEUROPATH EXP NEUR, V68, P217, DOI 10.1097/NEN.0b013e3181996688; Guo L, 1999, INVEST OPHTH VIS SCI, V40, P2676; Gupta N, 2003, EXP EYE RES, V76, P463, DOI 10.1016/S0014-4835(02)00332-9; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Holtkamp GM, 2001, PROG RETIN EYE RES, V20, P29, DOI 10.1016/S1350-9462(00)00017-3; Huang LW, 1999, J BIOL CHEM, V274, P38183, DOI 10.1074/jbc.274.53.38183; HUANG W, 2009, NEURON GLIA BIOL, P1; Innamorato NG, 2009, CURR OPIN NEUROL, V22, P308, DOI 10.1097/WCO.0b013e32832a3225; Johnson PT, 2005, INVEST OPHTH VIS SCI, V46, P4788, DOI 10.1167/iovs.05-0767; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Klein R, 2004, AM J OPHTHALMOL, V137, P486, DOI 10.1016/j.ajo.2003.11.069; Klein R, 1997, OPHTHALMOLOGY, V104, P7, DOI 10.1016/S0161-6420(97)30368-6; Kvanta A, 2000, CURR EYE RES, V21, P684, DOI 10.1076/0271-3683(200009)21:3;1-R;FT684; Lambert V, 2003, FASEB J, V17, P2290, DOI 10.1096/fj.03-0113fje; Lambert V, 2002, AM J PATHOL, V161, P1247, DOI 10.1016/S0002-9440(10)64401-X; Lampugnani MG, 1999, METH MOL B, V96, P177; Lee JE, 2008, INVEST OPHTH VIS SCI, V49, P4169, DOI 10.1167/iovs.08-2076; Li YW, 2008, NAT PROTOC, V3, P1703, DOI 10.1038/nprot.2008.172; LIANG KJ, 2009, INVEST OPHTHALMOL VI; LIVERSIDGE J, 1990, CURR EYE RES, V9, P131, DOI 10.3109/02713689008999432; LYNCH MA, 2009, MOL NEUROBIOL; Marra F, 1999, HEPATOLOGY, V29, P140, DOI 10.1002/hep.510290107; Ng TF, 2001, INVEST OPHTH VIS SCI, V42, P3301; Osusky R, 1997, OPHTHALMIC RES, V29, P124, DOI 10.1159/000268006; Osusky R, 1997, OPHTHALMIC RES, V29, P31, DOI 10.1159/000267988; Patel M, 2008, SEMIN IMMUNOPATHOL, V30, P97, DOI 10.1007/s00281-008-0112-9; Penfold PL, 2001, PROG RETIN EYE RES, V20, P385, DOI 10.1016/S1350-9462(00)00025-2; Rakoczy PE, 2006, EXP EYE RES, V82, P741, DOI 10.1016/j.exer.2005.10.012; Raoul W, 2008, J NEUROIMMUNOL, V198, P56, DOI 10.1016/j.jneuroim.2008.04.014; Rodrigues EB, 2007, OPHTHALMOLOGICA, V221, P143, DOI 10.1159/000099293; ROQUE RS, 1993, CURR EYE RES, V12, P285, DOI 10.3109/02713689308999475; SARKS JP, 1988, EYE, V2, P552, DOI 10.1038/eye.1988.106; Shi G, 2008, INVEST OPHTH VIS SCI, V49, P4620, DOI 10.1167/iovs.08-1816; Steen B, 1998, INVEST OPHTH VIS SCI, V39, P2194; Streilein JW, 2002, VISION RES, V42, P487, DOI 10.1016/S0042-6989(01)00185-7; Tuo JS, 2007, INVEST OPHTH VIS SCI, V48, P3827, DOI 10.1167/iovs.07-0051; Umeda S, 2005, FASEB J, V19, P1683, DOI 10.1096/fj.04-3525fje; Wang AL, 2005, NEUROCHEM INT, V47, P152, DOI 10.1016/j.neuint.2005.04.018; Wong T, 2008, OPHTHALMOLOGY, V115, P116, DOI 10.1016/j.ophtha.2007.03.008; Wu KHC, 2003, BRIT J OPHTHALMOL, V87, P1159, DOI 10.1136/bjo.87.9.1159; Xu HP, 2008, AGING CELL, V7, P58, DOI 10.1111/j.1474-9726.2007.00351.x; Xu HP, 2009, PROG RETIN EYE RES, V28, P348, DOI 10.1016/j.preteyeres.2009.06.001; Yang LP, 2007, MOL VIS, V13, P2048; Zamiri Parisa, 2007, Chem Immunol Allergy, V92, P86, DOI 10.1159/000099259; Zarbin MA, 2004, ARCH OPHTHALMOL-CHIC, V122, P598, DOI 10.1001/archopht.122.4.598; Zech JC, 1998, INVEST OPHTH VIS SCI, V39, P1600; Zeng HY, 2005, INVEST OPHTH VIS SCI, V46, P2992, DOI 10.1167/iovs.05-0118; Zhao L, 2007, MOL VIS, V13, P873	61	153	160	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2009	4	11							e7945	10.1371/journal.pone.0007945	http://dx.doi.org/10.1371/journal.pone.0007945			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522NL	19936204	Green Published, gold, Green Submitted			2022-12-25	WOS:000272004800021
J	den Broeder, MJ; van der Linde, H; Brouwer, JR; Oostra, BA; Willemsen, R; Ketting, RF				den Broeder, Marjo J.; van der Linde, Herma; Brouwer, Judith R.; Oostra, Ben A.; Willemsen, Rob; Ketting, Rene F.			Generation and Characterization of Fmr1 Knockout Zebrafish	PLOS ONE			English	Article							FRAGILE-X-SYNDROME; MENTAL-RETARDATION PROTEIN; MOUSE MODEL; CRANIOFACIAL DEVELOPMENT; DENDRITIC SPINES; MUTANT EMBRYOS; GENE; EXPRESSION; MICE; MORPHOGENESIS	Fragile X syndrome (FXS) is one of the most common known causes of inherited mental retardation. The gene mutated in FXS is named FMR1, and is well conserved from human to Drosophila. In order to generate a genetic tool to study FMR1 function during vertebrate development, we generated two mutant alleles of the fmr1 gene in zebrafish. Both alleles produce no detectable Fmr protein, and produce viable and fertile progeny with lack of obvious phenotypic features. This is in sharp contrast to published results based on morpholino mediated knock-down of fmr1, reporting defects in craniofacial development and neuronal branching in embryos. These phenotypes we specifically addressed in our knock-out animals, revealing no significant deviations from wild-type animals, suggesting that the published morpholino based fmr1 phenotypes are potential experimental artifacts. Therefore, their relation to fmr1 biology is questionable and morpholino induced fmr1 phenotypes should be avoided in screens for potential drugs suitable for the treatment of FXS. Importantly, a true genetic zebrafish model is now available which can be used to study FXS and to derive potential drugs for FXS treatment.			den Broeder, MJ (corresponding author), Royal Acad Arts & Sci, Hubrecht Inst, Utrecht, Netherlands.	r.willemsen@erasmusmc.nl; r.ketting@hubrecht.eu	den Broeder, Marjo/L-1316-2013	Ketting, Rene/0000-0001-6161-5621				AKIMENKO MA, 1994, J NEUROSCI, V14, P3475; Appel B, 1995, DEVELOPMENT, V121, P4117; BAKKER CE, 1994, CELL, V78, P23; Bear MF, 2008, NEUROPSYCHOPHARMACOL, V33, P84, DOI 10.1038/sj.npp.1301610; Bear MF, 2005, GENES BRAIN BEHAV, V4, P393, DOI 10.1111/j.1601-183X.2005.00135.x; Comery TA, 1997, P NATL ACAD SCI USA, V94, P5401, DOI 10.1073/pnas.94.10.5401; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; de Vrij FMS, 2008, NEUROBIOL DIS, V31, P127, DOI 10.1016/j.nbd.2008.04.002; DEVYS D, 1993, NAT GENET, V4, P335, DOI 10.1038/ng0893-335; Galvez R, 2003, BRAIN RES, V971, P83, DOI 10.1016/S0006-8993(03)02363-1; Grossman AW, 2006, J NEUROSCI, V26, P7151, DOI 10.1523/JNEUROSCI.1790-06.2006; Hagerman RJ, 2002, FRAGILE X SYNDROME D, P3; HINTON VJ, 1991, AM J MED GENET, V41, P289, DOI 10.1002/ajmg.1320410306; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Koekkoek SKE, 2005, NEURON, V47, P339, DOI 10.1016/j.neuron.2005.07.005; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Mientjes EJ, 2006, NEUROBIOL DIS, V21, P549, DOI 10.1016/j.nbd.2005.08.019; Neuhauss SCF, 1996, DEVELOPMENT, V123, P357; Nimchinsky EA, 2001, J NEUROSCI, V21, P5139, DOI 10.1523/JNEUROSCI.21-14-05139.2001; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; Otero YD, 2002, MOL CELL BIOL, V22, P8332, DOI 10.1128/MCB.22.23.8332-8341.2002; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Schaeffer C, 2001, EMBO J, V20, P4803, DOI 10.1093/emboj/20.17.4803; STRAHLE U, 1993, GENE DEV, V7, P1436, DOI 10.1101/gad.7.7b.1436; Tamanini F, 1997, HUM MOL GENET, V6, P1315, DOI 10.1093/hmg/6.8.1315; THISSE C, 1993, DEVELOPMENT, V119, P1203; Tucker B, 2006, HUM MOL GENET, V15, P3446, DOI 10.1093/hmg/ddl422; van 't Padje S, 2005, DEV GENES EVOL, V215, P198, DOI 10.1007/s00427-005-0466-0; VERHEIJ C, 1993, NATURE, V363, P722, DOI 10.1038/363722a0; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Wienholds E, 2004, METHOD CELL BIOL, V77, P69; Yan QJ, 2005, NEUROPHARMACOLOGY, V49, P1053, DOI 10.1016/j.neuropharm.2005.06.004	33	65	65	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2009	4	11							e7910	10.1371/journal.pone.0007910	http://dx.doi.org/10.1371/journal.pone.0007910			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522NJ	19936290	Green Published, gold, Green Submitted			2022-12-25	WOS:000272004600014
J	van Haagen, HHHBM; 't Hoen, PAC; Bovo, AB; de Morree, A; van Mulligen, EM; Chichester, C; Kors, JA; den Dunnen, JT; van Ommen, GJB; van der Maarel, SM; Kern, VM; Mons, B; Schuemie, MJ				van Haagen, Herman H. H. B. M.; 't Hoen, Peter A. C.; Bovo, Alessandro Botelho; de Morree, Antoine; van Mulligen, Erik M.; Chichester, Christine; Kors, Jan A.; den Dunnen, Johan T.; van Ommen, Gert-Jan B.; van der Maarel, Silvere M.; Kern, Vinicius Medina; Mons, Barend; Schuemie, Martijn J.			Novel Protein-Protein Interactions Inferred from Literature Context	PLOS ONE			English	Article							BIOLOGICAL NETWORKS; CONCEPT PROFILES; INTERACTION MAP; GENE; CALPAIN-3; KNOWLEDGE; DYSFERLIN; IDENTIFICATION; DISCOVERY; COMPONENT	We have developed a method that predicts Protein-Protein Interactions (PPIs) based on the similarity of the context in which proteins appear in literature. This method outperforms previously developed PPI prediction algorithms that rely on the conjunction of two protein names in MEDLINE abstracts. We show significant increases in coverage (76% versus 32%) and sensitivity (66% versus 41% at a specificity of 95%) for the prediction of PPIs currently archived in 6 PPI databases. A retrospective analysis shows that PPIs can efficiently be predicted before they enter PPI databases and before their interaction is explicitly described in the literature. The practical value of the method for discovery of novel PPIs is illustrated by the experimental confirmation of the inferred physical interaction between CAPN3 and PARVB, which was based on frequent co-occurrence of both proteins with concepts like Z-disc, dysferlin, and alpha-actinin. The relationships between proteins predicted by our method are broader than PPIs, and include proteins in the same complex or pathway. Dependent on the type of relationships deemed useful, the precision of our method can be as high as 90%. The full set of predicted interactions is available in a downloadable matrix and through the webtool Nermal, which lists the most likely interaction partners for a given protein. Our framework can be used for prioritizing potential interaction partners, hitherto undiscovered, for follow-up studies and to aid the generation of accurate protein interaction maps.			van Haagen, HHHBM (corresponding author), Leiden Univ, Dept Human Genet, Med Ctr, Biosemant Assoc, NL-2300 RA Leiden, Netherlands.	hvanhaagen@lumc.nl	dunnen, johan den/ABH-4228-2020; Hoen, Peter A 't/D-3950-2018; 't Hoen, Peter/A-4857-2012; Kern, Vinícius Medina/C-5574-2009; van der Maarel, Silvere/X-3631-2018	dunnen, johan den/0000-0002-6304-1710; Hoen, Peter A 't/0000-0003-4450-3112; Kern, Vinícius Medina/0000-0001-9240-304X; van der Maarel, Silvere/0000-0001-8103-711X; van Mulligen, Erik/0000-0003-1377-9386; de Morree, Antoine/0000-0002-8316-4531; Bovo, Alessandro/0000-0001-5863-9032; Mons, Barend/0000-0003-3934-0072; Schuemie, Martijn/0000-0002-0817-5361				Bendig G, 2006, GENE DEV, V20, P2361, DOI 10.1101/gad.1448306; BENHUR A, 2006, CHOOSING NEGATIVE EX; Bodenreider O, 2004, NUCLEIC ACIDS RES, V32, pD267, DOI 10.1093/nar/gkh061; Boutet Emmanuel, 2007, V406, P89; Chatr-Aryamontri A, 2007, NUCLEIC ACIDS RES, V35, pD572, DOI 10.1093/nar/gkl950; Chen LF, 2005, BIOINFORMATICS, V21, P248, DOI 10.1093/bioinformatics/bth496; Cohen AM, 2005, BRIEF BIOINFORM, V6, P57, DOI 10.1093/bib/6.1.57; Cohen N, 2006, PROTEOMICS, V6, P6075, DOI 10.1002/pmic.200600199; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Harrington ED, 2008, FEBS LETT, V582, P1251, DOI 10.1016/j.febslet.2008.02.033; Hermjakob H, 2004, NUCLEIC ACIDS RES, V32, pD452, DOI 10.1093/nar/gkh052; Hoffmann R, 2004, NAT GENET, V36, P664, DOI 10.1038/ng0704-664; Huang ML, 2004, BIOINFORMATICS, V20, P3604, DOI 10.1093/bioinformatics/bth451; Huang YC, 2008, HUM MOL GENET, V17, P1855, DOI 10.1093/hmg/ddn081; Huang YC, 2007, FASEB J, V21, P732, DOI 10.1096/fj.06-6628com; Ito T, 2000, P NATL ACAD SCI USA, V97, P1143, DOI 10.1073/pnas.97.3.1143; Jelier R, 2008, INT J MED INFORM, V77, P354, DOI 10.1016/j.ijmedinf.2007.07.004; Jelier R, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-14; Jelier R, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-r96; KORS JA, 2005, BIOLINK; Kuffner R, 2005, BIOINFORMATICS, V21, P259, DOI 10.1093/bioinformatics/bti1143; Lage K, 2007, NAT BIOTECHNOL, V25, P309, DOI 10.1038/nbt1295; Li S, 2006, BIOINFORMATICS, V22, P2143, DOI 10.1093/bioinformatics/btl363; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Matsuda C, 2005, J NEUROPATH EXP NEUR, V64, P334, DOI 10.1093/jnen/64.4.334; Morgan AA, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-S2-S3; Ojima K, 2007, J BIOL CHEM, V282, P14493, DOI 10.1074/jbc.M610806200; Peri S, 2003, GENOME RES, V13, P2363, DOI 10.1101/gr.1680803; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Schuemie M, 2007, PROTEOMICS, V7, P921, DOI 10.1002/pmic.200600693; Schuemie MJ, 2007, J BIOMED INFORM, V40, P316, DOI 10.1016/j.jbi.2006.09.002; SCHUEMIE MJ, 2007, BIOCR 2 WORKSH MADR; Sepulveda JL, 2006, CELL MOL LIFE SCI, V63, P25, DOI 10.1007/s00018-005-5355-1; Sorimachi H, 1995, J BIOL CHEM, V270, P31158, DOI 10.1074/jbc.270.52.31158; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; SWANSON DR, 1986, PERSPECT BIOL MED, V30, P7; SWANSON DR, 1990, B MED LIBR ASSOC, V78, P29; Taveau M, 2003, MOL CELL BIOL, V23, P9127, DOI 10.1128/MCB.23.24.9127-9135.2003; Tuason O, 2003, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2004, P238; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; van Driel MA, 2006, EUR J HUM GENET, V14, P535, DOI 10.1038/sj.ejhg.5201585; Vastrik I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r39; von Mering C, 2007, NUCLEIC ACIDS RES, V35, pD358, DOI 10.1093/nar/gkl825; Wren JD, 2004, BIOINFORMATICS, V20, P389, DOI 10.1093/bioinformatics/btg421; Yamaji S, 2004, J CELL BIOL, V165, P539, DOI 10.1083/jcb.200308141	47	37	38	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2009	4	11							e7894	10.1371/journal.pone.0007894	http://dx.doi.org/10.1371/journal.pone.0007894			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521QH	19924298	Green Published, gold, Green Submitted			2022-12-25	WOS:000271936700024
J	Beildeck, ME; Islam, M; Shah, S; Welsh, J; Byers, SW				Beildeck, Marcy E.; Islam, Md; Shah, Salimuddin; Welsh, JoEllen; Byers, Stephen W.			Control of TCF-4 Expression by VDR and Vitamin D in the Mouse Mammary Gland and Colorectal Cancer Cell Lines	PLOS ONE			English	Article							HUMAN-COLON-CANCER; BETA-CATENIN; D-RECEPTOR; ANDROGEN RECEPTOR; 1,25-DIHYDROXYVITAMIN D-3; TRANSCRIPTIONAL ACTIVITY; CRYSTAL-STRUCTURE; NUCLEAR RECEPTOR; CARCINOMA CELLS; C-MYC	Background: The vitamin D receptor (VDR) pathway is important in the prevention and potentially in the treatment of many cancers. One important mechanism of VDR action is related to its interaction with the Wnt/beta-catenin pathway. Agonist-bound VDR inhibits the oncogenic Wnt/beta-catenin/TCF pathway by interacting directly with beta-catenin and in some cells by increasing cadherin expression which, in turn, recruits beta-catenin to the membrane. Here we identify TCF-4, a transcriptional regulator and beta-catenin binding partner as an indirect target of the VDR pathway. Methodology/Principal Findings: In this work, we show that TCF-4 (gene name TCF7L2) is decreased in the mammary gland of the VDR knockout mouse as compared to the wild-type mouse. Furthermore, we show 1,25(OH)(2)D-3 increases TCF-4 at the RNA and protein levels in several human colorectal cancer cell lines, the effect of which is completely dependent on the VDR. In silico analysis of the human and mouse TCF7L2 promoters identified several putative VDR binding elements. Although TCF7L2 promoter reporters responded to exogenous VDR, and 1,25(OH)(2)D-3, mutation analysis and chromatin immunoprecipitation assays, showed that the increase in TCF7L2 did not require recruitment of the VDR to the identified elements and indicates that the regulation by VDR is indirect. This is further confirmed by the requirement of de novo protein synthesis for this up-regulation. Conclusions/Significance: Although it is generally assumed that binding of beta-catenin to members of the TCF/LEF family is cancer-promoting, recent studies have indicated that TCF-4 functions instead as a transcriptional repressor that restricts breast and colorectal cancer cell growth. Consequently, we conclude that the 1,25(OH)(2)D-3/VDR-mediated increase in TCF-4 may have a protective role in colon cancer as well as diabetes and Crohn's disease.			Beildeck, ME (corresponding author), Georgetown Univ, Sch Med, Dept Oncol, Lombardi Comprehens Canc Ctr, Washington, DC 20057 USA.	byerss@georgetown.edu			NCI NIH HHS [P30 CA051008, P30 CA51008, R01-CA-129-813] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA051008, R01CA129813] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aguilera O, 2007, CARCINOGENESIS, V28, P1877, DOI 10.1093/carcin/bgm094; Alonso M, 1998, BIOCHEM BIOPH RES CO, V247, P882, DOI 10.1006/bbrc.1998.8884; Amir AL, 2003, J BIOL CHEM, V278, P30828, DOI 10.1074/jbc.M301208200; Augenlicht LH, 1999, CANCER RES, V59, P5856; AUGENLICHT LH, 1999, CANCER RES, V59, P353; Bordonaro M, 1999, CELL GROWTH DIFFER, V10, P713; Brantjes H, 2001, NUCLEIC ACIDS RES, V29, P1410, DOI 10.1093/nar/29.7.1410; Byers S, 1996, ENDOCRINOLOGY, V137, P3265, DOI 10.1210/en.137.8.3265; CADE C, 1987, ENDOCRINOLOGY, V120, P1490, DOI 10.1210/endo-120-4-1490; CAO X, 1993, J BIOL CHEM, V268, P27371; Chesire DR, 2002, ONCOGENE, V21, P8453, DOI 10.1038/sj.onc.1206049; DARWISH HM, 1992, P NATL ACAD SCI USA, V89, P603, DOI 10.1073/pnas.89.2.603; Deeb KK, 2007, NAT REV CANCER, V7, P684, DOI 10.1038/nrc2196; Easwaran V, 1999, CURR BIOL, V9, P1415, DOI 10.1016/S0960-9822(00)80088-3; El-Tanani M, 2001, J BIOL CHEM, V276, P41675, DOI 10.1074/jbc.M103966200; Falzon M, 1996, MOL ENDOCRINOL, V10, P672, DOI 10.1210/me.10.6.672; Fretz JA, 2006, MOL ENDOCRINOL, V20, P2215, DOI 10.1210/me.2006-0102; GILL R, 1993, J BONE MINER RES, V8, pS223; GIULIANO AR, 1991, ARCH BIOCHEM BIOPHYS, V285, P261, DOI 10.1016/0003-9861(91)90358-P; Graham TA, 2000, CELL, V103, P885, DOI 10.1016/S0092-8674(00)00192-6; Gregorieff A, 2004, EMBO J, V23, P1825, DOI 10.1038/sj.emboj.7600191; HALLINE AG, 1994, ENDOCRINOLOGY, V134, P1710, DOI 10.1210/en.134.4.1710; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Jansson EA, 2005, P NATL ACAD SCI USA, V102, P1460, DOI 10.1073/pnas.0405928102; Liu M, 1996, GENE DEV, V10, P142, DOI 10.1101/gad.10.2.142; Mathieu C, 2005, DIABETOLOGIA, V48, P1247, DOI 10.1007/s00125-005-1802-7; MCINTYRE A, 1993, GUT, V34, P386, DOI 10.1136/gut.34.3.386; Merrill BJ, 2001, GENE DEV, V15, P1688, DOI 10.1101/gad.891401; Mulholland DJ, 2002, J BIOL CHEM, V277, P17933, DOI 10.1074/jbc.M200135200; NORMAN AW, 1980, SCIENCE, V209, P823, DOI 10.1126/science.6250216; Ohyama Y, 1996, J BIOL CHEM, V271, P30381, DOI 10.1074/jbc.271.48.30381; Palmer HG, 2001, J CELL BIOL, V154, P369, DOI 10.1083/jcb.200102028; Pawlowski JE, 2002, J BIOL CHEM, V277, P20702, DOI 10.1074/jbc.M200545200; Pendas-Franco N, 2008, ONCOGENE, V27, P4467, DOI 10.1038/onc.2008.88; PETERSON MD, 1992, J CELL SCI, V102, P581; Pike JW, 2007, J STEROID BIOCHEM, V103, P389, DOI 10.1016/j.jsbmb.2006.12.050; Polakis P, 1999, CURR OPIN GENET DEV, V9, P15, DOI 10.1016/S0959-437X(99)80003-3; Polakis P, 2000, GENE DEV, V14, P1837; RENOUF M, 2007, EXPT BIOL; Rini C, 2008, PSYCHO-ONCOL, V17, P354, DOI 10.1002/pon.1227; Rochel N, 2000, MOL CELL, V5, P173, DOI 10.1016/S1097-2765(00)80413-X; Roose J, 1999, SCIENCE, V285, P1923, DOI 10.1126/science.285.5435.1923; Rother K, 2004, GASTROENTEROLOGY, V126, pA80; Rother K, 2004, ONCOGENE, V23, P3376, DOI 10.1038/sj.onc.1207464; Saegusa M, 2005, LAB INVEST, V85, P768, DOI 10.1038/labinvest.3700273; Schrader M, 1997, BIOCHEM BIOPH RES CO, V230, P646, DOI 10.1006/bbrc.1996.6025; SHABAHANG M, 1993, CANCER RES, V53, P3712; Shah R, 2006, HUM GENET, V119, P61, DOI 10.1007/s00439-005-0112-y; Shah S, 2006, MOL CELL, V21, P799, DOI 10.1016/j.molcel.2006.01.037; Shah S, 2002, J BIOL CHEM, V277, P25313, DOI 10.1074/jbc.M203158200; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Shulewitz M, 2006, ONCOGENE, V25, P4361, DOI 10.1038/sj.onc.1209470; Skarosi SF, 1999, GASTROENTEROLOGY, V116, pA506; Song LN, 2008, J BIOL CHEM, V283, P25988, DOI 10.1074/jbc.M800325200; Song LN, 2003, MOL CELL BIOL, V23, P1674, DOI 10.1128/MCB.23.5.1674-1687.2003; Tang W, 2008, P NATL ACAD SCI USA, V105, P9697, DOI 10.1073/pnas.0804709105; Thorne J, 2008, P NUTR SOC, V67, P115, DOI 10.1017/S0029665108006964; Tong Y, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-15; Truica CI, 2000, CANCER RES, V60, P4709; Vaisanen S, 2005, J MOL BIOL, V350, P65, DOI 10.1016/j.jmb.2005.04.057; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Wang GF, 1998, MOL CELL BIOL, V18, P6023, DOI 10.1128/MCB.18.10.6023; Wang XN, 2009, CELL CYCLE, V8, P736, DOI 10.4161/cc.8.5.7870; Wehkamp J, 2007, J IMMUNOL, V179, P3109, DOI 10.4049/jimmunol.179.5.3109; Wilson AJ, 2002, CANCER RES, V62, P6006; Zella LA, 2006, MOL ENDOCRINOL, V20, P1231, DOI 10.1210/me.2006-0015; Zinser GA, 2004, J STEROID BIOCHEM, V89-90, P433, DOI 10.1016/j.jsbmb.2004.03.012; Zinser GM, 2003, MOL CELL ENDOCRINOL, V200, P67, DOI 10.1016/S0303-7207(02)00416-1	68	38	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2009	4	11							e7872	10.1371/journal.pone.0007872	http://dx.doi.org/10.1371/journal.pone.0007872			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520OG	19924301	gold, Green Submitted, Green Published			2022-12-25	WOS:000271854200019
J	Redaelli, E; Cassulini, RR; Silva, DF; Clement, H; Schiavon, E; Zamudio, FZ; Odell, G; Arcangeli, A; Clare, JJ; Alagon, A; de la Vega, RCR; Possani, LD; Wanke, E				Redaelli, Elisa; Restano Cassulini, Rita; Fuentes Silva, Deyanira; Clement, Herlinda; Schiavon, Emanuele; Zamudio, Fernando Z.; Odell, George; Arcangeli, Annarosa; Clare, Jeffrey J.; Alagon, Alejandro; Rodriguez de la Vega, Ricardo C.; Possani, Lourival D.; Wanke, Enzo			Target Promiscuity and Heterogeneous Effects of Tarantula Venom Peptides Affecting Na+ and K+ Ion Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATING MODIFIER TOXINS; GATED SODIUM-CHANNEL; VOLTAGE SENSORS; POTASSIUM; INHIBITOR; IDENTIFICATION; PHARMACOLOGY; SPECIFICITY; MUTATION; FEBRILE	Venom-derived peptide modulators of ion channel gating are regarded as essential tools for understanding the molecular motions that occur during the opening and closing of ion channels. In this study, we present the characterization of five spider toxins on 12 human voltage-gated ion channels, following observations about the target promiscuity of some spider toxins and the ongoing revision of their "canonical" gating-modifying mode of action. The peptides were purified de novo from the venom of Grammostola rosea tarantulas, and their sequences were confirmed by Edman degradation and mass spectrometry analysis. Their effects on seven tetrodotoxin-sensitive Na+ channels, the three human ether-a-go-go (hERG)-related K+ channels, and two human Shaker-related K+ channels were extensively characterized by electrophysiological techniques. All the peptides inhibited ion conduction through all the Na+ channels tested, although with distinctive patterns. The peptides also affected the three pharmaceutically relevant hERG isoforms differently. At higher concentrations, all peptides also modified the gating of the Na+ channels by shifting the activation to more positive potentials, whereas more complex effects were recorded on hERG channels. No effects were evident on the two Shaker-related K+ channels at concentrations well above the IC50 value for the affected channels. Given the sequence diversity of the tested peptides, we propose that tarantula toxins should be considered both as multimode and target-promiscuous ion channel modulators; both features should not be ignored when extracting mechanistic interpretations about ion channel gating. Our observations could also aid in future structure-function studies and might help the development of novel ion channel-specific drugs.	Univ Milano Bicocca, Dept Biotecnol & Biosci, I-20126 Milan, Italy; [Restano Cassulini, Rita; Clement, Herlinda; Zamudio, Fernando Z.; Odell, George; Alagon, Alejandro; Rodriguez de la Vega, Ricardo C.; Possani, Lourival D.] Univ Nacl Autonoma Mexico, Inst Biotechnol, Dept Med Mol & Bioproc, Cuernavaca 62210, Morelos, Mexico; [Fuentes Silva, Deyanira] Univ Nacl Autonoma Mexico, Inst Quim, Coyoacan 04510, DF, Mexico; [Arcangeli, Annarosa] Univ Florence, Dipartimento Patol & Oncol Sperimentali, I-50134 Florence, Italy; [Clare, Jeffrey J.] GlaxoSmithKline, Med Res Ctr, Gene Express & Prot Biochem, Stevenage SG1 2NY, Herts, England; European Mol Biol Lab, Struct & Computat Biol Unit, D-69117 Heidelberg, Germany; European Mol Biol Lab, Genome Biol Unit, D-69117 Heidelberg, Germany	University of Milano-Bicocca; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; University of Florence; GlaxoSmithKline; European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL)	Wanke, E (corresponding author), Univ Milano Bicocca, Dept Biotecnol & Biosci, Piazza Sci 2, I-20126 Milan, Italy.	enzo.wanke@unimib.it	Rodríguez de la Vega, Ricardo/A-4542-2008; Clement, Herlinda/AAT-1305-2021; Possani, Lourival D/J-2397-2013	Rodríguez de la Vega, Ricardo/0000-0002-9852-6654; Clement, Herlinda/0000-0001-7671-813X; milani, stefano/0000-0002-1337-9107; Schiavon, Emanuele/0000-0002-4592-6961	Italian Ministero dell'Universita e della Ricerca Scientifica e Tecnologica [MIUR-PRIN2003-20052001055320, 2003052919, MIUR-FIRB2001-RBNE01XMP4-002, MIUR-FISR2001 0300179]; Universita di Milano-Bicocca [MIURPRIN2003-2005]; National Council of Science and Technology, Mexican Government; Grant Fondo Salud [014109]; Direcion General de Asuntos de Personal Academico [IN227507]	Italian Ministero dell'Universita e della Ricerca Scientifica e Tecnologica(Ministry of Education, Universities and Research (MIUR)); Universita di Milano-Bicocca; National Council of Science and Technology, Mexican Government; Grant Fondo Salud; Direcion General de Asuntos de Personal Academico	This work was supported in part by Italian Ministero dell'Universita e della Ricerca Scientifica e Tecnologica Grants MIUR-PRIN2003-20052001055320 and 2003052919, MIUR-FIRB2001-RBNE01XMP4-002, and MIUR-FISR2001 0300179, the Universita di Milano-Bicocca Grant MIURPRIN2003-2005 (to E. W. and A. A.), the National Council of Science and Technology, Mexican Government, Grant Fondo Salud 014109, and by the Direcion General de Asuntos de Personal Academico Grant IN227507	Ackerman MJ, 2004, NAT MED, V10, P463, DOI 10.1038/nm0504-463; Ahern CA, 2004, TRENDS NEUROSCI, V27, P303, DOI 10.1016/j.tins.2004.03.008; Bosmans F, 2006, MOL PHARMACOL, V69, P419, DOI 10.1124/mol.105.015941; Burbidge SA, 2002, MOL BRAIN RES, V103, P80, DOI 10.1016/S0169-328X(02)00188-2; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Clement H, 2007, TOXICON, V50, P65, DOI 10.1016/j.toxicon.2007.02.015; de la Vega RCR, 2005, TOXICON, V46, P831, DOI 10.1016/j.toxicon.2005.09.006; De La Vega RCR, 2005, TOXIN REV, V24, P385, DOI [10.1080/07313830500237166, 10.3109/15569540509162660]; de la Vega RCR, 2003, TRENDS PHARMACOL SCI, V24, P222, DOI 10.1016/S0165-6147(02)00080-4; DELAVEGA RCR, 2009, ANIMAL TOXINS STATE, P194; Diochot S, 2007, TOXICON, V49, P271, DOI 10.1016/j.toxicon.2006.09.026; Diochot S, 1999, BRIT J PHARMACOL, V126, P251, DOI 10.1038/sj.bjp.0702283; Diochot S, 2003, MOL PHARMACOL, V64, P59, DOI 10.1124/mol.64.1.59; Edgerton GB, 2008, TOXICON, V52, P489, DOI 10.1016/j.toxicon.2008.06.023; Escoubas P, 2004, TOXICON, V43, P555, DOI 10.1016/j.toxicon.2004.02.007; Escoubas P, 2006, TOXICON, V47, P650, DOI 10.1016/j.toxicon.2006.01.018; Ferrat G, 2005, TOXIN REV, V24, P361, DOI 10.3109/15569540509162659; Garcia ML, 2007, TOXICON, V49, P123, DOI 10.1016/j.toxicon.2006.09.010; Gouaux E, 2005, SCIENCE, V310, P1461, DOI 10.1126/science.1113666; Gurrola GB, 1999, FASEB J, V13, P953, DOI 10.1096/fasebj.13.8.953; Jiang YX, 2003, NATURE, V423, P42, DOI 10.1038/nature01581; Jung HJ, 2006, BIOCHEM BIOPH RES CO, V340, P633, DOI 10.1016/j.bbrc.2005.12.046; Jurkat-Rott K, 2002, J NEUROL, V249, P1493, DOI 10.1007/s00415-002-0871-5; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kullmann DM, 2002, BRAIN, V125, P1177, DOI 10.1093/brain/awf130; Lampe R.A., 1999, Analgesic Peptides from Venom of Grammostola Spatulata and Use Thereof, Patent No. [US5877026, 5877026]; LAMPE RA, 1999, Patent No. 5968838; Lee SY, 2004, NATURE, V430, P232, DOI 10.1038/nature02632; Li DL, 2003, FEBS LETT, V555, P616, DOI 10.1016/S0014-5793(03)01303-6; Li-Smerin Y, 1998, P NATL ACAD SCI USA, V95, P8585, DOI 10.1073/pnas.95.15.8585; Liang S, 2008, EXPERT REV PROTEOMIC, V5, P731, DOI 10.1586/14789450.5.5.731; Liao Z, 2006, BIOCHEMISTRY-US, V45, P15591, DOI 10.1021/bi061457+; Mantegazza M, 2005, P NATL ACAD SCI USA, V102, P18177, DOI 10.1073/pnas.0506818102; McDonough SI, 2007, TOXICON, V49, P202, DOI 10.1016/j.toxicon.2006.09.018; Milescu M, 2007, J GEN PHYSIOL, V130, P497, DOI 10.1085/jgp.200709869; Nicholson GM, 2005, TOXIN REV, V24, P315, DOI 10.3109/15569540509162657; Oliveira JS, 2004, J BIOL CHEM, V279, P33323, DOI 10.1074/jbc.M404344200; Oswald RE, 2002, J BIOL CHEM, V277, P34443, DOI 10.1074/jbc.M202715200; Peng K, 2002, J BIOL CHEM, V277, P47564, DOI 10.1074/jbc.M204063200; Rash LD, 2002, TOXICON, V40, P225, DOI 10.1016/S0041-0101(01)00199-4; Restano-Cassulini R, 2006, MOL PHARMACOL, V69, P1673, DOI 10.1124/mol.105.019729; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schmalhofer WA, 2008, MOL PHARMACOL, V74, P1476, DOI 10.1124/mol.108.047670; Schmidt D, 2008, P NATL ACAD SCI USA, V105, P19276, DOI 10.1073/pnas.0810187105; Schonherr R, 1999, EUR J NEUROSCI, V11, P753, DOI 10.1046/j.1460-9568.1999.00493.x; SPINELLI W, 1993, CARDIOVASC RES, V27, P1580, DOI 10.1093/cvr/27.9.1580; Suchyna TM, 2000, J GEN PHYSIOL, V115, P583, DOI 10.1085/jgp.115.5.583; Sugawara T, 2001, P NATL ACAD SCI USA, V98, P6384, DOI 10.1073/pnas.111065098; Swartz KJ, 2007, TOXICON, V49, P213, DOI 10.1016/j.toxicon.2006.09.024; Swartz KJ, 2008, NATURE, V456, P891, DOI 10.1038/nature07620; SWARTZ KJ, 1995, NEURON, V15, P941, DOI 10.1016/0896-6273(95)90184-1; Tombola F, 2006, ANNU REV CELL DEV BI, V22, P23, DOI 10.1146/annurev.cellbio.21.020404.145837; Wang MC, 2007, BIOCHEM BIOPH RES CO, V357, P579, DOI 10.1016/j.bbrc.2007.02.168; Wanke E, 2007, TOXICON, V49, P239, DOI 10.1016/j.toxicon.2006.09.025; Winterfield JR, 2000, J GEN PHYSIOL, V116, P637, DOI 10.1085/jgp.116.5.637; Yu FH, 2005, PHARMACOL REV, V57, P387, DOI 10.1124/pr.57.4.13; Zamudio FZ, 1997, FEBS LETT, V405, P385, DOI 10.1016/S0014-5793(97)00227-5; Zhu SY, 2004, PROTEINS, V54, P361, DOI 10.1002/prot.10588; Zhu SY, 2004, J MOL EVOL, V58, P145, DOI 10.1007/s00239-003-2534-2	59	68	76	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					4130	4142		10.1074/jbc.M109.054718	http://dx.doi.org/10.1074/jbc.M109.054718			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19955179	Green Published, hybrid			2022-12-25	WOS:000275254000065
J	Flozak, AS; Lam, AP; Russell, S; Jain, M; Peled, ON; Sheppard, KA; Beri, R; Mutlu, GM; Budinger, GRS; Gottardi, CJ				Flozak, Annette S.; Lam, Anna P.; Russell, Susan; Jain, Manu; Peled, Ofra N.; Sheppard, Kerry A.; Beri, Rohinee; Mutlu, Goekhan M.; Budinger, G. R. Scott; Gottardi, Cara J.			beta-Catenin/T-cell Factor Signaling Is Activated during Lung Injury and Promotes the Survival and Migration of Alveolar Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; DUAL-KINASE MECHANISM; PHENOTYPE IN-VITRO; II CELLS; STEM-CELLS; DIFFERENTIAL EXPRESSION; ARTICULAR-CARTILAGE; C-MYC; WNT; PROTEIN	The Wnt/beta-catenin signaling cascade activates genes that allow cells to adopt particular identities throughout development. In adult self-renewing tissues like intestine and blood, activation of the Wnt pathway maintains a progenitor phenotype, whereas forced inhibition of this pathway promotes differentiation. In the lung alveolus, type 2 epithelial cells (AT2) have been described as progenitors for the type 1 cell (AT1), but whether AT2 progenitors use the same signaling mechanisms to control differentiation as rapidly renewing tissues is not known. Weshow that adult AT2 cells do not exhibit constitutive beta-catenin signaling in vivo, using the AXIN2(+/LacZ) reporter mouse, or after fresh isolation of an enriched population of AT2 cells. Rather, this pathway is activated in lungs subjected to bleomycin-induced injury, as well as upon placement of AT2 cells in culture. Forced inhibition of beta-catenin/T-cell factor signaling in AT2 cultures leads to increased cell death. Cells that survive show reduced migration after wounding and reduced expression of AT1 cell markers (T1 alpha and RAGE). These results suggest that AT2 cells may function as facultative progenitors, where activation of Wnt/beta-catenin signaling during lung injury promotes alveolar epithelial survival, migration, and differentiation toward an AT1-like phenotype.	[Flozak, Annette S.; Lam, Anna P.; Russell, Susan; Jain, Manu; Sheppard, Kerry A.; Beri, Rohinee; Mutlu, Goekhan M.; Budinger, G. R. Scott; Gottardi, Cara J.] Northwestern Univ, Feinberg Sch Med, Dept Med, Div Pulm & Crit Care, Chicago, IL 60611 USA; [Peled, Ofra N.] Natl Louis Univ, Dept Nat Sci, Chicago, IL 60603 USA	Northwestern University; Feinberg School of Medicine; National Louis University	Gottardi, CJ (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Med, Div Pulm & Crit Care, Chicago, IL 60611 USA.	c-gottardi@northwestern.edu	Gottardi, Cara J./AAU-4691-2021	Gottardi, Cara J./0000-0003-0912-7617	National Institutes of Health [GM076561, T32 HL076139]; NHLBI [HL78145]; Northwestern Memorial Faculty Foundation [HL071643, ES015024]; NIEHS, NIH ONES Award [HL071643, ES013995]; Schweppe Foundation; American Heart Association [0530304Z]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025741] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL076139, P01HL071643, F32HL078145, P30HL101292, K08HL093216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013995, R01ES015024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076561] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Northwestern Memorial Faculty Foundation; NIEHS, NIH ONES Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Schweppe Foundation; American Heart Association(American Heart Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM076561 (to C.J.G.). This work was also supported by a National Research Service Award (HL78145) from NHLBI, NIH (to A.P.L.), by Grant T32 HL076139 (to S.R.), by the Northwestern Memorial Faculty Foundation (to M.J.), by Grants HL071643 and ES015024 and an NIEHS, NIH ONES Award (to G.M.M.), by Grants HL071643 and ES013995 (to G.R.S.B.), and by Career Development Awards from the Schweppe Foundation and the American Heart Association (Grant 0530304Z).	ADAMSON IYR, 1974, LAB INVEST, V30, P35; ASO Y, 1976, LAB INVEST, V35, P558; Benhamouche S, 2006, DEV CELL, V10, P759, DOI 10.1016/j.devcel.2006.03.015; Bhaskaran M, 2007, J BIOL CHEM, V282, P3968, DOI 10.1074/jbc.M609060200; BONNEROT C, 1987, P NATL ACAD SCI USA, V84, P6795, DOI 10.1073/pnas.84.19.6795; Borok Z, 2006, PEDIATR RES, V59, p84R, DOI 10.1203/01.pdr.0000203563.37626.77; Borok Z, 1998, AM J RESP CELL MOL, V18, P554, DOI 10.1165/ajrcmb.18.4.2838; Borok Z, 1998, AM J PHYSIOL-LUNG C, V275, pL155, DOI 10.1152/ajplung.1998.275.1.L155; BRODY JS, 1992, ANNU REV PHYSIOL, V54, P351, DOI 10.1146/annurev.physiol.54.1.351; Budinger GRS, 2006, P NATL ACAD SCI USA, V103, P4604, DOI 10.1073/pnas.0507604103; Chen JW, 2004, LAB INVEST, V84, P727, DOI 10.1038/labinvest.3700095; Cheng JH, 2008, AM J PHYSIOL-GASTR L, V294, pG39, DOI 10.1152/ajpgi.00263.2007; Chilosi M, 2003, AM J PATHOL, V162, P1495, DOI 10.1016/S0002-9440(10)64282-4; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Daniels CB, 2003, NEWS PHYSIOL SCI, V18, P151, DOI 10.1152/nips.01438.2003; Daniels DL, 2002, MOL CELL, V10, P573, DOI 10.1016/S1097-2765(02)00631-7; DeBiase PJ, 2006, J HISTOCHEM CYTOCHEM, V54, P665, DOI 10.1369/jhc.5A6889.2006; Dell'Accio F, 2008, ARTHRITIS RHEUM-US, V58, P1410, DOI 10.1002/art.23444; Dell'Accio F, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2029; DOBBS LG, 1985, BIOCHIM BIOPHYS ACTA, V846, P155, DOI 10.1016/0167-4889(85)90121-1; DOBBS LG, 1986, AM REV RESPIR DIS, V134, P141; George CLS, 2008, INFECT IMMUN, V76, P380, DOI 10.1128/IAI.01043-07; Gonzalez R, 2005, AM J PHYSIOL-LUNG C, V288, pL179, DOI 10.1152/ajplung.00272.2004; Goodwin AM, 2006, DEV DYNAM, V235, P3110, DOI 10.1002/dvdy.20939; Hart M, 1999, CURR BIOL, V9, P207, DOI 10.1016/S0960-9822(99)80091-8; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hsieh JC, 1999, P NATL ACAD SCI USA, V96, P3546, DOI 10.1073/pnas.96.7.3546; Isakson BE, 2001, AM J PHYSIOL-CELL PH, V281, pC1291, DOI 10.1152/ajpcell.2001.281.4.C1291; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kim PJ, 2003, LANCET, V362, P205, DOI 10.1016/S0140-6736(03)13910-4; Konigshoff M, 2009, J CLIN INVEST, V119, P772, DOI 10.1172/JCI33950; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Liu B, 2007, DEV BIOL, V301, P298, DOI 10.1016/j.ydbio.2006.10.018; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Maher MT, 2009, J CELL BIOL, V186, P219, DOI 10.1083/jcb.200811108; Maher MT, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-5; Masckauchan T. Nestor H., 2005, Angiogenesis, V8, P43, DOI 10.1007/s10456-005-5612-9; Mucenski ML, 2005, AM J PHYSIOL-LUNG C, V289, pL971, DOI 10.1152/ajplung.00172.2005; Mucenski ML, 2003, J BIOL CHEM, V278, P40231, DOI 10.1074/jbc.M305892200; Okuse T, 2005, WOUND REPAIR REGEN, V13, P491, DOI 10.1111/j.1067-1927.2005.00069.x; PAPKOFF J, 1990, MOL CELL BIOL, V10, P2723, DOI 10.1128/MCB.10.6.2723; PEIFER M, 1994, DEVELOPMENT, V120, P369; Polakis P, 2000, GENE DEV, V14, P1837; Ramirez MI, 1997, J BIOL CHEM, V272, P26285, DOI 10.1074/jbc.272.42.26285; Reichsman F, 1996, J CELL BIOL, V135, P819, DOI 10.1083/jcb.135.3.819; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Reynolds SD, 2008, STEM CELLS, V26, P1337, DOI 10.1634/stemcells.2008-0053; Ridge KM, 1997, AM J PHYSIOL-LUNG C, V273, pL246, DOI 10.1152/ajplung.1997.273.1.L246; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Sekine S, 2006, HEPATOLOGY, V43, P817, DOI 10.1002/hep.21131; Serrano-Mollar A, 2007, AM J RESP CRIT CARE, V176, P1261, DOI 10.1164/rccm.200610-1491OC; Sheppard D, 2001, J CLIN INVEST, V107, P1501, DOI 10.1172/JCI13318; Shirasawa M, 2004, GENES CELLS, V9, P165, DOI 10.1111/j.1356-9597.2004.00712.x; Shu WG, 2005, DEV BIOL, V283, P226, DOI 10.1016/j.ydbio.2005.04.014; Staal FJT, 2002, EMBO REP, V3, P63, DOI 10.1093/embo-reports/kvf002; Stripp Barry R, 2008, Proc Am Thorac Soc, V5, P328, DOI 10.1513/pats.200711-167DR; Tago K, 2000, GENE DEV, V14, P1741; Thompson EB, 1998, ANNU REV PHYSIOL, V60, P575, DOI 10.1146/annurev.physiol.60.1.575; van der Loos CM, 2008, J HISTOCHEM CYTOCHEM, V56, P313, DOI 10.1369/jhc.2007.950170; van Es JH, 2005, NAT CELL BIOL, V7, P381, DOI 10.1038/ncb1240; van Noort M, 2002, J BIOL CHEM, V277, P17901, DOI 10.1074/jbc.M111635200; WEIBEL ER, 1986, B EUR PHYSIOPATH RES, V22, pS235; Willert K, 2006, GENE DEV, V20, P1394, DOI 10.1101/gad.1424006; Williams MC, 2003, ANNU REV PHYSIOL, V65, P669, DOI 10.1146/annurev.physiol.65.092101.142446; Wofford JA, 2007, AM J PHYSIOL-LUNG C, V293, pL1437, DOI 10.1152/ajplung.00239.2007; Yochum GS, 2007, P NATL ACAD SCI USA, V104, P3324, DOI 10.1073/pnas.0611576104; Yu HMI, 2005, DEVELOPMENT, V132, P1995, DOI 10.1242/dev.01786; Zemke AC, 2009, AM J RESP CELL MOL, V41, P535, DOI 10.1165/rcmb.2008-0407OC; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185; Zhang F, 2003, J BIOL CHEM, V278, P33067, DOI 10.1074/jbc.M212635200	70	86	89	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5					3157	3167		10.1074/jbc.M109.070326	http://dx.doi.org/10.1074/jbc.M109.070326			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19933277	hybrid, Green Published			2022-12-25	WOS:000273829000031
J	Karpurapu, M; Wang, D; Van Quyen, D; Kim, TK; Kundumani-Sridharan, V; Pulusani, S; Rao, GN				Karpurapu, Manjula; Wang, Dong; Van Quyen, Dong; Kim, Tae-Kang; Kundumani-Sridharan, Venkatesh; Pulusani, Srinidhi; Rao, Gadiparthi N.			Cyclin D1 Is a Bona Fide Target Gene of NFATc1 and Is Sufficient in the Mediation of Injury-induced Vascular Wall Remodeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED T-CELLS; RECEPTOR TYROSINE KINASE; SMOOTH-MUSCLE; TRANSCRIPTION FACTOR; NEOINTIMA FORMATION; NUCLEAR FACTOR; IN-VITRO; EXPRESSION; GROWTH; PROLIFERATION	Platelet-derived growth factor BB induced cyclin D1 expression in a time-and nuclear factor of activated T cells (NFAT)dependent manner in human aortic smooth muscle cells (HASMCs), and blockade of NFATs prevented HASMC DNA synthesis and their cell cycle progression from G(1) to S phase. Selective inhibition of NFATc1 by its small interfering RNA also blocked HASMC proliferation and migration. Characterization of the cyclin D1 promoter revealed the presence of several NFAT binding sites, and the site at nucleotide -1333 was found to be sufficient in mediating platelet-derived growth factor BB-induced cyclin D1 promoter-luciferase reporter gene activity. In addition to its role in cell cycle progression, cyclin D1 mediated HASMC migration in an NFATc1-dependent manner. Balloon injury-induced cyclin D1-CDK4 activity requires NFAT activation, and adenovirus-mediated transduction of cyclin D1 was found to be sufficient to overcome the blockade effect of NFATs by VIVIT on balloon injury-induced vascular wall remodeling events, including smooth muscle cell migration from the medial to luminal region, their proliferation in the intimal region, and neointima formation. Together, these results provide more mechanistic evidence for the role of NFATs, particularly NFATc1, in the regulation of HASMC proliferation and migration as well as vascular wall remodeling. NFATc1 could be a potential therapeutic target against the renarrowing of artery after angioplasty.	[Karpurapu, Manjula; Wang, Dong; Van Quyen, Dong; Kim, Tae-Kang; Kundumani-Sridharan, Venkatesh; Pulusani, Srinidhi; Rao, Gadiparthi N.] Univ Tennessee, Hlth Sci Ctr, Dept Physiol, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center	Rao, GN (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Physiol, 894 Union Ave, Memphis, TN 38163 USA.	grao@physio1.utmem.edu	Kundumani-Sridharan, Venkatesh/I-4799-2016	Kundumani-Sridharan, Venkatesh/0000-0002-6134-4371; Quyen, Dong Van/0000-0003-1002-7517	National Institutes of Health [HL069908]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069908] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL069908 (to G. N. R.).	Antos CL, 2002, P NATL ACAD SCI USA, V99, P907, DOI 10.1073/pnas.231619298; Aramburu J, 1999, SCIENCE, V285, P2129, DOI 10.1126/science.285.5436.2129; Baksh S, 2002, MOL CELL, V10, P1071, DOI 10.1016/S1097-2765(02)00701-3; BENDECK MP, 1994, CIRC RES, V75, P539, DOI 10.1161/01.RES.75.3.539; BERKNER KL, 1988, BIOTECHNIQUES, V6, P616; Caetano MS, 2002, FASEB J, V16, P1940, DOI 10.1096/fj.02-0282fje; Cao HQ, 2006, CIRC RES, V98, P913, DOI 10.1161/01.RES.0000216954.55724.a2; Carvalho LDS, 2007, CELL CYCLE, V6, P1789, DOI 10.4161/cc.6.14.4473; CASSCELLS W, 1992, CIRCULATION, V86, P723, DOI 10.1161/01.CIR.86.3.723; Chen W, 2004, CANCER RES, V64, P3949, DOI 10.1158/0008-5472.CAN-03-3906; Dronadula N, 2006, J LIPID RES, V47, P767, DOI 10.1194/jlr.M500369-JLR200; Fu MF, 2005, J BIOL CHEM, V280, P16934, DOI 10.1074/jbc.M500403200; Graef IA, 2001, CELL, V105, P863, DOI 10.1016/S0092-8674(01)00396-8; Heit JJ, 2006, NATURE, V443, P345, DOI 10.1038/nature05097; HERBER B, 1994, ONCOGENE, V9, P1295; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Horsley V, 2001, J CELL BIOL, V153, P329, DOI 10.1083/jcb.153.2.329; Horsley V, 2008, CELL, V132, P299, DOI 10.1016/j.cell.2007.11.047; Ishida N, 2002, J BIOL CHEM, V277, P41147, DOI 10.1074/jbc.M205063200; Jinnin M, 2008, NAT MED, V14, P1236, DOI 10.1038/nm.1877; JOHNSON DG, 1993, NATURE, V365, P349, DOI 10.1038/365349a0; Johnson EN, 2003, J BIOL CHEM, V278, P1686, DOI 10.1074/jbc.M210250200; Kao SC, 2009, SCIENCE, V323, P651, DOI 10.1126/science.1166562; Karpurapu M, 2008, J BIOL CHEM, V283, P26577, DOI 10.1074/jbc.M800423200; Kozar K, 2004, CELL, V118, P477, DOI 10.1016/j.cell.2004.07.025; Kundumani-Sridharan V, 2007, AM J PATHOL, V171, P1381, DOI 10.2353/ajpath.2007.061258; Lipskaia L, 2005, CIRC RES, V97, P488, DOI 10.1161/01.RES.0000180663.42594.aa; Liu ZM, 2005, J BIOL CHEM, V280, P14700, DOI 10.1074/jbc.M500322200; Liu ZM, 2004, J BIOL CHEM, V279, P41218, DOI 10.1074/jbc.M406917200; Macian F, 2002, CELL, V109, P719, DOI 10.1016/S0092-8674(02)00767-5; Miyakawa H, 1999, P NATL ACAD SCI USA, V96, P2538, DOI 10.1073/pnas.96.5.2538; Monticelli S, 2002, EUR J IMMUNOL, V32, P2971, DOI 10.1002/1521-4141(2002010)32:10<2971::AID-IMMU2971>3.0.CO;2-G; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Neal JW, 2003, J BIOL CHEM, V278, P17246, DOI 10.1074/jbc.M300528200; Neumeister P, 2003, MOL BIOL CELL, V14, P2005, DOI 10.1091/mbc.02-07-0102; NURSE P, 1994, CELL, V79, P547, DOI 10.1016/0092-8674(94)90539-8; Pavletich NP, 1999, J MOL BIOL, V287, P821, DOI 10.1006/jmbi.1999.2640; Ranger AM, 1998, NATURE, V392, P186, DOI 10.1038/32426; Robbs BK, 2008, MOL CELL BIOL, V28, P7168, DOI 10.1128/MCB.00256-08; Ryeom S, 2008, CANCER CELL, V13, P420, DOI 10.1016/j.ccr.2008.02.018; SCHWARTZ SM, 1986, CIRC RES, V58, P427, DOI 10.1161/01.RES.58.4.427; SHAW JP, 1988, SCIENCE, V241, P202, DOI 10.1126/science.3260404; Sherr CJ, 2004, GENE DEV, V18, P2699, DOI 10.1101/gad.1256504; Sunters A, 2004, J BIOL CHEM, V279, P9882, DOI 10.1074/jbc.M310184200; Tamamori-Adachi M, 2003, CIRC RES, V92, pE12, DOI 10.1161/01.RES.0000049105.15329.1C; Wang D, 2007, CIRC RES, V100, P807, DOI 10.1161/01.RES.0000261350.61711.9e; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Wilkins BJ, 2004, CIRC RES, V94, P110, DOI 10.1161/01.RES.0000109415.17511.18; Yellaturu CR, 2002, BIOCHEM J, V368, P183, DOI 10.1042/BJ20020347	49	44	48	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5					3510	3523		10.1074/jbc.M109.063727	http://dx.doi.org/10.1074/jbc.M109.063727			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19933579	Green Published, hybrid			2022-12-25	WOS:000273829000065
J	Nakada, T; Westhoff, CM; Yamaguchi, Y; Hyodo, S; Li, XJ; Muro, T; Kato, A; Nakamura, N; Hirose, S				Nakada, Tsutomu; Westhoff, Connie M.; Yamaguchi, Yoko; Hyodo, Susumu; Li, Xiaojin; Muro, Takayuki; Kato, Akira; Nakamura, Nobuhiro; Hirose, Shigehisa			Rhesus Glycoprotein P2 (Rhp2) Is a Novel Member of the Rh Family of Ammonia Transporters Highly Expressed in Shark Kidney	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TROUT ONCORHYNCHUS-MYKISS; D-GLUCOSE COTRANSPORTER; ZEBRAFISH DANIO-RERIO; THICK ASCENDING LIMB; RED-CELL MEMBRANE; RAINBOW-TROUT; SQUALUS-ACANTHIAS; UREA TRANSPORTER; FRESH-WATER; MOLECULAR-IDENTIFICATION	Rhesus (Rh) glycoproteins are a family of membrane proteins capable of transporting ammonia. We isolated the full-length cDNA of a novel Rh glycoprotein, Rhp2, from a kidney cDNA library from the banded hound shark, Triakis scyllium. Molecular cloning and characterization indicated that Rhp2 consists of 476 amino acid residues and has 12 putative transmembrane spans, consistent with the structure of other family members. The shark Rhp2 gene was found to consist of only one coding exon. Northern blotting and in situ hybridization revealed that Rhp2 mRNA is exclusively expressed in the renal tubules of the sinus zone but not in the bundle zone and renal corpuscles. Immunohistochemical staining with a specific antiserum showed that Rhp2 is localized in the basolateral membranes of renal tubule cells. Double fluorescence labeling with phalloidin or labeling of the Na+/K+-ATPase further narrowed the location to the second and fourth loops in the sinus zone. Vacuolar type H+-ATPase was localized in apical membranes of the Rhp2-expressing tubule cells. Quantitative real-time PCR analysis and Western blotting showed that expression of Rhp2 was increased in response to elevation of environmental salinity. Functional analysis using the Xenopus oocyte expression system showed that Rhp2 has transport activity for methylammonium, an analog of ammonia. This transport activity was inhibited by NH4Cl but not trimethylamine-N-oxide and urea. These results suggested that Rhp2 is involved in ammonia reabsorption in the kidney of the elasmobranch group of cartilaginous fish comprising the sharks and rays.	[Nakada, Tsutomu; Muro, Takayuki; Kato, Akira; Nakamura, Nobuhiro; Hirose, Shigehisa] Tokyo Inst Technol, Dept Biol Sci, Yokohama, Kanagawa 2268501, Japan; [Westhoff, Connie M.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Yamaguchi, Yoko; Hyodo, Susumu] Univ Tokyo, Ocean Res Inst, Physiol Lab, Tokyo 1648639, Japan; [Westhoff, Connie M.; Li, Xiaojin] Amer Red Cross, Philadelphia, PA 19130 USA	Tokyo Institute of Technology; University of Pennsylvania; University of Tokyo; American Red Cross	Westhoff, CM (corresponding author), 700 Spring Garden St, Philadelphia, PA 19130 USA.	westhoffc@usa.redcross.org; shirose@bio.titech.ac.jp	Nakamura, Nobuhiro/C-4265-2015; Kato, Akira/E-6328-2010	Nakamura, Nobuhiro/0000-0002-0249-2665; Kato, Akira/0000-0002-9083-1443; Yamaguchi, Yoko/0000-0002-0526-0069; Hyodo, Susumu/0000-0001-8146-2386	Ministry of Education, Culture, Sport, Science and Technology of Japan (MEXT) [14104002, 18059010, 18-5667]; Japan Society for the Promotion of Science Research Fellowships; Grants-in-Aid for Scientific Research [22370029] Funding Source: KAKEN	Ministry of Education, Culture, Sport, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science Research Fellowships(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-aid for Scientific Research 14104002 and 18059010 (to S. H.) and 18-5667 (to T. N.) from the Ministry of Education, Culture, Sport, Science and Technology of Japan (MEXT), the Japan Society for the Promotion of Science Research Fellowships for Young Scientists, and the 21st Century and Global Centers of Excellence Program of MEXT.	Althoff T, 2006, AM J PHYSIOL-REG I, V290, pR1094, DOI 10.1152/ajpregu.00334.2005; Althoff T, 2007, AM J PHYSIOL-REG I, V292, pR2391, DOI 10.1152/ajpregu.00454.2006; *AM PHYS SOC, 2002, AM J PHYSIOL-REG I, V283, pR281, DOI DOI 10.1152/AJPREGU.00279.2002; Attmane-Elakeb A, 2001, AM J PHYSIOL-RENAL, V280, pF1, DOI 10.1152/ajprenal.2001.280.1.F1; Bakouh N, 2004, J BIOL CHEM, V279, P15975, DOI 10.1074/jbc.M308528200; Benjelloun F, 2005, PFLUG ARCH EUR J PHY, V450, P155, DOI 10.1007/s00424-005-1381-y; Biemesderfer D, 1996, AM J PHYSIOL-RENAL, V270, pF927, DOI 10.1152/ajprenal.1996.270.6.F927; Biver S, 2008, NATURE, V456, P339, DOI 10.1038/nature07518; Braun MH, 2009, AM J PHYSIOL-RENAL, V296, pF994, DOI 10.1152/ajprenal.90656.2008; Cai SY, 2003, AM J PHYSIOL-REG I, V284, pR125, DOI 10.1152/ajpregu.00392.2002; DEETJEN P, 1974, PFLUG ARCH EUR J PHY, V346, P25, DOI 10.1007/BF00592647; Endeward V, 2006, TRANSFUS CLIN BIOL, V13, P123, DOI 10.1016/j.tracli.2006.02.007; Endeward V, 2008, FASEB J, V22, P64, DOI 10.1096/fj.07-9097com; Evans David H., 1993, P315; GOOD DW, 1984, AM J PHYSIOL, V247, pF35, DOI 10.1152/ajprenal.1984.247.1.F35; Handlogten ME, 2004, AM J PHYSIOL-RENAL, V287, pF628, DOI 10.1152/ajprenal.00363.2003; Hazon N, 2003, COMP BIOCHEM PHYS B, V136, P685, DOI 10.1016/S1096-4959(03)00280-X; Hirata T, 2003, AM J PHYSIOL-REG I, V284, pR1199, DOI 10.1152/ajpregu.00267.2002; HODLER J, 1955, AM J PHYSIOL, V183, P155, DOI 10.1152/ajplegacy.1955.183.1.155; Huang CH, 2001, BLOOD CELL MOL DIS, V27, P90, DOI 10.1006/bcmd.2000.0355; Huang CH, 2005, P NATL ACAD SCI USA, V102, P15512, DOI 10.1073/pnas.0507886102; Hung CYC, 2007, J EXP BIOL, V210, P2419, DOI 10.1242/jeb.002568; Hung CC, 2008, J EXP ZOOL PART A, V309A, P262, DOI 10.1002/jez.456; Hyodo S, 2004, GEN COMP ENDOCR, V138, P97, DOI 10.1016/j.ygcen.2004.05.009; Hyodo S, 2004, J EXP BIOL, V207, P347, DOI 10.1242/jeb.00773; Ji QM, 2006, P NATL ACAD SCI USA, V103, P5881, DOI 10.1073/pnas.0600901103; KING PA, 1983, AM J PHYSIOL, V245, pR581, DOI 10.1152/ajpregu.1983.245.4.R581; Kustu S, 2006, TRANSFUS CLIN BIOL, V13, P103, DOI 10.1016/j.tracli.2006.03.001; LACY ER, 1985, ANAT EMBRYOL, V173, P163, DOI 10.1007/BF00316299; Li X, 2007, P NATL ACAD SCI USA, V104, P19279, DOI 10.1073/pnas.0709710104; Liu Z, 2000, J BIOL CHEM, V275, P25641, DOI 10.1074/jbc.M003353200; Liu Z, 2001, J BIOL CHEM, V276, P1424, DOI 10.1074/jbc.M007528200; Ludewig U, 2004, J PHYSIOL-LONDON, V559, P751, DOI 10.1113/jphysiol.2004.067728; Mak DOD, 2006, AM J PHYSIOL-RENAL, V290, pF297, DOI 10.1152/ajprenal.00147.2005; Marini AM, 2000, NAT GENET, V26, P341, DOI 10.1038/81656; McDonald MD, 2006, J MEMBRANE BIOL, V212, P93, DOI 10.1007/s00232-006-0869-5; Mistry AC, 2001, AM J PHYSIOL-REG I, V281, pR1594, DOI 10.1152/ajpregu.2001.281.5.R1594; Musa-Aziz R, 2009, P NATL ACAD SCI USA, V106, P5406, DOI 10.1073/pnas.0813231106; Nakada T, 2005, AM J PHYSIOL-REG I, V289, pR575, DOI 10.1152/ajpregu.00725.2004; Nakada T, 2007, FASEB J, V21, P1067, DOI 10.1096/fj.06-6834com; Nakada T, 2007, AM J PHYSIOL-REG I, V293, pR1743, DOI 10.1152/ajpregu.00248.2007; Nawata CM, 2008, J EXP BIOL, V211, P3226, DOI 10.1242/jeb.020396; Nawata CM, 2007, PHYSIOL GENOMICS, V31, P463, DOI 10.1152/physiolgenomics.00061.2007; POULSEN JM, 1981, SPHYRNA TIBURO COMP, V70, P127; Quentin F, 2003, J AM SOC NEPHROL, V14, P545, DOI 10.1097/01.ASN.0000050413.43662.55; Ripoche P, 2004, P NATL ACAD SCI USA, V101, P17222, DOI 10.1073/pnas.0403704101; Shih TH, 2008, AM J PHYSIOL-CELL PH, V295, pC1625, DOI 10.1152/ajpcell.00255.2008; Smith HW, 1931, AM J PHYSIOL, V98, P279, DOI 10.1152/ajplegacy.1931.98.2.279; Soupene E, 2004, P NATL ACAD SCI USA, V101, P7787, DOI 10.1073/pnas.0401809101; Soupene E, 2002, P NATL ACAD SCI USA, V99, P7769, DOI 10.1073/pnas.112225599; SWENSON ER, 1994, AM J PHYSIOL-RENAL, V267, pF639, DOI 10.1152/ajprenal.1994.267.4.F639; THORSON TB, 1962, SCIENCE, V138, P688, DOI 10.1126/science.138.3541.688; Tsui TKN, 2009, J EXP BIOL, V212, P878, DOI 10.1242/jeb.021899; Verlander JW, 2003, AM J PHYSIOL-RENAL, V284, pF323, DOI 10.1152/ajprenal.00050.2002; Weihrauch D, 2004, J EXP BIOL, V207, P4491, DOI 10.1242/jeb.01308; Westhoff CM, 2004, J BIOL CHEM, V279, P17443, DOI 10.1074/jbc.M311853200; Westhoff CM, 2002, J BIOL CHEM, V277, P12499, DOI 10.1074/jbc.C200060200; WOOD CM, 1995, J EXP BIOL, V198, P1545; Yamaguchi Y, 2009, J EXP ZOOL PART A, V311A, P705, DOI 10.1002/jez.558	59	21	21	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2653	2664		10.1074/jbc.M109.052068	http://dx.doi.org/10.1074/jbc.M109.052068			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19926789	hybrid, Green Published			2022-12-25	WOS:000273697800044
J	Madinier, A; Bertrand, N; Mossiat, C; Prigent-Tessier, A; Beley, A; Marie, C; Garnier, P				Madinier, Alexandre; Bertrand, Nathalie; Mossiat, Claude; Prigent-Tessier, Anne; Beley, Alain; Marie, Christine; Garnier, Philippe			Microglial Involvement in Neuroplastic Changes Following Focal Brain Ischemia in Rats	PLOS ONE			English	Article							IRON CHELATOR 2,2'-DIPYRIDYL; MARROW CHIMERIC MICE; CEREBRAL-ISCHEMIA; NEUROTROPHIC FACTOR; POLY(ADP-RIBOSE) POLYMERASE; MOLECULAR-MECHANISMS; CELL-DEATH; NEURODEGENERATIVE DISORDERS; RESIDENT MICROGLIA; INFLAMMATION	The pathogenesis of ischemic stroke is a complex sequence of events including inflammatory reaction, for which the microglia appears to be a major cellular contributor. However, whether post-ischemic activation of microglial cells has beneficial or detrimental effects remains to be elucidated, in particular on long term brain plasticity events. The objective of our study was to determine, through modulation of post-stroke inflammatory response, to what extent microglial cells are involved in some specific events of neuronal plasticity, neurite outgrowth and synaptogenesis. Since microglia is a source of neurotrophic factors, the identification of the brain-derived neurophic factor (BDNF) as possible molecular actor involved in these events was also attempted. As a means of down-regulating the microglial response induced by ischemia, 3-aminobenzamide (3-AB, 90 mg/kg, i.p.) was used to inhibit the poly(ADP-ribose) polymerase-1 (PARP-1). Indeed, PARP-1 contributes to the activation of the transcription factor NF-kB, which is essential to the upregulation of proinflammatory genes, in particular responsible for microglial activation/proliferation. Experiments were conducted in rats subjected to photothrombotic ischemia which leads to a strong and early microglial cells activation/proliferation followed by an infiltration of macrophages within the cortical lesion, events evaluated at serial time points up to 1 month post-ictus by immunostaining for OX-42 and ED-1. Our most striking finding was that the decrease in acute microglial activation induced by 3-AB was associated with a long term down-regulation of two neuronal plasticity proteins expression, synaptophysin (marker of synaptogenesis) and GAP-43 (marker of neuritogenesis) as well as to a significant decrease in tissue BDNF production. Thus, our data argue in favour of a supportive role for microglia in brain neuroplasticity stimulation possibly through BDNF production, suggesting that a targeted protection of microglial cells could represent an innovative approach to potentiate post-stroke neuroregeneration.	[Madinier, Alexandre; Bertrand, Nathalie; Mossiat, Claude; Prigent-Tessier, Anne; Marie, Christine; Garnier, Philippe] Unite INSERM U887 Motricite Plastic, Dijon, France; [Madinier, Alexandre; Bertrand, Nathalie; Mossiat, Claude; Prigent-Tessier, Anne; Beley, Alain; Marie, Christine; Garnier, Philippe] Univ Bourgogne, Dijon, France; [Bertrand, Nathalie; Beley, Alain; Garnier, Philippe] IUT, Dept Genie Biol, Dijon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Universite de Bourgogne	Madinier, A (corresponding author), Unite INSERM U887 Motricite Plastic, Dijon, France.	pgarnier@u-bourgogne.fr		marie, christine/0000-0003-3724-0713; Garnier, Philippe/0000-0002-7877-3113; tessier, anne/0000-0001-6655-5074	Conseil Regional de Bourgogne, France	Conseil Regional de Bourgogne, France(Region Bourgogne-Franche-Comte)	This work was supported by grants from the Conseil Regional de Bourgogne, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batchelor PE, 1999, J NEUROSCI, V19, P1708; Batchelor PE, 2008, BRAIN RES, V1209, P49, DOI 10.1016/j.brainres.2008.02.098; Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; Bernaudin M, 1999, J CEREBR BLOOD F MET, V19, P643, DOI 10.1097/00004647-199906000-00007; Bessis A, 2007, GLIA, V55, P233, DOI 10.1002/glia.20459; Binder DK, 2004, GROWTH FACTORS, V22, P123, DOI 10.1080/08977190410001723308; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Brea D, 2009, CEREBROVASC DIS, V27, P48, DOI 10.1159/000200441; Carmichael ST, 2006, ANN NEUROL, V59, P735, DOI 10.1002/ana.20845; CHAMAK B, 1995, NEUROSCIENCE, V69, P177, DOI 10.1016/0306-4522(95)00236-C; Chen JL, 2005, J CEREBR BLOOD F MET, V25, P281, DOI 10.1038/sj.jcbfm.9600034; Chiarugi A, 2003, J NEUROCHEM, V85, P306, DOI 10.1046/j.1471-4159.2003.01684.x; Chong ZZ, 2005, PROG NEUROBIOL, V75, P207, DOI 10.1016/j.pneurobio.2005.02.004; Couturier JY, 2003, EXP NEUROL, V184, P973, DOI 10.1016/S0014-4886(03)00367-4; Demougeot C, 2004, J PHARMACOL EXP THER, V311, P1080, DOI 10.1124/jpet.104.072744; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Ekdahl CT, 2009, NEUROSCIENCE, V158, P1021, DOI 10.1016/j.neuroscience.2008.06.052; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Feuerstein GZ, 2001, ARCH NEUROL-CHICAGO, V58, P672, DOI 10.1001/archneur.58.4.672; GRIESBACH GS, 2009, BRAIN RES; Gupta SK, 2009, CELL DEATH DIFFER, V16, P624, DOI 10.1038/cdd.2008.188; Ha HC, 1999, P NATL ACAD SCI USA, V96, P13978, DOI 10.1073/pnas.96.24.13978; Hanisch UK, 2002, GLIA, V40, P140, DOI 10.1002/glia.10161; Imai F, 2007, J CEREBR BLOOD F MET, V27, P488, DOI 10.1038/sj.jcbfm.9600362; Kauppinen TM, 2007, NEUROSCIENCE, V145, P1267, DOI 10.1016/j.neuroscience.2006.09.034; Kauppinen TM, 2009, J CEREBR BLOOD F MET, V29, P820, DOI 10.1038/jcbfm.2009.9; Kempermann G, 2003, SCIENCE, V302, P1689, DOI 10.1126/science.1092864; Kim BJ, 2009, J NEUROL SCI, V279, P70, DOI 10.1016/j.jns.2008.12.025; Kim MW, 2005, BRAIN RES, V1052, P16, DOI 10.1016/j.brainres.2005.05.070; Kobayashi NR, 1997, J NEUROSCI, V17, P9583; Kobayashi T, 2006, STROKE, V37, P2361, DOI 10.1161/01.STR.0000236025.44089.e1; KOKAIA Z, 1995, EXP NEUROL, V136, P73, DOI 10.1006/exnr.1995.1085; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lai AY, 2008, GLIA, V56, P259, DOI 10.1002/glia.20610; Lalancette-Hebert M, 2007, J NEUROSCI, V27, P2596, DOI 10.1523/JNEUROSCI.5360-06.2007; Lipsky RH, 2007, ANN NY ACAD SCI, V1122, P130, DOI 10.1196/annals.1403.009; Marchetti B, 2005, TRENDS PHARMACOL SCI, V26, P517, DOI 10.1016/j.tips.2005.08.007; Mattson MP, 2008, ANN NY ACAD SCI, V1144, P97, DOI 10.1196/annals.1418.005; Millerot-Serrurot E, 2007, NEUROCHEM INT, V50, P328, DOI 10.1016/j.neuint.2006.08.016; Moroni F, 2008, CURR OPIN PHARMACOL, V8, P96, DOI 10.1016/j.coph.2007.10.005; Nagamoto-Combs K, 2007, J NEUROTRAUM, V24, P1719, DOI 10.1089/neu.2007.0377; Nakajima K, 2008, NEUROSCI LETT, V436, P331, DOI 10.1016/j.neulet.2008.03.058; Neumann J, 2008, J NEUROSCI, V28, P5965, DOI 10.1523/JNEUROSCI.0060-08.2008; Neumann J, 2006, FASEB J, V20, P714, DOI 10.1096/fj.05-4882fje; Oliver FJ, 1999, EMBO J, V18, P4446, DOI 10.1093/emboj/18.16.4446; Ploughman M, 2009, STROKE, V40, P1490, DOI 10.1161/STROKEAHA.108.531806; Pozzo-Miller LD, 1999, J NEUROSCI, V19, P4972; Rickhag M, 2007, BRAIN RES, V1151, P203, DOI 10.1016/j.brainres.2007.03.005; Schabitz WR, 1997, J CEREBR BLOOD F MET, V17, P500, DOI 10.1097/00004647-199705000-00003; Schabitz WR, 2007, STROKE, V38, P2165, DOI 10.1161/STROKEAHA.106.477331; Schilling M, 2005, EXP NEUROL, V196, P290, DOI 10.1016/j.expneurol.2005.08.004; Schilling M, 2003, EXP NEUROL, V183, P25, DOI 10.1016/S0014-4886(03)00082-7; Schroeter M, 1997, STROKE, V28, P382, DOI 10.1161/01.STR.28.2.382; Stoll G, 1999, PROG NEUROBIOL, V58, P233, DOI 10.1016/S0301-0082(98)00083-5; STROEMER RP, 1995, STROKE, V26, P2135, DOI 10.1161/01.STR.26.11.2135; Sulejczak D, 2007, J NEUROTRAUM, V24, P1362, DOI 10.1089/neu.2006.0261; Szabo C, 1998, TRENDS PHARMACOL SCI, V19, P287, DOI 10.1016/S0165-6147(98)01193-6; Takahashi K, 1999, NEUROREPORT, V10, P2017, DOI 10.1097/00001756-199907130-00005; Takahashi K, 1999, BRAIN RES, V829, P46, DOI 10.1016/S0006-8993(99)01335-9; Thored P, 2009, GLIA, V57, P835, DOI 10.1002/glia.20810; Tikka T, 2001, J NEUROSCI, V21, P2580, DOI 10.1523/JNEUROSCI.21-08-02580.2001; Tokime T, 1998, J CEREBR BLOOD F MET, V18, P991, DOI 10.1097/00004647-199809000-00008; Tuttolomondo A, 2008, CURR PHARM DESIGN, V14, P3547, DOI 10.2174/138161208786848829; Valtorta F, 2004, BIOESSAYS, V26, P445, DOI 10.1002/bies.20012; Van Hoecke M, 2005, EUR J NEUROSCI, V22, P1045, DOI 10.1111/j.1460-9568.2005.04297.x; Van Hoecke M, 2007, MOL CELL NEUROSCI, V34, P40, DOI 10.1016/j.mcn.2006.09.009; Vaynman S, 2003, NEUROSCIENCE, V122, P647, DOI 10.1016/j.neuroscience.2003.08.001; Vaynman SS, 2006, BRAIN RES, V1070, P124, DOI 10.1016/j.brainres.2005.11.062; Wang L, 2004, STROKE, V35, P1732, DOI 10.1161/01.STR.0000132196.49028.a4; WATERHOUSE EG, 2009, MOL CELL NEUROSCI; Wu Dafang, 2005, NeuroRx, V2, P120, DOI 10.1602/neurorx.2.1.120; Ying WH, 2002, J CEREBR BLOOD F MET, V22, P774, DOI 10.1097/00004647-200207000-00002; Yrjanheikki J, 1999, P NATL ACAD SCI USA, V96, P13496, DOI 10.1073/pnas.96.23.13496; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Zheng Z, 2004, NEUROL RES, V26, P884, DOI 10.1179/016164104X2357	76	106	108	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2009	4	12							e8101	10.1371/journal.pone.0008101	http://dx.doi.org/10.1371/journal.pone.0008101			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MT	19956568	Green Published, Green Submitted, gold			2022-12-25	WOS:000272828700013
J	Thurber, GM; Figueiredo, JL; Weissleder, R				Thurber, Greg M.; Figueiredo, Jose L.; Weissleder, Ralph			Multicolor Fluorescent Intravital Live Microscopy (FILM) for Surgical Tumor Resection in a Mouse Xenograft Model	PLOS ONE			English	Article							IN-VIVO; CANCER XENOGRAFTS; MICROVESSEL AREA; BREAST-CANCER; ANTIBODY; GROWTH; IDENTIFICATION; PROBES; MICE; INFLAMMATION	Background: Complete surgical resection of neoplasia remains one of the most efficient tumor therapies. However, malignant cell clusters are often left behind during surgery due to the inability to visualize and differentiate them against host tissue. Here we establish the feasibility of multicolor fluorescent intravital live microscopy (FILM) where multiple cellular and/or unique tissue compartments are stained simultaneously and imaged in real time. Methodology/Principal Findings: Theoretical simulations of imaging probe localization were carried out for three agents with specificity for cancer cells, stromal host response, or vascular perfusion. This transport analysis gave insight into the probe pharmacokinetics and tissue distribution, facilitating the experimental design and allowing predictions to be made about the localization of the probes in other animal models and in the clinic. The imaging probes were administered systemically at optimal time points based on the simulations, and the multicolor FILM images obtained in vivo were then compared to conventional pathological sections. Our data show the feasibility of real time in vivo pathology at cellular resolution and molecular specificity with excellent agreement between intravital and traditional in vitro immunohistochemistry. Conclusions/Significance: Multicolor FILM is an accurate method for identifying malignant tissue and cells in vivo. The imaging probes distributed in a manner similar to predictions based on transport principles, and these models can be used to design future probes and experiments. FILM can provide critical real time feedback and should be a useful tool for more effective and complete cancer resection.	[Thurber, Greg M.; Figueiredo, Jose L.; Weissleder, Ralph] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Syst Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Thurber, GM (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Syst Biol, Boston, MA 02115 USA.	rweissleder@mgh.harvard.edu		/0000-0003-0828-4143; Thurber, Greg/0000-0001-7570-2080	 [P50 CA86355];  [U24 CA092782];  [T32 CA079443]; NATIONAL CANCER INSTITUTE [U24CA092782, P50CA086355, T32CA079443] Funding Source: NIH RePORTER	; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants P50 CA86355, U24 CA092782, and T32 CA079443. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker JHE, 2008, CLIN CANCER RES, V14, P2171, DOI 10.1158/1078-0432.CCR-07-4465; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Bogdanov AA, 2002, NEOPLASIA, V4, P228, DOI 10.1038/sj.neo.7900238; Bremer C, 2002, RADIOLOGY, V222, P814, DOI 10.1148/radiol.2223010812; CLAUSS MA, 1990, CANCER RES, V50, P3487; Cortez-Retamozo V, 2008, J CLIN INVEST, V118, P4058, DOI 10.1172/JCI36335; DEBOER M, 2009, MICROMETASTASES ISOL, P653; Elenbaas B, 2001, EXP CELL RES, V264, P169, DOI 10.1006/excr.2000.5133; Elias DR, 2008, CANCER BIOMARK, V4, P287, DOI 10.3233/CBM-2008-4602; Fatouros M, 2005, EXPERT REV ANTICANC, V5, P737, DOI 10.1586/14737140.5.4.737; Germain RN, 2008, IMMUNOL REV, V221, P163, DOI 10.1111/j.1600-065X.2008.00591.x; Gounaris E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002916; HILMAS DE, 1974, CANCER, V33, P103, DOI 10.1002/1097-0142(197401)33:1<103::AID-CNCR2820330116>3.0.CO;2-7; Ishizawa T, 2009, CANCER-AM CANCER SOC, V115, P2491, DOI 10.1002/cncr.24291; JAKOWATZ JG, 1985, CANCER RES, V45, P5700; Ke S, 2003, CANCER RES, V63, P7870; Kelloff GJ, 2005, CLIN CANCER RES, V11, P7967, DOI 10.1158/1078-0432.CCR-05-1302; Kirsch DG, 2007, NAT MED, V13, P992, DOI 10.1038/nm1602; Leimgruber A, 2009, NEOPLASIA, V11, P459, DOI 10.1593/neo.09356; LEWIS JJ, 1997, ASS LOCAL RECURRENCE, P646; Liu GZ, 2005, EUR J NUCL MED MOL I, V32, P1115, DOI 10.1007/s00259-005-1853-5; Mertz KD, 2007, HUM PATHOL, V38, P1454, DOI 10.1016/j.humpath.2007.05.017; NAHRENDORF M, 2009, HYBRID IN VIVO FMT C; Newman JR, 2008, CANCER BIOL THER, V7, P1063, DOI 10.4161/cbt.7.7.6109; Nie SM, 2007, ANNU REV BIOMED ENG, V9, P257, DOI 10.1146/annurev.bioeng.9.060906.152025; NIMURA H, 2004, INFRARED RAY ELECT E, P575; Nuutila J, 2007, J IMMUNOL METHODS, V328, P189, DOI 10.1016/j.jim.2007.09.002; Parungo CP, 2005, J THORAC CARDIOV SUR, V129, P844, DOI 10.1016/j.jtcvs.2004.08.001; SHETH RA, 2009, GYNECOLOGIC ONCOLOGY; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; Stroh M, 2005, NAT MED, V11, P678, DOI 10.1038/nm1247; Stummer W, 2008, NEUROSURGERY, V62, P564, DOI [10.1227/01.NEU.0000297118.47076.5F, 10.1227/01.NEU.0000346230.80425.3A, 10.1227/01.neu.0000317304.31579.17]; Sullivan CAW, 2009, HUM PATHOL, V40, P156, DOI 10.1016/j.humpath.2008.07.005; Thurber GM, 2008, ADV DRUG DELIVER REV, V60, P1421, DOI 10.1016/j.addr.2008.04.012; Thurber GM, 2008, CANCER RES, V68, P3334, DOI 10.1158/0008-5472.CAN-07-3018; Thurber GM, 2007, J NUCL MED, V48, P995, DOI 10.2967/jnumed.106.037069; Van Dyke T, 2002, CELL, V108, P135, DOI 10.1016/S0092-8674(02)00621-9; Wasserberg N, 2008, J SURG ONCOL, V98, P611, DOI 10.1002/jso.21036; Weissleder R, 1999, NAT BIOTECHNOL, V17, P375, DOI 10.1038/7933; Weissleder R, 2006, SCIENCE, V312, P1168, DOI 10.1126/science.1125949; Weissleder R, 2008, NATURE, V452, P580, DOI 10.1038/nature06917; Winter MJ, 2003, AM J PATHOL, V163, P2139, DOI 10.1016/S0002-9440(10)63570-5; Wulfkuhle JD, 2003, NAT REV CANCER, V3, P267, DOI 10.1038/nrc1043; Yamaguchi H, 2005, CURR OPIN CELL BIOL, V17, P559, DOI 10.1016/j.ceb.2005.08.002; Zou P, 2009, MOL PHARMACEUT, V6, P428, DOI 10.1021/mp9000052; 2009, NATURE, V459, P629	46	23	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2009	4	11							e8053	10.1371/journal.pone.0008053	http://dx.doi.org/10.1371/journal.pone.0008053			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MQ	19956597	Green Published, gold, Green Submitted			2022-12-25	WOS:000272828400011
J	Wu, CY; Martel, J; Young, D; Young, JD				Wu, Cheng-Yeu; Martel, Jan; Young, David; Young, John D.			Fetuin-A/Albumin-Mineral Complexes Resembling Serum Calcium Granules and Putative Nanobacteria: Demonstration of a Dual Inhibition-Seeding Concept	PLOS ONE			English	Article							DENTIN MATRIX PROTEIN-1; ACID-CONTAINING PROTEIN; TAMM-HORSFALL PROTEIN; HYDROXYAPATITE FORMATION; IN-VITRO; BONE SIALOPROTEIN; RANDALLS PLAQUE; CALCIFYING NANOPARTICLES; PHOSPHATE PRECIPITATION; VASCULAR CALCIFICATION	Serum-derived granulations and purported nanobacteria (NB) are pleomorphic apatite structures shown to resemble calcium granules widely distributed in nature. They appear to be assembled through a dual inhibitory-seeding mechanism involving proteinaceous factors, as determined by protease (trypsin and chymotrypsin) and heat inactivation studies. When inoculated into cell culture medium, the purified proteins fetuin-A and albumin fail to induce mineralization, but they will readily combine with exogenously added calcium and phosphate, even in submillimolar amounts, to form complexes that will undergo morphological transitions from nanoparticles to spindles, films, and aggregates. As a mineralization inhibitor, fetuin-A is much more potent than albumin, and it will only seed particles at higher mineral-to-protein concentrations. Both proteins display a bell-shaped, dose-dependent relationship, indicative of the same dual inhibitory-seeding mechanism seen with whole serum. As ascertained by both seeding experiments and gel electrophoresis, fetuin-A is not only more dominant but it appears to compete avidly for nanoparticle binding at the expense of albumin. The nanoparticles formed in the presence of fetuin-A are smaller than their albumin counterparts, and they have a greater tendency to display a multilayered ring morphology. In comparison, the particles seeded by albumin appear mostly incomplete, with single walls. Chemically, spectroscopically, and morphologically, the protein-mineral particles resemble closely serum granules and NB. These particles are thus seen to undergo an amorphous to crystalline transformation, the kinetics and completeness of which depend on the protein-to-mineral ratios, with low ratios favoring faster conversion to crystals. Our results point to a dual inhibitory-seeding, de-repression model for the assembly of particles in supersaturated solutions like serum. The presence of proteins and other inhibitory factors tend to block apatite nuclei formation or to stabilize the nascent nuclei as amorphous or semi-crystalline spherical nanoparticles, until the same inhibitory influences are overwhelmed or derepressed, whereby the apatite nuclei grow in size to coalesce into crystalline spindles and films-a mechanism that may explain not only the formation of calcium granules in nature but also normal or ectopic calcification in the body.	[Wu, Cheng-Yeu; Martel, Jan; Young, David; Young, John D.] Chang Gung Univ, Lab Nanomat, Gueishan, Taiwan; [Wu, Cheng-Yeu] Chang Gung Univ, Res Ctr Bacterial Pathogenesis, Gueishan, Taiwan; [Martel, Jan] Chang Gung Univ, Grad Inst Biomed Sci, Dept Biochem & Mol Biol, Gueishan, Taiwan; [Young, David] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA; [Young, John D.] Rockefeller Univ, Cellular Physiol & Immunol Lab, New York, NY 10021 USA; [Young, John D.] Mingchi Univ Technol, Biochem Engn Res Ctr, Taipei, Taiwan	Chang Gung University; Chang Gung University; Chang Gung University; Massachusetts Institute of Technology (MIT); Rockefeller University; Ming Chi University of Technology	Wu, CY (corresponding author), Chang Gung Univ, Lab Nanomat, Gueishan, Taiwan.	dingeyoung@hotmail.com		Young, David/0000-0002-8290-5561; Martel, Jan/0000-0003-0879-109X	Chang Gung University [FMRPD2T02]; Mingchi University of Technology [0XB0]	Chang Gung University; Mingchi University of Technology	This study was supported by Primordia Institute of New Sciences and Medicine and by grants from Chang Gung University (FMRPD2T02) and from Mingchi University of Technology (0XB0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADDADI L, 1985, P NATL ACAD SCI USA, V82, P4110, DOI 10.1073/pnas.82.12.4110; Addadi L, 2008, NATO SCI PEACE SEC B, P1, DOI 10.1007/978-1-4020-6823-2_1; Aho K, 2003, J CLIN MICROBIOL, V41, P3460, DOI 10.1128/JCM.41.7.3460-3461.2003; Aizenberg J, 1996, ADV MATER, V8, P222, DOI 10.1002/adma.19960080307; Anderson HC, 2005, FRONT BIOSCI-LANDMRK, V10, P822, DOI 10.2741/1576; AOBA T, 1987, CALCIFIED TISSUE INT, V41, P281, DOI 10.1007/BF02555230; Areva S, 2002, CHEM MATER, V14, P1614, DOI 10.1021/cm0107272; Arvidsson A, 2009, J MATER SCI-MATER M, V20, P1869, DOI 10.1007/s10856-009-3755-8; ASHTON BA, 1974, EUR J BIOCHEM, V45, P525, DOI 10.1111/j.1432-1033.1974.tb03577.x; Ayman A, 2008, EUR PHYS J-SPEC TOP, V153, P497, DOI 10.1140/epjst/e2008-00493-5; Baht GS, 2008, MATRIX BIOL, V27, P600, DOI 10.1016/j.matbio.2008.06.004; Barralet J, 1998, J BIOMED MATER RES, V41, P79, DOI 10.1002/(SICI)1097-4636(199807)41:1<79::AID-JBM10>3.0.CO;2-C; Barrere F, 2006, INT J NANOMED, V1, P317; Benesch J, 2008, TISSUE ENG PART B-RE, V14, P433, DOI 10.1089/ten.teb.2008.0121; Beniash E, 2005, J STRUCT BIOL, V149, P182, DOI 10.1016/j.jsb.2004.11.001; Benzerara K, 2003, P NATL ACAD SCI USA, V100, P7438, DOI 10.1073/pnas.0832464100; Benzerara K, 2006, J INVEST MED, V54, P367, DOI 10.2310/6650.2006.06016; BERNARD JP, 1992, GASTROENTEROLOGY, V103, P1277, DOI 10.1016/0016-5085(92)91516-7; BESARAB A, 1981, J CLIN PATHOL, V34, P1361, DOI 10.1136/jcp.34.12.1361; Beshensky AM, 2001, J AM SOC NEPHROL, V12, P2108, DOI 10.1681/ASN.V12102108; Boskey A, 2000, CALCIFIED TISSUE INT, V67, P472, DOI 10.1007/s002230001169; BOSKEY AL, 1993, BONE MINER, V22, P147, DOI 10.1016/S0169-6009(08)80225-5; Boskey AL, 1997, CALCIFIED TISSUE INT, V61, P298, DOI 10.1007/s002239900339; BOSKEY AL, 1990, BONE MINER, V11, P55, DOI 10.1016/0169-6009(90)90015-8; BOSKEY AL, 1995, ANN NY ACAD SCI, V760, P249, DOI 10.1111/j.1749-6632.1995.tb44635.x; BOSKEY AL, 1991, CRIT REV ORAL BIOL M, V2, P369, DOI 10.1177/10454411910020030501; BOSKEY AL, 1985, CALCIFIED TISSUE INT, V37, P57, DOI 10.1007/BF02557680; Boskey AL, 1998, J CELL BIOCHEM, P83, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<83::AID-JCB12>3.0.CO;2-F; BOSKEY AL, 2008, METAL IONS LIFE SCI, V4, P457; Bratos-Perez MA, 2008, EUR HEART J, V29, P371, DOI 10.1093/eurheartj/ehm592; BROWN WM, 1992, BIOESSAYS, V14, P749, DOI 10.1002/bies.950141105; Carden A, 2000, J BIOMED OPT, V5, P259, DOI 10.1117/1.429994; Carson DA, 1998, P NATL ACAD SCI USA, V95, P7846, DOI 10.1073/pnas.95.14.7846; Cartellieri S, 2002, BIOTECHNOL APPL BIOC, V35, P83, DOI 10.1042/BA20010067; Cazalbou S, 2004, J BONE MINER METAB, V22, P310, DOI 10.1007/s00774-004-0488-0; CHEN CC, 1985, CALCIFIED TISSUE INT, V37, P395, DOI 10.1007/BF02553709; CHEN CC, 1984, CALCIFIED TISSUE INT, V36, P285, DOI 10.1007/BF02405332; CHEN CC, 1986, CALCIFIED TISSUE INT, V39, P324, DOI 10.1007/BF02555199; Chen CW, 2004, J MATER CHEM, V14, P2425, DOI 10.1039/b315095j; Chen WC, 2001, MOL UROL, V5, P1, DOI 10.1089/109153601750124186; CHRISTOFFERSEN J, 1989, J CRYST GROWTH, V94, P767, DOI 10.1016/0022-0248(89)90102-4; Ciftcioglu N, 2005, KIDNEY INT, V67, P483, DOI 10.1111/j.1523-1755.2005.67105.x; Ciftcioglu N, 1999, KIDNEY INT, V56, P1893, DOI 10.1046/j.1523-1755.1999.00755.x; Ciftcioglu N, 2002, ANTIMICROB AGENTS CH, V46, P2077, DOI 10.1128/AAC.46.7.2077-2086.2002; Ciftcioglu N, 1997, VACCINES, P99; Ciftcioglu N, 1998, PATHOPHYSIOLOGY, V4, P259, DOI DOI 10.1016/S0928-4680(97)10001-3; Ciftcioglu N, 2006, J INVEST MED, V54, P385, DOI 10.2310/6650.2006.06018; Ciftcioglu N, 2007, LANCET, V369, P2078, DOI 10.1016/S0140-6736(07)60977-5; Ciftcioglu N, 2008, INT J NANOMED, V3, P105; Cisar JO, 2000, P NATL ACAD SCI USA, V97, P11511, DOI 10.1073/pnas.97.21.11511; Coe FL, 2005, J CLIN INVEST, V115, P2598, DOI 10.1172/JCI26662; Combes C, 1999, J MATER SCI-MATER M, V10, P153, DOI 10.1023/A:1008933406806; Combes C, 2002, BIOMATERIALS, V23, P2817, DOI 10.1016/S0142-9612(02)00073-X; CUERPO EG, 2000, ARCH ESP UROL, V53, P291; Daculsi G, 1999, J BIOMED MATER RES, V47, P228, DOI 10.1002/(SICI)1097-4636(199911)47:2<228::AID-JBM13>3.0.CO;2-Z; DOI Y, 1989, CALCIFIED TISSUE INT, V44, P200, DOI 10.1007/BF02556565; DOI Y, 1984, J DENT RES, V63, P98, DOI 10.1177/00220345840630021801; Dorrell S, 1999, MOL MED TODAY, V5, P373, DOI 10.1016/S1357-4310(99)01553-1; Drancourt M, 2003, J CLIN MICROBIOL, V41, P368, DOI 10.1128/JCM.41.1.368-372.2003; EANES ED, 1992, GLYCOBIOLOGY, V2, P571, DOI 10.1093/glycob/2.6.571; EANES ED, 1973, CALC TISS RES, V12, P143, DOI 10.1007/BF02013730; EANES ED, 1994, CALCIFIED TISSUE INT, V55, P176, DOI 10.1007/BF00425872; Evan A, 2006, KIDNEY INT, V69, P1313, DOI 10.1038/sj.ki.5000238; Evan AP, 2008, SEMIN NEPHROL, V28, P111, DOI 10.1016/j.semnephrol.2008.01.004; Evan AP, 2007, ANAT REC, V290, P1315, DOI 10.1002/ar.20580; Evan AP, 2005, UROL RES, V33, P383, DOI 10.1007/s00240-005-0488-0; Evan AP, 2005, KIDNEY INT, V68, P145, DOI 10.1111/j.1523-1755.2005.00388.x; Evan AP, 2003, J CLIN INVEST, V111, P607, DOI 10.1172/JCI200317038; EVAN AP, 2009, PEDIAT NEPH IN PRESS; Fang JY, 2008, EUR J PHARM BIOPHARM, V70, P633, DOI 10.1016/j.ejpb.2008.05.008; FOGHANDERSEN N, 1977, CLIN CHEM, V23, P2122; FOLK RL, 1993, J SEDIMENT PETROL, V63, P990, DOI 10.1306/D4267C67-2B26-11D7-8648000102C1865D; Fujisawa R, 1996, BBA-PROTEIN STRUCT M, V1292, P53, DOI 10.1016/0167-4838(95)00190-5; FUJISAWA R, 1987, CALCIFIED TISSUE INT, V41, P44, DOI 10.1007/BF02555130; Ganss B, 1999, CRIT REV ORAL BIOL M, V10, P79, DOI 10.1177/10454411990100010401; Garcia-Ruiz JM, 2003, SCIENCE, V302, P1194, DOI 10.1126/science.1090163; GARNETT J, 1990, BIOCHEM J, V266, P863; George A, 2008, CHEM REV, V108, P4670, DOI 10.1021/cr0782729; GILMAN H, 1994, J INORG BIOCHEM, V55, P31, DOI 10.1016/0162-0134(94)85130-1; GILMAN H, 1994, J INORG BIOCHEM, V55, P21, DOI 10.1016/0162-0134(94)85129-8; Gorski JP, 2004, J BIOL CHEM, V279, P25455, DOI 10.1074/jbc.M312408200; Hamlin NJ, 2004, CALCIFIED TISSUE INT, V75, P231, DOI 10.1007/s00223-004-0190-1; Harris NL, 2000, BONE, V27, P795, DOI 10.1016/S8756-3282(00)00392-6; Hauge EM, 2001, J BONE MINER RES, V16, P1575, DOI 10.1359/jbmr.2001.16.9.1575; He G, 2003, NAT MATER, V2, P552, DOI 10.1038/nmat945; He G, 2003, CONNECT TISSUE RES, V44, P240, DOI 10.1080/03008200390181726; Heiss A, 2007, BIOINTERPHASES, V2, P16, DOI 10.1116/1.2714924; Heiss A, 2003, J BIOL CHEM, V278, P13333, DOI 10.1074/jbc.M210868200; Heiss A, 2008, J BIOL CHEM, V283, P14815, DOI 10.1074/jbc.M709938200; Hendig D, 2006, CLIN CHEM, V52, P227, DOI 10.1373/clinchem.2005.059253; HESS B, 1992, UROL RES, V20, P83, DOI 10.1007/BF00294343; Hjelle JT, 2000, KIDNEY INT, V57, P2360, DOI 10.1046/j.1523-1755.2000.00096.x; Hudelist G, 2004, HISTOPATHOLOGY, V45, P633, DOI 10.1111/j.1365-2559.2004.02030.x; Hugel B, 2005, PHYSIOLOGY, V20, P22, DOI 10.1152/physiol.00029.2004; Hunter GK, 1996, BIOCHEM J, V317, P59, DOI 10.1042/bj3170059; HUNTER GK, 1993, P NATL ACAD SCI USA, V90, P8562, DOI 10.1073/pnas.90.18.8562; Hunter GK, 1999, CALCIFIED TISSUE INT, V65, P226, DOI 10.1007/s002239900688; HUNTER GK, 1994, BIOCHEM J, V302, P175, DOI 10.1042/bj3020175; Jahnen-Dechent W, 2001, Z Kardiol, V90 Suppl 3, P47; Jahnen-Dechent W, 2008, J MOL MED, V86, P379, DOI 10.1007/s00109-007-0294-y; JahnenDechent W, 1997, J BIOL CHEM, V272, P31496, DOI 10.1074/jbc.272.50.31496; JAHNENDECHENT W, 2004, PROGR BIOL MOL BIOL, P243; Johansson L, 2003, CYTOTECHNOLOGY, V42, P67, DOI 10.1023/B:CYTO.0000009820.72920.cf; Jones JA, 2008, CURR CLIN UROL, P221, DOI 10.1007/978-1-59745-472-8_17; Kajander EO, 2006, LETT APPL MICROBIOL, V42, P549, DOI 10.1111/j.1472-765X.2006.01945.x; Kajander EO, 1997, P SOC PHOTO-OPT INS, V3111, P420, DOI 10.1117/12.278796; Kajander EO, 2003, UROL RES, V31, P47, DOI 10.1007/s002440-003-0304-7; Kajander EO, 1998, P NATL ACAD SCI USA, V95, P8274, DOI 10.1073/pnas.95.14.8274; Kale S, 2000, NAT BIOTECHNOL, V18, P954, DOI 10.1038/79439; Ketteler M, 2005, PEDIATR NEPHROL, V20, P383, DOI 10.1007/s00467-004-1614-x; Ketteler M, 2005, NEPHROL DIAL TRANSPL, V20, P673, DOI 10.1093/ndt/gfh734; Khullar M, 2004, UROL RES, V32, P190, DOI 10.1007/s00240-004-0400-3; Kirkland BL, 1999, GEOLOGY, V27, P347, DOI 10.1130/0091-7613(1999)027<0347:AOFNLO>2.3.CO;2; Komaba H, 2009, KIDNEY INT, V75, P874, DOI 10.1038/ki.2009.52; Kumar V, 2006, J INVEST MED, V54, P412, DOI 10.2310/6650.2006.06021; Lieske JC, 2008, NAT CLIN PRACT NEPHR, V4, P308, DOI 10.1038/ncpneph0794; LINDE A, 1989, CONNECT TISSUE RES, V21, P527; LINDE A, 1989, CALCIFIED TISSUE INT, V44, P286, DOI 10.1007/BF02553763; Ling YF, 2005, J BONE MINER RES, V20, P2169, DOI 10.1359/JBMR.050815; Luo GB, 1997, NATURE, V386, P78, DOI 10.1038/386078a0; LUSSI A, 1988, ARCH ORAL BIOL, V33, P685, DOI 10.1016/0003-9969(88)90124-0; Ma YH, 2009, BIOMATERIALS, V30, P3343, DOI 10.1016/j.biomaterials.2009.02.034; Mahamid J, 2008, P NATL ACAD SCI USA, V105, P12748, DOI 10.1073/pnas.0803354105; Malaval L, 2008, J EXP MED, V205, P1145, DOI 10.1084/jem.20071294; Maniscalco Benedict S., 2004, Pathophysiology, V11, P95, DOI 10.1016/j.pathophys.2004.06.001; MANN S, 1988, NATURE, V332, P119, DOI 10.1038/332119a0; MANN S, 2001, BIOMINERALIZATION PR, P38; Marques PAAP, 2004, J MATER CHEM, V14, P1861, DOI 10.1039/b403495c; Marques PAAP, 2003, BIOMATERIALS, V24, P451, DOI 10.1016/S0142-9612(02)00358-7; Martel J, 2008, P NATL ACAD SCI USA, V105, P5549, DOI 10.1073/pnas.0711744105; MARTIN RI, 1994, J MATER SCI-MATER M, V5, P96, DOI 10.1007/BF00121697; Matsui I, 2009, KIDNEY INT, V75, P915, DOI 10.1038/ki.2008.700; McKay DS, 1996, SCIENCE, V273, P924, DOI 10.1126/science.273.5277.924; MENANTEAU J, 1982, METAB BONE DIS RELAT, V4, P157, DOI 10.1016/0221-8747(82)90030-3; Midura RJ, 2004, J BIOL CHEM, V279, P25464, DOI 10.1074/jbc.M312409200; Miller VM, 2004, AM J PHYSIOL-HEART C, V287, pH1115, DOI 10.1152/ajpheart.00075.2004; Mo L, 2004, KIDNEY INT, V66, P1159, DOI 10.1111/j.1523-1755.2004.00867.x; Murshed M, 2004, J CELL BIOL, V165, P625, DOI 10.1083/jcb.200402046; NANCOLLAS GH, 1990, J DENT RES, V69, P1678, DOI 10.1177/00220345900690101001; Nishio S, 2000, MOL UROL, V4, P383; NYLEN MU, 1972, CALC TISS RES, V9, P95, DOI 10.1007/BF02061948; OHNISHI T, 1991, J BIOL CHEM, V266, P14636; Omelon S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005634; Parfitt AM, 2001, J BONE MINER RES, V16, P1583, DOI 10.1359/jbmr.2001.16.9.1583; Patard Louis, 2003, JOP, V4, P92; Penel G, 1998, CALCIFIED TISSUE INT, V63, P475, DOI 10.1007/s002239900561; Price PA, 2006, ARTERIOSCL THROM VAS, V26, P1079, DOI 10.1161/01.ATV.0000216406.44762.7c; Price PA, 2004, J BIOL CHEM, V279, P19169, DOI 10.1074/jbc.M307880200; Price PA, 2004, J BIOL CHEM, V279, P1594, DOI 10.1074/jbc.M305199200; Price PA, 2003, J BIOL CHEM, V278, P22153, DOI 10.1074/jbc.M300739200; Price PA, 2003, J BIOL CHEM, V278, P22144, DOI 10.1074/jbc.M300744200; PRICE PA, 1976, P NATL ACAD SCI USA, V73, P1447, DOI 10.1073/pnas.73.5.1447; Price PA, 2002, J BIOL CHEM, V277, P3926, DOI 10.1074/jbc.M106366200; Price PA, 2009, J BIOL CHEM, V284, P4594, DOI 10.1074/jbc.M803205200; Puskas LG, 2005, ACTA BIOL HUNG, V56, P233, DOI 10.1556/ABiol.56.2005.3-4.7; QUELCH KJ, 1984, CALCIFIED TISSUE INT, V36, P545, DOI 10.1007/BF02405363; RAJ PA, 1992, J BIOL CHEM, V267, P5968; Raoult D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040041; Raz S, 2002, BIOL BULL-US, V203, P269, DOI 10.2307/1543569; Rees SG, 2004, BIOMATERIALS, V25, P971, DOI 10.1016/S0142-9612(03)00618-5; Reynolds JL, 2005, J AM SOC NEPHROL, V16, P2920, DOI 10.1681/ASN.2004100895; Reynolds JL, 2004, J AM SOC NEPHROL, V15, P2857, DOI 10.1097/01.ASN.0000141960.01035.28; Rochette CN, 2009, CHEMBIOCHEM, V10, P735, DOI 10.1002/cbic.200800719; Rohanizadeh R, 1998, J BIOMED MATER RES, V42, P530, DOI 10.1002/(SICI)1097-4636(19981215)42:4<530::AID-JBM8>3.0.CO;2-6; ROMBERG RW, 1985, J BIOL CHEM, V260, P2728; Ruiz JMG, 2002, ASTROBIOLOGY, V2, P353, DOI 10.1089/153110702762027925; Ryall RL, 2008, UROL RES, V36, P77, DOI 10.1007/s00240-007-0131-3; Samoylov AM, 2005, CELLS TISSUES ORGANS, V179, P115, DOI 10.1159/000085003; SAROFF HA, 1963, J PHYS CHEM-US, V67, P1211, DOI 10.1021/j100800a011; Schafer C, 2003, J CLIN INVEST, V112, P357, DOI 10.1172/JCI17202; Schinke T, 1996, J BIOL CHEM, V271, P20789, DOI 10.1074/jbc.271.34.20789; Schoppet M, 2008, KIDNEY INT, V73, P384, DOI 10.1038/sj.ki.5002696; Schwartz MAK, 2008, INT J NANOMED, V3, P243; Schwartz MK, 2009, AM J PHYSIOL-HEART C, V296, pH1434, DOI 10.1152/ajpheart.00993.2008; Serro AP, 2004, J BIOMED MATER RES A, V70A, P420, DOI 10.1002/jbm.a.30096; Serro AP, 1997, BIOMATERIALS, V18, P963, DOI 10.1016/S0142-9612(97)00031-8; Shaw WJ, 2000, J AM CHEM SOC, V122, P7118, DOI 10.1021/ja000878q; Shiekh FA, 2009, CLIN NEPHROL, V71, P1; Shiekh FA, 2006, UROL RES, V34, P53, DOI 10.1007/s00240-005-0034-0; SHIRAGA H, 1992, P NATL ACAD SCI USA, V89, P426, DOI 10.1073/pnas.89.1.426; Shoskes DA, 2005, J UROLOGY, V173, P474, DOI 10.1097/01.ju.0000150062.60633.b2; Sillitoe RH, 1996, SCIENCE, V272, P1153, DOI 10.1126/science.272.5265.1153; Singh S, 2008, J COLLOID INTERF SCI, V319, P322, DOI 10.1016/j.jcis.2007.09.059; Smirnov GV, 2008, CONTEMP PROBL ECOL+, V1, P111, DOI 10.1134/S1995425508010128; Sommer AP, 2006, CHEMOTHERAPY, V52, P95, DOI 10.1159/000092475; Sommer AP, 2006, J ENVIRON MONITOR, V8, P341, DOI 10.1039/b512496d; Sommer AP, 2006, CRYST GROWTH DES, V6, P492, DOI 10.1021/cg050418e; Sommer AP, 2005, J PROTEOME RES, V4, P180, DOI 10.1021/pr0498382; Steitz SA, 2002, AM J PATHOL, V161, P2035, DOI 10.1016/S0002-9440(10)64482-3; Strate T, 2003, INT J COLORECTAL DIS, V18, P97, DOI 10.1007/s00384-002-0432-5; Stubbs JT, 1997, J BONE MINER RES, V12, P1210, DOI 10.1359/jbmr.1997.12.8.1210; Sugars RV, 2003, CONNECT TISSUE RES, V44, P189, DOI 10.1080/713713596; Suvorova EI, 1999, J MICROSC-OXFORD, V196, P46, DOI 10.1046/j.1365-2818.1999.00608.x; Suvorova EI, 2001, CRYSTALLOGR REP+, V46, P722, DOI 10.1134/1.1405856; SUZUKI M, 1994, J EXP ZOOL, V270, P501, DOI 10.1002/jez.1402700603; Suzuki S, 2009, MATRIX BIOL, V28, P221, DOI 10.1016/j.matbio.2009.03.006; Tartaix PH, 2004, J BIOL CHEM, V279, P18115, DOI 10.1074/jbc.M314114200; TERKELTAUB RA, 1988, ARTHRITIS RHEUM, V31, P1081, DOI 10.1002/art.1780310901; TERMINE JD, 1981, CELL, V26, P99, DOI 10.1016/0092-8674(81)90037-4; Toroian D, 2008, CALCIFIED TISSUE INT, V82, P116, DOI 10.1007/s00223-007-9085-2; Tsortos A, 1996, J COLLOID INTERF SCI, V177, P257, DOI 10.1006/jcis.1996.0029; Urbano P, 2007, PLOS PATHOG, V3, P567, DOI 10.1371/journal.ppat.0030055; Vali H, 2001, GEOCHIM COSMOCHIM AC, V65, P63, DOI 10.1016/S0016-7037(00)00525-1; Vallet-Regi M, 2000, CHEM MATER, V12, P961, DOI 10.1021/cm991110b; VODYANOY V, 2007, P SOC PHOTO-OPT INST, V6694, P1; Waddington R. J., 2003, European Cells & Materials, V6, P12; Wainwright M, 2004, MICROBIOL-SGM, V150, P756, DOI 10.1099/mic.0.26907-0; Wainwright M, 2003, FEMS MICROBIOL LETT, V218, P161, DOI 10.1111/j.1574-6968.2003.tb11513.x; Wang LM, 2006, DIGEST DIS SCI, V51, P1126, DOI 10.1007/s10620-006-8019-6; Wen HB, 2003, J BIOMED MATER RES A, V64A, P483, DOI 10.1002/jbm.a.10401; Wen Y, 2005, CHINESE MED J-PEKING, V118, P421; Westenfeld R, 2007, NEPHROL DIAL TRANSPL, V22, P1537, DOI 10.1093/ndt/gfm094; Westenfeld R, 2007, TRENDS CARDIOVAS MED, V17, P124, DOI 10.1016/j.tcm.2007.02.005; Wickramasinghe JT, 2006, ASTROPHYS SPACE SCI, V305, P411, DOI 10.1007/s10509-006-9181-1; WIKIEL K, 1994, ARCH ORAL BIOL, V39, P715, DOI 10.1016/0003-9969(94)90099-X; Wong F, 2007, NAT CLIN PRACT GASTR, V4, P43, DOI 10.1038/ncpgasthep0680; Ye L, 2004, J BIOL CHEM, V279, P19141, DOI 10.1074/jbc.M400490200; Young JD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005421; Young JD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004417; ZANETTI M, 1981, EUR J BIOCHEM, V113, P541, DOI 10.1111/j.1432-1033.1981.tb05096.x; Zeng H, 1999, BIOMATERIALS, V20, P443, DOI 10.1016/S0142-9612(98)00190-2; Zhou HD, 2006, MOL IMMUNOL, V43, P1864, DOI 10.1016/j.molimm.2005.10.021; Zhou ZS, 2008, UROLOGY, V71, P1091, DOI 10.1016/j.urology.2008.02.041	223	60	65	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2009	4	11							e8058	10.1371/journal.pone.0008058	http://dx.doi.org/10.1371/journal.pone.0008058			40	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MQ	19956594	Green Submitted, Green Published, gold			2022-12-25	WOS:000272828400013
J	Becerra, L; Harris, W; Grant, M; George, E; Boas, D; Borsook, D				Becerra, Lino; Harris, Will; Grant, Margaret; George, Edward; Boas, David; Borsook, David			Diffuse Optical Tomography Activation in the Somatosensory Cortex: Specific Activation by Painful vs. Non-Painful Thermal Stimuli	PLOS ONE			English	Article							MEDIAN NERVE-STIMULATION; REPRESENTATION; FMRI	Background: Pain is difficult to assess due to the subjective nature of self-reporting. The lack of objective measures of pain has hampered the development of new treatments as well as the evaluation of current ones. Functional MRI studies of pain have begun to delineate potential brain response signatures that could be used as objective read-outs of pain. Using Diffuse Optical Tomography (DOT), we have shown in the past a distinct DOT signal over the somatosensory cortex to a noxious heat stimulus that could be distinguished from the signal elicited by innocuous mechanical stimuli. Here we further our findings by studying the response to thermal innocuous and noxious stimuli. Methodology/Principal Findings: Innocuous and noxious thermal stimuli were applied to the skin of the face of the first division (ophthalmic) of the trigeminal nerve in healthy volunteers (N = 6). Stimuli temperatures were adjusted for each subject to evoke warm (equivalent to a 3/10) and painful hot (7/10) sensations in a verbal rating scale (0/10 = no/max pain). A set of 26 stimuli (5 sec each) was applied for each temperature with inter-stimulus intervals varied between 8 and 15 sec using a Peltier thermode. A DOT system was used to capture cortical responses on both sides of the head over the primary somatosensory cortical region (S1). For the innocuous stimuli, group results indicated mainly activation on the contralateral side with a weak ipsilateral response. For the noxious stimuli, bilateral activation was observed with comparable amplitudes on both sides. Furthermore, noxious stimuli produced a temporal biphasic response while innocuous stimuli produced a monophasic response. Conclusions/Significance: These results are in accordance with fMRI and our other DOT studies of innocuous mechanical and noxious heat stimuli. The data indicate the differentiation of DOT cortical responses for pain vs. innocuous stimuli that may be useful in assessing objectively acute pain.	[Becerra, Lino; Harris, Will; Grant, Margaret; George, Edward; Borsook, David] McLean Hosp, PAIN, Belmont, MA 02178 USA; [Boas, David] McLean Hosp, Photon Migrat Lab, Belmont, MA 02178 USA; [Becerra, Lino; Harris, Will; Grant, Margaret; George, Edward; Boas, David; Borsook, David] Massachusetts Gen Hosp, Charlestown, MA USA; [Becerra, Lino; Harris, Will; Grant, Margaret; Boas, David] Harvard Univ, Sch Med, Athinoula A Martinos Ctr Biomed Engn, Charlestown, MA USA	Harvard University; McLean Hospital; Harvard University; McLean Hospital; Harvard University; Massachusetts General Hospital; Harvard University	Becerra, L (corresponding author), McLean Hosp, PAIN, 115 Mill St, Belmont, MA 02178 USA.	lbecerra@partners.org			Mayday Foundation; NINDS [K24 NS064050]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K24NS064050] Funding Source: NIH RePORTER	Mayday Foundation; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by a grant from the Mayday Foundation and a NINDS Mentor Training Grant to DB (K24 NS064050). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becerra L, 2008, NEUROIMAGE, V41, P252, DOI 10.1016/j.neuroimage.2008.01.047; Becerra L, 2001, NEURON, V32, P927, DOI 10.1016/S0896-6273(01)00533-5; Chen JI, 2002, J NEUROPHYSIOL, V88, P464, DOI 10.1152/jn.2002.88.1.464; DaSilva AFM, 2002, J NEUROSCI, V22, P8183; Franceschini MA, 2003, PSYCHOPHYSIOLOGY, V40, P548, DOI 10.1111/1469-8986.00057; Franceschini MA, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2363365; Hlushchuk Y, 2006, J NEUROSCI, V26, P5819, DOI 10.1523/JNEUROSCI.5536-05.2006; Huppert TJ, 2009, APPL OPTICS, V48, pD280, DOI 10.1364/AO.48.00D280; Moulton EA, 2009, HUM BRAIN MAPP, V30, P757, DOI 10.1002/hbm.20541; NICHOLSON AN, 1978, BRIT J CLIN PHARMACO, V6, P3, DOI 10.1111/j.1365-2125.1978.tb01673.x; Nihashi T, 2005, CLIN NEUROPHYSIOL, V116, P842, DOI 10.1016/j.clinph.2004.10.011; Sutherland MT, 2006, NEUROIMAGE, V33, P1042, DOI 10.1016/j.neuroimage.2006.08.015; Suzuki T, 2004, JPN J PHYSIOL, V54, P161, DOI 10.2170/jjphysiol.54.161	13	38	38	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2009	4	11							e8016	10.1371/journal.pone.0008016	http://dx.doi.org/10.1371/journal.pone.0008016			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MH	19956637	gold, Green Published			2022-12-25	WOS:000272827500038
J	May, K; Grube, M; Malhotra, I; Long, CA; Singh, S; Mandaliya, K; Siegmund, W; Fusch, C; Schneider, H; King, CL				May, Karen; Grube, Markus; Malhotra, Indu; Long, Carole A.; Singh, Sanjay; Mandaliya, Kishor; Siegmund, Werner; Fusch, Christoph; Schneider, Henning; King, Christopher L.			Antibody-Dependent Transplacental Transfer of Malaria Blood-Stage Antigen Using a Human Ex Vivo Placental Perfusion Model	PLOS ONE			English	Article							MEROZOITE SURFACE PROTEIN-1; PLASMODIUM-FALCIPARUM; IMMUNE-COMPLEX; CORD-BLOOD; DIAPLACENTAL TRANSPORT; FC-RECEPTORS; IN-UTERO; IGG; TRANSMISSION; INFECTION	Prenatal exposure to allergens or antigens released by infections during pregnancy can stimulate an immune response or induce immunoregulatory networks in the fetus affecting susceptibility to infection and disease later in life. How antigen crosses from the maternal to fetal environment is poorly understood. One hypothesis is that transplacental antigen transfer occurs as immune complexes, via receptor-mediated transport across the syncytiotrophoblastic membrane and endothelium of vessels in fetal villi. This hypothesis has never been directly tested. Here we studied Plasmodium falciparum merozoite surface protein 1 (MSP1) that is released upon erythrocyte invasion. We found MSP1 in cord blood from a third of newborns of malaria-infected women and in >90% following treatment with acid dissociation demonstrating MSP1 immune complexes. Using an ex vivo human placental model that dually perfuses a placental cotyledon with independent maternal and fetal circuits, immune-complexed MSP1 transferred from maternal to fetal circulation. MSP1 alone or with non-immune plasma did not transfer; pre-incubation with human plasma containing anti-MSP1 was required. MSP1 bound to IgG was detected in the fetal perfusate. Laser scanning confocal microscopy demonstrated MSP1 in the fetal villous stroma, predominantly in fetal endothelial cells. MSP1 co-localized with IgG in endothelial cells, but not with placental macrophages. Thus we show, for the first time, antibody-dependent transplacental transfer of an antigen in the form of immune complexes. These studies imply frequent exposure of the fetus to certain antigens with implications for management of maternal infections during pregnancy and novel approaches to deliver vaccines or drugs to the fetus.	[May, Karen; Grube, Markus; Siegmund, Werner] Univ Greifswald, Dept Pharmacol, Greifswald, Germany; [Fusch, Christoph] Univ Greifswald, Dept Pediat, Greifswald, Germany; [Malhotra, Indu; King, Christopher L.] Case Western Reserve Univ, Ctr Global Hlth & Dis, Cleveland, OH 44106 USA; [Long, Carole A.; Singh, Sanjay] NIH, Malaria Vaccine Dev Unit, Bethesda, MD 20892 USA; [Long, Carole A.; Singh, Sanjay] NIH, Lab Malaria & Vector Res, Bethesda, MD 20892 USA; [Mandaliya, Kishor] Mombasa Gen Hosp, Kenyan Minist Hlth, Pathol Serv, Mombasa, Kenya; [Schneider, Henning] Univ Bern, Dept Obstet & Gynecol, CH-3000 Bern, Switzerland; [King, Christopher L.] Louis B Stokes Vet Affairs Med Ctr, Cleveland, OH USA	Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; Case Western Reserve University; National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; University of Bern; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center	May, K (corresponding author), Univ Greifswald, Dept Pharmacol, Greifswald, Germany.	cxk21@case.edu			Departments of Pharmacology and Pediatrics, Ernst Moritz Arndt University of Greifswald; National Institutes of Health [AI064687]; Veterans Affairs Research Service; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001020, R01AI064687] Funding Source: NIH RePORTER	Departments of Pharmacology and Pediatrics, Ernst Moritz Arndt University of Greifswald; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Research Service(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Departments of Pharmacology and Pediatrics, Ernst Moritz Arndt University of Greifswald, National Institutes of Health grant AI064687, and the Veterans Affairs Research Service. HS was Alfried Krupp Wissenschaftskolleg Fellow. The Department of Obstetrics and Gynecology, University of Greifswald provided the fresh placentas for the perfusion studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAJORIA R, 1992, J PHARM PHARMACOL, V44, P952, DOI 10.1111/j.2042-7158.1992.tb07073.x; BAUMAN WA, 1981, P NATL ACAD SCI-BIOL, V78, P4588, DOI 10.1073/pnas.78.7.4588; Biswas Sukla, 1999, Indian Journal of Malariology, V36, P33; BLACKMAN MJ, 1991, MOL BIOCHEM PARASIT, V49, P29, DOI 10.1016/0166-6851(91)90127-R; BLACKMAN MJ, 1991, MOL BIOCHEM PARASIT, V49, P35, DOI 10.1016/0166-6851(91)90128-S; Breman JG, 2001, AM J TROP MED HYG, V64, pIV, DOI 10.4269/ajtmh.2001.64.iv; Broen K, 2007, MOL BIOCHEM PARASIT, V151, P1, DOI 10.1016/j.molbiopara.2006.10.001; Brustoski K, 2006, J INFECT DIS, V193, P146, DOI 10.1086/498578; BUSE MG, 1962, J CLIN INVEST, V41, P29, DOI 10.1172/JCI104464; Casas R, 2004, CLIN EXP ALLERGY, V34, P591, DOI 10.1111/j.1365-2222.2004.1924.x; Casas R, 2001, PEDIATR ALLERGY IMMU, V12, P59, DOI 10.1034/j.1399-3038.2001.012002059.x; Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X; Edelbauer M, 2003, INT ARCH ALLERGY IMM, V130, P25, DOI 10.1159/000068373; Egan A, 1997, INFECT IMMUN, V65, P3024, DOI 10.1128/IAI.65.8.3024-3031.1997; Firan M, 2001, INT IMMUNOL, V13, P993, DOI 10.1093/intimm/13.8.993; Gabriel S, 2002, PARASITE IMMUNOL, V24, P521, DOI 10.1046/j.1365-3024.2002.00494.x; HOLDER AA, 1985, NATURE, V317, P270, DOI 10.1038/317270a0; Holloway JA, 2000, LANCET, V356, P1900, DOI 10.1016/S0140-6736(00)03265-7; HOLT P, 2004, CHEM IMMUNOL ALLERGY, V84; Jakobsen PH, 1998, IMMUNOLOGY, V93, P264, DOI 10.1046/j.1365-2567.1998.00421.x; Kaneda T, 1997, J PEDIATR-US, V130, P730, DOI 10.1016/S0022-3476(97)80014-5; Kassberger F, 2002, PARASITOL RES, V88, P1073, DOI 10.1007/s00436-002-0715-3; King CL, 2002, J IMMUNOL, V168, P356, DOI 10.4049/jimmunol.168.1.356; Koraka P, 2003, J CLIN MICROBIOL, V41, P4154, DOI 10.1128/JCM.41.9.4154-4159.2003; Kristoffersen EK, 1996, EUR J IMMUNOL, V26, P1668, DOI 10.1002/eji.1830260741; Kwiek JJ, 2006, PLOS MED, V3, P70, DOI 10.1371/journal.pmed.0030010; Leach JL, 1996, J IMMUNOL, V157, P3317; Leach L, 1997, MICROSC RES TECHNIQ, V38, P137; LEHNER PJ, 1988, T ROY SOC TROP MED H, V82, P822, DOI 10.1016/0035-9203(88)90006-5; Linnemann K, 2000, J CLIN ENDOCR METAB, V85, P4298, DOI 10.1210/jc.85.11.4298; Loibichler C., 2002, Clinical and Experimental Allergy, V32, P1546, DOI 10.1046/j.1365-2222.2002.01479.x; MAENO Y, 1993, AM J TROP MED HYG, V49, P574, DOI 10.4269/ajtmh.1993.49.574; Malek A, 1996, AM J REPROD IMMUNOL, V36, P248; Malek A, 1998, AM J REPROD IMMUNOL, V40, P347; Malek A, 1997, AM J REPROD IMMUNOL, V38, P263; MALEK A, 1994, PFLUG ARCH EUR J PHY, V427, P157, DOI 10.1007/BF00585955; Malhotra I, 2005, INFECT IMMUN, V73, P3462, DOI 10.1128/IAI.73.6.3462-3470.2005; Malhotra I, 2006, J INFECT DIS, V194, P176, DOI 10.1086/505150; MARSHALL DE, 1983, T ROY SOC TROP MED H, V77, P470, DOI 10.1016/0035-9203(83)90116-5; May K, 2008, DRUG METAB DISPOS, V36, P740, DOI 10.1124/dmd.107.019448; MCGREGOR IA, 1984, AM J TROP MED HYG, V33, P517, DOI 10.4269/ajtmh.1984.33.517; MENON RK, 1990, NEW ENGL J MED, V323, P309, DOI 10.1056/NEJM199008023230505; Metenou S, 2007, J IMMUNOL, V178, P2770, DOI 10.4049/jimmunol.178.5.2770; Mibei EK, 2008, PARASITE IMMUNOL, V30, P334, DOI 10.1111/j.1365-3024.2008.01030.x; Mibei EK, 2005, AM J TROP MED HYG, V72, P593, DOI 10.4269/ajtmh.2005.72.593; MILES SA, 1993, NEW ENGL J MED, V328, P297, DOI 10.1056/NEJM199302043280501; Mold JE, 2008, SCIENCE, V322, P1562, DOI 10.1126/science.1164511; Okoko BJ, 2001, J INFECT DIS, V184, P627, DOI 10.1086/322808; Pleass RJ, 2009, PARASITE IMMUNOL, V31, P61, DOI 10.1111/j.1365-3024.2008.01076.x; Qiao SW, 2008, P NATL ACAD SCI USA, V105, P9337, DOI 10.1073/pnas.0801717105; Redd SC, 1996, AM J TROP MED HYG, V55, P57, DOI 10.4269/ajtmh.1996.55.57; Rogerson SJ, 2007, LANCET INFECT DIS, V7, P105, DOI 10.1016/S1473-3099(07)70022-1; Saji F, 1999, REV REPROD, V4, P81, DOI 10.1530/ror.0.0040081; SCHNEIDE.H, 1972, AM J OBSTET GYNECOL, V114, P822, DOI 10.1016/0002-9378(72)90909-X; Simister NE, 1998, VACCINE, V16, P1451, DOI 10.1016/S0264-410X(98)00107-8; Simister NE, 1996, EUR J IMMUNOL, V26, P1527, DOI 10.1002/eji.1830260718; Simister NE, 1997, J REPROD IMMUNOL, V37, P1, DOI 10.1016/S0165-0378(97)00068-5; Simister NE, 2003, VACCINE, V21, P3365, DOI 10.1016/S0264-410X(03)00334-7; Szepfalusi Z, 2000, PEDIATR RES, V48, P404, DOI 10.1203/00006450-200009000-00024; Takizawa T, 2005, J IMMUNOL, V175, P2331, DOI 10.4049/jimmunol.175.4.2331; Xi GL, 2003, INFECT IMMUN, V71, P1242, DOI 10.1128/IAI.71.3.1242-1246.2003	61	49	49	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2009	4	11							e7986	10.1371/journal.pone.0007986	http://dx.doi.org/10.1371/journal.pone.0007986			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MH	19956710	gold, Green Published, Green Submitted			2022-12-25	WOS:000272827500016
J	Bar, M; Sharfman, M; Schuster, S; Avni, A				Bar, Maya; Sharfman, Miya; Schuster, Silvia; Avni, Adi			The Coiled-Coil Domain of EHD2 Mediates Inhibition of LeEix2 Endocytosis and Signaling	PLOS ONE			English	Article							ETHYLENE-INDUCING XYLANASE; NICOTIANA-TABACUM; VESICLE TRAFFICKING; DYNAMIN RECRUITMENT; TRICHODERMA-VIRIDE; PROTEIN; ARABIDOPSIS; MEMBRANE; RECEPTOR; ACTIN	Endocytosis has been suggested to be crucial for the induction of plant immunity in several cases. We have previously shown that two Arabidopsis proteins, AtEHD1 and AtEHD2, are involved in endocytosis in plant systems. AtEHD2 has an inhibitory effect on endocytosis of transferrin, FM-4-64, and LeEix2. There are many works in mammalian systems detailing the importance of the various domains in EHDs but, to date, the domains of plant EHD2 that are required for its inhibitory activity on endocytosis remained unknown. In this work we demonstrate that the coiled-coil domain of EHD2 is crucial for the ability of EHD2 to inhibit endocytosis in plants, as mutant EHD2 forms lacking the coiled-coil lost the ability to inhibit endocytosis and signaling of LeEix2. The coiled-coil was also required for binding of EHD2 to the LeEix2 receptor. It is therefore probable that binding of EHD2 to the LeEix2 receptor is required for inhibition of LeEix2 internalization. We also show herein that the P-loop of EHD2 is important for EHD2 to function properly. The EH domain of AtEHD2 does not appear to be involved in inhibition of endocytosis. Moreover, AtEHD2 influences actin organization and may exert its inhibitory effect on endocytosis through actin re-distribution. The coiled-coil domain of EHD2 functions in inhibition of endocytosis, while the EH domain does not appear to be involved in inhibition of endocytosis.			Bar, M (corresponding author), Tel Aviv Univ, Dept Plant Sci, IL-69978 Tel Aviv, Israel.	Lpavni@post.tau.ac.il	Avni, Adi/R-9048-2017	Avni, Adi/0000-0003-2092-9768; Bar, Maya/0000-0002-7823-9121				Abu-Abied M, 2006, PLANT J, V48, P367, DOI 10.1111/j.1365-313X.2006.02883.x; Aniento F, 2005, PROTOPLASMA, V226, P3, DOI 10.1007/s00709-005-0101-y; AVNI A, 1994, PLANT PHYSIOL, V106, P1049, DOI 10.1104/pp.106.3.1049; BAILEY BA, 1990, PLANT PHYSIOL, V94, P1849, DOI 10.1104/pp.94.4.1849; BAILEY BA, 1992, PLANT PHYSIOL, V100, P1615, DOI 10.1104/pp.100.3.1615; Bar M, 2008, PLANT J, V55, P1025, DOI 10.1111/j.1365-313X.2008.03571.x; Bar M, 2009, PLANT J, V59, P600, DOI 10.1111/j.1365-313X.2009.03897.x; Bloch D, 2005, MOL BIOL CELL, V16, P1913, DOI 10.1091/mbc.E04-07-0562; Blume JJ, 2007, EXP CELL RES, V313, P219, DOI 10.1016/j.yexcr.2006.10.006; Bolte S, 2004, J MICROSC-OXFORD, V214, P159, DOI 10.1111/j.0022-2720.2004.01348.x; Bracha-Drori K, 2004, PLANT J, V40, P419, DOI 10.1111/j.1365-313X.2004.02206.x; Caplan S, 2002, EMBO J, V21, P2557, DOI 10.1093/emboj/21.11.2557; Carbone R, 1997, CANCER RES, V57, P5498; Daumke O, 2007, NATURE, V449, P923, DOI 10.1038/nature06173; de Beer T, 2000, NAT STRUCT BIOL, V7, P1018, DOI 10.1038/80924; DEAN JFD, 1989, PHYTOPATHOLOGY, V79, P1071; DiFiore PP, 1997, TRENDS BIOCHEM SCI, V22, P411, DOI 10.1016/S0968-0004(97)01127-4; Elbaz M, 2002, CELL DEATH DIFFER, V9, P726, DOI 10.1038/sj.cdd.4401030; Galperin E, 2002, TRAFFIC, V3, P575, DOI 10.1034/j.1600-0854.2002.30807.x; Geldner N, 2007, GENE DEV, V21, P1598, DOI 10.1101/gad.1561307; George M, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-3; Grant B, 2001, NAT CELL BIOL, V3, P573, DOI 10.1038/35078549; Grant BD, 2008, TRAFFIC, V9, P2043, DOI 10.1111/j.1600-0854.2008.00834.x; Guilherme A, 2004, J BIOL CHEM, V279, P40062, DOI 10.1074/jbc.M401918200; Guilherme A, 2004, J BIOL CHEM, V279, P10593, DOI 10.1074/jbc.M307702200; Hanania U, 1997, PLANT J, V12, P113, DOI 10.1046/j.1365-313X.1997.12010113.x; Happel N, 2004, PLANT J, V37, P678, DOI 10.1111/j.1365-313X.2003.01995.x; Kirchhausen T, 1999, ANNU REV CELL DEV BI, V15, P705, DOI 10.1146/annurev.cellbio.15.1.705; Kleine-Vehn J, 2008, ANNU REV CELL DEV BI, V24, P447, DOI 10.1146/annurev.cellbio.24.110707.175254; Lam SK, 2007, TRENDS PLANT SCI, V12, P497, DOI 10.1016/j.tplants.2007.09.001; Le Roy C, 2005, NAT REV MOL CELL BIO, V6, P112, DOI 10.1038/nrm1571; Lin SX, 2001, NAT CELL BIOL, V3, P567, DOI 10.1038/35078543; Lisboa S, 2008, PLANT CELL REP, V27, P21, DOI 10.1007/s00299-007-0437-1; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; Mintz L, 1999, GENOMICS, V59, P66, DOI 10.1006/geno.1999.5800; Muller J, 2007, PLANT PHYSIOL, V145, P293, DOI 10.1104/pp.107.102863; Mukherjee S, 1997, PHYSIOL REV, V77, P759, DOI 10.1152/physrev.1997.77.3.759; Murphy AS, 2005, ANNU REV PLANT BIOL, V56, P221, DOI 10.1146/annurev.arplant.56.032604.144150; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; Olswang-Kutz Y, 2009, J CELL SCI, V122, P471, DOI 10.1242/jcs.038521; Park SY, 2004, BIOCHEMISTRY-US, V43, P7552, DOI 10.1021/bi049970f; Pelkmans L, 2002, SCIENCE, V296, P535, DOI 10.1126/science.1069784; POLO S, 2003, SCI STKE, pRE17, DOI DOI 10.1126/STKE.2132003RE17; Rapaport D, 2006, TRAFFIC, V7, P52, DOI 10.1111/j.1600-0854.2005.00359.x; Robatzek S, 2007, CELL MICROBIOL, V9, P1, DOI 10.1111/j.1462-5822.2006.00829.x; Ron M, 2004, PLANT CELL, V16, P1604, DOI 10.1105/tpc.022475; Rotem-Yehudar R, 2001, J BIOL CHEM, V276, P33054, DOI 10.1074/jbc.M009913200; Russinova E, 2004, PLANT CELL, V16, P3216, DOI 10.1105/tpc.104.025387; Samaj J, 2005, TRENDS CELL BIOL, V15, P425, DOI 10.1016/j.tcb.2005.06.006; Santolini E, 1999, EXP CELL RES, V253, P186, DOI 10.1006/excr.1999.4694; Silady RA, 2008, PLANT J, V53, P29, DOI 10.1111/j.1365-313X.2007.03314.x; SMITH CA, 2004, MOL BIOL CELL; Teh OK, 2007, NATURE, V448, P493, DOI 10.1038/nature06023; VANENGELEN FA, 1995, TRANSGENIC RES, V4, P288, DOI 10.1007/BF01969123; Voigt B, 2005, EUR J CELL BIOL, V84, P595, DOI 10.1016/j.ejcb.2004.11.011; WONG WT, 1995, P NATL ACAD SCI USA, V92, P9530, DOI 10.1073/pnas.92.21.9530	56	34	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2009	4	11							e7973	10.1371/journal.pone.0007973	http://dx.doi.org/10.1371/journal.pone.0007973			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522NJ	19936242	Green Published, gold, Green Submitted			2022-12-25	WOS:000272004600022
J	Kam, YW; Okumura, Y; Kido, H; Ng, LFP; Bruzzone, R; Altmeyer, R				Kam, Yiu-Wing; Okumura, Yuushi; Kido, Hiroshi; Ng, Lisa F. P.; Bruzzone, Roberto; Altmeyer, Ralf			Cleavage of the SARS Coronavirus Spike Glycoprotein by Airway Proteases Enhances Virus Entry into Human Bronchial Epithelial Cells In Vitro	PLOS ONE			English	Article							ACUTE RESPIRATORY SYNDROME; INFLUENZA-A VIRUSES; HUMAN-IMMUNODEFICIENCY-VIRUS; PROTEOLYTIC CLEAVAGE; MURINE CORONAVIRUS; MEMBRANE-FUSION; DC-SIGN; CONFORMATIONAL-CHANGES; FUNCTIONAL RECEPTOR; TRIGGERS INFECTION	Background: Entry of enveloped viruses into host cells requires the activation of viral envelope glycoproteins through cleavage by either intracellular or extracellular proteases. In order to gain insight into the molecular basis of protease cleavage and its impact on the efficiency of viral entry, we investigated the susceptibility of a recombinant native full-length S-protein trimer (triSpike) of the severe acute respiratory syndrome coronavirus (SARS-CoV) to cleavage by various airway proteases. Methodology/Principal Findings: Purified triSpike proteins were readily cleaved in vitro by three different airway proteases: trypsin, plasmin and TMPRSS11a. High Performance Liquid Chromatography (HPLC) and amino acid sequencing analyses identified two arginine residues (R667 and R797) as potential protease cleavage site(s). The effect of protease-dependent enhancement of SARS-CoV infection was demonstrated with ACE2 expressing human bronchial epithelial cells 16HBE. Airway proteases regulate the infectivity of SARS-CoV in a fashion dependent on previous receptor binding. The role of arginine residues was further shown with mutant constructs (R667A, R797A or R797AR667A). Mutation of R667 or R797 did not affect the expression of S-protein but resulted in a differential efficacy of pseudotyping into SARS-CoVpp. The R667A SARS-CoVpp mutant exhibited a lack of virus entry enhancement following protease treatment. Conclusions/Significance: These results suggest that SARS S-protein is susceptible to airway protease cleavage and, furthermore, that protease mediated enhancement of virus entry depends on specific conformation of SARS S-protein upon ACE2 binding. These data have direct implications for the cell entry mechanism of SARS-CoV along the respiratory system and, furthermore expand the possibility of identifying potential therapeutic agents against SARS-CoV.			Kam, YW (corresponding author), Univ Hong Kong, HKU Pasteur Res Ctr, Hong Kong, Hong Kong, Peoples R China.	bruzzone@hku.hk	Bruzzone, Roberto/G-9355-2017; Bruzzone, Roberto/C-4719-2009; Kam, Yiu/AAI-4148-2021	Bruzzone, Roberto/0000-0003-4373-1447; Bruzzone, Roberto/0000-0003-4373-1447; Kam, Yiu/0000-0002-8360-9537; Ng, Lisa/0000-0003-4071-5222				Belouzard S, 2009, P NATL ACAD SCI USA, V106, P5871, DOI 10.1073/pnas.0809524106; Beniac DR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001082; Bosch BJ, 2008, J VIROL, V82, P8887, DOI 10.1128/JVI.00415-08; Chaipan C, 2009, J VIROL, V83, P3200, DOI 10.1128/JVI.02205-08; Chan SY, 2001, CELL, V106, P117, DOI 10.1016/S0092-8674(01)00418-4; Chen Y, 2000, EUR J BIOCHEM, V267, P3189, DOI 10.1046/j.1432-1327.2000.01346.x; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; COZENS AL, 1994, AM J RESP CELL MOL, V10, P38, DOI 10.1165/ajrcmb.10.1.7507342; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Ding YQ, 2004, J PATHOL, V203, P622, DOI 10.1002/path.1560; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; FRANA MF, 1985, J VIROL, V56, P912, DOI 10.1128/JVI.56.3.912-920.1985; GAERTNER DJ, 1991, ARCH VIROL, V118, P57, DOI 10.1007/BF01311303; GARTEN W, 1980, J GEN VIROL, V50, P135, DOI 10.1099/0022-1317-50-1-135; Godfrey RWA, 1997, MICROSC RES TECHNIQ, V38, P488, DOI 10.1002/(SICI)1097-0029(19970901)38:5<488::AID-JEMT5>3.0.CO;2-E; GOMBOLD JL, 1993, J VIROL, V67, P4504, DOI 10.1128/JVI.67.8.4504-4512.1993; Harmer D, 2002, FEBS LETT, V532, P107, DOI 10.1016/S0014-5793(02)03640-2; Holmes KV, 2001, ADV EXP MED BIOL, V494, P173; Jackwood MW, 2001, AVIAN DIS, V45, P366, DOI 10.2307/1592976; Jeffers SA, 2002, J VIROL, V76, P12463, DOI 10.1128/JVI.76.24.12463-12472.2002; Jia HP, 2005, J VIROL, V79, P14614, DOI 10.1128/JVI.79.23.14614-14621.2005; Kam YW, 2007, VACCINE, V25, P729, DOI 10.1016/j.vaccine.2006.08.011; KIDO H, 1992, J BIOL CHEM, V267, P13573; Kido H, 2004, BIOL CHEM, V385, P1029, DOI 10.1515/BC.2004.133; Kido H, 1999, MOL CELLS, V9, P235; Klenk H D, 1988, Adv Virus Res, V34, P247, DOI 10.1016/S0065-3527(08)60520-5; Klenk Hans-Dieter, 1994, Trends in Microbiology, V2, P39, DOI 10.1016/0966-842X(94)90123-6; KLENK HD, 1975, VIROLOGY, V68, P426, DOI 10.1016/0042-6822(75)90284-6; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAZAROWITZ SG, 1975, VIROLOGY, V68, P440, DOI 10.1016/0042-6822(75)90285-8; Li F, 2005, SCIENCE, V309, P1864, DOI 10.1126/science.1116480; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Lozach PY, 2004, J BIOL CHEM, V279, P32035, DOI 10.1074/jbc.M402296200; Matsuyama S, 2005, P NATL ACAD SCI USA, V102, P12543, DOI 10.1073/pnas.0503203102; MCCUNE JM, 1988, CELL, V53, P55, DOI 10.1016/0092-8674(88)90487-4; Mossel EC, 2005, J VIROL, V79, P3846, DOI 10.1128/JVI.79.6.3846-3850.2005; Murakami M, 2001, EUR J BIOCHEM, V268, P2847, DOI 10.1046/j.1432-1327.2001.02166.x; Nagai Yoshiyuki, 1993, Trends in Microbiology, V1, P81, DOI 10.1016/0966-842X(93)90112-5; Nal B, 2005, J GEN VIROL, V86, P1423, DOI 10.1099/vir.0.80671-0; Nicholls JM, 2003, LANCET, V361, P1773, DOI 10.1016/S0140-6736(03)13413-7; Nie YC, 2004, BIOCHEM BIOPH RES CO, V321, P994, DOI 10.1016/j.bbrc.2004.07.060; Pohlmann S, 2003, J VIROL, V77, P4070, DOI 10.1128/JVI.77.7.4070-4080.2003; REDDEL RR, 1988, CANCER RES, V48, P1904; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; Sato M, 2003, BIOL CHEM, V384, P219, DOI 10.1515/BC.2003.024; Simmons G, 2004, P NATL ACAD SCI USA, V101, P4240, DOI 10.1073/pnas.0306446101; STORZ J, 1992, ARCH VIROL, V125, P193, DOI 10.1007/BF01309637; STORZ J, 1981, INFECT IMMUN, V31, P1214, DOI 10.1128/IAI.31.3.1214-1222.1981; STURMAN LS, 1985, J VIROL, V56, P904, DOI 10.1128/JVI.56.3.904-911.1985; TASHIRO M, 1983, ARCH VIROL, V77, P127, DOI 10.1007/BF01309262; Towatari T, 2002, EUR J BIOCHEM, V269, P2613, DOI 10.1046/j.1432-1033.2002.02937.x; Wang PG, 2004, BIOCHEM BIOPH RES CO, V315, P439, DOI 10.1016/j.bbrc.2004.01.076; Watanabe R, 2008, J VIROL, V82, P11985, DOI 10.1128/JVI.01412-08; Weissenhorn W, 1999, MOL MEMBR BIOL, V16, P3, DOI 10.1080/096876899294706; Wool-Lewis RJ, 1998, J VIROL, V72, P3155, DOI 10.1128/JVI.72.4.3155-3160.1998; Yamada YK, 1998, ADV EXP MED BIOL, V440, P89; Yang ZY, 2004, J VIROL, V78, P5642, DOI 10.1128/JVI.78.11.5642-5650.2004; Yu ITS, 2004, NEW ENGL J MED, V350, P1731, DOI 10.1056/NEJMoa032867; Zelus BD, 2003, J VIROL, V77, P830, DOI 10.1128/JVI.77.2.830-840.2003; Zhirnov O, 2003, VIROLOGY, V313, P198, DOI 10.1016/S0042-6822(03)00264-2; Zhu J, 1999, EUR RESPIR J, V13, P1318, DOI 10.1183/09031936.99.13613299	62	105	105	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2009	4	11							e7870	10.1371/journal.pone.0007870	http://dx.doi.org/10.1371/journal.pone.0007870			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520OG	19924243	gold, Green Published			2022-12-25	WOS:000271854200017
J	Katayama, K; Zine, A; Ota, M; Matsumoto, Y; Inoue, T; Fritzsch, B; Aruga, J				Katayama, Kei-ichi; Zine, Azel; Ota, Maya; Matsumoto, Yoshifumi; Inoue, Takashi; Fritzsch, Bernd; Aruga, Jun			Disorganized Innervation and Neuronal Loss in the Inner Ear of Slitrk6-Deficient Mice	PLOS ONE			English	Article							SPIRAL GANGLION NEURONS; SENSORY EPITHELIA; AXON GUIDANCE; AUDITORY DEVELOPMENT; NEUROTROPHIC FACTOR; NEURITE OUTGROWTH; CELL FATE; EXPRESSION; ROLES; SURVIVAL	Slitrks are type I transmembrane proteins that share conserved leucine-rich repeat domains similar to those in the secreted axonal guidance molecule Slit. They also show similarities to Ntrk neurotrophin receptors in their carboxy-termini, sharing a conserved tyrosine residue. Among 6 Slitrk family genes in mammals, Slitrk6 has a unique expression pattern, with strong expression in the sensory epithelia of the inner ear. We generated Slitrk6-knockout mice and investigated the development of their auditory and vestibular sensory organs. Slitrk6-deficient mice showed pronounced reduction in the cochlear innervation. In the vestibule, the innervation to the posterior crista was often lost, reduced, or sometimes misguided. These defects were accompanied by the loss of neurons in the spiral and vestibular ganglia. Cochlear sensory epithelia from Slitrk6-knockout mice have reduced ability in promoting neurite outgrowth of spiral ganglion neurons. Indeed the Slitrk6-deficient inner ear showed a mild but significant decrease in the expression of Bdnf and Ntf3, both of which are essential for the innervation and survival of sensory neurons. In addition, the expression of Ntrk receptors, including their phosphorylated forms was decreased in Slitrk6-knockout cochlea. These results suggest that Slitrk6 promotes innervation and survival of inner ear sensory neurons by regulating the expression of trophic and/or tropic factors including neurotrophins from sensory epithelia.			Katayama, K (corresponding author), RIKEN, Brain Sci Inst, Lab Behav & Dev Disorders, Wako, Saitama, Japan.	jaruga@brain.riken.jp	Aruga, Jun/H-5837-2011; Katayama, Kei-ichi/J-4699-2013	Aruga, Jun/0000-0001-7936-1375; Katayama, Kei-ichi/0000-0003-0527-4644; Fritzsch, Bernd/0000-0002-4882-8398	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005590] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC005590, R01 DC005590-07] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Aruga J, 2003, GENE EXPR PATTERNS, V3, P727, DOI 10.1016/S1567-133X(03)00141-8; Aruga J, 2003, GENE, V315, P87, DOI 10.1016/S0378-1119(03)00715-7; Aruga J, 2003, MOL CELL NEUROSCI, V24, P117, DOI 10.1016/S1044-7431(03)00129-5; Berkingali N, 2008, HEARING RES, V243, P121, DOI 10.1016/j.heares.2008.07.003; Bianchi LM, 1996, DEVELOPMENT, V122, P1965; BIANCHI LM, 1993, DEV BIOL, V159, P353, DOI 10.1006/dbio.1993.1247; BIANCHI LM, 2005, JARO-J ASSOC RES OTO, V16, P355; Brose K, 2000, CURR OPIN NEUROBIOL, V10, P95, DOI 10.1016/S0959-4388(99)00066-5; COLE KS, 1992, BRAIN RES, V575, P223; ERNFORS P, 1995, NEURON, V14, P1153, DOI 10.1016/0896-6273(95)90263-5; Farinas I, 2001, J NEUROSCI, V21, P6170, DOI 10.1523/JNEUROSCI.21-16-06170.2001; Fekete DM, 1996, CURR OPIN NEUROBIOL, V6, P533, DOI 10.1016/S0959-4388(96)80061-4; Fekete DM, 2007, INT J DEV BIOL, V51, P549, DOI 10.1387/ijdb.072341df; Fritzsch B, 2004, PROG BRAIN RES, V146, P265, DOI 10.1016/S0079-6123(03)46017-2; Fritzsch B, 1998, INT J DEV NEUROSCI, V16, P493, DOI 10.1016/S0736-5748(98)00043-4; Fritzsch B, 1997, J NEUROSCI, V17, P6213; Fritzsch B, 2002, J NEUROBIOL, V53, P143, DOI 10.1002/neu.10098; Fritzsch B, 2003, BRAIN RES BULL, V60, P423, DOI 10.1016/S0361-9230(03)00048-0; FRITZSCH B, 1993, HEARING RES, V65, P51, DOI 10.1016/0378-5955(93)90200-K; Fritzsch B, 1997, SEMIN CELL DEV BIOL, V8, P277, DOI 10.1006/scdb.1997.0144; Giraldez F, 2007, INT J DEV BIOL, V51, P429, DOI 10.1387/ijdb.072390fg; Hossain WA, 2008, J NEUROSCI RES, V86, P2376, DOI 10.1002/jnr.21685; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Huang EJ, 2001, DEVELOPMENT, V128, P2421; Inoue T, 2004, DEV BIOL, V270, P146, DOI 10.1016/j.ydbio.2004.02.017; KATAYAMA K, 2009, MOL PSYCHIA IN PRESS; Kelley MW, 2006, NAT REV NEUROSCI, V7, P837, DOI 10.1038/nrn1987; Kim WY, 2001, DEVELOPMENT, V128, P417; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Liu M, 2000, GENE DEV, V14, P2839, DOI 10.1101/gad.840500; Maklad A, 2003, BRAIN RES BULL, V60, P497, DOI 10.1016/S0361-9230(03)00054-6; Maklad A, 2003, DEV BRAIN RES, V140, P223, DOI 10.1016/S0165-3806(02)00609-0; Marzella PL, 1999, HEARING RES, V138, P73, DOI 10.1016/S0378-5955(99)00152-5; Morris JK, 2006, BRAIN RES, V1091, P186, DOI 10.1016/j.brainres.2006.02.090; PIRVOLA U, 1992, P NATL ACAD SCI USA, V89, P9915, DOI 10.1073/pnas.89.20.9915; Pirvola U, 2003, CURR TOP DEV BIOL, V57, P207, DOI 10.1016/S0070-2153(03)57007-7; Rubel EW, 2002, ANNU REV NEUROSCI, V25, P51, DOI 10.1146/annurev.neuro.25.112701.142849; Sakai K, 1997, BIOCHEM BIOPH RES CO, V237, P318, DOI 10.1006/bbrc.1997.7111; SCHECTERSON LC, 1994, HEARING RES, V73, P92, DOI 10.1016/0378-5955(94)90286-0; SCHIMMANG T, 1995, DEVELOPMENT, V121, P3381; Stankovic K, 2004, J NEUROSCI, V24, P8651, DOI 10.1523/JNEUROSCI.0733-04.2004; Stankovic KM, 2003, HEARING RES, V185, P97, DOI 10.1016/S0378-5955(03)00298-3; Sugawara M, 2005, JARO-J ASSOC RES OTO, V6, P136, DOI 10.1007/s10162-004-5050-1; Webber A, 2006, ANAT REC PART A, V288A, P390, DOI 10.1002/ar.a.20299	44	35	37	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2009	4	11					A151	A162	e7786	10.1371/journal.pone.0007786	http://dx.doi.org/10.1371/journal.pone.0007786			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518IX	19936227	gold, Green Published			2022-12-25	WOS:000271685800017
J	Kon, N; Kobayashi, Y; Li, M; Brooks, CL; Ludwig, T; Gu, W				Kon, N.; Kobayashi, Y.; Li, M.; Brooks, C. L.; Ludwig, T.; Gu, W.			Inactivation of HAUSP in vivo modulates p53 function	ONCOGENE			English	Article						hausp; p53; mdm2; deubiquitination; gene knockout; mouse	UBIQUITIN-SPECIFIC PROTEASE; EMBRYONIC LETHALITY; DEUBIQUITINATING ENZYMES; MDM2-DEFICIENT MICE; P53-MDM2 PATHWAY; CONTRIBUTES; USP7/HAUSP; REGULATOR; CARCINOMA; DOMAINS	Hausp is a deubiquitinase that has been shown to regulate the p53-Mdm2 pathway. Cotransfection of p53 and Hausp stabilizes p53 through the removal of ubiquitin moieties from polyubiquitinated p53. Interestingly, knockout or RNA interference-mediated knockdown of Hausp in human cells also resulted in the stabilization of p53 due to the destabilization of Mdm2, suggesting a dynamic role of Hausp in p53 activation. To understand the physiological functions of Hausp, we generated hausp knockout mice. Hausp knockout mice die during early embryonic development between embryonic days E6.5 and E7.5. The hausp knockout embryos showed p53 activation, but no apparent increase in apoptosis. Embryonic lethality was caused by a dramatic reduction in proliferation and termination in development, in part due to p53 activation and/or abrogation of p53-independent functions. Although deletion of p53 did not completely rescue the embryonic lethality of the hausp knockout, embryonic development was extended in both hausp and p53 double knockout embryos. These data show that Hausp has a critical role in regulating the p53-Mdm2 pathway. Oncogene (2010) 29, 1270-1279; doi:10.1038/onc.2009.427; published online 30 November 2009	[Gu, W.] Columbia Univ, Dept Pathol, Inst Canc Genet, New York, NY 10032 USA; [Ludwig, T.] Columbia Univ, Coll Phys & Surg, Dept Anat & Cell Biol, New York, NY 10032 USA	Columbia University; Columbia University	Gu, W (corresponding author), Columbia Univ, Dept Pathol, Inst Canc Genet, 1130 St Nicholas Ave Rm 609A, New York, NY 10032 USA.	wg8@columbia.edu	Ludwig, Thomas/Q-6484-2016	Ludwig, Thomas/0000-0003-3461-2585	NIH; NIH/NCI; NATIONAL CANCER INSTITUTE [R01CA129627, P01CA097403] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Qiong Li and Xi Sun for their expert assistance with histology. We also thank Dr Chi-Ming Li for helpful suggestions. This study was supported in part by a post-doctoral fellowship from NIH to NK and grants from NIH/NCI to TL and WG.	Amerik AY, 2000, BIOL CHEM, V381, P981, DOI 10.1515/BC.2000.121; Babu JR, 2003, J CELL BIOL, V160, P341, DOI 10.1083/jcb.200211048; Becker K, 2008, CELL CYCLE, V7, P1205, DOI 10.4161/cc.7.9.5756; Chen DL, 2005, CELL, V121, P1071, DOI 10.1016/j.cell.2005.03.037; Chen XB, 1996, GENE DEV, V10, P2438, DOI 10.1101/gad.10.19.2438; Cummins JM, 2004, NATURE, V428, DOI 10.1038/nature02501; Dornan D, 2004, NATURE, V429, P86, DOI 10.1038/nature02514; Everett RD, 1999, J VIROL, V73, P417, DOI 10.1128/JVI.73.1.417-426.1999; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Holowaty MN, 2003, J BIOL CHEM, V278, P47753, DOI 10.1074/jbc.M307200200; Hong S, 2002, MOL CELL NEUROSCI, V20, P298, DOI 10.1006/mcne.2002.1103; Hu M, 2002, CELL, V111, P1041, DOI 10.1016/S0092-8674(02)01199-6; Hu M, 2006, PLOS BIOL, V4, P228, DOI 10.1371/journal.pbio.0040027; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; Laney JD, 1999, CELL, V97, P427, DOI 10.1016/S0092-8674(00)80752-7; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; Li MY, 2004, MOL CELL, V13, P879, DOI 10.1016/S1097-2765(04)00157-1; LUNA RMD, 1995, NATURE, V378, P203; Meulmeester E, 2005, MOL CELL, V18, P565, DOI 10.1016/j.molcel.2005.04.024; Mori S, 2004, CANCER-AM CANCER SOC, V100, P1673, DOI 10.1002/cncr.20164; Niendorf S, 2007, MOL CELL BIOL, V27, P5029, DOI 10.1128/MCB.01566-06; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; PICKART CM, 2004, BIOCHIM BIOPHYS ACTA, V29, P55; Sherr CJ, 2000, CURR OPIN GENET DEV, V10, P94, DOI 10.1016/S0959-437X(99)00038-6; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Tang J, 2006, NAT CELL BIOL, V8, P855, DOI 10.1038/ncb1442; van der Horst A, 2006, NAT CELL BIOL, V8, P1064, DOI 10.1038/ncb1469; van der Knaap JA, 2005, MOL CELL, V17, P695, DOI 10.1016/j.molcel.2005.02.013; Wu XS, 2001, P NATL ACAD SCI USA, V98, P3191, DOI 10.1073/pnas.051631598	31	139	145	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 4	2010	29	9					1270	1279		10.1038/onc.2009.427	http://dx.doi.org/10.1038/onc.2009.427			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	563XJ	19946331	Green Accepted			2022-12-25	WOS:000275170600003
J	Cheng, LL; Guo, JF; Sun, LG; Fu, J; Barnes, PF; Metzger, D; Chambon, P; Oshima, RG; Amagai, T; Su, DM				Cheng, Lili; Guo, Jianfei; Sun, Liguang; Fu, Jian; Barnes, Peter F.; Metzger, Daniel; Chambon, Pierre; Oshima, Robert G.; Amagai, Takashi; Su, Dong-Ming			Postnatal Tissue-specific Disruption of Transcription Factor FoxN1 Triggers Acute Thymic Atrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-CELL DIFFERENTIATION; T-CELL; LYMPHOHEMATOPOIETIC PROGENITORS; CENTRAL TOLERANCE; TRANSGENIC MICE; NUDE PHENOTYPE; EXPRESSION; MOUSE; GENE; CRE	The transcription factor FoxN1 is essential for differentiation of thymic epithelial cell (TEC) progenitors during thymic organogenesis. However, limited information is available on the postnatal contribution of FoxN1 to thymic maintenance. To address this question, we generated a loxP-floxed FoxN1 (fx) mouse with three different promoter-driven inducible CreER(T) transgenes. Postnatal ubiquitous deletion of FoxN1 caused dramatic thymic atrophy in 5 days and more severe deterioration in medullary TECs (mTECs) than in cortical TECs (cTECs). Induction of FoxN1 deletion selectively in K5 promoter-driven somatic epithelial cells (mostly mTECs and possibly some adult epithelial stem cells) was sufficient to cause significant thymic atrophy, whereas FoxN1 deletion in K18 promoter-driven somatic epithelial cells (mostly cTECs) was not. Thymic atrophy resulted from increased apoptosis and was associated with activation of the p53 gene in mature mTECs. Although FoxN1 is required for the development of both mTECs and cTECs in thymic organogenesis, it is most important for the maintenance of mTECs in the postnatal thymus, which are in turn necessary to prevent thymic atrophy.	[Cheng, Lili; Guo, Jianfei; Sun, Liguang; Fu, Jian; Su, Dong-Ming] Univ Texas Tyler, Dept Biomed Res, Hlth Sci Ctr, Tyler, TX 75708 USA; [Barnes, Peter F.] Univ Texas Tyler, Ctr Pulm & Infect Dis Control, Hlth Sci Ctr, Tyler, TX 75708 USA; [Metzger, Daniel; Chambon, Pierre] Coll France, Inst Genet & Biol Mol & Cellulaire, F-67404 Strasbourg, France; [Oshima, Robert G.] Burnham Inst Med Res, La Jolla, CA 92037 USA; [Amagai, Takashi] Meiji Univ Integrat Med, Dept Immunol & Microbiol, Kyoto 6290392, Japan	University of Texas System; University of Texas at Tyler; University of Texas-Health Sciences Center at Tyler (UTHSCT); University of Texas System; University of Texas at Tyler; University of Texas-Health Sciences Center at Tyler (UTHSCT); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Sanford Burnham Prebys Medical Discovery Institute	Su, DM (corresponding author), Univ Texas Tyler, Dept Biomed Res, Hlth Sci Ctr, Tyler, TX 75708 USA.	dong-ming.su@uthct.edu		Metzger, Daniel/0000-0002-5555-046X	NIAID [R21AI064939, R01AI081995, R21AI079747]; University of Texas Health Science Center at Tyler; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081995, R21AI064939, R21AI079747] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of Texas Health Science Center at Tyler; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R21AI064939, R01AI081995, and R21AI079747 (to D.- M. S.) from NIAID. This work was also supported by the University of Texas Health Science Center at Tyler.	Adriani M, 2004, ANN HUM GENET, V68, P265, DOI 10.1046/j.1529-8817.2004.00091.x; Amorosi S, 2008, CLIN GENET, V73, P380, DOI 10.1111/j.1399-0004.2008.00977.x; Anderson G, 2009, EUR J IMMUNOL, V39, P1694, DOI 10.1002/eji.200939379; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Bleul CC, 2006, NATURE, V441, P992, DOI 10.1038/nature04850; Brissette JL, 1996, GENE DEV, V10, P2212, DOI 10.1101/gad.10.17.2212; Chen LZ, 2009, BLOOD, V113, P567, DOI 10.1182/blood-2008-05-156265; Coffer PJ, 2004, NAT REV IMMUNOL, V4, P889, DOI 10.1038/nri1488; Cunningham-Rundles C, 2005, NAT REV IMMUNOL, V5, P880, DOI 10.1038/nri1713; FARR AG, 1985, J IMMUNOL, V134, P2971; Farr AG, 2002, IMMUNOL REV, V189, P20, DOI 10.1034/j.1600-065X.2002.18903.x; Frank J, 1999, NATURE, V398, P473, DOI 10.1038/18997; Gillard GO, 2006, J IMMUNOL, V176, P5815, DOI 10.4049/jimmunol.176.10.5815; Goldberg GL, 2007, SEMIN IMMUNOL, V19, P289, DOI 10.1016/j.smim.2007.08.001; Gray DHD, 2006, BLOOD, V108, P3777, DOI 10.1182/blood-2006-02-004531; Gray DHD, 2002, J IMMUNOL METHODS, V260, P15, DOI 10.1016/S0022-1759(01)00493-8; Gruver AL, 2008, J LEUKOCYTE BIOL, V84, P915, DOI 10.1189/jlb.0108025; Gui JG, 2007, INT IMMUNOL, V19, P1201, DOI 10.1093/intimm/dxm095; Hamazaki Y, 2007, NAT IMMUNOL, V8, P304, DOI 10.1038/ni1438; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Hsu HC, 2005, IMMUNOL REV, V205, P130, DOI 10.1111/j.0105-2896.2005.00270.x; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; Itoi M, 2007, INT IMMUNOL, V19, P127, DOI 10.1093/intimm/dxl129; Jeffers JR, 2003, CANCER CELL, V4, P321, DOI 10.1016/S1535-6108(03)00244-7; Klug DB, 1998, P NATL ACAD SCI USA, V95, P11822, DOI 10.1073/pnas.95.20.11822; Klug DB, 2000, J IMMUNOL, V164, P1881, DOI 10.4049/jimmunol.164.4.1881; Klug DB, 2002, J IMMUNOL, V169, P2842, DOI 10.4049/jimmunol.169.6.2842; KOJIMA A, 1984, EXP CELL BIOL, V52, P107; Kronenberg M, 2005, NATURE, V435, P598, DOI 10.1038/nature03725; Kuraguchi M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000367; Kyewski B, 2006, ANNU REV IMMUNOL, V24, P571, DOI 10.1146/annurev.immunol.23.021704.115601; Ladi E, 2006, NAT IMMUNOL, V7, P338, DOI 10.1038/ni1323; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lomada D, 2007, J IMMUNOL, V178, P829, DOI 10.4049/jimmunol.178.2.829; Mecklenburg L, 2005, EXP DERMATOL, V14, P797, DOI 10.1111/j.1600-0625.2005.00362.x; Nehls M, 1996, SCIENCE, V272, P886, DOI 10.1126/science.272.5263.886; NEHLS M, 1994, NATURE, V372, P103, DOI 10.1038/372103a0; Ortman CL, 2002, INT IMMUNOL, V14, P813, DOI 10.1093/intimm/dxf042; Petrie HT, 2005, J EXP MED, V202, P11, DOI 10.1084/jem.20050990; Petrie HT, 2002, IMMUNOL REV, V189, P8, DOI 10.1034/j.1600-065X.2002.18902.x; Rodewald HR, 2001, NATURE, V414, P763, DOI 10.1038/414763a; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Rossi SW, 2006, NATURE, V441, P988, DOI 10.1038/nature04813; SCHEIFF JM, 1978, ANAT EMBRYOL, V153, P115, DOI 10.1007/BF00343368; Schorpp M, 1997, IMMUNOGENETICS, V46, P509, DOI 10.1007/s002510050312; Schuddekopf K, 1996, P NATL ACAD SCI USA, V93, P9661, DOI 10.1073/pnas.93.18.9661; Schwenk F, 1998, NUCLEIC ACIDS RES, V26, P1427, DOI 10.1093/nar/26.6.1427; Seibler J, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng012; Shakib S, 2009, J IMMUNOL, V182, P130, DOI 10.4049/jimmunol.182.1.130; Spits H, 2002, NAT REV IMMUNOL, V2, P760, DOI 10.1038/nri913; Su DM, 2003, NAT IMMUNOL, V4, P1128, DOI 10.1038/ni983; SURH CD, 1992, J EXP MED, V176, P495, DOI 10.1084/jem.176.2.495; Swann JB, 2007, EUR J IMMUNOL, V37, P2364, DOI 10.1002/eji.200737709; Taub DD, 2005, IMMUNOL REV, V205, P72, DOI 10.1111/j.0105-2896.2005.00275.x; VASSAR R, 1989, P NATL ACAD SCI USA, V86, P1563, DOI 10.1073/pnas.86.5.1563; Wen F, 2003, GENESIS, V35, P100, DOI 10.1002/gene.10169; Zhu X, 2007, AGING CELL, V6, P663, DOI 10.1111/j.1474-9726.2007.00325.x	57	83	88	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5836	5847		10.1074/jbc.M109.072124	http://dx.doi.org/10.1074/jbc.M109.072124			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	19955175	hybrid, Green Published			2022-12-25	WOS:000275327200074
J	Madeo, A; Vinciguerra, M; Lappano, R; Galgani, M; Gasperi-Campani, A; Maggiolini, M; Musti, AM				Madeo, A.; Vinciguerra, M.; Lappano, R.; Galgani, M.; Gasperi-Campani, A.; Maggiolini, M.; Musti, A. M.			c-Jun activation is required for 4-hydroxytamoxifen-induced cell death in breast cancer cells	ONCOGENE			English	Article						c-Jun; c-Fos; AP-1; JNK; apoptosis; 4-hydroxytamoxifen	COUPLED RECEPTOR GPR30; TRANSCRIPTION FACTOR; GENE-EXPRESSION; SIGNAL-TRANSDUCTION; ESTROGEN-RECEPTOR; INDUCED APOPTOSIS; OXIDATIVE STRESS; MAP KINASES; C/EBP-BETA; IN-VIVO	The c-Jun N-terminal kinase (JNK) has been shown to mediate tamoxifen-induced apoptosis in breast cancer cells. However, the downstream mediators of the JNK pathway linking tamoxifen to effectors of apoptosis have yet to be identified. In this study, we analysed whether c-Jun, the major nuclear target of JNK, has a role in tamoxifen-induced apoptosis of SkBr3 breast cancer cells. We show that before DNA fragmentation and caspase 3/7 activation, cytotoxic concentrations of 4-hydroxytamoxifen (OHT) induced JNK-dependent phosphorylation of c-Jun at JNK sites earlier shown to regulate c-Jun-mediated apoptosis. In addition, OHT induced ERK-dependent expression of c-Fos and transactivation of an AP-1-responsive promoter. In particular, the ectopic expression of dominant-negative constructs blocking either AP-1 activity or c-Jun N-terminal phosphorylation prevented DNA fragmentation after OHT treatment. Furthermore, both c-Fos expression and c-Jun N-terminal phosphorylation preceded OHT-dependent activation of caspase 3-7 in different types of tamoxifen-sensitive cancer cells, but not in OHT-resistant LNCaP prostate cancer cells. Taken together, our results indicate that the c-Jun/c-Fos AP-1 complex has a pro-apoptotic role in OHT-treated cancer cells and suggest that pharmacological boosts of c-Jun activation may be useful in a combination therapy setting to sensitize cancer cells to tamoxifen-mediated cell death. Oncogene (2010) 29, 978-991; doi:10.1038/onc.2009.400; published online 23 November 2009	[Madeo, A.; Lappano, R.; Maggiolini, M.; Musti, A. M.] Univ Calabria, Dept Pharmacobiol, I-87036 Cosenza, Italy; [Vinciguerra, M.; Galgani, M.] Univ Naples Federico 2, Dept Cellular & Mol Biol & Pathol, Naples, Italy; [Gasperi-Campani, A.] Univ Bologna, Dept Expt Pathol, I-40126 Bologna, Italy; [Gasperi-Campani, A.] Univ Bologna, Interdepartmental Ctr Res Canc, I-40126 Bologna, Italy	University of Calabria; University of Naples Federico II; University of Bologna; University of Bologna	Maggiolini, M (corresponding author), Univ Calabria, Dept Pharmacobiol, Via P Bucci, I-87036 Cosenza, Italy.	marcellomaggiolini@yahoo.it; ammusti@yahoo.it	Galgani, Mario/AAC-3298-2022; Lappano, Rosamaria/Z-4857-2019; Musti, Anna Maria/M-2520-2019; Maggiolini, Marcello/Z-4729-2019	Maggiolini, Marcello/0000-0002-7485-854X; Galgani, Mario/0000-0001-8414-1676; Lappano, Rosamaria/0000-0002-9374-9701; MUSTI, Anna Maria/0000-0003-1443-2739	Associazione Italiana Ricerca sul Cancro (AIRC); Ministero dell'Universita' e Ricerca; Regione Calabria	Associazione Italiana Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Ministero dell'Universita' e Ricerca(Ministry of Education, Universities and Research (MIUR)); Regione Calabria(Regione Calabria)	We thank Dr Lidia Albanito for continuous helpful experimental assistance. We thank Dr Anna Grazia Recchia for the English revision of the paper. We are grateful to C Vinson, K Nose and H van Dam for gifts of reagents. Funding for this project was provided by the Associazione Italiana Ricerca sul Cancro (AIRC), Ministero dell'Universita' e Ricerca, Regione Calabria.	Albanito L, 2008, ENDOCRINOLOGY, V149, P3799, DOI 10.1210/en.2008-0117; Albanito L, 2007, CANCER RES, V67, P1859, DOI 10.1158/0008-5472.CAN-06-2909; Ballatori N, 2009, BIOL CHEM, V390, P191, DOI 10.1515/BC.2009.033; Bannister AJ, 1995, ONCOGENE, V11, P2509; Basu S, 2004, GLYCOCONJUGATE J, V20, P563; Behrens A, 1999, NAT GENET, V21, P326, DOI 10.1038/6854; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Dunn C, 2002, CELL SIGNAL, V14, P585, DOI 10.1016/S0898-6568(01)00275-3; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Friesen C, 2004, CELL DEATH DIFFER, V11, pS73, DOI 10.1038/sj.cdd.4401431; Ham J, 2005, CELL DEATH DIFFER, V12, P1015, DOI 10.1038/sj.cdd.4401689; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Kallio A, 2005, APOPTOSIS, V10, P1395, DOI 10.1007/s10495-005-2137-z; Lagadec C, 2008, ONCOGENE, V27, P1472, DOI 10.1038/sj.onc.1210749; Lee YS, 2000, CELL DEATH DIFFER, V7, P925, DOI 10.1038/sj.cdd.4400717; Liu HT, 2000, J IMMUNOL, V164, P4277, DOI 10.4049/jimmunol.164.8.4277; LOVE RR, 1989, J CLIN ONCOL, V7, P803, DOI 10.1200/JCO.1989.7.6.803; Mabuchi S, 2004, ENDOCRINOLOGY, V145, P1302, DOI 10.1210/en.2003-0709; Maggiolini M, 2004, J BIOL CHEM, V279, P27008, DOI 10.1074/jbc.M403588200; Mandlekar S, 2000, CANCER RES, V60, P5995; Mandlekar S, 2001, APOPTOSIS, V6, P469, DOI 10.1023/A:1012437607881; Morton S, 2003, EMBO J, V22, P3876, DOI 10.1093/emboj/cdg388; Musti AM, 1997, SCIENCE, V275, P400, DOI 10.1126/science.275.5298.400; Nateri AS, 2005, NATURE, V437, P281, DOI 10.1038/nature03914; NEPHEW KP, 1993, ENDOCRINOLOGY, V133, P419, DOI 10.1210/en.133.1.419; Olive M, 1997, J BIOL CHEM, V272, P18586, DOI 10.1074/jbc.272.30.18586; PAPAVASSILIOU AG, 1995, EMBO J, V14, P2014, DOI 10.1002/j.1460-2075.1995.tb07193.x; PAPAVASSILIOU AG, 1992, SCIENCE, V258, P1941, DOI 10.1126/science.1470918; Pope R, 2000, CYTOKINE, V12, P1171, DOI 10.1006/cyto.2000.0691; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; PRICE MA, 1995, EMBO J, V14, P2589, DOI 10.1002/j.1460-2075.1995.tb07257.x; Prossnitz ER, 2009, MOL CELL ENDOCRINOL, V308, P32, DOI 10.1016/j.mce.2009.03.026; Raivich G, 2008, J NEUROCHEM, V107, P898, DOI 10.1111/j.1471-4159.2008.05684.x; Raivich G, 2006, PROG NEUROBIOL, V78, P347, DOI 10.1016/j.pneurobio.2006.03.006; Recktenwald CV, 2008, CANCER RES, V68, P10086, DOI 10.1158/0008-5472.CAN-08-0360; Schiff R, 2000, J NATL CANCER I, V92, P1926, DOI 10.1093/jnci/92.23.1926; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Shen HM, 1996, FREE RADICAL BIO MED, V21, P139, DOI 10.1016/0891-5849(96)00019-6; Smith WL, 1997, ACAD RADIOL, V4, P657, DOI 10.1016/S1076-6332(05)80273-9; STROBER W, 2001, CURR PROTOC IMMUNO S, V21; TREISMAN R, 1995, EMBO J, V14, P4905, DOI 10.1002/j.1460-2075.1995.tb00173.x; Vinciguerr M, 2008, INT J BIOCHEM CELL B, V40, P307, DOI 10.1016/j.biocel.2007.08.001; Vivacqua A, 2006, MOL ENDOCRINOL, V20, P631, DOI 10.1210/me.2005-0280; Vivacqua A, 2006, MOL PHARMACOL, V70, P1414, DOI 10.1124/mol.106.026344; Wada T, 2004, NAT CELL BIOL, V6, P215, DOI 10.1038/ncb1098; Watson A, 1998, J NEUROSCI, V18, P751; Weiss C, 2003, EMBO J, V22, P3686, DOI 10.1093/emboj/cdg364; Whitfield J, 2001, NEURON, V29, P629, DOI 10.1016/S0896-6273(01)00239-2; Young TW, 2004, CANCER RES, V64, P4577, DOI 10.1158/0008-5472.CAN-04-0222	49	21	22	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 18	2010	29	7					978	991		10.1038/onc.2009.400	http://dx.doi.org/10.1038/onc.2009.400			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	556PV	19935718				2022-12-25	WOS:000274604400005
J	Guce, AI; Clark, NE; Salgado, EN; Ivanen, DR; Kulminskaya, AA; Brumer, H; Garman, SC				Guce, Abigail I.; Clark, Nathaniel E.; Salgado, Eric N.; Ivanen, Dina R.; Kulminskaya, Anna A.; Brumer, Harry, III; Garman, Scott C.			Catalytic Mechanism of Human alpha-Galactosidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENZYME REPLACEMENT THERAPY; CRYSTAL-STRUCTURE; TRANSITION-STATE; FABRY-DISEASE; PHANEROCHAETE-CHRYSOSPORIUM; STRUCTURAL-ANALYSIS; MOLECULAR-BASIS; MANNOSIDASE-II; GLYCOSIDASE; INSIGHTS	The enzyme alpha-galactosidase (alpha-GAL, also known as alpha-GAL A; E.C. 3.2.1.22) is responsible for the breakdown of alpha-galactosides in the lysosome. Defects in human alpha-GAL lead to the development of Fabry disease, a lysosomal storage disorder characterized by the buildup of alpha-galactosylated substrates in the tissues. alpha-GAL is an active target of clinical research: there are currently two treatment options for Fabry disease, recombinant enzyme replacement therapy (approved in the United States in 2003) and pharmacological chaperone therapy (currently in clinical trials). Previously, we have reported the structure of human alpha-GAL, which revealed the overall structure of the enzyme and established the locations of hundreds of mutations that lead to the development of Fabry disease. Here, we describe the catalytic mechanism of the enzyme derived from x-ray crystal structures of each of the four stages of the double displacement reaction mechanism. Use of a difluoro-alpha-galactopyranoside allowed trapping of a covalent intermediate. The ensemble of structures reveals distortion of the ligand into a S-1(3) skew (or twist) boat conformation in the middle of the reaction cycle. The high resolution structures of each step in the catalytic cycle will allow for improved drug design efforts on alpha-GAL and other glycoside hydrolase family 27 enzymes by developing ligands that specifically target different states of the catalytic cycle. Additionally, the structures revealed a second ligand-binding site suitable for targeting by novel pharmacological chaperones.	[Clark, Nathaniel E.; Salgado, Eric N.; Garman, Scott C.] Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA; [Guce, Abigail I.; Garman, Scott C.] Univ Massachusetts, Dept Chem, Amherst, MA 01003 USA; [Ivanen, Dina R.; Kulminskaya, Anna A.] Russian Acad Sci, Petersburg Nucl Phys Inst, Mol & Radiat Biophys Div, Gatchina 188300, Russia; [Brumer, Harry, III] Royal Insitute Technol KTH, Dept Biotechnol, S-10691 Stockholm, Sweden	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst; National Research Centre - Kurchatov Institute; Petersburg Nuclear Physics Institute; Russian Academy of Sciences	Garman, SC (corresponding author), Univ Massachusetts, Dept Biochem & Mol Biol, 710 N Pleasant St, Amherst, MA 01003 USA.	garman@biochem.umass.edu	Kulminskaya, Anna A/Q-9948-2016	Kulminskaya, Anna A/0000-0002-3481-0007	National Institutes of Health [R01 DK76877]; National Science Foundation Integrative Graduate Education and Research Traineeship [0654128]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076877] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Integrative Graduate Education and Research Traineeship(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK76877 (to S. C. G.) and by National Science Foundation Integrative Graduate Education and Research Traineeship 0654128 (to N. E. C.).	[Anonymous], 2014, METABOLIC MOL BASES; Asano N, 2000, EUR J BIOCHEM, V267, P4179, DOI 10.1046/j.1432-1327.2000.01457.x; Asano N, 2003, GLYCOBIOLOGY, V13, p93R, DOI 10.1093/glycob/cwg090; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barends TRM, 2007, J BIOL CHEM, V282, P17242, DOI 10.1074/jbc.M701444200; BISHOP DF, 1981, J BIOL CHEM, V256, P1307; Brady RO, 2003, ACTA PAEDIATR, V92, P19, DOI 10.1080/08035320310000401; Brady RO, 2003, PHILOS T ROY SOC B, V358, P915, DOI 10.1098/rstb.2003.1269; Brumer H, 1999, BIOCHEM J, V339, P43, DOI 10.1042/0264-6021:3390043; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chrost B, 2007, PLANTA, V225, P311, DOI 10.1007/s00425-006-0350-9; Clark NE, 2009, J MOL BIOL, V393, P435, DOI 10.1016/j.jmb.2009.08.021; Comfort DA, 2007, BIOCHEMISTRY-US, V46, P3319, DOI 10.1021/bi061521n; DeLano WL., 2020, PYMOL MOL GRAPHICS S; Desnick RJ, 2002, NAT REV GENET, V3, P954, DOI 10.1038/nrg963; Eng CM, 2001, NEW ENGL J MED, V345, P9, DOI 10.1056/NEJM200107053450102; Fan JQ, 1999, NAT MED, V5, P112, DOI 10.1038/4801; Fenn TD, 2003, J APPL CRYSTALLOGR, V36, P944, DOI 10.1107/S0021889803006721; Frustaci A, 2001, NEW ENGL J MED, V345, P25, DOI 10.1056/NEJM200107053450104; Fujimoto Z, 2003, J BIOL CHEM, V278, P20313, DOI 10.1074/jbc.M302292200; Garman SC, 2004, J MOL BIOL, V337, P319, DOI 10.1016/j.jmb.2004.01.035; Garman SC, 2007, ACTA PAEDIATR, V96, P6, DOI 10.1111/j.1651-2227.2007.00198.x; Golubev AM, 2004, J MOL BIOL, V339, P413, DOI 10.1016/j.jmb.2004.03.062; Hart DO, 2000, BIOCHEMISTRY-US, V39, P9826, DOI 10.1021/bi0008074; Heck MP, 2004, J AM CHEM SOC, V126, P1971, DOI 10.1021/ja037822r; Holton J.B., 2000, METABOLIC MOL BASES, P1553; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kawatkar SP, 2006, J AM CHEM SOC, V128, P8310, DOI 10.1021/ja061216p; Kleywegt GJ, 1997, STRUCTURE, V5, P1557, DOI 10.1016/S0969-2126(97)00305-5; KOSHLAND DE, 1953, BIOL REV, V28, P416, DOI 10.1111/j.1469-185X.1953.tb01386.x; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee SY, 2003, J MICROBIOL BIOTECHN, V13, P313; LIEBERMAN RL, 2009, BIOCHEMISTRY; Liu QYP, 2007, NAT BIOTECHNOL, V25, P454, DOI 10.1038/nbt1298; Lovering AL, 2005, J BIOL CHEM, V280, P2105, DOI 10.1074/jbc.M410468200; Ly HD, 2000, CARBOHYD RES, V329, P539, DOI 10.1016/S0008-6215(00)00214-7; Numao S, 2003, J BIOL CHEM, V278, P48074, DOI 10.1074/jbc.M309249200; Olsson ML, 2008, BRIT J HAEMATOL, V140, P3, DOI 10.1111/j.1365-2141.2007.06839.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; REID JSG, 1992, BIOCHEM SOC T, V20, P23, DOI 10.1042/bst0200023; Schiffmann R, 2001, JAMA-J AM MED ASSOC, V285, P2743, DOI 10.1001/jama.285.21.2743; Stoddart J.F., 1971, STEREOCHEMISTRY CARB; Sulzenbacher G, 2004, J BIOL CHEM, V279, P13119, DOI 10.1074/jbc.M313783200; Tailford LE, 2008, NAT CHEM BIOL, V4, P306, DOI 10.1038/nchembio.81; Tu D, 2005, CELL, V121, P257, DOI 10.1016/j.cell.2005.02.005; Uitdehaag JCM, 1999, NAT STRUCT BIOL, V6, P432, DOI 10.1038/8235; Vocadlo DJ, 2008, CURR OPIN CHEM BIOL, V12, P539, DOI 10.1016/j.cbpa.2008.05.010; Vocadlo DJ, 2001, NATURE, V412, P835, DOI 10.1038/35090602; Weis WI, 1996, ANNU REV BIOCHEM, V65, P441, DOI 10.1146/annurev.bi.65.070196.002301; Wicki J, 2007, J AM CHEM SOC, V129, P4530, DOI 10.1021/ja0707254; Zechel DL, 2000, ACCOUNTS CHEM RES, V33, P11, DOI 10.1021/ar970172+	52	88	92	2	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3625	3632		10.1074/jbc.M109.060145	http://dx.doi.org/10.1074/jbc.M109.060145			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19940122	Green Published, hybrid			2022-12-25	WOS:000275254000014
J	Guan, ZW; Haque, MM; Wei, CC; Garcin, ED; Getzoff, ED; Stuehr, DJ				Guan, Zhi-Wen; Haque, Mohammad Mahfuzul; Wei, Chin-Chuan; Garcin, Elsa D.; Getzoff, Elizabeth D.; Stuehr, Dennis J.			Lys(842) in Neuronal Nitric-oxide Synthase Enables the Autoinhibitory Insert to Antagonize Calmodulin Binding, Increase FMN Shielding, and Suppress Interflavin Electron Transfer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; NO COMPLEX-FORMATION; C-TERMINAL TAIL; CONFORMATIONAL EQUILIBRIUM; CYTOCHROME-P450 REDUCTASE; REGULATORY SITES; CONTROL ELEMENT; HEME REDUCTION; FLAVIN DOMAIN; ENZYME	Neuronal nitric-oxide synthase (nNOS) contains a unique autoinhibitory insert (AI) in its FMN subdomain that represses nNOS reductase activities and controls the calcium sensitivity of calmodulin (CaM) binding to nNOS. How the AI does this is unclear. A conserved charged residue (Lys(842)) lies within a putative CaM binding helix in the middle of the AI. We investigated its role by substituting residues that neutralize (Ala) or reverse (Glu) the charge at Lys(842). Compared with wild type nNOS, the mutant enzymes had greater cytochrome c reductase and NADPH oxidase activities in the CaM-free state, were able to bind CaM at lower calcium concentration, and had lower rates of heme reduction and NO synthesis in one case (K842A). Moreover, stopped-flow spectrophotometric experiments with the nNOS reductase domain indicate that the CaM-free mutants had faster flavin reduction kinetics and had less shielding of their FMN subdomains compared with wild type and no longer increased their level of FMN shielding in response to NADPH binding. Thus, Lys(842) is critical for the known functions of the AI and also enables two additional functions of the AI as newly identified here: suppression of electron transfer to FMN and control of the conformational equilibrium of the nNOS reductase domain. Its effect on the conformational equilibrium probably explains suppression of catalysis by the AI.	[Guan, Zhi-Wen; Haque, Mohammad Mahfuzul; Stuehr, Dennis J.] Cleveland Clin, Lerner Res Inst, Dept Pathobiol, Cleveland, OH 44195 USA; [Wei, Chin-Chuan] So Illinois Univ, Dept Chem, Edwardsville, IL 62026 USA; [Garcin, Elsa D.] Univ Maryland Baltimore Cty, Dept Chem & Biochem, Baltimore, MD 21250 USA; [Getzoff, Elizabeth D.] Scripps Res Inst, Dept Mol Biol, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Cleveland Clinic Foundation; Southern Illinois University System; Southern Illinois University Edwardsville; University System of Maryland; University of Maryland Baltimore County; Scripps Research Institute	Stuehr, DJ (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Pathobiol, NC 22,9500 Euclid Ave, Cleveland, OH 44195 USA.	stuehrd@ccf.org	Garcin, Elsa D/C-1556-2013	Garcin, Elsa D/0000-0003-0501-8421; Wei, Chin-Chuan/0000-0001-6453-9409; HAQUE, MOHAMMAD/0000-0003-0852-6368	National Institutes of Health [GM51491, CA53914, HL76491, HL5883]; NATIONAL CANCER INSTITUTE [R01CA053914, R29CA053914] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL076491, R01HL058883] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051491] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM51491, CA53914, and HL76491 (to D. J. S.) and HL58883 (to E. D. G.).	ABUSOUD HM, 1993, P NATL ACAD SCI USA, V90, P10769, DOI 10.1073/pnas.90.22.10769; Adak S, 2002, P NATL ACAD SCI USA, V99, P13516, DOI 10.1073/pnas.192283399; Adak S, 2001, J BIOL CHEM, V276, P23246, DOI 10.1074/jbc.M102509200; Adak S, 2001, J BIOL CHEM, V276, P1244, DOI 10.1074/jbc.M006857200; Adak S, 1999, J BIOL CHEM, V274, P22313, DOI 10.1074/jbc.274.32.22313; Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Bauer PM, 2003, J BIOL CHEM, V278, P14841, DOI 10.1074/jbc.M211926200; BREDT DS, 1992, J BIOL CHEM, V267, P10976; BREDT DS, 1990, P NATL ACAD SCI USA, V87, P682, DOI 10.1073/pnas.87.2.682; BREDT DS, 1991, NATURE, V351, P714, DOI 10.1038/351714a0; BUSSE R, 1990, FEBS LETT, V265, P133, DOI 10.1016/0014-5793(90)80902-U; Chen PF, 2000, J BIOL CHEM, V275, P13155, DOI 10.1074/jbc.275.17.13155; Chen PF, 2003, J BIOL CHEM, V278, P52392, DOI 10.1074/jbc.M305469200; CHO HJ, 1992, J EXP MED, V176, P599, DOI 10.1084/jem.176.2.599; Craig DH, 2002, J BIOL CHEM, V277, P33987, DOI 10.1074/jbc.M203118200; Daff S, 2004, BIOCHEMISTRY-US, V43, P3929, DOI 10.1021/bi0360408; Daff S, 1999, J BIOL CHEM, V274, P30589, DOI 10.1074/jbc.274.43.30589; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Feng CJ, 2006, BIOCHEMISTRY-US, V45, P6354, DOI 10.1021/bi060223n; Gachhui R, 1998, J BIOL CHEM, V273, P5451, DOI 10.1074/jbc.273.10.5451; Garcin ED, 2004, J BIOL CHEM, V279, P37918, DOI 10.1074/jbc.M406204200; Garnaud PE, 2004, BIOCHEMISTRY-US, V43, P11035, DOI 10.1021/bi049312v; Guan ZW, 2003, J BIOL CHEM, V278, P30859, DOI 10.1074/jbc.M301929200; Guan ZW, 2003, ARCH BIOCHEM BIOPHYS, V412, P65, DOI 10.1016/S0003-9861(03)00009-2; Haque MM, 2007, P NATL ACAD SCI USA, V104, P9254, DOI 10.1073/pnas.0700332104; Haque MM, 2009, J BIOL CHEM, V284, P19237, DOI 10.1074/jbc.M109.013144; HEVEL JM, 1992, BIOCHEMISTRY-US, V31, P7160, DOI 10.1021/bi00146a019; Ilagan RP, 2008, J BIOL CHEM, V283, P19603, DOI 10.1074/jbc.M802914200; Jachymova M, 2005, P NATL ACAD SCI USA, V102, P15833, DOI 10.1073/pnas.0506522102; KLATT P, 1993, J BIOL CHEM, V268, P14781; Knight K, 2002, BIOCHEM J, V367, P19, DOI 10.1042/BJ20020667; Komeima K, 2000, J BIOL CHEM, V275, P28139; Konas DW, 2006, BIOCHEMISTRY-US, V45, P12596, DOI 10.1021/bi061011t; Konas DW, 2004, J BIOL CHEM, V279, P35412, DOI 10.1074/jbc.M400872200; Marletta MA, 1998, CURR OPIN CHEM BIOL, V2, P656, DOI 10.1016/S1367-5931(98)80098-7; Matsuda H, 1999, BBA-GEN SUBJECTS, V1473, P345, DOI 10.1016/S0304-4165(99)00193-2; MCMILLAN K, 1992, P NATL ACAD SCI USA, V89, P11141, DOI 10.1073/pnas.89.23.11141; Michell BJ, 2002, J BIOL CHEM, V277, P42344, DOI 10.1074/jbc.M205144200; Miller RT, 1999, BIOCHEM BIOPH RES CO, V265, P184, DOI 10.1006/bbrc.1999.1643; Montgomery HJ, 2000, J BIOL CHEM, V275, P5052, DOI 10.1074/jbc.275.7.5052; Nishida CR, 1999, J BIOL CHEM, V274, P14692, DOI 10.1074/jbc.274.21.14692; Panda K, 2001, J BIOL CHEM, V276, P23349, DOI 10.1074/jbc.M100687200; Roman LJ, 2006, J BIOL CHEM, V281, P23111, DOI 10.1074/jbc.M603671200; Roman LJ, 2000, J BIOL CHEM, V275, P29225, DOI 10.1074/jbc.M004766200; Roman LJ, 2002, CHEM REV, V102, P1179, DOI 10.1021/cr000661e; Rozhkova EA, 2002, J BIOL CHEM, V277, P16888, DOI 10.1074/jbc.M200642200; Salerno JC, 1997, J BIOL CHEM, V272, P29769, DOI 10.1074/jbc.272.47.29769; SCHMIDT HHHW, 1992, BIOCHEMISTRY-US, V31, P3243, DOI 10.1021/bi00127a028; Stuehr DJ, 2005, DALTON T, P3427, DOI 10.1039/b506355h; STUEHR DJ, 1991, P NATL ACAD SCI USA, V88, P7773, DOI 10.1073/pnas.88.17.7773; Stuehr DJ, 2004, J BIOL CHEM, V279, P36167, DOI 10.1074/jbc.R400017200; STUEHR DJ, 1992, J BIOL CHEM, V267, P20547; Tiso M, 2005, J BIOL CHEM, V280, P39208, DOI 10.1074/jbc.M507775200; Tiso M, 2007, BIOCHEMISTRY-US, V46, P14418, DOI 10.1021/bi701646k; Wu CQ, 1996, BIOCHEM BIOPH RES CO, V222, P439, DOI 10.1006/bbrc.1996.0763	55	15	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5							3064	10.1074/jbc.M109.000810	http://dx.doi.org/10.1074/jbc.M109.000810			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19948738	hybrid, Green Published			2022-12-25	WOS:000273829000022
J	Iizasa, E; Mitsutomi, M; Nagano, Y				Iizasa, Ei'ichi; Mitsutomi, Masaru; Nagano, Yukio			Direct Binding of a Plant LysM Receptor-like Kinase, LysM RLK1/CERK1, to Chitin in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; PTERIS-RYUKYUENSIS; PROTEIN; CELLS; SITE; ARABIDOPSIS; PERCEPTION; RECOGNITION; ELICITOR; DOMAINS	Plants induce immune responses against fungal pathogens by recognition of chitin, which is a component of the fungal cell wall. Recent studies have revealed that LysM receptor-like kinase 1/chitin elicitor receptor kinase 1 (LysM RLK1/CERK1) is a critical component for the immune responses to chitin in Arabidopsis thaliana. However, the molecular mechanism of the chitin recognition by LysM RLK1 still remains unknown. Here, we present the first evidence for direct binding of LysM RLK1 to chitin. We expressed LysM RLK1 fused with yeast-enhanced green fluorescent protein (LysM RLK1-yEGFP) in yeast cells. Binding studies using the solubilized LysM RLK1-yEGFP and several insoluble polysaccharides having similar structures showed that LysM RLK1-yEGFP specifically binds to chitin. Subsequently, the fluorescence microscopic observation of the solubilized LysM RLK1-yEGFP binding to chitin beads revealed that the binding was saturable and had a high affinity, with a K-d of similar to 82 nM. This binding was competed by the addition of soluble glycol chitin or high concentration of chitin oligosaccharides having 4-8 residues of N-acetyl glucosamine. However, the competition of these chitin oligosac-charides is weaker than that of glycol chitin. These data suggest that LysM RLK1 has a higher affinity for chitin having a longer residue of N-acetyl glucosamine. We also found that LysM RLK1-yEGFP was auto phosphorylated in vitro and that chitin does not affect the phosphorylation of LysM RLK1-yEGFP. Our results provide a new dimension to chitin elicitor perception in plants.	[Iizasa, Ei'ichi] Saga Univ, Analyt Res Ctr Expt Sci, Saga 8408502, Japan; [Mitsutomi, Masaru] Saga Univ, Dept Appl Biochem & Food Sci, Saga 8408502, Japan; [Iizasa, Ei'ichi; Mitsutomi, Masaru; Nagano, Yukio] Kagoshima Univ, United Grad Sch Agr Sci, Kagoshima 8900065, Japan	Saga University; Saga University; Kagoshima University	Iizasa, E (corresponding author), Saga Univ, Analyt Res Ctr Expt Sci, 1 Honjo Machi, Saga 8408502, Japan.	k5818326@kadai.jp; nagano@cc.saga-u.ac.jp	Nagano, Yukio/H-8734-2019; Iizasa, Ei'ichi/AAE-8654-2020	Nagano, Yukio/0000-0001-5030-676X; Iizasa, Ei'ichi/0000-0002-0081-6005	Japan Society for the Promotion of Science [17580082]; Foundation for Research Fellowships of Japan Society [19-8266]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Foundation for Research Fellowships of Japan Society	This work was supported in part by Grant-in-aid for Scientific Research (C) from the Japan Society for the Promotion of Science 17580082 (to Y. N.) and the Foundation for Research Fellowships of Japan Society for the Promotion of Science for Young Scientists (DC1) Grant 19-8266 (to E. I.).	Albert PK, 2006, PLANT BIOTECHNOL, V23, P459, DOI DOI 10.5511/PLANTBI0TECHN0L0GY.23.459; BARKER SA, 1958, J CHEM SOC, P2218, DOI 10.1039/jr9580002218; Buist G, 2008, MOL MICROBIOL, V68, P838, DOI 10.1111/j.1365-2958.2008.06211.x; Carninci P, 1998, P NATL ACAD SCI USA, V95, P520, DOI 10.1073/pnas.95.2.520; Day RB, 2001, PLANT PHYSIOL, V126, P1162, DOI 10.1104/pp.126.3.1162; GRANADO J, 1995, PLANT PHYSIOL, V107, P485, DOI 10.1104/pp.107.2.485; Gust AA, 2007, J BIOL CHEM, V282, P32338, DOI 10.1074/jbc.M704886200; Hardt M, 2004, ARCH BIOCHEM BIOPHYS, V426, P286, DOI 10.1016/j.abb.2004.03.017; Iizasa E, 2006, BIOTECHNIQUES, V40, P79, DOI 10.2144/000112041; Jerala R, 2007, INT J MED MICROBIOL, V297, P353, DOI 10.1016/j.ijmm.2007.04.001; JEUNIAUX C, 1958, ARCH INT PHYS BIOCH, V66, P408, DOI 10.3109/13813455809084218; Joshi MC, 2008, J BIOL CHEM, V283, P28287, DOI 10.1074/jbc.M804416200; Kaku H, 2006, P NATL ACAD SCI USA, V103, P11086, DOI 10.1073/pnas.0508882103; Kim CY, 1998, PLANT MOL BIOL, V37, P523, DOI 10.1023/A:1005960313459; Kohara J, 2006, PROTEIN EXPRES PURIF, V49, P276, DOI 10.1016/j.pep.2006.05.015; Madsen EB, 2003, NATURE, V425, P637, DOI 10.1038/nature02045; MITSUTOMI M, 1990, AGR BIOL CHEM TOKYO, V54, P871, DOI 10.1080/00021369.1990.10870047; Mitsutomi M, 2002, CHITIN CHITOSAN RES, V8, P228; Miya A, 2007, P NATL ACAD SCI USA, V104, P19613, DOI 10.1073/pnas.0705147104; Mulder L, 2006, GLYCOBIOLOGY, V16, P801, DOI 10.1093/glycob/cwl006; Nam KH, 2002, CELL, V110, P203, DOI 10.1016/S0092-8674(02)00814-0; Newstead S, 2007, P NATL ACAD SCI USA, V104, P13936, DOI 10.1073/pnas.0704546104; Ohnuma T, 2008, J BIOL CHEM, V283, P5178, DOI 10.1074/jbc.M707156200; Onaga S, 2008, GLYCOBIOLOGY, V18, P414, DOI 10.1093/glycob/cwn018; Park HC, 2004, PLANT PHYSIOL, V135, P2150, DOI 10.1104/pp.104.041442; Radutoiu S, 2003, NATURE, V425, P585, DOI 10.1038/nature02039; Reese TA, 2007, NATURE, V447, P92, DOI 10.1038/nature05746; Scheer JM, 1999, PLANT CELL, V11, P1525, DOI 10.1105/tpc.11.8.1525; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Shibuya N, 1996, PLANT CELL PHYSIOL, V37, P894, DOI 10.1093/oxfordjournals.pcp.a029030; Shimosato H, 2007, PLANT CELL, V19, P107, DOI 10.1105/tpc.105.038869; Tjoelker LW, 2000, J BIOL CHEM, V275, P514, DOI 10.1074/jbc.275.1.514; Vaaje-Kolstad G, 2005, J BIOL CHEM, V280, P11313, DOI 10.1074/jbc.M407175200; Wan JR, 2008, PLANT CELL, V20, P471, DOI 10.1105/tpc.107.056754; Wang XF, 2008, DEV CELL, V15, P220, DOI 10.1016/j.devcel.2008.06.011; Yabuki M, 1987, TECH B FAC HORT CHIB, V39, P23, DOI 10.1271/bbb1961.54.3341; YAMADA H, 1981, CARBOHYD RES, V92, P160, DOI 10.1016/S0008-6215(00)85993-5; Zhang B, 2002, MOL PLANT MICROBE IN, V15, P963, DOI 10.1094/MPMI.2002.15.9.963; Zhang XC, 2007, PLANT PHYSIOL, V144, P623, DOI 10.1104/pp.107.097097; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037; Zipfel C, 2009, CURR OPIN PLANT BIOL, V12, P414, DOI 10.1016/j.pbi.2009.06.003	41	135	146	1	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5							2996	10.1074/jbc.M109.027540	http://dx.doi.org/10.1074/jbc.M109.027540			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19951949	hybrid, Green Published			2022-12-25	WOS:000273829000014
J	Pillai, VB; Sundaresan, NR; Kim, G; Gupta, M; Rajamohan, SB; Pillai, JB; Samant, S; Ravindra, PV; Isbatan, A; Gupta, MP				Pillai, Vinodkumar B.; Sundaresan, Nagalingam R.; Kim, Gene; Gupta, Madhu; Rajamohan, Senthilkumar B.; Pillai, Jyothish B.; Samant, Sadhana; Ravindra, P. V.; Isbatan, Ayman; Gupta, Mahesh P.			Exogenous NAD Blocks Cardiac Hypertrophic Response via Activation of the SIRT3-LKB1-AMP-activated Kinase Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRACELLULAR SIGNALING PATHWAYS; OXIDATIVE STRESS; PROTEIN-KINASE; CALORIE RESTRICTION; NICOTINIC-ACID; HEART-FAILURE; CELL-SURVIVAL; SIR2 HOMOLOG; LIFE-SPAN; AMPK	Since the discovery of NAD-dependent deacetylases, sirtuins, it has been recognized that maintaining intracellular levels of NAD is crucial for the management of stress response of cells. Here we show that agonist-induced cardiac hypertrophy is associated with loss of intracellular levels of NAD, but not exercise-induced physiologic hypertrophy. Exogenous addition of NAD was capable of maintaining intracellular levels of NAD and blocking the agonist-induced cardiac hypertrophic response in vitro as well as in vivo. NAD treatment blocked the activation of pro-hypertrophic Akt1 signaling, and augmented the activity of anti-hypertrophic LKB1-AMPK signaling in the heart, which prevented subsequent induction of mTOR-mediated protein synthesis. By using gene knock-out and transgenic mouse models of SIRT3 and SIRT1, we showed that the anti-hypertrophic effects of exogenous NAD are mediated through activation of SIRT3, but not SIRT1. SIRT3 deacetylates and activates LKB1, thus augmenting the activity of the LKB1-AMPK pathway. These results reveal a novel role of NAD as an inhibitor of cardiac hypertrophic signaling, and suggest that prevention of NAD depletion may be critical in the treatment of cardiac hypertrophy and heart failure.	[Pillai, Jyothish B.; Samant, Sadhana; Ravindra, P. V.; Isbatan, Ayman; Gupta, Mahesh P.] Univ Chicago, Dept Surg, Chicago, IL 60637 USA; [Kim, Gene] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Gupta, Mahesh P.] Univ Chicago, Comm Cellular & Mol Physiol, Div Biol Sci, Chicago, IL 60637 USA; [Gupta, Madhu] Univ Illinois, Dept Physiol & Biophys, Chicago, IL 60612 USA	University of Chicago; University of Chicago; University of Chicago; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Gupta, MP (corresponding author), Univ Chicago, Dept Surg, 5841 S Maryland Ave, Chicago, IL 60637 USA.	mgupta@surgery.bsd.uchicago.edu		Veeranna, Ravindra/0000-0003-4228-1843; Kim, Gene/0000-0001-6461-1992	National Institutes of Health [RO1 HL-77788, HL-83423]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077788, R01HL083423] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 HL-77788 and HL-83423.	Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Alcendor RR, 2007, CIRC RES, V100, P1512, DOI 10.1161/01.RES.0000267723.65696.4a; Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Banks AS, 2008, CELL METAB, V8, P333, DOI 10.1016/j.cmet.2008.08.014; Bellizzi D, 2005, GENOMICS, V85, P258, DOI 10.1016/j.ygeno.2004.11.003; Bruzzone S, 2001, J BIOL CHEM, V276, P48300, DOI 10.1074/jbc.M107308200; Bruzzone S, 2001, FASEB J, V15, P10; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Chan AYM, 2008, J BIOL CHEM, V283, P24194, DOI 10.1074/jbc.M802869200; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Cheng SWY, 2004, J BIOL CHEM, V279, P15719, DOI 10.1074/jbc.C300534200; Chua KF, 2005, CELL METAB, V2, P67, DOI 10.1016/j.cmet.2005.06.007; Dasgupta B, 2007, P NATL ACAD SCI USA, V104, P7217, DOI 10.1073/pnas.0610068104; Diwan A, 2007, PHYSIOLOGY, V22, P56, DOI 10.1152/physiol.00033.2006; Dong J, 2008, ANTIOXID REDOX SIGN, V10, P2023, DOI 10.1089/ars.2007.2019; Dyck JRB, 2006, J PHYSIOL-LONDON, V574, P95, DOI 10.1113/jphysiol.2006.109389; Ek-Vitorin JF, 2005, AM J PHYSIOL-CELL PH, V289, pC1535, DOI 10.1152/ajpcell.00182.2005; ELFGANG C, 1995, J CELL BIOL, V129, P805, DOI 10.1083/jcb.129.3.805; Elvehjem C A, 2002, J Biol Chem, V277, pe22; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; Frey N, 2004, CIRCULATION, V109, P1580, DOI 10.1161/01.CIR.0000120390.68287.BB; Fulco M, 2008, DEV CELL, V14, P661, DOI 10.1016/j.devcel.2008.02.004; Gan L, 2008, NEURON, V58, P10, DOI 10.1016/j.neuron.2008.03.015; Gurd BJ, 2009, J PHYSIOL-LONDON, V587, P1817, DOI 10.1113/jphysiol.2008.168096; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Imai S, 2009, CELL BIOCHEM BIOPHYS, V53, P65, DOI 10.1007/s12013-008-9041-4; JACOBSON EL, 1976, ARCH BIOCHEM BIOPHYS, V175, P627, DOI 10.1016/0003-9861(76)90553-1; Kaeberlein M, 2008, CELL METAB, V8, P4, DOI 10.1016/j.cmet.2008.06.004; Lan F, 2008, J BIOL CHEM, V283, P27628, DOI 10.1074/jbc.M805711200; Lanza IR, 2008, DIABETES, V57, P2933, DOI 10.2337/db08-0349; Li Y, 2008, CELL METAB, V8, P38, DOI 10.1016/j.cmet.2008.05.004; Lin SJ, 2004, GENE DEV, V18, P12, DOI 10.1101/gad.1164804; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Morisco C, 2003, AM J PHYSIOL-HEART C, V284, pH1043, DOI 10.1152/ajpheart.00990.2002; Narala SR, 2008, MOL BIOL CELL, V19, P1210, DOI 10.1091/mbc.E07-09-0965; Neuwahl FJ, 1943, LANCET, V2, P348; Pillai JB, 2005, J BIOL CHEM, V280, P43121, DOI 10.1074/jbc.M506162200; Rajamohan SB, 2009, MOL CELL BIOL, V29, P4116, DOI 10.1128/MCB.00121-09; Rose G, 2003, EXP GERONTOL, V38, P1065, DOI 10.1016/S0531-5565(03)00209-2; Sasaki H, 2009, CIRCULATION, V119, P2568, DOI 10.1161/CIRCULATIONAHA.108.798561; Sawyer DB, 2002, J MOL CELL CARDIOL, V34, P379, DOI 10.1006/jmcc.2002.1526; Spies TD, 1938, P SOC EXP BIOL MED, V38, P178; Sugden PH, 2006, ANTIOXID REDOX SIGN, V8, P2111, DOI 10.1089/ars.2006.8.2111; Sugden PH, 2003, CIRC RES, V93, P1179, DOI 10.1161/01.RES.0000106132.04301.F5; Sundaresan NR, 2008, MOL CELL BIOL, V28, P6384, DOI 10.1128/MCB.00426-08; Sundaresan NR, 2009, J CLIN INVEST, V119, P2758, DOI 10.1172/JCI39162; YAMADA K, 1982, DIABETES, V31, P749, DOI 10.2337/diabetes.31.9.749; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; Ying WJ, 2007, FRONT BIOSCI-LANDMRK, V12, P2728, DOI 10.2741/2267	52	307	321	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5					3133	3144		10.1074/jbc.M109.077271	http://dx.doi.org/10.1074/jbc.M109.077271			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19940131	Green Published, hybrid			2022-12-25	WOS:000273829000029
J	Kowlessur, D; Tobacman, LS				Kowlessur, Devanand; Tobacman, Larry S.			Troponin Regulatory Function and Dynamics Revealed by H/D Exchange-Mass Spectrometry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CARDIAC TROPONIN; AMIDE HYDROGEN-EXCHANGE; SKELETAL-MUSCLE; THIN-FILAMENTS; STRUCTURAL-CHANGES; BINDING; DOMAIN; ACTIN; THERMODYNAMICS; ACTIVATION	Muscle contraction is tightly regulated by Ca2+ binding to the thin filament protein troponin. The mechanism of this regulation was investigated by detailed mapping of the dynamic properties of cardiac troponin using amide hydrogen exchange-mass spectrometry. Results were obtained in the presence of either saturation or non-saturation of the regulatory Ca2+ binding site in the NH2 domain of subunit TnC. Troponin was found to be highly dynamic, with 60% of amides exchanging H for D within seconds of exposure to D2O. In contrast, portions of the TnT-TnI coiled-coil exhibited high protection from exchange, despite 6 h in D2O. The data indicate that the most stable portion of the trimeric troponin complex is the coiled-coil. Regulatory site Ca2+ binding altered dynamic properties (i.e. H/D exchange protection) locally, near the binding site and in the TnI switch helix that attaches to the Ca2+-saturated TnC NH2 domain. More notably, Ca2+ also altered the dynamic properties of other parts of troponin: the TnI inhibitory peptide region that binds to actin, the TnT-TnI coiled-coil, and the TnC COOH domain that contains the regulatory Ca2+ sites in many invertebrate as opposed to vertebrate troponins. Mapping of these affected regions onto the troponin highly extended structure suggests that cardiac troponin switches between alternative sets of intramolecular interactions, similar to previous intermediate resolution x-ray data of skeletal muscle troponin.	[Kowlessur, Devanand; Tobacman, Larry S.] Univ Illinois, Dept Med, Chicago, IL 60612 USA; [Tobacman, Larry S.] Univ Illinois, Dept Physiol & Biophys, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Tobacman, LS (corresponding author), 1853 W Polk St,MC 784, Chicago, IL 60612 USA.	LST@uic.edu			National Institutes of Health [HL063774, HL038834]; Chicago Community Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063774, R29HL038834, R01HL038834] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chicago Community Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL063774 and HL038834. This work was also supported by the CBC/UIC Proteomics and Informatics Facility, established by a grant from The Searle Funds at the Chicago Community Trust to the Chicago Biomedical Consortium.	Anand GS, 2002, J MOL BIOL, V323, P377, DOI 10.1016/S0022-2836(02)00919-1; Arrington CB, 2000, METHOD ENZYMOL, V323, P104; BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; Biesiadecki BJ, 2007, CIRC RES, V100, P1486, DOI 10.1161/01.RES.0000267744.92677.7f; Brown LJ, 2002, P NATL ACAD SCI USA, V99, P12765, DOI 10.1073/pnas.202477399; Doi T, 2005, ARCH BIOCHEM BIOPHYS, V436, P83, DOI 10.1016/j.abb.2005.01.004; Englander SW, 2000, ANNU REV BIOPH BIOM, V29, P213, DOI 10.1146/annurev.biophys.29.1.213; Gafurov B, 2007, FEBS J, V274, P2287, DOI 10.1111/j.1742-4658.2007.05765.x; Galinska-Rakoczy A, 2008, J MOL BIOL, V379, P929, DOI 10.1016/j.jmb.2008.04.062; Heeley DH, 2006, J BIOL CHEM, V281, P668, DOI 10.1074/jbc.M505549200; Hinkle A, 2003, J BIOL CHEM, V278, P506, DOI 10.1074/jbc.M209194200; Houdusse A, 1997, STRUCTURE, V5, P1695, DOI 10.1016/S0969-2126(97)00315-8; Huyghues-Despointes BMP, 1999, NAT STRUCT BIOL, V6, P910; KIM KS, 1993, BIOCHEMISTRY-US, V32, P9600, DOI 10.1021/bi00088a012; Kobayashi T, 2005, ANNU REV PHYSIOL, V67, P39, DOI 10.1146/annurev.physiol.67.040403.114025; Li MX, 1997, BIOCHEMISTRY-US, V36, P12519, DOI 10.1021/bi971222l; Li MX, 1999, BIOCHEMISTRY-US, V38, P8289, DOI 10.1021/bi9901679; Luque I, 2002, ANNU REV BIOPH BIOM, V31, P235, DOI 10.1146/annurev.biophys.31.082901.134215; Matsumoto F, 2009, BIOCHEM BIOPH RES CO, V382, P205, DOI 10.1016/j.bbrc.2009.03.009; Poole KJV, 2006, J STRUCT BIOL, V155, P273, DOI 10.1016/j.jsb.2006.02.020; Qiu F, 2003, BIOCHEM J, V371, P811, DOI 10.1042/BJ20021814; Smith DA, 2003, BIOPHYS J, V84, P3155, DOI 10.1016/S0006-3495(03)70040-X; Smith DL, 1997, J MASS SPECTROM, V32, P135, DOI 10.1002/(SICI)1096-9888(199702)32:2<135::AID-JMS486>3.0.CO;2-M; Spyracopoulos L, 1998, BIOCHEMISTRY-US, V37, P18032, DOI 10.1021/bi9816960; Sun YB, 2006, P NATL ACAD SCI USA, V103, P17771, DOI 10.1073/pnas.0605430103; SYSKA H, 1976, BIOCHEM J, V153, P375, DOI 10.1042/bj1530375; Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780; Tobacman LS, 2000, J BIOL CHEM, V275, P27587; Tobacman LS, 1996, ANNU REV PHYSIOL, V58, P447, DOI 10.1146/annurev.physiol.58.1.447; Vinogradova MV, 2005, P NATL ACAD SCI USA, V102, P5038, DOI 10.1073/pnas.0408882102; Wang F, 1999, J AM SOC MASS SPECTR, V10, P703, DOI 10.1016/S1044-0305(99)00039-2; Xing J, 2008, BIOCHEMISTRY-US, V47, P13383, DOI 10.1021/bi801492x; Zhang ZQ, 1998, J AM SOC MASS SPECTR, V9, P225, DOI 10.1016/S1044-0305(97)00284-5; Zhang ZQ, 1996, BIOCHEMISTRY-US, V35, P779, DOI 10.1021/bi952227q	34	23	23	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2686	2694		10.1074/jbc.M109.062349	http://dx.doi.org/10.1074/jbc.M109.062349			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19920153	Green Published, hybrid			2022-12-25	WOS:000273697800047
J	Alper, S; McElwee, MK; Apfeld, J; Lackford, B; Freedman, JH; Schwartz, DA				Alper, Scott; McElwee, Matthew K.; Apfeld, Javier; Lackford, Brad; Freedman, Jonathan H.; Schwartz, David A.			The Caenorhabditis elegans Germ Line Regulates Distinct Signaling Pathways to Control Lifespan and Innate Immunity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-ELEGANS; OXIDATIVE STRESS; TRANSCRIPTION FACTOR; POLYMORPHIC VARIANTS; SERRATIA-MARCESCENS; RESISTANT MUTANTS; VIRULENCE FACTORS; I RECEPTOR; LONGEVITY; INSULIN	The relationship between the mechanisms that control an organism's lifespan and its ability to respond to environmental challenges are poorly understood. In Caenorhabditis elegans, an insulin-like signaling pathway modulates lifespan and the innate immune response to bacterial pathogens via a common mechanism involving transcriptional regulation by the DAF-16/FOXO transcription factor. The C. elegans germ line also modulates lifespan in a daf-16-dependent manner. Here, we show that the germ line controls the innate immune response of C. elegans somatic cells to two different Gram-negative bacteria. In contrast to the insulin-like signaling pathway, the germ line acts via distinct signaling pathways to control lifespan and innate immunity. Under standard nematode culture conditions, the germ line regulates innate immunity in parallel to a known p38 MAPK signaling pathway, via a daf-16-independent pathway. Our findings indicate that a complex regulatory network integrates inputs from insulin-like signaling, p38 MAPK signaling, and germ line stem cells to control innate immunity in C. elegans. We also confirm that innate immunity and lifespan in C. elegans are distinct processes, as nonoverlapping regulatory networks control survival in the presence of pathogenic and nonpathogenic bacteria. Finally, we demonstrate that the p38 MAPK pathway in C. elegans is activated to a similar extent by both pathogenic and nonpathogenic bacteria, suggesting that both can induce the nematode innate immune response.	[Alper, Scott] Natl Jewish Hlth, Integrated Dept Immunol, Denver, CO 80206 USA; [Schwartz, David A.] Natl Jewish Hlth, Dept Med, Denver, CO 80206 USA; [McElwee, Matthew K.; Freedman, Jonathan H.] NIEHS, Mol Toxicol Lab, NIH, Durham, NC 27709 USA; [Lackford, Brad] NIEHS, Mol Carcinogenesis Lab, NIH, Durham, NC 27709 USA; [Apfeld, Javier] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [McElwee, Matthew K.] Duke Univ, Nicholas Sch Environm, Durham, NC 27707 USA	National Jewish Health; National Jewish Health; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Harvard University; Harvard Medical School; Duke University	Alper, S (corresponding author), Natl Jewish Hlth, Integrated Dept Immunol, 1400 Jackson St,A640, Denver, CO 80206 USA.	alpers@njhealth.org		McElwee, Matthew/0000-0003-1659-6112; Apfeld, Javier/0000-0001-9897-5671	NHLBI; National Institutes of Health, NIEHS; National Institutes of Health; National Toxicology Program; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES102045] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health, NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Toxicology Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the Intramural Research Program of NHLBI, National Institutes of Health, NIEHS, National Institutes of Health, and the National Toxicology Program.	Alper S, 2008, P NATL ACAD SCI USA, V105, P7016, DOI 10.1073/pnas.0802405105; Alper S, 2007, MOL CELL BIOL, V27, P5544, DOI 10.1128/MCB.02070-06; Arantes-Oliveira N, 2002, SCIENCE, V295, P502, DOI 10.1126/science.1065768; AUSTIN J, 1987, CELL, V51, P589, DOI 10.1016/0092-8674(87)90128-0; Barsyte D, 2001, FASEB J, V15, P627, DOI 10.1096/fj.99-0966com; BEANAN MJ, 1992, DEVELOPMENT, V116, P755; Berkowitz LA, 2000, DEVELOPMENT, V127, P4419; Berman JR, 2006, CELL, V124, P1055, DOI 10.1016/j.cell.2006.01.039; Bonafe M, 2003, J CLIN ENDOCR METAB, V88, P3299, DOI 10.1210/jc.2002-021810; CAPOWSKI EE, 1991, GENETICS, V129, P1061; Cargill SL, 2003, AGING CELL, V2, P185, DOI 10.1046/j.1474-9728.2003.00049.x; Choy RKM, 1999, MOL CELL, V4, P143, DOI 10.1016/S1097-2765(00)80362-7; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Couillault C, 2004, NAT IMMUNOL, V5, P488, DOI 10.1038/ni1060; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Evans EA, 2008, AGING CELL, V7, P879, DOI 10.1111/j.1474-9726.2008.00435.x; Flatt T, 2008, P NATL ACAD SCI USA, V105, P6368, DOI 10.1073/pnas.0709128105; FLYG C, 1980, J GEN MICROBIOL, V120, P173; Garigan D, 2002, GENETICS, V161, P1101; Garsin DA, 2003, SCIENCE, V300, P1921, DOI 10.1126/science.1080147; Gems D, 1998, GENETICS, V150, P129; Gems D, 2000, GENETICS, V154, P1597; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Honda Y, 2002, ANN NY ACAD SCI, V959, P466, DOI 10.1111/j.1749-6632.2002.tb02117.x; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Inoue H, 2005, GENE DEV, V19, P2278, DOI 10.1101/gad.1324805; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kim DH, 2004, P NATL ACAD SCI USA, V101, P10990, DOI 10.1073/pnas.0403546101; Kim DH, 2002, SCIENCE, V297, P623, DOI 10.1126/science.1073759; KODOYIANNI V, 1992, MOL BIOL CELL, V3, P1199, DOI 10.1091/mbc.3.11.1199; Kojima T, 2004, EXP GERONTOL, V39, P1595, DOI 10.1016/j.exger.2004.05.007; Kurz CL, 2003, EMBO J, V22, P1451, DOI 10.1093/emboj/cdg159; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; LARSEN PL, 1993, P NATL ACAD SCI USA, V90, P8905, DOI 10.1073/pnas.90.19.8905; LARSEN PL, 1995, GENETICS, V139, P1567; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; LITHGOW GJ, 1995, P NATL ACAD SCI USA, V92, P7540, DOI 10.1073/pnas.92.16.7540; Mahajan-Miklos S, 1999, CELL, V96, P47, DOI 10.1016/S0092-8674(00)80958-7; Mallo GV, 2002, CURR BIOL, V12, P1209, DOI 10.1016/S0960-9822(02)00928-4; MITCHELL DH, 1979, J GERONTOL, V34, P28, DOI 10.1093/geronj/34.1.28; Miyata S, 2008, GENETICS, V178, P903, DOI 10.1534/genetics.107.083923; Murakami S, 1996, GENETICS, V143, P1207; O'Rourke D, 2006, GENOME RES, V16, P1005, DOI 10.1101/gr.50823006; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Perez GI, 2007, P NATL ACAD SCI USA, V104, P5229, DOI 10.1073/pnas.0608557104; Powell Jennifer R., 2008, V415, P403, DOI 10.1007/978-1-59745-570-1_24; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; Reinhart BJ, 2001, GENETICS, V157, P199; Selman C, 2008, FASEB J, V22, P807, DOI 10.1096/fj.07-9261com; Shapira M, 2006, P NATL ACAD SCI USA, V103, P14086, DOI 10.1073/pnas.0603424103; STROME S, 1995, DEVELOPMENT, V121, P2961; Suh Y, 2008, P NATL ACAD SCI USA, V105, P3438, DOI 10.1073/pnas.0705467105; Taguchi A, 2007, SCIENCE, V317, P369, DOI 10.1126/science.1142179; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Troemel ER, 2006, PLOS GENET, V2, P1725, DOI 10.1371/journal.pgen.0020183; VANFLETEREN JR, 1993, BIOCHEM J, V292, P605, DOI 10.1042/bj2920605; Wilicox BJ, 2008, P NATL ACAD SCI USA, V105, P13987, DOI 10.1073/pnas.0801030105; Wood WB, 1988, NEMATODE CAENORHABDI; Yamawaki TM, 2008, GENETICS, V178, P513, DOI 10.1534/genetics.107.083253	61	46	51	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2010	285	3					1822	1828		10.1074/jbc.M109.057323	http://dx.doi.org/10.1074/jbc.M109.057323			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	541PJ	19923212	Green Published, hybrid			2022-12-25	WOS:000273429100028
J	Araya-Ajoy, YM; Chaves-Campos, J; Kalko, EKV; DeWoody, JA				Araya-Ajoy, Yi-men; Chaves-Campos, Johel; Kalko, Elisabeth K. V.; DeWoody, J. Andrew			High-Pitched Notes during Vocal Contests Signal Genetic Diversity in Ocellated Antbirds	PLOS ONE			English	Article							GENOME-WIDE HETEROZYGOSITY; BIRD SONG; SEXUAL SELECTION; MALE QUALITY; MATE CHOICE; BODY-SIZE; PERFORMANCE; EVOLUTION; FREQUENCY; HYPOTHESES	Animals use honest signals to assess the quality of competitors during aggressive interactions. Current theory predicts that honest signals should be costly to produce and thus reveal some aspects of the phenotypic or genetic quality of the sender. In songbirds, research indicates that biomechanical constraints make the production of some acoustic features costly. Furthermore, recent studies have found that vocal features are related to genetic diversity. We linked these two lines of research by evaluating if constrained acoustic features reveal male genetic diversity during aggressive interactions in ocellated antbirds (Phaenostictus mcleannani). We recorded the aggressive vocalizations of radiotagged males at La Selva Biological Station in Costa Rica, and found significant variation in the highest frequency produced among individuals. Moreover, we detected a negative relationship between the frequency of the highest pitched note and vocalization duration, suggesting that high pitched notes might constrain the duration of vocalizations through biomechanical and/or energetic limitations. When we experimentally exposed wild radiotagged males to simulated acoustic challenges, the birds increased the pitch of their vocalization. We also found that individuals with higher genetic diversity (as measured by zygosity across 9 microsatellite loci) produced notes of higher pitch during aggressive interactions. Overall, our results suggest that the ability to produce high pitched notes is an honest indicator of male genetic diversity in male-male aggressive interactions.	[Araya-Ajoy, Yi-men] Univ Costa Rica, Escuela Biol, San Jose, Costa Rica; [Chaves-Campos, Johel; DeWoody, J. Andrew] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Kalko, Elisabeth K. V.] Univ Ulm, Inst Expt Ecol, Ulm, Germany; [Kalko, Elisabeth K. V.] Smithsonian Trop Res Inst, Balboa, Panama; [DeWoody, J. Andrew] Purdue Univ, Dept Forestry & Nat Resources, W Lafayette, IN 47907 USA	Universidad Costa Rica; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Ulm University; Smithsonian Institution; Smithsonian Tropical Research Institute; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Araya-Ajoy, YM (corresponding author), Univ Costa Rica, Escuela Biol, San Jose, Costa Rica.	jchaves@purdue.edu	Chaves-Campos, Johel/AAF-9147-2020; DeWoody, James Andrew/C-4909-2008	Chaves-Campos, Johel/0000-0001-8026-7626; DeWoody, James Andrew/0000-0002-7315-5631	U. S. National Science Foundation [DDIG 0608231, DEB 0514815]; Organization for Tropical Studies; American Ornithologists' Union; Cooper Ornithological Society; Sigma Xi Society; Deutscher Akademischer Austausch Dienst; Cornell Laboratory of Ornithology; Neotropical Ornithological Society; Direct For Biological Sciences [0851933] Funding Source: National Science Foundation	U. S. National Science Foundation(National Science Foundation (NSF)); Organization for Tropical Studies; American Ornithologists' Union; Cooper Ornithological Society; Sigma Xi Society; Deutscher Akademischer Austausch Dienst(Deutscher Akademischer Austausch Dienst (DAAD)); Cornell Laboratory of Ornithology; Neotropical Ornithological Society; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was partially funded by the U. S. National Science Foundation (DDIG 0608231 to J.C-C and DEB 0514815 to J.A.D.), the Organization for Tropical Studies (to Y.A-A and J.C-C.), the American Ornithologists' Union, Cooper Ornithological Society, and Sigma Xi Society (to J.C-C.), the Deutscher Akademischer Austausch Dienst (DAAD; ISAP program), Cornell Laboratory of Ornithology (Raven License Award) and the Neotropical Ornithological Society (to Y. A-A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. US National Science Foundation http://www.nsf.gov/Organization for Tropical Studies http://www.ots.ac.cr/American Ornithologists' Union http://www.aou.org/Cooper Ornithological Society http://www.cooper.org/Sigma Xi Society http://www.sigmaxi.org/Idea Wild http://www.ideawild.org/Deutscher Akademischer Austausch Dienst http://www.daad.de/en/index.html Cornell Laboratory of Ornithology http://www.birds.cornell.edu/Neotropical Ornithological Society http://www.ibiologia.unam.mx/links/neo/neo.html	Acevedo-Whitehouse K, 2003, NATURE, V422, P35, DOI 10.1038/422035a; Amador A, 2008, J NEUROPHYSIOL, V99, P2383, DOI 10.1152/jn.01002.2007; Amos W, 2001, P ROY SOC B-BIOL SCI, V268, P2021, DOI 10.1098/rspb.2001.1751; Aparicio JM, 2006, MOL ECOL, V15, P4659, DOI 10.1111/j.1365-294X.2006.03111.x; Ballentine B, 2004, BEHAV ECOL, V15, P163, DOI 10.1093/beheco/arg090; Brown JL, 1997, BEHAV ECOL, V8, P60, DOI 10.1093/beheco/8.1.60; Byers BE, 2007, BEHAV ECOL, V18, P130, DOI 10.1093/beheco/arl058; Campbell H, 2007, HUM MOL GENET, V16, P233, DOI 10.1093/hmg/ddl473; Cardoso GC, 2007, BEHAV ECOL, V18, P1051, DOI 10.1093/beheco/arm078; Charpentier MJE, 2008, BEHAV GENET, V38, P151, DOI 10.1007/s10519-008-9191-6; Chaves-Campos J, 2008, MOL ECOL, V17, P2963, DOI 10.1111/j.1365-294X.2008.03811.x; Chaves-Campos J, 2009, P ROY SOC B-BIOL SCI, V276, P3995, DOI 10.1098/rspb.2009.0730; Collins Sarah, 2004, P39, DOI 10.1016/B978-012473070-0/50005-0; DAVIES NB, 1978, NATURE, V274, P683, DOI 10.1038/274683a0; DeWoody YD, 2005, J HERED, V96, P85, DOI 10.1093/jhered/esi017; Draganoiu TI, 2002, P ROY SOC B-BIOL SCI, V269, P2525, DOI 10.1098/rspb.2002.2192; DuBois AL, 2009, BIOL LETTERS, V5, P163, DOI 10.1098/rsbl.2008.0626; FLEISCHER RC, 1983, NATURE, V304, P628, DOI 10.1038/304628a0; Fromhage L, 2009, EVOLUTION, V63, P684, DOI 10.1111/j.1558-5646.2008.00575.x; Gil D, 2002, TRENDS ECOL EVOL, V17, P133, DOI 10.1016/S0169-5347(02)02410-2; Goller F, 1996, J NEUROPHYSIOL, V76, P287, DOI 10.1152/jn.1996.76.1.287; GRAFEN A, 1990, J THEOR BIOL, V144, P517, DOI 10.1016/S0022-5193(05)80088-8; Hansson B, 2002, MOL ECOL, V11, P2467, DOI 10.1046/j.1365-294X.2002.01644.x; Hardouin LA, 2007, AM NAT, V169, P552, DOI 10.1086/512136; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Hood GM, 2006, POPTOOLS VERSION 2 7; Illes AE, 2006, P ROY SOC B-BIOL SCI, V273, P1907, DOI 10.1098/rspb.2006.3535; Janicke T, 2008, ANIM BEHAV, V75, P91, DOI 10.1016/j.anbehav.2007.04.007; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; Kotiaho JS, 2008, TRENDS ECOL EVOL, V23, P1, DOI 10.1016/j.tree.2007.09.012; KROODSMA DE, 1990, ANIM BEHAV, V40, P1138, DOI 10.1016/S0003-3472(05)80180-0; KROODSMA DE, 1984, AUK, V101, P13, DOI 10.1093/auk/101.1.13; Lambrechts Marcel M., 1996, P305; LEONARD ML, 1995, ANIM BEHAV, V49, P1283, DOI 10.1006/anbe.1995.0160; Lesbarreres D, 2005, MOL ECOL, V14, P311, DOI 10.1111/j.1365-294X.2004.02394.x; Marshall RC, 2003, P ROY SOC B-BIOL SCI, V270, pS248, DOI 10.1098/rsbl.2003.0081; MITTON JB, 1997, SELECTION NATURAL PO; MOLLER AP, 1991, ANIM BEHAV, V41, P723, DOI 10.1016/S0003-3472(05)80909-1; Ortego J, 2007, MOL ECOL, V16, P2383, DOI 10.1111/j.1365-294X.2007.03322.x; Pfaff JA, 2007, P ROY SOC B-BIOL SCI, V274, P2035, DOI 10.1098/rspb.2007.0170; Podos J, 2004, ANNU REV ECOL EVOL S, V35, P55, DOI 10.1146/annurev.ecolsys.35.021103.105719; Podos J, 1997, EVOLUTION, V51, P537, DOI 10.1111/j.1558-5646.1997.tb02441.x; Podos J, 2004, NATURES MUSIC SCI BI; Podos J, 2009, ADV STUD BEHAV, V40, P159, DOI 10.1016/S0065-3454(09)40005-6; Price JJ, 2006, ANIM BEHAV, V71, P799, DOI 10.1016/j.anbehav.2005.05.025; R Development Core Team, 2009, R FDN STAT COMP; Raposo Marcos A., 2003, Lundiana, V4, P35; Reby D, 2005, P ROY SOC B-BIOL SCI, V272, P941, DOI 10.1098/rspb.2004.2954; Reid JM, 2003, P ROY SOC B-BIOL SCI, V270, P2151, DOI 10.1098/rspb.2003.2480; RYAN MJ, 1985, AM NAT, V126, P87, DOI 10.1086/284398; Searcy W.N.S, 2005, EVOLUTION ANIMAL COM; SEARCY WA, 1986, ANNU REV ECOL SYST, V17, P507, DOI 10.1146/annurev.es.17.110186.002451; Seddon N, 2005, EVOLUTION, V59, P200; Seddon N, 2004, P ROY SOC B-BIOL SCI, V271, P1823, DOI 10.1098/rspb.2004.2805; Suthers RA, 1999, PHILOS T ROY SOC B, V354, P927, DOI 10.1098/rstb.1999.0444; Suthers Roderick A., 2004, P272, DOI 10.1016/B978-012473070-0/50012-8; TIERSCH TR, 1991, J HERED, V82, P363, DOI 10.1093/oxfordjournals.jhered.a111105; Tubaro PL, 1998, CONDOR, V100, P54, DOI 10.2307/1369896; WAGNER WE, 1992, ANIM BEHAV, V44, P449, DOI 10.1016/0003-3472(92)90055-E; WALLSCHLAGER D, 1980, EXPERIENTIA, V36, P412, DOI 10.1007/BF01975119; Willis E.O., 1973, Smithsonian Contributions to Zoology, VNo. 144, P1; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3	62	24	25	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2009	4	12							e8137	10.1371/journal.pone.0008137	http://dx.doi.org/10.1371/journal.pone.0008137			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MU	19956580	Green Submitted, Green Published, gold			2022-12-25	WOS:000272828800028
J	Chhikara, M; Wang, SB; Kern, SJ; Ferreyra, GA; Barb, JJ; Munson, PJ; Danner, RL				Chhikara, Maneesha; Wang, Shuibang; Kern, Steven J.; Ferreyra, Gabriela A.; Barb, Jennifer J.; Munson, Peter J.; Danner, Robert L.			Carbon Monoxide Blocks Lipopolysaccharide-Induced Gene Expression by Interfering with Proximal TLR4 to NF-kappa B Signal Transduction in Human Monocytes	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; INDUCED LUNG INJURY; THERAPEUTIC APPLICATIONS; ISCHEMIA/REPERFUSION INJURY; INFLAMMATORY RESPONSE; INDUCED ACTIVATION; ENDOTHELIAL-CELLS; HEME OXYGENASE; MAPK PATHWAY; PPAR-GAMMA	Carbon monoxide (CO) is an endogenous messenger that suppresses inflammation, modulates apoptosis and promotes vascular remodeling. Here, microarrays were employed to globally characterize the CO (250 ppm) suppression of early (1 h) LPS-induced inflammation in human monocytic THP-1 cells. CO suppressed 79 of 101 immediate-early genes induced by LPS; 19% (15/79) were transcription factors and most others were cytokines, chemokines and immune response genes. The prototypic effects of CO on transcription and protein production occurred early but decreased rapidly. CO activated p38 MAPK, ERK1/2 and Akt and caused an early and transitory delay in LPS-induced JNK activation. However, selective inhibitors of these kinases failed to block CO suppression of LPS-induced IL-1 beta, an inflammation marker. Of CO-suppressed genes, 81% (64/79) were found to have promoters with putative NF-kappa B binding sites. CO was subsequently shown to block LPS-induced phosphorylation and degradation of IkB alpha in human monocytes, thereby inhibiting NF-kappa B signal transduction. CO broadly suppresses the initial inflammatory response of human monocytes to LPS by reshaping proximal events in TLR4 signal transduction such as stress kinase responses and early NF-kappa B activation. These rapid, but transient effects of CO may have therapeutic applications in acute pulmonary and vascular injury.	[Chhikara, Maneesha; Wang, Shuibang; Kern, Steven J.; Ferreyra, Gabriela A.; Danner, Robert L.] NIH, Ctr Clin, Dept Crit Care Med, Bethesda, MD 20892 USA; [Barb, Jennifer J.; Munson, Peter J.] NIH, Math & Stat Comp Lab, Ctr Informat Technol, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH Center for Information Technology (CIT)	Chhikara, M (corresponding author), NIH, Ctr Clin, Dept Crit Care Med, Bethesda, MD 20892 USA.	rdanner@cc.nih.gov		Barb, Jennifer/0000-0003-3022-0154	National Institutes of Health Clinical Center; CENTER FOR INFORMATION TECHNOLOGY [ZIACT000266] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL000188, ZIACL001164, ZIACL001158] Funding Source: NIH RePORTER	National Institutes of Health Clinical Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CENTER FOR INFORMATION TECHNOLOGY(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Center for Information Technology (CIT)); CLINICAL CENTER	This study was supported by intramural funds from the National Institutes of Health Clinical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bilban M, 2006, IMMUNITY, V24, P601, DOI 10.1016/j.immuni.2006.03.012; Brouard S, 2002, J BIOL CHEM, V277, P17950, DOI 10.1074/jbc.M108317200; Cepinskas G, 2008, AM J PHYSIOL-GASTR L, V294, pG184, DOI 10.1152/ajpgi.00348.2007; Chin BY, 2007, P NATL ACAD SCI USA, V104, P5109, DOI 10.1073/pnas.0609611104; Conde de la Rosa L, 2008, FREE RADICAL BIO MED, V44, P1323, DOI 10.1016/j.freeradbiomed.2007.12.011; Dolinay T, 2004, AM J RESP CRIT CARE, V170, P613, DOI 10.1164/rccm.200401-023OC; Fujimoto H, 2004, ARTERIOSCL THROM VAS, V24, P1848, DOI 10.1161/01.ATV.0000142364.85911.0e; Goebel U, 2008, ANESTHESIOLOGY, V108, P1025, DOI 10.1097/ALN.0b013e3181733115; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; He XL, 2007, AM J PHYSIOL-LUNG C, V292, pL1039, DOI 10.1152/ajplung.00490.2006; Hoetzel A, 2008, AM J RESP CRIT CARE, V177, P1223, DOI 10.1164/rccm.200708-1265OC; Hoetzel A, 2007, ANTIOXID REDOX SIGN, V9, P2013, DOI 10.1089/ars.2007.1762; Jin SLC, 2002, P NATL ACAD SCI USA, V99, P7628, DOI 10.1073/pnas.122041599; Kaizu T, 2005, SURGERY, V138, P229, DOI 10.1016/j.surg.2005.06.015; Kim HS, 2008, AM J PHYSIOL-GASTR L, V295, pG146, DOI 10.1152/ajpgi.00105.2007; Kim HP, 2006, ANNU REV PHARMACOL, V46, P411, DOI 10.1146/annurev.pharmtox.46.120604.141053; Kirkby KA, 2006, AM J PHYSIOL-RENAL, V290, pF563, DOI 10.1152/ajprenal.00220.2005; Kohmotoa J, 2007, AM J TRANSPLANT, V7, P2279, DOI 10.1111/j.1600-6143.2007.01940.x; Masini E, 2008, FASEB J, V22, P3380, DOI 10.1096/fj.08-107110; Mayr FB, 2005, AM J RESP CRIT CARE, V171, P354, DOI 10.1164/rccm.200404-446OC; Megias J, 2007, BRIT J PHARMACOL, V150, P977, DOI 10.1038/sj.bjp.0707184; Mishra S, 2006, P NATL ACAD SCI USA, V103, P5191, DOI 10.1073/pnas.0600241103; Morse D, 2003, J BIOL CHEM, V278, P36993, DOI 10.1074/jbc.M302942200; Morse D, 2002, ANTIOXID REDOX SIGN, V4, P331, DOI 10.1089/152308602753666389; Motterlini R, 2005, EXPERT OPIN INV DRUG, V14, P1305, DOI 10.1517/13543784.14.11.1305; Nakahira K, 2006, J EXP MED, V203, P2377, DOI 10.1084/jem.20060845; Nakao A, 2003, AM J PATHOL, V163, P1587, DOI 10.1016/S0002-9440(10)63515-8; Nakao A, 2006, J CELL MOL MED, V10, P650, DOI 10.1111/j.1582-4934.2006.tb00426.x; Ning W, 2005, AM J PHYSIOL-LUNG C, V289, pL268, DOI 10.1152/ajplung.00168.2004; Otterbein LE, 2000, NAT MED, V6, P422, DOI 10.1038/74680; Pedersen I, 2008, CYTOKINE, V43, P391, DOI 10.1016/j.cyto.2008.07.016; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ryter SW, 2007, ANTIOXID REDOX SIGN, V9, P2157, DOI 10.1089/ars.2007.1811; Ryter SW, 2007, AM J RESP CELL MOL, V36, P175, DOI 10.1165/rcmb.2006-0333TR; Ryter SW, 2006, CURR OPIN PHARMACOL, V6, P257, DOI 10.1016/j.coph.2006.03.002; Ryter SW, 2004, BIOESSAYS, V26, P270, DOI 10.1002/bies.20005; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Sarady JK, 2004, FASEB J, V18, P854, DOI 10.1096/fj.03-0643fje; Sarady JK, 2002, AM J RESP CELL MOL, V27, P739, DOI 10.1165/rcmb.4816; Sharif O, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-1; Srisook K, 2006, BIOCHEM PHARMACOL, V71, P307, DOI 10.1016/j.bcp.2005.10.042; Suh GY, 2006, AM J RESP CELL MOL, V35, P220, DOI 10.1165/rcmb.2005-0154OC; Sun BW, 2008, INT J BIOL SCI, V4, P270; Sun BW, 2008, INT J BIOL SCI, V4, P176; TENHUNEN R, 1968, P NATL ACAD SCI USA, V61, P748, DOI 10.1073/pnas.61.2.748; Zhang JH, 2007, J BIOL CHEM, V282, P1003, DOI 10.1074/jbc.M607609200; Zuckerbraun BS, 2007, FASEB J, V21, P1099, DOI 10.1096/fj.06-6644com	49	50	52	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2009	4	12							e8139	10.1371/journal.pone.0008139	http://dx.doi.org/10.1371/journal.pone.0008139			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MU	19956541	Green Published, Green Submitted, gold			2022-12-25	WOS:000272828800029
J	Ii, H; Yokoyama, N; Yoshida, S; Tsutsumi, K; Hatakeyama, S; Sato, T; Ishihara, K; Akiba, S				Ii, Hiromi; Yokoyama, Naoki; Yoshida, Shintaro; Tsutsumi, Kae; Hatakeyama, Shinji; Sato, Takashi; Ishihara, Keiichi; Akiba, Satoshi			Alleviation of High-Fat Diet-Induced Fatty Liver Damage in Group IVA Phospholipase A(2)-Knockout Mice	PLOS ONE			English	Article							ACTIVATED RECEPTOR-GAMMA; INSULIN-RESISTANCE; ADIPOSE-TISSUE; METABOLIC SYNDROME; PROSTAGLANDIN D-2; BODY-WEIGHT; IN-VIVO; LEPTIN; ADIPONECTIN; ADIPOCYTES	Hepatic fat deposition with hepatocellular damage, a feature of non-alcoholic fatty liver disease, is mediated by several putative factors including prostaglandins. In the present study, we examined whether group IVA phospholipase A(2) (IVA-PLA(2)), which catalyzes the first step in prostanoid biosynthesis, is involved in the development of fatty liver, using IVA-PLA(2)-knockout mice. Male wild-type mice on high-fat diets (20% fat and 1.25% cholesterol) developed hepatocellular vacuolation and liver hypertrophy with an increase in the serum levels of liver damage marker aminotransferases when compared with wild-type mice fed normal diets. These high-fat diet-induced alterations were markedly decreased in IVA-PLA(2)-knockout mice. Hepatic triacylglycerol content was lower in IVA-PLA(2)-knockout mice than in wild-type mice under normal dietary conditions. Although high-fat diets increased hepatic triacylglycerol content in both genotypes, the degree was lower in IVA-PLA(2)-knockout mice than in wild-type mice. Under the high-fat dietary conditions, IVA-PLA(2)-knockout mice had lower epididymal fat pad weight and smaller adipocytes than wild-type mice. The serum level of prostaglandin E-2, which has a fat storage effect, was lower in IVA-PLA(2)-knockout mice than in wild-type mice, irrespective of the kind of diet. In both genotypes, high-fat diets increased serum leptin levels equally between the two groups, but did not affect the serum levels of adiponectin, resistin, free fatty acid, triacylglycerol, glucose, or insulin. Our findings suggest that a deficiency of IVA-PLA(2) alleviates fatty liver damage caused by high-fat diets, probably because of the lower generation of IVA-PLA(2) metabolites, such as prostaglandin E-2. IVA-PLA(2) could be a promising therapeutic target for obesity-related diseases including nonalcoholic fatty liver disease.	[Ii, Hiromi; Yokoyama, Naoki; Yoshida, Shintaro; Sato, Takashi; Ishihara, Keiichi; Akiba, Satoshi] Kyoto Pharmaceut Univ, Dept Pathol Biochem, Yamashina Ku, Kyoto 607, Japan; [Tsutsumi, Kae; Hatakeyama, Shinji] Novartis Inst BioMed Res, Tsukuba, Ibaraki, Japan	Kyoto Pharmaceutical University; Novartis	Ii, H (corresponding author), Kyoto Pharmaceut Univ, Dept Pathol Biochem, Yamashina Ku, Kyoto 607, Japan.	akiba@mb.kyoto-phu.ac.jp	Ishihara, Keiichi/M-5743-2019; Hatakeyama, Shinji/I-8873-2019	Hatakeyama, Shinji/0000-0002-0166-2773	Ministry of Education, Culture, Sports, Science and Technology of Japan; Takeda Research Foundation (Japan)	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Research Foundation (Japan)	This work was supported by a Grant-in-Aid for Scientific Research from, and by the Open Research Program of, the Ministry of Education, Culture, Sports, Science and Technology of Japan, and by Takeda Research Foundation ( Japan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LA, 2005, CAN MED ASSOC J, V172, P899, DOI 10.1503/cmaj.045232; Akagiri S, 2008, J CLIN BIOCHEM NUTR, V42, P150, DOI 10.3164/jcbn.2008022; Banerjee RR, 2004, SCIENCE, V303, P1195, DOI 10.1126/science.1092341; Bradbury MW, 2006, AM J PHYSIOL-GASTR L, V290, pG194, DOI 10.1152/ajpgi.00413.2005; Cernkovich ER, 2008, ENDOCRINOLOGY, V149, P1581, DOI 10.1210/en.2007-1148; Clark JM, 2003, AM J GASTROENTEROL, V98, P960, DOI [10.1016/S0002-9270(03)00265-X, 10.1111/j.1572-0241.2003.07486.x]; Enomoto N, 2000, AM J PHYSIOL-GASTR L, V279, pG100, DOI 10.1152/ajpgi.2000.279.1.G100; Fain JN, 2000, J LIPID RES, V41, P1689; Fishman S, 2007, FASEB J, V21, P53, DOI 10.1096/fj.06-6557com; FOLCH J, 1957, J BIOL CHEM, V226, P497; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Hsieh PS, 2009, OBESITY, V17, P1150, DOI 10.1038/oby.2008.674; Huang W, 2006, ENDOCRINOLOGY, V147, P1480, DOI 10.1210/en.2005-0731; Hui JM, 2004, HEPATOLOGY, V40, P46, DOI 10.1002/hep.20280; Ii H, 2008, PROSTAG OTH LIPID M, V86, P12, DOI 10.1016/j.prostaglandins.2007.12.002; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; KLIEWER SA, 1995, CELL, V83, P813, DOI 10.1016/0092-8674(95)90194-9; Kusminski CM, 2005, CLIN SCI, V109, P243, DOI 10.1042/CS20050078; Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161; Mazid MA, 2006, FEBS LETT, V580, P6885, DOI 10.1016/j.febslet.2006.11.049; Nunemaker CS, 2008, AM J PHYSIOL-ENDOC M, V295, pE1065, DOI 10.1152/ajpendo.90371.2008; Pagano C, 2006, J CLIN ENDOCR METAB, V91, P1081, DOI 10.1210/jc.2005-1056; Peeraully MR, 2006, PFLUG ARCH EUR J PHY, V453, P177, DOI 10.1007/s00424-006-0118-x; PEREZ S, 2006, BIOCHIM BIOPHYS ACTA, V176, P160; Ragolia L, 2005, J BIOL CHEM, V280, P29946, DOI 10.1074/jbc.M502927200; Reginato MJ, 1998, J BIOL CHEM, V273, P1855, DOI 10.1074/jbc.273.4.1855; Schaloske RH, 2006, BBA-MOL CELL BIOL L, V1761, P1246, DOI 10.1016/j.bbalip.2006.07.011; Su X, 2004, J BIOL CHEM, V279, P21740, DOI 10.1074/jbc.M314166200; Uozumi N, 1997, NATURE, V390, P618, DOI 10.1038/37622; VASSAUX G, 1992, ENDOCRINOLOGY, V131, P2393, DOI 10.1210/en.131.5.2393; Xu AM, 2003, J CLIN INVEST, V112, P91, DOI 10.1172/JCI200317797; Yu YH, 2005, CIRC RES, V96, P1042, DOI 10.1161/01.RES.0000165803.47776.38	32	42	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2009	4	12							e8089	10.1371/journal.pone.0008089	http://dx.doi.org/10.1371/journal.pone.0008089			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MT	19956652	gold, Green Published, Green Submitted			2022-12-25	WOS:000272828700007
J	Norgate, M; Chamings, J; Pavlova, A; Bull, JK; Murray, ND; Sunnucks, P				Norgate, Melanie; Chamings, Jay; Pavlova, Alexandra; Bull, James K.; Murray, Neil D.; Sunnucks, Paul			Mitochondrial DNA Indicates Late Pleistocene Divergence of Populations of Heteronympha merope, an Emerging Model in Environmental Change Biology	PLOS ONE			English	Article							CLIMATE-CHANGE; MOLECULAR PHYLOGENY; RANGE EXPANSION; LEPIDOPTERA; MUTATION; BUTTERFLIES; EVOLUTION; PHYLOGEOGRAPHY; BIOGEOGRAPHY; SEQUENCES	Knowledge of historical changes in species range distribution provides context for investigating adaptive potential and dispersal ability. This is valuable for predicting the potential impact of environmental change on species of interest. Butterflies are one of the most important taxa for studying such impacts, and Heteronympha merope has the potential to provide a particularly valuable model, in part due to the existence of historical data on morphological traits and glycolytic enzyme variation. This study investigates the population genetic structure and phylogeography of H. merope, comparing the relative resolution achieved through partial DNA sequences of two mitochondrial loci, COI and ND5. These data are used to define the relationship between subspecies, showing that the subspecies are reciprocally monophyletic. On this basis, the Western Australian subspecies H. m. duboulayi is genetically distinct from the two eastern subspecies. Throughout the eastern part of the range, levels of migration and the timing of key population splits of potential relevance to climatic adaptation are estimated and indicate Late Pleistocene divergence both of the Tasmanian subspecies and of an isolated northern population from the eastern mainland subspecies H. m. merope. This information is then used to revisit historical data and provides support for the importance of clinal variation in wing characters, as well as evidence for selective pressure acting on allozyme loci phosphoglucose isomerase and phosphoglucomutase in H. merope. The study has thus confirmed the value of H. merope as a model organism for measuring responses to environmental change, offering the opportunity to focus on isolated populations, as well as a latitudinal gradient, and to use historical changes to test the accuracy of predictions for the future.	[Norgate, Melanie; Chamings, Jay; Pavlova, Alexandra; Bull, James K.; Sunnucks, Paul] Monash Univ, Sch Biol Sci, Clayton, Vic, Australia; [Norgate, Melanie; Chamings, Jay; Pavlova, Alexandra; Bull, James K.; Sunnucks, Paul] Monash Univ, Australian Ctr Biodivers, Clayton, Vic, Australia; [Murray, Neil D.] La Trobe Univ, Dept Genet, Bundoora, Vic, Australia	Monash University; Monash University; La Trobe University	Norgate, M (corresponding author), Monash Univ, Sch Biol Sci, Clayton, Vic, Australia.	paul.sunnucks@sci.monash.edu.au	Pavlova, Alexandra/H-4749-2014	Pavlova, Alexandra/0000-0001-9455-4124; Sunnucks, Paul/0000-0002-8139-7059; Bull, James/0000-0002-0274-4359	Australian Research Council [DP0772837]	Australian Research Council(Australian Research Council)	This work was supported by Australian Research Council grant DP0772837 (http://www.arc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albre J, 2008, MOL PHYLOGENET EVOL, V47, P196, DOI 10.1016/j.ympev.2008.01.009; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Ballard JWO, 2000, J MOL EVOL, V51, P64, DOI 10.1007/s002390010067; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beaumont LJ, 2005, ECOL MODEL, V186, P250, DOI 10.1016/j.ecolmodel.2005.01.030; Braby MF, 2000, BUTTERFLIES AUSTR TH; Braby MF, 2007, SYST ENTOMOL, V32, P2, DOI 10.1111/j.1365-3113.2006.00349.x; Broughton RE, 2006, MOL BIOL EVOL, V23, P1516, DOI 10.1093/molbev/msl013; Crozier L, 2004, ECOLOGY, V85, P231, DOI 10.1890/02-0607; Dowling DK, 2008, TRENDS ECOL EVOL, V23, P546, DOI 10.1016/j.tree.2008.05.011; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Frankham R, 1997, HEREDITY, V78, P311, DOI 10.1038/hdy.1997.46; Fu YX, 1997, GENETICS, V147, P915; Garrick RC, 2004, MOL ECOL, V13, P3329, DOI 10.1111/j.1365-294X.2004.02340.x; GU HN, 1991, BIOCHEM GENET, V29, P345, DOI 10.1007/BF00554142; Haag-Liautard C, 2008, PLOS BIOL, V6, P1706, DOI 10.1371/journal.pbio.0060204; Hey J, 2007, P NATL ACAD SCI USA, V104, P2785, DOI 10.1073/pnas.0611164104; Hughes L, 2000, TRENDS ECOL EVOL, V15, P56, DOI 10.1016/S0169-5347(99)01764-4; Karl I, 2008, FUNCT ECOL, V22, P887, DOI 10.1111/j.1365-2435.2008.01438.x; Kato Y, 2004, SYST ENTOMOL, V29, P1, DOI 10.1111/j.1365-3113.2004.00238.x; Kearney M, 2009, ECOL LETT, V12, P334, DOI 10.1111/j.1461-0248.2008.01277.x; Kearney M, 2009, FUNCT ECOL, V23, P528, DOI 10.1111/j.1365-2435.2008.01538.x; Keith DA, 2008, BIOL LETTERS, V4, P560, DOI 10.1098/rsbl.2008.0049; Lenormand T, 2002, TRENDS ECOL EVOL, V17, P183, DOI 10.1016/S0169-5347(02)02497-7; Li W. H, 1997, MOL EVOLUTION; Lunt DH, 1996, INSECT MOL BIOL, V5, P153, DOI 10.1111/j.1365-2583.1996.tb00049.x; Marden JH, 2000, ANNU REV PHYSIOL, V62, P157, DOI 10.1146/annurev.physiol.62.1.157; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; McLaughlin JF, 2002, P NATL ACAD SCI USA, V99, P6070, DOI 10.1073/pnas.052131199; Meiklejohn CD, 2007, TRENDS GENET, V23, P259, DOI 10.1016/j.tig.2007.03.008; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mitikka V, 2008, BIODIVERS CONSERV, V17, P623, DOI 10.1007/s10531-007-9287-y; Morin X, 2008, BIOL LETTERS, V4, P573, DOI 10.1098/rsbl.2008.0181; Narita S, 2007, GENETICA, V131, P241, DOI 10.1007/s10709-006-9134-1; Nazari V, 2007, MOL PHYLOGENET EVOL, V42, P131, DOI 10.1016/j.ympev.2006.06.022; NEI M, 2000, MOL EVOLUTION PHYLOG; Ounap E, 2009, AUST J ENTOMOL, V48, P113, DOI 10.1111/j.1440-6055.2009.00695.x; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; PEARSE FK, 1982, EVOLUTION, V36, P1251, DOI 10.1111/j.1558-5646.1982.tb05494.x; PEARSE FK, 1981, AUST J ZOOL, V29, P631; PEARSE FK, 1978, GEOGRAPHIC VARIATION; Quek SP, 2004, EVOLUTION, V58, P554, DOI 10.1111/j.0014-3820.2004.tb01678.x; Rand DM, 1998, GENETICA, V102-3, P393, DOI 10.1023/A:1017006118852; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Saastamoinen M, 2008, AM NAT, V171, pE701, DOI 10.1086/587531; Schneider S, 1999, GENETICS, V152, P1079; Scriber JM, 2002, ECOGRAPHY, V25, P184, DOI 10.1034/j.1600-0587.2002.250206.x; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Simonato M, 2007, MOL ECOL, V16, P2273, DOI 10.1111/j.1365-294X.2007.03302.x; Sunnucks P, 1996, MOL BIOL EVOL, V13, P510, DOI 10.1093/oxfordjournals.molbev.a025612; Sunnucks P, 2000, MOL ECOL, V9, P1699, DOI 10.1046/j.1365-294x.2000.01084.x; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thomas I, 1996, J BIOGEOGR, V23, P717, DOI 10.1111/j.1365-2699.1996.tb00032.x; Thomas JA, 2005, PHILOS T R SOC B, V360, P339, DOI 10.1098/rstb.2004.1585; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Ward PI, 2004, MOL ECOL, V13, P3213, DOI 10.1111/j.1365-294X.2004.02293.x; Watt WB, 1996, MOL BIOL EVOL, V13, P699, DOI 10.1093/oxfordjournals.molbev.a025631; Yagi T, 2001, GENES GENET SYST, V76, P229, DOI 10.1266/ggs.76.229; Yagi T, 1999, J MOL EVOL, V48, P42, DOI 10.1007/PL00006443	63	27	29	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2009	4	11							e7950	10.1371/journal.pone.0007950	http://dx.doi.org/10.1371/journal.pone.0007950			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MH	19956696	Green Published, Green Submitted, gold			2022-12-25	WOS:000272827500002
J	Mas, E; Danjoux, M; Garcia, V; Carpentier, S; Segui, B; Levade, T				Mas, Emmanuel; Danjoux, Marie; Garcia, Virginie; Carpentier, Stephane; Segui, Bruno; Levade, Thierry			IL-6 Deficiency Attenuates Murine Diet-Induced Non-Alcoholic Steatohepatitis	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; FATTY LIVER-DISEASE; NF-KAPPA-B; FACTOR-ALPHA; TNF-ALPHA; HEPATOCYTE APOPTOSIS; HEPATIC STEATOSIS; ALCOHOLIC STEATOHEPATITIS; INTERLEUKIN-6 DOES/DOES; GLUCOSE-HOMEOSTASIS	Background: The role of inflammation in the pathogenesis of non-alcoholic steatohepatitis (NASH), a common cause of liver disease, is still poorly understood. This study aimed at assessing the involvement of a major inflammatory cytokine, IL-6, in NASH. Materials and Methods: Steatohepatitis was induced by feeding wild-type or IL-6(-/-) mice for 5 weeks with a methionine and choline-deficient (MCD) diet. Results: Whereas MCD diet-induced weight loss and decreases in serum glucose, cholesterol and triglyceride levels were similar in both genotypes, serum alanine aminotransferase was less elevated in IL-6(-/-) mice than in wild-type animals. Despite having a comparable liver steatosis score, IL-6-deficient mice exhibited less lobular inflammation than their wildtype littermates. Liver gene expression of TGF-beta and MCP-1 was also strongly attenuated in mutant mice; a more modest reduction was observed for PPAR-gamma and F4/80 transcripts as well as proteins. Chromatographic analysis of liver lipids demonstrated that MCD diet induced in normal and mutant mice a similar decrease in the ratio of phosphatidylcholine to phosphatidylethanolamine. However, the diet-induced increase in the levels of sphingomyelin and ceramide was less important in IL-6(-/-) mice. Conclusion: Altogether, these results indicate that IL-6 deficiency does not block the development of NASH; yet, IL-6 plays a critical role in the accompanying liver inflammation.			Mas, E (corresponding author), Fac Med Toulouse, INSERM, U858, Toulouse, France.	thierry.levade@inserm.fr	Mas, Emmanuel/ABF-6249-2020; GARCIA, Virginie/W-8313-2019; Ségui, Bruno/O-8957-2014; Levade, Thierry/O-8948-2014	Mas, Emmanuel/0000-0001-5425-7352; GARCIA, Virginie/0000-0002-9761-7036; Ségui, Bruno/0000-0002-6119-1889; 				Abiru S, 2006, LIVER INT, V26, P39, DOI 10.1111/j.1478-3231.2005.01191.x; Ames B. N., 1966, METHOD ENZYMOL, P115, DOI DOI 10.1016/0076-6879(66)08014-5; Bahcecioglu IH, 2005, HEPATO-GASTROENTEROL, V52, P1549; Baumgardner JN, 2008, AM J PHYSIOL-GASTR L, V294, pG27, DOI 10.1152/ajpgi.00296.2007; Bielawska A, 2001, ANAL BIOCHEM, V298, P141, DOI 10.1006/abio.2001.5342; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Crespo J, 2001, HEPATOLOGY, V34, P1158, DOI 10.1053/jhep.2001.29628; Cressman DE, 1996, SCIENCE, V274, P1379, DOI 10.1126/science.274.5291.1379; Cuvillier O, 2000, J BIOL CHEM, V275, P15691, DOI 10.1074/jbc.M000280200; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Dela Pena A, 2005, GASTROENTEROLOGY, V129, P1663, DOI 10.1053/j.gastro.2005.09.004; Deng QG, 2005, HEPATOLOGY, V42, P905, DOI 10.1002/hep.20877; Deutschman CS, 2006, CRIT CARE MED, V34, P2613, DOI 10.1097/01.CCM.0000240229.98275.07; Diehl AM, 2005, HEPATOL RES, V33, P138, DOI 10.1016/j.hepres.2005.09.022; El-Assal O, 2004, CELL MOL IMMUNOL, V1, P205; Feldstein AE, 2004, HEPATOLOGY, V40, P185, DOI 10.1002/hep.20283; Feldstein AE, 2003, GASTROENTEROLOGY, V125, P437, DOI 10.1016/S0016-5085(03)00907-7; Fernandez-Checa JC, 2005, ALCOHOL CLIN EXP RES, V29, p151S, DOI 10.1097/01.alc.0000189285.04059.b3; FOLCH J, 1957, J BIOL CHEM, V226, P497; George J, 2003, J HEPATOL, V39, P756, DOI 10.1016/S0168-8278(03)00376-3; Gyamfi MA, 2008, BIOCHEM PHARMACOL, V75, P981, DOI 10.1016/j.bcp.2007.09.030; Haque M, 2002, BEST PRACT RES CL GA, V16, P709, DOI 10.1053/bega.2002.0325; Haukeland JW, 2006, J HEPATOL, V44, P1167, DOI 10.1016/j.jhep.2006.02.011; HILL DB, 1992, J LAB CLIN MED, V119, P547; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Hong F, 2004, HEPATOLOGY, V40, P933, DOI 10.1002/hep.20400; Hong F, 2002, ONCOGENE, V21, P32, DOI 10.1038/sj.onc.1205016; Hotamisligil GS, 1999, J INTERN MED, V245, P621, DOI 10.1046/j.1365-2796.1999.00490.x; Jin XL, 2006, HEPATOLOGY, V43, P474, DOI 10.1002/hep.21087; Kim JH, 2009, VITAM HORM, V80, P613, DOI 10.1016/S0083-6729(08)00621-3; Kirsch R, 2006, J GASTROEN HEPATOL, V21, P174, DOI 10.1111/j.1440-1746.2005.04220.x; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Larter CZ, 2006, J HEPATOL, V44, P253, DOI 10.1016/j.jhep.2005.11.030; Leclercq IA, 2000, J CLIN INVEST, V105, P1067, DOI 10.1172/JCI8814; Li ZY, 2006, CELL METAB, V3, P321, DOI 10.1016/j.cmet.2006.03.007; LUDWIG J, 1980, MAYO CLIN PROC, V55, P434; Malagarie-Cazenave S, 2004, J BIOL CHEM, V279, P18648, DOI 10.1074/jbc.M314294200; MALAGARIECAZENA.S, 2002, EXPERT REV MOL MED, P1; Mari M, 2007, LIVER INT, V27, P440, DOI 10.1111/j.1478-3231.2007.01475.x; McCuskey RS, 2004, HEPATOLOGY, V40, P386, DOI 10.1002/hep.20302; McGettrick HM, 2009, EUR J IMMUNOL, V39, P113, DOI 10.1002/eji.200838232; Memon RA, 2001, NAT MED, V7, P2, DOI 10.1038/83316; Mooney RA, 2007, J APPL PHYSIOL, V102, P816, DOI 10.1152/japplphysiol.01208a.2006; Natori S, 2001, J HEPATOL, V34, P248, DOI 10.1016/S0168-8278(00)00089-1; Pedersen BK, 2007, J APPL PHYSIOL, V102, P814, DOI 10.1152/japplphysiol.01208.2006; Pedersen BK, 2007, CURR OPIN CLIN NUTR, V10, P265, DOI 10.1097/MCO.0b013e3280ebb5b3; Puri P, 2007, HEPATOLOGY, V46, P1081, DOI 10.1002/hep.21763; Ribeiro PS, 2004, AM J GASTROENTEROL, V99, P1708, DOI 10.1111/j.1572-0241.2004.40009.x; Rinella ME, 2008, J LIPID RES, V49, P1068, DOI 10.1194/jlr.M800042-JLR200; Rinella ME, 2004, J HEPATOL, V40, P47, DOI 10.1016/j.jhep.2003.09.020; Scheller J, 2006, MED MICROBIOL IMMUN, V195, P173, DOI 10.1007/s00430-006-0019-9; Senn JJ, 2002, DIABETES, V51, P3391, DOI 10.2337/diabetes.51.12.3391; Tomita K, 2006, GUT, V55, P415, DOI 10.1136/gut.2005.071118; Wallenius V, 2002, NAT MED, V8, P75, DOI 10.1038/nm0102-75; Wieckowska A, 2008, AM J GASTROENTEROL, V103, P1372, DOI 10.1111/j.1572-0241.2007.01774.x; YAO ZM, 1988, J BIOL CHEM, V263, P2998; Yin M, 1999, GASTROENTEROLOGY, V117, P942, DOI 10.1016/S0016-5085(99)70354-9	60	61	67	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2009	4	11							e7929	10.1371/journal.pone.0007929	http://dx.doi.org/10.1371/journal.pone.0007929			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522NL	19936233	Green Submitted, Green Published, gold			2022-12-25	WOS:000272004800010
J	Pogozelski, AR; Geng, TY; Li, P; Yin, XH; Lira, VA; Zhang, M; Chi, JT; Yan, Z				Pogozelski, Andrew R.; Geng, Tuoyu; Li, Ping; Yin, Xinhe; Lira, Vitor A.; Zhang, Mei; Chi, Jen-Tsan; Yan, Zhen			p38 gamma Mitogen-Activated Protein Kinase Is a Key Regulator in Skeletal Muscle Metabolic Adaptation in Mice	PLOS ONE			English	Article							JUN NH2-TERMINAL KINASE; PGC-1-ALPHA TRANSCRIPTION; MITOCHONDRIAL BIOGENESIS; GENE-EXPRESSION; CYTOCHROME-C; EXERCISE; CALCINEURIN; ANGIOGENESIS; SPECIFICITY; INTENSITY	Regular endurance exercise induces skeletal muscle contractile and metabolic adaptations, conferring salutary health benefits, such as protection against the metabolic syndrome. The plasticity of skeletal muscle has been extensively investigated, but how the adaptive processes are precisely controlled is largely unknown. Using muscle-specific gene deletion in mice, we now show that p38 gamma mitogen-activated protein kinase (MAPK), but not p38 alpha and p38 beta, is required for endurance exercise-induced mitochondrial biogenesis and angiogenesis, whereas none of the p38 isoforms are required for IIb-to-IIa fiber-type transformation. These phenotypic findings were further supported by microarray and real-time PCR analyses revealing contractile activity-dependent p38 gamma target genes, including peroxisome proliferator-activated receptor gamma co-activator-1 alpha (Pgc-1 alpha) and vascular endothelial growth factor (Vegf), in skeletal muscle following motor nerve stimulation. Gene transfer-mediated overexpression of a dominant negative form of p38 gamma, but not that of p38 alpha or p38 beta, blocked motor nerve stimulation-induced Pgc-1 alpha transcription. These findings provide direct evidence for an obligated role of p38 gamma MAPK-PGC-1 alpha regulatory axis in endurance exercise-induced metabolic adaptation, but not contractile adaptation, in skeletal muscle.			Pogozelski, AR (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.	zhen.yan@virginia.edu	Lira, Vitor/AAN-3403-2021; Chi, Jen-Tsan/AAI-4125-2020; Lira, Vitor/B-1709-2013	Lira, Vitor/0000-0002-3162-3804; Chi, Jen-Tsan/0000-0003-3433-903X; Lira, Vitor/0000-0002-3162-3804; Li, Ping/0000-0002-4549-9517; Yan, Zhen/0000-0002-4826-9813	Howard Hughes Medical Institute Funding Source: Medline; NIAMS NIH HHS [AR050429, R01 AR050429] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050429] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Akimoto T, 2005, J BIOL CHEM, V280, P19587, DOI 10.1074/jbc.M408862200; Akimoto T, 2004, AM J PHYSIOL-CELL PH, V287, pC1311, DOI 10.1152/ajpcell.00248.2004; Akimoto T, 2004, AM J PHYSIOL-CELL PH, V287, pC790, DOI 10.1152/ajpcell.00425.2003; AKIMOTO T, 2008, AM J PHYSL CELL PHYS; Allen DL, 2001, J APPL PHYSIOL, V90, P1900, DOI 10.1152/jappl.2001.90.5.1900; Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Arany Z, 2007, CELL METAB, V5, P35, DOI 10.1016/j.cmet.2006.12.003; Baar K, 2002, FASEB J, V16, P1879, DOI 10.1096/fj.02-0367com; Boppart MD, 2001, AM J PHYSIOL-CELL PH, V280, pC352, DOI 10.1152/ajpcell.2001.280.2.C352; Boppart MD, 2000, J PHYSIOL-LONDON, V526, P663, DOI 10.1111/j.1469-7793.2000.00663.x; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Chin ER, 1998, GENE DEV, V12, P2499, DOI 10.1101/gad.12.16.2499; Choi S, 2005, J APPL PHYSIOL, V99, P2406, DOI 10.1152/japplphysiol.00545.2005; Coffey VG, 2005, FASEB J, V19, P190, DOI 10.1096/fj.05-4809fje; DUDLEY GA, 1982, J APPL PHYSIOL, V53, P844, DOI 10.1152/jappl.1982.53.4.844; Dunn SE, 2000, J CELL BIOL, V151, P663, DOI 10.1083/jcb.151.3.663; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Gleyzer N, 2005, MOL CELL BIOL, V25, P1354, DOI 10.1128/MCB.25.4.1354-1366.2005; Gute Dean, 1994, Microcirculation (New York), V1, P183, DOI 10.3109/10739689409148273; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200; HASTY P, 1993, NATURE, V364, P501, DOI 10.1038/364501a0; HICKSON RC, 1981, J APPL PHYSIOL, V51, P746, DOI 10.1152/jappl.1981.51.3.746; Irrcher I, 2003, AM J PHYSIOL-CELL PH, V284, pC1669, DOI 10.1152/ajpcell.00409.2002; Kjaer M, 2006, J ANAT, V208, P445, DOI 10.1111/j.1469-7580.2006.00549.x; Leick L, 2009, AM J PHYSIOL-ENDOC M, V297, pE92, DOI 10.1152/ajpendo.00076.2009; Li SJ, 2005, P NATL ACAD SCI USA, V102, P1082, DOI 10.1073/pnas.0409103102; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; McCullagh KJA, 2004, P NATL ACAD SCI USA, V101, P10590, DOI 10.1073/pnas.0308035101; McGee SL, 2004, DIABETES, V53, P1208, DOI 10.2337/diabetes.53.5.1208; Nader GA, 2001, J APPL PHYSIOL, V90, P1936, DOI 10.1152/jappl.2001.90.5.1936; Naya FJ, 2000, J BIOL CHEM, V275, P4545, DOI 10.1074/jbc.275.7.4545; Oh M, 2005, MOL CELL BIOL, V25, P6629, DOI 10.1128/MCB.25.15.6629-6638.2005; Parsons SA, 2003, MOL CELL BIOL, V23, P4331, DOI 10.1128/MCB.23.12.4331-4343.2003; Pilegaard H, 2003, J PHYSIOL-LONDON, V546, P851, DOI 10.1113/jphysiol.2002.034850; Rothermel B, 2000, J BIOL CHEM, V275, P8719, DOI 10.1074/jbc.275.12.8719; Rothermel BA, 2001, P NATL ACAD SCI USA, V98, P3328, DOI 10.1073/pnas.041614798; Steenaart NAE, 1997, FEBS LETT, V415, P294, DOI 10.1016/S0014-5793(97)01145-9; Terada S, 2002, BIOCHEM BIOPH RES CO, V296, P350, DOI 10.1016/S0006-291X(02)00881-1; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; Waters RE, 2004, AM J PHYSIOL-CELL PH, V287, pC1342, DOI 10.1152/ajpcell.00247.2004; Widegren U, 1998, FASEB J, V12, P1379, DOI 10.1096/fasebj.12.13.1379; Wu H, 2001, EMBO J, V20, P6414, DOI 10.1093/emboj/20.22.6414; Wu H, 2000, EMBO J, V19, P1963, DOI 10.1093/emboj/19.9.1963; Wu H, 2002, SCIENCE, V296, P349, DOI 10.1126/science.1071163; Wu ZD, 2006, P NATL ACAD SCI USA, V103, P14379, DOI 10.1073/pnas.0606714103; Yu M, 2001, J PHYSIOL-LONDON, V536, P273, DOI 10.1111/j.1469-7793.2001.00273.x	47	105	108	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2009	4	11							e7934	10.1371/journal.pone.0007934	http://dx.doi.org/10.1371/journal.pone.0007934			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522NL	19936205	Green Published, Green Submitted, gold			2022-12-25	WOS:000272004800015
J	Marengo, EB; Commodaro, AG; Peron, JPS; de Moraes, LV; Portaro, FCV; Belfort, R; Rizzo, LV; Sant'Anna, OA				Marengo, Eliana B.; Commodaro, Alessandra Goncalves; Peron, Jean Pierre S.; de Moraes, Luciana V.; Portaro, Fernanda C. V.; Belfort, Rubens, Jr.; Rizzo, Luiz Vicente; Sant'Anna, Osvaldo Augusto			Administration of Mycobacterium leprae rHsp65 Aggravates Experimental Autoimmune Uveitis in Mice	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; B-CELL EPITOPES; BEHCETS-DISEASE; T-CELLS; GENETIC SUSCEPTIBILITY; IMMUNE-RESPONSES; STRESS PROTEINS; PEPTIDE 336-351; ORAL TOLERANCE; UVEORETINITIS	The 60kDa heat shock protein family, Hsp60, constitutes an abundant and highly conserved class of molecules that are highly expressed in chronic-inflammatory and autoimmune processes. Experimental autoimmune uveitis [EAU] is a T cell mediated intraocular inflammatory disease that resembles human uveitis. Mycobacterial and homologous Hsp60 peptides induces uveitis in rats, however their participation in aggravating the disease is poorly known. We here evaluate the effects of the Mycobacterium leprae Hsp65 in the development/progression of EAU and the autoimmune response against the eye through the induction of the endogenous disequilibrium by enhancing the entropy of the immunobiological system with the addition of homologous Hsp. B10. RIII mice were immunized subcutaneously with interphotoreceptor retinoid-binding protein [IRBP], followed by intraperitoneally inoculation of M. leprae recombinant Hsp65 [rHsp65]. We evaluated the proliferative response, cytokine production and the percentage of CD4(+)IL-17(+), CD4(+)IFN-gamma(+) and CD4(+)Foxp3(+) cells ex vivo, by flow cytometry. Disease severity was determined by eye histological examination and serum levels of anti-IRBP and anti-Hsp60/65 measured by ELISA. EAU scores increased in the Hsp65 group and were associated with an expansion of CD4(+)IFN-gamma(+) and CD4(+)IL-17(+) T cells, corroborating with higher levels of IFN-gamma. Our data indicate that rHsp65 is one of the managers with a significant impact over the immune response during autoimmunity, skewing it to a pathogenic state, promoting both Th1 and Th17 commitment. It seems comprehensible that the specificity and primary function of Hsp60 molecules can be considered as a potential pathogenic factor acting as a whistleblower announcing chronic-inflammatory diseases progression.			Marengo, EB (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Immunol, Sao Paulo, Brazil.	gbrazil@usp.br	Rizzo, Luiz Vicente/B-4458-2009; Portaro, Fernanda/I-6644-2015; Belfort, Rubens/E-2252-2012; de Moraes, Luciana/M-1619-2013; Portaro, F/B-8397-2012; Peron, Jean Pierre S/F-9248-2012	Belfort, Rubens/0000-0002-8422-3898; de Moraes, Luciana/0000-0001-6605-5547; Commodaro, Alessandra/0000-0002-7816-6508				Atherton E., 1990, SOLID PHASE PEPTIDE; Biozzi G, 1979, Curr Top Microbiol Immunol, V85, P31; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cancino-Diaz JC, 2004, BRIT J OPHTHALMOL, V88, P247, DOI 10.1136/bjo.2003.023390; CASPI RR, 1988, J IMMUNOL, V140, P1490; Caspi RR, 1996, J IMMUNOL, V157, P2668; Cohen IR, 2007, J AUTOIMMUN, V29, P246, DOI 10.1016/j.jaut.2007.07.016; Cohen IR, 2007, NAT REV IMMUNOL, V7, P569, DOI 10.1038/nri2102; da Silva AC, 1998, RES IMMUNOL, V149, P151, DOI 10.1016/S0923-2494(98)80298-8; Direskeneli H, 1996, SCAND J IMMUNOL, V43, P464, DOI 10.1046/j.1365-3083.1996.d01-53.x; DUDANI AK, 1989, INFECT IMMUN, V57, P2786, DOI 10.1128/IAI.57.9.2786-2793.1989; George J, 2001, J AM COLL CARDIOL, V38, P900, DOI 10.1016/S0735-1097(01)01440-1; HIGHTOWER LE, 1991, CELL, V66, P191, DOI 10.1016/0092-8674(91)90611-2; Hu W, 1998, EUR J IMMUNOL, V28, P2444, DOI 10.1002/(SICI)1521-4141(199808)28:08<2444::AID-IMMU2444>3.0.CO;2-N; Huhtinen M, 2001, INVEST OPHTH VIS SCI, V42, P1816; IBANEZ OM, 1992, EUR J IMMUNOL, V22, P2555, DOI 10.1002/eji.1830221014; Kaneko S, 1997, CLIN EXP IMMUNOL, V108, P204, DOI 10.1046/j.1365-2249.1997.3611265.x; KAUFMANN SHE, 1990, IMMUNOL TODAY, V11, P129, DOI 10.1016/0167-5699(90)90050-J; Kohm AP, 2003, TRENDS MICROBIOL, V11, P101, DOI 10.1016/S0966-842X(03)00006-4; Kol A, 2000, J IMMUNOL, V164, P13, DOI 10.4049/jimmunol.164.1.13; Lehner T, 1997, Int Rev Immunol, V14, P21, DOI 10.3109/08830189709116842; Luger D, 2008, J EXP MED, V205, P799, DOI 10.1084/jem.20071258; Marengo EB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003025; MOCHIZUKI M, 1985, INVEST OPHTH VIS SCI, V26, P1; MOR F, 1992, J CLIN INVEST, V90, P2447, DOI 10.1172/JCI116136; Moudgil KD, 2008, TRENDS IMMUNOL, V29, P412, DOI 10.1016/j.it.2008.06.003; Ogura H, 2008, IMMUNITY, V29, P628, DOI 10.1016/j.immuni.2008.07.018; Ohashi K, 2000, J IMMUNOL, V164, P558, DOI 10.4049/jimmunol.164.2.558; Peng Y, 2007, INVEST OPHTH VIS SCI, V48, P4153, DOI 10.1167/iovs.07-0251; Perschinka H, 2003, ARTERIOSCL THROM VAS, V23, P1060, DOI 10.1161/01.ATV.0000071701.62486.49; PERVIN K, 1993, J IMMUNOL, V151, P2273; Pockley AG, 1999, CELL STRESS CHAPERON, V4, P29, DOI 10.1054/csac.1998.0121; Portaro FCV, 2002, BIOCHEMISTRY-US, V41, P7400, DOI 10.1021/bi011999l; Prigogine I, 2003, ANN NY ACAD SCI, V988, P128, DOI 10.1111/j.1749-6632.2003.tb06091.x; PRIGOGINE I, 1978, SCIENCE, V201, P777, DOI 10.1126/science.201.4358.777; Quintana FJ, 2004, P NATL ACAD SCI USA, V101, P14615, DOI 10.1073/pnas.0404848101; Quintana FJ, 2004, BIOMED PHARMACOTHER, V58, P276, DOI 10.1016/j.biopha.2004.04.011; Quintana FJ, 2004, J AUTOIMMUN, V22, P297, DOI 10.1016/j.jaut.2004.03.003; Quintana FJ, 2001, J AUTOIMMUN, V17, P191, DOI 10.1006/jaut.2001.0544; Quintana FJ, 2008, P NATL ACAD SCI USA, V105, P18889, DOI 10.1073/pnas.0806310105; Rajaiah R, 2009, AUTOIMMUN REV, V8, P388, DOI 10.1016/j.autrev.2008.12.004; Rizzo LV, 1998, INT IMMUNOL, V10, P807, DOI 10.1093/intimm/10.6.807; Rizzo LV, 1999, J IMMUNOL, V162, P2613; Rizzo LV, 1996, J IMMUNOL, V156, P1654; Rossmann A, 2008, EXP GERONTOL, V43, P229, DOI 10.1016/j.exger.2007.11.009; SANTANNA OA, 1982, J IMMUNOGENET, V9, P191; Schett G, 1995, J CLIN INVEST, V96, P2569, DOI 10.1172/JCI118320; Stanford M, 2004, CLIN EXP IMMUNOL, V137, P201, DOI 10.1111/j.1365-2249.2004.02520.x; STANFORD MR, 1994, CLIN EXP IMMUNOL, V97, P226; Sun B, 1997, J IMMUNOL, V159, P1004; Tanaka T, 1999, OCUL IMMUNOL INFLAMM, V7, P69, DOI 10.1076/ocii.7.2.69.4018; THOLE JER, 1988, MICROB PATHOGENESIS, V4, P71, DOI 10.1016/0882-4010(88)90049-6; Uchio E, 1998, EXP EYE RES, V67, P719, DOI 10.1006/exer.1998.0574; Van Eden W, 2007, ANN NY ACAD SCI, V1113, P217, DOI 10.1196/annals.1391.020; Weitgasser R, 2003, EXP CLIN ENDOCR DIAB, V111, P127, DOI 10.1055/s-2003-39784; Whitcup SM, 1997, ARCH OPHTHALMOL-CHIC, V115, P520, DOI 10.1001/archopht.1997.01100150522013; Xu QB, 2000, CIRCULATION, V102, P14, DOI 10.1161/01.CIR.102.1.14; Yoshimura T, 2008, INT IMMUNOL, V20, P209, DOI 10.1093/intimm/dxm135; Yoshimura T, 2009, RHEUMATOLOGY, V48, P347, DOI 10.1093/rheumatology/ken489; YOUNG RA, 1990, ANNU REV IMMUNOL, V8, P401, DOI 10.1146/annurev.immunol.8.1.401; Zanin-Zhorov A, 2003, FASEB J, V17, P1567, DOI 10.1096/fj.02-1139fje; Zugel U, 1999, CLIN MICROBIOL REV, V12, P19, DOI 10.1128/CMR.12.1.19	62	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2009	4	11							e7912	10.1371/journal.pone.0007912	http://dx.doi.org/10.1371/journal.pone.0007912			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522NJ	19936251	Green Published, Green Submitted, gold			2022-12-25	WOS:000272004600016
J	Pitel, AL; Aupee, AM; Chetelat, G; Mezenge, F; Beaunieux, H; de la Sayette, V; Viader, F; Baron, JC; Eustache, F; Desgranges, B				Pitel, Anne-Lise; Aupee, Anne-Marie; Chetelat, Gael; Mezenge, Florence; Beaunieux, Helene; de la Sayette, Vincent; Viader, Fausto; Baron, Jean-Claude; Eustache, Francis; Desgranges, Beatrice			Morphological and Glucose Metabolism Abnormalities in Alcoholic Korsakoff's Syndrome: Group Comparisons and Individual Analyses	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; MILD COGNITIVE IMPAIRMENT; WERNICKES ENCEPHALOPATHY; MEMORY IMPAIRMENT; WHITE-MATTER; ALZHEIMERS-DISEASE; VOLUME DEFICITS; MAMMILLARY BODY; WORKING-MEMORY; GREY-MATTER	Background: Gray matter volume studies have been limited to few brain regions of interest, and white matter and glucose metabolism have received limited research attention in Korsakoff's syndrome (KS). Because of the lack of brain biomarkers, KS was found to be underdiagnosed in postmortem studies. Methodology/Principal Findings: Nine consecutively selected patients with KS and 22 matched controls underwent both structural magnetic resonance imaging and F-18-fluorodeoxyglucose positron emission tomography examinations. Using a whole-brain analysis, the between-group comparisons of gray matter and white matter density and relative glucose uptake between patients with KS and controls showed the involvement of both the frontocerebellar and the Papez circuits, including morphological abnormalities in their nodes and connection tracts and probably resulting hypometabolism. The direct comparison of the regional distribution and degree of gray matter hypodensity and hypometabolism within the KS group indicated very consistent gray matter distribution of both abnormalities, with a single area of significant difference in the middle cingulate cortex showing greater hypometabolism than hypodensity. Finally, the analysis of the variability in the individual patterns of brain abnormalities within our sample of KS patients revealed that the middle cingulate cortex was the only brain region showing significant GM hypodensity and hypometabolism in each of our 9 KS patients. Conclusions/Significance: These results indicate widespread brain abnormalities in KS including both gray and white matter damage mainly involving two brain networks, namely, the fronto-cerebellar circuit and the Papez circuit. Furthermore, our findings suggest that the middle cingulate cortex may play a key role in the pathophysiology of KS and could be considered as a potential in vivo brain biomarker.			Pitel, AL (corresponding author), Univ Caen Basse Normandie, EPHE, INSERM, Unite U923,GIP Cyceron,CHU Cote de Nacre, Caen, France.	desgranges-b@chu-caen.fr	Chetelat, Gael/G-2316-2015; Desgranges, Béatrice/L-7739-2015; Helene, Beaunieux/G-3751-2010; de la Sayette, Vincent/L-8074-2015; Pitel, Anne Lise/L-9693-2015; Eustache, Francis/J-9465-2015; DESGRANGES, BEATRICE/AAK-4756-2021	Eustache, Francis/0000-0003-4460-8686; DESGRANGES, BEATRICE/0000-0002-3657-9996; Gael, Chetelat/0000-0002-4889-7932; BEAUNIEUX, HELENE/0000-0003-1354-6558; PITEL, Anne Lise/0000-0001-8573-9506; baron, jean-claude/0000-0002-5264-2588				ADAMS RD, 1962, TROUBLES MEMOIRE APP, P272; ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; American Psychiatric A, 1994, DIAGN STAT MAN MENT; Aupee AM, 2001, NEUROIMAGE, V13, P1164, DOI 10.1006/nimg.2001.0762; Beauregard D, 1971, TEST AUTOMATISMES VE; BUTTERS N, 1980, ALCOHOLIC KORSAKOFFS; Caine D, 1997, J NEUROL NEUROSUR PS, V62, P51, DOI 10.1136/jnnp.62.1.51; CARDEBAT D, 1990, ACTA NEUROL BELG, V90, P207; CHANRAUD S, 2008, NEUROPSYCHOPHARMACOL; Chetelat G, 2008, BRAIN, V131, P60, DOI 10.1093/brain/awm288; Chetelat G, 2005, NEUROIMAGE, V27, P934, DOI 10.1016/j.neuroimage.2005.05.015; Chetelat G, 2003, BRAIN, V126, P1955, DOI 10.1093/brain/awg196; CHRISTIE JE, 1988, PSYCHOL MED, V18, P319, DOI 10.1017/S0033291700007868; Colchester A, 2001, J NEUROL NEUROSUR PS, V71, P13, DOI 10.1136/jnnp.71.1.13; CRAVIOTO H, 1961, ARCH NEUROL-CHICAGO, V4, P510, DOI 10.1001/archneur.1961.00450110040005; Delay J, 1969, SYNDROME KORSAKOFF; Delis DC., 2000, CALIFORNIA VERBAL LE; Desgranges B, 2007, NEUROBIOL AGING, V28, P1904, DOI 10.1016/j.neurobiolaging.2006.08.006; Desmond JE, 2003, NEUROIMAGE, V19, P1510, DOI 10.1016/S1053-8119(03)00102-2; Emsley R, 1996, ALCOHOL ALCOHOLISM, V31, P479; Fama R, 2004, J INT NEUROPSYCH SOC, V10, P427, DOI 10.1017/S135561770410310X; GILMAN S, 1990, ANN NEUROL, V28, P775, DOI 10.1002/ana.410280608; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; GROBER E, 1987, DEV NEUROPSYCHOL, V3, P13, DOI 10.1080/87565648709540361; HALLIDAY G, 1993, J NEUROPATH EXP NEUR, V52, P567, DOI 10.1097/00005072-199311000-00003; HALLIDAY G, 1992, BRAIN RES, V598, P33, DOI 10.1016/0006-8993(92)90164-5; Harding AJ, 1997, HIPPOCAMPUS, V7, P78, DOI 10.1002/(SICI)1098-1063(1997)7:1<78::AID-HIPO8>3.3.CO;2-B; Harding AJ, 1996, NEUROSCIENCE, V72, P699, DOI 10.1016/0306-4522(95)00577-3; Harper C, 2003, PROG NEURO-PSYCHOPH, V27, P951, DOI 10.1016/S0278-5846(03)00155-6; Harper C, 2006, EUR J NEUROL, V13, P1078, DOI 10.1111/j.1468-1331.2006.01530.x; Harper C, 2007, HUM EXP TOXICOL, V26, P251, DOI 10.1177/0960327107070499; Harris GJ, 2008, ALCOHOL CLIN EXP RES, V32, P1001, DOI 10.1111/j.1530-0277.2008.00661.x; JACOBSON RR, 1990, PSYCHOL MED, V20, P321, DOI 10.1017/S0033291700017633; Jauhar P, 2000, ALCOHOL ALCOHOLISM, V35, P212, DOI 10.1093/alcalc/35.2.212; JERNIGAN TL, 1991, NEUROPSYCHOPHARMACOL, V4, P175; JERNIGAN TL, 1991, ALCOHOL CLIN EXP RES, V15, P418, DOI 10.1111/j.1530-0277.1991.tb00540.x; JOYCE EM, 1994, PSYCHIAT RES, V54, P225, DOI 10.1016/0165-1781(94)90017-5; KOPELMAN MD, 1985, NEUROPSYCHOLOGIA, V23, P623, DOI 10.1016/0028-3932(85)90064-8; KOPELMAN MD, 1995, BRIT J PSYCHIAT, V166, P154, DOI 10.1192/bjp.166.2.154; Krabbendam L, 2000, J NEUROPSYCH CLIN N, V12, P44, DOI 10.1176/jnp.12.1.44; Kril JJ, 1997, NEUROSCIENCE, V79, P983, DOI 10.1016/S0306-4522(97)00083-3; MAIR WGP, 1979, BRAIN, V102, P749, DOI 10.1093/brain/102.4.749; Mevel K, 2007, NEUROIMAGE, V37, P18, DOI 10.1016/j.neuroimage.2007.04.048; Mori S.W., 2005, MRI ATLAS HUMAN WHIT; MULLERGARTNER HW, 1992, J CEREBR BLOOD F MET, V12, P571, DOI 10.1038/jcbfm.1992.81; National Institute on Alcohol Abuse and Alcoholism National Institute on Alcohol Abuse and Alcoholism, 2005, HELP PAT WHO DRINK T; NELSON HE, 1976, CORTEX, V12, P313, DOI 10.1016/S0010-9452(76)80035-4; Paller KA, 1997, J COGNITIVE NEUROSCI, V9, P277, DOI 10.1162/jocn.1997.9.2.277; PFEFFERBAUM A, 1992, ALCOHOL CLIN EXP RES, V16, P1078, DOI 10.1111/j.1530-0277.1992.tb00702.x; Pfefferbaum A, 2009, BIOL PSYCHIAT, V65, P680, DOI 10.1016/j.biopsych.2008.10.039; Pitel AL, 2008, ALCOHOL CLIN EXP RES, V32, P1229, DOI 10.1111/j.1530-0277.2008.00677.x; POLINE JB, 1995, J COMPUT ASSIST TOMO, V19, P788, DOI 10.1097/00004728-199509000-00017; Quarantelli M, 2004, J NUCL MED, V45, P192; Raven J. C., 1954, PROGRESSIVE MATRICE; Reed LJ, 2003, CORTEX, V39, P1027, DOI 10.1016/S0010-9452(08)70876-1; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Richardson MP, 1997, BRAIN, V120, P1961, DOI 10.1093/brain/120.11.1961; Rocher AB, 2003, NEUROIMAGE, V20, P1894, DOI 10.1016/j.neuroimage.2003.07.002; Rousset OG, 1998, J NUCL MED, V39, P904; Schmahmann JD, 1997, J NEUROSCI, V17, P438, DOI 10.1523/JNEUROSCI.17-01-00438.1997; Shear PK, 1996, ALCOHOL CLIN EXP RES, V20, P1489, DOI 10.1111/j.1530-0277.1996.tb01153.x; Sheedy D, 1999, ALCOHOL CLIN EXP RES, V23, P1624, DOI 10.1111/j.1530-0277.1999.tb04053.x; SHIMAMURA AP, 1988, J NEUROSCI, V8, P4400; Signoret JL, 1991, BATTERIE EFFICIENCE; SQUIRE LR, 1990, J NEUROSCI, V10, P3106; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Sullivan EV, 2009, ALCOHOL ALCOHOLISM, V44, P155, DOI 10.1093/alcalc/agn103; Sullivan EV, 2003, NEUROLOGY, V61, P1716, DOI 10.1212/01.WNL.0000098940.31882.BB; Sullivan EV, 2001, ALCOHOL CLIN EXP RES, V25, P1206, DOI 10.1097/00000374-200108000-00017; Sullivan EV, 1999, ALCOHOL CLIN EXP RES, V23, P1629, DOI 10.1097/00000374-199910000-00010; Sullivan EV, 2000, NEUROPSYCHOLOGY, V14, P341, DOI 10.1037//0894-4105.14.3.341; Talairach J., 1988, COPLANAR STEREOTAXIC; TORVIK A, 1982, J NEUROL SCI, V56, P233, DOI 10.1016/0022-510X(82)90145-9; Van Laere KJ, 2001, RADIOLOGY, V221, P810, DOI 10.1148/radiol.2213010295; Vengeliene V, 2008, BRIT J PHARMACOL, V154, P299, DOI 10.1038/bjp.2008.30; Victor M, 1971, Contemp Neurol Ser, V7, P1; Villain N, 2008, J NEUROSCI, V28, P6174, DOI 10.1523/JNEUROSCI.1392-08.2008; Visser PJ, 1999, J NEUROL NEUROSUR PS, V67, P774, DOI 10.1136/jnnp.67.6.774; Weschler D., 2001, WESCHLER ADULT INTEL	79	28	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2009	4	11							e7748	10.1371/journal.pone.0007748	http://dx.doi.org/10.1371/journal.pone.0007748			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	518VB	19936229	Green Submitted, gold, Green Published			2022-12-25	WOS:000271721900007
J	Adachi, M; Liu, Y; Fujii, K; Calderwood, SK; Nakai, A; Imai, K; Shinomura, Y				Adachi, Masaaki; Liu, Yaohua; Fujii, Kyoko; Calderwood, Stuart K.; Nakai, Akira; Imai, Kohzoh; Shinomura, Yasuhisa			Oxidative Stress Impairs the Heat Stress Response and Delays Unfolded Protein Recovery	PLOS ONE			English	Article							SHOCK TRANSCRIPTION FACTOR-1; MOLECULAR CHAPERONES; TARGETED DISRUPTION; INDUCED APOPTOSIS; CELL-SURVIVAL; PHOSPHORYLATION; HYPERTHERMIA; THERMOTOLERANCE; PROTECTION; BINDING	Background: Environmental changes, air pollution and ozone depletion are increasing oxidative stress, and global warming threatens health by heat stress. We now face a high risk of simultaneous exposure to heat and oxidative stress. However, there have been few studies investigating their combined adverse effects on cell viability. Principal Findings: Pretreatment of hydrogen peroxide (H(2)O(2)) specifically and highly sensitized cells to heat stress, and enhanced loss of mitochondrial membrane potential. H(2)O(2) exposure impaired the HSP40/HSP70 induction as heat shock response (HSR) and the unfolded protein recovery, and enhanced eIF2 alpha phosphorylation and/or XBP1 splicing, land marks of ER stress. These H(2)O(2)-mediated effects mimicked enhanced heat sensitivity in HSF1 knockdown or knockout cells. Importantly, thermal preconditioning blocked H(2)O(2)-mediated inhibitory effects on refolding activity and rescued HSF1 +/+ MEFs, but neither blocked the effects nor rescued HSF1 -/- MEFs. These data strongly suggest that inhibition of HSR and refolding activity is crucial for H(2)O(2)-mediated enhanced heat sensitivity. Conclusions: H(2)O(2) blocks HSR and refolding activity under heat stress, thereby leading to insufficient quality control and enhancing ER stress. These uncontrolled stress responses may enhance cell death. Our data thus highlight oxidative stress as a crucial factor affecting heat tolerance.			Adachi, M (corresponding author), Sapporo Med Univ, Sch Med, Div Mol Oncol & Mol Diag, Sapporo, Hokkaido, Japan.	adachi@sapmed.ac.jp						Ahn SG, 2003, GENE DEV, V17, P516, DOI 10.1101/gad.1044503; Burdon R H, 1987, Free Radic Res Commun, V3, P129, DOI 10.3109/10715768709069778; Chan WH, 2000, J CELL BIOCHEM, V78, P73, DOI 10.1002/(SICI)1097-4644(20000701)78:1<73::AID-JCB7>3.0.CO;2-P; Cullinan SB, 2003, MOL CELL BIOL, V23, P7198, DOI 10.1128/MCB.23.20.7198-7209.2003; Fernandez J, 2002, J BIOL CHEM, V277, P19198, DOI 10.1074/jbc.M201052200; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Heine GF, 2008, J BIOL CHEM, V283, P9555, DOI 10.1074/jbc.M707700200; Inouye S, 2004, J BIOL CHEM, V279, P38701, DOI 10.1074/jbc.M405986200; Ito H, 1999, LIFE SCI, V64, P755, DOI 10.1016/S0024-3205(98)00617-1; Jardine DS, 2007, PEDIATR REV, V28, P249, DOI 10.1542/pir.28-7-249; Kalmar B, 2009, ADV DRUG DELIVER REV, V61, P310, DOI 10.1016/j.addr.2009.02.003; Klein JA, 2003, J CLIN INVEST, V111, P785, DOI 10.1172/JCI200318182; Liu Y, 2009, CELL DEATH DIFFER, V16, P847, DOI 10.1038/cdd.2009.14; McAnulty SR, 2005, INT J SPORTS MED, V26, P188, DOI 10.1055/s-2004-820990; McMillan DR, 1998, J BIOL CHEM, V273, P7523, DOI 10.1074/jbc.273.13.7523; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; RANU RS, 1976, P NATL ACAD SCI USA, V73, P4349, DOI 10.1073/pnas.73.12.4349; SKIBBA JL, 1991, INT J HYPERTHER, V7, P749, DOI 10.3109/02656739109056444; Sucholeiki R, 2005, SEMIN NEUROL, V25, P307, DOI 10.1055/s-2005-917667; Valenzuela MT, 1997, INT J CANCER, V72, P307, DOI 10.1002/(SICI)1097-0215(19970717)72:2<307::AID-IJC18>3.3.CO;2-S; Wang XZ, 2006, J BIOL CHEM, V281, P782, DOI 10.1074/jbc.M505822200; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhang Y, 2002, J CELL BIOCHEM, V86, P376, DOI 10.1002/jcb.10232; Zhang Y, 2006, CELL DEATH DIFFER, V13, P129, DOI 10.1038/sj.cdd.4401686	25	50	51	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2009	4	11					A57	A66	e7719	10.1371/journal.pone.0007719	http://dx.doi.org/10.1371/journal.pone.0007719			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518IX	19936221	Green Published, gold, Green Submitted			2022-12-25	WOS:000271685800007
J	Chisari, M; Saini, DK; Cho, JH; Kalyanaraman, V; Gautam, N				Chisari, Mariangela; Saini, Deepak Kumar; Cho, Joon-Ho; Kalyanaraman, Vani; Gautam, N.			G Protein Subunit Dissociation and Translocation Regulate Cellular Response to Receptor Stimulation	PLOS ONE			English	Article							HETEROTRIMERIC G-PROTEINS; BETA-GAMMA COMPLEX; LIVING CELLS; PLASMA-MEMBRANE; SIGNAL-TRANSDUCTION; COUPLED RECEPTORS; PHOSPHOLIPASE-C; FUSION PROTEINS; GOLGI-COMPLEX; KINASE-C	We examined the role of G proteins in modulating the response of living cells to receptor activation. The response of an effector, phospholipase C-beta to M3 muscarinic receptor activation was measured using sensors that detect the generation of inositol triphosphate or diacylglycerol. The recently discovered translocation of G beta gamma from plasma membrane to endomembranes on receptor activation attenuated this response. A FRET based G protein sensor suggested that in contrast to translocating G beta gamma, non- translocating G beta gamma subunits do not dissociate from the alpha q subunit on receptor activation leading to prolonged retention of the heterotrimer state and an accentuated response. M3 receptors with tethered alpha q induced differential responses to receptor activation in cells with or without an endogenous translocation capable gamma subunit. G protein heterotrimer dissociation and beta gamma translocation are thus unanticipated modulators of the intensity of a cell's response to an extracellular signal.			Chisari, M (corresponding author), Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA.	gautam@wustl.edu			NIGMS NIH HHS [GM69027, R01 GM080558, R01 GM069027, GM080558] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080558, R01GM069027] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akgoz M, 2004, J BIOL CHEM, V279, P51541, DOI 10.1074/jbc.M410639200; Akgoz M, 2006, CELL SIGNAL, V18, P1758, DOI 10.1016/j.cellsig.2006.01.016; Arshavsky VY, 2002, ANNU REV PHYSIOL, V64, P153, DOI 10.1146/annurev.physiol.64.082701.102229; Azpiazu I, 2004, J BIOL CHEM, V279, P27709, DOI 10.1074/jbc.M403712200; Azpiazu I, 2006, CELL SIGNAL, V18, P1190, DOI 10.1016/j.cellsig.2005.09.007; Calvert PD, 2006, TRENDS CELL BIOL, V16, P560, DOI 10.1016/j.tcb.2006.09.001; Chisari M, 2007, J BIOL CHEM, V282, P24092, DOI 10.1074/jbc.M704246200; Digby GJ, 2006, P NATL ACAD SCI USA, V103, P17789, DOI 10.1073/pnas.0607116103; Elias R, 2004, MOL VIS, V10, P672; Evanko DS, 2005, CELL SIGNAL, V17, P1218, DOI 10.1016/j.cellsig.2004.12.008; Frank M, 2005, J BIOL CHEM, V280, P24584, DOI 10.1074/jbc.M414630200; Frechter S, 2007, J NEUROSCI, V27, P5571, DOI 10.1523/JNEUROSCI.0310-07.2007; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; Gales C, 2006, NAT STRUCT MOL BIOL, V13, P778, DOI 10.1038/nsmb1134; Gallegos LL, 2006, J BIOL CHEM, V281, P30947, DOI 10.1074/jbc.M603741200; Gautam N, 2003, STRUCTURE, V11, P359, DOI 10.1016/S0969-2126(03)00054-6; Hein P, 2005, EMBO J, V24, P4106, DOI 10.1038/sj.emboj.7600870; Horowitz LF, 2005, J GEN PHYSIOL, V126, P243, DOI 10.1085/jgp.200509309; Hou YM, 2000, J BIOL CHEM, V275, P38961, DOI 10.1074/jbc.C000604200; Kassai H, 2005, NEURON, V47, P529, DOI 10.1016/j.neuron.2005.07.025; Klein S, 2000, P NATL ACAD SCI USA, V97, P3219, DOI 10.1073/pnas.050015797; Kosloff M, 2003, EMBO J, V22, P459, DOI 10.1093/emboj/cdg054; LEVITZKI A, 1986, PHYSIOL REV, V66, P819, DOI 10.1152/physrev.1986.66.3.819; Milligan G, 2002, RECEPTOR CHANNEL, V8, P309, DOI 10.1080/10606820214639; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Rebois RV, 2006, J CELL SCI, V119, P2807, DOI 10.1242/jcs.03021; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Riven I, 2006, NEURON, V51, P561, DOI 10.1016/j.neuron.2006.08.017; Rosenzweig DH, 2007, J NEUROSCI, V27, P5484, DOI 10.1523/JNEUROSCI.1421-07.2007; Saini DK, 2009, TRENDS PHARMACOL SCI, V30, P278, DOI 10.1016/j.tips.2009.04.001; Saini DK, 2007, J BIOL CHEM, V282, P24099, DOI 10.1074/jbc.M701191200; Sakai N, 1997, J CELL BIOL, V139, P1465, DOI 10.1083/jcb.139.6.1465; Sekar RB, 2003, J CELL BIOL, V160, P629, DOI 10.1083/jcb.200210140; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; Suh BC, 2004, J GEN PHYSIOL, V123, P663, DOI 10.1085/jgp.200409029; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Yi TM, 2003, P NATL ACAD SCI USA, V100, P10764, DOI 10.1073/pnas.1834247100; Zhang J, 2002, NAT REV MOL CELL BIO, V3, P906, DOI 10.1038/nrm976	39	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2009	4	11					A181	A191	e7797	10.1371/journal.pone.0007797	http://dx.doi.org/10.1371/journal.pone.0007797			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518IX	19936219	Green Published, gold, Green Submitted			2022-12-25	WOS:000271685800020
J	Heeringa, SF; Moeller, CC; Du, JY; Yue, LX; Hinkes, B; Chernin, G; Vlangos, CN; Hoyer, PF; Reiser, J; Hildebrandt, F				Heeringa, Saskia F.; Moeller, Clemens C.; Du, Jianyang; Yue, Lixia; Hinkes, Bernward; Chernin, Gil; Vlangos, Christopher N.; Hoyer, Peter F.; Reiser, Jochen; Hildebrandt, Friedhelm			A Novel TRPC6 Mutation That Causes Childhood FSGS	PLOS ONE			English	Article							GLOMERULAR PROTEIN; NEPHROTIC SYNDROME; STEROID-RESISTANT; SLIT DIAPHRAGM; CHANNELS; PODOCIN; NPHS2; ACTIVATION; NEPHRIN; DISEASE	Background: TRPC6, encoding a member of the transient receptor potential (TRP) superfamily of ion channels, is a calcium-permeable cation channel, which mediates capacitive calcium entry into the cell. Until today, seven different mutations in TRPC6 have been identified as a cause of autosomal-dominant focal segmental glomerulosclerosis (FSGS) in adults. Methodology/Principal Findings: Here we report a novel TRPC6 mutation that leads to early onset FSGS. We identified one family in whom disease segregated with a novel TRPC6 mutation (M132T), that also affected pediatric individuals as early as nine years of age. Twenty-one pedigrees compatible with an autosomal-dominant mode of inheritance and biopsy-proven FSGS were selected from a worldwide cohort of 550 families with steroid resistant nephrotic syndrome (SRNS). Whole cell current recordings of the mutant TRPC6 channel, compared to the wild-type channel, showed a 3 to 5-fold increase in the average out-and inward TRPC6 current amplitude. The mean inward calcium current of M132T was 10-fold larger than that of wild-type TRPC6. Interestingly, M132T mutants also lacked time-dependent inactivation. Generation of a novel double mutant M132T/N143S did not further augment TRPC6 channel activity. Conclusions: In summary, our data shows that TRPC6 mediated FSGS can also be found in children. The large increase in channel currents and impaired channel inactivation caused by the M132T mutant leads to an aggressive phenotype that underlines the importance of calcium dose channeled through TRPC6.			Heeringa, SF (corresponding author), Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA.	fhilde@umich.edu	Du, Jianyang/B-3883-2010		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078960] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK039255, R01DK076683] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL078960, R01 HL078960-05] Funding Source: Medline; NIDDK NIH HHS [P50-DK039255, R01 DK076683, R01-DK076683, P50 DK039255] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Boute N, 2000, NAT GENET, V24, P349, DOI 10.1038/74166; Hinkes B, 2006, NAT GENET, V38, P1397, DOI 10.1038/ng1918; Hinkes BG, 2007, PEDIATRICS, V119, pE907, DOI 10.1542/peds.2006-2164; Hofmann T, 2002, P NATL ACAD SCI USA, V99, P7461, DOI 10.1073/pnas.102596199; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Hsu YJ, 2007, BBA-MOL BASIS DIS, V1772, P928, DOI 10.1016/j.bbadis.2007.02.001; Huber TB, 2007, NEPHRON EXP NEPHROL, V106, pE27, DOI 10.1159/000101789; Huber TB, 2006, P NATL ACAD SCI USA, V103, P17079, DOI 10.1073/pnas.0607465103; Ichikawa I, 1996, PEDIATR NEPHROL, V10, P374; Jiang JM, 2005, J GEN PHYSIOL, V126, P137, DOI 10.1085/jgp.200409185; Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Kim JY, 2005, J BIOL CHEM, V280, P32035, DOI 10.1074/jbc.M500429200; Li Y, 2005, NATURE, V434, P894, DOI 10.1038/nature03477; Lin SY, 2005, CURR OPIN NEUROBIOL, V15, P350, DOI 10.1016/j.conb.2005.05.012; Moeller CC, 2007, J AM SOC NEPHROL, V18, P29, DOI 10.1681/ASN.2006091010; MOLLER CC, 2008, J AM SOC NEPHROL; Reiser J, 2005, NAT GENET, V37, P739, DOI 10.1038/ng1592; Ruf RG, 2004, KIDNEY INT, V66, P564, DOI 10.1111/j.1523-1755.2004.00775.x; Ruf RG, 2004, J AM SOC NEPHROL, V15, P722, DOI 10.1097/01.ASN.0000113552.59155.72; Runnels LW, 2002, NAT CELL BIOL, V4, P329, DOI 10.1038/ncb781; Schlndorff JS, 2006, SEMIN CELL DEV BIOL, V17, P667, DOI 10.1016/j.semcdb.2006.11.003; Shih NY, 2001, AM J PATHOL, V159, P2303, DOI 10.1016/S0002-9440(10)63080-5; Troyanov S, 2004, KIDNEY INT, V66, P1199, DOI 10.1111/j.1523-1755.2004.00873.x; Tryggvason K, 2006, NEW ENGL J MED, V354, P1387, DOI 10.1056/NEJMra052131; Winn MP, 2005, SCIENCE, V308, P1801, DOI 10.1126/science.1106215; Yue LX, 2002, J GEN PHYSIOL, V120, P845, DOI 10.1085/jgp.20028699; ZHU B, 2008, MUTAT RES; 1998, LANCET, V1, P380	29	120	129	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2009	4	11							e7771	10.1371/journal.pone.0007771	http://dx.doi.org/10.1371/journal.pone.0007771			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	517ZU	19936226	Green Submitted, Green Published, gold			2022-12-25	WOS:000271658800009
J	Bua, DJ; Kuo, AJ; Cheung, P; Liu, CL; Migliori, V; Espejo, A; Casadio, F; Bassi, C; Amati, B; Bedford, MT; Guccione, E; Gozani, O				Bua, Dennis J.; Kuo, Alex J.; Cheung, Peggie; Liu, Chih Long; Migliori, Valentina; Espejo, Alexsandra; Casadio, Fabio; Bassi, Christian; Amati, Bruno; Bedford, Mark T.; Guccione, Ernesto; Gozani, Or			Epigenome Microarray Platform for Proteome-Wide Dissection of Chromatin-Signaling Networks	PLOS ONE			English	Article								Knowledge of protein domains that function as the biological effectors for diverse post-translational modifications of histones is critical for understanding how nuclear and epigenetic programs are established. Indeed, mutations of chromatin effector domains found within several proteins are associated with multiple human pathologies, including cancer and immunodeficiency syndromes. To date, relatively few effector domains have been identified in comparison to the number of modifications present on histone and non-histone proteins. Here we describe the generation and application of human modified peptide microarrays as a platform for high-throughput discovery of chromatin effectors and for epitope-specificity analysis of antibodies commonly utilized in chromatin research. Screening with a library containing a majority of the Royal Family domains present in the human proteome led to the discovery of TDRD7, JMJ2C, and MPP8 as three new modified histone-binding proteins. Thus, we propose that peptide microarray methodologies are a powerful new tool for elucidating molecular interactions at chromatin.			Bua, DJ (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	ogozani@stanford.edu	guccione, ernesto/G-9874-2011; Kuo, Alex/AAL-2845-2020; Gozani, Or P/I-6157-2013; Amati, Bruno/AAM-3418-2020; Bedford, Mark T/E-7856-2011	Bua, Dennis/0000-0002-5709-0268; Gozani, Or/0000-0002-1365-4463; Migliori, Valentina/0000-0003-4978-2245; Espejo, Alexsandra/0000-0002-8841-7219; Amati, Bruno/0000-0002-2958-1799	Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA025800] Funding Source: NIH RePORTER; NIDA NIH HHS [R21 DA025800, 5R21-DA025800] Funding Source: Medline; PHS HHS [PA-08-190] Funding Source: Medline	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Akhtar A, 2000, NATURE, V407, P405, DOI 10.1038/35030169; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bannister AJ, 2004, METHOD ENZYMOL, V376, P269; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Borde V, 2009, EMBO J, V28, P99, DOI 10.1038/emboj.2008.257; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Collins RE, 2008, NAT STRUCT MOL BIOL, V15, P245, DOI 10.1038/nsmb.1384; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Fischle W, 2008, J BIOL CHEM, V283, P19626, DOI 10.1074/jbc.M802655200; Flanagan JF, 2005, NATURE, V438, P1181, DOI 10.1038/nature04290; Friesen WJ, 2001, MOL CELL, V7, P1111, DOI 10.1016/S1097-2765(01)00244-1; Guccione E, 2007, NATURE, V449, P933, DOI 10.1038/nature06166; Huang J, 2007, NATURE, V449, P105, DOI 10.1038/nature06092; Huang Y, 2006, SCIENCE, V312, P748, DOI 10.1126/science.1125162; Hung T, 2009, MOL CELL, V33, P248, DOI 10.1016/j.molcel.2008.12.016; Kachirskaia I, 2008, J BIOL CHEM, V283, P34660, DOI 10.1074/jbc.M806020200; Kim J, 2006, EMBO REP, V7, P397, DOI 10.1038/sj.embor.7400625; Koh AS, 2008, P NATL ACAD SCI USA, V105, P15878, DOI 10.1073/pnas.0808470105; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Matthews AGW, 2007, NATURE, V450, P1106, DOI 10.1038/nature06431; Maurer-Stroh S, 2003, TRENDS BIOCHEM SCI, V28, P69, DOI 10.1016/S0968-0004(03)00004-5; Mulligan P, 2008, MOL CELL, V32, P718, DOI 10.1016/j.molcel.2008.10.025; Nielsen PR, 2002, NATURE, V416, P103, DOI 10.1038/nature722; Pena PV, 2008, J MOL BIOL, V380, P303, DOI 10.1016/j.jmb.2008.04.061; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Ponting CP, 1999, NUCLEIC ACIDS RES, V27, P229, DOI 10.1093/nar/27.1.229; RAMONMAIQUES S, 2007, NATL ACAD SCI US, V104, P18993; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; Schreiber SL, 2002, CELL, V111, P771, DOI 10.1016/S0092-8674(02)01196-0; Shi XB, 2007, MOL CELL, V27, P636, DOI 10.1016/j.molcel.2007.07.012; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Shi XB, 2007, J BIOL CHEM, V282, P2450, DOI 10.1074/jbc.C600286200; Sims RJ, 2005, J BIOL CHEM, V280, P41789, DOI 10.1074/jbc.C500395200; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Turner BM, 2000, BIOESSAYS, V22, P836, DOI 10.1002/1521-1878(200009)22:9<836::AID-BIES9>3.0.CO;2-X; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Zhang P, 2006, NUCLEIC ACIDS RES, V34, P6621, DOI 10.1093/nar/gkl989	39	77	79	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2009	4	8							e6789	10.1371/journal.pone.0006789	http://dx.doi.org/10.1371/journal.pone.0006789			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	488FQ	19956676	Green Published, gold, Green Submitted			2022-12-25	WOS:000269335000031
J	Wang, DY; Stewart, AK; Zhuang, LH; Zhu, YX; Wang, YD; Shi, CX; Keating, A; Slutsky, A; Zhang, HB; Wen, XY				Wang, Dingyan; Stewart, A. Keith; Zhuang, Lihua; Zhu, Yuanxiao; Wang, Youdong; Shi, Changxin; Keating, Armand; Slutsky, Arthur; Zhang, Haibo; Wen, Xiao-Yan			Enhanced adaptive immunity in mice lacking the immunoinhibitory adaptor Hacs1	FASEB JOURNAL			English	Article						adaptor protein; B cells; gene targeting; dendritic cells; SAM domain; immune regulation	PROTEIN-TYROSINE-PHOSPHATASE; TUMOR-SUPPRESSOR GENE; AUTOIMMUNE-DISEASE; CELL-DEVELOPMENT; DEFICIENT MICE; ACTIVATION; EXPRESSION; RECEPTOR; LYN; RESPONSES	Hacs1, a SH3 and SAM domain-containing adaptor protein, is up-regulated by IL-4 in activated B cells and strongly expressed in dendritic cells. To elucidate the function of Hacs1 in immune regulation, we generated Hacs1(-/-) mice by deletion of the SH3 and SAM domains. Hacs1(-/-) mice were viable and fertile and had normal bone marrow B-cell development and normal splenic T-and B-cell populations. However, adult Hacs1(-/-) mice had increased peritoneal B1a cells (IgM(+)CD5(+)). On immunization with T-cell-independent antigen TNP-Ficoll, Hacs1(-/-) mice had increased production of anti-TNP IgM and IgG3. Purified splenic B cells from Hacs1(-/-) mice showed increased cell proliferation on BCR (B-cell receptor) stimulation. We further demonstrate that the Hacs1(-/-) B cells had increased global tyrosine phosphorylation, including tyrosine kinases Lyn and Akt. Both T-helper type 1 (Th1) and T-helper type 2 (Th2) humoral responses were enhanced in Hacs1(-/-) mice. In vitro bone marrow-derived Hacs1(-/-) dendritic cells showed increased IL-12 production on stimulation with ovalbumin (OVA). This study suggests that Hacs1 is an immunoinhibitory adaptor that might be a useful target for immune suppression therapy.-Wang, D., Stewart, A. K., Zhuang, L., Zhu, Y., Wang, Y., Shi, C., Keating, A., Slutsky, A., Zhang, H., Wen, X.-Y. Enhanced adaptive immunity in mice lacking the immunoinhibitory adaptor Hacs1. FASEB J. 24, 947-956 (2010). www.fasebj.org	[Wang, Dingyan; Wang, Youdong; Slutsky, Arthur; Zhang, Haibo; Wen, Xiao-Yan] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Wang, Dingyan; Wang, Youdong; Slutsky, Arthur; Zhang, Haibo; Wen, Xiao-Yan] Univ Toronto, Dept Med, Toronto, ON, Canada; [Wang, Dingyan; Zhuang, Lihua; Keating, Armand; Wen, Xiao-Yan] Princess Margaret Hosp, Dept Med Oncol & Hematol, Univ Hlth Network, Toronto, ON M4X 1K9, Canada; [Stewart, A. Keith; Zhu, Yuanxiao; Shi, Changxin] Mayo Clin, Div Hematol Oncol, Scottsdale, AZ USA; [Wen, Xiao-Yan] Tianjin Med Univ, Tianjin Inst Urol, Sch Med 2, Tianjin, Peoples R China	University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Mayo Clinic; Mayo Clinic Phoenix; Tianjin Medical University	Wen, XY (corresponding author), St Michaels Hosp, Li Ka Shing Knowledge Inst, 30 Bond St,Queen Wing,Rm 8-019, Toronto, ON M5B 1W8, Canada.	x.wen@utoronto.ca	Slutsky, Arthur/M-3325-2019	Wen, Xiao-Yan/0000-0001-6728-0025				Beer S, 2005, MOL CELL BIOL, V25, P9646, DOI 10.1128/MCB.25.21.9646-9660.2005; Beer S, 2001, BBA-GENE STRUCT EXPR, V1520, P89, DOI 10.1016/S0167-4781(01)00242-1; Bolland S, 2000, IMMUNITY, V13, P277, DOI 10.1016/S1074-7613(00)00027-3; Bondada S, 2000, CURR TOP MICROBIOL, V252, P141; Claudio J, 2001, ONCOGENE, V20, P5373, DOI 10.1038/sj.onc.1204698; Clynes R, 1999, J EXP MED, V189, P179, DOI 10.1084/jem.189.1.179; DeFranco AL, 1998, SEMIN IMMUNOL, V10, P299, DOI 10.1006/smim.1998.0122; Fagarasan S, 2000, SCIENCE, V290, P89, DOI 10.1126/science.290.5489.89; Flynn DC, 2001, ONCOGENE, V20, P6270, DOI 10.1038/sj.onc.1204769; HIBBS ML, 1995, CELL, V83, P301, DOI 10.1016/0092-8674(95)90171-X; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Nakamura A, 2004, NAT IMMUNOL, V5, P623, DOI 10.1038/ni1074; O'Keefe TL, 1999, J EXP MED, V189, P1307, DOI 10.1084/jem.189.8.1307; Obermaier Bianca, 2003, Biol Proced Online, V5, P197, DOI 10.1251/bpo62; OKeefe TL, 1996, SCIENCE, V274, P798, DOI 10.1126/science.274.5288.798; Pan C, 1999, IMMUNITY, V11, P495, DOI 10.1016/S1074-7613(00)80124-7; Pao LI, 2007, IMMUNITY, V27, P35, DOI 10.1016/j.immuni.2007.04.016; Pawson T, 2007, CURR OPIN CELL BIOL, V19, P112, DOI 10.1016/j.ceb.2007.02.013; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Rimkus C, 2006, BRIT J CANCER, V95, P1419, DOI 10.1038/sj.bjc.6603452; Sen G, 1999, EUR J IMMUNOL, V29, P3319; Takai T, 2001, IMMUNOL REV, V181, P215, DOI 10.1034/j.1600-065X.2001.1810118.x; Uchida T, 2001, BIOCHEM BIOPH RES CO, V288, P137, DOI 10.1006/bbrc.2001.5722; Ujike A, 2002, NAT IMMUNOL, V3, P542, DOI 10.1038/ni801; Underhill DM, 2007, TRENDS IMMUNOL, V28, P66, DOI 10.1016/j.it.2006.12.004; Wang DY, 2008, TRANSGENIC RES, V17, P193, DOI 10.1007/s11248-007-9140-9; Xu YK, 2005, IMMUNITY, V22, P9, DOI 10.1016/j.immuni.2004.12.004; Zeller C, 2003, ONCOGENE, V22, P2972, DOI 10.1038/sj.onc.1206474; Zhu YX, 2004, J EXP MED, V200, P737, DOI 10.1084/jem.20031816	29	21	22	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2010	24	3					947	956		10.1096/fj.09-140806	http://dx.doi.org/10.1096/fj.09-140806			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	561KE	19923443				2022-12-25	WOS:000274974600030
J	North, SJ; Huang, HH; Sundaram, S; Jang-Lee, J; Etienne, AT; Trollope, A; Chalabi, S; Dell, A; Stanley, P; Haslam, SM				North, Simon J.; Huang, Hung-Hsiang; Sundaram, Subha; Jang-Lee, Jihye; Etienne, A. Tony; Trollope, Alana; Chalabi, Sara; Dell, Anne; Stanley, Pamela; Haslam, Stuart M.			Glycomics Profiling of Chinese Hamster Ovary Cell Glycosylation Mutants Reveals N-Glycans of a Novel Size and Complexity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLCNAC-GLYCOPEPTIDE BETA-4-N-ACETYLGLUCOSAMINYLTRANSFERASE-III; SIALIC ACID TRANSPORTER; GDP-FUCOSE; MOLECULAR-CLONING; CHO MUTANT; GLYCOPROTEIN; EXPRESSION; MUTATION; MANNOSE; ALPHA-1,3-FUCOSYL-TRANSFERASE	Identifying biological roles for mammalian glycans and the pathways by which they are synthesized has been greatly facilitated by investigations of glycosylation mutants of cultured cell lines and model organisms. Chinese hamster ovary (CHO) glycosylation mutants isolated on the basis of their lectin resistance have been particularly useful for glycosylation engineering of recombinant glycoproteins. To further enhance the application of these mutants, and to obtain insights into the effects of altering one specific glycosyltransferase or glycosylation activity on the overall expression of cellular glycans, an analysis of the N-glycans and major O-glycans of a panel of CHO mutants was performed using glycomic analyses anchored by matrix-assisted laser desorption ionization-time of flight/time of flight mass spectrometry. We report here the complement of the major N-glycans and O-glycans present in nine distinct CHO glycosylation mutants. Parent CHO cells grown in monolayer versus suspension culture had similar profiles of N- and O-GalNAc glycans, although the profiles of glycosylation mutants Lec1, Lec2, Lec3.2.8.1, Lec4, LEC10, LEC11, LEC12, Lec13, and LEC30 were consistent with available genetic and biochemical data. However, the complexity of the range of N-glycans observed was unexpected. Several of the complex N-glycan profiles contained structures of m/z similar to 13,000 representing complexN-glycans with a total of 26 N-acetyllactosamine (Gal beta 1-4GlcNAc)(n) units. Importantly, the LEC11, LEC12, and LEC30 CHO mutants exhibited unique complements of fucosylated complex N-glycans terminating in Lewis(x) and sialyl-Lewis(x) determinants. This analysis reveals the larger-than-expected complexity of N-glycans in CHO cell mutants that may be used in a broad variety of functional glycomics studies and for making recombinant glycoproteins.	[Huang, Hung-Hsiang; Sundaram, Subha; Stanley, Pamela] Albert Einstein Coll Med, Dept Cell Biol, New York, NY 10461 USA; [North, Simon J.; Jang-Lee, Jihye; Etienne, A. Tony; Trollope, Alana; Chalabi, Sara; Dell, Anne; Haslam, Stuart M.] Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, Fac Nat Sci, London SW7 2AZ, England	Yeshiva University; Imperial College London	Stanley, P (corresponding author), Albert Einstein Coll Med, Dept Cell Biol, New York, NY 10461 USA.	stanley@aecom.yu.edu; s.haslam@imperial.ac.uk		Huang, Hung-Hsiang/0000-0002-0157-2014; Stanley, Pamela/0000-0001-5704-3747	NCI [RO1-36434]; Consortium for Functional Glycomics [GM 62116]; Biotechnology and Biological Sciences Research Council [BBF0083091, B19088]; Wellcome Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Consortium for Functional Glycomics; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1-36434 from NCI (to P. S.). This work was also supported by Analytical Glycotechnology Core (Core C) of the Consortium for Functional Glycomics Grant GM 62116, Biotechnology and Biological Sciences Research Council Grants BBF0083091 and B19088, and the Wellcome Trust.; Biotechnology and Biological Sciences Research Council Professorial Research Fellow.	ALBERSHEIM PETER, 1967, CARBOHYD RES, V5, P340, DOI 10.1016/S0008-6215(00)80510-8; Babu P, 2009, GLYCOCONJUGATE J, V26, P975, DOI 10.1007/s10719-008-9146-4; Bardor M, 2005, J BIOL CHEM, V280, P4228, DOI 10.1074/jbc.M412040200; Becker DJ, 2003, GLYCOBIOLOGY, V13, p41R, DOI 10.1093/glycob/cwg054; Butters TD, 1999, PROTEIN SCI, V8, P1696, DOI 10.1110/ps.8.8.1696; CAMPBELL C, 1984, J BIOL CHEM, V259, P3370; Ceroni A, 2008, J PROTEOME RES, V7, P1650, DOI 10.1021/pr7008252; Chen W, 2003, GLYCOBIOLOGY, V13, P43, DOI 10.1093/glycob/cwg003; Chen W, 2005, GLYCOBIOLOGY, V15, P259, DOI 10.1093/glycob/cwi011; DELL A, 1994, METHOD ENZYMOL, V230, P108; Eckhardt M, 1998, J BIOL CHEM, V273, P20189, DOI 10.1074/jbc.273.32.20189; FUKUDA MN, 1976, J BIOL CHEM, V251, P6218; Goldberg D, 2005, PROTEOMICS, V5, P865, DOI 10.1002/pmic.200401071; Goldberg D, 2009, BIOINFORMATICS, V25, P365, DOI 10.1093/bioinformatics/btn636; Hong YJ, 2003, J BIOL CHEM, V278, P53045, DOI 10.1074/jbc.M309967200; HOWARD DR, 1987, J BIOL CHEM, V262, P16830; Kanda Y, 2006, BIOTECHNOL BIOENG, V94, P680, DOI 10.1002/bit.20880; Kawar ZS, 2005, J BIOL CHEM, V280, P12810, DOI 10.1074/jbc.M414273200; Lee J, 2003, BIOCHEMISTRY-US, V42, P12349, DOI 10.1021/bi0353068; Lim SF, 2008, GLYCOBIOLOGY, V18, P851, DOI 10.1093/glycob/cwn080; Moloney DJ, 2000, J BIOL CHEM, V275, P9604, DOI 10.1074/jbc.275.13.9604; NARASIMHAN S, 1982, J BIOL CHEM, V257, P235; Nishihara S, 1999, FEBS LETT, V462, P289, DOI 10.1016/S0014-5793(99)01549-5; Ohyama C, 1998, J BIOL CHEM, V273, P14582, DOI 10.1074/jbc.273.23.14582; Patnaik SK, 2006, METHOD ENZYMOL, V416, P159, DOI 10.1016/S0076-6879(06)16011-5; Patnaik SK, 2000, ARCH BIOCHEM BIOPHYS, V375, P322, DOI 10.1006/abbi.1999.1693; POTVIN B, 1991, CELL REGUL, V2, P989, DOI 10.1091/mbc.2.12.989; Raman R, 2005, NAT METHODS, V2, P817, DOI 10.1038/NMETH807; Raman R, 2006, GLYCOBIOLOGY, V16, p82R, DOI 10.1093/glycob/cwj080; RIPKA J, 1986, ARCH BIOCHEM BIOPHYS, V249, P533, DOI 10.1016/0003-9861(86)90031-7; SALLUSTIO S, 1989, SOMAT CELL MOLEC GEN, V15, P387, DOI 10.1007/BF01534890; SOLTER D, 1978, P NATL ACAD SCI USA, V75, P5565, DOI 10.1073/pnas.75.11.5565; Stanley P, 2005, GLYCOBIOLOGY, V15, P43, DOI 10.1093/glycob/cwh136; STANLEY P, 1984, ANNU REV GENET, V18, P525, DOI 10.1146/annurev.ge.18.120184.002521; STANLEY P, 1989, MOL CELL BIOL, V9, P377, DOI 10.1128/MCB.9.2.377; STANLEY P, 1980, J CELL BIOL, V85, P60, DOI 10.1083/jcb.85.1.60; Sullivan FX, 1998, J BIOL CHEM, V273, P8193, DOI 10.1074/jbc.273.14.8193; Sutton-Smith M, 2006, CELL BIOL LAB HDB, P415; Varki A, 2008, TRENDS MOL MED, V14, P351, DOI 10.1016/j.molmed.2008.06.002; Wada Y, 2007, GLYCOBIOLOGY, V17, P411, DOI 10.1093/glycob/cwl086; Wang J, 1999, CELL, V97, P791, DOI 10.1016/S0092-8674(00)80790-4; Weinstein J, 1996, J BIOL CHEM, V271, P27462, DOI 10.1074/jbc.271.44.27462; Zhang AM, 1999, J BIOL CHEM, V274, P10439, DOI 10.1074/jbc.274.15.10439; Zhao YY, 2008, FEBS J, V275, P1939, DOI 10.1111/j.1742-4658.2008.06346.x	44	154	157	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5759	5775		10.1074/jbc.M109.068353	http://dx.doi.org/10.1074/jbc.M109.068353			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	19951948	Green Published, hybrid			2022-12-25	WOS:000275327200068
J	Guilmeau, S; Flandez, M; Mariadason, JM; Augenlicht, LH				Guilmeau, S.; Flandez, M.; Mariadason, J. M.; Augenlicht, L. H.			Heterogeneity of Jagged1 expression in human and mouse intestinal tumors: implications for targeting Notch signaling	ONCOGENE			English	Article						Jagged1; Notch signaling; colon cancer	PROGENITOR CELLS; CANCER; GENES; LINE; WNT; APC; DIFFERENTIATION; INACTIVATION; REQUIREMENT; SUPPRESSOR	Inhibition of Notch signaling is effective in inhibiting colon tumorigenesis, but targeting specific components of the pathway may provide more effective strategies. Here we show that the expression of Jagged1, a ligand for canonical Notch signaling, was restricted to enteroendocrine cells or undetectable in the mucosa of the human small and large intestine, respectively. In contrast, increased expression characterized half of human colon tumors, although not all tumors with elevated Wnt signaling displayed elevated Jagged1. Increased Jagged1 was also present in intestinal tumors of Apc(1638N/+) and Apc(Min/+) mice, but to a higher level and more frequently in the former, and in 90% of mouse tumors Notch signaling was elevated when Jagged1 was elevated. In the human HT29Cl16E colonic carcinoma cell line, induction of goblet cell differentiation by contact inhibition of growth depended on the loss of Jagged1-mediated Notch activation, with signaling through Notch1 and Notch2 acting redundantly. Therefore, targeting of Jagged1 could be effective in downregulating Notch signaling in a subset of tumors, but may avoid the limiting gastrointestinal toxicity caused by pharmacological inhibition of Notch signaling. Oncogene (2010) 29, 992-1002; doi:10.1038/onc.2009.393; published online 23 November 2009	[Guilmeau, S.; Flandez, M.; Mariadason, J. M.; Augenlicht, L. H.] Montefiore Med Ctr, Albert Einstein Canc Ctr, Dept Oncol, Bronx, NY 10467 USA	Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine	Guilmeau, S (corresponding author), INSERM, Dept Endocrinol Canc & Metab, U567, 24 Rue Faubourg St Jacques, F-75014 Paris, France.	sandra.guilmeau@inserm.fr	Mariadason, John/N-2003-2013; Canet, Marta Flández/E-2681-2019; Guilmeau, Sandra/P-2318-2017	Canet, Marta Flández/0000-0002-9096-2267; Mariadason, John/0000-0001-9123-7684; Guilmeau, Sandra/0000-0002-8260-1218	NCI [RO1 CA114265, U54 CA100926]; Philippe Foundation; NATIONAL CANCER INSTITUTE [R01CA114265, U54CA100926] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Philippe Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank T Sudo (Toray Industries Inc., Kamakura, Japan) for sharing the Hes1 antibody, and Pamela Stanley (Albert Einstein College Medicine, Bronx, NY, USA) for the TP1-Luc plasmid. We are grateful to A Velcich and L Klampfer for helpful comments. This work was supported by NCI Grants RO1 CA114265 and U54 CA100926 to LH Augenlicht, and by the Philippe Foundation.	Akiyoshi T, 2008, GASTROENTEROLOGY, V134, P131, DOI 10.1053/j.gastro.2007.10.008; AUGENLICHT LH, 1987, CANCER RES, V47, P3763; AUGERON C, 1984, CANCER RES, V44, P3961; Estrach S, 2006, DEVELOPMENT, V133, P4427, DOI 10.1242/dev.02644; FODDE R, 1994, P NATL ACAD SCI USA, V91, P8969, DOI 10.1073/pnas.91.19.8969; FORTINI ME, 1994, CELL, V79, P273, DOI 10.1016/0092-8674(94)90196-1; Fre S, 2005, NATURE, V435, P964, DOI 10.1038/nature03589; Fre S, 2008, ADV CANCER RES, V100, P85, DOI 10.1016/S0065-230X(08)00003-1; Fre S, 2009, P NATL ACAD SCI USA, V106, P6309, DOI 10.1073/pnas.0900427106; Fryer CJ, 2002, GENE DEV, V16, P1397, DOI 10.1101/gad.991602; Ghaleb AM, 2008, MOL CANCER RES, V6, P1920, DOI 10.1158/1541-7786.MCR-08-0224; Guilmeau S, 2008, GASTROENTEROLOGY, V135, P849, DOI 10.1053/j.gastro.2008.05.050; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Jensen J, 2000, NAT GENET, V24, P36, DOI 10.1038/71657; Katoh M, 2006, INT J MOL MED, V17, P681; LABURTHE M, 1989, AM J PHYSIOL, V256, pG443, DOI 10.1152/ajpgi.1989.256.3.G443; LEVY DB, 1994, CANCER RES, V54, P5953; Martys-Zage JL, 2000, J MOL NEUROSCI, V15, P189, DOI 10.1385/JMN:15:3:189; McCarthy JV, 2005, BIOCHEM SOC T, V33, P568, DOI 10.1042/BST0330568; MERLIN D, 1994, J MEMBRANE BIOL, V137, P137; Milano J, 2004, TOXICOL SCI, V82, P341, DOI 10.1093/toxsci/kfh254; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333; Riccio O, 2008, EMBO REP, V9, P377, DOI 10.1038/embor.2008.7; Rodilla V, 2009, P NATL ACAD SCI USA, V106, P6315, DOI 10.1073/pnas.0813221106; Sander GR, 2004, J HISTOCHEM CYTOCHEM, V52, P509, DOI 10.1177/002215540405200409; Shroyer NF, 2007, GASTROENTEROLOGY, V132, P2478, DOI 10.1053/j.gastro.2007.03.047; Smits R, 1997, CARCINOGENESIS, V18, P321, DOI 10.1093/carcin/18.2.321; Stanger BZ, 2005, P NATL ACAD SCI USA, V102, P12443, DOI 10.1073/pnas.0505690102; Strobl LJ, 1997, IMMUNOBIOLOGY, V198, P299, DOI 10.1016/S0171-2985(97)80050-2; TAKEBAYASHI K, 1994, J BIOL CHEM, V269, P5150; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Velcich A, 2005, EXP CELL RES, V304, P28, DOI 10.1016/j.yexcr.2004.10.014; Wheeler JMD, 2002, GUT, V50, P218, DOI 10.1136/gut.50.2.218; Yang Q, 2001, SCIENCE, V294, P2155, DOI 10.1126/science.1065718; Zheng JL, 2000, DEVELOPMENT, V127, P4551	36	38	43	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 18	2010	29	7					992	1002		10.1038/onc.2009.393	http://dx.doi.org/10.1038/onc.2009.393			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	556PV	19935714				2022-12-25	WOS:000274604400006
J	Wadhwa, R; Ryu, J; Gao, R; Choi, IK; Morrow, G; Kaur, K; Kim, I; Kaul, SC; Yun, CO; Tanguay, RM				Wadhwa, Renu; Ryu, Jihoon; Gao, Ran; Choi, Il-Kyu; Morrow, Genevieve; Kaur, Kamaljit; Kim, Inwook; Kaul, Sunil C.; Yun, Chae-Ok; Tanguay, Robert M.			Proproliferative Functions of Drosophila Small Mitochondrial Heat Shock Protein 22 in Human Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN NEUROMUSCULAR DISORDERS; LIFE-SPAN EXTENSION; ALPHA-B-CRYSTALLIN; HSP22 HSPB8; BREAST-CANCER; P53; MORTALIN; EXPRESSION; MELANOGASTER; MEMBER	Aging is a complex process accompanied by a decreased capacity of cells to cope with random damages induced by reactive oxygen species, the natural by-products of energy metabolism, leading to protein aggregation in various components of the cell. Chaperones are important players in the aging process as they prevent protein misfolding and aggregation. Small chaperones, such as small heat shock proteins, are involved in the refolding and/or disposal of protein aggregates, a feature of many age-associated diseases. In Drosophila melanogaster, mitochondrial Hsp22 (DmHsp22), is localized in the mitochondrial matrix and is preferentially up-regulated during aging. Its overexpression results in an extension of life span (>30%) (Morrow, G., Samson, M., Michaud, S., and Tanguay, R. M. (2004) FASEB J. 18, 598-599 and Morrow, G., Battistini, S., Zhang, P., and Tanguay, R. M. (2004) J. Biol. Chem. 279, 43382-43385). Long lived flies expressing Hsp22 also have an increased resistance to oxidative stress and maintain locomotor activity longer. In the present study, the cross-species effects of Hsp22 expression were tested. DmHsp22 was found to be functionally active in human cells. It extended the life span of normal fibroblasts, slowing the aging process as evidenced by a lower level of the senescence associated beta-galactosidase. DmHsp22 expression in human cancer cells increased their malignant properties including anchorage-independent growth, tumor formation in nude mice, and resistance to a variety of anticancer drugs. We report that the DmHsp22 interacts and inactivates wild type tumor suppressor protein p53, which may be one possible way of its functioning in human cells.	[Ryu, Jihoon; Yun, Chae-Ok] Yonsei Univ, Coll Med, Inst Canc Res, Brain Korea Project Med Sci 21, Seoul, South Korea; [Kaul, Sunil C.] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058562, Japan; [Choi, Il-Kyu; Kim, Inwook; Yun, Chae-Ok] Yonsei Univ, Grad Program Nanomed Sci, Seoul, South Korea; [Morrow, Genevieve; Tanguay, Robert M.] Univ Laval, Pav CE Marchand, PROTEO, Dept Med,Lab Genet Cellulaire & Dev, Quebec City, PQ G1V 0A6, Canada	Yonsei University; Yonsei University Health System; National Institute of Advanced Industrial Science & Technology (AIST); Yonsei University; Laval University	Yun, CO (corresponding author), Yonsei Univ, Coll Med, Inst Canc Res, Brain Korea Project Med Sci 21, 134 Shinchon Dong, Seoul, South Korea.	chaeok@yuhs.ac; Robert.tanguay@rsvs.ulaval.ca	Kaul, Sunil C/L-8671-2018; Yun, Chae-Ok/P-3698-2015; Kim, In-Wook/AAN-8123-2020; Wadhwa, Renu/L-8898-2018	Kaul, Sunil C/0000-0002-0046-3916; Kim, In-Wook/0000-0002-5501-2928; Wadhwa, Renu/0000-0001-8248-5192; Yun, Chae-Ok/0000-0002-9466-4531; Gao, Ran/0000-0001-8712-429X	Canadian Institutes of Health Research [MOP-77796]; New Energy and Industrial Technology Development Organization (Japan); Ministry of Commerce Industry and Energy [10030051]; Korea Science and Engineering Foundation [R01-2006-000-10084-0, R15-2004-024-02001-0, M10416130002-04N1613-00210]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); New Energy and Industrial Technology Development Organization (Japan)(New Energy and Industrial Technology Development Organization (NEDO)); Ministry of Commerce Industry and Energy(Ministry of Trade, Industry & Energy (MOTIE), Republic of Korea); Korea Science and Engineering Foundation(Korea Science and Engineering Foundation)	This work was supported in part by grants from the Canadian Institutes of Health Research (MOP-77796), New Energy and Industrial Technology Development Organization (Japan), the Ministry of Commerce Industry and Energy (10030051), and the Korea Science and Engineering Foundation (R01-2006-000-10084-0, R15-2004-024-02001-0, M10416130002-04N1613-00210).	Benndorf R, 2001, J BIOL CHEM, V276, P26753, DOI 10.1074/jbc.M103001200; Besada V, 2006, PROTEOMICS, V6, P1038, DOI 10.1002/pmic.200500151; Carra S, 2005, HUM MOL GENET, V14, P1659, DOI 10.1093/hmg/ddi174; Deocaris CC, 2006, CELL STRESS CHAPERON, V11, P116, DOI 10.1379/CSC-144R.1; Dierick I, 2005, ANN MED, V37, P413, DOI 10.1080/07853890500296410; Dundas SR, 2005, J PATHOL, V205, P74, DOI 10.1002/path.1672; Fichtner I, 2004, EUR J CANCER, V40, P845, DOI 10.1016/j.ejca.2003.11.030; Fontaine JM, 2006, FASEB J, V20, P2168, DOI 10.1096/fj.06-5911fje; Fontaine JM, 2005, BIOCHEM BIOPH RES CO, V337, P1006, DOI 10.1016/j.bbrc.2005.09.148; Heikkila JJ, 2007, BIOTECHNOL ADV, V25, P385, DOI 10.1016/j.biotechadv.2007.03.003; Hu ZP, 2007, J NEUROSCI RES, V85, P2071, DOI 10.1002/jnr.21231; Irobi J, 2004, NAT GENET, V36, P597, DOI 10.1038/ng1328; Kampinga HH, 2009, CELL STRESS CHAPERON, V14, P105, DOI 10.1007/s12192-008-0068-7; Kaul SC, 2000, FEBS LETT, V474, P159, DOI 10.1016/S0014-5793(00)01594-5; Kaul SC, 2005, J BIOL CHEM, V280, P39373, DOI 10.1074/jbc.M500022200; Kaul SC, 2003, EXP CELL RES, V286, P96, DOI 10.1016/S0014-4827(03)00101-0; Kim MV, 2006, ARCH BIOCHEM BIOPHYS, V454, P32, DOI 10.1016/j.abb.2006.07.014; King V, 1999, DEV BIOL, V207, P107, DOI 10.1006/dbio.1998.9147; Kurapati R, 2000, J GERONTOL A-BIOL, V55, pB552, DOI 10.1093/gerona/55.11.B552; Ma Z, 2006, ONCOGENE, V25, P5377, DOI 10.1038/sj.onc.1209543; Michaud S, 1997, CELL MOL LIFE SCI, V53, P104, DOI 10.1007/PL00000572; Michaud Sebastien, 2002, Prog Mol Subcell Biol, V28, P79; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; Mihara Motohiro, 2003, Methods Mol Biol, V234, P203; Morrow G, 2000, J BIOL CHEM, V275, P31204, DOI 10.1074/jbc.M002960200; Morrow G, 2006, CELL STRESS CHAPERON, V11, P51, DOI 10.1379/CSC-166.1; Morrow G, 2004, J BIOL CHEM, V279, P43382, DOI 10.1074/jbc.C400357200; Morrow G, 2004, FASEB J, V18, P598, DOI 10.1096/fj.03-0860fje; Morrow Genevieve, 2008, Biotechnology Journal, V3, P728, DOI 10.1002/biot.200800015; Morselli E, 2009, CELL CYCLE, V8, P1647; Nakagawa M, 2001, EXP CELL RES, V271, P161, DOI 10.1006/excr.2001.5362; Robertson JFR, 1996, INT J BIOL MARKER, V11, P29, DOI 10.1177/172460089601100106; Shemetov AA, 2008, J NEUROSCI RES, V86, P264, DOI 10.1002/jnr.21441; Simon S, 2007, J BIOL CHEM, V282, P34276, DOI 10.1074/jbc.M703267200; Sun X, 2007, CELL STRESS CHAPERON, V12, P307, DOI 10.1379/CSC-276.1; Tao D, 2004, ACTA BIOCH BIOPH SIN, V36, P618, DOI 10.1093/abbs/36.9.618; Vaseva AV, 2009, CELL CYCLE, V8, P1711, DOI 10.4161/cc.8.11.8596; Wadhwa R, 1998, J BIOL CHEM, V273, P29586, DOI 10.1074/jbc.273.45.29586; Wadhwa R, 2006, INT J CANCER, V118, P2973, DOI 10.1002/ijc.21773; Walker C, 2006, AM J PATHOL, V168, P1526, DOI 10.2353/ajpath.2006.050603; Yi X, 2008, MOL CELL PROTEOMICS, V7, P315, DOI 10.1074/mcp.M700116-MCP200; Zhao YM, 2005, J EXP BIOL, V208, P697, DOI 10.1242/jeb.01439	42	25	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3833	3839		10.1074/jbc.M109.080424	http://dx.doi.org/10.1074/jbc.M109.080424			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19948727	hybrid, Green Published			2022-12-25	WOS:000275254000036
J	Chen, ZH; Akin, BL; Jones, LR				Chen, Zhenhui; Akin, Brandy L.; Jones, Larry R.			Ca2+ Binding to Site I of the Cardiac Ca2+ Pump Is Sufficient to Dissociate Phospholamban	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOPLASMIC-RETICULUM; TRANSMEMBRANE DOMAIN; CROSS-LINKING; FUNCTIONAL CONSEQUENCES; STRUCTURAL BASIS; ATPASE; CA2+-ATPASE; ACTIVATION; MECHANISM; CA-2+-ATPASE	Phospholamban (PLB) inhibits the activity of SERCA2a, the Ca2+-ATPase in cardiac sarcoplasmic reticulum, by decreasing the apparent affinity of the enzyme for Ca2+. Recent cross-linking studies have suggested that PLB binding and Ca2+ binding to SERCA2a are mutually exclusive. PLB binds to the E2 conformation of the Ca2+-ATPase, preventing formation of E1, the conformation that binds two Ca2+ (at sites I and II) with high affinity and is required for ATP hydrolysis. Here we determined whether Ca2+ binding to site I, site II, or both sites is sufficient to dissociate PLB from the Ca2+ pump. Seven SERCA2a mutants with amino acid substitutions at Ca2+-binding site I (E770Q, T798A, and E907Q), site II (E309Q and N795A), or both sites (D799N and E309Q/E770Q) were made, and the effects of Ca2+ on N30C-PLB cross-linking to Lys328 of SERCA2a were measured. In agreement with earlier reports with the skeletal muscle Ca2+-ATPase, none of the SERCA2a mutants (except E907Q) hydrolyzed ATP in the presence of Ca2+; however, all were phosphorylatable by Pi to form E2P. Ca2+ inhibition of E2P formation was observed only in SERCA2a mutants retaining site I. In cross-linking assays, strong cross-linking between N30C-PLB and each Ca2+-ATPase mutant was observed in the absence of Ca2+. Importantly, however, micromolar Ca2+ inhibited PLB cross-linking only to mutants retaining a functional Ca2+-binding site I. The dynamic equilibrium between Ca2+ pumps and N30C-PLB was retained by all mutants, demonstrating normal regulation of cross-linking by ATP, thapsigargin, and anti-PLB antibody. From these results we conclude that site I is the key Ca2+-binding site regulating the physical association between PLB and SERCA2a.	[Jones, Larry R.] Indiana Univ, Sch Med, Krannert Inst Cardiol, Indianapolis, IN 46202 USA; Indiana Univ, Sch Med, Dept Med, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Jones, LR (corresponding author), Indiana Univ, Sch Med, Krannert Inst Cardiol, 1800 N Capitol Ave, Indianapolis, IN 46202 USA.	lrjones@iupui.edu			National Institutes of Health [HL49428]; Showalter Cardiovascular Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL049428, R01HL049428] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Showalter Cardiovascular Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL49428 (to L.R.J.). This work was also supported by a Showalter Cardiovascular Research Grant (to Z.C.).	ANDERSEN JP, 1994, J BIOL CHEM, V269, P15931; ANDERSEN JP, 1992, J BIOL CHEM, V267, P19383; Andersen JP, 1995, BIOSCIENCE REP, V15, P243, DOI 10.1007/BF01788358; Autry JM, 1997, J BIOL CHEM, V272, P15872, DOI 10.1074/jbc.272.25.15872; CANTILINA T, 1993, J BIOL CHEM, V268, P17018; Chen ZH, 2005, J BIOL CHEM, V280, P10530, DOI 10.1074/jbc.M414007200; Chen ZH, 2003, J BIOL CHEM, V278, P48348, DOI 10.1074/jbc.M309545200; Chen Z, 2007, J BIOL CHEM, V282, P20968, DOI 10.1074/jbc.M703516200; Chen ZH, 2006, J BIOL CHEM, V281, P14163, DOI 10.1074/jbc.M601338200; CLARKE DM, 1990, J BIOL CHEM, V265, P6262; CLARKE DM, 1989, NATURE, V339, P476, DOI 10.1038/339476a0; Cornea RL, 2000, J BIOL CHEM, V275, P41487, DOI 10.1074/jbc.M008195200; Frank K, 2000, ANN MED, V32, P572, DOI 10.3109/07853890008998837; INESI G, 1980, J BIOL CHEM, V255, P3025; Jones LR, 2002, J BIOL CHEM, V277, P28319, DOI 10.1074/jbc.M204085200; Kimura Y, 1997, J BIOL CHEM, V272, P15061, DOI 10.1074/jbc.272.24.15061; Liu YY, 2009, J MOL BIOL, V391, P858, DOI 10.1016/j.jmb.2009.06.044; MACLENNAN DH, 1985, NATURE, V316, P696, DOI 10.1038/316696a0; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; Simmerman HKB, 1998, PHYSIOL REV, V78, P921, DOI 10.1152/physrev.1998.78.4.921; Strock C, 1998, J BIOL CHEM, V273, P15104, DOI 10.1074/jbc.273.24.15104; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; Toyoshima C, 2003, P NATL ACAD SCI USA, V100, P467, DOI 10.1073/pnas.0237326100; Toyoshima C, 2008, ARCH BIOCHEM BIOPHYS, V476, P3, DOI 10.1016/j.abb.2008.04.017; Vinge LE, 2008, CIRC RES, V102, P1458, DOI 10.1161/CIRCRESAHA.108.173195; Zhang ZS, 2000, BIOCHEMISTRY-US, V39, P8758, DOI 10.1021/bi000185m	26	21	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5					3253	3260		10.1074/jbc.M109.080820	http://dx.doi.org/10.1074/jbc.M109.080820			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19948724	Green Published, hybrid			2022-12-25	WOS:000273829000040
J	Meares, GP; Hughes, KJ; Jaimes, KF; Salvatori, AS; Rhodes, CJ; Corbett, JA				Meares, Gordon P.; Hughes, Katherine J.; Jaimes, Kimberly F.; Salvatori, Alison S.; Rhodes, Christopher J.; Corbett, John A.			AMP-activated Protein Kinase Attenuates Nitric Oxide-induced beta-Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIABETES-MELLITUS; ISLET DESTRUCTION; DNA-DAMAGE; RAT ISLETS; LANGERHANS; INTERLEUKIN-1-BETA; INHIBITION; APOPTOSIS; ENERGY; STRESS	During the initial autoimmune response in type 1 diabetes, islets are exposed to a damaging mix of pro-inflammatory molecules that stimulate the production of nitric oxide by beta-cells. Nitric oxide causes extensive but reversible cellular damage. In response to nitric oxide, the cell activates pathways for functional recovery and adaptation as well as pathways that direct beta-cell death. The molecular events that dictate cellular fate following nitric oxide-induced damage are currently unknown. In this study, we provide evidence that AMPK plays a primary role controlling the response of beta-cells to nitric oxide-induced damage. AMPK is transiently activated by nitric oxide in insulinoma cells and rat islets following IL-1 treatment or by the exogenous addition of nitric oxide. Active AMPK promotes the functional recovery of beta-cell oxidative metabolism and abrogates the induction of pathways that mediate cell death such as caspase-3 activation following exposure to nitric oxide. Overall, these data show that nitric oxide activates AMPK and that active AMPK suppresses apoptotic signaling allowing the beta-cell to recover from nitric oxide-mediated cellular stress.	[Meares, Gordon P.; Corbett, John A.] Univ Alabama Birmingham, Dept Med, Div Endocrinol Diabet & Metab, Birmingham, AL 35294 USA; [Corbett, John A.] Univ Alabama Birmingham, Comprehens Diabet Ctr, Birmingham, AL 35294 USA; [Salvatori, Alison S.] St Louis Univ, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63401 USA; [Rhodes, Christopher J.] Univ Chicago, Dept Med, Kovler Diabet Ctr, Chicago, IL 60637 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Saint Louis University; University of Chicago	Meares, GP (corresponding author), Univ Alabama Birmingham, Dept Med, Div Endocrinol Diabet & Metab, SHEL 1271A,1825 Univ Blvd, Birmingham, AL 35294 USA.	mearegp@uab.edu; corbettj@uab.edu	Meares, Gordon/AAJ-6716-2020	Meares, Gordon/0000-0002-0805-0155	National Institutes of Health-UAB program in Immunology Training [T32AI007051-31A1, R01-DK52194, AI 44458]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044458, T32AI007051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052194, R01DK055267] Funding Source: NIH RePORTER	National Institutes of Health-UAB program in Immunology Training(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by the National Institutes of Health-UAB program in Immunology Training Grant T32AI007051-31A1 (to G.P.M.) and Grants R01-DK52194 and AI 44458 (to J.A.C.).	BENDTZEN K, 1986, SCIENCE, V232, P1545, DOI 10.1126/science.3086977; Borniquel S, 2006, FASEB J, V20, P1889, DOI 10.1096/fj.05-5189fje; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Carrasco RA, 2003, BIOTECHNIQUES, V34, P1064, DOI 10.2144/03345dd02; COMENS PG, 1987, DIABETES, V36, P963, DOI 10.2337/diabetes.36.8.963; CORBETT JA, 1992, BIOCHEM J, V287, P229, DOI 10.1042/bj2870229; CORBETT JA, 1992, J CLIN INVEST, V90, P2384, DOI 10.1172/JCI116129; CORBETT JA, 1994, BIOCHEM J, V299, P719, DOI 10.1042/bj2990719; CUNNINGHAM JM, 1994, GROWTH REGULAT, V4, P173; Dali-Youcef N, 2007, ANN MED, V39, P335, DOI 10.1080/07853890701408194; DELANEY CA, 1993, FEBS LETT, V333, P291, DOI 10.1016/0014-5793(93)80673-I; FEHSEL K, 1993, DIABETES, V42, P496, DOI 10.2337/diabetes.42.3.496; GEPTS W, 1965, DIABETES, V14, P619, DOI 10.2337/diab.14.10.619; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Hohmeier HE, 2003, INT J OBESITY, V27, pS12, DOI 10.1038/sj.ijo.0802493; Hong SP, 2003, P NATL ACAD SCI USA, V100, P8839, DOI 10.1073/pnas.1533136100; Horman S, 2002, CURR BIOL, V12, P1419, DOI 10.1016/S0960-9822(02)01077-1; Hughes KJ, 2009, J BIOL CHEM, V284, P27402, DOI 10.1074/jbc.M109.046912; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Kefas BA, 2003, DIABETOLOGIA, V46, P250, DOI 10.1007/s00125-002-1030-3; Kefas BA, 2004, BIOCHEM PHARMACOL, V68, P409, DOI 10.1016/j.bcp.2004.04.003; Kelly Colleen B, 2003, Methods Mol Med, V83, P3; Koeck T, 2009, ARCH BIOCHEM BIOPHYS, V484, P221, DOI 10.1016/j.abb.2009.01.021; LACY PE, 1991, AM J PATHOL, V138, P1183; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; NybIorn HK, 2008, J MOL ENDOCRINOL, V41, P187, DOI 10.1677/JME-08-0006; Riboulet-Chavey A, 2008, DIABETES, V57, P415, DOI 10.2337/db07-0993; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Scarim AL, 2003, ENDOCRINOLOGY, V144, P3415, DOI 10.1210/en.2002-0112; Scarim AL, 1997, ENDOCRINOLOGY, V138, P5301, DOI 10.1210/en.138.12.5301; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Terai K, 2005, MOL CELL BIOL, V25, P9554, DOI 10.1128/MCB.25.21.9554-9575.2005; Tisch R, 1996, CELL, V85, P291, DOI 10.1016/S0092-8674(00)81106-X; Xie ZL, 2006, J BIOL CHEM, V281, P6366, DOI 10.1074/jbc.M511178200	41	27	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5					3191	3200		10.1074/jbc.M109.047365	http://dx.doi.org/10.1074/jbc.M109.047365			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19933272	Green Published, hybrid			2022-12-25	WOS:000273829000034
J	Erdmann, F; Weiwad, M; Kilka, S; Karanik, M; Patzel, M; Baumgrass, R; Liebscher, J; Fischer, G				Erdmann, Frank; Weiwad, Matthias; Kilka, Susann; Karanik, Magdalena; Paetzel, Michael; Baumgrass, Ria; Liebscher, Juergen; Fischer, Gunter			The Novel Calcineurin Inhibitor CN585 Has Potent Immunosuppressive Properties in Stimulated Human T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIS-TRANS-ISOMERASE; PROLYL CIS/TRANS ISOMERASES; KEY SIGNALING ENZYME; CYCLOSPORINE-A; PROTEIN PHOSPHATASES; ESCHERICHIA-COLI; CYCLOPHILIN-A; MECHANISM; DERIVATIVES; SUBSTRATE	The Ca2+/calmodulin-dependent protein phosphatase calcineurin is a key mediator in antigen-specific T cell activation. Thus, inhibitors of calcineurin, such as cyclosporin A or FK506, can block T cell activation and are used as immunosuppressive drugs to prevent graft-versus-host reactions and autoimmune diseases. In this study we describe the identification of 2,6-diaryl-substituted pyrimidine derivatives as a new class of calcineurin inhibitors, obtained by screening of a substance library. By rational design of the parent compound we have attained the derivative 6-(3,4-dichloro-phenyl)-4-(N,N-dimethylaminoethylthio)-2-phenyl-pyrimidine (CN585) that noncompetitively and reversibly inhibits calcineurin activity with a K-i value of 3.8 mu M. This derivative specifically inhibits calcineurin without affecting other Ser/Thr protein phosphatases or peptidyl prolyl cis/trans isomerases. CN585 shows potent immunosuppressive effects by inhibiting NFAT nuclear translocation and transactivation, cytokine production, and T cell proliferation. Moreover, the calcineurin inhibitor exhibits no cytotoxicity in the effective concentration range. Therefore, calcineurin inhibition by CN585 may represent a novel promising strategy for immune intervention.	[Fischer, Gunter] Max Planck Res Unit Enzymol Prot Folding, D-06120 Halle, Germany; [Karanik, Magdalena; Paetzel, Michael; Liebscher, Juergen] Humboldt Univ, Dept Chem, D-12489 Berlin, Germany; [Baumgrass, Ria] Deutsch Rheuma Forschungszentrum Berlin, D-10117 Berlin, Germany	Max Planck Society; Humboldt University of Berlin; Deutsches Rheuma-Forschungszentrum (DRFZ)		erdmann@enzyme-halle.mpg.de	Liebscher, Jürgen/R-1689-2019; Erdmann, Frank/AAF-1091-2021; Liebscher, Jürgen/A-8964-2012	Liebscher, Jürgen/0000-0002-1802-5543; Erdmann, Frank/0000-0001-5261-0984; Liebscher, Jürgen/0000-0002-1802-5543; Baumgrass, Ria/0000-0002-3289-1608	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The work was supported by the Deutsche Forschungsgemeinschaft.	Arora PD, 2001, J BIOL CHEM, V276, P14100, DOI 10.1074/jbc.M010298200; Ban M, 1998, BIOORGAN MED CHEM, V6, P1057, DOI 10.1016/S0968-0896(98)00064-9; Barford D, 1996, TRENDS BIOCHEM SCI, V21, P407, DOI 10.1016/S0968-0004(96)10060-8; Baumgrass R, 2001, J BIOL CHEM, V276, P47914, DOI 10.1074/jbc.M103273200; Baumgrass R, 2004, J BIOL CHEM, V279, P2470, DOI 10.1074/jbc.M304754200; Bechstein WO, 2000, TRANSPL INT, V13, P313, DOI 10.1111/j.1432-2277.2000.tb01004.x; BIALOJAN C, 1988, BIOCHEM J, V256, P283, DOI 10.1042/bj2560283; Brill GM, 1996, J ANTIBIOT, V49, P124, DOI 10.7164/antibiotics.49.124; Caramelo C, 2004, NEPHROL DIAL TRANSPL, V19, P285, DOI 10.1093/ndt/gfg516; Carruthers NJ, 2006, FASEB J, V20, pA1123; Ciancio G, 2000, Expert Opin Pharmacother, V1, P1307, DOI 10.1517/14656566.1.7.1307; CIRILLO R, 1995, BRIT J PHARMACOL, V114, P1117, DOI 10.1111/j.1476-5381.1995.tb13323.x; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; CLIPSTONE NA, 1994, J BIOL CHEM, V269, P26431; CLIPSTONE NA, 1993, ANN NY ACAD SCI, V696, P20; COGHLAN VM, 1995, SCIENCE, V267, P108, DOI 10.1126/science.7528941; Conklyn M, 2004, J LEUKOCYTE BIOL, V76, P1248, DOI 10.1189/jlb.0504282; CORNISHB.A, 1974, BIOCHEM J, V137, P143, DOI 10.1042/bj1370143; Dlugosz A, 1996, FARMACO, V51, P367; Enz A, 1997, BIOORG MED CHEM LETT, V7, P2513, DOI 10.1016/S0960-894X(97)10005-1; Enz A, 1997, BIOCHEM PHARMACOL, V54, P321, DOI 10.1016/S0006-2952(97)00175-5; FISCHER G, 1989, NATURE, V337, P476, DOI 10.1038/337476a0; Fischer G, 2004, REV PHYSIOL BIOCH P, V148, P105, DOI 10.1007/s10254-003-0011-3; FISCHER G, 1994, ANGEW CHEM INT EDIT, V33, P1415, DOI 10.1002/anie.199414151; Fuentes JJ, 2000, HUM MOL GENET, V9, P1681, DOI 10.1093/hmg/9.11.1681; Gualberto A, 1998, J BIOL CHEM, V273, P7088, DOI 10.1074/jbc.273.12.7088; HASHIMOTO Y, 1990, J BIOL CHEM, V265, P1924; Hong F, 2004, BIOCHEM BIOPH RES CO, V316, P1073, DOI 10.1016/j.bbrc.2004.02.160; Hong F, 2002, FASEB J, V16, P1633, DOI 10.1096/fj.02-0060fje; HOWS JM, 1983, BRIT J HAEMATOL, V54, P69, DOI 10.1111/j.1365-2141.1983.tb02068.x; IWATANI Y, 1982, J IMMUNOL METHODS, V54, P31, DOI 10.1016/0022-1759(82)90110-7; JAIN JN, 1993, NATURE, V365, P352, DOI 10.1038/365352a0; Jindal RM, 1997, DRUG SAFETY, V16, P242, DOI 10.2165/00002018-199716040-00002; Kilka S, 2009, BIOCHEMISTRY-US, V48, P1900, DOI 10.1021/bi8019355; KLINTMALM G, 1984, LANCET, V2, P950; Kolar F, 1996, MOL CELL BIOCHEM, V164, P253, DOI 10.1007/BF00408666; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Lai MM, 1998, J BIOL CHEM, V273, P18325, DOI 10.1074/jbc.273.29.18325; Lin X, 1999, J BIOL CHEM, V274, P36125, DOI 10.1074/jbc.274.51.36125; LOHSE DL, 1995, STRUCTURE, V3, P987, DOI 10.1016/S0969-2126(01)00234-9; Mai A, 2005, BIOORGAN MED CHEM, V13, P2065, DOI 10.1016/j.bmc.2005.01.005; Martin BL, 1998, BIOCHEM PHARMACOL, V56, P483, DOI 10.1016/S0006-2952(98)00181-6; Miskin JE, 1998, SCIENCE, V281, P562, DOI 10.1126/science.281.5376.562; Mokroz MJ, 1995, ARCH PHARM, V328, P659, DOI 10.1002/ardp.19953280906; Mondragon A, 1997, BIOCHEMISTRY-US, V36, P4934, DOI 10.1021/bi9631935; Moore R, 2001, DRUG SAFETY, V24, P755, DOI 10.2165/00002018-200124100-00004; Nakayama GR, 1998, J BIOMOL SCREEN, V3, P43, DOI 10.1177/108705719800300106; NITTA Y, 1965, CHEM PHARM BULL, V13, P901; Okamura H, 2000, MOL CELL, V6, P539, DOI 10.1016/S1097-2765(00)00053-8; Pan F, 2007, NATURE, V445, P433, DOI 10.1038/nature05476; Quintela JM, 1998, BIOORGAN MED CHEM, V6, P1911, DOI 10.1016/S0968-0896(98)00150-3; REGO A, 1990, J PHARMACOL EXP THER, V254, P799; Reis F, 2009, TRANSPL P, V41, P868, DOI 10.1016/j.transproceed.2009.02.005; Richter A, 1999, J EXP MED, V190, P1439, DOI 10.1084/jem.190.10.1439; SCHREIBER SL, 1992, IMMUNOL TODAY, V13, P136, DOI 10.1016/0167-5699(92)90111-J; Schutkowski M, 1998, BIOCHEMISTRY-US, V37, P5566, DOI 10.1021/bi973060z; Shah AK, 1999, CLIN NEUROPHARMACOL, V22, P67, DOI 10.1097/00002826-199903000-00001; SOLDIN SJ, 1993, THER DRUG MONIT, V15, P468, DOI 10.1097/00007691-199312000-00002; Sullivan E, 1997, J BIOMOL SCREEN, V2, P19, DOI 10.1177/108705719700200105; Sun L, 1998, IMMUNITY, V8, P703, DOI 10.1016/S1074-7613(00)80575-0; Thiel A, 1999, ARTHRITIS RES, V1, P25, DOI 10.1186/ar7; Tradler T, 1997, FEBS LETT, V407, P184, DOI 10.1016/S0014-5793(97)00345-1; TUNG HYL, 1985, EUR J BIOCHEM, V148, P253, DOI 10.1111/j.1432-1033.1985.tb08833.x; Wang H, 2008, IUBMB LIFE, V60, P549, DOI 10.1002/iub.94; Wang WG, 2005, CANCER BIOL THER, V4, P893, DOI 10.4161/cbt.4.8.2134	65	24	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2010	285	3					1888	1898		10.1074/jbc.M109.024844	http://dx.doi.org/10.1074/jbc.M109.024844			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	541PJ	19923214	Green Published, hybrid			2022-12-25	WOS:000273429100035
J	Israni, N; Goswami, R; Kumar, A; Rani, R				Israni, Neetu; Goswami, Ravinder; Kumar, Avinash; Rani, Rajni			Interaction of Vitamin D Receptor with HLA DRB1*0301 in Type 1 Diabetes Patients from North India	PLOS ONE			English	Article							BONE-MINERAL DENSITY; TRANSCRIPTIONAL REPRESSION; 1,25-DIHYDROXYVITAMIN D-3; GENE POLYMORPHISMS; NOD MICE; LINKAGE DISEQUILIBRIUM; ALLELIC VARIATION; HORMONE-RECEPTOR; DOWN-REGULATION; PROTEIN-LEVELS	Background: Type 1 diabetes (T1D) is a multifactorial autoimmune disorder where interaction and integration of immune response genes along with environmental factors play a role in autoimmune destruction of the insulin producing Pancreatic Beta cells. Methodology/Principal Findings: We have studied four single nucleotide polymorphisms (FokI site in Exon 2, BsmI and ApaI sites in Intron 8 and TaqI site in exon 9) in the vitamin D receptor (VDR) gene using PCR-RFLP and HLA-DRB1 alleles using PCR and hybridization with sequence specific oligonucleotide probes and studied their interaction using LD based statistics for non-linked loci followed by sequence analysis of the vitamin D response element (VDRE) present in the promoter region of HLA-DRB1*0301. Haplotypes, constructed using SHEsis program for four single nucleotide polymorphisms in the VDR gene, were studied for their interaction with HLA-DRB1 alleles in 233 T1D patients and 191 healthy controls from North India. A significant increase of haplotypes FBAt and fBAT (p<0.02, OR = 1.44 and p<0.002, OR = 3.23 respectively) was observed in the patients. Both the haplotypes FBAt and fBAT were significantly increased in male patients with age at onset less than 18 years; however, fBAT was significantly increased in female patients irrespective of their age at onset. LD based statistics showed significant interaction between the high producer F and T alleles with HLA-DRB1*0301. F and T alleles of VDR have been shown to contribute to VDR mRNA independently. The promoter sequence analysis of HLA-DRB1*0301 showed presence of VDRE involved in higher expression of HLA-DRB1*030, which was confirmed by flow cytometry and real time PCR analysis. Conclusions/Significance: These data suggest that the interaction between VDR and HLA alleles is mediated by VDRE present in the promoter region of HLA-DRB1*0301 allele, which may be detrimental for the manifestation of T1D in the absence of 1,25-(OH)(2)D(3) in early childhood due to poor expression of DRB1*0301 in the thymus resulting in autoimmunity.	[Israni, Neetu; Kumar, Avinash; Rani, Rajni] Natl Inst Immunol, Mol Immunogenet Grp, New Delhi 110067, India; [Goswami, Ravinder] All India Inst Med Sci, Dept Endocrinol & Metab, New Delhi, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); All India Institute of Medical Sciences (AIIMS) New Delhi	Israni, N (corresponding author), Natl Inst Immunol, Mol Immunogenet Grp, New Delhi 110067, India.	rajni@nii.res.in	Rani, Rajni/AAF-5860-2020		Department of Science and Technology (DST); Department of Biotechnology (DBT); Ministry of Science and Technology, Government of India; National Institute of Immunology, New Delhi, India	Department of Science and Technology (DST)(Department of Science & Technology (India)); Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India); Ministry of Science and Technology, Government of India(Ministry of Science and Technology, Government of India); National Institute of Immunology, New Delhi, India	The project was funded in part by a grant from Department of Science and Technology (DST), Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India and partly by Core funds of National Institute of Immunology, New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALROY I, 1995, MOL CELL BIOL, V15, P5789; Angel B, 2004, EUR J EPIDEMIOL, V19, P1085, DOI 10.1007/s10654-004-1026-z; Arai H, 1997, J BONE MINER RES, V12, P915, DOI 10.1359/jbmr.1997.12.6.915; BHALLA AK, 1984, J IMMUNOL, V133, P1748; Bianco MG, 2004, EUR J ENDOCRINOL, V151, P641, DOI 10.1530/eje.0.1510641; Boonstra A, 2001, J IMMUNOL, V167, P4974, DOI 10.4049/jimmunol.167.9.4974; Cantorna MT, 1998, J IMMUNOL, V160, P5314; Chang TJ, 2000, CLIN ENDOCRINOL, V52, P575, DOI 10.1046/j.1365-2265.2000.00985.x; Cippitelli M, 1998, EUR J IMMUNOL, V28, P3017, DOI 10.1002/(SICI)1521-4141(199810)28:10<3017::AID-IMMU3017>3.3.CO;2-Y; D'Ambrosio D, 1998, J CLIN INVEST, V101, P252, DOI 10.1172/JCI1050; Durrin LK, 1999, BBA-MOL BASIS DIS, V1453, P311, DOI 10.1016/S0925-4439(99)00007-1; EMERY P, 1993, HUM IMMUNOL, V38, P137, DOI 10.1016/0198-8859(93)90531-5; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; FARACO JH, 1989, NUCLEIC ACIDS RES, V17, P2150, DOI 10.1093/nar/17.5.2150; FERNANDEZVINA MA, 1991, IMMUNOGENETICS, V34, P299, DOI 10.1007/BF00211994; Goswami R, 2006, J CLIN ENDOCR METAB, V91, P4256, DOI 10.1210/jc.2006-1005; Gross C, 1996, J BONE MINER RES, V11, P1850; Gross C, 1998, J BONE MINER RES, V13, P1691, DOI 10.1359/jbmr.1998.13.11.1691; Guja C, 2002, J CELL MOL MED, V6, P75, DOI 10.1111/j.1582-4934.2002.tb00312.x; Guo SW, 2006, AM J EPIDEMIOL, V164, P711, DOI 10.1093/aje/kwj278; Guy M, 2004, CLIN CANCER RES, V10, P5472, DOI 10.1158/1078-0432.CCR-04-0206; Gysemans CA, 2005, ENDOCRINOLOGY, V146, P1956, DOI 10.1210/en.2004-1322; Haussler MR, 1998, J BONE MINER RES, V13, P325, DOI 10.1359/jbmr.1998.13.3.325; HUSTMYER FG, 1993, HUM MOL GENET, V2, P487, DOI 10.1093/hmg/2.4.487; Hypponen E, 2001, LANCET, V358, P1500, DOI 10.1016/S0140-6736(01)06580-1; Jones G, 1998, PHYSIOL REV, V78, P1193, DOI 10.1152/physrev.1998.78.4.1193; Jurutka PW, 2000, MOL ENDOCRINOL, V14, P401, DOI 10.1210/me.14.3.401; Komine M, 1999, ARCH DERMATOL RES, V291, P500, DOI 10.1007/s004030050444; Kumar R, 2007, TISSUE ANTIGENS, V69, P557, DOI 10.1111/j.1399-0039.2007.00817.x; LEMIRE JM, 1992, J CELL BIOCHEM, V49, P26, DOI 10.1002/jcb.240490106; LOUIS P, 1993, IMMUNOGENETICS, V38, P21, DOI 10.1007/BF00216386; MATHIEU C, 1992, DIABETES, V41, P1491, DOI 10.2337/diabetes.41.11.1491; MATHIEU C, 1994, DIABETOLOGIA, V37, P552, DOI 10.1007/BF00403372; McDermott MF, 1997, DIABETOLOGIA, V40, P971, DOI 10.1007/s001250050776; MORRISON NA, 1992, P NATL ACAD SCI USA, V89, P6665, DOI 10.1073/pnas.89.15.6665; Motohashi Y, 2003, J CLIN ENDOCR METAB, V88, P3137, DOI 10.1210/jc.2002-021881; Nejentsev S, 2004, HUM MOL GENET, V13, P1633, DOI 10.1093/hmg/ddh169; Ogunkolade BW, 2002, DIABETES, V51, P2294, DOI 10.2337/diabetes.51.7.2294; Pani MA, 2000, DIABETES, V49, P504, DOI 10.2337/diabetes.49.3.504; Park YC, 2000, FEBS LETT, V465, P93, DOI 10.1016/S0014-5793(99)01735-4; Ponsonby AL, 2008, AM J EPIDEMIOL, V168, P358, DOI 10.1093/aje/kwn142; Pugliese A, 1997, NAT GENET, V15, P293, DOI 10.1038/ng0397-293; Ramachandran A, 1996, DIABETES RES CLIN PR, V34, P79, DOI 10.1016/S0168-8227(96)01338-1; Ramagopalan SV, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000369; Rani R, 2004, TISSUE ANTIGENS, V64, P145, DOI 10.1111/j.1399-0039.2004.00246.x; Rani R, 1998, TISSUE ANTIGENS, V52, P37, DOI 10.1111/j.1399-0039.1998.tb03021.x; Rani R, 1998, TISSUE ANTIGENS, V52, P147, DOI 10.1111/j.1399-0039.1998.tb02278.x; RIGBY WFC, 1990, BLOOD, V76, P189, DOI 10.1182/blood.V76.1.189.bloodjournal761189; ROONEY JW, 1995, MOL CELL BIOL, V15, P6299; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; SKJODT H, 1990, J CLIN INVEST, V85, P1421, DOI 10.1172/JCI114586; Skrabic V, 2003, DIABETES RES CLIN PR, V59, P31, DOI 10.1016/S0168-8227(02)00195-X; Takeuchi A, 1998, J IMMUNOL, V160, P209; Towers TL, 1999, MOL CELL BIOL, V19, P4191; Turpeinen H, 2003, EUR J ENDOCRINOL, V149, P591, DOI 10.1530/eje.0.1490591; Uitterlinden AG, 2004, GENE, V338, P143, DOI 10.1016/j.gene.2004.05.014; Vafiadis P, 1997, NAT GENET, V15, P289, DOI 10.1038/ng0397-289; van Etten E, 2007, EUR J IMMUNOL, V37, P395, DOI 10.1002/eji.200636043; YU XP, 1995, P NATL ACAD SCI USA, V92, P10990, DOI 10.1073/pnas.92.24.10990; Zella JB, 2003, ARCH BIOCHEM BIOPHYS, V417, P77, DOI 10.1016/S0003-9861(03)00338-2; Zhao JY, 2006, AM J HUM GENET, V79, P831, DOI 10.1086/508571; Zmuda JM, 2000, EPIDEMIOL REV, V22, P203, DOI 10.1093/oxfordjournals.epirev.a018033; DIABETES CARE S1, V26, pS5	64	47	49	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2009	4	12							e8023	10.1371/journal.pone.0008023	http://dx.doi.org/10.1371/journal.pone.0008023			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MU	19956544	Green Published, gold, Green Submitted			2022-12-25	WOS:000272828800005
J	Leitz, J; Kuballa, T; Rehm, J; Lachenmeier, DW				Leitz, Jenny; Kuballa, Thomas; Rehm, Juergen; Lachenmeier, Dirk W.			Chemical Analysis and Risk Assessment of Diethyl Phthalate in Alcoholic Beverages with Special Regard to Unrecorded Alcohol	PLOS ONE			English	Article							HEALTH CONSEQUENCES; ETHYL CARBAMATE; PRODUCTS; QUALITY; CONSUMPTION; TOXICOLOGY; ESTERS; FOOD	Background: Phthalates are synthetic compounds with a widespread field of applications. For example, they are used as plasticizers in PVC plastics and food packaging, or are added to personal care products. Diethyl phthalate (DEP) may be used to denature alcohol, e.g., for cosmetic purposes. Public health concerns of phthalates include carcinogenic, teratogenic, hepatotoxic and endocrine effects. The aim of this study was to develop and validate a method for determining phthalates in alcohol samples and to provide a risk assessment for consumers of such products. Methodology/Principal Findings: A liquid-liquid extraction procedure was optimized by varying the following parameters: type of extraction solvent (cyclohexane, n-hexane, 1,1,2-trichlorotrifluoroethane), the ratio extraction solvent/sample volume (1:1 to 50:1) and the number of extraction repetitions (1-10). The best extraction yield (99.9%) was achieved with the solvent 1,1,2-trichlorotrifluoroethane, an extraction solvent volume/sample volume ratio of 10: 1 and a double extraction. For quantification, gas chromatography/mass spectrometry with deuterated internal standards was used. The investigated samples were alcoholic beverages and unrecorded alcohol products from different countries (n = 257). Two unrecorded alcohol samples from Lithuania contained diethyl phthalate in concentrations of 608 mg/L and 210 mg/L. Conclusions/Significance: The consumption of the phthalate-positive unrecorded alcohols would exceed tolerable daily intakes as derived from animal experiments. Both positive samples were labelled as cosmetic alcohol, but had clearly been offered for human consumption. DEP seems to be unsuitable as a denaturing agent as it has no effect on the organoleptic properties of ethanol. In light of our results that DEP might be consumed by humans in unrecorded alcohols, the prohibition of its use as a denaturing agent should be considered.	[Leitz, Jenny; Kuballa, Thomas; Lachenmeier, Dirk W.] CVUA, Karlsruhe, Germany; [Rehm, Juergen] CAMH, Toronto, ON, Canada; [Rehm, Juergen] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Rehm, Juergen] Tech Univ Dresden, Inst Clin Psychol & Psychotherapy, Dresden, Germany	University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; Technische Universitat Dresden	Leitz, J (corresponding author), CVUA, Karlsruhe, Germany.	lachenmeier@web.de	Rem, Jürgen/H-1309-2011; Lachenmeier, Dirk W/A-3210-2008	Lachenmeier, Dirk W/0000-0002-3115-864X	European Commission Seventh Framework Programme; AMPHORA (Alcohol Measures for Public Health Research Alliance) [223059]; Hospital Clinic de Barcelona	European Commission Seventh Framework Programme(European Commission); AMPHORA (Alcohol Measures for Public Health Research Alliance); Hospital Clinic de Barcelona	The work reported in this manuscript was partially financed by the European Commission Seventh Framework Programme Project AMPHORA (Alcohol Measures for Public Health Research Alliance), project number 223059, granted to the Hospital Clinic de Barcelona (http://www.amphoraproject.net). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anton R, 2005, EFSA J, V3, DOI 10.2903/j.efsa.2005.204/full; Api AM, 2001, FOOD CHEM TOXICOL, V39, P97, DOI 10.1016/S0278-6915(00)00124-1; ATSDR (Agency for Toxic Substances and Disease Registry), 1995, TOX PROF DIETH PHTH; Aurela B, 1999, FOOD ADDIT CONTAM, V16, P571, DOI 10.1080/026520399283713; BROWN D, 1978, FOOD COSMET TOXICOL, V16, P415, DOI 10.1016/S0015-6264(78)80258-2; Chou K, 2006, J MED TOXICOL, V2, P126, DOI 10.1007/BF03161027; Cosmetic Ingredient Review Expert, 2005, INT J TOXICOL, V24, P1, DOI 10.1080/10915810590918625; Del Carlo M, 2008, FOOD CHEM, V111, P771, DOI 10.1016/j.foodchem.2008.04.065; DIN, 1994, 32645 DIN; Ejim O. S., 2007, AFR J DRUG ALCOHOL S, V6, P65; *EUR COUNC, 1993, OFF J EUROP COMM L, V290, P14; Gruber L, 1998, DEUT LEBENSM-RUNDSCH, V94, P177; Heudorf U, 2007, INT J HYG ENVIR HEAL, V210, P623, DOI 10.1016/j.ijheh.2007.07.011; *ISO, 2005, 170252005 ISO IEC; Kanteres F, 2009, SCI TOTAL ENVIRON, V407, P5861, DOI 10.1016/j.scitotenv.2009.08.012; Kanteres F, 2009, ADDICTION, V104, P752, DOI 10.1111/j.1360-0443.2009.02507.x; Kueseng P, 2007, J ENVIRON SCI HEAL B, V42, P569, DOI 10.1080/03601230701389488; Lachenmeier DW, 2007, ALCOHOL CLIN EXP RES, V31, P1613, DOI 10.1111/j.1530-0277.2007.00474.x; Lachenmeier DW, 2009, ALCOHOL CLIN EXP RES, V33, P1757, DOI 10.1111/j.1530-0277.2009.01013.x; Lachenmeier DW, 2009, ADDICTION, V104, P875, DOI 10.1111/j.1360-0443.2009.02587.x; Lachenmeier DW, 2009, DEUT LEBENSM-RUNDSCH, V105, P507; Lachenmeier DW, 2009, INT J ENV RES PUB HE, V6, P2090, DOI 10.3390/ijerph6082090; Lachenmeier DW, 2009, INT J ENV RES PUB HE, V6, P349, DOI 10.3390/ijerph6010349; Lachenmeier DW, 2009, ALCOHOL ALCOHOLISM, V44, P93, DOI 10.1093/alcalc/agn095; LOUPY A, 1986, J ORG CHEM, V51, P740, DOI 10.1021/jo00355a032; Mikula P, 2005, CZECH J FOOD SCI, V23, P217, DOI 10.17221/3394-CJFS; *NTP, 1995, 429 NTP TR US DEP HH; Pfordt J, 2004, DEUT LEBENSM-RUNDSCH, V100, P431; RAPP A, 1994, BRANNTWEINWIRTSCH, V134, P286; Rehm J, 2010, DRUG ALCOHOL REV, V29, P426, DOI 10.1111/j.1465-3362.2009.00140.x; Roth M, 2007, DEUT LEBENSM-RUNDSCH, V103, P45; Savchuk SA, 2006, J ANAL CHEM+, V61, P1198, DOI 10.1134/S1061934806120136; SCHWETLICK K, 2001, ORGANIKUM, P241; Shibko S I, 1973, Environ Health Perspect, V3, P131, DOI 10.2307/3428039; *USEPA, 2003, 84662 CASRN USEPA; WHO, 2003, CONCISE INT CHEM ASS, V52, P1020	36	45	50	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2009	4	12							e8127	10.1371/journal.pone.0008127	http://dx.doi.org/10.1371/journal.pone.0008127			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MU	19956573	Green Submitted, Green Published, gold			2022-12-25	WOS:000272828800020
J	Ravindran, S; Lodoen, MB; Verhelst, SHL; Bogyo, M; Boothroyd, JC				Ravindran, Sandeep; Lodoen, Melissa B.; Verhelst, Steven H. L.; Bogyo, Matthew; Boothroyd, John C.			4-Bromophenacyl Bromide Specifically Inhibits Rhoptry Secretion during Toxoplasma Invasion	PLOS ONE			English	Article							HOST-CELL PENETRATION; GRANULE PROTEIN GRA7; PHOSPHOLIPASE A(2); GONDII; PARASITE; MACROPHAGES; EXPRESSION; VIRULENCE; MUTANTS; FORMS	Toxoplasma gondii is a eukaryotic parasite of the phylum Apicomplexa that is able to infect a wide variety of host cells. During its active invasion process it secretes proteins from discrete secretory organelles: the micronemes, rhoptries and dense granules. Although a number of rhoptry proteins have been shown to be involved in important interactions with the host cell, very little is known about the mechanism of secretion of any Toxoplasma protein into the host cell. We used a chemical inhibitor of phospholipase A2s, 4-bromophenacyl bromide (4-BPB), to look at the role of such lipases in the secretion of Toxoplasma proteins. We found that 4-BPB was a potent inhibitor of rhoptry secretion in Toxoplasma invasion. This drug specifically blocked rhoptry secretion but not microneme secretion, thus effectively showing that the two processes can be de-coupled. It affected parasite motility and invasion, but not attachment or egress. Using propargyl- or azido-derivatives of the drug (so-called click chemistry derivatives) and a series of 4-BPB-resistant mutants, we found that the drug has a very large number of target proteins in the parasite that are involved in at least two key steps: invasion and intracellular growth. This potent compound, the modified "click-chemistry'' forms of it, and the resistant mutants should serve as useful tools to further study the processes of Toxoplasma early invasion, in general, and rhoptry secretion, in particular.	[Ravindran, Sandeep; Lodoen, Melissa B.; Boothroyd, John C.] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Verhelst, Steven H. L.] Tech Univ Munich, Ctr Integrat Prot Sci Munich, D-8050 Freising Weihenstephan, Germany; [Bogyo, Matthew] Stanford Univ, Dept Pathol & Microbiol & Immunol, Stanford, CA 94305 USA	Stanford University; Technical University of Munich; Stanford University	Ravindran, S (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA.	jboothr@stanford.edu		Boothroyd, John C./0000-0001-9719-745X; Bogyo, Matthew/0000-0003-3753-4412; Verhelst, Steven/0000-0002-7400-1319	N.I.H [AI21423, AI078947, RR020843]; Stanford Graduate Fellowship; Giannini Foundation Medical Research Fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020843] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI021423, R01AI021423, R01AI078947] Funding Source: NIH RePORTER	N.I.H(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford Graduate Fellowship(Stanford University); Giannini Foundation Medical Research Fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the N.I.H. (AI21423, AI078947 and RR020843), a Stanford Graduate Fellowship (to S. R.) and an A. P. Giannini Foundation Medical Research Fellowship (to M. B. L). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DL, 2005, PLOS PATHOG, V1, P137, DOI 10.1371/journal.ppat.0010017; Besteiro S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000309; Black MW, 2000, MOL CELL BIOL, V20, P9399, DOI 10.1128/MCB.20.24.9399-9408.2000; Brown WJ, 2003, TRAFFIC, V4, P214, DOI 10.1034/j.1600-0854.2003.00078.x; Burke JE, 2009, CARDIOVASC DRUG THER, V23, P49, DOI 10.1007/s10557-008-6132-9; Carruthers VB, 1999, CELL MICROBIOL, V1, P225, DOI 10.1046/j.1462-5822.1999.00023.x; Carruthers VB, 1999, BIOCHEM J, V342, P379, DOI 10.1042/0264-6021:3420379; Carruthers VB, 1997, EUR J CELL BIOL, V73, P114; Cassaing S, 2000, INT J PARASITOL, V30, P1137, DOI 10.1016/S0020-7519(00)00101-6; Coppens I, 2006, CELL, V125, P261, DOI 10.1016/j.cell.2006.01.056; Dobrowolski JM, 1996, CELL, V84, P933, DOI 10.1016/S0092-8674(00)81071-5; Dunn JD, 2008, INFECT IMMUN, V76, P5853, DOI 10.1128/IAI.01667-07; ENDO T, 1987, J PROTOZOOL, V34, P291, DOI 10.1111/j.1550-7408.1987.tb03177.x; ENDO T, 1982, EXP PARASITOL, V53, P179, DOI 10.1016/0014-4894(82)90059-5; Gilbert LA, 2007, EUKARYOT CELL, V6, P73, DOI 10.1128/EC.00309-06; Hakansson S, 2001, EMBO J, V20, P3132, DOI 10.1093/emboj/20.12.3132; Jacobs D, 1998, MOL BIOCHEM PARASIT, V91, P237, DOI 10.1016/S0166-6851(97)00204-1; Kafsack BFC, 2004, MOL BIOCHEM PARASIT, V136, P309, DOI 10.1016/j.molbiopara.2004.04.004; Kato D, 2005, NAT CHEM BIOL, V1, P33, DOI 10.1038/nchembio707; Kessler H, 2008, J CELL SCI, V121, P947, DOI 10.1242/jcs.022350; Lebrun M, 2005, CELL MICROBIOL, V7, P1823, DOI 10.1111/j.1462-5822.2005.00646.x; LODOEN MB, 2009, CELLULAR MICROBIOLOG; Marin JEG, 1996, CELL IMMUNOL, V169, P218, DOI 10.1006/cimm.1996.0112; Marketon MM, 2005, SCIENCE, V309, P1739, DOI 10.1126/science.1114580; Radke JR, 2000, EXP PARASITOL, V96, P168, DOI 10.1006/expr.2000.4568; ROOS DS, 1994, METHOD CELL BIOL, V45, P27; Saeij JPJ, 2007, NATURE, V445, P324, DOI 10.1038/nature05395; Saeij JPJ, 2006, SCIENCE, V314, P1780, DOI 10.1126/science.1133690; SAFFER LD, 1989, AM J TROP MED HYG, V40, P145, DOI 10.4269/ajtmh.1989.40.145; SAFFER LD, 1991, J PROTOZOOL, V38, P454, DOI 10.1111/j.1550-7408.1991.tb04816.x; Schaloske RH, 2006, BBA-MOL CELL BIOL L, V1761, P1246, DOI 10.1016/j.bbalip.2006.07.011; Speers AE, 2003, J AM CHEM SOC, V125, P4686, DOI 10.1021/ja034490h; Speers AE, 2004, CHEM BIOL, V11, P535, DOI 10.1016/j.chembiol.2004.03.012; Straub KW, 2009, CELL MICROBIOL, V11, P590, DOI 10.1111/j.1462-5822.2008.01276.x; Taylor S, 2006, SCIENCE, V314, P1776, DOI 10.1126/science.1133643; THARDIN JF, 1993, INFECT IMMUN, V61, P1432, DOI 10.1128/IAI.61.4.1432-1441.1993; Zlokarnik G, 1998, SCIENCE, V279, P84, DOI 10.1126/science.279.5347.84	37	28	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2009	4	12							e8143	10.1371/journal.pone.0008143	http://dx.doi.org/10.1371/journal.pone.0008143			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MU	19956582	Green Published, gold			2022-12-25	WOS:000272828800031
J	Kartal, O; Ebenhoh, O				Kartal, Oender; Ebenhoeh, Oliver			Ground State Robustness as an Evolutionary Design Principle in Signaling Networks	PLOS ONE			English	Article							COMPLEX NETWORKS; TRANSDUCTION; MOTIFS; CELL; ORGANIZATION; SPECIFICITY; DATABASE; BIOLOGY; SYSTEMS; DOMAINS	The ability of an organism to survive depends on its capability to adapt to external conditions. In addition to metabolic versatility and efficient replication, reliable signal transduction is essential. As signaling systems are under permanent evolutionary pressure one may assume that their structure reflects certain functional properties. However, despite promising theoretical studies in recent years, the selective forces which shape signaling network topologies in general remain unclear. Here, we propose prevention of autoactivation as one possible evolutionary design principle. A generic framework for continuous kinetic models is used to derive topological implications of demanding a dynamically stable ground state in signaling systems. To this end graph theoretical methods are applied. The index of the underlying digraph is shown to be a key topological property which determines the so-called kinetic ground state (or off-state) robustness. The kinetic robustness depends solely on the composition of the subdigraph with the strongly connected components, which comprise all positive feedbacks in the network. The component with the highest index in the feedback family is shown to dominate the kinetic robustness of the whole network, whereas relative size and girth of these motifs are emphasized as important determinants of the component index. Moreover, depending on topological features, the maintenance of robustness differs when networks are faced with structural perturbations. This structural off-state robustness, defined as the average kinetic robustness of a network's neighborhood, turns out to be useful since some structural features are neutral towards kinetic robustness, but show up to be supporting against structural perturbations. Among these are a low connectivity, a high divergence and a low path sum. All results are tested against real signaling networks obtained from databases. The analysis suggests that ground state robustness may serve as a rationale for some structural peculiarities found in intracellular signaling networks.	[Kartal, Oender; Ebenhoeh, Oliver] Max Planck Inst Mol Plant Physiol, Potsdam, Germany; [Kartal, Oender; Ebenhoeh, Oliver] Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany; [Ebenhoeh, Oliver] Univ Aberdeen, Inst Complex Syst, Aberdeen, Scotland	Max Planck Society; University of Potsdam; University of Aberdeen	Kartal, O (corresponding author), Max Planck Inst Mol Plant Physiol, Potsdam, Germany.	kartal@mpimp-golm.mpg.de	Ebenhoeh, Oliver/C-8974-2011	Ebenhoeh, Oliver/0000-0002-7229-7398; Kartal, Onder/0000-0002-4203-9662	Scottish Funding Council; Scottish Universities Life Science Alliance (SULSA)	Scottish Funding Council; Scottish Universities Life Science Alliance (SULSA)	German Ministry of Education and Research (BMBF), GoFORSYS research initiative. Funding provided by the Scottish Funding Council, Scottish Universities Life Science Alliance (SULSA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; ALON N, 1995, J ASSOC COMPUT MACH, V42, P844, DOI 10.1145/210332.210337; Alon U, 1999, NATURE, V397, P168, DOI 10.1038/16483; BANGJENSEN J, 2001, DIGRAPHS THEORY ALGO; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; Bhattacharyya RP, 2006, ANNU REV BIOCHEM, V75, P655, DOI 10.1146/annurev.biochem.75.103004.142710; Binder Bernd, 2005, Genome Inform, V16, P164; Binder Bernd, 2004, Genome Inform, V15, P13; Brualdi R., 1982, LINEAR MULTILINEAR A, V11, P143, DOI DOI 10.1080/03081088208817439; CAMBIER JC, SCI SIGNAL; Choi C, 2004, COMP FUNCT GENOM, V5, P163, DOI 10.1002/cfg.386; COOPER CDH, 1973, MATH Z, V131, P213, DOI 10.1007/BF01187238; Cvetkovic DM, 1995, SPECTRA GRAPHS; Ebenhoh O, 2003, B MATH BIOL, V65, P323, DOI 10.1016/S0092-8240(03)00002-8; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Friedman A, 2007, CELL, V128, P225, DOI 10.1016/j.cell.2007.01.007; GLEICH DF, MATLAB BGL 4 0; GOMPERTS BD, 2002, SIGNAL TRANSDUCTION; Gough NR, 2002, ANN NY ACAD SCI, V971, P585, DOI 10.1111/j.1749-6632.2002.tb04532.x; Hammerstein Peter, 2006, Biological Theory, V1, P90, DOI 10.1162/biot.2006.1.1.90; Heinrich R, 2002, MOL CELL, V9, P957, DOI 10.1016/S1097-2765(02)00528-2; Horn RA, 1999, MATRIX ANAL; HORVATH CM, SCI SIGNAL; Kirschner M, 1998, P NATL ACAD SCI USA, V95, P8420, DOI 10.1073/pnas.95.15.8420; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; KOBILKA BK, SCI SIGNAL; Kollmann M, 2005, NATURE, V438, P504, DOI 10.1038/nature04228; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; MISHRA L, SCI SIGNAL; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Piao XH, 1996, P NATL ACAD SCI USA, V93, P14665, DOI 10.1073/pnas.93.25.14665; Prill RJ, 2005, PLOS BIOL, V3, P1881, DOI 10.1371/journal.pbio.0030343; Shinar G, 2007, P NATL ACAD SCI USA, V104, P19931, DOI 10.1073/pnas.0706792104; SONGYANG Z, 1995, NATURE, V373, P536, DOI 10.1038/373536a0; Soyer OS, 2006, J THEOR BIOL, V238, P416, DOI 10.1016/j.jtbi.2005.05.030; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; Wagner A, 2004, ADV COMPLEX SYST, V7, P419, DOI 10.1142/S0219525904000251; Wagner A, 2003, P ROY SOC B-BIOL SCI, V270, P457, DOI 10.1098/rspb.2002.2269; WAGNER A, 2003, SCI STKE, pPE41; Wagner A., 2005, ROBUSTNESS EVOLVABIL; Wagner A, 2008, NAT REV GENET, V9, P965, DOI 10.1038/nrg2473; Zhang XD, 2002, ACTA MATH SIN, V18, P293, DOI 10.1007/s101140200157	44	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2009	4	12							e8001	10.1371/journal.pone.0008001	http://dx.doi.org/10.1371/journal.pone.0008001			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MT	19956601	Green Published, Green Submitted, gold			2022-12-25	WOS:000272828700004
J	Kalantzis, G; Shouval, HZ				Kalantzis, Georgios; Shouval, Harel Z.			Structural Plasticity Can Produce Metaplasticity	PLOS ONE			English	Article							LONG-TERM POTENTIATION; TIMING-DEPENDENT PLASTICITY; DENDRITIC SPINES; SYNAPTIC PLASTICITY; BIOPHYSICAL MODEL; GLUTAMATE RECEPTORS; HIPPOCAMPAL-NEURONS; CALCIUM DYNAMICS; CA2+; LTP	Background: Synaptic plasticity underlies many aspect of learning memory and development. The properties of synaptic plasticity can change as a function of previous plasticity and previous activation of synapses, a phenomenon called metaplasticity. Synaptic plasticity not only changes the functional connectivity between neurons but in some cases produces a structural change in synaptic spines; a change thought to form a basis for this observed plasticity. Here we examine to what extent structural plasticity of spines can be a cause for metaplasticity. This study is motivated by the observation that structural changes in spines are likely to affect the calcium dynamics in spines. Since calcium dynamics determine the sign and magnitude of synaptic plasticity, it is likely that structural plasticity will alter the properties of synaptic plasticity. Methodology/Principal Findings: In this study we address the question how spine geometry and alterations of N-methyl-D-aspartic acid (NMDA) receptors conductance may affect plasticity. Based on a simplified model of the spine in combination with a calcium-dependent plasticity rule, we demonstrated that after the induction phase of plasticity a shift of the long term potentiation (LTP) or long term depression (LTD) threshold takes place. This induces a refractory period for further LTP induction and promotes depotentiation as observed experimentally. That resembles the BCM metaplasticity rule but specific for the individual synapse. In the second phase, alteration of the NMDA response may bring the synapse to a state such that further synaptic weight alterations are feasible. We show that if the enhancement of the NMDA response is proportional to the area of the post synaptic density (PSD) the plasticity curves most likely return to the initial state. Conclusions/Significance: Using simulations of calcium dynamics in synaptic spines, coupled with a biophysically motivated calcium-dependent plasticity rule, we find under what conditions structural plasticity can form the basis of synapse specific metaplasticity.	[Kalantzis, Georgios; Shouval, Harel Z.] Univ Texas Med Sch Houston, Dept Neurobiol & Anat, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Kalantzis, G (corresponding author), Univ Texas Med Sch Houston, Dept Neurobiol & Anat, Houston, TX 77030 USA.	kalantzi@bcm.edu; harel.shouval@uth.tmc.edu			National Institute of Health [2 P01-NS038310-06A2]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS038310] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by grant 2 P01-NS038310-06A2 from the National Institute of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarbanel HDI, 2003, BIOL CYBERN, V89, P214, DOI 10.1007/s00422-003-0422-x; Abraham WC, 1996, TRENDS NEUROSCI, V19, P126, DOI 10.1016/S0166-2236(96)80018-X; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; BLISS TVP, 1990, SCIENCE, V249, P973, DOI 10.1126/science.2396098; Castellani GC, 2001, P NATL ACAD SCI USA, V98, P12772, DOI 10.1073/pnas.201404598; Chevaleyre V, 2004, NEURON, V43, P871, DOI 10.1016/j.neuron.2004.08.036; Cheyne JE, 2008, MOL CELL NEUROSCI, V37, P432, DOI 10.1016/j.mcn.2007.10.015; Cummings JA, 1996, NEURON, V16, P825, DOI 10.1016/S0896-6273(00)80102-6; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Erreger K, 2005, J PHYSIOL-LONDON, V563, P345, DOI 10.1113/jphysiol.2004.080028; FIFKOVA E, 1977, J NEUROCYTOL, V6, P211, DOI 10.1007/BF01261506; FIFKOVA E, 1981, EXP NEUROL, V74, P621, DOI 10.1016/0014-4886(81)90197-7; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; GOLD JI, 1994, P NATL ACAD SCI USA, V91, P3941, DOI 10.1073/pnas.91.9.3941; Halpain S, 1998, J NEUROSCI, V18, P9835; HARRIS KM, 1989, J NEUROSCI, V9, P2982; Holcman D, 2004, BIOPHYS J, V87, P81, DOI 10.1529/biophysj.103.035972; HOLMES WR, 1990, J NEUROPHYSIOL, V63, P1148, DOI 10.1152/jn.1990.63.5.1148; Holtmaat A, 2006, NATURE, V441, P979, DOI 10.1038/nature04783; Ichikawa K, 2005, NEUROINFORMATICS, V3, P49, DOI 10.1385/NI:3:1:049; JAHR CE, 1990, J NEUROSCI, V10, P3178; Karmarkar UR, 2002, J NEUROPHYSIOL, V88, P507, DOI 10.1152/jn.2002.88.1.507; Keller DX, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002045; Kim CH, 1999, J NEUROSCI, V19, P4314; Korkotian E, 1999, NEUROREPORT, V10, P2875, DOI 10.1097/00001756-199909090-00032; Krucker T, 2000, P NATL ACAD SCI USA, V97, P6856, DOI 10.1073/pnas.100139797; Mainen ZF, 1999, METHODS, V18, P231, DOI 10.1006/meth.1999.0776; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Martin SJ, 2002, HIPPOCAMPUS, V12, P609, DOI 10.1002/hipo.10107; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Nishiyama M, 2000, NATURE, V408, P584, DOI 10.1038/35046067; Noguchi J, 2005, NEURON, V46, P609, DOI 10.1016/j.neuron.2005.03.015; Ostroff LE, 2002, NEURON, V35, P535, DOI 10.1016/S0896-6273(02)00785-7; Pavlov I, 2004, EUR J NEUROSCI, V20, P3019, DOI 10.1111/j.1460-9568.2004.03806.x; Racca C, 2000, J NEUROSCI, V20, P2512; Schuman EM, 2006, J NEUROSCI, V26, P7143, DOI 10.1523/JNEUROSCI.1796-06.2006; SEGAL M, 1995, NEUROSCI LETT, V193, P73, DOI 10.1016/0304-3940(95)11665-J; Shouval HZ, 2005, J NEUROPHYSIOL, V93, P1069, DOI 10.1152/jn.00504.2004; Shouval HZ, 2002, BIOL CYBERN, V87, P383, DOI 10.1007/s00422-002-0362-x; Shouval HZ, 2002, P NATL ACAD SCI USA, V99, P10831, DOI 10.1073/pnas.152343099; Sorra KE, 1998, J NEUROSCI, V18, P658; Takumi Y, 1999, ANN NY ACAD SCI, V868, P474, DOI 10.1111/j.1749-6632.1999.tb11316.x; Tanaka JI, 2008, SCIENCE, V319, P1683, DOI 10.1126/science.1152864; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Volfovsky N, 1999, J NEUROPHYSIOL, V82, P450, DOI 10.1152/jn.1999.82.1.450; Watt AJ, 2004, NAT NEUROSCI, V7, P518, DOI 10.1038/nn1220; Wittenberg GM, 2006, J NEUROSCI, V26, P6610, DOI 10.1523/JNEUROSCI.5388-05.2006; Yang SN, 1999, J NEUROPHYSIOL, V81, P781, DOI 10.1152/jn.1999.81.2.781; Yeung LC, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.011907; Yeung LC, 2004, P NATL ACAD SCI USA, V101, P14943, DOI 10.1073/pnas.0405555101; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011; Zuo Y, 2005, NEURON, V46, P181, DOI 10.1016/j.neuron.2005.04.001	54	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2009	4	11							e8062	10.1371/journal.pone.0008062	http://dx.doi.org/10.1371/journal.pone.0008062			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MQ	19956610	Green Submitted, Green Published, gold			2022-12-25	WOS:000272828400016
J	Walshe, VA; Hattotuwagama, CK; Doytchinova, IA; Wong, M; Macdonald, IK; Mulder, A; Claas, FHJ; Pellegrino, P; Turner, J; Williams, I; Turnbull, EL; Borrow, P; Flower, DR				Walshe, Valerie A.; Hattotuwagama, Channa K.; Doytchinova, Irini A.; Wong, MaiLee; Macdonald, Isabel K.; Mulder, Arend; Claas, Frans H. J.; Pellegrino, Pierre; Turner, Jo; Williams, Ian; Turnbull, Emma L.; Borrow, Persephone; Flower, Darren R.			Integrating In Silico and In Vitro Analysis of Peptide Binding Affinity to HLA-Cw*0102: A Bioinformatic Approach to the Prediction of New Epitopes	PLOS ONE			English	Article							T-CELL RESPONSES; MHC BINDING; HLA-C; MOLECULE HLA-A-ASTERISK-0201; QUANTITATIVE PREDICTION; HIV-1 INFECTION; RECOGNITION; DIVERSITY; VIRUS; IDENTIFICATION	Background: Predictive models of peptide-Major Histocompatibility Complex (MHC) binding affinity are important components of modern computational immunovaccinology. Here, we describe the development and deployment of a reliable peptide-binding prediction method for a previously poorly-characterized human MHC class I allele, HLA-Cw*0102. Methodology/Findings: Using an in-house, flow cytometry-based MHC stabilization assay we generated novel peptide binding data, from which we derived a precise two-dimensional quantitative structure-activity relationship (2D-QSAR) binding model. This allowed us to explore the peptide specificity of HLA-Cw*0102 molecule in detail. We used this model to design peptides optimized for HLA-Cw*0102-binding. Experimental analysis showed these peptides to have high binding affinities for the HLA-Cw*0102 molecule. As a functional validation of our approach, we also predicted HLA-Cw*0102-binding peptides within the HIV-1 genome, identifying a set of potent binding peptides. The most affine of these binding peptides was subsequently determined to be an epitope recognized in a subset of HLA-Cw*0102-positive individuals chronically infected with HIV-1. Conclusions/Significance: A functionally-validated in silico-in vitro approach to the reliable and efficient prediction of peptide binding to a previously uncharacterized human MHC allele HLA-Cw*0102 was developed. This technique is generally applicable to all T cell epitope identification problems in immunology and vaccinology.	[Walshe, Valerie A.; Hattotuwagama, Channa K.; Doytchinova, Irini A.; Wong, MaiLee; Macdonald, Isabel K.; Turnbull, Emma L.; Borrow, Persephone; Flower, Darren R.] Univ Oxford, Jenner Inst, Compton, Berks, England; [Mulder, Arend; Claas, Frans H. J.] Leiden Univ, Med Ctr, Dept Immunohaematol & Blood Transfus, Leiden, Netherlands; [Pellegrino, Pierre; Turner, Jo; Williams, Ian] Royal Free & Univ Coll London, Sch Med, Ctr Sexual Hlth & HIV Res, London, England; [Pellegrino, Pierre; Turner, Jo; Williams, Ian] Camden Primary Care Trust, London, England	University of Oxford; Jenner Institute; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of London; University College London; UCL Medical School	Walshe, VA (corresponding author), Hlth Protect Agcy, Ctr Emergency Preparedness & Response, Salisbury, Wilts, England.	darren.flower@jenner.ac.uk	Doytchinova, Irini/A-2949-2011; Flower, Darren/F-1263-2010; Doytchinova, Irini/ABG-3962-2020	Flower, Darren/0000-0002-8542-7067; Doytchinova, Irini/0000-0002-1469-1768; Borrow, Persephone/0000-0002-3877-9780	Biotechnology and Biological Sciences Research Council SRC [BB/D004020/1]; Grand Challenges in Global Health Program of the Bill and Melinda Gates Foundation [37384]; Edward Jenner Institute for Vaccine Research (EJIVR); Wellcome Trust [WT079287MA]; BBSRC [BB/D004020/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D004020/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council SRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Grand Challenges in Global Health Program of the Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Edward Jenner Institute for Vaccine Research (EJIVR); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council SRC Grant BB/D004020/1 and the Grand Challenges in Global Health Program of the Bill and Melinda Gates Foundation (# 37384). No part of the work was supported by the University of Oxford. Early stages of the work were funded by The Edward Jenner Institute for Vaccine Research (EJIVR). The Edward Jenner Institute for Vaccine Research thanks its erstwhile charitable sponsors: the Medical Research Council, the Biotechnology and Biological Sciences Research Council, the Department of Health, and GlaxoSmithKline. These funding bodies had no role of any kind in study design, data collection and analysis, the decision to publish, or the preparation of the manuscript. GlaxoSmithKline did not directly fund the work described here, but did make an indirect charitable donation to the core funding of the EJIVR. PB and DRF received salary support from Senior Jenner Fellowships, and are both Jenner Institute Investigators. IKM and DRF drew additional support from the Wellcome Trust Grant WT079287MA.	Altfeld M, 2007, NAT GENET, V39, P708, DOI 10.1038/ng0607-708; Andersen MH, 1999, TISSUE ANTIGENS, V54, P185, DOI 10.1034/j.1399-0039.1999.540210.x; Barber LD, 1996, J EXP MED, V184, P735, DOI 10.1084/jem.184.2.735; Barouch DH, 2008, NATURE, V455, P613, DOI 10.1038/nature07352; Bashirova AA, 2006, ANNU REV GENOM HUM G, V7, P277, DOI 10.1146/annurev.genom.7.080505.115726; Blythe MJ, 2002, BIOINFORMATICS, V18, P434, DOI 10.1093/bioinformatics/18.3.434; Boyington JC, 2002, MOL IMMUNOL, V38, P1007, DOI 10.1016/S0161-5890(02)00030-5; Brooks A G, 2000, Rev Immunogenet, V2, P433; Calderone CT, 2001, J AM CHEM SOC, V123, P6262, DOI 10.1021/ja003016y; Cao J, 2008, J VIROL, V82, P495, DOI 10.1128/JVI.01096-07; Davies MN, 2006, BMC STRUCT BIOL, V6, DOI 10.1186/1472-6807-6-5; Doytchinova IA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-131; Doytchinova IA, 2005, J IMMUNOL, V174, P7085, DOI 10.4049/jimmunol.174.11.7085; Doytchinova IA, 2004, METHODS, V34, P444, DOI 10.1016/j.ymeth.2004.06.007; Doytchinova IA, 2004, J IMMUNOL, V172, P4314, DOI 10.4049/jimmunol.172.7.4314; Doytchinova IA, 2004, J IMMUNOL, V172, P7495, DOI 10.4049/jimmunol.172.12.7495; Doytchinova IA, 2003, BIOINFORMATICS, V19, P2263, DOI 10.1093/bioinformatics/btg312; Doytchinova IA, 2002, J PROTEOME RES, V1, P263, DOI 10.1021/pr015513z; Doytchinova IA, 2001, J MED CHEM, V44, P3572, DOI 10.1021/jm010021j; Doytchinova IA, 2006, MOL IMMUNOL, V43, P2037, DOI 10.1016/j.molimm.2005.12.013; Doytchinova IA, 2007, J CHEM INF MODEL, V47, P234, DOI 10.1021/ci600318z; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Flower DR, 1998, J MOL GRAPH MODEL, V16, P239, DOI 10.1016/S1093-3263(98)80008-9; Goulder PJR, 2008, NAT REV IMMUNOL, V8, P619, DOI 10.1038/nri2357; Goulder PJR, 1997, AIDS, V11, P1884, DOI 10.1097/00002030-199715000-00016; Goulder PJR, 2001, J EXP MED, V193, P181, DOI 10.1084/jem.193.2.181; Guan PP, 2003, NUCLEIC ACIDS RES, V31, P3621, DOI 10.1093/nar/gkg510; Guan PP, 2003, PROTEIN ENG, V16, P11, DOI 10.1093/proeng/gzg005; Harndahl M, 2009, J BIOMOL SCREEN, V14, P173, DOI 10.1177/1087057108329453; Hattotuwagama CK, 2004, ORG BIOMOL CHEM, V2, P3274, DOI 10.1039/b409656h; Hauptmann G, 2004, CURR OPIN IMMUNOL, V16, P668, DOI 10.1016/j.coi.2004.07.001; Heinonen KM, 2008, CRIT REV IMMUNOL, V28, P441, DOI 10.1615/CritRevImmunol.v28.i5.40; Hoof I, 2009, IMMUNOGENETICS, V61, P1, DOI 10.1007/s00251-008-0341-z; Jensen PE, 2007, NAT IMMUNOL, V8, P1041, DOI 10.1038/ni1516; Kiepiela P, 2004, NATURE, V432, P769, DOI 10.1038/nature03113; Knapp B, 2009, J COMPUT AID MOL DES, V23, P301, DOI 10.1007/s10822-009-9259-2; Korber B, 2006, PLOS COMPUT BIOL, V2, P484, DOI 10.1371/journal.pcbi.0020071; KORBER BTM, 2007, LAUR074752 LOS AL NA; Liu Y, 2006, J VIROL, V80, P9519, DOI 10.1128/JVI.00575-06; Lopes AR, 2003, J IMMUNOL, V171, P307, DOI 10.4049/jimmunol.171.1.307; Lundegaard C, 2008, BIOINFORMATICS, V24, P1397, DOI 10.1093/bioinformatics/btn128; Lundegaard C, 2008, NUCLEIC ACIDS RES, V36, pW509, DOI 10.1093/nar/gkn202; McSparron H, 2003, J CHEM INF COMP SCI, V43, P1276, DOI 10.1021/ci030461e; Mulder A, 1998, TISSUE ANTIGENS, V52, P393, DOI 10.1111/j.1399-0039.1998.tb03062.x; Mullins JI, 2006, CURR TOP MICROBIOL, V299, P171; Rao XY, 2009, J IMMUNOL, V182, P1526, DOI 10.4049/jimmunol.182.3.1526; RUPPERT J, 1993, CELL, V74, P929, DOI 10.1016/0092-8674(93)90472-3; Schuler Mathias M., 2007, V409, P75; SNARY D, 1977, EUR J IMMUNOL, V7, P580, DOI 10.1002/eji.1830070816; Streeck H, 2008, J EXP MED, V205, P1789, DOI 10.1084/jem.20080281; STUBER G, 1992, EUR J IMMUNOL, V22, P2697, DOI 10.1002/eji.1830221033; Thananchai H, 2009, AIDS, V23, P189, DOI 10.1097/QAD.0b013e32831fb55a; Tong Joo Chuan, 2007, Immunome Res, V3, P7, DOI 10.1186/1745-7580-3-7; Toseland Christopher P, 2005, Immunome Res, V1, P4, DOI 10.1186/1745-7580-1-4; *TRIP INC, SYBYL6 9; Turnbull EL, 2009, J IMMUNOL, V182, P7131, DOI 10.4049/jimmunol.0803658; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Walker BD, 2008, SCIENCE, V320, P760, DOI 10.1126/science.1152622; Wan SZ, 2005, J IMMUNOL, V175, P1715, DOI 10.4049/jimmunol.175.3.1715; Willett P, 1995, TRENDS BIOTECHNOL, V13, P516, DOI 10.1016/S0167-7799(00)89015-0; Wilson I A, 1993, Semin Immunol, V5, P75, DOI 10.1006/smim.1993.1011; Yokoyama WM, 2005, IMMUNOL RES, V32, P317, DOI 10.1385/IR:32:1-3:317; Zhang H, 2009, BIOINFORMATICS, V25, P83, DOI 10.1093/bioinformatics/btn579	64	16	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2009	4	11							e8095	10.1371/journal.pone.0008095	http://dx.doi.org/10.1371/journal.pone.0008095			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MQ	19956609	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000272828400031
J	Protopopoff, N; Van Bortel, W; Speybroeck, N; Van Geertruyden, JP; Baza, D; D'Alessandro, U; Coosemans, M				Protopopoff, Natacha; Van Bortel, Wim; Speybroeck, Niko; Van Geertruyden, Jean-Pierre; Baza, Dismas; D'Alessandro, Umberto; Coosemans, Marc			Ranking Malaria Risk Factors to Guide Malaria Control Efforts in African Highlands	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; TARGETED VECTOR CONTROL; PUBLIC-HEALTH IMPACT; ANOPHELES-GAMBIAE; CLIMATE-CHANGE; WESTERN KENYA; ENVIRONMENTAL-MANAGEMENT; USAMBARA MOUNTAINS; LAND-COVER; SPATIAL-DISTRIBUTION	Introduction: Malaria is re-emerging in most of the African highlands exposing the non immune population to deadly epidemics. A better understanding of the factors impacting transmission in the highlands is crucial to improve well targeted malaria control strategies. Methods and Findings: A conceptual model of potential malaria risk factors in the highlands was built based on the available literature. Furthermore, the relative importance of these factors on malaria can be estimated through "classification and regression trees'', an unexploited statistical method in the malaria field. This CART method was used to analyse the malaria risk factors in the Burundi highlands. The results showed that Anopheles density was the best predictor for high malaria prevalence. Then lower rainfall, no vector control, higher minimum temperature and houses near breeding sites were associated by order of importance to higher Anopheles density. Conclusions: In Burundi highlands monitoring Anopheles densities when rainfall is low may be able to predict epidemics. The conceptual model combined with the CART analysis is a decision support tool that could provide an important contribution toward the prevention and control of malaria by identifying major risk factors.	[Protopopoff, Natacha; Van Bortel, Wim; Van Geertruyden, Jean-Pierre; D'Alessandro, Umberto; Coosemans, Marc] Inst Trop Med Prince Leopold, Dept Parasitol, B-2000 Antwerp, Belgium; [Protopopoff, Natacha] Med Sans Frontieres Belgium, Brussels, Belgium; [Speybroeck, Niko] Inst Trop Med Prince Leopold, Dept Anim Hlth, B-2000 Antwerp, Belgium; [Speybroeck, Niko] Catholic Univ Louvain, Sch Publ Hlth, B-1200 Brussels, Belgium; [Baza, Dismas] Minist Hlth, Programme Lutte Malad Transmissibles & Carentiell, Bujumbura, Burundi; [Coosemans, Marc] Univ Antwerp, Fac Pharmaceut Vet & Biomed Sci, Dept Biomed Sci, B-2020 Antwerp, Belgium	Institute of Tropical Medicine (ITM); Institute of Tropical Medicine (ITM); Universite Catholique Louvain; University of Antwerp	Protopopoff, N (corresponding author), Inst Trop Med Prince Leopold, Dept Parasitol, B-2000 Antwerp, Belgium.	nprotopopoff@itg.be	D'Alessandro, Umberto/D-3457-2015; Van geertruyden, Jean-Pierre/S-3254-2019; Van geertruyden, Jean-Pierre/K-6425-2014; Van Bortel, Wim/AFV-4687-2022; Van Bortel, Wim/AAU-5948-2021	D'Alessandro, Umberto/0000-0001-6341-5009; Van geertruyden, Jean-Pierre/0000-0001-5006-6364; Van geertruyden, Jean-Pierre/0000-0001-5006-6364; Van Bortel, Wim/0000-0002-6644-518X; Speybroeck, Niko/0000-0003-3322-3502; Protopopoff, Natacha/0000-0001-6698-4936	MSF-Belgium; Belgian co-operation	MSF-Belgium; Belgian co-operation	This work was funded by MSF-Belgium and the Belgian co-operation. MSF Belgium has a role in the study design, data collection and analysis, decision to publish and preparation of the manuscript. The Belgian cooperation has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeku TA, 2003, ACTA TROP, V87, P331, DOI 10.1016/S0001-706X(03)00123-2; Abeku TA, 2007, EMERG INFECT DIS, V13, P681, DOI 10.3201/eid1305.061333; Afrane YA, 2005, J MED ENTOMOL, V42, P974, DOI 10.1603/0022-2585(2005)042[0974:EOMCCB]2.0.CO;2; AULT SK, 1994, AM J TROP MED HYG, V50, P35, DOI 10.4269/ajtmh.1994.50.35; Balls MJ, 2004, T ROY SOC TROP MED H, V98, P400, DOI 10.1016/j.trstmh.2003.11.005; Barnes KI, 2005, PLOS MED, V2, P1123, DOI 10.1371/journal.pmed.0020330; Bayoh MN, 2004, MED VET ENTOMOL, V18, P174, DOI 10.1111/j.0269-283X.2004.00495.x; Bjorkman AB, 2005, ACTA TROP, V94, P163, DOI 10.1016/j.actatropica.2005.04.015; Bodker R, 2003, J MED ENTOMOL, V40, P706, DOI 10.1603/0022-2585-40.5.706; Bodker R, 2000, GLOBAL CHANGE HUMAN, V1, P134, DOI DOI 10.1023/A:1010077105257; Bodker R, 2006, AM J TROP MED HYG, V74, P716; Bonora S, 2001, TRENDS PARASITOL, V17, P572, DOI 10.1016/S1471-4922(01)02095-5; Bousema JT, 2003, TROP MED INT HEALTH, V8, P427, DOI 10.1046/j.1365-3156.2003.01047.x; Breiman L, 1993, CLASSIFICATION REGRE; Carlson JC, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-33; COOSEMANS MH, 1985, ANN SOC BELG MED TR, V65, P187; Craig MH, 2004, TROP MED INT HEALTH, V9, P1258, DOI 10.1111/j.1365-3156.2004.01341.x; Curtis C. F., 2003, Journal of Vector Borne Diseases, V40, P1; Deressa W, 2007, T ROY SOC TROP MED H, V101, P939, DOI 10.1016/j.trstmh.2007.04.018; Elghazali G, 2003, East Mediterr Health J, V9, P570; FONTAINE RE, 1961, AM J TROP MED HYG, V10, P795, DOI 10.4269/ajtmh.1961.10.795; GAMAGEMENDIS AC, 1991, AM J TROP MED HYG, V45, P77, DOI 10.4269/ajtmh.1991.45.77; GARNHAM PCC, 1945, BRIT MED J, V2, P45, DOI 10.1136/bmj.2.4410.45; GARNHAM PCC, 1948, TROP MED HYG, V51, P156; Gaudart Jean, 2005, BMC Med Res Methodol, V5, P22, DOI 10.1186/1471-2288-5-22; Ghebreyesus TA, 2000, T ROY SOC TROP MED H, V94, P17, DOI 10.1016/S0035-9203(00)90424-3; Gomez-Elipe A, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-129; Hargreaves K, 2000, MED VET ENTOMOL, V14, P181, DOI 10.1046/j.1365-2915.2000.00234.x; Hay SI, 2002, EMERG INFECT DIS, V8, P543, DOI 10.3201/eid0806.010309; Hay SI, 2002, TRENDS PARASITOL, V18, P530, DOI 10.1016/S1471-4922(02)02374-7; Hay SI, 2002, NATURE, V415, P905, DOI 10.1038/415905a; Hay SI, 2004, LANCET INFECT DIS, V4, P327, DOI 10.1016/S1473-3099(04)01043-6; HELD TK, 1994, Q J MED, V87, P17; Ijumba JN, 2001, MED VET ENTOMOL, V15, P1, DOI 10.1046/j.1365-2915.2001.00279.x; KHAEMBA BM, 1994, E AFR MED J, V71, P159; Kilian AHD, 1999, T ROY SOC TROP MED H, V93, P22, DOI 10.1016/S0035-9203(99)90165-7; Killeen GF, 2004, AM J TROP MED HYG, V71, P87, DOI 10.4269/ajtmh.2004.71.2_suppl.0700087; Koenraadt CJM, 2006, TROP MED INT HEALTH, V11, P1195, DOI 10.1111/j.1365-3156.2006.01675.x; Lindblade KA, 2000, J MED ENTOMOL, V37, P664, DOI 10.1603/0022-2585-37.5.664; Lindblade KA, 2000, TROP MED INT HEALTH, V5, P263, DOI 10.1046/j.1365-3156.2000.00551.x; Lindblade KA, 1999, T ROY SOC TROP MED H, V93, P480, DOI 10.1016/S0035-9203(99)90344-9; Lindsay SW, 1998, B WORLD HEALTH ORGAN, V76, P33; LINDSAY SW, 1991, MED VET ENTOMOL, V5, P477, DOI 10.1111/j.1365-2915.1991.tb00576.x; Lindsay SW, 2000, LANCET, V355, P989, DOI 10.1016/S0140-6736(00)90022-9; LOEVINSOHN ME, 1994, LANCET, V343, P714, DOI 10.1016/S0140-6736(94)91586-5; Macdonald G., 1957, EPIDEMIOLOGY CONTROL; Malakooti MA, 1998, EMERG INFECT DIS, V4, P671, DOI 10.3201/eid0404.980422; Martens P, 2000, EMERG INFECT DIS, V6, P103, DOI 10.3201/eid0602.000202; MARTENS WJM, 1995, ENVIRON HEALTH PERSP, V103, P458, DOI 10.2307/3432584; Massaga JJ, 2003, LANCET, V361, P1853, DOI 10.1016/S0140-6736(03)13504-0; Mathenge EM, 2001, J MED ENTOMOL, V38, P531, DOI 10.1603/0022-2585-38.4.531; MCCARTHY FD, 2000, NBER WORKING PAPERS, V7541; MENENDEZ C, 1995, PARASITOL TODAY, V11, P178, DOI 10.1016/0169-4758(95)80151-0; Minakawa N, 2002, J MED ENTOMOL, V39, P833, DOI 10.1603/0022-2585-39.6.833; Minakawa N, 2005, AM J TROP MED HYG, V73, P157, DOI 10.4269/ajtmh.2005.73.157; Minakawa N, 2004, MED VET ENTOMOL, V18, P301, DOI 10.1111/j.0269-283X.2004.00503.x; Moffett A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000824; Mouchet J, 1998, J AM MOSQUITO CONTR, V14, P121; Mouchet J, 1997, B SOC PATHOL EXOT, V90, P162; Munga S, 2006, AM J TROP MED HYG, V74, P69, DOI 10.4269/ajtmh.2006.74.69; Negash K, 2005, East Afr Med J, V82, P186; Nosten F, 2000, LANCET, V356, P297, DOI 10.1016/S0140-6736(00)02505-8; Paaijmans KP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001146; Pascual M, 2006, P NATL ACAD SCI USA, V103, P5829, DOI 10.1073/pnas.0508929103; Patz JA, 2002, NATURE, V420, P627, DOI 10.1038/420627a; Protopopoff N, 2008, TROP MED INT HEALTH, V13, P1479, DOI 10.1111/j.1365-3156.2008.02164.x; Protopopoff N, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-93; Protopopoff N, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-158; Protopopoff N, 2008, AM J TROP MED HYG, V79, P12, DOI 10.4269/ajtmh.2008.79.12; Rogers DJ, 2000, SCIENCE, V289, P1763, DOI 10.1126/science.289.5485.1763; Saegerman C, 2004, J CLIN MICROBIOL, V42, P172, DOI 10.1128/JCM.42.1.172-178.2004; Schwetz J., 1948, Acta Tropica Basle, V5, P78; Seyoum A, 2002, East Afr Med J, V79, P485; Shankar AH, 2000, J INFECT DIS, V182, pS37, DOI 10.1086/315906; Shanks GD, 2000, T ROY SOC TROP MED H, V94, P253, DOI 10.1016/S0035-9203(00)90310-9; Shanks GD, 2002, EMERG INFECT DIS, V8, P1404, DOI 10.3201/eid0812.020077; Sharp BL, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-52; Shiff C, 2002, CLIN MICROBIOL REV, V15, P278, DOI 10.1128/CMR.15.2.278-293.2002; Sissoko MS, 2004, ACTA TROP, V89, P161, DOI 10.1016/j.actatropica.2003.10.015; Small J, 2003, P NATL ACAD SCI USA, V100, P15341, DOI 10.1073/pnas.2236969100; Sowunmi A, 2003, TROP MED INT HEALTH, V8, P783, DOI 10.1046/j.1365-3156.2003.01093.x; Speybroeck N, 2004, AGR SYST, V80, P133, DOI 10.1016/j.agsy.2003.06.006; STEVENS PA, 1984, B WORLD HEALTH ORGAN, V62, P77; Tanser FC, 2003, LANCET, V362, P1792, DOI 10.1016/S0140-6736(03)14898-2; Teklehaimanot HD, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-41; Thang ND, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-28; Thomas CJ, 2004, TRENDS PARASITOL, V20, P216, DOI 10.1016/j.pt.2004.03.001; Trape JF, 2001, AM J TROP MED HYG, V64, P12, DOI 10.4269/ajtmh.2001.64.12; Utzinger J, 2001, TROP MED INT HEALTH, V6, P677, DOI 10.1046/j.1365-3156.2001.00769.x; van Eijk AM, 2004, TROP MED INT HEALTH, V9, P351, DOI 10.1111/j.1365-3156.2004.01196.x; Van Geertruyden JP, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-134; Walker K, 2007, MED VET ENTOMOL, V21, P2, DOI 10.1111/j.1365-2915.2007.00674.x; Warrell DA, 2002, ESSENTIAL MALARIOLOG; WHO, 2000, AB DECL PLAN ACT EXT; WHO, 2006, AFR MAL REP 2006; Yohannes M, 2005, TROP MED INT HEALTH, V10, P1274, DOI 10.1111/j.1365-3156.2005.01512.x; Zhou G, 2004, P NATL ACAD SCI USA, V101, P2375, DOI 10.1073/pnas.0308714100; Zhou GF, 2004, J MED ENTOMOL, V41, P1001, DOI 10.1603/0022-2585-41.6.1001; Zhou G, 2007, AM J TROP MED HYG, V77, P29, DOI 10.4269/ajtmh.2007.77.29; [No title captured]	100	65	65	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2009	4	11							e8022	10.1371/journal.pone.0008022	http://dx.doi.org/10.1371/journal.pone.0008022			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MK	19946627	Green Published, gold, Green Accepted			2022-12-25	WOS:000272827800014
J	Ahmet, I; Spangler, E; Shukitt-Hale, B; Joseph, JA; Ingram, DK; Talan, M				Ahmet, Ismayil; Spangler, Edward; Shukitt-Hale, Barbara; Joseph, James A.; Ingram, Donald K.; Talan, Mark			Survival and Cardioprotective Benefits of Long-Term Blueberry Enriched Diet in Dilated Cardiomyopathy Following Myocardial Infarction in Rats	PLOS ONE			English	Article							MITOCHONDRIAL PERMEABILITY TRANSITION; CARDIAC MYOCYTE APOPTOSIS; QUALITY-OF-LIFE; HEART-FAILURE; BEHAVIORAL DEFICITS; DISEASE; DEATH	Background: Despite remarkable progress in treatment of chronic heart failure (CHF) over the last two decades, mortality, personal suffering and cost remain staggering, and effective interventions are still a challenge. Previously we reported that a blueberry-enriched diet (BD) attenuated necroapoptosis and inflammation in periinfarct area in a rat model of myocardial infarction (MI). Objectives: To test the hypothesis that BD will attenuate the course of CHF, including mortality and cardiac remodeling during the first year after induction of MI in rats. Method and Results: Two weeks after coronary artery ligation, rats were divided into two groups of similar average MI size, measured by echocardiography, and then 12-mo dietary regimens were initiated as follows: ad libitum regular diet (control, CD, n = 27) and isocaloric food with 2% blueberry supplement (BD, n = 27) also available ad libitum. These dietary groups were compared to each other and to sham group (SH). Mortality over the 12 mo was reduced by 22% in BD compared with CD (p<0.01). In the course of developing CHF, BD had no effect on the body weight, heart rate or blood pressure. Bimonthly Echo revealed significant attenuation of the LV chamber remodeling, LV posterior wall thinning, and MI expansion in BD compared with CD. In fact, BD arrested the MI expansion. Conclusion: This is the first experimental evidence that a blueberry-enriched diet has positive effects on the course of CHF and thus warrants consideration for clinical evaluation.			Ahmet, I (corresponding author), NIA, Lab Cardiovasc Sci, NIH, Baltimore, MD 21224 USA.	talanm@grc.nia.nih.gov		Shukitt-Hale, Barbara/0000-0002-3810-1910	NATIONAL INSTITUTE ON AGING [ZIAAG000811] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Ahmet I, 2005, HEART FAIL REV, V10, P289, DOI 10.1007/s10741-005-7543-3; Ahmet I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005954; Bickford PC, 2000, BRAIN RES, V866, P211, DOI 10.1016/S0006-8993(00)02280-0; Dickstein K, 2008, EUR HEART J, V29, P2388, DOI 10.1093/eurheartj/ehn309; Foo RSY, 2005, J CLIN INVEST, V115, P565, DOI 10.1172/JCI200524569; Guerra S, 1999, CIRC RES, V85, P856, DOI 10.1161/01.RES.85.9.856; Hayakawa Y, 2003, CIRCULATION, V108, P3036, DOI 10.1161/01.CIR.0000101920.72665.58; Heart Failure Society Of America, 2006, J Card Fail, V12, pe1; Hobbs FDR, 2002, EUR HEART J, V23, P1867, DOI 10.1053/euhj.2002.3255; HOCHMAN JS, 1982, CIRCULATION, V65, P1446, DOI 10.1161/01.CIR.65.7.1446; Joseph JA, 1999, J NEUROSCI, V19, P8114; Joseph JA, 2003, NUTR NEUROSCI, V6, P153, DOI 10.1080/1028415031000111282; Juenger J, 2002, HEART, V87, P235, DOI 10.1136/heart.87.3.235; Juhaszova M, 2004, J CLIN INVEST, V113, P1535, DOI 10.1172/JCI200419906; Kitsis RN, 2008, HEART FAIL REV, V13, P107, DOI 10.1007/s10741-008-9080-3; Lau FC, 2007, J NEUROSCI RES, V85, P1010, DOI 10.1002/jnr.21205; McMurray JJV, 2005, LANCET, V365, P1877, DOI 10.1016/S0140-6736(05)66621-4; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; Prior RL, 2000, J AOAC INT, V83, P950; Ramassamy C, 2006, EUR J PHARMACOL, V545, P51, DOI 10.1016/j.ejphar.2006.06.025; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Stewart S, 2002, EUR J HEART FAIL, V4, P361, DOI 10.1016/S1388-9842(01)00198-2; Sweeney MI, 2002, NUTR NEUROSCI, V5, P427, DOI 10.1080/1028415021000055970; Wencker D, 2003, J CLIN INVEST, V111, P1497, DOI 10.1172/JCI200317664; Zorov DB, 2000, J EXP MED, V192, P1001, DOI 10.1084/jem.192.7.1001	25	28	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2009	4	11							e7975	10.1371/journal.pone.0007975	http://dx.doi.org/10.1371/journal.pone.0007975			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522NJ	19936253	Green Published, gold, Green Submitted			2022-12-25	WOS:000272004600024
J	MacConaill, LE; Campbell, CD; Kehoe, SM; Bass, AJ; Hatton, C; Niu, LL; Davis, M; Yao, KL; Hanna, M; Mondal, C; Luongo, L; Emery, CM; Baker, AC; Philips, J; Goff, DJ; Fiorentino, M; Rubin, MA; Polyak, K; Chan, J; Wang, YX; Fletcher, JA; Santagata, S; Corso, G; Roviello, F; Shivdasani, R; Kieran, MW; Ligon, KL; Stiles, CD; Hahn, WC; Meyerson, ML; Garraway, LA				MacConaill, Laura E.; Campbell, Catarina D.; Kehoe, Sarah M.; Bass, Adam J.; Hatton, Charles; Niu, Lili; Davis, Matt; Yao, Keluo; Hanna, Megan; Mondal, Chandrani; Luongo, Lauren; Emery, Caroline M.; Baker, Alissa C.; Philips, Juliet; Goff, Deborah J.; Fiorentino, Michelangelo; Rubin, Mark A.; Polyak, Kornelia; Chan, Jennifer; Wang, Yuexiang; Fletcher, Jonathan A.; Santagata, Sandro; Corso, Gianni; Roviello, Franco; Shivdasani, Ramesh; Kieran, Mark W.; Ligon, Keith L.; Stiles, Charles D.; Hahn, William C.; Meyerson, Matthew L.; Garraway, Levi A.			Profiling Critical Cancer Gene Mutations in Clinical Tumor Samples	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; CELL LUNG-CANCER; GEFITINIB; CETUXIMAB; KRAS; ASTROCYTOMAS; CHEMOTHERAPY; DUPLICATION; COMBINATION; ACTIVATION	Background: Detection of critical cancer gene mutations in clinical tumor specimens may predict patient outcomes and inform treatment options; however, high-throughput mutation profiling remains underdeveloped as a diagnostic approach. We report the implementation of a genotyping and validation algorithm that enables robust tumor mutation profiling in the clinical setting. Methodology: We developed and implemented an optimized mutation profiling platform ("OncoMap'') to interrogate similar to 400 mutations in 33 known oncogenes and tumor suppressors, many of which are known to predict response or resistance to targeted therapies. The performance of OncoMap was analyzed using DNA derived from both frozen and FFPE clinical material in a diverse set of cancer types. A subsequent in-depth analysis was conducted on histologically and clinically annotated pediatric gliomas. The sensitivity and specificity of OncoMap were 93.8% and 100% in fresh frozen tissue; and 89.3% and 99.4% in FFPE-derived DNA. We detected known mutations at the expected frequencies in common cancers, as well as novel mutations in adult and pediatric cancers that are likely to predict heightened response or resistance to existing or developmental cancer therapies. OncoMap profiles also support a new molecular stratification of pediatric low-grade gliomas based on BRAF mutations that may have immediate clinical impact. Conclusions: Our results demonstrate the clinical feasibility of high-throughput mutation profiling to query a large panel of "actionable'' cancer gene mutations. In the future, this type of approach may be incorporated into both cancer epidemiologic studies and clinical decision making to specify the use of many targeted anticancer agents.			MacConaill, LE (corresponding author), Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA.	Levi_Garraway@dfci.harvard.edu	Davis, Matt/F-9045-2012; Wang, Yuexiang/GNH-5248-2022; Corso, Giovanni/AAN-5976-2020; Fiorentino, Michelangelo/AAB-8056-2022; Meyerson, Matthew L/E-7123-2012	Hatton, Charlie/0000-0001-9903-4291; Rubin, Mark/0000-0002-8321-9950; Santagata, Sandro/0000-0002-7528-9668; Kieran, Mark/0000-0003-2184-7692	NCI NIH HHS [K08 CA134931, R21CA126674, K08CA134931, R21 CA126674] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K08CA134931, R21CA126674] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Cheng Y, 2000, HISTOPATHOLOGY, V37, P437, DOI 10.1046/j.1365-2559.2000.01005.x; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Cho DC, 2009, J CLIN ONCOL, V27; Demetri GD, 2002, NEW ENGL J MED, V347, P472, DOI 10.1056/NEJMoa020461; Eberhard DA, 2005, J CLIN ONCOL, V23, P5900, DOI 10.1200/JCO.2005.02.857; Forshew T, 2009, J PATHOL, V218, P172, DOI 10.1002/path.2558; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Khambata-Ford S, 2007, J CLIN ONCOL, V25, P3230, DOI 10.1200/JCO.2006.10.5437; Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; Loupakis F, 2009, J CLIN ONCOL, V27, P2622, DOI 10.1200/JCO.2008.20.2796; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Ogino S, 2005, CLIN CANCER RES, V11, P6650, DOI 10.1158/1078-0432.CCR-05-0738; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; PEARCE M, 2009, NATURE METHODS, V6; Pfister S, 2008, J CLIN INVEST, V118, P1739, DOI 10.1172/JCI33656; Prenen H, 2006, PHARMACOLOGY, V77, P11, DOI 10.1159/000091943; SCHWAB M, 1983, NATURE, V305, P245, DOI 10.1038/305245a0; Sievert AJ, 2009, BRAIN PATHOL, V19, P449, DOI 10.1111/j.1750-3639.2008.00225.x; Thomas RK, 2007, NAT GENET, V39, P347, DOI 10.1038/ng1975; Van Cutsem E, 2009, J CLIN ONCOL, V27, P4509, DOI DOI 10.1200/jco.2009.27.18s.lba4509; Velasco A, 2006, HUM PATHOL, V37, P1465, DOI 10.1016/j.humpath.2006.05.007; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Yeang CH, 2008, FASEB J, V22, P2605, DOI 10.1096/fj.08-108985	27	291	305	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2009	4	11							e7887	10.1371/journal.pone.0007887	http://dx.doi.org/10.1371/journal.pone.0007887			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521QH	19924296	Green Published, gold			2022-12-25	WOS:000271936700019
J	Zhang, P; Zucchelli, M; Bruce, S; Hambiliki, F; Stavreus-Evers, A; Levkov, L; Skottman, H; Kerkela, E; Kere, J; Hovatta, O				Zhang, Pu; Zucchelli, Marco; Bruce, Sara; Hambiliki, Fredwell; Stavreus-Evers, Anneli; Levkov, Lev; Skottman, Heli; Kerkela, Erja; Kere, Juha; Hovatta, Outi			Transcriptome Profiling of Human Pre-Implantation Development	PLOS ONE			English	Article							PYRUVATE UPTAKE; MOUSE OOCYTES; IN-VITRO; GENES; SELECTION	Background: Preimplantation development is a crucial step in early human development. However, the molecular basis of human preimplantation development is not well known. Methodology: By applying microarray on 397 human oocytes and embryos at six developmental stages, we studied the transcription dynamics during human preimplantation development. Principal Findings: We found that the preimplantation development consisted of two main transitions: from metaphase-II oocyte to 4-cell embryo where mainly the maternal genes were expressed, and from 8-cell embryo to blastocyst with down-regulation of the maternal genes and up-regulation of embryonic genes. Human preimplantation development proved relatively autonomous. Genes predominantly expressed in oocytes and embryos are well conserved during evolution. Significance: Our database and findings provide fundamental resources for understanding the genetic network controlling early human development.			Zhang, P (corresponding author), Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden.	outi.hovatta@ki.se	Kerkelä, Erja/P-9459-2016; Kere, Juha/AAX-9117-2021; Kere, Juha/A-9179-2008	Kerkelä, Erja/0000-0002-2923-5300; Kere, Juha/0000-0003-1974-0271; Kere, Juha/0000-0003-1974-0271; Skottman, Heli/0000-0002-4127-8792				Assou S, 2006, HUM REPROD, V21, P1705, DOI 10.1093/humrep/del065; Bustamante CD, 2005, NATURE, V437, P1153, DOI 10.1038/nature04240; CONAGHAN J, 1993, J ASSIST REPROD GEN, V10, P21, DOI 10.1007/BF01204436; CUI XS, 2006, MOL REPROD DEV; Dobson AT, 2004, HUM MOL GENET, V13, P1461, DOI 10.1093/hmg/ddh157; Eppig JJ, 1996, BIOL REPROD, V54, P197, DOI 10.1095/biolreprod54.1.197; Hamatani T, 2004, DEV CELL, V6, P117, DOI 10.1016/S1534-5807(03)00373-3; Houghton FD, 2002, HUM REPROD, V17, P999, DOI 10.1093/humrep/17.4.999; Jeffery IB, 2007, BIOINFORMATICS, V23, P298, DOI 10.1093/bioinformatics/btl597; Kocabas AM, 2006, P NATL ACAD SCI USA, V103, P14027, DOI 10.1073/pnas.0603227103; Kurihara I, 2007, PLOS GENET, V3, P1053, DOI 10.1371/journal.pgen.0030102; Leese HJ, 2002, BIOESSAYS, V24, P845, DOI 10.1002/bies.10137; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Mamo S, 2006, REPROD DOMEST ANIM, V41, P527, DOI 10.1111/j.1439-0531.2006.00708.x; Nielsen R, 2005, PLOS BIOL, V3, P976, DOI 10.1371/journal.pbio.0030170; O'Brien MJ, 2003, BIOL REPROD, V68, P1682, DOI 10.1095/biolreprod.102.013029; Pereira FA, 1999, GENE DEV, V13, P1037, DOI 10.1101/gad.13.8.1037; Petit FG, 2007, P NATL ACAD SCI USA, V104, P6293, DOI 10.1073/pnas.0702039104; Ross J, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews3004; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Tong ZB, 2000, NAT GENET, V26, P267, DOI 10.1038/81547; TURNER K, 1994, HUM REPROD, V9, P2362, DOI 10.1093/oxfordjournals.humrep.a138453; Ushizawa Koichi, 2004, Reprod Biol Endocrinol, V2, P77; Wang QT, 2004, DEV CELL, V6, P133, DOI 10.1016/S1534-5807(03)00404-0; Wu XM, 2003, NAT GENET, V33, P187, DOI 10.1038/ng1079; ZHANG P, 2006, FERTIL STERIL; Zhang P, 2007, FERTIL STERIL, V87, P677, DOI 10.1016/j.fertnstert.2006.07.1509	28	82	84	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2009	4	11							e7844	10.1371/journal.pone.0007844	http://dx.doi.org/10.1371/journal.pone.0007844			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520NG	19924284	Green Published, gold, Green Submitted			2022-12-25	WOS:000271851000004
J	Ghaemmaghami, S; Ullman, J; Ahn, M; St Martin, S; Prusiner, SB				Ghaemmaghami, Sina; Ullman, Julie; Ahn, Misol; St Martin, Susan; Prusiner, Stanley B.			Chemical Induction of Misfolded Prion Protein Conformers in Cell Culture	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCRAPIE PRION; BRANCHED POLYAMINES; POTENT INHIBITION; PRPSC; DISEASE; ACCUMULATION; ANTIBODIES; STRAINS; MUTANT; THERAPEUTICS	Prion-infected cells accumulate a heterogeneous population of aberrantly folded PrP conformers, including the disease-causing isoform (PrPSc). We found that specific chemicals can modulate the levels of various PrP conformers in cultured cells. Positively charged polyamidoamines (dendrimers) eliminated protease-resistant (r) PrPSc from prion-infected cells and induced the formation of insoluble, protease-sensitive PrP aggregates (designated PrPA). Larger, positively charged polyamidoamines more efficaciously induced the formation of PrPA and cleared rPrP(Sc), whereas negatively charged polyamidoamines neither induced PrPA nor cleared rPrP(Sc). Although the biochemical properties of PrPA were shown to be similar to protease-sensitive (s) PrPSc, bioassays of PrPA indicated that it is not infectious. Our studies argue that PrPA represents an aggregated PrP species that is off-pathway relative to the formation of rPrP(Sc). It remains to be established whether the formation of PrPA inhibits the formation of rPrP(Sc) by sequestering PrPC in the form of benign, insoluble aggregates.	[Ghaemmaghami, Sina; Ullman, Julie; Ahn, Misol; St Martin, Susan; Prusiner, Stanley B.] Univ Calif San Francisco, Inst Neurodegenerat Dis, San Francisco, CA 94143 USA; [Ghaemmaghami, Sina; Prusiner, Stanley B.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Prusiner, SB (corresponding author), 513 Parnassus Ave,HSE 774, San Francisco, CA 94143 USA.	stanley@ind.ucsf.edu		Ghaemmaghami, Sina/0000-0002-8696-2950; Ullman, Julie/0000-0003-1325-0650; Ahn, Misol/0000-0002-6088-8481	National Institutes of Health [AG02132, AG10770, AG021601]; NATIONAL INSTITUTE ON AGING [P01AG002132, P01AG010770, P01AG021601] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG02132, AG10770, and AG021601 as well as by gifts from the G. Harold and Leila Y. Mathers Foundation, Hillblom Foundation, Fight for Mike Homer Program, and Mr. Robert Galvin.	Baskakov IV, 2002, J BIOL CHEM, V277, P21140, DOI 10.1074/jbc.M111402200; BASLER K, 1986, CELL, V46, P417, DOI 10.1016/0092-8674(86)90662-8; BOLTON DC, 1982, SCIENCE, V218, P1309, DOI 10.1126/science.6815801; BORCHELT DR, 1992, J BIOL CHEM, V267, P16188; BUTLER DA, 1988, J VIROL, V62, P1558, DOI 10.1128/JVI.62.5.1558-1564.1988; CAUGHEY B, 1992, J NEUROCHEM, V59, P768, DOI 10.1111/j.1471-4159.1992.tb09437.x; Colby DW, 2007, P NATL ACAD SCI USA, V104, P20914, DOI 10.1073/pnas.0710152105; Colby DW, 2009, P NATL ACAD SCI USA, V106, P20417, DOI 10.1073/pnas.0910350106; Doh-Ura K, 2000, J VIROL, V74, P4894, DOI 10.1128/JVI.74.10.4894-4897.2000; Ertmer A, 2004, J BIOL CHEM, V279, P41918, DOI 10.1074/jbc.M405652200; Gambetti P, 2003, BRIT MED BULL, V66, P213, DOI 10.1093/bmb/66.1.213; Gambetti P, 2008, ANN NEUROL, V63, P697, DOI 10.1002/ana.21420; Ghaemmaghami S, 2007, P NATL ACAD SCI USA, V104, P17971, DOI 10.1073/pnas.0708372104; Gilch S, 2001, EMBO J, V20, P3957, DOI 10.1093/emboj/20.15.3957; Govaerts C, 2004, P NATL ACAD SCI USA, V101, P8342, DOI 10.1073/pnas.0402254101; Hegde RS, 1998, SCIENCE, V279, P827, DOI 10.1126/science.279.5352.827; HSIAO KK, 1990, SCIENCE, V250, P1587, DOI 10.1126/science.1980379; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; Kong Qingzhong, 2004, VVolume 41, P673; Korth C, 2001, P NATL ACAD SCI USA, V98, P9836, DOI 10.1073/pnas.161274798; Leclerc E, 2003, J MOL BIOL, V326, P475, DOI 10.1016/S0022-2836(02)01365-7; Lee IS, 2005, J AM CHEM SOC, V127, P13802, DOI 10.1021/ja055219y; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Legname G, 2006, P NATL ACAD SCI USA, V103, P19105, DOI 10.1073/pnas.0608970103; Ma JY, 2002, SCIENCE, V298, P1785, DOI 10.1126/science.1073619; May BCH, 2003, P NATL ACAD SCI USA, V100, P3416, DOI 10.1073/pnas.2627988100; MEYER RK, 1986, P NATL ACAD SCI USA, V83, P2310, DOI 10.1073/pnas.83.8.2310; PAN YT, 1983, BIOCHEMISTRY-US, V22, P3975, DOI 10.1021/bi00285a038; Pastrana MA, 2006, BIOCHEMISTRY-US, V45, P15710, DOI 10.1021/bi0615442; Peretz D, 2001, NATURE, V412, P739, DOI 10.1038/35089090; Prior M, 2007, J VIROL, V81, P11195, DOI 10.1128/JVI.02559-06; Prusiner SB, 2001, NEW ENGL J MED, V344, P1516, DOI 10.1056/NEJM200105173442006; PRUSINER SB, 1983, CELL, V35, P349, DOI 10.1016/0092-8674(83)90168-X; Rambold AS, 2008, J NEUROCHEM, V107, P218, DOI 10.1111/j.1471-4159.2008.05611.x; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Safar JG, 2005, P NATL ACAD SCI USA, V102, P3501, DOI 10.1073/pnas.0409651102; Safar JG, 2005, J GEN VIROL, V86, P2913, DOI 10.1099/vir.0.80947-0; Sonawane ND, 2003, J BIOL CHEM, V278, P44826, DOI 10.1074/jbc.M308643200; Supattapone S, 1999, P NATL ACAD SCI USA, V96, P14529, DOI 10.1073/pnas.96.25.14529; Supattapone S, 2001, J VIROL, V75, P3453, DOI 10.1128/JVI.75.7.3453-3461.2001; Tremblay P, 2004, J VIROL, V78, P2088, DOI 10.1128/JVI.78.4.2088-2099.2004; Trevitt CR, 2006, BRAIN, V129, P2241, DOI 10.1093/brain/awl150; Tzaban S, 2002, BIOCHEMISTRY-US, V41, P12868, DOI 10.1021/bi025958g; Williamson RA, 1998, J VIROL, V72, P9413, DOI 10.1128/JVI.72.11.9413-9418.1998; Williamson TL, 1998, P NATL ACAD SCI USA, V95, P9631, DOI 10.1073/pnas.95.16.9631	45	22	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10415	10423		10.1074/jbc.M109.045112	http://dx.doi.org/10.1074/jbc.M109.045112			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	19955177	Green Published, hybrid			2022-12-25	WOS:000276264600027
J	Lambert, JMR; Moshfegh, A; Hainaut, P; Wiman, KG; Bykov, VJN				Lambert, J. M. R.; Moshfegh, A.; Hainaut, P.; Wiman, K. G.; Bykov, V. J. N.			Mutant p53 reactivation by PRIMA-1(MET) induces multiple signaling pathways converging on apoptosis	ONCOGENE			English	Article						cancer; mutant p53; apoptosis; novel therapy	ENDOPLASMIC-RETICULUM STRESS; UNFOLDED-PROTEIN RESPONSE; WILD-TYPE P53; TUMOR-SUPPRESSOR; P53-DEPENDENT APOPTOSIS; P53-INDUCED APOPTOSIS; TARGET GENES; CANCER-CELLS; CORE DOMAIN; ER STRESS	The low molecular weight compound PRIMA-1(MET) reactivates mutant p53 and triggers mutant p53-dependent apoptosis in human tumor cells. We investigated the effect of PRIMA-1(MET) on global gene expression using microarray analysis of Saos-2 cells expressing His273 mutant p53 and parental p53 null Saos-2 cells. PRIMA-1(MET) affected transcription of a significantly larger number of genes in the mutant p53-expressing cells compared to the p53 null cells. Genes affected by PRIMA-1(MET) in a mutant p53-dependent manner include the cell-cycle regulators GADD45B and 14-3-3 gamma and the pro-apoptotic Noxa. Several of the affected genes are known p53 target genes and/or contain p53 DNA-binding motifs. We also found mutant p53-dependent disruption of the cytoskeleton, as well as transcriptional activation of the XBP1 gene and cleavage of its mRNA, a marker for endoplasmic reticulum stress. Our data show that PRIMA-1(MET) induces apoptosis through multiple transcription-dependent and -independent pathways. Such integral engagement of multiple pathways leading to apoptosis is consistent with restoration of wild-type properties to mutant p53 and is likely to reduce the risk of drug resistance development in clinical applications of PRIMA-1(MET). Oncogene (2010) 29, 1329-1338; doi:10.1038/onc.2009.425; published online 30 November 2009	[Lambert, J. M. R.; Moshfegh, A.; Wiman, K. G.; Bykov, V. J. N.] Karolinska Inst, Dept Oncol Pathol, Canc Ctr Karolinska, SE-17176 Stockholm, Sweden; [Lambert, J. M. R.; Hainaut, P.] Int Agcy Res Canc, Mol Carcinogenesis & Biomarkers Grp, F-69372 Lyon, France	Karolinska Institutet; World Health Organization; International Agency for Research on Cancer (IARC)	Wiman, KG (corresponding author), Karolinska Inst, Dept Oncol Pathol, Canc Ctr Karolinska, SE-17176 Stockholm, Sweden.	klas.wiman@ki.se	Hainaut, Pierre/B-6018-2012; Wiman, Klas/AAB-8399-2021	Hainaut, Pierre/0000-0002-1303-1610; Wiman, Klas/0000-0002-7113-524X; Nakade Bykov, Vladimir/0000-0002-7199-8942	Swedish Cancer Society (Cancerfonden); Cancerforeningen; Karolinska Institutet; EU	Swedish Cancer Society (Cancerfonden)(Swedish Cancer Society); Cancerforeningen; Karolinska Institutet(Karolinska Institutet); EU(European Commission)	We thank Bert Vogelstein, Johns Hopkins Oncology Center, for HCT116 cells. This work was supported by the Swedish Cancer Society (Cancerfonden), Cancerforeningen, Karolinska Institutet and the EU 6th framework program. This publication reflects the author's views and not necessarily those of the EC. The information in this document is provided as is and no guarantee or warranty is given that the information is fit for any particular purpose. The user thereof uses the information at his/her sole risk and liability. The Community is not liable for any use that may be made of the information contained herein.	Abcouwer SF, 2002, INVEST OPHTH VIS SCI, V43, P2791; Andersson J, 2005, ANN ONCOL, V16, P743, DOI 10.1093/annonc/mdi150; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Bykov VJN, 2005, ONCOGENE, V24, P3484, DOI 10.1038/sj.onc.1208419; Bykov VJN, 2002, NAT MED, V8, P282, DOI 10.1038/nm0302-282; Cadwell C, 2001, GENE, V277, P15, DOI 10.1016/S0378-1119(01)00696-5; CAELLES C, 1994, NATURE, V370, P220, DOI 10.1038/370220a0; Ceribelli M, 2006, CELL CYCLE, V5, P1102, DOI 10.4161/cc.5.10.2777; Chipuk JE, 2003, CANCER CELL, V4, P371, DOI 10.1016/S1535-6108(03)00272-1; Di Como CJ, 1999, MOL CELL BIOL, V19, P1438; Gaiddon C, 2001, MOL CELL BIOL, V21, P1874, DOI 10.1128/MCB.21.5.1874-1887.2001; Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986; Gronroos E, 2004, P NATL ACAD SCI USA, V101, P12165, DOI 10.1073/pnas.0402283101; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; He SK, 2008, GRAEF ARCH CLIN EXP, V246, P677, DOI 10.1007/s00417-008-0770-2; Hetz C, 2006, SCIENCE, V312, P572, DOI 10.1126/science.1123480; Hoh J, 2002, P NATL ACAD SCI USA, V99, P8467, DOI 10.1073/pnas.132268899; Hossain MM, 2003, AM J PHYSIOL-CELL PH, V284, pC156, DOI 10.1152/ajpcell.00233.2002; INESI G, 1992, ARCH BIOCHEM BIOPHYS, V298, P313, DOI 10.1016/0003-9861(92)90416-T; Johnson TM, 1996, P NATL ACAD SCI USA, V93, P11848, DOI 10.1073/pnas.93.21.11848; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lai ED, 2007, PHYSIOLOGY, V22, P193, DOI 10.1152/physiol.00050.2006; Lambert JMR, 2009, CANCER CELL, V15, P376, DOI 10.1016/j.ccr.2009.03.003; Li JZ, 2006, J BIOL CHEM, V281, P7260, DOI 10.1074/jbc.M509868200; Li Y, 2005, MOL CANCER THER, V4, P901, DOI 10.1158/1535-7163.MCT-04-0206; Livneh Z, 2006, CELL CYCLE, V5, P1918, DOI 10.4161/cc.5.17.3193; Mirza A, 2003, ONCOGENE, V22, P3645, DOI 10.1038/sj.onc.1206477; MUKHOPADHYAY D, 1995, CANCER RES, V55, P6161; Olivier M, 2002, HUM MUTAT, V19, P607, DOI 10.1002/humu.10081; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Rahman R, 2005, ONCOGENE, V24, P1320, DOI 10.1038/sj.onc.1208232; Rogojina A, 2003, MOL VIS, V9, P482; Rokaeus N, 2007, ONCOGENE, V26, P982, DOI 10.1038/sj.onc.1209858; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Shen J, 2008, ONCOGENE, V27, P6571, DOI 10.1038/onc.2008.249; Strano S, 2002, J BIOL CHEM, V277, P18817, DOI 10.1074/jbc.M201405200; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Vousden KH, 2009, NAT REV CANCER, V9, P691, DOI 10.1038/nrc2715; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wang LQ, 2001, J BIOL CHEM, V276, P43604, DOI 10.1074/jbc.M106570200; Wang T, 2007, BIOCHEM BIOPH RES CO, V352, P203, DOI 10.1016/j.bbrc.2006.11.006; Westhoff B, 2005, CURR BIOL, V15, P1058, DOI 10.1016/j.cub.2005.04.058; Wulfkuhle JD, 1999, J CELL SCI, V112, P2125; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Yakovleva T, 2004, BIOCHEM BIOPH RES CO, V318, P615, DOI 10.1016/j.bbrc.2004.04.065; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zache N, 2008, CELL ONCOL, V30, P411, DOI 10.3233/CLO-2008-0440	48	82	85	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR 4	2010	29	9					1329	1338		10.1038/onc.2009.425	http://dx.doi.org/10.1038/onc.2009.425			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	563XJ	19946333				2022-12-25	WOS:000275170600008
J	Humtsoe, JO; Kramer, RH				Humtsoe, J. O.; Kramer, R. H.			Differential epidermal growth factor receptor signaling regulates anchorage-independent growth by modulation of the PI3K/AKT pathway	ONCOGENE			English	Article						cell-cell adhesion; EGFR; PI3K/AKT	SQUAMOUS-CELL CARCINOMA; FACTOR EGF RECEPTOR; HYPOXIA-INDUCIBLE FACTOR; E-CADHERIN; PHOSPHATIDYLINOSITOL 3-KINASE; INTERCELLULAR-ADHESION; TYROSINE KINASE; CYCLIN D1; DEPENDENT REGULATION; CONTACT FORMATION	Tumor cells are capable of surviving loss of nutrients and anchorage in hostile microenvironments. Under these conditions, adapting to specific signaling pathways may shift the balance between growth and cellular dormancy. Here, we report a mechanism by which epidermal growth factor receptor (EGFR) differentially modulates the phosphatidylinositol 30-kinase (PI3K)/AKT pathway in cellular stress conditions. When carcinoma cells were cultured as multicellular aggregates (MCA), cyclin D1 was induced through a serum-dependent EGFR activating pathway, triggering cell proliferation. The expression of cyclin D1 required both EGFR-mediated ERK and AKT activation. In serum-starved MCAs, EGFR activation was associated with active ERK1/2, but not AKT, and failed to induce cyclin D1. Analysis revealed that, under serum-starved conditions, EGFR-Y1086 residue was poorly autophosphorylated and this correlated with failure to phosphorylate Gab1. Accordingly, the EGFR activation failed to induce EGFR/PI3K complex formation or AKT activation, preventing cyclin D1 induction. Furthermore, we show that in serum-starved MCA, expression of constitutively active AKT re-established cyclin D1 expression and induced proliferation in an EGFR-dependent manner. Thus, modulation of the PI3K/AKT pathway by context-dependent EGFR signaling may regulate tumor cell growth and dormancy. Oncogene (2010) 29, 1214-1226; doi: 10.1038/onc.2009.419; published online 23 November 2009	[Humtsoe, J. O.; Kramer, R. H.] Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Kramer, RH (corresponding author), Univ Calif San Francisco, Dept Cell & Tissue Biol, 521 Parnassus Ave,Room C-640,Box 0640, San Francisco, CA 94143 USA.	randall.kramer@ucsf.edu			NIH [R01 DE11436]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE011436] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank Dr KK Wary (UIC, Chicago) for the insightful discussions and comments, Dr SM Troyanovsky (Washington University, St Louis) for providing the E-cadherin constructs, Dr D Stokoe (UCSF, San Francisco) for the GFP-AKT constructs, L Lee and B Situ for their assistance in preparing the paper. This work was supported by NIH grant R01 DE11436.	Aguirre-Ghiso JA, 2007, NAT REV CANCER, V7, P834, DOI 10.1038/nrc2256; Alt-Holland A, 2005, SEMIN CANCER BIOL, V15, P84, DOI 10.1016/j.semcancer.2004.08.007; Bates RC, 2000, CRIT REV ONCOL HEMAT, V36, P61, DOI 10.1016/S1040-8428(00)00077-9; BERNARD O, 1987, P NATL ACAD SCI USA, V84, P2125, DOI 10.1073/pnas.84.8.2125; Bill HM, 2004, MOL CELL BIOL, V24, P8586, DOI 10.1128/MCB.24.19.8586-8599.2004; Bourguignon LYW, 2006, J BIOL CHEM, V281, P14026, DOI 10.1074/jbc.M507734200; Cabodi S, 2004, BIOCHEM SOC T, V32, P438, DOI 10.1042/BST0320438; Cai WJ, 2006, P NATL ACAD SCI USA, V103, P13801, DOI 10.1073/pnas.0600362103; Chen QM, 2004, BIOCHEM BIOPH RES CO, V315, P850, DOI 10.1016/j.bbrc.2004.01.143; Chitaev NA, 1998, J CELL BIOL, V142, P837, DOI 10.1083/jcb.142.3.837; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Fournier AK, 2008, J CELL SCI, V121, P226, DOI 10.1242/jcs.017012; Friedrich J, 2007, INT J RADIAT BIOL, V83, P849, DOI 10.1080/09553000701727531; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; Gilmore AP, 2005, CELL DEATH DIFFER, V12, P1473, DOI 10.1038/sj.cdd.4401723; Goodwin M, 2003, J BIOL CHEM, V278, P20533, DOI 10.1074/jbc.M213171200; HolgadoMadruga M, 1996, NATURE, V379, P560, DOI 10.1038/379560a0; HU P, 1992, MOL CELL BIOL, V12, P981, DOI 10.1128/MCB.12.3.981; Humtsoe JO, 2003, EMBO J, V22, P1539, DOI 10.1093/emboj/cdg165; Jiang BH, 2001, CELL GROWTH DIFFER, V12, P363; Jo H, 2008, MOL CELL BIOL, V28, P4285, DOI 10.1128/MCB.01240-07; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; Kang HG, 2007, CANCER RES, V67, P3094, DOI 10.1158/0008-5472.CAN-06-3259; Kantak SS, 1998, J BIOL CHEM, V273, P16953, DOI 10.1074/jbc.273.27.16953; Kawano K, 2001, EXP CELL RES, V262, P180, DOI 10.1006/excr.2000.5083; Kuwada SK, 2000, MOL BIOL CELL, V11, P2485, DOI 10.1091/mbc.11.7.2485; Lawlor ER, 2002, ONCOGENE, V21, P307, DOI 10.1038/sj.onc.1205053; Lenferink AEG, 2001, CANCER RES, V61, P6583; LeVea CM, 2004, EXP CELL RES, V297, P272, DOI 10.1016/j.yexcr.2004.03.026; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; MATSUMOTO K, 1994, J BIOL CHEM, V269, P31807; Mattoon DR, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-24; Miranti CK, 2002, NAT CELL BIOL, V4, pE83, DOI 10.1038/ncb0402-e83; Moro L, 2002, J BIOL CHEM, V277, P9405, DOI 10.1074/jbc.M109101200; Nurmenniemi S, 2009, AM J PATHOL, V175, P1281, DOI 10.2353/ajpath.2009.081110; Onishi A, 2008, EXP CELL RES, V314, P377, DOI 10.1016/j.yexcr.2007.09.018; Pece S, 2000, J BIOL CHEM, V275, P41227, DOI 10.1074/jbc.M006578200; Pore N, 2006, CANCER RES, V66, P3197, DOI 10.1158/0008-5472.CAN-05-3090; Ranganathan AC, 2006, CELL CYCLE, V5, P1799, DOI 10.4161/cc.5.16.3109; Rodrigues GA, 2000, MOL CELL BIOL, V20, P1448, DOI 10.1128/MCB.20.4.1448-1459.2000; Santini MT, 2000, CRIT REV ONCOL HEMAT, V36, P75, DOI 10.1016/S1040-8428(00)00078-0; Schmidt MHH, 2003, P NATL ACAD SCI USA, V100, P6505, DOI 10.1073/pnas.1031790100; Schneider MR, 2009, J CELL PHYSIOL, V218, P460, DOI 10.1002/jcp.21635; Shen XD, 2004, AM J PATHOL, V165, P1315, DOI 10.1016/S0002-9440(10)63390-1; Singh AB, 2005, CELL SIGNAL, V17, P1183, DOI 10.1016/j.cellsig.2005.03.026; Singh AB, 2007, J BIOL CHEM, V282, P32890, DOI 10.1074/jbc.M702677200; Thelemann A, 2005, MOL CELL PROTEOMICS, V4, P356, DOI 10.1074/mcp.M400118-MCP200; Walker JL, 2005, CANCER METAST REV, V24, P383, DOI 10.1007/s10555-005-5130-7; Weidner KM, 1996, NATURE, V384, P173, DOI 10.1038/384173a0	49	48	49	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 25	2010	29	8					1214	1226		10.1038/onc.2009.419	http://dx.doi.org/10.1038/onc.2009.419			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	560ON	19935697	Green Accepted			2022-12-25	WOS:000274912100012
J	Watanabe, Y; Kojima, T; Kagawa, S; Uno, F; Hashimoto, Y; Kyo, S; Mizuguchi, H; Tanaka, N; Kawamura, H; Ichimaru, D; Urata, Y; Fujiwara, T				Watanabe, Y.; Kojima, T.; Kagawa, S.; Uno, F.; Hashimoto, Y.; Kyo, S.; Mizuguchi, H.; Tanaka, N.; Kawamura, H.; Ichimaru, D.; Urata, Y.; Fujiwara, T.			A novel translational approach for human malignant pleural mesothelioma: heparanase-assisted dual virotherapy	ONCOGENE			English	Article						telomerase; adenovirus; mesothelioma; heparanase; dual virotherapy	I CLINICAL-TRIAL; GENE-THERAPY; CANCER; REPLICATION; EXPRESSION; INCREASES; P14(ARF); METASTASIS; EFFICACY; IMPROVES	Malignant pleural mesothelioma (MPM) is a highly aggressive tumor that is related to asbestos exposure. MPM is characterized by rapid and diffuse local growth in the thoracic cavity, and it has a poor prognosis because it is often refractory to conventional therapy. Although MPM is an extraordinarily challenging disease to treat, locoregional virotherapy may be useful against this aggressive disease because of the accessibility by intrapleural virus delivery. In this study, we show that telomerase-specific, replication-selective adenovirus OBP-301 can efficiently infect and kill human mesothelioma cells by viral replication. Intrathoracic administration of virus significantly reduced the number and size of human mesothelioma tumors intrathoracically implanted into nu/nu mice. A high-definition, fluorescence optical imaging system with an ultra-thin, flexible fibered microprobe clearly detected intracellular replication of green fluorescent protein-expressing oncolytic virus in intrathoracically established mesothelioma tumors. As the extracellular matrix (ECM) may contribute to the physiological resistance of a solid tumor by preventing the penetration of therapeutic agents (including oncolytic viruses), we also examined whether the co-expression of heparanase, an endoglucuronidase capable of specifically degrading heparan sulfate, that influences the physiological barrier to macromolecule penetration, can modify the permeability of the ECM, resulting in profound therapeutic efficacy. Co-injection of OBP-301 and a replication-defective adenovirus (Ad-S/hep)-expressing heparanase resulted in more profound antitumor effects without apparent toxicity in an orthotopic pleural dissemination model. Our results suggest that intrathoracic dual virotherapy with telomerase-specific oncolytic adenovirus in combination with heparanase-expressing adenovirus may be efficacious in the prevention and treatment of pleural dissemination of human malignant mesothelioma. Oncogene (2010) 29, 1145-1154; doi: 10.1038/onc.2009.415; published online 23 November 2009	[Fujiwara, T.] Okayama Univ, Ctr Gene & Cell Therapy, Grad Sch Med Dent & Pharmaceut Sci, Dept Surg, Okayama 7008558, Japan; [Watanabe, Y.; Kagawa, S.; Uno, F.; Fujiwara, T.] Okayama Univ Hosp, Ctr Gene & Cell Therapy, Okayama, Japan; [Watanabe, Y.; Hashimoto, Y.; Kawamura, H.; Ichimaru, D.; Urata, Y.] Oncolys BioPharma Inc, Minato Ku, Tokyo, Japan; [Kyo, S.] Kanazawa Univ, Sch Med, Dept Obstet & Gynecol, Kanazawa, Ishikawa 920, Japan; [Mizuguchi, H.] Osaka Univ, Grad Sch Pharmaceut Sci, Dept Biochem & Mol Biol, Osaka, Japan	Okayama University; Okayama University; Oncolys BioPharma; Kanazawa University; Osaka University	Fujiwara, T (corresponding author), Okayama Univ, Ctr Gene & Cell Therapy, Grad Sch Med Dent & Pharmaceut Sci, Dept Surg, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	toshi_f@md.okayama-u.ac.jp	Kagawa, Shunsuke/B-2189-2011	Mizuguchi, Hiroyuki/0000-0003-0594-8178; Kagawa, Shunsuke/0000-0002-3610-8211				ALBERTS AS, 1988, J CLIN ONCOL, V6, P527, DOI 10.1200/JCO.1988.6.3.527; BALL DL, 1990, AM J CLIN ONCOL-CANC, V13, P4, DOI 10.1097/00000421-199002000-00002; Blackburn JS, 2007, CANCER RES, V67, P10849, DOI 10.1158/0008-5472.CAN-07-1791; CHAHINIAN AP, 1982, ANN INTERN MED, V96, P746, DOI 10.7326/0003-4819-96-6-746; CHAILLEUX E, 1988, CHEST, V93, P159, DOI 10.1378/chest.93.1.159; Cheng J, 2007, MOL THER, V15, P1982, DOI 10.1038/sj.mt.6300264; CONNELLY RR, 1987, JNCI-J NATL CANCER I, V78, P1053; Eikenes L, 2004, CANCER RES, V64, P4768, DOI 10.1158/0008-5472.CAN-03-1472; Fitzgerald M, 1999, ATHEROSCLEROSIS, V145, P97, DOI 10.1016/S0021-9150(99)00019-2; Fujiwara T, 2008, J CLIN ONCOL, V26, DOI 10.1200/jco.2008.26.15_suppl.3572; Ganesh S, 2007, CANCER RES, V67, P4399, DOI 10.1158/0008-5472.CAN-06-4260; Goodrum FD, 1998, J VIROL, V72, P9479, DOI 10.1128/JVI.72.12.9479-9490.1998; Hioki M, 2008, INT J CANCER, V122, P2628, DOI 10.1002/ijc.23438; Kawashima T, 2004, CLIN CANCER RES, V10, P285, DOI 10.1158/1078-0432.CCR-1075-3; Kim JH, 2006, JNCI-J NATL CANCER I, V98, P1482, DOI 10.1093/jnci/djj397; Kishimoto H, 2006, NAT MED, V12, P1213, DOI 10.1038/nm1404; Kishimoto H, 2009, P NATL ACAD SCI USA, V106, P14514, DOI 10.1073/pnas.0906388106; Kuriyama N, 2001, CANCER RES, V61, P1805; McKee TD, 2006, CANCER RES, V66, P2509, DOI 10.1158/0008-5472.CAN-05-2242; McKenzie EA, 2007, BRIT J PHARMACOL, V151, P1, DOI 10.1038/sj.bjp.0707182; Molnar-Kimber KL, 1998, HUM GENE THER, V9, P2121, DOI 10.1089/hum.1998.9.14-2121; Murayama T, 2006, AM J IND MED, V49, P1, DOI 10.1002/ajim.20246; Price B, 1997, AM J EPIDEMIOL, V145, P211, DOI 10.1093/oxfordjournals.aje.a009093; Ries SJ, 2000, NAT MED, V6, P1128, DOI 10.1038/80466; RUFFIE P, 1989, J CLIN ONCOL, V7, P1157, DOI 10.1200/JCO.1989.7.8.1157; RUSCH VW, 1991, J THORAC CARDIOV SUR, V102, P1; Ryan CW, 1998, CHEST, V113, p66S, DOI 10.1378/chest.113.1_Supplement.66S; Sterman DH, 2007, CLIN CANCER RES, V13, P4456, DOI 10.1158/1078-0432.CCR-07-0403; Sterman DH, 2005, CLIN CANCER RES, V11, P7444, DOI 10.1158/1078-0432.CCR-05-0405; Sterman DH, 1998, HUM GENE THER, V9, P1083, DOI 10.1089/hum.1998.9.7-1083; Taki M, 2005, ONCOGENE, V24, P3130, DOI 10.1038/sj.onc.1208460; Tango Y, 2004, CANCER SCI, V95, P459, DOI 10.1111/j.1349-7006.2004.tb03232.x; Umeoka T, 2004, CANCER RES, V64, P6259, DOI 10.1158/0008-5472.CAN-04-1335; Uno F, 2001, CANCER RES, V61, P7855; Yang CT, 2000, J NATL CANCER I, V92, P636, DOI 10.1093/jnci/92.8.636; Yang CT, 2001, CANCER RES, V61, P5959	36	22	22	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 25	2010	29	8					1145	1154		10.1038/onc.2009.415	http://dx.doi.org/10.1038/onc.2009.415			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	560ON	19935710				2022-12-25	WOS:000274912100006
J	Huo, YQ; Guo, X; Li, HG; Wang, H; Zhang, WY; Wang, Y; Zhou, HJ; Gao, ZG; Telang, S; Chesney, J; Chen, YE; Ye, JP; Chapkin, RS; Wu, CD				Huo, Yuqing; Guo, Xin; Li, Honggui; Wang, Huan; Zhang, Weiyu; Wang, Ying; Zhou, Huaijun; Gao, Zhanguo; Telang, Sucheta; Chesney, Jason; Chen, Y. Eugene; Ye, Jianping; Chapkin, Robert S.; Wu, Chaodong			Disruption of Inducible 6-Phosphofructo-2-kinase Ameliorates Diet-induced Adiposity but Exacerbates Systemic Insulin Resistance and Adipose Tissue Inflammatory Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-FAT DIET; ACTIVATED-RECEPTOR-ALPHA; AGILENT MICROARRAY; OXIDATIVE STRESS; GENE-EXPRESSION; INDUCED OBESITY; ENERGY-BALANCE; MICE LACKING; COENZYME-A; TNF-ALPHA	Adiposity is commonly associated with adipose tissue dysfunction and many overnutrition-related metabolic diseases including type 2 diabetes. Much attention has been paid to reducing adiposity as a way to improve adipose tissue function and systemic insulin sensitivity. PFKFB3/iPFK2 is a master regulator of adipocyte nutrient metabolism. Using PFKFB3(+/-) mice, the present study investigated the role of PFKFB3/iPFK2 in regulating diet-induced adiposity and systemic insulin resistance. On a high-fat diet (HFD), PFKFB3(+/-) mice gained much less body weight than did wild-type littermates. This was attributed to a smaller increase in adiposity in PFKFB3(+/-) mice than in wild-type controls. However, HFD-induced systemic insulin resistance was more severe in PFKFB3(+/-) mice than in wildtype littermates. Compared with wild-type littermates, PFKFB3(+/-) mice exhibited increased severity of HFD-induced adipose tissue dysfunction, as evidenced by increased adipose tissue lipolysis, inappropriate adipokine expression, and decreased insulin signaling, as well as increased levels of proinflammatory cytokines in both isolated adipose tissue macrophages and adipocytes. In an in vitro system, knockdown of PFKFB3/iPFK2 in 3T3-L1 adipocytes caused a decrease in the rate of glucose incorporation into lipid but an increase in the production of reactive oxygen species. Furthermore, knockdown of PFKFB3/iPFK2 in 3T3-L1 adipocytes inappropriately altered the expression of adipokines, decreased insulin signaling, increased the phosphorylation states of JNK and NF kappa B p65, and enhanced the production of proinflammatory cytokines. Together, these data suggest that PFKFB3/iPFK2, although contributing to adiposity, protects against diet-induced insulin resistance and adipose tissue inflammatory response.	[Huo, Yuqing; Wang, Huan; Zhang, Weiyu] Univ Minnesota, Sch Med, Dept Med, Minneapolis, MN 55455 USA; [Guo, Xin; Li, Honggui; Chapkin, Robert S.; Wu, Chaodong] Texas A&M Univ, Dept Nutr & Food Sci, Intercoll Fac Nutr, College Stn, TX 77843 USA; [Wang, Ying; Zhou, Huaijun] Texas A&M Univ, Dept Poultry Sci, Intercoll Fac Genet, College Stn, TX 77843 USA; [Gao, Zhanguo; Ye, Jianping] Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA; [Telang, Sucheta; Chesney, Jason] Univ Louisville, James Graham Brown Canc Ctr, Louisville, KY 40202 USA; [Chen, Y. Eugene] Univ Michigan, Med Ctr, Dept Internal Med, Ctr Cardiovasc, Ann Arbor, MI 48105 USA	University of Minnesota System; University of Minnesota Twin Cities; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; University of Louisville; University of Michigan System; University of Michigan	Huo, YQ (corresponding author), 420 Delaware St SE,MMC508, Minneapolis, MN 55455 USA.	yuqing@umn.edu; cdwu@tamu.edu	Ye, Jianping/N-1998-2017	Ye, Jianping/0000-0003-3875-365X; Chapkin, Robert/0000-0002-6515-3898	National Institutes of Health [HL78679, HL080569]; AHA [0430151N]; William W. Allen Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080569, R01HL078679] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA(American Heart Association); William W. Allen Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL78679 and HL080569 (to Y. H.). This work was also supported by AHA Grant 0430151N (to Y. H.) and the William W. Allen Foundation (to C. W. and J. L.).	Air EL, 2002, NAT MED, V8, P179, DOI 10.1038/nm0202-179; Aoyama T, 1998, J BIOL CHEM, V273, P5678, DOI 10.1074/jbc.273.10.5678; Atsumi T, 2005, DIABETES, V54, P3349, DOI 10.2337/diabetes.54.12.3349; Badman MK, 2007, GASTROENTEROLOGY, V132, P2103, DOI 10.1053/j.gastro.2007.03.058; Benton CR, 2008, APPL PHYSIOL NUTR ME, V33, P843, DOI 10.1139/H08-074; Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; Berger JJ, 1999, J APPL PHYSIOL, V87, P227, DOI 10.1152/jappl.1999.87.1.227; Boden G, 2002, AM J PHYSIOL-ENDOC M, V283, pE12, DOI 10.1152/ajpendo.00429.2001; Bullen JW, 2007, AM J PHYSIOL-ENDOC M, V292, pE1079, DOI 10.1152/ajpendo.00245.2006; Chesney J, 2005, BIOCHEM BIOPH RES CO, V331, P139, DOI 10.1016/j.bbrc.2005.02.193; Cheung AT, 2000, DIABETES, V49, P810, DOI 10.2337/diabetes.49.5.810; Cheung AT, 1998, ENDOCRINOLOGY, V139, P4928, DOI 10.1210/en.139.12.4928; Chiang HI, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-526; Combs TP, 2004, ENDOCRINOLOGY, V145, P367, DOI 10.1210/en.2003-1068; Evans JL, 2002, ENDOCR REV, V23, P599, DOI 10.1210/er.2001-0039; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Gallou-Kabani C, 2007, OBESITY, V15, P1996, DOI 10.1038/oby.2007.238; Gao ZG, 2002, J BIOL CHEM, V277, P48115, DOI 10.1074/jbc.M209459200; Gavrilova O, 2003, J BIOL CHEM, V278, P34268, DOI 10.1074/jbc.M300043200; Ghibaudi L, 2002, OBES RES, V10, P956, DOI 10.1038/oby.2002.130; Haemmerle G, 2002, J BIOL CHEM, V277, P4806, DOI 10.1074/jbc.M110355200; Haugen F, 2007, P NUTR SOC, V66, P171, DOI 10.1017/S0029665107005423; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; Kabir M, 2005, AM J PHYSIOL-ENDOC M, V288, pE454, DOI 10.1152/ajpendo.00203.2004; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Krekoukia M, 2007, METABOLISM, V56, P206, DOI 10.1016/j.metabol.2006.09.014; Kusunoki M, 2000, DIABETOLOGIA, V43, P875, DOI 10.1007/s001250051464; Li PP, 2005, AM J PHYSIOL-ENDOC M, V289, pE617, DOI 10.1152/ajpendo.00010.2005; Li XY, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-60; Llagostera E, 2009, FEBS LETT, V583, P2121, DOI 10.1016/j.febslet.2009.05.043; Lumeng CN, 2007, DIABETES, V56, P16, DOI 10.2337/db06-1076; Mercader J, 2006, ENDOCRINOLOGY, V147, P5325, DOI 10.1210/en.2006-0760; Miyazaki Y, 2002, AM J PHYSIOL-ENDOC M, V283, pE1135, DOI 10.1152/ajpendo.0327.2001; Morin CL, 1997, ENDOCRINOLOGY, V138, P4665, DOI 10.1210/en.138.11.4665; Muurling M, 2003, METABOLISM, V52, P1078, DOI 10.1016/S0026-0495(03)00109-4; Nakamura S, 2009, J BIOL CHEM, V284, P14809, DOI 10.1074/jbc.M901488200; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Okar DA, 2004, ADV ENZYME REGUL, V44, P123, DOI 10.1016/j.advenzreg.2003.11.006; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Qatanani M, 2007, GENE DEV, V21, P1443, DOI 10.1101/gad.1550907; Rasmussen BB, 2002, J CLIN INVEST, V110, P1687, DOI 10.1172/JCI200215715; Rider MH, 2004, BIOCHEM J, V381, P561, DOI 10.1042/BJ20040752; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; STANSBIE D, 1976, BIOCHEM J, V160, P413, DOI 10.1042/bj1600413; Stienstra R, 2008, J BIOL CHEM, V283, P22620, DOI 10.1074/jbc.M710314200; Subauste AR, 2007, AM J PHYSIOL-ENDOC M, V293, pE159, DOI 10.1152/ajpendo.00629.2006; Wang H, 2009, ARTERIOSCL THROM VAS, V29, P1046, DOI 10.1161/ATVBAHA.109.188839; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wu CD, 2005, CELL METAB, V2, P131, DOI 10.1016/j.cmet.2005.07.003; Wu CD, 2001, J CLIN INVEST, V107, P91, DOI 10.1172/JCI11103; Wu CD, 2006, AM J PHYSIOL-ENDOC M, V291, pE536, DOI 10.1152/ajpendo.00126.2006; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yao-Borengasser A, 2007, J CLIN ENDOCR METAB, V92, P2590, DOI 10.1210/jc.2006-0816; Zhang JF, 2004, P NATL ACAD SCI USA, V101, P10703, DOI 10.1073/pnas.0403652101	56	66	67	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3713	3721		10.1074/jbc.M109.058446	http://dx.doi.org/10.1074/jbc.M109.058446			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19948719	hybrid, Green Published			2022-12-25	WOS:000275254000023
J	Hosy, E; Dupuis, JP; Vivaudou, M				Hosy, Eric; Dupuis, Julien P.; Vivaudou, Michel			Impact of Disease-causing SUR1 Mutations on the K-ATP Channel Subunit Interface Probed with a Rhodamine Protection Assay	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SULFONYLUREA RECEPTOR; MOLECULAR-BASIS; KIR6.2; TRAFFICKING; OPENERS; DOMAIN; ABCC8; HYPERINSULINISM; STOICHIOMETRY; NUCLEOTIDES	The function of the ATP-sensitive potassium (K-ATP) channel relies on the proper coupling between its two subunits: the pore-forming Kir6.2 and the regulator SUR. The conformation of the interface between these two subunits can be monitored using a rhodamine 123 (Rho) protection assay because Rho blocks Kir6.2 with an efficiency that depends on the relative position of transmembrane domain (TMD) 0 of the associated SUR (Hosy, E., Derand, R., Revilloud, J., and Vivaudou, M. (2007) J. Physiol. 582, 27-39). Here we find that the natural and synthetic K-ATP channel activators MgADP, zinc, and SR47063 induced a Rhoinsensitive conformation. The activating mutation F132L in SUR1, which causes neonatal diabetes, also rendered the channel resistant to Rho block, suggesting that it stabilized an activated conformation by uncoupling TMD0 from the rest of SUR1. At a nearby residue, the SUR1 mutation E128K impairs trafficking, thereby reducing surface expression and causing hyperinsulinism. To augment channel density at the plasma membrane to investigate the effect of mutating this residue on channel function, we introduced the milder mutation E126A at the matching residue of SUR2A. Mutation E126A imposed a hypersensitive Rho phenotype indicative of a functional uncoupling between TMD0 and Kir6.2. These results suggest that the TMD0-Kir6.2 interface is mobile and that the gating modes of Kir6.2 correlate with distinct positions of TMD0. They further demonstrate that the second intracellular loop of SUR, which contains the two residues studied here, is a key structural element of the TMD0-Kir6.2 interface.	[Hosy, Eric; Dupuis, Julien P.; Vivaudou, Michel] UJF, CNRS, CEA, IBS,LPM, F-38027 Grenoble, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Vivaudou, M (corresponding author), UJF, CNRS, CEA, IBS,LPM, 41 Rue Jules Horowitz, F-38027 Grenoble, France.	vivaudou@cea.fr	Dupuis, Julien/M-7092-2017; Vivaudou, Michel/C-5338-2008	Vivaudou, Michel/0000-0002-9777-3127; hosy, eric/0000-0002-2479-5915; Dupuis, Julien P./0000-0003-1660-7782	Commissariat a l'Energie Atomique	Commissariat a l'Energie Atomique(French Atomic Energy Commission)	This work was supported by grants (to M. V.) and a postdoctoral fellowship (to E. H.) from the Program Toxicologie Nucleaire Environnementale of the Commissariat a l'Energie Atomique.	Alekseev AE, 2005, J MOL CELL CARDIOL, V38, P895, DOI 10.1016/j.yjmcc.2005.02.022; Ashcroft FM, 2007, AM J PHYSIOL-ENDOC M, V293, pE880, DOI 10.1152/ajpendo.00348.2007; Babenko AP, 2003, J BIOL CHEM, V278, P41577, DOI 10.1074/jbc.C300363200; Babenko AP, 2002, J BIOL CHEM, V277, P43997, DOI 10.1074/jbc.M208085200; Chan KW, 2003, EMBO J, V22, P3833, DOI 10.1093/emboj/cdg376; Dupuis JP, 2008, J PHYSIOL-LONDON, V586, P3075, DOI 10.1113/jphysiol.2008.152744; Flanagan SE, 2009, HUM MUTAT, V30, P170, DOI 10.1002/humu.20838; Gribble FM, 1997, J PHYSIOL-LONDON, V504, P35, DOI 10.1111/j.1469-7793.1997.00035.x; Hosy E, 2007, J PHYSIOL-LONDON, V582, P27, DOI 10.1113/jphysiol.2007.134288; Karger AB, 2008, J GEN PHYSIOL, V131, P185, DOI 10.1085/jgp.200709852; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Moreau C, 2005, J MOL CELL CARDIOL, V38, P951, DOI 10.1016/j.yjmcc.2004.11.030; Moreau C, 2005, MOL PHARMACOL, V67, P1026, DOI 10.1124/mol.104.008698; Moreau C, 2000, EMBO J, V19, P6644, DOI 10.1093/emboj/19.24.6644; Moreau CJ, 2008, NAT NANOTECHNOL, V3, P620, DOI 10.1038/nnano.2008.242; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; Pratt EB, 2009, J BIOL CHEM, V284, P7951, DOI 10.1074/jbc.M807012200; Proks P, 2007, HUM MOL GENET, V16, P2011, DOI 10.1093/hmg/ddm149; Proks P, 2006, HUM MOL GENET, V15, P1793, DOI 10.1093/hmg/ddl101; Prost AL, 2004, J PHYSIOL-LONDON, V559, P157, DOI 10.1113/jphysiol.2004.065094; Raab-Graham KF, 1999, J BIOL CHEM, V274, P29122, DOI 10.1074/jbc.274.41.29122; Rainbow RD, 2004, BIOCHEM J, V379, P173, DOI 10.1042/BJ20031087; Reimann F, 1999, J PHYSIOL-LONDON, V518, P325, DOI 10.1111/j.1469-7793.1999.0325p.x; Ribalet B, 2003, BIOPHYS J, V84, P266, DOI 10.1016/S0006-3495(03)74847-4; Schwappach B, 2000, NEURON, V26, P155, DOI 10.1016/S0896-6273(00)81146-0; Shyng SL, 1997, J GEN PHYSIOL, V110, P643, DOI 10.1085/jgp.110.6.643; Tucker SJ, 1997, NATURE, V387, P179, DOI 10.1038/387179a0; VIVAUDOU M, 1995, J PHYSIOL-LONDON, V486, P629, DOI 10.1113/jphysiol.1995.sp020840; Yan FF, 2007, DIABETES, V56, P2339, DOI 10.2337/db07-0150; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zingman LV, 2001, NEURON, V31, P233, DOI 10.1016/S0896-6273(01)00356-7	31	4	4	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5							3084	10.1074/jbc.M109.043307	http://dx.doi.org/10.1074/jbc.M109.043307			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19933268	Green Published, hybrid			2022-12-25	WOS:000273829000024
J	Le Saux, S; Rousseau, F; Barbier, F; Ravon, E; Grimaud, L; Danger, Y; Froger, J; Chevalier, S; Gascan, H				Le Saux, Sabine; Rousseau, Francois; Barbier, Fabien; Ravon, Elisa; Grimaud, Linda; Danger, Yannic; Froger, Josy; Chevalier, Sylvie; Gascan, Hugues			Molecular Dissection of Human Interleukin-31-mediated Signal Transduction through Site-directed Mutagenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUKEMIA INHIBITORY FACTOR; IMMUNOGLOBULIN-LIKE DOMAIN; CELL STIMULATORY FACTOR; CYTOKINE RECEPTOR; ONCOSTATIN-M; T-CELLS; ATOPIC-DERMATITIS; EPITHELIAL-CELLS; LIF RECEPTOR; NC/NGA MICE	Interleukin (IL)-31 is a recently described cytokine, preferentially produced by T helper 2 lymphocytes and associated with skin diseases, such as atopic dermatitis. IL-31 is a member of the four alpha-helix bundle cytokine family and is related to the IL-6 subgroup. Its heterodimeric membrane receptor is composed of the gp130-like receptor (GPL) subunit associated to the oncostatin M receptor subunit. We identified critical amino acids implicated in the ligand receptor interaction by computational analysis combined with site-directed mutagenesis. Six IL-31 residues selected for their putative involvement in cytokine receptor contact sites were alanine-substituted, and the corresponding proteins were expressed in mammalian and bacterial systems. Biochemical, membrane binding, cell signaling, and cell proliferation analyses showed that mutation E44A, E106A, or H110A abolished IL-31 binding to GPL and the subsequent signaling events. A second ligand receptor-binding site involved Lys(134), with alanine substitution leading to a protein that still binds GPL, but is unable to recruit the second receptor subunit and the subsequent signaling pathways. The results indicate that IL-31 recognizes its receptor complex through two different binding sites, and we propose a three-dimensional model for IL-31.	[Gascan, Hugues] INSERM, U564, Unite Mixte 564, F-49933 Angers 09, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers	Gascan, H (corresponding author), INSERM, U564, Unite Mixte 564, Batiment Monteclair,4 Rue Larrey, F-49933 Angers 09, France.	hugues.gascan@univ-angers.fr		Danger, Yannic/0000-0002-5611-5048	Association pour la Recherche contre le Cancer [5176]; Region Pays de la Loire	Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Region Pays de la Loire(Region Pays de la Loire)	This work was supported by Grant 5176 from the Association pour la Recherche contre le Cancer and by the Ciblage Moleculaire et Applications Therapeutiques Program of the Region Pays de la Loire.	Aasland D, 2002, J MOL BIOL, V315, P637, DOI 10.1006/jmbi.2001.5282; BAZAN JF, 1990, IMMUNOL TODAY, V11, P350, DOI 10.1016/0167-5699(90)90139-Z; BAZAN JF, 1990, P NATL ACAD SCI USA, V87, P6934, DOI 10.1073/pnas.87.18.6934; BAZAN JF, 1989, BIOCHEM BIOPH RES CO, V164, P788, DOI 10.1016/0006-291X(89)91528-3; Bilsborough J, 2006, J ALLERGY CLIN IMMUN, V117, P418, DOI 10.1016/j.jaci.2005.10.046; Boulanger MJ, 2004, ADV PROTEIN CHEM, V68, P107; Boulanger MJ, 2003, MOL CELL, V12, P577, DOI 10.1016/S1097-2765(03)00365-4; Boulanger MJ, 2003, SCIENCE, V300, P2101, DOI 10.1126/science.1083901; Bravo J, 2000, EMBO J, V19, P2399, DOI 10.1093/emboj/19.11.2399; Chattopadhyay S, 2007, J BIOL CHEM, V282, P3014, DOI 10.1074/jbc.M609655200; Dambacher J, 2007, GUT, V56, P1257, DOI 10.1136/gut.2006.118679; Deller MC, 2000, STRUCT FOLD DES, V8, P863, DOI 10.1016/S0969-2126(00)00176-3; Dillon SR, 2004, NAT IMMUNOL, V5, P752, DOI 10.1038/ni1084; DiMarco A, 1996, P NATL ACAD SCI USA, V93, P9247, DOI 10.1073/pnas.93.17.9247; Diveu C, 2003, J BIOL CHEM, V278, P49850, DOI 10.1074/jbc.M307286200; Diveu C, 2004, EUR CYTOKINE NETW, V15, P291; Dreuw A, 2004, J BIOL CHEM, V279, P36112, DOI 10.1074/jbc.M401122200; Elson GCA, 2000, NAT NEUROSCI, V3, P867, DOI 10.1038/78765; GEARING DP, 1991, CELL, V66, P9, DOI 10.1016/0092-8674(91)90131-H; Ghilardi N, 2002, J BIOL CHEM, V277, P16831, DOI 10.1074/jbc.M201140200; Grimstad O, 2009, EXP DERMATOL, V18, P35, DOI 10.1111/j.1600-0625.2008.00766.x; Hammacher A, 1998, J BIOL CHEM, V273, P22701, DOI 10.1074/jbc.273.35.22701; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; HIBI M, 1990, CELL, V63, P1149, DOI 10.1016/0092-8674(90)90411-7; Hill EE, 2002, J MOL BIOL, V322, P205, DOI 10.1016/S0022-2836(02)00653-8; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Hudson KR, 1996, J BIOL CHEM, V271, P11971, DOI 10.1074/jbc.271.20.11971; Huyton T, 2007, P NATL ACAD SCI USA, V104, P12737, DOI 10.1073/pnas.0705577104; Jawa RS, 2008, J INTERF CYTOK RES, V28, P207, DOI 10.1089/jir.2007.0057; Layton JE, 1999, J BIOL CHEM, V274, P17445, DOI 10.1074/jbc.274.25.17445; Layton JE, 2001, J BIOL CHEM, V276, P36779, DOI 10.1074/jbc.M104787200; Lei Z, 2008, ALLERGY, V63, P327, DOI 10.1111/j.1398-9995.2007.01566.x; Leung DYM, 2003, LANCET, V361, P151, DOI 10.1016/S0140-6736(03)12193-9; Mosley B, 1996, J BIOL CHEM, V271, P32635, DOI 10.1074/jbc.271.51.32635; Neis MM, 2006, J ALLERGY CLIN IMMUN, V118, P930, DOI 10.1016/j.jaci.2006.07.015; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Plun-Favreau H, 2003, J BIOL CHEM, V278, P27169, DOI 10.1074/jbc.M303168200; Plun-Favreau H, 2001, EMBO J, V20, P1692, DOI 10.1093/emboj/20.7.1692; ROZWARSKI DA, 1994, STRUCTURE, V2, P159, DOI 10.1016/S0969-2126(00)00018-6; Schulz F, 2007, J ALLERGY CLIN IMMUN, V120, P1097, DOI 10.1016/j.jaci.2007.07.065; Skiniotis G, 2008, MOL CELL, V31, P737, DOI 10.1016/j.molcel.2008.08.011; Sonkoly E, 2006, J ALLERGY CLIN IMMUN, V117, P411, DOI 10.1016/j.jaci.2005.10.033; Takaoka A, 2006, EXP DERMATOL, V15, P161, DOI 10.1111/j.1600-0625.2006.00405.x; Takaoka A, 2005, EUR J PHARMACOL, V516, P180, DOI 10.1016/j.ejphar.2005.04.040; THOMA B, 1994, J BIOL CHEM, V269, P6215; Wang XQ, 2009, ANNU REV IMMUNOL, V27, P29, DOI 10.1146/annurev.immunol.24.021605.090616; WOLF SF, 1991, J IMMUNOL, V146, P3074	48	14	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5					3470	3477		10.1074/jbc.M109.049189	http://dx.doi.org/10.1074/jbc.M109.049189			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19920145	Green Published, hybrid			2022-12-25	WOS:000273829000061
J	Mera, PE; Escalante-Semerena, JC				Mera, Paola E.; Escalante-Semerena, Jorge C.			Dihydroflavin-driven Adenosylation of 4-Coordinate Co(II) Corrinoids ARE COBALAMIN REDUCTASES ENZYMES OR ELECTRON TRANSFER PROTEINS?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHIONINE SYNTHASE REDUCTASE; SEROVAR TYPHIMURIUM LT2; SALMONELLA-ENTERICA; ATP-COB(I)ALAMIN ADENOSYLTRANSFERASE; LACTOBACILLUS-REUTERI; TEV PROTEASE; ADENOSYLCOBALAMIN BIOSYNTHESIS; INITIAL-CHARACTERIZATION; ENZYMATIC CONVERSION; FUSION PROTEINS	The identity of the source of the biological reductant needed to convert cobalamin to its biologically active form adenosylcobalamin has remained elusive. Here we show that free or protein-bound dihydroflavins can serve as the reductant of Co2+ Cbl bound in the active site of PduO-type ATP-dependent corrinoid adenosyltransferase enzymes. Free dihydroflavins (dihydroriboflavin, FMNH2, and FADH(2)) effectively drove the adenosylation of Co2+ Cbl by the human and bacterial PduO-type enzymes at very low concentrations (1 mu M). These data show that adenosyltransferase enzymes lower the thermodynamic barrier of the Co2+ -> Co+ reduction needed for the formation of the unique organometalic Co-C bond of adenosylcobalamin. Collectively, our in vivo and in vitro data suggest that cobalamin reductases identified thus far are most likely electron transfer proteins, not enzymes.	[Mera, Paola E.; Escalante-Semerena, Jorge C.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Escalante-Semerena, JC (corresponding author), Univ Wisconsin, Dept Bacteriol, 1550 Linden Dr, Madison, WI 53706 USA.	escalante@bact.wisc.edu			National Institutes of Health Grant [GM40313]; Predoctoral National Research Service [F31-GM081979]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040313, F31GM081979, R37GM040313] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Predoctoral National Research Service; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM40313 from USPHS (to J. C. E.- S.).; Supported in part by Predoctoral National Research Service Award Fellowship F31-GM081979.	BANDARIAN V, 1999, CHEM BIOCH B, V12, P811; Banerjee R., 1999, Chemistry and biochemistry of B12., P707; BERKOWIT.D, 1968, J BACTERIOL, V96, P215, DOI 10.1128/JB.96.1.215-220.1968; Bertani G, 2004, J BACTERIOL, V186, P595, DOI 10.1128/JB.186.3.595-600.2004; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Blommel PG, 2007, PROTEIN EXPRES PURIF, V55, P53, DOI 10.1016/j.pep.2007.04.013; Buan NR, 2006, J BIOL CHEM, V281, P16971, DOI 10.1074/jbc.M603069200; Buan NR, 2005, J BIOL CHEM, V280, P40948, DOI 10.1074/jbc.M506713200; Buan NR, 2004, J BACTERIOL, V186, P5708, DOI 10.1128/JB.186.17.5708-5714.2004; Buckel W., 1999, Chemistry and biochemistry of B12., P757; Choi JW, 2008, J MOL BIOL, V377, P258, DOI 10.1016/j.jmb.2008.01.004; ESCALANTESEMERENA JC, 1990, J BACTERIOL, V172, P273, DOI 10.1128/JB.172.1.273-280.1990; Fonseca MV, 2001, J BIOL CHEM, V276, P32101, DOI 10.1074/jbc.M102510200; Fonseca MV, 2000, J BACTERIOL, V182, P4304, DOI 10.1128/JB.182.15.4304-4309.2000; Fontecave M, 1998, CELL MOL LIFE SCI, V54, P684, DOI 10.1007/s000180050195; Fontecave M., 1999, Chemistry and biochemistry of B12., P731; FREY PA, 2007, ENZYMATIC REACTION M, P189; Froese DS, 2008, MOL GENET METAB, V94, P68, DOI 10.1016/j.ymgme.2007.11.019; Hall DA, 2000, BIOCHEMISTRY-US, V39, P10711, DOI 10.1021/bi001096c; HALPERN J, 1985, SCIENCE, V227, P869, DOI 10.1126/science.2857503; Haspel J, 2001, BIOTECHNIQUES, V30, P60, DOI 10.2144/01301st01; Havemann GD, 2003, J BACTERIOL, V185, P5086, DOI 10.1128/JB.185.17.5086-5095.2003; Johnson CLV, 2004, J BACTERIOL, V186, P7881, DOI 10.1128/JB.186.23.7881-7887.2004; Kapust RB, 2000, PROTEIN EXPRES PURIF, V19, P312, DOI 10.1006/prep.2000.1251; Lawrence AD, 2008, J BIOL CHEM, V283, P10813, DOI 10.1074/jbc.M710431200; Leal NA, 2004, J BIOL CHEM, V279, P47536, DOI 10.1074/jbc.M405449200; Leclerc D, 1999, GENE, V240, P75, DOI 10.1016/S0378-1119(99)00431-X; LEXA D, 1983, ACCOUNTS CHEM RES, V16, P235, DOI 10.1021/ar00091a001; Mera PE, 2009, BIOCHEMISTRY-US, V48, P3138, DOI 10.1021/bi9000134; OTOOLE GA, 1993, J BACTERIOL, V175, P6328, DOI 10.1128/JB.175.19.6328-6336.1993; Park K, 2008, BIOCHEMISTRY-US, V47, P9007, DOI 10.1021/bi800419e; Rocco CJ, 2008, PLASMID, V59, P231, DOI 10.1016/j.plasmid.2008.01.001; Sampson EM, 2005, MICROBIOL-SGM, V151, P1169, DOI 10.1099/mic.0.27755-0; Shih YP, 2005, PROTEIN SCI, V14, P936, DOI 10.1110/ps.041129605; St Maurice M, 2008, BIOCHEMISTRY-US, V47, P5755, DOI 10.1021/bi800132d; St Maurice M, 2007, J BIOL CHEM, V282, P2596, DOI 10.1074/jbc.M609557200; Stich TA, 2005, J AM CHEM SOC, V127, P7660, DOI 10.1021/ja050546r; Stich TA, 2005, J AM CHEM SOC, V127, P8710, DOI 10.1021/ja042142p; Stich TA, 2004, J AM CHEM SOC, V126, P9735, DOI 10.1021/ja0481631; SUH SJ, 1995, J BACTERIOL, V177, P921, DOI 10.1128/jb.177.4.921-925.1995; Toraya T., 1999, Chemistry and biochemistry of B12., P783; WALKER GA, 1969, ARCH BIOCHEM BIOPHYS, V134, P95, DOI 10.1016/0003-9861(69)90255-0; Warren MJ, 2002, NAT PROD REP, V19, P390, DOI 10.1039/B108967F; Watanabe F, 1997, METHOD ENZYMOL, V281, P295; Wohlfarth G., 1999, Chemistry and biochemistry of B12., P871	45	27	28	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5							2911	10.1074/jbc.M109.059485	http://dx.doi.org/10.1074/jbc.M109.059485			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19933577	Green Published, hybrid			2022-12-25	WOS:000273829000005
J	Perez-Sala, D; Boya, P; Ramos, I; Herrera, M; Stamatakis, K				Perez-Sala, Dolores; Boya, Patricia; Ramos, Irene; Herrera, Monica; Stamatakis, Konstantinos			The C-Terminal Sequence of RhoB Directs Protein Degradation through an Endo-Lysosomal Pathway	PLOS ONE			English	Article							MEMBRANE; RAS; LOCALIZATION; TRAFFICKING; EXPRESSION; ENDOSOMES; AUTOPHAGY; DISEASE; GTPASES; ATPASE	Background: Protein degradation is essential for cell homeostasis. Targeting of proteins for degradation is often achieved by specific protein sequences or posttranslational modifications such as ubiquitination. Methodology/Principal Findings: By using biochemical and genetic tools we have monitored the localization and degradation of endogenous and chimeric proteins in live primary cells by confocal microscopy and ultra-structural analysis. Here we identify an eight amino acid sequence from the C-terminus of the short-lived GTPase RhoB that directs the rapid degradation of both RhoB and chimeric proteins bearing this sequence through a lysosomal pathway. Elucidation of the RhoB degradation pathway unveils a mechanism dependent on protein isoprenylation and palmitoylation that involves sorting of the protein into multivesicular bodies, mediated by the ESCRT machinery. Moreover, RhoB sorting is regulated by late endosome specific lipid dynamics and is altered in human genetic lipid traffic disease. Conclusions/Significance: Our findings characterize a short-lived cytosolic protein that is degraded through a lysosomal pathway. In addition, we define a novel motif for protein sorting and rapid degradation, which allows controlling protein levels by means of clinically used drugs.	[Perez-Sala, Dolores; Ramos, Irene; Herrera, Monica; Stamatakis, Konstantinos] CSIC, Dept Chem & Phys Biol, Ctr Invest Biol, Madrid, Spain; [Boya, Patricia] CSIC, Dept Mol & Cellular Med, Ctr Invest Biol, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Perez-Sala, D (corresponding author), CSIC, Dept Chem & Phys Biol, Ctr Invest Biol, Madrid, Spain.	dperezsala@cib.csic.es	Perez-Sala, Dolores/L-5969-2014; Boya, Patricia/P-8345-2019; RAMOS, IRENE/AAS-4772-2021; Boya, Patricia/K-2911-2014; Stamatakis, Konstantinos/A-6596-2017	Perez-Sala, Dolores/0000-0003-0600-665X; Boya, Patricia/0000-0003-3045-951X; RAMOS, IRENE/0000-0002-0223-0120; Boya, Patricia/0000-0003-3045-951X; Stamatakis, Konstantinos/0000-0001-9934-3502	MCI [SAF2006-03489]; RETICS "RIRAAF'' [RD07/0064/0007]; ISCIII [BFU2006-00508]	MCI; RETICS "RIRAAF''; ISCIII(Instituto de Salud Carlos III)	This work was supported by grants from MCI, SAF2006-03489 and RETICS "RIRAAF'' RD07/0064/0007 from ISCIII to DPS and BFU2006-00508 to PB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bishop N, 2000, MOL BIOL CELL, V11, P227, DOI 10.1091/mbc.11.1.227; Bivona TG, 2006, MOL CELL, V21, P481, DOI 10.1016/j.molcel.2006.01.012; Braulke T, 2009, BBA-MOL CELL RES, V1793, P605, DOI 10.1016/j.bbamcr.2008.10.016; Carreno S, 2000, J BIOL CHEM, V275, P36223, DOI 10.1074/jbc.M003901200; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; Dransart E, 2005, TRAFFIC, V6, P957, DOI 10.1111/j.1600-0854.2005.00335.x; Engel ME, 1998, J BIOL CHEM, V273, P9921, DOI 10.1074/jbc.273.16.9921; Fader CM, 2009, CELL DEATH DIFFER, V16, P70, DOI 10.1038/cdd.2008.168; Falguieres T, 2009, EXP CELL RES, V315, P1567, DOI 10.1016/j.yexcr.2008.12.006; Fritz G, 1997, J BIOL CHEM, V272, P30637, DOI 10.1074/jbc.272.49.30637; Fuertes G, 2003, INT J BIOCHEM CELL B, V35, P651, DOI 10.1016/S1357-2725(02)00382-5; Gorfe AA, 2007, J AM CHEM SOC, V129, P12280, DOI 10.1021/ja073949v; GUTIERREZ L, 1989, EMBO J, V8, P1093, DOI 10.1002/j.1460-2075.1989.tb03478.x; HANSEN SH, 1993, J CELL BIOL, V121, P61, DOI 10.1083/jcb.121.1.61; Huang M, 2006, ONCOGENE, V25, P1281, DOI 10.1038/sj.onc.1209174; Huang M, 2007, ARTERIOSCL THROM VAS, V27, P2597, DOI 10.1161/ATVBAHA.107.154211; Kobayashi T, 1999, NAT CELL BIOL, V1, P113, DOI 10.1038/10084; Lafourcade C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002758; Liu AX, 2001, MOL CELL BIOL, V21, P6906, DOI 10.1128/MCB.21.20.6906-6912.2001; Luyet PP, 2008, TRAFFIC, V9, P2279, DOI 10.1111/j.1600-0854.2008.00820.x; Malcolm T, 2003, ONCOGENE, V22, P6142, DOI 10.1038/sj.onc.1206638; Marchetti A, 2004, J CELL SCI, V117, P6053, DOI 10.1242/jcs.01524; Massey AC, 2006, CURR TOP DEV BIOL, V73, P205, DOI 10.1016/S0070-2153(05)73007-6; Matsuo H, 2004, SCIENCE, V303, P531, DOI 10.1126/science.1092425; McCormick PJ, 2008, TRAFFIC, V9, P1984, DOI 10.1111/j.1600-0854.2008.00814.x; Meiringer CTA, 2008, TRAFFIC, V9, P1510, DOI 10.1111/j.1600-0854.2008.00778.x; Mellor H, 1998, J BIOL CHEM, V273, P4811, DOI 10.1074/jbc.273.9.4811; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Peng YT, 2006, TRAFFIC, V7, P1378, DOI 10.1111/j.1600-0854.2006.00472.x; Percherancier Y, 2001, J BIOL CHEM, V276, P31936, DOI 10.1074/jbc.M104013200; Perez-Sala D, 1999, CELL DEATH DIFFER, V6, P722, DOI 10.1038/sj.cdd.4400557; ROBERTSON D, 1995, J HISTOCHEM CYTOCHEM, V43, P471, DOI 10.1177/43.5.7537292; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Russell MRG, 2006, CURR OPIN CELL BIOL, V18, P422, DOI 10.1016/j.ceb.2006.06.002; Sachse M, 2004, J CELL SCI, V117, P1699, DOI 10.1242/jcs.00998; Sandilands E, 2004, DEV CELL, V7, P855, DOI 10.1016/j.devcel.2004.09.019; Schwartz AL, 2009, ANNU REV PHARMACOL, V49, P73, DOI 10.1146/annurev.pharmtox.051208.165340; Sobo K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000851; Stamatakis K, 2002, J BIOL CHEM, V277, P49389, DOI 10.1074/jbc.M204049200; Wang DA, 2005, J BIOL CHEM, V280, P19243, DOI 10.1074/jbc.M411472200; Wennerberg K, 2004, J CELL SCI, V117, P1301, DOI 10.1242/jcs.01118; Wherlock M, 2004, J CELL SCI, V117, P3221, DOI 10.1242/jcs.01193; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162	44	51	51	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2009	4	12							e8117	10.1371/journal.pone.0008117	http://dx.doi.org/10.1371/journal.pone.0008117			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MU	19956591	Green Published, gold, Green Submitted			2022-12-25	WOS:000272828800014
J	Wu, M; Yang, XR; Chan, C				Wu, Ming; Yang, Xuerui; Chan, Christina			A Dynamic Analysis of IRS-PKR Signaling in Liver Cells: A Discrete Modeling Approach	PLOS ONE			English	Article							INSULIN-RECEPTOR SUBSTRATE-1; KINASE C-ZETA; PROTEIN-KINASE; SERINE/THREONINE PHOSPHORYLATION; PHOSPHATIDYLINOSITOL 3-KINASE; REGULATORY SUBUNIT; TYROSINE PHOSPHORYLATION; GLUCOSE-TRANSPORT; 3T3-L1 ADIPOCYTES; INDUCED APOPTOSIS	A major challenge in systems biology is to develop a detailed dynamic understanding of the functions and behaviors in a particular cellular system, which depends on the elements and their inter-relationships in a specific network. Computational modeling plays an integral part in the study of network dynamics and uncovering the underlying mechanisms. Here we proposed a systematic approach that incorporates discrete dynamic modeling and experimental data to reconstruct a phenotype-specific network of cell signaling. A dynamic analysis of the insulin signaling system in liver cells provides a proof-of-concept application of the proposed methodology. Our group recently identified that double-stranded RNA-dependent protein kinase (PKR) plays an important role in the insulin signaling network. The dynamic behavior of the insulin signaling network is tuned by a variety of feedback pathways, many of which have the potential to cross talk with PKR. Given the complexity of insulin signaling, it is inefficient to experimentally test all possible interactions in the network to determine which pathways are functioning in our cell system. Our discrete dynamic model provides an in silico model framework that integrates potential interactions and assesses the contributions of the various interactions on the dynamic behavior of the signaling network. Simulations with the model generated testable hypothesis on the response of the network upon perturbation, which were experimentally evaluated to identify the pathways that function in our particular liver cell system. The modeling in combination with the experimental results enhanced our understanding of the insulin signaling dynamics and aided in generating a context-specific signaling network.	[Wu, Ming; Chan, Christina] Michigan State Univ, Dept Comp Sci & Engn, E Lansing, MI 48824 USA; [Yang, Xuerui; Chan, Christina] Michigan State Univ, Dept Chem Engn & Mat Sci, E Lansing, MI 48824 USA; [Chan, Christina] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University	Wu, M (corresponding author), Michigan State Univ, Dept Comp Sci & Engn, E Lansing, MI 48824 USA.	krischan@egr.msu.edu	Wu, Ming/K-4074-2014	Yang, Xuerui/0000-0002-7731-2147	National Institute of Health [R01GM079688, R21CA126136, R21RR024439, P42 ES004911]; National Science Foundation [DBI 0701709]; MSU Foundation; Center for Systems Biology; Michigan State University (MSU); NATIONAL CANCER INSTITUTE [R21CA126136] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR024439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES004911] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079688] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); MSU Foundation; Center for Systems Biology; Michigan State University (MSU); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The work was supported in part by the National Institute of Health (R01GM079688, R21CA126136, R21RR024439 and P42 ES004911), the National Science Foundation (DBI 0701709), and the MSU Foundation and the Center for Systems Biology. M. W. is supported in part by Michigan State University (MSU) Quantitative Biology and Modeling Fellowship.	Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; Albert R, 2003, J THEOR BIOL, V223, P1, DOI 10.1016/S0022-5193(03)00035-3; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alon U, 1999, NATURE, V397, P168, DOI 10.1038/16483; BACKER JM, 1992, J BIOL CHEM, V267, P1367; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; Bollen M, 1998, BIOCHEM J, V336, P19, DOI 10.1042/bj3360019; Bornholdt S, 2005, SCIENCE, V310, P449, DOI 10.1126/science.1119959; Bornholdt S, 2008, J R SOC INTERFACE, V5, pS85, DOI 10.1098/rsif.2008.0132.focus; Davidich MI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001672; De Jong H, 2002, J COMPUT BIOL, V9, P67, DOI 10.1089/10665270252833208; Espinosa-soto C, 2004, PLANT CELL, V16, P2923, DOI 10.1105/tpc.104.021725; Faure A, 2006, BIOINFORMATICS, V22, pE124, DOI 10.1093/bioinformatics/btl210; Gao ZG, 2002, J BIOL CHEM, V277, P48115, DOI 10.1074/jbc.M209459200; Geva-Zatorsky N, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100068; Greil F, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.048701; Gual P, 2003, J BIOL CHEM, V278, P26550, DOI 10.1074/jbc.M212273200; Hasty J, 2001, NAT REV GENET, V2, P268, DOI 10.1038/35066056; Heinrich R, 2002, MOL CELL, V9, P957, DOI 10.1016/S1097-2765(02)00528-2; Herschkovitz A, 2007, J BIOL CHEM, V282, P18018, DOI 10.1074/jbc.M610949200; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; Klemm K, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.055101; Kuo YC, 2008, J BIOL CHEM, V283, P1882, DOI 10.1074/jbc.M709585200; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Lazebnik Y, 2002, CANCER CELL, V2, P179, DOI 10.1016/S1535-6108(02)00133-2; Li FT, 2004, P NATL ACAD SCI USA, V101, P4781, DOI 10.1073/pnas.0305937101; Li S, 2006, PLOS BIOL, V4, P1732, DOI 10.1371/journal.pbio.0040312; LOWENSTEIN EJ, 1992, CELL, V70, P431, DOI 10.1016/0092-8674(92)90167-B; Mendoza L, 1999, BIOINFORMATICS, V15, P593, DOI 10.1093/bioinformatics/15.7.593; Morimoto H, 2004, J BIOCHEM, V136, P433, DOI 10.1093/jb/mvh144; Novak M, 2004, J THEOR BIOL, V230, P563, DOI 10.1016/j.jtbi.2004.04.039; Ozes ON, 2001, P NATL ACAD SCI USA, V98, P4640, DOI 10.1073/pnas.051042298; Padmanabhan S, 2009, CELL, V136, P939, DOI 10.1016/j.cell.2009.01.025; Patti Mary-Elizabeth, 1998, Journal of Basic and Clinical Physiology and Pharmacology, V9, P89; Paz K, 1997, J BIOL CHEM, V272, P29911, DOI 10.1074/jbc.272.47.29911; Pederson TM, 2001, DIABETES, V50, P24, DOI 10.2337/diabetes.50.1.24; Rao CV, 2002, NATURE, V420, P231, DOI 10.1038/nature01258; Ravichandran LV, 2001, J BIOL CHEM, V276, P3543, DOI 10.1074/jbc.M007231200; Rondinone CM, 1999, DIABETOLOGIA, V42, P819, DOI 10.1007/s001250051232; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Sanchez L, 2001, J THEOR BIOL, V211, P115, DOI 10.1006/jtbi.2001.2335; SKOLNIK EY, 1993, EMBO J, V12, P1929, DOI 10.1002/j.1460-2075.1993.tb05842.x; Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012; Standaert ML, 1997, J BIOL CHEM, V272, P30075, DOI 10.1074/jbc.272.48.30075; THOMAS R, 1973, J THEOR BIOL, V42, P563, DOI 10.1016/0022-5193(73)90247-6; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; Tyson JJ, 2001, NAT REV MOL CELL BIO, V2, P908, DOI 10.1038/35103078; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; van Riel NAW, 2006, BRIEF BIOINFORM, V7, P364, DOI 10.1093/bib/bbl040; von Dassow G, 2000, NATURE, V406, P188, DOI 10.1038/35018085; Wada T, 2001, MOL CELL BIOL, V21, P1633, DOI 10.1128/MCB.21.5.1633-1646.2001; Wang XW, 2008, CURR OPIN BIOTECH, V19, P482, DOI 10.1016/j.copbio.2008.07.011; White MF, 1996, PHILOS T ROY SOC B, V351, P181, DOI 10.1098/rstb.1996.0015; WU M, 2009, DYNAMIC ANAL I UNPUB; Xu Z, 2000, MOL CELL BIOL, V20, P5285, DOI 10.1128/MCB.20.14.5285-5299.2000; YANG X, 2009, DOWNSTREAM TAR UNPUB; Yang XR, 2009, CELL RES, V19, P469, DOI 10.1038/cr.2009.25; Yao G, 2008, NAT CELL BIOL, V10, P476, DOI 10.1038/ncb1711; Zick Y, 2004, BIOCHEM SOC T, V32, P812, DOI 10.1042/BST0320812; Zick Yehiel, 2005, Sci STKE, V2005, ppe4, DOI 10.1126/stke.2682005pe4	60	29	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2009	4	12							e8040	10.1371/journal.pone.0008040	http://dx.doi.org/10.1371/journal.pone.0008040			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MT	19956598	Green Published, gold, Green Submitted			2022-12-25	WOS:000272828700006
J	Couturier, E; du Pont, SC; Douady, S				Couturier, Etienne; du Pont, Sylvain Courrech; Douady, Stephane			A Global Regulation Inducing the Shape of Growing Folded Leaves	PLOS ONE			English	Article							LEAF; DYNAMICS	Shape is one of the important characteristics for the structures observed in living organisms. Whereas biologists have proposed models where the shape is controlled on a molecular level [1], physicists, following Turing [2] and d'Arcy Thomson [3], have developed theories where patterns arise spontaneously [4]. Here, we propose that volume constraints restrict the possible shapes of leaves. Focusing on palmate leaves (with lobes), the central observation is that developing leaves first grow folded inside a bud, limited by the previous and subsequent leaves. We show that the lobe perimeters end at the border of this small volume. This induces a direct relationship between the way it was folded and the final unfolded shape of the leaf. These dependencies can be approximated as simple geometrical relationships that we confirm on both folded embryonic and unfolded mature leaves. We find that independent of their position in the phylogenetic tree, these relationships work for folded species, but do not work for non-folded species. This global regulation for the leaf growth could come from a mechanical steric constraint. Such steric regulation should be more general and considered as a new simple means of global regulation.	[Couturier, Etienne] CNRS, Lab MSC, UMR 7057, Paris, France; Univ Paris Diderot, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Couturier, E (corresponding author), CNRS, Lab MSC, UMR 7057, Mat & Syst Complexes, Paris, France.	douady@lps.ens.fr	DOUADY, Stephane/C-4498-2018	DOUADY, Stephane/0000-0002-3416-886X				Adanson M., 1763, FAMILLES PLANTES CON; Bailey IW, 1916, AM J BOT, V3, P24, DOI 10.2307/2435109; Bharathan G, 2002, SCIENCE, V296, P1858, DOI 10.1126/science.1070343; Blein T, 2008, SCIENCE, V322, P1835, DOI 10.1126/science.1166168; Boudaoud A, 2000, NATURE, V407, P718, DOI 10.1038/35037535; Braam J, 2005, NEW PHYTOL, V165, P373, DOI 10.1111/j.1469-8137.2004.01263.x; CLOS D, 1870, MONOGRAPHIE PREFOLIA; DEMAINE ED, 1998, P 10 ANN ACM SIAM S, P891; Douady S, 1996, J THEOR BIOL, V178, P255, DOI 10.1006/jtbi.1996.0024; Franks NR, 2000, P ROY SOC B-BIOL SCI, V267, P1295, DOI 10.1098/rspb.2000.1141; Gunawardena AHLAN, 2006, BOT J LINN SOC, V150, P25, DOI 10.1111/j.1095-8339.2006.00487.x; Hagemann W, 1996, PLANT SYST EVOL, V199, P121, DOI 10.1007/BF00984901; KAPLAN DR, 1982, CAN J BOT, V60, P2939, DOI 10.1139/b82-355; Kobayashi H, 1998, P ROY SOC B-BIOL SCI, V265, P147, DOI 10.1098/rspb.1998.0276; Mahadevan L, 2005, SCIENCE, V307, P1740, DOI 10.1126/science.1105169; Marder M, 2003, EUROPHYS LETT, V62, P498, DOI 10.1209/epl/i2003-00334-5; MELVILLE R, 1969, Botanical Journal of the Linnean Society, V62, P1, DOI 10.1111/j.1095-8339.1969.tb01952.x; Nath U, 2003, SCIENCE, V299, P1404, DOI 10.1126/science.1079354; Rolland-Lagan AG, 2003, NATURE, V422, P161, DOI 10.1038/nature01443; Scarpella E, 2006, GENE DEV, V20, P1015, DOI 10.1101/gad.1402406; Shraiman BI, 2005, P NATL ACAD SCI USA, V102, P3318, DOI 10.1073/pnas.0404782102; Thompson D. W., 1917, GROWTH FORM; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; USA The Angiosperm Phylogeny Group, 2003, Botanical Journal of the Linnean Society, V141, P399, DOI 10.1046/j.1095-8339.2003.t01-1-00158.x	24	28	29	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2009	4	11							e7968	10.1371/journal.pone.0007968	http://dx.doi.org/10.1371/journal.pone.0007968			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MF	19956690	gold, Green Published, Green Submitted			2022-12-25	WOS:000272827300022
J	Vernier, PT; Levine, ZA; Wu, YH; Joubert, V; Ziegler, MJ; Mir, LM; Tieleman, DP				Vernier, P. Thomas; Levine, Zachary A.; Wu, Yu-Hsuan; Joubert, Vanessa; Ziegler, Matthew J.; Mir, Lluis M.; Tieleman, D. Peter			Electroporating Fields Target Oxidatively Damaged Areas in the Cell Membrane	PLOS ONE			English	Article							PULSED ELECTRIC-FIELD; MOLECULAR-DYNAMICS SIMULATIONS; BILAYER LIPID-MEMBRANES; MAMMALIAN-CELLS; PLASMA-MEMBRANE; PORE FORMATION; HIGH-INTENSITY; GENE-TRANSFER; FLUORESCENCE MICROSCOPY; ANTIMICROBIAL PEPTIDES	Reversible electropermeabilization (electroporation) is widely used to facilitate the introduction of genetic material and pharmaceutical agents into living cells. Although considerable knowledge has been gained from the study of real and simulated model membranes in electric fields, efforts to optimize electroporation protocols are limited by a lack of detailed understanding of the molecular basis for the electropermeabilization of the complex biomolecular assembly that forms the plasma membrane. We show here, with results from both molecular dynamics simulations and experiments with living cells, that the oxidation of membrane components enhances the susceptibility of the membrane to electropermeabilization. Manipulation of the level of oxidative stress in cell suspensions and in tissues may lead to more efficient permeabilization procedures in the laboratory and in clinical applications such as electrochemotherapy and electrotransfection-mediated gene therapy.	[Vernier, P. Thomas] Univ So Calif, Viterbi Sch Engn, Ming Hsieh Dept Elect Engn, Los Angeles, CA 90089 USA; [Vernier, P. Thomas; Levine, Zachary A.; Ziegler, Matthew J.] Univ So Calif, Viterbi Sch Engn, Inst Informat Sci, MOSIS, Los Angeles, CA USA; [Levine, Zachary A.] Univ So Calif, Dept Phys & Astron, Los Angeles, CA USA; [Wu, Yu-Hsuan; Ziegler, Matthew J.] Univ So Calif, Viterbi Sch Engn, Mork Family Dept Chem Engn & Mat Sci, Los Angeles, CA USA; [Joubert, Vanessa; Mir, Lluis M.] Inst Gustave Roussy, CNRS, Unite Mixte Rech Vectorol & Gene Transfer 8121, Villejuif, France; [Tieleman, D. Peter] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [Joubert, Vanessa; Mir, Lluis M.] Univ Paris 11, UMR 8121, Orsay, France	University of Southern California; University of Southern California; University of Southern California; University of Southern California; Centre National de la Recherche Scientifique (CNRS); UNICANCER; Gustave Roussy; University of Calgary; UDICE-French Research Universities; Universite Paris Saclay	Vernier, PT (corresponding author), Univ So Calif, Viterbi Sch Engn, Ming Hsieh Dept Elect Engn, Los Angeles, CA 90089 USA.	vernier@mosis.com	Tieleman, D. Peter/A-4790-2011; MIR, Lluis M/AAJ-9110-2020; Vernier, P. Thomas/D-7926-2016	Tieleman, D. Peter/0000-0001-5507-0688; Vernier, P. Thomas/0000-0003-2335-1500	Air Force Office of Scientific Research, MOSIS, University of Southern California [FA9550-08-1-0096]; CNRS Institut Gustave Roussy; Clinigene EU Noe [LSHB-CT-2006-018933]; ANR PNANO [ANR-08-PNANO-024]; Natural Sciences and Engineering Research Council (Canada)	Air Force Office of Scientific Research, MOSIS, University of Southern California(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); CNRS Institut Gustave Roussy; Clinigene EU Noe; ANR PNANO(French National Research Agency (ANR)); Natural Sciences and Engineering Research Council (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding was provided by the Air Force Office of Scientific Research - Grant #FA9550-08-1-0096; MOSIS, University of Southern California; CNRS Institut Gustave Roussy; the Clinigene EU Noe (LSHB-CT-2006-018933); the ANR PNANO project Nanopulsebiochip (ANR-08-PNANO-024); and the Natural Sciences and Engineering Research Council (Canada). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABIDOR IG, 1979, BIOELECTROCH BIOENER, V6, P37; Ayuyan AG, 2006, BIOPHYS J, V91, P2172, DOI 10.1529/biophysj.106.087387; Beebe SJ, 2003, FASEB J, V17, P1493, DOI 10.1096/fj.02-0859fje; Bennett WFD, 2009, J AM CHEM SOC, V131, P1972, DOI 10.1021/ja808541r; BENZ R, 1980, BIOCHIM BIOPHYS ACTA, V597, P637, DOI 10.1016/0005-2736(80)90236-9; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berendsen HJC, 1981, INTERMOLECULAR FORCE, P331, DOI [DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658-1_21]; Berger O, 1997, BIOPHYS J, V72, P2002, DOI 10.1016/S0006-3495(97)78845-3; Bockmann RA, 2008, BIOPHYS J, V95, P1837, DOI 10.1529/biophysj.108.129437; Bonnafous P, 1999, BBA-BIOMEMBRANES, V1461, P123, DOI 10.1016/S0005-2736(99)00154-6; Brielmeier M, 1998, NUCLEIC ACIDS RES, V26, P2082, DOI 10.1093/nar/26.9.2082; Cemazar M, 1998, ELECTRO MAGNETOBIOL, V17, P263; Chiaramonte R, 2001, J CELL BIOCHEM, V82, P437, DOI 10.1002/jcb.1158; CHIZMADZHEV YA, 1980, BIOELECTROCH BIOENER, V7, P83, DOI 10.1016/0302-4598(80)87034-6; Cook JA, 2004, SEMIN RADIAT ONCOL, V14, P259, DOI 10.1016/j.semradonc.2004.04.001; Dyrka W, 2008, J COMPUT CHEM, V29, P1876, DOI 10.1002/jcc.20947; EISENBERG M, 1973, J MEMBRANE BIOL, V14, P143, DOI 10.1007/BF01868075; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Frey W, 2006, BIOPHYS J, V90, P3608, DOI 10.1529/biophysj.105.072777; GABRIEL B, 1994, EUR J BIOCHEM, V223, P25, DOI 10.1111/j.1432-1033.1994.tb18962.x; Gabriel B, 1998, EUR BIOPHYS J BIOPHY, V27, P291, DOI 10.1007/s002490050136; Garon EB, 2007, INT J CANCER, V121, P675, DOI 10.1002/ijc.22723; Girotti A W, 1985, J Free Radic Biol Med, V1, P87; Gurtovenko AA, 2005, J AM CHEM SOC, V127, P17570, DOI 10.1021/ja053129n; HAMILTON WA, 1967, BIOCHIM BIOPHYS ACTA, V148, P789, DOI 10.1016/0304-4165(67)90053-0; Harrison RL, 1998, FEBS LETT, V435, P1, DOI 10.1016/S0014-5793(98)00987-9; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; HICKMAN SE, 1994, BLOOD, V84, P2452; Hojman P, 2008, HUM GENE THER, V19, P1249, DOI 10.1089/hum.2008.059; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; IDZIOREK T, 1995, J IMMUNOL METHODS, V185, P249, DOI 10.1016/0022-1759(95)00172-7; Jacob RF, 2005, J BIOL CHEM, V280, P39380, DOI 10.1074/jbc.M507587200; Joshi RP, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.011913; KINOSITA K, 1977, BIOCHIM BIOPHYS ACTA, V471, P227, DOI 10.1016/0005-2736(77)90252-8; Kol MA, 2003, BIOCHEMISTRY-US, V42, P231, DOI 10.1021/bi0268403; Kramar P, 2007, BIOELECTROCHEMISTRY, V70, P23, DOI 10.1016/j.bioelechem.2006.03.022; MacCallum JL, 2008, BIOPHYS J, V94, P3393, DOI 10.1529/biophysj.107.112805; MACCARRONE M, 1995, BIOCHEM BIOPH RES CO, V206, P238, DOI 10.1006/bbrc.1995.1033; Marty M, 2006, EJC SUPPL, V4, P3, DOI 10.1016/j.ejcsup.2006.08.002; Mattila JP, 2008, BBA-BIOMEMBRANES, V1778, P2041, DOI 10.1016/j.bbamem.2008.03.020; Miklavcic D, 1998, BIOPHYS J, V74, P2152, DOI 10.1016/S0006-3495(98)77924-X; Mir LM, 1999, P NATL ACAD SCI USA, V96, P4262, DOI 10.1073/pnas.96.8.4262; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Muller KJ, 2001, J MEMBRANE BIOL, V184, P161, DOI 10.1007/s00232-001-0084-3; Naguib YMA, 1998, ANAL BIOCHEM, V265, P290, DOI 10.1006/abio.1998.2931; Neu JC, 1999, PHYS REV E, V59, P3471, DOI 10.1103/PhysRevE.59.3471; NEUMANN E, 1982, EMBO J, V1, P841, DOI 10.1002/j.1460-2075.1982.tb01257.x; Nuccitelli R, 2006, BIOCHEM BIOPH RES CO, V343, P351, DOI 10.1016/j.bbrc.2006.02.181; Nuccitelli R, 2009, INT J CANCER, V125, P438, DOI 10.1002/ijc.24345; Pakhomov AG, 2007, BIOELECTROMAGNETICS, V28, P655, DOI 10.1002/bem.20354; Pakhomov AG, 2007, ARCH BIOCHEM BIOPHYS, V465, P109, DOI 10.1016/j.abb.2007.05.003; Pap EHW, 1999, FEBS LETT, V453, P278, DOI 10.1016/S0014-5793(99)00696-1; POPESCU D, 1991, BIOELECTROCH BIOENER, V25, P91, DOI 10.1016/0302-4598(91)87021-8; Pucihar G, 2008, BIOPHYS J, V95, P2837, DOI 10.1529/biophysj.108.135541; Rols MP, 2006, BBA-BIOMEMBRANES, V1758, P423, DOI 10.1016/j.bbamem.2006.01.005; Rubinsky B, 2007, TECHNOL CANCER RES T, V6, P255, DOI 10.1177/153303460700600401; Schoenbach KH, 2004, P IEEE, V92, P1122, DOI 10.1109/JPROC.2004.829009; Sengupta D, 2008, BBA-BIOMEMBRANES, V1778, P2308, DOI 10.1016/j.bbamem.2008.06.007; Smith KC, 2008, BIOPHYS J, V95, P1547, DOI 10.1529/biophysj.107.121921; STARK G, 1991, BIOCHIM BIOPHYS ACTA, V1071, P103, DOI 10.1016/0304-4157(91)90020-W; SUGAR IP, 1984, BIOPHYS CHEM, V19, P211, DOI 10.1016/0301-4622(84)87003-9; Sukhorukov VL, 2005, J MEMBRANE BIOL, V206, P187, DOI 10.1007/s00232-005-0791-2; Tang T, 2007, IEEE T DIELECT EL IN, V14, P878, DOI 10.1109/TDEI.2007.4286519; Tarek M, 2005, BIOPHYS J, V88, P4045, DOI 10.1529/biophysj.104.050617; Tavazzi B, 2000, EUR J BIOCHEM, V267, P684, DOI 10.1046/j.1432-1327.2000.01042.x; TEISSIE J, 1981, BIOCHEMISTRY-US, V20, P1548, DOI 10.1021/bi00509a022; Teissie J, 2005, BBA-GEN SUBJECTS, V1724, P270, DOI 10.1016/j.bbagen.2005.05.006; Tieleman DP, 2003, J AM CHEM SOC, V125, P6382, DOI 10.1021/ja029504i; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Vaughn AE, 2008, NAT CELL BIOL, V10, P1477, DOI 10.1038/ncb1807; Vernier PT, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-37; Vernier PT, 2006, PHYS BIOL, V3, P233, DOI 10.1088/1478-3975/3/4/001; Vernier PT, 2003, IEEE T DIELECT EL IN, V10, P795, DOI 10.1109/TDEI.2003.1237329; Weaver JC, 2003, IEEE T DIELECT EL IN, V10, P754, DOI 10.1109/TDEI.2003.1237325; Wong-Ekkabut J, 2007, BIOPHYS J, V93, P4225, DOI 10.1529/biophysj.107.112565; ZAMZAMI N, 1995, J EXP MED, V182, P367, DOI 10.1084/jem.182.2.367; Zhou Y, 2007, BIOMATERIALS, V28, P1298, DOI 10.1016/j.biomaterials.2006.10.016; Ziegler MJ, 2008, J PHYS CHEM B, V112, P13588, DOI 10.1021/jp8027726; ZIMMERMANN U, 1974, BIOPHYS J, V14, P881, DOI 10.1016/S0006-3495(74)85956-4	79	93	94	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2009	4	11							e7966	10.1371/journal.pone.0007966	http://dx.doi.org/10.1371/journal.pone.0007966			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MF	19956595	gold, Green Published, Green Submitted			2022-12-25	WOS:000272827300021
J	Goncalves, RLS; Machado, ACL; Paiva-Silva, GO; Sorgine, MHF; Momoli, MM; Oliveira, JHM; Vannier-Santos, MA; Galina, A; Oliveira, PL; Oliveira, MF				Goncalves, Renata L. S.; Machado, Ana Carolina L.; Paiva-Silva, Gabriela O.; Sorgine, Marcos H. F.; Momoli, Marisa M.; Oliveira, Jose Henrique M.; Vannier-Santos, Marcos A.; Galina, Antonio; Oliveira, Pedro L.; Oliveira, Marcus F.			Blood-Feeding Induces Reversible Functional Changes in Flight Muscle Mitochondria of Aedes aegypti Mosquito	PLOS ONE			English	Article							REACTIVE OXYGEN; LIFE-SPAN; OXIDATIVE PHOSPHORYLATION; SUPEROXIDE-PRODUCTION; RESPIRATORY ENZYMES; HYDROGEN-PEROXIDE; RESTRICTION; PROTEIN; MIDGUT; STRESS	Background: Hematophagy poses a challenge to blood-feeding organisms since products of blood digestion can exert cellular deleterious effects. Mitochondria perform multiple roles in cell biology acting as the site of aerobic energy-transducing pathways, and also an important source of reactive oxygen species (ROS), modulating redox metabolism. Therefore, regulation of mitochondrial function should be relevant for hematophagous arthropods. Here, we investigated the effects of blood-feeding on flight muscle ( FM) mitochondria from the mosquito Aedes aegypti, a vector of dengue and yellow fever. Methodology/Principal Findings: Blood-feeding caused a reversible reduction in mitochondrial oxygen consumption, an event that was parallel to blood digestion. These changes were most intense at 24 h after blood meal (ABM), the peak of blood digestion, when oxygen consumption was inhibited by 68%. Cytochromes c and a+a(3) levels and cytochrome c oxidase activity of the electron transport chain were all reduced at 24 h ABM. Ultrastructural and molecular analyses of FM revealed that mitochondria fuse upon blood meal, a condition related to reduced ROS generation. Consistently, BF induced a reversible decrease in mitochondrial H2O2 formation during blood digestion, reaching their lowest values at 24 h ABM where a reduction of 51% was observed. Conclusion: Blood-feeding triggers functional and structural changes in hematophagous insect mitochondria, which may represent an important adaptation to blood feeding.			Goncalves, RLS (corresponding author), Univ Fed Rio de Janeiro, Lab Bioquim Redox, Inst Bioquim Med, Programa Biol Mol & Biotecnol, Rio De Janeiro, Brazil.	maroli@bioqmed.ufrj.br	Vannier-Santos, Marcos/AAG-5053-2021; Machado, Ana Carolina Loyola/AAR-7959-2021; Vannier-Santos, Marcos/G-5517-2012; Oliveira, Marcus/G-3158-2011; Galina, Antonio/A-9292-2008; Vannier-Santos, Marcos A/L-3649-2013; L. Oliveira, Pedro/A-9438-2010	Vannier-Santos, Marcos/0000-0001-9241-2261; Machado, Ana Carolina Loyola/0000-0002-4313-3730; Oliveira, Marcus/0000-0002-9890-8425; Oliveira, Jose Henrique M./0000-0003-3814-5312; L. Oliveira, Pedro/0000-0003-0307-354X				AVIDOR Y, 1959, BIOCHEM J, V72, P8, DOI 10.1042/bj0720008; BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707; BRIEGEL H, 1975, J INSECT PHYSIOL, V21, P1597, DOI 10.1016/0022-1910(75)90197-3; Brookes PS, 2002, FREE RADICAL BIO MED, V33, P755, DOI 10.1016/S0891-5849(02)00901-2; BURSELL E, 1975, COMP BIOCHEM PHYS B, V52, P235, DOI 10.1016/0305-0491(75)90057-7; CHANCE B, 1955, J BIOL CHEM, V217, P395; CHANCE B, 1955, J BIOL CHEM, V217, P409; CLEETER MWJ, 1994, FEBS LETT, V345, P50, DOI 10.1016/0014-5793(94)00424-2; Clements A., 1992, DEV NUTR REPROD; DANSAPETRETSKI M, 1995, J BIOL CHEM, V270, P10893, DOI 10.1074/jbc.270.18.10893; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; Ferguson M, 2005, BIOCHEM J, V390, P501, DOI 10.1042/BJ20042130; Gentile C, 2005, MEM I OSWALDO CRUZ, V100, P645; Giulivi C, 2008, BIOCHEM J, V415, P309, DOI 10.1042/BJ20080973; GONDA O, 1957, BIOCHEM J, V67, P487, DOI 10.1042/bj0670487; Graca-Souza AV, 2006, INSECT BIOCHEM MOLEC, V36, P322, DOI 10.1016/j.ibmb.2006.01.009; Hales KG, 1997, CELL, V90, P121, DOI 10.1016/S0092-8674(00)80319-0; Hetz SK, 2005, NATURE, V433, P516, DOI 10.1038/nature03106; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; Lenaz G, 2002, ANN NY ACAD SCI, V959, P199, DOI 10.1111/j.1749-6632.2002.tb02094.x; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu SJ, 2006, INSECT BIOCHEM MOLEC, V36, P336, DOI 10.1016/j.ibmb.2006.01.011; Magwere T, 2006, J GERONTOL A-BIOL, V61, P36, DOI 10.1093/gerona/61.1.36; Mair W, 2005, PLOS BIOL, V3, P1305, DOI 10.1371/journal.pbio.0030223; Marinotti O, 2005, INSECT MOL BIOL, V14, P365, DOI 10.1111/j.1365-2583.2005.00567.x; McQuibban GA, 2006, CURR BIOL, V16, P982, DOI 10.1016/j.cub.2006.03.062; Miwa S, 2005, BBA-BIOENERGETICS, V1709, P214, DOI 10.1016/j.bbabio.2005.08.003; Miwa S, 2003, FREE RADICAL BIO MED, V35, P938, DOI 10.1016/S0891-5849(03)00464-7; Neretti N, 2009, P NATL ACAD SCI USA, V106, P2277, DOI 10.1073/pnas.0812484106; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; Noriega FG, 1999, J INSECT PHYSIOL, V45, P613, DOI 10.1016/S0022-1910(99)00052-9; Oliveira PL, 2002, FEBS LETT, V525, P3, DOI 10.1016/S0014-5793(02)03026-0; Pascoa V, 2002, INSECT BIOCHEM MOLEC, V32, P517, DOI 10.1016/S0965-1748(01)00130-8; Pennington JE, 2003, J INSECT PHYSIOL, V49, P115, DOI 10.1016/S0022-1910(02)00267-6; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Radisky DC, 1999, J BIOL CHEM, V274, P4497, DOI 10.1074/jbc.274.8.4497; Ribeiro JMC, 2003, INSECT BIOCHEM MOLEC, V33, P865, DOI 10.1016/S0965-1748(03)00080-8; Ristow M, 2000, P NATL ACAD SCI USA, V97, P12239, DOI 10.1073/pnas.220403797; Riva A, 2006, MECH AGEING DEV, V127, P917, DOI 10.1016/j.mad.2006.09.002; SACKTOR BERTRAM, 1965, P483; Sanders HR, 2003, INSECT BIOCHEM MOLEC, V33, P1105, DOI 10.1016/S0965-1748(03)00124-3; Scaraffia PY, 2003, J INSECT PHYSIOL, V49, P591, DOI 10.1016/S0022-1910(03)00031-3; Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; TANDLER B, 1969, J CELL BIOL, V41, P477, DOI 10.1083/jcb.41.2.477; Tang S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004492; Tondera D, 2009, EMBO J, V28, P1589, DOI 10.1038/emboj.2009.89; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; WIGGLESWORTH VB, 1982, TISSUE CELL, V14, P501, DOI 10.1016/0040-8166(82)90043-X; Yan LJ, 1997, P NATL ACAD SCI USA, V94, P11168, DOI 10.1073/pnas.94.21.11168; Yan LJ, 1998, P NATL ACAD SCI USA, V95, P12896, DOI 10.1073/pnas.95.22.12896; Yu TZ, 2008, CARDIOVASC RES, V79, P341, DOI 10.1093/cvr/cvn104; Yu TZ, 2006, P NATL ACAD SCI USA, V103, P2653, DOI 10.1073/pnas.0511154103; Zhou GL, 2004, INSECT BIOCHEM MOLEC, V34, P919, DOI 10.1016/j.ibmb.2004.05.009; Zhou GL, 2007, J INSECT PHYSIOL, V53, P1169, DOI 10.1016/j.jinsphys.2007.06.009	56	30	34	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2009	4	11							e7854	10.1371/journal.pone.0007854	http://dx.doi.org/10.1371/journal.pone.0007854			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520NG	19924237	gold, Green Published, Green Submitted			2022-12-25	WOS:000271851000011
J	Osanai, M; Sawada, N; Lee, GH				Osanai, M.; Sawada, N.; Lee, G-H			Oncogenic and cell survival properties of the retinoic acid metabolizing enzyme, CYP26A1	ONCOGENE			English	Article						vitamin A; retinoic acid; CYP26A1; apoptosis; tumorigenesis	VITAMIN-A-DEFICIENCY; HUMAN BREAST; DIFFERENTIATION; EXPRESSION; APOPTOSIS	Vitamin A deficiency (VAD) is associated with increased susceptibility to carcinogenesis in animal models and elevated risk for a number of human cancers. Here, we found that CYP26A1, the gene encoding a cytochrome P450 enzyme specifically involved in metabolic inactivation of retinoic acid (RA), the most active vitamin A derivative, is highly expressed in 42% (27/65) of primary breast cancers. We also showed that enhanced expression of CYP26A1 suppresses cellular responses to anoikis and consequently promotes anchorage-independent growth. This transformed phenotype was sufficient to markedly increase tumorigenic and metastatic potential. Suppression of CYP26A1 significantly reversed the CYP26A1-mediated oncogenic characteristics, suggesting a direct link between intracellular RA status and tumorigenicity. Our observations provide strong evidence for oncogenic and cell survival properties of CYP26A1 in carcinogenesis, and suggest mechanisms whereby VAD might promote cancer development. Oncogene (2010) 29, 1135-1144; doi: 10.1038/onc.2009.414; published online 23 November 2009	[Osanai, M.] Kochi Univ, Sch Med, Dept Pathol, Nanko Ku, Kochi 7838505, Japan; [Sawada, N.] Sapporo Med Univ, Sch Med, Dept Pathol, Sapporo, Hokkaido, Japan	Kochi University; Sapporo Medical University	Osanai, M (corresponding author), Kochi Univ, Sch Med, Dept Pathol, Nanko Ku, Oko Cho, Kochi 7838505, Japan.	osanaim@kochi-u.ac.jp			Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science. We thank doctors at the Department of Surgical Pathology for providing archival formalin-fixed, paraffin-embedded tissue specimens and for their pathological diagnoses, and doctors at the Department of Surgical Oncology and Gastroenterological Surgery for scientific cooperation by providing surgically resected materials in patients with breast cancer, as well as the Animal Care Facility (Sapporo Medical University School of Medicine, Sapporo, Japan).	Abu-Abed S, 2001, GENE DEV, V15, P226, DOI 10.1101/gad.855001; Altucci L, 2001, NAT REV CANCER, V1, P181, DOI 10.1038/35106036; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Chang CL, 2008, ONCOGENE, V27, P2951, DOI 10.1038/sj.onc.1210969; ELLIOTT BE, 1988, CANCER RES, V48, P7237; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Fenaux P, 1997, NEW ENGL J MED, V337, P1076, DOI 10.1056/NEJM199710093371509; French AL, 2000, J INFECT DIS, V182, P1084, DOI 10.1086/315816; Gozani Or, 2002, Nature Cell Biology, V4, pE159, DOI 10.1038/ncb0602-e159; Kizaki M, 1997, LEUKEMIA LYMPHOMA, V25, P427, DOI 10.3109/10428199709039029; Lotan R, 1996, FASEB J, V10, P1031, DOI 10.1096/fasebj.10.9.8801164; Loudig O, 2005, BIOCHEM J, V392, P241, DOI 10.1042/BJ20050874; Loudig O, 2000, MOL ENDOCRINOL, V14, P1483, DOI 10.1210/me.14.9.1483; Osanai M, 2005, MOL PHARMACOL, V67, P1808, DOI 10.1124/mol.104.005769; Osanai M, 2006, CANCER RES, V66, P9125, DOI 10.1158/0008-5472.CAN-06-1864; Petkovich PM, 2001, J AM ACAD DERMATOL, V45, pS136, DOI 10.1067/mjd.2001.113715; Shelton DN, 2006, CANCER RES, V66, P7571, DOI 10.1158/0008-5472.CAN-06-1067; Sobin, 2009, UICC TNM CLASSIFICAT; Sonneveld E, 1998, CELL GROWTH DIFFER, V9, P629; Tavassoli FA, 2003, WHO CLASSIFICATION T; Van Heusden J, 1998, BRIT J CANCER, V77, P1229, DOI 10.1038/bjc.1998.207; Wang ZQ, 1999, NAT MED, V5, P418, DOI 10.1038/7417; White JA, 1997, J BIOL CHEM, V272, P18538, DOI 10.1074/jbc.272.30.18538; Wolbach SB, 1925, J EXP MED, V42, P753, DOI 10.1084/jem.42.6.753	24	32	33	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 25	2010	29	8					1135	1144		10.1038/onc.2009.414	http://dx.doi.org/10.1038/onc.2009.414			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	560ON	19935721	Green Submitted			2022-12-25	WOS:000274912100005
J	Duit, S; Mayer, H; Blake, SM; Schneider, WJ; Nimpf, J				Duit, Sarah; Mayer, Harald; Blake, Sophia M.; Schneider, Wolfgang J.; Nimpf, Johannes			Differential Functions of ApoER2 and Very Low Density Lipoprotein Receptor in Reelin Signaling Depend on Differential Sorting of the Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOLIPOPROTEIN-E RECEPTOR-2; CORTICAL PLATE DEVELOPMENT; BRAIN-DEVELOPMENT; NEURONAL MIGRATION; SYNAPTIC PLASTICITY; GAMMA-SECRETASE; BINDING DOMAIN; VLDL RECEPTOR; LIPID RAFTS; GENE FAMILY	ApoER2 and very low density lipoprotein (VLDL) receptor transmit the Reelin signal into target cells of the central nervous system. To a certain extent, both receptors can compensate for each other, and only the loss of both receptors results in the reeler phenotype, which is characterized by a gross defect in the architecture of laminated brain structures. Nevertheless, both receptors also have specific distinct functions, as corroborated by analyses of the subtle phenotypes displayed in mice lacking either ApoER2 or VLDL receptor. The differences in their function( s), however, have not been defined at the cellular level. Here, using a panel of chimeric receptors, we demonstrate that endocytosis of Reelin and the fate of the individual receptors upon stimulation are linked to their specific sorting to raft versus non-raft domains of the plasma membrane. VLDL receptor residing in the non-raft domain endocytoses and destines Reelin for degradation via the clathrin-coated pit/clathrin-coated vesicle/endosome pathway without being degraded to a significant extent. Binding of Reelin to ApoER2, a resident of rafts, leads to the production of specific receptor fragments with specific functions of their own and to degradation of ApoER2 via lysosomes. These features contribute to a receptor-specific fine tuning of the Reelin signal, leading to a novel model that emphasizes negative feedback loops specifically mediated by ApoER2 and VLDL receptor, respectively.	[Duit, Sarah; Mayer, Harald; Blake, Sophia M.; Schneider, Wolfgang J.; Nimpf, Johannes] Med Univ Vienna, Max F Perutz Labs, Univ Dept, Dept Med Biochem,Vienna Bioctr, A-1030 Vienna, Austria	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Nimpf, J (corresponding author), Med Univ Vienna, Max F Perutz Labs, Univ Dept, Dept Med Biochem,Vienna Bioctr, Dr Bohrgasse 9-2, A-1030 Vienna, Austria.	johannes.nimpf@meduniwien.ac.at		Nimpf, Johannes/0000-0002-9273-3492	"Fonds zur Forderung der Wissenschaftlichen Forschung, FWF," Austria [P16872-B09, P19611-B09]; Herzfelder'sche Familienstiftung	"Fonds zur Forderung der Wissenschaftlichen Forschung, FWF," Austria(Austrian Science Fund (FWF)); Herzfelder'sche Familienstiftung	This work was supported by the "Fonds zur Forderung der Wissenschaftlichen Forschung, FWF," Austria, Grants P16872-B09 and P19611-B09 and the Herzfelder'sche Familienstiftung.	Arnaud L, 2003, CURR BIOL, V13, P9, DOI 10.1016/S0960-9822(02)01397-0; Assadi AH, 2003, NAT GENET, V35, P270, DOI 10.1038/ng1257; Beffert U, 2006, J NEUROSCI, V26, P2041, DOI 10.1523/JNEUROSCI.4566-05.2006; Beffert U, 2005, NEURON, V47, P567, DOI 10.1016/j.neuron.2005.07.007; Beffert U, 2006, CURR BIOL, V16, P2446, DOI 10.1016/j.cub.2006.10.029; Blake SM, 2008, EMBO J, V27, P3069, DOI 10.1038/emboj.2008.223; Brandes C, 2001, J BIOL CHEM, V276, P22160, DOI 10.1074/jbc.M102662200; Brandes C, 1997, GENOMICS, V42, P185, DOI 10.1006/geno.1997.4702; BUJO H, 1994, EMBO J, V13, P5165, DOI 10.1002/j.1460-2075.1994.tb06847.x; Burk RF, 2007, J NEUROSCI, V27, P6207, DOI 10.1523/JNEUROSCI.1153-07.2007; Cheng HP, 2009, J BIOL CHEM, V284, P1373, DOI 10.1074/jbc.M806380200; Cooper JA, 2008, TRENDS NEUROSCI, V31, P113, DOI 10.1016/j.tins.2007.12.003; Cuitino L, 2005, TRAFFIC, V6, P820, DOI 10.1111/j.1600-0854.2005.00320.x; DAVIS CG, 1987, NATURE, V326, P760, DOI 10.1038/326760a0; Feng L, 2007, GENE DEV, V21, P2717, DOI 10.1101/gad.1604207; Forster E, 2006, EUR J NEUROSCI, V23, P901, DOI 10.1111/j.1460-9568.2006.04612.x; Gotthardt M, 2000, J BIOL CHEM, V275, P25616, DOI 10.1074/jbc.M000955200; Hack I, 2007, DEVELOPMENT, V134, P3883, DOI 10.1242/dev.005447; Hoe HS, 2005, MOL BRAIN RES, V137, P31, DOI 10.1016/j.molbrainres.2005.02.013; Howell BW, 2000, CURR BIOL, V10, P877, DOI 10.1016/S0960-9822(00)00608-4; Howell BW, 1997, EMBO J, V16, P121, DOI 10.1093/emboj/16.1.121; Howell BW, 1999, MOL CELL BIOL, V19, P5179; Jossin Y, 2003, J NEUROSCI, V23, P9953; Jossin Y, 2004, J NEUROSCI, V24, P514, DOI 10.1523/JNEUROSCI.3408-03.2004; Jossin Y, 2007, MOL CELL BIOL, V27, P7113, DOI 10.1128/MCB.00928-07; Jossin Y, 2007, J NEUROSCI, V27, P4243, DOI 10.1523/JNEUROSCI.0023-07.2007; Koch S, 2002, EMBO J, V21, P5996, DOI 10.1093/emboj/cdf599; Kuo G, 2005, J NEUROSCI, V25, P8578, DOI 10.1523/JNEUROSCI.1656-05.2005; Lambert de Rouvroit C, 1998, Adv Anat Embryol Cell Biol, V150, P1; Li YH, 2001, J BIOL CHEM, V276, P18000, DOI 10.1074/jbc.M101589200; Masiulis I, 2009, BIOL CHEM, V390, P67, DOI 10.1515/BC.2009.011; May P, 2003, J BIOL CHEM, V278, P37386, DOI 10.1074/jbc.M305858200; Mayer H, 2006, MOL CELL BIOL, V26, P19, DOI 10.1128/MCB.26.1.19-27.2006; NANDI PK, 1982, P NATL ACAD SCI-BIOL, V79, P5881, DOI 10.1073/pnas.79.19.5881; Niu S, 2004, NEURON, V41, P71, DOI 10.1016/S0896-6273(03)00819-5; Novak S, 1996, J BIOL CHEM, V271, P11732, DOI 10.1074/jbc.271.20.11732; Olson EC, 2006, J NEUROSCI, V26, P1767, DOI 10.1523/JNEUROSCI.3000-05.2006; Perez-Garcia CG, 2004, EUR J NEUROSCI, V20, P2827, DOI 10.1111/j.1460-9568.2004.03733.x; Pol A, 2000, J BIOL CHEM, V275, P30566, DOI 10.1074/jbc.M001131200; Pramatarova A, 2003, MOL CELL BIOL, V23, P7210, DOI 10.1128/MCB.23.20.7210-7221.2003; Rice DS, 2001, ANNU REV NEUROSCI, V24, P1005, DOI 10.1146/annurev.neuro.24.1.1005; Riddell DR, 2001, J LIPID RES, V42, P998; Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961; Schneider WJ, 2003, CELL MOL LIFE SCI, V60, P892, DOI 10.1007/s00018-003-2183-z; Stockinger W, 2000, J BIOL CHEM, V275, P25625, DOI 10.1074/jbc.M004119200; Stockinger W, 1998, J BIOL CHEM, V273, P32213, DOI 10.1074/jbc.273.48.32213; Strasser V, 2004, MOL CELL BIOL, V24, P1378, DOI 10.1128/MCB.24.3.1378-1386.2004; Tissir F, 2003, NAT REV NEUROSCI, V4, P496, DOI 10.1038/nrn1113; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Utsunomiya-Tate N, 2000, P NATL ACAD SCI USA, V97, P9729, DOI 10.1073/pnas.160272497; Vetrivel KS, 2004, J BIOL CHEM, V279, P44945, DOI 10.1074/jbc.M407986200; Yamabhai M, 2002, J BIOL CHEM, V277, P24843, DOI 10.1074/jbc.C200277200	52	52	54	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4896	4908		10.1074/jbc.M109.025973	http://dx.doi.org/10.1074/jbc.M109.025973			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	19948739	Green Published, hybrid			2022-12-25	WOS:000275274800067
J	Kondrikov, D; Fonseca, FV; Elms, S; Fulton, D; Black, SM; Block, ER; Su, Y				Kondrikov, Dmitry; Fonseca, Fabio V.; Elms, Shawn; Fulton, David; Black, Steven M.; Block, Edward R.; Su, Yunchao			beta-Actin Association with Endothelial Nitric-oxide Synthase Modulates Nitric Oxide and Superoxide Generation from the Enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOSKELETAL REGULATION; PROTEIN TRANSDUCTION; BINDING; TETRAHYDROBIOPTERIN; IDENTIFICATION; MECHANISMS; DOMAIN; ARTERY; CELLS	Protein-protein interactions represent an important post-translational mechanism for endothelial nitric-oxide synthase (eNOS) regulation. We have previously reported that beta-actin is associated with eNOS oxygenase domain and that association of eNOS with beta-actin increases eNOS activity and nitric oxide (NO) production. In the present study, we found that beta-actin-induced increase in NO production was accompanied by decrease in superoxide formation. A synthetic actin-binding sequence (ABS) peptide 326 with amino acid sequence corresponding to residues 326-333 of human eNOS, one of the putative ABSs, specifically bound to beta-actin and prevented eNOS association with beta-actin in vitro. Peptide 326 also prevented beta-actin-induced decrease in superoxide formation and increase in NO and L-citrulline production. A modified peptide 326 replacing hydrophobic amino acids leucine and tryptophan with neutral alanine was unable to interfere with eNOS-beta-actin binding and to prevent beta-actin-induced changes in NO and superoxide formation. Site-directed mutagenesis of the actin-binding domain of eNOS replacing leucine and tryptophan with alanine yielded an eNOS mutant that exhibited reduced eNOS-beta-actin association, decreased NO production, and increased superoxide formation in COS-7 cells. Disruption of eNOS-beta-actin interaction in endothelial cells using ABS peptide 326 resulted in decreased NO production, increased superoxide formation, and decreased endothelial monolayer wound repair, which was prevented by PEG-SOD and NO donor NOC-18. Taken together, this novel finding indicates that beta-actin binding to eNOS through residues 326-333 in the eNOS protein results in shifting the enzymatic activity from superoxide formation toward NO production. Modulation of NO and superoxide formation from eNOS by beta-actin plays an important role in endothelial function.	[Kondrikov, Dmitry; Fulton, David; Su, Yunchao] Med Coll Georgia, Dept Pharmacol & Toxicol, Augusta, GA 30912 USA; [Su, Yunchao] Med Coll Georgia, Dept Med, Augusta, GA 30912 USA; [Fonseca, Fabio V.; Elms, Shawn; Fulton, David; Black, Steven M.; Su, Yunchao] Med Coll Georgia, Vasc Biol Ctr, Augusta, GA 30912 USA; [Su, Yunchao] Med Coll Georgia, Ctr Biotechnol & Genom Med, Augusta, GA 30912 USA; [Block, Edward R.] Univ Florida, Coll Med, Dept Med, Gainesville, FL 32610 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; State University System of Florida; University of Florida	Su, Y (corresponding author), Med Coll Georgia, Dept Pharmacol & Toxicol, 1120 15th St, Augusta, GA 30912 USA.	ysu@mcg.edu			National Institutes of Health [R01HL088261]; Flight Attendants Medical Research Institute [032040, 072104]; American Heart Association [0555322B, 0855338E]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088261] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Flight Attendants Medical Research Institute; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01HL088261. This work was also supported by Flight Attendants Medical Research Institute Grants 032040 and 072104 and American Heart Association Greater Southeast Affiliate Grants 0555322B and 0855338E.	Abu-Soud HM, 2000, J BIOL CHEM, V275, P17349, DOI 10.1074/jbc.M000050200; BRESNICK AR, 1990, J BIOL CHEM, V265, P9236; CHEITLIN R, 1981, J BIOL CHEM, V256, P3156; Chen PF, 2003, J BIOL CHEM, V278, P52392, DOI 10.1074/jbc.M305469200; Church JE, 2006, J BIOL CHEM, V281, P1477, DOI 10.1074/jbc.M505968200; Dos Remedios CG, 2003, PHYSIOL REV, V83, P433, DOI 10.1152/physrev.00026.2002; Dudek SM, 2001, J APPL PHYSIOL, V91, P1487, DOI 10.1152/jappl.2001.91.4.1487; Garcia-Alvarez B, 2003, STRUCTURE, V11, P615, DOI 10.1016/S0969-2126(03)00090-X; Gustafsson AB, 2005, METH MOLEC MED, V112, P81; Gustafsson AB, 2002, CIRCULATION, V106, P735, DOI 10.1161/01.CIR.0000023943.50821.F7; IGNARRO LJ, 1987, P NATL ACAD SCI USA, V84, P9265, DOI 10.1073/pnas.84.24.9265; Ji Y, 2007, P NATL ACAD SCI USA, V104, P8839, DOI 10.1073/pnas.0611416104; Keep NH, 2000, NEUROL SCI, V21, pS929, DOI 10.1007/s100720070006; Kondrikov D, 2006, AM J PHYSIOL-LUNG C, V290, pL41, DOI 10.1152/ajplung.00444.2004; Kondrikov D, 2004, FASEB J, V18, pA1026; KWIATKOWSKI DJ, 1989, J CELL BIOL, V108, P1717, DOI 10.1083/jcb.108.5.1717; Lakshminrusimha S, 2007, AM J PHYSIOL-HEART C, V293, pH1491, DOI 10.1152/ajpheart.00185.2007; Le Cras TD, 2001, AM J PHYSIOL-LUNG C, V280, pL575, DOI 10.1152/ajplung.2001.280.4.L575; Maulik N, 2002, FREE RADICAL BIO MED, V33, P1047, DOI 10.1016/S0891-5849(02)01005-5; Michel T, 1997, J CLIN INVEST, V100, P2146, DOI 10.1172/JCI119750; MONCADA S, 1993, NEW ENGL J MED, V329, P2002; Ostergaard L, 2007, AM J PHYSIOL-HEART C, V293, pH2894, DOI 10.1152/ajpheart.01230.2006; Papapetropoulos A, 1999, CARDIOVASC RES, V43, P509, DOI 10.1016/S0008-6363(99)00161-3; Pritchard KA, 2001, J BIOL CHEM, V276, P17621, DOI 10.1074/jbc.C100084200; RodriguezCrespo I, 1996, J BIOL CHEM, V271, P11462, DOI 10.1074/jbc.271.19.11462; SU Y, 2007, SCI STKE; Su YC, 2005, CELL BIOCHEM BIOPHYS, V43, P439, DOI 10.1385/CBB:43:3:439; Su YC, 2003, AM J PHYSIOL-CELL PH, V284, pC1542, DOI 10.1152/ajpcell.00248.2002; Su YC, 2006, FASEB J, V20, P1443, DOI 10.1096/fj.05-5354com; Sud N, 2008, AM J PHYSIOL-CELL PH, V294, pC1407, DOI 10.1152/ajpcell.00384.2007; Sud N, 2007, AM J PHYSIOL-LUNG C, V293, pL1444, DOI 10.1152/ajplung.00175.2007; Vasquez-Vivar J, 1998, P NATL ACAD SCI USA, V95, P9220, DOI 10.1073/pnas.95.16.9220; Venema VJ, 1996, BIOCHEM BIOPH RES CO, V226, P703, DOI 10.1006/bbrc.1996.1417; Xia Y, 1998, J BIOL CHEM, V273, P25804, DOI 10.1074/jbc.273.40.25804	34	35	37	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4319	4327		10.1074/jbc.M109.063172	http://dx.doi.org/10.1074/jbc.M109.063172			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	19946124	hybrid, Green Published			2022-12-25	WOS:000275274800008
J	Drag, M; Bogyo, M; Ellman, JA; Salvesen, GS				Drag, Marcin; Bogyo, Matthew; Ellman, Jonathan A.; Salvesen, Guy S.			Aminopeptidase Fingerprints, an Integrated Approach for Identification of Good Substrates and Optimal Inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHIONINE AMINOPEPTIDASES; SPECIFICITY DETERMINANTS; LEUCINE AMINOPEPTIDASE; UNEXPECTED SPECIFICITY; LEUCYL AMINOPEPTIDASE; ANALOG INHIBITORS; BINDING-ENERGY; LIBRARIES; POTENT; METALLOPROTEASES	Aminopeptidases process the N-terminal amino acids of target substrates by sequential cleavage of one residue at a time. They are found in all cell compartments of prokaryotes and eukaryotes, being implicated in the major proteolytic events of cell survival, defense, growth, and development. We present a new approach for the fast and reliable evaluation of the substrate specificity of individual aminopeptidases. Using solid phase chemistry with the 7-amino-4-carbamoylmethylcoumarin fluorophore, we have synthesized a library of 61 individual natural and unnatural amino acids substrates, chosen to cover a broad spectrum of the possible interactions in the S1 pocket of this type of protease. As proof of concept, we determined the substrate specificity of human, pig, and rat orthologs of aminopeptidase N (CD13), a highly conserved cell surface protease that inactivates enkephalins and other bioactive peptides. Our data reveal a large and hydrophobic character for the S1 pocket of aminopeptidase N that is conserved with aminopeptidase Ns. Our approach, which can be applied in principle to all aminopeptidases, yields useful information for the design of specific inhibitors, and more importantly, reveals a relationship between the kinetics of substrate hydrolysis and the kinetics of enzyme inhibition.	[Drag, Marcin] Wroclaw Univ Technol, Fac Chem, Div Med Chem & Microbiol, PL-50370 Wroclaw, Poland; Burnham Inst Med Res, Apoptosis & Cell Death Res Program, La Jolla, CA 92037 USA; [Bogyo, Matthew] Stanford Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Ellman, Jonathan A.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA	Wroclaw University of Science & Technology; Sanford Burnham Prebys Medical Discovery Institute; Stanford University; University of California System; University of California Berkeley	Drag, M (corresponding author), Wroclaw Univ Technol, Fac Chem, Div Med Chem & Microbiol, Wybrzeze Wyspianskiego 27, PL-50370 Wroclaw, Poland.	mdrag@burnham.org; gsalvesen@burnham.org	Ellman, Jonathan A/C-7732-2013	Bogyo, Matthew/0000-0003-3753-4412	National Institutes of Health [AIG1139, RR20843, GM054051, EB005011]; State for Scientific Research in Poland [2 P05A 013 30]; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020843] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB005011] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054051] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); State for Scientific Research in Poland; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AIG1139 and RR20843 (to G.S.S.), GM054051 (to J.A.E.), and EB005011 (to M.B.). This work was also supported by State for Scientific Research Grant 2 P05A 013 30 in Poland.	Backes BJ, 2000, NAT BIOTECHNOL, V18, P187, DOI 10.1038/72642; BARTLETT PA, 1995, J ORG CHEM, V60, P3107, DOI 10.1021/jo00115a028; Bogyo M, 2006, NAT CHEM BIOL, V2, P229, DOI 10.1038/nchembio0506-229; Bradshaw RA, 2002, ESSAYS BIOCHEM, V38, P65, DOI 10.1042/bse0380065; Bradshaw RA, 1998, TRENDS BIOCHEM SCI, V23, P263, DOI 10.1016/S0968-0004(98)01227-4; Chan EWS, 2004, J AM CHEM SOC, V126, P14435, DOI 10.1021/ja047044i; Chen HX, 1999, BIOORG MED CHEM LETT, V9, P1511; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Choe Y, 2006, J BIOL CHEM, V281, P12824, DOI 10.1074/jbc.M513331200; Coombs GS, 1999, J BIOL CHEM, V274, P24074, DOI 10.1074/jbc.274.34.24074; Cunningham E, 2008, ANTIMICROB AGENTS CH, V52, P3221, DOI 10.1128/AAC.01327-07; David A, 2007, ANGEW CHEM INT EDIT, V46, P3275, DOI 10.1002/anie.200604408; DELMAS B, 1992, NATURE, V357, P417, DOI 10.1038/357417a0; Dive V, 2004, CELL MOL LIFE SCI, V61, P2010, DOI 10.1007/s00018-004-4050-y; Drag M, 2005, EUR J MED CHEM, V40, P764, DOI 10.1016/j.ejmech.2005.02.011; Drag M, 2005, TETRAHEDRON LETT, V46, P3359, DOI 10.1016/j.tetlet.2005.03.083; Drag M, 2008, BIOCHEM J, V415, P367, DOI 10.1042/BJ20080779; Drag M, 2008, BIOCHEM J, V409, P461, DOI 10.1042/BJ20070940; Drag M, 2007, BIOORG MED CHEM LETT, V17, P1516, DOI 10.1016/j.bmcl.2007.01.028; Drag M, 2006, SYNTHETIC COMMUN, V36, P2787, DOI 10.1080/00397910600767330; FOURNIEZALUSKI MC, 1992, J MED CHEM, V35, P1259, DOI 10.1021/jm00085a013; Gardiner DL, 2006, J BIOL CHEM, V281, P1741, DOI 10.1074/jbc.M508955200; GIANNOUSIS PP, 1987, J MED CHEM, V30, P1603, DOI 10.1021/jm00392a014; Harris JL, 2001, J BIOL CHEM, V276, P34941, DOI 10.1074/jbc.M102997200; Harris JL, 2000, P NATL ACAD SCI USA, V97, P7754, DOI 10.1073/pnas.140132697; LEJCZAK B, 1989, BIOCHEMISTRY-US, V28, P3549, DOI 10.1021/bi00434a060; Li X, 1995, P NATL ACAD SCI USA, V92, P12357, DOI 10.1073/pnas.92.26.12357; Lowther WT, 2002, CHEM REV, V102, P4581, DOI 10.1021/cr0101757; Mader MM, 1997, CHEM REV, V97, P1281, DOI 10.1021/cr960435y; Maly DJ, 2002, J ORG CHEM, V67, P910, DOI 10.1021/jo016140o; MORGAN BP, 1991, J AM CHEM SOC, V113, P297, DOI 10.1021/ja00001a043; Patterson AW, 2007, NAT PROTOC, V2, P424, DOI 10.1038/nprot.2007.28; Petrovic N, 2007, BLOOD, V110, P142, DOI 10.1182/blood-2006-02-002931; RANDO RR, 1974, SCIENCE, V185, P320, DOI 10.1126/science.185.4148.320; Rano TA, 1997, CHEM BIOL, V4, P149, DOI 10.1016/S1074-5521(97)90258-1; SAIKI I, 1993, INT J CANCER, V54, P137, DOI 10.1002/ijc.2910540122; Schneider Eric L., 2009, V539, P59, DOI 10.1007/978-1-60327-003-8_4; Sieber SA, 2006, NAT CHEM BIOL, V2, P274, DOI 10.1038/nchembio781; Skinner-Adams TS, 2007, J MED CHEM, V50, P6024, DOI 10.1021/jm070733v; Stack CM, 2007, J BIOL CHEM, V282, P2069, DOI 10.1074/jbc.M609251200; TAYLOR A, 1993, FASEB J, V7, P290, DOI 10.1096/fasebj.7.2.8440407; Tholander F, 2008, CHEM BIOL, V15, P920, DOI 10.1016/j.chembiol.2008.07.018; Vassiliou S, 2007, BIOORGAN MED CHEM, V15, P3187, DOI 10.1016/j.bmc.2007.02.042; Wood WJL, 2005, J AM CHEM SOC, V127, P15521, DOI 10.1021/ja0547230; YEAGER CL, 1992, NATURE, V357, P420, DOI 10.1038/357420a0	45	87	87	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5					3310	3318		10.1074/jbc.M109.060418	http://dx.doi.org/10.1074/jbc.M109.060418			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19948737	Green Published, hybrid			2022-12-25	WOS:000273829000046
J	Tung, JY; Yang, CW; Chou, SW; Lin, CC; Sun, YJ				Tung, Jung-Yu; Yang, Chih-Wei; Chou, Shao-Wen; Lin, Chien-Chih; Sun, Yuh-Ju			Calcium Binds to LipL32, a Lipoprotein from Pathogenic Leptospira, and Modulates Fibronectin Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE PROTEIN LIPL32; MOLECULAR-CLONING; SURFACE PROTEIN; EXPRESSION; GENE; DYE; INFECTION; SOFTWARE; DISEASE; GROWTH	Tubulointerstitial nephritis is a cardinal renal manifestation of leptospirosis. LipL32, a major lipoprotein and a virulence factor, locates on the outer membrane of the pathogen Leptospira. It evades immune response by recognizing and adhering to extracellular matrix components of the host cell. The crystal structure of Ca2+-bound LipL32 was determined at 2.3A resolution. LipL32 has a novel polyD sequence of seven aspartates that forms a continuous acidic surface patch for Ca2+ binding. A significant conformational change was observed for the Ca2+ bound form of LipL32. Calcium binding to LipL32 was determined by isothermal titration calorimetry. The binding of fibronectin to LipL32 was observed by Stains-all CD and enzyme-linked immunosorbent assay experiments. The interaction between LipL32 and fibronectin might be associated with Ca2+ binding. Based on the crystal structure of Ca2+-bound LipL32 and the Stains-all results, fibronectin probably binds near the polyD region on LipL32. Ca2+ binding to LipL32 might be important for Leptospira to interact with the extracellular matrix of the host cell.	Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu 30013, Taiwan; [Yang, Chih-Wei] Chang Gung Mem Hosp, Dept Nephrol, Taipei 10591, Taiwan	National Tsing Hua University; Chang Gung Memorial Hospital		yjsun@life.nthu.edu.tw			National Science Council of Taiwan [97-2311B-007-014]; National Tsing Hua University [98N2424E1]; Taiwan Ministry of Economic Affairs [98EC17A17S20101]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); National Tsing Hua University; Taiwan Ministry of Economic Affairs(Ministry of Economic Affairs, Taiwan)	This work was supported by National Science Council of Taiwan Grant 97-2311B-007-014 (to Y.-J.S.), National Tsing Hua University Grant 98N2424E1 (to Y.-J.S.), and Taiwan Ministry of Economic Affairs Grant 98EC17A17S20101 (to Y.-J.S.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Barbosa AS, 2006, INFECT IMMUN, V74, P6356, DOI 10.1128/IAI.00460-06; Barnett JK, 1999, INFECT IMMUN, V67, P853, DOI 10.1128/IAI.67.2.853-861.1999; Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2; Biegel E, 1995, Ugeskr Laeger, V157, P157; Brosh RM, 2000, J BIOL CHEM, V275, P23500, DOI 10.1074/jbc.M001557200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CADAY CG, 1986, BIOPOLYMERS, V25, P1579, DOI 10.1002/bip.360250814; CADAY CG, 1985, J BIOL CHEM, V260, P5985; CHANG YF, 1993, DNA CELL BIOL, V12, P351, DOI 10.1089/dna.1993.12.351; Choy HA, 2007, INFECT IMMUN, V75, P2441, DOI 10.1128/IAI.01635-06; CRUZ WT, 1990, MOL MICROBIOL, V4, P1933, DOI 10.1111/j.1365-2958.1990.tb02042.x; Dolhnikoff M, 2007, BRAZ J INFECT DIS, V11, P142, DOI 10.1590/S1413-86702007000100029; FARR RW, 1995, CLIN INFECT DIS, V21, P1, DOI 10.1093/clinids/21.1.1; FLIEGEL L, 1989, J BIOL CHEM, V264, P21522; Haake DA, 2000, INFECT IMMUN, V68, P2276, DOI 10.1128/IAI.68.4.2276-2285.2000; Haake DA, 1998, INFECT IMMUN, V66, P1579, DOI 10.1128/IAI.66.4.1579-1587.1998; Hauk P, 2008, INFECT IMMUN, V76, P2642, DOI 10.1128/IAI.01639-07; Hauk P, 2009, J MOL BIOL, V390, P722, DOI 10.1016/j.jmb.2009.05.034; HOFMANN SL, 1989, J BIOL CHEM, V264, P18083; Hoke DE, 2008, INFECT IMMUN, V76, P2063, DOI 10.1128/IAI.01643-07; IVEY DM, 1993, J BIOL CHEM, V268, P11296; JOHNSON RC, 1963, J BACTERIOL, V85, P983, DOI 10.1128/JB.85.5.983-985.1963; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lin YP, 2008, J BIOL CHEM, V283, P25140, DOI 10.1074/jbc.M801350200; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; MCPHERSON A, 1982, PREPARATION ANAL PRO, P94; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Michiels J, 2002, TRENDS MICROBIOL, V10, P87, DOI 10.1016/S0966-842X(01)02284-3; Murray GL, 2009, INFECT IMMUN, V77, P952, DOI 10.1128/IAI.01370-08; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NICOLL DA, 1990, SCIENCE, V250, P562, DOI 10.1126/science.1700476; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101; Rajini B, 2001, J BIOL CHEM, V276, P38464, DOI 10.1074/jbc.M102164200; SCOTT BT, 1988, J BIOL CHEM, V263, P8958; SHARMA Y, 1989, J BIOL CHEM, V264, P20923; SHENBERG E, 1967, J BACTERIOL, V93, P1598, DOI 10.1128/JB.93.5.1598-1606.1967; Stevenson B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001188; Vivian JP, 2009, J MOL BIOL, V387, P1229, DOI 10.1016/j.jmb.2009.02.038; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Yang CW, 2007, KIDNEY INT, V72, P918, DOI 10.1038/sj.ki.5002393; Yang CW, 2000, J AM SOC NEPHROL, V11, P2017, DOI 10.1681/ASN.V11112017; Yang CW, 2006, KIDNEY INT, V69, P815, DOI 10.1038/sj.ki.5000119; Yang CW, 2002, J AM SOC NEPHROL, V13, P2037, DOI 10.1097/01.ASN.0000022007.91733.62; Yang CW, 2001, NEPHROL DIAL TRANSPL, V16, P73, DOI 10.1093/ndt/16.suppl_5.73	46	35	36	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5					3245	3252		10.1074/jbc.M109.006320	http://dx.doi.org/10.1074/jbc.M109.006320			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19948735	Green Published, hybrid			2022-12-25	WOS:000273829000039
J	Whittaker, GC; Orr, SJ; Quigley, L; Hughes, L; Francischetti, IMB; Zhang, WG; McVicar, DW				Whittaker, Gillian C.; Orr, Selinda J.; Quigley, Laura; Hughes, Laurel; Francischetti, Ivo M. B.; Zhang, Weigou; McVicar, Daniel W.			The Linker for Activation of B Cells (LAB)/Non-T Cell Activation Linker (NTAL) Regulates Triggering Receptor Expressed on Myeloid Cells (TREM)-2 Signaling and Macrophage Inflammatory Responses Independently of the Linker for Activation of T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE; NEGATIVE REGULATION; CUTTING EDGE; AMPLIFIES INFLAMMATION; CYTOKINE PRODUCTION; TRANSDUCTION; DAP12; LAT; TREM-2; MONOCYTES	Triggering receptor expressed on myeloid cells-2 (TREM-2) is rapidly emerging as a key regulator of the innate immune response via its regulation of macrophage inflammatory responses. Here we demonstrate that proximal TREM-2 signaling parallels other DAP12-based receptor systems in its use of Syk and Src-family kinases. However, we find that the linker for activation of T cells (LAT) is severely reduced as monocytes differentiate into macrophages and that TREM-2 exclusively uses the linker for activation of B cells (LAB encoded by the gene Lat2(-/-)) to mediate downstream signaling. LAB is required for TREM-2-mediated activation of Erk1/2 and dampens proximal TREM-2 signals through a novel LAT-independent mechanism resulting in macrophages with proinflammatory properties. Thus, Lat2(-/-) macrophages have increased TREM-2-induced proximal phosphorylation, and lipopolysaccharide stimulation of these cells leads to increased interleukin-10 (IL-10) and decreased IL-12p40 production relative to wild type cells. Together these data identify LAB as a critical, LAT-independent regulator of TREM-2 signaling and macrophage development capable of controlling subsequent inflammatory responses.	[Whittaker, Gillian C.; Orr, Selinda J.; Quigley, Laura; Hughes, Laurel; McVicar, Daniel W.] NCI Frederick, Canc & Inflammat Program, Ctr Canc Res, NIH, Frederick, MD 21702 USA; [Francischetti, Ivo M. B.] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD 20892 USA; [Zhang, Weigou] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Duke University	McVicar, DW (corresponding author), NCI Frederick, Canc & Inflammat Program, Ctr Canc Res, NIH, Bldg 560,Rms 31-46, Frederick, MD 21702 USA.	mcvicard@mail.nih.gov	McVicar, Daniel/G-1970-2015	McVicar, Daniel/0000-0002-1112-5111; Orr, Selinda/0000-0001-8539-7825	National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC010300] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048674, R01AI056156, ZIAAI000810] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by the National Institutes of Health (Intramural Research Programs, NCI, Center for Cancer Research, and NIAID).	Andoniou CE, 2000, MOL CELL BIOL, V20, P851, DOI 10.1128/MCB.20.3.851-867.2000; BERG DJ, 1995, J CLIN INVEST, V96, P2339, DOI 10.1172/JCI118290; BLASI E, 1989, CANCER BIOCHEM BIOPH, V10, P303; Bouchon A, 2001, J EXP MED, V194, P1111, DOI 10.1084/jem.194.8.1111; Bouchon A, 2000, J IMMUNOL, V164, P4991, DOI 10.4049/jimmunol.164.10.4991; Bouchon A, 2001, NATURE, V410, P1103, DOI 10.1038/35074114; Brdicka T, 2002, J EXP MED, V196, P1617, DOI 10.1084/jem.20021405; Chen H, 2002, J BIOL CHEM, V277, P3011, DOI 10.1074/jbc.M109714200; Chiesa S, 2006, BLOOD, V107, P2364, DOI 10.1182/blood-2005-08-3504; FIORENTINO DF, 1991, J IMMUNOL, V147, P3815; Ford JW, 2009, CURR OPIN IMMUNOL, V21, P38, DOI 10.1016/j.coi.2009.01.009; Hamerman JA, 2005, NAT IMMUNOL, V6, P579, DOI 10.1038/ni1204; Hamerman JA, 2006, J IMMUNOL, V177, P2051, DOI 10.4049/jimmunol.177.4.2051; Hayashi A, 2004, J BIOL CHEM, V279, P29450, DOI 10.1074/jbc.M400950200; Janssen E, 2003, NAT IMMUNOL, V4, P117, DOI 10.1038/ni882; Janssen E, 2004, J IMMUNOL, V172, P6810, DOI 10.4049/jimmunol.172.11.6810; Lanier LL, 1998, NATURE, V391, P703, DOI 10.1038/35642; Lucas M, 2005, J IMMUNOL, V175, P469, DOI 10.4049/jimmunol.175.1.469; MALEFYT RD, 1991, J EXP MED, V174, P1209; Mason LH, 1998, J IMMUNOL, V160, P4148; Mason LH, 2006, J IMMUNOL, V176, P6615, DOI 10.4049/jimmunol.176.11.6615; McVicar DW, 1998, J BIOL CHEM, V273, P32934, DOI 10.1074/jbc.273.49.32934; Miyazaki T, 2004, J BIOL CHEM, V279, P17660, DOI 10.1074/jbc.M311032200; Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325; Ota S, 2000, J BIOL CHEM, V275, P414, DOI 10.1074/jbc.275.1.414; Piccio L, 2008, BRAIN, V131, P3081, DOI 10.1093/brain/awn217; Piccio L, 2007, EUR J IMMUNOL, V37, P1290, DOI 10.1002/eji.200636837; Schenk M, 2007, J CLIN INVEST, V117, P3097, DOI 10.1172/JCI30602; Takahashi K, 2005, J EXP MED, V201, P647, DOI 10.1084/jem.20041611; Takahashi K, 2007, PLOS MED, V4, P675, DOI 10.1371/journal.pmed.0040124; Tessarz AS, 2007, J IMMUNOL, V178, P1991, DOI 10.4049/jimmunol.178.4.1991; Tridandapani S, 2000, J BIOL CHEM, V275, P20480, DOI 10.1074/jbc.M909462199; Turnbull IR, 2005, J EXP MED, V202, P363, DOI 10.1084/jem.20050986; Turnbull IR, 2006, J IMMUNOL, V177, P3520, DOI 10.4049/jimmunol.177.6.3520; Volna P, 2004, J EXP MED, V200, P1001, DOI 10.1084/jem.20041213; WHITTAKER GC, UCSD NATURE MOL, DOI DOI 10.1038/MP.A000750.01; Zhang WG, 1999, IMMUNITY, V10, P323, DOI 10.1016/S1074-7613(00)80032-1; Zhang WG, 1998, IMMUNITY, V9, P239, DOI 10.1016/S1074-7613(00)80606-8; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0; Zheng YM, 2001, J BIOL CHEM, V276, P12999, DOI 10.1074/jbc.M009344200; Zhu MH, 2004, J EXP MED, V200, P991, DOI 10.1084/jem.20041223	41	23	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5							2976	10.1074/jbc.M109.038398	http://dx.doi.org/10.1074/jbc.M109.038398			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19948717	Green Published, hybrid			2022-12-25	WOS:000273829000012
J	Gallardo, O; Pastor, FIJ; Polaina, J; Diaz, P; Lysek, R; Vogel, P; Isorna, P; Gonzalez, B; Sanz-Aparicio, J				Gallardo, Oscar; Javier Pastor, F. I.; Polaina, Julio; Diaz, Pilar; Lysek, Robert; Vogel, Pierre; Isorna, Pablo; Gonzalez, Beatriz; Sanz-Aparicio, Julia			Structural Insights into the Specificity of Xyn10B from Paenibacillus barcinonensis and Its Improved Stability by Forced Protein Evolution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOSIDE HYDROLASE FAMILY-5; SITE-DIRECTED MUTAGENESIS; XYLAN-DEGRADING ENZYMES; IN-VITRO RECOMBINATION; AEROMONAS-CAVIAE ME-1; COLD-SHOCK PROTEIN; BETA-GLUCOSIDASE; BACILLUS SP; GEOBACILLUS-STEAROTHERMOPHILUS; CATALYTIC-PROPERTIES	Paenibacillus barcinonensis is a soil bacterium bearing a complex set of enzymes for xylan degradation, including several secreted enzymes and Xyn10B, one of the few intracellular xylanases reported to date. The crystal structure of Xyn10B has been determined by x-ray analysis. The enzyme folds into the typical (beta/alpha)(8) barrel of family 10 glycosyl hydrolases (GH10), with additional secondary structure elements within the beta/alpha motifs. One of these loops-L7-located at the beta 7 C terminus, was essential for xylanase activity as its partial deletion yielded an inactive enzyme. The loop contains residues His(249)-Glu(250), which shape a pocket opened to solvent in close proximity to the + 2 subsite, which has not been described in other GH10 enzymes. This wide cavity at the + 2 subsite, where methyl-2,4-pentanediol from the crystallization medium was found, is a noteworthy feature of Xyn10B, as compared with the narrow crevice described for other GH10 xylanases. Docking analysis showed that this open cavity can accommodate glucuronic acid decorations of xylo-oligosaccharides. Co-crystallization experiments with conduramine derivative inhibitors supported the importance of this open cavity at the + 2 subsite for Xyn10B activity. Several mutant derivatives of Xyn10B with improved thermal stability were obtained by forced evolution. Among them, mutant xylanases S15L and M93V showed increased half-life, whereas the double mutant S15L/M93V exhibited a further increase in stability, showing a 20-fold higher heat resistance than the wild type xylanase. All the mutations obtained were located on the surface of Xyn10B. Replacement of a Ser by a Leu residue in mutant xylanase S15L can increase hydrophobic packing efficiency and fill a superficial indentation of the protein, giving rise to a more compact structure of the enzyme.	[Gallardo, Oscar; Javier Pastor, F. I.; Diaz, Pilar] Univ Barcelona, Dept Microbiol, Fac Biol, E-08028 Barcelona, Spain; [Polaina, Julio] CSIC, Inst Agroquim & Tecnol Alimentos, E-46010 Valencia, Spain; [Lysek, Robert; Vogel, Pierre] Ecole Polytech Fed Lausanne, Lab Glycochim & Synth Asymetr, Inst Chem Sci & Engn, CH-1015 Lausanne, Switzerland; [Isorna, Pablo; Gonzalez, Beatriz; Sanz-Aparicio, Julia] CSIC, Inst Quim Fis Rocasolano, E-28006 Madrid, Spain	University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Agroquimica y Tecnologia de los Alimentos (IATA); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR)	Pastor, FIJ (corresponding author), Univ Barcelona, Dept Microbiol, Fac Biol, Av Diagonal 645, E-08028 Barcelona, Spain.	fpastor@ub.edu	Sanz-Aparicio, Julia/F-6201-2013; saso, luciano/F-6306-2012; Román, Óscar Gallardo/B-3924-2010; Polaina, Julio/H-4498-2012; Gonzalez, Beatriz/M-1219-2014; Diaz, Pilar/I-2465-2014	Sanz-Aparicio, Julia/0000-0002-6849-8621; saso, luciano/0000-0003-4530-8706; Román, Óscar Gallardo/0000-0003-0537-2498; Gonzalez, Beatriz/0000-0002-0710-0202; Polaina, Julio/0000-0001-9912-0640; Pastor, Francisco/0000-0003-0326-2527; Diaz, Pilar/0000-0003-4008-0669	Spanish Ministry of Education and Science [BIO2007-67708-C04-04]	Spanish Ministry of Education and Science(Spanish Government)	This work was supported in part by Spanish Ministry of Education and Science Grant BIO2007-67708-C04-04.	Arrizubieta MJ, 2000, J BIOL CHEM, V275, P28843, DOI 10.1074/jbc.M003036200; BABA T, 1994, APPL ENVIRON MICROB, V60, P2252, DOI 10.1128/AEM.60.7.2252-2258.1994; Biely P, 1997, J BIOTECHNOL, V57, P151, DOI 10.1016/S0168-1656(97)00096-5; BIELY P, 1981, EUR J BIOCHEM, V119, P559, DOI 10.1111/j.1432-1033.1981.tb05644.x; Blanco A, 1996, FEMS MICROBIOL LETT, V137, P285, DOI 10.1016/0378-1097(96)00074-2; BLANCO A, 1995, APPL ENVIRON MICROB, V61, P4468, DOI 10.1128/AEM.61.12.4468-4470.1995; Blanco A, 1999, MICROBIOL-SGM, V145, P2163, DOI 10.1099/13500872-145-8-2163; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Charnock SJ, 1998, J BIOL CHEM, V273, P32187, DOI 10.1074/jbc.273.48.32187; Collins T, 2005, FEMS MICROBIOL REV, V29, P3, DOI 10.1016/j.femsre.2004.06.005; Connerton I, 1999, BBA-PROTEIN STRUCT M, V1433, P110, DOI 10.1016/S0167-4838(99)00151-X; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Eijsink VGH, 2004, J BIOTECHNOL, V113, P105, DOI 10.1016/j.jbiotec.2004.03.026; ESTELL DA, 1985, J BIOL CHEM, V260, P6518; Fontes CMGA, 2000, MICROBIOL-SGM, V146, P1959, DOI 10.1099/00221287-146-8-1959; Frigerio F, 1996, PROTEIN ENG, V9, P439, DOI 10.1093/protein/9.5.439; FROMANT M, 1995, ANAL BIOCHEM, V224, P347, DOI 10.1006/abio.1995.1050; Fujimoto Z, 2004, J BIOL CHEM, V279, P9606, DOI 10.1074/jbc.M312293200; FUKUMURA M, 1995, BIOSCI BIOTECH BIOCH, V59, P40, DOI 10.1271/bbb.59.40; Gallardo O, 2003, APPL MICROBIOL BIOT, V61, P226, DOI 10.1007/s00253-003-1239-1; Gonzalez-Blasco G, 2000, J BIOL CHEM, V275, P13708, DOI 10.1074/jbc.275.18.13708; HARRIS GW, 1994, STRUCTURE, V2, P1107, DOI 10.1016/S0969-2126(94)00112-X; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kolenova K, 2006, J BIOTECHNOL, V121, P338, DOI 10.1016/j.jbiotec.2005.08.001; Kulkarni N, 1999, FEMS MICROBIOL REV, V23, P411, DOI 10.1111/j.1574-6976.1999.tb00407.x; Larson SB, 2003, BIOCHEMISTRY-US, V42, P8411, DOI 10.1021/bi034144c; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LIAO XB, 1990, GENE, V88, P107, DOI 10.1016/0378-1119(90)90066-Z; Lo Leggio L, 1999, PROTEINS, V36, P295; LOPEZCAMACHO C, 1993, MUTAT RES, V301, P73, DOI 10.1016/0165-7992(93)90027-S; LopezCamacho C, 1996, BIOCHEM J, V314, P833, DOI 10.1042/bj3140833; LUTHI E, 1990, APPL ENVIRON MICROB, V56, P1017; Lysek R, 2005, BIOORG MED CHEM LETT, V15, P3071, DOI 10.1016/j.bmcl.2005.04.023; Machius M, 2003, J BIOL CHEM, V278, P11546, DOI 10.1074/jbc.M212618200; Martin A, 2002, J MOL BIOL, V318, P1341, DOI 10.1016/S0022-2836(02)00243-7; MIKAELIAN I, 1992, NUCLEIC ACIDS RES, V20, P376, DOI 10.1093/nar/20.2.376; Miyazaki K, 1997, ANAEROBE, V3, P373, DOI 10.1006/anae.1997.0125; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pell G, 2004, J BIOL CHEM, V279, P9597, DOI 10.1074/jbc.M312278200; Perl D, 2000, NAT STRUCT BIOL, V7, P380; Polizeli MLTM, 2005, APPL MICROBIOL BIOT, V67, P577, DOI 10.1007/s00253-005-1904-7; Rye CS, 2000, CURR OPIN CHEM BIOL, V4, P573, DOI 10.1016/S1367-5931(00)00135-6; Sanchez MM, 2005, INT J SYST EVOL MICR, V55, P935, DOI 10.1099/ijs.0.63383-0; Sandgren M, 2003, PROTEIN SCI, V12, P848, DOI 10.1110/ps.0237703; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; Shulami S, 1999, J BACTERIOL, V181, P3695, DOI 10.1128/JB.181.12.3695-3704.1999; Shulami S, 2007, APPL ENVIRON MICROB, V73, P874, DOI 10.1128/AEM.02367-06; Sidhu G, 1999, BIOCHEMISTRY-US, V38, P5346, DOI 10.1021/bi982946f; Solomon V, 2007, ACTA CRYSTALLOGR D, V63, P845, DOI 10.1107/S0907444907024845; STEMMER WPC, 1994, P NATL ACAD SCI USA, V91, P10747, DOI 10.1073/pnas.91.22.10747; TABERNERO C, 1995, APPL ENVIRON MICROB, V61, P2420, DOI 10.1128/AEM.61.6.2420-2424.1995; Tabka MG, 2006, ENZYME MICROB TECH, V39, P897, DOI 10.1016/j.enzmictec.2006.01.021; Torres AL, 2000, BIORESOURCE TECHNOL, V74, P135, DOI 10.1016/S0960-8524(99)00178-9; Tsujibo H, 2004, J BACTERIOL, V186, P1029, DOI 10.1128/JB.186.4.1029-1037.2004; Usui K, 2003, J BIOSCI BIOENG, V95, P488, DOI 10.1016/S1389-1723(03)80050-6; Usui K, 1999, BIOSCI BIOTECH BIOCH, V63, P1346, DOI 10.1271/bbb.63.1346; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Van den Burg B, 1998, P NATL ACAD SCI USA, V95, P2056, DOI 10.1073/pnas.95.5.2056; Van Petegem F, 2003, J BIOL CHEM, V278, P7531, DOI 10.1074/jbc.M206862200; Vardakou M, 2005, J MOL BIOL, V352, P1060, DOI 10.1016/j.jmb.2005.07.051; VIIKARI L, 1994, FEMS MICROBIOL REV, V13, P335, DOI 10.1016/0168-6445(94)90090-6; Vrsanska M, 2007, FEBS J, V274, P1666, DOI 10.1111/j.1742-4658.2007.05710.x; WAKARCHUK WW, 1994, PROTEIN SCI, V3, P467; Yasukawa K, 2007, BBA-PROTEINS PROTEOM, V1774, P1281, DOI 10.1016/j.bbapap.2007.08.002	68	43	46	0	72	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2721	2733		10.1074/jbc.M109.064394	http://dx.doi.org/10.1074/jbc.M109.064394			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19940147	hybrid, Green Published			2022-12-25	WOS:000273697800050
J	Baraibar, MA; Muhoberac, BB; Garringer, HJ; Hurley, TD; Vidal, R				Baraibar, Martin A.; Muhoberac, Barry B.; Garringer, Holly J.; Hurley, Thomas D.; Vidal, Ruben			Unraveling of the E-helices and Disruption of 4-Fold Pores Are Associated with Iron Mishandling in a Mutant Ferritin Causing Neurodegeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							L-CHAIN; FUNCTIONAL-PROPERTIES; CLINICAL-FEATURES; JAPANESE FAMILY; H-CHAINS; MUTATION; NEUROFERRITINOPATHY; POLYPEPTIDE; EXPRESSION; MECHANISM	Mutations in the coding sequence of the ferritin light chain (FTL) gene cause a neurodegenerative disease known as neuro-ferritinopathy or hereditary ferritinopathy, which is characterized by the presence of intracellular inclusion bodies containing the mutant FTL polypeptide and by abnormal accumulation of iron in the brain. Here, we describe the x-ray crystallographic structure and report functional studies of ferritin homopolymers formed from the mutant FTL polypeptide p. Phe167SerfsX26, which has a C terminus that is altered in amino acid sequence and length. The structure was determined and refined to 2.85A resolution and was very similar to the wild type between residues Ile-5 and Arg-154. However, instead of the E-helices normally present in wild type ferritin, the C-terminal sequences of all 24 mutant subunits showed substantial amounts of disorder, leading to multiple C-terminal polypeptide conformations and a large disruption of the normally tiny 4-fold axis pores. Functional studies underscored the importance of the mutant C-terminal sequence in iron-induced precipitation and revealed iron mishandling by soluble mutant FTL homopolymers in that only wild type incorporated iron when in direct competition in solution with mutant ferritin. Even without competition, the amount of iron incorporation over the first few minutes differed severalfold. Our data suggest that disruption at the 4-fold pores may lead to direct iron mishandling through attenuated iron incorporation by the soluble form of mutant ferritin and that the disordered C-terminal polypeptides may play a major role in iron-induced precipitation and formation of ferritin inclusion bodies in hereditary ferritinopathy.	[Muhoberac, Barry B.] Indiana Univ Purdue Univ, Dept Chem & Biol Chem, Indianapolis, IN 46202 USA; [Baraibar, Martin A.; Garringer, Holly J.; Vidal, Ruben] Indiana Univ, Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA; [Hurley, Thomas D.] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Muhoberac, BB (corresponding author), Indiana Univ Purdue Univ, Dept Chem & Biol Chem, 402 N Blackford St LD 326, Indianapolis, IN 46202 USA.	bmuhober@iupui.edu; rvidal@iupui.edu		HURLEY, THOMAS/0000-0002-5942-1163	National Institutes of Health [NS050227, NS050227-04S1]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050227] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS050227 and NS050227-04S1. Results shown in this study are derived from work performed at Argonne National Laboratory, Structural Biology Center at the Advanced Photon Source.	Baes C.F., 1976, HYDROLYSIS CATIONS, P489; Baraibar MA, 2008, J BIOL CHEM, V283, P31679, DOI 10.1074/jbc.M805532200; Barbeito AG, 2009, J NEUROCHEM, V109, P1067, DOI 10.1111/j.1471-4159.2009.06028.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Crichton RR, 2001, BIOMETALS, V14, P99, DOI 10.1023/A:1016710810701; Curtis ARJ, 2001, NAT GENET, V28, P350, DOI 10.1038/ng571; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Devos D, 2009, BRAIN, V132, DOI 10.1093/brain/awn274; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FISH WW, 1988, METHOD ENZYMOL, V158, P357, DOI 10.1016/0076-6879(88)58067-9; FORD GC, 1984, PHILOS T R SOC B, V304, P551, DOI 10.1098/rstb.1984.0046; Granier T, 2001, ACTA CRYSTALLOGR D, V57, P1491, DOI 10.1107/S0907444901008897; HARRISON PM, 1991, BIOL MET, V4, P95, DOI 10.1007/BF01135385; Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9; Hempstead PD, 1997, J MOL BIOL, V268, P424, DOI 10.1006/jmbi.1997.0970; Ingrassia R, 2006, J BIOCHEM, V139, P881, DOI 10.1093/jb/mvj101; Kubota A, 2009, MOVEMENT DISORD, V24, P441, DOI 10.1002/mds.22435; LEVI S, 1989, BIOCHEMISTRY-US, V28, P5179, DOI 10.1021/bi00438a040; LEVI S, 1994, J MOL BIOL, V238, P649, DOI 10.1006/jmbi.1994.1325; LEVI S, 1988, J BIOL CHEM, V263, P18086; LEVI S, 1992, BIOCHEM J, V288, P591, DOI 10.1042/bj2880591; Maciel P, 2005, NEUROLOGY, V65, P603, DOI 10.1212/01.wnl.0000178224.81169.c2; Mancuso M, 2005, J NEUROPATH EXP NEUR, V64, P280, DOI 10.1093/jnen/64.4.280; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; Ohta E, 2008, NEUROLOGY, V70, P1493, DOI 10.1212/01.wnl.0000310428.74624.95; Santambrogio P, 1996, BIOCHEM J, V314, P139, DOI 10.1042/bj3140139; Takahashi T, 2003, BIOPHYS J, V84, P2256, DOI 10.1016/S0006-3495(03)75031-0; Theil EC, 2003, J NUTR, V133, p1549S, DOI 10.1093/jn/133.5.1549S; Theil EC, 2006, J BIOL INORG CHEM, V11, P803, DOI 10.1007/s00775-006-0125-6; Vidal R, 2004, J NEUROPATH EXP NEUR, V63, P363, DOI 10.1093/jnen/63.4.363; Vidal R, 2004, J NEUROPATH EXP NEUR, V63, P787, DOI 10.1093/jnen/63.8.787; Vidal R, 2003, J NEUROL SCI, V207, P110, DOI 10.1016/S0022-510X(02)00435-5; Vidal R, 2008, J NEUROSCI, V28, P60, DOI 10.1523/JNEUROSCI.3962-07.2008; Wang ZM, 2006, ACTA CRYSTALLOGR D, V62, P800, DOI 10.1107/S0907444906018294	34	39	40	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2010	285	3					1950	1956		10.1074/jbc.M109.042986	http://dx.doi.org/10.1074/jbc.M109.042986			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	541PJ	19923220	Green Published, hybrid			2022-12-25	WOS:000273429100041
J	Skalska, J; Brookes, PS; Nadtochiy, SM; Hilchey, SP; Jordan, CT; Guzman, ML; Maggirwar, SB; Briehl, MM; Bernstein, SH				Skalska, Jolanta; Brookes, Paul S.; Nadtochiy, Sergiy M.; Hilchey, Shannon P.; Jordan, Craig T.; Guzman, Monica L.; Maggirwar, Sanjay B.; Briehl, Margaret M.; Bernstein, Steven H.			Modulation of Cell Surface Protein Free Thiols: A Potential Novel Mechanism of Action of the Sesquiterpene Lactone Parthenolide	PLOS ONE			English	Article							OXIDATIVE STRESS; REDOX REGULATION; CANCER-CELLS; APOPTOSIS; PATHWAY; LINES; SUSCEPTIBILITY; THIOREDOXIN-1; LYMPHOMAS; RESPONSES	Background: There has been much interest in targeting intracellular redox pathways as a therapeutic approach for cancer. Given recent data to suggest that the redox status of extracellular protein thiol groups (i.e. exofacial thiols) effects cell behavior, we hypothesized that redox active anti-cancer agents would modulate exofacial protein thiols. Methodology/Principal Findings: To test this hypothesis, we used the sesquiterpene lactone parthenolide, a known anticancer agent. Using flow cytometry, and western blotting to label free thiols with Alexa Fluor 633 C(5) maleimide dye and N-biotinoyl)-N-(iodoacetyl) ethylendiamine (BIAM), respectively, we show that parthenolide decreases the level of free exofacial thiols on Granta mantle lymphoma cells. In addition, we used immuno-precipitation techniques to identify the central redox regulator thioredoxin, as one of the surface protein thiol targets modified by parthenolide. To examine the functional role of parthenolide induced surface protein thiol modification, we pretreated Granta cells with cell impermeable glutathione (GSH), prior to exposure to parthenolide, and showed that GSH pretreatment; (a) inhibited the interaction of parthenolide with exofacial thiols; (b) inhibited parthenolide mediated activation of JNK and inhibition of NF kappa B, two well established mechanisms of parthenolide activity and; (c) blocked the cytotoxic activity of parthenolide. That GSH had no effect on the parthenolide induced generation of intracellular reactive oxygen species supports the fact that GSH had no effect on intracellular redox. Together these data support the likelihood that GSH inhibits the effect of parthenolide on JNK, NF kappa B and cell death through its direct inhibition of parthenolide's modulation of exofacial thiols. Conclusions/Significance: Based on these data, we postulate that one component of parthenolide's anti-lymphoma activity derives from its ability to modify the redox state of critical exofacial thiols. Further, we propose that cancer cell exofacial thiols may be important and novel targets for therapy.	[Skalska, Jolanta; Hilchey, Shannon P.; Jordan, Craig T.; Guzman, Monica L.; Bernstein, Steven H.] Univ Rochester, Med Ctr, James P Wilmot Canc Ctr, Rochester, NY 14642 USA; [Brookes, Paul S.; Nadtochiy, Sergiy M.] Univ Rochester, Med Ctr, Dept Anesthesiol, Rochester, NY 14642 USA; [Maggirwar, Sanjay B.] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Briehl, Margaret M.] Univ Arizona, Arizona Canc Ctr, Dept Pathol, Tucson, AZ USA	University of Rochester; University of Rochester; University of Rochester; Arizona Center Cancer Care; University of Arizona	Skalska, J (corresponding author), Univ Rochester, Med Ctr, James P Wilmot Canc Ctr, Rochester, NY 14642 USA.	Steven_Bernstein@urmc.rochester.edu	jordan, craig/D-7666-2014	jordan, craig/0000-0003-0869-3465; Brookes, Paul/0000-0002-8639-8413	NIH/NCI [1 P50-CA130805-01]; Lymphoma Research Foundation; NATIONAL CANCER INSTITUTE [P50CA130805] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Lymphoma Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by a Lymphoma Spore Grant (NIH/NCI 1 P50-CA130805-01; Project 2 SHB, MB, SPH, PSB) and a Lymphoma Research Foundation Mantle Cell Lymphoma Research Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beech David J, 2007, Channels (Austin), V1, P400; Brookes PS, 2007, CANCER RES, V67, P1793, DOI 10.1158/0008-5472.CAN-06-2678; Chaiswing L, 2008, CANCER RES, V68, P5820, DOI 10.1158/0008-5472.CAN-08-0162; Fang JG, 2005, J BIOL CHEM, V280, P25284, DOI 10.1074/jbc.M414645200; Gelderman KA, 2006, P NATL ACAD SCI USA, V103, P12831, DOI 10.1073/pnas.0604571103; Guzman ML, 2005, BLOOD, V105, P4163, DOI 10.1182/blood-2004-10-4135; Hara T, 2007, ANTIOXID REDOX SIGN, V9, P1427, DOI 10.1089/ars.2007.1661; Jadayel DM, 1997, LEUKEMIA, V11, P64, DOI 10.1038/sj.leu.2400555; Janssen-Heininger YMW, 2008, FREE RADICAL BIO MED, V45, P1, DOI 10.1016/j.freeradbiomed.2008.03.011; Jones DP, 2008, AM J PHYSIOL-CELL PH, V295, pC849, DOI 10.1152/ajpcell.00283.2008; Kim JH, 2005, CANCER RES, V65, P6312, DOI 10.1158/0008-5472.CAN-04-4193; Laragione T, 2003, P NATL ACAD SCI USA, V100, P14737, DOI 10.1073/pnas.2434516100; Lecane PS, 2005, CANCER RES, V65, P11676, DOI 10.1158/0008-5472.CAN-05-2754; Lou H, 2007, J BIOL CHEM, V282, P29470, DOI 10.1074/jbc.M706145200; Mattila AM, 2008, SCAND J IMMUNOL, V68, P159, DOI 10.1111/j.1365-3083.2008.02129.x; Mehra S, 2002, GENE CHROMOSOME CANC, V33, P225, DOI 10.1002/gcc.10025; Nadtochiy SM, 2009, CARDIOVASC RES, V82, P333, DOI 10.1093/cvr/cvn323; Nakshatri H, 2004, ONCOGENE, V23, P7330, DOI 10.1038/sj.onc.1207995; Ou W, 2006, VIROLOGY, V350, P406, DOI 10.1016/j.virol.2006.01.041; Ray DM, 2006, EXP HEMATOL, V34, P1202, DOI 10.1016/j.exphem.2006.04.026; Renard P, 2001, Nucleic Acids Res, V29, pE21, DOI 10.1093/nar/29.4.e21; RIMOKH R, 1994, BLOOD, V83, P3689; Sahaf B, 2005, ARCH BIOCHEM BIOPHYS, V434, P26, DOI 10.1016/j.abb.2004.11.015; Sahaf B, 2003, P NATL ACAD SCI USA, V100, P4001, DOI 10.1073/pnas.2628032100; Schumacker PT, 2006, CANCER CELL, V10, P175, DOI 10.1016/j.ccr.2006.08.015; Schwertassek U, 2007, EMBO J, V26, P3086, DOI 10.1038/sj.emboj.7601746; Steele AJ, 2006, LEUKEMIA, V20, P1073, DOI 10.1038/sj.leu.2404230; Tanaka T, 2003, LIFE SCI, V73, P2985, DOI 10.1016/S0024-3205(03)00708-2; Tonissen KF, 2009, MOL NUTR FOOD RES, V53, P87, DOI 10.1002/mnfr.200700492; WINTER JN, 1984, BLOOD, V63, P140; Yip-Schneider MT, 2005, MOL CANCER THER, V4, P587, DOI 10.1158/1535-7163.MCT-04-0215	31	53	58	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2009	4	12							e8115	10.1371/journal.pone.0008115	http://dx.doi.org/10.1371/journal.pone.0008115			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MU	19956548	Green Published, gold, Green Submitted			2022-12-25	WOS:000272828800013
J	Zhang, L; Bonham, AJ; Li, J; Pei, YF; Chen, J; Papasian, CJ; Deng, HW				Zhang, Lei; Bonham, Aaron J.; Li, Jian; Pei, Yu-Fang; Chen, Jie; Papasian, Christopher J.; Deng, Hong-Wen			Family-Based Bivariate Association Tests for Quantitative Traits	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GENETIC-LINKAGE; SEMIPARAMETRIC TEST; UNRELATED SAMPLES; LOCI; STRATIFICATION; DISEQUILIBRIUM; POPULATIONS; PHENOTYPE; PEDIGREE	The availability of a large number of dense SNPs, high-throughput genotyping and computation methods promotes the application of family-based association tests. While most of the current family-based analyses focus only on individual traits, joint analyses of correlated traits can extract more information and potentially improve the statistical power. However, current TDT-based methods are low-powered. Here, we develop a method for tests of association for bivariate quantitative traits in families. In particular, we correct for population stratification by the use of an integration of principal component analysis and TDT. A score test statistic in the variance-components model is proposed. Extensive simulation studies indicate that the proposed method not only outperforms approaches limited to individual traits when pleiotropic effect is present, but also surpasses the power of two popular bivariate association tests termed FBAT-GEE and FBAT-PC, respectively, while correcting for population stratification. When applied to the GAW16 datasets, the proposed method successfully identifies at the genome-wide level the two SNPs that present pleiotropic effects to HDL and TG traits.	[Zhang, Lei; Pei, Yu-Fang; Deng, Hong-Wen] Xi An Jiao Tong Univ, Key Lab Biomed Informat Engn, Minist Educ, Xian 710049, Shaanxi, Peoples R China; [Zhang, Lei; Pei, Yu-Fang; Deng, Hong-Wen] Xi An Jiao Tong Univ, Inst Mol Genet, Sch Life Sci & Technol, Xian 710049, Shaanxi, Peoples R China; [Zhang, Lei; Bonham, Aaron J.; Li, Jian; Pei, Yu-Fang; Papasian, Christopher J.; Deng, Hong-Wen] Univ Missouri, Sch Med, Kansas City, MO 64108 USA; [Chen, Jie] Univ Missouri, Dept Math & Stat, Kansas City, MO 64108 USA; [Deng, Hong-Wen] Shanghai Univ Sci & Technol, Ctr Syst Biomed Sci, Shanghai 201800, Peoples R China; [Deng, Hong-Wen] Beijing Jiao Tong Univ, Coll Life Sci & Engn, Beijing, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University; University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City; University of Shanghai for Science & Technology; Beijing Jiaotong University	Zhang, L (corresponding author), Xi An Jiao Tong Univ, Key Lab Biomed Informat Engn, Minist Educ, Xian 710049, Shaanxi, Peoples R China.	dengh@umkc.edu	Zhang, Lei/L-1016-2016; Li, Jian/G-4445-2015	Zhang, Lei/0000-0002-1007-4834; Chen, Jie/0000-0003-2151-5276; Deng, Hong-Wen/0000-0002-0387-8818	National Institutes of Health [R01 AR050496, R21 AG027110, R01 AG026564, P50 AR055081, R21 AA015973]; National Science Foundation of China; Huo Ying Dong Education Foundation; Shanghai Leading Academic Discipline [S30501]; Xi'an Jiaotong University, and the Ministry of Education of China; Xi'an Jiaotong University; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050496, P50AR055081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026564, R21AG027110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA015973] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Huo Ying Dong Education Foundation; Shanghai Leading Academic Discipline(Shanghai Leading Academic Discipline Project); Xi'an Jiaotong University, and the Ministry of Education of China; Xi'an Jiaotong University(Xi'an Jiaotong University); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	The study was partially supported by grants from the National Institutes of Health (R01 AR050496, R21 AG027110, R01 AG026564, P50 AR055081 and R21 AA015973). The investigators of this work also benefited from grants from the National Science Foundation of China, Huo Ying Dong Education Foundation, Shanghai Leading Academic Discipline Project (S30501), HuNan Province, Xi'an Jiaotong University, and the Ministry of Education of China. Computing support was partially provided by the High Performance Computing Cluster Center at Xi'an Jiaotong University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2000, AM J HUM GENET, V66, P279, DOI 10.1086/302698; Abecasis GR, 2000, EUR J HUM GENET, V8, P545, DOI 10.1038/sj.ejhg.5200494; Almasy L, 1997, GENET EPIDEMIOL, V14, P953, DOI 10.1002/(SICI)1098-2272(1997)14:6<953::AID-GEPI65>3.0.CO;2-K; AMOS CI, 1990, AM J HUM GENET, V47, P247; AMOS CI, 1994, AM J HUM GENET, V54, P535; AMOS CI, 1993, GENET EPIDEMIOL, V10, P671, DOI 10.1002/gepi.1370100657; BALDING DJ, 1995, GENETICA, V96, P3, DOI 10.1007/BF01441146; Chen HS, 2003, ANN HUM GENET, V67, P250, DOI 10.1046/j.1469-1809.2003.00036.x; Chen WM, 2007, AM J HUM GENET, V81, P913, DOI 10.1086/521580; Cupples LA, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S1; de Andrade M, 2005, GENET EPIDEMIOL, V29, pS91, DOI 10.1002/gepi.20115; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Fulker DW, 1999, AM J HUM GENET, V64, P259, DOI 10.1086/302193; JIANG CJ, 1995, GENETICS, V140, P1111; Jung JS, 2008, GENET EPIDEMIOL, V32, P396, DOI 10.1002/gepi.20313; KANNEL WB, 1961, ANN INTERN MED, V55, P33, DOI 10.7326/0003-4819-55-1-33; Laird NM, 2000, GENET EPIDEMIOL, V19, pS36, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI6>3.3.CO;2-D; Lange C, 2003, BIOSTATISTICS, V4, P195, DOI 10.1093/biostatistics/4.2.195; Lange C, 2004, AM J HUM GENET, V74, P367, DOI 10.1086/381563; Lange C., 2004, STAT APPL GENET MOL, V3, P17, DOI [DOI 10.2202/1544-6115.1067, 10.2202/1544-6115.1067]; Li Y, 2007, AM J HUM GENET, V80, P705, DOI 10.1086/513205; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Schaid DJ, 1996, GENET EPIDEMIOL, V13, P423, DOI 10.1002/(SICI)1098-2272(1996)13:5<423::AID-GEPI1>3.0.CO;2-3; Wall JD, 2003, AM J HUM GENET, V73, P502, DOI 10.1086/378099; Williams JT, 1999, AM J HUM GENET, V65, P1134, DOI 10.1086/302570; ZHANG L, 2009, ANN HUMAN G IN PRESS; Zhang L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006502; Zhang SL, 2003, GENET EPIDEMIOL, V24, P44, DOI 10.1002/gepi.10196; Zhu XF, 2002, GENET EPIDEMIOL, V23, P181, DOI 10.1002/gepi.210; Zhu XF, 2008, AM J HUM GENET, V82, P352, DOI 10.1016/j.ajhg.2007.10.009	30	7	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2009	4	12							e8133	10.1371/journal.pone.0008133	http://dx.doi.org/10.1371/journal.pone.0008133			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MU	19956578	Green Submitted, Green Published, gold			2022-12-25	WOS:000272828800024
J	Neves-Costa, A; Will, WR; Vetter, AT; Miller, JR; Varga-Weisz, P				Neves-Costa, Ana; Will, W. Ryan; Vetter, Anna T.; Miller, J. Ross; Varga-Weisz, Patrick			The SNF2-Family Member Fun30 Promotes Gene Silencing in Heterochromatic Loci	PLOS ONE			English	Article							CHROMATIN REMODELING COMPLEX; ORIGIN RECOGNITION COMPLEX; RIBOSOMAL DNA LOCUS; RNA-POLYMERASE-II; SACCHAROMYCES-CEREVISIAE; UBIQUITIN-BINDING; CUE DOMAIN; PROTEIN; YEAST; REPLICATION	Chromatin regulates many key processes in the nucleus by controlling access to the underlying DNA. SNF2-like factors are ATP-driven enzymes that play key roles in the dynamics of chromatin by remodelling nucleosomes and other nucleoprotein complexes. Even simple eukaryotes such as yeast contain members of several subfamilies of SNF2-like factors. The FUN30/ETL1 subfamily of SNF2 remodellers is conserved from yeasts to humans, but is poorly characterized. We show that the deletion of FUN30 leads to sensitivity to the topoisomerase I poison camptothecin and to severe cell cycle progression defects when the Orc5 subunit is mutated. We demonstrate a role of FUN30 in promoting silencing in the heterochromatin-like mating type locus HMR, telomeres and the rDNA repeats. Chromatin immunoprecipitation experiments demonstrate that Fun30 binds at the boundary element of the silent HMR and within the silent HMR. Mapping of nucleosomes in vivo using micrococcal nuclease demonstrates that deletion of FUN30 leads to changes of the chromatin structure at the boundary element. A point mutation in the ATP-binding site abrogates the silencing function of Fun30 as well as its toxicity upon overexpression, indicating that the ATPase activity is essential for these roles of Fun30. We identify by amino acid sequence analysis a putative CUE motif as a feature of FUN30/ETL1 factors and show that this motif assists Fun30 activity. Our work suggests that Fun30 is directly involved in silencing by regulating the chromatin structure within or around silent loci.	[Neves-Costa, Ana; Will, W. Ryan; Vetter, Anna T.; Miller, J. Ross; Varga-Weisz, Patrick] Babraham Inst, Cambridge, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Neves-Costa, A (corresponding author), Inst Mol Med, Cell Biol Immune Syst Unit, Lisbon, Portugal.	Patrick.varga-weisz@bbsrc.ac.uk	Neves-Costa, Ana/AAJ-7066-2021	Neves-Costa, Ana/0000-0001-6506-7829; Varga-Weisz, Patrick/0000-0001-7409-8686	Portuguese Fundacao Para a Ciencia e a Tecnologia; DAAD German Academic Exchange Service; Biotechnology and Biological Sciences Research Council; EU Epigenome Network of Excellence; Biotechnology and Biological Sciences Research Council [BB/F020236/1] Funding Source: researchfish; Medical Research Council [G0701175] Funding Source: researchfish; BBSRC [BB/F020236/1] Funding Source: UKRI; MRC [G0701175] Funding Source: UKRI	Portuguese Fundacao Para a Ciencia e a Tecnologia(Portuguese Foundation for Science and Technology); DAAD German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EU Epigenome Network of Excellence; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a studentship of the Portuguese Fundacao Para a Ciencia e a Tecnologia to A.N.-C., a stipend of the DAAD German Academic Exchange Service to A.V., and by the Biotechnology and Biological Sciences Research Council and by the EU Epigenome Network of Excellence. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adra CN, 2000, GENOMICS, V69, P162, DOI 10.1006/geno.2000.6281; Altschul SF, 1998, TRENDS BIOCHEM SCI, V23, P444, DOI 10.1016/S0968-0004(98)01298-5; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anindya R, 2007, MOL CELL, V28, P386, DOI 10.1016/j.molcel.2007.10.008; Awad S, 2008, ANN NY ACAD SCI, V1138, P366, DOI 10.1196/annals.1414.038; BARTON AB, 1994, J BACTERIOL, V176, P1872, DOI 10.1128/jb.176.7.1872-1880.1994; Becker PB, 2002, ANNU REV BIOCHEM, V71, P247, DOI 10.1146/annurev.biochem.71.110601.135400; Belden WJ, 2007, MOL CELL, V25, P587, DOI 10.1016/j.molcel.2007.01.010; Bergink S, 2009, NATURE, V458, P461, DOI 10.1038/nature07963; Borkovich KA, 2004, MICROBIOL MOL BIOL R, V68, P1, DOI 10.1128/MMBR.68.1.1-108.2004; Bryk M, 1997, GENE DEV, V11, P255, DOI 10.1101/gad.11.2.255; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Corona DFV, 1999, MOL CELL, V3, P239, DOI 10.1016/S1097-2765(00)80314-7; Cuperus G, 2002, GENETICS, V162, P633; Davies BA, 2003, J BIOL CHEM, V278, P19826, DOI 10.1074/jbc.M301059200; Donaldson KM, 2003, CURR BIOL, V13, P258, DOI 10.1016/S0960-9822(03)00043-5; Donze D, 2001, EMBO J, V20, P520, DOI 10.1093/emboj/20.3.520; Dror V, 2004, MOL CELL BIOL, V24, P8227, DOI 10.1128/MCB.24.18.8227-8235.2004; Durr H, 2005, CELL, V121, P363, DOI 10.1016/j.cell.2005.03.026; Felsenfeld G, 2003, NATURE, V421, P448, DOI 10.1038/nature01411; Finn R., 2003, CURR PROTOC BIOINFOR; Flaus A, 2006, NUCLEIC ACIDS RES, V34, P2887, DOI 10.1093/nar/gkl295; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; Grune T, 2003, MOL CELL, V12, P449, DOI 10.1016/S1097-2765(03)00273-9; Guthrie C, 1991, GUIDE YEAST GENETICS; Harlow E., 1988, ANTIBODIES LAB MANUA; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Iida T, 2004, MOL CELL BIOL, V24, P217, DOI 10.1128/MCB.24.1.217-227.2004; Irlbacher H, 2005, GENE DEV, V19, P1811, DOI 10.1101/gad.334805; Kang RS, 2003, CELL, V113, P621, DOI 10.1016/S0092-8674(03)00362-3; KENT NA, 1995, NUCLEIC ACIDS RES, V23, P3786, DOI 10.1093/nar/23.18.3786; LAURENT BC, 1993, GENE DEV, V7, P583, DOI 10.1101/gad.7.4.583; Letunic I, 2002, NUCLEIC ACIDS RES, V30, P242, DOI 10.1093/nar/30.1.242; LOO S, 1995, MOL BIOL CELL, V6, P741, DOI 10.1091/mbc.6.6.741; Meijsing SH, 2001, GENE DEV, V15, P3169, DOI 10.1101/gad.929001; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Mueller JE, 2007, J MOL BIOL, V371, P1, DOI 10.1016/j.jmb.2007.04.089; Mueller JE, 2007, BIOCHEM BIOPH RES CO, V361, P1017, DOI 10.1016/j.bbrc.2007.07.140; Osada S, 2001, GENE DEV, V15, P3155, DOI 10.1101/gad.907201; Ouspenski II, 1999, NUCLEIC ACIDS RES, V27, P3001, DOI 10.1093/nar/27.15.3001; Papamichos-Chronakis M, 2008, NAT STRUCT MOL BIOL, V15, P338, DOI 10.1038/nsmb.1413; Pinskaya M, 2009, MOL CELL BIOL, V29, P2419, DOI 10.1128/MCB.01050-08; Ponting CP, 2000, BIOCHEM J, V351, P527, DOI 10.1042/0264-6021:3510527; Prag G, 2003, CELL, V113, P609, DOI 10.1016/S0092-8674(03)00364-7; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rusche LN, 2003, ANNU REV BIOCHEM, V72, P481, DOI 10.1146/annurev.biochem.72.121801.161547; Rusche LN, 2001, GENE DEV, V15, P955; SCHOOR M, 1993, DEV DYNAM, V197, P227, DOI 10.1002/aja.1001970307; Sharp JA, 2001, CURR BIOL, V11, P463, DOI 10.1016/S0960-9822(01)00140-3; Shen XT, 2000, NATURE, V406, P541, DOI 10.1038/35020123; Shih SC, 2003, EMBO J, V22, P1273, DOI 10.1093/emboj/cdg140; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Shimada K, 2008, CURR BIOL, V18, P566, DOI 10.1016/j.cub.2008.03.049; Smith JS, 1997, GENE DEV, V11, P241, DOI 10.1101/gad.11.2.241; Smith JS, 1999, MOL CELL BIOL, V19, P3184; SUSSEL L, 1993, MOL CELL BIOL, V13, P3919, DOI 10.1128/MCB.13.7.3919; Suter B, 2004, GENETICS, V167, P579, DOI 10.1534/genetics.103.024851; Sutton A, 2001, MOL CELL BIOL, V21, P3514, DOI 10.1128/MCB.21.10.3514-3522.2001; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1016/S0378-1097(99)00149-4; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; Tsukiyama T, 1999, GENE DEV, V13, P686, DOI 10.1101/gad.13.6.686; Vincent JA, 2008, NAT STRUCT MOL BIOL, V15, P477, DOI 10.1038/nsmb.1419; Xie JX, 1999, EMBO J, V18, P6448, DOI 10.1093/emboj/18.22.6448; Yang B, 2008, MOL BIOL CELL, V19, P4993, DOI 10.1091/mbc.E08-05-0524	66	49	51	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2009	4	12							e8111	10.1371/journal.pone.0008111	http://dx.doi.org/10.1371/journal.pone.0008111			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MT	19956593	Green Submitted, Green Published, gold			2022-12-25	WOS:000272828700022
J	Sui, SJH; Fedynak, A; Hsiao, WWL; Langille, MGI; Brinkman, FSL				Sui, Shannan J. Ho; Fedynak, Amber; Hsiao, William W. L.; Langille, Morgan G. I.; Brinkman, Fiona S. L.			The Association of Virulence Factors with Genomic Islands	PLOS ONE			English	Article							PROVIDES ACQUIRED-RESISTANCE; PATHOGENICITY ISLANDS; HORIZONTAL TRANSFER; COMMON THEMES; IN-VIVO; GENES; EVOLUTION; IDENTIFICATION; DATABASE; CRISPR	Background: It has been noted that many bacterial virulence factor genes are located within genomic islands (GIs; clusters of genes in a prokaryotic genome of probable horizontal origin). However, such studies have been limited to single genera or isolated observations. We have performed the first large-scale analysis of multiple diverse pathogens to examine this association. We additionally identified genes found predominantly in pathogens, but not non-pathogens, across multiple genera using 631 complete bacterial genomes, and we identified common trends in virulence for genes in GIs. Furthermore, we examined the relationship between GIs and clustered regularly interspaced palindromic repeats (CRISPRs) proposed to confer resistance to phage. Methodology/Principal Findings: We show quantitatively that GIs disproportionately contain more virulence factors than the rest of a given genome (p<1E-40 using three GI datasets) and that CRISPRs are also over-represented in GIs. Virulence factors in GIs and pathogen-associated virulence factors are enriched for proteins having more "offensive" functions, e. g. active invasion of the host, and are disproportionately components of type III/IV secretion systems or toxins. Numerous hypothetical pathogen-associated genes were identified, meriting further study. Conclusions/Significance: This is the first systematic analysis across diverse genera indicating that virulence factors are disproportionately associated with GIs. "Offensive" virulence factors, as opposed to host-interaction factors, may more often be a recently acquired trait (on an evolutionary time scale detected by GI analysis). Newly identified pathogen-associated genes warrant further study. We discuss the implications of these results, which cement the significant role of GIs in the evolution of many pathogens.	[Sui, Shannan J. Ho; Fedynak, Amber; Hsiao, William W. L.; Langille, Morgan G. I.; Brinkman, Fiona S. L.] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada	Simon Fraser University	Sui, SJH (corresponding author), Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada.	brinkman@sfu.ca	Langille, Morgan/D-4775-2009; Brinkman, Fiona/N-3195-2013	Brinkman, Fiona/0000-0002-0584-4099; Langille, Morgan/0000-0002-6604-3009; /0000-0002-6191-4709	International Business Machines Corporation (IBM); Genome Canada/Genome BC; Cystic Fibrosis Foundation; SFU Community Trust Endowment Fund; MSFHR/CIHR; Canadian Cystic Fibrosis Foundation Kin Canada	International Business Machines Corporation (IBM)(International Business Machines (IBM)); Genome Canada/Genome BC(Genome Canada); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); SFU Community Trust Endowment Fund; MSFHR/CIHR(Michael Smith Foundation for Health ResearchCanadian Institutes of Health Research (CIHR)); Canadian Cystic Fibrosis Foundation Kin Canada	This work was funded by grants from International Business Machines Corporation (IBM), Genome Canada/Genome BC (http://www.genomecanada.ca), the Cystic Fibrosis Foundation (http://www.cff.org), and the SFU Community Trust Endowment Fund. WWLH and FSLB are a Michael Smith Foundation for Health Research (MSFHR;www.msfhr.org) Trainee and Senior Scholar, respectively, and they are also Canadian Institutes for Health Research (CIHR;www.cihr-irsc.gc.ca) Doctoral award and New Investigator award recipients, respectively. MGIL is a recipient of a MSFHR/CIHR bioinformatics training award and SJHS is a recipient of the 2009 Canadian Cystic Fibrosis Foundation Kin Canada Fellowship (www.cysticfibrosis.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisimova M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-154; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Boutet Emmanuel, 2007, V406, P89; Boyd EF, 2002, TRENDS MICROBIOL, V10, P521, DOI 10.1016/S0966-842X(02)02459-9; Brown Nat F., 2006, PLoS Pathogens, V2, DOI 10.1371/journal.ppat.0020042; Champion OL, 2005, P NATL ACAD SCI USA, V102, P16043, DOI 10.1073/pnas.0503252102; Chen LH, 2005, NUCLEIC ACIDS RES, V33, pD325, DOI 10.1093/nar/gki008; Christie PJ, 2000, TRENDS MICROBIOL, V8, P354, DOI 10.1016/S0966-842X(00)01792-3; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Degnan PH, 2009, P NATL ACAD SCI USA, V106, P9063, DOI 10.1073/pnas.0900194106; Dobrindt U, 2004, NAT REV MICROBIOL, V2, P414, DOI 10.1038/nrmicro884; Dozois CM, 2003, P NATL ACAD SCI USA, V100, P247, DOI 10.1073/pnas.232686799; Escaich S, 2008, CURR OPIN CHEM BIOL, V12, P400, DOI 10.1016/j.cbpa.2008.06.022; Finlay BB, 1997, MICROBIOL MOL BIOL R, V61, P136, DOI 10.1128/.61.2.136-169.1997; Gandon S, 2003, P ROY SOC B-BIOL SCI, V270, P1129, DOI 10.1098/rspb.2003.2370; Gardy JL, 2005, BIOINFORMATICS, V21, P617, DOI 10.1093/bioinformatics/bti057; Godde JS, 2006, J MOL EVOL, V62, P718, DOI 10.1007/s00239-005-0223-z; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Groisman EA, 1996, CELL, V87, P791, DOI 10.1016/S0092-8674(00)81985-6; Hacker J, 2000, ANNU REV MICROBIOL, V54, P641, DOI 10.1146/annurev.micro.54.1.641; HACKER J, 1990, MICROB PATHOGENESIS, V8, P213, DOI 10.1016/0882-4010(90)90048-U; Hacker J, 1997, MOL MICROBIOL, V23, P1089, DOI 10.1046/j.1365-2958.1997.3101672.x; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Haft DH, 2005, BIOINFORMATICS, V21, P293, DOI 10.1093/bioinformatics/bti015; Hentschel U, 2001, MICROBES INFECT, V3, P545, DOI 10.1016/S1286-4579(01)01410-1; Holden M, 2004, NAT REV MICROBIOL, V2, P91, DOI 10.1038/nrmicro825; Hotopp JCD, 2006, MICROBIOL-SGM, V152, P3733, DOI 10.1099/mic.0.29261-0; Hsiao W, 2003, BIOINFORMATICS, V19, P418, DOI 10.1093/bioinformatics/btg004; Hsiao WWL, 2005, PLOS GENET, V1, P540, DOI 10.1371/journal.pgen.0010062; Hung DT, 2005, SCIENCE, V310, P670, DOI 10.1126/science.1116739; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Langille MGI, 2009, BIOINFORMATICS, V25, P664, DOI 10.1093/bioinformatics/btp030; Langille MGI, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-329; Liu CI, 2008, SCIENCE, V319, P1391, DOI 10.1126/science.1153018; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Ochman H, 2001, SCIENCE, V292, P1096, DOI 10.1126/science.1058543; Pallen MJ, 2007, NATURE, V449, P835, DOI 10.1038/nature06248; Plotkin SA, 2005, NAT MED, V11, pS5, DOI 10.1038/nm1209; Russmann H, 2004, INT J MED MICROBIOL, V293, P565, DOI 10.1078/1438-4221-00289; Schmidt H, 2004, CLIN MICROBIOL REV, V17, P14, DOI 10.1128/CMR.17.1.14-56.2004; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; Shankar N, 2002, NATURE, V417, P746, DOI 10.1038/nature00802; Shukla HD, 2005, CRIT REV MICROBIOL, V31, P11, DOI 10.1080/10408410590912952; Smith J, 2001, P ROY SOC B-BIOL SCI, V268, P61, DOI 10.1098/rspb.2000.1330; Snyder LAS, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-128; Sokurenko EV, 2006, NAT REV MICROBIOL, V4, P548, DOI 10.1038/nrmicro1446; Sorek R, 2008, NAT REV MICROBIOL, V6, P181, DOI 10.1038/nrmicro1793; Soubeyrand B, 2002, NATURE, V417, P609, DOI 10.1038/417609b; Stabler RA, 2005, MICROBIOL-SGM, V151, P2907, DOI 10.1099/mic.0.28099-0; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Vernikos GS, 2008, GENOME RES, V18, P331, DOI 10.1101/gr.7004508; Waack S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-142; Yang J, 2008, NUCLEIC ACIDS RES, V36, pD539, DOI 10.1093/nar/gkm951; Zhang R, 2006, MICROBES INFECT, V8, P1613, DOI 10.1016/j.micinf.2005.11.019; Zhou CE, 2007, NUCLEIC ACIDS RES, V35, pD391, DOI 10.1093/nar/gkl791	56	102	102	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2009	4	12							e8094	10.1371/journal.pone.0008094	http://dx.doi.org/10.1371/journal.pone.0008094			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MT	19956607	Green Published, Green Submitted, gold			2022-12-25	WOS:000272828700009
J	Gougelet, A; Mansuy, A; Blay, JY; Alberti, L; Vermot-Desroches, C				Gougelet, Angelique; Mansuy, Adeline; Blay, Jean-Yves; Alberti, Laurent; Vermot-Desroches, Claudine			Lymphoma and Myeloma Cell Resistance to Cytotoxic Agents and Ionizing Radiations Is Not Affected by Exposure to Anti-IL-6 Antibody	PLOS ONE			English	Article							NON-HODGKINS-LYMPHOMA; ANTI-INTERLEUKIN-6 MONOCLONAL-ANTIBODY; ENDOTHELIAL GROWTH-FACTOR; TUMOR-NECROSIS-FACTOR; WILD-TYPE P53; BREAST-CANCER; TYROSINE PHOSPHORYLATION; PROGNOSTIC VALUE; DOWN-REGULATION; CIS-DIAMMINEDICHLOROPLATINUM	Background: Production of high levels of IL-6 is often correlated with resistance to cytotoxics or ionizing radiations, in cancer cell lines as in various cancer patients. We investigated whether monoclonal antibodies directed against IL-6 may enable to reverse resistance of cancer cell lines. Methodology/Principal Findings: We exposed ten haematological cancer cells from lymphoma, myeloma, or leukemia origins to cytotoxics or ionizing radiations and assessed the effects of anti-IL-6 antibody addition on cell proliferation, apoptosis, or IL-6 signaling. A strong correlation between IL-6 secretion, measured by ELISA, and resistance to doxorubicin as ionizing radiations was observed in the multiple myeloma U266 and the Burkitt's lymphoma Daudi and Namalwa cells. Although an anti-IL-6 antibody combined to both treatments efficiently blocked IL-6 signaling in U266 cells, expressing the IL-6 receptor gp80, it did not increase treatment-induced anti-proliferative and pro-apoptotic effects on these cells, as well as on Daudi and Namalwa cells. This lack of effect could be related to diverse factors: 1) a higher release of the soluble form of IL-6 receptor gp80 in response to doxorubicin and irradiation from all cell lines, 2) an impaired level of the IL-6 pathway inhibitor SOCS3 in Daudi cells, and 3) an increased release of IL-10 and TNF alpha, two cytokines involved in cell radio- and chemoresistance. Conclusions/Significance: These data support the fact that IL-6 is not the preponderant actor of cell resistance to cytotoxics and ionizing radiations, which seems to be regulated by a complex network of proteins.	[Gougelet, Angelique; Mansuy, Adeline; Blay, Jean-Yves; Alberti, Laurent] Ctr Leon Berard, INSERM, U590, Equipe Cytokines & Canc, F-69373 Lyon, France; [Gougelet, Angelique; Mansuy, Adeline; Blay, Jean-Yves; Alberti, Laurent] IID Biotech, Conticanet Consortium FP6 06188, Dardilly, France; [Blay, Jean-Yves] EORTC, Brussels, Belgium; [Vermot-Desroches, Claudine] IDD Tech, Dardilly, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; European Organisation for Research & Treatment of Cancer	Gougelet, A (corresponding author), Ctr Leon Berard, INSERM, U590, Equipe Cytokines & Canc, F-69373 Lyon, France.	gougelet@lyon.fnclcc.fr	Blay, Jean-Yves/N-3966-2016; Gougelet, Angelique/E-2071-2017; Alberti, Laurent/HHZ-3296-2022	Blay, Jean-Yves/0000-0001-7190-120X; Gougelet, Angelique/0000-0001-7464-9804; Alberti, Laurent/0000-0002-7686-1750	Ligue Nationale contre le Cancer; Lyon BioPole	Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Lyon BioPole	This work has been supported by the Ligue Nationale contre le Cancer (grants from the Ain department) and the Lyon BioPole. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akmansu M, 2005, CYTOKINE, V31, P41, DOI 10.1016/j.cyto.2005.02.009; Alas S, 2001, CANCER RES, V61, P5137; Alas S, 2001, CLIN CANCER RES, V7, P709; Alberti L, 2004, INT J CANCER, V111, P653, DOI 10.1002/ijc.20287; Bachelot T, 2003, BRIT J CANCER, V88, P1721, DOI 10.1038/sj.bjc.6600956; BARUT BA, 1992, LEUKEMIA RES, V16, P951, DOI 10.1016/0145-2126(92)90073-G; BORSELLINO N, 1995, CANCER RES, V55, P4633; Cassatella MA, 1999, BLOOD, V94, P2880, DOI 10.1182/blood.V94.8.2880.420k31_2880_2889; Chung JK, 1997, MOL CELL BIOL, V17, P6508, DOI 10.1128/MCB.17.11.6508; Conze D, 2001, CANCER RES, V61, P8851; Cummings BS, 2004, J PHARMACOL EXP THER, V310, P126, DOI 10.1124/jpet.104.065862; Dedoussis GVZ, 1999, EXP CELL RES, V249, P269, DOI 10.1006/excr.1999.4442; Gonzalez-Angulo AM, 2007, ADV EXP MED BIOL, V608, P1; Guillemard V, 2004, CURR CANCER DRUG TAR, V4, P313, DOI 10.2174/1568009043332989; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; JOHNSTON JA, 1995, P NATL ACAD SCI USA, V92, P8705, DOI 10.1073/pnas.92.19.8705; Jourdan M, 1999, EUR CYTOKINE NETW, V10, P65; KISHIMOTO T, 1989, BLOOD, V74, P1, DOI 10.1182/blood.V74.1.1.1; Klein B, 1990, Eur Cytokine Netw, V1, P193; KLEIN B, 1989, BLOOD, V73, P517; Krebs DL, 2001, STEM CELLS, V19, P378, DOI 10.1634/stemcells.19-5-378; Lotem J, 1996, P NATL ACAD SCI USA, V93, P12507, DOI 10.1073/pnas.93.22.12507; Lufei C, 2007, ONCOGENE, V26, P7656, DOI 10.1038/sj.onc.1210567; MIZUTANI Y, 1994, J UROLOGY, V151, P1697, DOI 10.1016/S0022-5347(17)35347-8; MIZUTANI Y, 1995, CANCER RES, V55, P590; Moreau P, 2000, BRIT J HAEMATOL, V109, P661, DOI 10.1046/j.1365-2141.2000.02093.x; Naka T, 2002, ARTHRITIS RES THER, V4, pS233, DOI 10.1186/ar565; Negrier S, 2004, J CLIN ONCOL, V22, P2371, DOI 10.1200/JCO.2004.06.121; Niemand C, 2003, J IMMUNOL, V170, P3263, DOI 10.4049/jimmunol.170.6.3263; Otero DC, 2006, J IMMUNOL, V177, P6593, DOI 10.4049/jimmunol.177.10.6593; Park J, 2008, ANTI-CANCER DRUG, V19, P777, DOI 10.1097/CAD.0b013e32830c236a; Petrini B., 1992, In Vivo (Attiki), V6, P531; Preti HA, 1997, ANN INTERN MED, V127, P186, DOI 10.7326/0003-4819-127-3-199708010-00002; Razandi M, 2000, MOL ENDOCRINOL, V14, P1434, DOI 10.1210/me.14.9.1434; Schuringa JJ, 2001, FEBS LETT, V495, P71, DOI 10.1016/S0014-5793(01)02354-7; Shinomiya N, 2000, INT J RADIAT ONCOL, V47, P767, DOI 10.1016/S0360-3016(99)00517-9; Sommer U, 2005, J BIOL CHEM, V280, P31478, DOI 10.1074/jbc.M506008200; Tamatani T, 2004, INT J CANCER, V108, P912, DOI 10.1002/ijc.11640; Trikha M, 2003, CLIN CANCER RES, V9, P4653; TURNER B, 1991, P NATL ACAD SCI USA, V88, P1227, DOI 10.1073/pnas.88.4.1227; Visco C, 2004, LEUKEMIA LYMPHOMA, V45, P2085, DOI 10.1080/10428190410001712234; Voorzanger N, 1996, CANCER RES, V56, P5499; Voorzanger-Rousselot N, 1998, BLOOD, V92, P3381, DOI 10.1182/blood.V92.9.3381.421k02_3381_3387; YONISHROUACH E, 1991, NATURE, V352, P345, DOI 10.1038/352345a0; ZHANG XK, 1995, SCIENCE, V267, P1990, DOI 10.1126/science.7701321; Zhou ZH, 2005, APOPTOSIS, V10, P123, DOI 10.1007/s10495-005-6067-6	47	17	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2009	4	11							e8026	10.1371/journal.pone.0008026	http://dx.doi.org/10.1371/journal.pone.0008026			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MQ	19956602	Green Published, gold			2022-12-25	WOS:000272828400005
J	Pattanayek, R; Mori, T; Xu, Y; Pattanayek, S; Johnson, CH; Egli, M				Pattanayek, Rekha; Mori, Tetsuya; Xu, Yao; Pattanayek, Sabuj; Johnson, Carl H.; Egli, Martin			Structures of KaiC Circadian Clock Mutant Proteins: A New Phosphorylation Site at T426 and Mechanisms of Kinase, ATPase and Phosphatase	PLOS ONE			English	Article							SYNECHOCOCCUS-ELONGATUS; DIFFRACTION DATA; OSCILLATION; SYSTEM; AUTOPHOSPHORYLATION; EXPRESSION; FEEDBACK; RHYTHMS; COMPLEX; MODEL	Background: The circadian clock of the cyanobacterium Synechococcus elongatus can be reconstituted in vitro by three proteins, KaiA, KaiB and KaiC. Homo-hexameric KaiC displays kinase, phosphatase and ATPase activities; KaiA enhances KaiC phosphorylation and KaiB antagonizes KaiA. Phosphorylation and dephosphorylation of the two known sites in the C-terminal half of KaiC subunits, T432 and S431, follow a strict order (TS -> pTS -> pTpS -> TpS -> TS) over the daily cycle, the origin of which is not understood. To address this void and to analyze the roles of KaiC active site residues, in particular T426, we determined structures of single and double P-site mutants of S. elongatus KaiC. Methodology and Principal Findings: The conformations of the loop region harboring P-site residues T432 and S431 in the crystal structures of six KaiC mutant proteins exhibit subtle differences that result in various distances between Thr (or Ala/Asn/Glu) and Ser (or Ala/Asp) residues and the ATP gamma-phosphate. T432 is phosphorylated first because it lies consistently closer to P gamma. The structures of the S431A and T432E/S431A mutants reveal phosphorylation at T426. The environments of the latter residue in the structures and functional data for T426 mutants in vitro and in vivo imply a role in dephosphorylation. Conclusions and Significance: We provide evidence for a third phosphorylation site in KaiC at T426. T426 and S431 are closely spaced and a KaiC subunit cannot carry phosphates at both sites simultaneously. Fewer subunits are phosphorylated at T426 in the two KaiC mutants compared to phosphorylated T432 and/or S431 residues in the structures of wt and other mutant KaiCs, suggesting that T426 phosphorylation may be labile. The structures combined with functional data for a host of KaiC mutant proteins help rationalize why S431 trails T432 in the loss of its phosphate and shed light on the mechanisms of the KaiC kinase, ATPase and phosphatase activities.	[Pattanayek, Rekha; Pattanayek, Sabuj; Egli, Martin] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37212 USA; [Mori, Tetsuya; Xu, Yao; Johnson, Carl H.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University	Pattanayek, R (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37212 USA.	martin.egli@vanderbilt.edu	Johnson, Carl H/I-4655-2014	Mori, Tetsuya/0000-0001-6036-5261	USPHS [R01 GM073845, R01 GM067152]; U.S. Department of Energy, Basic Energy Sciences, Office of Science [W-31-109-Eng-38]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067152, R01GM073845, R37GM067152] Funding Source: NIH RePORTER	USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); U.S. Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by USPHS research grants R01 GM073845 (ME) and R01 GM067152 (CHJ). Vanderbilt University is a member institution of the Life Sciences Collaborative Access Team (LS-CAT) at sector 21 of the Advanced Photon Source (APS), Argonne, IL. Use of the APS was supported by the U.S. Department of Energy, Basic Energy Sciences, Office of Science, under Contract No. W-31-109-Eng-38. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CAMBILLAU C, 1997, TURBO FRODO VERSION; Dunlap J.C., 2004, CHRONOBIOLOGY BIOL T; Egli Martin, 2009, P121, DOI 10.1007/978-3-540-88431-6_7; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hayashi F, 2003, GENES CELLS, V8, P287, DOI 10.1046/j.1365-2443.2003.00633.x; Ishiura M, 1998, SCIENCE, V281, P1519, DOI 10.1126/science.281.5382.1519; Ito H, 2007, NAT STRUCT MOL BIOL, V14, P1084, DOI 10.1038/nsmb1312; Iwasaki H, 2002, P NATL ACAD SCI USA, V99, P15788, DOI 10.1073/pnas.222467299; Johnson CH, 2008, SCIENCE, V322, P697, DOI 10.1126/science.1150451; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kageyama H, 2006, MOL CELL, V23, P161, DOI 10.1016/j.molcel.2006.05.039; Kim SA, 2001, BIOCHEM BIOPH RES CO, V282, P773, DOI 10.1006/bbrc.2001.4651; Kitayama Y, 2003, EMBO J, V22, P2127, DOI 10.1093/emboj/cdg212; KONDO T, 1993, P NATL ACAD SCI USA, V90, P5672, DOI 10.1073/pnas.90.12.5672; Leipe DD, 2000, GENOME RES, V10, P5; Mori T, 2002, P NATL ACAD SCI USA, V99, P17203, DOI 10.1073/pnas.262578499; Mori T, 2007, PLOS BIOL, V5, P841, DOI 10.1371/journal.pbio.0050093; Murakami R, 2008, GENES CELLS, V13, P387, DOI 10.1111/j.1365-2443.2008.01174.x; Nakajima M, 2005, SCIENCE, V308, P414, DOI 10.1126/science.1108451; NICHOLLS A, 1993, BIOPHYS J, V64, pA166; Nishiwaki T, 2004, P NATL ACAD SCI USA, V101, P13927, DOI 10.1073/pnas.0403906101; Nishiwaki T, 2000, P NATL ACAD SCI USA, V97, P495, DOI 10.1073/pnas.97.1.495; Nishiwaki T, 2007, EMBO J, V26, P4029, DOI 10.1038/sj.emboj.7601832; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pattanayek R, 2004, MOL CELL, V15, P375, DOI 10.1016/j.molcel.2004.07.013; Pattanayek R, 2008, EMBO J, V27, P1767, DOI 10.1038/emboj.2008.104; Pattanayek R, 2006, EMBO J, V25, P2017, DOI 10.1038/sj.emboj.7601086; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rust MJ, 2007, SCIENCE, V318, P809, DOI 10.1126/science.1148596; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; Terauchi K, 2007, P NATL ACAD SCI USA, V104, P16377, DOI 10.1073/pnas.0706292104; Tomita J, 2005, SCIENCE, V307, P251, DOI 10.1126/science.1102540; Vakonakis Ioannis, 2009, P103, DOI 10.1007/978-3-540-88431-6_6; Williams SB, 2002, P NATL ACAD SCI USA, V99, P15357, DOI 10.1073/pnas.232517099; Woelfle MA, 2007, P NATL ACAD SCI USA, V104, P18819, DOI 10.1073/pnas.0706069104; Xu Y, 2004, P NATL ACAD SCI USA, V101, P13933, DOI 10.1073/pnas.0404768101; Xu Y, 2003, EMBO J, V22, P2117, DOI 10.1093/emboj/cdg168; XU Y, 2009, PLOS ONE IN PRESS	39	34	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2009	4	11							e7529	10.1371/journal.pone.0007529	http://dx.doi.org/10.1371/journal.pone.0007529			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MN	19956664	Green Published, gold, Green Submitted			2022-12-25	WOS:000272828100001
J	Suarez, R; Villalon, A; Kunzle, H; Mpodozis, J				Suarez, Rodrigo; Villalon, Aldo; Kuenzle, Heinz; Mpodozis, Jorge			Transposition and Intermingling of G alpha i2 and G alpha o Afferences into Single Vomeronasal Glomeruli in the Madagascan Lesser Tenrec Echinops telfairi	PLOS ONE			English	Article							ACCESSORY OLFACTORY-BULB; PUTATIVE PHEROMONE RECEPTORS; G-PROTEINS; DIFFERENTIAL LOCALIZATION; POSTERIOR DIVISIONS; SEGREGATED PATHWAYS; AXONAL PROJECTIONS; MULTIGENE FAMILY; SENSORY NEURONS; HEDGEHOG TENREC	The vomeronasal system (VNS) mediates pheromonal communication in mammals. From the vomeronasal organ, two populations of sensory neurons, expressing either G alpha i2 or G alpha o proteins, send projections that end in glomeruli distributed either at the rostral or caudal half of the accessory olfactory bulb (AOB), respectively. Neurons at the AOB contact glomeruli of a single subpopulation. The dichotomic segregation of AOB glomeruli has been described in opossums, rodents and rabbits, while Primates and Laurasiatheres present the G alpha i2-pathway only, or none at all (such as apes, some bats and aquatic species). We studied the AOB of the Madagascan lesser tenrec Echinops telfairi (Afrotheria: Afrosoricida) and found that G alpha i2 and G alpha o proteins are expressed in rostral and caudal glomeruli, respectively. However, the segregation of vomeronasal glomeruli at the AOB is not exclusive, as both pathways contained some glomeruli transposed into the adjoining subdomain. Moreover, some glomeruli seem to contain intermingled afferences from both pathways. Both the transposition and heterogeneity of vomeronasal afferences are features, to our knowledge, never reported before. The organization of AOB glomeruli suggests that synaptic integration might occur at the glomerular layer. Whether intrinsic AOB neurons may make synaptic contact with axon terminals of both subpopulations is an interesting possibility that would expand our understanding about the integration of vomeronasal pathways.	[Suarez, Rodrigo; Villalon, Aldo] Univ Chile, Fac Med, Escuela Posgrado, Santiago 7, Chile; [Suarez, Rodrigo; Mpodozis, Jorge] Univ Chile, Fac Ciencias, Dept Biol, Santiago 7, Chile; [Villalon, Aldo] Univ Diego Portales, Fac Ciencias Salud, Santiago, Chile; [Kuenzle, Heinz] Univ Munich, Anat Anstalt, D-8000 Munich, Germany	Universidad de Chile; Universidad de Chile; University Diego Portales; University of Munich	Suarez, R (corresponding author), Univ Chile, Fac Med, Escuela Posgrado, Santiago 7, Chile.	rsuarezsaa@gmail.com	mpodozis, jorge/A-1992-2013; Suarez, Rodrigo/J-1529-2014; Suarez, Rodrigo/N-9437-2016	Suarez, Rodrigo/0000-0001-5153-5652; Suarez, Rodrigo/0000-0001-5153-5652	FEBA (Fundacion para Estudios Biomedicos Avanzados); MecesupUCH 0306; Conicyt (Termino de tesis doctoral); Fondecyt [1080094]; Deutsche Forschungsgemeinschaft [Ku 624/3-3]	FEBA (Fundacion para Estudios Biomedicos Avanzados); MecesupUCH 0306; Conicyt (Termino de tesis doctoral)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The authors acknowledge financial support from FEBA (Fundacion para Estudios Biomedicos Avanzados), Mecesup UCH 0306, Conicyt (Termino de tesis doctoral), Fondecyt (1080094) and Deutsche Forschungsgemeinschaft (Ku 624/3-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Berghard A, 1996, J NEUROSCI, V16, P909; Cloutier JF, 2004, J NEUROSCI, V24, P9087, DOI 10.1523/JNEUROSCI.2786-04.2004; Del Punta K, 2002, NEURON, V35, P1057, DOI 10.1016/S0896-6273(02)00904-2; Dudley CA, 1999, NEUROSCIENCE, V91, P1549, DOI 10.1016/S0306-4522(98)00711-8; Dulac C, 2006, ANNU REV GENET, V40, P449, DOI 10.1146/annurev.genet.39.073003.093937; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; Glazko GV, 2003, MOL BIOL EVOL, V20, P424, DOI 10.1093/molbev/msg050; Halem HA, 2001, EUR J NEUROSCI, V13, P389, DOI 10.1046/j.1460-9568.2001.01382.x; Hallstrom BM, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-162; Halpern M, 1998, MICROSC RES TECHNIQ, V41, P519, DOI 10.1002/(SICI)1097-0029(19980615)41:6<519::AID-JEMT7>3.3.CO;2-C; Halpern M, 2003, PROG NEUROBIOL, V70, P245, DOI 10.1016/S0301-0082(03)00103-5; HALPERN M, 1995, BRAIN RES, V677, P157, DOI 10.1016/0006-8993(95)00159-N; Herrada G, 1997, CELL, V90, P763, DOI 10.1016/S0092-8674(00)80536-X; IMAMURA K, 1985, BRAIN RES, V328, P362, DOI 10.1016/0006-8993(85)91050-9; Inamura K, 1999, EUR J NEUROSCI, V11, P2254, DOI 10.1046/j.1460-9568.1999.00646.x; Jia CP, 1996, BRAIN RES, V719, P117, DOI 10.1016/0006-8993(96)00110-2; Jia CP, 1997, NEUROREPORT, V8, P1887, DOI 10.1097/00001756-199705260-00019; Kimoto H, 2005, NATURE, V437, P898, DOI 10.1038/nature04033; Knoll B, 2003, DEVELOPMENT, V130, P5073, DOI 10.1242/dev.00726; Kosaka K, 2005, NEUROSCI RES, V53, P353, DOI 10.1016/j.neures.2005.08.004; Kunzle H, 2007, ANIM REPROD SCI, V97, P364, DOI 10.1016/j.anireprosci.2006.02.011; Kumar A, 1999, J NEUROSCI, V19, DOI 10.1523/JNEUROSCI.19-20-j0003.1999; Laariva-Sahd J, 2008, J COMP NEUROL, V510, P309, DOI 10.1002/cne.21790; Leinders-Zufall T, 2004, SCIENCE, V306, P1033, DOI 10.1126/science.1102818; Leinders-Zufall T, 2000, NATURE, V405, P792, DOI 10.1038/35015572; Martinez-Marcos A, 1999, EUR J NEUROSCI, V11, P3789, DOI 10.1046/j.1460-9568.1999.00797.x; Matsunami H, 1997, CELL, V90, P775, DOI 10.1016/S0092-8674(00)80537-1; Matsuoka M, 1999, NEUROSCI RES, V35, P189, DOI 10.1016/S0168-0102(99)00082-6; Mohedano-Moriano A, 2007, EUR J NEUROSCI, V25, P2065, DOI 10.1111/j.1460-9568.2007.05472.x; Murphy WJ, 2007, GENOME RES, V17, P413, DOI 10.1101/gr.5918807; Peele P, 2003, EUR J NEUROSCI, V18, P622, DOI 10.1046/j.1460-9568.2003.02790.x; Radtke-Schuller S, 2000, J COMP NEUROL, V423, P687, DOI 10.1002/1096-9861(20000807)423:4<687::AID-CNE12>3.0.CO;2-F; Rodriguez I, 1999, CELL, V97, P199, DOI 10.1016/S0092-8674(00)80730-8; Ryba NJP, 1997, NEURON, V19, P371, DOI 10.1016/S0896-6273(00)80946-0; Shi P, 2007, GENOME RES, V17, P166, DOI 10.1101/gr.6040007; SHINOHARA H, 1992, J NEUROSCI, V12, P1275; Springer MS, 2003, P NATL ACAD SCI USA, V100, P1056, DOI 10.1073/pnas.0334222100; Suarez R, 2009, BEHAV BRAIN RES, V198, P306, DOI 10.1016/j.bbr.2008.11.009; Sugai T, 1997, NEUROSCIENCE, V79, P871, DOI 10.1016/S0306-4522(96)00690-2; Sugai T, 2006, NEUROREPORT, V17, P1663, DOI 10.1097/01.wnr.0000239950.14954.59; Takigami S, 2000, CHEM SENSES, V25, P387, DOI 10.1093/chemse/25.4.387; Takigami S, 2004, CHEM SENSES, V29, P301, DOI 10.1093/chemse/bjh032; von Campenhausen H, 2000, EUR J NEUROSCI, V12, P33, DOI 10.1046/j.1460-9568.2000.00879.x; Wagner S, 2006, NEURON, V50, P697, DOI 10.1016/j.neuron.2006.04.033; Wekesa KS, 1999, BRAIN RES, V837, P117, DOI 10.1016/S0006-8993(99)01630-3; Yonekura J, 2008, MOL CELL NEUROSCI, V37, P708, DOI 10.1016/j.mcn.2007.12.016; Young JM, 2007, TRENDS GENET, V23, P212, DOI 10.1016/j.tig.2007.03.004	48	7	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2009	4	11							e8005	10.1371/journal.pone.0008005	http://dx.doi.org/10.1371/journal.pone.0008005			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MH	19956694	Green Submitted, gold, Green Published			2022-12-25	WOS:000272827500029
J	Ayora-Talavera, G; Shelton, H; Scull, MA; Ren, JY; Jones, IM; Pickles, RJ; Barclay, WS				Ayora-Talavera, Guadalupe; Shelton, Holly; Scull, Margaret A.; Ren, Junyuan; Jones, Ian M.; Pickles, Raymond J.; Barclay, Wendy S.			Mutations in H5N1 Influenza Virus Hemagglutinin that Confer Binding to Human Tracheal Airway Epithelium	PLOS ONE			English	Article							RECEPTOR SPECIFICITY; AVIAN H5N1; CILIATED CELLS; A VIRUS; REPLICATION; TRANSMISSION; INFECTION; AMINO-ACID-226; ADAPTATION; CULTURES	The emergence in 2009 of a swine-origin H1N1 influenza virus as the first pandemic of the 21st Century is a timely reminder of the international public health impact of influenza viruses, even those associated with mild disease. The widespread distribution of highly pathogenic H5N1 influenza virus in the avian population has spawned concern that it may give rise to a human influenza pandemic. The mortality rate associated with occasional human infection by H5N1 virus approximates 60%, suggesting that an H5N1 pandemic would be devastating to global health and economy. To date, the H5N1 virus has not acquired the propensity to transmit efficiently between humans. The reasons behind this are unclear, especially given the high mutation rate associated with influenza virus replication. Here we used a panel of recombinant H5 hemagglutinin ( HA) variants to demonstrate the potential for H5 HA to bind human airway epithelium, the predominant target tissue for influenza virus infection and spread. While parental H5 HA exhibited limited binding to human tracheal epithelium, introduction of selected mutations converted the binding profile to that of a current human influenza strain HA. Strikingly, these amino-acid changes required multiple simultaneous mutations in the genomes of naturally occurring H5 isolates. Moreover, H5 HAs bearing intermediate sequences failed to bind airway tissues and likely represent mutations that are an evolutionary "dead end.'' We conclude that, although genetic changes that adapt H5 to human airways can be demonstrated, they may not readily arise during natural virus replication. This genetic barrier limits the likelihood that current H5 viruses will originate a human pandemic.			Ayora-Talavera, G (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Virol, London, England.	w.barclay@imperial.ac.uk	Scull, Margaret/K-9963-2019; Ayora-Talavera, Guadalupe/AAH-3165-2019; Jones, Ian/AAF-4986-2019	Ayora-Talavera, Guadalupe/0000-0002-2829-6945; Jones, Ian/0000-0002-7738-2516; shelton, Holly/0000-0002-5776-0735; Barclay, Wendy/0000-0002-3948-0895; Scull, Margaret/0000-0002-6860-2468	MRC [G0500597] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077844, P50HL084934, R21HL080098] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007419] Funding Source: NIH RePORTER; Medical Research Council [G0500597] Funding Source: Medline; NHLBI NIH HHS [R01 HL77844-1, R21 HL080098, R01 HL077844, R21 HL080098-01, 5 P50 HL084934, P50 HL084934] Funding Source: Medline; NIAID NIH HHS [5-T32-AI007419, T32 AI007419] Funding Source: Medline; Wellcome Trust Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Wellcome Trust(Wellcome Trust)		Auewarakul P, 2007, J VIROL, V81, P9950, DOI 10.1128/JVI.00468-07; Barclay WS, 2007, BIOORGAN MED CHEM, V15, P4038, DOI 10.1016/j.bmc.2007.03.085; Bartlett EJ, 2008, J VIROL, V82, P8059, DOI 10.1128/JVI.02263-07; Bateman AC, 2008, J VIROL, V82, P8204, DOI 10.1128/JVI.00718-08; Belser JA, 2008, P NATL ACAD SCI USA, V105, P7558, DOI 10.1073/pnas.0801259105; Chandrasekaran A, 2008, NAT BIOTECHNOL, V26, P107, DOI 10.1038/nbt1375; Chen LM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000072; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Gagneux P, 2003, J BIOL CHEM, V278, P48245, DOI 10.1074/jbc.M309813200; Gambaryan A, 2006, VIROLOGY, V344, P432, DOI 10.1016/j.virol.2005.08.035; Harvey R, 2004, J VIROL, V78, P502, DOI 10.1128/JVI.78.1.502-507.2004; HOYER LL, 1991, J BIOCHEM-TOKYO, V110, P462, DOI 10.1093/oxfordjournals.jbchem.a123603; Ibricevic A, 2006, J VIROL, V80, P7469, DOI 10.1128/JVI.02677-05; Ilyushina NA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000043; Jackson S, 2009, J VIROL, V83, P8131, DOI 10.1128/JVI.00534-09; Kongchanagul A, 2008, J GEN VIROL, V89, P1805, DOI 10.1099/vir.0.2008/002469-0; Kuiken T, 2006, SCIENCE, V312, P394, DOI 10.1126/science.1122818; Lee J, 2008, VACCINE; Maines TR, 2006, P NATL ACAD SCI USA, V103, P12121, DOI 10.1073/pnas.0605134103; Matrosovich M, 2000, J VIROL, V74, P8502, DOI 10.1128/JVI.74.18.8502-8512.2000; Matrosovich M, 1999, J VIROL, V73, P1146, DOI 10.1128/JVI.73.2.1146-1155.1999; Matrosovich M, 2007, VIROLOGY, V361, P384, DOI 10.1016/j.virol.2006.11.030; Matrosovich MN, 2004, P NATL ACAD SCI USA, V101, P4620, DOI 10.1073/pnas.0308001101; Medeiros R, 2007, ANTIVIR THER, V12, P571; Nicholls JM, 2008, TRENDS MICROBIOL, V16, P149, DOI 10.1016/j.tim.2008.01.008; Owen RE, 2007, J VIROL, V81, P11170, DOI 10.1128/JVI.01217-07; PARVIN JD, 1986, J VIROL, V59, P377, DOI 10.1128/JVI.59.2.377-383.1986; QI L, 2009, J VIROL; Reid AH, 2003, EMERG INFECT DIS, V9, P1249; Scull MA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000424; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Srinivasan A, 2008, P NATL ACAD SCI USA, V105, P2800, DOI 10.1073/pnas.0711963105; Stevens J, 2006, J MOL BIOL, V355, P1143, DOI 10.1016/j.jmb.2005.11.002; Stevens J, 2008, J MOL BIOL, V381, P1382, DOI 10.1016/j.jmb.2008.04.016; Thompson CI, 2006, J VIROL, V80, P8060, DOI 10.1128/JVI.00384-06; Tumpey TM, 2007, SCIENCE, V315, P655, DOI 10.1126/science.1136212; van Riel D, 2007, AM J PATHOL, V171, P1215, DOI 10.2353/ajpath.2007.070248; Wan H, 2007, J VIROL, V81, P5181, DOI 10.1128/JVI.02827-06; Wan HQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002923; *WHO, 2009, CUM NUMB CONF HUM CA; World Health Organization, 2009, PAND H1N1 2009 UPD 6; Yamada S, 2006, NATURE, V444, P378, DOI 10.1038/nature05264; Yang ZY, 2007, SCIENCE, V317, P825, DOI 10.1126/science.1135165; Yen HL, 2007, J VIROL, V81, P6890, DOI 10.1128/JVI.00170-07; Zhang LQ, 2005, J VIROL, V79, P1113, DOI 10.1128/JVI.79.2.1113-1124.2005; Zhang LQ, 2002, J VIROL, V76, P5654, DOI 10.1128/JVI.76.11.5654-5666.2002	46	51	53	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2009	4	11							e7836	10.1371/journal.pone.0007836	http://dx.doi.org/10.1371/journal.pone.0007836			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521QH	19924306	gold, Green Submitted, Green Published			2022-12-25	WOS:000271936700006
J	Finlayson, AE; Freeman, KW				Finlayson, Alexander E.; Freeman, Kevin W.			A Cell Motility Screen Reveals Role for MARCKS-Related Protein in Adherens Junction Formation and Tumorigenesis	PLOS ONE			English	Article							KINASE SUBSTRATE MARCKS; MESENCHYMAL TRANSITION; TUMOR INVASION; CANCER-CELLS; CALMODULIN; PHOSPHORYLATION; METASTASIS; EFFECTOR; PROTEOLYSIS; PODOPLANIN	Invasion through the extracellular matrix (ECM) is important for wound healing, immunological responses and metastasis. We established an invasion-based cell motility screen using Boyden chambers overlaid with Matrigel to select for pro-invasive genes. By this method we identified antisense to MARCKS related protein (MRP), whose family member MARCKS is a target of miR-21, a microRNA involved in tumor growth, invasion and metastasis in multiple human cancers. We confirmed that targeted knockdown of MRP, in both EpRas mammary epithelial cells and PC3 prostate cancer cells, promoted in vitro cell migration that was blocked by trifluoperazine. Additionally, we observed increased immunofluoresence of E-cadherin, beta-catenin and APC at sites of cell-cell contact in EpRas cells with MRP knockdown suggesting formation of adherens junctions. By wound healing assay we observed that reduced MRP supported collective cell migration, a type of cell movement where adherens junctions are maintained. However, destabilized adherens junctions, like those seen in EpRas cells, are frequently important for oncogenic signaling. Consequently, knockdown of MRP in EpRas caused loss of tumorigenesis in vivo, and reduced Wnt3a induced TCF reporter signaling in vitro. Together our data suggest that reducing MRP expression promotes formation of adherens junctions in EpRas cells, allowing collective cell migration, but interferes with oncogenic beta-catenin signaling and tumorigenesis.			Finlayson, AE (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	kevin.freeman@childrens.harvard.edu			NATIONAL CANCER INSTITUTE [F32CA112989] Funding Source: NIH RePORTER; National Institute for Health Research [ACF-2009-13-022] Funding Source: researchfish; NCI NIH HHS [F32 CA112989] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute for Health Research(National Institute for Health Research (NIHR)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Arbuzova A, 2002, BIOCHEM J, V362, P1, DOI 10.1042/0264-6021:3620001; Bidard FC, 2008, CANCER METAST REV, V27, P5, DOI 10.1007/s10555-007-9103-x; Brown MD, 2006, TRENDS CELL BIOL, V16, P242, DOI 10.1016/j.tcb.2006.03.002; Chang S, 1996, J BIOL CHEM, V271, P1174, DOI 10.1074/jbc.271.2.1174; Christiansen JJ, 2006, CANCER RES, V66, P8319, DOI 10.1158/0008-5472.CAN-06-0410; Faux MC, 2004, J CELL SCI, V117, P427, DOI 10.1242/jcs.00862; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Gimona M, 2008, CURR OPIN CELL BIOL, V20, P235, DOI 10.1016/j.ceb.2008.01.005; Koh EY, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf142; Lallemand D, 2003, GENE DEV, V17, P1090, DOI 10.1101/gad.1054603; Li T, 2009, BIOCHEM BIOPH RES CO, V383, P280, DOI 10.1016/j.bbrc.2009.03.077; Macpherson IR, 2007, ONCOGENE, V26, P5214, DOI 10.1038/sj.onc.1210334; McLaughlin S, 2005, BIOCHEM SOC SYMP, V72, P189, DOI 10.1042/bss0720189; Michaelson JS, 2001, ONCOGENE, V20, P5093, DOI 10.1038/sj.onc.1204586; Noritake J, 2004, MOL BIOL CELL, V15, P1065, DOI 10.1091/mbc.E03-08-0582; Pilot F, 2006, NATURE, V442, P580, DOI 10.1038/nature04935; Porumb T, 1997, EUR BIOPHYS J BIOPHY, V25, P239, DOI 10.1007/s002490050036; Ramsden JJ, 2000, INT J BIOCHEM CELL B, V32, P475, DOI 10.1016/S1357-2725(99)00152-1; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Sengupta P, 2007, J BIOL CHEM, V282, P8474, DOI 10.1074/jbc.M607211200; Sodek KL, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-223; VERGHESE GM, 1994, J BIOL CHEM, V269, P9361; Wang JY, 2001, J BIOL CHEM, V276, P5012, DOI 10.1074/jbc.M008355200; Wicki A, 2006, CANCER CELL, V9, P261, DOI 10.1016/j.ccr.2006.03.010; Wicki A, 2007, BRIT J CANCER, V96, P1, DOI 10.1038/sj.bjc.6603518; Willert K, 2006, GENE DEV, V20, P1394, DOI 10.1101/gad.1424006; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006	27	30	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2009	4	11							e7833	10.1371/journal.pone.0007833	http://dx.doi.org/10.1371/journal.pone.0007833			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521QH	19924305	Green Submitted, gold, Green Published			2022-12-25	WOS:000271936700004
J	Javerzat, S; Franco, M; Herbert, J; Platonova, N; Peille, AL; Pantesco, V; De Vos, J; Assou, S; Bicknell, R; Bikfalvi, A; Hagedorn, M				Javerzat, Sophie; Franco, Melanie; Herbert, John; Platonova, Natalia; Peille, Anne-Lise; Pantesco, Veronique; De Vos, John; Assou, Said; Bicknell, Roy; Bikfalvi, Andreas; Hagedorn, Martin			Correlating Global Gene Regulation to Angiogenesis in the Developing Chick Extra-Embryonic Vascular System	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; INTEGRIN-LINKED KINASE; INTUSSUSCEPTIVE CAPILLARY GROWTH; CHORIOALLANTOIC MEMBRANE CAM; CELL-SUBSTRATE INTERACTION; TUMOR ANGIOGENESIS; PLACENTAL DEVELOPMENT; DEPENDENT MECHANISM; REDUNDANT ROLES; BREAST-CANCER	Background: Formation of blood vessels requires the concerted regulation of an unknown number of genes in a spatial-, time-and dosage-dependent manner. Determining genes, which drive vascular maturation is crucial for the identification of new therapeutic targets against pathological angiogenesis. Methology/Principal Findings: We accessed global gene regulation throughout maturation of the chick chorio-allantoic membrane (CAM), a highly vascularized tissue, using pan genomic microarrays. Seven percent of analyzed genes showed a significant change in expression (>2-fold, FDR<5%) with a peak occurring from E7 to E10, when key morphogenetic and angiogenic genes such as BMP4, SMO, HOXA3, EPAS1 and FGFR2 were upregulated, reflecting the state of an activated endothelium. At later stages, a general decrease in gene expression occurs, including genes encoding mitotic factors or angiogenic mediators such as CYR61, EPAS1, MDK and MYC. We identified putative human orthologs for 77% of significantly regulated genes and determined endothelial cell enrichment for 20% of the orthologs in silico. Vascular expression of several genes including ENC1, FSTL1, JAM2, LDB2, LIMS1, PARVB, PDE3A, PRCP, PTRF and ST6GAL1 was demonstrated by in situ hybridization. Up to 9% of the CAM genes were also overexpressed in human organs with related functions, such as placenta and lung or the thyroid. 21-66% of CAM genes enriched in endothelial cells were deregulated in several human cancer types (P<.0001). Interfering with PARVB (encoding parvin, beta) function profoundly changed human endothelial cell shape, motility and tubulogenesis, suggesting an important role of this gene in the angiogenic process. Conclusions/Significance: Our study underlines the complexity of gene regulation in a highly vascularized organ during development. We identified a restricted number of novel genes enriched in the endothelium of different species and tissues, which may play crucial roles in normal and pathological angiogenesis.			Javerzat, S (corresponding author), Univ Bordeaux 1, INSERM, U920, Lab Mecanismes Mol Angiogenese, F-33405 Talence, France.	m.hagedorn@angio.u-bordeaux1.fr	De Vos, John/A-5703-2010; FRANCO, Melanie/I-1612-2015	De Vos, John/0000-0003-1880-4130; FRANCO, Melanie/0000-0001-6519-4131; assou, said/0000-0001-6448-7995; Hagedorn, Martin/0000-0002-0960-5116; Bicknell, Roy/0000-0002-0941-8919				Abdollahi A, 2007, P NATL ACAD SCI USA, V104, P12890, DOI 10.1073/pnas.0705505104; Albig AR, 2005, MOL BIOL CELL, V16, P609, DOI 10.1091/mbc.e04-06-0479; Altenhoff AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000262; Amatschek S, 2007, BLOOD, V109, P4777, DOI 10.1182/blood-2006-10-053280; Aoki M, 2007, DEV BIOL, V301, P218, DOI 10.1016/j.ydbio.2006.08.018; Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; AUSPRUNK DH, 1974, DEV BIOL, V38, P237, DOI 10.1016/0012-1606(74)90004-9; Banu N, 2006, FASEB J, V20, P2150, DOI 10.1096/fj.05-5698fje; Baudino TA, 2002, GENE DEV, V16, P2530, DOI 10.1101/gad.1024602; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Burri PH, 2004, DEV DYNAM, V231, P474, DOI 10.1002/dvdy.20184; Cermenati S, 2008, BLOOD, V111, P2657, DOI 10.1182/blood-2007-07-100412; Chen E, 2004, BLOOD, V103, P1710, DOI 10.1182/blood-2003-06-1783; Chua EL, 2000, GENOMICS, V69, P342, DOI 10.1006/geno.2000.6348; Cooke VG, 2008, METHOD ENZYMOL, V444, P1, DOI 10.1016/S0076-6879(08)02801-2; Coultas L, 2005, NATURE, V438, P937, DOI 10.1038/nature04479; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Djonov VG, 2000, ANAT EMBRYOL, V202, P347, DOI 10.1007/s004290000126; Doyonnas R, 2001, J EXP MED, V194, P13, DOI 10.1084/jem.194.1.13; Duan LJ, 2005, CIRCULATION, V111, P2227, DOI 10.1161/01.CIR.0000163580.98098.A3; EICHMANN A, 1993, MECH DEVELOP, V42, P33, DOI 10.1016/0925-4773(93)90096-G; Eliceiri BP, 2001, CURR OPIN CELL BIOL, V13, P563, DOI 10.1016/S0955-0674(00)00252-0; Favier J, 1999, FEBS LETT, V462, P19, DOI 10.1016/S0014-5793(99)01476-3; Favre CJ, 2003, AM J PHYSIOL-HEART C, V285, pH1917, DOI 10.1152/ajpheart.00983.2002; Fawcett SR, 2004, GENE EXPR PATTERNS, V4, P29, DOI 10.1016/j.modgep.2003.08.003; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Frank PG, 2003, ARTERIOSCL THROM VAS, V23, P1161, DOI 10.1161/01.ATV.0000070546.16946.3A; Friedrich EB, 2004, MOL CELL BIOL, V24, P8134, DOI 10.1128/MCB.24.18.8134-8144.2004; Fritz-Six KL, 2008, J CLIN INVEST, V118, P40, DOI 10.1172/JCI33302; Gasperowicz M, 2008, PLACENTA, V29, P651, DOI 10.1016/j.placenta.2008.06.004; Gellhaus Alexandra, 2007, Reprod Sci, V14, P46, DOI 10.1177/1933719107309816; Ghilardi C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-201; Guttmann-Raviv N, 2007, J BIOL CHEM, V282, P26294, DOI 10.1074/jbc.M609711200; Hagedorn M, 2004, DEV DYNAM, V230, P23, DOI 10.1002/dvdy.20020; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; Hartnett ME, 2003, EXP EYE RES, V77, P593, DOI 10.1016/S0014-4835(03)00189-1; Herbert JMJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-153; Herpers R, 2008, CIRC RES, V102, P12, DOI 10.1161/CIRCRESAHA.107.166066; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; Hosokawa H, 2002, J CELL SCI, V115, P1487; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ichikawa-Shindo Y, 2008, J CLIN INVEST, V118, P29, DOI 10.1172/JCI33022; Jeimy SB, 2008, PLATELETS, V19, P83, DOI 10.1080/09537100701832157; Kamphaus GD, 2000, J BIOL CHEM, V275, P1209, DOI 10.1074/jbc.275.2.1209; Kazanskaya O, 2008, DEVELOPMENT, V135, P3655, DOI 10.1242/dev.027284; KURZ H, 1995, DEV DYNAM, V203, P174, DOI 10.1002/aja.1002030206; Kuzniar A, 2008, TRENDS GENET, V24, P539, DOI 10.1016/j.tig.2008.08.009; Loboda A, 2006, VASC PHARMACOL, V44, P206, DOI 10.1016/j.vph.2005.11.007; Lu XW, 2004, NATURE, V432, P179, DOI 10.1038/nature03080; Makino Y, 2001, J CLIN ENDOCR METAB, V86, P5079, DOI 10.1210/jc.86.10.5079; Marin F, 2004, DEV DYNAM, V230, P144, DOI 10.1002/dvdy.20027; McDonald PC, 2008, J CELL SCI, V121, P3121, DOI 10.1242/jcs.017996; Mo FE, 2002, MOL CELL BIOL, V22, P8709, DOI 10.1128/MCB.22.24.8709-8720.2002; Mongroo PS, 2004, ONCOGENE, V23, P8959, DOI 10.1038/sj.onc.1208112; Moreaux J, 2008, BIOCHEM BIOPH RES CO, V366, P117, DOI 10.1016/j.bbrc.2007.11.103; Moreno-Hagelsieb G, 2008, BIOINFORMATICS, V24, P319, DOI 10.1093/bioinformatics/btm585; Nagai R, 2005, J THROMB HAEMOST, V3, P1569, DOI 10.1111/j.1538-7836.2005.01366.x; Ouchi N, 2008, J BIOL CHEM, V283, P32802, DOI 10.1074/jbc.M803440200; Pai JT, 2005, GENE, V347, P21, DOI 10.1016/j.gene.2004.12.034; Papoutsi M, 2001, DEV DYNAM, V222, P238, DOI 10.1002/dvdy.1187; PATAN S, 1993, ANAT EMBRYOL, V187, P121; Pendeville H, 2008, DEV BIOL, V317, P405, DOI 10.1016/j.ydbio.2008.01.028; Peng J, 2000, P NATL ACAD SCI USA, V97, P8386, DOI 10.1073/pnas.140087397; Pike SE, 1998, J EXP MED, V188, P2349, DOI 10.1084/jem.188.12.2349; PLATE KH, 1992, NATURE, V359, P845, DOI 10.1038/359845a0; PLATE KH, 1994, BRAIN PATHOL, V4, P207, DOI 10.1111/j.1750-3639.1994.tb00835.x; Pruett ND, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-93; Reddy SP, 2008, CLIN CANCER RES, V14, P2978, DOI 10.1158/1078-0432.CCR-07-4821; Reynolds PR, 2004, J BIOL CHEM, V279, P37124, DOI 10.1074/jbc.M405254200; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Rissanen TT, 2003, CIRC RES, V92, P1098, DOI 10.1161/01.RES.0000073584.46059.E3; Rodrigues CO, 2008, DEVELOPMENT, V135, P1903, DOI 10.1242/dev.011296; Ruoslahti E, 1997, J CLIN INVEST, V99, P1149, DOI 10.1172/JCI119269; Schlatter P, 1997, MICROVASC RES, V54, P65, DOI 10.1006/mvre.1997.2022; Seaman S, 2007, CANCER CELL, V11, P539, DOI 10.1016/j.ccr.2007.04.017; Shekhar MPV, 2004, AM J PATHOL, V165, P1931, DOI 10.1016/S0002-9440(10)63245-2; Shimizu H, 1999, J BIOL CHEM, V274, P11995, DOI 10.1074/jbc.274.17.11995; Song M, 2007, BIOCHEM BIOPH RES CO, V357, P924, DOI 10.1016/j.bbrc.2007.04.033; St Croix B, 2000, SCIENCE, V289, P1197; Stacker SA, 1999, J BIOL CHEM, V274, P32127, DOI 10.1074/jbc.274.45.32127; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Sun LX, 2006, CANCER CELL, V9, P287, DOI 10.1016/j.ccr.2006.03.003; Suzuki T, 2009, J BIOL CHEM, V284, P9549, DOI 10.1074/jbc.M806230200; Tan C, 2004, CANCER CELL, V5, P79, DOI 10.1016/S1535-6108(03)00281-2; Timur AA, 2005, CELL MOL LIFE SCI, V62, P1434, DOI 10.1007/s00018-005-4523-7; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Visel A, 2004, NUCLEIC ACIDS RES, V32, pD552, DOI 10.1093/nar/gkh029; Wallgard E, 2008, ARTERIOSCL THROM VAS, V28, P1469, DOI 10.1161/ATVBAHA.108.165738; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; Wu JH, 2008, J BIOL CHEM, V283, P3942, DOI 10.1074/jbc.M707882200; Yamada Y, 1997, GENOMICS, V42, P483, DOI 10.1006/geno.1997.4774; Yamaji S, 2004, J CELL BIOL, V165, P539, DOI 10.1083/jcb.200308141; Yamaji S, 2001, J CELL BIOL, V153, P1251, DOI 10.1083/jcb.153.6.1251; Zhong HB, 2006, P NATL ACAD SCI USA, V103, P16800, DOI 10.1073/pnas.0603959103	97	47	50	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2009	4	11							e7856	10.1371/journal.pone.0007856	http://dx.doi.org/10.1371/journal.pone.0007856			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520OG	19924294	Green Published, gold			2022-12-25	WOS:000271854200006
J	Chen, G; Wang, Y; Garate, M; Zhou, J; Li, G				Chen, G.; Wang, Y.; Garate, M.; Zhou, J.; Li, G.			The tumor suppressor ING3 is degraded by SCFSkp2-mediated ubiquitin-proteasome system	ONCOGENE			English	Article						ING3; protein degradation; Skp2; cell cycle; apoptosis	MEDIATED PROTEIN-DEGRADATION; CELL-CYCLE CONTROL; MELANOMA-CELLS; EXPRESSION; CANCER; SKP2; NUCLEAR; P33(ING1B); OVEREXPRESSION; PATHWAY	The inhibitor of growth family member 3 (ING3) has been shown to modulate transcription, cell cycle control and apoptosis. We previously reported that nuclear ING3 expression was remarkably reduced in melanomas, which correlated with a poorer patient survival, suggesting that decreased ING3 expression may be associated with melanoma progression. However, the mechanism of diminished ING3 expression in melanoma is not clear. Here we show that ING3 level was decreased in metastatic melanoma cells because of a rapid degradation. Furthermore, we showed that ING3 undergoes degradation through the ubiquitin proteasome pathway. ING3 physically interacts with subunits of E3 ligase Skp1-Cullin-F-box protein complex (SCF complex). Knockdown of F-box protein S-phase kinase-associated protein 2 (Skp2) reduces the ubiquitination of ING3 and significantly stabilizes ING3 in melanoma cells. In addition, lysine 96 residue is essential for ING3 ubiquitination as its mutation to arginine dramatically abrogated ING3 degradation. Disruption of ING3 degradation stimulated ING3-induced G1 cell-cycle arrest and enhanced ultraviolet-induced apoptosis. Taken together, our data show that ING3 is degraded by the ubiquitin-proteasome pathway through the SCFSkp2 complex and interruption of ING3 degradation enhances the tumor-suppressive function of ING3, which provides a potential cancer therapeutic approach by interfering ING3 degradation. Oncogene (2010) 29, 1498-1508; doi:10.1038/onc.2009.424; published online 23 November 2009	[Chen, G.; Wang, Y.; Garate, M.; Li, G.] Univ British Columbia, Vancouver Coastal Hlth Res Inst, Jack Bell Res Ctr, Dept Dermatol & Skin Sci, Vancouver, BC V6H 3Z6, Canada; [Zhou, J.] Nanjing Med Univ, Sch Publ Hlth, Dept Mol Cell Biol & Toxicol, Nanjing, Peoples R China	University of British Columbia; Vancouver Coastal Health Research Institute; Nanjing Medical University	Li, G (corresponding author), Univ British Columbia, Vancouver Coastal Hlth Res Inst, Jack Bell Res Ctr, Dept Dermatol & Skin Sci, Vancouver, BC V6H 3Z6, Canada.	gangli@interchange.ubc.ca	Li, Gang/A-8257-2011		Cancer Research Society; Canadian Institutes of Health Research [MOP-93810]; Canadian Dermatology Foundation; Michael Smith Foundation for Health Research; University of British Columbia; National Cancer Institute of Canada	Cancer Research Society; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Dermatology Foundation; Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); University of British Columbia; National Cancer Institute of Canada(Canadian Cancer Society (CCS))	We gratefully thank Drs HR Byers, AP Albino, H Silver, R Zhang, M Pagano, S Sun and J Hsieh for kindly providing the materials. This study was supported by Cancer Research Society, the Canadian Institutes of Health Research (MOP-93810) and the Canadian Dermatology Foundation (GL). GC is a recipient of Postdoctoral Trainee Award from Michael Smith Foundation for Health Research. YW is a recipient of Roman M Babicki Fellowship from the University of British Columbia and a research fellow of the Terry Fox Foundation through an award from the National Cancer Institute of Canada.	Ang XLL, 2005, ONCOGENE, V24, P2860, DOI 10.1038/sj.onc.1208614; Asher G, 2005, GENE DEV, V19, P316, DOI 10.1101/gad.319905; Ben-Shahar S, 1999, J BIOL CHEM, V274, P21963, DOI 10.1074/jbc.274.31.21963; Burger AM, 2004, EUR J CANCER, V40, P2217, DOI 10.1016/j.ejca.2004.07.006; Chiappetta G, 2007, ENDOCR-RELAT CANCER, V14, P405, DOI 10.1677/ERC-06-0030; Ciechanover A, 2004, TRENDS CELL BIOL, V14, P103, DOI 10.1016/j.tcb.2004.01.004; Doyon Y, 2004, MOL CELL BIOL, V24, P1884, DOI 10.1128/MCB.24.5.1884-1896.2004; Fadlelmola FM, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-2; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Garate M, 2008, EMBO REP, V9, P576, DOI 10.1038/embor.2008.48; Garate M, 2007, FASEB J, V21, P3705, DOI 10.1096/fj.07-8069com; Goldberg AL, 2007, BIOCHEM SOC T, V35, P12, DOI 10.1042/BST0350012; Gong W, 2006, MOL CELL BIOL, V26, P2947, DOI 10.1128/MCB.26.8.2947-2954.2006; Gunduz M, 2002, ONCOGENE, V21, P4462, DOI 10.1038/sj.onc.1205540; Gunduz M, 2008, CANCER SCI, V99, P531, DOI 10.1111/j.1349-7006.2007.00708.x; He GHY, 2005, MOL BIOL EVOL, V22, P104, DOI 10.1093/molbev/msh256; Hershko DD, 2008, CANCER-AM CANCER SOC, V112, P1415, DOI 10.1002/cncr.23317; Inoue T, 2001, J BIOL CHEM, V276, P45255, DOI 10.1074/jbc.M107477200; Katagiri Y, 2006, J DERMATOL SCI, V42, P215, DOI 10.1016/j.jdermsci.2005.12.016; Kuo ML, 2004, GENE DEV, V18, P1862, DOI 10.1101/gad.1213904; Li J, 2008, CARCINOGENESIS, V29, P1373, DOI 10.1093/carcin/bgn086; Li Q, 2004, J CUTAN PATHOL, V31, P633, DOI 10.1111/j.0303-6987.2004.00243.x; Lu F, 2006, BRIT J CANCER, V95, P80, DOI 10.1038/sj.bjc.6603205; Mani A, 2005, J CLIN ONCOL, V23, P4776, DOI 10.1200/JCO.2005.05.081; Masuda T, 2002, CANCER RES, V62, P3819; Nagashima M, 2003, ONCOGENE, V22, P343, DOI 10.1038/sj.onc.1206115; Nalepa G, 2006, NAT REV DRUG DISCOV, V5, P596, DOI 10.1038/nrd2056; Nandi D, 2006, J BIOSCIENCES, V31, P137, DOI 10.1007/BF02705243; Newton K, 2007, CANCER INVEST, V25, P502, DOI 10.1080/07357900701508041; Ng KCP, 2004, J INVEST DERMATOL, V123, P1127, DOI 10.1111/j.0022-202X.2004.23467.x; Nouman GS, 2002, HISTOPATHOLOGY, V40, P360, DOI 10.1046/j.1365-2559.2002.01369.x; Schwelchheimer C, 2004, CURR OPIN PLANT BIOL, V7, P677, DOI 10.1016/j.pbi.2004.09.009; Shah Imtiaz M., 2007, Cardiovascular & Hematological Disorders - Drug Targets, V7, P250, DOI 10.2174/187152907782793572; Sonoda H, 2006, CLIN CANCER RES, V12, P1215, DOI 10.1158/1078-0432.CCR-05-1709; Sumimoto H, 2006, INT J CANCER, V118, P472, DOI 10.1002/ijc.21286; Tsai KW, 2008, EXP CELL RES, V314, P3130, DOI 10.1016/j.yexcr.2008.08.002; von Mikecz A, 2006, J CELL SCI, V119, P1977, DOI 10.1242/jcs.03008; Wang YM, 2007, CLIN CANCER RES, V13, P4111, DOI 10.1158/1078-0432.CCR-07-0408; Wang YM, 2006, J BIOL CHEM, V281, P11887, DOI 10.1074/jbc.M511309200; Woenckhaus C, 2005, HISTOL HISTOPATHOL, V20, P501, DOI 10.14670/HH-20.501; Yang G, 2002, CLIN CANCER RES, V8, P3419; Yokoi S, 2004, AM J PATHOL, V165, P175, DOI 10.1016/S0002-9440(10)63286-5; Zetter Bruce R, 2005, Future Oncol, V1, P567, DOI 10.2217/14796694.1.5.567	43	29	30	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR	2010	29	10					1498	1508		10.1038/onc.2009.424	http://dx.doi.org/10.1038/onc.2009.424			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	566SD	19935701				2022-12-25	WOS:000275392400008
J	Ahn, BY; Trinh, DLN; Zajchowski, LD; Lee, B; Elwi, AN; Kim, SW				Ahn, B. Y.; Trinh, D. L. N.; Zajchowski, L. D.; Lee, B.; Elwi, A. N.; Kim, S-W			Tid1 is a new regulator of p53 mitochondrial translocation and apoptosis in cancer	ONCOGENE			English	Article						p53; Tid1; tumor suppressor; mitochondria; apoptosis	MUTANT P53; MEMBRANE PERMEABILIZATION; MEDIATED APOPTOSIS; DNA-DAMAGE; CELLS; ACTIVATION; BAX; PROTEIN; DEGRADATION; CHAPERONES	The p53 tumor suppressor protein induces apoptosis in response to genotoxic and environmental stresses. Recent studies have revealed the existence of a transcription-independent mitochondrial p53 apoptotic pathway; however, the mechanism that regulates its translocation to the mitochondria has been unknown. In this study, we show that the tumor suppressor Tid1 forms a complex with p53 under hypoxic conditions that directs p53 translocation to the mitochondria and the subsequent initiation of the mitochondrial apoptosis pathway. Loss of Tid1 expression abrogated p53 translocation to the mitochondria and inhibited apoptosis, whereas the over-expression of Tid1 promoted p53 mitochondrial localization and apoptosis. Tid1's mitochondrial signal sequence and DnaJ domain were both required for the movement of the p53-Tid1 complex from the cytosol to the mitochondria. When Tid is over-expressed in cancer cell lines expressing mutant p53 isoforms defective in transcriptional activity, mitochondrial localization and pro-apoptotic activities of the mutant p53 proteins was restored. Our results establish Tid1 as a novel regulator of p53-mediated apoptosis, and suggest that therapies designed to enhance Tid1's function in promoting mitochondrial localization of p53 and apoptosis could be an effective therapy in many cancers. Oncogene (2010) 29, 1155-1166; doi: 10.1038/onc.2009.413; published online 23 November 2009	[Ahn, B. Y.; Trinh, D. L. N.; Lee, B.; Elwi, A. N.; Kim, S-W] Univ Calgary, Dept Biochem, Calgary, AB T2N 4N1, Canada; [Ahn, B. Y.; Trinh, D. L. N.; Lee, B.; Elwi, A. N.; Kim, S-W] Univ Calgary, Dept Mol Biol, Calgary, AB T2N 4N1, Canada; [Kim, S-W] Univ Calgary, So Alberta Canc Res Inst, Calgary, AB T2N 4N1, Canada; [Zajchowski, L. D.; Kim, S-W] Univ Calgary, Clark H Smith Brain Tumour Ctr, Calgary, AB T2N 4N1, Canada	University of Calgary; University of Calgary; University of Calgary; University of Calgary	Kim, SW (corresponding author), Univ Calgary, Dept Biochem & Mol Biol, 3330 Hosp Dr,HRIC 2A08, Calgary, AB T2N 4N1, Canada.	swkim@ucalgary.ca			Alberta Cancer Research Institute [23123]; Canada Research Chairs Program [950203751]; Canada Institute of Health Research [MOP97962]; Alberta Cancer Board	Alberta Cancer Research Institute; Canada Research Chairs Program(Canada Research Chairs); Canada Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Cancer Board	We thank Drs F Jirik, S Robbins, P Forsyth, K Riabowol, S Grewal and X Feng for their invaluable suggestions, critical review of the paper and encouragement. This work was supported in part by grants from the Alberta Cancer Research Institute (23123), the Canada Research Chairs Program (950203751) and the Canada Institute of Health Research (MOP97962) to SWK. BYA and DT were supported by a postdoctoral fellowship and graduate scholarship, respectively, from the Alberta Cancer Board.	Anderson ARA, 2006, CELL, V127, P905, DOI 10.1016/j.cell.2006.09.042; Bissonnette N, 1997, BIOCHEM CELL BIOL, V75, P351, DOI 10.1139/bcb-75-4-351; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Chopin V, 2002, BRIT J PHARMACOL, V135, P79, DOI 10.1038/sj.bjp.0704456; Cui Q, 2007, ACTA PHARMACOL SIN, V28, P1057, DOI 10.1111/j.1745-7254.2007.00588.x; Dumont P, 2003, NAT GENET, V33, P357, DOI 10.1038/ng1093; Edwards KM, 2004, ONCOGENE, V23, P8419, DOI 10.1038/sj.onc.1207732; Erster S, 2004, MOL CELL BIOL, V24, P6728, DOI 10.1128/MCB.24.15.6728-6741.2004; Fridman JS, 2003, ONCOGENE, V22, P9030, DOI 10.1038/sj.onc.1207116; Gomez JA, 2007, BIOCHEM SOC T, V35, P797, DOI 10.1042/BST0350797; Hammond EM, 2005, BIOCHEM BIOPH RES CO, V331, P718, DOI 10.1016/j.bbrc.2005.03.154; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; HAUPT Y, 1995, GENE DEV, V9, P2170, DOI 10.1101/gad.9.17.2170; HINDS PW, 1990, CELL GROWTH DIFFER, V1, P571; Kim BM, 2007, TOXICOLOGY, V229, P226, DOI 10.1016/j.tox.2006.10.022; Kim SW, 2005, CANCER RES, V65, P8784, DOI 10.1158/0008-5472.CAN-04-4422; Kim SW, 2004, CANCER RES, V64, P7732, DOI 10.1158/0008-5472.CAN-04-1323; King FW, 2001, EMBO J, V20, P6297, DOI 10.1093/emboj/20.22.6297; Kokontis JM, 2001, ONCOGENE, V20, P659, DOI 10.1038/sj.onc.1204139; Leu JIJ, 2004, NAT CELL BIOL, V6, P443, DOI 10.1038/ncb1123; Lu B, 2006, J BIOL CHEM, V281, P13150, DOI 10.1074/jbc.M509179200; Lukashchuk N, 2007, MOL CELL BIOL, V27, P8284, DOI 10.1128/MCB.00050-07; Marchenko ND, 2007, EMBO J, V26, P923, DOI 10.1038/sj.emboj.7601560; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; Mooney LM, 2002, BRIT J CANCER, V87, P909, DOI 10.1038/sj.bjc.6600541; Murphy ME, 2004, CELL CYCLE, V3, P836; Nemajerova A, 2005, CELL DEATH DIFFER, V12, P197, DOI 10.1038/sj.cdd.4401526; Perfettini JL, 2004, NAT CELL BIOL, V6, P386, DOI 10.1038/ncb0504-386; Pietsch EC, 2008, J BIOL CHEM, V283, P21294, DOI 10.1074/jbc.M710539200; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Sansome C, 2001, FEBS LETT, V488, P110, DOI 10.1016/S0014-5793(00)02368-1; Schuler M, 2000, J BIOL CHEM, V275, P7337, DOI 10.1074/jbc.275.10.7337; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wang LH, 1998, ANTICANCER RES, V18, P321; Wang P, 2007, P NATL ACAD SCI USA, V104, P4054, DOI 10.1073/pnas.0700020104; Wolff S, 2008, CELL RES, V18, P733, DOI 10.1038/cr.2008.62	37	63	66	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 25	2010	29	8					1155	1166		10.1038/onc.2009.413	http://dx.doi.org/10.1038/onc.2009.413			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	560ON	19935715				2022-12-25	WOS:000274912100007
J	Carroll, SM; Hampton, RY				Carroll, Sarah M.; Hampton, Randolph Y.			Usa1p Is Required for Optimal Function and Regulation of the Hrd1p Endoplasmic Reticulum-associated Degradation Ubiquitin Ligase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ER-ASSOCIATED DEGRADATION; HMG-COA REDUCTASE; UNFOLDED PROTEIN RESPONSE; QUALITY-CONTROL; MEMBRANE-PROTEIN; 3-HYDROXY-3-METHYLGLUTARYL-COA REDUCTASE; MISFOLDED GLYCOPROTEINS; MEDIATED REGULATION; COMPLEX; YEAST	Usa1p is a recently discovered member of the HRD ubiquitin ligase complex. The HRD pathway is a conserved route of ubiquitin-dependent, endoplasmic reticulum (ER)-associated degradation (ERAD) of numerous lumenal (ERAD-L) and membrane-anchored (ERAD-M) substrates. We have investigated Usa1p to understand its importance in HRD complex action. Usa1p was required for the optimal function of the Hrd1p E3 ubiquitin ligase; its loss caused deficient degradation of both membrane-associated and lumenal proteins. Furthermore, Usa1p functioned in regulation of Hrd1p by two mechanisms. First, Hrd1p self-degradation, which serves to limit the levels of uncomplexed E3, is absolutely dependent on Usa1p and the ubiquitin-like (Ubl) domain of Usa1p. We found that Usa1p allows Hrd1p degradation by promoting trans interactions between Hrd1p molecules. The Ubl domain of Usa1p was required specifically for Hrd1p self-ubiquitination but not for degradation of either ERAD-L or ERAD-M substrates. In addition, Usa1p was able to attenuate the activity-dependent toxicity of Hrd1p without compromising substrate degradation, indicating a separate role in ligase regulation that operates in parallel to stability control. Many of the described actions of Usa1p are distinct from those of Der1p, which is recruited to the HRD complex by Usa1p. Thus, this novel, conserved factor is broadly involved in the function and regulation of the HRD pathway of ERAD.	[Carroll, Sarah M.; Hampton, Randolph Y.] Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Hampton, RY (corresponding author), Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	rhampton@ucsd.edu			National Institutes of Health, NIDDK [GM51996-06]; American Heart Association; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM051996] Funding Source: NIH RePORTER	National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM51996-06 (NIDDK, to R.Y.H.). This work was also supported by the American Heart Association (an Established Investigator award ( to R.Y.H.)).	Amano T, 2003, GENE DEV, V17, P2436, DOI 10.1101/gad.1096603; Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; Bays NW, 2001, MOL BIOL CELL, V12, P4114, DOI 10.1091/mbc.12.12.4114; Bays NW, 2002, CURR BIOL, V12, pR366, DOI 10.1016/S0960-9822(02)00862-X; Bhamidipati A, 2005, MOL CELL, V19, P741, DOI 10.1016/j.molcel.2005.07.027; Biederer T, 1996, EMBO J, V15, P2069, DOI 10.1002/j.1460-2075.1996.tb00560.x; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Cronin SR, 1999, METHOD ENZYMOL, V302, P58, DOI 10.1016/S0076-6879(99)02010-8; Denic V, 2006, CELL, V126, P349, DOI 10.1016/j.cell.2006.05.045; Emter R, 2002, FEBS LETT, V521, P57, DOI 10.1016/S0014-5793(02)02818-1; FINGER A, 1993, EUR J BIOCHEM, V218, P565, DOI 10.1111/j.1432-1033.1993.tb18410.x; Gardner R, 1998, MOL BIOL CELL, V9, P2611, DOI 10.1091/mbc.9.9.2611; Gardner RG, 2001, MOL CELL BIOL, V21, P4276, DOI 10.1128/MCB.21.13.4276-4291.2001; Gardner RG, 2000, J CELL BIOL, V151, P69, DOI 10.1083/jcb.151.1.69; Gardner RG, 1999, EMBO J, V18, P5994, DOI 10.1093/emboj/18.21.5994; Gardner RG, 1999, J BIOL CHEM, V274, P31671, DOI 10.1074/jbc.274.44.31671; Gauss R, 2006, NAT CELL BIOL, V8, P849, DOI 10.1038/ncb1445; Hampton RY, 2009, CHEM REV, V109, P1561, DOI 10.1021/cr800544v; Hampton RY, 1997, P NATL ACAD SCI USA, V94, P12944, DOI 10.1073/pnas.94.24.12944; HAMPTON RY, 1994, J CELL BIOL, V125, P299, DOI 10.1083/jcb.125.2.299; Hampton RY, 1996, MOL BIOL CELL, V7, P2029, DOI 10.1091/mbc.7.12.2029; Hochstrasser M, 2009, NATURE, V458, P422, DOI 10.1038/nature07958; Kim I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007604; Kim W, 2005, MOL CELL, V19, P753, DOI 10.1016/j.molcel.2005.08.010; Ng DTW, 2000, J CELL BIOL, V150, P77, DOI 10.1083/jcb.150.1.77; Plemper RK, 1999, J CELL SCI, V112, P4123; Plemper RK, 1999, FEBS LETT, V443, P241, DOI 10.1016/S0014-5793(98)01724-4; Sato BK, 2006, YEAST, V23, P1053, DOI 10.1002/yea.1407; Song BL, 2005, CELL METAB, V1, P179, DOI 10.1016/j.cmet.2005.01.001; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018	33	49	50	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5146	5156		10.1074/jbc.M109.067876	http://dx.doi.org/10.1074/jbc.M109.067876			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	19940128	Green Published, hybrid			2022-12-25	WOS:000275327200006
J	Hines, RM; Kang, RJ; Goytain, A; Quamme, GA				Hines, Rochelle M.; Kang, Rujun; Goytain, Angela; Quamme, Gary A.			Golgi-specific DHHC Zinc Finger Protein GODZ Mediates Membrane Ca2+ Transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GABA(A) RECEPTORS; PALMITOYLATION; CHANNEL; TRAFFICKING; SUBUNIT; IDENTIFICATION; HUNTINGTIN; HIP14; DOMAIN; STABILITY	The Golgi-specific zinc finger protein GODZ (palmitoyl acyltransferase/DHHC-3) mediates the palmitoylation and post-translational modification of many protein substrates that regulate membrane-protein interactions. Here, we show that GODZ also mediates Ca2+ transport in expressing Xenopus laevis oocytes. Two-electrode voltage-clamp, fluorescence, and Ca-45(2+) isotopic uptake determinations demonstrated voltage-and concentration-dependent, saturable, and substrate-inhibitable Ca2+ transport in oocytes expressing GODZ cRNA but not in oocytes injected with water alone. Moreover, we show that GODZ-mediated Ca2+ transport is regulated by palmitoylation, as the palmitoyl acyltransferase inhibitor 2-bromopalmitate or alteration of the acyltransferase DHHC motif (GODZ-DHHS) diminished GODZ-mediated Ca2+ transport by similar to 80%. The GODZ mutation V61R abolished Ca2+ transport but did not affect palmitoyl acyltransferase activity. Coexpression of GODZ-V61R with GODZ-DHHS restored GODZ-DHHS-mediated Ca2+ uptake to values observed with wild-type GODZ, excluding an endogenous effect of palmitoylation. Coexpression of an independent palmitoyl acyltransferase (HIP14) with the GODZ-DHHS mutant also rescued Ca2+ transport. HIP14 did not mediate Ca2+ transport when expressed alone. Immunocytochemistry studies showed that GODZ and HIP14 co-localized to the Golgi and the same post-Golgi vesicles, suggesting that heteropalmitoylation might play a physiological role in addition to a biochemical function. We conclude that GODZ encodes a Ca2+ transport protein in addition to its ability to palmitoylate protein substrates.	[Hines, Rochelle M.; Kang, Rujun] Univ British Columbia, Dept Psychiat, Vancouver, BC V6T 1Z3, Canada; [Goytain, Angela; Quamme, Gary A.] Univ British Columbia, Dept Med, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia	Quamme, GA (corresponding author), Vancouver Hosp, Dept Med, Koerner Pavil,2211 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada.	quamme@interchange.ubc.ca	Hines, Rochelle/AAE-3784-2020	Hines, Rochelle/0000-0002-0459-7911	Canadian Institutes of Health Research [MOP-53288] Funding Source: Medline	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))		Chan AW, 2007, CELL CALCIUM, V42, P419, DOI 10.1016/j.ceca.2007.04.009; Chaudhary J, 2002, ENDOCRINOLOGY, V143, P426, DOI 10.1210/en.143.2.426; Chen ZW, 2007, J NEUROCHEM, V100, P279, DOI 10.1111/j.1471-4159.2006.04206.x; Chien AJ, 1996, J BIOL CHEM, V271, P26465, DOI 10.1074/jbc.271.43.26465; El-Husseini AE, 2000, J CELL BIOL, V148, P159, DOI 10.1083/jcb.148.1.159; Fang C, 2006, J NEUROSCI, V26, P12758, DOI 10.1523/JNEUROSCI.4214-06.2006; Fernandez-Hernando C, 2006, J CELL BIOL, V174, P369, DOI 10.1083/jcb.200601051; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Goytain A, 2007, J BIOL CHEM, V282, P8060, DOI 10.1074/jbc.M610314200; Goytain A, 2008, J BIOL CHEM, V283, P33365, DOI 10.1074/jbc.M801469200; Greaves J, 2008, J BIOL CHEM, V283, P25014, DOI 10.1074/jbc.M802140200; Greaves J, 2007, J CELL BIOL, V176, P249, DOI 10.1083/jcb.200610151; Gubitosi-Klug RA, 2005, P NATL ACAD SCI USA, V102, P5964, DOI 10.1073/pnas.0501999102; Hayashi T, 2005, NEURON, V47, P709, DOI 10.1016/j.neuron.2005.06.035; Hou HT, 2009, TRAFFIC, V10, P1061, DOI 10.1111/j.1600-0854.2009.00925.x; Huang K, 2004, NEURON, V44, P977, DOI 10.1016/j.neuron.2004.11.027; Kanaani J, 2004, J CELL SCI, V117, P2001, DOI 10.1242/jcs.01030; Kang RJ, 2008, NATURE, V456, P904, DOI 10.1038/nature07605; Keller CA, 2004, J NEUROSCI, V24, P5881, DOI 10.1523/JNEUROSCI.1037-04.2004; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Mies F, 2007, J BIOL CHEM, V282, P18339, DOI 10.1074/jbc.M611160200; Peng JB, 1999, J BIOL CHEM, V274, P22739, DOI 10.1074/jbc.274.32.22739; Petaja-Repo UE, 2006, J BIOL CHEM, V281, P15780, DOI 10.1074/jbc.M602267200; Qin N, 1998, P NATL ACAD SCI USA, V95, P4690, DOI 10.1073/pnas.95.8.4690; Rathenberg J, 2004, MOL CELL NEUROSCI, V26, P251, DOI 10.1016/j.mcn.2004.01.012; Roth AF, 2006, CELL, V125, P1003, DOI 10.1016/j.cell.2006.03.042; SCHMIDT JW, 1987, J BIOL CHEM, V262, P13713; Singaraja RR, 2002, HUM MOL GENET, V11, P2815, DOI 10.1093/hmg/11.23.2815; Uemura T, 2002, BIOCHEM BIOPH RES CO, V296, P492, DOI 10.1016/S0006-291X(02)00900-2; Varner AS, 2003, BIOCHEM J, V373, P91, DOI 10.1042/BJ20021598; Yanai A, 2006, NAT NEUROSCI, V9, P824, DOI 10.1038/nn1702	31	17	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4621	4628		10.1074/jbc.M109.069849	http://dx.doi.org/10.1074/jbc.M109.069849			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	19955568	hybrid, Green Published			2022-12-25	WOS:000275274800040
J	Cole, HA; Tabor-Godwin, JM; Hayes, JJ				Cole, Hope A.; Tabor-Godwin, Jenna M.; Hayes, Jeffrey J.			Uracil DNA Glycosylase Activity on Nucleosomal DNA Depends on Rotational Orientation of Targets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE-EXCISION-REPAIR; HISTONE TAIL DOMAINS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; STRUCTURAL BASIS; LINKER HISTONES; GLOBULAR DOMAIN; IN-VIVO; CHROMATIN; MECHANISM	The activity of uracil DNA glycosylases (UDGs), which recognize and excise uracil bases from DNA, has been well characterized on naked DNA substrates but less is known about activity in chromatin. We therefore prepared a set of model nucleosome substrates in which single thymidine residues were replaced with uracil at specific locations and a second set of nucleosomes in which uracils were randomly substituted for all thymidines. We found that UDG efficiently removes uracil from internal locations in the nucleosome where the DNA backbone is oriented away from the surface of the histone octamer, without significant disruption of histone-DNA interactions. However, uracils at sites oriented toward the histone octamer surface were excised at much slower rates, consistent with a mechanism requiring spontaneous DNA unwrapping from the nucleosome. In contrast to the nucleosome core, UDG activity on DNA outside the core DNA region was similar to that of naked DNA. Association of linker histone reduced activity of UDG at selected sites near where the globular domain of H1 is proposed to bind to the nucleosome as well as within the extra-core DNA. Our results indicate that some sites within the nucleosome core and the extra-core (linker) DNA regions represent hot spots for repair that could influence critical biological processes.	[Cole, Hope A.; Tabor-Godwin, Jenna M.; Hayes, Jeffrey J.] Univ Rochester, Dept Biochem & Biophys, Rochester, NY 14642 USA	University of Rochester	Hayes, JJ (corresponding author), Univ Rochester, Dept Biochem & Biophys, 601 Elmwood Ave, Rochester, NY 14642 USA.	Jeffrey_Hayes@urmc.rochester.edu			National Institutes of Health [RO1GM52426]; American Cancer Society [RPG GMC-99742]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052426] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1GM52426 and American Cancer Society Grant RPG GMC-99742.	ALLAN J, 1986, J MOL BIOL, V187, P591, DOI 10.1016/0022-2836(86)90337-2; ALLAN J, 1980, NATURE, V288, P675, DOI 10.1038/288675a0; Anderson JD, 2002, MOL CELL BIOL, V22, P7147, DOI 10.1128/MCB.22.20.7147-7157.2002; Angelov D, 2001, P NATL ACAD SCI USA, V98, P6599, DOI 10.1073/pnas.121171498; Annunziato AT, 2000, GENE EXPRESSION, V9, P37; Aoyagi S, 2002, MOL CELL BIOL, V22, P7484, DOI 10.1128/MCB.22.21.7484-7490.2002; Barrett TE, 1998, CELL, V92, P117, DOI 10.1016/S0092-8674(00)80904-6; Beard BC, 2005, DNA REPAIR, V4, P203, DOI 10.1016/j.dnarep.2004.09.011; Beard BC, 2003, P NATL ACAD SCI USA, V100, P7465, DOI 10.1073/pnas.1330328100; Brown DT, 2006, NAT STRUCT MOL BIOL, V13, P250, DOI 10.1038/nsmb1050; Carruthers LM, 1998, BIOCHEMISTRY-US, V37, P14776, DOI 10.1021/bi981684e; Chafin DR, 2000, EMBO J, V19, P5492, DOI 10.1093/emboj/19.20.5492; Citterio E, 2000, MOL CELL BIOL, V20, P7643, DOI 10.1128/MCB.20.20.7643-7653.2000; CLARK DJ, 1990, J MOL BIOL, V211, P883, DOI 10.1016/0022-2836(90)90081-V; CLARK DJ, 1986, J MOL BIOL, V187, P569, DOI 10.1016/0022-2836(86)90335-9; Claudet C, 2005, J BIOL CHEM, V280, P19958, DOI 10.1074/jbc.M500121200; CraneRobinson C, 1997, TRENDS BIOCHEM SCI, V22, P75, DOI 10.1016/S0968-0004(97)01013-X; DODSON ML, 1994, J BIOL CHEM, V269, P32709; DUNCAN BK, 1982, J BACTERIOL, V151, P750, DOI 10.1128/JB.151.2.750-755.1982; Fan L, 2006, P NATL ACAD SCI USA, V103, P8384, DOI 10.1073/pnas.0508951103; FRIEDBERG EC, 1995, TRENDS BIOCHEM SCI, V20, P381, DOI 10.1016/S0968-0004(00)89082-9; FURRER P, 1995, J STRUCT BIOL, V114, P177, DOI 10.1006/jsbi.1995.1017; GODDE JS, 1995, J BIOL CHEM, V270, P27399, DOI 10.1074/jbc.270.46.27399; Golding A, 1999, EMBO J, V18, P3712, DOI 10.1093/emboj/18.13.3712; Gong F, 2008, CELL CYCLE, V7, P1067, DOI 10.4161/cc.7.8.5647; Gong F, 2006, NAT STRUCT MOL BIOL, V13, P902, DOI 10.1038/nsmb1152; HAYES JJ, 1990, P NATL ACAD SCI USA, V87, P7405, DOI 10.1073/pnas.87.19.7405; Hayes JJ, 1997, METHODS, V12, P2, DOI 10.1006/meth.1997.0441; HAYES JJ, 1993, P NATL ACAD SCI USA, V90, P6415, DOI 10.1073/pnas.90.14.6415; Hayes JJ, 1996, BIOCHEMISTRY-US, V35, P11931, DOI 10.1021/bi961590+; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Huggins CF, 2002, MOL CELL, V10, P1201, DOI 10.1016/S1097-2765(02)00736-0; Ishlbashi T, 2008, MOL CELL BIOL, V28, P4734, DOI 10.1128/MCB.00588-08; Kavli B, 2007, DNA REPAIR, V6, P505, DOI 10.1016/j.dnarep.2006.10.014; Krokan HE, 2000, FEBS LETT, V476, P73, DOI 10.1016/S0014-5793(00)01674-4; Krokan HE, 1997, BIOCHEM J, V325, P1; Lindahl T, 1999, SCIENCE, V286, P1897, DOI 10.1126/science.286.5446.1897; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Lindahl T, 1997, CURR OPIN GENET DEV, V7, P158, DOI 10.1016/S0959-437X(97)80124-4; Liu M, 2009, TRENDS IMMUNOL, V30, P173, DOI 10.1016/j.it.2009.01.007; Liu PF, 2002, CHEM RES TOXICOL, V15, P1001, DOI 10.1021/tx020030a; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Memisoglu A, 2000, MUTAT RES-FUND MOL M, V451, P39, DOI 10.1016/S0027-5107(00)00039-7; Menoni H, 2007, MOL CELL BIOL, V27, P5949, DOI 10.1128/MCB.00376-07; MOL CD, 1995, CELL, V80, P869, DOI 10.1016/0092-8674(95)90290-2; MOSBAUGH DW, 1994, PROG NUCLEIC ACID RE, V48, P315, DOI 10.1016/S0079-6603(08)60859-4; Nakanishi S, 2007, NUCLEIC ACIDS RES, V35, P4313, DOI 10.1093/nar/gkm436; Nilsen H, 2002, EMBO J, V21, P5943, DOI 10.1093/emboj/cdf581; Otterlei M, 2000, EMBO J, V19, P5542, DOI 10.1093/emboj/19.20.5542; Otterlei M, 1998, NUCLEIC ACIDS RES, V26, P4611, DOI 10.1093/nar/26.20.4611; Otterlei M, 1999, EMBO J, V18, P3834, DOI 10.1093/emboj/18.13.3834; Parikh SS, 2000, P NATL ACAD SCI USA, V97, P5083, DOI 10.1073/pnas.97.10.5083; Parikh SS, 2000, MUTAT RES-DNA REPAIR, V460, P183, DOI 10.1016/S0921-8777(00)00026-4; Pearl LH, 2000, MUTAT RES-DNA REPAIR, V460, P165, DOI 10.1016/S0921-8777(00)00025-2; Peterson CL, 2004, GENE DEV, V18, P602, DOI 10.1101/gad.1182704; POLACH KJ, 1995, J MOL BIOL, V254, P130, DOI 10.1006/jmbi.1995.0606; Prasad A, 2007, MOL CELL BIOL, V27, P8442, DOI 10.1128/MCB.00791-07; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SAVVA R, 1995, NATURE, V373, P487, DOI 10.1038/373487a0; Schalch T, 2005, NATURE, V436, P138, DOI 10.1038/nature03686; Shen HM, 2009, J EXP MED, V206, P1057, DOI 10.1084/jem.20082678; SIMPSON RT, 1978, BIOCHEMISTRY-US, V17, P5524, DOI 10.1021/bi00618a030; Slupphaug G, 1996, NATURE, V384, P87, DOI 10.1038/384087a0; Smerdon MJ, 1999, PROG NUCLEIC ACID RE, V62, P227; Stivers JT, 2001, ARCH BIOCHEM BIOPHYS, V396, P1, DOI 10.1006/abbi.2001.2605; Thiriet C, 1998, J BIOL CHEM, V273, P21352, DOI 10.1074/jbc.273.33.21352; Ura K, 2002, EUR J BIOCHEM, V269, P2288, DOI 10.1046/j.1432-1033.2002.02888.x; van Holde KE., 1989, SPRINGER SERIES MOL; Wolffe A., 1998, CHROMATIN STRUCTURE; Wood RD, 1996, ANNU REV BIOCHEM, V65, P135, DOI 10.1146/annurev.bi.65.070196.001031; Xiao GY, 1999, PROTEINS, V35, P13; Yang ZY, 2007, J BIOL CHEM, V282, P7930, DOI 10.1074/jbc.M610584200	72	69	70	3	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2876	2885		10.1074/jbc.M109.073544	http://dx.doi.org/10.1074/jbc.M109.073544			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19933279	hybrid, Green Published			2022-12-25	WOS:000273697800063
J	Tchen, CR; Martins, JRS; Paktiawal, N; Perelli, R; Saklatvala, J; Clark, AR				Tchen, Carmen R.; Martins, Joana R. S.; Paktiawal, Nasren; Perelli, Roberta; Saklatvala, Jeremy; Clark, Andrew R.			Glucocorticoid Regulation of Mouse and Human Dual Specificity Phosphatase 1 (DUSP1) Genes UNUSUAL CIS-ACTING ELEMENTS AND UNEXPECTED EVOLUTIONARY DIVERGENCE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; N-TERMINAL KINASE; MAP KINASE; INFLAMMATORY RESPONSES; DNA-BINDING; MOLECULAR-MECHANISMS; RECEPTOR; EXPRESSION; INHIBITION; DEXAMETHASONE	Anti-inflammatory effects of glucocorticoids (GCs) are partly mediated by up-regulation of DUSP1 (dual specificity phosphatase 1), which dephosphorylates and inactivates mitogen-activated protein kinases. We identified putative GC-responsive regions containing GC receptor (GR) binding site consensus sequences that are well conserved between human and mouse DUSP1 loci in position, orientation, and sequence (at least 11 of 15 positions identical) and lie within regions of extended sequence conservation (minimum 65% identity over at least 100 bp). These were located similar to 29, 28, 24, 4.6, and 1.3 kb upstream of the DUSP1 transcription start site. The homology-based approach successfully identified four cis-acting regions that mediated transcriptional responses to dexamethasone. However, there was surprising interspecies divergence in site usage. This could not be explained by variations of the GR binding sites themselves. Instead, variations in flanking sequences appear to have driven the evolutionary divergence in mechanisms of regulation of mouse and human DUSP1 genes. There was a good correlation between the ability of cis-acting elements to respond to GC in transiently transfected reporter constructs and their ability to recruit GR in the context of intact chromatin. We propose that divergence of gene regulation has involved the loss or gain of binding sites for accessory transcription factors that assist in GR recruitment. Finally, a novel GC-responsive region of the human DUSP1 gene contains a highly unusual element, in which three closely spaced GR half-sites are required for potent transcriptional activation by GC.	[Tchen, Carmen R.; Martins, Joana R. S.; Paktiawal, Nasren; Perelli, Roberta; Saklatvala, Jeremy; Clark, Andrew R.] Univ London Imperial Coll Sci Technol & Med, Kennedy Inst, Div Rheumatol, London W6 8LH, England	Imperial College London; University of Oxford	Clark, AR (corresponding author), Univ London Imperial Coll Sci Technol & Med, Kennedy Inst, Div Rheumatol, 65 Aspenlea Rd, London W6 8LH, England.	andy.clark@imperial.ac.uk	Clark, Andrew/AAN-4043-2021	Clark, Andy/0000-0003-4996-8322	Medical Research Council (United Kingdom); Arthritis Research Campaign (United Kingdom); MRC [G8623776] Funding Source: UKRI; Medical Research Council [G8623776] Funding Source: researchfish	Medical Research Council (United Kingdom)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Arthritis Research Campaign (United Kingdom)(Versus Arthritis); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Medical Research Council (United Kingdom) and the Arthritis Research Campaign (United Kingdom).	Abraham SM, 2006, BIOCHEM SOC T, V34, P1018, DOI 10.1042/BST0341018; Abraham SM, 2006, J EXP MED, V203, P1883, DOI 10.1084/jem.20060336; Adams M, 2003, MOL ENDOCRINOL, V17, P2583, DOI 10.1210/me.2002-0305; Adcock IM, 2008, CHEST, V134, P394, DOI 10.1378/chest.08-0440; Ananieva O, 2008, NAT IMMUNOL, V9, P1028, DOI 10.1038/ni.1644; Bhattacharyya S, 2007, BLOOD, V109, P4313, DOI 10.1182/blood-2006-10-048215; Bhavsar P, 2008, THORAX, V63, P784, DOI 10.1136/thx.2007.090027; Breitwieser W, 2007, GENE DEV, V21, P2069, DOI 10.1101/gad.430207; Brook M, 2006, MOL CELL BIOL, V26, P2408, DOI 10.1128/MCB.26.6.2408-2418.2006; Brosius J, 1999, GENE, V238, P115, DOI 10.1016/S0378-1119(99)00227-9; Brosius J, 1999, GENETICA, V107, P209, DOI 10.1023/A:1004018519722; Chi HB, 2006, P NATL ACAD SCI USA, V103, P2274, DOI 10.1073/pnas.0510965103; Chivers JE, 2004, EUR J BIOCHEM, V271, P4042, DOI 10.1111/j.1432-1033.2004.04342.x; Chivers JE, 2006, MOL PHARMACOL, V70, P2084, DOI 10.1124/mol.106.025841; Clark AR, 2008, J BIOL CHEM, V283, P25765, DOI 10.1074/jbc.R700053200; Clark AR, 2007, MOL CELL ENDOCRINOL, V275, P79, DOI 10.1016/j.mce.2007.04.013; Clark AR, 2003, J ENDOCRINOL, V178, P5, DOI 10.1677/joe.0.1780005; Couronne O, 2003, GENOME RES, V13, P73, DOI 10.1101/gr.762503; De Bosscher K, 2008, EUR J PHARMACOL, V583, P290, DOI 10.1016/j.ejphar.2007.11.076; Dewannieux M, 2005, CYTOGENET GENOME RES, V110, P35, DOI 10.1159/000084936; Dorfman K, 1996, ONCOGENE, V13, P925; Fan WJ, 2009, LIFE SCI, V84, P838, DOI 10.1016/j.lfs.2009.03.014; Furst R, 2007, FASEB J, V21, P74, DOI 10.1096/fj.06-6752com; Hammer M, 2006, J EXP MED, V203, P15, DOI 10.1084/jem.20051753; HECK S, 1994, EMBO J, V13, P4087, DOI 10.1002/j.1460-2075.1994.tb06726.x; Hinrichs AS, 2006, NUCLEIC ACIDS RES, V34, pD590, DOI 10.1093/nar/gkj144; Hu JH, 2007, CELL SIGNAL, V19, P393, DOI 10.1016/j.cellsig.2006.07.010; Issa R, 2007, J IMMUNOL, V178, P7366, DOI 10.4049/jimmunol.178.11.7366; Jang BC, 2007, FEMS IMMUNOL MED MIC, V51, P171, DOI 10.1111/j.1574-695X.2007.00293.x; Johansson-Haque K, 2008, J MOL ENDOCRINOL, V41, P239, DOI 10.1677/JME-08-0015; John S, 2008, MOL CELL, V29, P611, DOI 10.1016/j.molcel.2008.02.010; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kaiser RA, 2004, J BIOL CHEM, V279, P15524, DOI 10.1074/jbc.M313717200; Kang BN, 2008, AM J PHYSIOL-LUNG C, V295, pL186, DOI 10.1152/ajplung.00352.2007; Kassel O, 2001, EMBO J, V20, P7108, DOI 10.1093/emboj/20.24.7108; Kassel O, 2007, MOL CELL ENDOCRINOL, V275, P13, DOI 10.1016/j.mce.2007.07.003; Komatsu K, 2008, BIOCHEM BIOPH RES CO, V377, P763, DOI 10.1016/j.bbrc.2008.10.091; Kracht M, 2002, CYTOKINE, V20, P91, DOI 10.1006/cyto.2002.0895; Lang R, 2006, J IMMUNOL, V177, P7497, DOI 10.4049/jimmunol.177.11.7497; Lasa M, 2002, MOL CELL BIOL, V22, P7802, DOI 10.1128/MCB.22.22.7802-7811.2002; Le PP, 2005, PLOS GENET, V1, P159, DOI 10.1371/journal.pgen.0010016; Li LW, 2009, INT J CLIN EXP MED, V2, P48; Loke TK, 2006, J ALLERGY CLIN IMMUN, V118, P368, DOI 10.1016/j.jaci.2006.04.055; Lowe CB, 2007, P NATL ACAD SCI USA, V104, P8005, DOI 10.1073/pnas.0611223104; Maier JV, 2007, MOL ENDOCRINOL, V21, P2663, DOI 10.1210/me.2007-0067; Meijsing SH, 2009, SCIENCE, V324, P407, DOI 10.1126/science.1164265; Mikkelsen TS, 2007, NATURE, V447, P167, DOI 10.1038/nature05805; Newton R, 2000, THORAX, V55, P603, DOI 10.1136/thorax.55.7.603; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Quante T, 2008, AM J RESP CELL MOL, V39, P208, DOI 10.1165/rcmb.2007-0014OC; Reichardt HM, 2001, EMBO J, V20, P7168, DOI 10.1093/emboj/20.24.7168; Rogatsky I, 2003, P NATL ACAD SCI USA, V100, P13845, DOI 10.1073/pnas.2336092100; Rogatsky I, 2002, P NATL ACAD SCI USA, V99, P16701, DOI 10.1073/pnas.262671599; Saccani S, 2001, J EXP MED, V193, P1351, DOI 10.1084/jem.193.12.1351; Saklatvala J, 2003, BIOCHEM SOC SYMP, V70, P95, DOI 10.1042/bss0700095; Salojin KV, 2006, J IMMUNOL, V176, P1899, DOI 10.4049/jimmunol.176.3.1899; Santangelo AM, 2007, PLOS GENET, V3, P1813, DOI 10.1371/journal.pgen.0030166; Schacke Heike, 2005, Curr Opin Investig Drugs, V6, P503; Schoneveld OJLM, 2004, BBA-GENE STRUCT EXPR, V1680, P114, DOI 10.1016/j.bbaexp.2004.09.004; So AYL, 2008, P NATL ACAD SCI USA, V105, P5745, DOI 10.1073/pnas.0801551105; So AYL, 2007, PLOS GENET, V3, P927, DOI 10.1371/journal.pgen.0030094; Sousa AR, 1999, J ALLERGY CLIN IMMUN, V104, P565, DOI 10.1016/S0091-6749(99)70325-8; Tuckermann JP, 1999, J CELL BIOL, V147, P1365, DOI 10.1083/jcb.147.7.1365; Wang JC, 2004, P NATL ACAD SCI USA, V101, P15603, DOI 10.1073/pnas.0407008101; Wang XX, 2007, J IMMUNOL, V178, P5312, DOI 10.4049/jimmunol.178.8.5312; Zhao Q, 2006, J EXP MED, V203, P131, DOI 10.1084/jem.20051794; Zhou Y, 2007, J NEUROCHEM, V102, P667, DOI 10.1111/j.1471-4159.2007.04535.x	67	57	60	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2642	2652		10.1074/jbc.M109.037309	http://dx.doi.org/10.1074/jbc.M109.037309			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19940143	Green Published, hybrid			2022-12-25	WOS:000273697800043
J	Ayollo, DV; Zhitnyak, IY; Vasiliev, JM; Gloushankova, NA				Ayollo, Dmitry V.; Zhitnyak, Irina Y.; Vasiliev, Jury M.; Gloushankova, Natalya A.			Rearrangements of the Actin Cytoskeleton and E-Cadherin-Based Adherens Junctions Caused by Neoplasic Transformation Change Cell-Cell Interactions	PLOS ONE			English	Article							CONTACT FORMATION; RHO; RAC; POLYMERIZATION; DYNAMICS; ADHESION; KINASE; ORGANIZATION; PROTEIN; CORTACTIN	E-cadherin-mediated cell-cell adhesion, which is essential for the maintenance of the architecture and integrity of epithelial tissues, is often lost during carcinoma progression. To better understand the nature of alterations of cell-cell interactions at the early stages of neoplastic evolution of epithelial cells, we examined the line of nontransformed IAR-2 epithelial cells and their descendants, lines of IAR-6-1 epithelial cells transformed with dimethylnitrosamine and IAR1170 cells transformed with N-RasG12D. IAR-6-1 and IAR1170 cells retained E-cadherin, displayed discoid or polygonal morphology, and formed monolayers similar to IAR-2 monolayer. Fluorescence staining, however, showed that in IAR1170 and IAR-6-1 cells the marginal actin bundle, which is typical of nontransformed IAR-2 cells, disappeared, and the continuous adhesion belt (tangential adherens junctions (AJs)) was replaced by radially oriented E-cadherin-based AJs. Time-lapse imaging of IAR-6-1 cells stably transfected with GFP-E-cadherin revealed that AJs in transformed cells are very dynamic and unstable. The regulation of AJ assembly by Rho family small GTPases was different in nontransformed and in transformed IAR epithelial cells. As our experiments with the ROCK inhibitor Y-27632 and the myosin II inhibitor blebbistatin have shown, the formation and maintenance of radial AJs critically depend on myosin II-mediated contractility. Using the RNAi technique for the depletion of mDia1 and loading cells with N17Rac, we established that mDia1 and Rac are involved in the assembly of tangential AJs in nontransformed epithelial cells but not in radial AJs in transformed cells. Neoplastic transformation changed cell-cell interactions, preventing contact paralysis after the establishment of cell-cell contact and promoting dynamic cell-cell adhesion and motile behavior of cells. It is suggested that the disappearance of the marginal actin bundle and rearrangements of AJs may change the adhesive function of E-cadherin and play an active role in migratory activity of carcinoma cells.	[Ayollo, Dmitry V.; Zhitnyak, Irina Y.; Vasiliev, Jury M.; Gloushankova, Natalya A.] Russian Acad Med Sci, Inst Carcinogenesis, NN Blokhin Canc Res Ctr, Moscow, Russia	N.N. Blokhin Russian Cancer Research Center; Russian Academy of Medical Sciences	Ayollo, DV (corresponding author), Russian Acad Med Sci, Inst Carcinogenesis, NN Blokhin Canc Res Ctr, Moscow, Russia.	natglu@hotmail.com	Zhitnyak, Irina Y/I-2967-2015; Gloushankova, Natalya/S-2577-2019	Zhitnyak, Irina Y/0000-0002-6717-3745; Gloushankova, Natalya/0000-0002-2044-2063; AYOLLO, Dmitry/0000-0002-9915-7918	Russian Foundation for Basic Research [08-04-00408a]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	This work was funded from the Russian Foundation for Basic Research (Grant 08-04-00408a). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE M, 1970, IN VITRO CELL DEV B, V6, P128; Beraud N, 2009, J BIOENERG BIOMEMBR, V41, P195, DOI 10.1007/s10863-009-9214-x; Bieling P, 1996, J CLIN ONCOL, V14, P848, DOI 10.1200/JCO.1996.14.3.848; Braga VMM, 1999, MOL BIOL CELL, V10, P9, DOI 10.1091/mbc.10.1.9; Braga VMM, 1997, J CELL BIOL, V137, P1421, DOI 10.1083/jcb.137.6.1421; Brock J, 1996, J CELL BIOL, V135, P1097, DOI 10.1083/jcb.135.4.1097; Carmona-Fontaine C, 2008, NATURE, V456, P957, DOI 10.1038/nature07441; Carramusa L, 2007, J CELL SCI, V120, P3870, DOI 10.1242/jcs.014365; El Sayegh TY, 2004, J CELL SCI, V117, P5117, DOI 10.1242/jcs.01385; Gillett CE, 2001, J PATHOL, V193, P433, DOI 10.1002/path.831; Gloushankova NA, 1997, P NATL ACAD SCI USA, V94, P879, DOI 10.1073/pnas.94.3.879; Gloushankova NA, 1998, P NATL ACAD SCI USA, V95, P4362, DOI 10.1073/pnas.95.8.4362; Helwani FM, 2004, J CELL BIOL, V164, P899, DOI 10.1083/jcb.200309034; Hirata H, 2008, J CELL SCI, V121, P2795, DOI 10.1242/jcs.030320; Ishizaki T, 1996, EMBO J, V15, P1885, DOI 10.1002/j.1460-2075.1996.tb00539.x; Ivanov AI, 2005, MOL BIOL CELL, V16, P2636, DOI 10.1091/mbc.E05-01-0043; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kobielak A, 2004, NAT CELL BIOL, V6, P21, DOI 10.1038/ncb1075; KOLEGA J, 1986, J CELL BIOL, V102, P1400, DOI 10.1083/jcb.102.4.1400; Krendel MF, 1999, CELL MOTIL CYTOSKEL, V43, P296, DOI 10.1002/(SICI)1097-0169(1999)43:4<296::AID-CM3>3.0.CO;2-U; LEUNG T, 1995, J BIOL CHEM, V270, P29051, DOI 10.1074/jbc.270.49.29051; Miyake Y, 2006, EXP CELL RES, V312, P1637, DOI 10.1016/j.yexcr.2006.01.031; MONTESANO R, 1975, INT J CANCER, V16, P550, DOI 10.1002/ijc.2910160405; Nelson WJ, 2008, BIOCHEM SOC T, V36, P149, DOI 10.1042/BST0360149; Pellegrin S, 2007, J CELL SCI, V120, P3491, DOI 10.1242/jcs.018473; Sahai E, 2002, NAT CELL BIOL, V4, P408, DOI 10.1038/ncb796; SELF AJ, 1995, METHOD ENZYMOL, V256, P3; Shewan AM, 2005, MOL BIOL CELL, V16, P4531, DOI 10.1091/mbc.E05-04-0330; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; STROMSKAYA TP, 1995, FEBS LETT, V368, P373, DOI 10.1016/0014-5793(95)00662-S; Takaishi K, 1997, J CELL BIOL, V139, P1047, DOI 10.1083/jcb.139.4.1047; Takeichi M, 1993, CURR OPIN CELL BIOL, V5, P806, DOI 10.1016/0955-0674(93)90029-P; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tuschl T, 1999, GENE DEV, V13, P3191, DOI 10.1101/gad.13.24.3191; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Watanabe N, 1997, EMBO J, V16, P3044, DOI 10.1093/emboj/16.11.3044; Wheelock MJ, 2008, J CELL SCI, V121, P727, DOI 10.1242/jcs.000455; Yamada S, 2007, J CELL BIOL, V178, P517, DOI 10.1083/jcb.200701058; Yamana N, 2006, MOL CELL BIOL, V26, P6844, DOI 10.1128/MCB.00283-06; Yamazaki D, 2007, J CELL SCI, V120, P86, DOI 10.1242/jcs.03311	40	41	44	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2009	4	11							e8027	10.1371/journal.pone.0008027	http://dx.doi.org/10.1371/journal.pone.0008027			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MQ	19956566	gold, Green Submitted, Green Published			2022-12-25	WOS:000272828400006
J	Navon, R; Wang, H; Steinfeld, I; Tsalenko, A; Ben-Dor, A; Yakhini, Z				Navon, Roy; Wang, Hui; Steinfeld, Israel; Tsalenko, Anya; Ben-Dor, Amir; Yakhini, Zohar			Novel Rank-Based Statistical Methods Reveal MicroRNAs with Differential Expression in Multiple Cancer Types	PLOS ONE			English	Article							GENE-EXPRESSION; MOLECULAR CLASSIFICATION; COLORECTAL-CANCER; BREAST-CANCER; IDENTIFICATION; PROFILES; DISEASE; CELLS; RNA; ACCUMULATION	Background: microRNAs (miRNAs) regulate target genes at the post-transcriptional level and play important roles in cancer pathogenesis and development. Variation amongst individuals is a significant confounding factor in miRNA (or other) expression studies. The true character of biologically or clinically meaningful differential expression can be obscured by inter-patient variation. In this study we aim to identify miRNAs with consistent differential expression in multiple tumor types using a novel data analysis approach. Methods: Using microarrays we profiled the expression of more than 700 miRNAs in 28 matched tumor/normal samples from 8 different tumor types (breast, colon, liver, lung, lymphoma, ovary, prostate and testis). This set is unique in putting emphasis on minimizing tissue type and patient related variability using normal and tumor samples from the same patient. We develop scores for comparing miRNA expression in the above matched sample data based on a rigorous characterization of the distribution of order statistics over a discrete state set, including exact p-values. Specifically, we compute a Rank Consistency Score (RCoS) for every miRNA measured in our data. Our methods are also applicable in various other contexts. We compare our methods, as applied to matched samples, to paired t-test and to the Wilcoxon Signed Rank test. Results: We identify consistent (across the cancer types measured) differentially expressed miRNAs. 41 miRNAs are under-expressed in cancer compared to normal, at FDR (False Discovery Rate) of 0.05 and 17 are over-expressed at the same FDR level. Differentially expressed miRNAs include known oncomiRs (e. g miR-96) as well as miRNAs that were not previously universally associated with cancer. Specific examples include miR-133b and miR-486-5p, which are consistently down regulated and mir-629* which is consistently up regulated in cancer, in the context of our cohort. Data is available in GEO. Software is available at: http://bioinfo.cs.technion.ac.il/people/zohar/RCoS/	[Navon, Roy; Steinfeld, Israel; Ben-Dor, Amir; Yakhini, Zohar] Agilent Labs, Tel Aviv, Israel; [Wang, Hui; Tsalenko, Anya] Agilent Labs, Santa Clara, CA USA; [Navon, Roy] Tel Aviv Univ, Sch Comp Sci, IL-69978 Tel Aviv, Israel; [Steinfeld, Israel] Technion Israel Inst Technol, Dept Comp Sci, IL-32000 Haifa, Israel	Agilent Technologies; Agilent Technologies; Tel Aviv University; Technion Israel Institute of Technology	Navon, R (corresponding author), Agilent Labs, Tel Aviv, Israel.	rnavon@gmail.com		Yakhini, Zohar/0000-0002-0420-5412	European Union	European Union(European Commission)	RN, IS and ZY were partially supported by a European Union FP6 grant, under the framework of the MultiKnowledge Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akao Y, 2006, ONCOL REP, V16, P845; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; [Anonymous], 1967, HDB METHODS APPL STA; Bandres E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-29; Ben-Dor A, 2000, J COMPUT BIOL, V7, P559, DOI 10.1089/106652700750050943; Ben-Dor A, 2001, P 5 ANN INT C COMP M, P31, DOI DOI 10.1145/369133.369167; BENDOR A, 2007, FRAMEWORK IDENTIFYIN, P122; Benjamini Y, CONTROLLING FALSE DI; Bittner M, 2000, NATURE, V406, P536, DOI 10.1038/35020115; CALDAS C, 1994, NAT GENET, V8, P27, DOI 10.1038/ng0994-27; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Chen MM, 2003, CIRCULATION, V108, P1432, DOI 10.1161/01.CIR.0000091235.94914.75; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Evans DL, 2006, INFORMS J COMPUT, V18, P19, DOI 10.1287/ijoc.1040.0105; Gal H, 2008, BIOCHEM BIOPH RES CO, V376, P86, DOI 10.1016/j.bbrc.2008.08.107; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hedenfalk I, 2001, NEW ENGL J MED, V344, P539, DOI 10.1056/NEJM200102223440801; Hedenfalk I, 2003, P NATL ACAD SCI USA, V100, P2532, DOI 10.1073/pnas.0533805100; Ho M, 2003, PHYSIOL GENOMICS, V13, P249, DOI 10.1152/physiolgenomics.00186.2002; Hollander M., 1973, NONPARAMETRIC STAT M; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Huang Q, 2001, SCIENCE, V294, P870, DOI 10.1126/science.294.5543.870; JARQUE CM, 1987, INT STAT REV, V55, P163, DOI 10.2307/1403192; Lebanony D, 2008, J CLIN ONCOL, V26, DOI 10.1200/jco.2008.26.15_suppl.22018; Levy AM, 2005, P NATL ACAD SCI USA, V102, P14831, DOI 10.1073/pnas.0506849102; Liggett WH, 1998, J CLIN ONCOL, V16, P1197, DOI 10.1200/JCO.1998.16.3.1197; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lui WO, 2007, CANCER RES, V67, P6031, DOI 10.1158/0008-5472.CAN-06-0561; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Michael MZ, 2003, MOL CANCER RES, V1, P882; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Oren M, 1999, J BIOL CHEM, V274, P36031, DOI 10.1074/jbc.274.51.36031; Perkins DO, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r27; Rice J., 1995, MATH STAT DATA ANAL; Rocco JW, 2001, EXP CELL RES, V264, P42, DOI 10.1006/excr.2000.5149; Rosenfeld N, 2008, NAT BIOTECHNOL, V26, P462, DOI 10.1038/nbt1392; Shyamsundar R, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r22; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Slaby O, 2007, ONCOLOGY-BASEL, V72, P397, DOI 10.1159/000113489; Sonkoly E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000610; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Thum T, 2008, CARDIOVASC RES, V79, P562, DOI 10.1093/cvr/cvn137; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang H, 2007, RNA, V13, P151, DOI 10.1261/rna.234507; Zhang L, 2008, P NATL ACAD SCI USA, V105, P7004, DOI 10.1073/pnas.0801615105; Zuo FR, 2002, P NATL ACAD SCI USA, V99, P6292, DOI 10.1073/pnas.092134099; AGILENT FEATURE EXTR	54	140	152	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2009	4	11							e8003	10.1371/journal.pone.0008003	http://dx.doi.org/10.1371/journal.pone.0008003			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MK	19946373	Green Submitted, Green Published, gold			2022-12-25	WOS:000272827800012
J	Pennetier, C; Costantini, C; Corbel, V; Licciardi, S; Dabire, RK; Lapied, B; Chandre, F; Hougard, JM				Pennetier, Cedric; Costantini, Carlo; Corbel, Vincent; Licciardi, Severine; Dabire, Roch K.; Lapied, Bruno; Chandre, Fabrice; Hougard, Jean-Marc			Synergy between Repellents and Organophosphates on Bed Nets: Efficacy and Behavioural Response of Natural Free-Flying An. gambiae Mosquitoes	PLOS ONE			English	Article							RESISTANT ANOPHELES-GAMBIAE; CULEX-QUINQUEFASCIATUS MOSQUITOS; PYRETHROID RESISTANCE; INSECT REPELLENTS; EXPERIMENTAL HUTS; MALARIA VECTORS; TREATED NETS; SAFETY; DEET; COMBINATION	Background: Chemicals are used on bed nets in order to prevent infected bites and to kill aggressive malaria vectors. Because pyrethroid resistance has become widespread in the main malaria vectors, research for alternative active ingredients becomes urgent. Mixing a repellent and a non-pyrethroid insecticide seemed to be a promising tool as mixtures in the laboratory showed the same features as pyrethroids. Methodology/Principal Findings: We present here the results of two trials run against free-flying Anopheles gambiae populations comparing the effects of two insect repellents (either DEET or KBR 3023, also known as icaridin) and an organophosphate insecticide at low-doses (pirimiphos-methyl, PM) used alone and in combination on bed nets. We showed that mixtures of PM and the repellents induced higher exophily, blood feeding inhibition and mortality among wild susceptible and resistant malaria vectors than compounds used alone. Nevertheless the synergistic interactions are only involved in the high mortality induced by the two mixtures. Conclusion: These field trials argue in favour of the strategy of mixing repellent and organophosphate on bed nets to better control resistant malaria vectors.			Pennetier, C (corresponding author), IRD, CCPV, UR016, Montpellier, France.	cedric.pennetier@ird.fr	Pennetier, Cedric/K-2010-2016; Dabire, Roch Kounbobr/ABF-3525-2020; Costantini, Carlo/F-3470-2012; Chandre, Fabrice/Q-3429-2019; Corbel, VIncent/G-9576-2016	Costantini, Carlo/0000-0003-1016-129X; Chandre, Fabrice/0000-0002-1994-9705; corbel, vincent/0000-0003-0995-3257; Pennetier, Cedric/0000-0002-3362-6371; Lapied, Bruno/0000-0002-0354-4375				Abdoulaye D, 2003, J MED ENTOMOL, V40, P195, DOI 10.1603/0022-2585-40.2.195; Asidi AN, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-25; Buka RL, 2004, CURR OPIN PEDIATR, V16, P378, DOI 10.1097/01.mop.0000133082.32384.76; Chandre F, 1999, B WORLD HEALTH ORGAN, V77, P230; Chandre F, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P319; Collett D., 1991, MODELLING BINARY DAT; Corbel V, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-47; Costantini C, 1998, AM J TROP MED HYG, V58, P56, DOI 10.4269/ajtmh.1998.58.56; Costantini C, 1996, MED VET ENTOMOL, V10, P220, DOI 10.1111/j.1365-2915.1996.tb00734.x; Costantini C, 1996, CIBA F SYMP, V200, P124; Costantini C, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P209; Crawley M.J., 1993, GLIM ECOLOGISTS; Darriet F, 2002, B SOC PATHOL EXOT, V95, P299; Diabate A, 2004, TROP MED INT HEALTH, V9, P1267, DOI 10.1111/j.1365-3156.2004.01336.x; Favia G, 2001, INSECT MOL BIOL, V10, P19, DOI 10.1046/j.1365-2583.2001.00236.x; Greenwood BM, 2005, LANCET, V365, P1487, DOI 10.1016/S0140-6736(05)66420-3; Grieco JP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000716; Guillet P, 2001, MED VET ENTOMOL, V15, P105, DOI 10.1046/j.1365-2915.2001.00288.x; Hougard JM, 2003, B ENTOMOL RES, V93, P491, DOI 10.1079/BER2003261; Kendrick DB, 2006, CURR OPIN PEDIATR, V18, P180, DOI 10.1097/01.mop.0000193273.54742.6f; KILLEEN GF, 2007, T R SOC TROP MED HYG; Koren G, 2003, CAN MED ASSOC J, V169, P209; Martinez-Torres D, 1998, INSECT MOL BIOL, V7, P179, DOI 10.1046/j.1365-2583.1998.72062.x; McGready R, 2001, AM J TROP MED HYG, V65, P285, DOI 10.4269/ajtmh.2001.65.285; MEHR ZA, 1990, J AM MOSQUITO CONTR, V6, P469; N'Guessan R, 2007, EMERG INFECT DIS, V13, P199, DOI 10.3201/eid1302.060631; N'Guessan R, 2006, T ROY SOC TROP MED H, V100, P1091, DOI 10.1016/j.trstmh.2006.04.005; NGUESSAN R, 2007, T R SOC TROP MED HYG; PAYNE CD, 1987, GLIM SYSTEM RELEASE; Pennetier C, 2005, AM J TROP MED HYG, V72, P739, DOI 10.4269/ajtmh.2005.72.739; Pennetier C, 2008, EMERG INFECT DIS, V14, P1707, DOI 10.3201/eid1411.071575; Pennetier C, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-38; PETERS W, 1990, ANN PARASIT HUM COMP, V65, P103, DOI 10.1051/parasite/1990651103; TOMLIN CDS, 2000, PESTICIDE MANUEL WOR; Torr SJ, 2007, MED VET ENTOMOL, V21, P53, DOI 10.1111/j.1365-2915.2006.00657.x; Torr SJ, 2005, TRENDS PARASITOL, V21, P537, DOI 10.1016/j.pt.2005.08.021; Weill M, 2004, INSECT MOL BIOL, V13, P1, DOI 10.1111/j.1365-2583.2004.00452.x; WHO, 2006, GUIDELINES TESTING M; WHO UNICEF, 2005, WORLD MALARIA REPORT; Zaim M, 2000, MED VET ENTOMOL, V14, P1, DOI 10.1046/j.1365-2915.2000.00211.x	40	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2009	4	11							e7896	10.1371/journal.pone.0007896	http://dx.doi.org/10.1371/journal.pone.0007896			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522NJ	19936249	Green Published, gold			2022-12-25	WOS:000272004600002
J	Kim, YC; Morrison, SL				Kim, Yun-Cheol; Morrison, Sherie L.			A Rapid and Economic In-House DNA Purification Method Using Glass Syringe Filters	PLOS ONE			English	Article								Background: Purity, yield, speed and cost are important considerations in plasmid purification, but it is difficult to achieve all of these at the same time. Currently, there are many protocols and kits for DNA purification, however none maximize all four considerations. Methodology/Principal Findings: We now describe a fast, efficient and economic in-house protocol for plasmid preparation using glass syringe filters. Plasmid yield and quality as determined by enzyme digestion and transfection efficiency were equivalent to the expensive commercial kits. Importantly, the time required for purification was much less than that required using a commercial kit. Conclusions/Significance: This method provides DNA yield and quality similar to that obtained with commercial kits, but is more rapid and less costly.			Kim, YC (corresponding author), Invitrogen, Camarillo, CA USA.	kyc8402@ucla.edu						Ausubel F. M., 2001, CURRENT PROTOCOLS MO; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Gerstein AS., 2001, MOL BIOL PROBLEM SOL; HOLMES DS, 1981, ANAL BIOCHEM, V114, P193, DOI 10.1016/0003-2697(81)90473-5; Itoh M, 1999, GENOME RES, V9, P463; KIESER T, 1984, PLASMID, V12, P19, DOI 10.1016/0147-619X(84)90063-5; MAITRA R, 1994, INDIAN J BIOCHEM BIO, V31, P97; *QIAG INC, 2005, QIAG PLASM PUR HDB; RADLOFF R, 1967, P NATL ACAD SCI USA, V57, P1514, DOI 10.1073/pnas.57.5.1514; ROMANOWSKI G, 1991, APPL ENVIRON MICROB, V57, P1057, DOI 10.1128/AEM.57.4.1057-1061.1991; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Sambrook J, 2001, MOL CLONING LAB MANU; VAUGHANLARRY, 2001, PURIFICATION PLASMID	14	6	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2009	4	11							e7750	10.1371/journal.pone.0007750	http://dx.doi.org/10.1371/journal.pone.0007750			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521QH	19924285	Green Published, Green Submitted, gold			2022-12-25	WOS:000271936700001
J	Russ, BE; Cohen, YE				Russ, Brian E.; Cohen, Yale E.			Rhesus Monkeys' Valuation of Vocalizations during a Free-Choice Task	PLOS ONE			English	Article							DISCRIMINATION; MACAQUES; CALLS; FIELD	Adaptive behavior requires that animals integrate current and past information with their decision-making. One important type of information is auditory-communication signals (i.e., species-specific vocalizations). Here, we tested how rhesus monkeys incorporate the opportunity to listen to different species-specific vocalizations into their decision-making processes. In particular, we tested how monkeys value these vocalizations relative to the opportunity to get a juice reward. To test this hypothesis, monkeys chose one of two targets to get a varying juice reward; at one of those targets, in addition to the juice reward, a vocalization was presented. By titrating the juice amounts at the two targets, we quantified the relationship between the monkeys' juice choices relative to the opportunity to listen to a vocalization. We found that, rhesus were not willing to give up a large juice reward to listen to vocalizations indicating that, relative to a juice reward, listening to vocalizations has a low value.			Russ, BE (corresponding author), Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA.	ycohen@mail.med.upenn.edu		Russ, Brian/0000-0003-0320-1257	NIDCD NIH HHS [5R01DC007172, R01 DC007172, 5R01DC00922] Funding Source: Medline; NIMH NIH HHS [F31 MH075634, 5F31MH075634] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH075634] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007172, R01DC000922] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Adachi I, 2007, BEHAV PROCESS, V74, P27, DOI 10.1016/j.beproc.2006.09.004; Andersson M, 1996, SEXUAL SELECTION; Bell AH, 2003, EUR J NEUROSCI, V18, P2867, DOI 10.1111/j.1460-9568.2003.02976.x; Bennett ATD, 1997, P NATL ACAD SCI USA, V94, P8618, DOI 10.1073/pnas.94.16.8618; Bon L, 2006, EXP BRAIN RES, V168, P441, DOI 10.1007/s00221-005-0197-5; Bon L, 1997, EXP BRAIN RES, V113, P180, DOI 10.1007/BF02454156; BUTLER RA, 1958, AM J PSYCHOL, V71, P591, DOI 10.2307/1420258; BUTLER RA, 1957, J COMP PHYSIOL PSYCH, V50, P239, DOI 10.1037/h0045931; Cheney D. L., 1990, MONKEYS SEE WORLD IN; COHEN YE, 2009, MULTIMODAL ACTIVITY; Deaner RO, 2005, CURR BIOL, V15, P543, DOI 10.1016/j.cub.2005.01.044; Fitch WT, 2003, SPR HDB AUD, V16, P65; Gifford GW, 2004, J NEUROPHYSIOL, V91, P2929, DOI 10.1152/jn.01117.2003; Gifford GW, 2003, BRAIN BEHAV EVOLUT, V61, P213, DOI 10.1159/000070704; Glimcher PW, 2003, BRADFORD BOOKS, P1; Greenfield MD, 2002, SIGNALERS RECEIVERS; HAUSER MD, 1993, BEHAV ECOL, V4, P194, DOI 10.1093/beheco/4.3.194; Hauser MD, 1998, ANIM BEHAV, V55, P1647, DOI 10.1006/anbe.1997.0712; HAUSER MD, 1997, EVOLUTION COMMUNICAT; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; Jusczyk P., 1997, DISCOVERY SPOKEN LAN; Klein JT, 2008, CURR BIOL, V18, P419, DOI 10.1016/j.cub.2008.02.047; LAU WWL, 2000, HEARING WHALES DOLPH; Macmillan N. A., 1991, DETECTION THEORY USE; Mech D., 2003, WOLVES BEHAV ECOLOGY; Platt ML, 2008, NAT NEUROSCI, V11, P398, DOI 10.1038/nn2062; RECANZONE GH, 2009, INTERACTIONS AUDITOR; Seyfarth RM, 2003, ANNU REV PSYCHOL, V54, P145, DOI 10.1146/annurev.psych.54.101601.145121; Sugrue LP, 2005, NAT REV NEUROSCI, V6, P363, DOI 10.1038/nrn1666; Watson KK, 2008, PHILOS T R SOC B, V363, P3825, DOI 10.1098/rstb.2008.0159	30	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2009	4	11							e7834	10.1371/journal.pone.0007834	http://dx.doi.org/10.1371/journal.pone.0007834			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521QH	19924223	Green Submitted, Green Published, gold			2022-12-25	WOS:000271936700005
J	Alvarez, Y; Astudillo, O; Jensen, L; Reynolds, AL; Waghorne, N; Brazil, DP; Cao, YH; O'Connor, JJ; Kennedy, BN				Alvarez, Yolanda; Astudillo, Olaya; Jensen, Lasse; Reynolds, Alison L.; Waghorne, Nora; Brazil, Derek P.; Cao, Yihai; O'Connor, John J.; Kennedy, Breandan N.			Selective Inhibition of Retinal Angiogenesis by Targeting PI3 Kinase	PLOS ONE			English	Article							CHOROIDAL NEOVASCULARIZATION; 3-KINASE INHIBITOR; MODEL; VEGF; SUPPRESSION; RETINOPATHY; MECHANISMS; ZEBRAFISH; ANTITUMOR; THERAPY	Ocular neovascularisation is a pathological hallmark of some forms of debilitating blindness including diabetic retinopathy, age related macular degeneration and retinopathy of prematurity. Current therapies for delaying unwanted ocular angiogenesis include laser surgery or molecular inhibition of the pro-angiogenic factor VEGF. However, targeting of angiogenic pathways other than, or in combination to VEGF, may lead to more effective and safer inhibitors of intraocular angiogenesis. In a small chemical screen using zebrafish, we identify LY294002 as an effective and selective inhibitor of both developmental and ectopic hyaloid angiogenesis in the eye. LY294002, a PI3 kinase inhibitor, exerts its anti-angiogenic effect in a dose-dependent manner, without perturbing existing vessels. Significantly, LY294002 delivered by intraocular injection, significantly inhibits ocular angiogenesis without systemic side-effects and without diminishing visual function. Thus, targeting of PI3 kinase pathways has the potential to effectively and safely treat neovascularisation in eye disease.			Alvarez, Y (corresponding author), Univ Coll Dublin, UCD Conway Inst, UCD Sch Biomol, Dublin 2, Ireland.	yolanda.alvarez@ucd.ie; brendan.kennedy@ucd.ie	kennedy, Breandan/H-5643-2019	kennedy, Breandan/0000-0001-7991-4689; Reynolds, Alison/0000-0002-3147-0094; O'Connor, John/0000-0001-8229-8602; Brazil, Derek/0000-0003-1375-1076; Jensen, Lasse/0000-0003-2338-357X				Alvarez Y, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-114; Avery RL, 2006, OPHTHALMOLOGY, V113, P363, DOI 10.1016/j.ophtha.2005.11.019; Bayliss PE, 2006, NAT CHEM BIOL, V2, P265, DOI 10.1038/nchembio778; Billottet C, 2009, CANCER RES, V69, P1027, DOI 10.1158/0008-5472.CAN-08-2608; Brazil DP, 2002, CELL, V111, P293, DOI 10.1016/S0092-8674(02)01083-8; Brockerhoff SE, 2006, NAT PROTOC, V1, P2448, DOI 10.1038/nprot.2006.255; Campochiaro PA, 2004, INVEST OPHTH VIS SCI, V45, P922, DOI 10.1167/iovs.03-0955; Cao RH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002748; Cao Y, 2008, ADV CANCER RES, V100, P113, DOI 10.1016/S0065-230X(08)00004-3; Dorrell MI, 2007, P NATL ACAD SCI USA, V104, P967, DOI 10.1073/pnas.0607542104; Doukas J, 2008, J CELL PHYSIOL, V216, P29, DOI 10.1002/jcp.21426; Ellis LM, 2008, NAT REV CANCER, V8, P579, DOI 10.1038/nrc2403; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Fish G, 2003, OPHTHALMOLOGY, V110, P979, DOI 10.1016/S0161-6420(03)00085-X; FLEISCH VJ, 2008, MEASUREMENTS LARVAL, DOI DOI 10.1103/PDB.PROT4973; Frank RN, 2004, NEW ENGL J MED, V350, P48, DOI 10.1056/NEJMra021678; Garlich JR, 2008, CANCER RES, V68, P206, DOI 10.1158/0008-5472.CAN-07-0669; Gharbi SI, 2007, BIOCHEM J, V404, P15, DOI 10.1042/BJ20061489; Graupera M, 2008, NATURE, V453, P662, DOI 10.1038/nature06892; HAYAT M, 1987, PRINCIPLES TECHNIQUE; Hernandez C, 2007, EXPERT OPIN INV DRUG, V16, P1209, DOI 10.1517/13543784.16.8.1209; Ihle NT, 2009, MOL CANCER THER, V8, P1, DOI 10.1158/1535-7163.MCT-08-0801; Jager RD, 2008, NEW ENGL J MED, V358, P2606, DOI 10.1056/NEJMra0801537; Jia SD, 2009, CURR OPIN CELL BIOL, V21, P199, DOI 10.1016/j.ceb.2008.12.007; Kitambi SS, 2009, MECH DEVELOP, V126, P464, DOI 10.1016/j.mod.2009.01.002; Kleinman ME, 2008, NATURE, V452, P591, DOI 10.1038/nature06765; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Peterson RT, 2000, P NATL ACAD SCI USA, V97, P12965, DOI 10.1073/pnas.97.24.12965; Pierce EA, 1996, ARCH OPHTHALMOL-CHIC, V114, P1219, DOI 10.1001/archopht.1996.01100140419009; Rosenfeld PJ, 2006, OPHTHALMOLOGY, V113, P623, DOI 10.1016/j.ophtha.2006.01.027; Saint-Geniez M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003554; Takahashi K, 2009, ARCH OPHTHALMOL-CHIC, V127, P494, DOI 10.1001/archophthalmol.2009.27; Torres-Vazquez J, 2004, DEV CELL, V7, P117, DOI 10.1016/j.devcel.2004.06.008; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Yang XM, 2009, INVEST OPHTH VIS SCI, V50, P1873, DOI 10.1167/iovs.08-2591; Yoo SA, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/129873; Yu WZ, 2008, OPHTHALMIC RES, V40, P19, DOI 10.1159/000111154; Zon LI, 2005, NAT REV DRUG DISCOV, V4, P35, DOI 10.1038/nrd1606	41	58	66	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2009	4	11							e7867	10.1371/journal.pone.0007867	http://dx.doi.org/10.1371/journal.pone.0007867			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520OG	19924235	Green Published, gold, Green Submitted			2022-12-25	WOS:000271854200014
J	Butt, T; Mufti, T; Humayun, A; Rosenthal, PB; Khan, S; Khan, S; Molloy, JE				Butt, Tariq; Mufti, Tabish; Humayun, Ahmad; Rosenthal, Peter B.; Khan, Sohaib; Khan, Shahid; Molloy, Justin E.			Myosin Motors Drive Long Range Alignment of Actin Filaments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELLULAR MOTILITY; PROTEINS; MUSCLE; CYTOSKELETON; FIBROBLASTS; ADAPTATIONS; NETWORKS; DYNAMICS; TRACKING; MOTION	The bulk alignment of actin filament sliding movement, powered by randomly oriented myosin molecules, has been observed and studied using an in vitro motility assay. The well established, actin filament gliding assay is a minimal experimental system for studying actomyosin motility. Here, we show that when the assay is performed at densities of actin filaments approaching those found in living cells, filament gliding takes up a preferred orientation. The oriented patterns of movement that we have observed extend over a length scale of 10-100 mu m, similar to the size of a mammalian cell. We studied the process of filament alignment and found that it depends critically upon filament length and density. We developed a simple quantitative measure of filament sliding orientation and this enabled us to follow the time course of alignment and the formation and disappearance of oriented domains. Domains of oriented filaments formed spontaneously and were separated by distinct boundaries. The pattern of the domain structures changed on the time scale of several seconds and the collision of neighboring domains led to emergence of new patterns. Our results indicate that actin filament crowding may play an important role in structuring the leading edge of migrating cells. Filament alignment due to near-neighbor mechanical interactions can propagate over a length scale of several microns; much greater than the size of individual filaments and analogous to a log drive. Self-alignment of actin filaments may make an important contribution to cell polarity and provide a mechanism by which cell migration direction responds to chemical cues.	[Butt, Tariq; Khan, Shahid] LUMS Sch Sci & Engn, Sector U DHA, Dept Life Sci, Lahore 54792, Pakistan; [Mufti, Tabish; Humayun, Ahmad; Khan, Sohaib] LUMS Sch Sci & Engn, Sector U DHA, Dept Comp Sci, Lahore 54792, Pakistan; [Rosenthal, Peter B.; Molloy, Justin E.] Natl Inst Med Res, Div Phys Biochem, MRC, London NW7 1AA, England	Lahore University of Management Sciences; Lahore University of Management Sciences; MRC National Institute for Medical Research	Khan, S (corresponding author), LUMS Sch Sci & Engn, Sector U DHA, Dept Life Sci, Lahore 54792, Pakistan.	shahidkh@lums.edu.pk; jmolloy@nimr.mrc.ac.uk		Molloy, Justin/0000-0002-8307-2450; Khan, Shahid/0000-0002-0361-6068; Butt, Tariq/0000-0002-8789-9543; Butt, Tariq/0000-0001-7532-1747	Higher Education Commission-British Council Link; Lahore University of Management Sciences; School of Science and Engineering; Computer Science Department; Medical Research Council, UK; Medical Research Council [MC_U117570592, MC_U117581334] Funding Source: researchfish; MRC [MC_U117581334, MC_U117570592] Funding Source: UKRI	Higher Education Commission-British Council Link; Lahore University of Management Sciences; School of Science and Engineering; Computer Science Department; Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The work was supported by a Higher Education Commission-British Council Link grant in "Bionanotechnology" (to Sh. K.), Lahore University of Management Sciences, School of Science and Engineering, Computer Science Department for research assistant stipends (to A. H. and T. M.), and a Medical Research Council, UK, grant-in-aid (to J. E. M. and P. B. R.).	Bresnick AR, 1999, CURR OPIN CELL BIOL, V11, P26, DOI 10.1016/S0955-0674(99)80004-0; Bunk R, 2003, BIOCHEM BIOPH RES CO, V301, P783, DOI 10.1016/S0006-291X(03)00027-5; Diefenbach TJ, 2002, J CELL BIOL, V158, P1207, DOI 10.1083/jcb.200202028; HALL A, 1994, ANNU REV CELL BIOL, V10, P31, DOI 10.1146/annurev.cb.10.110194.000335; Howard J, 1997, NATURE, V389, P561, DOI 10.1038/39247; ISAMBERT H, 1995, J BIOL CHEM, V270, P11437, DOI 10.1074/jbc.270.19.11437; JANMEY PA, 1994, J BIOL CHEM, V269, P32503; Kovacs M, 2003, J BIOL CHEM, V278, P38132, DOI 10.1074/jbc.M305453200; KRON SJ, 1986, P NATL ACAD SCI USA, V83, P6272, DOI 10.1073/pnas.83.17.6272; KUIPER NH, 1962, P KON NED AK WET A, V63, P38; MARGOSSIAN SS, 1982, METHOD ENZYMOL, V85, P55; Marston SB, 1996, J MUSCLE RES CELL M, V17, P497, DOI 10.1007/BF00123365; Mashanov GI, 2007, BIOPHYS J, V92, P2199, DOI 10.1529/biophysj.106.081117; Mizuno D, 2007, SCIENCE, V315, P370, DOI 10.1126/science.1134404; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pollard TD, 2003, NATURE, V422, P741, DOI 10.1038/nature01598; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; SHEETZ MP, 1986, METHOD ENZYMOL, V134, P531; Small JV, 2002, TRENDS CELL BIOL, V12, P112, DOI 10.1016/S0962-8924(01)02237-1; SYMONS MH, 1991, J CELL BIOL, V114, P503, DOI 10.1083/jcb.114.3.503; Takenawa T, 2001, J CELL SCI, V114, P1801; THERIOT JA, 1991, NATURE, V352, P126, DOI 10.1038/352126a0; Uttenweiler D, 2000, BIOPHYS J, V78, P2709, DOI 10.1016/S0006-3495(00)76815-9; Verkhovsky AB, 1999, CURR BIOL, V9, P11, DOI 10.1016/S0960-9822(99)80042-6; VERKHOVSKY AB, 1995, J CELL BIOL, V131, P989, DOI 10.1083/jcb.131.4.989; Wagner B, 2006, P NATL ACAD SCI USA, V103, P13974, DOI 10.1073/pnas.0510190103; Wang F, 2003, J BIOL CHEM, V278, P27439, DOI 10.1074/jbc.M302510200; Wiggins CH, 1998, BIOPHYS J, V74, P1043, DOI 10.1016/S0006-3495(98)74029-9; WORK SS, 1992, ANAL BIOCHEM, V202, P275, DOI 10.1016/0003-2697(92)90106-H; Wylie SR, 2001, NAT CELL BIOL, V3, P88, DOI 10.1038/35050613; YANAGIDA T, 1984, NATURE, V307, P58, DOI 10.1038/307058a0	32	81	82	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4964	4974		10.1074/jbc.M109.044792	http://dx.doi.org/10.1074/jbc.M109.044792			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	19940124	Green Published, hybrid			2022-12-25	WOS:000275274800073
J	Amunts, A; Toporik, H; Borovikova, A; Nelson, N				Amunts, Alexey; Toporik, Hila; Borovikova, Anna; Nelson, Nathan			Structure Determination and Improved Model of Plant Photosystem I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HARVESTING-COMPLEX-II; CRYSTAL-STRUCTURE; MEMBRANE-PROTEIN; RESOLUTION STRUCTURE; STATE TRANSITIONS; LIGHT; PSI; SUBUNIT; ANTENNA; ARABIDOPSIS	Photosystem I functions as a sunlight energy converter, catalyzing one of the initial steps in driving oxygenic photosynthesis in cyanobacteria, algae, and higher plants. Functionally, Photosystem I captures sunlight and transfers the excitation energy through an intricate and precisely organized antenna system, consisting of a pigment network, to the center of the molecule, where it is used in the transmembrane electron transfer reaction. Our current understanding of the sophisticated mechanisms underlying these processes has profited greatly from elucidation of the crystal structures of the Photosystem I complex. In this report, we describe the developments that ultimately led to enhanced structural information of plant Photosystem I. In addition, we report an improved crystallographic model at 3.3-angstrom resolution, which allows analysis of the structure in more detail. An improved electron density map yielded identification and tracing of subunit PsaK. The location of an additional ten beta-carotenes as well as five chlorophylls and several loop regions, which were previously uninterpretable, are now modeled. This represents the most complete plant Photosystem I structure obtained thus far, revealing the locations of and interactions among 17 protein subunits and 193 non-covalently bound photochemical cofactors. Using the new crystal structure, we examine the network of contacts among the protein subunits from the structural perspective, which provide the basis for elucidating the functional organization of the complex.	[Amunts, Alexey; Toporik, Hila; Borovikova, Anna; Nelson, Nathan] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem, IL-69978 Tel Aviv, Israel	Tel Aviv University	Nelson, N (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem, IL-69978 Tel Aviv, Israel.	nelson@post.tau.ac.il	Amunts, A./AAZ-2279-2020	Amunts, A./0000-0002-5302-1740; Nelson, Nathan/0000-0003-3588-7265	Israel Science Foundation [356/06]; United States-Israel Binational Agricultural Research and Development [IS-4229-09]	Israel Science Foundation(Israel Science Foundation); United States-Israel Binational Agricultural Research and Development	This work was supported by The Israel Science Foundation (Grant 356/06) and by the United States-Israel Binational Agricultural Research and Development Fund (Grant IS-4229-09).	Alboresi A, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-71; Amunts A, 2005, PHOTOCH PHOTOBIO SCI, V4, P1011, DOI 10.1039/b506132f; Amunts A, 2008, PLANT PHYSIOL BIOCH, V46, P228, DOI 10.1016/j.plaphy.2007.12.013; Amunts A, 2007, NATURE, V447, P58, DOI 10.1038/nature05687; Amunts A, 2009, STRUCTURE, V17, P637, DOI 10.1016/j.str.2009.03.006; ANDERSEN B, 1994, STRUCTURE FUNCTION P; Ballottari M, 2004, EUR J BIOCHEM, V271, P4659, DOI 10.1111/j.1432-1033.2004.04426.x; Ballottari M, 2007, J BIOL CHEM, V282, P8947, DOI 10.1074/jbc.M606417200; Barros T, 2009, BBA-BIOENERGETICS, V1787, P753, DOI 10.1016/j.bbabio.2009.03.012; Barth P, 2009, P NATL ACAD SCI USA, V106, P1409, DOI 10.1073/pnas.0808323106; Ben-Shem A, 2004, FEBS LETT, V564, P274, DOI 10.1016/S0014-5793(04)00360-6; Ben-Shem A, 2003, NATURE, V426, P630, DOI 10.1038/nature02200; BLANKENSHIP RE, 1992, PHOTOSYNTH RES, V33, P91, DOI 10.1007/BF00039173; Croce R, 1998, BIOCHEMISTRY-US, V37, P17355, DOI 10.1021/bi9813227; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Forsberg J, 2001, PHOTOSYNTH RES, V68, P71, DOI 10.1023/A:1011891017067; Frank HA, 1996, PHOTOCHEM PHOTOBIOL, V63, P257, DOI 10.1111/j.1751-1097.1996.tb03022.x; Fromme P, 2004, PHOTOSYNTH RES, V80, P109, DOI 10.1023/B:PRES.0000030657.88242.e1; Fromme P, 2001, BBA-BIOENERGETICS, V1507, P5, DOI 10.1016/S0005-2728(01)00195-5; Fromme Petra, 2008, V45, P33, DOI 10.1007/400_2007_044; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; Haldrup A, 1999, PLANT J, V17, P689, DOI 10.1046/j.1365-313X.1999.00419.x; Haldrup A, 2000, J BIOL CHEM, V275, P31211, DOI 10.1074/jbc.M002933200; Hansson A, 2007, FEBS J, V274, P1734, DOI 10.1111/j.1742-4658.2007.05722.x; HE WZ, 1992, FEBS LETT, V308, P298, DOI 10.1016/0014-5793(92)81297-Y; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; Iwata S, 2004, CURR OPIN STRUC BIOL, V14, P447, DOI 10.1016/j.sbi.2004.07.002; Jensen PE, 2002, J BIOL CHEM, V277, P2798, DOI 10.1074/jbc.M110448200; Jensen PE, 2007, BBA-BIOENERGETICS, V1767, P335, DOI 10.1016/j.bbabio.2007.03.004; Jolley C, 2005, J BIOL CHEM, V280, P33627, DOI 10.1074/jbc.M500937200; Jordan P, 2001, NATURE, V411, P909, DOI 10.1038/35082000; Kargul J, 2005, FEBS J, V272, P4797, DOI 10.1111/j.1742-4658.2005.04894.x; Khrouchtchova A, 2005, FEBS LETT, V579, P4808, DOI 10.1016/j.febslet.2005.07.061; KJAERULFF S, 1993, J BIOL CHEM, V268, P18912; Klimmek F, 2005, BIOCHEMISTRY-US, V44, P3065, DOI 10.1021/bi047873g; Knoetzel H, 2002, FEBS LETT, V510, P145, DOI 10.1016/S0014-5793(01)03253-7; Kouril R, 2005, BIOCHEMISTRY-US, V44, P10935, DOI 10.1021/bi051097a; Landau M, 2007, J BIOL CHEM, V282, P37854, DOI 10.1074/jbc.M705460200; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; Lucinski R, 2006, FEBS LETT, V580, P6485, DOI 10.1016/j.febslet.2006.10.063; Lunde C, 2000, NATURE, V408, P613, DOI 10.1038/35046121; Moseley JL, 2002, EMBO J, V21, P6709, DOI 10.1093/emboj/cdf666; Mozzo M, 2006, BBA-BIOENERGETICS, V1757, P1607, DOI 10.1016/j.bbabio.2006.06.018; Muh F, 2008, PLANT PHYSIOL BIOCH, V46, P238, DOI 10.1016/j.plaphy.2008.01.003; Nelson N, 2004, NAT REV MOL CELL BIO, V5, P971, DOI 10.1038/nrm1525; Nelson N, 2006, ANNU REV PLANT BIOL, V57, P521, DOI 10.1146/annurev.arplant.57.032905.105350; Nield J, 2004, EUKARYOT CELL, V3, P1370, DOI 10.1128/EC.3.6.1370-1380.2004; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palsdottir H, 2004, BBA-BIOMEMBRANES, V1666, P2, DOI 10.1016/j.bbamem.2004.06.012; PASLLON LO, 1995, BIOCHIM BIOPHYS ACTA, V1230, P1; Qian B, 2007, NATURE, V450, P259, DOI 10.1038/nature06249; Qin XC, 2006, PHOTOSYNTH RES, V90, P195, DOI 10.1007/s11120-006-9104-6; Schottler MA, 2007, BIOCHEM J, V403, P251, DOI 10.1042/BJ20061573; Screpanti E, 2006, J MOL BIOL, V362, P192, DOI 10.1016/j.jmb.2006.07.019; Sharon I, 2009, NATURE, V461, P258, DOI 10.1038/nature08284; Standfuss R, 2005, EMBO J, V24, P919, DOI 10.1038/sj.emboj.7600585; Storf S, 2005, J BIOL CHEM, V280, P5163, DOI 10.1074/jbc.M411248200; Storf S, 2004, BIOCHEMISTRY-US, V43, P9214, DOI 10.1021/bi0498196; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Takahashi H, 2006, P NATL ACAD SCI USA, V103, P477, DOI 10.1073/pnas.0509952103; Vacha F, 2005, MICRON, V36, P483, DOI 10.1016/j.micron.2005.04.004; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; van Oort B, 2008, BIOPHYS J, V95, P5851, DOI 10.1529/biophysj.108.140467; Vanselow C, 2009, BBA-BIOENERGETICS, V1787, P46, DOI 10.1016/j.bbabio.2008.10.004; Varotto C, 2002, PLANT PHYSIOL, V129, P616, DOI 10.1104/pp.002089; White SH, 2009, NATURE, V459, P344, DOI [10.1038/nature08142, 10.1038/nature]; Wientjes E, 2009, J BIOL CHEM, V284, P7803, DOI 10.1074/jbc.M808395200	70	213	222	0	66	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5					3478	3486		10.1074/jbc.M109.072645	http://dx.doi.org/10.1074/jbc.M109.072645			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19923216	Green Published, hybrid			2022-12-25	WOS:000273829000062
J	Ravimohan, S; Gama, L; Barber, SA; Clements, JE				Ravimohan, Shruthi; Gama, Lucio; Barber, Sheila A.; Clements, Janice E.			Regulation of SIV(mac)239 Basal Long Terminal Repeat Activity and Viral Replication in Macrophages FUNCTIONAL ROLES OF TWO CCAAT/ENHANCER-BINDING PROTEIN beta SITES IN ACTIVATION AND INTERFERON beta-MEDIATED SUPPRESSION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; CENTRAL-NERVOUS-SYSTEM; TRANSCRIPTIONAL INHIBITORY PROTEIN; LEUCINE ZIPPER PROTEINS; C/EBP-BETA; HIV-1 REPLICATION; CEREBROSPINAL-FLUID; GENE-EXPRESSION; MESSENGER-RNA; DNA-BINDING	CCAAT/enhancer-binding protein (C/EBP) beta and C/EBP sites in the HIV-1 long terminal repeat (LTR) are crucial for HIV-1 replication in monocyte/macrophages and for the ability of interferon beta(IFN beta) to inhibit ongoing active HIV replication in these cells. This IFN beta-mediated down-regulation involves induction of the truncated, dominant-negative isoform of C/EBP beta referred to as liver-enriched transcriptional inhibitory protein (LIP). Although binding of the C/EBP beta isoform to C/EBP sites in the simian immunodeficiency virus (SIV) LTR has previously been examined, the importance of these sites in core promoter-mediated transcription, virus replication, IFN beta-mediated regulation, and the relative binding of the two isoforms (C/EBP beta and LIP) has not been investigated. Here, we specifically examine two C/EBP sites, JC1 (-100 bp) and DS1 (+134 bp), located within the minimal region of the SIV LTR, required for core promoter-mediated transcription and virus replication in macrophages. Our studies revealed that the JC1 but not DS1 C/EBP site is important for basal level transcription, whereas the DS1 C/EBP site is imperative for productive virus replication in primary macrophages. In contrast, either JC1 or DS1 C/EBP site is sufficient to mediate IFN beta-induced down-regulation of SIV LTR activity and virus replication in these cells. We also characterized the differential binding properties of C/EBP beta and LIP to the JC1 and DS1 sites. In conjunction with previous studies from our laboratory, we demonstrate the importance of these sites in virus gene expression, and we propose a model for their role in establishing latency and persistence in macrophages in the brain.	[Ravimohan, Shruthi; Gama, Lucio; Barber, Sheila A.; Clements, Janice E.] Johns Hopkins Univ, Sch Med, Dept Mol & Comparat Pathobiol, Baltimore, MD 21205 USA; [Clements, Janice E.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Clements, Janice E.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Ravimohan, Shruthi] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Clements, JE (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol & Comparat Pathobiol, 733 N Broadway,BRB831, Baltimore, MD 21205 USA.	jclement@jhmi.edu		Gama, Lucio/0000-0001-9511-012X	National Institutes of Health [NS047984, MH070306, HL75840]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075840] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P01MH070306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047984] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS047984, MH070306, and HL75840.	Abraham S, 2005, J NEUROIMMUNOL, V160, P219, DOI 10.1016/j.jneuroim.2004.11.009; AKIRA S, 1990, EMBO J, V9, P1897, DOI 10.1002/j.1460-2075.1990.tb08316.x; Ambrosino C, 1997, J BIOL CHEM, V272, P14883, DOI 10.1074/jbc.272.23.14883; An SF, 1999, J NEUROPATH EXP NEUR, V58, P1156, DOI 10.1097/00005072-199911000-00005; ANDERSON MG, 1992, VIROLOGY, V191, P559, DOI 10.1016/0042-6822(92)90231-D; ANDERSON MG, 1991, J VIROL, V65, P51, DOI 10.1128/JVI.65.1.51-60.1991; Aweeka F, 1999, J ACQ IMMUN DEF SYND, V20, P39, DOI 10.1097/00042560-199901010-00006; Barber SA, 2006, J INFECT DIS, V193, P963, DOI 10.1086/500983; Barber SA, 2004, J NEUROVIROL, V10, P15, DOI 10.1080/13550280490268179; Barr SD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000007; Berberich-Siebelt F, 2006, J IMMUNOL, V176, P4843, DOI 10.4049/jimmunol.176.8.4843; BERKHOUT B, 1992, NUCLEIC ACIDS RES, V20, P27, DOI 10.1093/nar/20.1.27; Bouazzaoui A, 2006, VIROLOGY, V356, P79, DOI 10.1016/j.virol.2006.07.025; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; CARLBERG K, 1988, J VIROL, V62, P1617, DOI 10.1128/JVI.62.5.1617-1624.1988; Centlivre M, 2008, J VIROL, V82, P9171, DOI 10.1128/JVI.00530-08; Clements JE, 2002, J INFECT DIS, V186, P905, DOI 10.1086/343768; Coyle-Rink J, 2002, VIROLOGY, V299, P240, DOI 10.1006/viro.2002.1439; DAVIS LE, 1992, NEUROLOGY, V42, P1736, DOI 10.1212/WNL.42.9.1736; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; Dudaronek JM, 2007, J IMMUNOL, V179, P7262, DOI 10.4049/jimmunol.179.11.7262; FENRICK R, 1989, J VIROL, V63, P5006, DOI 10.1128/JVI.63.12.5006-5012.1989; Flaherty MT, 1997, J VIROL, V71, P5790, DOI 10.1128/JVI.71.8.5790-5798.1997; Foudraine NA, 1998, LANCET, V351, P1547, DOI 10.1016/S0140-6736(98)07333-4; Gama Lucio, 2002, Methods Mol Biol, V182, P77; GARTNER S, 1990, AIDS RES HUM RETROV, V6, P1017, DOI 10.1089/aid.1990.6.1017; GARTNER S, 1986, JAMA-J AM MED ASSOC, V256, P2365, DOI 10.1001/jama.256.17.2365; GATIGNOL A, 1991, SCIENCE, V251, P1597, DOI 10.1126/science.2011739; Griffin DE, 2003, NAT REV IMMUNOL, V3, P493, DOI 10.1038/nri1105; Henderson AJ, 1997, P NATL ACAD SCI USA, V94, P8714, DOI 10.1073/pnas.94.16.8714; HENDERSON AJ, 1995, J VIROL, V69, P5337, DOI 10.1128/JVI.69.9.5337-5344.1995; Henderson AJ, 1996, IMMUNITY, V5, P91, DOI 10.1016/S1074-7613(00)80313-1; Honda Y, 1998, J EXP MED, V188, P1255, DOI 10.1084/jem.188.7.1255; JAKOBOVITS A, 1988, MOL CELL BIOL, V8, P2555, DOI 10.1128/MCB.8.6.2555; JONES KA, 1986, SCIENCE, V232, P755, DOI 10.1126/science.3008338; Kim RB, 1998, J CLIN INVEST, V101, P289, DOI 10.1172/JCI1269; KORNBLUTH RS, 1989, J EXP MED, V169, P1137, DOI 10.1084/jem.169.3.1137; Kravcik S, 1999, J ACQ IMMUN DEF SYND, V21, P371; Lavrrar JL, 2004, J BIOL CHEM, V279, P46343, DOI 10.1074/jbc.M402692200; Lee ES, 2002, VIROLOGY, V299, P20, DOI 10.1006/viro.2002.1500; Li Y, 2008, J BIOL CHEM, V283, P22443, DOI 10.1074/jbc.M801046200; LICHTSTEINER S, 1987, CELL, V51, P963, DOI 10.1016/0092-8674(87)90583-6; Liu CY, 2004, CYTOKINE, V27, P93, DOI 10.1016/j.cyto.2004.02.003; Mameli G, 2007, J GEN VIROL, V88, P631, DOI 10.1099/vir.0.82487-0; Mancebo HSY, 1997, GENE DEV, V11, P2633, DOI 10.1101/gad.11.20.2633; Mink S, 1997, MOL CELL BIOL, V17, P6609, DOI 10.1128/MCB.17.11.6609; MUESING MA, 1987, CELL, V48, P691, DOI 10.1016/0092-8674(87)90247-9; NABEL G, 1987, NATURE, V326, P711, DOI 10.1038/326711a0; Nonnemacher MR, 2003, BIOMED PHARMACOTHER, V57, P34, DOI 10.1016/S0753-3322(02)00334-7; Osada S, 1996, J BIOL CHEM, V271, P3891; Peng G, 2006, J EXP MED, V203, P41, DOI 10.1084/jem.20051512; Pilipuk GP, 2003, J BIOL CHEM, V278, P35668, DOI 10.1074/jbc.M305182200; Piwien-Pilipuk G, 2001, J BIOL CHEM, V276, P19664, DOI 10.1074/jbc.M010193200; POLI V, 1990, CELL, V63, P643, DOI 10.1016/0092-8674(90)90459-R; Roos JW, 2000, VIROLOGY, V273, P307, DOI 10.1006/viro.2000.0431; Rue SM, 2005, J VIROL, V79, P2484, DOI 10.1128/JVI.79.4.2484-2492.2005; Rue SM, 2003, J VIROL, V77, P8009, DOI 10.1128/JVI.77.14.8009-8018.2003; RYDEN TA, 1989, MOL CELL BIOL, V9, P1155, DOI 10.1128/MCB.9.3.1155; RYDEN TA, 1993, J VIROL, V67, P2862, DOI 10.1128/JVI.67.5.2862-2870.1993; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Schneider-Merck T, 2006, J BIOL CHEM, V281, P269, DOI 10.1074/jbc.M503459200; Schwartz C, 2003, EMBO J, V22, P882, DOI 10.1093/emboj/cdg076; Su WC, 2003, J BIOL CHEM, V278, P51150, DOI 10.1074/jbc.M305501200; SUN XH, 1991, CELL, V64, P459, DOI 10.1016/0092-8674(91)90653-G; Tesmer VM, 1996, J MOL BIOL, V262, P327, DOI 10.1006/jmbi.1996.0516; TESMER VM, 1993, P NATL ACAD SCI USA, V90, P7298, DOI 10.1073/pnas.90.15.7298; TISSOT C, 1995, J BIOL CHEM, V270, P14891, DOI 10.1074/jbc.270.25.14891; VINSON CR, 1989, SCIENCE, V246, P911, DOI 10.1126/science.2683088; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; Weiden M, 2000, J IMMUNOL, V165, P2028, DOI 10.4049/jimmunol.165.4.2028; Wells J, 2002, METHODS, V26, P48, DOI 10.1016/S1046-2023(02)00007-5; Williams K, 2001, GLIA, V36, P156, DOI 10.1002/glia.1105; WITWER KW, 2009, PLOS ONE IN PRESS; Wright EK, 2008, GENES IMMUN, V9, P419, DOI 10.1038/gene.2008.33; Zink MC, 1999, J VIROL, V73, P10480, DOI 10.1128/JVI.73.12.10480-10488.1999	75	10	11	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2268	2283		10.1074/jbc.M109.075929	http://dx.doi.org/10.1074/jbc.M109.075929			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19933495	Green Published, hybrid			2022-12-25	WOS:000273697800006
J	Huang, T; Cui, WR; Hu, LL; Feng, KY; Li, YX; Cai, YD				Huang, Tao; Cui, WeiRen; Hu, Lele; Feng, KaiYan; Li, Yi-Xue; Cai, Yu-Dong			Prediction of Pharmacological and Xenobiotic Responses to Drugs Based on Time Course Gene Expression Profiles	PLOS ONE			English	Article							COMPARATIVE TOXICOGENOMICS DATABASE; SIGNAL-TRANSDUCTION; CLINICAL IMPORTANCE; FUNCTIONAL DOMAIN; CONNECTIVITY MAP; CYTOCHROMES P450; DISCOVERY; METABOLISM; TOXICITY; PROTEINS	More and more people are concerned by the risk of unexpected side effects observed in the later steps of the development of new drugs, either in late clinical development or after marketing approval. In order to reduce the risk of the side effects, it is important to look out for the possible xenobiotic responses at an early stage. We attempt such an effort through a prediction by assuming that similarities in microarray profiles indicate shared mechanisms of action and/or toxicological responses among the chemicals being compared. A large time course microarray database derived from livers of compound-treated rats with thirty-four distinct pharmacological and toxicological responses were studied. The mRMR (Minimum-Redundancy-Maximum-Relevance) method and IFS (Incremental Feature Selection) were used to select a compact feature set (141 features) for the reduction of feature dimension and improvement of prediction performance. With these 141 features, the Leave-one-out cross-validation prediction accuracy of first order response using NNA (Nearest Neighbor Algorithm) was 63.9%. Our method can be used for pharmacological and xenobiotic responses prediction of new compounds and accelerate drug development.	[Cui, WeiRen; Hu, Lele; Cai, Yu-Dong] Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China; [Cui, WeiRen] Fudan Univ, Ctr Computat Syst Biol, Shanghai 200433, Peoples R China; [Huang, Tao; Li, Yi-Xue] Chinese Acad Sci, Key Lab Syst Biol, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Huang, Tao; Feng, KaiYan; Li, Yi-Xue] Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China	Shanghai University; Fudan University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences	Huang, T (corresponding author), Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China.	yxli@sibs.ac.cn; cai_yud@yahoo.com.cn		cai, yudong/0000-0001-5664-7979				Anzenbacher P, 2001, CELL MOL LIFE SCI, V58, P737, DOI 10.1007/PL00000897; Blomme EAG, 2009, TOXICOL LETT, V186, P22, DOI 10.1016/j.toxlet.2008.09.017; Boorman GA, 2002, TOXICOL PATHOL, V30, P15, DOI 10.1080/01926230252824671; Butte A, 2002, NAT REV DRUG DISCOV, V1, P951, DOI 10.1038/nrd961; Cai YD, 2008, MOL DIVERS, V12, P131, DOI 10.1007/s11030-008-9085-9; Cai YD, 2009, J PROTEOME RES, V8, P999, DOI 10.1021/pr800717y; Davis AP, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-48; Davis AP, 2009, NUCLEIC ACIDS RES, V37, pD786, DOI 10.1093/nar/gkn580; FRIEDMAN JH, 1975, IEEE T COMPUT, V24, P1000, DOI 10.1109/T-C.1975.224110; Ganter B, 2006, PHARMACOGENOMICS, V7, P1025, DOI 10.2217/14622416.7.7.1025; Gueguen Y, 2006, ANN BIOL CLIN-PARIS, V64, P535; Hamadeh HK, 2002, TOXICOL SCI, V67, P232, DOI 10.1093/toxsci/67.2.232; Huang T, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-44; Jia PL, 2008, J PROTEOME RES, V7, P1131, DOI 10.1021/pr700715c; Jia PL, 2007, BIOCHEM BIOPH RES CO, V357, P366, DOI 10.1016/j.bbrc.2007.03.139; Kim SK, 2007, PHARMACOL THERAPEUT, V113, P88, DOI 10.1016/j.pharmthera.2006.07.004; Lamb J, 2007, NAT REV CANCER, V7, P54, DOI 10.1038/nrc2044; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Li SJ, 2007, J BIOMOL STRUCT DYN, V25, P49, DOI 10.1080/07391102.2007.10507154; Li SJ, 2006, COMPUT BIOL CHEM, V30, P203, DOI 10.1016/j.compbiolchem.2006.02.002; Li WJ, 2008, MOL DIVERS, V12, P171, DOI 10.1007/s11030-008-9093-9; LU L, 2009, MOL DIVERS; Mattingly CJ, 2006, TOXICOL SCI, V92, P587, DOI 10.1093/toxsci/kfl008; Morgan Kevin T, 2004, Toxicol Pathol, V32 Suppl 1, P13, DOI 10.1080/01926230490424789; Mortishire-Smith RJ, 2004, CHEM RES TOXICOL, V17, P165, DOI 10.1021/tx034123j; Natsoulis G, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.9; Nebert DW, 2002, LANCET, V360, P1155, DOI 10.1016/S0140-6736(02)11203-7; Niu B, 2008, MOL DIVERS, V12, P41, DOI 10.1007/s11030-008-9073-0; Niu B, 2009, MOL DIVERS, V13, P313, DOI 10.1007/s11030-009-9116-1; Parker GA, 2005, TOXICOL PATHOL, V33, P52, DOI 10.1080/01926230590522365; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Porter AC, 1998, ONCOGENE, V17, P1343, DOI 10.1038/sj.onc.1202171; Qian ZL, 2006, BIOCHEM BIOPH RES CO, V348, P1034, DOI 10.1016/j.bbrc.2006.07.149; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; Ulrich R, 2002, NAT REV DRUG DISCOV, V1, P84, DOI 10.1038/nrd710; Wakil SJ, 2009, J LIPID RES, V50, pS138, DOI 10.1194/jlr.R800079-JLR200; Waring JF, 2001, TOXICOL LETT, V120, P359, DOI 10.1016/S0378-4274(01)00267-3; Waring JF, 2001, TOXICOL APPL PHARM, V175, P28, DOI 10.1006/taap.2001.9243; Yu XJ, 2006, J THEOR BIOL, V240, P175, DOI 10.1016/j.jtbi.2005.09.018	39	75	75	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2009	4	12							e8126	10.1371/journal.pone.0008126	http://dx.doi.org/10.1371/journal.pone.0008126			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MU	19956587	Green Published, gold, Green Submitted			2022-12-25	WOS:000272828800019
J	Kim, Y; Comte, I; Szabo, G; Hockberger, P; Szele, FG				Kim, Yongsoo; Comte, Isabelle; Szabo, Gabor; Hockberger, Philip; Szele, Francis G.			Adult Mouse Subventricular Zone Stem and Progenitor Cells Are Sessile and Epidermal Growth Factor Receptor Negatively Regulates Neuroblast Migration	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; OLFACTORY-BULB; NEURAL STEM; MAMMALIAN BRAIN; FACTOR-ALPHA; POSTNATAL NEUROGENESIS; NEURONAL MIGRATION; TRANSGENIC MICE; RAT BRAIN; EGFR	Background: The adult subventricular zone (SVZ) contains stem and progenitor cells that generate neuroblasts throughout life. Although it is well accepted that SVZ neuroblasts are migratory, recent evidence suggests their progenitor cells may also exhibit motility. Since stem and progenitor cells are proliferative and multipotential, if they were also able to move would have important implications for SVZ neurogenesis and its potential for repair. Methodology/Principal Findings: We studied whether SVZ stem and/or progenitor cells are motile in transgenic GFP+ slices with two photon time lapse microscopy and post hoc immunohistochemistry. We found that stem and progenitor cells; mGFAP-GFP+ cells, bright nestin-GFP+ cells and Mash1+ cells were stationary in the SVZ and rostral migratory stream (RMS). In our search for motile progenitor cells, we uncovered a population of motile beta III-tubulin+ neuroblasts that expressed low levels of epidermal growth factor receptor (EGFr). This was intriguing since EGFr drives proliferation in the SVZ and affects migration in other systems. Thus we examined the potential role of EGFr in modulating SVZ migration. Interestingly, EGFr(low) neuroblasts moved slower and in more tortuous patterns than EGFr-negative neuroblasts. We next questioned whether EGFr stimulation affects SVZ cell migration by imaging Gad65-GFP+ neuroblasts in the presence of transforming growth factor alpha (TGF-alpha), an EGFr-selective agonist. Indeed, acute exposure to TGF-alpha decreased the percentage of motile cells by approximately 40%. Conclusions/Significance: In summary, the present study directly shows that SVZ stem and progenitor cells are static, that EGFr is retained on some neuroblasts, and that EGFr stimulation negatively regulates migration. This result suggests an additional role for EGFr signaling in the SVZ.	[Kim, Yongsoo] Northwestern Univ, Interdept Neurosci Program, Chicago, IL 60611 USA; [Szabo, Gabor] Hungarian Acad Sci, Inst Expt Med, Dept Gene Technol & Dev Neurobiol, Budapest, Hungary; [Hockberger, Philip] Northwestern Univ, Dept Physiol, Feinberg Sch Med, Chicago, IL 60611 USA; [Szele, Francis G.] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England	Northwestern University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; Northwestern University; Feinberg School of Medicine; University of Oxford	Kim, Y (corresponding author), Northwestern Univ, Interdept Neurosci Program, Chicago, IL 60611 USA.	francis.szele@dpag.ox.ac.uk	Kim, Yongsoo/C-9163-2009; Szabo, Gabor/A-5087-2008; Kim, Yongsoo/AAE-4970-2020	Kim, Yongsoo/0000-0002-4277-0279; Szabo, Gabor/0000-0001-5438-5151; Kim, Yongsoo/0000-0002-4277-0279; Hockberger, Philip/0000-0002-4013-4885	NIH [NS-42253]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042253] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	FGS and PH supported by NIH grant NS-42253 (http://www.ninds.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre A, 2005, J NEUROSCI, V25, P11092, DOI 10.1523/JNEUROSCI.2981-05.2005; Aguirre A, 2004, J NEUROSCI, V24, P10530, DOI 10.1523/JNEUROSCI.3572-04.2004; Aguirre AA, 2004, J CELL BIOL, V165, P575, DOI 10.1083/jcb.200311141; Aguirre A, 2007, NEURON GLIA BIOL, V3, P209, DOI 10.1017/S1740925X08000082; Aguirre A, 2007, NAT NEUROSCI, V10, P990, DOI 10.1038/nn1938; ALTMAN J, 1969, J COMP NEUROL, V137, P433, DOI 10.1002/cne.901370404; Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Anton ES, 2004, NAT NEUROSCI, V7, P1319, DOI 10.1038/nn1345; Boockvar JA, 2003, MOL CELL NEUROSCI, V24, P1116, DOI 10.1016/j.mcn.2003.09.011; Burrows RC, 1997, NEURON, V19, P251, DOI 10.1016/S0896-6273(00)80937-X; Caric D, 2001, DEVELOPMENT, V128, P4203; Cayre M, 2009, PROG NEUROBIOL, V88, P41, DOI 10.1016/j.pneurobio.2009.02.001; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; Ciccolini F, 2005, DEV BIOL, V284, P112, DOI 10.1016/j.ydbio.2005.05.007; Cooper O, 2004, J NEUROSCI, V24, P8924, DOI 10.1523/JNEUROSCI.2344-04.2004; COSKUN V, 2007, EUR J NEUROSCI; Craig CG, 1996, J NEUROSCI, V16, P2649; Danilov AI, 2009, GLIA, V57, P136, DOI 10.1002/glia.20741; de Chevigny A, 2008, STEM CELLS, V26, P2349, DOI 10.1634/stemcells.2008-0080; De Marchis S, 2004, EUR J NEUROSCI, V20, P1307, DOI 10.1111/j.1460-9568.2004.03584.x; De Marchis S, 2001, J NEUROBIOL, V49, P326, DOI 10.1002/neu.10012; Denise A, 2004, NAT NEUROSCI, V7, P1233, DOI 10.1038/nn1340; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Doetsch F, 1997, J NEUROSCI, V17, P5046; Duchek P, 2001, SCIENCE, V291, P131, DOI 10.1126/science.291.5501.131; EMMETT CJ, 1991, J COMP NEUROL, V311, P330, DOI 10.1002/cne.903110304; EMMETT CJ, 1988, BRAIN RES, V447, P223, DOI 10.1016/0006-8993(88)91123-7; Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387; Fallon J, 2000, P NATL ACAD SCI USA, V97, P14686, DOI 10.1073/pnas.97.26.14686; Ghashghaei HT, 2006, P NATL ACAD SCI USA, V103, P1930, DOI 10.1073/pnas.0510410103; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Gonzalez-Perez O, 2009, STEM CELLS, V27, P2032, DOI 10.1002/stem.119; Gritti A, 1999, J NEUROSCI, V19, P3287; Iwabu A, 2004, J BIOL CHEM, V279, P14551, DOI 10.1074/jbc.M311981200; Komitova M, 2009, J COMP NEUROL, V512, P702, DOI 10.1002/cne.21917; Kuhn HG, 1997, J NEUROSCI, V17, P5820; Kuzmanovic M, 2003, INVEST OPHTH VIS SCI, V44, P3606, DOI 10.1167/iovs.02-1265; Lehmann R, 2001, CURR OPIN GENET DEV, V11, P457, DOI 10.1016/S0959-437X(00)00217-3; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Menn B, 2006, J NEUROSCI, V26, P7907, DOI 10.1523/JNEUROSCI.1299-06.2006; Merkle FT, 2007, SCIENCE, V317, P381, DOI 10.1126/science.1144914; Mignone JL, 2004, J COMP NEUROL, V469, P311, DOI 10.1002/cne.10964; NAGOSHI N, 2009, J CELL BIOCH; Nam SC, 2007, J COMP NEUROL, V505, P190, DOI 10.1002/cne.21473; Noctor SC, 2007, ARCH NEUROL-CHICAGO, V64, P639, DOI 10.1001/archneur.64.5.639; Parras CM, 2004, EMBO J, V23, P4495, DOI 10.1038/sj.emboj.7600447; Parrish-Aungst S, 2007, J COMP NEUROL, V501, P825, DOI 10.1002/cne.21205; PASTRANA E, 2009, P NATL ACAD SCI US; Platel JC, 2009, GLIA, V57, P66, DOI 10.1002/glia.20735; Pontious A, 2008, DEV NEUROSCI-BASEL, V30, P24, DOI 10.1159/000109848; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Rio C, 1997, NEURON, V19, P39, DOI 10.1016/S0896-6273(00)80346-3; SATO H, 2005, CANC GENE THER; Seidenfaden R, 2006, MOL CELL NEUROSCI, V32, P187, DOI 10.1016/j.mcn.2006.04.003; Smith CM, 1998, DEV DYNAM, V213, P220, DOI 10.1002/(SICI)1097-0177(199810)213:2<220::AID-AJA7>3.0.CO;2-I; Sun Y, 2005, NEURON, V45, P873, DOI 10.1016/j.neuron.2005.01.045; Sundholm-Peters NL, 2005, J NEUROPATH EXP NEUR, V64, P1089, DOI 10.1097/01.jnen.0000190066.13312.8f; Tropepe V, 1997, J NEUROSCI, V17, P7850; Yang HKC, 2004, J NEUROSCI RES, V76, P282, DOI 10.1002/jnr.20071; Young KM, 2007, J NEUROSCI, V27, P8286, DOI 10.1523/JNEUROSCI.0476-07.2007	62	46	47	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2009	4	12							e8122	10.1371/journal.pone.0008122	http://dx.doi.org/10.1371/journal.pone.0008122			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MU	19956583	Green Published, Green Submitted, gold			2022-12-25	WOS:000272828800016
J	Hong, YY; Li, HZ; Ye, JJ; Miki, Y; Yuan, YC; Sasano, H; Evans, DB; Chen, SA				Hong, Yanyan; Li, Hongzhi; Ye, Jingjing; Miki, Yasuhiro; Yuan, Yate-Ching; Sasano, Hironobu; Evans, Dean B.; Chen, Shiuan			Epitope Characterization of an Aromatase Monoclonal Antibody Suitable for the Assessment of Intratumoral Aromatase Activity	PLOS ONE			English	Article							SITE-DIRECTED MUTAGENESIS; HUMAN BREAST; ELECTROSTATIC INTERACTIONS; BINDING DOMAIN; REDUCTASE; ESTROGEN; IMMUNOHISTOCHEMISTRY; CYTOCHROME-P-450; VALIDATION; INHIBITION	Immunohistochemistry is one of the most suitable methods for the detection of intratumoral aromatase in order to identify patients who may respond to aromatase inhibitor therapy in hormone-dependent breast cancer. Previous studies showed statistically significant correlation between results of immnuohistochemistry and biochemical analysis in carcinoma components stained by aromatase monoclonal antibody 677. In this study, determination of the antigenic peptides recognized by aromatase antibodies through epitope mapping, combined with the new knowledge on aromatase-reductase interaction, provide insights for understanding various immunostaining patterns using different aromatase antibodies. Our studies on aromatase-reductase interaction also provided critical information on how aromatase and reductase interact with each other on the endoplasmic reticulum membrane, and identified key residues, including K108 of aromatase, that are involved in the interaction with reductase. Through epitope mapping and taking into consideration the interference with aromatase immunohistochemical staining by NADPH-cytochrome P450 reductase, we demonstrated that monoclonal antibody 677 is a suitable antibody for an assessment of intratumoral aromatase activity in breast cancer patients for making clinical management decisions. These results also provide valuable information to identify new aromatase antibodies for immunohistochemical diagnosis of hormone-dependent breast cancer in future.	[Hong, Yanyan; Ye, Jingjing; Chen, Shiuan] Beckman Res Inst City Hope, Div Tumor Cell Biol, Duarte, CA USA; [Miki, Yasuhiro; Sasano, Hironobu] Tohoku Univ, Grad Sch Med, Dept Pathol, Aoba Ku, Sendai, Miyagi 980, Japan; [Li, Hongzhi; Yuan, Yate-Ching] Beckman Res Inst City Hope, Div Informat Sci, Duarte, CA USA; [Evans, Dean B.] Novartis Pharma Ag, Novartis Inst Biomed Res, Oncol Res, Zurich, Switzerland	City of Hope; Beckman Research Institute of City of Hope; Tohoku University; City of Hope; Beckman Research Institute of City of Hope; Novartis	Hong, YY (corresponding author), Beckman Res Inst City Hope, Div Tumor Cell Biol, Duarte, CA USA.	schen@coh.org	Li, Hongzhi/E-8530-2012		National Institutes of Health [CA44735, CA33572]; NATIONAL CANCER INSTITUTE [P30CA033572, R01CA044735] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by National Institutes of Health [CA44735 (SC), and CA33572 (the City of Hope Cancer Center Grant)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERNHARDT R, 1987, BIOCHEM INT, V14, P823; BERNHARDT R, 1988, BIOMED BIOCHIM ACTA, V47, P581; BEZWODA WR, 1987, ONCOLOGY, V44, P345, DOI 10.1159/000226509; BULUN SE, 1993, J CLIN ENDOCR METAB, V77, P1622, DOI 10.1210/jc.77.6.1622; ESTEBAN JM, 1992, AM J PATHOL, V140, P337; Ghosh D, 2009, NATURE, V457, P219, DOI 10.1038/nature07614; Hamdane D, 2009, J BIOL CHEM, V284, P11374, DOI 10.1074/jbc.M807868200; Hong YY, 2007, MOL ENDOCRINOL, V21, P401, DOI 10.1210/me.2006-0281; Hong YY, 2009, ANN NY ACAD SCI, V1155, P112, DOI 10.1111/j.1749-6632.2009.03703.x; JAMES V H T, 1987, Steroids, V50, P269, DOI 10.1016/0039-128X(83)90077-6; Lu Q, 1996, ENDOCRINOLOGY, V137, P3061, DOI 10.1210/en.137.7.3061; MILLER W R, 1987, Steroids, V50, P537, DOI 10.1016/0039-128X(87)90037-7; Mintseris J, 2007, PROTEINS, V69, P511, DOI 10.1002/prot.21502; NADLER SG, 1988, ARCH BIOCHEM BIOPHYS, V261, P418, DOI 10.1016/0003-9861(88)90358-X; NADLER SG, 1991, ARCH BIOCHEM BIOPHYS, V290, P277, DOI 10.1016/0003-9861(91)90542-Q; NELSON DR, 1988, J BIOL CHEM, V263, P6038; NISIMOTO Y, 1986, J BIOL CHEM, V261, P14232; Sasano H, 1998, ENDOCR REV, V19, P593, DOI 10.1210/er.19.5.593; SASANO H, 1994, HUM PATHOL, V25, P530, DOI 10.1016/0046-8177(94)90127-9; Sasano H, 2005, J STEROID BIOCHEM, V95, P35, DOI 10.1016/j.jsbmb.2005.04.027; Sasano H, 2003, J STEROID BIOCHEM, V86, P239, DOI 10.1016/S0960-0760(03)00363-7; Sevrioukova IF, 1999, P NATL ACAD SCI USA, V96, P1863, DOI 10.1073/pnas.96.5.1863; SHEN AL, 1989, J BIOL CHEM, V264, P7584; Shenton KC, 1998, BREAST CANCER RES TR, V49, pS101, DOI 10.1023/A:1006033813899; SHIMIZU T, 1991, J BIOL CHEM, V266, P3372; STAYTON PS, 1990, BIOCHEMISTRY-US, V29, P7381, DOI 10.1021/bi00484a005; STROBEL HW, 1989, DRUG METAB REV, V20, P519, DOI 10.3109/03602538909103558; Turner KJ, 2002, J ENDOCRINOL, V172, P21, DOI 10.1677/joe.0.1720021; Wang M, 1997, P NATL ACAD SCI USA, V94, P8411, DOI 10.1073/pnas.94.16.8411; ZHOU D, 1990, CANCER RES, V50, P6949	30	25	25	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2009	4	11							e8050	10.1371/journal.pone.0008050	http://dx.doi.org/10.1371/journal.pone.0008050			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MQ	19956630	gold, Green Published, Green Submitted			2022-12-25	WOS:000272828400009
J	Sakar, Y; Nazaret, C; Letteron, P; Omar, AA; Avenati, M; Viollet, B; Ducroc, R; Bado, A				Sakar, Yassine; Nazaret, Corinne; Letteron, Philippe; Omar, Amal Ait; Avenati, Mathilde; Viollet, Benoit; Ducroc, Robert; Bado, Andre			Positive Regulatory Control Loop between Gut Leptin and Intestinal GLUT2/GLUT5 Transporters Links to Hepatic Metabolic Functions in Rodents	PLOS ONE			English	Article							BRUSH-BORDER MEMBRANE; RAT SMALL-INTESTINE; DIET-INDUCED OBESITY; LUMINAL LEPTIN; FOOD-INTAKE; INSULIN SENSITIVITY; SIGNALING PATHWAY; SUGAR ABSORPTION; GENE-EXPRESSION; GASTRIC-MUCOSA	Background and Aims: The small intestine is the major site of absorption of dietary sugars. The rate at which they enter and exit the intestine has a major effect on blood glucose homeostasis. In this study, we determine the effects of luminal leptin on activity/expression of GLUT2 and GLUT5 transporters in response to sugars intake and analyse their physiological consequences. Methodology: Wistar rats, wild type and AMPK alpha(-/-)(2) mice were used. In vitro and in vivo isolated jejunal loops were used to quantify transport of fructose and galactose in the absence and the presence of leptin. The effects of fructose and galactose on gastric leptin release were determined. The effects of leptin given orally without or with fructose were determined on the expression of GLUT2/5, on some gluconeogenesis and lipogenic enzymes in the intestine and the liver. Principal Findings: First, in vitro luminal leptin activating its receptors coupled to PKC beta II and AMPK alpha, increased insertion of GLUT2/5 into the brush-border membrane leading to enhanced galactose and fructose transport. Second in vivo, oral fructose but not galactose induced in mice a rapid and potent release of gastric leptin in gastric juice without significant changes in plasma leptin levels. Moreover, leptin given orally at a dose reproducing comparable levels to those induced by fructose, stimulated GLUT5-fructose transport, and potentiated fructose-induced: i) increase in blood glucose and mRNA levels of key gluconeogenesis enzymes; ii) increase in blood triglycerides and reduction of mRNA levels of intestinal and hepatic Fasting-induced adipocyte factor (Fiaf) and iii) increase in SREBP-1c, ACC-1, FAS mRNA levels and dephosphorylation/activation of ACC-1 in liver. Conclusion/Significance: These data identify for the first time a positive regulatory control loop between gut leptin and fructose in which fructose triggers release of gastric leptin which, in turn, up-regulates GLUT5 and concurrently modulates metabolic functions in the liver. This loop appears to be a new mechanism (possibly pathogenic) by which fructose consumption rapidly becomes highly lipogenic and deleterious.	[Sakar, Yassine; Nazaret, Corinne; Letteron, Philippe; Omar, Amal Ait; Avenati, Mathilde; Ducroc, Robert; Bado, Andre] INSERM, U773, Ctr Rech Biomed Bichat Beaujon, UFR Med Paris Denis Diderot 7,Claude Bernard IFR0, Paris, France; [Viollet, Benoit] INSERM, U567, Paris, France; [Viollet, Benoit] Univ Paris 05, Inst Cochin, CNRS, UMR 8104, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Sakar, Y (corresponding author), INSERM, U773, Ctr Rech Biomed Bichat Beaujon, UFR Med Paris Denis Diderot 7,Claude Bernard IFR0, Paris, France.	andre.bado@inserm.fr	Viollet, Benoit/N-2397-2019; Viollet, Benoit/O-6927-2017	Viollet, Benoit/0000-0002-0121-0224; Viollet, Benoit/0000-0002-0121-0224; BADO, Andre/0000-0002-8007-1460	INSERM (Institut National de la Sante et de la Recherche Medicale); UFR of Medicine of University Paris 7 Denis Diderot	INSERM (Institut National de la Sante et de la Recherche Medicale)(Institut National de la Sante et de la Recherche Medicale (Inserm)); UFR of Medicine of University Paris 7 Denis Diderot	This work was supported by the INSERM (Institut National de la Sante et de la Recherche Medicale), the UFR of Medicine of University Paris 7 Denis Diderot, and by a grant (to YS) of Societe Francophone de Nutrition Clinique et Metabolisme (SFNEP- Antadir Federation), a grant (to RD) of Association pour l'Etude du Diabete et des Maladies Metaboliques (ALFEDIAM-Becton Dickinson), and a grant (to AB) of Institut Benjamin Delessert. The funders have no role in study design, data collection, analysis, decision to publish or to prepare the manuscript.	Au A, 2002, BIOCHEM J, V367, P247, DOI 10.1042/BJ20020393; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Bado A, 1998, NATURE, V394, P790, DOI 10.1038/29547; Barone S, 2009, J BIOL CHEM, V284, P5056, DOI 10.1074/jbc.M808128200; Begriche K, 2008, AM J PHYSIOL-ENDOC M, V294, pE939, DOI 10.1152/ajpendo.00379.2007; Bray GA, 2004, AM J CLIN NUTR, V79, P537; Buyse M, 2002, J BIOL CHEM, V277, P28182, DOI 10.1074/jbc.M203281200; Buyse M, 2001, J CLIN INVEST, V108, P1483, DOI 10.1172/JCI13219; Cammisotto PG, 2006, AM J PHYSIOL-GASTR L, V290, pG242, DOI 10.1152/ajpgi.00334.2005; Cammisotto PG, 2005, J HISTOCHEM CYTOCHEM, V53, P851, DOI 10.1369/jhc.5A6620.2005; Cha SH, 2008, P NATL ACAD SCI USA, V105, P16871, DOI 10.1073/pnas.0809255105; Cheeseman CI, 1997, AM J PHYSIOL-REG I, V273, pR1965, DOI 10.1152/ajpregu.1997.273.6.R1965; Chong MFF, 2007, AM J CLIN NUTR, V85, P1511, DOI 10.1093/ajcn/85.6.1511; Crosson SM, 2000, J BIOL CHEM, V275, P5804, DOI 10.1074/jbc.275.8.5804; Cui XL, 2005, AM J PHYSIOL-GASTR L, V288, pG1310, DOI 10.1152/ajpgi.00550.2004; Cui XL, 2004, PHYSIOL GENOMICS, V18, P206, DOI 10.1152/physiolgenomics.00056.2004; Ducroc R, 2005, DIABETES, V54, P348, DOI 10.2337/diabetes.54.2.348; ECKEL RH, 1989, NEW ENGL J MED, V320, P1060; Elliott SS, 2002, AM J CLIN NUTR, V76, P911, DOI 10.1093/ajcn/76.5.911; Ferraris RP, 2001, BIOCHEM J, V360, P265, DOI 10.1042/0264-6021:3600265; Foretz M, 1999, P NATL ACAD SCI USA, V96, P12737, DOI 10.1073/pnas.96.22.12737; Foretz M, 1999, MOL CELL BIOL, V19, P3760; Gao S, 2007, P NATL ACAD SCI USA, V104, P17358, DOI 10.1073/pnas.0708385104; Gertler A, 2006, TRENDS ENDOCRIN MET, V17, P372, DOI 10.1016/j.tem.2006.09.006; Gouyon F, 2003, BIOCHEM J, V375, P167, DOI 10.1042/BJ20030661; Guilmeau S, 2004, CURR OPIN PHARMACOL, V4, P561, DOI 10.1016/j.coph.2004.06.008; Guilmeau S, 2003, DIABETES, V52, P1664, DOI 10.2337/diabetes.52.7.1664; Hardie DG, 2008, INT J OBESITY, V32, pS7, DOI 10.1038/ijo.2008.116; Helliwell PA, 2003, J BIOL CHEM, V278, P28644, DOI 10.1074/jbc.M301479200; Hirsh AJ, 1998, J BIOL CHEM, V273, P14545, DOI 10.1074/jbc.273.23.14545; Ishikawa Y, 1997, BBA-MOL CELL RES, V1357, P306, DOI 10.1016/S0167-4889(97)00043-8; Janovska A, 2008, MOL CELL ENDOCRINOL, V284, P1, DOI 10.1016/j.mce.2007.12.013; Jorgensen SB, 2004, J BIOL CHEM, V279, P1070, DOI 10.1074/jbc.M306205200; Kellett GL, 2000, BIOCHEM J, V350, P155, DOI 10.1042/0264-6021:3500155; Kellett GL, 2005, DIABETES, V54, P3056, DOI 10.2337/diabetes.54.10.3056; Kelly AC, 2008, PRION, V2, P28, DOI 10.4161/pri.2.1.6321; Kersten S, 2000, J BIOL CHEM, V275, P28488, DOI 10.1074/jbc.M004029200; Obici S, 2003, NAT MED, V9, P756, DOI 10.1038/nm873; Plaisancie P, 2006, AM J PHYSIOL-GASTR L, V290, pG805, DOI 10.1152/ajpgi.00433.2005; Rajas F, 1999, GASTROENTEROLOGY, V117, P132, DOI 10.1016/S0016-5085(99)70559-7; Rajas F, 2000, DIABETES, V49, P1165, DOI 10.2337/diabetes.49.7.1165; Salomon G, 2006, PROTEIN EXPRES PURIF, V47, P128, DOI 10.1016/j.pep.2005.09.016; Shapiro A, 2008, AM J PHYSIOL-REG I, V295, pR1370, DOI 10.1152/ajpregu.00195.2008; Stanhope KL, 2009, J CLIN INVEST, V119, P1322, DOI 10.1172/JCI37385; Steinberg GR, 2003, AM J PHYSIOL-ENDOC M, V284, pE648, DOI 10.1152/ajpendo.00318.2002; TARTAGLIA LA, 1995, OB R CELL, V83, P1263; Teff KL, 2004, J CLIN ENDOCR METAB, V89, P2963, DOI 10.1210/jc.2003-031855; Viollet B, 2003, J CLIN INVEST, V111, P91, DOI 10.1172/JCI200316567; Wakil SJ, 2009, J LIPID RES, V50, pS138, DOI 10.1194/jlr.R800079-JLR200; Walker J, 2005, BIOCHEM J, V385, P485, DOI 10.1042/BJ20040694; White DW, 1999, J CELL BIOCHEM, V73, P278, DOI 10.1002/(SICI)1097-4644(19990501)73:2<278::AID-JCB13>3.0.CO;2-W	51	61	62	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2009	4	11							e7935	10.1371/journal.pone.0007935	http://dx.doi.org/10.1371/journal.pone.0007935			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MQ	19956534	Green Submitted, Green Published, gold			2022-12-25	WOS:000272828400002
J	Meeks, LR; Addepalli, B; Hunt, AG				Meeks, Lisa R.; Addepalli, Balasubrahmanyam; Hunt, Arthur G.			Characterization of Genes Encoding Poly(A) Polymerases in Plants: Evidence for Duplication and Functional Specialization	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; RNA; EXPRESSION; BINDING; TESTIS; TPAP; DOMAIN	Background: Poly(A) polymerase is a key enzyme in the machinery that mediates mRNA 3' end formation in eukaryotes. In plants, poly(A) polymerases are encoded by modest gene families. To better understand this multiplicity of genes, poly(A) polymerase-encoding genes from several other plants, as well as from Selaginella, Physcomitrella, and Chlamydomonas, were studied. Methodology/Principal Findings: Using bioinformatics tools, poly(A) polymerase-encoding genes were identified in the genomes of eight species in the plant lineage. Whereas Chlamydomonas reinhardtii was found to possess a single poly(A) polymerase gene, other species possessed between two and six possible poly(A) polymerase genes. With the exception of four intron-lacking genes, all of the plant poly(A) polymerase genes (but not the C. reinhardtii gene) possessed almost identical intron positions within the poly(A) polymerase coding sequences, suggesting that all plant poly(A) polymerase genes derive from a single ancestral gene. The four Arabidopsis poly(A) polymerase genes were found to be essential, based on genetic analysis of T-DNA insertion mutants. GFP fusion proteins containing three of the four Arabidopsis poly(A) polymerases localized to the nucleus, while one such fusion protein was localized in the cytoplasm. The fact that this latter protein is largely pollen-specific suggests that it has important roles in male gametogenesis. Conclusions/Significance: Our results indicate that poly(A) polymerase genes have expanded from a single ancestral gene by a series of duplication events during the evolution of higher plants, and that individual members have undergone sorts of functional specialization so as to render them essential for plant growth and development. Perhaps the most interesting of the plant poly(A) polymerases is a novel cytoplasmic poly(A) polymerase that is expressed in pollen in Arabidopsis; this is reminiscent of spermatocyte-specific cytoplasmic poly(A) polymerases in mammals.	[Meeks, Lisa R.; Addepalli, Balasubrahmanyam; Hunt, Arthur G.] Univ Kentucky, Dept Plant & Soil Sci, Lexington, KY 40506 USA	University of Kentucky	Meeks, LR (corresponding author), Univ Kentucky, Dept Plant & Soil Sci, Lexington, KY 40506 USA.	aghunt00@uky.edu	Hunt, Arthur/A-8040-2009	Hunt, Arthur/0000-0002-0008-4158; Addepalli, Balasubrahmanyam/0000-0001-6257-7700	NSF [MCB-0313472]; USDA-NRI [2002-35301-12284]	NSF(National Science Foundation (NSF)); USDA-NRI(United States Department of Agriculture (USDA))	This research was supported by NSF Grant MCB-0313472 and USDA-NRI grant 2002-35301-12284. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addepalli B, 2004, BBA-GENE STRUCT EXPR, V1679, P117, DOI 10.1016/j.bbaexp.2004.06.001; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Armougom F, 2006, NUCLEIC ACIDS RES, V34, pW604, DOI 10.1093/nar/gkl092; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Colgan DF, 1998, EMBO J, V17, P1053, DOI 10.1093/emboj/17.4.1053; Forbes KP, 2006, J BIOL CHEM, V281, P176, DOI 10.1074/jbc.M510964200; Goodin MM, 2002, PLANT J, V31, P375, DOI 10.1046/j.1365-313X.2002.01360.x; Howden R, 1998, GENETICS, V149, P621; Hunt AG, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-220; Kashiwabara S, 2002, SCIENCE, V298, P1999, DOI 10.1126/science.1074632; Kashiwabara S, 2000, DEV BIOL, V228, P106, DOI 10.1006/dbio.2000.9894; Kuhn U, 2004, BBA-GENE STRUCT EXPR, V1678, P67, DOI 10.1016/j.bbaexp.2004.03.008; Lee YJ, 2000, FEBS LETT, V487, P287, DOI 10.1016/S0014-5793(00)02367-X; Mandel CR, 2008, CELL MOL LIFE SCI, V65, P1099, DOI 10.1007/s00018-007-7474-3; Martin G, 1996, EMBO J, V15, P2593, DOI 10.1002/j.1460-2075.1996.tb00617.x; Martin G, 2007, RNA, V13, P1834, DOI 10.1261/rna.652807; RAABE T, 1994, MOL CELL BIOL, V14, P2946, DOI 10.1128/MCB.14.5.2946; SCHARDL CL, 1987, GENE, V61, P1, DOI 10.1016/0378-1119(87)90359-3; STOMP AM, 1992, GUS PROTOCOLS USING; Woody ST, 2007, J PLANT RES, V120, P157, DOI 10.1007/s10265-006-0048-x; Zhelkovsky A, 1998, MOL CELL BIOL, V18, P5942, DOI 10.1128/MCB.18.10.5942; Zhuang TG, 2004, J REPROD DEVELOP, V50, P207, DOI 10.1262/jrd.50.207	23	18	31	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2009	4	11							e8082	10.1371/journal.pone.0008082	http://dx.doi.org/10.1371/journal.pone.0008082			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MN	19956626	Green Published, Green Submitted, gold			2022-12-25	WOS:000272828100019
J	Koushik, SV; Blank, PS; Vogel, SS				Koushik, Srinagesh V.; Blank, Paul S.; Vogel, Steven S.			Anomalous Surplus Energy Transfer Observed with Multiple FRET Acceptors	PLOS ONE			English	Article							INTRINSICALLY FLUORESCENT PROTEINS; LIVING CELLS; SPECTROSCOPIC RULER; CRYSTAL-STRUCTURE; LIVE CELLS; ACTIVATION; MATURATION; MICROSCOPY; EFFICIENCY; DYNAMICS	Background: Forster resonance energy transfer (FRET) is a mechanism where energy is transferred from an excited donor fluorophore to adjacent chromophores via non-radiative dipole-dipole interactions. FRET theory primarily considers the interactions of a single donor-acceptor pair. Unfortunately, it is rarely known if only a single acceptor is present in a molecular complex. Thus, the use of FRET as a tool for measuring protein-protein interactions inside living cells requires an understanding of how FRET changes with multiple acceptors. When multiple FRET acceptors are present it is assumed that a quantum of energy is either released from the donor, or transferred in toto to only one of the acceptors present. The rate of energy transfer between the donor and a specific acceptor (k(D -> A)) can be measured in the absence of other acceptors, and these individual FRET transfer rates can be used to predict the ensemble FRET efficiency using a simple kinetic model where the sum of all FRET transfer rates is divided by the sum of all radiative and non-radiative transfer rates. Methodology/Principal Findings: The generality of this approach was tested by measuring the ensemble FRET efficiency in two constructs, each containing a single fluorescent-protein donor (Cerulean) and either two or three FRET acceptors (Venus). FRET transfer rates between individual donor-acceptor pairs within these constructs were calculated from FRET efficiencies measured after systematically introducing point mutations to eliminate all other acceptors. We find that the amount of energy transfer observed in constructs having multiple acceptors is significantly greater than the FRET efficiency predicted from the sum of the individual donor to acceptor transfer rates. Conclusions/Significance: We conclude that either an additional energy transfer pathway exists when multiple acceptors are present, or that a theoretical assumption on which the kinetic model prediction is based is incorrect.	[Koushik, Srinagesh V.; Vogel, Steven S.] NIAAA, NIH, Rockville, MD 20852 USA; [Blank, Paul S.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Vogel, SS (corresponding author), NIAAA, NIH, Rockville, MD 20852 USA.	stevevog@mail.nih.gov	Vogel, Steven/A-3585-2012; Blank, Paul/Q-9673-2019	Vogel, Steven/0000-0002-3005-2667	NIH; NIAAA; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000452] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This research was supported by the intramural research program of the NIH, NIAAA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews DL, 1999, RESONANCE ENERGY TRA; Becker W, 2005, ADV TIME CORRELATED; Bevington PR., 2002, DATA REDUCTION ERROR; CANTOR CR, 1980, BIOPHYSICAL CHEM 2, P846; Chen H, 2006, BIOPHYS J, V91, pL39, DOI 10.1529/biophysj.106.088773; Clegg R. M, 1996, FLUORESCENCE IMAGING, V137, P179; Clegg RM, 2009, LAB TECH BIOCHEM MOL, V33, P1, DOI 10.1016/S0075-7535(08)00001-6; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; Gadella TWJ, 2009, LAB TECH BIOCHEM MOL, V33, P395, DOI 10.1016/S0075-7535(08)00009-0; Garcia-Parajo MF, 2001, P NATL ACAD SCI USA, V98, P14392, DOI 10.1073/pnas.251525598; Gilmore J, 2008, J PHYS CHEM A, V112, P2162, DOI 10.1021/jp710243t; Heikal AA, 2000, P NATL ACAD SCI USA, V97, P11996, DOI 10.1073/pnas.97.22.11996; Hess ST, 2003, BIOPHYS J, V85, P2566, DOI 10.1016/S0006-3495(03)74679-7; Hettich C, 2002, SCIENCE, V298, P385, DOI 10.1126/science.1075606; Jares-Erijman EA, 2006, CURR OPIN CHEM BIOL, V10, P409, DOI 10.1016/j.cbpa.2006.08.021; Koushik SV, 2006, BIOPHYS J, V91, pL99, DOI 10.1529/biophysj.106.096206; Koushik SV, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2940367; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Lounis B, 2001, J PHYS CHEM B, V105, P5048, DOI 10.1021/jp010116x; Malo GD, 2007, BIOCHEMISTRY-US, V46, P9865, DOI 10.1021/bi602664c; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; Periasamy A., 2005, MOL IMAGING FRET MIC; Rekas A, 2002, J BIOL CHEM, V277, P50573, DOI 10.1074/jbc.M209524200; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Sarkar P, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3156842; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; STEINBERG IZ, 1971, ANNU REV BIOCHEM, V40, P83, DOI 10.1146/annurev.bi.40.070171.000503; STRYER L, 1967, P NATL ACAD SCI USA, V58, P719, DOI 10.1073/pnas.58.2.719; STRYER L, 1978, ANNU REV BIOCHEM, V47, P819, DOI 10.1146/annurev.bi.47.070178.004131; Thaler C, 2005, BIOPHYS J, V89, P2736, DOI 10.1529/biophysj.105.061853; Thaler C, 2009, P NATL ACAD SCI USA, V106, P6369, DOI 10.1073/pnas.0901913106; Valeur B, 2002, MOL FLUORESCENCE; Visser NV, 2002, FEBS LETT, V521, P31, DOI 10.1016/S0014-5793(02)02808-9; VOGEL SS, 2006, SCI STKE, pRE2, DOI DOI 10.1126/STKE.3312006RE2; Vogel SS, 2009, FLIM MICROSCOPY BIOL, P245; Vogel SS, 2009, LAB TECH BIOCHEM MOL, V33, P351, DOI 10.1016/S0075-7535(08)00008-9; WU PG, 1994, ANAL BIOCHEM, V218, P1, DOI 10.1006/abio.1994.1134; Yasuda R, 2006, NAT NEUROSCI, V9, P283, DOI 10.1038/nn1635; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zal T, 2004, BIOPHYS J, V86, P3923, DOI 10.1529/biophysj.103.022087	43	59	59	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2009	4	11							e8031	10.1371/journal.pone.0008031	http://dx.doi.org/10.1371/journal.pone.0008031			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MK	19946626	Green Published, gold, Green Submitted			2022-12-25	WOS:000272827800019
J	Wu, CJ; Cai, TX; Rikova, K; Merberg, D; Kasif, S; Steffen, M				Wu, Chang-Jiun; Cai, Tianxi; Rikova, Klarisa; Merberg, David; Kasif, Simon; Steffen, Martin			A Predictive Phosphorylation Signature of Lung Cancer	PLOS ONE			English	Article							PROTEIN-PHOSPHORYLATION; TYROSINE PHOSPHORYLATION; MASS-SPECTROMETRY; KINASES; CLASSIFICATION; INHIBITION; VALIDATION; CARCINOMAS; REGRESSION; PROTEOMICS	Background: Aberrant activation of signaling pathways drives many of the fundamental biological processes that accompany tumor initiation and progression. Inappropriate phosphorylation of intermediates in these signaling pathways are a frequently observed molecular lesion that accompanies the undesirable activation or repression of pro- and antioncogenic pathways. Therefore, methods which directly query signaling pathway activation via phosphorylation assays in individual cancer biopsies are expected to provide important insights into the molecular "logic'' that distinguishes cancer and normal tissue on one hand, and enables personalized intervention strategies on the other. Results: We first document the largest available set of tyrosine phosphorylation sites that are, individually, differentially phosphorylated in lung cancer, thus providing an immediate set of drug targets. Next, we develop a novel computational methodology to identify pathways whose phosphorylation activity is strongly correlated with the lung cancer phenotype. Finally, we demonstrate the feasibility of classifying lung cancers based on multi-variate phosphorylation signatures. Conclusions: Highly predictive and biologically transparent phosphorylation signatures of lung cancer provide evidence for the existence of a robust set of phosphorylation mechanisms (captured by the signatures) present in the majority of lung cancers, and that reliably distinguish each lung cancer from normal. This approach should improve our understanding of cancer and help guide its treatment, since the phosphorylation signatures highlight proteins and pathways whose phosphorylation should be inhibited in order to prevent unregulated proliferation.	[Wu, Chang-Jiun; Kasif, Simon; Steffen, Martin] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Cai, Tianxi] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Rikova, Klarisa] Cell Signaling Technol, Danvers, MA USA; [Merberg, David] Vertex Pharmaceut, Cambridge, MA USA; [Kasif, Simon] Harvard Mit Div Hlth Sci & Technol, Childrens Hosp Informat Program, Boston, MA USA; [Kasif, Simon] Boston Univ, Ctr Adv Genom Technol, Boston, MA 02215 USA; [Steffen, Martin] Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02215 USA	Boston University; Harvard University; Harvard T.H. Chan School of Public Health; Vertex Pharmaceuticals; Harvard University; Boston Children's Hospital; Boston University; Boston University	Steffen, M (corresponding author), Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.	steffen@bu.edu		Steffen, Martin/0000-0002-7853-7364	National Human Genome Research Institute [R01 HG003367-01A1]; American Lung Association [RG-52430-N]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003367] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); American Lung Association; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported in part by a grant from the National Human Genome Research Institute (R01 HG003367-01A1 to S. K.), and the American Lung Association (RG-52430-N to M. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albeck JG, 2006, NAT REV MOL CELL BIO, V7, P803, DOI 10.1038/nrm2042; Baselga J, 2006, SCIENCE, V312, P1175, DOI 10.1126/science.1125951; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Efron B, 1997, J AM STAT ASSOC, V92, P548, DOI 10.2307/2965703; Ficarro SB, 2002, NAT BIOTECHNOL, V20, P301, DOI 10.1038/nbt0302-301; Goeman JJ, 2008, STAT APPL GENET MOL, V7; Hashibe M, 2008, NAT GENET, V40, P707, DOI 10.1038/ng.151; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; HONEGGER A, 1988, EMBO J, V7, P3045, DOI 10.1002/j.1460-2075.1988.tb03169.x; Huang SM, 1999, CANCER RES, V59, P1935; Jiang WY, 2007, STAT MED, V26, P5320, DOI 10.1002/sim.2968; Jones RB, 2006, NATURE, V439, P168, DOI 10.1038/nature04177; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; KOPANTZEV EP, 2008, LUNG CANC; KREBS EG, 1993, BIOSCIENCE REP, V13, P127, DOI 10.1007/BF01149958; Kumar N, 2007, PLOS COMPUT BIOL, V3, P35, DOI 10.1371/journal.pcbi.0030004; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; MANNING BD, 2002, SCI STKE, pPE49; McCawley LJ, 1997, ENDOCRINOLOGY, V138, P121, DOI 10.1210/en.138.1.121; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; Miller ML, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1159433; Mishra GR, 2006, NUCLEIC ACIDS RES, V34, pD411, DOI 10.1093/nar/gkj141; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pawson T, 2005, TRENDS BIOCHEM SCI, V30, P286, DOI 10.1016/j.tibs.2005.04.013; Petrelli A, 2008, CURR MED CHEM, V15, P422; Peus D, 1997, J INVEST DERMATOL, V109, P751, DOI 10.1111/1523-1747.ep12340759; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Sawyers CL, 2007, NATURE, V449, P993, DOI 10.1038/449993a; Sebolt-Leopold JS, 2006, NATURE, V441, P457, DOI 10.1038/nature04874; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Stang A, 2006, LUNG CANCER, V52, P29, DOI 10.1016/j.lungcan.2005.11.012; STEHELIN D, 1976, NATURE, V260, P170, DOI 10.1038/260170a0; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Stommel JM, 2007, SCIENCE, V318, P287, DOI 10.1126/science.1142946; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Triano EA, 2003, CANCER RES, V63, P3092; Zhang Y, 2005, MOL CELL PROTEOMICS, V4, P1240, DOI 10.1074/mcp.M500089-MCP200; Zheng Z, 2007, NEW ENGL J MED, V356, P800, DOI 10.1056/NEJMoa065411; Zhou HL, 2001, NAT BIOTECHNOL, V19, P375, DOI 10.1038/86777	45	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2009	4	11							e7994	10.1371/journal.pone.0007994	http://dx.doi.org/10.1371/journal.pone.0007994			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MK	19946374	Green Submitted, Green Published, gold			2022-12-25	WOS:000272827800009
J	Santagata, S; Maire, CL; Idbaih, A; Geffers, L; Correll, M; Holton, K; Quackenbush, J; Ligon, KL				Santagata, Sandro; Maire, Cecile L.; Idbaih, Ahmed; Geffers, Lars; Correll, Mick; Holton, Kristina; Quackenbush, John; Ligon, Keith L.			CRX Is a Diagnostic Marker of Retinal and Pineal Lineage Tumors	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; LEBER CONGENITAL AMAUROSIS; GENE-EXPRESSION PATTERNS; TRANSCRIPTION FACTOR CRX; CONE-ROD DYSTROPHY; GERM-CELL TUMORS; S-ANTIGEN; TRILATERAL RETINOBLASTOMA; PARENCHYMAL TUMORS; HOMEOBOX GENE	Background: CRX is a homeobox transcription factor whose expression and function is critical to maintain retinal and pineal lineage cells and their progenitors. To determine the biologic and diagnostic potential of CRX in human tumors of the retina and pineal, we examined its expression in multiple settings. Methodology/Principal Findings: Using situ hybridization and immunohistochemistry we show that Crx RNA and protein expression are exquisitely lineage restricted to retinal and pineal cells during normal mouse and human development. Gene expression profiling analysis of a wide range of human cancers and cancer cell lines also supports that CRX RNA is highly lineage restricted in cancer. Immunohistochemical analysis of 22 retinoblastomas and 13 pineal parenchymal tumors demonstrated strong expression of CRX in over 95% of these tumors. Importantly, CRX was not detected in the majority of tumors considered in the differential diagnosis of pineal region tumors (n = 78). The notable exception was medulloblastoma, 40% of which exhibited CRX expression in a heterogeneous pattern readily distinguished from that seen in retino-pineal tumors. Conclusions/Significance: These findings describe new potential roles for CRX in human cancers and highlight the general utility of lineage restricted transcription factors in cancer biology. They also identify CRX as a sensitive and specific clinical marker and a potential lineage dependent therapeutic target in retinoblastoma and pineoblastoma.			Santagata, S (corresponding author), Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA.	keith_ligon@dfci.harvard.edu	; Idbaih, Ahmed/N-8746-2017	Ligon, Keith/0000-0002-7733-600X; Geffers, Lars/0000-0001-6800-4305; Idbaih, Ahmed/0000-0001-5290-1204; Quackenbush, John/0000-0002-2702-5879; Santagata, Sandro/0000-0002-7528-9668	NINDS NIH HHS [NS047213, K08 NS064168, K08 NS047213, NS064168] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS047213, K08NS064168] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Amoaku WMK, 1996, CANCER, V78, P858, DOI 10.1002/(SICI)1097-0142(19960815)78:4<858::AID-CNCR24>3.0.CO;2-T; Bibb LC, 2001, HUM MOL GENET, V10, P1571, DOI 10.1093/hmg/10.15.1571; Chen SM, 1997, NEURON, V19, P1017, DOI 10.1016/S0896-6273(00)80394-3; CZERWIONKA M, 1989, ACTA NEUROPATHOL, V78, P629, DOI 10.1007/BF00691290; De Girolami U, 2008, REV NEUROL-FRANCE, V164, P882, DOI 10.1016/j.neurol.2008.01.008; de Jong J, 2008, J PATHOL, V215, P21, DOI 10.1002/path.2332; DEPOTTER P, 1994, J PEDIATR OPHTHALMOL, V31, P26; Eberhart CG, 2004, J NEUROPATH EXP NEUR, V63, P441, DOI 10.1093/jnen/63.5.441; Fevre-Montange M, 2006, J NEUROPATH EXP NEUR, V65, P675, DOI 10.1097/01.jnen.0000225907.90052.e3; Folpe AL, 2002, ADV ANAT PATHOL, V9, P198, DOI 10.1097/00125480-200205000-00003; Freund CL, 1997, CELL, V91, P543, DOI 10.1016/S0092-8674(00)80440-7; Furukawa T, 1999, NAT GENET, V23, P466, DOI 10.1038/70591; Gamse JT, 2002, NAT GENET, V30, P117, DOI 10.1038/ng793; Garraway LA, 2006, CANCER RES, V66, P2506, DOI 10.1158/0008-5472.CAN-05-4604; Gilbertson RJ, 2008, ANNU REV PATHOL-MECH, V3, P341, DOI 10.1146/annurev.pathmechdis.3.121806.151518; Gilheeney SW, 2008, J NEURO-ONCOL, V89, P89, DOI 10.1007/s11060-008-9589-2; Glasker S, 2006, CANCER RES, V66, P4167, DOI 10.1158/0008-5472.CAN-05-3505; GONZALEZFERNANDEZ F, 1992, AM J PATHOL, V141, P363; Gulino A, 2008, CURR OPIN ONCOL, V20, P668, DOI 10.1097/CCO.0b013e32831369f4; HASSOUN J, 1983, ACTA NEUROPATHOL, V62, P31, DOI 10.1007/BF00684917; Hattab EM, 2005, AM J SURG PATHOL, V29, P368, DOI 10.1097/01.pas.0000149709.19958.a7; HERRICK MK, 1979, BRAIN, V102, P289, DOI 10.1093/brain/102.2.289; Hirato J, 2001, J NEURO-ONCOL, V54, P239, DOI 10.1023/A:1012721723387; Hsiau THC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000643; Huang J, 2006, BMC IMMUNOL, V7, DOI 10.1186/1471-2172-7-7; IRONSIDE JW, 2001, DIAGNOSTIC PATHOLOGY, P253; Jacobson SG, 1998, INVEST OPHTH VIS SCI, V39, P2417; JAFFEY PB, 1995, J NEUROPATH EXP NEUR, V54, P664, DOI 10.1097/00005072-199509000-00008; Jouvet A, 2000, BRAIN PATHOL, V10, P49; JOUVET A, 1994, ACTA NEUROPATHOL, V88, P334; Kivela T, 1999, J CLIN ONCOL, V17, P1829, DOI 10.1200/JCO.1999.17.6.1829; Kool M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003088; KORF HW, 1986, ACTA NEUROPATHOL, V69, P165, DOI 10.1007/BF00687054; Li MK, 2004, ADV ANAT PATHOL, V11, P101, DOI 10.1097/00125480-200403000-00004; Li XD, 1998, P NATL ACAD SCI USA, V95, P1876, DOI 10.1073/pnas.95.4.1876; Ligon KL, 2007, NEURON, V53, P503, DOI 10.1016/j.neuron.2007.01.009; Ligon KL, 2004, J NEUROPATH EXP NEUR, V63, P499, DOI 10.1093/jnen/63.5.499; LIVINGSTONE CD, 1993, COMPUT APPL BIOSCI, V9, P745; LOPES MBS, 1993, J NEUROPATH EXP NEUR, V52, P516; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; MARAZIOTIS T, 1992, ACTA NEUROPATHOL, V84, P355; MENA H, 1995, HUM PATHOL, V26, P20, DOI 10.1016/0046-8177(95)90110-8; MIN KW, 1987, LAB INVEST, V57, P724; Ngan KW, 2008, J CLIN NEUROSCI, V15, P149, DOI 10.1016/j.jocn.2006.08.013; NIELSEN SL, 1975, J NEUROPATH EXP NEUR, V34, P148, DOI 10.1097/00005072-197503000-00003; Nishida A, 2003, NAT NEUROSCI, V6, P1255, DOI 10.1038/nn1155; Parwani AV, 2005, CANCER CYTOPATHOL, V105, P80, DOI 10.1002/cncr.20849; PERENTES E, 1986, ACTA NEUROPATHOL, V71, P224, DOI 10.1007/BF00688043; Ponzoni M, 2007, ADV ANAT PATHOL, V14, P25, DOI 10.1097/PAP.0b013e31802f0495; Rath MF, 2007, EXP EYE RES, V85, P65, DOI 10.1016/j.exer.2007.02.016; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Romeo S, 2006, J PATHOL, V209, P143, DOI 10.1002/path.1987; Santagata S, 2007, AM J SURG PATHOL, V31, P836, DOI 10.1097/PAS.0b013e31802e708a; Santagata S, 2006, AM J SURG PATHOL, V30, P1613, DOI 10.1097/01.pas.0000213320.04919.1a; Sawai J, 2003, NEUROPATHOLOGY, V23, P119, DOI 10.1046/j.1440-1789.2003.00488.x; Schegloff EA, 1999, THEOR CULT SOC, V16, P1; Scheithauer BW, 2008, BRAIN PATHOL, V18, P307, DOI 10.1111/j.1750-3639.2008.00179.x; Shyamsundar R, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r22; Sohocki MM, 2000, NAT GENET, V24, P79, DOI 10.1038/71732; Swain PK, 1997, NEURON, V19, P1329, DOI 10.1016/S0896-6273(00)80423-7; Swaroop A, 1999, HUM MOL GENET, V8, P299, DOI 10.1093/hmg/8.2.299; VANVEEN T, 1986, P NATL ACAD SCI USA, V83, P912; Visel A, 2004, NUCLEIC ACIDS RES, V32, pD552, DOI 10.1093/nar/gkh029; Vogel Hannes, 2003, Ann Diagn Pathol, V7, P387, DOI 10.1016/j.anndiagpath.2003.09.007; Yanai I, 2005, BIOINFORMATICS, V21, P650, DOI 10.1093/bioinformatics/bti042; Yaylaoglu MB, 2005, DEV DYNAM, V234, P371, DOI 10.1002/dvdy.20441	67	33	34	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2009	4	11							e7932	10.1371/journal.pone.0007932	http://dx.doi.org/10.1371/journal.pone.0007932			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522NL	19936203	Green Published, gold, Green Submitted			2022-12-25	WOS:000272004800013
J	Au, C; Benedetto, A; Anderson, J; Labrousse, A; Erikson, K; Ewbank, JJ; Aschner, M				Au, Catherine; Benedetto, Alexandre; Anderson, Joel; Labrousse, Arnaud; Erikson, Keith; Ewbank, Jonathan J.; Aschner, Michael			SMF-1, SMF-2 and SMF-3 DMT1 Orthologues Regulate and Are Regulated Differentially by Manganese Levels in C. elegans	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; BLOOD-BRAIN-BARRIER; MICROCYTIC ANEMIA; METAL TRANSPORTER; IRON TRANSPORT; APICAL SECRETION; PROTEIN; NRAMP2; MEMBRANE; FAMILY	Manganese (Mn) is an essential metal that can exert toxic effects at high concentrations, eventually leading to Parkinsonism. A major transporter of Mn in mammals is the divalent-metal transporter (DMT1). We characterize here DMT1-like proteins in the nematode C. elegans, which regulate and are regulated by Mn and iron (Fe) content. We identified three new DMT1-like genes in C. elegans: smf-1, smf-2 and smf-3. All three can functionally substitute for loss of their yeast orthologues in S. cerevisiae. In the worm, deletion of smf-1 or smf-3 led to an increased Mn tolerance, while loss of smf-2 led to increased Mn sensitivity. smf mRNA levels measured by QRT-PCR were up-regulated upon low Mn and down-regulated upon high Mn exposures. Translational GFP-fusions revealed that SMF-1 and SMF-3 strongly localize to partially overlapping apical regions of the gut epithelium, suggesting a differential role for SMF-1 and SMF-3 in Mn nutritional intake. Conversely, SMF-2 was detected in the marginal pharyngeal epithelium, possibly involved in metal-sensing. Analysis of metal content upon Mn exposure in smf mutants revealed that SMF-3 is required for normal Mn uptake, while smf-1 was dispensable. Higher smf-2 mRNA levels correlated with higher Fe content, supporting a role for SMF-2 in Fe uptake. In smf-1 and smf-3 but not in smf-2 mutants, increased Mn exposure led to decreased Fe levels, suggesting that both metals compete for transport by SMF-2. Finally, SMF-3 was post-translationally and reversibly down-regulated following Mn-exposure. In sum, we unraveled a complex interplay of transcriptional and post-translational regulations of 3 DMT1-like transporters in two adjacent tissues, which regulate metal-content in C. elegans.			Au, C (corresponding author), Vanderbilt Univ, Dept Pediat, Nashville, TN 37203 USA.	michael.aschner@vanderbilt.edu	Ewbank, Jonathan J/G-4948-2010; Benedetto, Alexandre/W-5930-2019; Benedetto, Alexandre/A-5766-2014	Ewbank, Jonathan J/0000-0002-1257-6862; Benedetto, Alexandre/0000-0002-4593-2114; Benedetto, Alexandre/0000-0002-4593-2114; Anderson, Joel/0000-0002-6216-4014; Au, Catherine/0000-0002-1923-9121; Labrousse, Arnaud/0000-0002-6525-6627	NIEHS NIH HHS [R01 ES010563, R01 ES10563] Funding Source: Medline; NINDS NIH HHS [R15 NS] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010563] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Addess KJ, 1997, J MOL BIOL, V274, P72, DOI 10.1006/jmbi.1997.1377; ALBERTSON DG, 1976, PHILOS T ROY SOC B, V275, P299, DOI 10.1098/rstb.1976.0085; Andrews NC, 1999, INT J BIOCHEM CELL B, V31, P991, DOI 10.1016/S1357-2725(99)00065-5; ASCHNER M, 1994, BRAIN RES BULL, V33, P345, DOI 10.1016/0361-9230(94)90204-6; Aschner M, 2002, NEUROTOXICOLOGY, V23, P123, DOI 10.1016/S0161-813X(01)00097-3; ASCHNER M, 1992, J NEUROCHEM, V58, P730, DOI 10.1111/j.1471-4159.1992.tb09778.x; Aschner M, 2000, ENVIRON HEALTH PERSP, V108, P429, DOI 10.2307/3454532; ASCHNER M, 1991, NEUROSCI BIOBEHAV R, V15, P333, DOI 10.1016/S0149-7634(05)80026-0; Au C, 2008, NEUROTOXICOLOGY, V29, P569, DOI 10.1016/j.neuro.2008.04.022; BANSAL SK, 1985, ECOTOX ENVIRON SAFE, V9, P373, DOI 10.1016/0147-6513(85)90055-7; Beaumont C, 2006, BLOOD, V107, P4168, DOI 10.1182/blood-2005-10-4269; BRENNER S, 1974, GENETICS, V77, P71; Brown RC, 2005, ENVIRON HEALTH PERSP, V113, P1250, DOI 10.1289/ehp.7567; Burdo JR, 2001, J NEUROSCI RES, V66, P1198, DOI 10.1002/jnr.1256.abs; CALNE DB, 1994, NEUROLOGY, V44, P1583, DOI 10.1212/WNL.44.9.1583; Canonne-Hergaux F, 1999, P ASSOC AM PHYSICIAN, V111, P283, DOI 10.1046/j.1525-1381.1999.99236.x; Canonne-Hergaux F, 1999, BLOOD, V93, P4406, DOI 10.1182/blood.V93.12.4406.412k21_4406_4417; Canonne-Hergaux FS, 2002, KIDNEY INT, V62, P147, DOI 10.1046/j.1523-1755.2002.00405.x; CELLIER M, 1995, P NATL ACAD SCI USA, V92, P10089, DOI 10.1073/pnas.92.22.10089; Cersosimo MG, 2006, NEUROTOXICOLOGY, V27, P340, DOI 10.1016/j.neuro.2005.10.006; Cohen A, 2000, J BIOL CHEM, V275, P33388, DOI 10.1074/jbc.M004611200; Courville P, 2006, BIOCHEM CELL BIOL, V84, P960, DOI 10.1139/O06-193; Dorman DC, 2004, INHAL TOXICOL, V16, P481, DOI 10.1080/08958370490439687; Dorsey ER, 2007, NEUROLOGY, V68, P384, DOI 10.1212/01.wnl.0000247740.47667.03; Eguez L, 2004, GENETICS, V167, P107, DOI 10.1534/genetics.167.1.107; Eide DJ, 1998, ANNU REV NUTR, V18, P441, DOI 10.1146/annurev.nutr.18.1.441; Fitsanakis VA, 2005, TOXICOL APPL PHARM, V204, P343, DOI 10.1016/j.taap.2004.11.013; Fleming MD, 1998, J LAB CLIN MED, V132, P464, DOI 10.1016/S0022-2143(98)90123-8; Forbes JR, 2003, BLOOD, V102, P1884, DOI 10.1182/blood-2003-02-0425; Garrick MD, 2006, BIOL RES, V39, P79, DOI 10.4067/S0716-97602006000100009; Garrick MD, 2003, BIOMETALS, V16, P41, DOI 10.1023/A:1020702213099; Gruenheid S, 1999, J EXP MED, V189, P831, DOI 10.1084/jem.189.5.831; GRUENHEID S, 1995, GENOMICS, V25, P514, DOI 10.1016/0888-7543(95)80053-O; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Guven K, 1998, TOXICOL LETT, V99, P91, DOI 10.1016/S0378-4274(98)00128-3; Hoogewijs D, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-9; Huang WH, 2004, J TOXICOL-CLIN TOXIC, V42, P305, DOI 10.1081/CLT-120037433; Iolascon A, 2006, BLOOD, V107, P349, DOI 10.1182/blood-2005-06-2477; Jensen LT, 2003, J BIOL CHEM, V278, P42036, DOI 10.1074/jbc.M307413200; Kannurpatti SS, 2000, NEUROCHEM RES, V25, P1527, DOI 10.1023/A:1026602100160; Knopfel M, 2005, BIOCHEMISTRY-US, V44, P3454, DOI 10.1021/bi048768; Lam-Yuk-Tseung S, 2005, BLOOD CELL MOL DIS, V35, P212, DOI 10.1016/j.bcmd.2005.05.008; Lam-Yuk-Tseung S, 2006, BLOOD CELL MOL DIS, V36, P347, DOI 10.1016/j.bcmd.2006.01.011; Lee PL, 1998, BLOOD CELL MOL DIS, V24, P199, DOI 10.1006/bcmd.1998.0186; Liao SL, 2001, NEUROREPORT, V12, P3877, DOI 10.1097/00001756-200112210-00004; Liegeois S, 2007, GENETICS, V175, P709, DOI 10.1534/genetics.106.066035; Liegeois S, 2006, J CELL BIOL, V173, P949, DOI 10.1083/jcb.200511072; Lin YT, 2006, FREE RADICAL BIO MED, V40, P1185, DOI 10.1016/j.freeradbiomed.2005.11.007; Liu XF, 1999, J BIOL CHEM, V274, P4863, DOI 10.1074/jbc.274.8.4863; Luk EEC, 2001, J BIOL CHEM, V276, P47556, DOI 10.1074/jbc.M108923200; Mackenzie B, 2005, AM J PHYSIOL-GASTR L, V289, pG981, DOI 10.1152/ajpgi.00363.2005; Mackenzie B, 2007, BIOCHEM J, V403, P59, DOI 10.1042/BJ20061290; Malecki EA, 1999, J NEUROSCI RES, V56, P113; Mango Susan E, 2007, WormBook, P1; Mayeux R, 2003, ANNU REV NEUROSCI, V26, P81, DOI 10.1146/annurev.neuro.26.043002.094919; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Mims MP, 2005, HEMATOLOGY, V10, P339, DOI 10.1080/10245330500093419; Mulero V, 2002, BIOCHEM J, V363, P89, DOI 10.1042/0264-6021:3630089; MURPHY VA, 1991, J NEUROCHEM, V57, P948, DOI 10.1111/j.1471-4159.1991.tb08242.x; NELSON FK, 1984, J EXP ZOOL, V231, P45, DOI 10.1002/jez.1402310107; Nelson N, 1999, PHYSIOL REV, V79, P361, DOI 10.1152/physrev.1999.79.2.361; Olanow CW, 2004, ANN NY ACAD SCI, V1012, P209, DOI 10.1196/annals.1306.018; Pfeifer GD, 2004, SCI TOTAL ENVIRON, V334, P397, DOI 10.1016/j.scitotenv.2004.04.043; Piccinelli P, 2007, RNA, V13, P952, DOI 10.1261/rna.464807; Pinner E, 1997, J BIOL CHEM, V272, P28933, DOI 10.1074/jbc.272.46.28933; Ponnapakkam T, 2003, INT J TOXICOL, V22, P227, DOI 10.1080/10915810305103; Portnoy ME, 2000, MOL CELL BIOL, V20, P7893, DOI 10.1128/MCB.20.21.7893-7902.2000; Portnoy ME, 2002, BIOCHEM J, V362, P119, DOI 10.1042/bj3620119; Post JE, 1999, P NATL ACAD SCI USA, V96, P3447, DOI 10.1073/pnas.96.7.3447; Priwitzerova M, 2005, BLOOD, V106, P3985, DOI 10.1182/blood-2005-04-1550; PROHASKA JR, 1987, PHYSIOL REV, V67, P858, DOI 10.1152/physrev.1987.67.3.858; RABIN O, 1993, J NEUROCHEM, V61, P509; Ressler T, 1999, J SYNCHROTRON RADIAT, V6, P656, DOI 10.1107/S0909049598015623; Rollin H, 2005, ENVIRON RES, V97, P93, DOI 10.1016/j.envres.2004.05.003; Roth JA, 2002, J NEUROSCI RES, V68, P76, DOI 10.1002/jnr.10207; Salazar J, 2008, P NATL ACAD SCI USA, V105, P18578, DOI 10.1073/pnas.0804373105; SARIC M, 1986, AM J IND MED, V9, P217, DOI 10.1002/ajim.4700090303; Searle S, 1998, J CELL SCI, V111, P2855; STEINBERG SF, 1986, J PHARMACOL EXP THER, V237, P764; Su MA, 1998, BLOOD, V92, P2157, DOI 10.1182/blood.V92.6.2157.418k16_2157_2163; Supek F, 1996, P NATL ACAD SCI USA, V93, P5105, DOI 10.1073/pnas.93.10.5105; Tabuchi M, 2000, J BIOL CHEM, V275, P22220, DOI 10.1074/jbc.M001478200; Takeda A, 2003, BRAIN RES, V965, P279, DOI 10.1016/S0006-8993(02)04157-4; Techau ME, 2007, J BIOL CHEM, V282, P35646, DOI 10.1074/jbc.M707057200; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thompson K, 2006, TOXICOL APPL PHARM, V210, P17, DOI 10.1016/j.taap.2005.05.014; Thompson K, 2007, FASEB J, V21, P223, DOI 10.1096/fj.06-6710com; Touret N, 2003, J BIOL CHEM, V278, P25548, DOI 10.1074/jbc.M212374200; VIDAL S, 1995, MAMM GENOME, V6, P224, DOI 10.1007/BF00352405; WEDLER FC, 1984, CURR TOP CELL REGUL, V24, P153; ZHANG SZ, 2008, NEUROBIOL AGING	92	65	74	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2009	4	11							e7792	10.1371/journal.pone.0007792	http://dx.doi.org/10.1371/journal.pone.0007792			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521QH	19924247	Green Published, Green Submitted, gold			2022-12-25	WOS:000271936700003
J	Bai, B; Song, WG; Ji, YW; Liu, X; Tian, L; Wang, C; Chen, DW; Zhang, XN; Zhang, MH				Bai, Bo; Song, Wengang; Ji, Yewei; Liu, Xi; Tian, Lei; Wang, Chao; Chen, Dongwei; Zhang, Xiaoning; Zhang, Minghui			Microglia and Microglia-Like Cell Differentiated from DC Inhibit CD4 T Cell Proliferation	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; REGULATORY DENDRITIC CELLS; ANTIGEN-PRESENTING CELLS; SPLEEN MACROPHAGES DIFFERENTIATE; MULTIPLE-SCLEROSIS; BLOOD MONOCYTES; ASTROCYTES; BRAIN; CNS; MICROENVIRONMENT	The central nervous system (CNS) is generally regarded as a site of immune privilege, whether the antigen presenting cells (APCs) are involved in the immune homeostasis of the CNS is largely unknown. Microglia and DCs are major APCs in physiological and pathological conditions, respectively. In this work, primary microglia and microglia-like cells obtained by co-culturing mature dendritic cells with CNS endothelial cells in vitro were functional evaluated. We found that microglia not only cannot prime CD4 T cells but also inhibit mature DCs (maDCs) initiated CD4 T cells proliferation. More importantly, endothelia from the CNS can differentiate maDCs into microglia-like cells (MLCs), which possess similar phenotype and immune inhibitory function as microglia. Soluble factors including NO lie behind the suppression of CD4 T cell proliferation induced by both microglia and MLCs. All the data indicate that under physiological conditions, microglia play important roles in maintaining immune homeostasis of the CNS, whereas in a pathological situation, the infiltrated DCs can be educated by the local microenvironment and differentiate into MLCs with inhibitory function.			Bai, B (corresponding author), Taishan Med Coll, Dept Neurobiol, Tai An, Shandong, Peoples R China.	drugman@tsinghua.edu.cn; mh-zhang@tsinghua.edu.cn	Ji, Yewei/F-5040-2014	Ji, Yewei/0000-0002-4249-6812				Aloisi F, 2000, IMMUNOL TODAY, V21, P141, DOI 10.1016/S0167-5699(99)01512-1; Bailey SL, 2006, CRIT REV IMMUNOL, V26, P149, DOI 10.1615/CritRevImmunol.v26.i2.40; Carson MJ, 1998, GLIA, V22, P72, DOI 10.1002/(SICI)1098-1136(199801)22:1<72::AID-GLIA7>3.0.CO;2-A; Greter M, 2005, NAT MED, V11, P328, DOI 10.1038/nm1197; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Leone C, 2006, GLIA, V54, P183, DOI 10.1002/glia.20372; Li GL, 2007, BLOOD, V110, P2872, DOI 10.1182/blood-2006-10-050583; McMahon EJ, 2005, NAT MED, V11, P335, DOI 10.1038/nm1202; McMenamin PG, 1999, J COMP NEUROL, V405, P553, DOI 10.1002/(SICI)1096-9861(19990322)405:4<553::AID-CNE8>3.0.CO;2-6; MEDAWAR PB, 1948, BRIT J EXP PATHOL, V29, P58; Perry VH, 1998, J NEUROIMMUNOL, V90, P113; Pestka S, 2004, ANNU REV IMMUNOL, V22, P929, DOI 10.1146/annurev.immunol.22.012703.104622; Rodriguez M, 2007, NEUROBIOL DIS, V28, P316, DOI 10.1016/j.nbd.2007.07.024; Sato K, 2003, IMMUNITY, V18, P367, DOI 10.1016/S1074-7613(03)00055-4; SCHMIDTMAYER J, 1994, GLIA, V12, P259, DOI 10.1002/glia.440120403; SIEVERS J, 1994, GLIA, V12, P245, DOI 10.1002/glia.440120402; Smits HH, 2005, TRENDS IMMUNOL, V26, P123, DOI 10.1016/j.it.2005.01.002; Sozzani S, 2007, TRENDS IMMUNOL, V28, P385, DOI 10.1016/j.it.2007.07.006; Strauss L, 2005, MED SCI MONITOR, V11, pBR280; Suter T, 2003, EUR J IMMUNOL, V33, P2998, DOI 10.1002/eji.200323611; Tambuyzer BR, 2009, J LEUKOCYTE BIOL, V85, P352, DOI 10.1189/jlb.0608385; Tang H, 2006, BLOOD, V108, P1189, DOI 10.1182/blood-2006-01-007187; Tompkins SM, 2002, J IMMUNOL, V168, P4173, DOI 10.4049/jimmunol.168.8.4173; ULVESTAD E, 1994, J LEUKOCYTE BIOL, V56, P732, DOI 10.1002/jlb.56.6.732; Wilms H, 1997, CELL TISSUE RES, V287, P447, DOI 10.1007/s004410050769; Xia S, 2008, BLOOD, V112, P3175, DOI 10.1182/blood-2008-05-159921; Zhang MH, 2004, NAT IMMUNOL, V5, P1124, DOI 10.1038/ni1130; ZIPORI D, 1985, BLOOD, V66, P447	29	18	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2009	4	11							e7869	10.1371/journal.pone.0007869	http://dx.doi.org/10.1371/journal.pone.0007869			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520OG	19924241	gold, Green Published, Green Submitted			2022-12-25	WOS:000271854200016
J	Huppert, J; Closhen, D; Croxford, A; White, R; Kulig, P; Pietrowski, E; Bechmann, I; Becher, B; Luhmann, HJ; Waisman, A; Kuhlmann, CRW				Huppert, Jula; Closhen, Dorothea; Croxford, Andrew; White, Robin; Kulig, Paulina; Pietrowski, Eweline; Bechmann, Ingo; Becher, Burkhard; Luhmann, Heiko J.; Waisman, Ari; Kuhlmann, Christoph R. W.			Cellular mechanisms of IL-17-induced blood-brain barrier disruption	FASEB JOURNAL			English	Article						multiple sclerosis; neuroinflammation; reactive oxygen species	CENTRAL-NERVOUS-SYSTEM; LIGHT-CHAIN KINASE; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MICROVESSEL ENDOTHELIAL-CELLS; MULTIPLE-SCLEROSIS LESIONS; SPHINGOSINE 1-PHOSPHATE; MEDICAL PROGRESS; FREE-RADICALS; T-CELL; IL-17	Recently T-helper 17 (Th17) cells were demonstrated to disrupt the blood-brain barrier (BBB) by the action of IL-17A. The aim of the present study was to examine the mechanisms that underlie IL-17A-induced BBB breakdown. Barrier integrity was analyzed in the murine brain endothelial cell line bEnd. 3 by measuring the electrical resistance values using electrical call impedance sensing technology. Furthermore, in-cell Western blots, fluorescence imaging, and monocyte adhesion and transendothelial migration assays were performed. Experimental autoimmune encephalomyelitis (EAE) was induced in C57BL/6 mice. IL-17A induced NADPH oxidase-or xanthine oxidase-dependent reactive oxygen species (ROS) production. The resulting oxidative stress activated the endothelial contractile machinery, which was accompanied by a down-regulation of the tight junction molecule occludin. Blocking either ROS formation or myosin light chain phosphorylation or applying IL-17A-neutralizing antibodies prevented IL-17A-induced BBB disruption. Treatment of mice with EAE using ML-7, an inhibitor of the myosin light chain kinase, resulted in less BBB disruption at the spinal cord and less infiltration of lymphocytes via the BBB and subsequently reduced the clinical characteristics of EAE. These observations indicate that IL-17A accounts for a crucial step in the development of EAE by impairing the integrity of the BBB, involving augmented production of ROS.-Huppert, J., Closhen, D., Croxford, A., White, R., Kulig, P., Pietrowski, E., Bechmann, I., Becher, B., Luhmann, H. J., Waisman, A., Kuhlmann, C. R. W. Cellular mechanisms of IL-17-induced blood-brain barrier disruption. FASEB J. 24, 1023-1034 (2010). www.fasebj.org	[Kuhlmann, Christoph R. W.] Johannes Gutenberg Univ Mainz, Inst Physiol & Pathophysiol, Univ Med Ctr, D-55131 Mainz, Germany; [Huppert, Jula; Croxford, Andrew; Waisman, Ari; Kuhlmann, Christoph R. W.] Johannes Gutenberg Univ Mainz, Dept Med 1, D-55131 Mainz, Germany; [Kulig, Paulina; Becher, Burkhard] Univ Zurich Hosp, Dept Pathol, Inst Expt Immunol, CH-8091 Zurich, Switzerland; [Bechmann, Ingo] Univ Leipzig, Inst Anat, Leipzig, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; University of Zurich; University Zurich Hospital; Leipzig University	Kuhlmann, CRW (corresponding author), Johannes Gutenberg Univ Mainz, Inst Physiol & Pathophysiol, Univ Med Ctr, Duesbergweg 6, D-55131 Mainz, Germany.	waisman@uni-mainz.de; kuhlma@uni-mainz.de	Becher, Burkhard/ABE-4225-2020; Waisman, Ari/C-7383-2015; Luhmann, Heiko J./N-8797-2019	Becher, Burkhard/0000-0002-1541-7867; Waisman, Ari/0000-0003-4304-8234; Luhmann, Heiko J./0000-0002-7934-8661	Interdisziplinarer Forschungsschwerpunkt Neurowissenschaften; Hertie Foundation; Deutsche Forschungsgemeinschaft [SFB TR52/C2]	Interdisziplinarer Forschungsschwerpunkt Neurowissenschaften; Hertie Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Interdisziplinarer Forschungsschwerpunkt Neurowissenschaften at the University of Mainz (C.R.W.K., H.L., and A.W.), by the Hertie Foundation (C.R.W.K.and A.W.), by Deutsche Forschungsgemeinschaft grant SFB TR52/C2 (A.W.), and by funds from the Boehringer Ingelheim Stiftung (A.W.).Parts of this work represent partial fulfillment of the requirements for the Ph.D.thesis of J.H.	Afonso PV, 2007, J IMMUNOL, V179, P2576, DOI 10.4049/jimmunol.179.4.2576; Benton RL, 2008, J CEREBR BLOOD F MET, V28, P1771, DOI 10.1038/jcbfm.2008.76; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Brown RC, 2007, BRAIN RES, V1130, P17, DOI 10.1016/j.brainres.2006.10.083; Cayrol R, 2008, NAT IMMUNOL, V9, P137, DOI 10.1038/ni1551; Dudek SM, 2004, J BIOL CHEM, V279, P24692, DOI 10.1074/jbc.M313969200; Floris S, 2004, BRAIN, V127, P616, DOI 10.1093/brain/awh068; Frohman EM, 2006, NEW ENGL J MED, V354, P942, DOI 10.1056/NEJMra052130; Garcia JGN, 2001, J CLIN INVEST, V108, P689, DOI 10.1172/JCI12450; Haak S, 2009, J CLIN INVEST, V119, P61, DOI 10.1172/JCI35997; Haorah J, 2005, ALCOHOL CLIN EXP RES, V29, P999, DOI 10.1097/01.ALC.0000166944.79914.0A; Haorah J, 2008, GLIA, V56, P78, DOI 10.1002/glia.20596; Hofstetter HH, 2005, CELL IMMUNOL, V237, P123, DOI 10.1016/j.cellimm.2005.11.002; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Koch M, 2006, J NEUROL, V253, P483, DOI 10.1007/s00415-005-0037-3; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Kuhlmann CRW, 2007, J NEUROCHEM, V102, P501, DOI 10.1111/j.1471-4159.2007.04506.x; Kuhlmann CRW, 2009, STROKE, V40, P1458, DOI 10.1161/STROKEAHA.108.535930; Lagrange P, 1999, FREE RADICAL BIO MED, V27, P667, DOI 10.1016/S0891-5849(99)00112-4; Lander HM, 1997, FASEB J, V11, P118, DOI 10.1096/fasebj.11.2.9039953; Lubberts E, 2001, J IMMUNOL, V167, P1004, DOI 10.4049/jimmunol.167.2.1004; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; Matusevicius D, 1999, MULT SCLER J, V5, P101, DOI 10.1177/135245859900500206; Minagar A, 2003, MULT SCLER J, V9, P540, DOI 10.1191/1352458503ms965oa; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; Prat A, 2002, ARCH NEUROL-CHICAGO, V59, P391, DOI 10.1001/archneur.59.3.391; Reijerkerk A, 2006, FASEB J, V20, P2550, DOI 10.1096/fj.06-6099fje; Rohn TA, 2006, EUR J IMMUNOL, V36, P2857, DOI 10.1002/eji.200636658; ROUVIER E, 1993, J IMMUNOL, V150, P5445; Schreibelt G, 2008, FREE RADICAL BIO MED, V45, P256, DOI 10.1016/j.freeradbiomed.2008.03.024; Schreibelt G, 2007, FASEB J, V21, P3666, DOI 10.1096/fj.07-8329com; Schreibelt G, 2006, J IMMUNOL, V177, P2630, DOI 10.4049/jimmunol.177.4.2630; STEFFEN BJ, 1994, AM J PATHOL, V145, P189; Tzartos JS, 2008, AM J PATHOL, V172, P146, DOI 10.2353/ajpath.2008.070690; Uyttenhove C, 2006, EUR J IMMUNOL, V36, P2868, DOI 10.1002/eji.200636662; van Horssen J, 2008, FREE RADICAL BIO MED, V45, P1729, DOI 10.1016/j.freeradbiomed.2008.09.023; Verin AD, 2000, J CELL BIOCHEM, V79, P113, DOI 10.1002/1097-4644(2000)79:1<113::AID-JCB110>3.0.CO;2-9; Volk T, 2000, MOL CELL BIOCHEM, V206, P105, DOI 10.1023/A:1007059616914; Wong CK, 2000, LUPUS, V9, P589, DOI 10.1191/096120300678828703; Wong D, 2007, J NEUROIMMUNOL, V184, P136, DOI 10.1016/j.jneuroim.2006.12.003; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404	41	310	323	3	58	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2010	24	4					1023	1034		10.1096/fj.09-141978	http://dx.doi.org/10.1096/fj.09-141978			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	580PV	19940258				2022-12-25	WOS:000276462300010
J	Sinning, S; Musgaard, M; Jensen, M; Severinsen, K; Celik, L; Koldso, H; Meyer, T; Bols, M; Jensen, HH; Schiott, B; Wiborg, O				Sinning, Steffen; Musgaard, Maria; Jensen, Marie; Severinsen, Kasper; Celik, Leyla; Koldso, Heidi; Meyer, Tine; Bols, Mikael; Jensen, Henrik Helligso; Schiott, Birgit; Wiborg, Ove			Binding and Orientation of Tricyclic Antidepressants within the Central Substrate Site of the Human Serotonin Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-BRAIN; REUPTAKE INHIBITORS; BACTERIAL HOMOLOG; NEUROTRANSMITTER; IMIPRAMINE; MECHANISM; LEUT; 5-HYDROXYTRYPTAMINE; DOPAMINE; SYNAPTOSOMES	Tricyclic antidepressants (TCAs) have been used for decades, but their orientation within and molecular interactions with their primary target is yet unsettled. The recent finding of a TCA binding site in the extracellular vestibule of the bacterial leucine transporter 11 angstrom above the central site has prompted debate about whether this vestibular site in the bacterial transporter is applicable to binding of antidepressants to their relevant physiological target, the human serotonin transporter (hSERT). We present an experimentally validated structural model of imipramine and analogous TCAs in the central substrate binding site of hSERT. Two possible binding modes were observed from induced fit docking calculations. We experimentally validated a single binding mode by combining mutagenesis of hSERT with uptake inhibition studies of different TCA analogs according to the paired mutation ligand analog complementation paradigm. Using this experimental method, we identify a salt bridge between the tertiary aliphatic amine and Asp(98). Furthermore, the 7-position of the imipramine ring is found vicinal to Phe(335), and the pocket lined by Ala(173) and Thr(439) is utilized by 3-substituents. These protein-ligand contact points unambiguously orient the TCA within the central binding site and reveal differences between substrate binding and inhibitor binding, giving important clues to the inhibition mechanism. Consonant with the well established competitive inhibition of uptake by TCAs, the resulting binding site for TCAs in hSERT is fully overlapping with the serotonin binding site in hSERT and dissimilar to the low affinity noncompetitive TCA site reported in the leucine transporter (LeuT).	[Musgaard, Maria; Jensen, Marie; Celik, Leyla; Koldso, Heidi; Meyer, Tine; Bols, Mikael; Jensen, Henrik Helligso; Schiott, Birgit] Aarhus Univ, Dept Chem, DK-8000 Aarhus C, Denmark; [Celik, Leyla; Schiott, Birgit] Aarhus Univ, iNANO Ctr, DK-8000 Aarhus C, Denmark; [Celik, Leyla; Schiott, Birgit] Aarhus Univ, InSPIN Ctr, DK-8000 Aarhus C, Denmark; [Sinning, Steffen; Severinsen, Kasper; Wiborg, Ove] Aarhus Univ Hosp, Mol Neurobiol Lab, Ctr Psychiat Res, DK-8240 Risskov, Denmark	Aarhus University; Aarhus University; Aarhus University; Aarhus University	Schiott, B (corresponding author), Aarhus Univ, Dept Chem, Langelandsgade 140, DK-8000 Aarhus C, Denmark.	birgit@chem.au.dk; owiborg@post.tele.dk	Schiott, Birgit/F-5067-2011; Bols, Mikael/F-6882-2014	Schiott, Birgit/0000-0001-9937-1562; Bols, Mikael/0000-0002-6561-6952; Musgaard, Maria/0000-0001-6096-9014; Sinning, Steffen/0000-0001-6971-6929	iNANO Center; Danish Center for Scientific Computing; Danish National Research Foundation; Danish Natural Science Research Council; Carlsberg, Novo Nordisk; Lundbeck Foundations	iNANO Center; Danish Center for Scientific Computing; Danish National Research Foundation(Danmarks Grundforskningsfond); Danish Natural Science Research Council(Danish Natural Science Research Council); Carlsberg, Novo Nordisk(Novo NordiskCarlsberg Foundation); Lundbeck Foundations	This work was supported by the iNANO Center, the Danish Center for Scientific Computing, the Danish National Research Foundation, the Danish Natural Science Research Council, and the Carlsberg, Novo Nordisk, and Lundbeck Foundations.	Andersen J, 2009, J BIOL CHEM, V284, P10276, DOI 10.1074/jbc.M806907200; Anderson IM, 2000, J AFFECT DISORDERS, V58, P19, DOI 10.1016/S0165-0327(99)00092-0; Apparsundaram S, 2008, J PHARMACOL EXP THER, V327, P982, DOI 10.1124/jpet.108.142315; Barker EL, 1999, J NEUROSCI, V19, P4705; Bauer Michael, 2002, World J Biol Psychiatry, V3, P5, DOI 10.3109/15622970209150599; Beuming T, 2008, NAT NEUROSCI, V11, P780, DOI 10.1038/nn.2146; Beuming T, 2006, MOL PHARMACOL, V70, P1630, DOI 10.1124/mol.106.026120; Celik L, 2008, J AM CHEM SOC, V130, P3853, DOI 10.1021/ja076403h; Celik L, 2008, BIOPHYS J, V94, P1600, DOI 10.1529/biophysj.107.117580; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; Forrest LR, 2007, P NATL ACAD SCI USA, V104, P12761, DOI 10.1073/pnas.0705600104; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Henry LK, 2006, J BIOL CHEM, V281, P2012, DOI 10.1074/jbc.M505055200; HORN AS, 1974, BRIT J PHARMACOL, V51, P399, DOI 10.1111/j.1476-5381.1974.tb10675.x; HORN AS, 1971, MOL PHARMACOL, V7, P66; Indarte M, 2008, PROTEINS, V70, P1033, DOI 10.1002/prot.21598; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Koldso H, 2010, J AM CHEM SOC, V132, P1311, DOI 10.1021/ja906923j; KUHN R, 1958, AM J PSYCHIAT, V115, P459, DOI 10.1176/ajp.115.5.459; Larsen MB, 2004, J BIOL CHEM, V279, P42147, DOI 10.1074/jbc.M405579200; LEE CM, 1982, J NEUROSCI, V2, P1515; LEE CM, 1981, P NATL ACAD SCI-BIOL, V78, P5250, DOI 10.1073/pnas.78.8.5250; LINGJAERDE O, 1971, ACTA PHYSIOL SCAND, V83, P257, DOI 10.1111/j.1748-1716.1971.tb05075.x; Masson J, 1999, PHARMACOL REV, V51, P439; Nelson N, 1998, J NEUROCHEM, V71, P1785; Noskov SY, 2008, J MOL BIOL, V377, P804, DOI 10.1016/j.jmb.2008.01.015; PLENGE P, 1985, EUR J PHARMACOL, V119, P1, DOI 10.1016/0014-2999(85)90314-0; Rudnick G, 1998, J BIOENERG BIOMEMBR, V30, P173, DOI 10.1023/A:1020573325823; RUDNICK G, 1977, J BIOL CHEM, V252, P2170; Rudnick G, 2007, ACS CHEM BIOL, V2, P606, DOI 10.1021/cb7001818; Rudnick G, 2006, J MEMBRANE BIOL, V213, P101, DOI 10.1007/s00232-006-0878-4; Saier MH, 2000, MICROBIOL-SGM, V146, P1775, DOI 10.1099/00221287-146-8-1775; Schildkraut J. J., 1965, J NEUROPSYCHIATRY CL, V7, P524; Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; TALVENHEIMO J, 1979, J BIOL CHEM, V254, P4631; TALVENHEIMO J, 1983, J BIOL CHEM, V258, P6115; Torres GE, 2003, NAT REV NEUROSCI, V4, P13, DOI 10.1038/nrn1008; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhou Z, 2007, SCIENCE, V317, P1390, DOI 10.1126/science.1147614; Zomot E, 2007, NATURE, V449, P726, DOI 10.1038/nature06133	45	83	83	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8363	8374		10.1074/jbc.M109.045401	http://dx.doi.org/10.1074/jbc.M109.045401			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	19948720	Green Published, hybrid			2022-12-25	WOS:000275413800052
J	Sakuma, R; Ohmine, S; Ikeda, Y				Sakuma, Ryuta; Ohmine, Seiga; Ikeda, Yasuhiro			Determinants for the Rhesus Monkey TRIM5 alpha-mediated Block of the Late Phase of HIV-1 Replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; B-BOX 2; CYTOPLASMIC BODIES; RESTRICTION FACTOR; RETROVIRUS RESTRICTION; CAPSID-BINDING; OLD-WORLD; DOMAINS; ASSOCIATION; INFECTION	Rhesus monkey TRIM5 alpha (TRIM5 alpha rh) includes RING, B-box, coiled-coil, and B30.2(PRYSPRY) domains and blocks HIV-1 infection by targeting HIV-1 core through a B30.2(PRYSPRY) domain. Previously, we reported that TRIM5 alpha rh also blocks HIV-1 production in a B30.2(PRYSPRY)-independent manner. Efficient encapsidation of TRIM5 alpha rh, but not human TRIM5 alpha (TRIM5 alpha hu), in HIV-1 virus-like particles suggests the interaction between Gag and TRIM5 alpha rh during viral assembly. Here, we determined responsible regions for late restriction activity of TRIM5 alpha rh. The RING disruption, but not the replacement with human TRIM21 RING, ablated the efficient encapsidation and the late restriction, suggesting that a RING structure was essential for the late restriction and efficient interaction with HIV-1 Gag. The prominent cytoplasmic body formation of TRIM5 alpha rh, which depended on the coiled-coil domain and the ensuing linker 2 region, was not required for the encapsidation. Intriguingly, TRIM5 alpha rh coiled-coil domain mutants (M133T and/or T146A) showed impaired late restriction activity, despite the efficient encapsidation and cytoplasmic body formation. Our results suggest that the TRIM5 alpha rh-mediated late restriction involves at least two distinct activities as follows: (i) interaction with HIV-1 Gag polyprotein through the N-terminal, RING, and B-box 2 regions of a TRIM5 alpha rh monomer, and (ii) an effector function(s) that depends upon the coiled-coil and linker 2 domains of TRIM5 alpha rh. We speculate that the TRIM5 alpha rh coiled coil region recruits additional factor(s), such as other TRIM family proteins or a cellular protease, during the late restriction. RBCC domains of TRIM family proteins may play a role in sensing newly synthesized viral proteins as a part of innate immunity against viral infection.	[Sakuma, Ryuta; Ohmine, Seiga; Ikeda, Yasuhiro] Mayo Clin, Dept Mol Med, Rochester, MN 55905 USA	Mayo Clinic	Ikeda, Y (corresponding author), 200 1st St SW, Rochester, MN 55905 USA.	ikeda.yasuhiro@mayo.edu			National Institutes of Health [1R56AI074363-01A1]; Mayo Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI074363] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R56AI074363-01A1 (to Y.I.). This work was also supported by the Mayo Foundation (to Y.I.) and Siebens Ph. D. training fellowship (to S. O.).	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Barr SD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000007; Campbell EM, 2007, MOL BIOL CELL, V18, P2102, DOI 10.1091/mbc.E06-12-1075; CHESEBRO B, 1992, J VIROL, V66, P6547, DOI 10.1128/JVI.66.11.6547-6554.1992; Diaz-Griffero F, 2006, VIROLOGY, V351, P404, DOI 10.1016/j.virol.2006.03.023; Diaz-Griffero F, 2006, VIROLOGY, V349, P300, DOI 10.1016/j.virol.2005.12.040; Javanbakht H, 2005, J BIOL CHEM, V280, P26933, DOI 10.1074/jbc.M502145200; Javanbakht H, 2006, VIROLOGY, V353, P234, DOI 10.1016/j.virol.2006.05.017; Langelier CR, 2008, J VIROL, V82, P11682, DOI 10.1128/JVI.01562-08; Li X, 2007, VIROLOGY, V366, P234, DOI 10.1016/j.virol.2007.04.022; Li X, 2006, J VIROL, V80, P6198, DOI 10.1128/JVI.00283-06; Li X, 2008, J VIROL, V82, P11495, DOI 10.1128/JVI.01548-08; Li Y, 2006, J VIROL, V80, P6738, DOI 10.1128/JVI.00270-06; Mische CC, 2005, J VIROL, V79, P14446, DOI 10.1128/JVI.79.22.14446-14450.2005; Morner A, 1999, J VIROL, V73, P2343; Perez-Caballero D, 2005, J VIROL, V79, P15567, DOI 10.1128/JVI.79.24.15567-15572.2005; Perez-Caballero D, 2005, J VIROL, V79, P8969, DOI 10.1128/JVI.79.14.8969-8978.2005; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Richardson MW, 2008, J VIROL, V82, P11117, DOI 10.1128/JVI.01046-08; Rold CJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000074; Sakuma R, 2008, NAT MED, V14, P236, DOI 10.1038/nm0308-236; Sakuma R, 2007, NAT MED, V13, P631, DOI 10.1038/nm1562; Sakuma R, 2007, J VIROL, V81, P10201, DOI 10.1128/JVI.00419-07; SIMM M, 1995, J VIROL, V69, P4582, DOI 10.1128/JVI.69.7.4582-4586.1995; Song B, 2005, VIROLOGY, V343, P201, DOI 10.1016/j.virol.2005.08.019; Song B, 2005, J VIROL, V79, P3930, DOI 10.1128/JVI.79.7.3930-3937.2005; Stremlau M, 2006, P NATL ACAD SCI USA, V103, P5514, DOI 10.1073/pnas.0509996103; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Uchil PD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040016; Yamauchi K, 2008, FEBS J, V275, P1540, DOI 10.1111/j.1742-4658.2008.06313.x; Yap MW, 2005, CURR BIOL, V15, P73, DOI 10.1016/j.cub.2004.12.042; Zhang F, 2008, NAT MED, V14, P235, DOI 10.1038/nm0308-235	32	16	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3784	3793		10.1074/jbc.M109.059063	http://dx.doi.org/10.1074/jbc.M109.059063			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19951947	Green Published, hybrid			2022-12-25	WOS:000275254000031
J	Park, YK; Park, H				Park, Young-Kwon; Park, Hyunsung			Prevention of CCAAT/Enhancer-binding Protein beta DNA Binding by Hypoxia during Adipogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOTIC CLONAL EXPANSION; ACTIVATED RECEPTOR-GAMMA; STEM-CELL FUNCTION; ADIPOCYTE DIFFERENTIATION; C/EBP-BETA; INDUCIBLE FACTOR; EMBRYONIC-DEVELOPMENT; GENE-EXPRESSION; DOWN-REGULATION; CYCLE ARREST	Upon exposure to adipogenesis-inducing hormones, confluent 3T3-L1 preadipocytes express C/EBP beta (CCAAT/enhancer binding protein beta). Early induced C/EBP beta is inactive but, after a lag period, acquires its DNA-binding capability by sequential phosphorylation. During this period, preadipocytes pass the G(1)/S checkpoint synchronously. Thr(188) of C/EBP beta is phosphorylated initially to prime the factor for subsequent phosphorylation at Ser(184) or Thr(179) by GSK3 beta, which translocates into the nuclei during the G(1)/S transition. Many events take place during the G(1)/S transition, including reduction in p27(Kip1) protein levels, retinoblastoma (Rb) phosphorylation, GSK3 beta nuclear translocation, and C/EBP beta binding to target promoters. During hypoxia, hypoxia-inducible factor-1 alpha (HIF-1 alpha) is stabilized, thus maintaining expression of p27(Kip1), which inhibits Rb phosphorylation. Even under normoxic conditions, constitutive expression of p27(Kip1) blocks the nuclear translocation of GSK3 beta and DNA binding capability of C/EBP beta. Hypoxia also blocks nuclear translocation of GSK3 beta and DNA binding capability of C/EBP beta in HIF-1 alpha knockdown 3T3-L1 cells that fail to induce p27(Kip1). Nonetheless, under hypoxia, these cells can block Rb phosphorylation and the G(1)/S transition. Altogether, these findings suggest that hypoxia prevents the nuclear translocation of GSK3 beta and the DNA binding capability of C/EBP beta by blocking the G(1)/S transition through HIF-1 alpha-dependent induction of p27(Kip1) and an HIF-1 alpha/p27-independent mechanism.	[Park, Young-Kwon; Park, Hyunsung] Univ Seoul, Dept Life Sci, Seoul 130743, South Korea	University of Seoul	Park, H (corresponding author), Univ Seoul, Dept Life Sci, Siripdae Gil 13, Seoul 130743, South Korea.	hspark@uos.ac.kr		Park, Young-Kwon/0000-0002-3473-7233	Korea Healthcare Technology RD Project [A090616]; Seoul Science Fellowship	Korea Healthcare Technology RD Project; Seoul Science Fellowship	This work was supported by Korea Healthcare Technology R&D Project Grant A090616 (to H.P.).; Supported by a Seoul Science Fellowship.	Altiok S, 1997, GENE DEV, V11, P1987, DOI 10.1101/gad.11.15.1987; Amarilio R, 2007, DEVELOPMENT, V134, P3917, DOI 10.1242/dev.008441; Brahimi-Horn MC, 2007, FEBS LETT, V581, P3582, DOI 10.1016/j.febslet.2007.06.018; Carriere A, 2004, J BIOL CHEM, V279, P40462, DOI 10.1074/jbc.M407258200; Chen PL, 1996, GENE DEV, V10, P2794, DOI 10.1101/gad.10.21.2794; Choi SM, 2008, NUCLEIC ACIDS RES, V36, P6372, DOI 10.1093/nar/gkn620; Choi SM, 2006, J BIOL CHEM, V281, P34056, DOI 10.1074/jbc.M603913200; Cole KA, 2004, AM J PHYSIOL-CELL PH, V286, pC349, DOI 10.1152/ajpcell.00255.2003; Covello KL, 2006, GENE DEV, V20, P557, DOI 10.1101/gad.1399906; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Fajas L, 1998, CURR OPIN CELL BIOL, V10, P165, DOI 10.1016/S0955-0674(98)80138-5; Gardner LB, 2001, J BIOL CHEM, V276, P7919, DOI 10.1074/jbc.M010189200; Goda N, 2003, MOL CELL BIOL, V23, P359, DOI 10.1128/MCB.23.1.359-369.2003; Green SL, 2001, MOL CELL BIOL, V21, P1196, DOI 10.1128/MCB.21.4.1196-1206.2001; Gulbagci NT, 2009, EMBO REP, V10, P79, DOI 10.1038/embor.2008.207; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Hackenbeck T, 2009, CELL CYCLE, V8, P1386, DOI 10.4161/cc.8.9.8306; Hammer S, 2007, CELL CYCLE, V6, P1919, DOI 10.4161/cc.6.15.4515; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kaidi A, 2007, NAT CELL BIOL, V9, P210, DOI 10.1038/ncb1534; Kang S, 2007, J BIOL CHEM, V282, P14515, DOI 10.1074/jbc.M700030200; Kanichai M, 2008, J CELL PHYSIOL, V216, P708, DOI 10.1002/jcp.21446; Kim J, 2007, P NATL ACAD SCI USA, V104, P1800, DOI 10.1073/pnas.0611137104; Ko HSP, 1996, MOL CELL BIOL, V16, P430; Krtolica A, 1998, ONCOGENE, V17, P2295, DOI 10.1038/sj.onc.1202159; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Lane MD, 1999, BIOCHEM BIOPH RES CO, V266, P677, DOI 10.1006/bbrc.1999.1885; Li X, 2007, P NATL ACAD SCI USA, V104, P11597, DOI 10.1073/pnas.0703771104; Liu JJ, 2006, MOL CELL BIOL, V26, P5827, DOI 10.1128/MCB.00441-06; Okada M, 2009, BIOCHEM BIOPH RES CO, V379, P249, DOI 10.1016/j.bbrc.2008.12.069; OLASHAW N, 2002, SCI STKE, pRE7; Park SK, 2004, DIABETES, V53, P2757, DOI 10.2337/diabetes.53.11.2757; Patel YM, 2000, J BIOL CHEM, V275, P17653, DOI 10.1074/jbc.M910445199; PIWIENPILIPUK G, 2003, J BIOL CHEM, V278, P35668; Prestwich TC, 2007, CURR OPIN CELL BIOL, V19, P612, DOI 10.1016/j.ceb.2007.09.014; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Rosen ED, 2000, GENE DEV, V14, P1293; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Sebastian T, 2005, EMBO J, V24, P3301, DOI 10.1038/sj.emboj.7600789; Simon MC, 2008, NAT REV MOL CELL BIO, V9, P285, DOI 10.1038/nrm2354; Sitkovsky M, 2005, NAT REV IMMUNOL, V5, P712, DOI 10.1038/nri1685; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tang QQ, 2000, P NATL ACAD SCI USA, V97, P12446, DOI 10.1073/pnas.220425597; Tang QQ, 2004, BIOCHEM BIOPH RES CO, V318, P213, DOI 10.1016/j.bbrc.2004.04.017; Tang QQ, 2005, P NATL ACAD SCI USA, V102, P9766, DOI 10.1073/pnas.0503891102; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P850, DOI 10.1073/pnas.0337434100; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P44, DOI 10.1073/pnas.0137044100; Tang QQ, 1999, GENE DEV, V13, P2231, DOI 10.1101/gad.13.17.2231; Wang HM, 2001, MOL CELL, V8, P817, DOI 10.1016/S1097-2765(01)00366-5; Wouters BG, 2008, NAT REV CANCER, V8, P851, DOI 10.1038/nrc2501; Yim S, 2004, BIOCHEM BIOPH RES CO, V322, P9, DOI 10.1016/j.bbrc.2004.07.072; Yun Z, 2002, DEV CELL, V2, P331, DOI 10.1016/S1534-5807(02)00131-4; Zhang JW, 2004, P NATL ACAD SCI USA, V101, P43, DOI 10.1073/pnas.0307229101	53	26	28	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5					3289	3299		10.1074/jbc.M109.059212	http://dx.doi.org/10.1074/jbc.M109.059212			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19940121	Green Published, hybrid			2022-12-25	WOS:000273829000044
J	Pieslinger, AM; Hoepflinger, MC; Tenhaken, R				Pieslinger, Anja Maria; Hoepflinger, Marion Christine; Tenhaken, Raimund			Cloning of Glucuronokinase from Arabidopsis thaliana, the Last Missing Enzyme of the myo-Inositol Oxygenase Pathway to Nucleotide Sugars	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							D-GLUCURONATE 4-EPIMERASE; L-ARABINOSE; D-XYLOSE; FUNCTIONAL CLONING; DEFICIENT MUTANT; GHMP KINASE; GENE FAMILY; D-GALACTOSE; CELL-WALLS; BIOSYNTHESIS	Nucleotide sugars are building blocks for carbohydrate polymers in plant cell walls. They are synthesized from sugar-1-phosphates or epimerized as nucleotide sugars. The main precursor for primary cell walls is UDP-glucuronic acid, which can be synthesized via two independent pathways. One starts with the ring cleavage of myo-inositol into glucuronic acid, which requires a glucuronokinase and a pyrophosphorylase for activation into UDP-glucuronate. Here we report on the purification of glucuronokinase from Lilium pollen. A 40-kDa protein was purified combining six chromatographic steps and peptides were de novo sequenced. This allowed the cloning of the gene from Arabidopsis thaliana and the expression of the recombinant protein in Escherichia coli for biochemical characterization. Glucuronokinase is a novel member of the GHMP-kinase superfamily having an unique substrate specificity for D-glucuronic acid with a K-m of 0.7 mM. It requires ATP as phosphate donor (K-m 0.56 mM). In Arabidopsis, the gene is expressed in all plant tissues with a preference for pollen. Genes for glucuronokinase are present in (all) plants, some algae, and a few bacteria as well as in some lower animals.	[Pieslinger, Anja Maria; Hoepflinger, Marion Christine; Tenhaken, Raimund] Salzburg Univ, Dept Cell Biol, A-5020 Salzburg, Austria	Salzburg University	Tenhaken, R (corresponding author), Salzburg Univ, Dept Cell Biol, Hellbrunnerstr 34, A-5020 Salzburg, Austria.	raimund.tenhaken@sbg.ac.at	Tenhaken, Raimund/O-6556-2019	Tenhaken, Raimund/0000-0002-6764-4826	German Research Foundation; Austrian Science Fund [FWF P20297-B16]; Austrian Science Fund (FWF) [P 20297] Funding Source: researchfish	German Research Foundation(German Research Foundation (DFG)); Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported in part by grants of the German Research Foundation (Deutsche Forschungsgemeinschaft, Bonn) and Austrian Science Fund Grant FWF P20297-B16 (Vienna).	ANDERSON RL, 1962, J BIOL CHEM, V237, P1029; Andreassi JL, 2004, BIOCHEMISTRY-US, V43, P14594, DOI 10.1021/bi048963o; BORK P, 1993, PROTEIN SCI, V2, P31; Burget EG, 2003, PLANT CELL, V15, P523, DOI 10.1105/tpc.008425; CHAN PH, 1975, ANAL BIOCHEM, V64, P372, DOI 10.1016/0003-2697(75)90445-5; Chevallet M, 2006, NAT PROTOC, V1, P1852, DOI 10.1038/nprot.2006.288; Davey MW, 1999, PLANT PHYSIOL, V121, P535, DOI 10.1104/pp.121.2.535; DICKINSON DB, 1982, PHYTOCHEMISTRY, V21, P843, DOI 10.1016/0031-9422(82)80076-9; DOLEZAL O, 1991, PLANT PHYSIOL, V96, P1255, DOI 10.1104/pp.96.4.1255; DYBALLA N, 2008, LABORJOURNAL, V4, P44; Endres S, 2009, PLANT PHYSIOL, V149, P1042, DOI 10.1104/pp.108.130948; FEINGOLD DS, 1982, ENCY PLANT PHYSL; FEINGOLD DS, 1980, BIOCH PLANTS; GIBEAUT DM, 1994, FASEB J, V8, P904, DOI 10.1096/fasebj.8.12.8088456; Harper AD, 2002, PLANT PHYSIOL, V130, P2188, DOI 10.1104/pp.009654; Hinterberg B, 2002, PLANT PHYSIOL BIOCH, V40, P1011, DOI 10.1016/S0981-9428(02)01465-1; Kanter U, 2005, PLANTA, V221, P243, DOI 10.1007/s00425-004-1441-0; Kaplan CP, 1997, PLANT MOL BIOL, V34, P497, DOI 10.1023/A:1005816104743; Kotake T, 2008, J BIOL CHEM, V283, P8125, DOI 10.1074/jbc.M710078200; KROH M, 1970, PLANT PHYSIOL, V45, P92, DOI 10.1104/pp.45.1.92; LEIBOWITZ MD, 1977, ARCH BIOCHEM BIOPHYS, V179, P559, DOI 10.1016/0003-9861(77)90144-8; LOEWUS FA, 1962, P NATL ACAD SCI USA, V48, P421, DOI 10.1073/pnas.48.3.421; LOEWUS FA, 1983, ANNU REV PLANT PHYS, V34, P137, DOI 10.1146/annurev.pp.34.060183.001033; Molhoj M, 2004, PLANT PHYSIOL, V135, P1221, DOI 10.1104/pp.104.043745; Molhoj M, 2003, PLANT J, V35, P693, DOI 10.1046/j.1365-313X.2003.01841.x; NEUFELD EF, 1961, J BIOL CHEM, V236, P3102; NEUFELD EF, 1960, J BIOL CHEM, V235, P906; Pieslinger AM, 2009, ANAL BIOCHEM, V388, P254, DOI 10.1016/j.ab.2009.03.002; Reiter WD, 2001, PLANT MOL BIOL, V47, P95, DOI 10.1023/A:1010671129803; REITER WD, 1993, SCIENCE, V261, P1032, DOI 10.1126/science.261.5124.1032; Schneider S, 2006, PLANT PHYSIOL, V141, P565, DOI 10.1104/pp.106.077123; Seifert GJ, 2004, CURR OPIN PLANT BIOL, V7, P277, DOI 10.1016/j.pbi.2004.03.004; Sherson S, 1999, PLANT MOL BIOL, V39, P1003, DOI 10.1023/A:1006181908753; Smirnoff N, 2001, ANNU REV PLANT PHYS, V52, P437, DOI 10.1146/annurev.arplant.52.1.437; Swarbreck D, 2008, NUCLEIC ACIDS RES, V36, pD1009, DOI 10.1093/nar/gkm965; Tenhaken R, 1996, PLANT PHYSIOL, V112, P1127, DOI 10.1104/pp.112.3.1127; Usadel B, 2004, FEBS LETT, V569, P327, DOI 10.1016/j.febslet.2004.06.005; Yang T, 2009, J BIOL CHEM, V284, P21526, DOI 10.1074/jbc.M109.014761; ZABLACKIS E, 1995, PLANT PHYSIOL, V107, P1129, DOI 10.1104/pp.107.4.1129; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	40	31	37	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5							2902	10.1074/jbc.M109.069369	http://dx.doi.org/10.1074/jbc.M109.069369			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19951951	Green Published, hybrid			2022-12-25	WOS:000273829000004
J	Tseng, IC; Xu, H; Chou, FP; Li, G; Vazzano, AP; Kao, JPY; Johnson, MD; Lin, CY				Tseng, I-Chu; Xu, Han; Chou, Feng-Pai; Li, Gong; Vazzano, Alexander P.; Kao, Joseph P. Y.; Johnson, Michael D.; Lin, Chen-Yong			Matriptase Activation, an Early Cellular Response to Acidosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; AUTOSOMAL RECESSIVE ICHTHYOSIS; SERINE-PROTEASE; EPITHELIAL-CELLS; NA+/H+ EXCHANGER; INTRACELLULAR PH; TUMOR INVASION; IN-VITRO; INHIBITOR; CLONING	Extracellular acidosis often rapidly causes intracellular acidification, alters ion channel activities, and activates G protein-coupled receptors. In this report, we demonstrated a novel cellular response to acidosis: induction of the zymogen activation of matriptase. Acid-induced matriptase activation is ubiquitous among epithelial and carcinoma cells and is characterized by rapid onset, fast kinetics, and the magnitude of activation seen. Trace amounts of activated matriptase can be detected 1 min after cells are exposed to pH 6.0 buffer, and the vast majority of latent matriptase within the cells is converted to activated matriptase within 20 min. Matriptase activation may be a direct response to proton exposure because acid-induced matriptase activation also occurs in an in vitro, cell-free setting in which intracellular signaling molecules and ion channel activities are largely absent. Acid-induced matriptase activation takes place both on the cell surface and inside the cells, likely due to the parallel intracellular acidification that activates intracellular matriptase. Following matriptase activation, the active enzyme is immediately inhibited by binding to hepatocyte growth factor activator inhibitor 1, resulting in stable matriptase-hepatocyte growth factor activator inhibitor 1 complexes that are rapidly secreted. As an early response to acidosis, matriptase activation can also be induced by perturbation of intracellular pH homeostasis by 5-(N-methyl-N-isobutyl)-amiloride and 5-(N-ethyl-Nisopropyl)-amiloride, both of which inhibit Na+/H+ exchangers, and diisothiocyanostilbene-2,2'-disulfonic acid, which can inhibit other acid-base ion channels. This study uncovers a novel mechanism regulating proteolysis in epithelial and carcinoma cells, and also demonstrates that a likely function of matriptase is as an early response to acidosis.	[Tseng, I-Chu; Xu, Han; Chou, Feng-Pai; Vazzano, Alexander P.; Lin, Chen-Yong] Univ Maryland, Dept Biochem & Mol Biol, Greenebaum Canc Ctr, Baltimore, MD 21201 USA; [Li, Gong; Kao, Joseph P. Y.] Univ Maryland, Inst Biotechnol, Ctr Biomed Engn & Technol, Ctr Med Biotechnol, Baltimore, MD 21201 USA; [Johnson, Michael D.] Georgetown Univ, Lombardi Canc Ctr, Dept Oncol, Washington, DC 20057 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Georgetown University	Lin, CY (corresponding author), BRB 10-027,655 W Baltimore St, Baltimore, MD 21201 USA.	cylin@som.umaryland.edu	Tseng, I-Chu/C-1936-2013; Feng-Pai, Chou/AGS-4250-2022	Tseng, I-Chu/0000-0001-8522-6524; johnson, Michael/0000-0001-6260-7586; Kao, Joseph/0000-0002-8875-2180	National Institutes of Health [R01CA096851, R01CA104944]; Maryland Cigarette Restitution Fund Program; NATIONAL CANCER INSTITUTE [R01CA123223, R01CA096851, R01CA104944] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Maryland Cigarette Restitution Fund Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA096851 and R01CA104944 (to C.Y.L.) and the Maryland Cigarette Restitution Fund Program.	Avrahami L, 2008, CLIN GENET, V74, P47, DOI 10.1111/j.1399-0004.2008.01006.x; Basel-Vanagaite L, 2007, AM J HUM GENET, V80, P467, DOI 10.1086/512487; Benaud C, 2002, J BIOL CHEM, V277, P10539, DOI 10.1074/jbc.M109064200; Benaud C, 2001, EUR J BIOCHEM, V268, P1439, DOI 10.1046/j.1432-1327.2001.02016.x; Benaud CM, 2002, CLIN EXP METASTAS, V19, P639, DOI 10.1023/A:1020985632550; Bernardo AA, 1999, J CLIN INVEST, V104, P195, DOI 10.1172/JCI5344; Bertog M, 1999, J PHYSIOL-LONDON, V521, P3, DOI 10.1111/j.1469-7793.1999.00003.x; Carney TJ, 2007, DEVELOPMENT, V134, P3461, DOI 10.1242/dev.004556; CHERNEW I, 1962, J CLIN INVEST, V41, P1945, DOI 10.1172/JCI104652; Cox T, 1997, J EXP BIOL, V200, P3055; Drummond HA, 2008, HYPERTENSION, V51, P1265, DOI 10.1161/HYPERTENSIONAHA.107.093401; FURUCHI T, 1993, J BIOL CHEM, V268, P27345; Gatenby RA, 2006, CANCER RES, V66, P5216, DOI 10.1158/0008-5472.CAN-05-4193; Gillies RJ, 2004, IEEE ENG MED BIOL, V23, P57, DOI 10.1109/MEMB.2004.1360409; Hachem JP, 2003, J INVEST DERMATOL, V121, P345, DOI 10.1046/j.1523-1747.2003.12365.x; Hung RJ, 2004, AM J PHYSIOL-CELL PH, V286, pC1159, DOI 10.1152/ajpcell.00400.2003; Hunter RC, 2005, APPL ENVIRON MICROB, V71, P2501, DOI 10.1128/AEM.71.5.2501-2510.2005; ICHIHARA K, 1984, AM J PHYSIOL, V246, pH652, DOI 10.1152/ajpheart.1984.246.5.H652; Ihara S, 2002, J BIOL CHEM, V277, P16960, DOI 10.1074/jbc.M200673200; Kim MG, 1999, IMMUNOGENETICS, V49, P420, DOI 10.1007/s002510050515; Kiyomiya KI, 2006, AM J PHYSIOL-CELL PH, V291, pC40, DOI 10.1152/ajpcell.00351.2005; KORTING HC, 1990, ACTA DERM-VENEREOL, V70, P429; Lee MS, 2007, AM J PHYSIOL-CELL PH, V293, pC95, DOI 10.1152/ajpcell.00611.2006; Lee MS, 2005, AM J PHYSIOL-CELL PH, V288, pC932, DOI 10.1152/ajpcell.00497.2004; Lin CY, 1999, J BIOL CHEM, V274, P18237, DOI 10.1074/jbc.274.26.18237; Lin CY, 1999, J BIOL CHEM, V274, P18231, DOI 10.1074/jbc.274.26.18231; Lin CY, 1997, J BIOL CHEM, V272, P9147; List K, 2002, ONCOGENE, V21, P3765, DOI 10.1038/sj.onc.1205502; List K, 2003, J CELL BIOL, V163, P901, DOI 10.1083/jcb.200304161; List K, 2005, GENE DEV, V19, P1934, DOI 10.1101/gad.1300705; List K, 2007, J CELL PHYSIOL, V213, P237, DOI 10.1002/jcp.21115; List K, 2009, AM J PATHOL, V175, P1453, DOI 10.2353/ajpath.2009.090240; Ludwig MG, 2003, NATURE, V425, P93, DOI 10.1038/nature01905; Marcotte N, 2005, J PHYS CHEM B, V109, P11819, DOI 10.1021/jp0510138; Masereel B, 2003, EUR J MED CHEM, V38, P547, DOI 10.1016/S0223-5234(03)00100-4; Mathias JR, 2007, J CELL SCI, V120, P3372, DOI 10.1242/jcs.009159; Mauro T, 1998, ARCH DERMATOL RES, V290, P215, DOI 10.1007/s004030050293; MUALLEM S, 1990, J BIOL CHEM, V265, P12813; Murakami N, 2004, J BIOL CHEM, V279, P42484, DOI 10.1074/jbc.M406561200; Oberst M, 2001, AM J PATHOL, V158, P1301, DOI 10.1016/S0002-9440(10)64081-3; Oberst MD, 2005, AM J PHYSIOL-CELL PH, V289, pC462, DOI 10.1152/ajpcell.00076.2005; Oberst MD, 2003, J BIOL CHEM, V278, P26773, DOI 10.1074/jbc.M304282200; Oberst MD, 2003, J HISTOCHEM CYTOCHEM, V51, P1017, DOI 10.1177/002215540305100805; Press AG, 1998, ALIMENT PHARM THER, V12, P673; Romero MF, 1997, NATURE, V387, P409, DOI 10.1038/387409a0; Shum WWC, 2009, J EXP BIOL, V212, P1753, DOI 10.1242/jeb.027284; SIMMEN HP, 1994, INFECTION, V22, P386, DOI 10.1007/BF01715494; Soleimani M, 2001, J MEMBRANE BIOL, V183, P71, DOI 10.1007/s00232-001-0055-8; Stockand JD, 2008, IUBMB LIFE, V60, P620, DOI 10.1002/iub.89; Suzuki M, 2004, J BIOL CHEM, V279, P14899, DOI 10.1074/jbc.M313130200; Szabo R, 2007, ONCOGENE, V26, P1546, DOI 10.1038/sj.onc.1209966; Szabo R, 2009, AM J PATHOL, V174, P2015, DOI 10.2353/ajpath.2009.090053; TAGGART M, 1994, J PHYSIOL-LONDON, V475, P285, DOI 10.1113/jphysiol.1994.sp020069; Takeuchi T, 2000, J BIOL CHEM, V275, P26333, DOI 10.1074/jbc.M002941200; Takeuchi T, 1999, P NATL ACAD SCI USA, V96, P11054, DOI 10.1073/pnas.96.20.11054; Taylor CJ, 2006, J PHYSIOL-LONDON, V576, P769, DOI 10.1113/jphysiol.2006.117374; Wang CZ, 2000, J BIOL CHEM, V275, P35486, DOI 10.1074/jbc.C000456200; Wang JK, 2009, AM J PHYSIOL-CELL PH, V297, pC459, DOI 10.1152/ajpcell.00201.2009	58	59	59	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5					3261	3270		10.1074/jbc.M109.055640	http://dx.doi.org/10.1074/jbc.M109.055640			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19940125	Green Published, hybrid			2022-12-25	WOS:000273829000041
J	Broglie, P; Matsumoto, K; Akira, S; Brautigan, DL; Ninomiya-Tsuji, J				Broglie, Peter; Matsumoto, Kunihiro; Akira, Shizuo; Brautigan, David L.; Ninomiya-Tsuji, Jun			Transforming Growth Factor beta-activated Kinase 1 (TAK1) Kinase Adaptor, TAK1-binding Protein 2, Plays Dual Roles in TAK1 Signaling by Recruiting Both an Activator and an Inhibitor of TAK1 Kinase in Tumor Necrosis Factor Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TNF-ALPHA; POLYUBIQUITIN CHAINS; CELL-DEATH; TAB2; IL-1; UBIQUITIN; IKK; APOPTOSIS; COMPLEX	Transforming growth factor beta-activated kinase 1 (TAK1) kinase is an indispensable signaling intermediate in tumor necrosis factor (TNF), interleukin 1, and Toll-like receptor signaling pathways. TAK1-binding protein 2 (TAB2) and its closely related protein, TAB3, are binding partners of TAK1 and have previously been identified as adaptors of TAK1 that recruit TAK1 to a TNF receptor signaling complex. TAB2 and TAB3 redundantly mediate activation of TAK1. In this study, we investigated the role of TAB2 by analyzing fibroblasts having targeted deletion of the tab2 gene. In TAB2-deficient fibroblasts, TAK1 was associated with TAB3 and was activated following TNF stimulation. However, TAB2-deficient fibroblasts displayed a significantly prolonged activation of TAK1 compared with wild type control cells. This suggests that TAB2 mediates deactivation of TAK1. We found that a TAK1-negative regulator, protein phosphatase 6 (PP6), was recruited to the TAK1 complex in wild type but not in TAB2-deficient fibroblasts. Furthermore, we demonstrated that both PP6 and TAB2 interacted with the polyubiquitin chains and this interaction mediated the assembly with TAK1. Our results indicate that TAB2 not only activates TAK1 but also plays an essential role in the deactivation of TAK1 by recruiting PP6 through a polyubiquitin chain-dependent mechanism.	[Broglie, Peter; Ninomiya-Tsuji, Jun] N Carolina State Univ, Dept Environm & Mol Toxicol, Raleigh, NC 27695 USA; [Matsumoto, Kunihiro] Nagoya Univ, Grad Sch Sci, Dept Mol Biol, Nagoya, Aichi 4648602, Japan; [Akira, Shizuo] Osaka Univ, Microbial Dis Res Inst, Dept Host Def, Suita, Osaka 5650871, Japan; [Brautigan, David L.] Univ Virginia, Sch Med, Ctr Cell Signaling, Charlottesville, VA 22908 USA	University of North Carolina; North Carolina State University; Nagoya University; Osaka University; University of Virginia	Ninomiya-Tsuji, J (corresponding author), N Carolina State Univ, Dept Environm & Mol Toxicol, Campus Box 7633, Raleigh, NC 27695 USA.	jun_tsuji@ncsu.edu	Akira, Shizuo/C-3134-2009	Ninomiya-Tsuji, Jun/0000-0002-5584-0176	National Institutes of Health [GM068812]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084406, R01GM068812] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM068812 (to J.N.-T.).	Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; DIXIT VM, 1990, J BIOL CHEM, V265, P2973; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Ishitani T, 2003, EMBO J, V22, P6277, DOI 10.1093/emboj/cdg605; Kajino T, 2006, J BIOL CHEM, V281, P39891, DOI 10.1074/jbc.M608155200; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kim JY, 2008, J BIOL CHEM, V283, P137, DOI 10.1074/jbc.M704746200; Kim SI, 2008, J BIOL CHEM, V283, P10753, DOI 10.1074/jbc.M801263200; Kishida S, 2005, GENES CELLS, V10, P447, DOI 10.1111/j.1365-2443.2005.00852.x; Kishimoto K, 2000, J BIOL CHEM, V275, P7359, DOI 10.1074/jbc.275.10.7359; Komander D, 2009, EMBO REP, V10, P466, DOI 10.1038/embor.2009.55; Mendoza H, 2008, BIOCHEM J, V409, P711, DOI 10.1042/BJ20071149; Mi J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004395; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Omori E, 2008, J BIOL CHEM, V283, P26161, DOI 10.1074/jbc.M804513200; Omori E, 2006, J BIOL CHEM, V281, P19610, DOI 10.1074/jbc.M603384200; Pham CG, 2004, CELL, V119, P529, DOI 10.1016/j.cell.2004.10.017; Rahighi S, 2009, CELL, V136, P1098, DOI 10.1016/j.cell.2009.03.007; Sakon S, 2003, EMBO J, V22, P3898, DOI 10.1093/emboj/cdg379; Sanjo H, 2003, MOL CELL BIOL, V23, P1231, DOI 10.1128/MCB.23.4.1231-1238.2003; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Singhirunnusorn P, 2005, J BIOL CHEM, V280, P7359, DOI 10.1074/jbc.M407537200; Stefansson B, 2007, CELL CYCLE, V6, P1386, DOI 10.4161/cc.6.11.4276; Stefansson B, 2006, J BIOL CHEM, V281, P22624, DOI 10.1074/jbc.M601772200; Takaesu G, 2003, J MOL BIOL, V326, P105, DOI 10.1016/S0022-2836(02)01404-3; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; Takaesu G, 2001, MOL CELL BIOL, V21, P2475, DOI 10.1128/MCB.21.7.2475-2484.2001; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Uemura N, 2006, J BIOL CHEM, V281, P7863, DOI 10.1074/jbc.M509834200; Ventura JJ, 2004, GENE DEV, V18, P2905, DOI 10.1101/gad.1223004; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Xu M, 2009, MOL CELL, V36, P302, DOI 10.1016/j.molcel.2009.10.002; Zabrocki P, 2002, MOL MICROBIOL, V43, P835, DOI 10.1046/j.1365-2958.2002.02786.x	37	53	55	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2333	2339		10.1074/jbc.M109.090522	http://dx.doi.org/10.1074/jbc.M109.090522			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19955178	hybrid, Green Published			2022-12-25	WOS:000273697800013
J	Xiong, SQ; Salazar, G; San Martin, A; Ahmad, M; Patrushev, N; Hilenski, L; Nazarewicz, RR; Ma, MH; Ushio-Fukai, M; Alexander, RW				Xiong, Shiqin; Salazar, Gloria; San Martin, Alejandra; Ahmad, Mushtaq; Patrushev, Nikolay; Hilenski, Lula; Nazarewicz, Rafal Robert; Ma, Minhui; Ushio-Fukai, Masuko; Alexander, R. Wayne			PGC-1 alpha Serine 570 Phosphorylation and GCN5-mediated Acetylation by Angiotensin II Drive Catalase Down-regulation and Vascular Hypertrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; TRANSCRIPTIONAL COACTIVATOR PGC-1-ALPHA; ACTIVATED PROTEIN-KINASE; SENSITIVE SIGNALING PATHWAYS; INDUCED AKT ACTIVATION; ENERGY-METABOLISM; OXIDATIVE STRESS; CARDIOMYOCYTE HYPERTROPHY; GAMMA COACTIVATOR-1; CARDIAC-HYPERTROPHY	Angiotensin II (Ang II) is a pleuripotential hormone that is important in the pathophysiology of multiple conditions including aging, cardiovascular and renal diseases, and insulin resistance. Reactive oxygen species (ROS) are important mediators of Ang II-induced signaling generally and have a well defined role in vascular hypertrophy, which is inhibited by overexpression of catalase, inferring a specific role of H2O2. The molecular mechanisms are understood incompletely. The transcriptional coactivator peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC-1 alpha) is a key regulator of energy metabolism and ROS-scavenging enzymes including catalase. We show that Ang II stimulates Akt-dependent PGC-1 alpha serine 570 phosphorylation, which is required for the binding of the histone acetyltransferase GCN5 (general control nonderepressible 5) to PGC-1 alpha and for its lysine acetylation. These sequential post-translational modifications suppress PGC-1 alpha activity and prevent its binding to the catalase promoter through the forkhead box O1 transcription factor, thus decreasing catalase expression. We demonstrate that overexpression of the phosphorylation-defective mutant PGC-1 alpha (S570A) prevents Ang II-induced increases in H2O2 levels and hypertrophy ([H-3]leucine incorporation). Knockdown of PGC-1 alpha by small interfering RNA promotes basal and Ang II-stimulated ROS and hypertrophy, which is reversed by polyethylene glycol-conjugated catalase. Thus, endogenous PGC-1 alpha is a negative regulator of vascular hypertrophy by up-regulating catalase expression and thus reducing ROS levels. We provide novel mechanistic insights by which Ang II may mediate its ROS-dependent pathophysiologic effects on multiple cardiometabolic diseases.	[Alexander, R. Wayne] Emory Univ Hosp, Div Cardiol, Dept Med, Atlanta, GA 30322 USA; [Alexander, R. Wayne] Emory Univ, Sch Med, Emory Univ Hosp, Atlanta, GA 30322 USA; [Ushio-Fukai, Masuko] Univ Illinois, Dept Pharmacol, Chicago, IL 60612 USA	Emory University; Emory University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Alexander, RW (corresponding author), Emory Univ Hosp, Div Cardiol, Dept Med, Suite H-153,1364 Clifton Rd NE, Atlanta, GA 30322 USA.	ralexan@emory.edu	San Martin, Alejandra/HDN-0012-2022	San Martin, Alejandra/0000-0002-4620-1591	National Institutes of Health [UO1 HL80711, HL60728]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077524, R01HL060728, U01HL080711] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants UO1 HL80711 and HL60728.	Anilkumar N, 2009, FRONT BIOSCI-LANDMRK, V14, P3168, DOI 10.2741/3443; Arany Z, 2005, CELL METAB, V1, P259, DOI 10.1016/j.cmet.2005.03.002; Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Arany Z, 2006, P NATL ACAD SCI USA, V103, P10086, DOI 10.1073/pnas.0603615103; BECKMAN JS, 1988, J BIOL CHEM, V263, P6884; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Ferrario CM, 2002, AM J HYPERTENS, V15, p9S, DOI 10.1016/S0895-7061(01)02274-9; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Finck BN, 2007, CIRCULATION, V115, P2540, DOI 10.1161/CIRCULATIONAHA.107.670588; Finkel T, 2005, NAT REV MOL CELL BIO, V6, P971, DOI 10.1038/nrm1763; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; GRIENDLING KK, 1991, J BIOL CHEM, V266, P15498; Griendling KK, 1997, HYPERTENSION, V29, P366, DOI 10.1161/01.HYP.29.1.366; Handschin C, 2005, CELL, V122, P505, DOI 10.1016/j.cell.2005.06.040; Hoo WS, 2004, CYTOM PART A, V58A, P140, DOI 10.1002/cyto.a.10097; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Kim EJ, 2008, YONSEI MED J, V49, P811, DOI 10.3349/ymj.2008.49.5.811; Kim MJ, 2008, MOL CANCER RES, V6, P1872, DOI 10.1158/1541-7786.MCR-08-0084; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Lapante MA, 2005, FREE RADICAL BIO MED, V38, P589, DOI 10.1016/j.freeradbiomed.2004.11.026; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Lerin C, 2006, CELL METAB, V3, P429, DOI 10.1016/j.cmet.2006.04.013; Leuner K, 2007, ANTIOXID REDOX SIGN, V9, P1659, DOI 10.1089/ars.2007.1763; Li F, 2005, J PHARMACOL EXP THER, V312, P1043, DOI 10.1124/jpet.104.076588; Li XH, 2007, NATURE, V447, P1012, DOI 10.1038/nature05861; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Lin JD, 2009, MOL ENDOCRINOL, V23, P2, DOI 10.1210/me.2008-0344; Lu T, 2008, EXP CELL RES, V314, P1918, DOI 10.1016/j.yexcr.2008.01.011; Murtaza I, 2008, J BIOL CHEM, V283, P5996, DOI 10.1074/jbc.M706466200; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; Ni YG, 2006, CIRCULATION, V114, P1159, DOI 10.1161/CIRCULATIONAHA.106.637124; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Puigserver P, 2001, MOL CELL, V8, P971, DOI 10.1016/S1097-2765(01)00390-2; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Rane MJ, 2001, J BIOL CHEM, V276, P3517, DOI 10.1074/jbc.M005953200; Rocic P, 2003, J BIOL CHEM, V278, P36973, DOI 10.1074/jbc.M302099200; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rosen P, 2001, DIABETES-METAB RES, V17, P189, DOI 10.1002/dmrr.196; Seshiah PN, 2002, CIRC RES, V91, P406, DOI 10.1161/01.RES.0000033523.08033.16; Skurk C, 2005, J BIOL CHEM, V280, P20814, DOI 10.1074/jbc.M500528200; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Tan WQ, 2008, J BIOL CHEM, V283, P29730, DOI 10.1074/jbc.M805514200; Taniyama Y, 2004, AM J PHYSIOL-CELL PH, V287, pC494, DOI 10.1152/ajpcell.00439.2003; Ushio-Fukai M, 1999, J BIOL CHEM, V274, P22699, DOI 10.1074/jbc.274.32.22699; Ushio-Fukai M, 1998, J BIOL CHEM, V273, P15022, DOI 10.1074/jbc.273.24.15022; UshioFukai M, 1996, J BIOL CHEM, V271, P23317, DOI 10.1074/jbc.271.38.23317; Valle I, 2005, CARDIOVASC RES, V66, P562, DOI 10.1016/j.cardiores.2005.01.026; Venkatesan B, 2007, J CELL PHYSIOL, V211, P457, DOI 10.1002/jcp.20953; Wu R, 2005, HYPERTENSION, V45, P1139, DOI 10.1161/01.HYP.0000164572.92049.29; Zafari AM, 1998, HYPERTENSION, V32, P488, DOI 10.1161/01.HYP.32.3.488; Zhang Y, 2005, HYPERTENSION, V46, P732, DOI 10.1161/01.HYP.0000182660.74266.6d	52	65	70	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2474	2487		10.1074/jbc.M109.065235	http://dx.doi.org/10.1074/jbc.M109.065235			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19940161	Green Published, hybrid			2022-12-25	WOS:000273697800026
J	Sethi, MK; Buettner, FFR; Krylov, VB; Takeuchi, H; Nifantiev, NE; Haltiwanger, RS; Gerardy-Schahn, R; Bakker, H				Sethi, Maya K.; Buettner, Falk F. R.; Krylov, Vadim B.; Takeuchi, Hideyuki; Nifantiev, Nikolay E.; Haltiwanger, Robert S.; Gerardy-Schahn, Rita; Bakker, Hans			Identification of Glycosyltransferase 8 Family Members as Xylosyltransferases Acting on O-Glucosylated Notch Epidermal Growth Factor Repeats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL LINE HEPG2; PROTEIN O-FUCOSYL-TRANSFERASE-1; LIGAND-BINDING; MODIFIES NOTCH; FRINGE; DOMAIN; GLUCOSYLTRANSFERASE; GLYCOSYLATION; BIOSYNTHESIS; SPECIFICITY	The epidermal growth factor repeats of the Notch receptor are extensively glycosylated with three different O-glycans. O-Fucosylation and elongation by the glycosyltransferase Fringe have been well studied and shown to be essential for proper Notch signaling. In contrast, biosynthesis of O-glucose and O-N-acetylglucosamine is less well understood. Recently, the isolation of the Drosophila mutant rumi has shown that absence of O-glucose impairs Notch function. O-Glucose is further extended by two contiguous alpha 1,3-linked xylose residues. We have identified two enzymes of the human glycosyltransferase 8 family, now named GXYLT1 and GXYLT2 (glucoside xylosyltransferase), as UDP-D-xylose:beta D-glucoside alpha 1,3-D-xylosyltransferases adding the first xylose. The enzymes are specific for beta-glucose-terminating acceptors and UDP-xylose as donor substrate. Generation of the alpha 1,3-linkage was confirmed by nuclear magnetic resonance. Activity on a natural acceptor could be shown by in vitro xylosylation of a Notch fragment expressed in a UDP-xylose-deficient cell line and in vivo by co-expression of the enzymes and the Notch fragment in insect cells followed by mass spectrometric analysis of peptide fragments.	[Sethi, Maya K.; Buettner, Falk F. R.; Gerardy-Schahn, Rita; Bakker, Hans] Hannover Med Sch, Dept Cellular Chem, D-30625 Hannover, Germany; [Buettner, Falk F. R.] Univ Vet Med Hannover, Dept Infect Dis, Inst Microbiol, D-30173 Hannover, Germany; [Krylov, Vadim B.; Nifantiev, Nikolay E.] Russian Acad Sci, Lab Glycoconjugate Chem, ND Zelinsky Inst Organ Chem, Moscow 119991, Russia; [Takeuchi, Hideyuki; Haltiwanger, Robert S.] SUNY Stony Brook, Dept Biochem & Cell Biol, Inst Cell & Dev Biol, Stony Brook, NY 11794 USA	Hannover Medical School; University of Veterinary Medicine Hannover, Foundation; Russian Academy of Sciences; Zelinsky Institute of Organic Chemistry; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Bakker, H (corresponding author), Hannover Med Sch, Dept Cellular Chem, Carl Neuberg Str 1, D-30625 Hannover, Germany.	bakker.hans@mh-hannover.de	Bakker, Hans/AAA-1623-2020; Nifantiev, Nikolay E/O-6579-2015; Takeuchi, Hideyuki/AAZ-9210-2020; Krylov, Vadim B./AAE-9936-2022; Bakker, Hans/A-1787-2017; Krylov, Vadim B./AES-8666-2022	Bakker, Hans/0000-0002-1364-9154; Nifantiev, Nikolay E/0000-0002-0727-4050; Krylov, Vadim B./0000-0001-9477-4610; Bakker, Hans/0000-0002-1364-9154; Krylov, Vadim B./0000-0001-9477-4610	National Institutes of Health [GM061126]; Deutsche Forschungsgemeinschaft (DFG); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061126] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health grown in Insect-Xpress medium (Lonza) by baculovirus Grant GM061126 (to R. S. H.). This work was also supported by a grant from the Deutsche Forschungsgemeinschaft (DFG) (to R. G.-S.) for the Junior Research Group "Stem Cell Glycans" established under the roof of REBIRTH, a DFG cluster of Excellence at Hannover Medical School.	Acar M, 2008, CELL, V132, P247, DOI 10.1016/j.cell.2007.12.016; Bakker H, 2009, J BIOL CHEM, V284, P2576, DOI 10.1074/jbc.M804394200; BJOERN S, 1991, J BIOL CHEM, V266, P11051; Bruckner K, 2000, NATURE, V406, P411, DOI 10.1038/35019075; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; HASE S, 1990, J BIOL CHEM, V265, P1858; Hicks C, 2000, NAT CELL BIOL, V2, P515, DOI 10.1038/35019553; Ishimizu T, 2007, J BIOCHEM, V141, P593, DOI 10.1093/jb/mvm064; Kanagawa M, 2004, CELL, V117, P953, DOI 10.1016/j.cell.2004.06.003; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; Krylov V, 2007, SYNTHESIS-STUTTGART, P3147, DOI 10.1055/s-2007-990784; Luther KB, 2009, INT J BIOCHEM CELL B, V41, P1011, DOI 10.1016/j.biocel.2008.10.001; Matsuura A, 2008, J BIOL CHEM, V283, P35486, DOI 10.1074/jbc.M806202200; Minamida S, 1996, J BIOCHEM-TOKYO, V120, P1002; Moloney DJ, 2000, J BIOL CHEM, V275, P9604, DOI 10.1074/jbc.275.13.9604; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Okajima T, 2005, SCIENCE, V307, P1599, DOI 10.1126/science.1108995; Okamura Y, 2008, MECH DEVELOP, V125, P663, DOI 10.1016/j.mod.2008.04.007; Omichi K, 1997, EUR J BIOCHEM, V245, P143, DOI 10.1111/j.1432-1033.1997.00143.x; PALCIC MM, 1988, GLYCOCONJUGATE J, V5, P49, DOI 10.1007/BF01048331; PITCHER J, 1988, EUR J BIOCHEM, V176, P391, DOI 10.1111/j.1432-1033.1988.tb14294.x; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Rampal R, 2005, J BIOL CHEM, V280, P42454, DOI 10.1074/jbc.M509552200; Shao L, 2003, J BIOL CHEM, V278, P7775, DOI 10.1074/jbc.M212221200; Shao L, 2002, GLYCOBIOLOGY, V12, P763, DOI 10.1093/glycob/cwf085; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shi SL, 2003, P NATL ACAD SCI USA, V100, P5234, DOI 10.1073/pnas.0831126100; Stahl M, 2008, J BIOL CHEM, V283, P13638, DOI 10.1074/jbc.M802027200; Xu AG, 2007, J BIOL CHEM, V282, P35153, DOI 10.1074/jbc.M707040200	29	79	82	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2010	285	3					1582	1586		10.1074/jbc.C109.065409	http://dx.doi.org/10.1074/jbc.C109.065409			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	541PJ	19940119	Green Published, hybrid			2022-12-25	WOS:000273429100003
J	Xu, D; Zhang, Y				Xu, Dong; Zhang, Yang			Generating Triangulated Macromolecular Surfaces by Euclidean Distance Transform	PLOS ONE			English	Article							SOLVENT-ACCESSIBLE SURFACE; ANALYTICAL SHAPE; COMPUTATION; EFFICIENT; PROTEINS; AREAS; APPROXIMATION; DOCKING; VOLUME	Macromolecular surfaces are fundamental representations of their three-dimensional geometric shape. Accurate calculation of protein surfaces is of critical importance in the protein structural and functional studies including ligand-protein docking and virtual screening. In contrast to analytical or parametric representation of macromolecular surfaces, triangulated mesh surfaces have been proved to be easy to describe, visualize and manipulate by computer programs. Here, we develop a new algorithm of EDTSurf for generating three major macromolecular surfaces of van der Waals surface, solvent-accessible surface and molecular surface, using the technique of fast Euclidean Distance Transform (EDT). The triangulated surfaces are constructed directly from volumetric solids by a Vertex-Connected Marching Cube algorithm that forms triangles from grid points. Compared to the analytical result, the relative error of the surface calculations by EDTSurf is <2-4% depending on the grid resolution, which is 1.5-4 times lower than the methods in the literature; and yet, the algorithm is faster and costs less computer memory than the comparative methods. The improvements in both accuracy and speed of the macromolecular surface determination should make EDTSurf a useful tool for the detailed study of protein docking and structure predictions. Both source code and the executable program of EDTSurf are freely available at http://zhang.bioinformatics.ku.edu/EDTSurf.	[Xu, Dong; Zhang, Yang] Univ Michigan, Ctr Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Xu, Dong; Zhang, Yang] Univ Kansas, Ctr Bioinformat, Lawrence, KS 66045 USA; [Xu, Dong; Zhang, Yang] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA	University of Michigan System; University of Michigan; University of Kansas; University of Kansas	Xu, D (corresponding author), Univ Michigan, Ctr Computat Med & Bioinformat, Ann Arbor, MI 48109 USA.	zhng@umich.edu	YZ, YZ/B-3243-2011; xu, dong/I-7737-2013	xu, dong/0000-0002-6616-1427	Alfred P. Sloan Foundation; NSF [0746198]; National Institute of General Medical Sciences [GM083107, GM084222]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083107, R01GM084222] Funding Source: NIH RePORTER	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); NSF(National Science Foundation (NSF)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The project is supported by the Alfred P. Sloan Foundation, NSF Career Award 0746198 and the National Institute of General Medical Sciences Grant GM083107 and GM084222. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Can T, 2006, J MOL GRAPH MODEL, V25, P442, DOI 10.1016/j.jmgm.2006.02.012; CONNOLLY ML, 1983, J APPL CRYSTALLOGR, V16, P548, DOI 10.1107/S0021889883010985; CONNOLLY ML, 1993, J MOL GRAPH MODEL, V11, P139, DOI 10.1016/0263-7855(93)87010-3; CONNOLLY ML, 1985, J APPL CRYSTALLOGR, V18, P499, DOI 10.1107/S0021889885010779; CONNOLLY ML, 1983, SCIENCE, V221, P709, DOI 10.1126/science.6879170; DUNCAN BS, 1993, BIOPOLYMERS, V33, P219, DOI 10.1002/bip.360330204; EDELSBRUNNER H, 1994, ACM T GRAPHIC, V13, P43, DOI 10.1145/174462.156635; Fraczkiewicz R, 1998, J COMPUT CHEM, V19, P319, DOI 10.1002/(SICI)1096-987X(199802)19:3<319::AID-JCC6>3.0.CO;2-W; GREER J, 1978, P NATL ACAD SCI USA, V75, P303, DOI 10.1073/pnas.75.1.303; Hayryan S, 2005, J COMPUT CHEM, V26, P334, DOI 10.1002/jcc.20125; HUANG CT, 1994, IEEE T PATTERN ANAL, V16, P443, DOI 10.1109/34.277600; Juffer AH, 1998, J COMPUT AID MOL DES, V12, P289, DOI 10.1023/A:1016089901704; Kanamori E, 2007, PROTEINS, V69, P832, DOI 10.1002/prot.21737; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Liang J, 1998, PROTEINS, V33, P18, DOI 10.1002/(SICI)1097-0134(19981001)33:1<18::AID-PROT2>3.3.CO;2-X; Liang J, 1998, PROTEINS, V33, P1; Liang J, 1997, BIOPHYS J, V73, P1830, DOI 10.1016/S0006-3495(97)78213-4; Locasale JW, 2009, J MOL BIOL, V386, P1054, DOI 10.1016/j.jmb.2009.01.007; Lorensen WE., 1987, ACM SIGGRAPH COMPUTE, P163, DOI [10.1145/37401.37422, DOI 10.1145/37401.37422]; PERROT G, 1992, J COMPUT CHEM, V13, P1, DOI 10.1002/jcc.540130102; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; RICHARDS FM, 1977, ANNU REV BIOPHYS BIO, V6, P151, DOI 10.1146/annurev.bb.06.060177.001055; RICHMOND TJ, 1984, J MOL BIOL, V178, P63, DOI 10.1016/0022-2836(84)90231-6; Rychkov G, 2007, J COMPUT CHEM, V28, P1974, DOI 10.1002/jcc.20550; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.3.CO;2-8; Schneidman-Duhovny D, 2003, PROTEINS, V52, P107, DOI 10.1002/prot.10397; VINCENT L, 1991, EXACT EUCLIDEAN DIST, P520; Wu ST, 2008, PROTEINS, V72, P547, DOI 10.1002/prot.21945; XIANG ZX, 1995, J COMPUT CHEM, V16, P512, DOI 10.1002/jcc.540160414; Xu D, 2006, LECT NOTES COMPUT SC, V4261, P72; YE QZ, 1988, SIGNED EUCLIDEAN DIS, P495; Zavodszky MI, 2002, J COMPUT AID MOL DES, V16, P883, DOI 10.1023/A:1023866311551; Zhang Y, 2008, CURR OPIN STRUC BIOL, V18, P342, DOI 10.1016/j.sbi.2008.02.004; Zhang YJ, 2006, COMPUT AIDED GEOM D, V23, P510, DOI 10.1016/j.cagd.2006.01.008	34	73	74	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2009	4	12							e8140	10.1371/journal.pone.0008140	http://dx.doi.org/10.1371/journal.pone.0008140			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MU	19956577	gold, Green Submitted, Green Published			2022-12-25	WOS:000272828800030
J	Eleftherohorinou, H; Wright, V; Hoggart, C; Hartikainen, AL; Jarvelin, MR; Balding, D; Coin, L; Levin, M				Eleftherohorinou, Hariklia; Wright, Victoria; Hoggart, Clive; Hartikainen, Anna-Liisa; Jarvelin, Marjo-Riitta; Balding, David; Coin, Lachlan; Levin, Michael			Pathway Analysis of GWAS Provides New Insights into Genetic Susceptibility to 3 Inflammatory Diseases	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; NF-KAPPA-B; TYPE-1 DIABETES RISK; RHEUMATOID-ARTHRITIS; AUTOIMMUNE-DISEASE; PROMOTER REGION; LOCI; PREDICTION; POLYMORPHISMS; PATHOGENESIS	Although the introduction of genome-wide association studies (GWAS) have greatly increased the number of genes associated with common diseases, only a small proportion of the predicted genetic contribution has so far been elucidated. Studying the cumulative variation of polymorphisms in multiple genes acting in functional pathways may provide a complementary approach to the more common single SNP association approach in understanding genetic determinants of common disease. We developed a novel pathway-based method to assess the combined contribution of multiple genetic variants acting within canonical biological pathways and applied it to data from 14,000 UK individuals with 7 common diseases. We tested inflammatory pathways for association with Crohn's disease (CD), rheumatoid arthritis (RA) and type 1 diabetes (T1D) with 4 non-inflammatory diseases as controls. Using a variable selection algorithm, we identified variants responsible for the pathway association and evaluated their use for disease prediction using a 10 fold cross-validation framework in order to calculate out-of-sample area under the Receiver Operating Curve (AUC). The generalisability of these predictive models was tested on an independent birth cohort from Northern Finland. Multiple canonical inflammatory pathways showed highly significant associations (p 10(-3) -10(-20)) with CD, T1D and RA. Variable selection identified on average a set of 205 SNPs (149 genes) for T1D, 350 SNPs (189 genes) for RA and 493 SNPs (277 genes) for CD. The pattern of polymorphisms at these SNPS were found to be highly predictive of T1D (91% AUC) and RA (85% AUC), and weakly predictive of CD (60% AUC). The predictive ability of the T1D model (without any parameter refitting) had good predictive ability (79% AUC) in the Finnish cohort. Our analysis suggests that genetic contribution to common inflammatory diseases operates through multiple genes interacting in functional pathways.	[Eleftherohorinou, Hariklia; Wright, Victoria; Levin, Michael] Univ London Imperial Coll Sci Technol & Med, Dept Paediat, Div Med, London, England; [Eleftherohorinou, Hariklia; Hoggart, Clive; Jarvelin, Marjo-Riitta; Balding, David; Coin, Lachlan] Univ London Imperial Coll Sci Technol & Med, Div Epidemiol, Dept Epidemiol & Publ Hlth, London, England; [Hartikainen, Anna-Liisa] Univ Oulu, Dept Clin Sci Obstet & Gynecol, Oulu, Finland; [Jarvelin, Marjo-Riitta] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Jarvelin, Marjo-Riitta] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Jarvelin, Marjo-Riitta] Univ Oulu, Natl Inst Hlth & Welf, Dept Child & Adolescent Hlth, Oulu, Finland	Imperial College London; Imperial College London; University of Oulu; University of Oulu; University of Oulu; Finland National Institute for Health & Welfare; University of Oulu	Eleftherohorinou, H (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Paediat, Div Med, London, England.	m.levin@imperial.ac.uk	Coin, Lachlan JM/A-9001-2014; Coin, Lachlan/O-4976-2019; Balding, David/G-9898-2011	Coin, Lachlan JM/0000-0002-4300-455X; Coin, Lachlan/0000-0002-4300-455X; Balding, David/0000-0002-1480-6115; Wright, Victoria/0000-0001-7826-1516; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Levin, Michael/0000-0003-2767-6919	Wellcome Trust [076113]; Academy of Finland [104781, 120315]; Biocenter, University of Oulu, Finland [5R01HL087679-02]; STAMPEED [1RL1MH083268-01]; ENGAGE [HEALTH-F4-2007-201413]; ESPID; European Network for Genetic-Epidemiological Studies; Imperial College Faculty of Medicine; Medical Research Council [G0300766] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [RL1MH083268] Funding Source: NIH RePORTER; MRC [G0300766] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Academy of Finland(Academy of Finland); Biocenter, University of Oulu, Finland; STAMPEED; ENGAGE; ESPID; European Network for Genetic-Epidemiological Studies; Imperial College Faculty of Medicine; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding for the WTCCC project was provided by the Wellcome Trust under award 076113. For the NFBC1966, the financial support was received from the Academy of Finland (project grants 104781, 120315), Biocenter, University of Oulu, Finland, NHLBI grant 5R01HL087679-02 through the STAMPEED program (1RL1MH083268-01), ENGAGE project and grant agreement HEALTH-F4-2007-201413. Lachlan Coin is supported by a research council UK fellowship; Victoria Wright is supported by a grant from ESPID, Clive Hoggart is supported by the European Network for Genetic-Epidemiological Studies, Hariklia Eleftherohorinou is supported by the Imperial College Faculty of Medicine studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atzeni F, 2007, AUTOIMMUN REV, V6, P529, DOI 10.1016/j.autrev.2007.03.009; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; BARRETT JC, 2009, NAT GENET; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Barton A, 2008, NAT GENET, V40, P1156, DOI 10.1038/ng.218; Benfey PN, 2008, SCIENCE, V320, P495, DOI 10.1126/science.1153716; Blackwell JM, 2003, IMMUNOL LETT, V85, P197, DOI 10.1016/S0165-2478(02)00231-6; Brandtzaeg P, 2002, CURR OPIN INFECT DIS, V15, P247, DOI 10.1097/00001432-200206000-00006; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Buzzetti R, 2004, DIABETES-METAB RES, V20, P137, DOI 10.1002/dmrr.426; Casanova JL, 2002, ANNU REV IMMUNOL, V20, P581, DOI 10.1146/annurev.immunol.20.081501.125851; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Cooper JD, 2008, NAT GENET, V40, P1399, DOI 10.1038/ng.249; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Fisher SA, 2008, NAT GENET, V40, P710, DOI 10.1038/ng.145; Fung EYMG, 2009, GENES IMMUN, V10, P188, DOI 10.1038/gene.2008.99; Hahn C G, 1999, Bipolar Disord, V1, P81, DOI 10.1034/j.1399-5618.1999.010204.x; Han SW, 2009, J RHEUMATOL, V36, P693, DOI 10.3899/jrheum.081054; Hill AVS, 2006, ANNU REV GENET, V40, P469, DOI 10.1146/annurev.genet.40.110405.090546; Hoggart CJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000130; Horton R, 2004, NAT REV GENET, V5, P889, DOI 10.1038/nrg1489; Hunter DJ, 2007, NEW ENGL J MED, V357, P436, DOI 10.1056/NEJMp078120; Jakkula E, 2008, AM J HUM GENET, V83, P787, DOI 10.1016/j.ajhg.2008.11.005; Janssens ACJW, 2008, HUM MOL GENET, V17, pR166, DOI 10.1093/hmg/ddn250; Jono H, 2004, J BIOL CHEM, V279, P36171, DOI 10.1074/jbc.M406638200; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kathiresan S, 2008, NEW ENGL J MED, V358, P1240, DOI 10.1056/NEJMoa0706728; Kirsten H, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2683; Kruglyak L, 2008, NAT REV GENET, V9, P314, DOI 10.1038/nrg2316; Kwiatkowski Dominic P., 2006, Parassitologia (Rome), V48, P450; Lee HS, 2008, MOL MED, V14, P293, DOI 10.2119/2007-00123.Lee; Lesnick TG, 2007, PLOS GENET, V3, P984, DOI 10.1371/journal.pgen.0030098; Lettre G, 2008, HUM MOL GENET, V17, pR116, DOI 10.1093/hmg/ddn246; Lin J, 2008, CLIN IMMUNOL, V126, P13, DOI 10.1016/j.clim.2007.08.012; Lin SC, 2008, J MOL BIOL, V376, P526, DOI 10.1016/j.jmb.2007.11.092; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; Martinez A, 2008, ARTHRITIS RHEUM-US, V58, P2598, DOI 10.1002/art.23792; Martinez A, 2001, ARTHRITIS RHEUM-US, V44, P1261, DOI 10.1002/1529-0131(200106)44:6<1261::AID-ART217>3.0.CO;2-L; Mason SJ, 2002, Q J ROY METEOR SOC, V128, P2145, DOI 10.1256/003590002320603584; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; Noble JA, 2008, HUM IMMUNOL, V69, P291, DOI 10.1016/j.humimm.2008.02.003; Ounissi-Benkalha H, 2008, TRENDS MOL MED, V14, P268, DOI 10.1016/j.molmed.2008.04.002; Pharoah PDP, 2007, PLOS GENET, V3, P401, DOI 10.1371/journal.pgen.0030042; Plenge RM, 2007, NAT GENET, V39, P1477, DOI 10.1038/ng.2007.27; Raychaudhuri S, 2008, NAT GENET, V40, P1216, DOI 10.1038/ng.233; Sabatti C, 2009, NAT GENET, V41, P35, DOI 10.1038/ng.271; Shimane K, 2009, ANN RHEUM DIS, V68, P377, DOI 10.1136/ard.2007.085704; Sigurdsson S, 2007, ARTHRITIS RHEUM-US, V56, P2202, DOI 10.1002/art.22704; Silverman GJ, 2003, ARTHRITIS RES THER, V5, pS1, DOI 10.1186/ar1010; Skyler JS, 2007, CLIN PHARMACOL THER, V81, P768, DOI 10.1038/sj.clpt.6100179; Smyth DJ, 2008, NEW ENGL J MED, V359, P2767, DOI 10.1056/NEJMoa0807917; Thomson W, 2007, NAT GENET, V39, P1431, DOI 10.1038/ng.2007.32; Torkamani A, 2008, GENOMICS, V92, P265, DOI 10.1016/j.ygeno.2008.07.011; van der Poll T, 2008, LANCET INFECT DIS, V8, P32, DOI 10.1016/S1473-3099(07)70265-7; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Wang K, 2009, AM J HUM GENET, V84, P399, DOI 10.1016/j.ajhg.2009.01.026; Wray NR, 2008, CURR OPIN GENET DEV, V18, P257, DOI 10.1016/j.gde.2008.07.006; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Zhang J, 2006, J CLIN INVEST, V116, P3042, DOI 10.1172/JCI28746; Zhernakova A, 2008, AM J HUM GENET, V82, P1202, DOI 10.1016/j.ajhg.2008.03.016	60	112	118	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2009	4	11							e8068	10.1371/journal.pone.0008068	http://dx.doi.org/10.1371/journal.pone.0008068			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MQ	19956648	Green Published, gold			2022-12-25	WOS:000272828400020
J	Santos, SFA; Luz, LL; Szucs, P; Lima, D; Derkach, VA; Safronov, BV				Santos, Sonia F. A.; Luz, Liliana L.; Szucs, Peter; Lima, Deolinda; Derkach, Victor A.; Safronov, Boris V.			Transmission Efficacy and Plasticity in Glutamatergic Synapses Formed by Excitatory Interneurons of the Substantia Gelatinosa in the Rat Spinal Cord	PLOS ONE			English	Article							DORSAL-HORN NEURONS; LOCAL CIRCUIT CONNECTIONS; ACUTE NOXIOUS-STIMULATION; LONG-TERM POTENTIATION; HAMSTER LAMINA-III; PROTEIN-KINASE-II; AMPA RECEPTORS; PATCH-CLAMP; CENTRAL SENSITIZATION; NOCICEPTIVE SYNAPSES	Background: Substantia gelatinosa (SG, lamina II) is a spinal cord region where most unmyelinated primary afferents terminate and the central nociceptive processing begins. The glutamatergic excitatory interneurons (EINs) form the majority of the SG neuron population, but little is known about the mechanisms of signal processing in their synapses. Methodology: To describe the functional organization and properties of excitatory synapses formed by SG EINs, we did non-invasive recordings from 183 pairs of monosynaptically connected neurons. An intact presynaptic SG EIN was specifically stimulated through the cell-attached pipette while the evoked EPSCs/EPSPs were recorded through perforated-patch from a postsynaptic neuron (laminae I-III). Principal Findings: We found that the axon of an SG EIN forms multiple functional synapses on the dendrites of a postsynaptic neuron. In many cases, EPSPs evoked by stimulating an SG EIN were sufficient to elicit spikes in a postsynaptic neuron. EPSCs were carried through both Ca2+-permeable (CP) and Ca2+-impermeable (CI) AMPA receptors (AMPARs) and showed diverse forms of functional plasticity. The synaptic efficacy could be enhanced through both activation of silent synapses and strengthening of already active synapses. We have also found that a high input resistance (R-IN, > 0.5 G Omega) of the postsynaptic neuron is necessary for resolving distal dendritic EPSCs/EPSPs and correct estimation of their efficacy. Conclusions/Significance: We conclude that the multiple synapses formed by an SG EIN on a postsynaptic neuron increase synaptic excitation and provide basis for diverse forms of plasticity. This functional organization can be important for sensory, i.e. nociceptive, processing in the spinal cord.	[Santos, Sonia F. A.; Luz, Liliana L.; Szucs, Peter; Safronov, Boris V.] Univ Porto, IBMC, P-4100 Oporto, Portugal; [Santos, Sonia F. A.; Luz, Liliana L.; Lima, Deolinda; Safronov, Boris V.] Univ Porto, Fac Med, Lab Biol Celular & Mol, P-4100 Oporto, Portugal; [Derkach, Victor A.] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA	Universidade do Porto; Universidade do Porto; Oregon Health & Science University	Santos, SFA (corresponding author), Univ Porto, IBMC, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	safronov@ibmc.up.pt	Szucs, Peter/A-4441-2013; Luz, Liliana L/A-4208-2019; Safronov, Boris/K-2219-2013	Luz, Liliana L/0000-0001-8109-3891; Safronov, Boris/0000-0002-4614-3184; Szucs, Peter/0000-0003-4635-6427; Lima, Deolinda/0000-0002-5723-0777	Portuguese Foundation for Science and Technology; Medical Research Foundation; NIH [NS027037]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027037] Funding Source: NIH RePORTER	Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); Medical Research Foundation(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was supported by the grant from the Portuguese Foundation for Science and Technology (to B. V. S.), Medical Research Foundation grant (to V. A. D.) and NIH grant NS027037 (to Thomas Soderling and V. A. D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antal M, 2008, J NEUROSCI, V28, P9692, DOI 10.1523/JNEUROSCI.1551-08.2008; ARAKI T, 1962, J NEUROPHYSIOL, V25, P772, DOI 10.1152/jn.1962.25.6.772; BARRY PH, 1991, J MEMBRANE BIOL, V121, P101, DOI 10.1007/BF01870526; BARRY PH, 1994, J NEUROSCI METH, V51, P107, DOI 10.1016/0165-0270(94)90031-0; BASBAUM AI, 2000, PRINCIPLES NEURAL SC, P472; BERRY MS, 1976, BRAIN RES, V105, P1, DOI 10.1016/0006-8993(76)90919-7; Bertil H., 2001, ION CHANNELS EXCITAB; Chery N, 1999, J NEUROSCI, V19, P7342, DOI 10.1523/JNEUROSCI.19-17-07342.1999; COOMBS JS, 1957, J PHYSIOL-LONDON, V139, P198, DOI 10.1113/jphysiol.1957.sp005887; COOMBS JS, 1955, J PHYSIOL-LONDON, V130, P291, DOI 10.1113/jphysiol.1955.sp005411; COOMBS JS, 1957, J PHYSIOL-LONDON, V139, P232, DOI 10.1113/jphysiol.1957.sp005888; Derkach VA, 2007, NAT REV NEUROSCI, V8, P101, DOI 10.1038/nrn2055; Diba K, 2004, J NEUROSCI, V24, P9723, DOI 10.1523/JNEUROSCI.1721-04.2004; Dingledine R, 1999, PHARMACOL REV, V51, P7; Fang L, 2002, J NEUROSCI, V22, P4196, DOI 10.1523/JNEUROSCI.22-10-04196.2002; Graham BA, 2008, J NEUROPHYSIOL, V99, P2048, DOI 10.1152/jn.01176.2007; Graham BA, 2007, J NEUROPHYSIOL, V98, P1057, DOI 10.1152/jn.00581.2007; Hantman AW, 2004, J NEUROSCI, V24, P836, DOI 10.1523/JNEUROSCI.4221-03.2004; Hines M, 1993, NEURAL SYSTEMS ANAL, P127; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145; Jacobson GA, 2005, J PHYSIOL-LONDON, V564, P145, DOI 10.1113/jphysiol.2004.080903; Katano T, 2008, EUR J NEUROSCI, V27, P3161, DOI 10.1111/j.1460-9568.2008.06293.x; Kato G, 2007, J PHYSIOL-LONDON, V580, P815, DOI 10.1113/jphysiol.2007.128314; Landry M, 2004, J COMP NEUROL, V468, P380, DOI 10.1002/cne.10988; Larsson M, 2006, J NEUROSCI, V26, P4198, DOI 10.1523/JNEUROSCI.0352-06.2006; Larsson M, 2005, EUR J NEUROSCI, V21, P2445, DOI 10.1111/j.1460-9568.2005.04081.x; Larsson M, 2008, J NEUROSCI, V28, P7084, DOI 10.1523/JNEUROSCI.5749-07.2008; Lu VB, 2009, J PHYSIOL-LONDON, V587, P1013, DOI 10.1113/jphysiol.2008.166306; Lu Y, 2005, J NEUROSCI, V25, P3900, DOI 10.1523/JNEUROSCI.0102-05.2005; Lu Y, 2003, J NEUROSCI, V23, P8752; Lu Y, 2008, J NEUROPHYSIOL, V99, P1051, DOI 10.1152/jn.00027.2008; Marty Alain, 1995, P31; Melnick IV, 2004, J PHYSIOL-LONDON, V559, P383, DOI 10.1113/jphysiol.2004.066415; Melnick IV, 2004, J NEUROPHYSIOL, V91, P646, DOI 10.1152/jn.00883.2003; MELZACK R, 1965, SCIENCE, V150, P971, DOI 10.1126/science.150.3699.971; Morisset V, 2001, J NEUROPHYSIOL, V86, P40, DOI 10.1152/jn.2001.86.1.40; Nagy GG, 2004, J NEUROSCI, V24, P5766, DOI 10.1523/JNEUROSCI.1237-04.2004; Ohana O, 1998, J PHYSIOL-LONDON, V513, P135, DOI 10.1111/j.1469-7793.1998.135by.x; Oren I, 2009, J NEUROSCI, V29, P939, DOI 10.1523/JNEUROSCI.3251-08.2009; Park JS, 2009, J NEUROSCI, V29, P3206, DOI 10.1523/JNEUROSCI.4514-08.2009; Pedersen LM, 2005, BRAIN RES, V1041, P66, DOI 10.1016/j.brainres.2005.02.004; Polgar E, 2008, J NEUROSCI, V28, P13150, DOI 10.1523/JNEUROSCI.4053-08.2008; RAE J, 1991, J NEUROSCI METH, V37, P15, DOI 10.1016/0165-0270(91)90017-T; Safronov BV, 2007, J NEUROSCI METH, V164, P292, DOI 10.1016/j.jneumeth.2007.05.010; Safronov BV, 1997, J PHYSIOL-LONDON, V503, P371, DOI 10.1111/j.1469-7793.1997.371bh.x; Safronov BV, 1999, PROG NEUROBIOL, V59, P217, DOI 10.1016/S0301-0082(98)00051-3; Safronov BV, 1999, J PHYSIOL-LONDON, V514, P729, DOI 10.1111/j.1469-7793.1999.729ad.x; Safronov BV, 2000, BIOPHYS J, V78, P2998, DOI 10.1016/S0006-3495(00)76838-X; Santos SFA, 2004, ANESTHESIOLOGY, V101, P1177, DOI 10.1097/00000542-200411000-00018; Santos SFA, 2007, J PHYSIOL-LONDON, V581, P241, DOI 10.1113/jphysiol.2006.126912; Schneider SP, 2008, J NEUROPHYSIOL, V99, P1306, DOI 10.1152/jn.00962.2007; Szucs P, 2009, J NEUROSCI METH, V177, P369, DOI 10.1016/j.jneumeth.2008.10.024; TODD AJ, 1990, J COMP NEUROL, V296, P496, DOI 10.1002/cne.902960312; Vikman KS, 2008, J PHYSIOL-LONDON, V586, P515, DOI 10.1113/jphysiol.2007.145581; YOSHIMURA M, 1993, NEUROSCIENCE, V53, P519, DOI 10.1016/0306-4522(93)90216-3	56	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2009	4	11							e8047	10.1371/journal.pone.0008047	http://dx.doi.org/10.1371/journal.pone.0008047			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MQ	19956641	Green Published, gold, Green Submitted			2022-12-25	WOS:000272828400008
J	Shepherd, AK; Singh, R; Wesley, CS				Shepherd, Andrew K.; Singh, Ravinder; Wesley, Cedric S.			Notch mRNA Expression in Drosophila Embryos Is Negatively Regulated at the Level of mRNA 3 ' Processing	PLOS ONE			English	Article							CELL-FATE; POLY(A) POLYMERASE; GENETIC CIRCUITRY; TRUNCATED NOTCH; DELTA; LOCUS; POLYADENYLATION; MELANOGASTER; MUTATIONS; RECEPTOR	Notch receptor regulates differentiation of almost all tissues and organs during animal development. Many mechanisms function at the protein level to finely regulate Notch activity. Here we provide evidence for Notch regulation at an earlier step - mRNA 3' processing. Processing at the Notch consensus polyadenylation site appears by default to be suppressed in Drosophila embryos. Interference with this suppression, by a mutation, results in increased levels of polyadenylated Notch mRNA, excess Notch signaling, and severe developmental defects. We propose that Notch mRNA 3' processing is negatively regulated to limit the production of Notch protein and render it a controlling factor in the generation of Notch signaling.	[Shepherd, Andrew K.; Wesley, Cedric S.] Univ Vermont, Dept Microbiol & Mol Genet, Burlington, VT 05405 USA; [Singh, Ravinder] Univ Colorado, Dept Mol Cell & Dev Biol, Boulder, CO 80309 USA	University of Vermont; University of Colorado System; University of Colorado Boulder	Shepherd, AK (corresponding author), Univ Vermont, Dept Microbiol & Mol Genet, Burlington, VT 05405 USA.	cwesley@uvm.edu			National Institutes of Health [R01 NS43122]; Department of Microbiology and Molecular Genetics, University of Vermont; College of Medicine Bridge Funds, University of Vermont; National Institutes of Health COBRE [P20 RR016435]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016435] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043122] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Microbiology and Molecular Genetics, University of Vermont; College of Medicine Bridge Funds, University of Vermont; National Institutes of Health COBRE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health grant R01 NS43122; the Department of Microbiology and Molecular Genetics, University of Vermont; College of Medicine Bridge Funds, University of Vermont; and the National Institutes of Health COBRE grant P20 RR016435. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahimou F, 2004, J CELL BIOL, V167, P1217, DOI 10.1083/jcb.200407100; ALTON AK, 1989, DEV GENET, V10, P261, DOI 10.1002/dvg.1020100315; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Ashburner M., 2004, DROSOPHILA LAB HDB; Baker NE, 2007, CURR OPIN GENET DEV, V17, P287, DOI 10.1016/j.gde.2007.05.005; Bardot B, 2005, EXP CELL RES, V304, P202, DOI 10.1016/j.yexcr.2004.10.030; Bentley DL, 2005, CURR OPIN CELL BIOL, V17, P251, DOI 10.1016/j.ceb.2005.04.006; Blank U, 2008, BLOOD, V111, P492, DOI 10.1182/blood-2007-07-075168; Brennan K, 1997, GENETICS, V147, P177; CABRERA CV, 1990, DEVELOPMENT, V110, P733; Campos-Ortega J, 1997, EMBRYONIC DEV DROSOP; Carlson ME, 2007, CURR OPIN PHARMACOL, V7, P303, DOI 10.1016/j.coph.2007.02.004; Castelo-Branco P, 2004, MOL CELL BIOL, V24, P4174, DOI 10.1128/MCB.24.10.4174-4183.2004; Danckwardt S, 2004, BLOOD, V104, P428, DOI 10.1182/blood-2003-08-2894; DELACONCHA A, 1988, GENETICS, V118, P499; Emerson SG, 2005, BIOL BLOOD MARROW TR, V11, P1, DOI 10.1016/S1083-8791(04)00985-1; FORTINI ME, 1993, NATURE, V365, P555, DOI 10.1038/365555a0; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; HARDINGTHEOBALD ER, 2007, N ND 1 MOL LESION; HEITZLER P, 1991, CELL, V64, P1083, DOI 10.1016/0092-8674(91)90263-X; Hentze MW, 1999, CELL, V96, P307, DOI 10.1016/S0092-8674(00)80542-5; Herranz H, 2006, BIOESSAYS, V28, P113, DOI 10.1002/bies.20366; Juge F, 2002, EMBO J, V21, P6603, DOI 10.1093/emboj/cdf633; Kankel MW, 2007, GENETICS, V177, P2493, DOI 10.1534/genetics.107.080994; Kornblihtt AR, 2004, RNA, V10, P1489, DOI 10.1261/rna.7100104; Lai EC, 2004, DEVELOPMENT, V131, P965, DOI 10.1242/dev.01074; Le Borgne R, 2005, DEVELOPMENT, V132, P1751, DOI 10.1242/dev.01789; LeComte M, 2006, DEV DYNAM, V235, P411, DOI 10.1002/dvdy.20650; LIEBER T, 1993, GENE DEV, V7, P1949, DOI 10.1101/gad.7.10.1949; LYMAN D, 1993, P NATL ACAD SCI USA, V90, P10395, DOI 10.1073/pnas.90.21.10395; Mishra-Gorur K, 2002, J CELL BIOL, V159, P313, DOI 10.1083/jcb.200203117; Murata T, 2001, DEV BIOL, V233, P137, DOI 10.1006/dbio.2001.0205; Norga KK, 2003, CURR BIOL, V13, P1388, DOI 10.1016/S0960-9822(03)00546-3; Okano H, 2002, J CELL SCI, V115, P1355; PALKA J, 1990, DEVELOPMENT, V109, P167; Reed R, 2002, CELL, V108, P523, DOI 10.1016/S0092-8674(02)00627-X; Salles FJ, 1999, METHODS, V17, P38, DOI 10.1006/meth.1998.0705; Sapir A, 2005, DEVELOPMENT, V132, P123, DOI 10.1242/dev.01546; Schweisguth F, 2004, CURR BIOL, V14, pR129, DOI 10.1016/j.cub.2004.01.023; SHELLENBARGER DL, 1975, GENETICS, V81, P143; SHELLENBARGER DL, 1978, DEV BIOL, V62, P432, DOI 10.1016/0012-1606(78)90226-9; STRUHL G, 1993, CELL, V74, P331, DOI 10.1016/0092-8674(93)90424-O; Wells SE, 1998, MOL CELL, V2, P135, DOI 10.1016/S1097-2765(00)80122-7; Wesley CS, 2003, MOL CELL BIOL, V23, P5581, DOI 10.1128/MCB.23.16.5581-5593.2003; Wesley CS, 2000, J CELL BIOL, V149, P683, DOI 10.1083/jcb.149.3.683; Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025; Wilusz CJ, 2001, RNA, V7, P1416; XU T, 1990, GENE DEV, V4, P464, DOI 10.1101/gad.4.3.464; ZANGAR RC, 1995, BIOTECHNIQUES, V18, P465; ZHANG SA, 1995, MOL CELL BIOL, V15, P2231; Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999; Zolkiewska A, 2008, CELL MOL LIFE SCI, V65, P2056, DOI 10.1007/s00018-008-7586-4	52	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2009	4	11							e8063	10.1371/journal.pone.0008063	http://dx.doi.org/10.1371/journal.pone.0008063			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MQ	19956683	gold, Green Published, Green Submitted			2022-12-25	WOS:000272828400017
J	van der Plas, MJA; van Dissel, JT; Nibbering, PH				van der Plas, Mariena J. A.; van Dissel, Jaap T.; Nibbering, Peter H.			Maggot Secretions Skew Monocyte-Macrophage Differentiation Away from a Pro-Inflammatory to a Pro-Angiogenic Type	PLOS ONE			English	Article							DIABETIC FOOT ULCERS; MIGRATION INHIBITORY FACTOR; APOPTOTIC CELLS; CYCLIC-AMP; INNATE IMMUNITY; CHRONIC WOUNDS; LEG ULCERS; CYTOKINE; THERAPY; EXPRESSION	Background: Maggots of the blowfly Lucilia sericata are used for the treatment of chronic wounds. Earlier we reported maggot secretions to inhibit pro-inflammatory responses of human monocytes. The aim of this study was to investigate the effect of maggot secretions on the differentiation of monocytes into pro-inflammatory (MO-1) and anti-inflammatory/proangiogenic macrophages (MO-2) as these cells play a central role in wound healing. Methodology/Principal Findings: Freshly isolated monocytes were incubated with secretions and GM-CSF or M-CSF for 6 days and then stimulated with LPS or LTA for 18 h. The expression of cell surface molecules and the levels of cytokines, chemokines and growth factors in supernatants were measured. Our results showed secretions to affect monocyte-macrophage differentiation leading to MO-1 with a partial MO-2-like morphology but lacking CD163, which is characteristic for MO-2. In response to LPS or LTA, secretions-differentiated MO-1 produced less pro-inflammatory cytokines (TNF-alpha, IL-12p40 and MIF) than control cells. Similar results were observed for MO-2 when stimulated with low concentrations of LPS. Furthermore, secretions dose-dependently led to MO-1 and MO-2 characterized by an altered chemokine production. Secretions led to MO-2, but not MO-1, producing enhanced levels of the growth factors bFGF and VEGF, as compared to control cells. The expression of cell-surface receptors involved in LPS/LTA was enhanced by secretions, that of CD86 and HLA-DR down-regulated, while receptors involved in phagocytosis remained largely unaffected. Conclusions: Maggot secretions skew the differentiation of monocytes into macrophages away from a pro-inflammatory to a pro-angiogenic type.	[van der Plas, Mariena J. A.; van Dissel, Jaap T.; Nibbering, Peter H.] Leiden Univ, Med Ctr, Dept Infect Dis, Leiden, Netherlands; [van der Plas, Mariena J. A.] Leiden Univ, Med Ctr, Dept Surg, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	van der Plas, MJA (corresponding author), Leiden Univ, Med Ctr, Dept Infect Dis, Leiden, Netherlands.	p.h.nibbering@lumc.nl	van der Plas, Mariena/GYV-3702-2022	van der Plas, Mariena/0000-0002-3233-2881	Kinetics Concepts Inc. (KCI); Europe Holding (Amstelveen, the Netherlands)	Kinetics Concepts Inc. (KCI); Europe Holding (Amstelveen, the Netherlands)(Netherlands Government)	This work was financially supported by a research grant of Kinetics Concepts Inc. (KCI), Europe Holding (Amstelveen, the Netherlands). The role of this funder was the following: the salary of the first author was paid by KCI. The funder has read and approved the manuscript. There were no restrictions with respect to publication of this manuscript.	Agren Magnus S, 2007, Int J Low Extrem Wounds, V6, P82, DOI 10.1177/1534734607301394; APELQVIST J, 1993, J INTERN MED, V233, P485, DOI 10.1111/j.1365-2796.1993.tb01003.x; Armstrong DG, 2005, J AM PODIAT MED ASSN, V95, P254, DOI 10.7547/0950254; Baer ES, 1931, J BONE JOINT SURG, V13, P438; Boulton AJM, 2005, LANCET, V366, P1719, DOI 10.1016/S0140-6736(05)67698-2; BRIGGAMAN RA, 1984, J EXP MED, V160, P1027, DOI 10.1084/jem.160.4.1027; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; CHEN SM, 1997, WOUND REPAIR REGEN, V5, P23; Distler JHW, 2003, Q J NUCL MED, V47, P149; Ehlers MRW, 2000, MICROBES INFECT, V2, P289, DOI 10.1016/S1286-4579(00)00299-9; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Falanga V, 2005, LANCET, V366, P1736, DOI 10.1016/S0140-6736(05)67700-8; Gauss KA, 2007, J LEUKOCYTE BIOL, V82, P729, DOI 10.1189/jlb.1206735; Goren I, 2003, DIABETES, V52, P2821, DOI 10.2337/diabetes.52.11.2821; Herrick S, 1997, LAB INVEST, V77, P281; Hirano Y, 2007, EUR J PHARMACOL, V560, P81, DOI 10.1016/j.ejphar.2007.01.003; Jeffcoate WJ, 2006, DIABETES CARE, V29, P1784, DOI 10.2337/dc06-0306; Jeffcoate WJ, 2003, LANCET, V361, P1545, DOI 10.1016/S0140-6736(03)13169-8; Lauer G, 2000, J INVEST DERMATOL, V115, P12, DOI 10.1046/j.1523-1747.2000.00036.x; Lavery LA, 2008, DIABETES CARE, V31, P154, DOI 10.2337/dc07-1302; LEIBOVICH SJ, 1975, AM J PATHOL, V78, P71; Lin ZQ, 2003, J LEUKOCYTE BIOL, V73, P713, DOI 10.1189/jlb.0802397; Lobmann R, 2005, DIABETES CARE, V28, P461, DOI 10.2337/diacare.28.2.461; Lobmann R, 2002, DIABETOLOGIA, V45, P1011, DOI 10.1007/s00125-002-0868-8; Loots MAM, 1998, J INVEST DERMATOL, V111, P850, DOI 10.1046/j.1523-1747.1998.00381.x; Makino M, 2007, MICROBES INFECT, V9, P70, DOI 10.1016/j.micinf.2006.10.011; Meier B, 2001, PROTOPLASMA, V217, P117, DOI 10.1007/BF01289420; Mumcuoglu KY, 1998, DIABETES CARE, V21, P2030, DOI 10.2337/diacare.21.11.2030; Oyibo SO, 2001, DIABETIC MED, V18, P133, DOI 10.1046/j.1464-5491.2001.00422.x; Park JE, 2004, AM J SURG, V187, p11S, DOI 10.1016/S0002-9610(03)00296-4; Peters EJG, 2001, DIABETES CARE, V24, P1799, DOI 10.2337/diacare.24.10.1799; Sato S, 2000, J IMMUNOL, V165, P7096, DOI 10.4049/jimmunol.165.12.7096; Savage NDL, 2008, J IMMUNOL, V181, P2220, DOI 10.4049/jimmunol.181.3.2220; Serezani CH, 2008, AM J RESP CELL MOL, V39, P127, DOI 10.1165/rcmb.2008-0091TR; Sherman RA, 2003, DIABETES CARE, V26, P446, DOI 10.2337/diacare.26.2.446; SHERMAN RA, 1993, AM J TROP MED HYG  S, P266; Steenvoorde P, 2007, ANN ROY COLL SURG, V89, P598, DOI 10.1308/003588407X205404; STODDARD SR, 1995, J AM PODIAT MED ASSN, V85, P218, DOI 10.7547/87507315-85-4-218; SUNDERKOTTER C, 1994, J LEUKOCYTE BIOL, V55, P410, DOI 10.1002/jlb.55.3.410; Tassiulas I, 2007, HUM IMMUNOL, V68, P156, DOI 10.1016/j.humimm.2006.12.008; Trengove NJ, 2000, WOUND REPAIR REGEN, V8, P13, DOI 10.1046/j.1524-475x.2000.00013.x; Trengove NJ, 1999, WOUND REPAIR REGEN, V7, P442, DOI 10.1046/j.1524-475X.1999.00442.x; Tsirogianni AK, 2006, INJURY, V37, pS5, DOI 10.1016/j.injury.2006.02.035; van der Plas MJA, 2009, DIABETOLOGIA, V52, P1962, DOI 10.1007/s00125-009-1432-6; van der Plas MJA, 2007, MICROBES INFECT, V9, P507, DOI 10.1016/j.micinf.2007.01.008; Verreck FAW, 2004, P NATL ACAD SCI USA, V101, P4560, DOI 10.1073/pnas.0400983101; Verreck FAW, 2006, J LEUKOCYTE BIOL, V79, P285, DOI 10.1189/jlb.0105015; WAHL SM, 1985, CIBA F SYMP, V114, P175; Wang Shouyu, 2008, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V22, P472; Waugh HV, 2006, B MATH BIOL, V68, P197, DOI 10.1007/s11538-005-9022-3; Whitney JD, 2005, NURS CLIN N AM, V40, P191, DOI 10.1016/j.cnur.2004.09.002; Xu W, 2006, BLOOD, V107, P4930, DOI 10.1182/blood-2005-10-4144; Yabunaka N, 2000, DIABETES CARE, V23, P256, DOI 10.2337/diacare.23.2.256; Zidek Z, 1999, EUR CYTOKINE NETW, V10, P319	54	43	46	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2009	4	11							e8071	10.1371/journal.pone.0008071	http://dx.doi.org/10.1371/journal.pone.0008071			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MQ	19956650	Green Published, Green Submitted, gold			2022-12-25	WOS:000272828400021
J	Hall, KD; Guo, J; Dore, M; Chow, CC				Hall, Kevin D.; Guo, Juen; Dore, Michael; Chow, Carson C.			The Progressive Increase of Food Waste in America and Its Environmental Impact	PLOS ONE			English	Article							ENERGY-EXPENDITURE; BODY-FAT; MASS	Food waste contributes to excess consumption of freshwater and fossil fuels which, along with methane and CO2 emissions from decomposing food, impacts global climate change. Here, we calculate the energy content of nationwide food waste from the difference between the US food supply and the food consumed by the population. The latter was estimated using a validated mathematical model of metabolism relating body weight to the amount of food eaten. We found that US per capita food waste has progressively increased by similar to 50% since 1974 reaching more than 1400 kcal per person per day or 150 trillion kcal per year. Food waste now accounts for more than one quarter of the total freshwater consumption and similar to 300 million barrels of oil per year.	[Hall, Kevin D.; Guo, Juen; Dore, Michael; Chow, Carson C.] NIDDK, Lab Biol Modeling, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Hall, KD (corresponding author), NIDDK, Lab Biol Modeling, Bethesda, MD 20892 USA.	kevinh@niddk.nih.gov; carsonc@niddk.nih.gov	Chow, Carson C/A-7970-2009; Hall, Kevin/F-2383-2010	Hall, Kevin/0000-0003-4062-3133; Guo, Juen/0000-0003-2876-5884	National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK013036] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by the Intramural Research Program of the National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AG USEP, 2009, US EM INV 2009 INV U; Blaxter K, 1989, ENERGY METABOLISM AN; BOUCHARD C, 1990, NEW ENGL J MED, V322, P1477, DOI 10.1056/NEJM199005243222101; DIAZ EO, 1992, AM J CLIN NUTR, V56, P641, DOI 10.1093/ajcn/56.4.641; FAO, 2001, FOOD BALANCE SHEETS; FORBES GB, 1987, NUTR REV, V45, P225; Forster P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P129; Griffin M, 2009, AGR HUM VALUES, V26, P67, DOI 10.1007/s10460-008-9178-1; Hall KD, 2008, INT J OBESITY, V32, P573, DOI 10.1038/sj.ijo.0803720; HALL KD, 2009, BR J NUTR UNPUB; Hall KD, 2008, AM J CLIN NUTR, V88, P1495, DOI 10.3945/ajcn.2008.26333; Hill JO, 2003, SCIENCE, V299, P853, DOI 10.1126/science.1079857; Horrigan L, 2002, ENVIRON HEALTH PERSP, V110, P445, DOI 10.1289/ehp.02110445; Institute of Medicine of the National Academies, 2002, DIET REF INT EN CARB; Jackson AS, 2002, INT J OBESITY, V26, P789, DOI 10.1038/sj.ijo.0802006; Kant AK, 2005, INT J OBESITY, V29, P950, DOI 10.1038/sj.ijo.0802980; Kantor L. S., 1997, FoodReview, V20, P2; Muth MK, 2007, EXPLORATORY RES ESTI; NELSON KM, 1992, AM J CLIN NUTR, V56, P848, DOI 10.1093/ajcn/56.5.848; Postel SL, 1996, SCIENCE, V271, P785, DOI 10.1126/science.271.5250.785; Putnam J., 2002, FoodReview, V25, P2; SCHOELLER DA, 1990, NUTR REV, V48, P373, DOI 10.1111/j.1753-4887.1990.tb02882.x; Smil V., 2000, FEEDING WORLD CHALLE; SWINBURN B, 2009, AM J CLIN NUTR; *US EN INF ADM, US PROD SUPPL CRUD O; *US EPA OFF SOL WA, 2007, MUN SOL WAST US 2007; USDA Economic Research Service, FOOD AV PER CAP DAT; Ventour L., 2008, FOOD WE WASTE WRAP E; Von Braun J., 2008, GLOBALIZATION FOOD A; Weyer C, 2000, J CLIN ENDOCR METAB, V85, P1087, DOI 10.1210/jc.85.3.1087; WIGGINS S, 2008, RISING FOOD PRICES C	31	310	320	3	153	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2009	4	11							e7940	10.1371/journal.pone.0007940	http://dx.doi.org/10.1371/journal.pone.0007940			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MK	19946359	gold, Green Submitted, Green Published			2022-12-25	WOS:000272827800008
J	Kelkar, A; Thakur, V; Ramaswamy, R; Deobagkar, D				Kelkar, Ashwin; Thakur, Vivek; Ramaswamy, Ramakrishna; Deobagkar, Deepti			Characterisation of Inactivation Domains and Evolutionary Strata in Human X Chromosome through Markov Segmentation	PLOS ONE			English	Article							DNA-SEQUENCE; NUCLEOTIDE; PROFILE	Markov segmentation is a method of identifying compositionally different subsequences in a given symbolic sequence. We have applied this technique to the DNA sequence of the human X chromosome to analyze its compositional structure. The human X chromosome is known to have acquired DNA through distinct evolutionary events and is believed to be composed of five evolutionary strata. In addition, in female mammals all copies of X chromosome in excess of one are transcriptionally inactivated. The location of a gene is correlated with its ability to undergo inactivation, but correlations between evolutionary strata and inactivation domains are less clear. Our analysis provides an accurate estimate of the location of stratum boundaries and gives a high-resolution map of compositionally different regions on the X chromosome. This leads to the identification of a novel stratum, as well as segments wherein a group of genes either undergo inactivation or escape inactivation in toto. We identify oligomers that appear to be unique to inactivation domains alone.	[Thakur, Vivek; Ramaswamy, Ramakrishna] Jawaharlal Nehru Univ, Sch Informat Technol, Ctr Computat Biol & Bioinformat, New Delhi 110067, India; [Kelkar, Ashwin; Deobagkar, Deepti] Pune Univ, Dept Zool, Pune, Maharashtra, India; [Thakur, Vivek] Int Crops Res Inst Semi Arid Trop, Patancheru, Andhra Pradesh, India; [Ramaswamy, Ramakrishna] Jawaharlal Nehru Univ, Sch Phys Sci, New Delhi 110067, India	Jawaharlal Nehru University, New Delhi; Savitribai Phule Pune University; CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT); Jawaharlal Nehru University, New Delhi	Ramaswamy, R (corresponding author), Jawaharlal Nehru Univ, Sch Informat Technol, Ctr Computat Biol & Bioinformat, New Delhi 110067, India.	r.ramaswamy@mail.jnu.ac.in; dddeo@unipune.ernet.in	Ramaswamy, Ramakrishna/L-5306-2019	Ramaswamy, Ramakrishna/0000-0002-9085-8224; Kelkar, Ashwin/0000-0002-2208-5258	University Grants Commission (UGC); Department of Biotechnology (DBT); Council of Scientific and Industrial Research (CSIR), India	University Grants Commission (UGC)(University Grants Commission, India); Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India)	This work has been supported (research fellowships and project grants) by University Grants Commission (UGC), Department of Biotechnology (DBT), and Council of Scientific and Industrial Research (CSIR), India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AZAD RK, 2007, ADV COMPUTATIONAL ME, P107; Bailey D M, 2000, High Alt Med Biol, V1, P9, DOI 10.1089/152702900320649; BernaolaGalvan P, 1996, PHYS REV E, V53, P5181, DOI 10.1103/PhysRevE.53.5181; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Carrel L, 1999, P NATL ACAD SCI USA, V96, P14440, DOI 10.1073/pnas.96.25.14440; Carrel L, 2006, PLOS GENET, V2, P1477, DOI 10.1371/journal.pgen.0020151; Curwen V, 2004, GENOME RES, V14, P942, DOI 10.1101/gr.1858004; Deobagkar DD, 2003, J GENET, V82, P13, DOI 10.1007/BF02715875; Hall LL, 2002, HUM MOL GENET, V11, P3157, DOI 10.1093/hmg/11.25.3157; Kohn M, 2004, TRENDS GENET, V20, P598, DOI 10.1016/j.tig.2004.09.008; LAHN BT, 1999, SCIENCE, V286, P5441; Li WT, 2002, COMPUT CHEM, V26, P491, DOI 10.1016/S0097-8485(02)00010-4; LIN JH, 1991, IEEE T INFORM THEORY, V37, P145, DOI 10.1109/18.61115; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Rigoutsos I, 1998, BIOINFORMATICS, V14, P55, DOI 10.1093/bioinformatics/14.1.55; Ross MT, 2005, NATURE, V434, P325, DOI 10.1038/nature03440; Smit A, 1996, REPEATMASKER OPEN 30; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1016/S0378-1097(99)00149-4; Thakur V, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.011915; Wang Z, 2006, PLOS COMPUT BIOL, V2, P979, DOI 10.1371/journal.pcbi.0020113	20	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2009	4	11							e7885	10.1371/journal.pone.0007885	http://dx.doi.org/10.1371/journal.pone.0007885			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MK	19946363	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000272827800006
J	Song, GS; Wang, L				Song, Guisheng; Wang, Li			A Conserved Gene Structure and Expression Regulation of miR-433 and miR-127 in Mammals	PLOS ONE			English	Article							OVERLAPPING GENES; HUMAN GENOME; ANTISENSE TRANSCRIPTS; MICRORNAS; REGION; LOCUS; MECHANISM; EVOLUTION; CLUSTER; ORIGIN	MicroRNAs play essential roles in many cellular processes. However, limited information is available regarding the gene structure and transcriptional regulation of miRNAs. We explored the gene cluster encoding miR-433/127 in mammalian species using bioinformatics and in vitro "gene'' expression approaches. Multiple sequence alignments (MSA) showed that the precursors of miR-433 and of miR-127 exhibited 95% and 100% similarity, respectively, in human, chimpanzee, horse, dog, monkey, rat, cow, and mouse. MSA of the promoter sequences of miR-433 and of miR-127 revealed lower sequence similarity among these mammalian species. However, the distance between miR-433 and miR-127 was strikingly similar, which was between 986 and 1007 bp and the position of transcription factor (TF) binding motifs, including estrogen related receptor response element (ERRE), was well conserved. Transient transfection assays showed that promoters of miR-433 and of miR-127 from human, rat, and dog were activated by estrogen related receptor gamma (ERR gamma) and inhibited by small heterodimer partner (SHP). ChIP assays confirmed the physical association of ERR gamma with the endogenous promoters of miR-433 and miR-127. In vitro over-expression of the human, rat, or dog miR-433/127 loci in cells, using an expression vector containing miR-433/127 and their promoter regions, markedly induced a differential expression of both primary and mature miR-433 and miR-127, indicating that miR-433 and miR-127 were possessed from their independent promoters. Our studies for the first time demonstrate a conserved gene structure and transcriptional regulation of miR-433 and miR-127 in mammals. The data suggest that the miR-433/127 loci may have evolved from a common gene of origin.	[Wang, Li] Univ Utah, Sch Med, Huntsman Canc Inst, Dept Med, Salt Lake City, UT 84112 USA; Univ Utah, Sch Med, Huntsman Canc Inst, Dept Oncol Sci, Salt Lake City, UT USA	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah	Wang, L (corresponding author), Univ Utah, Sch Med, Huntsman Canc Inst, Dept Med, Salt Lake City, UT 84112 USA.	l.wang@hsc.utah.edu	song, guisheng/E-4913-2011		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080440] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bachman NJ, 1999, MAMM GENOME, V10, P506, DOI 10.1007/s003359901031; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Cui XS, 2009, BIOCHEM BIOPH RES CO, V379, P390, DOI 10.1016/j.bbrc.2008.12.148; Davis E, 2005, CURR BIOL, V15, P743, DOI 10.1016/j.cub.2005.02.060; Dufour CR, 2007, CELL METAB, V5, P345, DOI 10.1016/j.cmet.2007.03.007; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Gibbs A., 1995, MOL BASIS VIRUS EVOL, P76; Kircher M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-346; Kiyosawa H, 2002, CYTOGENET GENOME RES, V99, P151, DOI 10.1159/000071587; LAZAR MA, 1989, MOL CELL BIOL, V9, P1128, DOI 10.1128/MCB.9.3.1128; Lehner B, 2002, TRENDS GENET, V18, P63, DOI 10.1016/S0168-9525(02)02598-2; Lin SP, 2003, NAT GENET, V35, P97, DOI 10.1038/ng1233; Lipman DJ, 1997, NUCLEIC ACIDS RES, V25, P3580, DOI 10.1093/nar/25.18.3580; Misener SR, 2000, BBA-GENE STRUCT EXPR, V1492, P269, DOI 10.1016/S0167-4781(00)00096-8; MIYATA T, 1978, NATURE, V272, P532, DOI 10.1038/272532a0; NORMARK S, 1983, ANNU REV GENET, V17, P499, DOI 10.1146/annurev.ge.17.120183.002435; Saito Y, 2006, CANCER CELL, V9, P435, DOI 10.1016/j.ccr.2006.04.020; Seitz H, 2004, GENOME RES, V14, P1741, DOI 10.1101/gr.2743304; Seitz H, 2003, NAT GENET, V34, P261, DOI 10.1038/ng1171; Shintani S, 1999, GENETICS, V152, P743; Song GS, 2008, NUCLEIC ACIDS RES, V36, P5727, DOI 10.1093/nar/gkn567; Song GS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003574; Takahashi N, 2009, HUM MOL GENET, V18, P1879, DOI 10.1093/hmg/ddp108; Veeramachaneni V, 2004, GENOME RES, V14, P280, DOI 10.1101/gr.1590904; WILLIAMS T, 1986, NATURE, V322, P275, DOI 10.1038/322275a0; Yelin R, 2003, NAT BIOTECHNOL, V21, P379, DOI 10.1038/nbt808; Zhuo D, 2001, GENOME RES, V11, P904, DOI 10.1101/gr.GR-1645R	27	46	47	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2009	4	11							e7829	10.1371/journal.pone.0007829	http://dx.doi.org/10.1371/journal.pone.0007829			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MK	19946636	gold, Green Submitted, Green Published			2022-12-25	WOS:000272827800004
J	Castello, A; Franco, D; Moral-Lopez, P; Berlanga, JJ; Alvarez, E; Wimmer, E; Carrasco, L				Castello, Alfredo; Franco, David; Moral-Lopez, Pablo; Berlanga, Juan J.; Alvarez, Enrique; Wimmer, Eckard; Carrasco, Luis			HIV-1 Protease Inhibits Cap- and Poly(A)-Dependent Translation upon eIF4GI and PABP Cleavage	PLOS ONE			English	Article							INITIATION-FACTOR 4G; RIBOSOME ENTRY SITE; MESSENGER-RNA TRANSLATION; POLY(A) BINDING-PROTEIN; POLY(A)-BINDING PROTEIN; POLIOVIRUS 2A(PRO); CELL-FREE; IMMUNODEFICIENCY-VIRUS; IN-VITRO; MAMMALIAN-CELLS	A number of viral proteases are able to cleave translation initiation factors leading to the inhibition of cellular translation. This is the case of human immunodeficiency virus type 1 protease (HIV-1 PR), which hydrolyzes eIF4GI and poly(A)-binding protein (PABP). Here, the effect of HIV-1 PR on cellular and viral protein synthesis has been examined using cell-free systems. HIV-1 PR strongly hampers translation of pre-existing capped luc mRNAs, particularly when these mRNAs contain a poly(A) tail. In fact, HIV-1 PR efficiently blocks cap-and poly(A)-dependent translation initiation in HeLa extracts. Addition of exogenous PABP to HIV-1 PR treated extracts partially restores the translation of polyadenylated luc mRNAs, suggesting that PABP cleavage is directly involved in the inhibition of poly(A)-dependent translation. In contrast to these data, PABP cleavage induced by HIV-1 PR has little impact on the translation of polyadenylated encephalomyocarditis virus internal ribosome entry site (IRES)-containing mRNAs. In this case, the loss of poly(A)-dependent translation is compensated by the IRES transactivation provided by eIF4G cleavage. Finally, translation of capped and polyadenylated HIV-1 genomic mRNA takes place in HeLa extracts when eIF4GI and PABP have been cleaved by HIV-1 PR. Together these results suggest that proteolytic cleavage of eIF4GI and PABP by HIV-1 PR blocks cap-and poly(A)-dependent initiation of translation, leading to the inhibition of cellular protein synthesis. However, HIV-1 genomic mRNA can be translated under these conditions, giving rise to the production of Gag polyprotein.	[Castello, Alfredo; Moral-Lopez, Pablo; Berlanga, Juan J.; Alvarez, Enrique; Carrasco, Luis] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, CSIC, Canto Blanco, Spain; [Franco, David; Wimmer, Eckard] SUNY Stony Brook, Long Isl City, NY USA	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Castello, A (corresponding author), European Mol Biol Lab, Heidelberg, Germany.	lcarrasco@cbm.uam.es	Palomares, Alfredo Castello/K-8062-2019; Berlanga, Juan José/N-1718-2015; Carrasco, Luis/E-2435-2012; Castello, Alfredo/U-6317-2018; Franco, David/AAQ-6839-2021; Carrasco, Luis/H-3001-2017	Palomares, Alfredo Castello/0000-0002-1499-4662; Berlanga, Juan José/0000-0002-2408-6561; Castello, Alfredo/0000-0002-1499-4662; Carrasco, Luis/0000-0003-3833-8835; Alvarez Vazquez, Enrique/0000-0002-4889-175X	DGICYT [BFU2009-07352]; FIPSE [24720/08]; Fundacion Ramon Areces	DGICYT(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); FIPSE; Fundacion Ramon Areces	This study was supported by Grants from DGICYT (BFU2009-07352) and FIPSE 24720/08. The Institutional Grant awarded to the Centro de Biologia Molecular "Severo Ochoa'' by the Fundacion Ramon Areces is also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDABE R, 1995, BIOCHEM BIOPH RES CO, V215, P928, DOI 10.1006/bbrc.1995.2553; Aldabe R, 1995, FEBS LETT, V377, P1, DOI 10.1016/0014-5793(95)01269-9; Alvarez E, 2006, BIOCHEM J, V396, P219, DOI 10.1042/BJ20060108; Alvarez E, 2003, J VIROL, V77, P12392, DOI 10.1128/JVI.77.23.12392-12400.2003; Anderson EC, 2006, J VIROL, V80, P10478, DOI 10.1128/JVI.02596-05; AVIV H, 1971, P NATL ACAD SCI USA, V68, P2303, DOI 10.1073/pnas.68.9.2303; Back SH, 2002, J VIROL, V76, P2529, DOI 10.1128/JVI.76.5.2529-2542.2002; Barco A, 2000, J VIROL, V74, P2383, DOI 10.1128/JVI.74.5.2383-2392.2000; Bonderoff JM, 2008, J VIROL, V82, P9389, DOI 10.1128/JVI.00006-08; Brasey A, 2003, J VIROL, V77, P3939, DOI 10.1128/JVI.77.7.3939-3949.2003; Buck CB, 2001, J VIROL, V75, P181, DOI 10.1128/JVI.75.1.181-191.2001; Burgui I, 2003, J GEN VIROL, V84, P3263, DOI 10.1099/vir.0.19487-0; Camerini V, 2008, J VIROL, V82, P3574, DOI 10.1128/JVI.02038-07; Castello A, 2006, J MOL BIOL, V355, P942, DOI 10.1016/j.jmb.2005.11.024; Castello A, 2006, J BIOL CHEM, V281, P33206, DOI 10.1074/jbc.M604340200; CHENG S, 2007, J BIOL CHEM; Cosson B, 2002, BIOL CELL, V94, P205, DOI 10.1016/S0248-4900(02)01194-2; Craig AWB, 1998, NATURE, V392, P520, DOI 10.1038/33198; Cuconati A, 1998, J VIROL, V72, P6456, DOI 10.1128/JVI.72.8.6456-6464.1998; de Breyne S, 2008, VIROLOGY, V378, P118, DOI 10.1016/j.virol.2008.05.019; Franco D, 2005, J VIROL, V79, P6358, DOI 10.1128/JVI.79.10.6358-6367.2005; Gallie DR, 1998, GENE, V216, P1, DOI 10.1016/S0378-1119(98)00318-7; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Gradi A, 2004, J VIROL, V78, P3271, DOI 10.1128/JVI.78.7.3271-3278.2004; Gradi A, 1998, P NATL ACAD SCI USA, V95, P11089, DOI 10.1073/pnas.95.19.11089; Gradi A, 1998, MOL CELL BIOL, V18, P334, DOI 10.1128/MCB.18.1.334; GROOM HC, 2009, J GEN VIROL; Herbreteau CH, 2005, NAT STRUCT MOL BIOL, V12, P1001, DOI 10.1038/nsmb1011; Imataka H, 1998, EMBO J, V17, P7480, DOI 10.1093/emboj/17.24.7480; Joachims M, 1999, J VIROL, V73, P718, DOI 10.1128/JVI.73.1.718-727.1999; Kahvejian A, 2001, COLD SPRING HARB SYM, V66, P293, DOI 10.1101/sqb.2001.66.293; Kahvejian A, 2005, GENE DEV, V19, P104, DOI 10.1101/gad.1262905; Khaleghpour K, 2001, MOL CELL BIOL, V21, P5200, DOI 10.1128/MCB.21.15.5200-5213.2001; Khaleghpour K, 2001, MOL CELL, V7, P205, DOI 10.1016/S1097-2765(01)00168-X; Kuyumcu-Martinez M, 2004, J VIROL, V78, P8172, DOI 10.1128/JVI.78.15.8172-8182.2004; Kuyumcu-Martinez NM, 2004, MOL CELL BIOL, V24, P1779, DOI 10.1128/MCB.24.4.1779-1790.2004; Kuyumcu-Martinez NM, 2002, J VIROL, V76, P2062, DOI 10.1128/JVI.76.5.2062-2074.2002; Le H, 1997, J BIOL CHEM, V272, P16247, DOI 10.1074/jbc.272.26.16247; Lloyd RE, 2006, VIRUS RES, V119, P76, DOI 10.1016/j.virusres.2005.10.016; MADER S, 1995, MOL CELL BIOL, V15, P4990; Martinez-Salas E, 2004, CURR PHARM DESIGN, V10, P3757, DOI 10.2174/1381612043382657; Michel YM, 2000, J BIOL CHEM, V275, P32268, DOI 10.1074/jbc.M004304200; Michel YM, 2001, MOL CELL BIOL, V21, P4097, DOI 10.1128/MCB.21.13.4097-4109.2001; Miele G, 1996, J VIROL, V70, P944, DOI 10.1128/JVI.70.2.944-951.1996; MOLLA A, 1991, SCIENCE, V254, P1647, DOI 10.1126/science.1661029; Novoa I, 1999, MOL CELL BIOL, V19, P2445; Novoa I, 1997, BIOCHEMISTRY-US, V36, P7802, DOI 10.1021/bi9631172; Perales C, 2005, BBA-MOL CELL RES, V1743, P169, DOI 10.1016/j.bbamcr.2004.09.030; Perales C, 2003, FEBS LETT, V533, P89, DOI 10.1016/S0014-5793(02)03764-X; Prevot D, 2003, BIOL CELL, V95, P141, DOI 10.1016/S0248-4900(03)00031-5; Ricci EP, 2008, BIOCHEM SOC T, V36, P690, DOI 10.1042/BST0360690; Ricci EP, 2008, RNA, V14, P1443, DOI 10.1261/rna.813608; Rivera CI, 2008, VIROLOGY, V375, P59, DOI 10.1016/j.virol.2008.02.002; Pulido MR, 2007, VIROLOGY, V364, P466, DOI 10.1016/j.virol.2007.03.013; Schneider RJ, 2003, TRENDS BIOCHEM SCI, V28, P130, DOI 10.1016/S0968-0004(03)00029-X; Svitkin Yuri V., 2004, V257, P155; Svitkin YV, 2001, RNA, V7, P1743; SVITKIN YV, 1978, VIROLOGY, V87, P199, DOI 10.1016/0042-6822(78)90172-1; Uchida N, 2002, J BIOL CHEM, V277, P50286, DOI 10.1074/jbc.M203029200; VENTOSO I, 1995, J VIROL, V69, P6280, DOI 10.1128/JVI.69.10.6280-6288.1995; Ventoso I, 1998, J BIOL CHEM, V273, P27960, DOI 10.1074/jbc.273.43.27960; Ventoso I, 2001, P NATL ACAD SCI USA, V98, P12966, DOI 10.1073/pnas.231343498; Willcocks MM, 2004, J GEN VIROL, V85, P1125, DOI 10.1099/vir.0.19564-0; WILSON W, 1988, CELL, V55, P1159, DOI 10.1016/0092-8674(88)90260-7; Zhang B, 2007, NUCLEIC ACIDS RES, V35, P5975, DOI 10.1093/nar/gkm645	65	51	53	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2009	4	11							e7997	10.1371/journal.pone.0007997	http://dx.doi.org/10.1371/journal.pone.0007997			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MH	19956697	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000272827500024
J	Drahos, KE; Welsh, JD; Finkielstein, CV; Capelluto, DGS				Drahos, Karen E.; Welsh, John D.; Finkielstein, Carla V.; Capelluto, Daniel G. S.			Sulfatides Partition Disabled-2 in Response to Platelet Activation	PLOS ONE			English	Article							PTB DOMAIN; SIGNAL-TRANSDUCTION; BINDING-PROTEIN; AGGREGATION; CELLS; MEMBRANE; INTERNALIZATION; INHIBITION; EXPRESSION; RECEPTOR	Background: aggregation is Disabled-2 (Dab2), which is released to the extracellular surface upon platelet activation. Dab2 inhibits platelet aggregation through its phosphotyrosine-binding (PTB) domain by competing with fibrinogen for alpha IIb beta 3 integrin receptor binding by an unknown mechanism. Methodology/Principal Findings: Using protein-lipid overlay and liposome-binding assays, we identified that the N-terminal region of Dab2, including its PTB domain (N-PTB), specifically interacts with sulfatides. Moreover, we determined that such interaction is mediated by two conserved basic motifs with a dissociation constant (K-d) of 0.6 mu M as estimated by surface plasmon resonance (SPR) analysis. In addition, liposome-binding assays combined with mass spectroscopy studies revealed that thrombin, a strong platelet agonist, cleaved N-PTB at a site located between the basic motifs, a region that becomes protected from thrombin cleavage when bound to sulfatides. Sulfatides on the platelet surface interact with coagulation proteins, playing a major role in haemostasis. Our results show that sulfatides recruit N-PTB to the platelet surface, sequestering it from integrin receptor binding during platelet activation. This is a transient recruitment that follows N-PTB internalization by an actin-dependent process. Conclusions/Significance: Our experimental data support a model where two pools of Dab2 co-exist at the platelet surface, in both sulfatide-and integrin receptor-bound states, and their balance controls the extent of the clotting response.	[Drahos, Karen E.; Capelluto, Daniel G. S.] Virginia Polytech Inst & State Univ, Prot Signaling Domains Lab, Blacksburg, VA 24061 USA; [Drahos, Karen E.; Welsh, John D.; Finkielstein, Carla V.] Virginia Polytech Inst & State Univ, Dept Biol Sci, Integrated Cellular Responses Lab, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Drahos, KE (corresponding author), Virginia Polytech Inst & State Univ, Prot Signaling Domains Lab, Blacksburg, VA 24061 USA.	finkielc@vt.edu; capellut@vt.edu		finkielstein, carla/0000-0002-8417-4643	Department of Biological Sciences, Virginia Polytechnic Institute and State University	Department of Biological Sciences, Virginia Polytechnic Institute and State University	This work was supported by the Department of Biological Sciences, Virginia Polytechnic Institute and State University to DGSC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anupam K, 2006, WORLD J GASTROENTERO, V12, P6041, DOI 10.3748/wjg.v12.i37.6041; ARUFFO A, 1991, CELL, V67, P35, DOI 10.1016/0092-8674(91)90570-O; BAJORATH J, 1994, BIOCHEMISTRY-US, V33, P1332, DOI 10.1021/bi00172a007; Basani RB, 2001, J BIOL CHEM, V276, P13975, DOI 10.1074/jbc.M011511200; Berntson Z, 1998, J NEUROSCI RES, V52, P559, DOI 10.1002/(SICI)1097-4547(19980601)52:5<559::AID-JNR8>3.0.CO;2-B; Blair P, 2009, BLOOD REV, V23, P177, DOI 10.1016/j.blre.2009.04.001; Bodin S, 2005, J CELL SCI, V118, P759, DOI 10.1242/jcs.01648; Capelluto DGS, 2002, NATURE, V419, P726, DOI 10.1038/nature01056; CASELLA JF, 1981, NATURE, V293, P302, DOI 10.1038/293302a0; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; Eckhardt M, 2008, MOL NEUROBIOL, V37, P93, DOI 10.1007/s12035-008-8022-3; Fazili Z, 1999, ONCOGENE, V18, P3104, DOI 10.1038/sj.onc.1202649; FUJIMOTO T, 1982, J CLIN INVEST, V69, P1212, DOI 10.1172/JCI110560; Hailstones D, 1998, J LIPID RES, V39, P369; HANSSON CG, 1978, J BIOCHEM-TOKYO, V83, P813, DOI 10.1093/oxfordjournals.jbchem.a131977; Hocevar BA, 2003, EMBO J, V22, P3084, DOI 10.1093/emboj/cdg286; Howell BW, 1997, EMBO J, V16, P121, DOI 10.1093/emboj/16.1.121; Howell BW, 1999, MOL CELL BIOL, V19, P5179; Huang CL, 2006, J CELL SCI, V119, P4420, DOI 10.1242/jcs.03195; Huang CL, 2004, J BIOL CHEM, V279, P42279, DOI 10.1074/jbc.M402540200; Ida M, 2004, J BIOCHEM, V135, P583, DOI 10.1093/jb/mvh071; Isaac G, 2006, FEBS J, V273, P1782, DOI 10.1111/j.1742-4658.2006.05195.x; Jackson SP, 2007, BLOOD, V109, P5087, DOI 10.1182/blood-2006-12-027698; Jones ML, 2004, J BIOL CHEM, V279, P40475, DOI 10.1074/jbc.M402970200; Kushi Y, 1996, BBA-LIPID LIPID MET, V1304, P254, DOI 10.1016/S0005-2760(96)00125-7; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Li SH, 2005, J CELL BIOL, V169, P179, DOI 10.1083/jcb.200501098; Mackman N, 2008, NATURE, V451, P914, DOI 10.1038/nature06797; Merten M, 2005, ARTERIOSCL THROM VAS, V25, P258, DOI 10.1161/01.ATV.0000149675.83552.83; Merten M, 2001, CIRCULATION, V104, P2955, DOI 10.1161/hc4901.100383; Miller MW, 2009, P NATL ACAD SCI USA, V106, P719, DOI 10.1073/pnas.0811622106; Mishra SK, 2002, EMBO J, V21, P4915, DOI 10.1093/emboj/cdf487; MOK SC, 1994, GYNECOL ONCOL, V52, P247, DOI 10.1006/gyno.1994.1040; Morris SM, 2001, TRAFFIC, V2, P111, DOI 10.1034/j.1600-0854.2001.020206.x; Mosesson Y, 2008, NAT REV CANCER, V8, P835, DOI 10.1038/nrc2521; Nakayama T, 2008, INT J HEMATOL, V87, P363, DOI 10.1007/s12185-008-0065-8; Ni HY, 2003, TRANSFUS APHER SCI, V28, P257, DOI 10.1016/S1473-0502(03)00044-2; Orlandi PA, 1998, J CELL BIOL, V141, P905, DOI 10.1083/jcb.141.4.905; ROBERTS DD, 1985, J BIOL CHEM, V260, P9405; ROBERTS DD, 1988, ARCH BIOCHEM BIOPHYS, V267, P405, DOI 10.1016/0003-9861(88)90046-X; Sandhoff R, 2005, BBA-MOL CELL BIOL L, V1687, P52, DOI 10.1016/j.bbalip.2004.11.011; Sheng ZJ, 2000, ONCOGENE, V19, P4847, DOI 10.1038/sj.onc.1203853; Snook CF, 2006, BBA-MOL CELL BIOL L, V1761, P927, DOI 10.1016/j.bbalip.2006.06.004; Stolt PC, 2005, J BIOL CHEM, V280, P9671, DOI 10.1074/jbc.M413356200; Stolt PC, 2004, BIOCHEMISTRY-US, V43, P10979, DOI 10.1021/bi049092l; Takada Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-215; Tseng CP, 1998, ENDOCRINOLOGY, V139, P3542, DOI 10.1210/en.139.8.3542; VANDERGEER P, 1995, TRENDS BIOCHEM SCI, V20, P277, DOI 10.1016/S0968-0004(00)89043-X; WANG LH, 1993, J CELL BIOL, V123, P1107, DOI 10.1083/jcb.123.5.1107; WencelDrake JD, 1996, BLOOD, V87, P602, DOI 10.1182/blood.V87.2.602.bloodjournal872602; XU XX, 1995, J BIOL CHEM, V270, P14184, DOI 10.1074/jbc.270.23.14184; Yamashita T, 2003, P NATL ACAD SCI USA, V100, P3445, DOI 10.1073/pnas.0635898100; Yun M, 2003, J BIOL CHEM, V278, P36572, DOI 10.1074/jbc.M304384200; Zhou J, 2001, J BIOL CHEM, V276, P27793, DOI 10.1074/jbc.M102803200	54	22	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2009	4	11							e8007	10.1371/journal.pone.0008007	http://dx.doi.org/10.1371/journal.pone.0008007			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MH	19956625	Green Submitted, gold, Green Published			2022-12-25	WOS:000272827500030
J	Monahan, WB				Monahan, William B.			A Mechanistic Niche Model for Measuring Species' Distributional Responses to Seasonal Temperature Gradients	PLOS ONE			English	Article							CLIMATE-CHANGE; ECOLOGICAL NICHES; ENVELOPE MODELS; FIELD SPARROW; CONSTRAINTS; ENERGY; RANGE; EVOLUTION; HABITAT; IMPACT	Niche theory is central to understanding how species respond geographically to climate change. It defines a species' realized niche in a biological community, its fundamental niche as determined by physiology, and its potential niche-the fundamental niche in a given environment or geographic space. However, most predictions of the effects of climate change on species' distributions are limited to correlative models of the realized niche, which assume that species are in distributional equilibrium with respect to the variables or gradients included in the model. Here, I present a mechanistic niche model that measures species' responses to major seasonal temperature gradients that interact with the physiology of the organism. I then use lethal physiological temperatures to parameterize the model for bird species in North and South America and show that most focal bird species are not in direct physiological equilibrium with the gradients. Results also show that most focal bird species possess broad thermal tolerances encompassing novel climates that could become available with climate change. I conclude with discussion of how mechanistic niche models may be used to (i) gain insights into the processes that cause species to respond to climate change and (ii) build more accurate correlative distribution models in birds and other species.			Monahan, WB (corresponding author), Audubon Calif, Emeryville, CA USA.	wmonahan@audubon.org						*AM ORN UN, 2009, AOU CHECK LIST N AM; Araujo MB, 2005, ECOGRAPHY, V28, P693, DOI 10.1111/j.2005.0906-7590.04253.x; Araujo MB, 2005, GLOBAL CHANGE BIOL, V11, P1504, DOI 10.1111/j.1365-2486.2005.01000.x; ARNOLD SJ, 1983, AM ZOOL, V23, P347, DOI 10.1093/icb/23.2.347; Austin M, 2007, ECOL MODEL, V200, P1, DOI 10.1016/j.ecolmodel.2006.07.005; Barton N.H, 2001, INTEGRATING ECOLOGY, P365; Bernardo J, 2006, BIOL LETTERS, V2, P135, DOI 10.1098/rsbl.2005.0417; Blem C.R., 1973, Ornithological Monographs, VNo. 14, P96; Bohning-Gaese K, 2003, J EVOLUTION BIOL, V16, P956, DOI 10.1046/j.1420-9101.2003.00605.x; Brown JH, 1996, ANNU REV ECOL SYST, V27, P597, DOI 10.1146/annurev.ecolsys.27.1.597; Cheddadi R, 2006, GLOBAL ECOL BIOGEOGR, V15, P271, DOI [10.1111/j.1466-822x.2006.00226.x, 10.1111/j.1466-822X.2006.00226.x]; CLEMANS RJ, 1973, CONDOR, V76, P358; Colwell RK, 2000, TRENDS ECOL EVOL, V15, P70, DOI 10.1016/S0169-5347(99)01767-X; COX GW, 1961, ECOLOGY, V42, P253, DOI 10.2307/1932077; Davis MB, 2001, SCIENCE, V292, P673, DOI 10.1126/science.292.5517.673; Gomulkiewicz R, 1999, THEOR POPUL BIOL, V55, P283, DOI 10.1006/tpbi.1998.1405; Grinnell J, 1917, AM NAT, V51, P115, DOI 10.1086/279591; Grinnell J., 1917, Auk Cambridge Mass, V34; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hawkins BA, 2003, ECOLOGY, V84, P3105, DOI 10.1890/03-8006; Heikkinen RK, 2006, PROG PHYS GEOG, V30, P751, DOI 10.1177/0309133306071957; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, 2006, GLOBAL CHANGE BIOL, V12, P2272, DOI 10.1111/j.1365-2486.2006.01256.x; Holt RD, 2004, AM NAT, V164, P187, DOI 10.1086/422343; HOLT RD, 1992, EVOLUTIONARY ECOLOGY, V6, P443; Jackson ST, 2000, PALEOBIOLOGY, V26, P194, DOI 10.1666/0094-8373(2000)26[194:ROPPAC]2.0.CO;2; Kearney M, 2004, ECOLOGY, V85, P3119, DOI 10.1890/03-0820; Kearney M, 2009, ECOL LETT, V12, P334, DOI 10.1111/j.1461-0248.2008.01277.x; KENDEIGH SC, 1969, WILSON BULL, V81, P441; Kirkpatrick M, 1997, AM NAT, V150, P1, DOI 10.1086/286054; KONTOGIANNIS JE, 1968, PHYSIOL ZOOL, V41, P54, DOI 10.1086/physzool.41.1.30158484; LEVINS R, 1966, AM SCI, V54, P421; Lobo Jorge M., 2008, Biodiversity Informatics, V5, P14; Long J.L., 1981, INTRO BIRDS WORLD WO; Losos JB, 2003, NATURE, V424, P542, DOI 10.1038/nature01814; MAGUIRE B, 1973, AM NAT, V107, P213, DOI 10.1086/282827; Martinez-Meyer E, 2004, GLOBAL ECOL BIOGEOGR, V13, P305, DOI 10.1111/j.1466-822X.2004.00107.x; Monahan WB, 2008, BIOL LETTERS, V4, P595, DOI 10.1098/rsbl.2008.0154; Moritz C, 2008, SCIENCE, V322, P261, DOI 10.1126/science.1163428; Mustin K, 2007, CLIM RES, V35, P165, DOI 10.3354/cr00723; *NAT CLIM DAT CTR, 2009, GLOB MEAS EXTR TEMP; Nosil P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001907; OLSON JB, 1980, AUK, V97, P704; OSMOND CB, 1987, BIOSCIENCE, V37, P38, DOI 10.2307/1310176; OWEN RB, 1970, CONDOR, V72, P153, DOI 10.2307/1366625; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Reich PB, 2008, ECOL LETT, V11, P588, DOI 10.1111/j.1461-0248.2008.01172.x; Ridgely R. S, 2007, DIGITAL DISTRIBUTION; ROOT T, 1988, ECOLOGY, V69, P330, DOI 10.2307/1940431; Svenning JC, 2004, ECOL LETT, V7, P565, DOI 10.1111/j.1461-0248.2004.00614.x; Thuiller W, 2004, ECOGRAPHY, V27, P165, DOI 10.1111/j.0906-7590.2004.03673.x; Tingley MW, 2009, P NATL ACAD SCI USA, V106, P19637, DOI 10.1073/pnas.0901562106; VanDerWal J, 2009, ECOL MODEL, V220, P589, DOI 10.1016/j.ecolmodel.2008.11.010; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; WEST GEORGE C., 1960, AUK, V77, P306; WILLIAMS JE, 1982, J WILDLIFE MANAGE, V46, P588, DOI 10.2307/3808549; Williams JW, 2007, P NATL ACAD SCI USA, V104, P5738, DOI 10.1073/pnas.0606292104; WOODWARD FI, 1990, PHILOS T ROY SOC B, V326, P585, DOI 10.1098/rstb.1990.0033; Yeh PJ, 2004, AM NAT, V164, P531, DOI 10.1086/423825; ZIMMERMA.JL, 1965, PHYSIOL ZOOL, V38, P370, DOI 10.1086/physzool.38.4.30152415; [No title captured]	62	55	55	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2009	4	11							e7921	10.1371/journal.pone.0007921	http://dx.doi.org/10.1371/journal.pone.0007921			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522NL	19936234	Green Published, Green Submitted, gold			2022-12-25	WOS:000272004800006
J	Bruel-Jungerman, E; Veyrac, A; Dufour, F; Horwood, J; Laroche, S; Davis, S				Bruel-Jungerman, Elodie; Veyrac, Alexandra; Dufour, Franck; Horwood, Jennifer; Laroche, Serge; Davis, Sabrina			Inhibition of PI3K-Akt Signaling Blocks Exercise-Mediated Enhancement of Adult Neurogenesis and Synaptic Plasticity in the Dentate Gyrus	PLOS ONE			English	Article							PROTEIN-KINASE-B; LONG-TERM POTENTIATION; NEURAL PROGENITOR CELLS; ELEMENT-BINDING PROTEIN; HIPPOCAMPAL NEUROGENESIS; GENE-EXPRESSION; GROWTH-FACTOR; ENVIRONMENTAL ENRICHMENT; PHYSICAL-ACTIVITY; RAT HIPPOCAMPUS	Background: Physical exercise has been shown to increase adult neurogenesis in the dentate gyrus and enhances synaptic plasticity. The antiapoptotic kinase, Akt has also been shown to be phosphorylated following voluntary exercise; however, it remains unknown whether the PI3K-Akt signaling pathway is involved in exercise-induced neurogenesis and the associated facilitation of synaptic plasticity in the dentate gyrus. Methodology/Principal Findings: To gain insight into the potential role of this signaling pathway in exercise-induced neurogenesis and LTP in the dentate gyrus rats were infused with the PI3K inhibitor, LY294002 or vehicle control solution (icv) via osmotic minipumps and exercised in a running wheel for 10 days. Newborn cells in the dentate gyrus were date-labelled with BrdU on the last 3 days of exercise. Then, they were either returned to the home cage for 2 weeks to assess exercise-induced LTP and neurogenesis in the dentate gyrus, or were killed on the last day of exercise to assess proliferation and activation of the PI3K-Akt cascade using western blotting. Conclusions/Significance: Exercise increases cell proliferation and promotes survival of adult-born neurons in the dentate gyrus. Immediately after exercise, we found that Akt and three downstream targets, BAD, GSK3 beta and FOXO1 were activated. LY294002 blocked exercise-induced phosphorylation of Akt and downstream target proteins. This had no effect on exercise-induced cell proliferation, but it abolished most of the beneficial effect of exercise on the survival of newly generated dentate gyrus neurons and prevented exercise-induced increase in dentate gyrus LTP. These results suggest that activation of the PI3 kinase-Akt signaling pathway plays a significant role via an antiapoptotic function in promoting survival of newly formed granule cells generated during exercise and the associated increase in synaptic plasticity in the dentate gyrus.			Bruel-Jungerman, E (corresponding author), UPMC, INSERM, Inst Fer Moulin, U839 S, Paris, France.	sabrina.davis@u-psud.fr	Veyrac, Alexandra/G-8313-2017	VEYRAC, Alexandra/0000-0002-8063-4016				Aberg MAI, 2003, MOL CELL NEUROSCI, V24, P23, DOI 10.1016/S1044-7431(03)00082-4; Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Berchtold NC, 2005, NEUROSCIENCE, V133, P853, DOI 10.1016/j.neuroscience.2005.03.026; Beurel E, 2006, PROG NEUROBIOL, V79, P173, DOI 10.1016/j.pneurobio.2006.07.006; Brazil DP, 2004, TRENDS BIOCHEM SCI, V29, P233, DOI 10.1016/j.tibs.2004.03.006; Brazil DP, 2001, TRENDS BIOCHEM SCI, V26, P657, DOI 10.1016/S0968-0004(01)01958-2; Bruel-Jungerman E, 2005, EUR J NEUROSCI, V21, P513, DOI 10.1111/j.1460-9568.2005.03875.x; Bruel-Jungerman E, 2006, J NEUROSCI, V26, P5888, DOI 10.1523/JNEUROSCI.0782-06.2006; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cao L, 2004, NAT GENET, V36, P827, DOI 10.1038/ng1395; Chen MJ, 2005, MOL BRAIN RES, V135, P181, DOI 10.1016/j.molbrainres.2004.12.001; Choi YS, 2008, GLIA, V56, P791, DOI 10.1002/glia.20653; Cotman CW, 2007, TRENDS NEUROSCI, V30, P464, DOI 10.1016/j.tins.2007.06.011; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Davis S, 2000, J NEUROSCI, V20, P4563, DOI 10.1523/JNEUROSCI.20-12-04563.2000; Ding Q, 2006, NEUROSCIENCE, V140, P823, DOI 10.1016/j.neuroscience.2006.02.084; Endl E, 2000, EXP CELL RES, V257, P231, DOI 10.1006/excr.2000.4888; Fabel K, 2003, EUR J NEUROSCI, V18, P2803, DOI 10.1111/j.1460-9568.2003.03041.x; Farmer J, 2004, NEUROSCIENCE, V124, P71, DOI 10.1016/j.neuroscience.2003.09.029; Galvan V, 2006, MINI-REV MED CHEM, V6, P667, DOI 10.2174/138955706777435742; Galve-Roperh I, 2007, NEUROSCIENTIST, V13, P109, DOI 10.1177/1073858406296407; Ge SY, 2007, NEURON, V54, P559, DOI 10.1016/j.neuron.2007.05.002; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Hagg T, 2005, TRENDS NEUROSCI, V28, P589, DOI 10.1016/j.tins.2005.08.009; Hill MM, 2002, PHARMACOL THERAPEUT, V93, P243, DOI 10.1016/S0163-7258(02)00193-6; Hillman CH, 2008, NAT REV NEUROSCI, V9, P58, DOI 10.1038/nrn2298; Hillman CH, 2006, HEALTH PSYCHOL, V25, P678, DOI 10.1037/0278-6133.25.6.678; Ho KK, 2008, ONCOGENE, V27, P2300, DOI 10.1038/onc.2008.23; Horwood JM, 2006, EUR J NEUROSCI, V23, P3375, DOI 10.1111/j.1460-9568.2006.04859.x; Jin KL, 2002, J NEUROCHEM, V80, P119, DOI 10.1046/j.0022-3042.2001.00678.x; Kee N, 2002, J NEUROSCI METH, V115, P97, DOI 10.1016/S0165-0270(02)00007-9; Kelly A, 2003, J NEUROSCI, V23, P5354; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Kim SJ, 2008, J BIOL CHEM, V283, P14497, DOI 10.1074/jbc.M708373200; Koehl M, 2008, FASEB J, V22, P2253, DOI 10.1096/fj.07-099101; Kolodziej A, 2008, J NEUROSCI, V28, P4488, DOI 10.1523/JNEUROSCI.4721-07.2008; Kramer AF, 2007, TRENDS COGN SCI, V11, P342, DOI 10.1016/j.tics.2007.06.009; Kramer AF, 2006, J APPL PHYSIOL, V101, P1237, DOI 10.1152/japplphysiol.00500.2006; Kuhn HG, 2005, EUR J NEUROSCI, V22, P1907, DOI 10.1111/j.1460-9568.2005.04377.x; Lai K, 2003, NAT NEUROSCI, V6, P21, DOI 10.1038/nn983; Lee E, 2009, BMB REP, V42, P239, DOI 10.5483/BMBRep.2009.42.5.239; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Morgan D, 2007, EXP NEUROL, V205, P330, DOI 10.1016/j.expneurol.2007.03.006; Muller AP, 2008, NEUROCHEM RES, V33, P880, DOI 10.1007/s11064-007-9530-7; Olson AK, 2006, HIPPOCAMPUS, V16, P250, DOI 10.1002/hipo.20157; Parcellier A, 2008, CELL SIGNAL, V20, P21, DOI 10.1016/j.cellsig.2007.07.010; Park SM, 2008, CELL PROLIFERAT, V41, P248, DOI 10.1111/j.1365-2184.2008.00514.x; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Schweitzer NB, 2006, NEUROCHEM INT, V48, P9, DOI 10.1016/j.neuint.2005.08.006; Shaul YD, 2007, BBA-MOL CELL RES, V1773, P1213, DOI 10.1016/j.bbamcr.2006.10.005; Shen H, 2001, NEUROSCIENCE, V107, P219, DOI 10.1016/S0306-4522(01)00315-3; Sinor AD, 2004, J NEUROSCI, V24, P8531, DOI 10.1523/JNEUROSCI.1470-04.2004; Snyder JS, 2001, J NEUROPHYSIOL, V85, P2423, DOI 10.1152/jn.2001.85.6.2423; Sun W, 2004, J NEUROSCI, V24, P11205, DOI 10.1523/JNEUROSCI.1436-04.2004; Tong LQ, 2001, NEUROBIOL DIS, V8, P1046, DOI 10.1006/nbdi.2001.0427; Trejo JL, 2008, MOL CELL NEUROSCI, V37, P402, DOI 10.1016/j.mcn.2007.10.016; Trejo JL, 2001, J NEUROSCI, V21, P1628, DOI 10.1523/JNEUROSCI.21-05-01628.2001; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Vaynman S, 2004, EUR J NEUROSCI, V20, P2580, DOI 10.1111/j.1460-9568.2004.03720.x; Woodgett JR, 2005, CURR OPIN CELL BIOL, V17, P150, DOI 10.1016/j.ceb.2005.02.010; Wu HT, 2008, J NEUROTRAUM, V25, P130, DOI 10.1089/neu.2007.0369; Wymann MP, 2003, TRENDS PHARMACOL SCI, V24, P366, DOI 10.1016/S0165-6147(03)00163-9; Yan XB, 2007, NEUROPHARMACOLOGY, V53, P487, DOI 10.1016/j.neuropharm.2007.06.020; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	70	92	94	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2009	4	11							e7901	10.1371/journal.pone.0007901	http://dx.doi.org/10.1371/journal.pone.0007901			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522NJ	19936256	Green Submitted, Green Published, gold			2022-12-25	WOS:000272004600006
J	Vaughan, MB; Ramirez, RD; Andrews, CM; Wright, WE; Shay, JW				Vaughan, Melville B.; Ramirez, Ruben D.; Andrews, Capri M.; Wright, Woodring E.; Shay, Jerry W.			H-Ras Expression in Immortalized Keratinocytes Produces an Invasive Epithelium in Cultured Skin Equivalents	PLOS ONE			English	Article							BASEMENT-MEMBRANE; EPIDERMAL CARCINOGENESIS; INTERMEDIATE-FILAMENTS; 3-DIMENSIONAL MODELS; STEM-CELLS; IN-VITRO; FIBROBLASTS; GROWTH; DIFFERENTIATION; TUMORIGENESIS	Background: Ras proteins affect both proliferation and expression of collagen-degrading enzymes, two important processes in cancer progression. Normal skin architecture is dependent both on the coordinated proliferation and stratification of keratinocytes, as well as the maintenance of a collagen-rich basement membrane. In the present studies we sought to determine whether expression of H-ras in skin keratinocytes would affect these parameters during the establishment and maintenance of an in vitro skin equivalent. Methodology/Principal Findings: Previously described cdk4 and hTERT immortalized foreskin keratinocytes were engineered to express ectopically introduced H-ras. Skin equivalents, composed of normal fibroblast-contracted collagen gels overlaid with keratinocytes (immortal or immortal expressing H-ras), were prepared and incubated for 3 weeks. Harvested tissues were processed and sectioned for histology and antibody staining. Antigens specific to differentiation (involucrin, keratin-14, p63), basement-membrane formation (collagen IV, laminin-5), and epithelial to mesenchymal transition (EMT; e-cadherin, vimentin) were studied. Results showed that H-ras keratinocytes produced an invasive, disorganized epithelium most apparent in the lower strata while immortalized keratinocytes fully stratified without invasive properties. The superficial strata retained morphologically normal characteristics. Vimentin and p63 co-localization increased with H-ras overexpression, similar to basal wound-healing keratinocytes. In contrast, the cdk4 and hTERT immortalized keratinocytes differentiated similarly to normal unimmortalized keratinocytes. Conclusions/Significance: The use of isogenic derivatives of stable immortalized keratinocytes with specified genetic alterations may be helpful in developing more robust in vitro models of cancer progression.			Vaughan, MB (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA.	mvaughan4@uco.edu; Jerry.Shay@utsouthwestern.edu	Vaughan, Melville B/J-6637-2016; Shay, Jerry W/F-7878-2011	Vaughan, Melville B/0000-0003-4648-6141; 	NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016478] Funding Source: NIH RePORTER; NCRR NIH HHS [P20 RR016478] Funding Source: Medline; PHS HHS [P2PRR016478] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Andriani F, 2004, INT J CANCER, V108, P348, DOI 10.1002/ijc.11525; Biddle D, 1996, ARCH DERMATOL RES, V288, P621, DOI 10.1007/s004030050113; BOUKAMP P, 1990, CANCER RES, V50, P2840; Chamulitrat W, 2003, EUR J CELL BIOL, V82, P313, DOI 10.1078/0171-9335-00317; El-Ghalbzouri A, 2002, BRIT J DERMATOL, V147, P230, DOI 10.1046/j.1365-2133.2002.04871.x; Escamez MJ, 2004, J INVEST DERMATOL, V123, P1182, DOI 10.1111/j.0022-202X.2004.23473.x; Fisher GJ, 2009, AM J PATHOL, V174, P101, DOI 10.2353/ajpath.2009.080599; Fuchs E, 2002, NAT REV GENET, V3, P199, DOI 10.1038/nrg758; Fuchs E, 1998, SCIENCE, V279, P514, DOI 10.1126/science.279.5350.514; Fusenig NE, 1998, MOL CARCINOGEN, V23, P144, DOI 10.1002/(SICI)1098-2744(199811)23:3<144::AID-MC3>3.0.CO;2-U; Garlick JA, 2007, ADV BIOCHEM ENG BIOT, V103, P207; Gollahon LS, 1996, ONCOGENE, V12, P715; GUARINO M, 1995, HISTOL HISTOPATHOL, V10, P171; Guarino M, 2007, INT J BIOCHEM CELL B, V39, P2153, DOI 10.1016/j.biocel.2007.07.011; Jensen KB, 2009, CELL STEM CELL, V4, P427, DOI 10.1016/j.stem.2009.04.014; Koster MI, 2004, GENE DEV, V18, P126, DOI 10.1101/gad.1165104; Kranenburg O, 2004, BBA-REV CANCER, V1654, P23, DOI 10.1016/j.bbcan.2003.09.004; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; Lazarov M, 2002, NAT MED, V8, P1105, DOI 10.1038/nm779; Lee DY, 2005, ARCH DERMATOL RES, V296, P296, DOI 10.1007/s00403-004-0529-5; MARINKOVICH MP, 1993, DEV DYNAM, V197, P255, DOI 10.1002/aja.1001970404; Nova D, 2003, CLIN EXP METASTAS, V20, P675, DOI 10.1023/B:CLIN.0000006816.09548.31; Owens DM, 2003, NAT REV CANCER, V3, P444, DOI 10.1038/nrc1096; PARENTEAU N, 1994, KERATINOCYTE METHODS, P45; Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098; Perez-Moreno M, 2003, CELL, V112, P535, DOI 10.1016/S0092-8674(03)00108-9; QUINTANILLA M, 1991, CARCINOGENESIS, V12, P1875, DOI 10.1093/carcin/12.10.1875; Ramirez RD, 2003, ONCOGENE, V22, P433, DOI 10.1038/sj.onc.1206046; Ramirez RD, 2001, GENE DEV, V15, P398, DOI 10.1101/gad.859201; Ridky TW, 2004, CELL CYCLE, V3, P621; Robertson D, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-13; Roig AI, 2009, RADIAT RES, V171, P33, DOI 10.1667/RR1415.1; Shay JW, 2005, ANN NY ACAD SCI, V1057, P479, DOI 10.1196/annals.1356.037; Shields JM, 2000, TRENDS CELL BIOL, V10, P147, DOI 10.1016/S0962-8924(00)01740-2; SMOLA H, 1993, J CELL BIOL, V122, P417, DOI 10.1083/jcb.122.2.417; STEINERT PM, 1988, ANNU REV BIOCHEM, V57, P593, DOI 10.1146/annurev.bi.57.070188.003113; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Tornakidi P, 2003, J PATHOL, V200, P298, DOI 10.1002/path.1366; Vaughan MB, 2006, DIFFERENTIATION, V74, P141, DOI 10.1111/j.1432-0436.2006.00069.x; Vaughan MB, 2004, REJUV RES, V7, P99, DOI 10.1089/1549168041552982; Vosseler S, 2009, INT J CANCER, V125, P2296, DOI 10.1002/ijc.24589; WATT FM, 1982, NATURE, V295, P434, DOI 10.1038/295434a0; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Windsor ML, 2009, AUSTRALAS J DERMATOL, V50, P29, DOI 10.1111/j.1440-0960.2008.00512.x; WU YJ, 1982, CELL, V31, P693, DOI 10.1016/0092-8674(82)90324-5; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0	46	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2009	4	11							e7908	10.1371/journal.pone.0007908	http://dx.doi.org/10.1371/journal.pone.0007908			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522NJ	19936293	gold, Green Published, Green Submitted			2022-12-25	WOS:000272004600012
J	Delprat, A; Negre, B; Puig, M; Ruiz, A				Delprat, Alejandra; Negre, Barbara; Puig, Marta; Ruiz, Alfredo			The Transposon Galileo Generates Natural Chromosomal Inversions in Drosophila by Ectopic Recombination	PLOS ONE			English	Article							DOUBLE-STRAND BREAK; P-ELEMENT TRANSPOSASE; HOMOLOGOUS RECOMBINATION; STRUCTURAL VARIATION; YERSINIA-PESTIS; MOLECULAR CHARACTERIZATION; SEGMENTAL DUPLICATIONS; BORDETELLA-PERTUSSIS; EVOLUTIONARY HISTORY; POPULATION-GENETICS	Background: Transposable elements (TEs) are responsible for the generation of chromosomal inversions in several groups of organisms. However, in Drosophila and other Dipterans, where inversions are abundant both as intraspecific polymorphisms and interspecific fixed differences, the evidence for a role of TEs is scarce. Previous work revealed that the transposon Galileo was involved in the generation of two polymorphic inversions of Drosophila buzzatii. Methodology/Principal Findings: To assess the impact of TEs in Drosophila chromosomal evolution and shed light on the mechanism involved, we isolated and sequenced the two breakpoints of another widespread polymorphic inversion from D. buzzatii, 2z(3). In the non inverted chromosome, the 2z(3) distal breakpoint was located between genes CG2046 and CG10326 whereas the proximal breakpoint lies between two novel genes that we have named Dlh and Mdp. In the inverted chromosome, the analysis of the breakpoint sequences revealed relatively large insertions (2,870-bp and 4,786-bp long) including two copies of the transposon Galileo (subfamily Newton), one at each breakpoint, plus several other TEs. The two Galileo copies: (i) are inserted in opposite orientation; (ii) present exchanged target site duplications; and (iii) are both chimeric. Conclusions/Significance: Our observations provide the best evidence gathered so far for the role of TEs in the generation of Drosophila inversions. In addition, they show unequivocally that ectopic recombination is the causative mechanism. The fact that the three polymorphic D. buzzatii inversions investigated so far were generated by the same transposon family is remarkable and is conceivably due to Galileo's unusual structure and current (or recent) transpositional activity.			Delprat, A (corresponding author), Univ Autonoma Barcelona, Dept Genet & Microbiol, E-08193 Barcelona, Spain.	Alfredo.Ruiz@uab.es	Negre, Barbara/F-2540-2013; Puig, Marta/F-7885-2016; Ruiz, Alfredo/AAB-2759-2019; Delprat Obeaga, Alejandra/F-8007-2016; Ruiz, Alfredo/ABH-2402-2020; Obeaga, Alejandra Delprat/AAE-6301-2021	Negre, Barbara/0000-0002-7333-3979; Puig, Marta/0000-0002-4439-6372; Delprat Obeaga, Alejandra/0000-0002-5187-802X; 				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andolfatto P, 2000, GENETICS, V154, P1681; Andolfatto P, 2001, GENET RES, V77, P1, DOI 10.1017/S0016672301004955; Antonacci F, 2009, HUM MOL GENET, V18, P2555, DOI 10.1093/hmg/ddp187; Armengol L, 2003, HUM MOL GENET, V12, P2201, DOI 10.1093/hmg/ddg223; Bailey JA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-r23; Bailey JA, 2006, NAT REV GENET, V7, P552, DOI 10.1038/nrg1895; Beall EL, 1997, GENE DEV, V11, P2137, DOI 10.1101/gad.11.16.2137; Beare PA, 2009, INFECT IMMUN, V77, P642, DOI 10.1128/IAI.01141-08; Bergman CM, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-r112; BERGMAN CM, 2002, GENOME BIOL, V3, P86, DOI DOI 10.1186/GB-2002-3-12-RESEARCH0086; Bhutkar A, 2008, GENETICS, V179, P1657, DOI 10.1534/genetics.107.086108; Brinig MM, 2006, J BACTERIOL, V188, P2375, DOI 10.1128/JB.188.7.2375-2382.2006; Caceres M, 1999, SCIENCE, V285, P415, DOI 10.1126/science.285.5426.415; Caceres M, 2001, GENOME RES, V11, P1353, DOI 10.1101/gr.174001; Caceres M, 2007, P NATL ACAD SCI USA, V104, P18571, DOI 10.1073/pnas.0706604104; Casals F, 2005, GENETICS, V169, P2047, DOI 10.1534/genetics.104.035048; Casals F, 2003, MOL BIOL EVOL, V20, P674, DOI 10.1093/molbev/msg070; Casals F, 2006, CHROMOSOMA, V115, P403, DOI 10.1007/s00412-006-0071-7; Chain PSG, 2004, P NATL ACAD SCI USA, V101, P13826, DOI 10.1073/pnas.0404012101; CHARLESWORTH B, 1994, NATURE, V371, P215, DOI 10.1038/371215a0; Cho NH, 2007, P NATL ACAD SCI USA, V104, P7981, DOI 10.1073/pnas.0611553104; CIRERA S, 1995, GENETICS, V139, P321; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Coghlan A, 2005, TRENDS GENET, V21, P673, DOI 10.1016/j.tig.2005.09.009; Coulibaly MB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000849; da Costa OP, 2009, CHROMOSOMA, V118, P349, DOI 10.1007/s00412-008-0201-5; Daveran-Mingot ML, 1998, J BACTERIOL, V180, P4834, DOI 10.1128/JB.180.18.4834-4842.1998; Deng W, 2002, J BACTERIOL, V184, P4601, DOI 10.1128/JB.184.16.4601-4611.2002; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Evans AL, 2007, GENETICS, V177, P1303, DOI 10.1534/genetics.107.073932; Eykelenboom JK, 2008, MOL CELL, V29, P644, DOI 10.1016/j.molcel.2007.12.020; Feschotte C, 2008, NAT REV GENET, V9, P397, DOI 10.1038/nrg2337; Feschotte C, 2007, ANNU REV GENET, V41, P331, DOI 10.1146/annurev.genet.40.110405.090448; Feuk L, 2005, PLOS GENET, V1, P489, DOI 10.1371/journal.pgen.0010056; FINNEGAN DJ, 1989, TRENDS GENET, V5, P103, DOI 10.1016/0168-9525(89)90039-5; Gonzalez J, 2005, GENOME RES, V15, P885, DOI 10.1101/gr.3263105; Gray YHM, 2000, TRENDS GENET, V16, P461, DOI 10.1016/S0168-9525(00)02104-1; Gray YHM, 1996, GENETICS, V144, P1601; HASSON E, 1995, J EVOLUTION BIOL, V8, P369, DOI 10.1046/j.1420-9101.1995.8030369.x; HASSON E, 1991, J EVOLUTION BIOL, V4, P209, DOI 10.1046/j.1420-9101.1991.4020209.x; Hefferin ML, 2005, DNA REPAIR, V4, P639, DOI 10.1016/j.dnarep.2004.12.005; Huang JT, 2008, PLANT CELL, V20, P2019, DOI 10.1105/tpc.108.060582; Hurles ME, 2008, TRENDS GENET, V24, P238, DOI 10.1016/j.tig.2008.03.001; Iriarte PJF, 2003, HEREDITY, V91, P51, DOI 10.1038/sj.hdy.6800280; Ji XL, 2008, GENOMICS, V91, P249, DOI 10.1016/j.ygeno.2007.10.014; Jordan IK, 1998, J MOL EVOL, V47, P14, DOI 10.1007/PL00006358; Kaminker JS, 2002, GENOME BIOL, V3, P0084, DOI DOI 10.1186/GB-2002-3-12-RFESEARCH84; Kehrer-Sawatzki H, 2008, CHROMOSOME RES, V16, P41, DOI 10.1007/s10577-007-1207-1; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Kidwell MG, 2002, MOBILE DNA, P59; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; KREITMAN M, 1991, GENETICS, V127, P565; KUPIEC M, 1988, MOL CELL BIOL, V8, P2942, DOI 10.1128/MCB.8.7.2942; Laayouni H, 2000, GENETICS, V156, P1797; Lee J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004047; LEVIS R, 1982, CELL, V30, P551, DOI 10.1016/0092-8674(82)90252-5; Lewis SM, 2006, DNA REPAIR, V5, P1146, DOI 10.1016/j.dnarep.2006.05.014; LIM JK, 1994, BIOESSAYS, V16, P269, DOI 10.1002/bies.950160410; Lobachev KS, 2000, EMBO J, V19, P3822, DOI 10.1093/emboj/19.14.3822; Lobachev KS, 1998, GENETICS, V148, P1507; Marzo M, 2008, P NATL ACAD SCI USA, V105, P2957, DOI 10.1073/pnas.0712110105; Mathiopoulos KD, 1998, P NATL ACAD SCI USA, V95, P12444, DOI 10.1073/pnas.95.21.12444; Matzkin LM, 2005, GENETICS, V170, P1143, DOI 10.1534/genetics.104.038810; MCDONALD JF, 1993, CURR OPIN GENET DEV, V3, P855, DOI 10.1016/0959-437X(93)90005-A; MONTGOMERY E, 1987, GENET RES, V49, P31, DOI 10.1017/S0016672300026707; Murphy WJ, 2005, GENOMICS, V86, P383, DOI 10.1016/j.ygeno.2005.05.013; Nag DK, 1997, GENETICS, V146, P835; Navarro A, 1997, GENETICS, V146, P695; Negre B, 2005, GENOME RES, V15, P692, DOI 10.1101/gr.3468605; Negre B, 2003, MOL BIOL EVOL, V20, P2042, DOI 10.1093/molbev/msg238; Nei M, 1987, MOL EVOLUTIONARY GEN; Ortiz MD, 2009, GENETICA, V135, P67, DOI 10.1007/s10709-008-9259-5; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083; Pastink A, 2001, MUTAT RES-FUND MOL M, V480, P37, DOI 10.1016/S0027-5107(01)00167-1; Pereira Vini, 2009, PLoS One, V4, pe4321, DOI 10.1371/journal.pone.0004321; PETES TD, 1988, ANNU REV GENET, V22, P147, DOI 10.1146/annurev.ge.22.120188.001051; Petrov DA, 2003, MOL BIOL EVOL, V20, P880, DOI 10.1093/molbev/msg102; Piccinali RV, 2007, J MOL EVOL, V64, P158, DOI 10.1007/s00239-005-0224-y; PICOLOGLOU S, 1988, MOL GEN GENET, V211, P272, DOI 10.1007/BF00330604; Powell J. R., 1997, PROGR PROSPECTS EVOL; Puig M, 2004, P NATL ACAD SCI USA, V101, P9013, DOI 10.1073/pnas.0403090101; Ranz JM, 2007, PLOS BIOL, V5, P1366, DOI 10.1371/journal.pbio.0050152; Redder P, 2006, J BACTERIOL, V188, P4198, DOI 10.1128/JB.00061-06; Reith ME, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-427; Richards S, 2005, GENOME RES, V15, P1, DOI 10.1101/gr.3059305; Rodriguez C, 1999, EVOLUTION, V53, P612, DOI 10.2307/2640797; ROEDER GS, 1983, MOL GEN GENET, V190, P117; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; RUIZ A, 1993, HEREDITY, V70, P582, DOI 10.1038/hdy.1993.85; RUIZ A, 1986, EVOLUTION, V40, P740, DOI 10.1111/j.1558-5646.1986.tb00534.x; Ruiz A., 1984, Genetica Iberica, V36, P13; Runcie DE, 2009, GENETICA, V136, P5, DOI 10.1007/s10709-008-9296-0; Sambrook J., 1989, MOL CLONING LAB MANU; Schaeffer SW, 2008, GENETICS, V179, P1601, DOI 10.1534/genetics.107.086074; Schweitzer F., 1998, ADV COMPLEX SYST, V1, P11, DOI DOI 10.1142/S021952599800003X; Shaffer LG, 2000, ANNU REV GENET, V34, P297, DOI 10.1146/annurev.genet.34.1.297; Sharakhov IV, 2006, P NATL ACAD SCI USA, V103, P6258, DOI 10.1073/pnas.0509683103; SMITH JM, 1992, J MOL EVOL, V34, P126; SMITH PA, 1991, ADV GENET, V29, P229, DOI 10.1016/S0065-2660(08)60109-1; Sonoda E, 2006, DNA REPAIR, V5, P1021, DOI 10.1016/j.dnarep.2006.05.022; SVOBODA YHM, 1995, GENETICS, V139, P1601; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang M, 2007, J BIOL CHEM, V282, P29002, DOI 10.1074/jbc.M704106200; VanHulle K, 2007, MOL CELL BIOL, V27, P2601, DOI 10.1128/MCB.01740-06; Voineagu I, 2008, P NATL ACAD SCI USA, V105, P9936, DOI 10.1073/pnas.0804510105; WESLEY CS, 1994, P NATL ACAD SCI USA, V91, P3132, DOI 10.1073/pnas.91.8.3132; Yang HP, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r39; Zhang JB, 2009, GENE DEV, V23, P755, DOI 10.1101/gad.1776909; Zhou ZH, 2001, P NATL ACAD SCI USA, V98, P8326, DOI 10.1073/pnas.151008498; Zody MC, 2006, NATURE, V440, P1045, DOI 10.1038/nature04689	113	52	53	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2009	4	11							e7883	10.1371/journal.pone.0007883	http://dx.doi.org/10.1371/journal.pone.0007883			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521QH	19936241	Green Published, Green Submitted, gold			2022-12-25	WOS:000271936700016
J	Kimura, HJ; Chen, CY; Tzou, SC; Rocchi, R; Landek-Salgado, MA; Suzuki, K; Kimura, M; Rose, NR; Caturegli, P				Kimura, Hiroaki J.; Chen, Cindy Y.; Tzou, Shey-Cherng; Rocchi, Roberto; Landek-Salgado, Melissa A.; Suzuki, Koichi; Kimura, Miho; Rose, Noel R.; Caturegli, Patrizio			Immunoproteasome Overexpression Underlies the Pathogenesis of Thyroid Oncocytes and Primary Hypothyroidism: Studies in Humans and Mice	PLOS ONE			English	Article							PROTEASOME WORSENS ATHEROSCLEROSIS; AUTOIMMUNE-DISEASES; SJOGRENS-SYNDROME; INTERFERON-GAMMA; LMP2 EXPRESSION; NOD MICE; INHIBITION; SUBUNITS; CELL; BORTEZOMIB	Background: Oncocytes of the thyroid gland (Hurthle cells) are found in tumors and autoimmune diseases. They have a unique appearance characterized by abundant granular eosinophilic cytoplasm and hyperchromatic nucleus. Their pathogenesis has remained, thus far, unknown. Methodology/Principal Findings: Using transgenic mice chronically expressing IFN gamma in thyroid gland, we showed changes in the thyroid follicular epithelium reminiscent of the human oncocyte. Transcriptome analysis comparing transgenic to wild type thyrocytes revealed increased levels of immunoproteasome subunits like LMP2 in transgenics, suggesting an important role of the immunoproteasome in oncocyte pathogenesis. Pharmacologic blockade of the proteasome, in fact, ameliorated the oncocytic phenotype. Genetic deletion of LMP2 subunit prevented the development of the oncocytic phenotype and primary hypothyroidism. LMP2 was also found expressed in oncocytes from patients with Hashimoto thyroiditis and Hurthle cell tumors. Conclusions/Significance: In summary, we report that oncocytes are the result of an increased immunoproteasome expression secondary to a chronic inflammatory milieu, and suggest LMP2 as a novel therapeutic target for the treatment of oncocytic lesions and autoimmune hypothyroidism.			Kimura, HJ (corresponding author), Johns Hopkins Sch Med, Dept Pathol, Baltimore, MD 21218 USA.	pcat@jhmi.edu	Kimura, Hiroaki/E-3224-2010; Suzuki, Koichi/C-4177-2013	Kimura, Hiroaki/0000-0002-7441-0382; Landek-Salgado, Melissa/0000-0002-4707-2066; Suzuki, Koichi/0000-0001-8659-4660	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK080334, R01DK055670, R56DK055670] Funding Source: NIH RePORTER; NIDDK NIH HHS [R56 DK055670, DK55670, R01 DK055670, R21 DK080334, DK080334] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adams J, 1999, CANCER RES, V59, P2615; Adams J, 2002, ONCOLOGIST, V7, P9, DOI 10.1634/theoncologist.7-1-9; Benvenga S, 2008, HORM METAB RES, V40, P323, DOI 10.1055/s-2008-1073155; Bonuccelli G, 2007, CELL CYCLE, V6, P1242, DOI 10.4161/cc.6.10.4182; Casp CB, 2003, GENES IMMUN, V4, P492, DOI 10.1038/sj.gene.6364016; Caturegli P, 2005, THYROID, V15, P121, DOI 10.1089/thy.2005.15.121; Caturegli P, 2000, P NATL ACAD SCI USA, V97, P1719, DOI 10.1073/pnas.020522597; Chade AR, 2005, J AM SOC NEPHROL, V16, P1005, DOI 10.1681/ASN.2004080674; Cooper GS, 2003, AUTOIMMUN REV, V2, P119, DOI 10.1016/S1568-9972(03)00006-5; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; Egerer K, 2002, J RHEUMATOL, V29, P2045; Egerer T, 2006, ARTHRITIS RHEUM-US, V54, P1501, DOI 10.1002/art.21782; Fissolo N, 2008, EUR J IMMUNOL, V38, P2401, DOI 10.1002/eji.200838413; Fukai T, 2007, CIRC RES, V101, P859, DOI 10.1161/CIRCRESAHA.107.164020; Griffin TA, 1998, J EXP MED, V187, P97, DOI 10.1084/jem.187.1.97; Groettrup M, 1997, P NATL ACAD SCI USA, V94, P8970, DOI 10.1073/pnas.94.17.8970; Hayashi T, 1999, MOL CELL BIOL, V19, P8646; Hayashi T, 2000, NAT MED, V6, P1065, DOI 10.1038/80353; Herrmann J, 2007, CIRC RES, V101, P865, DOI 10.1161/CIRCRESAHA.107.152959; Hu GQ, 2006, MOL MICROBIOL, V59, P1417, DOI 10.1111/j.1365-2958.2005.05036.x; Kessler BM, 2000, NAT MED, V6, P1064, DOI 10.1038/80346; Kimura H, 2005, INT J EXP PATHOL, V86, P97, DOI 10.1111/j.0959-9673.2005.00418.x; Kloetzel PM, 2004, NAT IMMUNOL, V5, P661, DOI 10.1038/ni1090; Kraemer U, 2007, GENES IMMUN, V8, P513, DOI 10.1038/sj.gene.6364404; Krause S, 2006, ANN RHEUM DIS, V65, P1021, DOI 10.1136/ard.2005.045930; Kuhn DJ, 2009, BLOOD, V113, P4667, DOI 10.1182/blood-2008-07-171637; Lindenthal C, 2005, PARASITOLOGY, V131, P37, DOI 10.1017/S003118200500747X; Ludwig A, 2008, CIRC RES, V102, pE37, DOI 10.1161/CIRCRESAHA.107.168963; Maksymowych WP, 2000, J RHEUMATOL, V27, P183; Montone KT, 2008, ARCH PATHOL LAB MED, V132, P1241, DOI 10.1043/1543-2165(2008)132[1241:TTHOCA]2.0.CO;2; Neubert K, 2008, NAT MED, V14, P748, DOI 10.1038/nm1763; Nussbaum AK, 2005, J IMMUNOL, V175, P1153, DOI 10.4049/jimmunol.175.2.1153; Richardson PG, 2006, ANNU REV MED, V57, P33, DOI 10.1146/annurev.med.57.042905.122625; Runnels HA, 2000, NAT MED, V6, P1064, DOI 10.1038/80349; Saha S, 2002, NAT BIOTECHNOL, V20, P508, DOI 10.1038/nbt0502-508; Scheffler S, 2008, RHEUMATOLOGY, V47, P622, DOI 10.1093/rheumatology/ken042; TALLINI G, 1992, ACTA PATHOL JAPON, V42, P305; Tanaka K, 2009, P JPN ACAD B-PHYS, V85, P12, DOI [10.2183/pjab.85.12, 10.2183/pjab/85.12]; VivesPi M, 1997, TISSUE ANTIGENS, V50, P153, DOI 10.1111/j.1399-0039.1997.tb02854.x	39	24	25	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2009	4	11							e7857	10.1371/journal.pone.0007857	http://dx.doi.org/10.1371/journal.pone.0007857			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520OG	19924240	Green Published, gold, Green Submitted			2022-12-25	WOS:000271854200007
J	Chakrabarti, AK; Pawar, SD; Cherian, SS; Koratkar, SS; Jadhav, SM; Pal, B; Raut, S; Thite, V; Kode, SS; Keng, SS; Payyapilly, BJ; Mullick, J; Mishra, AC				Chakrabarti, Alok K.; Pawar, Shailesh D.; Cherian, Sarah S.; Koratkar, Santosh S.; Jadhav, Santosh M.; Pal, Biswajoy; Raut, Satish; Thite, Vishal; Kode, Sadhana S.; Keng, Sachin S.; Payyapilly, Bestin J.; Mullick, Jayati; Mishra, Akhilesh C.			Characterization of the Influenza A H5N1 Viruses of the 2008-09 Outbreaks in India Reveals a Third Introduction and Possible Endemicity	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; SEQUENCE-ANALYSIS; PATHOGENICITY; RESISTANCE; HEMAGGLUTININ; INHIBITORS; EFFICIENCY; POULTRY	Widespread infection of highly pathogenic avian influenza A H5N1 was reported from backyard and commercial poultry in West Bengal (WB), an eastern state of India in early 2008. Infection gradually spread to Tripura, Assam and Sikkim, the northeastern states, with 70 outbreaks reported between January 2008 and May 2009. Whole genome sequence analysis of three isolates from WB, one isolate from Tripura along with the analysis of hemagglutinin (HA) and neuraminidase (NA) genes of 17 other isolates was performed during this study. In the HA gene phylogenetic tree, all the 2008-09 Indian isolates belonged to EMA3 sublineage of clade 2.2. The closest phylogenetic relationship was found to be with the 2007-09 isolates from Bangladesh and not with the earlier 2006 and 2007 Indian isolates implying a third introduction into the country. The receptor-binding pocket of HA1 of two isolates from WB showed S221P mutation, one of the markers predicted to be associated with human receptor specificity. Two substitutions E119A (2 isolates of WB) and N294S (2 other isolates of WB) known to confer resistance to NA inhibitors were observed in the active site of neuraminidase. Several additional mutations were observed within the 2008-09 Indian isolates indicating genetic diversification. Overall, the study is indicative of a possible endemicity in the eastern and northeastern parts of the country, demanding active surveillance specifically in view of the critical mutations that have been observed in the influenza A H5N1 viruses.			Chakrabarti, AK (corresponding author), Natl Inst Virol, Microbial Containment Complex, Pune, Maharashtra, India.	acm1750@rediffmail.com	Cherian, Sarah/ABA-6207-2021; Koratkar, Santosh/GLN-7548-2022; Cherian, /411001/H-1332-2016; Raut, Satish/AAP-2262-2021; Jadhav, Santoshkumar/AAB-7634-2021	Koratkar, Santosh/0000-0002-9413-950X; Keng, Sachin/0000-0002-4831-9745				ARNOLD SM, 2006, ANTIMICROB AGENTS CH, V50, P2395; Aubin JT, 2005, EMERG INFECT DIS, V11, P1515; Biswas PK, 2008, EMERG INFECT DIS, V14, P1909, DOI 10.3201/eid1412.071567; BROOKS WA, 2009, EMERG INFECT DIS, V15, P7; Cattoli G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004842; de Jong MD, 2005, NEW ENGL J MED, V353, P2667, DOI 10.1056/NEJMoa054512; Deyde VM, 2009, ANTIMICROB AGENTS CH, V53, P1039, DOI 10.1128/AAC.01446-08; Ducatez MF, 2007, J GEN VIROL, V88, P2297, DOI 10.1099/vir.0.82939-0; Gabriel G, 2005, P NATL ACAD SCI USA, V102, P18590, DOI 10.1073/pnas.0507415102; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Hulse DJ, 2004, J VIROL, V78, P9954, DOI 10.1128/JVI.78.18.9954-9964.2004; Ilyushina NA, 2009, ANTIVIR RES, V82, pA71, DOI 10.1016/j.antiviral.2009.02.176; ISLAM MR, BANGK INT C AV INFL; Kaverin NV, 2004, J VIROL, V78, P240, DOI 10.1128/JVI.78.1.240-249.2004; Kiss I, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-113; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Le QM, 2005, NATURE, V437, P1108, DOI 10.1038/4371108a; McKimm-Breschkin J, 2003, ANTIMICROB AGENTS CH, V47, P2264, DOI 10.1128/AAC.47.7.2264-2272.2003; McKimm-Breschkin JL, 2007, EMERG INFECT DIS, V13, P1354, DOI 10.3201/eid1309.070164; Mishra AC, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-26; Monto AS, 2006, ANTIMICROB AGENTS CH, V50, P2395, DOI 10.1128/AAC.01339-05; Obenauer JC, 2006, SCIENCE, V311, P1576, DOI 10.1126/science.1121586; OIE, UPD HIGHL PATH AV IN; Peiris JSM, 2007, CLIN MICROBIOL REV, V20, P243, DOI 10.1128/CMR.00037-06; Rameix-Welti MA, 2006, ANTIMICROB AGENTS CH, V50, P3809, DOI 10.1128/AAC.00645-06; Ray K, 2008, VIRUS GENES, V36, P345, DOI 10.1007/s11262-007-0195-8; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Russell RJ, 2006, NATURE, V443, P45, DOI 10.1038/nature05114; Salzberg SL, 2007, EMERG INFECT DIS, V13, P713, DOI 10.3201/eid1305.070013; SEOSH SH, 2007, NAT MED, V8, P950; Shaw M, 2002, J MED VIROL, V66, P107, DOI 10.1002/jmv.2118; Shinya K, 2004, VIROLOGY, V320, P258, DOI 10.1016/j.virol.2003.11.030; Starick E, 2008, VET MICROBIOL, V128, P243, DOI 10.1016/j.vetmic.2007.10.012; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; Stevens J, 2004, SCIENCE, V303, P1866, DOI 10.1126/science.1093373; Suzuki Hiroshi, 2003, Journal of Infection and Chemotherapy, V9, P195; *WHO, WHO H5N1 AV INFL TIM; *WHO, REC LAB TESTS ID AV; World Health Organization, CUM NUMB CONF HUM CA; Yen HL, 2007, J VIROL, V81, P12418, DOI 10.1128/JVI.01067-07; 2009, CONTINUING PROGR UNI	42	61	62	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2009	4	11							e7846	10.1371/journal.pone.0007846	http://dx.doi.org/10.1371/journal.pone.0007846			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520NG	19924254	Green Published, Green Submitted, gold			2022-12-25	WOS:000271851000006
J	Cai, X; Conley, SM; Nash, Z; Fliesler, SJ; Cooper, MJ; Naash, MI				Cai, Xue; Conley, Shannon M.; Nash, Zack; Fliesler, Steven J.; Cooper, Mark J.; Naash, Muna I.			Gene delivery to mitotic and postmitotic photoreceptors via compacted DNA nanoparticles results in improved phenotype in a mouse model of retinitis pigmentosa	FASEB JOURNAL			English	Article						gene replacement therapy; retinal degeneration slow protein; mouse opsin promoter	OUTER SEGMENT MORPHOGENESIS; DEGENERATION SLOW RDS; RETINAL DEGENERATION; TRANSGENIC MICE; ROD PHOTORECEPTORS; IN-VIVO; REPLACEMENT THERAPY; R172W MUTATION; DISK MEMBRANE; MUTANT MICE	The purpose of the present study was to test the therapeutic efficiency and safety of compacted-DNA nanoparticle-mediated gene delivery into the sub-retinal space of a juvenile mouse model of retinitis pigmentosa. Nanoparticles containing the mouse opsin promoter and wild-type mouse Rds gene were injected subretinally into mice carrying a haploinsufficiency mutation in the retinal degeneration slow (rds(+/-)) gene at postnatal day (P) 5 and 22. Control mice were either injected with saline, injected with uncompacted naked plasmid DNA carrying the Rds gene, or remained untreated. Rds mRNA levels peaked at postinjection day 2 to 7 (PI-2 to PI-7) for P5 injections, stabilized at levels 2-fold higher than in uninjected controls for both P5 and P22 injections, and remained elevated at the latest time point examined (PI-120). Rod function (measured by electroretinography) showed modest but statistically significant improvement compared with controls after both P5 and P22 injections. Cone function in nanoparticle-injected eyes reached wild-type levels for both ages of injections, indicating full prevention of cone degeneration. Ultrastructural examination at PI-120 revealed significant improvement in outer segment structures in P5 nanoparticle-injected eyes, while P22 injection had a modest structural improvement. There was no evidence of macrophage activation or induction of IL-6 or TNF-alpha mRNA in P5 or P22 nanoparticle-dosed eyes at either PI-2 or PI-30. Thus, compacted-DNA nanoparticles can efficiently and safely drive gene expression in both mitotic and postmitotic photoreceptors and retard degeneration in this model. These findings, using a clinically relevant treatment paradigm, illustrate the potential for application of nanoparticle-based gene replacement therapy for treatment of human retinal degenerations.-Cai, X., Conley, S. M., Nash, Z., Fliesler, S. J., Cooper, M. J., Naash, M. I. Gene delivery to mitotic and postmitotic photoreceptors via compacted DNA nanoparticles results in improved phenotype in a mouse model of retinitis pigmentosa. FASEB J. 24, 1178-1191 (2010). www.fasebj.org	[Cai, Xue; Conley, Shannon M.; Nash, Zack; Naash, Muna I.] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73104 USA; [Fliesler, Steven J.] Vet Adm Western New York Healthcare Syst, Res Serv, Buffalo, NY USA; [Fliesler, Steven J.] SUNY Buffalo, Dept Ophthalmol, Ross Eye Inst, Buffalo, NY 14260 USA; [Fliesler, Steven J.] SUNY Buffalo, Dept Biochem, Buffalo, NY 14260 USA; [Cooper, Mark J.] Copernicus Therapeut Inc, Cleveland, OH USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Naash, MI (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, 940 Stanton L Young Blvd,BMSB 781, Oklahoma City, OK 73104 USA.	muna-naash@ouhsc.edu	Fliesler, Steven J./AAE-9243-2020	Fliesler, Steven/0000-0002-2557-142X	National Institutes of Health [EY-010609, EY-018656, EY-007361]; Foundation Fighting Blindness, Baltimore; Oklahoma Center for the Advancement of Science and Technology (OCAST), Oklahoma City, OK, USA; NATIONAL EYE INSTITUTE [R01EY010609, R01EY018656, R55EY010609, R56EY010609, R01EY007361] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Fighting Blindness, Baltimore; Oklahoma Center for the Advancement of Science and Technology (OCAST), Oklahoma City, OK, USA; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The authors thank Barbara Nagel for excellent EM and Lauren Brush for visual behavior studies. The authors also thank Rasha Makkia and Ehsan Nour- Mohammadi for excellent technical assistance. Drs. Robert Barlow and Yumiko Umino provided assistance with the visual behavior testing, and Dr. Michelle Callegan generously shared positive control specimens. This work was supported by National Institutes of Health grants EY-010609 and EY-018656 (to M.I.N.) and EY-007361 (to S.J.F.); the Foundation Fighting Blindness, Baltimore, MD, USA (to M.I.N.); Oklahoma Center for the Advancement of Science and Technology (OCAST), Oklahoma City, OK, USA (to M.I.N.); a vision COBRE (to M.I.N.); and an unrestricted grant from Research to Prevent Blindness (to S.J.F.). M.I.N. and S.J.F. are recipients of the Research to Prevent Blindness James S. Adams Scholar Award and Senior Scientific Investigator Award, respectively. M.J.C. is an employee of Copernicus Therapeutics and owns stock in the company.	Ali RR, 2000, NAT GENET, V25, P306, DOI 10.1038/77068; Bainbridge JWB, 2001, GENE THER, V8, P1665, DOI 10.1038/sj.gt.3301574; Cai X, 2008, VISION RES, V48, P319, DOI 10.1016/j.visres.2007.07.012; Cai X, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005290; Cepko CL, 1996, P NATL ACAD SCI USA, V93, P589, DOI 10.1073/pnas.93.2.589; CHANG GQ, 1993, NEURON, V11, P595, DOI 10.1016/0896-6273(93)90072-Y; Chang GQ, 1997, MICROSC RES TECHNIQ, V36, P123, DOI 10.1002/(SICI)1097-0029(19970115)36:2<123::AID-JEMT5>3.0.CO;2-Q; Cheng T, 1997, J NEUROSCI, V17, P8118, DOI 10.1523/jneurosci.17-21-08118.1997; Conley S, 2007, INVEST OPHTH VIS SCI, V48, P5397, DOI 10.1167/iovs.07-0663; CONNELL G, 1991, P NATL ACAD SCI USA, V88, P723, DOI 10.1073/pnas.88.3.723; CONNELL GJ, 1990, BIOCHEMISTRY-US, V29, P4691, DOI 10.1021/bi00471a025; Davies M, 2006, MOL VIS, V12, P467; Davila I, 2007, J INVEST ALLERG CLIN, V17, P9; Ding XQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007410; Ding XQ, 2004, HUM MOL GENET, V13, P2075, DOI 10.1093/hmg/ddh211; Espinosa-Heidmann DG, 2003, INVEST OPHTH VIS SCI, V44, P3586, DOI 10.1167/iovs.03-0038; Farjo R, 2006, J CELL BIOL, V173, P59, DOI 10.1083/jcb.200509036; Farjo R, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000038; Farjo R, 2007, J COMP NEUROL, V504, P619, DOI 10.1002/cne.21476; Farjo R, 2006, OPHTHALMIC GENET, V27, P117, DOI 10.1080/13816810600976806; Fink TL, 2006, GENE THER, V13, P1048, DOI 10.1038/sj.gt.3302761; Glushakova LG, 2006, MOL VIS, V12, P298; HAWKINS RK, 1985, EXP EYE RES, V41, P701, DOI 10.1016/0014-4835(85)90179-4; Kalloniatis Michael, 2004, Clin Exp Optom, V87, P65; Kedzierski W, 2001, P NATL ACAD SCI USA, V98, P7718, DOI 10.1073/pnas.141124198; Keen TJ, 1996, HUM MUTAT, V8, P297; Kohl S, 1998, ACTA ANAT, V162, P75; Lagali PS, 2008, NAT NEUROSCI, V11, P667, DOI 10.1038/nn.2117; Le YZ, 2006, MOL VIS, V12, P389; Lee ES, 2006, INVEST OPHTH VIS SCI, V47, P2150, DOI 10.1167/iovs.05-0919; LEIBOVICH SJ, 1987, NATURE, V329, P630, DOI 10.1038/329630a0; Li CB, 2001, OPTOMETRY VISION SCI, V78, P425, DOI 10.1097/00006324-200106000-00015; Liu G, 2003, J BIOL CHEM, V278, P32578, DOI 10.1074/jbc.M305776200; MA JS, 1995, GENOMICS, V28, P212, DOI 10.1006/geno.1995.1133; Nour M, 2004, INVEST OPHTH VIS SCI, V45, P2514, DOI 10.1167/iovs.04-0065; Nour M, 2003, INVEST OPHTH VIS SCI, V44, P4505, DOI 10.1167/iovs.03-0453; Nour M, 2008, ADV EXP MED BIOL, V613, P129, DOI 10.1007/978-0-387-74904-4_14; Pang JJ, 2006, MOL VIS, V12, P756; PORTERACAILLIAU C, 1994, P NATL ACAD SCI USA, V91, P974, DOI 10.1073/pnas.91.3.974; Quiambao AB, 1997, VISUAL NEUROSCI, V14, P617, DOI 10.1017/S095252380001258X; Sarra GM, 2001, HUM MOL GENET, V10, P2353, DOI 10.1093/hmg/10.21.2353; Schlichtenbrede FC, 2003, J GENE MED, V5, P757, DOI 10.1002/jgm.401; SUNDERKOTTER C, 1994, J LEUKOCYTE BIOL, V55, P410, DOI 10.1002/jlb.55.3.410; Tan E, 2001, INVEST OPHTH VIS SCI, V42, P589; TRAVIS GH, 1991, NEURON, V6, P61, DOI 10.1016/0896-6273(91)90122-G; WELEBER R, 1999, DIGIT J OPTHALMOL, V5; Ziady AG, 2003, MOL THER, V8, P948, DOI 10.1016/j.ymthe.2003.09.002	47	95	109	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2010	24	4					1178	1191		10.1096/fj.09-139147	http://dx.doi.org/10.1096/fj.09-139147			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	580PV	19952284	Green Published			2022-12-25	WOS:000276462300025
J	Kim, EY; Seo, JM; Cho, KJ; Kim, JH				Kim, E-Y; Seo, J-M; Cho, K-J; Kim, J-H			Ras-induced invasion and metastasis are regulated by a leukotriene B-4 receptor BLT2-linked pathway	ONCOGENE			English	Article						H-Ras; leukotriene B-4 receptor BLT2; ROS; metastasis; MMP-9	NF-KAPPA-B; PANCREATIC-CANCER; ONCOGENIC RAS; H-RAS; EXPRESSION; CYCLOOXYGENASE-2; PROLIFERATION; ACTIVATION; MIGRATION; MECHANISM	Ras signaling pathways are well-recognized for their involvement in cancer cell proliferation; however, considerably less is known regarding their contribution to invasion and metastasis. Here, we demonstrate that a novel BLT2, a low-affinity leukotriene B-4 receptor-linked signaling cascade involving the generation of reactive oxygen species (ROS) via Nox1, NF-kappa B stimulation and subsequent upregulation of matrix metalloproteinase-9 (MMP-9) is a potential mechanism by which Ras promotes invasion and metastasis. We found that inhibition of BLT2 signaling markedly suppressed Ras-evoked metastasis and reduced the associated mortality in mice. Consistent with the proposed role of BLT2 as a key downstream mediator of Ras signaling to metastasis, BLT2 expression alone resulted in the formation of numerous metastatic lung nodules and the nodules formation was significantly attenuated by the inhibition of MMP-9, a downstream component of BLT2. Together, our results reveal the previously unsuspected function of BLT2-linked cascade in driving oncogenic Ras-induced metastasis and would provide a valuable insight into invasion and metastasis. Oncogene (2010) 29, 1167-1178; doi: 10.1038/onc.2009.412; published online 23 November 2009	[Kim, E-Y; Seo, J-M; Cho, K-J; Kim, J-H] Korea Univ, Sch Life Sci & Biotechnol, Inflammatory Signaling Lab, Seoul 136701, South Korea	Korea University	Kim, JH (corresponding author), Korea Univ, Sch Life Sci & Biotechnol, Inflammatory Signaling Lab, 5-1 Anam Dong, Seoul 136701, South Korea.	jhongkim@korea.ac.kr	Kim, Jae-Hong/B-2530-2009	Kim, Jae-Hong/0000-0002-8019-0208	Ministry of Education, Science, and Technology, Korea [M10751050001-08N5105-00110, 20090062880]	Ministry of Education, Science, and Technology, Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	We thank Dr Takao Shimizu (University of Tokyo, Tokyo, Japan) and Dr Takehiko Yokomizo (University of Kyushu, Fukuoka, Japan) for the BLT2 expression plasmids. This work was supported by the Diseases Network Research Program (M10751050001-08N5105-00110), and the SRC-Aging and Apoptosis Research program (20090062880) from the Ministry of Education, Science, and Technology, Korea.	Behrend L, 2003, BIOCHEM SOC T, V31, P1441; Bjorklund M, 2005, BBA-REV CANCER, V1755, P37, DOI 10.1016/j.bbcan.2005.03.001; BONDY GP, 1985, CANCER RES, V45, P6005; Bonfil RD, 2006, INT J CANCER, V118, P2721, DOI 10.1002/ijc.21645; Bortuzzo C, 1996, BBA-LIPID LIPID MET, V1300, P240, DOI 10.1016/0005-2760(96)00003-3; BOS JL, 1989, CANCER RES, V49, P4682; Brock TG, 2007, THESCIENTIFICWORLDJO, V7, P1273, DOI 10.1100/tsw.2007.180; Campbell PM, 2004, SEMIN CANCER BIOL, V14, P105, DOI 10.1016/j.semcancer.2003.09.015; Cha YI, 2007, ANNU REV MED, V58, P239, DOI 10.1146/annurev.med.57.121304.131253; Choi JA, 2008, FREE RADICAL BIO MED, V44, P624, DOI 10.1016/j.freeradbiomed.2007.10.041; Choi JA, 2010, CARCINOGENESIS, V31, P543, DOI 10.1093/carcin/bgp203; Chun KS, 2004, BIOCHEM PHARMACOL, V68, P1089, DOI 10.1016/j.bcp.2004.05.031; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Ding Xian-Zhong, 2003, Mol Cancer, V2, P10, DOI 10.1186/1476-4598-2-10; Ding XZ, 2005, ANTI-CANCER DRUG, V16, P467, DOI 10.1097/00001813-200506000-00001; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Giehl K, 2005, BIOL CHEM, V386, P193, DOI 10.1515/BC.2005.025; Gu ZZ, 2005, J NEUROSCI, V25, P6401, DOI 10.1523/JNEUROSCI.1563-05.2005; Harris Randall E, 2007, Subcell Biochem, V42, P93; Hennig R, 2008, BRIT J CANCER, V99, P1064, DOI 10.1038/sj.bjc.6604655; Hennig R, 2005, NEOPLASIA, V7, P417, DOI 10.1593/neo.04559; Heukamp I, 2006, PROSTAG LEUKOTR ESS, V74, P223, DOI 10.1016/j.plefa.2006.01.005; Hsu TC, 2000, FREE RADICAL BIO MED, V28, P1338, DOI 10.1016/S0891-5849(00)00220-3; Iizuka Y, 2005, J BIOL CHEM, V280, P24816, DOI 10.1074/jbc.M413257200; Kim GY, 2009, ARTERIOSCL THROM VAS, V29, P915, DOI 10.1161/ATVBAHA.109.185793; Kruger A, 2005, CANCER RES, V65, P3523, DOI 10.1158/0008-5472.CAN-04-3570; KUMAR CC, 1992, CANCER RES, V52, P6877; Lee KW, 2006, INT J CANCER, V119, P1767, DOI 10.1002/ijc.22056; Mayoral R, 2005, CARCINOGENESIS, V26, P753, DOI 10.1093/carcin/bgi022; Nie DT, 2001, CANCER METAST REV, V20, P195, DOI 10.1023/A:1015579209850; Nikkola J, 2005, CLIN CANCER RES, V11, P5158, DOI 10.1158/1078-0432.CCR-04-2478; Oft M, 2002, NAT CELL BIOL, V4, P487, DOI 10.1038/ncb807; Qiu H, 2006, P NATL ACAD SCI USA, V103, P6913, DOI 10.1073/pnas.0602208103; Rocconi RP, 2008, REPROD SCI, V15, P321, DOI 10.1177/1933719108316390; Romano M, 2003, FASEB J, V17, P1986, DOI 10.1096/fj.03-0053rev; Shin EH, 2006, BIOCHEM BIOPH RES CO, V348, P606, DOI 10.1016/j.bbrc.2006.07.084; SU ZZ, 1993, ONCOGENE, V8, P1211; Subbaramaiah K, 2002, J BIOL CHEM, V277, P18649, DOI 10.1074/jbc.M111415200; Tong WG, 2002, CLIN CANCER RES, V8, P3232; Van Putten V, 2001, J BIOL CHEM, V276, P1226, DOI 10.1074/jbc.M003581200; Wang MT, 2007, CANCER METAST REV, V26, P525, DOI 10.1007/s10555-007-9096-5; Woo CH, 2002, J BIOL CHEM, V277, P8572, DOI 10.1074/jbc.M104766200; Wu WS, 2006, CANCER METAST REV, V25, P695, DOI 10.1007/s10555-006-9037-8; Yang JQ, 2001, FREE RADICAL BIO MED, V31, P520, DOI 10.1016/S0891-5849(01)00613-X; YOKOMIZO T, 1995, J LIPID MEDIAT CELL, V12, P321, DOI 10.1016/0929-7855(95)00041-N; Yokomizo T, 2000, J EXP MED, V192, P421, DOI 10.1084/jem.192.3.421; Yokomizo T, 2001, J BIOL CHEM, V276, P12454, DOI 10.1074/jbc.M011361200; Yoo MH, 2004, ONCOGENE, V23, P9259, DOI 10.1038/sj.onc.1208151; Yoo MH, 2001, J BIOL CHEM, V276, P24645, DOI 10.1074/jbc.M101975200; Zampetaki A, 2005, AM J PHYSIOL-HEART C, V288, pH2946, DOI 10.1152/ajpheart.00919.2004	50	44	45	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 25	2010	29	8					1167	1178		10.1038/onc.2009.412	http://dx.doi.org/10.1038/onc.2009.412			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	560ON	19935719				2022-12-25	WOS:000274912100008
J	Alkhouri, N; Gornicka, A; Berk, MP; Thapaliya, S; Dixon, LJ; Kashyap, S; Schauer, PR; Feldstein, AE				Alkhouri, Naim; Gornicka, Agnieszka; Berk, Michael P.; Thapaliya, Samjhana; Dixon, Laura J.; Kashyap, Sangeeta; Schauer, Philip R.; Feldstein, Ariel E.			Adipocyte Apoptosis, a Link between Obesity, Insulin Resistance, and Hepatic Steatosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY LIVER-DISEASE; ADIPOSE-TISSUE; NONALCOHOLIC STEATOHEPATITIS; METABOLIC SYNDROME; MICE; INFLAMMATION; SENSITIVITY; DEATH; EXPRESSION; PATHWAYS	Adipocyte death has been reported in both obese humans and rodents. However, its role in metabolic disorders, including insulin resistance, hepatic steatosis, and inflammation associated with obesity has not been studied. We now show using real-time reverse transcription-PCR arrays that adipose tissue of obese mice display a pro-apoptotic phenotype. Moreover, caspase activation and adipocyte apoptosis were markedly increased in adipose tissue from both mice with diet-induced obesity and obese humans. These changes were associated with activation of both the extrinsic, death receptor-mediated, and intrinsic, mitochondrial-mediated pathways of apoptosis. Genetic inactivation of Bid, a key pro-apoptotic molecule that serves as a link between these two cell death pathways, significantly reduced caspase activation, adipocyte apoptosis, prevented adipose tissue macrophage infiltration, and protected against the development of systemic insulin resistance and hepatic steatosis independent of body weight. These data strongly suggest that adipocyte apoptosis is a key initial event that contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis associated with obesity in both mice and humans. Inhibition of adipocyte apoptosis may be a new therapeutic strategy for the treatment of obesity-associated metabolic complications.	[Feldstein, Ariel E.] Cleveland Clin, Lerner Coll Med, Lerner Res Inst, Dept Cell Biol, Cleveland, OH 44195 USA; [Schauer, Philip R.] Cleveland Clin, Bariatr & Metab Inst, Cleveland, OH 44195 USA; [Alkhouri, Naim; Feldstein, Ariel E.] Cleveland Clin, Dept Pediat Gastroenterol, Cleveland, OH 44195 USA; [Kashyap, Sangeeta] Cleveland Clin, Dept Endocrinol, Cleveland, OH 44195 USA	Case Western Reserve University; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Feldstein, AE (corresponding author), Cleveland Clin, Lerner Coll Med, Lerner Res Inst, Dept Cell Biol, NE10,9500 Euclid Ave, Cleveland, OH 44195 USA.	feldsta@ccf.org	Berk, Michael/M-3585-2019; Berk, Michael/M-7891-2013	Berk, Michael/0000-0002-5554-6946; Berk, Michael/0000-0002-5554-6946; Kashyap, Sangeeta/0000-0002-7489-6650; Schauer, Philip/0000-0002-4029-7537	National Institutes of Health [DK076852, DK082451]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082451, R01DK076852] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK076852 and DK082451 (to A. E. F.).	Angulo P, 2007, NUTR REV, V65, pS57, DOI 10.1111/j.1753-4887.2007.tb00329.x; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Cosson E, 2005, DIABETES METAB, V31, P47, DOI 10.1016/S1262-3636(07)70166-0; Diehl Anna Mae, 2003, Endocr Pract, V9 Suppl 2, P93; Feldstein AE, 2004, HEPATOLOGY, V40, P185, DOI 10.1002/hep.20283; Feldstein AE, 2003, GASTROENTEROLOGY, V125, P437, DOI 10.1016/S0016-5085(03)00907-7; Feldstein AE, 2003, J HEPATOL, V39, P978, DOI 10.1016/S0168-8278(03)00460-4; Friedman JM, 2000, NATURE, V404, P632, DOI 10.1038/35007504; Green DR, 1998, CELL, V94, P695, DOI 10.1016/S0092-8674(00)81728-6; Green DR, 2005, CELL, V121, P671, DOI 10.1016/j.cell.2005.05.019; Guicciardi ME, 2009, FASEB J, V23, P1625, DOI 10.1096/fj.08-111005; Hevener AL, 2007, J CLIN INVEST, V117, P1658, DOI 10.1172/JCI31561; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Koteish A, 2001, SEMIN LIVER DIS, V21, P89, DOI 10.1055/s-2001-12932; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Lauber K, 2003, CELL, V113, P717, DOI 10.1016/S0092-8674(03)00422-7; Li ZZ, 2009, J BIOL CHEM, V284, P5637, DOI 10.1074/jbc.M807616200; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Murano I, 2008, J LIPID RES, V49, P1562, DOI 10.1194/jlr.M800019-JLR200; Nanji Amin A, 2004, Clin Liver Dis, V8, P559, DOI 10.1016/j.cld.2004.04.002; Neels JG, 2006, J CLIN INVEST, V116, P33, DOI 10.1172/JCI27280; Nolsoe RL, 2006, GENES IMMUN, V7, P316, DOI 10.1038/sj.gene.6364300; PANG C, 2008, J AM J PHYSL ENDOCRI, V295, pE313; Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260; Staels B, 2006, NAT MED, V12, P54, DOI 10.1038/nm0106-54; Strissel KJ, 2007, DIABETES, V56, P2910, DOI 10.2337/db07-0767; Syn WK, 2009, CLIN LIVER DIS, V13, P565, DOI 10.1016/j.cld.2009.07.003; Tilg H, 2008, MOL MED, V14, P222, DOI 10.2119/2007-00119.Tilg; Tilg H, 2008, TRENDS ENDOCRIN MET, V19, P371, DOI 10.1016/j.tem.2008.08.005; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Weiss R, 2004, NEW ENGL J MED, V350, P2362, DOI 10.1056/NEJMoa031049; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; YE J, 2007, Q AM J PHYSL ENDOCRI, V293, pE1118; Yin XM, 1999, NATURE, V400, P886, DOI 10.1038/23730; Zou CB, 2007, NAT MED, V13, P1078, DOI 10.1038/nm1625	39	249	255	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5					3428	3438		10.1074/jbc.M109.074252	http://dx.doi.org/10.1074/jbc.M109.074252			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19940134	hybrid, Green Published			2022-12-25	WOS:000273829000057
J	Fiaux, J; Horst, J; Scior, A; Preissler, S; Koplin, A; Bukau, B; Deuerling, E				Fiaux, Jocelyne; Horst, Janina; Scior, Annika; Preissler, Steffen; Koplin, Ansgar; Bukau, Bernd; Deuerling, Elke			Structural Analysis of the Ribosome-associated Complex (RAC) Reveals an Unusual Hsp70/Hsp40 Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TETHERED MOLECULAR CHAPERONES; AMIDE HYDROGEN-EXCHANGE; CONFORMATIONAL-CHANGES; MASS-SPECTROMETRY; HSP70 CHAPERONES; J-PROTEIN; MECHANISM; DYNAMICS; ZUOTIN; HSP110	Yeast Zuotin and Ssz are members of the conserved Hsp40 and Hsp70 chaperone families, respectively, but compared with canonical homologs, they atypically form a stable heterodimer termed ribosome-associated complex (RAC). RAC acts as cochaperone for another Hsp70 to assist de novo protein folding. In this study, we identified the molecular basis for the unusual Hsp70/Hsp40 pairing using amide hydrogen exchange (HX) coupled with mass spectrometry and mutational analysis. Association of Ssz with Zuotin strongly decreased the conformational dynamics mainly in the C-terminal domain of Ssz, whereas Zuotin acquired strong conformational stabilization in its N-terminal segment. Deletion of the highly flexible N terminus of Zuotin abolished stable association with Ssz in vitro and caused a phenotype resembling the loss of Ssz function in vivo. Thus, the C-terminal domain of Ssz, the N-terminal extension of Zuotin, and their mutual stabilization are the major structural determinants for RAC assembly. We furthermore found dynamic changes in the J-domain of Zuotin upon complex formation that might be crucial for RAC co-chaperone function. Taken together, we present a novel mechanism for converting Zuotin and Ssz chaperones into a functionally active dimer.	Univ Heidelberg ZMBH, DKFZ ZMBH Alliance, Zentrum Mol Biol, D-69120 Heidelberg, Germany; [Horst, Janina; Scior, Annika; Preissler, Steffen] Univ Konstanz, Konstanz Res Sch Chem Biol, D-78457 Constance, Germany; [Horst, Janina; Scior, Annika; Preissler, Steffen; Koplin, Ansgar; Deuerling, Elke] Univ Konstanz, Dept Biol, D-78457 Constance, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of Konstanz; University of Konstanz		bukau@zmbh.uni-heidelberg.de; Elke.Deuerling@uni-konstanz.de		Bukau, Bernd/0000-0003-0521-7199; Preissler, Steffen/0000-0001-7936-9836	Konstanz Graduate School Chemical Biology; Interdisciplinary Research Center Proteostasis; Zukunftskolleg; HFSP; DFG [DE-783/3-1, SFB638]	Konstanz Graduate School Chemical Biology; Interdisciplinary Research Center Proteostasis; Zukunftskolleg; HFSP(Human Frontier Science Program); DFG(German Research Foundation (DFG))	This work was supported in part by the Konstanz Graduate School Chemical Biology and the Interdisciplinary Research Center Proteostasis, a fellowship of the Zukunftskolleg (to S.P.), an HFSP fellowship (to J.F.), and DFG Grants DE-783/3-1 (to E.D.) and SFB638 (to B.B.).	Andreasson C, 2008, P NATL ACAD SCI USA, V105, P16519, DOI 10.1073/pnas.0804187105; Andreasson C, 2008, J BIOL CHEM, V283, P8877, DOI 10.1074/jbc.M710063200; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Conz C, 2007, J BIOL CHEM, V282, P33977, DOI 10.1074/jbc.M706737200; Craig EA, 2003, CURR OPIN MICROBIOL, V6, P157, DOI 10.1016/S1369-5274(03)00030-4; FLAHERTY KM, 1990, NATURE, V346, P623, DOI 10.1038/346623a0; Gautschi M, 2001, P NATL ACAD SCI USA, V98, P3762, DOI 10.1073/pnas.071057198; GUTHRIE C, 2004, GUIDE YEAST GENETICS; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Huang P, 2005, NAT STRUCT MOL BIOL, V12, P497, DOI 10.1038/nsmb942; Hundley H, 2002, P NATL ACAD SCI USA, V99, P4203, DOI 10.1073/pnas.062048399; Hundley HA, 2005, SCIENCE, V308, P1032, DOI 10.1126/science.1109247; Kim SY, 2005, EUKARYOT CELL, V4, P82, DOI 10.1128/EC.4.1.82-89.2005; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Otto H, 2005, P NATL ACAD SCI USA, V102, P10064, DOI 10.1073/pnas.0504400102; Polier S, 2008, CELL, V133, P1068, DOI 10.1016/j.cell.2008.05.022; Rist W, 2005, ANAL BIOCHEM, V342, P160, DOI 10.1016/j.ab.2004.11.043; Rist W, 2003, J BIOL CHEM, V278, P51415, DOI 10.1074/jbc.M307160200; Rist W, 2006, J BIOL CHEM, V281, P16493, DOI 10.1074/jbc.M600847200; Schuermann JP, 2008, MOL CELL, V31, P232, DOI 10.1016/j.molcel.2008.05.006; Wales TE, 2006, MASS SPECTROM REV, V25, P158, DOI 10.1002/mas.20064; Wegrzyn RD, 2005, CELL MOL LIFE SCI, V62, P2727, DOI 10.1007/s00018-005-5292-z; Yan W, 1998, EMBO J, V17, P4809, DOI 10.1093/emboj/17.16.4809	23	24	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5					3227	3234		10.1074/jbc.M109.075804	http://dx.doi.org/10.1074/jbc.M109.075804			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19920147	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000273829000037
J	Kang, HW; Vitko, I; Lee, SS; Perez-Reyes, E; Lee, JH				Kang, Ho-Won; Vitko, Iuliia; Lee, Sang-Soo; Perez-Reyes, Edward; Lee, Jung-Ha			Structural Determinants of the High Affinity Extracellular Zinc Binding Site on Ca(v)3.2 T-type Calcium Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VOLTAGE-DEPENDENT ACTIVATION; K+ CHANNEL; TRANSMEMBRANE SEGMENTS; POTASSIUM CHANNELS; CA2+ CHANNELS; ELECTROSTATIC INTERACTIONS; MOLECULAR DETERMINANTS; CHARGED RESIDUES; SENSORY NEURONS; INHIBITION	Ca(v)3.2 T-type channels contain a high affinity metal binding site for trace metals such as copper and zinc. This site is occupied at physiologically relevant concentrations of these metals, leading to decreased channel activity and pain transmission. A histidine at position 191 was recently identified as a critical determinant for both trace metal block of Ca(v)3.2 and modulation by redox agents. His(191) is found on the extracellular face of the Ca(v)3.2 channel on the IS3-S4 linker and is not conserved in other Ca(v)3 channels. Mutation of the corresponding residue in Ca(v)3.1 to histidine, Gln(172), significantly enhances trace metal inhibition, but not to the level observed in wild-type Ca(v)3.2, implying that other residues also contribute to the metal binding site. The goal of the present study is to identify these other residues using a series of chimeric channels. The key findings of the study are that the metal binding site is composed of a Asp-Gly-His motif in IS3-S4 and a second aspartate residue in IS2. These results suggest that metal binding stabilizes the closed conformation of the voltage-sensor paddle in repeat I, and thereby inhibits channel opening. These studies provide insight into the structure of T-type channels, and identify an extracellular motif that could be targeted for drug development.	Sogang Univ, Dept Life Sci, Seoul 121742, South Korea; [Kang, Ho-Won; Lee, Sang-Soo; Lee, Jung-Ha] Sogang Univ, Basic Sci Inst Cell Damage Control, Seoul 121742, South Korea; [Vitko, Iuliia; Perez-Reyes, Edward] Univ Virginia, Dept Pharmacol, Charlottesville, VA 22911 USA; [Perez-Reyes, Edward] Univ Virginia, Grad Program Neurosci, Charlottesville, VA 22911 USA	Sogang University; Sogang University; University of Virginia; University of Virginia	Lee, JH (corresponding author), Shinsu Dong 1, Seoul 121742, South Korea.	jhleem@sogang.ac.kr		Lee, Sang Soo/0000-0003-0467-9025	Korea Science and Engineering Foundation [R11-2009-036-01003-0]; National Research Foundation of Korea [2009-0093822, 2009-0087964]; University of Virginia	Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); National Research Foundation of Korea(National Research Foundation of Korea); University of Virginia	This work was supported by Korea Science and Engineering Foundation Grant R11-2009-036-01003-0, Priority Research Centers Program 2009-0093822, and Basic Science Research Program 2009-0087964 through the National Research Foundation of Korea, and a grant from the University of Virginia (to E.P.R.).	Bourinet E, 2005, EMBO J, V24, P315, DOI 10.1038/sj.emboj.7600515; Chanda B, 2005, NATURE, V436, P852, DOI 10.1038/nature03888; Chemin J, 2002, J PHYSIOL-LONDON, V540, P3, DOI 10.1113/jphysiol.2001.013269; Chen HJ, 2000, PFLUG ARCH EUR J PHY, V439, P423, DOI 10.1007/s004240050959; Choi S, 2007, GENES BRAIN BEHAV, V6, P425, DOI 10.1111/j.1601-183X.2006.00268.x; ELLINOR PT, 1995, NEURON, V15, P1121, DOI 10.1016/0896-6273(95)90100-0; FOX AP, 1987, J PHYSIOL-LONDON, V394, P149, DOI 10.1113/jphysiol.1987.sp016864; Gomora JC, 2002, BIOPHYS J, V83, P229, DOI 10.1016/S0006-3495(02)75164-3; Iftinca MC, 2009, TRENDS PHARMACOL SCI, V30, P32, DOI 10.1016/j.tips.2008.10.004; Jacob J, 1999, BIOPHYS J, V76, P1367, DOI 10.1016/S0006-3495(99)77298-X; Jeong SW, 2003, NEUROREPORT, V14, P1537, DOI 10.1097/00001756-200308060-00028; Kang HW, 2007, FEBS LETT, V581, P5774, DOI 10.1016/j.febslet.2007.11.045; Kang HW, 2006, J BIOL CHEM, V281, P4823, DOI 10.1074/jbc.M510197200; Kozlov AS, 1999, EUR J NEUROSCI, V11, P4149, DOI 10.1046/j.1460-9568.1999.00841.x; LAUSSAC JP, 1980, J BIOL CHEM, V255, P7563; Lee JH, 1999, BIOPHYS J, V77, P3034, DOI 10.1016/S0006-3495(99)77134-1; Li-Smerin Y, 2000, J GEN PHYSIOL, V115, P673, DOI 10.1085/jgp.115.6.673; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Ma ZM, 2008, J GEN PHYSIOL, V131, P483, DOI 10.1085/jgp.200809980; NARAHASHI T, 1987, J PHYSIOL-LONDON, V383, P231; Nelson MT, 2007, J NEUROSCI, V27, P12577, DOI 10.1523/JNEUROSCI.2206-07.2007; Nelson MT, 2007, J NEUROSCI, V27, P8250, DOI 10.1523/JNEUROSCI.1800-07.2007; Obejero-Paz CA, 2004, J GEN PHYSIOL, V124, P631, DOI 10.1085/jgp.200409167; Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002; PLANELLSCASES R, 1995, P NATL ACAD SCI USA, V92, P9422, DOI 10.1073/pnas.92.20.9422; Ramsey IS, 2006, NATURE, V440, P1213, DOI 10.1038/nature04700; Rogers JC, 1996, J BIOL CHEM, V271, P15950, DOI 10.1074/jbc.271.27.15950; Sato Y, 2003, J BIOL CHEM, V278, P13227, DOI 10.1074/jbc.M300431200; Shin HS, 2008, CURR OPIN PHARMACOL, V8, P33, DOI 10.1016/j.coph.2007.12.003; Silverman WR, 2000, J GEN PHYSIOL, V116, P663, DOI 10.1085/jgp.116.5.663; Silverman WR, 2003, P NATL ACAD SCI USA, V100, P2935, DOI 10.1073/pnas.0636603100; Swartz KJ, 2007, TOXICON, V49, P213, DOI 10.1016/j.toxicon.2006.09.024; SWENSON RP, 1981, NATURE, V291, P427, DOI 10.1038/291427a0; Talavera K, 2001, J BIOL CHEM, V276, P45628, DOI 10.1074/jbc.M103047200; TANABE T, 1991, NATURE, V352, P800, DOI 10.1038/352800a0; TiwariWoodruff SK, 1997, BIOPHYS J, V72, P1489, DOI 10.1016/S0006-3495(97)78797-6; Traboulsie A, 2007, J PHYSIOL-LONDON, V578, P159, DOI 10.1113/jphysiol.2006.114496; TSIEN RW, 1987, ANNU REV BIOPHYS BIO, V16, P265; Vitko I, 2007, J NEUROSCI, V27, P322, DOI 10.1523/JNEUROSCI.1817-06.2007; Vitko I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003560; Zhang LY, 2007, P NATL ACAD SCI USA, V104, P8263, DOI 10.1073/pnas.0611007104	41	32	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5					3271	3281		10.1074/jbc.M109.067660	http://dx.doi.org/10.1074/jbc.M109.067660			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19940152	Green Published, hybrid			2022-12-25	WOS:000273829000042
J	Kassavetis, GA; Prakash, P; Shim, E				Kassavetis, George A.; Prakash, Prachee; Shim, Eunjung			The C53/C37 Subcomplex of RNA Polymerase III Lies Near the Active Site and Participates in Promoter Opening	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR-IIIB; TATA-BINDING PROTEIN; SACCHAROMYCES-CEREVISIAE; STRUCTURAL BASIS; ELONGATION COMPLEX; CROSS-LINKING; DNA CONTACTS; SUBSTRATE-SPECIFICITY; PREINITIATION COMPLEX; CHAIN ELONGATION	The C53 and C37 subunits of RNA polymerase III (pol III) form a subassembly that is required for efficient termination; pol III lacking this subcomplex displays increased processivity of RNA chain elongation. We show that the C53/C37 subcomplex additionally plays a role in formation of the initiation-ready open promoter complex similar to that of the Brf1 N-terminal zinc ribbon domain. In the absence of C53 and C37, the transcription bubble fails to stably propagate to and beyond the transcriptional start site even when the DNA template is supercoiled. The C53/C37 subcomplex also stimulates the formation of an artificially assembled elongation complex from its component DNA and RNA strands. Protein-RNA and protein-DNA photochemical cross-linking analysis places a segment of C53 close to the RNA 3' end and transcribed DNA strand at the catalytic center of the pol III elongation complex. We discuss the implications of these findings for the mechanism of transcriptional termination by pol III and propose a structural as well as functional correspondence between the C53/C37 subcomplex and the RNA polymerase II initiation factor TFIIF.	[Kassavetis, George A.] Univ Calif San Diego, Ctr Mol Genet, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Kassavetis, GA (corresponding author), Univ Calif San Diego, Ctr Mol Genet, Div Biol Sci, 9500 Gilman Dr, La Jolla, CA 92093 USA.	gak@ucsd.edu			National Institutes of Health (NIGMS) [GM18386]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM018386, R01GM018386, F32GM018386] Funding Source: NIH RePORTER	National Institutes of Health (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM18386 (NIGMS).	AGARWAL K, 1991, BIOCHEMISTRY-US, V30, P7842, DOI 10.1021/bi00245a026; Alic N, 2007, P NATL ACAD SCI USA, V104, P10400, DOI 10.1073/pnas.0704116104; BARDELEBEN C, 1994, J MOL BIOL, V235, P1193, DOI 10.1006/jmbi.1994.1073; BARTHOLOMEW B, 1993, MOL CELL BIOL, V13, P942, DOI 10.1128/MCB.13.2.942; Bartholomew B, 1995, METHOD ENZYMOL, V262, P476; BARTHOLOMEW B, 1994, J BIOL CHEM, V269, P18090; Bobkova EV, 1997, J BIOL CHEM, V272, P22832, DOI 10.1074/jbc.272.36.22832; Bushnell DA, 2004, SCIENCE, V303, P983, DOI 10.1126/science.1090838; CAMPBELL FE, 1992, MOL CELL BIOL, V12, P2260, DOI 10.1128/MCB.12.5.2260; Chedin S, 1998, GENE DEV, V12, P3857, DOI 10.1101/gad.12.24.3857; Chen BS, 2004, BIOCHEMISTRY-US, V43, P12741, DOI 10.1021/bi048993r; Chen HT, 2004, CELL, V119, P169, DOI 10.1016/j.cell.2004.09.028; Chen HT, 2007, NAT STRUCT MOL BIOL, V14, P696, DOI 10.1038/nsmb1272; Cramer P, 2008, ANNU REV BIOPHYS, V37, P337, DOI 10.1146/annurev.biophys.37.032807.130008; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; DEDRICK RL, 1985, BIOCHEMISTRY-US, V24, P2245, DOI 10.1021/bi00330a019; DIECI G, 1995, EMBO J, V14, P3766, DOI 10.1002/j.1460-2075.1995.tb00046.x; Dieci G, 2007, TRENDS GENET, V23, P614, DOI 10.1016/j.tig.2007.09.001; Fernandez-Tornero C, 2007, MOL CELL, V25, P813, DOI 10.1016/j.molcel.2007.02.016; Freire-Picos MA, 2005, NUCLEIC ACIDS RES, V33, P5045, DOI 10.1093/nar/gki825; Geiduschek EP, 2001, J MOL BIOL, V310, P1, DOI 10.1006/jmbi.2001.4732; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Guthrie C., 1991, GUIDE YEAST GENETICS, V194; Hamada M, 2000, J BIOL CHEM, V275, P29076, DOI 10.1074/jbc.M003980200; HANNA MM, 1993, NUCLEIC ACIDS RES, V21, P2073, DOI 10.1093/nar/21.9.2073; Jasiak AJ, 2006, MOL CELL, V23, P71, DOI 10.1016/j.molcel.2006.05.013; Joazeiro CAP, 1996, GENE DEV, V10, P725, DOI 10.1101/gad.10.6.725; Kassavetis GA, 2005, P NATL ACAD SCI USA, V102, P15406, DOI 10.1073/pnas.0507653102; KASSAVETIS GA, 1989, MOL CELL BIOL, V9, P2551, DOI 10.1128/MCB.9.6.2551; KASSAVETIS GA, 1990, CELL, V60, P235, DOI 10.1016/0092-8674(90)90739-2; KASSAVETIS GA, 1995, P NATL ACAD SCI USA, V92, P9786, DOI 10.1073/pnas.92.21.9786; KASSAVETIS GA, 1992, J MOL BIOL, V226, P47, DOI 10.1016/0022-2836(92)90123-2; Kassavetis GA, 1998, P NATL ACAD SCI USA, V95, P9196, DOI 10.1073/pnas.95.16.9196; Kassavetis GA, 2002, EMBO J, V21, P5508, DOI 10.1093/emboj/cdf533; Kassavetis GA, 2001, EMBO J, V20, P2823, DOI 10.1093/emboj/20.11.2823; KASSAVETIS GA, 1986, J BIOL CHEM, V261, P14256; Kettenberger H, 2003, CELL, V114, P347, DOI 10.1016/S0092-8674(03)00598-1; Kettenberger H, 2004, MOL CELL, V16, P955, DOI 10.1016/j.molcel.2004.11.040; Khaperskyy DA, 2008, MOL CELL BIOL, V28, P3757, DOI 10.1128/MCB.02272-07; Kireeva ML, 2000, J BIOL CHEM, V275, P6530, DOI 10.1074/jbc.275.9.6530; Kuhn CD, 2007, CELL, V131, P1260, DOI 10.1016/j.cell.2007.10.051; Landrieux E, 2006, EMBO J, V25, P118, DOI 10.1038/sj.emboj.7600915; Lannutti BJ, 1996, BIOCHEMISTRY-US, V35, P9821, DOI 10.1021/bi960525x; MATSUZAKI H, 1994, J MOL BIOL, V235, P1173, DOI 10.1006/jmbi.1994.1072; Micorescu M, 2008, J BACTERIOL, V190, P157, DOI 10.1128/JB.01498-07; NIGRO JM, 1992, MOL CELL BIOL, V12, P1357, DOI 10.1128/MCB.12.3.1357; NUDLER E, 1994, SCIENCE, V265, P793, DOI 10.1126/science.8047884; Powell W, 1996, J BIOL CHEM, V271, P22301, DOI 10.1074/jbc.271.37.22301; Schramm L, 2002, GENE DEV, V16, P2593, DOI 10.1101/gad.1018902; SHAABAN SA, 1995, MOL CELL BIOL, V15, P1467; Shaaban SA, 1996, MOL CELL BIOL, V16, P6468; Sidorenkov I, 1998, MOL CELL, V2, P55, DOI 10.1016/S1097-2765(00)80113-6; SIKORSKI RS, 1989, GENETICS, V122, P19; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Soragni E, 2008, J BIOL CHEM, V283, P26568, DOI 10.1074/jbc.M803769200; Sydow JF, 2009, MOL CELL, V34, P710, DOI 10.1016/j.molcel.2009.06.002; Tate JJ, 1998, NUCLEIC ACIDS RES, V26, P1421, DOI 10.1093/nar/26.6.1421; Thompson NE, 2009, J BIOL CHEM, V284, P24754, DOI 10.1074/jbc.M109.030486; Voth WP, 2003, YEAST, V20, P985, DOI 10.1002/yea.1018; Walmacq C, 2009, J BIOL CHEM, V284, P19601, DOI 10.1074/jbc.M109.006908; Wang D, 2006, CELL, V127, P941, DOI 10.1016/j.cell.2006.11.023; Werner F, 2005, MOL CELL BIOL, V25, P8344, DOI 10.1128/MCB.25.18.8344-8355.2005; WERNER M, 1993, J BIOL CHEM, V268, P20721; WHITEHALL SK, 1994, J BIOL CHEM, V269, P2299; Wooddell CI, 2000, BIOCHEMISTRY-US, V39, P13405, DOI 10.1021/bi0014249; Yieh L, 2000, J BIOL CHEM, V275, P29800, DOI 10.1074/jbc.M003149200; Zhang CF, 2005, MOL CELL BIOL, V25, P3583, DOI 10.1128/MCB.25.9.3583-3595.2005; Ziegler LM, 2003, J BIOL CHEM, V278, P48950, DOI 10.1074/jbc.M309656200	69	56	57	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2695	2706		10.1074/jbc.M109.074013	http://dx.doi.org/10.1074/jbc.M109.074013			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19940126	Green Published, hybrid			2022-12-25	WOS:000273697800048
J	Tokhunts, R; Singh, S; Chu, TY; D'Angelo, G; Baubet, V; Goetz, JA; Huang, Z; Yuan, ZQ; Ascano, M; Zavros, Y; Therond, PP; Kunes, S; Dahmane, N; Robbins, DJ				Tokhunts, Robert; Singh, Samer; Chu, Tehyen; D'Angelo, Gisela; Baubet, Valerie; Goetz, John A.; Huang, Zhen; Yuan, Ziqiang; Ascano, Manuel; Zavros, Yana; Therond, Pascal P.; Kunes, Sam; Dahmane, Nadia; Robbins, David J.			The Full-length Unprocessed Hedgehog Protein Is an Active Signaling Molecule	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SONIC-HEDGEHOG; LONG-RANGE; CHOLESTEROL MODIFICATION; DROSOPHILA EYE; GENE HEDGEHOG; TOUT-VELU; MUTATIONS; CLEAVAGE; PRODUCT; CELLS	The hedgehog (HH) family of ligands plays an important instructional role in metazoan development. HH proteins are initially produced as similar to 45-kDa full-length proteins, which undergo an intramolecular cleavage to generate an amino-terminal product that subsequently becomes cholesterol-modified (HH-Np). It is well accepted that this cholesterol-modified amino-terminal cleavage product is responsible for all HH-dependent signaling events. Contrary to this model we show here that full-length forms of HH proteins are able to traffic to the plasma membrane and participate directly in cell-cell signaling, both in vitro and in vivo. We were also able to rescue a Drosophila eye-specific hh loss of function phenotype by expressing a full-length form of hh that cannot be processed into HH-Np. These results suggest that in some physiological contexts full-length HH proteins may participate directly in HH signaling and that this novel activity of full-length HH may be evolutionarily conserved.	[Tokhunts, Robert; Singh, Samer; Goetz, John A.; Huang, Zhen; Yuan, Ziqiang; Ascano, Manuel; Robbins, David J.] Dartmouth Med Sch, Dept Pharmacol & Toxicol, Hanover, NH 03755 USA; [Robbins, David J.] Dartmouth Hitchcock Med Ctr, Norris Cotton Canc Ctr, Lebanon, NH 03756 USA; [Chu, Tehyen; Kunes, Sam] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Baubet, Valerie; Dahmane, Nadia] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; [Zavros, Yana] Univ Cincinnati, Dept Mol & Cellular Physiol, Cincinnati, OH 45267 USA; [D'Angelo, Gisela; Therond, Pascal P.] Univ Nice Sophia Antipolis, Inst Signaling Dev Biol & Canc Res, CNRS, Ctr Biochim,UMR 6543, F-06108 Nice 02, France	Dartmouth College; Dartmouth College; Norris Cotton Cancer Center; Harvard University; The Wistar Institute; University System of Ohio; University of Cincinnati; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur	Robbins, DJ (corresponding author), Dartmouth Med Sch, Dept Pharmacol & Toxicol, Hanover, NH 03755 USA.	David.J.Robbins@Dartmouth.edu	Ascano, Manuel/ABA-3586-2020; Therond, pascal/AAE-4811-2019; Singh, Samer/H-8468-2013	Ascano, Manuel/0000-0002-9370-5493; Singh, Samer/0000-0002-0921-1686; D'ANGELO, Gisela/0000-0003-3150-2241	National Institutes of Health [GM64011]; American Lung Association/LUNGevity Foundation; Graduate Assistance in Areas of National Need; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064011, R56GM064011] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lung Association/LUNGevity Foundation; Graduate Assistance in Areas of National Need; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM64011 (to D. J. R.). This work was also supported by an award from the American Lung Association/LUNGevity Foundation (to D. J. R.) and a Graduate Assistance in Areas of National Need (GAANN) predoctoral fellowship in nanomedicine (to R. T.).	Bellaiche Y, 1998, NATURE, V394, P85, DOI 10.1038/27932; Belloni E, 1996, NAT GENET, V14, P353, DOI 10.1038/ng1196-353; Burke R, 1999, CELL, V99, P803, DOI 10.1016/S0092-8674(00)81677-3; Caspary T, 2002, CURR BIOL, V12, P1628, DOI 10.1016/S0960-9822(02)01147-8; Chu TY, 2006, DEV CELL, V10, P635, DOI 10.1016/j.devcel.2006.03.003; Cooper MK, 1998, SCIENCE, V280, P1603, DOI 10.1126/science.280.5369.1603; El-Zaatari M, 2009, CURR OPIN ENDOCRINOL, V16, P60, DOI 10.1097/MED.0b013e328320a821; Gallet A, 2003, DEV CELL, V4, P191, DOI 10.1016/S1534-5807(03)00031-5; Goetz JA, 2006, J BIOL CHEM, V281, P4087, DOI 10.1074/jbc.M511427200; HEBERLEIN U, 1993, CELL, V75, P913, DOI 10.1016/0092-8674(93)90535-X; Hehr U, 2004, EUR J PEDIATR, V163, P347, DOI 10.1007/s00431-004-1459-0; Huang Z, 1996, CELL, V86, P411, DOI 10.1016/S0092-8674(00)80114-2; Incardona JP, 2000, P NATL ACAD SCI USA, V97, P12044, DOI 10.1073/pnas.220251997; Incardona JP, 1998, DEVELOPMENT, V125, P3553; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; INGHAM PW, 1995, CURR BIOL, V5, P432, DOI 10.1016/S0960-9822(95)00084-4; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Kawakami T, 2002, DEVELOPMENT, V129, P5753, DOI 10.1242/dev.00178; LEE JJ, 1992, CELL, V71, P33, DOI 10.1016/0092-8674(92)90264-D; Li YN, 2006, P NATL ACAD SCI USA, V103, P6548, DOI 10.1073/pnas.0600124103; LOPEZMARTINEZ A, 1995, CURR BIOL, V5, P791, DOI 10.1016/S0960-9822(95)00156-4; Ma Y, 2002, CELL, V111, P63, DOI 10.1016/S0092-8674(02)00977-7; Nanni L, 1999, HUM MOL GENET, V8, P2479, DOI 10.1093/hmg/8.13.2479; Odent S, 1999, HUM MOL GENET, V8, P1683, DOI 10.1093/hmg/8.9.1683; Pappu KS, 2003, DEVELOPMENT, V130, P3053, DOI 10.1242/dev.00534; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; PORTER JA, 1995, NATURE, V374, P363, DOI 10.1038/374363a0; ROELINK H, 1995, CELL, V81, P445, DOI 10.1016/0092-8674(95)90397-6; Roessler E, 1996, NAT GENET, V14, P357, DOI 10.1038/ng1196-357; Sanson B, 2001, EMBO REP, V2, P1083, DOI 10.1093/embo-reports/kve255; Scott WJ, 2005, REPROD TOXICOL, V19, P479, DOI 10.1016/j.reprotox.2004.11.013; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; The I, 1999, MOL CELL, V4, P633, DOI 10.1016/S1097-2765(00)80214-2; Tickle C, 2006, NAT REV MOL CELL BIO, V7, P45, DOI 10.1038/nrm1830; Zavros Y, 2008, AM J PHYSIOL-GASTR L, V295, pG99, DOI 10.1152/ajpgi.00389.2007; Zeng X, 2001, NATURE, V411, P716, DOI 10.1038/35079648	36	38	40	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2562	2568		10.1074/jbc.M109.078626	http://dx.doi.org/10.1074/jbc.M109.078626			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19920144	Green Published, hybrid			2022-12-25	WOS:000273697800035
J	Wang, TT; Dabbas, B; Laperriere, D; Bitton, AJ; Soualhine, H; Tavera-Mendoza, LE; Dionne, S; Servant, MJ; Bitton, A; Seidman, EG; Mader, S; Behr, MA; White, JH				Wang, Tian-Tian; Dabbas, Basel; Laperriere, David; Bitton, Ari J.; Soualhine, Hafid; Tavera-Mendoza, Luz E.; Dionne, Serge; Servant, Marc J.; Bitton, Alain; Seidman, Ernest G.; Mader, Sylvie; Behr, Marcel A.; White, John H.			Direct and Indirect Induction by 1,25-Dihydroxyvitamin D-3 of the NOD2/CARD15-Defensin beta 2 Innate Immune Pathway Defective in Crohn Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VITAMIN-D-RECEPTOR; CUTTING EDGE; GENE; DIPEPTIDE; EPIDEMIOLOGY; POLYMORPHISM; SYMPTOMS; TARGET; CELLS; NOD2	Vitamin D signaling through its nuclear vitamin D receptor has emerged as a key regulator of innate immunity in humans. Here we show that hormonal vitamin D, 1,25-dihydroxyvitamin D-3, robustly stimulates expression of pattern recognition receptor NOD2/CARD15/IBD1 gene and protein in primary human monocytic and epithelial cells. The vitamin D receptor signals through distal enhancers in the NOD2 gene, whose function was validated by chromatin immunoprecipitation and chromatin conformation capture assays. A key downstream signaling consequence of NOD2 activation by agonist muramyl dipeptide is stimulation of NF-kappa B transcription factor function, which induces expression of the gene encoding antimicrobial peptide defensin beta 2 (DEFB2/HBD2). Pretreatment with 1,25-dihydroxyvitamin D-3 synergistically induced NF-kappa B function and expression of genes encoding DEFB2/HBD2 and antimicrobial peptide cathelicidin in the presence of muramyl dipeptide. Importantly, this synergistic response was also seen in macrophages from a donor wild type for NOD2 but was absent in macrophages from patients with Crohn disease homozygous for non-functional NOD2 variants. These studies provide strong molecular links between vitamin D deficiency and the genetics of Crohn disease, a chronic incurable inflammatory bowel condition, as Crohn's pathogenesis is associated with attenuated NOD2 or DEFB2/HBD2 function.	[Wang, Tian-Tian; Dabbas, Basel; Bitton, Ari J.; Tavera-Mendoza, Luz E.; White, John H.] McGill Univ, Dept Physiol, Montreal, PQ H3G 1Y6, Canada; [Dionne, Serge; Bitton, Alain; Seidman, Ernest G.; Behr, Marcel A.; White, John H.] McGill Univ, Dept Med, Montreal, PQ H3G 1Y6, Canada; [Soualhine, Hafid; Seidman, Ernest G.; Behr, Marcel A.] McGill Univ, Montreal Gen Hosp, Montreal, PQ H3G 1Y6, Canada; [Soualhine, Hafid; Behr, Marcel A.] McGill Univ, Div Infect Dis & Med Microbiol, Montreal, PQ H3G 1Y6, Canada; [Dionne, Serge; Seidman, Ernest G.] McGill Univ, Div Gastroenterol, Montreal, PQ H3G 1Y6, Canada; [Laperriere, David; Mader, Sylvie] Univ Montreal, Dept Biochem, Montreal, PQ H3C 3J7, Canada; [Laperriere, David; Mader, Sylvie] Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ H3C 3J7, Canada; [Servant, Marc J.] Univ Montreal, Fac Pharm, Montreal, PQ H3C 3J7, Canada	McGill University; McGill University; McGill University; McGill University; McGill University; Universite de Montreal; Universite de Montreal; Universite de Montreal	White, JH (corresponding author), McGill Univ, Dept Physiol, 3655 Drummond St, Montreal, PQ H3G 1Y6, Canada.	john.white@mcgill.ca	Soualhine, Hafid/AAH-3735-2019; white, john h/N-9782-2013	Soualhine, Hafid/0000-0002-5526-6741; white, john h/0000-0002-4785-2687	McGill University	McGill University	This work was supported by a nutrition grant from McGill University (to J.H.W. and M.B.).	Aratari A, 2006, DIGEST LIVER DIS, V38, P319, DOI 10.1016/j.dld.2005.10.002; Cantorna MT, 2000, J NUTR, V130, P2648, DOI 10.1093/jn/130.11.2648; Cantorna MT, 2004, EXP BIOL MED, V229, P1136, DOI 10.1177/153537020422901108; Cho JH, 2008, NAT REV IMMUNOL, V8, P458, DOI 10.1038/nri2340; Dostie J, 2007, NAT PROTOC, V2, P988, DOI 10.1038/nprot.2007.116; Fellermann K, 2006, AM J HUM GENET, V79, P439, DOI 10.1086/505915; Froicu M, 2003, MOL ENDOCRINOL, V17, P2386, DOI 10.1210/me.2003-0281; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Gombart AF, 2005, FASEB J, V19, P1067, DOI 10.1096/fj.04-3284com; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; Jia HP, 2001, GENE, V263, P211; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Levy E, 2000, J LIPID RES, V41, P12; Lewis JD, 2004, GASTROENTEROLOGY, V126, P665, DOI 10.1053/j.gastro.2003.12.003; Lim WC, 2005, NAT CLIN PRACT GASTR, V2, P308, DOI 10.1038/ncpgasthep0215; Lin R, 2004, BIOESSAYS, V26, P21, DOI 10.1002/bies.10368; Liu N, 2008, ENDOCRINOLOGY, V149, P4799, DOI 10.1210/en.2008-0060; Liu PT, 2008, CURR OPIN IMMUNOL, V20, P371, DOI 10.1016/j.coi.2008.05.014; Liu PT, 2007, J IMMUNOL, V179, P2060, DOI 10.4049/jimmunol.179.4.2060; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Loftus EV, 2002, GASTROENTEROL CLIN N, V31, P1, DOI 10.1016/S0889-8553(01)00002-4; Loftus EV, 2004, GASTROENTEROLOGY, V126, P1504, DOI 10.1053/j.gastro.2004.01.063; Martin K, 2002, DIGESTION, V66, P121, DOI 10.1159/000065592; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Pasparakis M, 2009, NAT REV IMMUNOL, V9, P778, DOI 10.1038/nri2655; Prosser DE, 2004, TRENDS BIOCHEM SCI, V29, P664, DOI 10.1016/j.tibs.2004.10.005; Rochel N, 2000, MOL CELL, V5, P173, DOI 10.1016/S1097-2765(00)80413-X; Simmons JD, 2000, GUT, V47, P211, DOI 10.1136/gut.47.2.211; van Heel DA, 2005, LANCET, V365, P1794, DOI 10.1016/S0140-6736(05)66582-8; Voss E, 2006, J BIOL CHEM, V281, P2005, DOI 10.1074/jbc.M511044200; Wang TT, 2005, MOL ENDOCRINOL, V19, P2685, DOI 10.1210/me.2005-0106; Wang TT, 2004, J IMMUNOL, V173, P2909, DOI 10.4049/jimmunol.173.5.2909; Weber G, 2005, J INVEST DERMATOL, V124, P1080, DOI 10.1111/j.0022-202X.2005.23687.x; White JH, 2008, INFECT IMMUN, V76, P3837, DOI 10.1128/IAI.00353-08; Zeng L, 1996, SCAND J GASTROENTERO, V31, P79, DOI 10.3109/00365529609031631	38	265	274	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2237	2241		10.1074/jbc.C109.071225	http://dx.doi.org/10.1074/jbc.C109.071225			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19948723	Green Published, hybrid			2022-12-25	WOS:000273697800003
J	Pawitan, Y; Seng, KC; Magnusson, PKE				Pawitan, Yudi; Seng, Ku Chee; Magnusson, Patrik K. E.			How Many Genetic Variants Remain to Be Discovered?	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; CYSTIC-FIBROSIS; CANCER; POPULATION; GENOTYPE; DISEASES; TRAITS; RISK	A great majority of genetic markers discovered in recent genome-wide association studies have small effect sizes, and they explain only a small fraction of the genetic contribution to the diseases. How many more variants can we expect to discover and what study sizes are needed? We derive the connection between the cumulative risk of the SNP variants to the latent genetic risk model and heritability of the disease. We determine the sample size required for case-control studies in order to achieve a certain expected number of discoveries in a collection of most significant SNPs. Assuming similar allele frequencies and effect sizes of the currently validated SNPs, complex phenotypes such as type-2 diabetes would need approximately 800 variants to explain its 40% heritability. Much smaller numbers of variants are needed if we assume rare-variants but higher penetrance models. We estimate that up to 50,000 cases and an equal number of controls are needed to discover 800 common low-penetrant variants among the top 5000 SNPs. Under common and rare low-penetrance models, the very large studies required to discover the numerous variants are probably at the limit of practical feasibility. Under rare-variant with medium- to high-penetrance models (odds-ratios between 1.6 and 4.0), studies comparable in size to many existing studies are adequate provided the genotyping technology can interrogate more and rarer variants.	[Pawitan, Yudi; Magnusson, Patrik K. E.] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Seng, Ku Chee] Natl Univ Singapore, Ctr Mol Epidemiol, Singapore 117548, Singapore	Karolinska Institutet; National University of Singapore	Pawitan, Y (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden.	yudi.pawitan@ki.se	Magnusson, Patrik KE/C-4458-2017	Magnusson, Patrik KE/0000-0002-7315-7899	Karolinska Institutet and the Center for Molecular Epidemiology, National University of Singapore	Karolinska Institutet and the Center for Molecular Epidemiology, National University of Singapore(National University of Singapore)	Funded by the Karolinska Institutet and the Center for Molecular Epidemiology, National University of Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benyamin B, 2009, AM J HUM GENET, V84, P60, DOI 10.1016/j.ajhg.2008.11.011; Bhangale TR, 2008, NAT GENET, V40, P841, DOI 10.1038/ng.180; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Drumm ML, 1988, GENOMICS, V2, P346, DOI 10.1016/0888-7543(88)90024-9; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Ferla R, 2007, ANN ONCOL, V18, P93, DOI 10.1093/annonc/mdm234; Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554; Iles MM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040033; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; McKone EF, 2006, CHEST, V130, P1441, DOI 10.1378/chest.130.5.1441; McKone EF, 2003, LANCET, V361, P1671, DOI 10.1016/S0140-6736(03)13368-5; Noh M, 2006, GENET EPIDEMIOL, V30, P37, DOI 10.1002/gepi.20099; Pawitan Y, 2005, BIOINFORMATICS, V21, P3017, DOI 10.1093/bioinformatics/bti448; Poulsen P, 1999, DIABETOLOGIA, V42, P139, DOI 10.1007/s001250051131; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; SHAM PC, 1997, STAT HUMAN GENETICS; Thorleifsson G, 2007, SCIENCE, V317, P1397, DOI 10.1126/science.1146554; Weischer M, 2008, J CLIN ONCOL, V26, P542, DOI 10.1200/JCO.2007.12.5922; Wray NR, 2008, CURR OPIN GENET DEV, V18, P257, DOI 10.1016/j.gde.2008.07.006; Yang QH, 2005, INT J EPIDEMIOL, V34, P1129, DOI 10.1093/ije/dyi130; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120	22	34	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2009	4	12							e7969	10.1371/journal.pone.0007969	http://dx.doi.org/10.1371/journal.pone.0007969			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MU	19956539	Green Published, gold, Green Submitted			2022-12-25	WOS:000272828800003
J	Huang, LL; Cheng, TC; Xu, PZ; Cheng, DJ; Fang, T; Xia, QY				Huang, Lulin; Cheng, Tingcai; Xu, Pingzhen; Cheng, Daojun; Fang, Ting; Xia, Qingyou			A Genome-Wide Survey for Host Response of Silkworm, Bombyx mori during Pathogen Bacillus bombyseptieus Infection	PLOS ONE			English	Article							BORDER MEMBRANE-VESICLES; INNATE IMMUNE-RESPONSE; GENE-EXPRESSION; AMINOPEPTIDASE-N; IMMUNOGLOBULIN SUPERFAMILY; THURINGIENSIS-RESISTANT; DOMESTICATED SILKWORM; HELICOVERPA-ARMIGERA; PERITROPHIC MEMBRANE; BINDING PROTEIN	Host-pathogen interactions are complex relationships, and a central challenge is to reveal the interactions between pathogens and their hosts. Bacillus bombysepticus (Bb) which can produces spores and parasporal crystals was firstly separated from the corpses of the infected silkworms (Bombyx mori). Bb naturally infects the silkworm can cause an acute fuliginosa septicaemia and kill the silkworm larvae generally within one day in the hot and humid season. Bb pathogen of the silkworm can be used for investigating the host responses after the infection. Gene expression profiling during four time-points of silkworm whole larvae after Bb infection was performed to gain insight into the mechanism of Bb-associated host whole body effect. Genome-wide survey of the host genes demonstrated many genes and pathways modulated after the infection. GO analysis of the induced genes indicated that their functions could be divided into 14 categories. KEGG pathway analysis identified that six types of basal metabolic pathway were regulated, including genetic information processing and transcription, carbohydrate metabolism, amino acid and nitrogen metabolism, nucleotide metabolism, metabolism of cofactors and vitamins, and xenobiotic biodegradation and metabolism. Similar to Bacillus thuringiensis (Bt), Bb can also induce a silkworm poisoning-related response. In this process, genes encoding midgut peritrophic membrane proteins, aminopeptidase N receptors and sodium/calcium exchange protein showed modulation. For the first time, we found that Bb induced a lot of genes involved in juvenile hormone synthesis and metabolism pathway upregulated. Bb also triggered the host immune responses, including cellular immune response and serine protease cascade melanization response. Real time PCR analysis showed that Bb can induce the silkworm systemic immune response, mainly by the Toll pathway. Anti-microorganism peptides (AMPs), including of Attacin, Lebocin, Enbocin, Gloverin and Moricin families, were upregulated at 24 hours post the infection.	[Huang, Lulin; Xu, Pingzhen; Cheng, Daojun; Fang, Ting; Xia, Qingyou] Southwest Univ, Inst Sericulture & Syst Biol, Chongqing, Peoples R China; [Cheng, Tingcai; Xia, Qingyou] Chongqing Univ, Inst Agron & Life Sci, Chongqing 630044, Peoples R China; [Huang, Lulin] Sichuan Acad Agr Sci, Inst Econ Crops Breeding & Cultivat, Chengdu, Peoples R China	Southwest University - China; Chongqing University; Sichuan Academy of Agricultural Sciences (SAAS)	Xia, QY (corresponding author), Southwest Univ, Inst Sericulture & Syst Biol, Chongqing, Peoples R China.	xiaqy@swu.edu.cn		cheng, tingcai/0000-0002-3862-0817	National Basic Research Program of China [2005CBI21000]; Ministry of Education Development Plan of Changjiang Scholars; Innovative Team [IRT0750]	National Basic Research Program of China(National Basic Research Program of China); Ministry of Education Development Plan of Changjiang Scholars; Innovative Team	This work was supported by research grants from the National Basic Research Program of China (http://www.973.gov.cn/English/Index.aspx), grant number No. 2005CBI21000, to QYX; the Ministry of Education Development Plan of Changjiang Scholars and their Innovative Team, grant number IRT0750, to QYX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGAISSE H, 1995, J BACTERIOL, V177, P6027, DOI 10.1128/jb.177.21.6027-6032.1995; Agarwala KL, 2000, MOL BRAIN RES, V79, P118, DOI 10.1016/S0169-328X(00)00108-X; Alvarez-Alfageme F, 2008, TRANSGENIC RES, V17, P943, DOI 10.1007/s11248-008-9177-4; Angelucci C, 2008, INSECT BIOCHEM MOLEC, V38, P685, DOI 10.1016/j.ibmb.2008.03.010; Arnesen LPS, 2008, FEMS MICROBIOL REV, V32, P579, DOI 10.1111/j.1574-6976.2008.00112.x; ASHIDA M, 1988, TISSUE CELL, V20, P599, DOI 10.1016/0040-8166(88)90061-4; Ashok Y, 2009, SCI SIGNAL, V1, DOI 10.1126/scisignal.252jc1; Aslett M, 2006, YEAST, V23, P913, DOI 10.1002/yea.1420; BECK WS, 1953, CANCER RES, V13, P309; Bergman NH, 2007, INFECT IMMUN, V75, P3434, DOI 10.1128/IAI.01345-06; BORGHETTI P, 2009, VET IMMUNOL IMMUNOPA; BOUTROS A R, 1962, Can Anaesth Soc J, V9, P353; Chaudhuri A, 2008, BLOOD, V111, P2062, DOI 10.1182/blood-2007-05-091207; Christensen BM, 2005, TRENDS PARASITOL, V21, P192, DOI 10.1016/j.pt.2005.02.007; Couble P, 2008, INSECT BIOCHEM MOLEC, V38, P1035, DOI [10.1016/j.ibmb.2009.01.004, 10.1016/j.ibmb.2008.11.004]; De Gregorio E, 2002, DEV CELL, V3, P581, DOI 10.1016/S1534-5807(02)00267-8; Dean DH, 1996, GENE, V179, P111, DOI 10.1016/S0378-1119(96)00442-8; Dingwall C, 1990, Semin Cell Biol, V1, P11; Dutz W, 1971, Pathol Annu, V6, P209; Edwards JF, 1998, J MED ENTOMOL, V35, P261, DOI 10.1093/jmedent/35.3.261; Ferrandon D, 2007, NAT REV IMMUNOL, V7, P862, DOI 10.1038/nri2194; Frehlick LJ, 2007, BIOESSAYS, V29, P49, DOI 10.1002/bies.20512; Gan H, 2001, INSECT BIOCHEM MOLEC, V31, P887, DOI 10.1016/S0965-1748(01)00034-0; Garver LS, 2008, DEV COMP IMMUNOL, V32, P519, DOI 10.1016/j.dci.2007.09.007; Glinski Zdzislaw, 1997, Archivum Immunologiae et Therapiae Experimentalis, V45, P149; Goldberg AV, 2002, J INVERTEBR PATHOL, V80, P148, DOI 10.1016/S0022-2011(02)00101-5; Grace Michael J., 2004, Antiviral Chemistry & Chemotherapy, V15, P287; HARTMAN ERNEST, 1931, LINGNAN SCI JOUR, V10, P279; Hartzer KL, 2005, ARCH INSECT BIOCHEM, V59, P67, DOI 10.1002/arch.20056; Harvie DR, 2005, MICROBIOL-SGM, V151, P569, DOI 10.1099/mic.0.27744-0; Hashimoto K, 2006, GLYCOBIOLOGY, V16, p63R, DOI 10.1093/glycob/cwj010; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; HOFTE H, 1989, MICROBIOL REV, V53, P242; Huang L, 2009, INSECT MOL BIOL, V18, P517, DOI 10.1111/j.1365-2583.2009.00896.x; Ibiza-Palacios MS, 2008, BIOCHEM J, V409, P215, DOI 10.1042/BJ20070956; Ihara H, 2008, J INVERTEBR PATHOL, V98, P177, DOI 10.1016/j.jip.2008.02.007; Ingle SS, 2001, CURR MICROBIOL, V43, P255, DOI 10.1007/s002840010297; Jung JJ, 2007, ONCOL REP, V18, P593; Kallberg Y, 2002, PROTEIN SCI, V11, P636, DOI 10.1110/ps.26902; Kamatani N, 1997, Nihon Naika Gakkai Zasshi, V86, P374; Kanehisa M, 2002, NOVART FDN SYMP, V247, P91; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karumbaiah L, 2007, COMP BIOCHEM PHYS B, V146, P139, DOI 10.1016/j.cbpb.2006.10.104; Kinjoh T, 2007, INSECT BIOCHEM MOLEC, V37, P808, DOI 10.1016/j.ibmb.2007.03.008; LAFORCE FM, 1994, CLIN INFECT DIS, V19, P1009, DOI 10.1093/clinids/19.6.1009; Lan N, 2003, CURR OPIN CHEM BIOL, V7, P44, DOI 10.1016/S1367-5931(02)00020-0; Lavazec C, 2005, INSECT MOL BIOL, V14, P163, DOI 10.1111/j.1365-2583.2004.00541.x; LECHNER AJ, 1993, MICROSC RES TECHNIQ, V26, P444, DOI 10.1002/jemt.1070260512; LEE MK, 1992, J BIOL CHEM, V267, P3115; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Lesieur C, 1997, MOL MEMBR BIOL, V14, P45, DOI 10.3109/09687689709068435; Li HR, 2004, INSECT BIOCHEM MOLEC, V34, P753, DOI 10.1016/j.ibmb.2004.03.010; Li S, 2005, INSECT BIOCHEM MOLEC, V35, P1235, DOI 10.1016/j.ibmb.2005.06.005; Luo H, 2001, BIOESSAYS, V23, P1138, DOI 10.1002/bies.10016; Maurer AP, 2007, PLOS PATHOG, V3, P752, DOI 10.1371/journal.ppat.0030083; Marak HB, 2002, J CHEM ECOL, V28, P2429, DOI 10.1023/A:1021475800765; Masoudi-Nejad Ali, 2007, V406, P437; Massari P, 2002, J IMMUNOL, V168, P1533, DOI 10.4049/jimmunol.168.4.1533; Matova N, 2006, P NATL ACAD SCI USA, V103, P16424, DOI 10.1073/pnas.0605721103; Meidanis J, 2002, MICROBIOL MOL BIOL R, V66, P272, DOI 10.1128/MMBR.66.2.272-299.2002; Meunier L, 2006, INSECT MOL BIOL, V15, P475, DOI 10.1111/j.1365-2583.2006.00659.x; Molina-Heredia FP, 2006, P NATL ACAD SCI USA, V103, P14750, DOI 10.1073/pnas.0510828103; Moran NA, 2006, MOL ECOL, V15, P1251, DOI 10.1111/j.1365-294X.2005.02744.x; Naitza S, 2004, MOL IMMUNOL, V40, P887, DOI 10.1016/j.molimm.2003.10.008; Nakanishi K, 2002, FEBS LETT, V519, P215, DOI 10.1016/S0014-5793(02)02708-4; Neill JD, 2003, BIOLOGICALS, V31, P97, DOI 10.1016/S1045-1056(03)00022-8; O'Shea JJ, 2002, CELL, V109, pS121, DOI 10.1016/S0092-8674(02)00701-8; Oyama T, 2001, Nihon Rinsho, V59 Suppl 2, P156; Pancer Z, 2004, NATURE, V430, P174, DOI 10.1038/nature02740; Pandian GN, 2008, APPL ENVIRON MICROB, V74, P1324, DOI 10.1128/AEM.01901-07; Pourquie O, 2003, SCIENCE, V301, P328, DOI 10.1126/science.1085887; Prestwich GD, 1996, ARCH INSECT BIOCHEM, V32, P407, DOI 10.1002/(SICI)1520-6327(1996)32:3/4&lt;407::AID-ARCH13&gt;3.0.CO;2-G; Priyadharshini P., 2008, Current Biotica, V2, P181; Rebers JE, 2001, INSECT BIOCHEM MOLEC, V31, P1083, DOI 10.1016/S0965-1748(01)00056-X; Rees JS, 2009, J INVERTEBR PATHOL, V100, P139, DOI 10.1016/j.jip.2009.01.002; Roth CW, 2003, MOL CELLS, V15, P150; Samant S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040037; Sanchis V, 1999, J Soc Biol, V193, P523; Sanders HR, 2005, INSECT BIOCHEM MOLEC, V35, P1293, DOI 10.1016/j.ibmb.2005.07.006; Satoh D, 1999, J BIOL CHEM, V274, P7441, DOI 10.1074/jbc.274.11.7441; Schmidt RL, 2008, FASEB J, V22, P918, DOI 10.1096/fj.06-7907com; Schoeni JL, 2005, J FOOD PROTECT, V68, P636, DOI 10.4315/0362-028X-68.3.636; Shinkawa A, 1999, CURR MICROBIOL, V39, P14, DOI 10.1007/PL00006820; Shinoda T, 2003, P NATL ACAD SCI USA, V100, P11986, DOI 10.1073/pnas.2134232100; Shitomi Y, 2006, J BIOCHEM, V139, P223, DOI 10.1093/jb/mvj024; SLAMA K, 1971, ANNU REV BIOCHEM, V40, P1079, DOI 10.1146/annurev.bi.40.070171.005243; SRIVASTAVA US, 1985, PROG FOOD NUTR SCI, V9, P63; Szarowicz SE, 2009, INFECT IMMUN, V77, P2455, DOI 10.1128/IAI.00839-08; Takase H, 2009, DEV COMP IMMUNOL, V33, P789, DOI 10.1016/j.dci.2009.01.005; Takehana A, 2004, EMBO J, V23, P4690, DOI 10.1038/sj.emboj.7600466; Tanaka H, 2005, BBA-GENE STRUCT EXPR, V1730, P10, DOI 10.1016/j.bbaexp.2005.05.007; Tanaka H, 2008, INSECT BIOCHEM MOLEC, V38, P1087, DOI 10.1016/j.ibmb.2008.09.001; Tanji T, 2007, MOL CELL BIOL, V27, P4578, DOI 10.1128/MCB.01814-06; THEOPOLD U, 1995, GENE, V156, P247, DOI 10.1016/0378-1119(95)00019-3; Thomas K, 2007, MOL CELL ENDOCRINOL, V270, P1, DOI 10.1016/j.mce.2007.03.001; Towb P, 1998, DEVELOPMENT, V125, P2443; UDAYASURIYAN V, 1994, BIOSCI BIOTECH BIOCH, V58, P830, DOI 10.1271/bbb.58.830; Vallet-Gely I, 2008, NAT REV MICROBIOL, V6, P302, DOI 10.1038/nrmicro1870; Veening JW, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.18; Vieira CU, 2008, ARCH INSECT BIOCHEM, V67, P97, DOI 10.1002/arch.20224; Vilas-Boas GT, 2007, CAN J MICROBIOL, V53, P673, DOI 10.1139/W07-029; WALTERS LL, 1993, J MED ENTOMOL, V30, P179, DOI 10.1093/jmedent/30.1.179; Wang F, 2006, VIRUS GENES, V33, P351, DOI 10.1007/s11262-006-0075-7; Wang Y, 2007, DEV COMP IMMUNOL, V31, P1002, DOI 10.1016/j.dci.2007.01.001; Watanabe A, 2006, J IMMUNOL, V177, P4594, DOI 10.4049/jimmunol.177.7.4594; Waterhouse RM, 2007, SCIENCE, V316, P1738, DOI 10.1126/science.1139862; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Xi ZY, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-1; Xia QY, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r162; Xia QY, 2004, SCIENCE, V306, P1937, DOI 10.1126/science.1102210; Yaoi K, 1999, FEBS LETT, V463, P221, DOI 10.1016/S0014-5793(99)01626-9; Zegers ND, 1999, J APPL MICROBIOL, V87, P309, DOI 10.1046/j.1365-2672.1999.00900.x; Zhang QR, 2005, INSECT BIOCHEM MOLEC, V35, P153, DOI 10.1016/j.ibmb.2004.10.010; Zhang RJ, 2009, SCI CHINA SER C, V52, P163, DOI 10.1007/s11427-009-0019-2; Zhou YJ, 2002, BIOSCI BIOTECH BIOCH, V66, P1488, DOI 10.1271/bbb.66.1488; Zou Z, 2008, P NATL ACAD SCI USA, V105, P18454, DOI 10.1073/pnas.0804658105	116	88	105	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2009	4	12							e8098	10.1371/journal.pone.0008098	http://dx.doi.org/10.1371/journal.pone.0008098			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MT	19956592	gold, Green Published, Green Submitted			2022-12-25	WOS:000272828700011
J	Aguilar, JL; Kulkarni, R; Randis, TM; Soman, S; Kikuchi, A; Yin, YX; Ratner, AJ				Aguilar, Jorge L.; Kulkarni, Ritwij; Randis, Tara M.; Soman, Sandeep; Kikuchi, Alexander; Yin, Yuxin; Ratner, Adam J.			Phosphatase-Dependent Regulation of Epithelial Mitogen-Activated Protein Kinase Responses to Toxin-Induced Membrane Pores	PLOS ONE			English	Article							INNATE IMMUNE-RESPONSES; FORMING TOXINS; MAPK PHOSPHATASES; CELL-SURVIVAL; P38 MAPK; PATHWAYS; PNEUMOLYSIN; INHIBITION; PP2A; 2A	Diverse bacterial species produce pore-forming toxins (PFT) that can puncture eukaryotic cell membranes. Host cells respond to sublytic concentrations of PFT through conserved intracellular signaling pathways, including activation of mitogen-activated protein kinases (MAPK), which are critical to cell survival. Here we demonstrate that in respiratory epithelial cells p38 and JNK MAPK were phosphorylated within 30 min of exposure to pneumolysin, the PFT from Streptococcus pneumoniae. This activation was tightly regulated, and dephosphorylation of both MAPK occurred within 60 min following exposure. Pretreatment of epithelial cells with inhibitors of cellular phosphatases, including sodium orthovanadate, calyculin A, and okadaic acid, prolonged and intensified MAPK activation. Specific inhibition of MAPK phosphatase-1 did not affect the kinetics of MAPK activation in PFT-exposed epithelial cells, but siRNA-mediated knockdown of serine/threonine phosphatases PP1 and PP2A were potent inhibitors of MAPK dephosphorylation. These results indicate an important role for PP1 and PP2A in termination of epithelial responses to PFT and only a minor contribution of dual-specificity phosphatases, such as MAPK phosphatase-1, which are the major regulators of MAPK signals in other cell types. Epithelial regulation of MAPK signaling in response to membrane disruption involves distinct pathways and may require different strategies for therapeutic interventions.	[Aguilar, Jorge L.; Kulkarni, Ritwij; Randis, Tara M.; Soman, Sandeep; Kikuchi, Alexander; Ratner, Adam J.] Columbia Univ, Dept Pediat, New York, NY 10027 USA; [Ratner, Adam J.] Columbia Univ, Dept Microbiol & Immunol, New York, NY 10027 USA; [Yin, Yuxin] Columbia Univ, Dept Radiat Oncol, New York, NY 10027 USA	Columbia University; Columbia University; Columbia University	Aguilar, JL (corresponding author), Columbia Univ, Dept Pediat, New York, NY 10027 USA.	ar127@columbia.edu		Randis, Tara/0000-0003-0348-6766; Ratner, Adam/0000-0003-1761-794X	National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/ NIAID) [AI065450]; Stony WoldHerbert Fund; Louis V. Gerstner, Jr., Scholars Program; Irving Scholars Program; John M. Driscoll, M. D., Children's Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI065450] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/ NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Stony WoldHerbert Fund; Louis V. Gerstner, Jr., Scholars Program; Irving Scholars Program; John M. Driscoll, M. D., Children's Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/ NIAID: AI065450), the Stony WoldHerbert Fund (Grant-in-Aid), the Louis V. Gerstner, Jr., Scholars Program, the Irving Scholars Program, and the John M. Driscoll, M. D., Children's Fund (to A. J. R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aroian R, 2007, CURR OPIN MICROBIOL, V10, P57, DOI 10.1016/j.mib.2006.12.008; Avery OT, 1944, J EXP MED, V79, P137, DOI 10.1084/jem.79.2.137; BERRY AM, 1989, INFECT IMMUN, V57, P2037, DOI 10.1128/IAI.57.7.2037-2042.1989; Bischof LJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000176; Boudreau RM, 2007, CELL SIGNAL, V19, P139, DOI 10.1016/j.cellsig.2006.05.030; Boudreau RTM, 2004, J LEUKOCYTE BIOL, V76, P1075, DOI 10.1189/jlb.1003498; DOBROWSKY RT, 1993, J BIOL CHEM, V268, P15523; Dolinay T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001601; Gelber SE, 2008, J BACTERIOL, V190, P3896, DOI 10.1128/JB.01965-07; Gould JM, 2002, J INFECT DIS, V186, P361, DOI 10.1086/341658; Gurcel L, 2006, CELL, V126, P1135, DOI 10.1016/j.cell.2006.07.033; Hammer M, 2006, J EXP MED, V203, P15, DOI 10.1084/jem.20051753; Huffman DL, 2004, P NATL ACAD SCI USA, V101, P10995, DOI 10.1073/pnas.0404073101; Iacovache I, 2008, BBA-BIOMEMBRANES, V1778, P1611, DOI 10.1016/j.bbamem.2008.01.026; Junttila MR, 2008, FASEB J, V22, P954, DOI 10.1096/fj.06-7859rev; Kitatani K, 2006, J BIOL CHEM, V281, P36793, DOI 10.1074/jbc.M608137200; Korchev YE, 1998, BIOCHEM J, V329, P571; Lang R, 2006, J IMMUNOL, V177, P7497, DOI 10.4049/jimmunol.177.11.7497; Liu YS, 2007, NAT REV IMMUNOL, V7, P202, DOI 10.1038/nri2035; Mitsuhashi S, 2003, J BIOL CHEM, V278, P82, DOI 10.1074/jbc.M208888200; Park JM, 2004, J EXP MED, V200, P1647, DOI 10.1084/jem.20041215; Randis TM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005207; Ratner AJ, 2006, J BIOL CHEM, V281, P12994, DOI 10.1074/jbc.M511431200; Ratner AJ, 2005, P NATL ACAD SCI USA, V102, P3429, DOI 10.1073/pnas.0500599102; RUBINS JB, 1995, J CLIN INVEST, V95, P142, DOI 10.1172/JCI117631; Sablina AA, 2007, CELL, V129, P969, DOI 10.1016/j.cell.2007.03.047; Salojin KV, 2006, J IMMUNOL, V176, P1899, DOI 10.4049/jimmunol.176.3.1899; Silverstein AM, 2002, P NATL ACAD SCI USA, V99, P4221, DOI 10.1073/pnas.072071699; St-Onge M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004902; Strack S, 2002, J BIOL CHEM, V277, P20750, DOI 10.1074/jbc.M202992200; Sundaresan P, 2002, FEBS LETT, V528, P139, DOI 10.1016/S0014-5793(02)03277-5; Walev I, 2001, FASEB J, V15, P237, DOI 10.1096/fj.01-0572fje; WALEV I, 1994, MICROB PATHOGENESIS, V17, P187, DOI 10.1006/mpat.1994.1065; Wang XX, 2007, J IMMUNOL, V178, P5312, DOI 10.4049/jimmunol.178.8.5312; Wiles TJ, 2008, MOL BIOL CELL, V19, P1427, DOI 10.1091/mbc.E07-07-0638; Zhao Q, 2006, J EXP MED, V203, P131, DOI 10.1084/jem.20051794	36	26	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2009	4	11							e8076	10.1371/journal.pone.0008076	http://dx.doi.org/10.1371/journal.pone.0008076			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MQ	19956644	Green Published, gold, Green Submitted			2022-12-25	WOS:000272828400023
J	Bruzzone, S; Fruscione, F; Morando, S; Ferrando, T; Poggi, A; Garuti, A; D'Urso, A; Selmo, M; Benvenuto, F; Cea, M; Zoppoli, G; Moran, E; Soncini, D; Ballestrero, A; Sordat, B; Patrone, F; Mostoslavsky, R; Uccelli, A; Nencioni, A				Bruzzone, Santina; Fruscione, Floriana; Morando, Sara; Ferrando, Tiziana; Poggi, Alessandro; Garuti, Anna; D'Urso, Agustina; Selmo, Martina; Benvenuto, Federica; Cea, Michele; Zoppoli, Gabriele; Moran, Eva; Soncini, Debora; Ballestrero, Alberto; Sordat, Bernard; Patrone, Franco; Mostoslavsky, Raul; Uccelli, Antonio; Nencioni, Alessio			Catastrophic NAD(+) Depletion in Activated T Lymphocytes through Nampt Inhibition Reduces Demyelination and Disability in EAE	PLOS ONE			English	Article							BIOSYNTHESIS INHIBITOR; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; CELL-SURVIVAL; CYCLING ASSAY; APOPTOSIS; PATHWAY; FK866; ENZYME; DEATH; CD38	Nicotinamide phosphoribosyltransferase (Nampt) inhibitors such as FK866 are potent inhibitors of NAD(+) synthesis that show promise for the treatment of different forms of cancer. Based on Nampt upregulation in activated T lymphocytes and on preliminary reports of lymphopenia in FK866 treated patients, we have investigated FK866 for its capacity to interfere with T lymphocyte function and survival. Intracellular pyridine nucleotides, ATP, mitochondrial function, viability, proliferation, activation markers and cytokine secretion were assessed in resting and in activated human T lymphocytes. In addition, we used experimental autoimmune encephalomyelitis (EAE) as a model of T-cell mediated autoimmune disease to assess FK866 efficacy in vivo. We show that activated, but not resting, T lymphocytes undergo massive NAD(+) depletion upon FK866-mediated Nampt inhibition. As a consequence, impaired proliferation, reduced IFN-gamma and TNF-alpha production, and finally autophagic cell demise result. We demonstrate that upregulation of the NAD(+)-degrading enzyme poly-(ADP-ribose)polymerase (PARP) by activated T cells enhances their susceptibility to NAD(+) depletion. In addition, we relate defective IFN-gamma and TNF-alpha production in response to FK866 to impaired Sirt6 activity. Finally, we show that FK866 strikingly reduces the neurological damage and the clinical manifestations of EAE. In conclusion, Nampt inhibitors (and possibly Sirt6 inhibitors) could be used to modulate T cell-mediated immune responses and thereby be beneficial in immune-mediated disorders.			Bruzzone, S (corresponding author), Univ Genoa, Biochem Sect, Dept Expt Med, Genoa, Italy.	A.Nencioni@gmx.net	Poggi, Alessandro/K-6664-2016; fruscione, floriana/AAA-8747-2020; Zoppoli, Gabriele/A-9540-2010; Soncini, Debora/AAB-2230-2019; UCCELLI, Antonio/E-7343-2012; Zoppoli, Gabriele/B-6935-2016; cea, Michele/K-3863-2018; Nencioni, Alessio/K-3692-2018; Ballestrero, Alberto/K-7546-2016; Bruzzone, Santina/A-4264-2015; Zoppoli, Gabriele/B-6935-2016	Poggi, Alessandro/0000-0002-1860-430X; Soncini, Debora/0000-0001-5156-498X; UCCELLI, Antonio/0000-0002-2008-6038; Zoppoli, Gabriele/0000-0003-3890-5588; cea, Michele/0000-0002-1530-6729; Ballestrero, Alberto/0000-0002-2601-7711; Bruzzone, Santina/0000-0003-2034-3716; DUrso, Agustina/0000-0003-1406-4390; NENCIONI, ALESSIO/0000-0001-5068-8884; Zoppoli, Gabriele/0000-0002-1619-1708; fruscione, floriana/0000-0002-4054-645X	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088190] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093072] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK088190] Funding Source: Medline; NIGMS NIH HHS [R01 GM093072] Funding Source: Medline; Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)		Avalos JL, 2005, MOL CELL, V17, P855, DOI 10.1016/j.molcel.2005.02.022; Belka C, 2000, ONCOGENE, V19, P1181, DOI 10.1038/sj.onc.1203401; BERGER SJ, 1987, EXP CELL RES, V169, P149, DOI 10.1016/0014-4827(87)90233-3; Billington RA, 2008, AUTOPHAGY, V4, P385, DOI 10.4161/auto.5635; Bogan KL, 2008, ANNU REV NUTR, V28, P115, DOI 10.1146/annurev.nutr.28.061807.155443; Busso N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002267; Cohen-Armon M, 2007, TRENDS PHARMACOL SCI, V28, P556, DOI 10.1016/j.tips.2007.08.005; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Feske S, 2001, NAT IMMUNOL, V2, P316, DOI 10.1038/86318; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Gasser A, 2006, J BIOL CHEM, V281, P16906, DOI 10.1074/jbc.M601347200; Graeff R, 2002, BIOCHEM J, V361, P379, DOI 10.1042/bj3610379; GUIDA L, 1995, FEBS LETT, V368, P481, DOI 10.1016/0014-5793(95)00715-L; Hasmann M, 2003, CANCER RES, V63, P7436; Holen K, 2008, INVEST NEW DRUG, V26, P45, DOI 10.1007/s10637-007-9083-2; Hwu P, 2000, J IMMUNOL, V164, P3596, DOI 10.4049/jimmunol.164.7.3596; Khan JA, 2006, NAT STRUCT MOL BIOL, V13, P582, DOI 10.1038/nsmb1105; Lum JJ, 2005, NAT REV MOL CELL BIO, V6, P439, DOI 10.1038/nrm1660; MCNERNEY R, 1989, BIOCHIM BIOPHYS ACTA, V1009, P185, DOI 10.1016/0167-4781(89)90099-7; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; Miglino M, 2006, LEUKEMIA LYMPHOMA, V47, P1348, DOI 10.1080/10428190500525607; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Nahimana A, 2009, BLOOD, V113, P3276, DOI 10.1182/blood-2008-08-173369; Nencioni A, 2003, J IMMUNOL, V171, P5148, DOI 10.4049/jimmunol.171.10.5148; Nencioni A, 2002, J IMMUNOL, V169, P1228, DOI 10.4049/jimmunol.169.3.1228; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Poggi A, 2005, J IMMUNOL, V174, P2653, DOI 10.4049/jimmunol.174.5.2653; Pogrebniak A, 2006, EUR J MED RES, V11, P313; Pollak N, 2007, J BIOL CHEM, V282, P33562, DOI 10.1074/jbc.M704442200; Rich PR, 2003, BIOCHEM SOC T, V31, P1095; Rongvaux A, 2002, EUR J IMMUNOL, V32, P3225, DOI 10.1002/1521-4141(200211)32:11<3225::AID-IMMU3225>3.0.CO;2-L; Rongvaux A, 2008, J IMMUNOL, V181, P4685, DOI 10.4049/jimmunol.181.7.4685; Sestini S, 2000, ARCH BIOCHEM BIOPHYS, V379, P277, DOI 10.1006/abbi.2000.1888; Shaffer AL, 2001, IMMUNITY, V15, P375, DOI 10.1016/S1074-7613(01)00194-7; Shimizu S, 1998, P NATL ACAD SCI USA, V95, P1455, DOI 10.1073/pnas.95.4.1455; Shubinsky G, 1997, IMMUNITY, V7, P315, DOI 10.1016/S1074-7613(00)80353-2; Van Gool F, 2009, NAT MED, V15, P206, DOI 10.1038/nm.1906; Wosikowski K, 2002, CANCER RES, V62, P1057; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; Ying WH, 2001, P NATL ACAD SCI USA, V98, P12227, DOI 10.1073/pnas.211202598; Zappia E, 2005, BLOOD, V106, P1755, DOI 10.1182/blood-2005-04-1496; Zocchi E, 1998, J BIOL CHEM, V273, P8017, DOI 10.1074/jbc.273.14.8017	43	123	143	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2009	4	11							e7897	10.1371/journal.pone.0007897	http://dx.doi.org/10.1371/journal.pone.0007897			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522NJ	19936064	Green Published, Green Submitted, gold			2022-12-25	WOS:000272004600003
J	Morgan, EA; Schneider, JG; Baroni, TE; Ulckan, O; Heller, E; Hurchla, MA; Deng, HJ; Floyd, D; Berdy, A; Prior, JL; Piwnica-Worms, D; Teitelbaum, SL; Ross, FP; Weilbaecher, KN				Morgan, Elizabeth A.; Schneider, Jochen G.; Baroni, Timothy E.; Ulckan, Oezge; Heller, Emanuela; Hurchla, Michelle A.; Deng, Hongju; Floyd, Desiree; Berdy, Andrew; Prior, Julie L.; Piwnica-Worms, David; Teitelbaum, Steven L.; Ross, F. Patrick; Weilbaecher, Katherine N.			Dissection of platelet and myeloid cell defects by conditional targeting of the beta 3-integrin subunit	FASEB JOURNAL			English	Article						Pf4-Cre; LysM-Cre; conditional knockout	ENDOTHELIAL GROWTH-FACTOR; INTEGRIN-LINKED KINASE; MARROW-DERIVED CELLS; BETA(3)-INTEGRIN-DEFICIENT MICE; PATHOLOGICAL ANGIOGENESIS; ALPHA-V-BETA-3 INTEGRIN; BETA(3) INTEGRIN; BONE-RESORPTION; GLIOMA GROWTH; TUMOR-GROWTH	The purpose of this work was to determine platelet and myeloid cell-specific requirements for beta 3-containing integrins in hemostasis, bone resorption, and tumor growth. LoxP-flanked mice were generated to study the conditional deletion of beta 3-integrin in platelets [knockout in platelets (KOP)] and myeloid cells [knockout in myeloid (KOM)]. Using the beta 3KOP and beta 3KOM strains of mice, we studied the role of beta 3-integrin in hemostasis, bone resorption, and subcutaneous tumor growth. Tissue-specific deletion of platelet beta 3-integrins in beta 3KOP mice did not affect bone mass but resulted in a severe bleeding phenotype. No growth difference of tumor xenografts or in neoangiogenesis were found in beta 3KOP mice, in contrast to the defects observed in germline beta 3(-/-) mice. Conditional deletion of myeloid beta 3-integrins in beta 3KOM mice resulted in osteopetrosis but had no effect on hemostasis or mortality. Tumor growth in beta 3KOM mice was increased and accompanied by decreased macrophage infiltration, without increase in blood vessel number. Platelet beta 3-integrin deficiency was sufficient to disrupt hemostasis but had no effect on bone mass or tumor growth. Myeloid-specific beta 3-integrin deletion was sufficient to perturb bone mass and enhance tumor growth due to reduced macrophage infiltration in the tumors. These results suggest that beta 3-integrins have cell-specific roles in complex biological processes.-Morgan, E. A., Schneider, J. G., Baroni, T. E., Uluckan, O., Heller, E., Hurchla, M. A., Deng, H., Floyd, D., Berdy, A., Prior, J. L., Piwnica-Worms, D., Teitelbaum, S. L., Ross, F. P., Weilbaecher, K. N. Dissection of platelet and myeloid cell defects by conditional targeting of the beta 3-integrin subunit. FASEB J. 24, 1117-1127 (2010). www.fasebj.org	[Morgan, Elizabeth A.; Schneider, Jochen G.; Baroni, Timothy E.; Ulckan, Oezge; Heller, Emanuela; Hurchla, Michelle A.; Deng, Hongju; Floyd, Desiree; Berdy, Andrew; Weilbaecher, Katherine N.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Prior, Julie L.; Piwnica-Worms, David] Washington Univ, Sch Med, Mol Imaging Ctr, Mallinckrodt Inst Radiol, St Louis, MO 63110 USA; [Teitelbaum, Steven L.; Ross, F. Patrick] Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA; [Schneider, Jochen G.] Univ Wurzburg, Dept Clin Biochem & Pathobiochem, Wurzburg, Germany	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Wurzburg	Weilbaecher, KN (corresponding author), Washington Univ, Sch Med, Div Oncol, Dept Med & Cell Biol & Physiol, 660 S Euclid Ave,POB 8069, St Louis, MO 63110 USA.	kweilbae@dom.wustl.edu	Uluckan, Ozge/H-6912-2015	Uluckan, Ozge/0000-0001-9468-1211; Morgan, Elizabeth/0000-0001-5880-9337; Teitelbaum, Steven/0000-0002-4054-6679	NATIONAL CANCER INSTITUTE [R56CA097250, P50CA094056, R01CA097250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR032788, R01AR046523, R01AR046852, P30AR057235, R37AR046523] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK052574, P30DK056341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007200] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA097250, P50 CA94056, P50 CA094056, R56 CA097250] Funding Source: Medline; NIAMS NIH HHS [R01 AR046852, AR032788, R01 AR046523, R37 AR046523, AR046852, AR046523, R01 AR032788, P30 AR057235] Funding Source: Medline; NIDDK NIH HHS [P30 DK52574, DK56341, P30 DK056341-09, P30 DK056341, P30 DK052574] Funding Source: Medline; NIGMS NIH HHS [T32 GM007200, T32 GM7200] Funding Source: Medline; PHS HHS [NIHR0152152] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Bakewell SJ, 2003, P NATL ACAD SCI USA, V100, P14205, DOI 10.1073/pnas.2234372100; BEER J, 1989, J BIOL CHEM, V264, P17564; BROOKS PC, 1994, SCIENCE, V264, P569, DOI 10.1126/science.7512751; BROOKS PC, 1995, J CLIN INVEST, V96, P1815, DOI 10.1172/JCI118227; BROOKS PC, 1994, CELL, V79, P1157, DOI 10.1016/0092-8674(94)90007-8; Castro CHM, 2003, CELL COMMUN ADHES, V10, P445, DOI 10.1080/15419060390267700; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; DEJANA E, 1979, THROMB RES, V15, P199, DOI 10.1016/0049-3848(79)90065-3; Faccio R, 2003, J CLIN INVEST, V111, P749, DOI 10.1172/JCI200316924; Feng WY, 2008, J CELL BIOL, V183, P1145, DOI 10.1083/jcb.200802179; FRENETTE PS, 1995, P NATL ACAD SCI USA, V92, P7450, DOI 10.1073/pnas.92.16.7450; Friedrich EB, 2004, MOL CELL BIOL, V24, P8134, DOI 10.1128/MCB.24.18.8134-8144.2004; Galarneau H, 2007, CANCER RES, V67, P8874, DOI 10.1158/0008-5472.CAN-07-0177; Graubert TA, 1998, NUCLEIC ACIDS RES, V26, P2849, DOI 10.1093/nar/26.12.2849; Guerrero CA, 2000, P NATL ACAD SCI USA, V97, P14644, DOI 10.1073/pnas.250299897; Hagemann T, 2008, J EXP MED, V205, P1261, DOI 10.1084/jem.20080108; HILLIARD TJ, 1990, J BONE MINER RES, V5, P1217; Hirbe AC, 2007, BLOOD, V109, P3424, DOI 10.1182/blood-2006-09-048686; Hodivala-Dilke KM, 1999, J CLIN INVEST, V103, P229, DOI 10.1172/JCI5487; HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Italiano JE, 2008, BLOOD, V111, P1227, DOI 10.1182/blood-2007-09-113837; Jones JI, 1996, P NATL ACAD SCI USA, V93, P2482, DOI 10.1073/pnas.93.6.2482; Kanamori M, 2006, J BIOL CHEM, V281, P37256, DOI 10.1074/jbc.M605344200; Kim HJ, 2006, J CLIN INVEST, V116, P2152, DOI 10.1172/JCI28084; Law DA, 1999, NATURE, V401, P808, DOI 10.1038/44599; Mahabeleshwar GH, 2006, J EXP MED, V203, P2495, DOI 10.1084/jem.20060807; McHugh KP, 2000, J CLIN INVEST, V105, P433, DOI 10.1172/JCI8905; PHILLIPS DR, 1991, CELL, V65, P359, DOI 10.1016/0092-8674(91)90451-4; Rafii DC, 2008, ARTERIOSCL THROM VAS, V28, P217, DOI 10.1161/ATVBAHA.107.151159; Ren J, 2007, J MOL CELL CARDIOL, V42, P367, DOI 10.1016/j.yjmcc.2006.11.002; Reynolds AR, 2004, CANCER RES, V64, P8643, DOI 10.1158/0008-5472.CAN-04-2760; Reynolds LE, 2005, NAT MED, V11, P167, DOI 10.1038/nm1165; Reynolds LE, 2002, NAT MED, V8, P27, DOI 10.1038/nm0102-27; Robinson SD, 2004, ARTERIOSCL THROM VAS, V24, P2108, DOI 10.1161/01.ATV.0000143857.27408.de; Rosen HN, 2000, CALCIFIED TISSUE INT, V66, P100, DOI 10.1007/PL00005830; ROSS FP, 1993, J BIOL CHEM, V268, P9901; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; Schaffner A, 2005, J LEUKOCYTE BIOL, V78, P202, DOI 10.1189/jlb.0105024; Schneider JG, 2007, ARTERIOSCL THROM VAS, V27, P2699, DOI 10.1161/ATVBAHA.107.153650; Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cellbio.11.1.549; Srivatsa SS, 1997, CARDIOVASC RES, V36, P408, DOI 10.1016/S0008-6363(97)00184-3; Stockmann C, 2008, NATURE, V456, P814, DOI 10.1038/nature07445; Taverna D, 2004, P NATL ACAD SCI USA, V101, P763, DOI 10.1073/pnas.0307289101; Tiedt R, 2007, BLOOD, V109, P1503, DOI 10.1182/blood-2006-04-020362; Tucker KL, 2008, BLOOD, V112, P4523, DOI 10.1182/blood-2008-03-148502; Uluckan O, 2008, J CELL BIOCHEM, V104, P1311, DOI 10.1002/jcb.21709; Weerasinghe D, 1998, J CELL BIOL, V142, P595, DOI 10.1083/jcb.142.2.595; Ye M, 2003, IMMUNITY, V19, P689, DOI 10.1016/S1074-7613(03)00299-1	50	38	38	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2010	24	4					1117	1127		10.1096/fj.09-138420	http://dx.doi.org/10.1096/fj.09-138420			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	580PV	19933310	Green Published			2022-12-25	WOS:000276462300019
J	Verkaar, F; Blankesteijn, WM; Smits, JFM; Zaman, GJR				Verkaar, Folkert; Blankesteijn, W. Matthijs; Smits, Jos F. M.; Zaman, Guido J. R.			beta-Galactosidase enzyme fragment complementation for the measurement of Wnt/beta-catenin signaling	FASEB JOURNAL			English	Article						AEB-071; GSK3; PKC; sotrastaurin; Wnt-3a; Wnt-5a	WNT PATHWAY; PROTEIN; ASSAY; INHIBITOR; LITHIUM; IDENTIFICATION; MECHANISM	Wnt/beta-catenin signaling is an important regulator of cell polarity, proliferation, and stem cell maintenance during development and adulthood. Wnt proteins induce the nuclear accumulation of beta-catenin, which regulates the expression of Wnt-responsive genes through association with TCF/LEF transcription factors. Aberrant Wnt/beta-catenin signaling has been implicated in a plethora of pathologies and, most notably, underlies initiation and expansion of several cancers. Here, we apply enzyme fragment complementation to measure the nuclear accumulation of beta-catenin. beta-catenin was tagged with a peptide fragment of beta-galactosidase and transfected into cells expressing a corresponding deletion mutant of the enzyme exclusively in the nucleus. Stimulation of the cells with recombinant Wnt-3a restored beta-galactosidase activity in a dose-dependent manner with nanomolar potency. Using the assay, we confirmed that Wnt-5a represses beta-catenin-driven reporter gene activity downstream of nuclear entry of beta-catenin. In addition, we tested a library of >2000 synthetic chemical compounds for their ability to induce beta-catenin nuclear accumulation. The immunosuppressive protein kinase C inhibitor sotrastaurin (AEB-071) was identified as an activator of Wnt/beta-catenin signaling at micromolar concentrations. It was confirmed that the compound stabilizes endogenous beta-catenin protein and can induce TCF/LEF-dependent gene transcription. Subsequent biochemical profiling of >200 kinases revealed both isoforms of glycogen synthase kinase 3, as previously unappreciated targets of sotrastaurin. We show that the beta-catenin nuclear accumulation assay contributes to our knowledge of molecular interactions within the Wnt/beta-catenin pathway and can be used to find new therapeutics targeting Wnt/beta-catenin signaling.-Verkaar, F., Blankesteijn, W. M., Smits, J. F. M., Zaman, G. J. R. beta-Galactosidase enzyme fragment complementation for the measurement of Wnt/beta-catenin signaling. FASEB J. 24, 1205-1217 (2010). www.fasebj.org	[Verkaar, Folkert; Zaman, Guido J. R.] Schering Plough Res Inst, NL-5340 BH Oss, Netherlands; [Verkaar, Folkert; Blankesteijn, W. Matthijs; Smits, Jos F. M.] Maastricht Univ, Dept Pharmacol & Toxicol, Cardiovasc Res Inst, Maastricht, Netherlands	Merck & Company; Maastricht University	Zaman, GJR (corresponding author), Schering Plough Res Inst, POB 20, NL-5340 BH Oss, Netherlands.	guido.zaman@spcorp.com			Netherlands BSIK	Netherlands BSIK(Ministry of Economic Affairs, Netherlands)	The authors thank Els van Doornmalen for assistance with high-content image analysis, and Martine Prinsen, Duby Ballak, Lonneke Voorneveld, and Bridget Bulwer for technical assistance. The authors thank Ruben Smeets, Martin Smit, and Jac Wijkmans for critical reading of the manuscript. Prof. Dr. Randall Moon (University of Washington, Seattle, WA, USA), Prof. Dr. Yasuhiro Minami (Kobe University, Kobe, Japan), and Dr. Jan Kitajewski (Columbia University, New York, NY, USA) are acknowledged for providing plasmids. This research is supported by The Netherlands BSIK program (to F. V., W. M. B., and J.F.M.S.).	Barker N, 2006, NAT REV DRUG DISCOV, V5, P997, DOI 10.1038/nrd2154; Baron R, 2006, CURR TOP DEV BIOL, V76, P103, DOI 10.1016/S0070-2153(06)76004-5; Binnerts ME, 2007, P NATL ACAD SCI USA, V104, P14700, DOI 10.1073/pnas.0702305104; Borchert KM, 2005, ASSAY DRUG DEV TECHN, V3, P133, DOI 10.1089/adt.2005.3.133; Borchert KM, 2006, METHOD ENZYMOL, V414, P140; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cohen Y, 1998, MED ONCOL, V15, P32, DOI 10.1007/BF02787342; Crisman TJ, 2007, J CHEM INF MODEL, V47, P1319, DOI 10.1021/ci6005504; Cywin CL, 2007, BIOORG MED CHEM LETT, V17, P225, DOI 10.1016/j.bmcl.2006.09.056; DU SJ, 1995, MOL CELL BIOL, V15, P2625; FLEMING PE, 2005, Patent No. 2005066139; Gould TD, 2003, PHARMACOL RES, V48, P49, DOI 10.1016/S0143-6618(03)00096-3; Hannoush RN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003498; Horecka J, 2006, BIOTECHNIQUES, V40, P381, DOI 10.2144/000112119; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; Jope RS, 2007, NEUROCHEM RES, V32, P577, DOI 10.1007/s11064-006-9128-5; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Knight ZA, 2005, CHEM BIOL, V12, P621, DOI 10.1016/j.chembiol.2005.04.011; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Loomans EEMG, 2003, ASSAY DRUG DEV TECHN, V1, P445, DOI 10.1089/154065803322163759; Merani S, 2009, TRANSPLANTATION, V87, P59, DOI 10.1097/TP.0b013e31819198b4; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Morrell NT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002930; Naik S, 2007, P NATL ACAD SCI USA, V104, P17465, DOI 10.1073/pnas.0704465104; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Shimizu H, 1997, CELL GROWTH DIFFER, V8, P1349; Skvara H, 2008, J CLIN INVEST, V118, P3151, DOI 10.1172/JCI35636; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; Topol L, 2003, J CELL BIOL, V162, P899, DOI 10.1083/jcb.200303158; Torres MA, 1996, J CELL BIOL, V133, P1123, DOI 10.1083/jcb.133.5.1123; Van der Lee MMC, 2008, J BIOMOL SCREEN, V13, P986, DOI 10.1177/1087057108326144; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Verkaar F, 2009, CELL SIGNAL, V21, P22, DOI 10.1016/j.cellsig.2008.09.008; Wehrman TS, 2005, NAT METHODS, V2, P521, DOI 10.1038/NMETH771; Yokoyama Noriko, 2007, J Mol Signal, V2, P11, DOI 10.1186/1750-2187-2-11; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhu PJ, 2008, COMB CHEM HIGH T SCR, V11, P545, DOI 10.2174/138620708785204045	40	17	18	1	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2010	24	4					1205	1217		10.1096/fj.09-141671	http://dx.doi.org/10.1096/fj.09-141671			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	580PV	19940259	Green Submitted			2022-12-25	WOS:000276462300027
J	Pike, ST; Rajendra, R; Artzt, K; Appling, DR				Pike, Schuyler T.; Rajendra, Rashmi; Artzt, Karen; Appling, Dean R.			Mitochondrial C-1-Tetrahydrofolate Synthase (MTHFD1L) Supports the Flow of Mitochondrial One-carbon Units into the Methyl Cycle in Embryos	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEHYDROGENASE-METHENYLTETRAHYDROFOLATE CYCLOHYDROLASE; DEPENDENT METHYLENETETRAHYDROFOLATE DEHYDROGENASE; NEURAL-TUBE DEFECTS; SERINE HYDROXYMETHYLTRANSFERASE ISOZYMES; C-13 NMR ANALYSIS; SACCHAROMYCES-CEREVISIAE; MESSENGER-RNA; C1-TETRAHYDROFOLATE SYNTHASE; HOMOCYSTEINE REMETHYLATION; CELLS	Mitochondrial folate-dependent one-carbon (1-C) metabolism converts 1-C donors such as serine and glycine to formate, which is exported and incorporated into the cytoplasmic tetrahydrofolate (THF) 1-C pool. Developing embryos depend on this mitochondrial pathway to provide 1-C units for cytoplasmic process such as de novo purine biosynthesis and the methyl cycle. This pathway is composed of sequential methylene-THF dehydrogenase, methenyl-THF cyclohydrolase, and 10-formyl-THF synthetase activities. In embryonic mitochondria, the bifunctional MTHFD2 enzyme catalyzes the dehydrogenase and cyclohydrolase reactions, but the enzyme responsible for the mitochondrial synthetase reaction has not been identified in embryos. A monofunctional 10-formyl-THF synthetase (MTHFD1L gene product) functions in adult mitochondria and is a likely candidate for the embryonic activity. Here we show that the MTHFD1L enzyme is present in mitochondria from normal embryonic tissues and embryonic fibroblast cell lines, and embryonic mitochondria possess the ability to synthesize formate from glycine. The MTHFD1L transcript was detected at all stages of mouse embryogenesis examined. In situ hybridizations showed that MTHFD1L was expressed ubiquitously throughout the embryo but with localized regions of higher expression. The spatial pattern of MTHFD1L expression was virtually indistinguishable from that of MTHFD2 and MTHFD1 (cytoplasmic C-1-THF synthase) in embryonic day 9.5 mouse embryos, suggesting coordinated regulation. Finally, we show using stable isotope labeling that in an embryonic mouse cell line, greater than 75% of 1-C units entering the cytoplasmic methyl cycle are mitochondrially derived. Thus, a complete pathway of enzymes for supplying 1-C units from the mitochondria to the methyl cycle in embryonic tissues is established.	[Pike, Schuyler T.; Appling, Dean R.] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA; [Rajendra, Rashmi; Artzt, Karen] Univ Texas Austin, Mol Genet Sect, Austin, TX 78712 USA; [Rajendra, Rashmi; Artzt, Karen] Univ Texas Austin, Inst Mol & Cellular Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Appling, DR (corresponding author), Univ Texas Austin, Dept Chem & Biochem, 1 Univ Stn,A5300, Austin, TX 78712 USA.	dappling@mail.utexas.edu		Pike, Schuyler/0000-0003-1366-9486	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD010668] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086856] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD010668, HD10668] Funding Source: Medline; NIDDK NIH HHS [DK61425, R01 DK061425] Funding Source: Medline; NIGMS NIH HHS [R01 GM086856, GM086856] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anguera MC, 2006, J BIOL CHEM, V281, P18335, DOI 10.1074/jbc.M510623200; Antony AC, 2000, TERATOLOGY, V62, P42, DOI 10.1002/1096-9926(200007)62:1&lt;42::AID-TERA9&gt;3.0.CO;2-U; APPLING DR, 1991, FASEB J, V5, P2645, DOI 10.1096/fasebj.5.12.1916088; Atkinson DE, 1977, CELLULAR ENERGY META, DOI DOI 10.1016/C2009-0-03136-5; Bai SM, 2005, MOL CELL BIOL, V25, P751, DOI 10.1128/MCB.25.2.751-766.2005; BARLOWE C K, 1988, Biofactors, V1, P171; BARLOWE CK, 1990, MOL CELL BIOL, V10, P5679, DOI 10.1128/MCB.10.11.5679; Basch Martin L, 2004, Birth Defects Res C Embryo Today, V72, P109, DOI 10.1002/bdrc.20015; BELANGER C, 1989, J BIOL CHEM, V264, P4837; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carter M, 2005, P NATL ACAD SCI USA, V102, P12843, DOI 10.1073/pnas.0501963102; Carter M, 1999, HUM MOL GENET, V8, P2199, DOI 10.1093/hmg/8.12.2199; Chen J, 1996, CANCER RES, V56, P4862; Christensen KE, 2005, J BIOL CHEM, V280, P7597, DOI 10.1074/jbc.M409380200; CONLON RA, 1992, DEVELOPMENT, V116, P357; Davis SR, 2004, AM J PHYSIOL-ENDOC M, V286, pE272, DOI 10.1152/ajpendo.00351.2003; Di Pietro E, 2004, BBA-GEN SUBJECTS, V1674, P78, DOI 10.1016/j.bbagen.2004.06.014; Di Pietro E, 2002, MOL CELL BIOL, V22, P4158, DOI 10.1128/MCB.22.12.4158-4166.2002; Fu TF, 2001, ARCH BIOCHEM BIOPHYS, V393, P42, DOI 10.1006/abbi.2001.2471; GARCIAMARTINEZ LF, 1993, BIOCHEMISTRY-US, V32, P4671, DOI 10.1021/bi00068a027; Greene NDE, 2005, AM J MED GENET C, V135C, P31, DOI 10.1002/ajmg.c.30051; Gregory JF, 2000, AM J CLIN NUTR, V72, P1535; Helgadottir S, 2007, J BACTERIOL, V189, P575, DOI 10.1128/JB.01269-06; Herbig K, 2002, J BIOL CHEM, V277, P38381, DOI 10.1074/jbc.M205000200; Horswill MA, 2008, EXP EYE RES, V86, P586, DOI 10.1016/j.exer.2008.01.003; Howard KM, 2003, GENE, V319, P85, DOI 10.1016/S0378-1119(03)00796-0; Huang X, 2004, DEV BIOL, V275, P1, DOI 10.1016/j.ydbio.2004.07.033; HUM DW, 1988, J BIOL CHEM, V263, P15946; Kastanos EK, 1997, BIOCHEMISTRY-US, V36, P14956, DOI 10.1021/bi971610n; Kawakami K, 2003, CLIN CANCER RES, V9, P5860; Kobayakawa S, 2007, GENES CELLS, V12, P447, DOI 10.1111/j.1365-2443.2007.01063.x; Lamers Y, 2009, J NUTR, V139, P666, DOI 10.3945/jn.108.103580; MacFarlane AJ, 2008, J BIOL CHEM, V283, P25846, DOI 10.1074/jbc.M802671200; MacFarlane AJ, 2009, J BIOL CHEM, V284, P1533, DOI 10.1074/jbc.M808281200; MEJIA NR, 1988, BIOCHEM BIOPH RES CO, V155, P1, DOI 10.1016/S0006-291X(88)81040-4; MEJIA NR, 1986, J BIOL CHEM, V261, P9509; MEJIA NR, 1985, J BIOL CHEM, V260, P4616; Parle-McDermott A, 2009, HUM MUTAT, V30, P1650, DOI 10.1002/humu.21109; Pasternack LB, 1996, ARCH BIOCHEM BIOPHYS, V326, P158, DOI 10.1006/abbi.1996.0060; PASTERNACK LB, 1994, BIOCHEMISTRY-US, V33, P74, DOI 10.1021/bi00167a010; Patel H, 2005, ARCH BIOCHEM BIOPHYS, V442, P133, DOI 10.1016/j.abb.2005.07.022; Patel H, 2003, J BIOL CHEM, V278, P19436, DOI 10.1074/jbc.M301718200; PAUKERT JL, 1977, BIOCHEM BIOPH RES CO, V77, P147, DOI 10.1016/S0006-291X(77)80176-9; Prasannan P, 2003, J BIOL CHEM, V278, P43178, DOI 10.1074/jbc.M304319200; Prasannan P, 2009, ARCH BIOCHEM BIOPHYS, V481, P86, DOI 10.1016/j.abb.2008.10.028; Quinlivan EP, 2005, J NUTR, V135, P389, DOI 10.1093/jn/135.3.389; SCHIRCH L, 1978, ARCH BIOCHEM BIOPHYS, V189, P283, DOI 10.1016/0003-9861(78)90214-X; Sies H., 1982, METABOLIC COMPARTMEN, P205; SMITH GK, 1980, BIOCHEMISTRY-US, V19, P4313, DOI 10.1021/bi00559a026; Spiegelstein O, 2004, DEV DYNAM, V231, P221, DOI 10.1002/dvdy.20107; STORCH KJ, 1988, AM J PHYSIOL, V255, pE322, DOI 10.1152/ajpendo.1988.255.3.E322; Sugiura T, 2004, BIOCHEM BIOPH RES CO, V315, P204, DOI 10.1016/j.bbrc.2004.01.035; THIGPEN AE, 1990, J BIOL CHEM, V265, P7907; VATANKHAH M, 1994, BIOL MASS SPECTROM, V23, P277, DOI 10.1002/bms.1200230507; Veech R. L., 1987, PYRIDINE NUCLEOTIDE, P79; Walkup AS, 2005, ARCH BIOCHEM BIOPHYS, V442, P196, DOI 10.1016/j.abb.2005.08.007; West MG, 1996, BIOCHEMISTRY-US, V35, P3122, DOI 10.1021/bi952713d; Woeller CF, 2007, J BIOL CHEM, V282, P17623, DOI 10.1074/jbc.M702526200	58	93	94	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4612	4620		10.1074/jbc.M109.079855	http://dx.doi.org/10.1074/jbc.M109.079855			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	19948730	Green Published, hybrid			2022-12-25	WOS:000275274800039
J	Ishikawa, HO; Ayukawa, T; Nakayama, M; Higashi, S; Kamiyama, S; Nishihara, S; Aoki, K; Ishida, N; Sanai, Y; Matsuno, K				Ishikawa, Hiroyuki O.; Ayukawa, Tomonori; Nakayama, Minoru; Higashi, Shunsuke; Kamiyama, Shin; Nishihara, Shoko; Aoki, Kazuhisa; Ishida, Nobuhiro; Sanai, Yutaka; Matsuno, Kenji			Two Pathways for Importing GDP-fucose into the Endoplasmic Reticulum Lumen Function Redundantly in the O-Fucosylation of Notch in Drosophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE SUGAR TRANSPORTERS; DEFICIENCY TYPE-II; CONGENITAL DISORDER; MOLECULAR-CLONING; GLYCOSYLATION; GENE; CELL; GLYCOSYLTRANSFERASE; ENCODES; FRINGE	Notch is a transmembrane receptor that shares homology with proteins containing epidermal growth factor-like repeats and mediates the cell-cell interactions necessary for many cell fate decisions. In Drosophila, O-fucosyltransferase 1 catalyzes the O-fucosylation of these epidermal growth factor-like repeats. This O-fucose elongates, resulting in an O-linked tetrasaccharide that regulates the signaling activities of Notch. Fucosyltransferases utilize GDP-fucose, which is synthesized in the cytosol, but fucosylation occurs in the lumen of the endoplasmic reticulum (ER) and Golgi. Therefore, GDP-fucose uptake into the ER and Golgi is essential for fucosylation. However, although GDP-fucose biosynthesis is well understood, the mechanisms and intracellular routes of GDP-fucose transportation remain unclear. Our previous study on the Drosophila Golgi GDP-fucose transporter (Gfr), which specifically localizes to the Golgi, suggested that another GDP-fucose transporter(s) exists in Drosophila. Here, we identified Efr (ER GDP-fucose transporter), a GDP-fucose transporter that localizes specifically to the ER. Efr is a multifunctional nucleotide sugar transporter involved in the biosynthesis of heparan sulfate-glycosaminoglycan chains and the O-fucosylation of Notch. Comparison of the fucosylation defects in the N-glycans in Gfr and Efr mutants revealed that Gfr and Efr made distinct contributions to this modification; Gfr but not Efr was crucial for the fucosylation of N-glycans. We also found that Gfr and Efr function redundantly in the O-fucosylation of Notch, although they had different localizations and nucleotide sugar transportation specificities. These results indicate that two pathways for the nucleotide sugar supply, involving two nucleotide sugar transporters with distinct characteristics and distributions, contribute to the O-fucosylation of Notch.	[Ishikawa, Hiroyuki O.; Nakayama, Minoru; Matsuno, Kenji] Tokyo Univ Sci, Res Inst Sci & Technol, Genome & Drug Res Ctr, Chiba 2788510, Japan; [Ayukawa, Tomonori; Higashi, Shunsuke; Matsuno, Kenji] Tokyo Univ Sci, Dept Biol Sci & Technol, Chiba 2788510, Japan; [Kamiyama, Shin; Nishihara, Shoko] Soka Univ, Dept Bioinformat, Tokyo 1928577, Japan; [Aoki, Kazuhisa; Ishida, Nobuhiro; Sanai, Yutaka] Tokyo Metropolitan Inst Med Sci, Dept Biochem Cell Res, Bunkyo Ku, Tokyo 1138613, Japan	Tokyo University of Science; Tokyo University of Science; Soka University; Tokyo Metropolitan Institute of Medical Science	Matsuno, K (corresponding author), Tokyo Univ Sci, Res Inst Sci & Technol, Genome & Drug Res Ctr, 2641 Yamazaki, Chiba 2788510, Japan.	matsuno@rs.noda.tus.ac.jp		Nishihara, Shoko/0000-0002-1668-2603	Japanese Ministry of Education, Culture, Sports and Science; Proposal-oriented Research Promotion Program, Japan Science and Technology Agency	Japanese Ministry of Education, Culture, Sports and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Proposal-oriented Research Promotion Program, Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported by grants-in-aid from the Japanese Ministry of Education, Culture, Sports and Science (to K. M.) and grants from the Proposal-oriented Research Promotion Program, Japan Science and Technology Agency (to K. M.).	Acar M, 2008, CELL, V132, P247, DOI 10.1016/j.cell.2007.12.016; Aoki K, 2003, J BIOL CHEM, V278, P22887, DOI 10.1074/jbc.M302620200; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bakker H, 2005, GLYCOBIOLOGY, V15, P193, DOI 10.1093/glycob/cwh159; Becker DJ, 2003, GLYCOBIOLOGY, V13, p41R, DOI 10.1093/glycob/cwg054; Berninsone PM, 2000, CURR OPIN STRUC BIOL, V10, P542, DOI 10.1016/S0959-440X(00)00128-7; Bornemann DJ, 2004, DEVELOPMENT, V131, P1927, DOI 10.1242/dev.01061; Bruckner K, 2000, NATURE, V406, P411, DOI 10.1038/35019075; DAVID G, 1992, J CELL BIOL, V119, P961, DOI 10.1083/jcb.119.4.961; DECELIS JF, 1994, MECH DEVELOP, V46, P109, DOI 10.1016/0925-4773(94)90080-9; ETZIONI A, 1992, NEW ENGL J MED, V327, P1789, DOI 10.1056/NEJM199212173272505; Fiuza UM, 2007, J ENDOCRINOL, V194, P459, DOI 10.1677/JOE-07-0242; Gerardy-Schahn R, 2001, BIOCHIMIE, V83, P775, DOI 10.1016/S0300-9084(01)01322-0; Haltiwanger RS, 2002, BBA-GEN SUBJECTS, V1573, P328, DOI 10.1016/S0304-4165(02)00400-2; Han C, 2004, DEVELOPMENT, V131, P1563, DOI 10.1242/dev.01051; Hellbusch CC, 2007, J BIOL CHEM, V282, P10762, DOI 10.1074/jbc.M700314200; Hidalgo A, 2003, BLOOD, V101, P1705, DOI 10.1182/blood-2002-09-2840; Hirschberg CB, 2001, J CLIN INVEST, V108, P3; Ishida N, 2004, PFLUG ARCH EUR J PHY, V447, P768, DOI 10.1007/s00424-003-1093-0; Ishikawa HO, 2005, P NATL ACAD SCI USA, V102, P18532, DOI 10.1073/pnas.0504115102; KOCHIBE N, 1980, BIOCHEMISTRY-US, V19, P2841, DOI 10.1021/bi00554a004; KUROSAKA A, 1991, J BIOL CHEM, V266, P4168; Lin XH, 2000, MATRIX BIOL, V19, P303, DOI 10.1016/S0945-053X(00)00073-1; Lubke T, 2001, NAT GENET, V28, P73, DOI 10.1038/ng0501-73; Luhn K, 2004, EXP CELL RES, V301, P242, DOI 10.1016/j.yexcr.2004.08.043; Luhn K, 2001, NAT GENET, V28, P69, DOI 10.1038/ng0501-69; Luo Y, 2005, J BIOL CHEM, V280, P11289, DOI 10.1074/jbc.M414574200; Marquardt T, 1999, BLOOD, V94, P3976, DOI 10.1182/blood.V94.12.3976.424k06_3976_3985; Matsuno K, 2002, DEVELOPMENT, V129, P1049; Moloney DJ, 2000, J BIOL CHEM, V275, P9604, DOI 10.1074/jbc.275.13.9604; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; NAKATO H, 1995, DEVELOPMENT, V121, P3687; Okajima T, 2005, SCIENCE, V307, P1599, DOI 10.1126/science.1108995; Okajima T, 2002, CELL, V111, P893, DOI 10.1016/S0092-8674(02)01114-5; Okajima T, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-1; Persson U, 1998, FEBS LETT, V434, P83, DOI 10.1016/S0014-5793(98)00954-5; Roos C, 2002, J BIOL CHEM, V277, P3168, DOI 10.1074/jbc.m107927200; Sasamura T, 2003, DEVELOPMENT, V130, P4785, DOI 10.1242/dev.00679; Sasamura T, 2007, DEVELOPMENT, V134, P1347, DOI 10.1242/dev.02811; Selleck SB, 2001, SEMIN CELL DEV BIOL, V12, P127, DOI 10.1006/scdb.2000.0242; Smith PL, 2002, J CELL BIOL, V158, P801, DOI 10.1083/jcb.200203125; Sturla L, 2003, J BIOL CHEM, V278, P26727, DOI 10.1074/jbc.M304068200; Takei Y, 2004, DEVELOPMENT, V131, P73, DOI 10.1242/dev.00913; Tanimoto H, 2000, MOL CELL, V5, P59, DOI 10.1016/S1097-2765(00)80403-7; WILLIAMS JA, 1993, DEVELOPMENT, V117, P571; Yakubenia S, 2008, BLOOD, V112, P1472, DOI 10.1182/blood-2008-01-132035	47	36	38	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					4122	4129		10.1074/jbc.M109.016964	http://dx.doi.org/10.1074/jbc.M109.016964			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19948734	Green Published, hybrid			2022-12-25	WOS:000275254000064
J	Rahman, MA; Senga, T; Ito, S; Hyodo, T; Hasegawa, H; Hamaguchi, M				Rahman, Mohammad Aminur; Senga, Takeshi; Ito, Satoko; Hyodo, Toshinori; Hasegawa, Hitoki; Hamaguchi, Michinari			S-Nitrosylation at Cysteine 498 of c-Src Tyrosine Kinase Regulates Nitric Oxide-mediated Cell Invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLUSTER MOTIF; E-CADHERIN; CANCER; TRANSFORMATION; MEMBRANE; MYRISTYLATION; ACTIVATION; SYNTHASES; PROTEINS; RESIDUES	Nitric oxide (NO) plays a pivotal role in tumorigenesis, particularly with relation to cancer cell invasion and metastasis. NO can reversibly couple to cysteine thiols to form an S-nitrosothiol, which regulates the enzymatic activities of target proteins. c-Src is a tyrosine kinase that promotes cancer cell invasion and metastasis. Interestingly, c-Src can be activated by NO stimulation. However, mechanisms by which NO stimulates Src kinase activity have not been elucidated. We report here that NO causes S-nitrosylation of c-Src at cysteine 498 (Cys(498)) to stimulate its kinase activity. Cys(498) is conserved among Src family kinases, and Cys(506) of c-Yes, which corresponds to Cys(498) of c-Src, was also important for the NO-mediated activation of c-Yes. Estrogens may work synergistically with NO to induce the proliferation and migration of many kinds of breast cancer cells. For example, beta-estradiol induces the expression of endothelial nitric synthase and production of NO in MCF7 cells. We found that activation of c-Src in MCF7 cells by beta-estradiol stimulation was mediated by the S-nitrosylation of Cys(498). In addition, we report that disruption of E-cadherin junctions and enhancement of cell invasion by beta-estradiol stimulation was mediated by NO-dependent activation of c-Src. These results identify a novel signaling pathway that links NO and Src family kinases to cancer cell invasion and metastasis.	[Rahman, Mohammad Aminur; Senga, Takeshi; Ito, Satoko; Hyodo, Toshinori; Hasegawa, Hitoki; Hamaguchi, Michinari] Nagoya Univ, Sch Med, Div Canc Biol, Nagoya, Aichi 4668550, Japan	Nagoya University	Senga, T (corresponding author), Nagoya Univ, Sch Med, Div Canc Biol, Nagoya, Aichi 4668550, Japan.	tsenga@med.nagoya-u.ac.jp; mhamagu@med.nagoya-u.ac.jp		Hyodo, Toshinori/0000-0003-3046-5338	Ministry of Education, Science, Culture and Technology of Japan	Ministry of Education, Science, Culture and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the Ministry of Education, Science, Culture and Technology of Japan.	Akhand AK, 1999, J BIOL CHEM, V274, P25821, DOI 10.1074/jbc.274.36.25821; ALBINI A, 1986, P NATL ACAD SCI USA, V83, P8182, DOI 10.1073/pnas.83.21.8182; Brown MT, 1996, BBA-REV CANCER, V1287, P121, DOI 10.1016/0304-419X(96)00003-0; CARTWRIGHT CA, 1987, CELL, V49, P83, DOI 10.1016/0092-8674(87)90758-6; Chiarugi P, 2008, MOL CELLS, V26, P329; CROSS FR, 1984, MOL CELL BIOL, V4, P1834, DOI 10.1128/MCB.4.9.1834; Forrester MT, 2007, J BIOL CHEM, V282, P13977, DOI 10.1074/jbc.M609684200; Frame MC, 2002, BBA-REV CANCER, V1602, P114, DOI 10.1016/S0304-419X(02)00040-9; Frame MC, 2002, NAT REV MOL CELL BIO, V3, P233, DOI 10.1038/nrm779; Giannoni E, 2005, MOL CELL BIOL, V25, P6391, DOI 10.1128/MCB.25.15.6391-6403.2005; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; JOVE R, 1989, ONCOGENE RES, V5, P49; JOVE R, 1987, CELL, V50, P937, DOI 10.1016/0092-8674(87)90520-4; Kemble DJ, 2009, P NATL ACAD SCI USA, V106, P5070, DOI 10.1073/pnas.0806117106; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; Lim KH, 2008, NATURE, V452, P646, DOI 10.1038/nature06778; Loibl S, 2006, PATHOL RES PRACT, V202, P1, DOI 10.1016/j.prp.2005.10.003; Mayer BJ, 1998, CURR TOP MICROBIOL, V228, P1; NATHAN C, 1994, CELL, V78, P915, DOI 10.1016/0092-8674(94)90266-6; Oesterreich S, 2003, CANCER RES, V63, P5203; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Oo ML, 2003, ONCOGENE, V22, P1411, DOI 10.1038/sj.onc.1206286; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; PELLMAN D, 1985, NATURE, V314, P374, DOI 10.1038/314374a0; Rahman MA, 2008, ONCOL REP, V19, P975; Senga T, 2000, ONCOGENE, V19, P273, DOI 10.1038/sj.onc.1203296; Senga T, 2008, CANCER SCI, V99, P571, DOI 10.1111/j.1349-7006.2007.00714.x; STAMLER JS, 1992, P NATL ACAD SCI USA, V89, P444, DOI 10.1073/pnas.89.1.444; STAMLER JS, 1992, P NATL ACAD SCI USA, V89, P7674, DOI 10.1073/pnas.89.16.7674; Stamler JS, 2001, CELL, V106, P675, DOI 10.1016/S0092-8674(01)00495-0; STAMLER JS, 1992, SCIENCE, V258, P1898, DOI 10.1126/science.1281928; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Ying L, 2005, CANCER RES, V65, P9132, DOI 10.1158/0008-5472.CAN-05-1358	34	85	88	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3806	3814		10.1074/jbc.M109.059782	http://dx.doi.org/10.1074/jbc.M109.059782			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19948721	Green Published, hybrid			2022-12-25	WOS:000275254000033
J	Haque, F; Mazzeo, D; Patel, JT; Smallwood, DT; Ellis, JA; Shanahan, CM; Shackleton, S				Haque, Farhana; Mazzeo, Daniela; Patel, Jennifer T.; Smallwood, Dawn T.; Ellis, Juliet A.; Shanahan, Catherine M.; Shackleton, Sue			Mammalian SUN Protein Interaction Networks at the Inner Nuclear Membrane and Their Role in Laminopathy Disease Processes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DREIFUSS-MUSCULAR-DYSTROPHY; GILFORD-PROGERIA-SYNDROME; LAMIN-A; ACTIN CYTOSKELETON; TRANSMEMBRANE PROTEIN; PARTIAL LIPODYSTROPHY; MECHANICAL STIFFNESS; ENVELOPE INTEGRITY; SKELETAL-MUSCLE; IN-VITRO	The nuclear envelope (NE) LINC complex, in mammals comprised of SUN domain and nesprin proteins, provides a direct connection between the nuclear lamina and the cytoskeleton, which contributes to nuclear positioning and cellular rigidity. SUN1 and SUN2 interact with lamin A, but lamin A is only required for NE localization of SUN2, and it remains unclear how SUN1 is anchored. Here, we identify emerin and short nesprin-2 isoforms as novel nucleoplasmic binding partners of SUN1/2. These have overlapping binding sites distinct from the lamin A binding site. However, we demonstrate that tight association of SUN1 with the nuclear lamina depends upon a short motif within residues 209-228, a region that does not interact significantly with known SUN1 binding partners. Moreover, SUN1 localizes correctly in cells lacking emerin. Importantly then, the major determinant of SUN1 NE localization has yet to be identified. We further find that a subset of lamin A mutations, associated with laminopathies Emery-Dreifuss muscular dystrophy (EDMD) and Hutchinson-Gilford progeria syndrome (HGPS), disrupt lamin A interaction with SUN1 and SUN2. Despite this, NE localization of SUN1 and SUN2 is not impaired in cell lines from either class of patients. Intriguingly, SUN1 expression at the NE is instead enhanced in a significant proportion of HGPS but not EDMD cells and strongly correlates with pre-lamin A accumulation due to preferential interaction of SUN1 with pre-lamin A. We propose that these different perturbations in lamin A-SUN protein interactions may underlie the opposing effects of EDMD and HGPS mutations on nuclear and cellular mechanics.	[Haque, Farhana; Mazzeo, Daniela; Patel, Jennifer T.; Smallwood, Dawn T.; Shackleton, Sue] Univ Leicester, Dept Biochem, Leicester LE1 9HN, Leics, England; [Ellis, Juliet A.] Kings Coll London, Randall Div Cell & Mol Biophys, London SE1 1UL, England; [Shanahan, Catherine M.] Kings Coll London, James Black Ctr, Div Cardiovasc, London SE5 9NU, England	University of Leicester; University of London; King's College London; University of London; King's College London	Shackleton, S (corresponding author), Univ Leicester, Dept Biochem, Henry Wellcome Bldg, Leicester LE1 9HN, Leics, England.	ss115@le.ac.uk		Patel, Jennifer/0000-0002-5378-035X; Shanahan, Catherine/0000-0002-8352-8171	Wellcome Trust; British Heart Foundation; Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom; British Heart Foundation [RG/09/008/27923] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); British Heart Foundation(British Heart Foundation); Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation)	This work was funded by Wellcome Trust and British Heart Foundation grants (to S. S.) and a Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom studentship awarded (to J. T. P.).	Agarwal AK, 2003, HUM MOL GENET, V12, P1995, DOI 10.1093/hmg/ddg213; Apel ED, 2000, J BIOL CHEM, V275, P31986, DOI 10.1074/jbc.M004775200; BIONE S, 1994, NAT GENET, V8, P323, DOI 10.1038/ng1294-323; Broers JLV, 2004, HUM MOL GENET, V13, P2567, DOI 10.1093/hmg/ddh295; Cartegni L, 1997, HUM MOL GENET, V6, P2257, DOI 10.1093/hmg/6.13.2257; Chi YH, 2007, J BIOL CHEM, V282, P27447, DOI 10.1074/jbc.M703098200; Chikashige Y, 2006, CELL, V125, P59, DOI 10.1016/j.cell.2006.01.048; Clements L, 2000, BIOCHEM BIOPH RES CO, V267, P709, DOI 10.1006/bbrc.1999.2023; Crisp M, 2006, J CELL BIOL, V172, P41, DOI 10.1083/jcb.200509124; Dahl KN, 2006, P NATL ACAD SCI USA, V103, P10271, DOI 10.1073/pnas.0601058103; Davies BSJ, 2009, ANNU REV GENOM HUM G, V10, P153, DOI 10.1146/annurev-genom-082908-150150; Denecke J, 2006, HUM MUTAT, V27, P524, DOI 10.1002/humu.20315; Dhe-Paganon S, 2002, J BIOL CHEM, V277, P17381, DOI 10.1074/jbc.C200038200; Ding X, 2007, DEV CELL, V12, P863, DOI 10.1016/j.devcel.2007.03.018; Ellis JA, 1998, J CELL SCI, V111, P781; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Fukuchi K, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.014688; Gartenberg MR, 2009, GENE DEV, V23, P1027, DOI 10.1101/gad.1805309; Goldman RD, 2004, P NATL ACAD SCI USA, V101, P8963, DOI 10.1073/pnas.0402943101; HAGAN I, 1995, J CELL BIOL, V129, P1033, DOI 10.1083/jcb.129.4.1033; Haque F, 2006, MOL CELL BIOL, V26, P3738, DOI 10.1128/MCB.26.10.3738-3751.2006; Haraguchi T, 2004, EUR J BIOCHEM, V271, P1035, DOI 10.1111/j.1432-1033.2004.04007.x; Hodzic DM, 2004, J BIOL CHEM, V279, P25805, DOI 10.1074/jbc.M313157200; Holaska JM, 2004, PLOS BIOL, V2, P1354, DOI 10.1371/journal.pbio.0020231; Holt I, 2003, J CELL SCI, V116, P3027, DOI 10.1242/jcs.00599; Houben F, 2007, BBA-MOL CELL RES, V1773, P675, DOI 10.1016/j.bbamcr.2006.09.018; Hutchison CJ, 2001, J CELL SCI, V114, P9; Kandert S, 2007, HUM MOL GENET, V16, P2944, DOI 10.1093/hmg/ddm255; Krimm I, 2002, STRUCTURE, V10, P811, DOI 10.1016/S0969-2126(02)00777-3; Lammerding J, 2005, J CELL BIOL, V170, P781, DOI 10.1083/jcb.200502148; Lammerding J, 2004, J CLIN INVEST, V113, P370, DOI 10.1172/JCI200419670; Lei K, 2009, P NATL ACAD SCI USA, V106, P10207, DOI 10.1073/pnas.0812037106; Libotte T, 2005, MOL BIOL CELL, V16, P3411, DOI 10.1091/mbc.E04-11-1009; Lloyd DJ, 2002, HUM MOL GENET, V11, P769, DOI 10.1093/hmg/11.7.769; Malone CJ, 1999, DEVELOPMENT, V126, P3171; Mislow JMK, 2002, FEBS LETT, V525, P135, DOI 10.1016/S0014-5793(02)03105-8; Mislow JMK, 2002, J CELL SCI, V115, P61; Motsch I, 2005, EUR J CELL BIOL, V84, P765, DOI 10.1016/j.ejcb.2005.04.004; Muchir A, 2007, CURR NEUROL NEUROSCI, V7, P78, DOI 10.1007/s11910-007-0025-3; Navarro CL, 2005, HUM MOL GENET, V14, P1503, DOI 10.1093/hmg/ddi159; Ostlund C, 1999, J CELL SCI, V112, P1709; Oza P, 2009, GENE DEV, V23, P912, DOI 10.1101/gad.1782209; Padmakumar VC, 2005, J CELL SCI, V118, P3419, DOI 10.1242/jcs.02471; Padmakumar VC, 2004, EXP CELL RES, V295, P330, DOI 10.1016/j.yexcr.2004.01.014; Razafsky D, 2009, J CELL BIOL, V186, P461, DOI 10.1083/jcb.200906068; Salpingidou G, 2007, J CELL BIOL, V178, P897, DOI 10.1083/jcb.200702026; Schmitt J, 2007, P NATL ACAD SCI USA, V104, P7426, DOI 10.1073/pnas.0609198104; Schober H, 2009, GENE DEV, V23, P928, DOI 10.1101/gad.1787509; Shackleton S, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.029751; Starr DA, 2003, J CELL SCI, V116, P211, DOI 10.1242/jcs.00248; Starr DA, 2002, SCIENCE, V298, P406, DOI 10.1126/science.1075119; Stewart-Hutchinson PJ, 2008, EXP CELL RES, V314, P1892, DOI 10.1016/j.yexcr.2008.02.022; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; Talkop UA, 2002, NEUROMUSCULAR DISORD, V12, P878, DOI 10.1016/S0960-8966(02)00134-7; Verstraeten VLRM, 2008, AGING CELL, V7, P383, DOI 10.1111/j.1474-9726.2008.00382.x; Wheeler MA, 2007, EXP CELL RES, V313, P2845, DOI 10.1016/j.yexcr.2007.03.025; Wilhelmsen K, 2005, J CELL BIOL, V171, P799, DOI 10.1083/jcb.200506083; Wilkinson FL, 2003, EUR J BIOCHEM, V270, P2459, DOI 10.1046/j.1432-1033.2003.03617.x; Worman HJ, 2007, EXP CELL RES, V313, P2121, DOI 10.1016/j.yexcr.2007.03.028; Xiong HJ, 2008, TRAFFIC, V9, P708, DOI 10.1111/j.1600-0854.2008.00721.x; Zhang QP, 2007, HUM MOL GENET, V16, P2816, DOI 10.1093/hmg/ddm238; Zhang QP, 2005, J CELL SCI, V118, P673, DOI 10.1242/jcs.01642; Zhang QP, 2002, GENOMICS, V80, P473, DOI 10.1006/geno.2002.6859; Zhang QP, 2001, J CELL SCI, V114, P4485; Zhang XC, 2007, DEVELOPMENT, V134, P901, DOI 10.1242/dev.02783; Zhen YY, 2002, J CELL SCI, V115, P3207	66	189	204	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5					3487	3498		10.1074/jbc.M109.071910	http://dx.doi.org/10.1074/jbc.M109.071910			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19933576	Green Published, hybrid			2022-12-25	WOS:000273829000063
J	McGuire, RM; Liu, HY; Pereira, FA; Raphael, RM				McGuire, Ryan M.; Liu, Haiying; Pereira, Fred A.; Raphael, Robert M.			Cysteine Mutagenesis Reveals Transmembrane Residues Associated with Charge Translocation in Prestin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER HAIR CELL; MOTOR PROTEIN PRESTIN; COCHLEAR AMPLIFIER; PLASMA-MEMBRANE; GENE FAMILY; ELECTROMOTILITY; LOCALIZATION; CHOLESTEROL; CAPACITANCE; INHIBITION	The solute carrier transmembrane protein prestin (SLC26A5) drives an active electromechanical transduction process in cochlear outer hair cells that increases hearing sensitivity and frequency discrimination in mammals. A large intramembraneous charge movement, the nonlinear capacitance (NLC), is the electrical signature of prestin function. The transmembrane domain (TMD) helices and residues involved in the intramembrane charge displacement remain unknown. We have performed cysteine-scanning mutagenesis with serine or valine replacement to investigate the importance of cysteine residues to prestin structure and function. The distribution of oligomeric states and membrane abundance of prestin was also probed to investigate whether cysteine residues participate in prestin oligomerization and/or NLC. Our results reveal that 1) Cys-196 (TMD 4) and Cys-415 (TMD 10) do not tolerate serine replacement, and thus maintaining hydrophobicity at these locations is important for the mechanism of charge movement; 2) Cys-260 (TMD 6) and Cys-381 (TMD 9) tolerate serine replacement and are probably water-exposed; and 3) if disulfide bonds are present, they do not serve a functional role as measured via NLC. These novel findings are consistent with a recent structural model, which proposes that prestin contains an occluded aqueous pore, and we posit that the orientations of transmembrane domain helices 4 and 10 are essential for proper prestin function.	[Liu, Haiying; Pereira, Fred A.] Baylor Coll Med, Huffington Ctr Aging, Dept Otolaryngol Head & Neck Surg, Houston, TX 77030 USA; [Liu, Haiying; Pereira, Fred A.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Rice Univ, Dept Bioengn, Houston, TX 77005 USA	Baylor College of Medicine; Baylor College of Medicine; Rice University	Pereira, FA (corresponding author), Baylor Coll Med, Huffington Ctr Aging, Dept Otolaryngol Head & Neck Surg, 1 Baylor Plaza, Houston, TX 77030 USA.	fpereira@bcm.edu; rraphael@rice.edu		Pereira, Fred/0000-0003-2100-0280	National Institutes of Health; NIDCD [R01 DC009622, DC00354]; National Institutes of Health, NIDCD [R21 DC008134]; National Science Foundation [044379]; National Science Foundation Major Research Instrumentation [BES 0321275]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F32DC000354, R01DC009622, R21DC008134, R01DC000354] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Institutes of Health, NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Science Foundation(National Science Foundation (NSF)); National Science Foundation Major Research Instrumentation(National Science Foundation (NSF)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health, NIDCD, Grants R01 DC009622 (to R.M.R. and F.A.P.) and DC00354 (to F.A.P.) and National Institutes of Health, NIDCD, Grant R21 DC008134 (to R.M.R. and F.A.P.). This work was also supported by National Science Foundation Career Award BES 044379 (to R.M.R.) and National Science Foundation Major Research Instrumentation Grant BES 0321275 (to R.M.R.).	Ashmore J F, 1990, Neurosci Res Suppl, V12, pS39, DOI 10.1016/0921-8696(90)90007-P; BORDO D, 1991, J MOL BIOL, V217, P721, DOI 10.1016/0022-2836(91)90528-E; BROWNELL WE, 1985, SCIENCE, V227, P194, DOI 10.1126/science.3966153; Brownell WE, 2001, ANNU REV BIOMED ENG, V3, P169, DOI 10.1146/annurev.bioeng.3.1.169; Dallos P, 2006, J PHYSIOL-LONDON, V576, P37, DOI 10.1113/jphysiol.2006.114652; Deak L, 2005, J PHYSIOL-LONDON, V563, P483, DOI 10.1113/jphysiol.2004.078857; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Fakler B, 2003, BIOPHYSICS OF THE COCHLEA: FROM MOLECULES TO MODELS, P110, DOI 10.1142/9789812704931_0014; Greeson JN, 2009, BIOPHYS J, V96, P510, DOI 10.1016/j.bpj.2008.09.016; KALINEC F, 1993, NEUROSCI LETT, V157, P231, DOI 10.1016/0304-3940(93)90744-6; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Liberman MC, 2002, NATURE, V419, P300, DOI 10.1038/nature01059; LINDAU M, 1988, PFLUG ARCH EUR J PHY, V411, P137, DOI 10.1007/BF00582306; Matsuda K, 2004, J NEUROCHEM, V89, P928, DOI 10.1111/j.1471-4159.2004.02377.x; MCGUIRE RM, 2006, ASS RES OT ABS, P125; Mio K, 2008, J BIOL CHEM, V283, P1137, DOI 10.1074/jbc.M702681200; Moseley RH, 1999, AM J PHYSIOL-GASTR L, V276, pG185, DOI 10.1152/ajpgi.1999.276.1.G185; Mount DB, 2004, PFLUG ARCH EUR J PHY, V447, P710, DOI 10.1007/s00424-003-1090-3; Navaratnam D, 2005, BIOPHYS J, V89, P3345, DOI 10.1529/biophysj.105.068759; Oliver D, 2001, SCIENCE, V292, P2340, DOI 10.1126/science.1060939; Oliver D, 1999, J PHYSIOL-LONDON, V519, P791, DOI 10.1111/j.1469-7793.1999.0791n.x; Organ LE, 2009, JARO-J ASSOC RES OTO, V10, P383, DOI 10.1007/s10162-009-0171-1; Rajagopalan L, 2007, J BIOL CHEM, V282, P36659, DOI 10.1074/jbc.M705078200; Rajagopalan L, 2006, J NEUROSCI, V26, P12727, DOI 10.1523/JNEUROSCI.2734-06.2006; Rotman-Pikielny P, 2002, HUM MOL GENET, V11, P2625, DOI 10.1093/hmg/11.21.2625; Rybalchenko V, 2003, J PHYSIOL-LONDON, V547, P873, DOI 10.1113/jphysiol.2002.036434; Rybalchenko V, 2008, BIOPHYS J, V95, P4439, DOI 10.1529/biophysj.108.134197; Saier MH, 1999, BBA-REV BIOMEMBRANES, V1422, P1, DOI 10.1016/S0304-4157(98)00023-9; Santos-Sacchi J, 2006, J NEUROSCI, V26, P3992, DOI 10.1523/JNEUROSCI.4548-05.2006; Santos-Sacchi J, 2004, J MEMBRANE BIOL, V200, P83, DOI 10.1007/s00232-004-0699-2; SANTOS-SACCHI J, 1991, J NEUROSCI, V11, P3096, DOI 10.1523/jneurosci.11-10-03096.1991; Sfondouris J, 2008, J BIOL CHEM, V283, P22473, DOI 10.1074/jbc.M803722200; Sturm AK, 2007, OTOLARYNG HEAD NECK, V136, P434, DOI 10.1016/j.otohns.2006.10.030; Thomas Philip, 2005, Journal of Pharmacological and Toxicological Methods, V51, P187, DOI 10.1016/j.vascn.2004.08.014; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Waldegger S, 2001, GENOMICS, V72, P43, DOI 10.1006/geno.2000.6445; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Zacharias D. A., 2002, SCI STKE, V2002, ppe23; Zheng J, 2001, NEUROREPORT, V12, P1929, DOI 10.1097/00001756-200107030-00032; Zheng J, 2006, J BIOL CHEM, V281, P19916, DOI 10.1074/jbc.M513854200	40	9	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5					3103	3113		10.1074/jbc.M109.053249	http://dx.doi.org/10.1074/jbc.M109.053249			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19926791	Green Published, hybrid			2022-12-25	WOS:000273829000026
J	Song, YH; Ahn, SH				Song, Young-Ha; Ahn, Seong Hoon			A Bre1-associated Protein, Large 1 (Lge1), Promotes H2B Ubiquitylation during the Early Stages of Transcription Elongation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATES H3 METHYLATION; HISTONE H2B; SACCHAROMYCES-CEREVISIAE; SYSTEMATIC IDENTIFICATION; UBIQUITINATION; SAGA; MONOUBIQUITINATION; ASSOCIATION; RECRUITMENT; ACTIVATION	Transcription activation has been proposed to require both ubiquitylation and deubiquitylation of histone H2B. Here, we show that Lge1 (Large 1) is found in a complex containing Rad6.Bre1 and that it controls the recruitment of Bre1, a ubiquitin ligase, and Ubp8, a deubiquitylase, to promote ubiquitylation during the early steps in elongation. Chromatin immuno-precipitation experiments showed that Lge1 associates with promoter and coding regions of actively transcribed genes in a transcription-dependent manner. Disruption of Lge1 abolished ubiquitylation of histone H2B on lysine 123 and H3 methylation on lysines 4 and 79 and resulted in significant sensitivity to 6-azauracil and mycophenolic acid. In particular, in Lge1-deficient cells, Bre1 recruitment was attenuated, whereas recruitment of Ubp8 was facilitated. These alterations were coincident with changes in the interaction between Bre1.Ubp8 and RNA polymerase II phosphorylated at serine 5 of the C-terminal domain. We propose that Lge1 has a novel function in disrupting the balance between the recruitment of Bre1 and Ubp8, thus promoting transcription elongation.	[Song, Young-Ha; Ahn, Seong Hoon] Hanyang Univ, Coll Sci & Technol, Div Mol & Life Sci, Ansan 426791, Gyeonggi Do, South Korea	Hanyang University	Ahn, SH (corresponding author), Hanyang Univ, Coll Sci & Technol, Div Mol & Life Sci, 1271 Sa 3 Dong, Ansan 426791, Gyeonggi Do, South Korea.	hoon320@hanyang.ac.kr		Ahn, Seong-Hoon/0000-0002-9174-4966	Korea Research Foundation [KRF-2007521-C00200]; Korea Science and Engineering Foundation [2009-0079344]; Korean government	Korea Research Foundation(National Research Foundation of Korea); Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); Korean government(Korean Government)	This work was supported by Korea Research Foundation Grant KRF-2007521-C00200 and by Korea Science and Engineering Foundation Grant 2009-0079344 funded by the Korean government (Ministry of Education, Science, and Technology) (to S.H.A.).	Ahn SH, 2009, EMBO J, V28, P205, DOI 10.1038/emboj.2008.280; Ahn SH, 2004, MOL CELL, V13, P67, DOI 10.1016/S1097-2765(03)00492-1; Barbaric S, 2001, EMBO J, V20, P4944, DOI 10.1093/emboj/20.17.4944; BRADBURY EM, 1992, BIOESSAYS, V14, P9; Braun MA, 2007, MOL CELL BIOL, V27, P2800, DOI 10.1128/MCB.01947-06; Briggs SD, 2002, NATURE, V418, P498, DOI 10.1038/nature00970; Cho EJ, 2001, GENE DEV, V15, P3319, DOI 10.1101/gad.935901; Daniel JA, 2004, J BIOL CHEM, V279, P1867, DOI 10.1074/jbc.C300494200; Dehe PM, 2005, J MOL BIOL, V353, P477, DOI 10.1016/j.jmb.2005.08.059; Dover J, 2002, J BIOL CHEM, V277, P28368, DOI 10.1074/jbc.C200348200; Emre NCT, 2005, MOL CELL, V17, P585, DOI 10.1016/j.molcel.2005.01.007; Foster ER, 2009, J CELL BIOL, V184, P631, DOI 10.1083/jcb.200812088; Game JC, 2006, GENETICS, V173, P1951, DOI 10.1534/genetics.106.057794; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Henry KW, 2003, GENE DEV, V17, P2648, DOI 10.1101/gad.1144003; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hwang WW, 2003, MOL CELL, V11, P261, DOI 10.1016/S1097-2765(02)00826-2; Ingvarsdottir K, 2005, MOL CELL BIOL, V25, P1162, DOI 10.1128/MCB.25.3.1162-1172.2005; Jorgensen P, 2002, SCIENCE, V297, P395, DOI 10.1126/science.1070850; Kao CF, 2004, GENE DEV, V18, P184, DOI 10.1101/gad.1149604; Kim M, 2004, EMBO J, V23, P354, DOI 10.1038/sj.emboj.7600053; Kim T, 2009, CELL, V137, P259, DOI 10.1016/j.cell.2009.02.045; Krogan NJ, 2003, MOL CELL BIOL, V23, P4207, DOI 10.1128/MCB.23.12.4207-4218.2003; Laribee RN, 2005, CURR BIOL, V15, P1487, DOI 10.1016/j.cub.2005.07.028; Lee JS, 2007, CELL, V131, P1084, DOI 10.1016/j.cell.2007.09.046; Lee KK, 2005, MOL CELL BIOL, V25, P1173, DOI 10.1128/MCB.25.3.1173-1182.2005; Lee TI, 2000, NATURE, V405, P701, DOI 10.1038/35015104; Ng HH, 2002, J BIOL CHEM, V277, P34655, DOI 10.1074/jbc.C200433200; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Panavas T, 2005, P NATL ACAD SCI USA, V102, P7326, DOI 10.1073/pnas.0502604102; Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501; Sanders SL, 2002, MOL CELL BIOL, V22, P4723, DOI 10.1128/MCB.22.13.4723-4738.2002; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Shukla A, 2006, MOL CELL BIOL, V26, P3339, DOI 10.1128/MCB.26.9.3339-3352.2006; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Weake VM, 2008, MOL CELL, V29, P653, DOI 10.1016/j.molcel.2008.02.014; Wood A, 2003, J BIOL CHEM, V278, P34739, DOI 10.1074/jbc.C300269200; Wood A, 2003, MOL CELL, V11, P267, DOI 10.1016/S1097-2765(02)00802-X; Wyce A, 2007, MOL CELL, V27, P275, DOI 10.1016/j.molcel.2007.01.035; Xiao TJ, 2005, MOL CELL BIOL, V25, P637, DOI 10.1128/MCB.25.2.637-651.2005; Xiao TJ, 2003, GENE DEV, V17, P654, DOI 10.1101/gad.1055503; Zhang XT, 2005, J BIOL CHEM, V280, P2759, DOI 10.1074/jbc.M408333200	43	35	35	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2361	2367		10.1074/jbc.M109.039255	http://dx.doi.org/10.1074/jbc.M109.039255			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19923226	hybrid, Green Published			2022-12-25	WOS:000273697800016
J	Salameh, MA; Robinson, JL; Navaneetham, D; Sinha, D; Madden, BJ; Walsh, PN; Radisky, ES				Salameh, Moh'd A.; Robinson, Jessica L.; Navaneetham, Duraiswamy; Sinha, Dipali; Madden, Benjamin J.; Walsh, Peter N.; Radisky, Evette S.			The Amyloid Precursor Protein/Protease Nexin 2 Kunitz Inhibitor Domain Is a Highly Specific Substrate of Mesotrypsin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-PROTEIN-PRECURSOR; HUMAN CATIONIC TRYPSINOGEN; COAGULATION-FACTOR-XIA; ALZHEIMERS-DISEASE; PLASMINOGEN-ACTIVATOR; CATALYTIC DOMAIN; MESSENGER-RNA; HUMAN BRAIN; CHYMOTRYPSIN INHIBITOR-2; CEREBRAL THROMBOSIS	The amyloid precursor protein (APP) is a ubiquitously expressed transmembrane adhesion protein and the progenitor of amyloid-beta peptides. The major splice isoforms of APP expressed by most tissues contain a Kunitz protease inhibitor domain; secreted APP containing this domain is also known as protease nexin 2 and potently inhibits serine proteases, including trypsin and coagulation factors. The atypical human trypsin isoform mesotrypsin is resistant to inhibition by most protein protease inhibitors and cleaves some inhibitors at a substantially accelerated rate. Here, in a proteomic screen to identify potential physiological substrates of mesotrypsin, we find that APP/protease nexin 2 is selectively cleaved by mesotrypsin within the Kunitz protease inhibitor domain. In studies employing the recombinant Kunitz domain of APP (APPI), we show that mesotrypsin cleaves selectively at the Arg15-Ala16 reactive site bond, with kinetic constants approaching those of other proteases toward highly specific protein substrates. Finally, we show that cleavage of APPI compromises its inhibition of other serine proteases, including cationic trypsin and factor XIa, by 2 orders of magnitude. Because APP/protease nexin 2 and mesotrypsin are coexpressed in a number of tissues, we suggest that processing by mesotrypsin may ablate the protease inhibitory function of APP/protease nexin 2 in vivo and may also modulate other activities of APP/protease nexin 2 that involve the Kunitz domain.	[Radisky, Evette S.] Mayo Clin, Ctr Canc, Dept Canc Biol, Jacksonville, FL 32224 USA; [Navaneetham, Duraiswamy; Sinha, Dipali; Walsh, Peter N.] Temple Univ, Sch Med, Dept Med, Sol Sherry Thrombosis Res Ctr, Philadelphia, PA 19140 USA; [Navaneetham, Duraiswamy; Sinha, Dipali; Walsh, Peter N.] Temple Univ, Sch Med, Dept Biochem, Philadelphia, PA 19140 USA; [Madden, Benjamin J.] Mayo Clin, Mayo Prote Res Ctr, Rochester, MN 55905 USA	Mayo Clinic; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Mayo Clinic	Radisky, ES (corresponding author), 310 Griffin Bldg,4500 San Pablo Rd, Jacksonville, FL 32224 USA.	radisky.evette@mayo.edu	Radisky, Evette S/C-8526-2012; Paditz, Ekkehart/F-5351-2015	Radisky, Evette S/0000-0003-3121-109X; 	National Institutes of Health [P50 CA091956-08, HL74124, HL46213]; Bankhead-Coley Florida Biomedical Research Program [07BN-07]; NATIONAL CANCER INSTITUTE [P50CA091956] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL046213, P01HL074124] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bankhead-Coley Florida Biomedical Research Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants P50 CA091956-08 (to E. S. R.) and HL74124 and HL46213 (to P. N. W.). This work was also supported by Bankhead-Coley Florida Biomedical Research Program Award 07BN-07 (to E. S. R.).	Apostoluk W, 1998, PROTEINS, V32, P459, DOI 10.1002/(SICI)1097-0134(19980901)32:4<459::AID-PROT5>3.0.CO;2-B; Badellino KO, 2000, BIOCHEMISTRY-US, V39, P4769, DOI 10.1021/bi9925468; BODE W, 1992, EUR J BIOCHEM, V204, P433, DOI 10.1111/j.1432-1033.1992.tb16654.x; CHASE T, 1967, BIOCHEM BIOPH RES CO, V29, P508, DOI 10.1016/0006-291X(67)90513-X; Chen JM, 2000, PANCREAS, V21, P57, DOI 10.1097/00006676-200007000-00052; Cornish-Bowden A., 1995, FUNDAMENTALS ENZYME, P105; Dachsel JC, 2007, PARKINSONISM RELAT D, V13, P382, DOI 10.1016/j.parkreldis.2007.01.008; DELMAR EG, 1979, ANAL BIOCHEM, V99, P316, DOI 10.1016/S0003-2697(79)80013-5; Diederichs S, 2004, CANCER RES, V64, P5564, DOI 10.1158/0008-5472.CAN-04-2004; DING L, 1995, P NATL ACAD SCI USA, V92, P7627, DOI 10.1073/pnas.92.17.7627; Galliers B, 2001, J STRATEGIC INF SYST, V10, P1, DOI 10.1016/S0963-8687(01)00045-2; Ge XJ, 2005, GENOMICS, V86, P127, DOI 10.1016/j.ygeno.2005.04.008; GOLDE TE, 1990, NEURON, V4, P253, DOI 10.1016/0896-6273(90)90100-T; Golde Todd E., 2006, Current Alzheimer Research, V3, P421, DOI 10.2174/156720506779025189; Gralle M, 2006, J MOL BIOL, V357, P493, DOI 10.1016/j.jmb.2005.12.053; Gralle M, 2007, PROG NEUROBIOL, V82, P11, DOI 10.1016/j.pneurobio.2007.02.001; Grishina Z, 2005, BRIT J PHARMACOL, V146, P990, DOI 10.1038/sj.bjp.0706410; HUBBARD SJ, 1991, J MOL BIOL, V220, P507, DOI 10.1016/0022-2836(91)90027-4; ITOH H, 1991, INT J CANCER, V49, P436, DOI 10.1002/ijc.2910490322; Jacobsen KT, 2009, CELL MOL LIFE SCI, V66, P2299, DOI 10.1007/s00018-009-0020-8; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; KATAOKA H, 1995, INT J CANCER, V60, P123, DOI 10.1002/ijc.2910600118; Katona G, 2002, J MOL BIOL, V315, P1209, DOI 10.1006/jmbi.2001.5305; KITAGUCHI N, 1990, BIOCHIM BIOPHYS ACTA, V1038, P105, DOI 10.1016/0167-4838(90)90017-A; Knecht W, 2007, J BIOL CHEM, V282, P26089, DOI 10.1074/jbc.M703840200; KOUNNAS MZ, 1995, CELL, V82, P331, DOI 10.1016/0092-8674(95)90320-8; Krowarsch D, 2003, CELL MOL LIFE SCI, V60, P2427, DOI 10.1007/s00018-003-3120-x; Lamba D, 1996, J MOL BIOL, V258, P117, DOI 10.1006/jmbi.1996.0238; LASKOWSKI M, 1980, ANNU REV BIOCHEM, V49, P593, DOI 10.1146/annurev.bi.49.070180.003113; LIJNEN HR, 1984, EUR J BIOCHEM, V144, P541, DOI 10.1111/j.1432-1033.1984.tb08499.x; LONGSTAFF C, 1990, BIOCHEMISTRY-US, V29, P7339, DOI 10.1021/bi00483a025; MADISON EL, 1995, J BIOL CHEM, V270, P7558, DOI 10.1074/jbc.270.13.7558; Navaneetham D, 2005, J BIOL CHEM, V280, P36165, DOI 10.1074/jbc.M504990200; Nemeth AL, 2007, FEBS J, V274, P1610, DOI 10.1111/j.1742-4658.2007.05708.x; Nemoda Z, 2005, J BIOL CHEM, V280, P29645, DOI 10.1074/jbc.M505661200; Nierodzik ML, 2006, CANCER CELL, V10, P355, DOI 10.1016/j.ccr.2006.10.002; PERONA JJ, 1993, J MOL BIOL, V230, P919, DOI 10.1006/jmbi.1993.1210; PONTE P, 1988, NATURE, V331, P525, DOI 10.1038/331525a0; QIU WQ, 1995, J NEUROSCI, V15, P2157, DOI 10.1523/JNEUROSCI.15-03-02157.1995; Radisky ES, 2003, BIOCHEMISTRY-US, V42, P6484, DOI 10.1021/bi034275d; Rawlings ND, 2004, BIOCHEM J, V378, P705, DOI 10.1042/BJ20031825; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; Ruf W, 2006, SEMIN THROMB HEMOST, V32, P61, DOI 10.1055/s-2006-939555; Sahin-Toth M, 2000, J BIOL CHEM, V275, P22750, DOI 10.1074/jbc.M002943200; Salameh MA, 2008, J BIOL CHEM, V283, P4115, DOI 10.1074/jbc.M708268200; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P379; Scheidig AJ, 1997, PROTEIN SCI, V6, P1806, DOI 10.1002/pro.5560060902; Schmitz A, 2002, HISTOCHEM CELL BIOL, V117, P171, DOI 10.1007/s00418-001-0351-5; Seguchi K, 1999, BIOL CHEM, V380, P473, DOI 10.1515/BC.1999.061; SMITH RP, 1990, SCIENCE, V248, P1126, DOI 10.1126/science.2111585; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Szmola R, 2003, J BIOL CHEM, V278, P48580, DOI 10.1074/jbc.M310301200; Takayama KI, 2009, CANCER RES, V69, P137, DOI 10.1158/0008-5472.CAN-08-3633; TANZI RE, 1988, NATURE, V331, P528, DOI 10.1038/331528a0; Timmer JC, 2009, NAT STRUCT MOL BIOL, V16, P1101, DOI 10.1038/nsmb.1668; Toth J, 2007, NEUROCHEM RES, V32, P1423, DOI 10.1007/s11064-007-9327-8; VANNOSTRAND WE, 1994, BBA-PROTEIN STRUCT M, V1209, P165, DOI 10.1016/0167-4838(94)90180-5; VANNOSTRAND WE, 1990, J BIOL CHEM, V265, P9591; Walsh P, 2006, HEMOSTASIS THROMBOSI, P221; Wang YF, 2006, J NEUROCHEM, V99, P759, DOI 10.1111/j.1471-4159.2006.04105.x; Webber MM, 2001, PROSTATE, V47, P1; WIEGAND U, 1993, GENE, V136, P167, DOI 10.1016/0378-1119(93)90460-K; WRIGHT HT, 1977, EUR J BIOCHEM, V73, P567, DOI 10.1111/j.1432-1033.1977.tb11352.x; Xu F, 2005, P NATL ACAD SCI USA, V102, P18135, DOI 10.1073/pnas.0507798102; Xu F, 2007, STROKE, V38, P2598, DOI 10.1161/STROKEAHA.106.480103; Xu F, 2009, J NEUROSCI, V29, P5666, DOI 10.1523/JNEUROSCI.0095-09.2009; Yanai I, 2005, BIOINFORMATICS, V21, P650, DOI 10.1093/bioinformatics/bti042; Yang L, 2008, J BIOL CHEM, V283, P35295, DOI 10.1074/jbc.M806965200	68	30	31	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2010	285	3					1939	1949		10.1074/jbc.M109.057216	http://dx.doi.org/10.1074/jbc.M109.057216			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	541PJ	19920152	Green Published, hybrid			2022-12-25	WOS:000273429100040
J	Kusi, KA; Faber, BW; Thomas, AW; Remarque, EJ				Kusi, Kwadwo A.; Faber, Bart W.; Thomas, Alan W.; Remarque, Edmond J.			Humoral Immune Response to Mixed PfAMA1 Alleles; Multivalent PfAMA1 Vaccines Induce Broad Specificity	PLOS ONE			English	Article							APICAL MEMBRANE ANTIGEN-1; PLASMODIUM-FALCIPARUM APICAL-MEMBRANE-ANTIGEN-1; MALARIA VACCINE; PASSIVE-IMMUNIZATION; PROTECTS MICE; IN-VITRO; ANTIBODIES; CANDIDATE; INVASION; AMA1	Apical Membrane Antigen 1 (AMA1), a merozoite protein essential for red cell invasion, is a candidate malaria vaccine component. Immune responses to AMA1 can protect in experimental animal models and antibodies isolated from AMA1-vaccinated or malaria-exposed humans can inhibit parasite multiplication in vitro. The parasite is haploid in the vertebrate host and the genome contains a single copy of AMA1, yet on a population basis a number of AMA1 molecular surface residues are polymorphic, a property thought to be primarily as a result of selective immune pressure. After immunisation with AMA1, antibodies more effectively inhibit strains carrying homologous AMA1 genes, suggesting that polymorphism may compromise vaccine efficacy. Here, we analyse induction of broad strain inhibitory antibodies with a multi-allele Plasmodium falciparum AMA1 (PfAMA1) vaccine, and determine the relative importance of cross-reactive and strain-specific IgG fractions by competition ELISA and in vitro parasite growth inhibition assays. Immunisation of rabbits with a PfAMA1 allele mixture yielded an increased proportion of antibodies to epitopes common to all vaccine alleles, compared to single allele immunisation. Competition ELISA with the anti-PfAMA1 antibody fraction that is cross-reactive between FVO and 3D7 AMA1 alleles showed that over 80% of these common antibodies were shared with other PfAMA1 alleles. Furthermore, growth inhibition assays revealed that for any PfAMA1 allele (FVO or 3D7), the cross-reactive fraction alone, on basis of weight, had the same functional capacity on homologous parasites as the total affinity-purified IgGs (cross-reactive+strain-specific). By contrast, the strain-specific IgG fraction of either PfAMA1 allele showed slightly less inhibition of red cell invasion by homologous strains. Thus multi-allele immunisation relatively increases the levels of antibodies to common allele epitopes. This explains the broadened cross inhibition of diverse malaria parasites, and suggests multi-allele approaches warrant further clinical investigation.	[Kusi, Kwadwo A.; Faber, Bart W.; Thomas, Alan W.; Remarque, Edmond J.] Biomed Primate Res Ctr, Dept Parasitol, Rijswijk, Netherlands; [Kusi, Kwadwo A.] Univ Ghana, Coll Hlth Sci, Noguchi Mem Inst Med Res, Dept Immunol, Legon, Accra, Ghana	University of Ghana	Kusi, KA (corresponding author), Biomed Primate Res Ctr, Dept Parasitol, Rijswijk, Netherlands.	Thomas@bprc.nl	Kusi, Kwadwo Asamoah/J-5941-2019; Remarque, Ed/AAE-8643-2020; Remarque, Edmond J/B-2217-2010	Kusi, Kwadwo Asamoah/0000-0001-5483-9985; Faber, Bart/0000-0001-6808-1204	European Malaria Vaccine Initiative (EMVI) [5-2007]; European Malaria Vaccine Development Association (EMVDA) [LSHP-CT-2007-037506]; Ghana Education Trust	European Malaria Vaccine Initiative (EMVI); European Malaria Vaccine Development Association (EMVDA)(European Commission); Ghana Education Trust	This work was funded by the European Malaria Vaccine Initiative (EMVI), grant number 5-2007, and the European Malaria Vaccine Development Association (EMVDA), grant number LSHP-CT-2007-037506. KAK was also supported by the Ghana Education Trust Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders RF, 1998, VACCINE, V16, P240, DOI 10.1016/S0264-410X(97)88331-4; Bai T, 2005, P NATL ACAD SCI USA, V102, P12736, DOI 10.1073/pnas.0501808102; Barclay VC, 2008, VACCINE, V26, P6099, DOI 10.1016/j.vaccine.2008.09.004; Chesne-Seck ML, 2005, MOL BIOCHEM PARASIT, V144, P55, DOI 10.1016/j.molbiopara.2005.07.007; COLLINS WE, 1994, AM J TROP MED HYG, V51, P711, DOI 10.4269/ajtmh.1994.51.711; Cortes A, 2005, INFECT IMMUN, V73, P422, DOI 10.1128/IAI.73.1.422-430.2005; Crewther PE, 1996, INFECT IMMUN, V64, P3310, DOI 10.1128/IAI.64.8.3310-3317.1996; DEANS JA, 1982, CLIN EXP IMMUNOL, V49, P297; DEANS JA, 1988, PARASITE IMMUNOL, V10, P535, DOI 10.1111/j.1365-3024.1988.tb00241.x; Dicko A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001045; Dicko A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001563; Duan JH, 2008, P NATL ACAD SCI USA, V105, P7857, DOI 10.1073/pnas.0802328105; Dutta S, 2005, INFECT IMMUN, V73, P2116, DOI 10.1128/IAI.73.4.2116-2122.2005; Dutta S, 2003, P NATL ACAD SCI USA, V100, P12295, DOI 10.1073/pnas.2032858100; Dutta S, 2007, P NATL ACAD SCI USA, V104, P12488, DOI 10.1073/pnas.0701464104; Faber BW, 2007, INFECT IMMUN, V75, P5947, DOI 10.1128/IAI.01804-06; FABER BW, 2008, VACCINE; Good MF, 1998, ANNU REV IMMUNOL, V16, P57, DOI 10.1146/annurev.immunol.16.1.57; Healer J, 2002, INFECT IMMUN, V70, P5751, DOI 10.1128/IAI.70.10.5751-5758.2002; Healer J, 2004, MOL MICROBIOL, V52, P159, DOI 10.1111/j.1365-2958.2003.03974.x; Hodder AN, 2001, INFECT IMMUN, V69, P3286, DOI 10.1128/IAI.69.5.3286-3294.2001; Howell SA, 2005, MOL MICROBIOL, V57, P1342, DOI 10.1111/j.1365-2958.2005.04772.x; Kennedy MC, 2002, INFECT IMMUN, V70, P6948, DOI 10.1128/IAI.70.12.6948-6960.2002; Kocken CHM, 1998, J BIOL CHEM, V273, P15119, DOI 10.1074/jbc.273.24.15119; Kostolansky F, 2000, J GEN VIROL, V81, P1727, DOI 10.1099/0022-1317-81-7-1727; Malkin EM, 2005, INFECT IMMUN, V73, P3677, DOI 10.1128/IAI.73.6.3677-3685.2005; Mitchell GH, 2004, INFECT IMMUN, V72, P154, DOI 10.1128/IAI.72.1.154-158.2004; Miura K, 2007, INFECT IMMUN, V75, P5827, DOI 10.1128/IAI.00593-07; Narum DL, 2006, INFECT IMMUN, V74, P5529, DOI 10.1128/IAI.00573-06; Narum DL, 2000, INFECT IMMUN, V68, P2899, DOI 10.1128/IAI.68.5.2899-2906.2000; Pizarro JC, 2005, SCIENCE, V308, P408, DOI 10.1126/science.1107449; Polley SD, 2004, VACCINE, V23, P718, DOI 10.1016/j.vaccine.2004.05.031; Polley SD, 2001, GENETICS, V158, P1505; Remarque EJ, 2008, INFECT IMMUN, V76, P2660, DOI 10.1128/IAI.00170-08; Remarque EJ, 2008, TRENDS PARASITOL, V24, P74, DOI 10.1016/j.pt.2007.12.002; Stanley SL, 1998, LANCET, V352, P1163, DOI 10.1016/S0140-6736(05)60525-9; Targett GA, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S10; THOMAS AW, 1990, MOL BIOCHEM PARASIT, V42, P285, DOI 10.1016/0166-6851(90)90172-I; THOMAS AW, 1984, MOL BIOCHEM PARASIT, V13, P187, DOI 10.1016/0166-6851(84)90112-9; Treeck M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000322; WHO, 2008, WORLD HLTH REP 2008; ZAMAN S, 1993, ARCH DIS CHILD, V68, P198, DOI 10.1136/adc.68.2.198	42	61	61	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2009	4	12							e8110	10.1371/journal.pone.0008110	http://dx.doi.org/10.1371/journal.pone.0008110			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MT	19956619	Green Published, Green Submitted, gold			2022-12-25	WOS:000272828700021
J	Malakhova, M; Kurinov, I; Liu, KD; Zheng, D; D'Angelo, I; Shim, JH; Steinman, V; Bode, AM; Dong, ZG				Malakhova, Margarita; Kurinov, Igor; Liu, Kangdong; Zheng, Duo; D'Angelo, Igor; Shim, Jung-Hyun; Steinman, Valerie; Bode, Ann M.; Dong, Zigang			Structural Diversity of the Active N-Terminal Kinase Domain of p90 Ribosomal S6 Kinase 2	PLOS ONE			English	Article							CANCER-CELL-PROLIFERATION; PROTEIN-KINASE; CRYSTAL-STRUCTURE; DOCKING SITE; MOTIF PHOSPHORYLATION; HISTONE H3; AMP-PNP; C-SRC; ACTIVATION; IDENTIFICATION	The p90 ribosomal protein kinase 2 (RSK2) is a highly expressed Ser/Thr kinase activated by growth factors and is involved in cancer cell proliferation and tumor promoter-induced cell transformation. RSK2 possesses two non-identical kinase domains, and the structure of its N-terminal domain (NTD), which is responsible for phosphorylation of a variety of substrates, is unknown. The crystal structure of the NTD RSK2 was determined at 1.8 angstrom resolution in complex with AMP-PNP. The N-terminal kinase domain adopted a unique active conformation showing a significant structural diversity of the kinase domain compared to other kinases. The NTD RSK2 possesses a three-stranded beta B-sheet inserted in the N-terminal lobe, resulting in displacement of the alpha C-helix and disruption of the Lys-Glu interaction, classifying the kinase conformation as inactive. The purified protein was phosphorylated at Ser227 in the T-activation loop and exhibited in vitro kinase activity. A key characteristic is the appearance of a new contact between Lys216 (beta B-sheet) and the beta-phosphate of AMP-PNP. Mutation of this lysine to alanine impaired both NTDs in vitro and full length RSK2 ex vivo activity, emphasizing the importance of this interaction. Even though the N-terminal lobe undergoes structural re-arrangement, it possesses an intact hydrophobic groove formed between the alpha C-helix, the beta 4-strand, and the beta B-sheet junction, which is occupied by the N-terminal tail. The presence of a unique beta B-sheet insert in the N-lobe suggests a different type of activation mechanism for RSK2.	[Malakhova, Margarita; Liu, Kangdong; Zheng, Duo; Shim, Jung-Hyun; Bode, Ann M.; Dong, Zigang] Univ Minnesota, Hormel Inst, Dept Cellular & Mol Biol, 801 16th Ave NE, Austin, MN 55912 USA; [Kurinov, Igor] Cornell Univ, NE CAT, APS, Argonne, IL USA; [D'Angelo, Igor] Canadian Light Source Inc, Canadian Macromol Crystallog Facil, Saskatoon, SK, Canada; [Steinman, Valerie] Coll St Benedict, Dept Biochem, St Joseph, MN USA	University of Minnesota System; Cornell University; United States Department of Energy (DOE); Argonne National Laboratory; University of Saskatchewan; College of Saint Benedict & Saint Johns University	Malakhova, M (corresponding author), Univ Minnesota, Hormel Inst, Dept Cellular & Mol Biol, 801 16th Ave NE, Austin, MN 55912 USA.	mailtozgdong@hi.umn.edu		Shim, Jung-Hyun/0000-0002-4062-4016	Hormel Foundation; National Institutes of Health (NIH) [CA027502, CA077646, CA120388, R37CA08164, ES016548]; NATIONAL CANCER INSTITUTE [P01CA027502, R01CA120388, R01CA077646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016548] Funding Source: NIH RePORTER	Hormel Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was funded by The Hormel Foundation and National Institutes of Health (NIH) grants CA027502, CA077646, CA120388, R37CA08164, and ES016548. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Biondi RM, 2001, EMBO J, V20, P4380, DOI 10.1093/emboj/20.16.4380; Biondi RM, 2002, EMBO J, V21, P4219, DOI 10.1093/emboj/cdf437; Biondi RM, 2000, EMBO J, V19, P979, DOI 10.1093/emboj/19.5.979; Boggon TJ, 2004, ONCOGENE, V23, P7918, DOI 10.1038/sj.onc.1208081; CHEN RH, 1993, P NATL ACAD SCI USA, V90, P10952, DOI 10.1073/pnas.90.23.10952; Cho YY, 2007, CANCER RES, V67, P8104, DOI 10.1158/0008-5472.CAN-06-4668; Cho YY, 2007, J BIOL CHEM, V282, P8380, DOI 10.1074/jbc.M611322200; Cho YY, 2005, CANCER RES, V65, P3596, DOI 10.1158/0008-5472.CAN-04-3935; Chrestensen CA, 2002, J BIOL CHEM, V277, P27733, DOI 10.1074/jbc.M202663200; Clark DE, 2005, CANCER RES, V65, P3108; Dalby KN, 1998, J BIOL CHEM, V273, P1496, DOI 10.1074/jbc.273.3.1496; DEBONDT HL, 1993, NATURE, V363, P595, DOI 10.1038/363595a0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engh RA, 2002, PHARMACOL THERAPEUT, V93, P99, DOI 10.1016/S0163-7258(02)00180-8; Engh RA, 2001, ADV ENZYME REGUL, V41, P121, DOI 10.1016/S0065-2571(00)00010-8; Fisher TL, 1996, MOL CELL BIOL, V16, P1212; Frodin M, 2000, EMBO J, V19, P2924, DOI 10.1093/emboj/19.12.2924; Gavin AC, 1999, CURR BIOL, V9, P281, DOI 10.1016/S0960-9822(99)80120-1; Gonfloni S, 2000, NAT STRUCT BIOL, V7, P281; Hauge C, 2007, EMBO J, V26, P2251, DOI 10.1038/sj.emboj.7601682; Honda R, 2005, EMBO J, V24, P452, DOI 10.1038/sj.emboj.7600554; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Ikuta M, 2007, PROTEIN SCI, V16, P2626, DOI 10.1110/ps.073123707; Jacobs MD, 2008, PROTEINS, V70, P1451, DOI 10.1002/prot.21633; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; Jensen CJ, 1999, J BIOL CHEM, V274, P27168, DOI 10.1074/jbc.274.38.27168; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; JONES SW, 1988, P NATL ACAD SCI USA, V85, P3377, DOI 10.1073/pnas.85.10.3377; Kannan N, 2005, J MOL BIOL, V351, P956, DOI 10.1016/j.jmb.2005.06.057; Kannan N, 2007, P NATL ACAD SCI USA, V104, P1272, DOI 10.1073/pnas.0610251104; Komander D, 2005, J BIOL CHEM, V280, P18797, DOI 10.1074/jbc.M500977200; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liang J, 1998, PROTEIN SCI, V7, P1884, DOI 10.1002/pro.5560070905; Lietha D, 2007, CELL, V129, P1177, DOI 10.1016/j.cell.2007.05.041; Malakhova M, 2008, NAT STRUCT MOL BIOL, V15, P112, DOI 10.1038/nsmb1347; Moarefi I, 1997, NATURE, V385, P650, DOI 10.1038/385650a0; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Sassone-Corsi P, 1999, SCIENCE, V285, P886, DOI 10.1126/science.285.5429.886; Scheeff ED, 2005, PLOS COMPUT BIOL, V1, P359, DOI 10.1371/journal.pcbi.0010049; Schwab MS, 2001, CURR BIOL, V11, P141, DOI 10.1016/S0960-9822(01)00045-8; Sicheri F, 1997, CURR OPIN STRUC BIOL, V7, P777, DOI 10.1016/S0959-440X(97)80146-7; Silverman E, 2004, MOL CELL BIOL, V24, P10573, DOI 10.1128/MCB.24.24.10573-10583.2004; Smith JA, 1999, J BIOL CHEM, V274, P2893, DOI 10.1074/jbc.274.5.2893; Smith JA, 2005, CANCER RES, V65, P1027; Smith KJ, 2004, STRUCTURE, V12, P1067, DOI 10.1016/j.str.2004.02.040; STURGILL TW, 1988, NATURE, V334, P715, DOI 10.1038/334715a0; Swanson KD, 1999, J BIOL CHEM, V274, P3385, DOI 10.1074/jbc.274.6.3385; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Yang J, 2002, NAT STRUCT BIOL, V9, P940, DOI 10.1038/nsb870; Yang J, 2002, MOL CELL, V9, P1227, DOI 10.1016/S1097-2765(02)00550-6; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7; Zhao B, 2007, PROTEIN SCI, V16, P2761, DOI 10.1110/ps.073161707	59	25	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2009	4	11							e8044	10.1371/journal.pone.0008044	http://dx.doi.org/10.1371/journal.pone.0008044			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MQ	19956600	Green Published, gold, Green Submitted			2022-12-25	WOS:000272828400007
J	Bidon, C; Lachuer, J; Molgo, J; Wierinckx, A; de la Porte, S; Pignol, B; Christen, Y; Meloni, R; Koenig, H; Faucon-Biguet, N; Mallet, J				Bidon, Caroline; Lachuer, Joel; Molgo, Jordi; Wierinckx, Anne; de la Porte, Sabine; Pignol, Bernadette; Christen, Yves; Meloni, Rolando; Koenig, Herbert; Faucon-Biguet, Nicole; Mallet, Jacques			The Extract of Ginkgo biloba EGb 761 Reactivates a Juvenile Profile in the Skeletal Muscle of Sarcopenic Rats by Transcriptional Reprogramming	PLOS ONE			English	Article							FATTY-ACID OXIDATION; GENE-EXPRESSION; CALORIC RESTRICTION; LIFE-SPAN; BETA; COLLAGEN; GLUCOSE; REGENERATION; METABOLISM; RESISTANCE	Background: Sarcopenia is a major public health problem in industrialized nations, placing an increasing burden on public healthcare systems because the loss of skeletal muscle mass and strength that characterizes this affection increases the dependence and the risk of injury caused by sudden falls in elderly people. Albeit exercise and caloric restriction improve sarcopenia-associated decline of the muscular performances, a more suitable and focused pharmacological treatment is still lacking. Methodology/Principal Findings: In order to evaluate such a possible treatment, we investigated the effects of EGb 761, a Ginkgo biloba extract used in chronic age-dependent neurological disorders, on the function of the soleus muscle in aged rats. EGb 761 induced a gain in muscular mass that was associated with an improvement of the muscular performances as assessed by biochemical and electrophysiological tests. DNA microarray analysis shows that these modifications are accompanied by the transcriptional reprogramming of genes related to myogenesis through the TGF beta signaling pathway and to energy production via fatty acids and glucose oxidation. EGb 761 restored a more juvenile gene expression pattern by regenerating the aged muscle and reversing the age-related metabolic shift from lipids to glucose utilization. Conclusions/Significance: Thus, EGb 761 may represent a novel treatment for sarcopenia both more manageable and less cumbersome than exercise and caloric restriction.	[Bidon, Caroline; Meloni, Rolando; Koenig, Herbert; Faucon-Biguet, Nicole; Mallet, Jacques] Hop La Pitie Salpetriere, CNRS, Biotechnol & Biotherapie UMR 7225, Paris, France; [Bidon, Caroline; Meloni, Rolando; Koenig, Herbert; Faucon-Biguet, Nicole; Mallet, Jacques] Hop La Pitie Salpetriere, INSERM, CRICM UMR S 975, Paris, France; [Bidon, Caroline; Meloni, Rolando; Koenig, Herbert; Faucon-Biguet, Nicole; Mallet, Jacques] UPMC Univ Paris 06, Paris, France; [Lachuer, Joel; Wierinckx, Anne] INSERM, Lab Neurooncol & Neuroinflammat U842, F-69008 Lyon, France; [Lachuer, Joel] ProfileXpert, IFR19, Bron, France; [Lachuer, Joel] Univ Lyon 1, UMR S842, F-69365 Lyon, France; [Molgo, Jordi; de la Porte, Sabine] CNRS, Inst Neurobiol Alfred Fessard, Cellular & Mol Neurobiol Lab, UPR9040, Gif Sur Yvette, France; [Christen, Yves] Ipsen, Boulogne Billancourt, France; [Pignol, Bernadette] Ipsen Res Labs, Les Ulis, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Ipsen	Bidon, C (corresponding author), Hop La Pitie Salpetriere, CNRS, Biotechnol & Biotherapie UMR 7225, Paris, France.	jacques.mallet@upmc.fr	de la PORTE, Sabine/AAE-4208-2022; de la Porte, Sabine/N-5275-2018; Wierinckx, Anne/AAF-5233-2021; Meloni, Rolando/GOJ-7446-2022	de la PORTE, Sabine/0000-0002-7725-8646; Wierinckx, Anne/0000-0002-0186-6645; Meloni, Rolando/0000-0002-6464-8469; lachuer, joel/0000-0002-5209-5094	IPSEN; Beaufour-Ipsen; C.N.R.S.	IPSEN(Ipsen); Beaufour-Ipsen(Ipsen); C.N.R.S.(Centre National de la Recherche Scientifique (CNRS)European Commission)	This work was partly financed by IPSEN ("Institut des produits de synthese et d'extraction naturelle'') http://web2.ipsen.com/. CB was the recipient of a thesis bursary from IPSEN. BP and YC are employed by IPSEN. This work was supported by Beaufour-Ipsen and the C.N.R.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlemeyer B, 2003, PHARMACOPSYCHIATRY, V36, pS8; Ahtikoski AM, 2003, ACTA PHYSIOL SCAND, V177, P473, DOI 10.1046/j.1365-201X.2003.01061.x; Armand AS, 2003, DEV DYNAM, V227, P256, DOI 10.1002/dvdy.10306; Bezaire V, 2007, FASEB J, V21, P312, DOI 10.1096/fj.06-6966rev; Blaak EE, 1999, J CLIN ENDOCR METAB, V84, P3764, DOI 10.1210/jc.84.10.3764; Bruce CR, 2006, AM J PHYSIOL-ENDOC M, V291, pE99, DOI 10.1152/ajpendo.00587.2005; CHRISTEN Y, 2004, OXIDAT STRESS DIS, P145; Criscuolo F, 2005, P ROY SOC B-BIOL SCI, V272, P803, DOI 10.1098/rspb.2004.3044; Dardevet D, 2002, J NUTR, V132, P95, DOI 10.1093/jn/132.1.95; Faulkner JA, 1995, ADV EXP MED BIOL, V384, P471; Fontaniere S, 2006, ENDOCR-RELAT CANCER, V13, P1223, DOI 10.1677/erc.1.01294; HANSON AN, 1983, ANAL BIOCHEM, V130, P32, DOI 10.1016/0003-2697(83)90646-2; HEPPLE RT, 2003, SCI AGING KNOWLEDGE, V46, pPE31; Huijing PA, 1999, J BIOMECH, V32, P329, DOI 10.1016/S0021-9290(98)00186-9; Ibrahimi A, 1999, J BIOL CHEM, V274, P26761, DOI 10.1074/jbc.274.38.26761; Ker RF, 2002, COMP BIOCHEM PHYS A, V133, P987, DOI 10.1016/S1095-6433(02)00171-X; Kollias HD, 2008, J APPL PHYSIOL, V104, P579, DOI 10.1152/japplphysiol.01091.2007; Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390; Lynch Gordon S, 2004, Expert Opin Emerg Drugs, V9, P345, DOI 10.1517/14728214.9.2.345; Marzetti E, 2008, FREE RADICAL BIO MED, V44, P160, DOI 10.1016/j.freeradbiomed.2007.05.028; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; McLennan IS, 2002, INT J DEV BIOL, V46, P559; Navarro A, 2001, FRONT BIOSCI-LANDMRK, V6, pD26, DOI 10.2741/Navarro; Nguyen-Huu T, 2005, ANESTHESIOLOGY, V103, P788, DOI 10.1097/00000542-200510000-00017; Oh KS, 2007, EXP MOL MED, V39, P385, DOI 10.1038/emm.2007.43; Park SK, 2005, CARDIOVASC RES, V66, P205, DOI 10.1016/j.cardiores.2005.01.005; Pattison JS, 2003, PHYSIOL GENOMICS, V15, P34, DOI 10.1152/physiolgenomics.00040.2003; Perez CF, 2005, AM J PHYSIOL-CELL PH, V288, pC640, DOI 10.1152/ajpcell.00407.2004; Randle PJ, 1998, DIABETES METAB REV, V14, P263, DOI 10.1002/(SICI)1099-0895(199812)14:4&lt;263::AID-DMR233&gt;3.0.CO;2-C; ROSENBERG IH, 1989, AM J CLIN NUTR, V50, P1231, DOI 10.1093/ajcn/50.5.1231; Sastre J, 2002, CELL MOL BIOL, V48, P685; Sekiya T, 2004, BIOCHEM BIOPH RES CO, V320, P680, DOI 10.1016/j.bbrc.2004.06.017; Selman C, 2006, PHYSIOL GENOMICS, V27, P187, DOI 10.1152/physiolgenomics.00084.2006; Speakman JR, 2004, AGING CELL, V3, P87, DOI 10.1111/j.1474-9728.2004.00097.x; Toth MJ, 2000, EUR J CLIN NUTR, V54, pS121, DOI 10.1038/sj.ejcn.1601033; Vianna CR, 2001, PHYSIOL GENOMICS, V5, P137, DOI 10.1152/physiolgenomics.2001.5.3.137; Watanabe CMH, 2001, P NATL ACAD SCI USA, V98, P6577, DOI 10.1073/pnas.111126298; WHALEN RG, 1990, DEV BIOL, V141, P24, DOI 10.1016/0012-1606(90)90099-5; Winter JC, 1998, PHYSIOL BEHAV, V63, P425, DOI 10.1016/S0031-9384(97)00464-2; Wu ZX, 2002, CELL MOL BIOL, V48, P725; Yamaza H, 2002, MICROSC RES TECHNIQ, V59, P325, DOI 10.1002/jemt.10212; Yarasheski K E, 2002, J Nutr Health Aging, V6, P343	42	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2009	4	11							e7998	10.1371/journal.pone.0007998	http://dx.doi.org/10.1371/journal.pone.0007998			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MH	19956636	gold, Green Submitted, Green Published			2022-12-25	WOS:000272827500025
J	Niu, XM; Nouraie, M; Campbell, A; Rana, S; Minniti, CP; Sable, C; Darbari, D; Dham, N; Reading, NS; Prchal, JT; Kato, GJ; Gladwin, MT; Castro, OL; Gordeuk, VR				Niu, Xiaomei; Nouraie, Mehdi; Campbell, Andrew; Rana, Sohail; Minniti, Caterina P.; Sable, Craig; Darbari, Deepika; Dham, Niti; Reading, N. Scott; Prchal, Josef T.; Kato, Gregory J.; Gladwin, Mark T.; Castro, Oswaldo L.; Gordeuk, Victor R.			Angiogenic and Inflammatory Markers of Cardiopulmonary Changes in Children and Adolescents with Sickle Cell Disease	PLOS ONE			English	Article							PULMONARY ARTERIAL-HYPERTENSION; REGURGITANT JET VELOCITY; GENE-EXPRESSION; PULSE OXIMETRY; RISK-FACTOR; HEMOLYSIS; DEATH; VEGF; ENDOTHELIUM; ACTIVATION	Background: Pulmonary hypertension and left ventricular diastolic dysfunction are complications of sickle cell disease. Pulmonary hypertension is associated with hemolysis and hypoxia, but other unidentified factors are likely involved in pathogenesis as well. Design and Methods: Plasma concentrations of three angiogenic markers (fibroblast growth factor, platelet derived growth factor-BB [PDGF-BB], vascular endothelial growth factor [VEGF]) and seven inflammatory markers implicated in pulmonary hypertension in other settings were determined by Bio-Plex suspension array in 237 children and adolescents with sickle cell disease at steady state and 43 controls. Tricuspid regurgitation velocity (which reflects systolic pulmonary artery pressure), mitral valve E/Edti ratio (which reflects left ventricular diastolic dysfunction), and a hemolytic component derived from four markers of hemolysis and hemoglobin oxygen saturation were also determined. Results: Plasma concentrations of interleukin-8, interleukin-10 and VEGF were elevated in the patients with sickle cell disease compared to controls (P <= 0.003). By logistic regression, greater values for PDGF-BB (P = 0.009), interleukin-6 (P = 0.019) and the hemolytic component (P = 0.026) were independently associated with increased odds of elevated tricuspid regurgitation velocity while higher VEGF concentrations were associated with decreased odds (P = 0.005) among the patients with sickle cell disease. These findings, which are consistent with reports that PDGF-BB stimulates and VEGF inhibits vascular smooth muscle cell proliferation, did not apply to E/Etdi. Conclusions: Circulating concentrations of angiogenic and pro-Inflammatory markers are altered in sickle cell disease children and adolescents with elevated tricuspid regurgitation velocity, a subgroup that may be at risk for developing worsening pulmonary hypertension. Further studies to understand the molecular changes in these children are indicated.	[Niu, Xiaomei; Nouraie, Mehdi; Rana, Sohail; Castro, Oswaldo L.; Gordeuk, Victor R.] Howard Univ, Ctr Sickle Cell Dis, Washington, DC 20059 USA; [Darbari, Deepika] Childrens Natl Med Ctr, Dept Hematol, Washington, DC 20010 USA; [Sable, Craig; Dham, Niti] Childrens Natl Med Ctr, Dept Cardiol, Washington, DC 20010 USA; [Campbell, Andrew] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; [Minniti, Caterina P.; Kato, Gregory J.] Natl Heart Lung & Blood Inst, Pulm & Vasc Med Branch, Ctr Clin, NIH, Bethesda, MD USA; [Reading, N. Scott; Prchal, Josef T.] Univ Utah, ARUP Inst Clin & Expt Pathol, Salt Lake City, UT USA; [Reading, N. Scott; Prchal, Josef T.] Univ Utah, Vet Adm Hosp, Salt Lake City, UT USA; [Gladwin, Mark T.] Univ Pittsburgh, Med Ctr, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA USA; [Gladwin, Mark T.] Univ Pittsburgh, Hemostasis & Vasc Biol Res Inst, Pittsburgh, PA USA	Howard University; Children's National Health System; Children's National Health System; University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); NIH National Heart Lung & Blood Institute (NHLBI); Utah System of Higher Education; University of Utah; ARUP Laboratories; Utah System of Higher Education; University of Utah; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Niu, XM (corresponding author), Howard Univ, Ctr Sickle Cell Dis, Washington, DC 20059 USA.	vgordeuk@howard.edu	Campbell, Andrew/AAX-8590-2020; Gordeuk, Victor/AAG-6577-2019; Nouraie, Seyed Mehdi/O-4071-2018; Minniti, Caterina/AAX-3187-2021; Reading, Noel/J-8911-2016; Kato, Gregory J/I-7615-2014	Campbell, Andrew/0000-0002-8829-0043; Nouraie, Seyed Mehdi/0000-0001-7465-0581; Reading, Noel/0000-0003-0806-5661; Kato, Gregory J/0000-0003-4465-3217	National Heart, Lung and Blood Institute [2 R25 HL003679-08, 1 R01 HL079912-02]; National Center for Research Resources, National Institutes of Health (NIH), Bethesda, MD [2MOI RR10284-10]; National Institutes of Health; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR010284] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R25HL003679, R01HL079912, ZIAHL006016] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Center for Research Resources, National Institutes of Health (NIH), Bethesda, MD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported in part by grants no. 2 R25 HL003679-08 and 1 R01 HL079912-02 from the National Heart, Lung and Blood Institute; by Howard University GCRC grant no. 2MOI RR10284-10 from the National Center for Research Resources, National Institutes of Health (NIH), Bethesda, MD; and by the Intramural Research Program of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ataga KI, 2007, HAEMATOLOGICA, V93, P20, DOI 10.3324/haematol.11763; Belcher JD, 2000, BLOOD, V96, P2451, DOI 10.1182/blood.V96.7.2451.h8002451_2451_2459; Bourantas KL, 1998, EUR J HAEMATOL, V61, P49; Damas JK, 2004, CIRCULATION, V110, P999, DOI 10.1161/01.CIR.0000139859.68513.FC; Dorfmuller P, 2002, AM J RESP CRIT CARE, V165, P534, DOI 10.1164/rccm.2012112; Duits AJ, 2003, ANN HEMATOL, V82, P171, DOI 10.1007/S00277-003-0610-8; Fong GH, 2009, J MOL MED-JMM, V87, P549, DOI 10.1007/s00109-009-0458-z; Fujita M, 2002, J APPL PHYSIOL, V93, P2162, DOI 10.1152/japplphysiol.00083.2002; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Gladwin MT, 2004, NEW ENGL J MED, V350, P886, DOI 10.1056/NEJMoa035477; Greenberg JI, 2008, NATURE, V456, P809, DOI 10.1038/nature07424; Guzman MJ, 2008, J SURG RES, V150, P286, DOI 10.1016/j.jss.2007.12.772; Hargrave DR, 2003, BLOOD, V101, P846, DOI 10.1182/blood-2002-05-1392; Hebbel RP, 2004, MICROCIRCULATION, V11, P129, DOI 10.1080/10739680490278402; Hibbert JM, 2005, EXP BIOL MED, V230, P68; Holtzclaw JD, 2004, AM J RESP CRIT CARE, V169, P687, DOI 10.1164/rccm.200302-224OC; Homi J, 1997, CLIN LAB HAEMATOL, V19, P17, DOI 10.1046/j.1365-2257.1997.00215.x; Hsieh PCH, 2006, CIRCULATION, V114, P637, DOI 10.1161/CIRCULATIONAHA.106.639831; HUMBERT M, 1995, AM J RESP CRIT CARE, V151, P1628, DOI 10.1164/ajrccm.151.5.7735624; Humbert M, 2008, AM J RESP CRIT CARE, V177, P574, DOI 10.1164/rccm.200801-029UP; Ito T, 2007, CIRC RES, V101, P734, DOI 10.1161/CIRCRESAHA.107.153023; Jison ML, 2004, BLOOD, V104, P270, DOI 10.1182/blood-2003-08-2760; Jones R, 2006, ULTRASTRUCT PATHOL, V30, P267, DOI 10.1080/01913120600820336; Joppa P, 2006, CHEST, V130, P326, DOI 10.1378/chest.130.2.326; Josko J, 2004, MED SCI MONITOR, V10, pRA89; Kato GJ, 2005, BRIT J HAEMATOL, V130, P943, DOI 10.1111/j.1365-2141.2005.05701.x; Kato GJ, 2007, PEDIATR HEMAT ONCOL, V24, P159, DOI 10.1080/08880010601185892; Klein M, 2008, CIRCULATION, V118, P2081, DOI 10.1161/CIRCULATIONAHA.108.779751; Klings ES, 2008, AM J HEMATOL, V83, P547, DOI 10.1002/ajh.21187; Liem RI, 2007, HAEMATOLOGICA, V92, P1549, DOI 10.3324/haematol.11576; Machado RF, 2005, BRIT J HAEMATOL, V130, P445, DOI 10.1111/j.1365-2141.2005.05625.x; Minniti CR, 2009, HAEMATOL-HEMATOL J, V94, P340, DOI 10.3324/haematol.13812; MIYATA M, 1995, INT ARCH ALLERGY IMM, V108, P287, DOI 10.1159/000237166; Morris CR, 2005, JAMA-J AM MED ASSOC, V294, P81, DOI 10.1001/jama.294.1.81; Nagueh SF, 1997, J AM COLL CARDIOL, V30, P1527, DOI 10.1016/S0735-1097(97)00344-6; Partovian C, 2000, AM J RESP CELL MOL, V23, P762, DOI 10.1165/ajrcmb.23.6.4106; Pashankar FD, 2008, PEDIATRICS, V121, P777, DOI 10.1542/peds.2007-0730; PATEL N, 2008, BLOOD; Patterson KC, 2006, ANN INTERN MED, V145, P152, DOI 10.7326/0003-4819-145-2-200607180-00020; PEREZ AV, 2009, INT J CARDIOL; Perros F, 2008, AM J RESP CRIT CARE, V178, P81, DOI 10.1164/rccm.200707-1037OC; Pont-Kingdon G, 2007, BIOTECHNIQUES, V42, P191, DOI 10.2144/000112330; Prabhu SD, 2004, CIRC RES, V95, P1140, DOI 10.1161/01.RES.0000150734.79804.92; Preston IR, 2007, ANTIOXID REDOX SIGN, V9, P711, DOI 10.1089/ars.2007.1587; Quinones MA, 2002, J AM SOC ECHOCARDIOG, V15, P167, DOI 10.1067/mje.2002.120202; Rabinovitch M, 2008, J CLIN INVEST, V118, P2372, DOI 10.1172/JCI33452; RACKOFF WR, 1993, BLOOD, V81, P3422; Reiter CD, 2002, NAT MED, V8, P1383, DOI 10.1038/nm799; Sachdev V, 2007, J AM COLL CARDIOL, V49, P472, DOI 10.1016/j.jacc.2006.09.038; SAMUELS MP, 1992, ARCH DIS CHILD, V67, P925, DOI 10.1136/adc.67.7.925; Schermuly RT, 2005, J CLIN INVEST, V115, P2811, DOI 10.1172/JCI24838; Schultz K, 2006, AM J PHYSIOL-HEART C, V290, pH2528, DOI 10.1152/ajpheart.01077.2005; Setty BNY, 2003, LANCET, V362, P1450, DOI 10.1016/S0140-6736(03)14689-2; Taraseviciene-Stewart L, 2001, FASEB J, V15, P427, DOI 10.1096/fj.00-0343com; Taylor JG, 2008, AM J HEMATOL, V83, P6, DOI 10.1002/ajh.21035; Taylor SC, 1997, J NATL MED ASSOC, V89, P753; Uong EC, 2006, J PEDIATR-US, V149, P707, DOI 10.1016/j.jpeds.2006.06.038; Villagra J, 2007, BLOOD, V110, P2166, DOI 10.1182/blood-2006-12-061697; Wanstall JC, 2002, CARDIOVASC RES, V55, P361, DOI 10.1016/S0008-6363(02)00440-6; Wedgwood S, 2007, PEDIATR RES, V61, P32, DOI 10.1203/01.pdr.0000250013.77008.28; Zilberman MV, 2007, AM J HEMATOL, V82, P433, DOI 10.1002/ajh.20866	61	52	53	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2009	4	11							e7956	10.1371/journal.pone.0007956	http://dx.doi.org/10.1371/journal.pone.0007956			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MF	19956689	Green Published, gold, Green Accepted			2022-12-25	WOS:000272827300013
J	Gordon, A; Videa, E; Saborio, S; Lopez, R; Kuan, G; Reingold, A; Balmaseda, A; Harris, E				Gordon, Aubree; Videa, Elsa; Saborio, Saira; Lopez, Roger; Kuan, Guillermina; Reingold, Arthur; Balmaseda, Angel; Harris, Eva			Performance of an Influenza Rapid Test in Children in a Primary Healthcare Setting in Nicaragua	PLOS ONE			English	Article							REVERSE TRANSCRIPTION-PCR; VIRAL CULTURE; VIRUS-INFECTION; A+B TEST; DIAGNOSIS; ACCURACY; IMPACT	Background: Influenza is major public health threat worldwide, yet the diagnostic accuracy of rapid tests in developing country settings is not well described. Methodology/Principal Findings: To investigate the diagnostic accuracy of the QuickVue Influenza A+B test in a primary care setting in a developing country, we performed a prospective study of diagnostic accuracy of the QuickVue Influenza A+B test in comparison to reverse transcriptase-polymerase chain reaction (RT-PCR) in a primary healthcare setting in children aged 2 to 12 years in Managua, Nicaragua. The sensitivity and specificity of the QuickVue test compared to RT-PCR were 68.5% (95% CI 63.4, 73.3) and 98.1% (95% CI 96.9, 98.9), respectively, for children with a fever or history of a fever and cough and/or sore throat. Test performance was found to be lower on the first day that symptoms developed in comparison to test performance on days two or three of illness. Conclusions/Significance: Our study found that the QuickVue Influenza A+B test performed as well in a developing country primary healthcare facility setting as in developed country settings.			Gordon, A (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Div Epidemiol, Berkeley, CA 94720 USA.	eharris@berkeley.edu	Gordon, Aubree/X-1113-2019	Gordon, Aubree/0000-0002-9352-7877				Agoritsas K, 2006, J CLIN MICROBIOL, V44, P2638, DOI 10.1128/JCM.02644-05; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Cheng CKY, 2009, DIAGN MICR INFEC DIS, V65, P35, DOI 10.1016/j.diagmicrobio.2009.05.003; Grijalva CG, 2007, PEDIATRICS, V119, pE6, DOI 10.1542/peds.2006-1694; Hurt AC, 2007, J CLIN VIROL, V39, P132, DOI 10.1016/j.jcv.2007.03.002; Kuan G, 2009, AM J EPIDEMIOL, V170, P120, DOI 10.1093/aje/kwp092; Mehlmann M, 2007, J CLIN MICROBIOL, V45, P1234, DOI 10.1128/JCM.02202-06; Poehling KA, 2006, ARCH PEDIAT ADOL MED, V160, P713, DOI 10.1001/archpedi.160.7.713; Pregliasco F, 1998, J MED VIROL, V56, P168, DOI 10.1002/(SICI)1096-9071(199810)56:2&lt;168::AID-JMV11&gt;3.0.CO;2-C; Rodriguez WJ, 2002, PEDIATR INFECT DIS J, V21, P193, DOI 10.1097/00006454-200203000-00006; Ruest A, 2003, J CLIN MICROBIOL, V41, P3487, DOI 10.1128/JCM.41.8.3487-3493.2003; Schoub BD, 2002, VACCINE, V20, pS45, DOI 10.1016/S0264-410X(02)00129-9; Simmerman JM, 2007, INT J INFECT DIS, V11, P166, DOI 10.1016/j.ijid.2006.01.005; Simonsen L, 1999, VACCINE, V17, pS3, DOI 10.1016/S0264-410X(99)00099-7; Steininger C, 2002, J CLIN MICROBIOL, V40, P2051, DOI 10.1128/JCM.40.6.2051-2056.2002; Stockton J, 1998, J CLIN MICROBIOL, V36, P2990, DOI 10.1128/JCM.36.10.2990-2995.1998; Uyeki TM, 2009, CLIN INFECT DIS, V48, pE89, DOI 10.1086/597828; Uyeki TM, 2003, PEDIATR INFECT DIS J, V22, P164; Weinberg GA, 2004, J INFECT DIS, V189, P706, DOI 10.1086/381456; World Health Organization, GLOB AG INFL SURV CO	20	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2009	4	11							e7907	10.1371/journal.pone.0007907	http://dx.doi.org/10.1371/journal.pone.0007907			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522NJ	19936063	Green Published, gold, Green Submitted			2022-12-25	WOS:000272004600011
J	Herraez, DL; Bauchet, M; Tang, K; Theunert, C; Pugach, I; Li, J; Nandineni, MR; Gross, A; Scholz, M; Stoneking, M				Herraez, David Lopez; Bauchet, Marc; Tang, Kun; Theunert, Christoph; Pugach, Irina; Li, Jing; Nandineni, Madhusudan R.; Gross, Arnd; Scholz, Markus; Stoneking, Mark			Genetic Variation and Recent Positive Selection in Worldwide Human Populations: Evidence from Nearly 1 Million SNPs	PLOS ONE			English	Article							LACTASE PERSISTENCE; NATURAL-SELECTION; WIDE ANALYSIS; GENOME; DIVERSITY; ASSOCIATION; COLONIZATION; POLYMORPHISM; EXPANSIONS; ADMIXTURE	Background: Genome-wide scans of hundreds of thousands of single-nucleotide polymorphisms (SNPs) have resulted in the identification of new susceptibility variants to common diseases and are providing new insights into the genetic structure and relationships of human populations. Moreover, genome-wide data can be used to search for signals of recent positive selection, thereby providing new insights into the genetic adaptations that occurred as modern humans spread out of Africa and around the world. Methodology: We genotyped approximately 500,000 SNPs in 255 individuals (5 individuals from each of 51 worldwide populations) from the Human Genome Diversity Panel (HGDP-CEPH). When merged with non-overlapping SNPs typed previously in 250 of these same individuals, the resulting data consist of over 950,000 SNPs. We then analyzed the genetic relationships and ancestry of individuals without assigning them to populations, and we also identified candidate regions of recent positive selection at both the population and regional (continental) level. Conclusions: Our analyses both confirm and extend previous studies; in particular, we highlight the impact of various dispersals, and the role of substructure in Africa, on human genetic diversity. We also identified several novel candidate regions for recent positive selection, and a gene ontology (GO) analysis identified several GO groups that were significantly enriched for such candidate genes, including immunity and defense related genes, sensory perception genes, membrane proteins, signal receptors, lipid binding/metabolism genes, and genes involved in the nervous system. Among the novel candidate genes identified are two genes involved in the thyroid hormone pathway that show signals of selection in African Pygmies that may be related to their short stature.			Herraez, DL (corresponding author), Max Planck Inst Evolutionary Anthropol, Leipzig, Germany.	stoneking@eva.mpg.de	Tang, Kun/GSD-3218-2022	Gross, Arnd/0000-0002-5961-5507; Nandineni, Madhusudan Reddy/0000-0002-8933-4503				Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Annunen S, 1999, AM J HUM GENET, V65, P974, DOI 10.1086/302585; Auton A, 2009, GENOME RES, V19, P795, DOI 10.1101/gr.088898.108; Beaumont MA, 2004, MOL ECOL, V13, P969, DOI 10.1111/j.1365-294X.2004.02125.x; Biswas S, 2009, AM J HUM GENET, V84, P641, DOI 10.1016/j.ajhg.2009.04.015; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cann HM, 2002, SCIENCE, V296, P261; DIAMOND JM, 1991, NATURE, V354, P111, DOI 10.1038/354111a0; DORMITZER PR, 1989, AM J PHYS ANTHROPOL, V78, P527, DOI 10.1002/ajpa.1330780408; Excoffier L, 2008, TRENDS ECOL EVOL, V23, P347, DOI 10.1016/j.tree.2008.04.004; Fix AG, 2002, HUM BIOL, V74, P1, DOI 10.1353/hub.2002.0003; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Friedlaender JS, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040019; Frisse L, 2001, AM J HUM GENET, V69, P831, DOI 10.1086/323612; GREENBERG JH, 1972, J AFR HIST, V13, P189, DOI 10.1017/S0021853700011427; Hawks J, 2007, P NATL ACAD SCI USA, V104, P20753, DOI 10.1073/pnas.0707650104; Hofer T, 2009, ANN HUM GENET, V73, P95, DOI 10.1111/j.1469-1809.2008.00489.x; Hoggart CJ, 2007, GENETICS, V177, P1725, DOI 10.1534/genetics.106.069088; Hughes DA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001686; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; Kayser M, 2008, AM J HUM GENET, V82, P194, DOI 10.1016/j.ajhg.2007.09.010; Kimura R, 2008, MOL BIOL EVOL, V25, P1750, DOI 10.1093/molbev/msn128; Koronyo-Hamaoui M, 2004, AM J MED GENET B, V131B, P76, DOI 10.1002/ajmg.b.20154; Kuhar MJ, 2002, NEUROPEPTIDES, V36, P1, DOI 10.1054/npep.2002.0887; Lao O, 2008, CURR BIOL, V18, P1241, DOI 10.1016/j.cub.2008.07.049; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; McEvoy BP, 2009, GENOME RES, V19, P804, DOI 10.1101/gr.083394.108; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Nielsen R, 2005, GENOME RES, V15, P1566, DOI 10.1101/gr.4252305; Nielsen R, 2007, NAT REV GENET, V8, P857, DOI 10.1038/nrg2187; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Novembre J, 2008, NAT GENET, V40, P646, DOI 10.1038/ng.139; O'Connell JF, 2004, J ARCHAEOL SCI, V31, P835, DOI 10.1016/j.jas.2003.11.005; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Perry GH, 2009, TRENDS ECOL EVOL, V24, P218, DOI 10.1016/j.tree.2008.11.008; Pickrell JK, 2009, GENOME RES, V19, P826, DOI 10.1101/gr.087577.108; Prufer K, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-41; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ritsner M, 2002, BIOL PSYCHIAT, V51, P788, DOI 10.1016/S0006-3223(01)01348-8; ROSE SR, 1995, PEDIATR RES, V38, P967, DOI 10.1203/00006450-199512000-00023; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Rosenberg NA, 2006, ANN HUM GENET, V70, P841, DOI 10.1111/j.1469-1809.2006.00285.x; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305; Sultan M, 2008, JCPSP-J COLL PHYSICI, V18, P493, DOI 08.2008/JCPSP.493497; Swallow DM, 2003, ANNU REV GENET, V37, P197, DOI 10.1146/annurev.genet.37.110801.143820; Tang H, 2005, GENET EPIDEMIOL, V28, P289, DOI 10.1002/gepi.20064; Tang K, 2007, PLOS BIOL, V5, P1587, DOI 10.1371/journal.pbio.0050171; TISHKOFF SA, 2009, SCIENCE; Tishkoff SA, 2007, NAT GENET, V39, P31, DOI 10.1038/ng1946; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Williamson SH, 2007, PLOS GENET, V3, P901, DOI 10.1371/journal.pgen.0030090; Xing JC, 2009, GENOME RES, V19, P815, DOI 10.1101/gr.085589.108; Xu SH, 2008, AM J HUM GENET, V83, P322, DOI 10.1016/j.ajhg.2008.08.001; Zhang F, 2007, PHILOS T R SOC B, V362, P987, DOI 10.1098/rstb.2007.2028	56	103	107	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2009	4	11							e7888	10.1371/journal.pone.0007888	http://dx.doi.org/10.1371/journal.pone.0007888			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	521QH	19924308	Green Submitted, Green Published, gold			2022-12-25	WOS:000271936700020
J	Halama, N; Zoernig, I; Spille, A; Westphal, K; Schirmacher, P; Jaeger, D; Grabe, N				Halama, Niels; Zoernig, Inka; Spille, Anna; Westphal, Kathi; Schirmacher, Peter; Jaeger, Dirk; Grabe, Niels			Estimation of Immune Cell Densities in Immune Cell Conglomerates: An Approach for High-Throughput Quantification	PLOS ONE			English	Article							TUMOR-INFILTRATING LYMPHOCYTES; COLORECTAL-CANCER; T-CELLS; PROGNOSTIC ROLE; OVARIAN-CANCER; METASTASIS; SURVIVAL; RATIO	Background: Determining the correct number of positive immune cells in immunohistological sections of colorectal cancer and other tumor entities is emerging as an important clinical predictor and therapy selector for an individual patient. This task is usually obstructed by cell conglomerates of various sizes. We here show that at least in colorectal cancer the inclusion of immune cell conglomerates is indispensable for estimating reliable patient cell counts. Integrating virtual microscopy and image processing principally allows the high-throughput evaluation of complete tissue slides. Methodology/Principal findings: For such large-scale systems we demonstrate a robust quantitative image processing algorithm for the reproducible quantification of cell conglomerates on CD3 positive T cells in colorectal cancer. While isolated cells (28 to 80 mm(2)) are counted directly, the number of cells contained in a conglomerate is estimated by dividing the area of the conglomerate in thin tissues sections (<= 6 mu m) by the median area covered by an isolated T cell which we determined as 58 mm(2). We applied our algorithm to large numbers of CD3 positive T cell conglomerates and compared the results to cell counts obtained manually by two independent observers. While especially for high cell counts, the manual counting showed a deviation of up to 400 cells/mm(2) (41% variation), algorithm-determined T cell numbers generally lay in between the manually observed cell numbers but with perfect reproducibility. Conclusion: In summary, we recommend our approach as an objective and robust strategy for quantifying immune cell densities in immunohistological sections which can be directly implemented into automated full slide image processing systems.			Halama, N (corresponding author), Univ Heidelberg, Natl Ctr Tumor Dis, Heidelberg, Germany.	Niels.Grabe@bioquant.uni-heidelberg.de	Grabe, Niels/AAP-6493-2020; Grabe, Niels/I-6214-2016	Grabe, Niels/0000-0003-1732-3706; Halama, Niels/0000-0003-0344-6027				Choi YJ, 2008, MODERN PATHOL, V21, P1224, DOI 10.1038/modpathol.2008.106; Diederichsen ACP, 2003, CANCER IMMUNOL IMMUN, V52, P423, DOI 10.1007/s00262-003-0388-5; FUCHS TJ, 2008, COMPUTATIONAL PATHOL, P1; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Grabe N, 2008, Pathologe, V29 Suppl 2, P259, DOI 10.1007/s00292-008-1083-2; GUNDERSEN HJG, 1988, APMIS, V96, P379, DOI 10.1111/j.1699-0463.1988.tb05320.x; Halama Niels, 2009, Cancer Immun, V9, P1; Laghi L, 2009, LANCET ONCOL, V10, P877, DOI 10.1016/S1470-2045(09)70186-X; Matkowski R, 2009, ANTICANCER RES, V29, P2445; Menon AG, 2004, LAB INVEST, V84, P493, DOI 10.1038/labinvest.3700055; Naito Y, 1998, CANCER RES, V58, P3491; Ohtani Haruo, 2007, Cancer Immun, V7, P4; Pages F, 2005, NEW ENGL J MED, V353, P2654, DOI 10.1056/NEJMoa051424; Prall F, 2004, HUM PATHOL, V35, P808, DOI 10.1016/j.humpath.2004.01.022; SALAMA P, 2008, J CLIN ONCOL, V27, P168; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177	17	29	31	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2009	4	11							e7847	10.1371/journal.pone.0007847	http://dx.doi.org/10.1371/journal.pone.0007847			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520NG	19924291	Green Submitted, gold, Green Published			2022-12-25	WOS:000271851000007
J	Zhang, X; Shephard, F; Kim, HB; Palmer, IR; McHarg, S; Fowler, GJS; O'Neill, LAJ; Kiss-Toth, E; Qwarnstrom, EE				Zhang, Xiao; Shephard, Freya; Kim, Hong B.; Palmer, Ian R.; McHarg, Selina; Fowler, Gregory J. S.; O'Neill, Luke A. J.; Kiss-Toth, Endre; Qwarnstrom, Eva E.			TILRR, a Novel IL-1RI Co-receptor, Potentiates MyD88 Recruitment to Control Ras-dependent Amplification of NF-kappa B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; TOLL-LIKE RECEPTORS; HEPARAN-SULFATE; EXTRACELLULAR-MATRIX; CELLS; MECHANOTRANSDUCTION; INTERLEUKIN-1-BETA; PHOSPHORYLATION; IDENTIFICATION; EXPRESSION	Host defense against infection is induced by Toll-like and interleukin (IL)-1 receptors, and controlled by the transcription factor NF-kappa B. Our earlier studies have shown that IL-1 activation impacts cytoskeletal structure and that IL-1 receptor (IL-1RI) function is substrate-dependent. Here we identify a novel regulatory component, TILRR, which amplifies activation of IL-1RI and coordinates IL-1-induced control with mechanotransduction. We show that TILRR is a highly conserved and widely expressed enhancer of IL-1-regulated inflammatory responses and, further, that it is a membrane-bound glycosylated protein with sequence homology to members of the FRAS-1 family. We demonstrate that TILRR is recruited to the IL-1 receptor complex and magnifies signal amplification by increasing receptor expression and ligand binding. In addition, we show that the consequent potentiation of NF-kappa B is controlled through IL-1RI-associated signaling components in coordination with activation of the Ras GTPase. Using mutagenesis, we demonstrate that TILRR function is dependent on association with its signaling partner and, further, that formation of the TILRR-containing IL-1RI complex imparts enhanced association of the MyD88 adapter during ligand-induced activation of NF-kappa B. We conclude that TILRR is an IL-1RI co-receptor, which associates with the signaling receptor complex to enhance recruitment of MyD88 and control Ras-dependent amplification of NF-kappa B and inflammatory responses.	[Qwarnstrom, Eva E.] Univ Sheffield, Sch Med & Biomed Sci, Cell Biol Unit, Sheffield S10 2RX, S Yorkshire, England; [Kiss-Toth, Endre] Univ Sheffield, Sch Med & Biomed Sci, Cardiovasc Res Unit, Sheffield S10 2RX, S Yorkshire, England; [O'Neill, Luke A. J.] Trinity Coll Dublin, Sch Biochem & Immunol, Dublin 2, Ireland; [Qwarnstrom, Eva E.] Univ Washington, Affiliated Dept Pathol, Seattle, WA 98195 USA	University of Sheffield; University of Sheffield; Trinity College Dublin; University of Washington; University of Washington Seattle	Qwarnstrom, EE (corresponding author), Univ Sheffield, Sch Med & Biomed Sci, Cell Biol Unit, Beech Hill Rd, Sheffield S10 2RX, S Yorkshire, England.	e.qwarnstrom@sheffield.ac.uk	Kiss-Toth, Endre/A-8596-2014; Kiss-Toth, Endre/AAC-4252-2020	Kiss-Toth, Endre/0000-0003-4406-4017; Kiss-Toth, Endre/0000-0003-4406-4017; Fowler, Gregory/0000-0002-0420-7661; Qwarnstrom, Eva/0000-0003-4417-8663; Palmer, Ian Roy/0000-0002-6884-8900; O'Neill, Luke/0000-0002-4333-2748; Zhang, Xiao/0000-0002-3894-8513	Biotechnology and Biological Sciences Research Council [BB/C515798/1, BBS/B/04056]; British Heart Foundation [PG/2000094, PG/07/094/23742]; Engineering and Physical Sciences Research Council [EP/E036252/1] Funding Source: researchfish; EPSRC [EP/E036252/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by Biotechnology and Biological Sciences Research Council Grants BB/C515798/1 and BBS/B/04056 and British Heart Foundation Grants PG/2000094 and PG/07/094/23742 (to E. E. Q.).	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Akira S, 2003, BIOCHEM SOC T, V31, P637, DOI 10.1042/BST0310637; Ashcroft AE, 2003, NAT PROD REP, V20, P202, DOI 10.1039/b201368c; Banno T, 2004, J BIOL CHEM, V279, P32633, DOI 10.1074/jbc.M400642200; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Caunt CJ, 2001, J BIOL CHEM, V276, P6280, DOI 10.1074/jbc.M006772200; Cumberbatch M, 1997, IMMUNOLOGY, V92, P388, DOI 10.1046/j.1365-2567.1997.00360.x; Dinarello CA, 2005, J EXP MED, V201, P1355, DOI 10.1084/jem.20050640; Fukushima K, 2005, J BIOL CHEM, V280, P18056, DOI 10.1074/jbc.M413297200; Gay NJ, 2007, ANNU REV BIOCHEM, V76, P141, DOI 10.1146/annurev.biochem.76.060305.151318; Gay NJ, 2006, NAT REV IMMUNOL, V6, P693, DOI 10.1038/nri1916; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; Hahn C, 2009, NAT REV MOL CELL BIO, V10, P53, DOI 10.1038/nrm2596; Haubert D, 2007, EMBO J, V26, P3308, DOI 10.1038/sj.emboj.7601778; Kamon H, 2006, EMBO J, V25, P4108, DOI 10.1038/sj.emboj.7601286; Kiss-Toth E, 2006, CELL SIGNAL, V18, P202, DOI 10.1016/j.cellsig.2005.04.012; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; LOPEZCASILLAS F, 1993, CELL, V73, P1435, DOI 10.1016/0092-8674(93)90368-Z; McGregor L, 2003, NAT GENET, V34, P203, DOI 10.1038/ng1142; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; O'Neill LAJ, 2006, CURR OPIN IMMUNOL, V18, P3, DOI 10.1016/j.coi.2005.11.012; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Pogson M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002367; QWARNSTROM EE, 1991, P NATL ACAD SCI USA, V88, P1232, DOI 10.1073/pnas.88.4.1232; SCHLESSINGER J, 1995, CELL, V83, P357, DOI 10.1016/0092-8674(95)90112-4; Sims JE, 2002, CURR OPIN IMMUNOL, V14, P117, DOI 10.1016/S0952-7915(01)00306-5; Slack JL, 2000, J BIOL CHEM, V275, P4670, DOI 10.1074/jbc.275.7.4670; Tanaka M, 2004, REV PHYSIOL BIOCH P, V149, P39, DOI 10.1007/s10254-003-0013-1; Valles S, 2002, LAB INVEST, V82, P855, DOI 10.1097/01.LAB.0000020420.07575.3F; Valles S, 1999, J BIOL CHEM, V274, P20103, DOI 10.1074/jbc.274.29.20103; Vigers GPA, 1997, NATURE, V386, P190, DOI 10.1038/386190a0; Wang N, 2009, NAT REV MOL CELL BIO, V10, P75, DOI 10.1038/nrm2594; Wesche H, 1997, IMMUNITY, V7, P837, DOI 10.1016/S1074-7613(00)80402-1; Wyllie DH, 2000, J IMMUNOL, V165, P7125, DOI 10.4049/jimmunol.165.12.7125; Yang L, 2003, J BIOL CHEM, V278, P30881, DOI 10.1074/jbc.M212216200; Zeisel MB, 2005, J IMMUNOL, V174, P7393, DOI 10.4049/jimmunol.174.11.7393	36	30	35	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7222	7232		10.1074/jbc.M109.073429	http://dx.doi.org/10.1074/jbc.M109.073429			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	19940113	hybrid, Green Published			2022-12-25	WOS:000275415600035
J	Li, GR; Luna, C; Qiu, JM; Epstein, DL; Gonzalez, P				Li, Guorong; Luna, Coralia; Qiu, Jianming; Epstein, David L.; Gonzalez, Pedro			Targeting of Integrin beta 1 and Kinesin 2 alpha by MicroRNA 183	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRABECULAR MESHWORK CELLS; KINASE EXPRESSION INCREASES; RETINAL GANGLION-CELLS; GENE-EXPRESSION; EXTRACELLULAR-MATRIX; CELLULAR SENESCENCE; MALIGNANT PHENOTYPE; SIGNALING PATHWAYS; COLORECTAL-CANCER; MOUSE MODEL	MicroRNA 183 (miR-183) has been reported to inhibit tumor invasiveness and is believed to be involved in the development and function of ciliated neurosensory organs. We have recently found that expression of miR-183 increased after the induction of cellular senescence by exposure to H2O2. To gain insight into the biological roles of miR-183 we investigated two potential novel targets: integrin beta 1 (ITGB1) and kinesin 2 alpha (KIF2A). miR-183 significantly decreased the expression of ITGB1 and KIF2A measured by Western blot. Targeting of the 3'-untranslated region (3'-UTR) of ITGB1 and KIF2A by miR-183 was confirmed by luciferase assay. Transfection with miR-183 led to a significant decrease in cell invasion and migration capacities of HeLa cells that could be rescued by expression of ITGB1 lacking the 3'-UTR. Although miR-183 had no effects on cell adhesion in HeLa cells, it significantly decreased adhesion to laminin, gelatin, and collagen type I in normal human diploid fibroblasts and human trabecular meshwork cells. These effects were also rescued by expression of ITGB1 lacking the 3'-UTR. Targeting of KIF2A by miR-183 resulted in some increase in the formation of cells with monopolar spindles in HeLa cells but not in human diploid fibroblast or human trabecular meshwork cells. The regulation of ITGB1 expression by miR-183 provides a new mechanism for the anti-metastatic role of miR-183 and suggests that this miRNA could influence the development and function in neurosensory organs, and contribute to functional alterations associated with cellular senescence in human diploid fibroblasts and human trabecular meshwork cells.	[Li, Guorong; Luna, Coralia; Qiu, Jianming; Epstein, David L.; Gonzalez, Pedro] Duke Univ, Dept Ophthalmol, Durham, NC 27710 USA	Duke University	Gonzalez, P (corresponding author), 4002 AERI Bldg,2351 Erwin Rd, Durham, NC 27710 USA.	gonza012@mc.duke.edu	Ariel, Pablo/AGJ-4118-2022		NEI [EY01894, EY016228, EY019137, EY05722]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY016228, R01EY001894, R21EY019137, P30EY005722] Funding Source: NIH RePORTER	NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY01894, EY016228, EY019137, and EY05722 from the NEI, and Research to Prevent Blindness.	Ahmed N, 2003, J PATHOL, V201, P229, DOI 10.1002/path.1441; Bandres E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-29; Belvindrah R, 2007, J NEUROSCI, V27, P2704, DOI 10.1523/JNEUROSCI.2991-06.2007; Borras T, 2003, PROG RETIN EYE RES, V22, P435, DOI 10.1016/S1350-9462(03)00018-1; Bradley JMB, 2003, INVEST OPHTH VIS SCI, V44, P5174, DOI 10.1167/iovs.03-0213; Cann GM, 1996, DEV BIOL, V180, P82, DOI 10.1006/dbio.1996.0286; CANNISTRA SA, 1995, GYNECOL ONCOL, V58, P216, DOI 10.1006/gyno.1995.1214; Carlson TR, 2008, DEVELOPMENT, V135, P2193, DOI 10.1242/dev.016378; Casey RC, 2000, CLIN EXP METASTAS, V18, P67, DOI 10.1023/A:1026519016213; Chow J, 2007, MOL VIS, V13, P1926; Clegg D O, 2000, Results Probl Cell Differ, V31, P141; Davies D, 2002, J COMP NEUROL, V445, P122, DOI 10.1002/cne.10161; De Arcangelis A, 2000, TRENDS GENET, V16, P389, DOI 10.1016/S0168-9525(00)02074-6; Dupuy AG, 2008, J CELL SCI, V121, P1773, DOI 10.1242/jcs.018036; Emsley JG, 2003, EXP NEUROL, V183, P273, DOI 10.1016/S0014-4886(03)00209-7; Evans AL, 2000, NAT GENET, V24, P424, DOI 10.1038/74286; Fais S, 2007, CANCER LETT, V258, P155, DOI 10.1016/j.canlet.2007.09.014; FASSLER R, 1995, J CELL BIOL, V128, P979, DOI 10.1083/jcb.128.5.979; Felding-Habermann B, 2003, CLIN EXP METASTAS, V20, P203, DOI 10.1023/A:1022983000355; Filla MS, 2006, INVEST OPHTH VIS SCI, V47, P1956, DOI 10.1167/iovs.05-0626; Friedland JC, 2009, SCIENCE, V323, P642, DOI 10.1126/science.1168441; Ganem NJ, 2004, J CELL BIOL, V166, P473, DOI 10.1083/jcb.200404012; Graff JR, 2001, CLIN CANCER RES, V7, P1987; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; Jang CY, 2008, J CELL BIOL, V181, P255, DOI 10.1083/jcb.200711032; Johnstone MA, 2004, J GLAUCOMA, V13, P421, DOI 10.1097/01.ijg.0000131757.63542.24; Kanasaki K, 2008, DEV BIOL, V313, P584, DOI 10.1016/j.ydbio.2007.10.047; KEMPERMAN H, 1994, INVAS METAST, V14, P98; Leu ST, 2004, DEV BIOL, V276, P416, DOI 10.1016/j.ydbio.2004.09.003; Li GR, 2009, MECH AGEING DEV, V130, P731, DOI 10.1016/j.mad.2009.09.002; Loscher CJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r248; Lugini L, 2003, LAB INVEST, V83, P1555, DOI 10.1097/01.LAB.0000098425.03006.42; Luna C, 2009, MOL VIS, V15, P534; Marotta A, 2001, ONCOGENE, V20, P6250, DOI 10.1038/sj.onc.1204791; Marrs GS, 2006, MOL CELL NEUROSCI, V32, P230, DOI 10.1016/j.mcn.2006.04.005; Motoyama K, 2009, INT J ONCOL, V34, P1069, DOI 10.3892/ijo_00000233; Ohtani N, 2009, CANCER SCI, V100, P792, DOI 10.1111/j.1349-7006.2009.01123.x; Oktay MH, 2003, HUM PATHOL, V34, P240, DOI 10.1053/hupa.2003.40; Puklin-Faucher E, 2009, J CELL SCI, V122, P179, DOI 10.1242/jcs.042127; Ramsay AG, 2007, CANCER METAST REV, V26, P567, DOI 10.1007/s10555-007-9078-7; Skeith A, 1999, DEV BRAIN RES, V116, P123, DOI 10.1016/S0165-3806(99)00070-X; Soukup GA, 2009, BRAIN RES, V1277, P104, DOI 10.1016/j.brainres.2009.02.027; STEPHENS LE, 1993, J CELL BIOL, V123, P1607, DOI 10.1083/jcb.123.6.1607; Toyama K, 2005, HEARING RES, V201, P21, DOI 10.1016/j.heares.2004.04.019; Wang F, 2002, JNCI-J NATL CANCER I, V94, P1494, DOI 10.1093/jnci/94.19.1494; Wang GF, 2008, FEBS LETT, V582, P3663, DOI 10.1016/j.febslet.2008.09.051; Weaver VM, 1997, J CELL BIOL, V137, P231, DOI 10.1083/jcb.137.1.231; Wederell ED, 2006, SEMIN CELL DEV BIOL, V17, P759, DOI 10.1016/j.semcdb.2006.10.006; White DE, 2004, CANCER CELL, V6, P159, DOI 10.1016/j.ccr.2004.06.025; White DE, 2007, J MAMMARY GLAND BIOL, V12, P135, DOI 10.1007/s10911-007-9045-5; Yantiss RK, 2009, AM J SURG PATHOL, V33, P572, DOI 10.1097/PAS.0b013e31818afd6b	51	83	89	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5461	5471		10.1074/jbc.M109.037127	http://dx.doi.org/10.1074/jbc.M109.037127			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	19940135	Green Published, hybrid			2022-12-25	WOS:000275327200039
J	Zhao, YB; Shen, Y; Yang, SL; Wang, JY; Hu, QW; Wang, Y; He, Q				Zhao, Yuanbiao; Shen, Ye; Yang, Silu; Wang, Jiyong; Hu, Qiwen; Wang, Ying; He, Qun			Ubiquitin Ligase Components Cullin4 and DDB1 Are Essential for DNA Methylation in Neurospora crassa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE H3 METHYLTRANSFERASE; CIRCADIAN CLOCK; EPIGENETIC INHERITANCE; LYSINE-9 METHYLATION; PROTEINS; HP1; HETEROCHROMATIN; ARABIDOPSIS; FREQUENCY; COMPLEX	DNA methylation and H3K9 trimethylation are involved in gene silencing and heterochromatin assembly in mammals and fungi. In the filamentous fungus Neurospora crassa, it has been demonstrated that H3K9 trimethylation catalyzed by histone methyltransferase DIM-5 is essential for DNA methylation. Trimethylated H3K9 is recognized by HP1, which then recruits the DNA methyltransferase DIM-2 to methylate the DNA. Here, we show that in Neurospora, ubiquitin ligase components Cullin4 and DDB1 are essential for DNA methylation. These proteins regulate DNA methylation through their effects on the trimethylation of histone H3K9. In addition, we showed that the E3 ligase activity of the Cul4-based ubiquitin ligase is required for its function in histone H3K9 trimethylation in Neurospora. Furthermore, we demonstrated that Cul4 and DDB1 are associated with the histone methyltransferase DIM-5 protein in vivo. Together, these results suggest a mechanism for DNA methylation control that may be applicable in other eukaryotic organisms.	[Zhao, Yuanbiao; Shen, Ye; Yang, Silu; Wang, Jiyong; Hu, Qiwen; Wang, Ying; He, Qun] China Agr Univ, State Key Lab Agrobiotechnol, Coll Biol Sci, Beijing 100193, Peoples R China	China Agricultural University	He, Q (corresponding author), China Agr Univ, State Key Lab Agrobiotechnol, Coll Biol Sci, Beijing 100193, Peoples R China.	qunhe@cau.edu.cn	zhao, yuanbiao/I-2990-2019		State Key Laboratory of Agrobiotechnology [2008SKLAB03-02]; Program for New Century Excellent Talents in University [NCET-06-0104]; Doctoral Program of Higher Education of China [20070019020]	State Key Laboratory of Agrobiotechnology; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by State Key Laboratory of Agrobiotechnology Grant 2008SKLAB03-02 (to Q. H.), Program for New Century Excellent Talents in University Grant NCET-06-0104, and Specialized Research Fund for the Doctoral Program of Higher Education of China Grant 20070019020.	Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; ARONSON BD, 1994, SCIENCE, V263, P1578, DOI 10.1126/science.8128244; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; CAMBARERI EB, 1989, SCIENCE, V244, P1571, DOI 10.1126/science.2544994; Cheng P, 2001, EMBO J, V20, P101, DOI 10.1093/emboj/20.1.101; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; El-Shami M, 2007, GENE DEV, V21, P2539, DOI 10.1101/gad.451207; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Freitag M, 2004, SCIENCE, V304, P1939, DOI 10.1126/science.1099709; Freitag M, 2005, CURR OPIN GENET DEV, V15, P191, DOI 10.1016/j.gde.2005.02.003; Freitag M, 2004, MOL CELL, V13, P427, DOI 10.1016/S1097-2765(04)00024-3; Garceau NY, 1997, CELL, V89, P469, DOI 10.1016/S0092-8674(00)80227-5; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; He Q, 2005, GENE DEV, V19, P1518, DOI 10.1101/gad.1322205; He Q, 2006, GENE DEV, V20, P2552, DOI 10.1101/gad.1463506; He QY, 2005, GENE DEV, V19, P2888, DOI 10.1101/gad.1369605; He YZJ, 2006, GENE DEV, V20, P2949, DOI 10.1101/gad.1483206; Henderson IR, 2007, NATURE, V447, P418, DOI 10.1038/nature05917; Higa LA, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-5; Higa LA, 2006, NAT CELL BIOL, V8, P1277, DOI 10.1038/ncb1490; Honda S, 2008, MOL CELL BIOL, V28, P6044, DOI 10.1128/MCB.00823-08; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Jia ST, 2005, NAT CELL BIOL, V7, P1007, DOI 10.1038/ncb1300; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Kouzminova E, 2001, EMBO J, V20, P4309, DOI 10.1093/emboj/20.15.4309; Kuramochi-Miyagawa S, 2008, GENE DEV, V22, P908, DOI 10.1101/gad.1640708; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; Li T, 2006, CELL, V124, P105, DOI 10.1016/j.cell.2005.10.033; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Luo CH, 1998, EMBO J, V17, P1228, DOI 10.1093/emboj/17.5.1228; Martienssen RA, 2001, SCIENCE, V293, P1070, DOI 10.1126/science.293.5532.1070; Miao VPW, 2000, J MOL BIOL, V300, P249, DOI 10.1006/jmbi.2000.3864; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Ninomiya Y, 2004, P NATL ACAD SCI USA, V101, P12248, DOI 10.1073/pnas.0402780101; O'Connell BC, 2007, CURR OPIN CELL BIOL, V19, P206, DOI 10.1016/j.ceb.2007.02.014; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; REIS A, 1994, AM J HUM GENET, V54, P741; Saze H, 2008, SCIENCE, V319, P462, DOI 10.1126/science.1150987; Selker EU, 2003, NATURE, V422, P893, DOI 10.1038/nature01564; Shames DS, 2007, CURR MOL MED, V7, P85, DOI 10.2174/156652407779940413; SINGER MJ, 1995, MOL CELL BIOL, V15, P5586; Sleutels F, 2002, NATURE, V415, P810, DOI 10.1038/415810a; Tamaru H, 2001, NATURE, V414, P277, DOI 10.1038/35104508; Tamaru H, 2003, NAT GENET, V34, P75, DOI 10.1038/ng1143; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wang HB, 2006, MOL CELL, V22, P383, DOI 10.1016/j.molcel.2006.03.035	51	47	49	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4355	4365		10.1074/jbc.M109.034710	http://dx.doi.org/10.1074/jbc.M109.034710			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	19948733	Green Published, hybrid			2022-12-25	WOS:000275274800012
J	Peterfy, M; Harris, TE; Fujita, N; Reue, K				Peterfy, Miklos; Harris, Thurl E.; Fujita, Naoya; Reue, Karen			Insulin-stimulated Interaction with 14-3-3 Promotes Cytoplasmic Localization of Lipin-1 in Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MG2+-DEPENDENT PHOSPHATIDATE PHOSPHATASE; SUBCELLULAR-LOCALIZATION; RAT HEPATOCYTES; DEPENDENT ACTIVATION; MAMMALIAN TARGET; KINASE-ACTIVITY; RAF-1 KINASE; FATTY-ACIDS; PHOSPHORYLATION; PROTEINS	Lipin-1 is a bifunctional protein involved in lipid metabolism and adipogenesis. Lipin-1 plays a role in the biosynthesis of triacylglycerol through its phosphatidate phosphatase activity and also acts as a transcriptional co-activator of genes involved in oxidative metabolism. Lipin-1 resides in the cytoplasm and translocates to the endoplasmic reticulum membrane to catalyze the phosphatidate phosphatase reaction. It also possesses a nuclear localization signal, which is required for its translocation to the nucleus and may therefore be important for lipin-1 co- activator function. Thus, subcellular localization may be an important factor in the regulation of this protein. Here, we show that the nuclear localization signal alone is not sufficient for lipin-1 nuclear localization, and identify lipin-1 interaction with 14-3-3 as a determinant of its subcellular localization. We demonstrate that lipin-1 interacts with 14-3-3 proteins and that overexpression of 14-3-3 promotes the cytoplasmic localization of lipin-1 in 3T3-L1 adipocytes. The effect of 14-3-3 is mediated through a serine-rich domain in lipin-1. Functional mapping of the 14-3-3-interacting region within the serine-rich domain indicates redundancy and cooperativity among several sites, including five phosphorylated serine and threonine residues. Insulin stimulation of 3T3-L1 adipocytes results in increased lipin-1 phosphorylation, enhanced interaction with 14-3-3, and predominantly cytoplasmic localization. In summary, our studies suggest that insulin may modulate the cellular function of lipin-1 by regulating its subcellular localization through interactions with 14-3-3 proteins.	[Reue, Karen] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Peterfy, Miklos] Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA 90073 USA; [Peterfy, Miklos] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Harris, Thurl E.] Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA; [Fujita, Naoya] Japanese Fdn Canc Res, Ctr Canc Chemotherapy, Tokyo 1358550, Japan	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; Cedars Sinai Medical Center; University of Virginia; Japanese Foundation for Cancer Research	Reue, K (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Gonda 6506A,695 Charles E Young Dr S, Los Angeles, CA 90095 USA.	reuek@ucla.edu			National Institutes of Health [HL28481, DK28312]; American Diabetes Association [23018]; Cedars-Sinai Medical Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL028481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK028312] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Cedars-Sinai Medical Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL28481 (to M. P. and K. R.) and DK28312 (to T. E. H.). This work was also supported by American Diabetes Association Grant 23018 (to M. P.) and the Cedars-Sinai Medical Center (to M. P.).	Andrews RK, 1998, BIOCHEMISTRY-US, V37, P638, DOI 10.1021/bi970893g; BRINDLEY DN, 1988, PHOSPHATIDATE PHOSPH; Brunn GJ, 1997, J BIOL CHEM, V272, P32547, DOI 10.1074/jbc.272.51.32547; CASCALES C, 1984, BIOCHEM J, V219, P911, DOI 10.1042/bj2190911; DIGGLE TA, 1991, BIOCHEM J, V279, P545, DOI 10.1042/bj2790545; Donkor J, 2007, J BIOL CHEM, V282, P3450, DOI 10.1074/jbc.M610745200; Dougherty MK, 2004, J CELL SCI, V117, P1875, DOI 10.1242/jcs.01171; Finck BN, 2006, CELL METAB, V4, P199, DOI 10.1016/j.cmet.2006.08.005; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Fujita N, 2002, J BIOL CHEM, V277, P28706, DOI 10.1074/jbc.M203668200; Gardino AK, 2006, SEMIN CANCER BIOL, V16, P173, DOI 10.1016/j.semcancer.2006.03.007; GOMEZMUNOZ A, 1992, FEBS LETT, V301, P103, DOI 10.1016/0014-5793(92)80219-7; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Harris TE, 2007, J BIOL CHEM, V282, P277, DOI 10.1074/jbc.M609537200; Harris TE, 2006, EMBO J, V25, P1659, DOI 10.1038/sj.emboj.7601047; Hausser A, 1999, J BIOL CHEM, V274, P9258, DOI 10.1074/jbc.274.14.9258; Heesom KJ, 1998, BIOCHEM J, V336, P39, DOI 10.1042/bj3360039; HOPEWELL R, 1985, BIOCHEM J, V232, P485, DOI 10.1042/bj2320485; Huffman TA, 2002, P NATL ACAD SCI USA, V99, P1047, DOI 10.1073/pnas.022634399; Khalil MB, 2009, J LIPID RES, V50, P47, DOI 10.1194/jlr.M800204-JLR200; Kim YJ, 2007, P NATL ACAD SCI USA, V104, P6596, DOI 10.1073/pnas.0702099104; Kosaki A, 1998, J BIOL CHEM, V273, P940, DOI 10.1074/jbc.273.2.940; Ku NO, 1998, EMBO J, V17, P1892, DOI 10.1093/emboj/17.7.1892; Lehoux S, 2001, J BIOL CHEM, V276, P15794, DOI 10.1074/jbc.M100410200; Liu GH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007031; Liu YC, 1997, J BIOL CHEM, V272, P9979, DOI 10.1074/jbc.272.15.9979; MARTINSANZ P, 1984, FEBS LETT, V175, P284, DOI 10.1016/0014-5793(84)80752-8; Muslin AJ, 2000, CELL SIGNAL, V12, P703, DOI 10.1016/S0898-6568(00)00131-5; O'Hara L, 2006, J BIOL CHEM, V281, P34537, DOI 10.1074/jbc.M606654200; Peterfy M, 2005, J BIOL CHEM, V280, P32883, DOI 10.1074/jbc.M503885200; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Phan J, 2005, CELL METAB, V1, P73, DOI 10.1016/j.cmet.2004.12.002; Phan J, 2004, J BIOL CHEM, V279, P29558, DOI 10.1074/jbc.M403506200; Pierrat B, 2000, EUR J BIOCHEM, V267, P2680, DOI 10.1046/j.1432-1327.2000.01285.x; PITTNER RA, 1985, BIOCHEM J, V230, P525, DOI 10.1042/bj2300525; Porras A, 1996, INT J OBESITY, V20, pS43; Reue K, 2000, J LIPID RES, V41, P1067; Reue K, 2008, J LIPID RES, V49, P2493, DOI 10.1194/jlr.R800019-JLR200; Reue K, 2009, CURR OPIN LIPIDOL, V20, P165, DOI 10.1097/MOL.0b013e32832adee5; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; Sato S, 2002, J BIOL CHEM, V277, P39360, DOI 10.1074/jbc.M205141200; Thorson JA, 1998, MOL CELL BIOL, V18, P5229, DOI 10.1128/MCB.18.9.5229; Tzivion G, 2002, J BIOL CHEM, V277, P3061, DOI 10.1074/jbc.R100059200; van Hemert MJ, 2001, BIOESSAYS, V23, P936, DOI 10.1002/bies.1134; Waterman MJF, 1998, NAT GENET, V19, P175, DOI 10.1038/542; WITTERS LA, 1983, J BIOL CHEM, V258, P5643; Zhang LX, 1997, J BIOL CHEM, V272, P13717, DOI 10.1074/jbc.272.21.13717	47	60	63	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3857	3864		10.1074/jbc.M109.072488	http://dx.doi.org/10.1074/jbc.M109.072488			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19955570	hybrid, Green Published			2022-12-25	WOS:000275254000039
J	Rai, K; Jafri, IF; Chidester, S; James, SR; Karpf, AR; Cairns, BR; Jones, DA				Rai, Kunal; Jafri, Itrat F.; Chidester, Stephanie; James, Smitha R.; Karpf, Adam R.; Cairns, Bradley R.; Jones, David A.			Dnmt3 and G9a Cooperate for Tissue-specific Development in Zebrafish	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CPG-BINDING-PROTEIN; DNA METHYLATION; EXPRESSION PATTERN; BHLH GENES; LIVER; BRAIN; METHYLTRANSFERASE; DIFFERENTIATION; REPLICATION; HOMEOBOX	Although DNA methylation is critical for proper embryonic and tissue-specific development, how different DNA methyltransferases affect tissue-specific development and their targets remains unknown. We address this issue in zebrafish through antisense-based morpholino knockdown of Dnmt3 and Dnmt1. Our data reveal that Dnmt3 is required for proper neurogenesis, and its absence results in profound defects in brain and retina. Interestingly, other organs such as intestine remain unaffected suggesting tissue-specific requirements of Dnmt3. Further, comparison of Dnmt1 knockdown phenotypes with those of Dnmt3suggested that these two families have distinct functions. Consistent with this idea, Dnmt1 failed to complement Dnmt3 deficiency, and Dnmt3 failed to complement Dnmt1 deficiency. Downstream of Dnmt3 we identify a neurogenesis regulator, lef1, as a Dnmt3-specific target gene that is demethylated and up-regulated in dnmt3 morphants. Knockdown of lef1 rescued neurogenesis defects resulting from Dnmt3 absence. Mechanistically, we show cooperation between Dnmt3 and an H3K9 methyltransferase G9a in regulating lef1. Further, like Dnmt1Suv39h1 cooperativity, Dnmt3 and G9a seemed to function together for tissue-specific development. G9a knockdown, but not Suv39h1 loss, phenocopied dnmt3 morphants and G9a overexpression provided a striking rescue of dnmt3 morphant phenotypes, whereas Suv39h1 overexpression failed, supporting the notion of specific DNMT-histone methyltransferase networks. Consistent with this model, H3K9me3 levels on the lef1 promoter were reduced in both dnmt3 and g9a morphants, and its knockdown rescued neurogenesis defects in g9a morphants. We propose a model wherein specific DNMT-histone methyltransferase networks are utilized to silence critical regulators of cell fate in a tissue-specific manner.	[Rai, Kunal; Jafri, Itrat F.; Chidester, Stephanie; Cairns, Bradley R.; Jones, David A.] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; [Jones, David A.] Univ Utah, Dept Oncol Sci, Salt Lake City, UT 84112 USA; [Jones, David A.] Univ Utah, Dept Med Chem, Salt Lake City, UT 84112 USA; [Rai, Kunal; Jafri, Itrat F.; Cairns, Bradley R.] Univ Utah, Howard Hughes Med Inst, Salt Lake City, UT 84112 USA; [James, Smitha R.; Karpf, Adam R.] Roswell Pk Canc Inst, Dept Pharm & Therapeut, Buffalo, NY 14263 USA	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; Roswell Park Cancer Institute	Cairns, BR (corresponding author), Univ Utah, Huntsman Canc Inst, 2000 Circle Hope, Salt Lake City, UT 84112 USA.	brad.cairns@hci.utah.edu; david.jones@hci.utah.edu		Chidester, Stephanie/0000-0003-4163-3480; Karpf, Adam/0000-0002-0866-0666; Rai, Kunal/0000-0003-2321-6894	National Institutes of Health [R01 HD058506]; NCI [R01 CA116468, R01 CA11674]; Howard Hughes Medical Institute; HuntsmanCancer Foundation; Cancer Center [CA042014]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058506] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA042014, R01CA116468, R01CA116674] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); HuntsmanCancer Foundation; Cancer Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HD058506 (to D. A. J. and B. R. C.) and by NCI Grants R01 CA116468 and R01 CA11674 (to D. A. J. and A. R. K.). This work was also supported by the Howard Hughes Medical Institute (to B. R. C.), the HuntsmanCancer Foundation (to D. A. J. and B. R. C.), and Cancer Center Support Grant CA042014.	AKIMENKO MA, 1994, J NEUROSCI, V14, P3475; ALLENDE ML, 1994, DEV BIOL, V166, P509, DOI 10.1006/dbio.1994.1334; Anderson RM, 2009, DEV BIOL, V334, P213, DOI 10.1016/j.ydbio.2009.07.017; Beri S, 2007, J NEUROCHEM, V101, P1380, DOI 10.1111/j.1471-4159.2007.04539.x; Biemar F, 2001, DEV BIOL, V230, P189, DOI 10.1006/dbio.2000.0103; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; Blader P, 1997, DEVELOPMENT, V124, P4557; De Smet C, 1999, MOL CELL BIOL, V19, P7327; Denovan-Wright EM, 2000, BBA-GENE STRUCT EXPR, V1492, P227, DOI 10.1016/S0167-4781(00)00102-0; Douet V, 2007, BIOCHEM BIOPH RES CO, V354, P66, DOI 10.1016/j.bbrc.2006.12.151; Ellies DL, 1997, GENOMICS, V45, P580, DOI 10.1006/geno.1997.4978; Esteve PO, 2006, GENE DEV, V20, P3089, DOI 10.1101/gad.1463706; Field HA, 2003, DEV BIOL, V253, P279, DOI 10.1016/S0012-1606(02)00017-9; Forsell J, 2001, J EXP BIOL, V204, P2517; Fujita N, 2003, J BIOL CHEM, V278, P24132, DOI 10.1074/jbc.M302283200; Fuks F, 2003, NUCLEIC ACIDS RES, V31, P2305, DOI 10.1093/nar/gkg332; Gimona M, 2002, FEBS LETT, V513, P98, DOI 10.1016/S0014-5793(01)03240-9; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Goll MG, 2006, SCIENCE, V311, P395, DOI 10.1126/science.1120976; Hatakeyama J, 2004, SEMIN CELL DEV BIOL, V15, P83, DOI 10.1016/j.semcdb.2003.09.005; Hatakeyama J, 2001, DEVELOPMENT, V128, P1313; Hsu M, 2007, MOL CELL BIOL, V27, P5047, DOI 10.1128/MCB.02234-06; JACKSONGRUSBY L, 2001, NAT GENET, V39, P27; Kim CH, 1997, NEUROSCI LETT, V239, P113, DOI 10.1016/S0304-3940(97)00908-7; Kimura H, 2003, J BIOL CHEM, V278, P4806, DOI 10.1074/jbc.M209923200; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Korzh V, 1998, DEV DYNAM, V213, P92, DOI 10.1002/(SICI)1097-0177(199809)213:1<92::AID-AJA9>3.0.CO;2-T; KRAUSS S, 1991, NATURE, V353, P267, DOI 10.1038/353267a0; Lee JE, 2006, DEVELOPMENT, V133, P4451, DOI 10.1242/dev.02613; LI HS, 1994, DEV BIOL, V162, P181, DOI 10.1006/dbio.1994.1077; Mudumana SP, 2004, DEV DYNAM, V230, P165, DOI 10.1002/dvdy.20032; Nadauld LD, 2004, J BIOL CHEM, V279, P51581, DOI 10.1074/jbc.M408830200; Nornes S, 1998, MECH DEVELOP, V77, P185, DOI 10.1016/S0925-4773(98)00156-7; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; PUSCHEL AW, 1992, MECH DEVELOP, V38, P197, DOI 10.1016/0925-4773(92)90053-M; Rai K, 2006, MOL CELL BIOL, V26, P7077, DOI 10.1128/MCB.00312-06; Rai K, 2007, GENE DEV, V21, P261, DOI 10.1101/gad.1472907; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; RAZIN A, 1991, MICROBIOL REV, V55, P451, DOI 10.1128/MMBR.55.3.451-458.1991; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Sarraf SA, 2004, MOL CELL, V15, P595, DOI 10.1016/j.molcel.2004.06.043; Schilling E, 2007, GENOMICS, V90, P314, DOI 10.1016/j.ygeno.2007.04.011; SCHNEIDERMAUNOURY S, 1993, CELL, V75, P1199, DOI 10.1016/0092-8674(93)90329-O; Shimoda N, 2005, DEV DYNAM, V233, P1509, DOI 10.1002/dvdy.20455; Stenkamp D L, 1998, Mol Vis, V4, P26; Tatematsu K, 2000, GENES CELLS, V5, P677, DOI 10.1046/j.1365-2443.2000.00359.x; Thomas T, 1998, DEVELOPMENT, V125, P3005; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990	48	95	97	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					4110	4121		10.1074/jbc.M109.073676	http://dx.doi.org/10.1074/jbc.M109.073676			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19946145	Green Published, hybrid			2022-12-25	WOS:000275254000063
J	Wan, T; Liu, T; Zhang, HF; Tang, SB; Min, W				Wan, Ting; Liu, Ting; Zhang, Haifeng; Tang, Shibo; Min, Wang			AIP1 Functions as Arf6-GAP to Negatively Regulate TLR4 Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTORS; ADAPTER MOLECULE; INTERFERON-BETA; PLASMA-MEMBRANE; PROTEIN; PATHWAY; FAMILY; ACTIVATION; TIRAP; TOLL-LIKE-RECEPTOR-4	Toll-like receptor 4 (TLR4) is unique among the Toll-like receptors in its ability to utilize TLR/IL1R-domain-containing adaptor protein (TIRAP), which recruits TLR4-MyD88 to phosphatidylinositol 4,5-bisphosphate (PIP2)-rich sites on the plasma membrane, to activate NF-kappa B and MAPK pathways. Here, we show that AIP1 disrupts formation of the TLR4-TIRAP-MyD88 complex without directly binding to any of the complex components. AIP1 via its pleckstrin homology and C2 domains binds to phosphatidylinositol 4-phosphate, a lipid precursor of PIP2. Knock-out of AIP1 in cells increases and overexpression of AIP1 reduces cellular PIP2 levels. We further show that AIP1 is a novel GTPase-activating protein (GAP) for Arf6, a small GTPase regulating cellular PIP2 production and formation of the TLR4-TIRAP-MyD88 complex. Thus, deletion of the GAPdomain on AIP1 results in a loss of its ability to mediate the inhibition of Arf6- and TLR4-induced signaling events. We conclude that AIP1 functions as a novel Arf6- GAP to negatively regulate PIP2-dependent TLR4-TIRAP-MyD88 signaling.	[Wan, Ting; Tang, Shibo; Min, Wang] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510060, Guangdong, Peoples R China; Yale Univ, Sch Med, Dept Pathol, Interdepartmental Program Vasc Biol & Therapeut, New Haven, CT 06520 USA	Sun Yat Sen University; Yale University	Tang, SB (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510060, Guangdong, Peoples R China.	tangsb@mail.sysu.edu.cn; wang.min@yale.edu	TANG, Shi/GXH-5719-2022		National Institutes of Health [R01 HL-65978-5, P01HL070295-6]; National Nature Science Foundation of China [30828032]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065978, P01HL070295] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL-65978-5 and P01HL070295-6. This work was also supported by National Nature Science Foundation of China Grant 30828032 (to W. M.).	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Anderson RA, 1999, J BIOL CHEM, V274, P9907, DOI 10.1074/jbc.274.15.9907; Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Carty M, 2006, NAT IMMUNOL, V7, P1074, DOI 10.1038/ni1382; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Dell'Angelica EC, 2000, J CELL BIOL, V149, P81, DOI 10.1083/jcb.149.1.81; Donaldson JG, 2003, J BIOL CHEM, V278, P41573, DOI 10.1074/jbc.R300026200; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Honda A, 1999, CELL, V99, P521, DOI 10.1016/S0092-8674(00)81540-8; Horng T, 2002, NATURE, V420, P329, DOI 10.1038/nature01180; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Liu YM, 2001, J CLIN INVEST, V107, P917, DOI 10.1172/JCI11947; McCudden CR, 2005, CELL MOL LIFE SCI, V62, P551, DOI 10.1007/s00018-004-4462-3; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Oshiumi H, 2003, J BIOL CHEM, V278, P49751, DOI 10.1074/jbc.M305820200; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Radhakrishna H, 1997, J CELL BIOL, V139, P49, DOI 10.1083/jcb.139.1.49; Takeda K, 2005, INT IMMUNOL, V17, P1, DOI 10.1093/intimm/dxh186; Wang Z, 2002, J BIOL CHEM, V277, P12622, DOI 10.1074/jbc.M110568200; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamamoto M, 2003, NAT IMMUNOL, V4, P1144, DOI 10.1038/ni986; Zhang HF, 2004, J BIOL CHEM, V279, P44955, DOI 10.1074/jbc.M407617200	26	24	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3750	3757		10.1074/jbc.M109.069385	http://dx.doi.org/10.1074/jbc.M109.069385			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19948740	Green Published, hybrid			2022-12-25	WOS:000275254000027
J	Falae, A; Combe, A; Amaladoss, A; Carvalho, T; Menard, R; Bhanot, P				Falae, Adebola; Combe, Audrey; Amaladoss, Anburaj; Carvalho, Teresa; Menard, Robert; Bhanot, Purnima			Role of Plasmodium berghei cGMP-dependent Protein Kinase in Late Liver Stage Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MALARIA PARASITE; PROTECTIVE IMMUNITY; SPOROZOITES; CELLS; VACCINATION	The liver is the first organ infected by Plasmodium sporozoites during malaria infection. In the infected hepatocytes, sporozoites undergo a complex developmental program to eventually generate hepatic merozoites that are released into the bloodstream in membrane-bound vesicles termed merosomes. Parasites blocked at an early developmental stage inside hepatocytes elicit a protective host immune response, making them attractive targets in the effort to develop a pre-erythrocytic stage vaccine. Here, we generated parasites blocked at a late developmental stage inside hepatocytes by conditionally disrupting the Plasmodium berghei cGMP-dependent protein kinase in sporozoites. Mutant sporozoites are able to invade hepatocytes and undergo intracellular development. However, they remain blocked as late liver stages that do not release merosomes into the medium. These late arrested liver stages induce protection in immunized animals. This suggests that, similar to the well studied early liver stages, late stage liver stages too can confer protection from sporozoite challenge.	[Bhanot, Purnima] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Microbiol & Mol Genet, Newark, NJ 07103 USA; [Combe, Audrey; Carvalho, Teresa; Menard, Robert] Inst Pasteur, Unite Biol & Genet Paludisme, F-75724 Paris 15, France	Rutgers State University New Brunswick; Rutgers State University Medical Center; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Bhanot, P (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Microbiol & Mol Genet, 225 Warren St,E450D, Newark, NJ 07103 USA.	bhanotpu@umdnj.edu	Carvalho, Teresa/F-6414-2013; Carvalho, Teresa/P-4333-2019	Carvalho, Teresa/0000-0002-4947-371X; Carvalho, Teresa/0000-0002-4947-371X	American Heart Association [0735036N]	American Heart Association(American Heart Association)	This work was supported by American Heart Association Grant 0735036N (to P.B.).	Aly ASI, 2008, MOL MICROBIOL, V69, P152, DOI 10.1111/j.1365-2958.2008.06271.x; Baker DA, 2004, TRENDS PARASITOL, V20, P227, DOI 10.1016/j.pt.2004.02.007; Belnoue E, 2004, J IMMUNOL, V172, P2487, DOI 10.4049/jimmunol.172.4.2487; Bhanot P, 2005, J BIOL CHEM, V280, P6752, DOI 10.1074/jbc.M411465200; Combe A, 2009, CELL HOST MICROBE, V5, P386, DOI 10.1016/j.chom.2009.03.008; Deng WS, 2002, MOL MICROBIOL, V44, P1141, DOI 10.1046/j.1365-2958.2002.02948.x; Diaz CA, 2006, MOL BIOCHEM PARASIT, V146, P78, DOI 10.1016/j.molbiopara.2005.10.020; Douradinha B, 2007, INT J PARASITOL, V37, P1511, DOI 10.1016/j.ijpara.2007.05.005; Galinski MR, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S9; Gurnett AM, 2002, J BIOL CHEM, V277, P15913, DOI 10.1074/jbc.M108393200; Ishino T, 2009, CELL MICROBIOL, V11, P1329, DOI 10.1111/j.1462-5822.2009.01333.x; Janse CJ, 2006, NAT PROTOC, V1, P346, DOI 10.1038/nprot.2006.53; Kumar KA, 2006, NATURE, V444, P937, DOI 10.1038/nature05361; Kumar KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004480; McRobert L, 2008, PLOS BIOL, V6, P1243, DOI 10.1371/journal.pbio.0060139; Mueller AK, 2005, NATURE, V433, P164, DOI 10.1038/nature03188; Mueller AK, 2005, P NATL ACAD SCI USA, V102, P3022, DOI 10.1073/pnas.0408442102; Prudencio M, 2006, NAT REV MICROBIOL, V4, P849, DOI 10.1038/nrmicro1529; Renia L, 2008, PARASITE, V15, P379, DOI 10.1051/parasite/2008153379; Roestenberg M, 2009, NEW ENGL J MED, V361, P468, DOI 10.1056/NEJMoa0805832; Silvie O, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000086; Sturm A, 2006, SCIENCE, V313, P1287, DOI 10.1126/science.1129720; Tarun AS, 2008, P NATL ACAD SCI USA, V105, P305, DOI 10.1073/pnas.0710780104; TSUJI M, 1994, PARASITOL RES, V80, P16, DOI 10.1007/BF00932618; van Dijk MR, 2005, P NATL ACAD SCI USA, V102, P12194, DOI 10.1073/pnas.0500925102; Vaughan AM, 2009, CELL MICROBIOL, V11, P506, DOI 10.1111/j.1462-5822.2008.01270.x; Yu Min, 2008, Cell Host Microbe, V4, P567, DOI 10.1016/j.chom.2008.11.001	27	73	75	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5					3282	3288		10.1074/jbc.M109.070367	http://dx.doi.org/10.1074/jbc.M109.070367			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19940133	hybrid, Green Published			2022-12-25	WOS:000273829000043
J	Paleskava, A; Konevega, AL; Rodnina, MV				Paleskava, Alena; Konevega, Andrey L.; Rodnina, Marina V.			Thermodynamic and Kinetic Framework of Selenocysteyl-tRNA(Sec) Recognition by Elongation Factor SelB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINOACYL-TRANSFER-RNA; ESCHERICHIA-COLI; FACTOR-TU; TRANSLATION FACTOR; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; TERNARY COMPLEX; SELENOCYSTEINE; BINDING; PURIFICATION	SelB is a specialized translation elongation factor that delivers selenocysteyl-tRNA(Sec) (Sec-tRNA(Sec)) to the ribosome. Here we show that Sec-tRNA(Sec) binds to SelB.GTP with an extraordinary high affinity (K-d = 0.2 pM). The tight binding is driven enthalpically and involves the net formation of four ion pairs, three of which may involve the Sec residue. The dissociation of tRNA from the ternary complex SelB.GTP.Sec-tRNA(Sec) is very slow (0.3 h(-1)), and GTP hydrolysis accelerates the release of Sect-RNA(Sec) by more than a million-fold (to 240 s(-1)). The affinities of Sec-tRNA(Sec) to SelB in the GDP or apoforms, or Ser-tRNA(Sec) and tRNA(Sec) to SelB in any form, are similar (K-d = 0.5 mu M). Thermodynamic coupling in binding of Sec-tRNA(Sec) and GTP to SelB ensures at the same time the specificity of Sec-versus Ser-tRNA(Sec) selection and rapid release of Sec-tRNA(Sec) from SelB after GTP cleavage on the ribosome. SelB provides an example for the evolution of a highly specialized protein-RNA complex toward recognition of unique set of identity elements. The mode of tRNA recognition by SelB is reminiscent of another specialized factor, eIF2, rather than of EF-Tu, the common delivery factor for all other aminoacyl-tRNAs, in line with a common evolutionary ancestry of SelB and eIF2.	[Paleskava, Alena; Konevega, Andrey L.; Rodnina, Marina V.] Max Planck Inst Biophys Chem, Dept Phys Biochem, D-37077 Gottingen, Germany	Max Planck Society	Rodnina, MV (corresponding author), Max Planck Inst Biophys Chem, Dept Phys Biochem, Fassberg 11, D-37077 Gottingen, Germany.	rodnina@mpibpc.mpg.de	Rodnina, Marina V./AAD-4667-2019; Konevega, Andrey L./B-7887-2008; Paleskava, Alena/AAO-7332-2020	Rodnina, Marina V./0000-0003-0105-3879; Konevega, Andrey L./0000-0003-0125-7150; Paleskava, Alena/0000-0001-8623-8404	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the Deutsche Forschungsgemeinschaft.	ABRAHAMSON JK, 1985, BIOCHEMISTRY-US, V24, P692, DOI 10.1021/bi00324a023; Asahara H, 2002, P NATL ACAD SCI USA, V99, P3499, DOI 10.1073/pnas.052028599; Atkins JF, 2000, NATURE, V407, P463, DOI 10.1038/35035189; AXLEY MJ, 1991, P NATL ACAD SCI USA, V88, P8450, DOI 10.1073/pnas.88.19.8450; BARON C, 1991, J BIOL CHEM, V266, P20375; Baron Christian, 1995, P529; Commans S, 1999, FEMS MICROBIOL REV, V23, P335, DOI 10.1111/j.1574-6976.1999.tb00403.x; DELL VA, 1990, BIOCHEMISTRY-US, V29, P1757, DOI 10.1021/bi00459a014; Fischer N, 2007, BIOL CHEM, V388, P1061, DOI 10.1515/BC.2007.108; FORCHHAMMER K, 1989, NATURE, V342, P453, DOI 10.1038/342453a0; Gromadski KB, 2002, BIOCHEMISTRY-US, V41, P162, DOI 10.1021/bi015712w; Hilgenfeld R, 1996, BIOCHIMIE, V78, P971, DOI 10.1016/S0300-9084(97)86719-3; HUBER RE, 1967, ARCH BIOCHEM BIOPHYS, V122, P164, DOI 10.1016/0003-9861(67)90136-1; Huttenhofer A, 1998, COLD SPRING HARBOR M, P603; JOHN J, 1990, BIOCHEMISTRY-US, V29, P6058, DOI 10.1021/bi00477a025; Kapp LD, 2004, J MOL BIOL, V335, P923, DOI 10.1016/j.jmb.2003.11.025; Keeling PJ, 1998, J MOL EVOL, V47, P649, DOI 10.1007/PL00006422; Konevega AL, 2004, RNA, V10, P90, DOI 10.1261/rna.5142404; Kothe U, 2006, ANAL BIOCHEM, V356, P148, DOI 10.1016/j.ab.2006.04.038; LaRiviere FJ, 2001, SCIENCE, V294, P165, DOI 10.1126/science.1064242; Leibundgut M, 2005, EMBO J, V24, P11, DOI 10.1038/sj.emboj.7600505; LEINFELDER W, 1990, P NATL ACAD SCI USA, V87, P543, DOI 10.1073/pnas.87.2.543; LOHMAN TM, 1980, BIOCHEMISTRY-US, V19, P3522, DOI 10.1021/bi00556a017; LOUIE A, 1985, BIOCHEMISTRY-US, V24, P6433, DOI 10.1021/bi00344a019; Milon P, 2008, MOL CELL, V30, P712, DOI 10.1016/j.molcel.2008.04.014; Milon P, 2006, P NATL ACAD SCI USA, V103, P13962, DOI 10.1073/pnas.0606384103; Nissen P, 1999, STRUCTURE, V7, P143, DOI 10.1016/S0969-2126(99)80021-5; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; Ose T, 2007, STRUCTURE, V15, P577, DOI 10.1016/j.str.2007.03.007; Pape T, 1998, EMBO J, V17, P7490, DOI 10.1093/emboj/17.24.7490; RECORD MT, 1976, J MOL BIOL, V107, P145, DOI 10.1016/S0022-2836(76)80023-X; Rodnina MV, 1996, J BIOL CHEM, V271, P646, DOI 10.1074/jbc.271.2.646; Rudinger J, 1996, EMBO J, V15, P650, DOI 10.1002/j.1460-2075.1996.tb00397.x; Selmer M, 2002, EMBO J, V21, P4145, DOI 10.1093/emboj/cdf408; Thanbichler M, 2000, J BIOL CHEM, V275, P20458, DOI 10.1074/jbc.M002496200; Thanbichler M, 2003, PROTEIN EXPRES PURIF, V31, P265, DOI 10.1016/S1046-5928(03)00167-0; Thanbichler M, 2002, METHOD ENZYMOL, V347, P3; Wilden B, 2006, P NATL ACAD SCI USA, V103, P13670, DOI 10.1073/pnas.0606099103; Wintermeyer W, 1974, Methods Enzymol, V29, P667; Yoshizawa S, 2005, NAT STRUCT MOL BIOL, V12, P198, DOI 10.1038/nsmb890	40	35	37	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5							3014	10.1074/jbc.M109.081380	http://dx.doi.org/10.1074/jbc.M109.081380			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19940162	Green Published, hybrid			2022-12-25	WOS:000273829000016
J	Skerget, K; Taler-Vercic, A; Bavdek, A; Hodnik, V; Ceru, S; Tusek-Znidaric, M; Kumm, T; Pitsi, D; Pompe-Novak, M; Palumaa, P; Soriano, S; Kopitar-Jerala, N; Turk, V; Anderluh, G; Zerovnik, E				Skerget, Katja; Taler-Vercic, Ajda; Bavdek, Andrej; Hodnik, Vesna; Ceru, Slavko; Tusek-Znidaric, Magda; Kumm, Tiina; Pitsi, Didier; Pompe-Novak, Marusa; Palumaa, Peep; Soriano, Salvador; Kopitar-Jerala, Natasa; Turk, Vito; Anderluh, Gregor; Zerovnik, Eva			Interaction between Oligomers of Stefin B and Amyloid-beta in Vitro and in Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRESSIVE MYOCLONUS EPILEPSY; HEAT-SHOCK PROTEINS; HUMAN CYSTATIN-C; FIBRIL FORMATION; ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; EPM1; COMPLEX; CONFORMATION; AGGREGATION	To contribute to the question of the putative role of cystatins in Alzheimer disease and in neuroprotection in general, we studied the interaction between human stefin B (cystatin B) and amyloid-beta-(1-40) peptide (A beta). Using surface plasmon resonance and electrospray mass spectrometry we were able to show a direct interaction between the two proteins. As an interesting new fact, we show that stefin B binding to A beta is oligomer specific. The dimers and tetramers of stefin B, which bind A beta, are domain-swapped as judged from structural studies. Consistent with the binding results, the same oligomers of stefin B inhibit A beta fibril formation. When expressed in cultured cells, stefin B co-localizes with A beta intracellular inclusions. It also co-immunoprecipitates with the APP fragment containing the A beta epitope. Thus, stefin B is another APP/A beta-binding protein in vitro and likely in cells.	[Kopitar-Jerala, Natasa] Jozef Stefan Inst, Dept Biochem Mol & Struct Biol, Ljubljana 1000, Slovenia; [Bavdek, Andrej; Hodnik, Vesna; Anderluh, Gregor] Univ Ljubljana, Biotech Fac, Dept Biol, Ljubljana 1000, Slovenia; [Tusek-Znidaric, Magda; Pompe-Novak, Marusa] Natl Inst Biol, Dept Plant Physiol & Biotechnol, Ljubljana 1000, Slovenia; [Kumm, Tiina; Palumaa, Peep] Tallinn Univ Technol, Dept Gene Technol, EE-12618 Tallinn, Estonia; [Pitsi, Didier; Soriano, Salvador] Kings Coll London, Inst Psychiat, MRC Ctr Neurodegenerat Res, Dept Neurosci, London SE5 8AF, England; [Soriano, Salvador] Loma Linda Univ & Med Ctr, Div Human Anat, Dept Pathol & Human Anat, Loma Linda, CA 92350 USA	Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; University of Ljubljana; National Institute of Biology - Slovenia; Tallinn University of Technology; University of London; King's College London; Loma Linda University		eva.zerovnik@ijs.si	Zerovnik, Eva/AAB-6498-2022; Anderluh, Gregor/C-6905-2014; Palumaa, Peep/AAF-7617-2020; Palumaa, Peep/B-4668-2019; soriano, salvador/AAB-5595-2022	Anderluh, Gregor/0000-0002-9916-8465; Palumaa, Peep/0000-0002-3505-3466; Palumaa, Peep/0000-0002-3505-3466; Kirsipuu, Tiina/0000-0002-2462-5617; Pompe Novak, Marusa/0000-0003-4176-849X	Slovenian Research Agency (ARRS) [P1-0140]; Estonian Science Foundation [9171]	Slovenian Research Agency (ARRS)(Slovenian Research Agency - Slovenia); Estonian Science Foundation	This work was supported by Program P1-0140 (proteolysis and its regulation, led by B. Turk) via the Slovenian Research Agency (ARRS) and Estonian Science Foundation Grant 9171 (to P.P.).	Anderluh G, 2005, FEBS J, V272, P3042, DOI 10.1111/j.1742-4658.2005.04717.x; BENUSSI L, 2006, HUMAN STEFINS CYSTAT, P115; Bernstein HG, 1996, MOL CHEM NEUROPATHOL, V27, P225, DOI 10.1007/BF02815106; BERNSTEIN HG, 1994, BRAIN RES BULL, V33, P477, DOI 10.1016/0361-9230(94)90071-X; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Buckig A, 2002, HISTOCHEM CELL BIOL, V118, P353, DOI 10.1007/s00418-002-0459-2; Ceru S, 2008, AMYLOID, V15, P147, DOI 10.1080/13506120802193555; Cipollini E, 2008, BBA-MOL CELL RES, V1783, P312, DOI 10.1016/j.bbamcr.2007.08.007; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Di Giaimo R, 2002, HUM MOL GENET, V11, P2941, DOI 10.1093/hmg/11.23.2941; Ekiel I, 1997, J MOL BIOL, V271, P266, DOI 10.1006/jmbi.1997.1150; ENGH RA, 1993, J MOL BIOL, V234, P1060, DOI 10.1006/jmbi.1993.1659; II K, 1993, VIRCHOWS ARCH A, V423, P185, DOI 10.1007/BF01614769; IVERFELDT K, 1993, P NATL ACAD SCI USA, V90, P4146, DOI 10.1073/pnas.90.9.4146; Janowski R, 2001, NAT STRUCT BIOL, V8, P316, DOI 10.1038/86188; Jenko S, 2004, PROTEINS, V55, P417, DOI 10.1002/prot.20041; JERALA R, 1988, FEBS LETT, V239, P41, DOI 10.1016/0014-5793(88)80541-6; Jerala R, 1999, J MOL BIOL, V291, P1079, DOI 10.1006/jmbi.1999.3045; Joensuu T, 2008, EPILEPSIA, V49, P557, DOI 10.1111/j.1528-1167.2007.01422.x; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kokalj SJ, 2007, J MOL BIOL, V366, P1569, DOI 10.1016/j.jmb.2006.12.025; KOPITARJERALA N, 1993, BIOCHIM BIOPHYS ACTA, V1164, P75, DOI 10.1016/0167-4838(93)90114-7; Lehtinen MK, 2009, J NEUROSCI, V29, P5910, DOI 10.1523/JNEUROSCI.0682-09.2009; MARTIN JR, 1995, J MOL BIOL, V246, P331, DOI 10.1006/jmbi.1994.0088; MARUYAMA K, 1992, NEUROSCI LETT, V144, P38, DOI 10.1016/0304-3940(92)90710-O; Mi W, 2007, NAT GENET, V39, P1440, DOI 10.1038/ng.2007.29; Morgan GJ, 2008, J MOL BIOL, V375, P487, DOI 10.1016/j.jmb.2007.10.033; Pennacchio LA, 1996, SCIENCE, V271, P1731, DOI 10.1126/science.271.5256.1731; Perez RG, 1996, J BIOL CHEM, V271, P9100, DOI 10.1074/jbc.271.15.9100; Rabzelj S, 2005, PROTEIN SCI, V14, P2713, DOI 10.1110/ps.051609705; Rabzelj S, 2008, FEBS J, V275, P2455, DOI 10.1111/j.1742-4658.2008.06390.x; Raman B, 2005, BIOCHEM J, V392, P573, DOI 10.1042/BJ20050339; Rawlings ND, 2004, NUCLEIC ACIDS RES, V32, pD160, DOI 10.1093/nar/gkp971; Rekas A, 2004, J MOL BIOL, V340, P1167, DOI 10.1016/j.jmb.2004.05.054; RITONJA A, 1985, BIOCHEM BIOPH RES CO, V131, P1187, DOI 10.1016/0006-291X(85)90216-5; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Saibil HR, 2008, CURR OPIN STRUC BIOL, V18, P35, DOI 10.1016/j.sbi.2007.11.006; Sastre M, 2004, NEUROBIOL AGING, V25, P1033, DOI 10.1016/j.neurobiolaging.2003.11.006; Skerget K, 2009, PROTEINS, V74, P425, DOI 10.1002/prot.22156; Staniforth RA, 2001, EMBO J, V20, P4774, DOI 10.1093/emboj/20.17.4774; STUBBS MT, 1990, EMBO J, V9, P1939, DOI 10.1002/j.1460-2075.1990.tb08321.x; Turk V, 2008, FRONT BIOSCI-LANDMRK, V13, P5406, DOI 10.2741/3089; Walsh DM, 2004, PROTEIN PEPTIDE LETT, V11, P213, DOI 10.2174/0929866043407174; Wilhelmus MMM, 2007, MOL NEUROBIOL, V35, P203, DOI 10.1007/s12035-007-0029-7; Wilhelmus MMM, 2006, BRAIN RES, V1089, P67, DOI 10.1016/j.brainres.2006.03.058; Yoon IS, 2007, FASEB J, V21, P2742, DOI 10.1096/fj.07-8114com; Yoshiike Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003235; Zerovnik E, 2002, BBA-PROTEIN STRUCT M, V1594, P1, DOI 10.1016/S0167-4838(01)00295-3; Zerovnik E, 1997, EUR J BIOCHEM, V245, P364, DOI 10.1111/j.1432-1033.1997.t01-1-00364.x; ZEROVNIK E, 2005, AMYLOID AMYLOIDOSIS, P21	50	33	33	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5					3201	3210		10.1074/jbc.M109.024620	http://dx.doi.org/10.1074/jbc.M109.024620			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19955183	Green Published, hybrid			2022-12-25	WOS:000273829000035
J	Attia, RR; Connnaughton, S; Boone, LR; Wang, F; Elam, MB; Ness, GC; Cook, GA; Park, EA				Attia, Ramy R.; Connnaughton, Sara; Boone, Lindsey R.; Wang, Fang; Elam, Marshall B.; Ness, Gene C.; Cook, George A.; Park, Edwards A.			Regulation of Pyruvate Dehydrogenase Kinase 4 (PDK4) by Thyroid Hormone ROLE OF THE PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR gamma COACTIVATOR (PGC-1 alpha)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; FATTY-ACIDS; IN-VIVO; HEPATIC GLUCONEOGENESIS; OXIDATIVE-METABOLISM; PROTEIN EXPRESSION; ALPHA; INDUCTION; ISOFORM-4; MECHANISM	PDK4 (pyruvate dehydrogenase kinase 4) regulates pyruvate oxidation through the phosphorylation and inhibition of the pyruvate dehydrogenase complex (PDC). PDC catalyzes the conversion of pyruvate to acetyl-CoA and is an important control point in glucose and pyruvate metabolism. PDK4 gene expression is stimulated by thyroid hormone (T-3), glucocorticoids, and long chain fatty acids. The effects of T-3 on gene expression in the liver are mediated via the thyroid hormone receptor. Here, we have identified two binding sites for thyroid hormone receptor beta in the promoter of the rat PDK4 (rPDK4) gene. In addition, we have investigated the role of transcriptional coactivators and found that the PGC-1 alpha (peroxisome proliferator-activated receptor gamma coactivator) enhances the T-3 induction of rPDK4. Following T-3 administration, there is an increase in the association of PGC-1 alpha with the rPDK4 promoter. Interestingly, this increased association is with the proximal rPDK4 promoter rather than the distal region of the gene that contains the T-3 response elements. Administration of T-3 to hypothyroid rats elevated the abundance of PGC-1 alpha mRNA and protein in the liver. In addition, we observed greater association of PGC-1 alpha not only with the rPDK4 gene but also with phosphoenolpyruvate carboxykinase and CPT-1a (carnitine palmitoyltransferase 1a) genes. Knockdown of PGC-1 alpha in rat hepatocytes reduced the T-3 induction of PDK4, PEPCK, and CPT-1a genes. Our results indicate that T-3 regulates PGC-1 alpha abundance and association with hepatic genes, and in turn PGC-1 alpha is an important participant in the T-3 induction of selected genes.	[Attia, Ramy R.; Connnaughton, Sara; Wang, Fang; Elam, Marshall B.; Cook, George A.; Park, Edwards A.] Univ Tennessee, Hlth Sci Ctr, Coll Med, Dept Pharmacol, Memphis, TN 38163 USA; [Elam, Marshall B.] Dept Vet Affairs Med Ctr, Memphis, TN 38104 USA; [Boone, Lindsey R.; Ness, Gene C.] Univ S Florida, Coll Med, Dept Mol Med, Tampa, FL 33612 USA	University of Tennessee System; University of Tennessee Health Science Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center; State University System of Florida; University of South Florida	Park, EA (corresponding author), Univ Tennessee, Hlth Sci Ctr, Coll Med, Dept Pharmacol, 874 Union Ave, Memphis, TN 38163 USA.	epark@uthsc.edu			National Institutes of Health [DK0059368, DK075504, DK075414]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059368, R01DK075414, R01DK075504] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK0059368 (to E.A.P.), DK075504 (to M.B.E.), and DK075414 (to G.C.N.).	Bowker-Kinley MM, 1998, BIOCHEM J, V329, P191, DOI 10.1042/bj3290191; Crunkhorn S, 2008, THYROID, V18, P227, DOI 10.1089/thy.2007.0249; Deng X, 2002, BIOCHEM BIOPH RES CO, V290, P256, DOI 10.1006/bbrc.2001.6148; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; GLASS CK, 1994, ENDOCR REV, V15, P391, DOI 10.1210/er.15.3.391; Goldenthal MJ, 2004, MOL CELL BIOCHEM, V265, P97, DOI 10.1023/B:MCBI.0000044321.17680.a2; Harris RA, 2002, ADV ENZYME REGUL, V42, P249, DOI 10.1016/S0065-2571(01)00061-9; Harris RA, 2001, ADV ENZYME REGUL, V41, P269, DOI 10.1016/S0065-2571(00)00020-0; HEIMBERG M, 1985, ENDOCR REV, V6, P590, DOI 10.1210/edrv-6-4-590; Holness MJ, 2003, BIOCHEM SOC T, V31, P1143; Holness MJ, 2003, BIOCHEM J, V369, P687, DOI 10.1042/BJ20021509; Huang BL, 2002, DIABETES, V51, P276, DOI 10.2337/diabetes.51.2.276; Irrcher I, 2003, AM J PHYSIOL-CELL PH, V284, pC1669, DOI 10.1152/ajpcell.00409.2002; Jeoung NH, 2008, AM J PHYSIOL-ENDOC M, V295, pE46, DOI 10.1152/ajpendo.00536.2007; Jeoung NH, 2006, BIOCHEM J, V397, P417, DOI 10.1042/BJ20060125; Kwon HS, 2004, ADV ENZYME REGUL, V44, P109, DOI 10.1016/j.advenzreg.2003.11.020; Kwon HS, 2004, DIABETES, V53, P899, DOI 10.2337/diabetes.53.4.899; Kwon HS, 2006, BBA-GENE STRUCT EXPR, V1759, P141, DOI 10.1016/j.bbaexp.2006.04.005; Lagor WR, 2007, EXP BIOL MED, V232, P353; LAZAR MA, 1993, ENDOCR REV, V14, P184, DOI 10.1210/er.14.2.184; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Lonard DM, 2006, CELL, V125, P411, DOI 10.1016/j.cell.2006.04.021; Lopez D, 2006, BBA-MOL CELL BIOL L, V1761, P492, DOI 10.1016/j.bbalip.2006.03.012; Ma K, 2005, J BIOL CHEM, V280, P29525, DOI 10.1074/jbc.M502236200; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Moreno M, 2008, THYROID, V18, P239, DOI 10.1089/thy.2007.0248; MYNATT RL, 1994, BIOCHEM BIOPH RES CO, V201, P932, DOI 10.1006/bbrc.1994.1791; NESS GC, 1994, ARCH BIOCHEM BIOPHYS, V315, P199, DOI 10.1006/abbi.1994.1490; Park EA, 1999, J BIOL CHEM, V274, P211, DOI 10.1074/jbc.274.1.211; Park EA, 1997, BIOCHEM J, V322, P343, DOI 10.1042/bj3220343; Patel MS, 2001, EXP MOL MED, V33, P191, DOI 10.1038/emm.2001.32; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Priestman DA, 1997, FEBS LETT, V419, P55, DOI 10.1016/S0014-5793(97)01430-0; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; RASTINEJAD F, 1995, NATURE, V375, P203, DOI 10.1038/375203a0; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Sugden MC, 1996, MOL CELL ENDOCRINOL, V119, P219, DOI 10.1016/0303-7207(96)03817-8; Sugden MC, 2002, BIOCHEM J, V364, P361, DOI 10.1042/BJ20011699; Sugden MC, 2000, BIOCHEM J, V352, P731, DOI 10.1042/0264-6021:3520731; Sugden MC, 2001, ARCH BIOCHEM BIOPHYS, V395, P246, DOI 10.1006/abbi.2001.2586; Wang JC, 1999, MOL ENDOCRINOL, V13, P604, DOI 10.1210/me.13.4.604; Weitzel JM, 2001, NUCLEIC ACIDS RES, V29, P5148, DOI 10.1093/nar/29.24.5148; Wende AR, 2005, MOL CELL BIOL, V25, P10684, DOI 10.1128/MCB.25.24.10684-10694.2005; Wu YF, 2002, J BIOL CHEM, V277, P8898, DOI 10.1074/jbc.M110761200; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Wulf A, 2007, MOL CELL ENDOCRINOL, V270, P57, DOI 10.1016/j.mce.2007.02.008; Yen PM, 2001, PHYSIOL REV, V81, P1097, DOI 10.1152/physrev.2001.81.3.1097; Yen PM, 2006, MOL CELL ENDOCRINOL, V246, P121, DOI 10.1016/j.mce.2005.11.030; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zhang JS, 2000, ANNU REV PHYSIOL, V62, P439, DOI 10.1146/annurev.physiol.62.1.439; Zhang Y, 2004, J BIOL CHEM, V279, P53963, DOI 10.1074/jbc.M406028200; Zhang Y, 2006, J BIOL CHEM, V281, P39897, DOI 10.1074/jbc.M608657200	54	52	55	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2375	2385		10.1074/jbc.M109.039081	http://dx.doi.org/10.1074/jbc.M109.039081			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19948729	Green Published, hybrid			2022-12-25	WOS:000273697800018
J	Xiao, LP; Naganawa, T; Lorenzo, J; Carpenter, TO; Coffin, JD; Hurley, MM				Xiao, Liping; Naganawa, Takahiro; Lorenzo, Joseph; Carpenter, Thomas O.; Coffin, J. Douglas; Hurley, Marja M.			Nuclear Isoforms of Fibroblast Growth Factor 2 Are Novel Inducers of Hypophosphatemia via Modulation of FGF23 and KLOTHO	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-MOLECULAR-WEIGHT; BONE MINERALIZATION; FACTOR FGF-2; GENE; PROTEIN; EXPRESSION; DISORDERS; RECEPTOR; MATRIX; LOCALIZATION	FGF2 transgenic mice were developed in which type I collagen regulatory sequences drive the nuclear high molecular weight FGF2 isoforms in osteoblasts (TgHMW). The phenotype of TgHMW mice included dwarfism, decreased bone mineral density (BMD), osteomalacia, and decreased serum phosphate (P-i). When TgHMW mice were fed a high P-i diet, BMD was increased, and dwarfism was partially reversed. The TgHMW phenotype was similar to mice overexpressing FGF23. Serum FGF23 was increased in TgHMW mice. Fgf23 mRNA in bones and fibroblast growth factor receptors 1c and 3c and Klotho mRNAs in kidneys were increased in TgHMW mice, whereas the renal Na+/P-i co-transporter Npt2a mRNA was decreased. Immunohistochemistry and Western blot analyses of TgHMW kidneys showed increased KLOTHO and decreased NPT2a protein. The results suggest that overexpression of HMW FGF2 increases FGF23/FGFR/KLOTHO signaling to down-regulate NPT2a, causing P-i wasting, osteomalacia, and decreased BMD. We assessed whether HMW FGF2 expression was altered in the Hyp mouse, a mouse homolog of the human disease X-linked hypophosphatemic rickets/osteomalacia. Fgf2 mRNA was increased in bones, and Western blots showed increased FGF2 protein in nuclear fractions from osteoblasts of Hyp mice. In addition, immunohistochemistry demonstrated co-localization of FGF23 and HMW FGF2 protein in osteoblasts and osteocytes from Hyp mice. This study reveals a novel mechanism of regulation of the FGF23-P-i homeostatic axis.	[Hurley, Marja M.] Univ Connecticut, Sch Med, Div Endocrinol & Metab, Dept Med,Hlth Ctr, Farmington, CT 06030 USA; [Carpenter, Thomas O.] Yale Univ, Sch Med, Dept Pediat Endocrinol, New Haven, CT 06520 USA; [Coffin, J. Douglas] Univ Montana, Dept Biomed & Pharmaceut Sci, Missoula, MT 59812 USA	University of Connecticut; Yale University; University of Montana System; University of Montana	Hurley, MM (corresponding author), Univ Connecticut, Sch Med, Div Endocrinol & Metab, Dept Med,Hlth Ctr, 263 Farmington Ave, Farmington, CT 06030 USA.	hurley@exchange.uchc.edu			National Institutes of Health [AG021189]; NATIONAL INSTITUTE ON AGING [R01AG021189] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG021189 (to M. M. H.).	Arese M, 1999, MOL BIOL CELL, V10, P1429, DOI 10.1091/mbc.10.5.1429; Beck L, 1997, J CLIN INVEST, V99, P1200, DOI 10.1172/JCI119276; COFFIN JD, 1995, MOL BIOL CELL, V6, P1861, DOI 10.1091/mbc.6.12.1861; Dacic S, 2001, J BONE MINER RES, V16, P1228, DOI 10.1359/jbmr.2001.16.7.1228; Delrieu I, 2000, FEBS LETT, V468, P6, DOI 10.1016/S0014-5793(00)01189-3; DeMoerlooze L, 1997, CURR OPIN GENET DEV, V7, P378, DOI 10.1016/S0959-437X(97)80152-9; EICHER EM, 1976, P NATL ACAD SCI USA, V73, P4667, DOI 10.1073/pnas.73.12.4667; Feng JQ, 2006, NAT GENET, V38, P1310, DOI 10.1038/ng1905; FLORKIEWICZ RZ, 1991, ANN NY ACAD SCI, V638, P109, DOI 10.1111/j.1749-6632.1991.tb49022.x; FLORKIEWICZ RZ, 1989, P NATL ACAD SCI USA, V86, P3978, DOI 10.1073/pnas.86.11.3978; FRANCIS F, 1995, NAT GENET, V11, P130, DOI 10.1038/ng1095-130; Fukumoto S, 2008, INTERNAL MED, V47, P337, DOI 10.2169/internalmedicine.47.0730; GLOBUS RK, 1989, ENDOCRINOLOGY, V124, P1539, DOI 10.1210/endo-124-3-1539; Holick MF, 2006, J CLIN INVEST, V116, P2062, DOI 10.1172/JCI29449; Hollberg K, 2008, BONE, V42, P1111, DOI 10.1016/j.bone.2008.01.019; HURLEY MM, 2002, PRINCIPLES BONE BIOL, P825; Itoh N, 2004, TRENDS GENET, V20, P563, DOI 10.1016/j.tig.2004.08.007; Jiang ZS, 2007, J MOL CELL CARDIOL, V42, P222, DOI 10.1016/j.yjmcc.2006.09.002; Korpela J, 2006, ANTICANCER RES, V26, P3127; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Larsson T, 2004, ENDOCRINOLOGY, V145, P3087, DOI 10.1210/en.2003-1768; Liao SY, 2007, J MOL CELL CARDIOL, V42, P106, DOI 10.1016/j.yjmcc.2006.10.005; Liu SG, 2003, J BIOL CHEM, V278, P37419, DOI 10.1074/jbc.M304544200; Liu SG, 2008, AM J PHYSIOL-ENDOC M, V295, pE254, DOI 10.1152/ajpendo.90201.2008; Liu SG, 2007, AM J PHYSIOL-ENDOC M, V293, pE1636, DOI 10.1152/ajpendo.00396.2007; Liu SG, 2008, J AM SOC NEPHROL, V19, P2342, DOI 10.1681/ASN.2007121301; Lizarraga G, 2002, DEV BIOL, V243, P44, DOI 10.1006/dbio.2001.0559; Lorenz-Depiereux B, 2006, NAT GENET, V38, P1248, DOI 10.1038/ng1868; Ma X, 2007, J CELL PHYSIOL, V213, P690, DOI 10.1002/jcp.21139; MARIE PJ, 1983, CALCIFIED TISSUE INT, V35, P443, DOI 10.1007/BF02405074; Montero A, 2000, J CLIN INVEST, V105, P1085, DOI 10.1172/JCI8641; MUENKE M, 1995, TRENDS GENET, V11, P308, DOI 10.1016/S0168-9525(00)89088-5; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Quarles LD, 2003, J CLIN INVEST, V112, P642, DOI 10.1172/JC1200319687; Razzaque MS, 2007, J ENDOCRINOL, V194, P1, DOI 10.1677/JOE-07-0095; Shimada T, 2001, P NATL ACAD SCI USA, V98, P6500, DOI 10.1073/pnas.101545198; Sobue T, 2005, J CELL BIOCHEM, V95, P83, DOI 10.1002/jcb.20389; Suttamanatwong S, 2007, J CELL BIOCHEM, V102, P496, DOI 10.1002/jcb.21314; Terashima Y, 2008, J CELL PHYSIOL, V216, P640, DOI 10.1002/jcp.21443; Touriol C, 2003, BIOL CELL, V95, P169, DOI 10.1016/S0248-4900(03)00033-9; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Wamsley HL, 2005, TOXICOL PATHOL, V33, P577, DOI 10.1080/01926230500243060; Wang JS, 1996, ACTA ORTHOP SCAND, V67, P1; Weber TJ, 2003, J BONE MINER RES, V18, P1227, DOI 10.1359/jbmr.2003.18.7.1227; White KE, 2000, NAT GENET, V26, P345, DOI 10.1038/81664; Xiao LP, 2009, J BIOL CHEM, V284, P3170, DOI 10.1074/jbc.M804900200; Yamashita T, 2002, J BIOL CHEM, V277, P28265, DOI 10.1074/jbc.M202527200; Yu PJ, 2007, J CELL BIOCHEM, V100, P1100, DOI 10.1002/jcb.21116; Yu XJ, 2005, CYTOKINE GROWTH F R, V16, P221, DOI 10.1016/j.cytogfr.2005.01.002	50	50	53	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2834	2846		10.1074/jbc.M109.030577	http://dx.doi.org/10.1074/jbc.M109.030577			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19933269	Green Published, hybrid			2022-12-25	WOS:000273697800059
J	Sachdeva, R; Banerjea, AC; Malla, N; Dubey, ML				Sachdeva, Rakhee; Banerjea, Akhil C.; Malla, Nancy; Dubey, Mohan Lal			Immunogenicity and Efficacy of Single Antigen Gp63, Polytope and PolytopeHSP70 DNA Vaccines against Visceral Leishmaniasis in Experimental Mouse Model	PLOS ONE			English	Article							T-CELL EPITOPES; MAJOR SURFACE GLYCOPROTEIN; HEAT-SHOCK PROTEINS; IMMUNE-RESPONSES; MYCOBACTERIAL HEAT-SHOCK-PROTEIN-70; CUTANEOUS LEISHMANIASIS; PROTECTIVE IMMUNITY; CYTOKINES; HSP70; LYMPHOCYTES	Polytope approach of genetic immunization is a promising strategy for the prevention of infectious disease as it is capable of generating effective cell mediated immunity by delivering the T cell epitopes assembled in series. Leishmaniasis is a significant world wide health problem for which no vaccine exists. In this study we have compared immunogenicity and efficacy of three types of DNA vaccines: single antigen Gp63 (Gp63/pcDNA), polytope (Poly/pcDNA) and Polytope fused with hsp70 (Poly/hsp/pcDNA) against visceral leishmaniasis in susceptible BALB/c mice. Mice vaccinated with these plasmids generated strong Th1 immune response as seen by dominating IFN-gamma over IL-10 cytokine. Interestingly, cytotoxic responses generated by polytope DNA plasmid fused with hsp70 of Leishmania donovani were significantly higher when compared to polytope and single antigen Gp63 vaccine. Challenge studies revealed that the parasite load in liver and spleen was significantly lower with Poly/hsp/pcDNA vaccination compared to other vaccines. Therefore, our study indicates that polytope DNA vaccine is a feasible, practical and effective approach for visceral leishmaniasis.	[Sachdeva, Rakhee; Malla, Nancy; Dubey, Mohan Lal] Postgrad Inst Med Educ & Res, Dept Parasitol, Chandigarh 160012, India; [Banerjea, Akhil C.] Natl Inst Immunol, New Delhi 110067, India	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Sachdeva, R (corresponding author), Postgrad Inst Med Educ & Res, Dept Parasitol, Chandigarh 160012, India.	mldubey@gmail.com		Sachdeva, Rakhee/0000-0001-9624-5624	Indian Council of Medical Research, New Delhi [Immuno/18/11/21/2002-ECD-1]	Indian Council of Medical Research, New Delhi(Indian Council of Medical Research (ICMR))	Financial assistance from Indian Council of Medical Research, New Delhi supported this work: Grant No. Immuno/18/11/21/2002-ECD-1 and URL ishttp://icmr.nic.in/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afrin F, 2002, INFECT IMMUN, V70, P6697, DOI 10.1128/IAI.70.12.6697-6706.2002; Asea A, 2000, CELL STRESS CHAPERON, V5, P425, DOI 10.1379/1466-1268(2000)005<0425:HPBAPN>2.0.CO;2; Awasthi A, 2004, INDIAN J MED RES, V119, P238; Bacellar O, 2000, CYTOKINE, V12, P1228, DOI 10.1006/cyto.2000.0694; Basu S, 2001, IMMUNITY, V14, P303, DOI 10.1016/S1074-7613(01)00111-X; Bazhan SI, 2004, VACCINE, V22, P1672, DOI 10.1016/j.vaccine.2003.09.048; BOGDAN C, 1993, IMMUNOBIOLOGY, V189, P356, DOI 10.1016/S0171-2985(11)80366-9; BUTTON LL, 1989, MOL BIOCHEM PARASIT, V32, P271, DOI 10.1016/0166-6851(89)90076-5; Chen CH, 2000, CANCER RES, V60, P1035; CURRY AJ, 1994, INFECT IMMUN, V62, P1733, DOI 10.1128/IAI.62.5.1733-1741.1994; Di Paolo NC, 2006, CANCER RES, V66, P960, DOI 10.1158/0008-5472.CAN-05-2388; Duraiswamy J, 2004, CANCER RES, V64, P1483, DOI 10.1158/0008-5472.CAN-03-2196; Fonseca DPAJ, 2001, INFECT IMMUN, V69, P4839, DOI 10.1128/IAI.69.8.4839-4845.2001; GERMAIN RN, 1993, ANNU REV IMMUNOL, V11, P403, DOI 10.1146/annurev.immunol.11.1.403; Gilbert SC, 1997, NAT BIOTECHNOL, V15, P1280, DOI 10.1038/nbt1197-1280; KAYE PM, 1991, J IMMUNOL, V146, P2763; Khalil EAG, 2005, CLIN EXP IMMUNOL, V140, P349, DOI 10.1111/j.1365-2249.2005.02768.x; Li XM, 2005, INT IMMUNOL, V17, P1293, DOI 10.1093/intimm/dxh305; Livingston BD, 2001, VACCINE, V19, P4652, DOI 10.1016/S0264-410X(01)00233-X; Loing E, 2000, J IMMUNOL, V164, P900, DOI 10.4049/jimmunol.164.2.900; Miles SA, 2005, J EXP MED, V201, P747, DOI 10.1084/jem.20041470; MIRALLES GD, 1994, INFECT IMMUN, V62, P1058, DOI 10.1128/IAI.62.3.1058-1063.1994; ORMEROD MG, 1989, FURTHER APPL CELL BI, P265; Ozbilge H, 2006, J MED MICROBIOL, V55, P1329, DOI 10.1099/jmm.0.46667-0; Peng ML, 2006, VACCINE, V24, P887, DOI 10.1016/j.vaccine.2005.12.050; Ribeiro-de-Jesus A, 1998, BRAZ J MED BIOL RES, V31, P143, DOI 10.1590/S0100-879X1998000100020; RUSSO DM, 1993, J IMMUNOL, V150, P4713; Saha S, 2006, INDIAN J MED RES, V123, P245; Schirmbeck R, 2003, J IMMUNOL, V171, P1240, DOI 10.4049/jimmunol.171.3.1240; Scott P, 2004, IMMUNOL REV, V201, P318, DOI 10.1111/j.0105-2896.2004.00198.x; Sette A, 2001, BIOLOGICALS, V29, P271, DOI 10.1006/biol.2001.0297; Srivastava PK, 2001, VACCINE, V19, P2590, DOI 10.1016/S0264-410X(00)00492-8; SUHRBIER A, 1998, INT C AIDS, V12, P277; Suhrbier Andreas, 2002, Expert Rev Vaccines, V1, P207, DOI 10.1586/14760584.1.2.207; Sukumaran B, 2003, VACCINE, V21, P1292, DOI 10.1016/S0264-410X(02)00352-3; Suzue K, 1997, P NATL ACAD SCI USA, V94, P13146, DOI 10.1073/pnas.94.24.13146; Suzue K, 1996, J IMMUNOL, V156, P873; Thomson SA, 1998, J IMMUNOL, V160, P1717; Toes REM, 1997, P NATL ACAD SCI USA, V94, P14660, DOI 10.1073/pnas.94.26.14660; TOWNSEND ARM, 1986, CELL, V44, P959, DOI 10.1016/0092-8674(86)90019-X; Trinchieri G, 2001, J EXP MED, V194, pF53, DOI 10.1084/jem.194.10.f53; Tripathi P, 2007, FEMS IMMUNOL MED MIC, V51, P229, DOI 10.1111/j.1574-695X.2007.00311.x; Tsagozis P, 2005, PARASITOL INT, V54, P139, DOI 10.1016/j.parint.2005.02.005; Udono H, 2001, INT IMMUNOL, V13, P1233, DOI 10.1093/intimm/13.10.1233; Walker PS, 1998, HUM GENE THER, V9, P1899, DOI 10.1089/hum.1998.9.13-1899; Wang YF, 2001, IMMUNITY, V15, P971, DOI 10.1016/S1074-7613(01)00242-4; WEBB JR, 1991, MOL BIOCHEM PARASIT, V48, P173, DOI 10.1016/0166-6851(91)90113-K; Wei WZ, 2001, J IMMUNOL METHODS, V258, P141, DOI 10.1016/S0022-1759(01)00484-7; Woodberry T, 1999, J VIROL, V73, P5320, DOI 10.1128/JVI.73.7.5320-5325.1999; XU D, 1995, IMMUNOLOGY, V84, P173; YANG DM, 1991, IMMUNOLOGY, V72, P3	51	32	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2009	4	12							e7880	10.1371/journal.pone.0007880	http://dx.doi.org/10.1371/journal.pone.0007880			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MU	19956549	Green Published, Green Submitted, gold			2022-12-25	WOS:000272828800001
J	Takahashi, K; Narita, M; Yokura, M; Ichisaka, T; Yamanaka, S				Takahashi, Kazutoshi; Narita, Megumi; Yokura, Midori; Ichisaka, Tomoko; Yamanaka, Shinya			Human Induced Pluripotent Stem Cells on Autologous Feeders	PLOS ONE			English	Article							PROLONGED UNDIFFERENTIATED GROWTH; LINES; ESTABLISHMENT; MAINTENANCE; CULTURE; DIFFERENTIATION; EFFICIENT; MOUSE; STO	Background: For therapeutic usage of induced Pluripotent Stem (iPS) cells, to accomplish xeno-free culture is critical. Previous reports have shown that human embryonic stem (ES) cells can be maintained in feeder-free condition. However, absence of feeder cells can be a hostile environment for pluripotent cells and often results in karyotype abnormalities. Instead of animal feeders, human fibroblasts can be used as feeder cells of human ES cells. However, one still has to be concerned about the existence of unidentified pathogens, such as viruses and prions in these nonautologous feeders. Methodology/Principal Findings: This report demonstrates that human induced Pluripotent Stem (iPS) cells can be established and maintained on isogenic parental feeder cells. We tested four independent human skin fibroblasts for the potential to maintain self-renewal of iPS cells. All the fibroblasts tested, as well as their conditioned medium, were capable of maintaining the undifferentiated state and normal karyotypes of iPS cells. Furthermore, human iPS cells can be generated on isogenic parental fibroblasts as feeders. These iPS cells carried on proliferation over 19 passages with undifferentiated morphologies. They expressed undifferentiated pluripotent cell markers, and could differentiate into all three germ layers via embryoid body and teratoma formation. Conclusions/Significance: These results suggest that autologous fibroblasts can be not only a source for iPS cells but also be feeder layers. Our results provide a possibility to solve the dilemma by using isogenic fibroblasts as feeder layers of iPS cells. This is an important step toward the establishment of clinical grade iPS cells.	[Takahashi, Kazutoshi; Narita, Megumi; Yokura, Midori; Ichisaka, Tomoko; Yamanaka, Shinya] Kyoto Univ, Ctr iPS Cell Res & Applicat, Inst Integrated Cell Mat Sci, Kyoto, Japan; [Yamanaka, Shinya] Kyoto Univ, Dept Stem Cell Biol, Inst Frontier Med Sci, Kyoto, Japan; [Yamanaka, Shinya] Japan Sci & Technol Agcy, Yamanaka iPS Cell Special Project, Kawaguchi, Saitama, Japan; [Yamanaka, Shinya] Gladstone Inst Cardiovasc Dis, San Francisco, CA USA	Kyoto University; Kyoto University; Japan Science & Technology Agency (JST); University of California System; University of California San Francisco; The J David Gladstone Institutes	Takahashi, K (corresponding author), Kyoto Univ, Ctr iPS Cell Res & Applicat, Inst Integrated Cell Mat Sci, Kyoto, Japan.	takahash@cira.kyoto-u.ac.jp; yamanaka@cira.kyoto-u.ac.jp	Takahashi, Kazutoshi/ABE-5504-2020	Takahashi, Kazutoshi/0000-0002-5329-8395	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); Japan Science and Technology Agency (JST); National Institute of Biomedical Innovation (NIBIO); Japan Society for the Promotion of Science (JSPS)	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); National Institute of Biomedical Innovation (NIBIO)(National Institute of Biomedical Innovation); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT), Japan Science and Technology Agency (JST), National Institute of Biomedical Innovation (NIBIO), Japan Society for the Promotion of Science (JSPS). All of them are non-profit foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Catalina P, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-76; Draper JS, 2004, NAT BIOTECHNOL, V22, P53, DOI 10.1038/nbt922; Martin MJ, 2005, NAT MED, V11, P228, DOI 10.1038/nm1181; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Osafune K, 2008, NAT BIOTECHNOL, V26, P313, DOI 10.1038/nbt1383; Park JH, 2003, BIOL REPROD, V69, P2007, DOI 10.1095/biolreprod.103.017467; Park SP, 2004, HUM REPROD, V19, P676, DOI 10.1093/humrep/deh102; Richards M, 2002, NAT BIOTECHNOL, V20, P933, DOI 10.1038/nbt726; Richards M, 2003, STEM CELLS, V21, P546, DOI 10.1634/stemcells.21-5-546; Rittie L, 2005, METH MOLEC MED, V117, P83; Skottman H, 2006, REPRODUCTION, V132, P691, DOI 10.1530/rep.1.01079; Suemori H, 2006, BIOCHEM BIOPH RES CO, V345, P926, DOI 10.1016/j.bbrc.2006.04.135; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Unger C, 2009, HUM REPROD, V24, P2567, DOI 10.1093/humrep/dep232; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Xu CH, 2004, STEM CELLS, V22, P972, DOI 10.1634/stemcells.22-6-972; Yamanaka S, 2000, EMBO J, V19, P5533, DOI 10.1093/emboj/19.20.5533; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482	22	72	83	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2009	4	12							e8067	10.1371/journal.pone.0008067	http://dx.doi.org/10.1371/journal.pone.0008067			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MU	19956543	Green Published, Green Submitted, gold			2022-12-25	WOS:000272828800007
J	Barrenas, F; Chavali, S; Holme, P; Mobini, R; Benson, M				Barrenas, Fredrik; Chavali, Sreenivas; Holme, Petter; Mobini, Reza; Benson, Mikael			Network Properties of Complex Human Disease Genes Identified through Genome-Wide Association Studies	PLOS ONE			English	Article							TOPOLOGICAL FEATURES; INTERACTOME; MICROARRAY; EXPRESSION; CENTRALITY; DISORDERS; TRAITS	Background: Previous studies of network properties of human disease genes have mainly focused on monogenic diseases or cancers and have suffered from discovery bias. Here we investigated the network properties of complex disease genes identified by genome-wide association studies (GWAs), thereby eliminating discovery bias. Principal findings: We derived a network of complex diseases (n = 54) and complex disease genes (n = 349) to explore the shared genetic architecture of complex diseases. We evaluated the centrality measures of complex disease genes in comparison with essential and monogenic disease genes in the human interactome. The complex disease network showed that diseases belonging to the same disease class do not always share common disease genes. A possible explanation could be that the variants with higher minor allele frequency and larger effect size identified using GWAs constitute disjoint parts of the allelic spectra of similar complex diseases. The complex disease gene network showed high modularity with the size of the largest component being smaller than expected from a randomized null-model. This is consistent with limited sharing of genes between diseases. Complex disease genes are less central than the essential and monogenic disease genes in the human interactome. Genes associated with the same disease, compared to genes associated with different diseases, more often tend to share a protein-protein interaction and a Gene Ontology Biological Process. Conclusions: This indicates that network neighbors of known disease genes form an important class of candidates for identifying novel genes for the same disease.	[Barrenas, Fredrik; Chavali, Sreenivas; Mobini, Reza; Benson, Mikael] Univ Gothenburg, Unit Clin Syst Biol, Gothenburg, Sweden; [Holme, Petter] Umea Univ, Dept Phys, Umea, Sweden; [Holme, Petter] Sungkyunkwan Univ, Dept Energy Sci, Suwon, South Korea	University of Gothenburg; Umea University; Sungkyunkwan University (SKKU)	Barrenas, F (corresponding author), Univ Gothenburg, Unit Clin Syst Biol, Gothenburg, Sweden.	fredrik.barrenas@gu.se	Holme, Petter/A-7646-2008	Holme, Petter/0000-0003-2156-1096; Mobini, Reza/0000-0002-3690-5739	Swedish Research Council; European Commission; Swedish Foundation for Strategic Research; WCU (World Class University); Ministry of Education, Science and Technology [R31-R312008-000-10029-0]	Swedish Research Council(Swedish Research CouncilEuropean Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); WCU (World Class University); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the Swedish Research Council, The European Commission, The Swedish Foundation for Strategic Research (PH), and the WCU (World Class University) program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology R31-R312008-000-10029-0 (PH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts S, 2006, NAT BIOTECHNOL, V24, P537, DOI 10.1038/nbt1203; Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Benson M, 2007, ACTA OTO-LARYNGOL, V127, P1074, DOI 10.1080/00016480701200277; Benson M, 2009, ALLERGY, V64, P1286, DOI 10.1111/j.1398-9995.2009.01991.x; Benson M, 2006, CURR MOL MED, V6, P695, DOI 10.2174/156652406778195044; Blake JA, 2009, NUCLEIC ACIDS RES, V37, pD712, DOI 10.1093/nar/gkn886; Craft S, 2009, ARCH NEUROL-CHICAGO, V66, P300, DOI 10.1001/archneurol.2009.27; Feldman I, 2008, P NATL ACAD SCI USA, V105, P4323, DOI 10.1073/pnas.0701722105; Franke L, 2006, AM J HUM GENET, V78, P1011, DOI 10.1086/504300; Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Holme P, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.046111; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Jimenez-Sanchez G, 2001, NATURE, V409, P853, DOI 10.1038/35057050; Jonsson PF, 2006, BIOINFORMATICS, V22, P2291, DOI 10.1093/bioinformatics/btl390; Lage K, 2007, NAT BIOTECHNOL, V25, P309, DOI 10.1038/nbt1295; Mathivanan S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S5-S19; Mobini R, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-19; Oti M, 2007, CLIN GENET, V71, P1, DOI 10.1111/j.1399-0004.2006.00708.x; Oti M, 2006, J MED GENET, V43, DOI 10.1136/jmg.2006.041376; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Wachi S, 2005, BIOINFORMATICS, V21, P4205, DOI 10.1093/bioinformatics/bti688; Wu XB, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.27; Xu JZ, 2006, BIOINFORMATICS, V22, P2800, DOI 10.1093/bioinformatics/btl467	25	82	82	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2009	4	11							e8090	10.1371/journal.pone.0008090	http://dx.doi.org/10.1371/journal.pone.0008090			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MQ	19956617	Green Published, gold, Green Submitted			2022-12-25	WOS:000272828400029
J	Sohn, JA; Litwin, S; Seeger, C				Sohn, Ji A.; Litwin, Samuel; Seeger, Christoph			Mechanism for CCC DNA Synthesis in Hepadnaviruses	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; CLOSED CIRCULAR DNA; REVERSE TRANSCRIPTION; VIRAL-DNA; REPLICATION; PROTEIN; GENOME; WOODCHUCK; INTERMEDIATE; HEPATOCYTES	Hepadnavirus replication requires the synthesis of a covalently closed circular (CCC) DNA from the relaxed circular (RC) viral genome by an unknown mechanism. CCC DNA formation could require enzymatic activities of the viral reverse transcriptase (RT), or cellular DNA repair enzymes, or both. Physical mapping of the 59 and 39 ends of RC DNA and sequence analysis of CCC DNA revealed that CCC DNA synthesis requires the removal of the RT and an RNA oligomer from the 59 ends of minus and plus strand DNA, respectively, removal of sequences from the terminally redundant minus strand, completion of the less than full-length plus strand, and ligation of the ends. Two models have been proposed that could explain CCC DNA formation. The first (model 1) invokes a role for the RT to catalyze a cleavage-ligation reaction leading to the formation of a unit length minus strand in CCC DNA and a DNA repair reaction for the completion and ligation of plus strand DNA; the second (model 2) predicts that CCC DNA formation depends entirely on cellular DNA repair enzymes. To determine which mechanism is utilized, we developed cell lines expressing duck hepatitis B virus genomes carrying mutations permitting us to follow the fate of viral DNA sequences during their conversion from RC to CCC DNA. Our results demonstrated that the oligomer at the 59 end of minus strand DNA is completely or at least partially removed prior to CCC DNA synthesis. The results indicated that both RC DNA strands undergo DNA repair reactions carried out by the cellular DNA repair machinery as predicted by model 2. Thus, our study provided the basis for the identification of the cellular components required for CCC DNA formation.	[Sohn, Ji A.; Litwin, Samuel; Seeger, Christoph] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA	Fox Chase Cancer Center	Sohn, JA (corresponding author), Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	seeger@fccc.edu			NIH; Commonwealth of Pennsylvania	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Commonwealth of Pennsylvania	Supported by grants from NIH and an appropriation from the Commonwealth of Pennsylvania. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae SH, 2001, NATURE, V412, P456, DOI 10.1038/35086609; Gao WF, 2007, J VIROL, V81, P6164, DOI 10.1128/JVI.02721-06; GUO H, 2009, J VIROL; Guo H, 2007, J VIROL, V81, P12472, DOI 10.1128/JVI.01123-07; Guo JT, 2003, J VIROL, V77, P1885, DOI 10.1128/JVI.77.3.1885-1893.2003; Kann M, 1999, J CELL BIOL, V145, P45, DOI 10.1083/jcb.145.1.45; KAWAGUCHI T, 1987, CANCER RES, V47, P4460; LENHOFF RJ, 1994, J VIROL, V68, P5706, DOI 10.1128/JVI.68.9.5706-5713.1994; Liao SR, 2008, NUCLEIC ACIDS RES, V36, P6091, DOI 10.1093/nar/gkn616; LIEN JM, 1986, J VIROL, V57, P229, DOI 10.1128/JVI.57.1.229-236.1986; Loeb DD, 1997, J VIROL, V71, P152, DOI 10.1128/JVI.71.1.152-160.1997; MANDART E, 1984, J VIROL, V49, P782, DOI 10.1128/JVI.49.3.782-792.1984; MASON WS, 1983, VIROLOGY, V131, P375, DOI 10.1016/0042-6822(83)90505-6; Moraleda G, 1997, J VIROL, V71, P9392, DOI 10.1128/JVI.71.12.9392-9399.1997; Nassal M, 1996, J VIROL, V70, P2764, DOI 10.1128/JVI.70.5.2764-2773.1996; Rabe B, 2003, P NATL ACAD SCI USA, V100, P9849, DOI 10.1073/pnas.1730940100; ROTH MJ, 1984, J BIOL CHEM, V259, P556; SEEGER C, 1986, SCIENCE, V232, P477, DOI 10.1126/science.3961490; Seeger C, 1996, VIROLOGY, V222, P430, DOI 10.1006/viro.1996.0440; SEEGER C, 2006, HEPADNAVIRUS; SEEGER C, 2007, HEPADNAVIRUSES; SUMMERS J, 1982, CELL, V29, P403, DOI 10.1016/0092-8674(82)90157-X; TAGAWA M, 1986, VIROLOGY, V152, P477, DOI 10.1016/0042-6822(86)90151-0; TUTTLEMAN JS, 1986, CELL, V47, P451, DOI 10.1016/0092-8674(86)90602-1; WANG GH, 1993, J VIROL, V67, P6507, DOI 10.1128/JVI.67.11.6507-6512.1993; WANG GH, 1992, CELL, V71, P663, DOI 10.1016/0092-8674(92)90599-8; WU TT, 1990, VIROLOGY, V175, P255, DOI 10.1016/0042-6822(90)90206-7; Yang WG, 1996, J VIROL, V70, P4567, DOI 10.1128/JVI.70.7.4567-4575.1996; ZOULIM F, 1994, J VIROL, V68, P6, DOI 10.1128/JVI.68.1.6-13.1994	29	38	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2009	4	11							e8093	10.1371/journal.pone.0008093	http://dx.doi.org/10.1371/journal.pone.0008093			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MQ	19956651	Green Published, Green Submitted, gold			2022-12-25	WOS:000272828400030
J	Bhanja, P; Saha, S; Kabarriti, R; Liu, LB; Roy-Chowdhury, N; Roy-Chowdhury, J; Sellers, RS; Alfieri, AA; Guha, C				Bhanja, Payel; Saha, Subhrajit; Kabarriti, Rafi; Liu, Laibin; Roy-Chowdhury, Namita; Roy-Chowdhury, Jayanta; Sellers, Rani S.; Alfieri, Alan A.; Guha, Chandan			Protective Role of R-spondin1, an Intestinal Stem Cell Growth Factor, against Radiation-Induced Gastrointestinal Syndrome in Mice	PLOS ONE			English	Article							INDUCED APOPTOSIS; R-SPONDIN; EPITHELIUM; GENE; SURVIVAL; DAMAGE; LRP6; IRRADIATION; HOMEOSTASIS; PROTEINS	Background: Radiation-induced gastrointestinal syndrome (RIGS) results from a combination of direct cytocidal effects on intestinal crypt and endothelial cells and subsequent loss of the mucosal barrier, resulting in electrolyte imbalance, diarrhea, weight loss, infection and mortality. Because R-spondin1 (Rspo1) acts as a mitogenic factor for intestinal stem cells, we hypothesized that systemic administration of Rspo1 would amplify the intestinal crypt cells and accelerate the regeneration of the irradiated intestine, thereby, ameliorating RIGS. Methods and Findings: Male C57Bl/6 mice received recombinant adenovirus expressing human R-spondin1 (AdRspo1) or E. coli Lacz (AdLacz), 1-3 days before whole body irradiation (WBI) or abdominal irradiation (AIR). Post-irradiation survival was assessed by Kaplan Meier analysis. RIGS was assessed by histological examination of intestine after hematoxilin and eosin staining, immunohistochemical staining of BrdU incorporation, Lgr5 and beta-catenin expression and TUNEL staining. The xylose absorption test (XAT) was performed to evaluate the functional integrity of the intestinal mucosal barrier. In order to examine the effect of R-spondin1 on tumor growth, AdRspo1 and AdLacZ was administered in the animals having palpable tumor and then exposed to AIR. There was a significant increase in survival in AdRspo1 cohorts compared to AdLacZ (p<0.003) controls, following WBI (10.4 Gy). Significant delay in tumor growth was observed after AIR in both cohorts AdRspo1 and AdLacZ but AdRspo1 treated animals showed improved survival compared to AdLacZ. Histological analysis and XAT demonstrated significant structural and functional regeneration of the intestine in irradiated animals following AdRspo1 treatment. Immunohistochemical analysis demonstrated an increase in Lgr5+ve crypt cells and the translocation of beta-catenin from the cytosol to nucleus and upregulation of beta-catenin target genes in AdRspo1-treated mice, as compared to AdLacz-treated mice. Conclusion: Rspo1 promoted radioprotection against RIGS and improved survival of mice exposed to WBI. The mechanism was likely related to induction of the Wnt-beta-catenin pathway and promotion of intestinal stem cell regeneration. Rspo1 has protective effect only on normal intestinal tissue but not in tumors after AIR and thereby may increase the therapeutic ratio of chemoradiation therapy in patients undergoing abdominal irradiation for GI malignancies.	[Bhanja, Payel; Saha, Subhrajit; Kabarriti, Rafi; Liu, Laibin; Alfieri, Alan A.; Guha, Chandan] Albert Einstein Coll Med, Dept Radiat Oncol, Bronx, NY 10467 USA; [Roy-Chowdhury, Namita; Roy-Chowdhury, Jayanta] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Roy-Chowdhury, Namita; Roy-Chowdhury, Jayanta] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA; [Sellers, Rani S.; Guha, Chandan] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA; [Sellers, Rani S.; Guha, Chandan] Montefiore Med Ctr, Albert Einstein Coll Med, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine	Bhanja, P (corresponding author), Albert Einstein Coll Med, Dept Radiat Oncol, Bronx, NY 10467 USA.	cguhamd@pol.net	SAHA, SUBHRAJIT/AAJ-9272-2021	SAHA, SUBHRAJIT/0000-0002-7287-073X	Department of Radiation Oncology	Department of Radiation Oncology	The work has been supported internally by the Department of Radiation Oncology and no commercial support or other benefits were received for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Binnerts ME, 2007, P NATL ACAD SCI USA, V104, P14700, DOI 10.1073/pnas.0702305104; Ch'ang HJ, 2005, NAT MED, V11, P484, DOI 10.1038/nm1237; Chartier C, 1996, J VIROL, V70, P4805, DOI 10.1128/JVI.70.7.4805-4810.1996; CHENG H, 1974, AM J ANAT, V141, P503, DOI 10.1002/aja.1001410405; COIA LR, 1995, INT J RADIAT ONCOL, V31, P1213, DOI 10.1016/0360-3016(94)00419-L; EBERTS TJ, 1979, CLIN CHEM, V25, P1440; FERRARIS RP, 1992, AM J PHYSIOL, V262, pG1047, DOI 10.1152/ajpgi.1992.262.6.G1047; Francois S, 2006, STEM CELLS, V24, P1020, DOI 10.1634/stemcells.2005-0260; Gregorieff A, 2005, GENE DEV, V19, P877, DOI 10.1101/gad.1295405; HANSON WR, 1983, RADIAT RES, V96, P393, DOI 10.2307/3576222; HAUERJENSEN M, 1990, ACTA ONCOL, V29, P401, DOI 10.3109/02841869009090022; Inagaki-Ohara K, 2001, ONCOGENE, V20, P812, DOI 10.1038/sj.onc.1204172; Kamata T, 2004, BBA-GENE STRUCT EXPR, V1676, P51, DOI 10.1016/j.bbaexp.2003.10.009; Khan WB, 1997, RADIAT RES, V148, P248, DOI 10.2307/3579609; Kim KA, 2005, SCIENCE, V309, P1256, DOI 10.1126/science.1112521; Kim KA, 2008, MOL BIOL CELL, V19, P2588, DOI 10.1091/mbc.E08-02-0187; Kuo CJ, 2001, P NATL ACAD SCI USA, V98, P4605, DOI 10.1073/pnas.081615298; Marshman E, 2002, BIOESSAYS, V24, P91, DOI 10.1002/bies.10028; Monti P., 2005, BRIT J RADIOL, P89, DOI DOI 10.1259/BJR/53186341; Nam JS, 2006, J BIOL CHEM, V281, P13247, DOI 10.1074/jbc.M508324200; Paris F, 2001, SCIENCE, V293, P293, DOI 10.1126/science.1060191; Pinto D, 2003, GENE DEV, V17, P1709, DOI 10.1101/gad.267103; POTTEN CS, 1974, CELL TISSUE KINET, V7, P271, DOI 10.1111/j.1365-2184.1974.tb00907.x; POTTEN CS, 1995, INT J CANCER, V62, P356, DOI 10.1002/ijc.2910620321; POTTEN CS, 1988, J CELL SCI, P45; Potten CS, 1997, BRIT J CANCER, V75, P1454, DOI 10.1038/bjc.1997.249; Potten CS, 1997, COMP BIOCHEM PHYS B, V118, P473, DOI 10.1016/S0305-0491(97)00219-8; POTTEN CS, 1994, INT J RADIAT BIOL, V65, P71, DOI 10.1080/09553009414550101; Potten CS, 1998, PHILOS T R SOC B, V353, P821, DOI 10.1098/rstb.1998.0246; POTTEN CS, 1981, INT J RADIAT BIOL, V40, P321, DOI 10.1080/09553008114551251; Potten CS, 1997, INT J EXP PATHOL, V78, P219, DOI 10.1046/j.1365-2613.1997.280362.x; POTTEN CS, 1992, CANCER METAST REV, V11, P179, DOI 10.1007/BF00048063; Wei Q, 2007, J BIOL CHEM, V282, P15903, DOI 10.1074/jbc.M701927200; WITHERS HR, 1970, INT J RADIAT BIOL RE, V17, P261, DOI 10.1080/09553007014550291; Woodward WA, 2007, P NATL ACAD SCI USA, V104, P618, DOI 10.1073/pnas.0606599104; Zhao JS, 2007, GASTROENTEROLOGY, V132, P1331, DOI 10.1053/j.gastro.2007.02.001; Zhao JS, 2009, P NATL ACAD SCI USA, V106, P2331, DOI 10.1073/pnas.0805159106; Zimmerer T, 2008, Z GASTROENTEROL, V46, P441, DOI 10.1055/s-2008-1027150	39	87	95	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2009	4	11							e8014	10.1371/journal.pone.0008014	http://dx.doi.org/10.1371/journal.pone.0008014			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MH	19956666	Green Published, Green Submitted, gold			2022-12-25	WOS:000272827500036
J	Brown, SA; Whiteley, M				Brown, Stacie A.; Whiteley, Marvin			Characterization of the L-Lactate Dehydrogenase from Aggregatibacter actinomycetemcomitans	PLOS ONE			English	Article							HUMAN PERIODONTAL-DISEASE; ESCHERICHIA-COLI; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; PURIFICATION; PLAQUE; GENE; EXCLUSION; TRANSPORT; SURFACES; SYSTEM	Aggregatibacter actinomycetemcomitans is a Gram-negative opportunistic pathogen and the proposed causative agent of localized aggressive periodontitis. A. actinomycetemcomitans is found exclusively in the mammalian oral cavity in the space between the gums and the teeth known as the gingival crevice. Many bacterial species reside in this environment where competition for carbon is high. A. actinomycetemcomitans utilizes a unique carbon resource partitioning system whereby the presence of L-lactate inhibits uptake of glucose, thus allowing preferential catabolism of L-lactate. Although the mechanism for this process is not fully elucidated, we previously demonstrated that high levels of intracellular pyruvate are critical for L-lactate preference. As the first step in L-lactate catabolism is conversion of L-lactate to pyruvate by lactate dehydrogenase, we proposed a model in which the A. actinomycetemcomitans L-lactate dehydrogenase, unlike homologous enzymes, is not feedback inhibited by pyruvate. This lack of feedback inhibition allows intracellular pyruvate to rise to levels sufficient to inhibit glucose uptake in other bacteria. In the present study, the A. actinomycetemcomitans L-lactate dehydrogenase was purified and shown to convert L-lactate, but not D-lactate, to pyruvate with a K(m) of approximately 150 mu M. Inhibition studies reveal that pyruvate is a poor inhibitor of L-lactate dehydrogenase activity, providing mechanistic insight into L-lactate preference in A. actinomycetemcomitans.			Brown, SA (corresponding author), Univ Texas Austin, Sect Mol Genet & Microbiol, Austin, TX 78712 USA.	mwhiteley@mail.utexas.edu			NCRR NIH HHS [5P20RR081741] Funding Source: Medline	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Ausubel F, 1997, SHORT PROTOCOLS MOL; Barnard JP, 1999, INFECT IMMUN, V67, P6558; BERNARD N, 1991, FEBS LETT, V290, P61, DOI 10.1016/0014-5793(91)81226-X; Brown SA, 2007, J BACTERIOL, V189, P6407, DOI 10.1128/JB.00554-07; Bunch PK, 1997, MICROBIOL-UK, V143, P187, DOI 10.1099/00221287-143-1-187; FUTAI M, 1977, J BIOL CHEM, V252, P5820; FUTAI M, 1973, BIOCHEMISTRY-US, V12, P2468, DOI 10.1021/bi00737a016; GARVIE EI, 1980, MICROBIOL REV, V44, P106, DOI 10.1128/MMBR.44.1.106-139.1980; Hogema BM, 1998, MOL MICROBIOL, V30, P487, DOI 10.1046/j.1365-2958.1998.01053.x; Horikiri S, 2004, BIOSCI BIOTECH BIOCH, V68, P516, DOI 10.1271/bbb.68.516; JENSEN ME, 1983, J DENT RES, V62, P1058, DOI 10.1177/00220345830620101001; JENSEN ME, 1982, ARCH ORAL BIOL, V27, P21, DOI 10.1016/0003-9969(82)90172-8; KISTLER WA, 1971, J BACTERIOL, V108, P1224, DOI 10.1128/JB.108.3.1224-1234.1971; KLINE ES, 1965, ANN NY ACAD SCI, V119, P905, DOI 10.1111/j.1749-6632.1965.tb47451.x; KOHN LD, 1973, J BIOL CHEM, V248, P7012; MARKWELL JP, 1978, J BACTERIOL, V133, P593, DOI 10.1128/JB.133.2.593-600.1978; Mintz KP, 2000, INFECT IMMUN, V68, P6580, DOI 10.1128/IAI.68.12.6580-6586.2000; MOLINARI R, 1960, BIOCHEM J, V75, P57, DOI 10.1042/bj0750057; Norskov-Lauritsen N, 2006, INT J SYST EVOL MICR, V56, P2135, DOI 10.1099/ijs.0.64207-0; Nuttall FQ, 2000, METABOLISM, V49, P1565, DOI 10.1053/meta.2000.18553; POSTMA PW, 1993, MICROBIOL REV, V57, P543, DOI 10.1128/MMBR.57.3.543-594.1993; SCHACHTELE CF, 1982, J DENT RES, V61, P1117, DOI 10.1177/00220345820610100201; SLOTS J, 1980, INFECT IMMUN, V29, P1013; SOCRANSKY SS, 1985, J CLIN MICROBIOL, V22, P303, DOI 10.1128/JCM.22.2.303-305.1985; SOYAMA K, 1984, CLIN CHEM, V30, P293; WEIGEL N, 1982, J BIOL CHEM, V257, P4477; ZAMBON JJ, 1985, J CLIN PERIODONTOL, V12, P1, DOI 10.1111/j.1600-051X.1985.tb01348.x	27	13	14	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2009	4	11							e7864	10.1371/journal.pone.0007864	http://dx.doi.org/10.1371/journal.pone.0007864			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520OG	19924225	gold, Green Submitted, Green Published			2022-12-25	WOS:000271854200012
J	Crampton, SP; Wu, BB; Park, EJ; Kim, JH; Solomon, C; Waterman, ML; Hughes, CCW				Crampton, Steve P.; Wu, Beibei; Park, Edward J.; Kim, Jai-Hyun; Solomon, Candice; Waterman, Marian L.; Hughes, Christopher C. W.			Integration of the beta-Catenin-Dependent Wnt Pathway with Integrin Signaling through the Adaptor Molecule Grb2	PLOS ONE			English	Article							FOCAL-ADHESION-KINASE; C-JUN; LINKED KINASE; TARGET GENES; PROTEIN; ACTIVATION; PROLIFERATION; INVASION; CANCER; RAS	Background: The complexity of wnt signaling likely stems from two sources: multiple pathways emanating from frizzled receptors in response to wnt binding, and modulation of those pathways and target gene responsiveness by context-dependent signals downstream of growth factor and matrix receptors. Both rac1 and c-jun have recently been implicated in wnt signaling, however their upstream activators have not been identified. Methodology/Principal Findings: Here we identify the adapter protein Grb2, which is itself an integrator of multiple signaling pathways, as a modifier of beta-catenin-dependent wnt signaling. Grb2 synergizes with wnt3A, constitutively active (CA) LRP6, Dvl2 or CA-beta-catenin to drive a LEF/TCF-responsive reporter, and dominant negative (DN) Grb2 or siRNA to Grb2 block wnt3A-mediated reporter activity. MMP9 is a target of beta-catenin-dependent wnt signaling, and an MMP9 promoter reporter is also responsive to signals downstream of Grb2. Both a jnk inhibitor and DN-c-jun block transcriptional activation downstream of Dvl2 and Grb2, as does DN-rac1. Integrin ligation by collagen also synergizes with wnt signaling as does overexpression of Focal Adhesion Kinase (FAK), and this is blocked by DN-Grb2. Conclusions/Significance: These data suggest that integrin ligation and FAK activation synergize with wnt signaling through a Grb2-rac-jnk-c-jun pathway, providing a context-dependent mechanism for modulation of wnt signaling.			Crampton, SP (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, UCI Inst Immunol, Irvine, CA 92717 USA.	cchughes@uci.edu	Wu, Beibei/B-5169-2010; Wu, Beibei/B-7463-2011; Hughes, Christopher/F-7510-2010		NCI NIH HHS [CA096878, R01 CA096878, P30 CA062203, CA-62203, R01 CA108697, CA108697] Funding Source: Medline; NIAID NIH HHS [R01 AI040710, T32 AI60573, R01 AI40710, T32 AI060573] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA096878, R01CA108697, P30CA062203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI060573, R01AI040710] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Arce L, 2006, ONCOGENE, V25, P7492, DOI 10.1038/sj.onc.1210056; Bikkavilli RK, 2008, J CELL SCI, V121, P234, DOI 10.1242/jcs.021964; Brennan K, 2004, ONCOGENE, V23, P4873, DOI 10.1038/sj.onc.1207642; Carmena A, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000066; Cheng AM, 1998, CELL, V95, P793, DOI 10.1016/S0092-8674(00)81702-X; Cohen ED, 2002, DEV CELL, V2, P437, DOI 10.1016/S1534-5807(02)00142-9; de Lau W, 2007, FRONT BIOSCI-LANDMRK, V12, P471, DOI 10.2741/2076; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; Dharmawardana PG, 2006, ANTI-CANCER DRUG, V17, P13, DOI 10.1097/01.cad.0000185180.72604.ac; Fujimura N, 2007, J BIOL CHEM, V282, P1225, DOI 10.1074/jbc.M605851200; Gan XQ, 2008, J CELL BIOL, V180, P1087, DOI 10.1083/jcb.200710050; Genersch E, 2000, J CELL SCI, V113, P4319; Gong K, 2001, NAT IMMUNOL, V2, P29, DOI 10.1038/83134; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Gupta RW, 1998, ONCOGENE, V17, P2155, DOI 10.1038/sj.onc.1202158; Hehlgans S, 2007, BBA-REV CANCER, V1775, P163, DOI 10.1016/j.bbcan.2006.09.001; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; Hovanes K, 2000, NUCLEIC ACIDS RES, V28, P1994, DOI 10.1093/nar/28.9.1994; Jackson A, 2005, BONE, V36, P585, DOI 10.1016/j.bone.2005.01.007; Jin TR, 2008, CELL SIGNAL, V20, P1697, DOI 10.1016/j.cellsig.2008.04.014; Kim SE, 2007, CELL SIGNAL, V19, P1554, DOI 10.1016/j.cellsig.2007.02.003; Kishida S, 1999, MOL CELL BIOL, V19, P4414; Lai SL, 2009, CELL RES, V19, P532, DOI 10.1038/cr.2009.41; Le Floch N, 2004, FASEB J, V18, P144, DOI 10.1096/fj.04-2373fje; LEE YN, 2007, CELL SIGNAL; Li L, 1999, J BIOL CHEM, V274, P129, DOI 10.1074/jbc.274.1.129; Liu T, 2001, SCIENCE, V292, P1718, DOI 10.1126/science.1060100; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lorenz K, 2007, J CELL BIOL, V177, P501, DOI 10.1083/jcb.200608125; MacDonald BT, 2007, CELL, V131, DOI 10.1016/j.cell.2007.11.036; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Nateri AS, 2005, NATURE, V437, P281, DOI 10.1038/nature03914; Oloumi A, 2006, ONCOGENE, V25, P7747, DOI 10.1038/sj.onc.1209752; Oloumi A, 2004, BBA-MOL CELL RES, V1691, P1, DOI 10.1016/j.bbamcr.2003.12.002; Pandur P, 2001, BIOESSAYS, V23, P207, DOI 10.1002/1521-1878(200103)23:3<207::AID-BIES1029>3.0.CO;2-0; Penton A, 2002, GENETICS, V161, P747; Phelps RA, 2009, CELL, V137, P623, DOI 10.1016/j.cell.2009.02.037; Pomerance M, 1998, J BIOL CHEM, V273, P24301, DOI 10.1074/jbc.273.38.24301; Qiang YW, 2005, BLOOD, V106, P1786, DOI 10.1182/blood-2005-01-0049; Schlaepfer DD, 1997, MOL CELL BIOL, V17, P1702, DOI 10.1128/MCB.17.3.1702; Schlange T, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1769; Schlessinger K, 2009, GENE DEV, V23, P265, DOI 10.1101/gad.1760809; Schwarz-Romond T, 2005, J CELL SCI, V118, P5269, DOI 10.1242/jcs.02646; Schwarz-Romond T, 2007, NAT STRUCT MOL BIOL, V14, P484, DOI 10.1038/nsmb1247; Segarra M, 2005, FASEB J, V19, P1875, DOI 10.1096/fj.04-3574fje; Semenov MV, 2007, CELL, V131, DOI 10.1016/j.cell.2007.12.011; Slusarski DC, 1997, NATURE, V390, P410, DOI 10.1038/37138; Staal FJT, 2004, J IMMUNOL, V172, P1099, DOI 10.4049/jimmunol.172.2.1099; Suh J, 2004, J CELL BIOCHEM, V91, P100, DOI 10.1002/jcb.10729; TANAKA M, 1995, MOL CELL BIOL, V15, P6829; Toualbi K, 2007, ONCOGENE, V26, P3492, DOI 10.1038/sj.onc.1210133; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Vlad A, 2008, CELL SIGNAL, V20, P795, DOI 10.1016/j.cellsig.2007.10.031; Weeraratna AT, 2002, CANCER CELL, V1, P279, DOI 10.1016/S1535-6108(02)00045-4; Wu BB, 2007, IMMUNITY, V26, P227, DOI 10.1016/j.immuni.2006.12.007; Wu XM, 2008, CELL, V133, P340, DOI 10.1016/j.cell.2008.01.052; Yi FH, 2008, ENDOCRINOLOGY, V149, P2341, DOI 10.1210/en.2007-1142	57	53	55	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2009	4	11							e7841	10.1371/journal.pone.0007841	http://dx.doi.org/10.1371/journal.pone.0007841			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520NG	19924227	Green Published, gold			2022-12-25	WOS:000271851000003
J	Joannes, A; Bonnomet, A; Bindels, S; Polette, M; Gilles, C; Burlet, H; Cutrona, J; Zahm, JM; Birembaut, P; Nawrocki-Raby, B				Joannes, A.; Bonnomet, A.; Bindels, S.; Polette, M.; Gilles, C.; Burlet, H.; Cutrona, J.; Zahm, J-M; Birembaut, P.; Nawrocki-Raby, B.			Fhit regulates invasion of lung tumor cells	ONCOGENE			English	Article						Fhit; tumor invasion; epithelial-mesenchymal transition; cell-cell adhesion molecules; matrix metalloproteinases; vimentin	FRAGILE HISTIDINE TRIAD; EPITHELIAL-MESENCHYMAL TRANSITION; BREAST-CANCER CELLS; MEMBRANE-TYPE-1 MATRIX-METALLOPROTEINASE; BETA-CATENIN; SUPPRESSES TUMORIGENICITY; ZONULA OCCLUDENS-1; PROTEIN EXPRESSION; GENE; CARCINOMA	In many types of cancers, the fragile histidine triad (Fhit) gene is frequently targeted by genomic alterations leading to a decrease or loss of gene and protein expression. Fhit has been described as a tumor suppressor gene because of its ability to induce apoptosis and to inhibit proliferation of tumor cells. Moreover, several studies have shown a correlation between the lack of Fhit expression and tumor aggressiveness, thus suggesting that Fhit could be involved in tumor progression. In this study, we explored the potential role of Fhit during tumor cell invasion. We first showed that a low Fhit expression is associated with in vivo and in vitro invasiveness of tumor cells. Then, we showed that Fhit overexpression in Fhit-negative highly invasive NCI-H1299 cells by transfection of Fhit cDNA and Fhit inhibition in Fhit-positive poorly invasive HBE4-E6/E7 cells by transfection of Fhit small interfering RNA induce, respectively, a decrease and an increase in migratory/invasive capacities. These changes in cell behavior were associated with a reorganization of tight and adherens junction molecules and a regulation of matrix metalloproteinase and vimentin expression. These results show that Fhit controls the invasive phenotype of lung tumor cells by regulating the expression of genes associated with epithelial-mesenchymal transition. Oncogene (2010) 29, 1203-1213; doi: 10.1038/onc.2009.418; published online 23 November 2009	[Nawrocki-Raby, B.] CHU Maison Blanche, INSERM, U903, UMRS 903, F-51100 Reims, France; [Joannes, A.; Polette, M.; Burlet, H.; Zahm, J-M; Birembaut, P.; Nawrocki-Raby, B.] Univ Reims, IFR53, UMR S903, Reims, France; [Bonnomet, A.; Bindels, S.; Gilles, C.] Univ Liege, CHU Sart Tilman, Lab Biol Tumeurs & Dev, Liege, Belgium; [Polette, M.; Birembaut, P.] Hop Maison Blanche, CHU Reims, Lab Pol Bouin, Reims, France; [Cutrona, J.] Univ Reims, CRESTIC, Reims, France	CHU de Reims; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Reims Champagne-Ardenne; Universite de Reims Champagne-Ardenne; University of Liege; CHU de Reims; Universite de Reims Champagne-Ardenne; Universite de Reims Champagne-Ardenne	Nawrocki-Raby, B (corresponding author), CHU Maison Blanche, INSERM, U903, UMRS 903, 45 Rue Cognacq Jay, F-51100 Reims, France.	beatrice.raby@univ-reims.fr	Raby, Beatrice/P-5666-2016; BIREMBAUT, Philippe/P-5210-2016; Cutrona, Jérôme/P-6658-2016; POLETTE, Myriam/P-5147-2016	Raby, Beatrice/0000-0002-3163-8619; BONNOMET, Arnaud/0000-0002-4933-3338; POLETTE, Myriam/0000-0001-8173-3246	Region Champagne-Ardenne; Ligue Contre le Cancer (Comite de la Marne); Lions Club of Soissons; Un Euro contre le Cancer; Fond National pour la Sante [ACI 2004-2010 INCa]	Region Champagne-Ardenne(Region Grand-Est); Ligue Contre le Cancer (Comite de la Marne); Lions Club of Soissons; Un Euro contre le Cancer; Fond National pour la Sante	This study was supported by the Region Champagne-Ardenne, the Ligue Contre le Cancer (Comite de la Marne), the Lions Club of Soissons, Un Euro contre le Cancer and the Fond National pour la Sante ACI 2004-2010 INCa (Canceropole Grand-Est project).	Barnes LD, 1996, BIOCHEMISTRY-US, V35, P11529, DOI 10.1021/bi961415t; Brabletz T, 1999, AM J PATHOL, V155, P1033, DOI 10.1016/S0002-9440(10)65204-2; Campiglio M, 2006, J CELL PHYSIOL, V208, P274, DOI 10.1002/jcp.20633; Cavazzoni A, 2004, ONCOGENE, V23, P8439, DOI 10.1038/sj.onc.1207847; Chang C, 2001, TRENDS CELL BIOL, V11, pS37, DOI 10.1016/S0962-8924(01)82222-4; Crawford HC, 1999, ONCOGENE, V18, P2883, DOI 10.1038/sj.onc.1202627; Dumon KR, 2001, P NATL ACAD SCI USA, V98, P3346, DOI 10.1073/pnas.061020098; Gavert N, 2008, TRENDS MOL MED, V14, P199, DOI 10.1016/j.molmed.2008.03.004; Gavert N, 2007, J CELL BIOCHEM, V102, P820, DOI 10.1002/jcb.21505; Gilles C, 1999, J CELL SCI, V112, P4615; Gilles C, 1996, J PATHOL, V180, P175, DOI 10.1002/(SICI)1096-9896(199610)180:2<175::AID-PATH630>3.0.CO;2-G; Gilles C, 2003, CANCER RES, V63, P2658; GILLES C, 1996, BREAST J, V2, P83; Hazgui S, 2005, AM J PHYSIOL-CELL PH, V289, pC1547, DOI 10.1152/ajpcell.00319.2005; Hendrix MJC, 1997, AM J PATHOL, V150, P483; Huebner K, 2003, BRIT J CANCER, V88, P1501, DOI 10.1038/sj.bjc.6600937; Ishii H, 2001, JAMA-J AM MED ASSOC, V286, P2441, DOI 10.1001/jama.286.19.2441; Jayachandran G, 2007, CANCER RES, V67, P10379, DOI 10.1158/0008-5472.CAN-07-0677; Ji L, 1999, CANCER RES, V59, P3333; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Luo J, 1999, CANCER RES, V59, P3552; Marchenko GN, 2002, BIOCHEM J, V363, P253, DOI 10.1042/0264-6021:3630253; Maruyama R, 2004, CANCER-AM CANCER SOC, V100, P1472, DOI 10.1002/cncr.20144; Nakagawa Y, 2006, EXP CELL RES, V312, P2433, DOI 10.1016/j.yexcr.2006.04.004; Nakata S, 2006, CANCER-AM CANCER SOC, V106, P2190, DOI 10.1002/cncr.21870; Nawrocki-Raby B, 2003, AM J PATHOL, V163, P653, DOI 10.1016/S0002-9440(10)63692-9; Negrini M, 1996, CANCER RES, V56, P3173; Ohta M, 1996, CELL, V84, P587, DOI 10.1016/S0092-8674(00)81034-X; Pace HC, 1998, P NATL ACAD SCI USA, V95, P5484, DOI 10.1073/pnas.95.10.5484; Pekarsky Y, 2004, P NATL ACAD SCI USA, V101, P3775, DOI 10.1073/pnas.0400481101; Pekarsky Y, 2002, LANCET ONCOL, V3, P748, DOI 10.1016/S1470-2045(02)00931-2; Polette M, 2005, CANCER RES, V65, P7691, DOI 10.1158/0008-5472.CAN-04-4230; Polette M, 2004, CRIT REV ONCOL HEMAT, V49, P179, DOI 10.1016/j.critrevonc.2003.10.008; Polette M, 2007, CELLS TISSUES ORGANS, V185, P61, DOI 10.1159/000101304; Pylkkanen L, 2002, INT J ONCOL, V20, P285; Reichert M, 2000, J BIOL CHEM, V275, P9492, DOI 10.1074/jbc.275.13.9492; Roz L, 2002, P NATL ACAD SCI USA, V99, P3615, DOI 10.1073/pnas.062030799; Seiki M, 2003, CANCER LETT, V194, P1, DOI 10.1016/S0304-3835(02)00699-7; Semba S, 2006, ONCOGENE, V25, P2860, DOI 10.1038/sj.onc.1209323; Siprashvili Z, 1997, P NATL ACAD SCI USA, V94, P13771, DOI 10.1073/pnas.94.25.13771; Sozzi G, 1998, CANCER RES, V58, P5032; Sozzi G, 1996, CELL, V85, P17, DOI 10.1016/S0092-8674(00)81078-8; Takahashi M, 2002, ONCOGENE, V21, P5861, DOI 10.1038/sj.onc.1205755; Tobioka H, 2004, HUM PATHOL, V35, P159, DOI 10.1016/j.humpath.2003.09.013; Trapasso F, 2003, P NATL ACAD SCI USA, V100, P1592, DOI 10.1073/pnas.0437915100; Van Aken E, 2001, VIRCHOWS ARCH, V439, P725, DOI 10.1007/S004280100516; Weiske J, 2007, P NATL ACAD SCI USA, V104, P20344, DOI 10.1073/pnas.0703664105; Zahm JM, 1997, CELL MOTIL CYTOSKEL, V37, P33, DOI 10.1002/(SICI)1097-0169(1997)37:1<33::AID-CM4>3.0.CO;2-I	48	33	35	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 25	2010	29	8					1203	1213		10.1038/onc.2009.418	http://dx.doi.org/10.1038/onc.2009.418			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	560ON	19935706				2022-12-25	WOS:000274912100011
J	Bruni, F; Polosa, PL; Gadaleta, MN; Cantatore, P; Roberti, M				Bruni, Francesco; Polosa, Paola Loguercio; Gadaleta, Maria Nicola; Cantatore, Palmiro; Roberti, Marina			Nuclear Respiratory Factor 2 Induces the Expression of Many but Not All Human Proteins Acting in Mitochondrial DNA Transcription and Replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-BINDING SITES; GENE-EXPRESSION; POLYMERASE GAMMA; MTDNA TRANSCRIPTION; ACCESSORY SUBUNIT; BIOGENESIS; PROMOTER; GABP; IDENTIFICATION; TERMINATION	In mammals, NRF-2 (nuclear respiratory factor 2), also named GA-binding protein, is an Ets family transcription factor that controls many genes involved in cell cycle progression and protein synthesis as well as in mitochondrial biogenesis. In this paper, we analyzed the role of NRF-2 in the regulation of human genes involved in mitochondrial DNA transcription and replication. By a combination of bioinformatic and biochemical approaches, we found that the factor binds in vitro and in vivo to the proximal promoter region of the genes coding for the transcription termination factor mTERF, the RNA polymerase POLRMT, the B subunit of the DNA polymerase-gamma, the DNA helicase TWINKLE, and the single-stranded DNA-binding protein mtSSB. The role of NRF-2 in modulating the expression of those genes was further established by RNA interference and overexpression strategies. On the contrary, we found that NRF-2 does not control the genes for the subunit A of DNA polymerase-gamma and for the transcription repressor MTERF3; we suggest that these genes are under regulatory mechanisms that do not involve NRF proteins. Since NRFs are known to positively control the expression of transcription-activating proteins, the novelty emerging from our data is that proteins playing antithetical roles in mitochondrial DNA transcription, namely activators and repressors, are under different regulatory pathways. Finally, we developed a more stringent consensus with respect to the general consensus of NRF-2/GA-binding protein when searching for NRF-2 binding sites in the promoter of mitochondrial proteins.	[Bruni, Francesco; Polosa, Paola Loguercio; Gadaleta, Maria Nicola; Cantatore, Palmiro; Roberti, Marina] Univ Bari, Dept Biochem & Mol Biol Ernesto Quagliariello, I-70125 Bari, Italy; [Gadaleta, Maria Nicola; Cantatore, Palmiro] CNR, Inst Biomembrane & Bioenerget, I-70126 Bari, Italy	Universita degli Studi di Bari Aldo Moro; Consiglio Nazionale delle Ricerche (CNR)	Roberti, M (corresponding author), Via Orabona 4, I-70125 Bari, Italy.	marina.roberti@biologia.uniba.it	Loguercio Polosa, Paola/I-5633-2012; Bruni, Francesco/I-4074-2018	Bruni, Francesco/0000-0001-5120-5936	Universita di Bari; Progetto di Ricerca di Ateneo; Telethon-Italy [GGP06233]	Universita di Bari; Progetto di Ricerca di Ateneo; Telethon-Italy(Fondazione Telethon)	This work was supported by grants from Universita di Bari, Progetto di Ricerca di Ateneo, and Telethon-Italy (Grant GGP06233).	Blesa JR, 2007, GENE, V391, P198, DOI 10.1016/j.gene.2006.12.024; Cam H, 2004, MOL CELL, V16, P399, DOI 10.1016/j.molcel.2004.09.037; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Cotney J, 2009, HUM MOL GENET, V18, P2670, DOI 10.1093/hmg/ddp208; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Di Re M, 2009, NUCLEIC ACIDS RES, V37, P5701, DOI 10.1093/nar/gkp614; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028; Fernandez-Moreno MA, 2009, BIOCHEM J, V418, P453, DOI 10.1042/BJ20081174; GASTON K, 1995, GENE, V157, P257, DOI 10.1016/0378-1119(95)00120-U; Gleyzer N, 2005, MOL CELL BIOL, V25, P1354, DOI 10.1128/MCB.25.4.1354-1366.2005; Gong QM, 2000, J BIOL CHEM, V275, P38012, DOI 10.1074/jbc.M004078200; Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d; GUGNEJA S, 1995, MOL CELL BIOL, V15, P102, DOI 10.1128/MCB.15.1.102; Hegde ML, 2008, CELL RES, V18, P27, DOI 10.1038/cr.2008.8; Holt IJ, 2009, TRENDS BIOCHEM SCI, V34, P358, DOI 10.1016/j.tibs.2009.03.007; Kataoka K, 2007, J BIOCHEM, V141, P775, DOI 10.1093/jb/mvm105; Kropotov A, 2007, FEBS J, V274, P5804, DOI 10.1111/j.1742-4658.2007.06103.x; Lefai E, 2000, J BIOL CHEM, V275, P33123, DOI 10.1074/jbc.M003024200; Marinescu VD, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-79; Martin M, 2005, CELL, V123, P1227, DOI 10.1016/j.cell.2005.09.040; Matsukage A, 2008, BBA-GENE REGUL MECH, V1779, P81, DOI 10.1016/j.bbagrm.2007.11.011; Ongwijitwat S, 2006, GENE, V374, P39, DOI 10.1016/j.gene.2006.01.009; Park CB, 2007, CELL, V130, P273, DOI 10.1016/j.cell.2007.05.046; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Roberti M, 2009, BBA-BIOENERGETICS, V1787, P303, DOI 10.1016/j.bbabio.2009.01.013; Rosmarin  AG, 2004, BLOOD CELL MOL DIS, V32, P143, DOI 10.1016/j.bcmd.2003.09.005; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Scarpulla RC, 2008, ANN NY ACAD SCI, V1147, P321, DOI 10.1196/annals.1427.006; Schultz RA, 1998, J BIOL CHEM, V273, P3447, DOI 10.1074/jbc.273.6.3447; Takahashi K, 2008, J BIOL CHEM, V283, P15134, DOI 10.1074/jbc.M800498200; Takahashi Y, 2002, BBA-GENE STRUCT EXPR, V1574, P359, DOI 10.1016/S0167-4781(01)00374-8; Valouev A, 2008, NAT METHODS, V5, P829, DOI 10.1038/NMETH.1246; VIRBASIUS JV, 1994, P NATL ACAD SCI USA, V91, P1309, DOI 10.1073/pnas.91.4.1309; Wenz T, 2009, CELL METAB, V9, P499, DOI 10.1016/j.cmet.2009.04.010; Yang ZF, 2007, NAT CELL BIOL, V9, P339, DOI 10.1038/ncb1548; Ye F, 1996, NUCLEIC ACIDS RES, V24, P1481, DOI 10.1093/nar/24.8.1481	37	54	57	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3939	3948		10.1074/jbc.M109.044305	http://dx.doi.org/10.1074/jbc.M109.044305			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19951946	hybrid, Green Published			2022-12-25	WOS:000275254000047
J	Meulemans, A; Seneca, S; Pribyl, T; Smet, J; Alderweirldt, V; Waeytens, A; Lissens, W; Van Coster, R; De Meirleir, L; di Rago, JP; Gatti, DL; Ackerman, SH				Meulemans, Ann; Seneca, Sara; Pribyl, Thomas; Smet, Joel; Alderweirldt, Valerie; Waeytens, Anouk; Lissens, Willy; Van Coster, Rudy; De Meirleir, Linda; di Rago, Jean-Paul; Gatti, Domenico L.; Ackerman, Sharon H.			Defining the Pathogenesis of the Human Atp12p W94R Mutation Using a Saccharomyces cerevisiae Yeast Model	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							QUASI-NEWTON MATRICES; MOLECULAR-DYNAMICS; HYPERTROPHIC CARDIOMYOPATHY; MITOCHONDRIAL F-1-ATPASE; ESCHERICHIA-COLI; LEIGH-SYNDROME; ALPHA-SUBUNIT; F-1 ATPASE; SYNTHASE; PROTEINS	Studies in yeast have shown that a deficiency in Atp12p prevents assembly of the extrinsic domain (F-1) of complex V and renders cells unable to make ATP through oxidative phosphorylation. De Meirleir et al. (De Meirleir, L., Seneca, S., Lissens, W., De Clercq, I., Eyskens, F., Gerlo, E., Smet, J., and Van Coster, R. (2004) J. Med. Genet. 41, 120-124) have reported that a homozygous missense mutation in the gene for human Atp12p (HuAtp12p), which replaces Trp-94 with Arg, was linked to the death of a 14-month-old patient. We have investigated the impact of the pathogenic W94R mutation on Atp12p structure/function. Plasmid-borne wild type human Atp12p rescues the respiratory defect of a yeast ATP12 deletion mutant (Delta atp12). The W94R mutation alters the protein at the most highly conserved position in the Pfam sequence and renders HuAtp12p insoluble in the background of Delta atp12. In contrast, the yeast protein harboring the corresponding mutation, ScAtp12p(W103R), is soluble in the background of Delta atp12 but not in the background of Delta atp12 Delta fmc1, a strain that also lacks Fmc1p. Fmc1p is a yeast mitochondrial protein not found in higher eukaryotes. Tryptophan 94 (human) or 103 (yeast) is located in a positively charged region of Atp12p, and hence its mutation to arginine does not alter significantly the electrostatic properties of the protein. Instead, we provide evidence that the primary effect of the substitution is on the dynamic properties of Atp12p.	[Pribyl, Thomas; Gatti, Domenico L.; Ackerman, Sharon H.] Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48201 USA; [Lissens, Willy] Vrije Univ Brussel, Ctr Genet, B-1050 Brussels, Belgium; [De Meirleir, Linda] Vrije Univ Brussel, UZ Brussel, Dept Pediat Neurol, B-1050 Brussels, Belgium; [Smet, Joel; Van Coster, Rudy] Ghent Univ Hosp, Dept Pediat, B-9000 Ghent, Belgium; [Waeytens, Anouk] Ghent Univ Hosp, Dept Pathol, Div Pediat Neurol & Metab, B-9000 Ghent, Belgium; [di Rago, Jean-Paul] Univ Bordeaux 2, CNRS, Inst Biochim & Genet Cellulaires, F-33077 Bordeaux, France	Wayne State University; Vrije Universiteit Brussel; University Hospital Brussels; Vrije Universiteit Brussel; Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux	Ackerman, SH (corresponding author), Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48201 USA.	sackerm@med.wayne.edu	De Meirleir, Linda/D-6591-2016; Lissens, Willy/B-2892-2013	Lissens, Willy/0000-0003-3875-9955; Meulemans, Ann/0000-0003-3938-2408; Seneca, Sara/0000-0002-0853-9890	National Institutes of Health [GM69840, GM48157]; Research Council of the Vrije Universiteit Brussel [OZR887, ORZ1216]; Fund of Scientific Research-Flanders [FWO 6.06666.06]; Agence Nationale de la Recherche; Association Francaise Contre les Myopathies; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048157, R01GM069840] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Council of the Vrije Universiteit Brussel; Fund of Scientific Research-Flanders(FWO); Agence Nationale de la Recherche(French National Research Agency (ANR)); Association Francaise Contre les Myopathies(Association Francaise contre les Myopathies); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM69840 (to D. L. G.) and GM48157 (to S. H. A.). This work was also supported by Research Council of the Vrije Universiteit Brussel Grants OZR887 and ORZ1216, the Fund of Scientific Research-Flanders Grant FWO 6.06666.06, Agence Nationale de la Recherche grants, and the Association Francaise Contre les Myopathies grants (to J.-P. d. R.).	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Ackerman SH, 2005, PROG NUCLEIC ACID RE, V80, P95, DOI 10.1016/S0079-6603(05)80003-0; ACKERMAN SH, 1990, P NATL ACAD SCI USA, V87, P4986, DOI 10.1073/pnas.87.13.4986; Ackerman SH, 2002, BBA-BIOENERGETICS, V1555, P101, DOI 10.1016/S0005-2728(02)00262-1; Ackerman Sharon H, 2007, Methods Mol Biol, V372, P363, DOI 10.1007/978-1-59745-365-3_26; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Basu T, 1997, BIOCHEM MOL BIOL INT, V41, P1093; Berendsen H., 1981, INTERMOLECULAR FORCE, DOI DOI 10.1007/978-94-015-7658-1_21; Bianchet MA, 1998, P NATL ACAD SCI USA, V95, P11065, DOI 10.1073/pnas.95.19.11065; Bowers K.J., 2006, SC 06 P 2006 ACM IEE; BOWMAN S, 1991, J BIOL CHEM, V266, P7517; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; BYRD RH, 1994, MATH PROGRAM, V63, P129, DOI 10.1007/BF01582063; Chinnery PF, 2003, J NEUROL NEUROSUR PS, V74, P1188, DOI 10.1136/jnnp.74.9.1188; Cizkova A, 2008, NAT GENET, V40, P1288, DOI 10.1038/ng.246; De Meirleir L, 2004, J MED GENET, V41, P120, DOI 10.1136/jmg.2003.012047; Debray FG, 2007, AM J MED GENET A, V143A, P2046, DOI 10.1002/ajmg.a.31880; DeLano W. L., 2007, PYMOL MOL GRAPHICS S; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; EVANS DJ, 1985, J CHEM PHYS, V83, P4069, DOI 10.1063/1.449071; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; Hinton A, 2004, J BIOL CHEM, V279, P9016, DOI 10.1074/jbc.M312631200; Jonckheere AI, 2008, J MED GENET, V45, P129, DOI 10.1136/jmg.2007.052084; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Kabaleeswaran V, 2006, EMBO J, V25, P5433, DOI 10.1038/sj.emboj.7601410; Lefebvre-Legendre L, 2005, J BIOL CHEM, V280, P18386, DOI 10.1074/jbc.M410789200; Lefebvre-Legendre L, 2001, J BIOL CHEM, V276, P6789, DOI 10.1074/jbc.M009557200; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Ludlam A, 2009, J BIOL CHEM, V284, P17138, DOI 10.1074/jbc.M109.002568; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; METOKI K, 1984, J INHERIT METAB DIS, V7, P9, DOI 10.1007/BF01805611; MUKHOPADHYAY A, 1994, FEBS LETT, V343, P160, DOI 10.1016/0014-5793(94)80310-2; NOCEDAL J, 1980, MATH COMPUT, V35, P773, DOI 10.1090/S0025-5718-1980-0572855-7; PASTORES GM, 1994, AM J MED GENET, V50, P265, DOI 10.1002/ajmg.1320500310; Ponder JW, 2003, ADV PROTEIN CHEM, V66, P27; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Santamaria M, 2007, BIOL CHEM, V388, P943, DOI 10.1515/BC.2007.121; SANTORELLI FM, 1993, ANN NEUROL, V34, P827, DOI 10.1002/ana.410340612; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Schuster-Bockler B, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-7; Schutz CN, 2001, PROTEINS, V44, P400, DOI 10.1002/prot.1106; Senior AE, 2002, BBA-BIOENERGETICS, V1553, P188, DOI 10.1016/S0005-2728(02)00185-8; Sept D, 1999, J MOL BIOL, V294, P1181, DOI 10.1006/jmbi.1999.3332; Sperl W, 2006, NEUROMUSCULAR DISORD, V16, P821, DOI 10.1016/j.nmd.2006.08.008; TUCKERMAN M, 1992, J CHEM PHYS, V97, P1990, DOI 10.1063/1.463137; Wagoner JA, 2006, P NATL ACAD SCI USA, V103, P8331, DOI 10.1073/pnas.0600118103; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wang ZG, 1998, J BIOL CHEM, V273, P2993, DOI 10.1074/jbc.273.5.2993; Wang ZG, 2000, EMBO J, V19, P1486, DOI 10.1093/emboj/19.7.1486; Wang ZG, 2001, J BIOL CHEM, V276, P30773, DOI 10.1074/jbc.M104133200; Warshel A, 2006, BBA-PROTEINS PROTEOM, V1764, P1647, DOI 10.1016/j.bbapap.2006.08.007	53	16	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					4099	4109		10.1074/jbc.M109.046920	http://dx.doi.org/10.1074/jbc.M109.046920			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19933271	Green Published, hybrid			2022-12-25	WOS:000275254000062
J	Ross, JA; Cheng, HY; Nagy, ZS; Frost, JA; Kirken, RA				Ross, Jeremy A.; Cheng, Hanyin; Nagy, Zsuzsanna S.; Frost, Jeffrey A.; Kirken, Robert A.			Protein Phosphatase 2A Regulates Interleukin-2 Receptor Complex Formation and JAK3/STAT5 Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN T-CELLS; TYROSINE PHOSPHORYLATION; SERINE PHOSPHORYLATION; FAMILY CYTOKINES; IL-2 RECEPTOR; SERINE/THREONINE KINASES; NEGATIVE REGULATOR; SIGNALING PATHWAY; IMMUNE-SYSTEM; OKADAIC ACID	Reversible protein phosphorylation plays a key role in interleukin-2 (IL-2) receptor-mediated activation of Janus tyrosine kinase 3 (JAK3) and signal transducer and activator of transcription 5 (STAT5) in lymphocytes. Although the mechanisms governing IL-2-induced tyrosine phosphorylation and activation of JAK3/STAT5 have been extensively studied, the role of serine/threonine phosphorylation in controlling these effectors remains to be elucidated. Using phosphoamino acid analysis, JAK3 and STAT5 were determined to be serine and tyrosine-phosphorylated in response to IL-2 stimulation of the human natural killer-like cell line, YT. IL-2 stimulation also induced serine/threonine phosphorylation of IL-2R beta, but not IL-2R gamma. To investigate the regulation of serine/threonine phosphorylation in IL-2 signaling, the roles of protein phosphatase 1 (PP1) and 2A (PP2A) were examined. Inhibition of phosphatase activity by calyculin A treatment of YT cells resulted in a significant induction of serine phosphorylation of JAK3 and STAT5, and serine/threonine phosphorylation of IL-2R beta. Moreover, inhibition of PP2A, but not PP1, diminished IL-2-induced tyrosine phosphorylation of IL-2R beta, JAK3, and STAT5, and abolished STAT5 DNA binding activity. Serine/threonine phosphorylation of IL-2R beta by a staurosporine-sensitive kinase also blocked its association with JAK3 and IL-2R beta in YT cells. Taken together, these data indicate that serine/threonine phosphorylation negatively regulates IL-2 signaling at multiple levels, including receptor complex formation and JAK3/STAT5 activation, and that this regulation is counteracted by PP2A. These findings also suggest that PP2A may serve as a therapeutic target for modulating JAK3/STAT5 activation in human disease.	[Ross, Jeremy A.; Cheng, Hanyin; Nagy, Zsuzsanna S.; Kirken, Robert A.] Univ Texas El Paso, Dept Biol Sci, El Paso, TX 79968 USA; [Cheng, Hanyin] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Frost, Jeffrey A.] Univ Texas Hlth Sci Ctr, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA	University of Texas System; University of Texas El Paso; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston	Kirken, RA (corresponding author), 500 W Univ Ave, El Paso, TX 79968 USA.	rkirken@utep.edu		Frost, Jeffrey/0000-0001-9722-1536	Lizanell and Colbert Coldwell Foundation; National Center for Research Resources [5G12RR008124]; National Institutes of Health [5RO1CA116356-02]; University of Texas at El Paso; NATIONAL CANCER INSTITUTE [R01CA116356] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR008124] Funding Source: NIH RePORTER	Lizanell and Colbert Coldwell Foundation; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Texas at El Paso; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by grants from the Lizanell and Colbert Coldwell Foundation (to R.A.K.) and the National Center for Research Resources (5G12RR008124), a component of the National Institutes of Health, and the University of Texas at El Paso. This work was also supported by National Institutes of Health Grant 5RO1CA116356-02 (to J.A.F.).	ASAO H, 1992, FEBS LETT, V304, P141, DOI 10.1016/0014-5793(92)80605-G; Behbod F, 2003, J IMMUNOL, V171, P3919, DOI 10.4049/jimmunol.171.8.3919; BIALOJAN C, 1988, BIOCHEM J, V256, P283, DOI 10.1042/bj2560283; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Brockdorff J, 1997, TISSUE ANTIGENS, V49, P228, DOI 10.1111/j.1399-0039.1997.tb02743.x; CHEN J, 1994, J BIOL CHEM, V269, P7957; CHEN J, 1992, SCIENCE, V257, P1261, DOI 10.1126/science.1325671; Chen Y, 2003, J BIOL CHEM, V278, P16520, DOI 10.1074/jbc.M210572200; Cheng H, 2008, MOL CELL BIOL, V28, P2271, DOI 10.1128/MCB.01789-07; Decker T, 2000, ONCOGENE, V19, P2628, DOI 10.1038/sj.onc.1203481; Gaffen SL, 2001, CYTOKINE, V14, P63, DOI 10.1006/cyto.2001.0862; GIRI JG, 1994, EMBO J, V13, P2822, DOI 10.1002/j.1460-2075.1994.tb06576.x; Goldberg Y, 1999, BIOCHEM PHARMACOL, V57, P321, DOI 10.1016/S0006-2952(98)00245-7; Greenhalgh CJ, 2001, J LEUKOCYTE BIOL, V70, P348; GUO H, 1993, P NATL ACAD SCI USA, V90, P2500, DOI 10.1073/pnas.90.6.2500; HONKANAN RE, 1994, TOXICON, V32, P339, DOI 10.1016/0041-0101(94)90086-8; HOWARD OMZ, 1995, BIOCHEM J, V306, P217, DOI 10.1042/bj3060217; Irie-Sasaki J, 2001, NATURE, V409, P349, DOI 10.1038/35053086; ISHIHARA H, 1989, BIOCHEM BIOPH RES CO, V159, P871, DOI 10.1016/0006-291X(89)92189-X; Juntilla MA, 2008, IMMUNOL LETT, V116, P104, DOI 10.1016/j.imlet.2007.12.008; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; KARNITZ LM, 1995, MOL CELL BIOL, V15, P3049; Kirken RA, 1997, J BIOL CHEM, V272, P15459, DOI 10.1074/jbc.272.24.15459; Kirken RA, 1997, J BIOL CHEM, V272, P14098, DOI 10.1074/jbc.272.22.14098; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Leonard WJ, 1996, NAT MED, V2, P968, DOI 10.1038/nm0996-968; Lin JX, 1996, J BIOL CHEM, V271, P10738, DOI 10.1074/jbc.271.18.10738; Lin JX, 2000, ONCOGENE, V19, P2566, DOI 10.1038/sj.onc.1203523; MACKINTOSH C, 1990, FEBS LETT, V277, P137, DOI 10.1016/0014-5793(90)80828-7; Malabarba MG, 1996, BIOCHEM J, V319, P865, DOI 10.1042/bj3190865; Matthews SA, 2006, CURR OPIN IMMUNOL, V18, P314, DOI 10.1016/j.coi.2006.03.006; Matthews SA, 2009, IMMUNOL REV, V228, P241, DOI 10.1111/j.1600-065X.2008.00759.x; Mazurkiewicz-Munoz AM, 2006, MOL CELL BIOL, V26, P4052, DOI 10.1128/MCB.01591-05; Millward TA, 1999, TRENDS BIOCHEM SCI, V24, P186, DOI 10.1016/S0968-0004(99)01375-4; Mitsuhashi S, 2005, MOL CELL BIOCHEM, V269, P183, DOI 10.1007/s11010-005-3089-x; Nagy ZS, 2002, J LEUKOCYTE BIOL, V72, P819; Nagy ZS, 2006, J IMMUNOL, V177, P5032, DOI 10.4049/jimmunol.177.8.5032; Nelson BH, 1998, ADV IMMUNOL, V70, P1, DOI 10.1016/S0065-2776(08)60386-7; Nelson BH, 2004, J IMMUNOL, V172, P3983, DOI 10.4049/jimmunol.172.7.3983; Park SH, 2001, MOL ENDOCRINOL, V15, P2157, DOI 10.1210/me.15.12.2157; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; Ross JA, 2008, J BIOL CHEM, V283, P4699, DOI 10.1074/jbc.M708232200; Schillace RV, 2006, CRIT REV IMMUNOL, V26, P113, DOI 10.1615/CritRevImmunol.v26.i2.20; SHENOLIKAR S, 1991, ADV SEC MESS PHOSPH, V23, P1; Shuai K, 2005, NAT REV IMMUNOL, V5, P593, DOI 10.1038/nri1667; Shuai K, 2003, NAT REV IMMUNOL, V3, P900, DOI 10.1038/nri1226; Simoncic PD, 2002, CURR BIOL, V12, P446, DOI 10.1016/S0960-9822(02)00697-8; Vang T, 2001, J EXP MED, V193, P497, DOI 10.1084/jem.193.4.497; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Wang YL, 2004, J BIOL CHEM, V279, P25196, DOI 10.1074/jbc.M313668200; Winston LA, 1996, CURR BIOL, V6, P668, DOI 10.1016/S0960-9822(09)00445-X; WITTHUHN BA, 1994, NATURE, V370, P153, DOI 10.1038/370153a0; Woetmann A, 2003, J BIOL CHEM, V278, P2787, DOI 10.1074/jbc.M210196200; Woetmann A, 1999, P NATL ACAD SCI USA, V96, P10620, DOI 10.1073/pnas.96.19.10620; Yamashita H, 1998, J BIOL CHEM, V273, P30218, DOI 10.1074/jbc.273.46.30218; Yamashita H, 2001, MOL CELL ENDOCRINOL, V183, P151, DOI 10.1016/S0303-7207(01)00546-9; YODOI J, 1985, J IMMUNOL, V134, P1623; Yokoyama N, 2001, J INTERF CYTOK RES, V21, P369, DOI 10.1089/107999001750277844	60	32	33	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3582	3591		10.1074/jbc.M109.053843	http://dx.doi.org/10.1074/jbc.M109.053843			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19923221	Green Published, hybrid			2022-12-25	WOS:000275254000009
J	Savkina, M; Temiakov, D; McAllister, WT; Anikin, M				Savkina, Maria; Temiakov, Dmitry; McAllister, William T.; Anikin, Michael			Multiple Functions of Yeast Mitochondrial Transcription Factor Mtf1p during Initiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORE RNA-POLYMERASE; PROMOTER RECOGNITION; SPECIFICITY FACTOR; RIBOSOMAL-RNA; SACCHAROMYCES-CEREVISIAE; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; STRUCTURAL BASIS; SIGMA-FACTORS; SC-MTTFB	Transcription of the yeast mitochondrial genome is carried out by an RNA polymerase (Rpo41p) that is related to single subunit bacteriophage RNA polymerases but requires an additional factor (Mtf1p) for initiation. In this work we show that Mtf1p is involved in multiple roles during initiation including discrimination of upstream base pairs in the promoter, initial melting of three to four base pairs around the site of transcript initiation, and suppression of nonspecific initiation. It, thus, appears that Mtf1p is functionally analogous to initiation factors of multisubunit RNA polymerases, such as sigma. Photocross-linking experiments reveal close proximity between Mtf1p and the promoter DNA and show that the C-terminal domain makes contacts with the template strand in the vicinity of the start site. Interestingly, Mtf1p is related to a class of RNA methyltransferases, suggesting an early evolutionary link between RNA synthesis and processing.	Univ Med & Dent New Jersey, Stratford Div, Sch Osteopath Med, Dept Cell Biol, Stratford, NJ 08084 USA; [Savkina, Maria] Univ Med & Dent New Jersey, Stratford Div, Grad Sch Biomed Sci, Stratford, NJ 08084 USA	Rowan University; Rowan University School of Osteopathic Medicine; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Anikin, M (corresponding author), 2 Med Ctr Dr,SC-B207, Stratford, NJ 08084 USA.	anikinmi@umdnj.edu	Savkina, Maria/C-9075-2018	Savkina, Maria/0000-0002-8527-2157	National Institutes of Health [GM38147]; Research Foundation of University of Medicine and Dentistry of New Jersey; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038147] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Foundation of University of Medicine and Dentistry of New Jersey; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM38147 (to W. T. M.). This work was also supported by grants from the Research Foundation of University of Medicine and Dentistry of New Jersey (to M. A., D. T., and W. T. M.).	BISWAS TK, 1986, J BIOL CHEM, V261, P3927; BISWAS TK, 1987, J BIOL CHEM, V262, P13690; Cermakian N, 1997, J MOL EVOL, V45, P671, DOI 10.1007/PL00006271; Cermakian N, 1996, NUCLEIC ACIDS RES, V24, P648, DOI 10.1093/nar/24.4.648; Cheetham GMT, 1999, NATURE, V399, P80, DOI 10.1038/19999; Cliften PF, 1997, GENE DEV, V11, P2897, DOI 10.1101/gad.11.21.2897; Cliften PF, 2000, MOL CELL BIOL, V20, P7013, DOI 10.1128/MCB.20.18.7013-7023.2000; Cotney J, 2006, J MOL EVOL, V63, P707, DOI 10.1007/s00239-006-0075-1; DIAZ GA, 1993, J MOL BIOL, V229, P805, DOI 10.1006/jmbi.1993.1086; Favre A, 1998, J PHOTOCH PHOTOBIO B, V42, P109, DOI 10.1016/S1011-1344(97)00116-4; Gleghorn ML, 2008, MOL CELL, V32, P707, DOI 10.1016/j.molcel.2008.11.010; Imburgio D, 2000, BIOCHEMISTRY-US, V39, P10419, DOI 10.1021/bi000365w; JANG SH, 1991, J BIOL CHEM, V266, P22671; Karlok MA, 2002, J BIOL CHEM, V277, P28143, DOI 10.1074/jbc.M204123200; Ma KY, 2002, J BIOL CHEM, V277, P43206, DOI 10.1074/jbc.M206658200; MANGUS DA, 1994, J BIOL CHEM, V269, P26568; Markov DA, 2009, YEAST, V26, P423, DOI 10.1002/yea.1672; MASTERS BS, 1987, CELL, V51, P89, DOI 10.1016/0092-8674(87)90013-4; Matsunaga M, 2004, J BIOL CHEM, V279, P44239, DOI 10.1074/jbc.C400384200; Matsunaga M, 2004, J BIOL CHEM, V279, P2012, DOI 10.1074/jbc.M307819200; Nayak D, 2009, J BIOL CHEM, V284, P13641, DOI 10.1074/jbc.M900718200; O'Farrell HC, 2004, J MOL BIOL, V339, P337, DOI 10.1016/j.jmb.2004.02.068; Paratkar S, 2010, J BIOL CHEM, V285, P3949, DOI 10.1074/jbc.M109.050732; Perocchi F, 2006, PLOS GENET, V2, P1612, DOI 10.1371/journal.pgen.0020170; SCHINKEL AH, 1988, NUCLEIC ACIDS RES, V16, P9147, DOI 10.1093/nar/16.19.9147; SCHINKEL AH, 1986, EMBO J, V5, P1041, DOI 10.1002/j.1460-2075.1986.tb04320.x; SCHINKEL AH, 1988, EMBO J, V7, P3255, DOI 10.1002/j.1460-2075.1988.tb03192.x; Schubot FD, 2001, PROTEIN SCI, V10, P1980, DOI 10.1110/ps.11201; Seidel-Rogol BL, 2003, NAT GENET, V33, P23, DOI 10.1038/ng1064; SHADEL GS, 1995, MOL CELL BIOL, V15, P2101; Sologub M, 2009, CELL, V139, P934, DOI 10.1016/j.cell.2009.10.031; TABOR S, 1987, J BIOL CHEM, V262, P16212; Tang GQ, 2009, J BIOL CHEM, V284, P5514, DOI 10.1074/jbc.M807880200; Temiakov D, 2003, METHOD ENZYMOL, V371, P133; Wang ZB, 2007, J BIOL CHEM, V282, P12610, DOI 10.1074/jbc.M700461200	35	27	27	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3957	3964		10.1074/jbc.M109.051003	http://dx.doi.org/10.1074/jbc.M109.051003			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19920143	Green Published, hybrid			2022-12-25	WOS:000275254000049
J	Aryal, RP; Ju, TZ; Cummings, RD				Aryal, Rajindra P.; Ju, Tongzhong; Cummings, Richard D.			The Endoplasmic Reticulum Chaperone Cosmc Directly Promotes in Vitro Folding of T-synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; MOLECULAR CHAPERONE; CORE-1 BETA-1,3-GALACTOSYLTRANSFERASE; ESCHERICHIA-COLI; O-GLYCOSYLATION; QUALITY-CONTROL; BINDING; ATP; SPECIFICITY; EXPRESSION	The T-synthase is the key beta 3-galactosyltransferase essential for biosynthesis of core 1 O-glycans (Gal beta 1-3GalNAc alpha 1-Ser/Thr) in animal cell glycoproteins. Here we describe the novel ability of an endoplasmic reticulum-localized molecular chaperone termed Cosmc to specifically interact with partly denatured T-synthase in vitro to cause partial restoration of activity. By contrast, a mutated form of Cosmc observed in patients with Tn syndrome has reduced chaperone function. The chaperone activity of Cosmc is specific, does not require ATP in vitro, and is effective toward T-synthase but not another beta-galactosyltransferase. Cosmc represents the first ER chaperone identified to be required for folding of a glycosyltransferase.	[Cummings, Richard D.] Emory Univ, Sch Med, O Wayne Rollins Res Ctr, Dept Biochem, Atlanta, GA 30322 USA	Emory University	Cummings, RD (corresponding author), Emory Univ, Sch Med, O Wayne Rollins Res Ctr, Dept Biochem, 1510 Clifton Rd,Suite 4001, Atlanta, GA 30322 USA.	rdcummi@emory.edu		Ju, Tongzhong/0000-0002-4429-1976; Aryal, Rajindra P/0000-0001-8718-636X	National Institutes of Health [R01 GM068559]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068559] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM068559 (to R.D.C.).	ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; BARONDES SH, 1994, CELL, V76, P597, DOI 10.1016/0092-8674(94)90498-7; BLONDELGUINDI S, 1993, CELL, V75, P717, DOI 10.1016/0092-8674(93)90492-9; Brockhausen I, 2006, EMBO REP, V7, P599, DOI 10.1038/sj.embor.7400705; Buck TM, 2007, SEMIN CELL DEV BIOL, V18, P751, DOI 10.1016/j.semcdb.2007.09.001; Crew VK, 2008, BRIT J HAEMATOL, V142, P657, DOI 10.1111/j.1365-2141.2008.07215.x; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Ellis R J, 1990, Semin Cell Biol, V1, P1; Fink AL, 1999, PHYSIOL REV, V79, P425, DOI 10.1152/physrev.1999.79.2.425; Fu JX, 2008, J CLIN INVEST, V118, P3725, DOI 10.1172/JCI36077; GOLOUBINOFF P, 1989, NATURE, V342, P884, DOI 10.1038/342884a0; Hafizur RM, 2004, J BIOCHEM, V135, P193, DOI 10.1093/jb/mvh023; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; HELENIUS A, 1994, MOL BIOL CELL, V5, P253, DOI 10.1091/mbc.5.3.253; Helenius Ari, 1992, Trends in Cell Biology, V2, P227, DOI 10.1016/0962-8924(92)90309-B; HILL RL, 1975, ADV ENZYMOL RAMB, V43, P411; Hoshino M, 1996, J MOL BIOL, V262, P575, DOI 10.1006/jmbi.1996.0536; Inoue S, 2000, BIOCHEM BIOPH RES CO, V268, P553, DOI 10.1006/bbrc.2000.2170; ITZKOWITZ SH, 1990, CANCER-AM CANCER SOC, V66, P1960, DOI 10.1002/1097-0142(19901101)66:9<1960::AID-CNCR2820660919>3.0.CO;2-X; JAKOB U, 1993, J BIOL CHEM, V268, P1517; Ju TZ, 2008, J CELL BIOL, V182, P531, DOI 10.1083/jcb.200711151; Ju TZ, 2008, CANCER RES, V68, P1636, DOI 10.1158/0008-5472.CAN-07-2345; Ju TZ, 2005, NATURE, V437, P1252, DOI 10.1038/4371252a; Ju TZ, 2002, P NATL ACAD SCI USA, V99, P16613, DOI 10.1073/pnas.262438199; Ju TZ, 2002, J BIOL CHEM, V277, P169, DOI 10.1074/jbc.M109056200; Ju TZ, 2002, J BIOL CHEM, V277, P178, DOI 10.1074/jbc.M109060200; Kota J, 2005, J CELL BIOL, V168, P79, DOI 10.1083/jcb.200408106; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laufen T, 1999, P NATL ACAD SCI USA, V96, P5452, DOI 10.1073/pnas.96.10.5452; LEE GJ, 1995, J BIOL CHEM, V270, P10432, DOI 10.1074/jbc.270.18.10432; Marini I, 2005, CELL MOL LIFE SCI, V62, P599, DOI 10.1007/s00018-005-4474-z; MCCARTY JS, 1995, J MOL BIOL, V249, P126, DOI 10.1006/jmbi.1995.0284; Muchowski PJ, 1998, P NATL ACAD SCI USA, V95, P1004, DOI 10.1073/pnas.95.3.1004; NAKAI A, 1992, J CELL BIOL, V117, P903, DOI 10.1083/jcb.117.4.903; NARIMATSU H, 1986, P NATL ACAD SCI USA, V83, P4720, DOI 10.1073/pnas.83.13.4720; Qasba PK, 2008, CURR DRUG TARGETS, V9, P292, DOI 10.2174/138945008783954943; RANDALL LL, 1995, TRENDS BIOCHEM SCI, V20, P65, DOI 10.1016/S0968-0004(00)88959-8; Ranson NA, 2001, CELL, V107, P869, DOI 10.1016/S0092-8674(01)00617-1; Rogalla T, 1999, J BIOL CHEM, V274, P18947, DOI 10.1074/jbc.274.27.18947; SAGA S, 1987, J CELL BIOL, V105, P517, DOI 10.1083/jcb.105.1.517; Schietinger A, 2006, SCIENCE, V314, P304, DOI 10.1126/science.1129200; SCHMID D, 1994, SCIENCE, V263, P971, DOI 10.1126/science.8310296; SHAPER NL, 1986, P NATL ACAD SCI USA, V83, P1573, DOI 10.1073/pnas.83.6.1573; Springer GF, 1997, J MOL MED, V75, P594, DOI 10.1007/s001090050144; Stowell SR, 2008, J IMMUNOL, V180, P3091, DOI 10.4049/jimmunol.180.5.3091; Sullivan W, 1997, J BIOL CHEM, V272, P8007, DOI 10.1074/jbc.272.12.8007; Terada K, 1997, J CELL BIOL, V139, P1089, DOI 10.1083/jcb.139.5.1089; van Die I, 1999, FEBS LETT, V450, P52, DOI 10.1016/S0014-5793(99)00462-7; Xia LJ, 2004, J CELL BIOL, V164, P451, DOI 10.1083/jcb.200311112; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; ZIEMIENOWICZ A, 1993, J BIOL CHEM, V268, P25425	51	49	54	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2456	2462		10.1074/jbc.M109.065169	http://dx.doi.org/10.1074/jbc.M109.065169			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19923218	Green Published, hybrid			2022-12-25	WOS:000273697800024
J	Banerjee, S; Zmijewski, JW; Lorne, E; Liu, G; Sha, YG; Abraham, E				Banerjee, Sami; Zmijewski, Jaroslaw W.; Lorne, Emmanuel; Liu, Gang; Sha, Yonggang; Abraham, Edward			Modulation of SCF beta-TrCP-dependent I kappa B alpha Ubiquitination by Hydrogen Peroxide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE LUNG INJURY; F-BOX PROTEINS; NEUTROPHIL ACTIVATION; LIGASE COMPLEX; PROTEASOME ACTIVITY; ENDOTHELIAL-CELLS; EXTRACELLULAR-SUPEROXIDE; S-GLUTATHIONYLATION; OXIDATIVE STRESS; REDOX REGULATION	Reactive oxygen species are known to participate in the regulation of intracellular signaling pathways, including activation of NF-kappa B. Recent studies have indicated that increases in intracellular concentrations of hydrogen peroxide (H2O2) have antiinflammatory effects in neutrophils, including inhibition of the degradation of I kappa B alpha after TLR4 engagement. In the present experiments, we found that culture of lipopolysaccharide-stimulated neutrophils and HEK 293 cells with H2O2 resulted in diminished ubiquitination of I kappa B alpha and decreased SCF beta-TrCP ubiquitin ligase activity. Exposure of neutrophils or HEK 293 cells to H2O2 was associated with reduced binding between phosphorylated I kappa B alpha and SCF beta-TrCP but no change in the composition of the SCF beta-TrCP complex. Lipopolysaccharide-induced SCF beta-TrCP ubiquitin ligase activity as well as binding of beta-TrCP to phosphorylated I kappa B alpha was decreased in the lungs of acatalasemic mice and mice treated with the catalase inhibitor aminotriazole, situations in which intracellular concentrations of H2O2 are increased. Exposure to H2O2 resulted in oxidative modification of cysteine residues in beta-TrCP. Cysteine 308 in Blade 1 of the beta-TrCP beta-propeller region was found to be required for maximal binding between beta-TrCP and phosphorylated I kappa B alpha. These findings suggest that the anti-inflammatory effects of H2O2 may result from its ability to decrease ubiquitination as well as subsequent degradation of I kappa B alpha through inhibiting the association between I kappa B alpha and SCF beta-TrCP.	[Abraham, Edward] Univ Alabama, Sch Med, Dept Med, Birmingham, AL 35294 USA; [Zmijewski, Jaroslaw W.; Abraham, Edward] Univ Alabama, Ctr Free Rad Biol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Abraham, E (corresponding author), Univ Alabama, Sch Med, Dept Med, BDB 420,1530 3rd Ave S, Birmingham, AL 35294 USA.	eabraham@uab.edu	Sha, Yonggang/J-5100-2012	Lorne, Emmanuel/0000-0001-6409-5449; , Gang/0000-0002-6999-7633; Liu, Gang/0000-0003-2615-131X	National Institutes of Health [HL62221, HL76206, GM87748]; Societe Francaise d'Anesthesie et de Reanimation; University Hospital of Amiens (France); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076206, R01HL062221] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087748] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Societe Francaise d'Anesthesie et de Reanimation; University Hospital of Amiens (France); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL62221, HL76206, and GM87748 (to E. A.). This work was also supported by grants from the Societe Francaise d'Anesthesie et de Reanimation and the University Hospital of Amiens (France) (to E. L.).	Abraham E, 2003, CRIT CARE MED, V31, pS195, DOI 10.1097/01.CCM.0000057843.47705.E8; Arcaroli JJ, 2009, AM J RESP CRIT CARE, V179, P105, DOI 10.1164/rccm.200710-1566OC; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Blackwell TS, 1996, J IMMUNOL, V157, P1630; Brass DM, 2007, AM J PHYSIOL-LUNG C, V293, pL77, DOI 10.1152/ajplung.00282.2006; Cave AC, 2006, ANTIOXID REDOX SIGN, V8, P691, DOI 10.1089/ars.2006.8.691; Chen ZJ, 1996, CELL, V84, P853, DOI 10.1016/S0092-8674(00)81064-8; Choi KS, 2006, PREP BIOCHEM BIOTECH, V36, P65, DOI 10.1080/10826060500388520; Ciechanover A, 1998, EMBO J, V17, P7151, DOI 10.1093/emboj/17.24.7151; Craig A, 2009, INFECT IMMUN, V77, P568, DOI 10.1128/IAI.00832-08; Cross JV, 2006, ANTIOXID REDOX SIGN, V8, P1819, DOI 10.1089/ars.2006.8.1819; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Ding QX, 2002, J BIOL CHEM, V277, P13935, DOI 10.1074/jbc.M107706200; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Foster WM, 2001, J APPL PHYSIOL, V90, P1111, DOI 10.1152/jappl.2001.90.3.1111; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Hattori K, 1999, J BIOL CHEM, V274, P29641, DOI 10.1074/jbc.274.42.29641; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Jaspers I, 2001, AM J RESP CELL MOL, V24, P769, DOI 10.1165/ajrcmb.24.6.4344; Kanayama A, 2002, J BIOL CHEM, V277, P24049, DOI 10.1074/jbc.M110832200; Kil IS, 2008, BIOCHEM BIOPH RES CO, V373, P169, DOI 10.1016/j.bbrc.2008.06.007; Kim JR, 2000, ANAL BIOCHEM, V283, P214, DOI 10.1006/abio.2000.4623; Korn SH, 2001, J BIOL CHEM, V276, P35693, DOI 10.1074/jbc.M104321200; Kotamraju S, 2003, P NATL ACAD SCI USA, V100, P10653, DOI 10.1073/pnas.1933581100; Kumar A, 2007, EMBO J, V26, P4457, DOI 10.1038/sj.emboj.7601867; Landar A, 2006, FREE RADICAL BIO MED, V40, P459, DOI 10.1016/j.freeradbiomed.2005.08.046; Lorne E, 2008, AM J PHYSIOL-CELL PH, V294, pC985, DOI 10.1152/ajpcell.00454.2007; Maniatis T, 1999, GENE DEV, V13, P505, DOI 10.1101/gad.13.5.505; MATTHEWS JR, 1992, NUCLEIC ACIDS RES, V20, P3821, DOI 10.1093/nar/20.15.3821; Nakayama K, 2003, P NATL ACAD SCI USA, V100, P8752, DOI 10.1073/pnas.1133216100; Nam S, 2001, J BIOL CHEM, V276, P13322, DOI 10.1074/jbc.M004209200; Nishi T, 2002, J BIOL CHEM, V277, P44548, DOI 10.1074/jbc.M202970200; Pajonk F, 2002, FREE RADICAL BIO MED, V32, P536, DOI 10.1016/S0891-5849(02)00743-8; Pantano C, 2003, J BIOL CHEM, V278, P44091, DOI 10.1074/jbc.M308487200; Petroski MD, 2005, CELL, V123, P1107, DOI 10.1016/j.cell.2005.09.033; Rahman I, 2006, EUR RESPIR J, V28, P219, DOI 10.1183/09031936.06.00053805; Read MA, 2000, MOL CELL BIOL, V20, P2326, DOI 10.1128/MCB.20.7.2326-2333.2000; Reynaert NL, 2006, P NATL ACAD SCI USA, V103, P13086, DOI 10.1073/pnas.0603290103; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Rubenfeld GD, 2007, CHEST, V131, P554, DOI 10.1378/chest.06-1976; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Strack P, 2000, ONCOGENE, V19, P3529, DOI 10.1038/sj.onc.1203647; Strassheim D, 2004, AM J PHYSIOL-CELL PH, V286, pC683, DOI 10.1152/ajpcell.00296.2003; Suzuki H, 1999, BIOCHEM BIOPH RES CO, V256, P121, DOI 10.1006/bbrc.1999.0296; Suzuki H, 2000, J BIOL CHEM, V275, P2877, DOI 10.1074/jbc.275.4.2877; Suzuki H, 1999, BIOCHEM BIOPH RES CO, V256, P127, DOI 10.1006/bbrc.1999.0289; Taggart CC, 2002, J BIOL CHEM, V277, P33648, DOI 10.1074/jbc.M203710200; Torrie LJ, 2001, BRIT J PHARMACOL, V134, P393, DOI 10.1038/sj.bjp.0704259; Tsuruta Y, 2007, J IMMUNOL, V179, P7079, DOI 10.4049/jimmunol.179.10.7079; Vuillard L, 1999, FEBS LETT, V455, P311, DOI 10.1016/S0014-5793(99)00895-9; Ward NE, 2000, BIOCHEMISTRY-US, V39, P10319, DOI 10.1021/bi000781g; Watanabe N, 2006, AM J PATHOL, V168, P1737, DOI 10.2353/ajpath.2006.050648; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Wrona M, 2005, FREE RADICAL BIO MED, V38, P262, DOI 10.1016/j.freeradbiomed.2004.10.022; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Yaron A, 1997, EMBO J, V16, P6486, DOI 10.1093/emboj/16.21.6486; Yaron A, 1998, NATURE, V396, P590, DOI 10.1038/25159; Ying J, 2007, FREE RADICAL BIO MED, V43, P1099, DOI 10.1016/j.freeradbiomed.2007.07.014; Yum HK, 2001, J IMMUNOL, V167, P6601, DOI 10.4049/jimmunol.167.11.6601; Zhao X, 2008, AM J PHYSIOL-LUNG C, V295, pL497, DOI 10.1152/ajplung.90210.2008; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zmijewski JW, 2008, AM J RESP CRIT CARE, V178, P168, DOI 10.1164/rccm.200710-1602OC; Zmijewski JW, 2007, AM J PHYSIOL-CELL PH, V293, pC255, DOI 10.1152/ajpcell.00618.2006; Zmijewski JW, 2009, J BIOL CHEM, V284, P22213, DOI 10.1074/jbc.M109.028902; Zmijewski JW, 2009, AM J RESP CRIT CARE, V179, P694, DOI 10.1164/rccm.200806-851OC; Zmijewski JW, 2005, AM J PHYSIOL-HEART C, V289, pH852, DOI 10.1152/ajpheart.00015.2005; Zmijewski JW, 2009, AM J PHYSIOL-LUNG C, V296, pL624, DOI DOI 10.1152/ajplung.90522.2008	71	18	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2665	2675		10.1074/jbc.M109.060822	http://dx.doi.org/10.1074/jbc.M109.060822			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19933270	Green Published, hybrid			2022-12-25	WOS:000273697800045
J	Maerz, S; Funakoshi, Y; Negishi, Y; Suzuki, T; Seiler, S				Maerz, Sabine; Funakoshi, Yoko; Negishi, Yuki; Suzuki, Tadashi; Seiler, Stephan			The Neurospora Peptide:N-Glycanase Ortholog PNG1 Is Essential for Cell Polarity despite Its Lack of Enzymatic Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							I-RESTRICTED EPITOPE; N-GLYCANASE; CYTOPLASMIC PEPTIDE; ENDOPLASMIC-RETICULUM; GLYCOPROTEIN TURNOVER; YEAST; DEGLYCOSYLATION; DEGRADATION; PROTEIN; CYTOSOL	Secretory proteins are subjected to a stringent endoplasmic reticulum-based quality control system that distinguishes aberrant from correctly folded proteins. The cytoplasmic peptide: N-glycanase cleaves oligosaccharides from misfolded glycoproteins and prepares them for degradation by the 26 S proteasome. In contrast to abundant in vitro data on its enzymatic function, the in vivo relevance of peptide: N-glycanase activity remains unclear. Here we show that the PNG1 ortholog from the filamentous ascomycete Neurospora crassa is an essential protein, and its deletion results in strong polarity defects. PNG1 and its predicted binding partner RAD23 have distinct functions in N. crassa and are involved in cell wall integrity and DNA repair, respectively. Moreover, wild type PNG1 has substitutions in essential catalytic amino acids, and its deglycosylation activity is lost. These substitutions are conserved in many PNG1 orthologs of the fungal kingdom, implying a so far unrecognized enzyme-independent function of PNG1 that may only become apparent in highly polar cells such as fungal hyphae.	[Maerz, Sabine; Seiler, Stephan] Univ Gottingen, Inst Microbiol & Genet, D-37077 Gottingen, Germany; [Maerz, Sabine; Seiler, Stephan] DFG Res Ctr Mol Physiol Brain CMPB, D-37073 Gottingen, Germany; [Funakoshi, Yoko; Negishi, Yuki; Suzuki, Tadashi] RIKEN, Adv Sci Inst, Syst Glycobiol Res Grp, Glycometabolome Team, Wako, Saitama 3510198, Japan	University of Gottingen; German Research Foundation (DFG); RIKEN	Seiler, S (corresponding author), Univ Gottingen, Inst Microbiol & Genet, Grisebachstr 8, D-37077 Gottingen, Germany.	sseiler@gwdg.de	Suzuki, Tadashi/I-4536-2014; Suzuki, Tadashi/AAX-5707-2021	Suzuki, Tadashi/0000-0003-1030-7631	CREST; JST; Global COE Program (Osaka University); Deutsche Forschungsgemeinschaft (DFG); DFG [SP1111]	CREST(Core Research for Evolutional Science and Technology (CREST)); JST(Japan Science & Technology Agency (JST)); Global COE Program (Osaka University)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG))	This work was supported by grants from the CREST, JST, and Global COE Program (Osaka University) (to T. S.) and by the Deutsche Forschungsgemeinschaft (DFG) through the DFG Research Center of Molecular Physiology of the Brain and the DFG Priority Program Cell Polarity (Grant SP1111) (to S. S.).	Ahner A, 2004, TRENDS CELL BIOL, V14, P474, DOI 10.1016/j.tcb.2004.07.013; Altrich-VanLith ML, 2006, J IMMUNOL, V177, P5440, DOI 10.4049/jimmunol.177.8.5440; Blom D, 2004, EMBO J, V23, P650, DOI 10.1038/sj.emboj.7600090; Borkovich KA, 2004, MICROBIOL MOL BIOL R, V68, P1, DOI 10.1128/MMBR.68.1.1-108.2004; Diepold A, 2007, PLANT J, V52, P94, DOI 10.1111/j.1365-313X.2007.03215.x; Dunlap JC, 2007, ADV GENET, V57, P49, DOI 10.1016/S0065-2660(06)57002-6; FtouhiPaquin N, 1997, J BIOL CHEM, V272, P22960, DOI 10.1074/jbc.272.36.22960; Hagihara S, 2007, GLYCOBIOLOGY, V17, P1070, DOI 10.1093/glycob/cwm079; Harris SD, 2006, INT REV CYTOL, V251, P41, DOI 10.1016/S0074-7696(06)51002-2; Hirsch C, 2003, EMBO J, V22, P1036, DOI 10.1093/emboj/cdg107; Joshi S, 2005, FEBS LETT, V579, P823, DOI 10.1016/j.febslet.2004.12.060; Katiyar S, 2002, J BIOL CHEM, V277, P12953, DOI 10.1074/jbc.M111383200; Kato T, 2007, J BIOCHEM, V142, P175, DOI 10.1093/jb/mvm117; Kim I, 2006, J CELL BIOL, V172, P211, DOI 10.1083/jcb.200507149; Lee JH, 2005, P NATL ACAD SCI USA, V102, P9144, DOI 10.1073/pnas.0502082102; McCluskey K, 2003, ADV APPL MICROBIOL, V52, P245, DOI 10.1016/S0065-2164(03)01010-4; Misaghi S, 2004, CHEM BIOL, V11, P1677, DOI 10.1016/j.chembiol.2004.11.010; Miyazaki A, 2009, GLYCOCONJUGATE J, V26, P133, DOI 10.1007/s10719-008-9171-3; Moseley JB, 2006, MICROBIOL MOL BIOL R, V70, P605, DOI 10.1128/MMBR.00013-06; Ostankovitch M, 2009, J IMMUNOL, V182, P4830, DOI 10.4049/jimmunol.0802902; Palanivelu R, 2000, TRENDS CELL BIOL, V10, P517, DOI 10.1016/S0962-8924(00)01849-3; Park H, 2001, P NATL ACAD SCI USA, V98, P11163, DOI 10.1073/pnas.201393498; Park HO, 2007, MICROBIOL MOL BIOL R, V71, P48, DOI 10.1128/MMBR.00028-06; Prakash S, 2000, MUTAT RES-FUND MOL M, V451, P13, DOI 10.1016/S0027-5107(00)00037-3; Romisch K, 1997, P NATL ACAD SCI USA, V94, P6730, DOI 10.1073/pnas.94.13.6730; Seiler S, 2003, MOL BIOL CELL, V14, P4352, DOI 10.1091/mbc.E02-07-0433; Seiler S, 2006, MOL BIOL CELL, V17, P4080, DOI 10.1091/mbc.E06-01-0072; Suzuki T, 2002, FASEB J, V16, DOI 10.1096/fj.01-0889rev; Suzuki T, 2005, METHODS, V35, P360, DOI 10.1016/j.ymeth.2004.10.008; Suzuki T, 2002, P NATL ACAD SCI USA, V99, P9691, DOI 10.1073/pnas.152333599; Suzuki T, 2001, J BIOL CHEM, V276, P21601, DOI 10.1074/jbc.M100826200; SUZUKI T, 1994, J BIOL CHEM, V269, P17611; SUZUKI T, 1993, BIOCHEM BIOPH RES CO, V194, P1124, DOI 10.1006/bbrc.1993.1938; Suzuki T, 1998, J BIOL CHEM, V273, P21526, DOI 10.1074/jbc.273.34.21526; Suzuki T, 2000, J CELL BIOL, V149, P1039, DOI 10.1083/jcb.149.5.1039; Suzuki T, 2007, SEMIN CELL DEV BIOL, V18, P762, DOI 10.1016/j.semcdb.2007.09.010; Suzuki T, 2007, BIOCHEM BIOPH RES CO, V358, P837, DOI 10.1016/j.bbrc.2007.04.199; Suzuki T, 2006, J BIOL CHEM, V281, P22152, DOI 10.1074/jbc.M603236200; Tanabe K, 2006, METHOD ENZYMOL, V415, P46, DOI 10.1016/S0076-6879(06)15004-1; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; YEE VC, 1994, P NATL ACAD SCI USA, V91, P7296, DOI 10.1073/pnas.91.15.7296; Zhao G, 2009, GLYCOBIOLOGY, V19, P118, DOI 10.1093/glycob/cwn108	43	38	38	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2326	2332		10.1074/jbc.M109.045302	http://dx.doi.org/10.1074/jbc.M109.045302			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19940117	Green Published, hybrid			2022-12-25	WOS:000273697800012
J	Nasu-Nishimura, Y; Jaffe, H; Isaac, JTR; Roche, KW				Nasu-Nishimura, Yukiko; Jaffe, Howard; Isaac, John T. R.; Roche, Katherine W.			Differential Regulation of Kainate Receptor Trafficking by Phosphorylation of Distinct Sites on GluR6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXCITATORY SYNAPTIC-TRANSMISSION; MOSSY FIBER SYNAPSES; ER RETENTION SIGNAL; PROTEIN-KINASE-C; SURFACE EXPRESSION; GLUTAMATE RELEASE; THALAMOCORTICAL SYNAPSES; ENDOPLASMIC-RETICULUM; MOLECULAR-MECHANISMS; SPLICE VARIANTS	Kainate receptors are widely expressed in the brain, and are present at pre- and postsynaptic sites where they play a prominent role in synaptic plasticity and the regulation of network activity. Within individual neurons, kainate receptors of different subunit compositions are targeted to various locations where they serve distinct functional roles. Despite this complex targeting, relatively little is known about the molecular mechanisms regulating kainate receptor subunit trafficking. Here we investigate the role of phosphorylation in the trafficking of the GluR6 kainate receptor subunit. We identify two specific residues on the GluR6 C terminus, Ser(846) and Ser(868), which are phosphorylated by protein kinase C(PKC) and dramatically regulate GluR6 surface expression. By using GluR6 containing phosphomimetic and nonphosphorylatable mutations for these sites expressed in heterologous cells or in neurons lacking endogenous GluR6, we show that phosphorylation of Ser(846) or Ser(868) regulates receptor trafficking through the biosynthetic pathway. Additionally, Ser(846) phosphorylation dynamically regulates endocytosis of GluR6 at the plasma membrane. Our findings thus demonstrate that phosphorylation of PKC sites on GluR6 regulates surface expression of GluR6 at distinct intracellular trafficking pathways, providing potential molecular mechanisms for the PKC-dependent regulation of synaptic kainate receptor function observed during various forms of synaptic plasticity.	[Nasu-Nishimura, Yukiko; Jaffe, Howard; Isaac, John T. R.; Roche, Katherine W.] NINDS, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Roche, KW (corresponding author), Bldg 35,Rm 2C903, Bethesda, MD 20892 USA.	rochek@ninds.nih.gov	Roche, Katherine/W-9893-2019	Roche, Katherine/0000-0001-7282-6539	National Institutes of Health; Japan Society for the Promotion of Science; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003035, ZIANS002994] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by the National Institutes of Health NINDS Intramural Research Program and a Japan Society for the Promotion of Science Research Fellowship for Japanese Biomedical and Behavioral Researchers at National Institutes of Health.	Ahmadian G, 2004, EMBO J, V23, P1040, DOI 10.1038/sj.emboj.7600126; BAHN S, 1994, J NEUROSCI, V14, P5525; Bortolotto ZA, 1999, NATURE, V402, P297, DOI 10.1038/46290; Castillo PE, 1997, NATURE, V388, P182, DOI 10.1038/40645; Chittajallu R, 1996, NATURE, V379, P78, DOI 10.1038/379078a0; Chung HJ, 2004, J NEUROSCI, V24, P10248, DOI 10.1523/JNEUROSCI.0546-04.2004; Clarke VRJ, 2002, NEUROPHARMACOLOGY, V42, P889, DOI 10.1016/S0028-3908(02)00039-4; Contractor A, 2001, NEURON, V29, P209, DOI 10.1016/S0896-6273(01)00191-X; Coussen F, 2005, NEURON, V47, P555, DOI 10.1016/j.neuron.2005.06.033; Fisahn A, 2004, J NEUROSCI, V24, P9658, DOI 10.1523/JNEUROSCI.2973-04.2004; Greger IH, 2002, NEURON, V34, P759, DOI 10.1016/S0896-6273(02)00693-1; Hayes DM, 2003, BIOCHEM BIOPH RES CO, V310, P8, DOI 10.1016/j.bbrc.2003.08.115; HERB A, 1992, NEURON, V8, P775, DOI 10.1016/0896-6273(92)90098-X; Hirbec H, 2003, NEURON, V37, P625, DOI 10.1016/S0896-6273(02)01191-1; Isaac JTR, 2004, PHARMACOL THERAPEUT, V104, P163, DOI 10.1016/j.pharmthera.2004.08.006; Jaskolski F, 2004, J NEUROSCI, V24, P2506, DOI 10.1523/JNEUROSCI.5116-03.2004; Kidd FL, 1999, NATURE, V400, P569, DOI 10.1038/23040; Kidd FL, 2002, NEURON, V34, P635, DOI 10.1016/S0896-6273(02)00699-2; Kim CH, 2005, J BIOL CHEM, V280, P25409, DOI 10.1074/jbc.M502644200; Lauri SE, 2006, NEURON, V50, P415, DOI 10.1016/j.neuron.2006.03.020; Lauri SE, 2005, J NEUROSCI, V25, P4473, DOI 10.1523/JNEUROSCI.4050-04.2005; Lavezzari G, 2004, J NEUROSCI, V24, P6383, DOI 10.1523/JNEUROSCI.1890-04.2004; Lavezzari G, 2003, NEUROPHARMACOLOGY, V45, P729, DOI 10.1016/S0028-3908(03)00308-3; Lee HK, 2006, PHARMACOL THERAPEUT, V112, P810, DOI 10.1016/j.pharmthera.2006.06.003; Lerma J, 2001, PHYSIOL REV, V81, P971, DOI 10.1152/physrev.2001.81.3.971; Lin JW, 2000, NAT NEUROSCI, V3, P1282, DOI 10.1038/81814; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Martin S, 2004, EMBO J, V23, P4749, DOI 10.1038/sj.emboj.7600483; Mulle C, 1998, NATURE, V392, P601, DOI 10.1038/33408; Nasu-Nishimura Y, 2006, J NEUROSCI, V26, P7014, DOI 10.1523/JNEUROSCI.0573-06.2006; Park YY, 2006, NEURON, V49, P95, DOI 10.1016/j.neuron.2005.11.035; Ren Z, 2003, J NEUROSCI, V23, P6608; Rivera R, 2007, EMBO J, V26, P4359, DOI 10.1038/sj.emboj.7601865; Roche KW, 1996, NEURON, V16, P1179, DOI 10.1016/S0896-6273(00)80144-0; Roche KW, 2001, NAT NEUROSCI, V4, P794, DOI 10.1038/90498; RodriguezMoreno A, 1997, NEURON, V19, P893, DOI 10.1016/S0896-6273(00)80970-8; Schmitz D, 2003, NAT NEUROSCI, V6, P1058, DOI 10.1038/nn1116; Scott DB, 2003, NEUROPHARMACOLOGY, V45, P755, DOI 10.1016/S0028-3908(03)00250-8; Scott DB, 2001, J NEUROSCI, V21, P3063, DOI 10.1523/JNEUROSCI.21-09-03063.2001; Scott HL, 2007, NEUROPHARMACOLOGY, V52, P185, DOI 10.1016/j.neuropharm.2006.06.016; Smolders I, 2002, NAT NEUROSCI, V5, P796, DOI 10.1038/nn880; Standley S, 2000, NEURON, V28, P887, DOI 10.1016/S0896-6273(00)00161-6; Vignes M, 1998, NEUROPHARMACOLOGY, V37, P1269, DOI 10.1016/S0028-3908(98)00148-8; Vignes M, 1997, NATURE, V388, P179, DOI 10.1038/40639; Wenthold RJ, 2003, ANNU REV PHARMACOL, V43, P335, DOI 10.1146/annurev.pharmtox.43.100901.135803; WERNER P, 1991, NATURE, V351, P742, DOI 10.1038/351742a0; Wikstrom MA, 2003, NEUROPHARMACOLOGY, V45, P828, DOI 10.1016/S0028-3908(03)00336-8; WISDEN W, 1993, J NEUROSCI, V13, P3582	48	36	36	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2847	2856		10.1074/jbc.M109.081141	http://dx.doi.org/10.1074/jbc.M109.081141			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19920140	hybrid, Green Published			2022-12-25	WOS:000273697800060
J	Elsayad, K; Heinze, KG				Elsayad, Kareem; Heinze, Katrin G.			Defining a Superlens Operating Regime for Imaging Fluorescent Molecules	PLOS ONE			English	Article							NEGATIVE REFRACTION; LIFETIMES; DIPOLE	It has been shown that thin metal-based films can at certain frequencies act as planar near-field lenses for certain polarization components. A desirable property of such "lenses" is that they can also enhance and focus some large transverse spatial frequency components which contain sub-diffraction limit details. Over the last decade there has been much work in optimizing designs to reduce effects (such as material losses and surface roughness) that are detrimental to image reconstruction. One design that can reduce some of these undesirable effects, and which has received a fair amount of attention recently, is the stacked metal-dielectric superlens. Here we theoretically explore the imaging ability of such a design for the specific purpose of imaging a fluorescent dye (the common bio-marker GFP) in the vicinity of the superlens surface. Our calculations take into consideration the interaction (damping) of an oscillating electric dipole with the metallic layers in the superlens. We also assume a Gaussian frequency distribution spectrum for the dipole. We treat the metallic-alloy and dielectric-alloy layers separately using an appropriate effective medium theory. The transmission properties are evaluated via Transfer matrix (T-matrix) calculations that were performed in the MatLab (TM) and MathCad (TM) environments. Our study shows that it is in principle possible to image fluorescent molecules using a simple bilayer planar superlens. We find that optimal parameters for such a superlens occur when the peak dipole emission-frequency is slightly offset from the Surface Plasmon resonance frequency of the metal-dielectric interfaces. The best resolution is obtained when the fluorescent molecules are not too close (greater than or similar to 10 nm) or too far (less than or similar to 30 nm) from the superlens surface. The realization and application of a superlens with the specified design is possible using current nanofabrication techniques. When combined with e. g. a sub-wavelength grating structure (such as in the far-field superlens design previously proposed [1]) or a fast near-field scanning probe, it could provide a means for fast fluorescent imaging with sub-diffraction limit resolution.	[Elsayad, Kareem; Heinze, Katrin G.] Res Inst Mol Pathol IMP, Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Elsayad, K (corresponding author), Res Inst Mol Pathol IMP, Vienna, Austria.	elsayad@imp.ac.at		Elsayad, Kareem/0000-0003-1642-2905	FWF; Boehringer Ingelheim	FWF(Austrian Science Fund (FWF)); Boehringer Ingelheim(Boehringer Ingelheim)	This research was funded in part by the FWF (Wittgenstein Award). Basic research at the Research Institute of Molecular Pathology ( IMP) is funded by Boehringer Ingelheim. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBROSE WP, 1994, SCIENCE, V265, P364, DOI 10.1126/science.265.5170.364; BENNER RE, 1979, OPT COMMUN, V30, P145, DOI 10.1016/0030-4018(79)90063-4; Born M., 1999, PRINCIPLES OPTICS, P461; Bratkovsky AM, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2040012; Cai WS, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.193101; CHANCE PR, 1978, ADV CHEM PHYS, V1, P37; Chuang WH, 2009, OPT EXPRESS, V17, P104, DOI 10.1364/OE.17.000104; Drexhage K.H., 1970, J LUMIN, V1-2, P693, DOI [10.1016/0022-2313(70)90082-7, DOI 10.1016/0022-2313(70)90082-7]; DUCOURTIEUX S, 2001, PHYS REV B, V64; Geddes CD, 2002, J FLUORESC, V12, P121, DOI 10.1023/A:1016875709579; Haupts U, 1998, P NATL ACAD SCI USA, V95, P13573, DOI 10.1073/pnas.95.23.13573; HEIM R, 1994, P NATL ACAD SCI USA, V91, P12501, DOI 10.1073/pnas.91.26.12501; HOLLAND WR, 1984, PHYS REV LETT, V52, P1041, DOI 10.1103/PhysRevLett.52.1041; Ikonen P, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.073102; JACKSON JD, 1998, CLASSICAL ELECTRODYN, P410; Kastel J, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.011804; Kik PG, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.045418; Kotynski R, 2009, J OPT A-PURE APPL OP, V11, DOI 10.1088/1464-4258/11/1/015001; Kubitscheck U, 2000, BIOPHYS J, V78, P2170, DOI 10.1016/S0006-3495(00)76764-6; Lakowicz JR, 2005, ANAL BIOCHEM, V337, P171, DOI 10.1016/j.ab.2004.11.026; Larkin IA, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.121403; Liu ZW, 2007, NANO LETT, V7, P403, DOI 10.1021/nl062635n; Logeeswaran VJ, 2007, APPL PHYS A-MATER, V87, P187, DOI 10.1007/s00339-006-3836-1; LUKOSZ W, 1981, OPT LETT, V6, P251, DOI 10.1364/OL.6.000251; MAHAN GD, 1990, MANY PARTICLE PHYSIC, P430; MAXWELLGARNETT JC, 1905, PHIL T R SOC LONDON, V203, P385; Palik E.D., 1985, HDB OPTICAL CONSTANT, V2; Palik E. D., 1985, HDB OPTICAL CONSTANT, V1; Palik ED., 1985, HDB OPTICAL CONSTANT; Pendry JB, 2000, PHYS REV LETT, V85, P3966, DOI 10.1103/PhysRevLett.85.3966; Pribil GK, 2004, THIN SOLID FILMS, V455, P443, DOI 10.1016/j.tsf.2003.11.243; Ram S, 2006, P NATL ACAD SCI USA, V103, P4457, DOI 10.1073/pnas.0508047103; Ramakrishna SA, 2003, J MOD OPTIC, V50, P1419, DOI 10.1080/0950034021000020824; Ruppin R, 2004, J CHEM PHYS, V121, P11358, DOI 10.1063/1.1812742; Sambale A, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.053828; Scalora M, 2007, OPT EXPRESS, V15, P508, DOI 10.1364/OE.15.000508; Shi LH, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.045116; Suhling K, 2002, BIOPHYS J, V83, P3589, DOI 10.1016/S0006-3495(02)75359-9; Tomita S, 2008, OPT EXPRESS, V16, P9942, DOI 10.1364/OE.16.009942; TOMPKINS HG, 2005, HDB ELLIPSOMETRY, P252; Wormeester H, 2008, PHYS STATUS SOLIDI A, V205, P756, DOI 10.1002/pssa.200777740; Xie HY, 2009, SOLID STATE COMMUN, V149, P625, DOI 10.1016/j.ssc.2009.01.027; XIE XS, 1994, SCIENCE, V265, P361, DOI 10.1126/science.265.5170.361	43	3	4	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2009	4	12							e7963	10.1371/journal.pone.0007963	http://dx.doi.org/10.1371/journal.pone.0007963			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MT	19956608	Green Published, Green Submitted, gold			2022-12-25	WOS:000272828700002
J	Ji, JF; Werbowetski-Ogilvie, TE; Zhong, BN; Hong, SH; Bhatia, M				Ji, Junfeng; Werbowetski-Ogilvie, Tamra E.; Zhong, Bonan; Hong, Seok-Ho; Bhatia, Mickie			Pluripotent Transcription Factors Possess Distinct Roles in Normal versus Transformed Human Stem Cells	PLOS ONE			English	Article							RNA INTERFERENCE; MYELOID-LEUKEMIA; SELF-RENEWAL; NANOG; EXPRESSION; IDENTIFICATION; OCT4; DIFFERENTIATION; OCT-3/4; MAINTENANCE	Background: Cancer and normal stem cells (SCs) share proliferative properties of self-renewal and expression of key transcription factors (TFs). Despite similar TF identities, the functional role of specific TFs responsible for retaining SC state has yet to be examined in cancer. Methodology/Principal Findings: Here, we compare the role of Oct4 and Nanog, two-core pluripotent TFs, in transformed (t-hPSCs), and normal human pluripotent stem cells (hPSCs). Unlike normal SCs, self-renewal and survival of t-hPSCs were found to be independent of Oct4. In contrast, t-hPSCs exhibit hypersensitivity to reduction in Nanog and demonstrate complete loss of self-renewal coupled with apoptosis. Dual and sequential knockdown of Oct4 and Nanog revealed that sensitivity of t-hPSCs to Nanog was Oct4 dependent. Conclusions/Significance: Our study indicates a bifurcation for the role of two-core SC and cancer related TFs in self-renewal and survival processes. We suggest that the divergent roles of these TFs establish a paradigm to develop novel therapeutics towards selective destruction of aggressive tumors harboring cancer stem cells (CSCs) with similar molecular signatures.	[Ji, Junfeng; Werbowetski-Ogilvie, Tamra E.; Hong, Seok-Ho; Bhatia, Mickie] McMaster Univ, Stem Cell & Canc Res Inst, Hamilton, ON, Canada; [Ji, Junfeng] Ontario Inst Canc Res, Toronto, ON, Canada; [Zhong, Bonan] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA	McMaster University; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; Fred Hutchinson Cancer Center	Ji, JF (corresponding author), McMaster Univ, Stem Cell & Canc Res Inst, Hamilton, ON, Canada.	mbhatia@mcmaster.ca		Werbowetski-Ogilvie, Tamra/0000-0002-5469-0559	Canadian Institute of Health Research (CIHR); National Cancer Institute of Canada (NCIC); Ontario Institute for Cancer Research (OICR); Canadian Cancer Society (CCS)	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); National Cancer Institute of Canada (NCIC)(Canadian Cancer Society (CCS)); Ontario Institute for Cancer Research (OICR); Canadian Cancer Society (CCS)(Canadian Cancer Society (CCS))	This work was funded by the Canadian Institute of Health Research (CIHR), the National Cancer Institute of Canada (NCIC), Ontario Institute for Cancer Research (OICR), and the Canadian Cancer Society (CCS). A fellowship from the CCS supports T. E. W. O. and the Canada Research Chair Program provides support to M. B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Alldridge L, 2008, J PROTEOME RES, V7, P1458, DOI 10.1021/pr7007829; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Boyer LA, 2006, CURR OPIN GENET DEV, V16, P455, DOI 10.1016/j.gde.2006.08.009; BURNS JC, 1993, P NATL ACAD SCI USA, V90, P8033, DOI 10.1073/pnas.90.17.8033; Bussolati B, 2008, FASEB J, V22, P3696, DOI 10.1096/fj.08-102590; Chadwick K, 2003, BLOOD, V102, P906, DOI 10.1182/blood-2003-03-0832; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chang CC, 2008, CANCER RES, V68, P6281, DOI 10.1158/0008-5472.CAN-08-0094; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; Chiou SH, 2008, CLIN CANCER RES, V14, P4085, DOI 10.1158/1078-0432.CCR-07-4404; Damjanov I, 2007, NAT BIOTECHNOL, V25, P1212, DOI 10.1038/nbt1107-1212a; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Ezeh UI, 2005, CANCER-AM CANCER SOC, V104, P2255, DOI 10.1002/cncr.21432; Gidekel S, 2003, CANCER CELL, V4, P361, DOI 10.1016/S1535-6108(03)00270-8; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Hoei-Hansen CE, 2008, CANCER TREAT REV, V34, P348, DOI 10.1016/j.ctrv.2007.12.007; Jeter CR, 2009, STEM CELLS, V27, P993, DOI 10.1002/stem.29; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Knoepfler PS, 2009, STEM CELLS, V27, P1050, DOI 10.1002/stem.37; Lengner CJ, 2007, CELL STEM CELL, V1, P403, DOI 10.1016/j.stem.2007.07.020; Lensch MW, 2007, NAT BIOTECHNOL, V25, P1211, DOI 10.1038/nbt1107-1211a; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Matin MM, 2004, STEM CELLS, V22, P659, DOI 10.1634/stemcells.22-5-659; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Rosen JM, 2009, SCIENCE, V324, P1670, DOI 10.1126/science.1171837; Rubio CA, 2003, EUR J CLIN INVEST, V33, P406, DOI 10.1046/j.1365-2362.2003.01151.x; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Somervaille TCP, 2009, CELL STEM CELL, V4, P129, DOI 10.1016/j.stem.2008.11.015; Stewart MH, 2006, NAT METHODS, V3, P807, DOI 10.1038/nmeth939; Sumi T, 2007, ONCOGENE, V26, P5564, DOI 10.1038/sj.onc.1210353; Werbowetski-Ogilvie TE, 2009, NAT BIOTECHNOL, V27, P91, DOI 10.1038/nbt.1516; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Ye F, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-108; Zaehres H, 2005, STEM CELLS, V23, P299, DOI 10.1634/stemcells.2004-0252; Zhang S, 2008, CANCER RES, V68, P4311, DOI 10.1158/0008-5472.CAN-08-0364	44	24	27	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2009	4	11							e8065	10.1371/journal.pone.0008065	http://dx.doi.org/10.1371/journal.pone.0008065			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MQ	19956629	Green Submitted, gold, Green Published			2022-12-25	WOS:000272828400019
J	Lambert, DM; Shepherd, LD; Huynen, L; Beans-Picon, G; Walter, GH; Millar, CD				Lambert, David M.; Shepherd, Lara D.; Huynen, Leon; Beans-Picon, Gabrielle; Walter, Gimme H.; Millar, Craig D.			The Molecular Ecology of the Extinct New Zealand Huia	PLOS ONE			English	Article							POPULATION; ASSIGNMENT; INFERENCE; SAMPLES; ERRORS	The extinct Huia (Heteralocha acutirostris) of New Zealand represents the most extreme example of beak dimorphism known in birds. We used a combination of nuclear genotyping methods, molecular sexing, and morphometric analyses of museum specimens collected in the late 19(th) and early 20(th) centuries to quantify the sexual dimorphism and population structure of this extraordinary species. We report that the classical description of Huia as having distinctive sex-linked morphologies is not universally correct. Four Huia, sexed as females had short beaks and, on this basis, were indistinguishable from males. Hence, we suggest it is likely that Huia males and females were indistinguishable as juveniles and that the well-known beak dimorphism is the result of differential beak growth rates in males and females. Furthermore, we tested the prediction that the social organisation and limited powers of flight of Huia resulted in high levels of population genetic structure. Using a suite of microsatellite DNA loci, we report high levels of genetic diversity in Huia, and we detected no significant population genetic structure. In addition, using mitochondrial hypervariable region sequences, and likely mutation rates and generation times, we estimated that the census population size of Huia was moderately high. We conclude that the social organization and limited powers of flight did not result in a highly structured population.	[Lambert, David M.] Griffith Univ, Griffith Sch Environm, Nathan, Qld 4111, Australia; [Lambert, David M.] Griffith Univ, Sch Biomol & Phys Sci, Nathan, Qld 4111, Australia; [Lambert, David M.; Shepherd, Lara D.] Massey Univ, Allan Wilson Ctr Mol Ecol & Evolut, Auckland, New Zealand; [Huynen, Leon; Beans-Picon, Gabrielle] Massey Univ, Inst Nat Sci, Auckland, New Zealand; [Walter, Gimme H.] Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia; [Millar, Craig D.] Univ Auckland, Allan Wilson Ctr Mol Ecol & Evolut, Auckland 1, New Zealand	Griffith University; Griffith University; Massey University; Massey University; University of Queensland; Massey University; University of Auckland	Lambert, DM (corresponding author), Griffith Univ, Griffith Sch Environm, Nathan, Qld 4111, Australia.	d.lambert@griffith.edu.au	Walter, Gimme/AAC-3635-2019; Shepherd, Lara/E-6663-2011	Walter, Gimme/0000-0003-1025-7101; Shepherd, Lara/0000-0002-7136-0017; Lambert, David/0000-0002-5821-3637	Griffith University; Marsden Fund; Allan Wilson Centre for Molecular Ecology and Evolution	Griffith University(Griffith University); Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); Allan Wilson Centre for Molecular Ecology and Evolution	This research was supported by Griffith University, the Marsden Fund and the Allan Wilson Centre for Molecular Ecology and Evolution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong DP, 2005, J ANIM ECOL, V74, P160, DOI 10.1111/j.1365-2656.2004.00908.x; Broquet T, 2004, MOL ECOL, V13, P3601, DOI 10.1111/j.1365-294X.2004.02352.x; Buller WL., 1888, HIST BIRDS NZ, V2; BURTON P J K, 1974, Bulletin of the British Museum (Natural History) Zoology, V27, P1; COLENSO W, 1887, T P NZ I, V19, P140; Creel S, 2003, MOL ECOL, V12, P2003, DOI 10.1046/j.1365-294X.2003.01868.x; Dawson KJ, 2001, GENET RES, V78, P59, DOI 10.1017/S001667230100502X; DOUBLE M, 2000, 176 DEP CONS; ELLEGREN H, 1995, NAT GENET, V11, P360, DOI 10.1038/ng1295-360; Falush D, 2003, GENETICS, V164, P1567; FRANKHAM R, 1995, GENET RES, V66, P95, DOI 10.1017/S0016672300034455; Gagneux P, 1997, MOL ECOL, V6, P861, DOI 10.1111/j.1365-294X.1997.tb00140.x; Gould, 1837, SYNOPSIS BIRDS AUSTR; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; GROSLER AG, 1990, POPULATION BIOL PASS, P167; GROSLER AG, 1994, J AVIAN BIOL, V25, P171; HEATHER BD, 1998, FIELD GUIDE BIRDS NZ; Hudson QJ, 2000, BIOL CONSERV, V96, P105, DOI 10.1016/S0006-3207(00)00057-4; HUDSON QJ, 1999, THESIS U WAIKATO; Hung CM, 2004, ANIM CONSERV, V7, P301, DOI 10.1017/S1367943004001453; INNES J, 1999, THREATENED SPECIES R, V30; Kuhner MK, 2006, BIOINFORMATICS, V22, P768, DOI 10.1093/bioinformatics/btk051; Lack D.L., 1971, ECOLOGICAL ISOLATION; Lambert DM, 2005, CONSERV GENET, V6, P1, DOI 10.1007/s10592-004-7857-z; Manel S, 2005, TRENDS ECOL EVOL, V20, P136, DOI 10.1016/j.tree.2004.12.004; Millar CD, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000209; Moorhouse Ron J., 1996, Notornis, V43, P19; NAVIDI W, 1992, AM J HUM GENET, V50, P347; Paetkau D, 2003, MOL ECOL, V12, P1375, DOI 10.1046/j.1365-294X.2003.01820.x; Pearse DE, 2004, CONSERV GENET, V5, P585, DOI 10.1007/s10592-003-1863-4; PHILLIPS WJ, 1963, BOOK HUIA; POTTS T, 1885, NZ J SCI, V2, P373; Pritchard JK, 2000, GENETICS, V155, P945; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Selander R.K., 1972, SEXUAL SELECTION DES, P180, DOI DOI 10.4324/9781315129266-8; SELANDER RK, 1966, CONDOR, V68, P113, DOI 10.2307/1365712; Taberlet P, 1996, NUCLEIC ACIDS RES, V24, P3189, DOI 10.1093/nar/24.16.3189; WENINK PW, 1994, MOL BIOL EVOL, V11, P22; WORTHY TH, 2002, LOST WORLD MOA	40	12	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2009	4	11							e8019	10.1371/journal.pone.0008019	http://dx.doi.org/10.1371/journal.pone.0008019			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MK	19946368	Green Published, gold			2022-12-25	WOS:000272827800013
J	Ogasawara, O; Okubo, K				Ogasawara, Osamu; Okubo, Kousaku			On Theoretical Models of Gene Expression Evolution with Random Genetic Drift and Natural Selection	PLOS ONE			English	Article							MOUSE; PRESERVATION; DIVERGENCE; DISTRIBUTIONS; PROBABILITY; DISSECTION; VARIANCE; PROFILES; PRIMATES; HUMANS	Background: The relative contributions of natural selection and random genetic drift are a major source of debate in the study of gene expression evolution, which is hypothesized to serve as a bridge from molecular to phenotypic evolution. It has been suggested that the conflict between views is caused by the lack of a definite model of the neutral hypothesis, which can describe the long-run behavior of evolutionary change in mRNA abundance. Therefore previous studies have used inadequate analogies with the neutral prediction of other phenomena, such as amino acid or nucleotide sequence evolution, as the null hypothesis of their statistical inference. Methodology/Principal Findings: In this study, we introduced two novel theoretical models, one based on neutral drift and the other assuming natural selection, by focusing on a common property of the distribution of mRNA abundance among a variety of eukaryotic cells, which reflects the result of long-term evolution. Our results demonstrated that (1) our models can reproduce two independently found phenomena simultaneously: the time development of gene expression divergence and Zipf's law of the transcriptome; (2) cytological constraints can be explicitly formulated to describe long-term evolution; (3) the model assuming that natural selection optimized relative mRNA abundance was more consistent with previously published observations than the model of optimized absolute mRNA abundances. Conclusions/Significance: The models introduced in this study give a formulation of evolutionary change in the mRNA abundance of each gene as a stochastic process, on the basis of previously published observations. This model provides a foundation for interpreting observed data in studies of gene expression evolution, including identifying an adequate time scale for discriminating the effect of natural selection from that of random genetic drift of selectively neutral variations.			Ogasawara, O (corresponding author), Natl Inst Genet, Ctr Informat Biol, Shizuoka, Japan.	oogasawa@genes.nig.ac.jp	Ogasawara, Osamu/GPS-6997-2022	Ogasawara, Osamu/0000-0001-6001-3397				Aitchison J, 1996, LOG NORMAL DISTRIBUT; Araki R, 2006, STEM CELLS, V24, P2522, DOI 10.1634/stemcells.2006-0005; Bedford T, 2009, P NATL ACAD SCI USA, V106, P1133, DOI 10.1073/pnas.0812009106; BISHOP JO, 1974, NATURE, V250, P199, DOI 10.1038/250199a0; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Cavalieri D, 2000, P NATL ACAD SCI USA, V97, P12369, DOI 10.1073/pnas.210395297; Cheung VG, 2003, NAT GENET, V33, P422, DOI 10.1038/ng1094; Crow E. L., 1988, LOGNORMAL DISTRIBUTI; Enard W, 2002, SCIENCE, V296, P340, DOI 10.1126/science.1068996; Ferea TL, 1999, P NATL ACAD SCI USA, V96, P9721, DOI 10.1073/pnas.96.17.9721; Force A, 2005, GENETICS, V170, P433, DOI 10.1534/genetics.104.027607; Force A, 1999, GENETICS, V151, P1531; Furusawa C, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.088102; Gage TB, 1998, ANNU REV ANTHROPOL, V27, P197, DOI 10.1146/annurev.anthro.27.1.197; Gibrat R., 1930, B STAT, V19, P469; Gibrat R., 1931, INEGALITES EC; Gibson G, 2004, GENETICS, V167, P1791, DOI 10.1534/genetics.104.026583; Glazko GV, 2003, MOL BIOL EVOL, V20, P424, DOI 10.1093/molbev/msg050; Haldane JBS, 1942, BIOMETRIKA, V32, P226, DOI 10.2307/2332127; Hsieh WP, 2003, GENETICS, V165, P747; Jin W, 2001, NAT GENET, V29, P389, DOI 10.1038/ng766; Johnson N.L., 1970, DISTRIBUTIONS STAT C; Khaitovich P, 2005, GENETICS, V170, P929, DOI 10.1534/genetics.104.037135; Khaitovich P, 2004, PLOS BIOL, V2, P682, DOI 10.1371/journal.pbio.0020132; KIMURA M, 1968, NATURE, V217, P624, DOI 10.1038/217624a0; KIMURA M, 1972, J MOL EVOL, V2, P87, DOI 10.1007/BF01653945; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Kolmogoroff AN, 1941, CR ACAD SCI URSS, V31, P99; Konishi T, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-5; Kuznetsov VA, 2003, SIGNAL PROCESS, V83, P889, DOI 10.1016/S0165-1684(02)00481-4; Kuznetsov VA, 2002, GENETICS, V161, P1321; LANDE R, 1976, EVOLUTION, V30, P314, DOI 10.1111/j.1558-5646.1976.tb00911.x; LANDE R, 1977, EVOLUTION, V31, P442, DOI 10.1111/j.1558-5646.1977.tb01025.x; Lemos B, 2005, EVOLUTION, V59, P126; Luscombe NM, 2002, GENOME BIOL, V3; Lynch M, 2000, GENETICS, V154, P459; Lynch M, 2001, GENETICS, V159, P1789; Lynch M, 2007, NAT REV GENET, V8, P803, DOI 10.1038/nrg2192; Mandelbrot B., 1953, COMMUN THEOR, P486; MCLAREN CE, 1994, STATISTICIAN, V43, P247, DOI 10.2307/2348342; Mitzenmacher M., 2003, INTERNET MATH, V2, P226, DOI [10.1080/15427951.2004.10129088, DOI 10.1080/15427951.2004.10129088]; Monks SA, 2004, AM J HUM GENET, V75, P1094, DOI 10.1086/426461; Nuzhdin SV, 2004, MOL BIOL EVOL, V21, P1308, DOI 10.1093/molbev/msh128; Ogasawara O, 2003, CR BIOL, V326, P1097, DOI 10.1016/j.crvi.2003.09.031; Ogasawara O, 2006, NUCLEIC ACIDS RES, V34, pD628, DOI 10.1093/nar/gkj137; Ohta T, 1972, J Mol Evol, V1, P150, DOI 10.1007/BF01659161; OHTA T, 1993, P NATL ACAD SCI USA, V90, P10676, DOI 10.1073/pnas.90.22.10676; Oleksiak MF, 2005, NAT GENET, V37, P67, DOI 10.1038/ng1483; Oleksiak MF, 2002, NAT GENET, V32, P261, DOI 10.1038/ng983; Pritchard CC, 2001, P NATL ACAD SCI USA, V98, P13266, DOI 10.1073/pnas.221465998; Rifkin SA, 2003, NAT GENET, V33, P138, DOI 10.1038/ng1086; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Sharma A, 2005, PHYSIOL GENOMICS, V21, P117, DOI 10.1152/physiolgenomics.00228.2003; SIMON HA, 1955, BIOMETRIKA, V42, P425; Tan QH, 2005, HUM GENET, V117, P267, DOI 10.1007/s00439-005-1308-x; Townsend JP, 2003, MOL BIOL EVOL, V20, P955, DOI 10.1093/molbev/msg106; TURELLI M, 1988, EVOLUTION, V42, P1085, DOI [10.2307/2408923, 10.1111/j.1558-5646.1988.tb02526.x]; Ueda HR, 2004, P NATL ACAD SCI USA, V101, P3765, DOI 10.1073/pnas.0306244101; Wayne ML, 2004, GENETICS, V168, P1413, DOI 10.1534/genetics.104.030973; Whitehead A, 2006, P NATL ACAD SCI USA, V103, P5425, DOI 10.1073/pnas.0507648103; Whitehead A, 2006, MOL ECOL, V15, P1197, DOI 10.1111/j.1365-294X.2006.02868.x; Whitehead A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r13; Yanai I, 2004, OMICS, V8, P15, DOI 10.1089/153623104773547462; Yule GU, 1925, PHILOS T R SOC LON B, V213, P21, DOI 10.1098/rstb.1925.0002; Zhang YW, 2001, J MOL EVOL, V52, P516, DOI 10.1007/s002390010182; Zipf G. K., 1949, HUMAN BEHAV PRINCIPL	66	6	6	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2009	4	11							e7943	10.1371/journal.pone.0007943	http://dx.doi.org/10.1371/journal.pone.0007943			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522NL	19936214	Green Submitted, Green Published, gold			2022-12-25	WOS:000272004800020
J	Cerezo, M; Bandelt, HJ; Martin-Guerrero, I; Ardanaz, M; Vega, A; Carracedo, A; Garcia-Orad, A; Salas, A				Cerezo, Maria; Bandelt, Hans-Juergen; Martin-Guerrero, Idoia; Ardanaz, Maite; Vega, Ana; Carracedo, Angel; Garcia-Orad, Africa; Salas, Antonio			High Mitochondrial DNA Stability in B-Cell Chronic Lymphocytic Leukemia	PLOS ONE			English	Article							SEQUENCE VARIATION; HAPLOGROUP-H; NEAR-EASTERN; MTDNA; MUTATIONS; HETEROPLASMY; POPULATION; TRANSPLANTATION; REANALYSIS; EVOLUTION	Background: Chronic Lymphocytic Leukemia (CLL) leads to progressive accumulation of lymphocytes in the blood, bone marrow, and lymphatic tissues. Previous findings have suggested that the mtDNA could play an important role in CLL. Methodology/Principal Findings: The mitochondrial DNA (mtDNA) control-region was analyzed in lymphocyte cell DNA extracts and compared with their granulocyte counterpart extract of 146 patients suffering from B-Cell CLL; B-CLL (all recruited from the Basque country). Major efforts were undertaken to rule out methodological artefacts that would render a high false positive rate for mtDNA instabilities and thus lead to erroneous interpretation of sequence instabilities. Only twenty instabilities were finally confirmed, most of them affecting the homopolymeric stretch located in the second hypervariable segment (HVS-II) around position 310, which is well known to constitute an extreme mutational hotspot of length polymorphism, as these mutations are frequently observed in the general human population. A critical revision of the findings in previous studies indicates a lack of proper methodological standards, which eventually led to an overinterpretation of the role of the mtDNA in CLL tumorigenesis. Conclusions/Significance: Our results suggest that mtDNA instability is not the primary causal factor in B-CLL. A secondary role of mtDNA mutations cannot be fully ruled out under the hypothesis that the progressive accumulation of mtDNA instabilities could finally contribute to the tumoral process. Recommendations are given that would help to minimize erroneous interpretation of sequencing results in mtDNA studies in tumorigenesis.			Cerezo, M (corresponding author), Univ Santiago Compostela, Inst Med Legal, Unidade Xenet, Santiago De Compostela, Galicia, Spain.	antonio.salas@usc.es	Salas, Antonio/U-2029-2019; Carracedo, Angel/D-4257-2012; Martin-Guerrero, Idoia/AAF-3446-2020; Salas, Antonio/E-3977-2012; Vega, Ana/R-4758-2019	Salas, Antonio/0000-0002-2336-702X; Carracedo, Angel/0000-0003-1085-8986; Salas, Antonio/0000-0002-2336-702X; Martin-Guerrero, Idoia/0000-0002-0098-1908; Cerezo Fernandez, Maria/0000-0003-3073-1130; Garcia.Orad, Africa/0000-0002-5575-3080				Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590; Achilli A, 2005, AM J HUM GENET, V76, P883, DOI 10.1086/430073; Alvarez-Iglesias V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005112; Anaissie EJ, 1998, ANN INTERN MED, V129, P559, DOI 10.7326/0003-4819-129-7-199810010-00010; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bandelt HJ, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-113; Bandelt HJ, 2005, J MED GENET, V42, P957, DOI 10.1136/jmg.2005.033589; Bandelt HJ, 2005, BIOCHEM BIOPH RES CO, V333, P122, DOI 10.1016/j.bbrc.2005.04.055; Bandelt HJ, 2004, SCIENCE, V305, P1402; Bandelt HJ, 2004, INT J LEGAL MED, V118, P267, DOI 10.1007/s00414-004-0455-2; Bandelt HJ, 2002, AM J HUM GENET, V71, P1150, DOI 10.1086/344397; BANDELT HJ, 2006, LAB SPECIFIC MUTATIO, P119; Behar DM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002062; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERTRANPETIT J, 1991, ANN HUM GENET, V55, P51, DOI 10.1111/j.1469-1809.1991.tb00398.x; Brandstatter A, 2005, ELECTROPHORESIS, V26, P3414, DOI 10.1002/elps.200500307; Brandstatter A, 2003, INT J LEGAL MED, V117, P180, DOI 10.1007/s00414-002-0350-7; Carew JS, 2003, LEUKEMIA, V17, P1437, DOI 10.1038/sj.leu.2403043; Cheson BD, 1996, BLOOD, V87, P4990, DOI 10.1182/blood.V87.12.4990.bloodjournal87124990; Chiorazzi N, 2005, NEW ENGL J MED, V352, P804, DOI 10.1056/NEJMra041720; Egeland T, 2000, FORENSIC SCI INT, V110, P47, DOI 10.1016/S0379-0738(00)00147-X; Esteve J, 2001, LEUKEMIA, V15, P445, DOI 10.1038/sj.leu.2402036; Gattermann N, 2004, LEUKEMIA, V18, P18, DOI 10.1038/sj.leu.2403209; Gonzalez AM, 2003, AM J PHYS ANTHROPOL, V120, P391, DOI 10.1002/ajpa.10168; Grist SA, 2004, LEUKEMIA, V18, P1313, DOI 10.1038/sj.leu.2403380; Grzybowski T, 2000, ELECTROPHORESIS, V21, P548, DOI 10.1002/(SICI)1522-2683(20000201)21:3<548::AID-ELPS548>3.0.CO;2-U; Grzybowski T, 2003, ELECTROPHORESIS, V24, P1159, DOI 10.1002/elps.200390149; He L, 2003, LEUKEMIA, V17, P2487, DOI 10.1038/sj.leu.2403146; Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933; Ivanova R, 1998, INT J CANCER, V76, P495, DOI 10.1002/(SICI)1097-0215(19980518)76:4<495::AID-IJC9>3.0.CO;2-M; KIPPS TJ, 1995, CHRONIC LYMPHOCYTIC, P1017; Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901; Linnartz B, 2004, CANCER RES, V64, P1966, DOI 10.1158/0008-5472.CAN-03-2956; Meierhofer D, 2006, LEUKEMIA, V20, P362, DOI 10.1038/sj.leu.2404070; Pereira L, 2007, MOL BIOL EVOL, V24, P868, DOI 10.1093/molbev/msm004; Quintans B, 2004, FORENSIC SCI INT, V140, P251, DOI 10.1016/j.forsciint.2003.12.005; Rawstron AC, 2002, BLOOD, V100, P635, DOI 10.1182/blood.V100.2.635; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Roostalu U, 2007, MOL BIOL EVOL, V24, P436, DOI 10.1093/molbev/msl173; ROZMAN C, 1995, NEW ENGL J MED, V333, P1052, DOI 10.1056/NEJM199510193331606; Salas A, 2007, FORENSIC SCI INT, V168, P1, DOI 10.1016/j.forsciint.2006.05.037; Salas A, 2005, PLOS MED, V2, P1158, DOI 10.1371/journal.pmed.0020296; Salas A, 2005, FORENSIC SCI INT, V148, P191, DOI 10.1016/j.forsciint.2004.06.008; Salas A, 2005, BIOCHEM BIOPH RES CO, V335, P891, DOI 10.1016/j.bbrc.2005.07.161; Salas A, 2001, INT J LEGAL MED, V114, P186, DOI 10.1007/s004140000164; SALAS A, 2006, PLOS MED        0105; Salas A, 2017, EUR J HUM GENET, V25, pS33, DOI 10.1038/sj.ejhg.5200202; Shin MG, 2003, BLOOD, V101, P3118, DOI 10.1182/blood-2002-06-1825; Shvidel L, 1998, LEUKEMIA, V12, P1612, DOI 10.1038/sj.leu.2401140; Tully G, 2004, FORENSIC SCI INT, V140, P1, DOI 10.1016/S0379-0738(03)00181-6; VALVERDE E, 1993, INT J LEGAL MED, V105, P251, DOI 10.1007/BF01370381; van Besien K, 2001, LEUKEMIA, V15, P1317, DOI 10.1038/sj.leu.2402178; Vega A, 2004, ONCOGENE, V23, P1314, DOI 10.1038/sj.onc.1207214; Yao YG, 2008, J MED GENET, V45, P769, DOI 10.1136/jmg.2008.059782; Yao YG, 2006, HUM GENET, V119, P505, DOI 10.1007/s00439-006-0154-9; Yao YG, 2007, BLOOD, V109, P756, DOI 10.1182/blood-2006-01-011007	56	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2009	4	11							e7902	10.1371/journal.pone.0007902	http://dx.doi.org/10.1371/journal.pone.0007902			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521QH	19924307	Green Published, Green Submitted, gold			2022-12-25	WOS:000271936700027
J	Massignan, T; Stewart, RS; Biasini, E; Solomon, IH; Bonetto, V; Chiesa, R; Harris, DA				Massignan, Tania; Stewart, Richard S.; Biasini, Emiliano; Solomon, Isaac H.; Bonetto, Valentina; Chiesa, Roberto; Harris, David A.			A Novel, Drug-based, Cellular Assay for the Activity of Neurotoxic Mutants of the Prion Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; SCRAPIE; CELLS; PRP; GENTAMICIN; ANTIBODIES; BLEOMYCIN; DISEASE; ATAXIA; MICE	In prion diseases, the infectious isoform of the prion protein (PrPSc) may subvert a normal, physiological activity of the cellular isoform (PrPC). A deletion mutant of the prion protein (Delta 105-125) that produces a neonatal lethal phenotype when expressed in transgenic mice provides a window into the normal function of PrPC and how it can be corrupted to produce neurotoxic effects. We report here the surprising and unexpected observation that cells expressing Delta 105-125 PrP and related mutants are hypersensitive to the toxic effects of two classes of antibiotics (aminoglycosides and bleomycin analogues) that are commonly used for selection of stably transfected cell lines. This unusual phenomenon mimics several essential features of Delta 105-125 PrP toxicity seen in transgenic mice, including rescue by co-expression of wild type PrP. Cells expressing Delta 105-125 PrP are susceptible to drug toxicity within minutes, suggesting that the mutant protein enhances cellular accumulation of these cationic compounds. Our results establish a screenable cellular phenotype for the activity of neurotoxic forms of PrP, and they suggest possible mechanisms by which these molecules could produce their pathological effects in vivo.	[Harris, David A.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Massignan, Tania; Biasini, Emiliano; Bonetto, Valentina; Chiesa, Roberto] Ist Ric Farmacol Mario Negri, Dulbecco Telethon Inst, I-20156 Milan, Italy; [Massignan, Tania; Bonetto, Valentina] Ist Ric Farmacol Mario Negri, Dept Mol Pharmacol & Biochem, I-20156 Milan, Italy; [Biasini, Emiliano; Chiesa, Roberto] Ist Ric Farmacol Mario Negri, Dept Neurosci, I-20156 Milan, Italy	Washington University (WUSTL); Fondazione Telethon; Dulbecco Telethon Institute (DTI); Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Harris, DA (corresponding author), Boston Univ, Sch Med, Dept Biochem, 72 E Concord St,K225, Boston, MA 02118 USA.	daharris@bu.edu	Chiesa, Roberto/G-1561-2017; Bonetto, Valentina/ABB-6383-2020; Biasini, Emiliano/A-3147-2011; Bonetto, Valentina/I-4694-2018	Chiesa, Roberto/0000-0002-3842-3733; Bonetto, Valentina/0000-0003-0456-2054; Biasini, Emiliano/0000-0002-3927-6341; Bonetto, Valentina/0000-0003-0456-2054; massignan, tania/0000-0002-6176-2696; Harris, David/0000-0002-6985-5790	National Institutes of Health [NS052526, NS040975]; Department of Defense [DAMD17-03-1-0531]; Telethon Foundation [GFP04007, TCR08002, TCR08005]; National Institutes of Health Neuroscience Blueprint Core [P30 NS057105]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040975, P30NS057105, R01NS052526, R01NS065244] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Telethon Foundation(Fondazione Telethon); National Institutes of Health Neuroscience Blueprint Core(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS052526 and NS040975 (to D. A. H.). This work was also supported by Department of Defense Grant DAMD17-03-1-0531 (to R. S. S.) and Telethon Foundation Grants GFP04007 (to E. B.), TCR08002 (to V. B.), and TCR08005 (to R.C.). The Hope Center Viral Vectors Core is supported by National Institutes of Health Neuroscience Blueprint Core Grant P30 NS057105 (to Washington University).	Abraham AT, 2003, CHEM BIOL, V10, P45, DOI 10.1016/S1074-5521(02)00306-X; Aguzzi A, 2008, ANNU REV NEUROSCI, V31, P439, DOI 10.1146/annurev.neuro.31.060407.125620; Aouida M, 2004, BIOCHEM J, V384, P47, DOI 10.1042/BJ20040392; Aouida M, 2004, CANCER RES, V64, P1102, DOI 10.1158/0008-5472.CAN-03-2729; Baumann F, 2007, EMBO J, V26, P538, DOI 10.1038/sj.emboj.7601510; BOLTON DC, 1991, J VIROL, V65, P3667, DOI 10.1128/JVI.65.7.3667-3675.1991; Brandner S, 1996, NATURE, V379, P339, DOI 10.1038/379339a0; Celeste A, 2003, NAT CELL BIOL, V5, P675, DOI 10.1038/ncb1004; Chen JY, 2005, NAT REV CANCER, V5, P102, DOI 10.1038/nrc1547; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; Christensen HM, 2009, J NEUROCHEM, V108, P44, DOI 10.1111/j.1471-4159.2008.05719.x; Drisaldi B, 2004, J BIOL CHEM, V279, P55443, DOI 10.1074/jbc.M404794200; Du JP, 2005, INT J CANCER, V113, P213, DOI 10.1002/ijc.20570; Harris DA, 2006, NEURON, V50, P353, DOI 10.1016/j.neuron.2006.04.020; Hobbie SN, 2007, NUCLEIC ACIDS RES, V35, P6086, DOI 10.1093/nar/gkm658; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Li AM, 2007, EMBO J, V26, P548, DOI 10.1038/sj.emboj.7601507; Li AM, 2007, J NEUROSCI, V27, P852, DOI 10.1523/JNEUROSCI.4244-06.2007; Li MJ, 2005, METH MOL B, V309, P261; Louis Sharon A, 2005, Methods Mol Biol, V290, P265; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; Marcotti W, 2005, J PHYSIOL-LONDON, V567, P505, DOI 10.1113/jphysiol.2005.085951; Matucci A, 2005, BRAIN RES BULL, V65, P155, DOI 10.1016/j.brainresbull.2004.12.008; Moore RC, 1999, J MOL BIOL, V292, P797, DOI 10.1006/jmbi.1999.3108; Myrdal SE, 2005, HEARING RES, V204, P170, DOI 10.1016/j.heares.2005.02.005; Myrdal SE, 2005, HEARING RES, V204, P156, DOI 10.1016/j.heares.2005.02.002; Pankiewicz J, 2006, EUR J NEUROSCI, V23, P2635, DOI 10.1111/j.1460-9568.2006.04805.x; Peretz D, 1997, J MOL BIOL, V273, P614, DOI 10.1006/jmbi.1997.1328; Poehlsgaard J, 2005, NAT REV MICROBIOL, V3, P870, DOI 10.1038/nrmicro1265; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rambold AS, 2008, EMBO J, V27, P1974, DOI 10.1038/emboj.2008.122; Rivera-Milla E, 2006, FASEB J, V20, P317, DOI 10.1096/fj.05-4279fje; Rossi D, 2001, EMBO J, V20, P694, DOI 10.1093/emboj/20.4.694; Sandoval RM, 2000, AM J PHYSIOL-RENAL, V279, pF884, DOI 10.1152/ajprenal.2000.279.5.F884; SCHURR E, 1989, CANCER RES, V49, P2729; Sharom FJ, 2008, PHARMACOGENOMICS, V9, P105, DOI 10.2217/14622416.9.1.105; Shmerling D, 1998, CELL, V93, P203, DOI 10.1016/S0092-8674(00)81572-X; Solforosi L, 2004, SCIENCE, V303, P1514, DOI 10.1126/science.1094273; Thornton G, 2005, GENES CELLS, V10, P941, DOI 10.1111/j.1365-2443.2005.00891.x; Watts JC, 2007, EMBO J, V26, P4038, DOI 10.1038/sj.emboj.7601830; Westergard L, 2007, BBA-MOL BASIS DIS, V1772, P629, DOI 10.1016/j.bbadis.2007.02.011; Williamson RA, 1998, J VIROL, V72, P9413, DOI 10.1128/JVI.72.11.9413-9418.1998; Wolkowicz Roland, 2004, Methods Mol Biol, V246, P391; Zanusso G, 1998, P NATL ACAD SCI USA, V95, P8812, DOI 10.1073/pnas.95.15.8812	44	32	32	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7752	7765		10.1074/jbc.M109.064949	http://dx.doi.org/10.1074/jbc.M109.064949			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	19940127	Green Published, hybrid			2022-12-25	WOS:000275415600083
J	Tan, SX; Greetham, D; Raeth, S; Grant, CM; Dawes, IW; Perrone, GG				Tan, Shi-Xiong; Greetham, Darren; Raeth, Sebastian; Grant, Chris M.; Dawes, Ian W.; Perrone, Gabriel G.			The Thioredoxin-Thioredoxin Reductase System Can Function in Vivo as an Alternative System to Reduce Oxidized Glutathione in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS-RESPONSE; HYDROGEN-PEROXIDE; REDOX STATE; MONOTHIOL GLUTAREDOXINS; GAMMA-GLUTAMYLCYSTEINE; ENDOPLASMIC-RETICULUM; GENETIC-ANALYSIS; CELL-CYCLE; YEAST; PROTECTION	Cellular mechanisms that maintain redox homeostasis are crucial, providing buffering against oxidative stress. Glutathione, the most abundant low molecular weight thiol, is considered the major cellular redox buffer in most cells. To better understand how cells maintain glutathione redox homeostasis, cells of Saccharomyces cerevisiae were treated with extracellular oxidized glutathione (GSSG), and the effect on intracellular reduced glutathione (GSH) and GSSG were monitored over time. Intriguingly cells lacking GLR1 encoding the GSSG reductase in S. cerevisiae accumulated increased levels of GSH via a mechanism independent of the GSH biosynthetic pathway. Furthermore, residual NADPH-dependent GSSG reductase activity was found in lysate derived from glr1 cell. The cytosolic thioredoxin-thioredoxin reductase system and not the glutaredoxins (Grx1p, Grx2p, Grx6p, and Grx7p) contributes to the reduction of GSSG. Overexpression of the thioredoxins TRX1 or TRX2 in glr1 cells reduced GSSG accumulation, increased GSH levels, and reduced cellular glutathione E-h'. Conversely, deletion of TRX1 or TRX2 in the glr1 strain led to increased accumulation of GSSG, reduced GSH levels, and increased cellular E-h'. Furthermore, it was found that purified thioredoxins can reduce GSSG to GSH in the presence of thioredoxin reductase and NADPH in a reconstituted in vitro system. Collectively, these data indicate that the thioredoxin-thioredoxin reductase system can function as an alternative system to reduce GSSG in S. cerevisiae in vivo.	[Tan, Shi-Xiong; Dawes, Ian W.; Perrone, Gabriel G.] Univ New S Wales, Ramaciotti Ctr Gene Funct Anal, Sydney, NSW 2052, Australia; [Tan, Shi-Xiong; Raeth, Sebastian; Dawes, Ian W.; Perrone, Gabriel G.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia; [Greetham, Darren; Grant, Chris M.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of New South Wales Sydney; University of New South Wales Sydney; University of Manchester	Dawes, IW (corresponding author), Univ New S Wales, Ramaciotti Ctr Gene Funct Anal, Sydney, NSW 2052, Australia.	i.dawes@unsw.edu.au	Tan, Shi-Xiong/Y-3728-2019	Grant, Chris/0000-0002-0616-6576; Tan, Shi-Xiong/0000-0002-0020-2572	Australian Research Council; Cancer Institute New South Wales	Australian Research Council(Australian Research Council); Cancer Institute New South Wales	This work was supported by grants from the Australian Research Council and the Cancer Institute New South Wales.	Alberti S, 2007, YEAST, V24, P913, DOI 10.1002/yea.1502; Arner ESJ, 1999, METHOD ENZYMOL, V300, P226; Bao R, 2009, BBA-PROTEINS PROTEOM, V1794, P1218, DOI 10.1016/j.bbapap.2009.04.001; Bourbouloux A, 2000, J BIOL CHEM, V275, P13259, DOI 10.1074/jbc.275.18.13259; Draculic T, 2000, MOL MICROBIOL, V36, P1167, DOI 10.1046/j.1365-2958.2000.01948.x; Drakulic T, 2005, FEMS YEAST RES, V5, P1215, DOI 10.1016/j.femsyr.2005.06.001; Gelperin DM, 2005, GENE DEV, V19, P2816, DOI 10.1101/gad.1362105; Grant CM, 1997, MOL BIOL CELL, V8, P1699, DOI 10.1091/mbc.8.9.1699; Grant CM, 1998, BIOCHEM BIOPH RES CO, V253, P893, DOI 10.1006/bbrc.1998.9864; Grant CM, 1996, CURR GENET, V29, P511, DOI 10.1007/BF02426954; Grant CM, 1996, MOL MICROBIOL, V21, P171, DOI 10.1046/j.1365-2958.1996.6351340.x; Grant CM, 2000, BBA-GENE STRUCT EXPR, V1490, P33, DOI 10.1016/S0167-4781(99)00234-1; Herrero E, 2007, CELL MOL LIFE SCI, V64, P1518, DOI 10.1007/s00018-007-6554-8; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; HOLMGREN A, 1995, METHOD ENZYMOL, V252, P199; HOLMGREN A, 1989, J BIOL CHEM, V264, P13963; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; Inoue Y, 1998, BBA-GENE STRUCT EXPR, V1395, P315, DOI 10.1016/S0167-4781(97)00199-1; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; IZAWA S, 1995, FEBS LETT, V368, P73, DOI 10.1016/0014-5793(95)00603-7; Izquierdo A, 2008, EUKARYOT CELL, V7, P1415, DOI 10.1128/EC.00133-08; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Johansson C, 2004, J BIOL CHEM, V279, P7537, DOI 10.1074/jbc.M312719200; Kanzok SM, 2001, SCIENCE, V291, P643, DOI 10.1126/science.291.5504.643; Kanzok SM, 2000, J BIOL CHEM, V275, P40180, DOI 10.1074/jbc.M007633200; KUGE S, 1994, EMBO J, V13, P655, DOI 10.1002/j.1460-2075.1994.tb06304.x; Luikenhuis S, 1998, MOL BIOL CELL, V9, P1081, DOI 10.1091/mbc.9.5.1081; Machado AK, 1997, J BIOL CHEM, V272, P17045, DOI 10.1074/jbc.272.27.17045; Marty L, 2009, P NATL ACAD SCI USA, V106, P9109, DOI 10.1073/pnas.0900206106; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; Mesecke N, 2008, MOL BIOL CELL, V19, P2673, DOI 10.1091/mbc.E07-09-0896; Muhlenhoff U, 2003, EMBO J, V22, P4815, DOI 10.1093/emboj/cdg446; Mukhopadhyay R, 2000, J BIOL CHEM, V275, P21149, DOI 10.1074/jbc.M910401199; MULLER EGD, 1991, J BIOL CHEM, V266, P9194; Muller EGD, 1996, MOL BIOL CELL, V7, P1805, DOI 10.1091/mbc.7.11.1805; Ng CH, 2008, FREE RADICAL BIO MED, V44, P1131, DOI 10.1016/j.freeradbiomed.2007.12.008; OHTAKE Y, 1991, YEAST, V7, P953, DOI 10.1002/yea.320070907; Ojeda L, 2006, J BIOL CHEM, V281, P17661, DOI 10.1074/jbc.M602165200; Pearson GD, 1998, J BIOL CHEM, V273, P5431, DOI 10.1074/jbc.273.10.5431; Perrone GG, 2008, BBA-MOL CELL RES, V1783, P1354, DOI 10.1016/j.bbamcr.2008.01.023; Perrone GG, 2005, MOL BIOL CELL, V16, P218, DOI 10.1091/mbc.E04-07-0560; Pujol-Carrion N, 2006, J CELL SCI, V119, P4554, DOI 10.1242/jcs.03229; Rietsch A, 1998, ANNU REV GENET, V32, P163, DOI 10.1146/annurev.genet.32.1.163; Rodriguez-Manzaneque MT, 2002, MOL BIOL CELL, V13, P1109, DOI 10.1091/mbc.01-10-0517; ROSE M, 1983, METHOD ENZYMOL, V101, P167; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Stephen DWS, 1996, FEMS MICROBIOL LETT, V141, P207, DOI 10.1111/j.1574-6968.1996.tb08386.x; Tamarit J, 2003, J BIOL CHEM, V278, P25745, DOI 10.1074/jbc.M303477200; Tan SX, 2009, MOL BIOL CELL, V20, P1493, DOI 10.1091/mbc.E08-07-0697; Trotter EW, 2003, EMBO REP, V4, P184, DOI 10.1038/sj.embor.embor729; Trotter EW, 2002, MOL MICROBIOL, V46, P869, DOI 10.1046/j.1365-2958.2002.03216.x; VANDEPUTTE C, 1994, CELL BIOL TOXICOL, V10, P415, DOI 10.1007/BF00755791; WHEALS AE, 1982, MOL CELL BIOL, V2, P361, DOI 10.1128/MCB.2.4.361; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901	54	71	74	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6118	6126		10.1074/jbc.M109.062844	http://dx.doi.org/10.1074/jbc.M109.062844			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	19951944	Green Published, hybrid			2022-12-25	WOS:000275367500015
J	Chatterjee, A; Wang, L; Armstrong, DL; Rossie, S				Chatterjee, Anindya; Wang, Ling; Armstrong, David L.; Rossie, Sandra			Activated Rac1 GTPase Translocates Protein Phosphatase 5 to the Cell Membrane and Stimulates Phosphatase Activity in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TETRATRICOPEPTIDE REPEAT DOMAIN; HUMAN BREAST-CANCER; SERINE/THREONINE PHOSPHATASE; EPITHELIAL-CELLS; RHO-GTPASES; TPR DOMAIN; NUCLEAR-LOCALIZATION; CARDIAC-ARRHYTHMIA; TERMINAL REGION; MOLECULAR-BASIS	Physiological studies of ion channel regulation have implicated the Ser/Thr protein phosphatase 5 (PP5) as an effector of Rac1 GTPase signaling, but direct biochemical evidence for PP5 regulation by Rac1 is lacking. In this study we used immunoprecipitation, in vitro binding, cellular fractionation, and immunofluorescence techniques to show that the tetratricopeptide repeat domain of PP5 interacts specifically and directly with active Rac1. Consequently, activation of Rac1 promoted PP5 translocation to the plasma membrane in intact cells and stimulated PP5 phosphatase activity in vitro. In contrast, neither constitutively active RhoA-V14 nor dominant negative Rac1N17, which preferentially binds GDP and retains an inactive conformation, bound PP5 or stimulated its activity. In addition, Rac1N17 and Rac1(PBRM), a mutant lacking the C-terminal polybasic region required for Rac1 association with the membrane, both failed to cause membrane translocation of PP5. Mutation of predicted contact residues in the PP5 tetratricopeptide repeat domain or within Rac1 also disrupted co-immunoprecipitation of Rac1-PP5 complexes and membrane translocation of PP5. Specific binding of PP5 to activated Rac1 provides a direct mechanism by which PP5 can be stimulated and recruited to participate in Rac1-mediated signaling pathways.	[Chatterjee, Anindya; Wang, Ling; Rossie, Sandra] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA; [Chatterjee, Anindya; Wang, Ling; Rossie, Sandra] Purdue Univ, Ctr Canc Res, W Lafayette, IN 47907 USA; [Armstrong, David L.] NIEHS, Environm Biol Program, NIH, Dept Hlth & Human Serv, Res Triangle Pk, NC 27709 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Rossie, S (corresponding author), Purdue Univ, Dept Biochem, 175 S Univ St, W Lafayette, IN 47907 USA.	rossie@purdue.edu			National Institutes of Health [NS031221, NCI-2P30CA23168]; National Institutes of Health Intramural Research Program at NIEHS [Z01-ES080043]; NATIONAL CANCER INSTITUTE [P30CA023168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES080043, ZIAES102285] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS031221, R29NS031221] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Intramural Research Program at NIEHS; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS031221 (to S.R.). This work was also supported in part by Purdue Cancer Center NCI Core Grant NCI-2P30CA23168 from the National Institutes of Health and the National Institutes of Health Intramural Research Program at NIEHS through Grant Z01-ES080043 (to D. L. A.).	ABO A, 1991, NATURE, V353, P668, DOI 10.1038/353668a0; Bahl R, 2001, MOL BRAIN RES, V90, P101, DOI 10.1016/S0169-328X(01)00089-4; BECKER W, 1994, J BIOL CHEM, V269, P22586; Borthwick EB, 2001, FEBS LETT, V491, P279, DOI 10.1016/S0014-5793(01)02177-9; Bustelo XR, 2007, BIOESSAYS, V29, P356, DOI 10.1002/bies.20558; Chae YC, 2008, MOL BIOL CELL, V19, P3111, DOI 10.1091/mbc.E07-04-0337; CHEN MX, 1994, EMBO J, V13, P4278, DOI 10.1002/j.1460-2075.1994.tb06748.x; Chen MX, 1997, FEBS LETT, V400, P136, DOI 10.1016/S0014-5793(96)01427-5; CHINKERS M, 1994, P NATL ACAD SCI USA, V91, P11075, DOI 10.1073/pnas.91.23.11075; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; Das AK, 1998, EMBO J, V17, P1192, DOI 10.1093/emboj/17.5.1192; Del Pozo MA, 2002, NAT CELL BIOL, V4, P232, DOI 10.1038/ncb759; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; DIEKMANN D, 1994, SCIENCE, V265, P531, DOI 10.1126/science.8036496; Du J, 2004, J NEUROSCI, V24, P6578, DOI 10.1523/JNEUROSCI.1258-04.2004; Egloff MP, 1997, EMBO J, V16, P1876, DOI 10.1093/emboj/16.8.1876; FARNSWORTH CL, 1991, MOL CELL BIOL, V11, P4822, DOI 10.1128/MCB.11.10.4822; Fritz G, 1999, INT J CANCER, V81, P682, DOI 10.1002/(SICI)1097-0215(19990531)81:5<682::AID-IJC2>3.0.CO;2-B; Gentile S, 2006, P NATL ACAD SCI USA, V103, P5202, DOI 10.1073/pnas.0600080103; Gentile S, 2008, P NATL ACAD SCI USA, V105, P14704, DOI 10.1073/pnas.0802250105; Golden T, 2008, CANCER METAST REV, V27, P169, DOI 10.1007/s10555-008-9125-z; Golden T, 2008, BBA-MOL BASIS DIS, V1782, P259, DOI 10.1016/j.bbadis.2008.01.004; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; HAWKINS PT, 1995, CURR BIOL, V5, P393, DOI 10.1016/S0960-9822(95)00080-7; Hewett JW, 2007, P NATL ACAD SCI USA, V104, P7271, DOI 10.1073/pnas.0701185104; Hinds TD, 2008, INT J BIOCHEM CELL B, V40, P2358, DOI 10.1016/j.biocel.2007.08.010; Kreck ML, 1996, BIOCHEMISTRY-US, V35, P15683, DOI 10.1021/bi962064l; Kuhn TB, 1998, J NEUROBIOL, V37, P524, DOI 10.1002/(SICI)1097-4695(199812)37:4<524::AID-NEU3>3.0.CO;2-H; Lapouge K, 2000, MOL CELL, V6, P899, DOI 10.1016/S1097-2765(00)00087-3; Manser Edward J, 2002, Methods Mol Biol, V189, P3; Messner DJ, 2006, J CELL BIOCHEM, V99, P241, DOI 10.1002/jcb.20919; Moissoglu K, 2006, MOL BIOL CELL, V17, P2770, DOI 10.1091/mbc.E06-01-0005; Morita K, 2001, EMBO J, V20, P6028, DOI 10.1093/emboj/20.21.6028; Nawshad A, 2007, J CELL SCI, V120, P1646, DOI 10.1242/jcs.003129; Ni L, 2007, ASSAY DRUG DEV TECHN, V5, P645, DOI 10.1089/adt.2007.079; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; Patil S, 2004, AM J PHYSIOL-LUNG C, V287, pL1314, DOI 10.1152/ajplung.00383.2003; Russell LC, 1999, J BIOL CHEM, V274, P20060, DOI 10.1074/jbc.274.29.20060; Sanchez-Ortiz E, 2009, J NEUROCHEM, V111, P391, DOI 10.1111/j.1471-4159.2009.06337.x; Sander EE, 1998, J CELL BIOL, V143, P1385, DOI 10.1083/jcb.143.5.1385; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; Schnelzer A, 2000, ONCOGENE, V19, P3013, DOI 10.1038/sj.onc.1203621; Schuster MK, 2004, BIOL REPROD, V70, P1493, DOI 10.1095/biolreprod.103.024331; Schwarz JR, 2004, J CELL MOL MED, V8, P22, DOI 10.1111/j.1582-4934.2004.tb00256.x; SELF AJ, 1995, METHOD ENZYMOL, V256, P3; Sinclair C, 1999, J BIOL CHEM, V274, P23666, DOI 10.1074/jbc.274.33.23666; Skinner J, 1997, J BIOL CHEM, V272, P22464, DOI 10.1074/jbc.272.36.22464; STACEY DW, 1991, MOL CELL BIOL, V11, P4053, DOI 10.1128/MCB.11.8.4053; Storey NM, 2002, CURR BIOL, V12, P27, DOI 10.1016/S0960-9822(01)00625-X; Syriani E, 2008, FASEB J, V22, P1581, DOI 10.1096/fj.06-7654com; van Horck FPG, 2001, J BIOL CHEM, V276, P4948, DOI 10.1074/jbc.M003839200; Wennerberg K, 2004, J CELL SCI, V117, P1301, DOI 10.1242/jcs.01118; Williams CL, 2003, CELL SIGNAL, V15, P1071, DOI 10.1016/S0898-6568(03)00098-6; Yamaguchi Y, 2002, CURR BIOL, V12, P1353, DOI 10.1016/S0960-9822(02)01034-5; Yang J, 2005, EMBO J, V24, P1, DOI 10.1038/sj.emboj.7600496; Yang WL, 2009, SCIENCE, V325, P1134, DOI 10.1126/science.1175065; Zhao ZS, 2005, BIOCHEM J, V386, P201, DOI 10.1042/BJ20041638	57	15	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3872	3882		10.1074/jbc.M109.088427	http://dx.doi.org/10.1074/jbc.M109.088427			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19948726	hybrid, Green Published			2022-12-25	WOS:000275254000041
J	Jang, ER; Ryu, M; Park, JE; Kim, JH; Lee, JS; Song, K				Jang, Eun Ryoung; Ryu, Minsook; Park, Jeong Eun; Kim, Jung-Ho; Lee, Jong-Soo; Song, Kiwon			A New Isoquinolinium Derivative, Cadein1, Preferentially Induces Apoptosis in p53-defective Cancer Cells with Functional Mismatch Repair via a p38-dependent Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE PATHWAY; COLON-CANCER; MICROSATELLITE INSTABILITY; METHYLATING AGENTS; DNA METHYLATION; G(2) CHECKPOINT; CARCINOMA-CELLS; DEFICIENT CELLS; CYCLE ARREST; G2/M ARREST	We screened a protoberberine backbone derivative library for compounds with anti-proliferative effects on p53-defective cancer cells. A compound identified from this small molecule library, cadein1 (cancer-selective death inducer 1), an isoquinolinium derivative, effectively leads to a G(2)/M delay and caspase-dependent apoptosis in various carcinoma cells with nonfunctional p53. The ability of cadein1 to induce apoptosis in p53-defective colon cancer cells was tightly linked to the presence of a functional DNA mismatch repair(MMR) system, which is an important determinant in chemosensitivity. Cadein1 was very effective in MMR+/p53(-) cells, whereas it was not effective in p53(+) cells regardless of the MMR status. Consistently, when the function of MMR was blocked with short hairpin RNA in SW620 (MMR+/p53(-)) cells, cadein1 was no longer effective in inducing apoptosis. Besides, the inhibition of p53 increased the pro-apoptotic effect of cadein1 in HEK293(MMR+/p53(+)) cells, whereas it did not affect the response to cadein1 in RKO (MMR-/p53(+)) cells. The apoptotic effects of cadein1 depended on the activation of p38 but not on the activation of Chk2 or other stress-activated kinases in p53-defective cells. Taken together, our results show that cadein1 may have a potential to be an anticancer chemotherapeutic agent that is preferentially effective on p53-mutant colon cancer cells with functional MMR.	[Jang, Eun Ryoung; Park, Jeong Eun; Song, Kiwon] Yonsei Univ, Dept Biochem, Coll Life Sci & Biotechnol, Seoul 120749, South Korea; [Ryu, Minsook; Lee, Jong-Soo] Ajou Univ, Dept Mol Sci & Technol, Coll Nat Sci, Suwon 443749, South Korea; [Kim, Jung-Ho] Hanwha Chem Res & Dev Ctr, Taejon 305345, South Korea	Yonsei University; Ajou University	Song, K (corresponding author), Yonsei Univ, Dept Biochem, Coll Life Sci & Biotechnol, Seoul 120749, South Korea.	bc5012@yonsei.ac.kr			National Research and Development; Ministry of Health and Welfare, Republic of Korea [NCCR-0920300]; Korea Health Industry Development Institute [B05-0016-AM0815-07A3-00030B]; Korean Government Ministry of Education (Ministry of Education and Human Resources Development) [KRF-2006-8-1284]	National Research and Development; Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Korea Health Industry Development Institute(Korea Health Industry Development Institute (KHIDI)); Korean Government Ministry of Education (Ministry of Education and Human Resources Development)(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	This work was supported by National Research and Development Program for Cancer Control, Ministry of Health and Welfare, Republic of Korea Grant NCCR-0920300 and in part by Korea Health Industry Development Institute (Grant B05-0016-AM0815-07A3-00030B).; Supported by Korea Research Foundation Grant KRF-2006-8-1284 funded by the Korean Government Ministry of Education (Ministry of Education and Human Resources Development).	BOYER JC, 1995, CANCER RES, V55, P6063; Brown KD, 2003, NAT GENET, V33, P80, DOI 10.1038/ng1052; Cejka P, 2003, EMBO J, V22, P2245, DOI 10.1093/emboj/cdg216; Corazzari M, 2005, BIOCHEM BIOPH RES CO, V331, P810, DOI 10.1016/j.bbrc.2005.03.184; Craig WJ, 1997, J AM DIET ASSOC, V97, pS199, DOI 10.1016/S0002-8223(97)00765-7; Craig WJ, 1999, AM J CLIN NUTR, V70, p491S, DOI 10.1093/ajcn/70.3.491s; El-Deiry WS, 2003, ONCOGENE, V22, P7486, DOI 10.1038/sj.onc.1206949; Fink D, 1996, CANCER RES, V56, P4881; FISHEL R, 1995, CURR OPIN GENET DEV, V5, P382, DOI 10.1016/0959-437X(95)80055-7; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; Franchitto A, 2003, ONCOGENE, V22, P2110, DOI 10.1038/sj.onc.1206254; Fuster JJ, 2007, TRENDS MOL MED, V13, P192, DOI 10.1016/j.molmed.2007.03.002; GRIFFIN S, 1994, BIOCHEMISTRY-US, V33, P4787, DOI 10.1021/bi00182a006; Gudkov AV, 2003, CANCER BIOL THER, V2, P444, DOI 10.4161/cbt.2.4.480; Hickman MJ, 1999, P NATL ACAD SCI USA, V96, P10764, DOI 10.1073/pnas.96.19.10764; Hirose Y, 2003, MOL CELL BIOL, V23, P8306, DOI 10.1128/MCB.23.22.8306-8315.2003; Hsu WH, 2007, ARCH TOXICOL, V81, P719, DOI 10.1007/s00204-006-0169-y; Hsu YL, 2005, J PHARMACOL EXP THER, V313, P333, DOI 10.1124/jpet.104.078808; Iizuka N, 2003, INT J CANCER, V107, P666, DOI 10.1002/ijc.11452; KAT A, 1993, P NATL ACAD SCI USA, V90, P6424, DOI 10.1073/pnas.90.14.6424; Kim HJ, 2006, CHEM BIOL, V13, P881, DOI 10.1016/j.chembiol.2006.06.012; KOI M, 1994, CANCER RES, V54, P4308; Levesque AA, 2007, CARCINOGENESIS, V28, P13, DOI 10.1093/carcin/bgl214; Li Y, 2007, ONCOGENE, V26, P2220, DOI 10.1038/sj.onc.1210311; Lin XJ, 2001, CANCER RES, V61, P1508; Lioni M, 2008, MOL CANCER THER, V7, P2866, DOI 10.1158/1535-7163.MCT-08-0391; Liu LL, 1996, CANCER RES, V56, P5375; LOWE SW, 1993, CELL, V74, P957, DOI 10.1016/0092-8674(93)90719-7; Mikhailov A, 2004, J CELL BIOL, V166, P517, DOI 10.1083/jcb.200405167; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nehme A, 1999, BRIT J CANCER, V79, P1104, DOI 10.1038/sj.bjc.6690176; Nehme A, 1997, CANCER RES, V57, P3253; Orfila L, 2000, J ETHNOPHARMACOL, V71, P449, DOI 10.1016/S0378-8741(00)00177-X; PAPADOPOULOS N, 1994, SCIENCE, V263, P1625, DOI 10.1126/science.8128251; Reinhardt HC, 2007, CANCER CELL, V11, P175, DOI 10.1016/j.ccr.2006.11.024; SAYA H, 2007, 19 FED AS OC BIOCH M; STEIN GS, 1972, J CELL BIOL, V52, P292, DOI 10.1083/jcb.52.2.292; Stojic L, 2004, GENE DEV, V18, P1331, DOI 10.1101/gad.294404; Wahl AF, 1996, NAT MED, V2, P72, DOI 10.1038/nm0196-72; Wang Y, 2003, P NATL ACAD SCI USA, V100, P15387, DOI 10.1073/pnas.2536810100; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Weinstein JN, 1997, SCIENCE, V275, P343, DOI 10.1126/science.275.5298.343; Yamane K, 2004, BIOCHEM BIOPH RES CO, V318, P297, DOI 10.1016/j.bbrc.2004.04.030; Zhuang SG, 2000, J BIOL CHEM, V275, P25939, DOI 10.1074/jbc.M001185200	44	7	7	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5							2986	10.1074/jbc.M109.070466	http://dx.doi.org/10.1074/jbc.M109.070466			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19948725	Green Published, hybrid			2022-12-25	WOS:000273829000013
J	Qian, Y; Lee, I; Lee, WS; Qian, MQ; Kudo, M; Canfield, WM; Lobel, P; Kornfeld, S				Qian, Yi; Lee, Intaek; Lee, Wang-Sik; Qian, Meiqian; Kudo, Mariko; Canfield, William M.; Lobel, Peter; Kornfeld, Stuart			Functions of the alpha, beta, and gamma Subunits of UDP-GlcNAc:Lysosomal Enzyme N-Acetylglucosamine-1-phosphotransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANNOSE 6-PHOSPHATE RECEPTORS; NEURONAL CEROID-LIPOFUSCINOSIS; ASN-LINKED OLIGOSACCHARIDES; PSEUDO-HURLER POLYDYSTROPHY; SITE-DIRECTED MUTAGENESIS; LYSINE-BASED STRUCTURE; LYSOSOMAL-ENZYME; N-ACETYLGLUCOSAMINE; CATHEPSIN-D; DNASE I	UDP-GlcNAc:lysosomal enzyme N-acetylglucosamine-1-phosphotransferase is an alpha(2)beta(2)gamma(2) hexamer that mediates the first step in the synthesis of the mannose 6-phosphate recognition marker on lysosomal acid hydrolases. Using a multifaceted approach, including analysis of acid hydrolase phosphorylation in mice and fibroblasts lacking the gamma subunit along with kinetic studies of recombinant alpha(2)beta(2)gamma(2) and alpha(2)beta(2) forms of the transferase, we have explored the function of the alpha/beta and gamma subunits. The findings demonstrate that the alpha/beta subunits recognize the protein determinant of acid hydrolases in addition to mediating the catalytic function of the transferase. In mouse brain, the alpha/beta subunits phosphorylate about one-third of the acid hydrolases at close to wild-type levels but require the gamma subunit for optimal phosphorylation of the rest of the acid hydrolases. In addition to enhancing the activity of the alpha/beta subunits toward a subset of the acid hydrolases, the gamma subunit facilitates the addition of the second GlcNAc-P to high mannose oligosaccharides of these substrates. We postulate that the mannose 6-phosphate receptor homology domain of the gamma subunit binds and presents the high mannose glycans of the acceptor to the alpha/beta catalytic site in a favorable manner.	[Kornfeld, Stuart] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; [Kudo, Mariko; Kornfeld, Stuart] Univ Med & Dent New Jersey, Ctr Adv Biotechnol & Med, Piscataway, NJ 08851 USA; [Qian, Meiqian; Lobel, Peter] Univ Med & Dent New Jersey, Dept Pharmacol, Piscataway, NJ 08851 USA; [Canfield, William M.; Lobel, Peter] Genzyme Corp, Oklahoma City, OK 73104 USA	Washington University (WUSTL); Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Sanofi-Aventis; Genzyme Corporation	Kornfeld, S (corresponding author), Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA.	skornfel@dom.wustl.edu		Lee, Intaek/0000-0003-1084-674X	National Institutes of Health [CA08759, DK054317]; NATIONAL CANCER INSTITUTE [R01CA008759, R37CA008759] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR017992] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054317] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants CA08759 (to S. K.) and DK054317 (to P. L.).	Bao M, 1996, J BIOL CHEM, V271, P31437, DOI 10.1074/jbc.271.49.31437; BARANSKI TJ, 1990, CELL, V63, P281, DOI 10.1016/0092-8674(90)90161-7; Bargal R, 2007, MOL GENET METAB, V91, P299, DOI 10.1016/j.ymgme.2007.04.007; Bargal R, 2006, MOL GENET METAB, V88, P359, DOI 10.1016/j.ymgme.2006.03.003; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Braulke T, 2009, BBA-MOL CELL RES, V1793, P605, DOI 10.1016/j.bbamcr.2008.10.016; Cacia J, 1998, BIOCHEMISTRY-US, V37, P15154, DOI 10.1021/bi981465t; CANTOR AB, 1992, J BIOL CHEM, V267, P23357; CATHEY SS, 2009, J MED GENET IN PRESS; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; CUOZZO JW, 1994, J BIOL CHEM, V269, P14490; Cuozzo JW, 1998, J BIOL CHEM, V273, P21067, DOI 10.1074/jbc.273.33.21067; CUOZZO JW, 1995, J BIOL CHEM, V270, P15611, DOI 10.1074/jbc.270.26.15611; Dittmer F, 1997, J BIOL CHEM, V272, P852, DOI 10.1074/jbc.272.2.852; DUBOIS M, 1956, ANAL CHEM, V28, P356; DUSTIN ML, 1995, J BIOL CHEM, V270, P170, DOI 10.1074/jbc.270.1.170; Gelfman CM, 2007, INVEST OPHTH VIS SCI, V48, P5221, DOI 10.1167/iovs.07-0452; GOLDBERG DE, 1981, J BIOL CHEM, V256, P3060; KORNFELD S, 2000, METABOLIC MOL BASES, P3469; Kudo M, 2006, J BIOL CHEM, V281, P11761, DOI 10.1074/jbc.M513717200; Kudo M, 2005, J BIOL CHEM, V280, P36141, DOI 10.1074/jbc.m509008200; LANG L, 1984, J BIOL CHEM, V259, P4663; LANG L, 1985, J CLIN INVEST, V76, P2191, DOI 10.1172/JCI112227; LAZZARINO DA, 1988, J BIOL CHEM, V263, P10118; Lee WS, 2007, J BIOL CHEM, V282, P27198, DOI 10.1074/jbc.M704067200; Lin L, 2001, BIOCHEM J, V357, P49, DOI 10.1042/0264-6021:3570049; Liou HL, 2006, J BIOL CHEM, V281, P36710, DOI 10.1074/jbc.M608743200; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Lubke T, 2009, BBA-MOL CELL RES, V1793, P625, DOI 10.1016/j.bbamcr.2008.09.018; Munro S, 2001, CURR BIOL, V11, pR499, DOI 10.1016/S0960-9822(01)00302-5; Nishikawa A, 1999, J BIOL CHEM, V274, P19309, DOI 10.1074/jbc.274.27.19309; Nishikawa A, 1997, J BIOL CHEM, V272, P19408, DOI 10.1074/jbc.272.31.19408; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; Qian MQ, 2008, MOL CELL PROTEOMICS, V7, P58, DOI 10.1074/mcp.M700217-MCP200; Raas-Rothschild A, 2000, J CLIN INVEST, V105, P673, DOI 10.1172/JCI5826; SHIPLEY JM, 1993, J BIOL CHEM, V268, P12193; Sleat DE, 1996, J BIOL CHEM, V271, P19191, DOI 10.1074/jbc.271.32.19191; Sohar I, 2000, CLIN CHEM, V46, P1005; SONDERFELDFRESKO S, 1989, J BIOL CHEM, V264, P7692; Steet R, 2005, J BIOL CHEM, V280, P33318, DOI 10.1074/jbc.M505994200; Stigliano ID, 2009, MOL BIOL CELL, V20, P3974, DOI 10.1091/mbc.E09-04-0316; Tiede S, 2005, NAT MED, V11, P1109, DOI 10.1038/nm1305; Tikkanen R, 1997, EMBO J, V16, P6684, DOI 10.1093/emboj/16.22.6684; VALENZANO KJ, 1993, ANAL BIOCHEM, V209, P156, DOI 10.1006/abio.1993.1096; VARKI AP, 1981, P NATL ACAD SCI-BIOL, V78, P7773, DOI 10.1073/pnas.78.12.7773; Vogel P, 2009, VET PATHOL, V46, P313, DOI 10.1354/vp.46-2-313; Warner JB, 2002, J BIOL CHEM, V277, P41897, DOI 10.1074/jbc.M203097200; Watanabe T, 2009, GLYCOBIOLOGY, V19, P834, DOI 10.1093/glycob/cwp061; WEITZ G, 1992, J BIOL CHEM, V267, P10039; Yaghootfam A, 2003, J BIOL CHEM, V278, P32653, DOI 10.1074/jbc.M304865200	50	51	55	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5					3360	3370		10.1074/jbc.M109.068650	http://dx.doi.org/10.1074/jbc.M109.068650			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19955174	Green Published, hybrid			2022-12-25	WOS:000273829000051
J	Seong, HA; Jung, H; Ichijo, H; Ha, H				Seong, Hyun-A; Jung, Haiyoung; Ichijo, Hidenori; Ha, Hyunjung			Reciprocal Negative Regulation of PDK1 and ASK1 Signaling by Direct Interaction and Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-B; FORKHEAD TRANSCRIPTION FACTOR; PROMOTES CELL-SURVIVAL; TYROSINE PHOSPHORYLATION; PHYSICAL INTERACTION; OXIDATIVE STRESS; APOPTOSIS; ACTIVATION; DEATH; IDENTIFICATION	Cell survival and death-inducing signals are tightly associated with each other, and the decision as to whether a cell survives or dies is determined by controlling the relationship between these signals. However, the mechanism underlying the reciprocal regulation of such signals remains unclear. In this study, we reveal a functional association between PDK1 (3-phosphoinositide-dependent protein kinase 1), a critical mediator of cell survival, and ASK1 (apoptosis signal-regulating kinase 1), an apoptotic stress-activated MAPKKK. The physical association between PDK1 and ASK1 is mediated through the pleckstrin homology domain of PDK1 and the C-terminal regulatory domain of ASK1 and is decreased by ASK1-activating stimuli, such as H2O2, tumor necrosis factor alpha, thapsigargin, and ionomycin, as well as insulin, a PDK1 stimulator. Wild-type PDK1, but not kinase-dead PDK1, negatively regulates ASK1 activity by phosphorylating Ser(967), a binding site for 14-3-3 protein, on ASK1. PDK1 functionally suppresses ASK1-mediated AP-1 transactivation and H2O2-mediated apoptosis in a kinase-dependent manner. On the other hand, ASK1 has been shown to inhibit PDK1 functions, including PDK1-mediated regulation of apoptosis and cell growth, by phosphorylating PDK1 at Ser(394) and Ser(398), indicating that these putative phosphorylation sites are involved in the negative regulation of PDK1 activity. These results provide evidence that PDK1 and ASK1 directly interact and phosphorylate each other and act as negative regulators of their respective kinases in resting cells.	[Seong, Hyun-A; Jung, Haiyoung; Ha, Hyunjung] Chungbuk Natl Univ, Sch Life Sci, Biotechnol Res Inst, Dept Biochem, Cheongju 361763, South Korea; [Ichijo, Hidenori] Univ Tokyo, Japan Sci & Technol Corp, Global Ctr Excellence Program, Grad Sch Pharmaceut Sci,Lab Cell Signaling,Bunkyo, Tokyo 1130033, Japan	Chungbuk National University; Japan Science & Technology Agency (JST); University of Tokyo	Ha, H (corresponding author), Chungbuk Natl Univ, Sch Life Sci, Biotechnol Res Inst, Dept Biochem, Cheongju 361763, South Korea.	hyunha@chungbuk.ac.kr		Ichijo, Hidenori/0000-0002-5005-6438	Korea Science and Engineering Foundation [R0A-2007-000-20006-0]	Korea Science and Engineering Foundation(Korea Science and Engineering Foundation)	This work was supported by Korea Science and Engineering Foundation Grant R0A-2007-000-20006-0.	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Casamayor A, 1999, BIOCHEM J, V342, P287, DOI 10.1042/0264-6021:3420287; Chang HY, 1998, SCIENCE, V281, P1860, DOI 10.1126/science.281.5384.1860; Chen J, 2001, P NATL ACAD SCI USA, V98, P7783, DOI 10.1073/pnas.141224398; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; DEL PL, 1997, SCIENCE, V278, P687; Fayard E, 2005, J CELL SCI, V118, P5675, DOI 10.1242/jcs.02724; Fujii K, 2004, ONCOGENE, V23, P5099, DOI 10.1038/sj.onc.1207668; Gil M, 1997, GENE, V195, P295, DOI 10.1016/S0378-1119(97)00181-9; Grillo S, 2000, EUR J BIOCHEM, V267, P6642, DOI 10.1046/j.1432-1327.2000.01759.x; Hatai T, 2000, J BIOL CHEM, V275, P26576, DOI 10.1074/jbc.M003412200; Hetman M, 2000, J NEUROSCI, V20, P2567; Hinton HJ, 2004, NAT IMMUNOL, V5, P539, DOI 10.1038/ni1062; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Jung HY, 2007, J BIOL CHEM, V282, P35293, DOI 10.1074/jbc.M705181200; Jung H, 2008, J BIOL CHEM, V283, P34541, DOI 10.1074/jbc.M807219200; Kikani CK, 2005, J CELL BIOCHEM, V96, P1157, DOI 10.1002/jcb.20651; Kim AH, 2001, MOL CELL BIOL, V21, P893, DOI 10.1128/MCB.21.3.893-901.2001; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Liu H, 2000, MOL CELL BIOL, V20, P2198, DOI 10.1128/MCB.20.6.2198-2208.2000; Mora A, 2004, SEMIN CELL DEV BIOL, V15, P161, DOI 10.1016/j.semcdb.2003.12.022; Morita K, 2001, EMBO J, V20, P6028, DOI 10.1093/emboj/20.21.6028; Ouyang MX, 2006, J NEUROCHEM, V97, P234, DOI 10.1111/j.1471-4159.2006.03730.x; Park HS, 2002, MOL CELL BIOL, V22, P7721, DOI 10.1128/MCB.22.22.7721-7730.2002; Park J, 2001, J BIOL CHEM, V276, P37459, DOI 10.1074/jbc.M105916200; Patel T, 1996, FASEB J, V10, P587, DOI 10.1096/fasebj.10.5.8621058; Prasad N, 2000, BIOCHEMISTRY-US, V39, P6929, DOI 10.1021/bi000387i; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Seong HA, 2005, J BIOL CHEM, V280, P42897, DOI 10.1074/jbc.M507539200; Seong HA, 2007, J BIOL CHEM, V282, P12272, DOI 10.1074/jbc.M609279200; Song JJ, 2002, J BIOL CHEM, V277, P46566, DOI 10.1074/jbc.M206826200; Takeda K, 2007, J BIOL CHEM, V282, P7522, DOI 10.1074/jbc.M607177200; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Zhang LX, 1999, P NATL ACAD SCI USA, V96, P8511, DOI 10.1073/pnas.96.15.8511	37	26	28	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2397	2414		10.1074/jbc.M109.064295	http://dx.doi.org/10.1074/jbc.M109.064295			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19920149	Green Published, hybrid			2022-12-25	WOS:000273697800020
J	Shao, HS; Wu, CY; Wells, A				Shao, Hanshuang; Wu, Chuanyue; Wells, Alan			Phosphorylation of alpha-Actinin 4 upon Epidermal Growth Factor Exposure Regulates Its Interaction with Actin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; BINDING DOMAIN; CELL MOTILITY; PHOSPHOINOSITIDE BINDING; SIGNALING PATHWAY; CALPAIN PROTEASES; CRYSTAL-STRUCTURE; ALPHA-ACTININ-4; MECHANISM; MIGRATION	The ubiquitously expressed family of alpha-actinins bridges actin filaments to stabilize adhesions, a process disrupted during growth factor-induced migration of cells. During the dissolution of the actin cytoskeleton, actinins are phosphorylated on tyrosines, although the consequences of this are unknown. We expressed the two isoforms of human alpha-actinin in murine fibroblasts that express human epidermal growth factor receptor (EGFR) and found that both alpha-actinin 1 (ACTN1) and alpha-actinin 4 (ACTN4) were phosphorylated on tyrosine residues after stimulation with EGF, although ACTN4 was phosphorylated to the greater extent. This required the activation of Src protein-tyrosine kinase and p38-MAPK (and phosphoinositide trisphosphate kinase in part) but not MEK/ERK or Rac1, as determined by inhibitors. The EGF-induced phosphorylation sites of ACTN4 were mapped to tyrosine 4, the major site, and tyrosine 31, the minor one. Truncation mutagenesis showed that the C-terminal domains of ACTN4 (amino acids 300 - 911), which cross-link the actin binding head domains, act as an inhibitory domain for both actin binding and EGF-mediated phosphorylation. These two properties were mutually exclusive; removal of the C terminus enhanced actin binding of ACTN4 mutants while limiting EGF-induced phosphorylation, and conversely EGF-stimulated phosphorylation of ACTN4 decreased its affinity to actin. Interestingly, a phosphomimetic of tyrosine 265 (which can be found in carcinoma cells and lies near the K255E mutation that causes focal segmental glomerulosclerosis) demonstrated increased actin binding activity and susceptibility of ACTN4 to calpain-mediated cleavage; this variant also retarded cell spreading. Remarkably, either treatment of cells with low concentrations of latrunculin A, which has been shown to depolymerize F-actin, or the deletion of the actin binding domain (100 - 252 amino acids) of ACTN4Y265E restored EGF-induced phosphorylation. An F-actin binding assay in vitro showed that Y4E/Y31E, a mimetic of diphosphorylated ACTN4, bound F-actin slightly compared with wild type (WT). Importantly, the EGF-mediated phosphorylation of ACTN4 at tyrosine 4 and 31 significantly inhibited multinucleation of proliferating NR6WT fibroblasts that overexpress ACTN4. These results suggest that EGF regulates the actin binding activity of ACTN4 by inducing tyrosyl-directed phosphorylation.	[Shao, Hanshuang; Wu, Chuanyue; Wells, Alan] Univ Pittsburgh, Dept Pathol, Sch Med, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wells, A (corresponding author), Univ Pittsburgh, Dept Pathol, Sch Med, 713 Scaife, Pittsburgh, PA 15261 USA.	wellsa@upmc.edu		Wells, Alan/0000-0002-1637-8150	National Institutes of Health NIGMS; NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054639] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065188, R01GM069668] Funding Source: NIH RePORTER	National Institutes of Health NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by grants from the National Institutes of Health NIGMS and NIDDK.	BECKERLE MC, 1987, CELL, V51, P569, DOI 10.1016/0092-8674(87)90126-7; Choi CK, 2008, NAT CELL BIOL, V10, P1039, DOI 10.1038/ncb1763; Chou J, 2003, EXP CELL RES, V287, P47, DOI 10.1016/S0014-4827(03)00119-8; Dandapani SV, 2007, J BIOL CHEM, V282, P467, DOI 10.1074/jbc.M605024200; Fraley TS, 2005, J BIOL CHEM, V280, P15479, DOI 10.1074/jbc.M500631200; Glading A, 2000, J BIOL CHEM, V275, P2390, DOI 10.1074/jbc.275.4.2390; Glading A, 2002, TRENDS CELL BIOL, V12, P46, DOI 10.1016/S0962-8924(01)02179-1; HEMMINGS L, 1992, J CELL BIOL, V116, P1369, DOI 10.1083/jcb.116.6.1369; Izaguirre G, 2001, J BIOL CHEM, V276, P28676, DOI 10.1074/jbc.M101678200; Lee SH, 2008, J MOL BIOL, V376, P317, DOI 10.1016/j.jmb.2007.11.084; Mukhina S, 2007, DEV CELL, V13, P554, DOI 10.1016/j.devcel.2007.08.003; Otey CA, 2004, CELL MOTIL CYTOSKEL, V58, P104, DOI 10.1002/cm.20007; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Selliah N, 1996, J IMMUNOL, V156, P3215; Sprague CR, 2008, J BIOL CHEM, V283, P9217, DOI 10.1074/jbc.M707436200; Weins A, 2007, P NATL ACAD SCI USA, V104, P16080, DOI 10.1073/pnas.0702451104; Wells A, 2000, ADV CANCER RES, V78, P31; Wells A, 2005, INT REV CYTOL, V245, P1, DOI 10.1016/S0074-7696(05)45001-9; Xie H, 1998, J CELL SCI, V111, P615; Ylanne J, 2001, STRUCTURE, V9, P597, DOI 10.1016/S0969-2126(01)00619-0; Zhang ZY, 2006, J BIOL CHEM, V281, P1746, DOI 10.1074/jbc.M509590200	23	52	52	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2591	2600		10.1074/jbc.M109.035790	http://dx.doi.org/10.1074/jbc.M109.035790			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19920151	Green Published, hybrid			2022-12-25	WOS:000273697800038
J	Yan, LP; Holleran, BJ; Lavigne, P; Escher, E; Guillemette, G; Leduc, R				Yan, Liping; Holleran, Brian J.; Lavigne, Pierre; Escher, Emanuel; Guillemette, Gaetan; Leduc, Richard			Analysis of Transmembrane Domains 1 and 4 of the Human Angiotensin II AT(1) Receptor by Cysteine-scanning Mutagenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; BETA(2) ADRENERGIC-RECEPTOR; SITE-DIRECTED MUTAGENESIS; LIGAND-BINDING POCKET; TYPE-1 RECEPTOR; CONSTITUTIVE ACTIVATION; ACCESSIBILITY METHOD; CRYSTAL-STRUCTURE; CONFORMATIONAL-CHANGES; IDENTIFICATION	The octapeptide hormone angiotensin II (AngII) exerts a wide variety of cardiovascular effects through the activation of the AT(1) receptor, which belongs to the G protein-coupled receptor superfamily. Like other G protein-coupled receptors, the AT(1) receptor possesses seven transmembrane domains that provide structural support for the formation of the ligand- binding pocket. Here, we investigated the role of the first and fourth transmembrane domains (TMDs) in the formation of the binding pocket of the human AT(1) receptor using the substituted-cysteine accessibility method. Each residue within the Phe-28((1.32))-Ile-53((1.57)) fragment of TMD1 and Leu-143((4.40))-Phe-170((4.67)) fragment of TMD4 was mutated, one at a time, to a cysteine. The resulting mutant receptors were expressed in COS-7 cells, which were subsequently treated with the charged sulfhydryl-specific alkylating agent methanethiosulfonate ethylammonium (MTSEA). This treatment led to a significant reduction in the binding affinity of TMD1 mutants M30C((1.34))-AT(1) and T33C((1.37))-AT(1) and TMD4 mutant V169C((4.66))-AT(1). Although this reduction in binding of the TMD1 mutants was maintained when examined in a constitutively active receptor (N111G-AT(1)) background, we found that V169C((4.66))-AT(1) remained unaffected when treated with MTSEA compared with untreated in this context. Moreover, the complete loss of binding observed for R167C((4.64))-AT(1) was restored upon treatment with MTSEA. Our results suggest that the extracellular portion of TMD1, particularly residues Met-30((1.34)) and Thr-33((1.37)), aswellasresiduesArg-167((4.64)) andVal-169((4.66)) at the junction of TMD4 and the second extracellular loop, are important binding determinants within the AT1 receptor binding pocket but that these TMDs undergo very little movement, if at all, during the activation process.	[Yan, Liping; Holleran, Brian J.; Lavigne, Pierre; Escher, Emanuel; Guillemette, Gaetan; Leduc, Richard] Univ Sherbrooke, Fac Med & Hlth Sci, Dept Pharmacol, Sherbrooke, PQ J1H 5N4, Canada	University of Sherbrooke	Leduc, R (corresponding author), Univ Sherbrooke, Fac Med & Hlth Sci, Dept Pharmacol, Sherbrooke, PQ J1H 5N4, Canada.	Richard.Leduc@USherbrooke.ca		Escher, Emanuel/0000-0001-6601-987X	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported in part by the Canadian Institutes of Health Research.	Ahuja S, 2009, NAT STRUCT MOL BIOL, V16, P168, DOI 10.1038/nsmb.1549; AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; Alberts GL, 1998, MOL PHARMACOL, V54, P379, DOI 10.1124/mol.54.2.379; BALLESTEROS JA, 1995, INTEGRATED METHODS C; Balmforth AJ, 1997, J BIOL CHEM, V272, P4245, DOI 10.1074/jbc.272.7.4245; Billet S, 2008, KIDNEY INT, V74, P1379, DOI 10.1038/ki.2008.358; Borhan B, 2000, SCIENCE, V288, P2209, DOI 10.1126/science.288.5474.2209; Boucard AA, 2003, J BIOL CHEM, V278, P36628, DOI 10.1074/jbc.M305952200; Burnier M, 2001, CIRCULATION, V103, P904, DOI 10.1161/01.CIR.103.6.904; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; de Gasparo M, 2000, PHARMACOL REV, V52, P415; Domazet I, 2009, J BIOL CHEM, V284, P31953, DOI 10.1074/jbc.M109.051839; Domazet I, 2009, J BIOL CHEM, V284, P11922, DOI 10.1074/jbc.M808113200; Dunham TD, 1999, J BIOL CHEM, V274, P1683, DOI 10.1074/jbc.274.3.1683; Feng YH, 1998, BIOCHEMISTRY-US, V37, P15791, DOI 10.1021/bi980863t; Feng YH, 1999, J BIOL CHEM, V274, P35546, DOI 10.1074/jbc.274.50.35546; FONG TM, 1994, J BIOL CHEM, V269, P14957; Gether U, 1998, J BIOL CHEM, V273, P17979, DOI 10.1074/jbc.273.29.17979; Ghanouni P, 2001, P NATL ACAD SCI USA, V98, P5997, DOI 10.1073/pnas.101126198; GREEN SA, 1993, J BIOL CHEM, V268, P23116; Groblewski T, 1997, J BIOL CHEM, V272, P1822, DOI 10.1074/jbc.272.3.1822; GUILLEMETTE G, 1983, BIOCHEMISTRY-US, V22, P5591, DOI 10.1021/bi00293a021; Heitz F, 1999, EUR J PHARMACOL, V380, P183, DOI 10.1016/S0014-2999(99)00439-2; HJORTH SA, 1994, J BIOL CHEM, V269, P30953; HUANG RRC, 1995, BIOCHEMISTRY-US, V34, P10048, DOI 10.1021/bi00031a029; Inoue Y, 1997, J HYPERTENS, V15, P703, DOI 10.1097/00004872-199715070-00001; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Javitch JA, 2000, BIOCHEMISTRY-US, V39, P12190, DOI 10.1021/bi001069m; Javitch JA, 2002, METHOD ENZYMOL, V343, P137; JAVITCH JA, 1994, P NATL ACAD SCI USA, V91, P10355, DOI 10.1073/pnas.91.22.10355; JOSEPH MP, 1995, J PROTEIN CHEM, V14, P381, DOI 10.1007/BF01886795; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Martin SS, 2004, J BIOL CHEM, V279, P51415, DOI 10.1074/jbc.M407965200; Martin SS, 2007, MOL PHARMACOL, V72, P182, DOI 10.1124/mol.106.033670; MATSUI H, 1989, BIOCHEMISTRY-US, V28, P4125, DOI 10.1021/bi00435a075; Miura S, 2003, HYPERTENS RES, V26, P937, DOI 10.1291/hypres.26.937; NODA K, 1995, J BIOL CHEM, V270, P2284, DOI 10.1074/jbc.270.5.2284; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; PAN Y, 1994, J BIOL CHEM, V269, P31933; Rasmussen SGF, 1999, MOL PHARMACOL, V56, P175, DOI 10.1124/mol.56.1.175; ROBERTS DD, 1986, BIOCHEMISTRY-US, V25, P5595, DOI 10.1021/bi00367a038; Santos EL, 2004, REGUL PEPTIDES, V119, P183, DOI 10.1016/j.regpep.2004.02.009; Seifert R, 2002, N-S ARCH PHARMACOL, V366, P381, DOI 10.1007/s00210-002-0588-0; STAUFFER DA, 1994, BIOCHEMISTRY-US, V33, P6840, DOI 10.1021/bi00188a013; Ulloa-Aguirre A, 2009, FRONT BIOSCI-LANDMRK, V14, P973, DOI 10.2741/3290; Unger VM, 1997, NATURE, V389, P203, DOI 10.1038/38316; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Waugh DJJ, 2000, J BIOL CHEM, V275, P11698, DOI 10.1074/jbc.275.16.11698; WERGE TM, 1994, J BIOL CHEM, V269, P22054; YAMANO Y, 1992, BIOCHEM BIOPH RES CO, V187, P1426, DOI 10.1016/0006-291X(92)90461-S	51	12	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2227	2236		10.1074/jbc.M109.077180	http://dx.doi.org/10.1074/jbc.M109.077180			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19940150	Green Published, hybrid			2022-12-25	WOS:000273697800002
J	Deligny, A; Denys, A; Marcant, A; Melchior, A; Mazurier, J; van Kuppevelt, TH; Allain, F				Deligny, Audrey; Denys, Agnes; Marcant, Adeline; Melchior, Aurelie; Mazurier, Joel; van Kuppevelt, Toin H.; Allain, Fabrice			Synthesis of Heparan Sulfate with Cyclophilin B-binding Properties Is Determined by Cell Type-specific Expression of Sulfotransferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNSUBSTITUTED GLUCOSAMINE RESIDUES; MOLECULAR-CLONING; PROTEIN-KINASE; N-SULFATION; ADHESION; MICE; BIOSYNTHESIS; LACTOFERRIN; ACTIVATION; ANTIBODIES	Cyclophilin B (CyPB) induces migration and adhesion of T lymphocytes via a mechanism that requires interaction with 3-O-sulfated heparan sulfate (HS). HS biosynthesis is a complex process with many sulfotransferases involved. N-Deacetylases/N-sulfotransferases are responsible for N-sulfation, which is essential for subsequent modification steps, whereas 3-O-sulfotransferases (3-OSTs) catalyze the least abundant modification. These enzymes are represented by several isoforms, which differ in term of distribution pattern, suggesting their involvement in making tissue-specific HS. To elucidate how the specificity of CyPB binding is determined, we explored the relationships between the expression of these sulfotransferases and the generation of HS motifs with CyPB-binding properties. We demonstrated that high N-sulfate density and the presence of 2-O- and 3-O-sulfates determine binding of CyPB, as evidenced by competitive experiments with heparin derivatives, soluble HS, and anti-HS antibodies. We then showed that target cells, i.e. CD4(+) lymphocyte subsets, monocytes/macrophages, and related cell lines, specifically expressed high levels of NDST2 and 3-OST3 isoforms. Silencing the expression of NDST1, NDST2, 2-OST, and 3-OST3 by RNA interference efficiently decreased binding and activity of CyPB, thus confirming their involvement in the biosynthesis of binding sequences for CyPB. Moreover, we demonstrated that NDST1 was able to partially sulfate exogenous substrate in the absence of NDST2 but not vice versa, suggesting that both isoenzymes do not have redundant activities but do have rather complementary activities in making N-sulfated sequences with CyPB-binding properties. Altogether, these results suggest a regulatory mechanism in which cell type-specific expression of certain HS sulfotransferases determines the specific binding of CyPB to target cells.	[Deligny, Audrey; Denys, Agnes; Marcant, Adeline; Melchior, Aurelie; Mazurier, Joel; Allain, Fabrice] Univ Sci & Tech Lille Flandres Artois, Unite Glycobiol Struct & Fonctionnelle, CNRS, UMR 8576,Inst Rech Federatif 147, F-59655 Villeneuve Dascq, France; [van Kuppevelt, Toin H.] Nijmegen Ctr Mol Life Sci, Dept Matrix Biochem, NL-6500 HB Nijmegen, Netherlands	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Radboud University Nijmegen	Allain, F (corresponding author), Univ Sci & Tech Lille Flandres Artois, Unite Glycobiol Struct & Fonctionnelle, CNRS, UMR 8576,Inst Rech Federatif 147, F-59655 Villeneuve Dascq, France.	fabrice.allain@univ-lille1.fr	van Kuppevelt, A.H.M.S.M./L-4463-2015	Allain, Fabrice/0000-0002-4484-6302	CNRS; Universite des Sciences et Technologies de Lille, France	CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite des Sciences et Technologies de Lille, France	This work was supported by the CNRS and the Universite des Sciences et Technologies de Lille, France.	Aikawa J, 1999, J BIOL CHEM, V274, P2690, DOI 10.1074/jbc.274.5.2690; Aikawa J, 2001, J BIOL CHEM, V276, P5876, DOI 10.1074/jbc.M009606200; Allain F, 2002, P NATL ACAD SCI USA, V99, P2714, DOI 10.1073/pnas.052284899; Arora K, 2005, J IMMUNOL, V175, P517, DOI 10.4049/jimmunol.175.1.517; BAME KJ, 1991, J BIOL CHEM, V266, P12461; Barik S, 2006, CELL MOL LIFE SCI, V63, P2889, DOI 10.1007/s00018-006-6215-3; Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391; Carlsson P, 2008, J BIOL CHEM, V283, P20008, DOI 10.1074/jbc.M801652200; Carpentier M, 2002, BIOCHEMISTRY-US, V41, P5222, DOI 10.1021/bi015951j; Damiens E, 1998, EUR J CELL BIOL, V77, P344, DOI 10.1016/S0171-9335(98)80093-9; Dennissen MABA, 2002, J BIOL CHEM, V277, P10982, DOI 10.1074/jbc.M104852200; Denys A, 1998, BIOCHEM J, V336, P689, DOI 10.1042/bj3360689; Dhennin-Duthille I, 2000, J CELL BIOCHEM, V79, P583, DOI 10.1002/1097-4644(20001215)79:4<583::AID-JCB70>3.0.CO;2-9; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Forsberg E, 1999, NATURE, V400, P773, DOI 10.1038/23488; Forster-Horvath C, 2001, EUR J IMMUNOL, V31, P600, DOI 10.1002/1521-4141(200102)31:2<600::AID-IMMU600>3.0.CO;2-8; HANDSCHUMACHER RE, 1984, SCIENCE, V226, P544, DOI 10.1126/science.6238408; Jones KS, 2005, J VIROL, V79, P12692, DOI 10.1128/JVI.79.20.12692-12702.2005; Kusche-Gullberg M, 1998, J BIOL CHEM, V273, P11902, DOI 10.1074/jbc.273.19.11902; Ledin J, 2004, J BIOL CHEM, V279, P42732, DOI 10.1074/jbc.M405382200; Ledin J, 2006, J BIOL CHEM, V281, P35727, DOI 10.1074/jbc.M604113200; Lindahl U, 2007, THROMB HAEMOSTASIS, V98, P109, DOI 10.1160/Th07-04-0310; Liu J, 2002, J BIOL CHEM, V277, P33456, DOI 10.1074/jbc.M202034200; Liu JA, 1999, J BIOL CHEM, V274, P38155, DOI 10.1074/jbc.274.53.38155; Melchior A, 2008, EXP CELL RES, V314, P616, DOI 10.1016/j.yexcr.2007.11.007; Mochizuki H, 2008, J BIOL CHEM, V283, P31237, DOI 10.1074/jbc.M801586200; Ori A, 2008, FRONT BIOSCI-LANDMRK, V13, P4309, DOI 10.2741/3007; Pakula R, 2007, GLYCOBIOLOGY, V17, P492, DOI 10.1093/glycob/cwm009; Pallerla SR, 2008, J BIOL CHEM, V283, P16885, DOI 10.1074/jbc.M709774200; Pejler G, 1996, BIOCHEM J, V320, P897, DOI 10.1042/bj3200897; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pikas DS, 2000, BIOCHEMISTRY-US, V39, P4552, DOI 10.1021/bi992524l; Presto J, 2008, P NATL ACAD SCI USA, V105, P4751, DOI 10.1073/pnas.0705807105; Ringvall M, 2000, J BIOL CHEM, V275, P25926, DOI 10.1074/jbc.C000359200; Rong JH, 2000, BIOCHEM J, V346, P463, DOI 10.1042/0264-6021:3460463; SHIVELY JE, 1976, BIOCHEMISTRY-US, V15, P3932, DOI 10.1021/bi00663a005; Shukla D, 1999, CELL, V99, P13, DOI 10.1016/S0092-8674(00)80058-6; Shworak NW, 1997, J BIOL CHEM, V272, P28008, DOI 10.1074/jbc.272.44.28008; Smetsers TFCM, 2004, J INVEST DERMATOL, V122, P707, DOI 10.1111/j.0022-202X.2004.22316.x; Smits NC, 2006, METHOD ENZYMOL, V416, P61, DOI 10.1016/S0076-6879(06)16005-X; SPIK G, 1982, EUR J BIOCHEM, V121, P413, DOI 10.1111/j.1432-1033.1982.tb05803.x; SPIK G, 1991, J BIOL CHEM, V266, P10735; Taylor KR, 2006, FASEB J, V20, P9, DOI 10.1096/fj.05-4682rev; ten Dam GB, 2006, J BIOL CHEM, V281, P4654, DOI 10.1074/jbc.M506357200; Tiwari V, 2007, FEBS LETT, V581, P4468, DOI 10.1016/j.febslet.2007.08.029; Turnbull J, 2001, TRENDS CELL BIOL, V11, P75, DOI 10.1016/S0962-8924(00)01897-3; van den Born J, 2003, GLYCOBIOLOGY, V13, P1, DOI 10.1093/glycob/cwg011; van Kuppevelt TH, 1998, J BIOL CHEM, V273, P12960, DOI 10.1074/jbc.273.21.12960; Vanpouille C, 2004, BIOCHEM J, V382, P733, DOI 10.1042/BJ20031453; Vanpouille C, 2007, J BIOL CHEM, V282, P24416, DOI 10.1074/jbc.M701835200; Wang LC, 2005, NAT IMMUNOL, V6, P902, DOI 10.1038/ni1233; Wegrowski Y, 2006, CLIN EXP IMMUNOL, V144, P485, DOI 10.1111/j.1365-2249.2006.03059.x; Wei Z, 2005, J BIOL CHEM, V280, P15742, DOI 10.1074/jbc.M501102200; Westling C, 2002, J BIOL CHEM, V277, P49247, DOI 10.1074/jbc.M209139200; Xu D, 2005, BIOCHEM J, V385, P451, DOI 10.1042/BJ20040908; Yurchenko V, 2006, IMMUNOLOGY, V117, P301, DOI 10.1111/j.1365-2567.2005.02316.x; Yurchenko V, 2001, BIOCHEM BIOPH RES CO, V288, P786, DOI 10.1006/bbrc.2001.5847	57	17	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2010	285	3					1701	1715		10.1074/jbc.M109.018184	http://dx.doi.org/10.1074/jbc.M109.018184			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	541PJ	19940140	Green Published, hybrid			2022-12-25	WOS:000273429100016
J	Bohlin, J; Skjerve, E				Bohlin, Jon; Skjerve, Eystein			Examination of Genome Homogeneity in Prokaryotes Using Genomic Signatures	PLOS ONE			English	Article							DINUCLEOTIDE RELATIVE ABUNDANCE; DEPENDENT DNA-STRUCTURE; USAGE PATTERNS; CODON USAGE; EVOLUTIONARY IMPLICATIONS; BACTERIAL GENOMES; GC CONTENT; SEQUENCE; BIAS; CHROMOSOMES	Background: DNA word frequencies, normalized for genomic AT content, are remarkably stable within prokaryotic genomes and are therefore said to reflect a "genomic signature.'' The genomic signatures can be used to phylogenetically classify organisms from arbitrary sampled DNA. Genomic signatures can also be used to search for horizontally transferred DNA or DNA regions subjected to special selection forces. Thus, the stability of the genomic signature can be used as a measure of genomic homogeneity. The factors associated with the stability of the genomic signatures are not known, and this motivated us to investigate further. We analyzed the intra-genomic variance of genomic signatures based on AT content normalization (0(th) order Markov model) as well as genomic signatures normalized by smaller DNA words (1(st) and 2(nd) order Markov models) for 636 sequenced prokaryotic genomes. Regression models were fitted, with intra-genomic signature variance as the response variable, to a set of factors representing genomic properties such as genomic AT content, genome size, habitat, phylum, oxygen requirement, optimal growth temperature and oligonucleotide usage variance (OUV, a measure of oligonucleotide usage bias), measured as the variance between genomic tetranucleotide frequencies and Markov chain approximated tetranucleotide frequencies, as predictors. Principal Findings: Regression analysis revealed that OUV was the most important factor (p<0.001) determining intragenomic homogeneity as measured using genomic signatures. This means that the less random the oligonucleotide usage is in the sense of higher OUV, the more homogeneous the genome is in terms of the genomic signature. The other factors influencing variance in the genomic signature (p<0.001) were genomic AT content, phylum and oxygen requirement. Conclusions: Genomic homogeneity in prokaryotes is intimately linked to genomic GC content, oligonucleotide usage bias (OUV) and aerobiosis, while oligonucleotide usage bias (OUV) is associated with genomic GC content, aerobiosis and habitat.	[Bohlin, Jon; Skjerve, Eystein] Norwegian Sch Vet Sci, Dept Food Safety & Infect Biol, Oslo, Norway	Norwegian University of Life Sciences	Bohlin, J (corresponding author), Norwegian Sch Vet Sci, Dept Food Safety & Infect Biol, Oslo, Norway.	jon.bohlin@veths.no	Skjerve, Eystein/D-7491-2014	Skjerve, Eystein/0000-0001-9652-6952; Bohlin, Jon/0000-0002-0992-1311	Norwegian School of Veterinary Science	Norwegian School of Veterinary Science	Jon Bohlin and Eystein Skjerve are both funded by the Norwegian School of Veterinary Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TE, 2006, PLOS COMPUT BIOL, V2, P13, DOI 10.1371/journal.pcbi.0020002; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Baran RH, 2008, DNA RES, V15, P267, DOI 10.1093/dnares/dsn021; Bohlin J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000057; Bohlin J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-104; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Chen LL, 2003, BIOCHEM BIOPH RES CO, V306, P310, DOI 10.1016/S0006-291X(03)00973-2; Chen SL, 2004, P NATL ACAD SCI USA, V101, P3480, DOI 10.1073/pnas.0307827100; Collins NE, 2005, P NATL ACAD SCI USA, V102, P838, DOI 10.1073/pnas.0406633102; Dufresne A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r14; Elhai J, 2001, J COMPUT BIOL, V8, P151, DOI 10.1089/106652701300312922; Ewens W.J., 2001, STAT METHODS BIOINFO; Foerstner KU, 2005, EMBO REP, V6, P1208, DOI 10.1038/sj.embor.7400538; Fournier PE, 2007, LANCET INFECT DIS, V7, P711, DOI 10.1016/S1473-3099(07)70260-8; Garcia JAL, 2008, GENOMICS, V91, P538, DOI 10.1016/j.ygeno.2008.03.001; Gomez-Valero L, 2007, GENOME RES, V17, P1178, DOI 10.1101/gr.6360207; JOSSE J, 1961, J BIOL CHEM, V236, P864; KARLIN S, 1995, TRENDS GENET, V11, P283; Karlin S, 1997, J BACTERIOL, V179, P3899, DOI 10.1128/jb.179.12.3899-3913.1997; Karlin S, 1998, CURR OPIN MICROBIOL, V1, P598, DOI 10.1016/S1369-5274(98)80095-7; Kozobay-Avraham L, 2006, NUCLEIC ACIDS RES, V34, P2316, DOI 10.1093/nar/gkl230; Kulkarni OC, 2005, BIOINFORMATICS, V21, P3818, DOI 10.1093/bioinformatics/bti639; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Lawrence JG, 1997, J MOL EVOL, V44, P383, DOI 10.1007/PL00006158; Lukashin AV, 1998, NUCLEIC ACIDS RES, V26, P1107, DOI 10.1093/nar/26.4.1107; McEwan CEA, 1998, HEREDITAS, V128, P173, DOI 10.1111/j.1601-5223.1998.00173.x; Mitchell D, 2007, BIOCHEM BIOPH RES CO, V353, P207, DOI 10.1016/j.bbrc.2006.12.008; Moran NA, 2002, CELL, V108, P583, DOI 10.1016/S0092-8674(02)00665-7; Musto H, 2006, BIOCHEM BIOPH RES CO, V347, P1, DOI 10.1016/j.bbrc.2006.06.054; Naya H, 2002, J MOL EVOL, V55, P260, DOI 10.1007/s00239-002-2323-3; Nelson KE, 1999, NATURE, V399, P323, DOI 10.1038/20601; Normand P, 2007, GENOME RES, V17, P7, DOI 10.1101/gr.5798407; Packer MJ, 2000, J MOL BIOL, V295, P71, DOI 10.1006/jmbi.1999.3236; Packer MJ, 1998, J MOL BIOL, V280, P407, DOI 10.1006/jmbi.1998.1865; Pallen MJ, 2007, NATURE, V449, P835, DOI 10.1038/nature06248; PHILLIPS GJ, 1987, NUCLEIC ACIDS RES, V15, P2611, DOI 10.1093/nar/15.6.2611; Pride DT, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-8; Pride DT, 2003, GENOME RES, V13, P145, DOI 10.1101/gr.335003; *R DEV CT, 2007, R LANG ENV STAT COMP; Reva ON, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-90; Rocha EPC, 2002, TRENDS GENET, V18, P291, DOI 10.1016/S0168-9525(02)02690-2; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; SINDEN R. R., 1994, DNA STRUCTURE FUNCTI; Taylor W. R, 2004, PROTEIN BIOINFORMATI; Teeling H, 2004, ENVIRON MICROBIOL, V6, P938, DOI 10.1111/j.1462-2920.2004.00624.x; Ussery D, 2002, COMPUT CHEM, V26, P531, DOI 10.1016/S0097-8485(02)00013-X; Vaillant C, 2006, EUR PHYS J E, V19, P263, DOI 10.1140/epje/i2005-10053-3; Willenbrock H, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-r114; Worning P, 2006, ENVIRON MICROBIOL, V8, P353, DOI 10.1111/j.1462-2920.2005.00917.x	50	19	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2009	4	12							e8113	10.1371/journal.pone.0008113	http://dx.doi.org/10.1371/journal.pone.0008113			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MU	19956556	Green Published, gold, Green Submitted			2022-12-25	WOS:000272828800011
J	Lisik, W; Tejpal, N; Gong, YQ; Skelton, TS; Ganachari, M; Bremer, EG; Kloc, M; Ghobrial, RM				Lisik, Wojciech; Tejpal, Neelam; Gong, Yongquan; Skelton, T. Spencer; Ganachari, Malathesh; Bremer, Eric G.; Kloc, Malgorzata; Ghobrial, Rafik M.			Down Regulation of Genes Involved in T Cell Polarity and Motility during the Induction of Heart Allograft Tolerance by Allochimeric MHC I	PLOS ONE			English	Article							IMMUNOLOGICAL SYNAPSE FORMATION; ACTIN CYTOSKELETON; TRANSPLANTATION TOLERANCE; ADHESION MOLECULES; CHRONIC REJECTION; ACTIVATION; RHO; PATHWAY; IDENTIFICATION; POLARIZATION	Background: The allochimeric MHC class I molecule [alpha 1h1/u]-RT1. Aa that contains donor-type (Wistar Furth, WF; RT1u) epitopes displayed on recipient-type (ACI, RT1a) administered in conjunction with sub-therapeutic dose of cyclosporine (CsA) induces indefinite survival of heterotopic cardiac allografts in rat model. In vascularized transplantation models, the spleen contributes to graft rejection by generating alloantigen reactive T cells. The immune response in allograft rejection involves a cascade of molecular events leading to the formation of immunological synapses between T cells and the antigen-presenting cells. Methodology/Principal Findings: To elucidate the molecular pathways involved in the immunosuppressive function of allochimeric molecule we performed microarray and quantitative RTPCR analyses of gene expression profile of splenic T cells from untreated, CsA treated, and allochimeric molecule + subtherapeutic dose of CsA treated animals at day 1, 3 and 7 of post transplantation. Allochimeric molecule treatment caused down regulation of genes involved in actin filament polymerization (RhoA and Rac1), cell adhesion (Catna1, Vcam and CD9), vacuolar transport (RhoB, Cln8 and ATP6v1b2), and MAPK pathway (Spred1 and Dusp6) involved in tubulin cytoskeleton reorganization and interaction between actin and microtubule cytoskeleton. All these genes are involved in T cell polarity and motility, i.e., their ability to move, scan and to form functional immunological synapse with antigen presenting cells (APCs). Conclusions: These results indicate that the immunosuppressive function of allochimeric molecule may depend on the impairment of T cells' movement and scanning ability, and possibly also the formation of immunological synapse. We believe that these novel findings may have important clinical implications for organ transplantation.	[Lisik, Wojciech] Warsaw Med Univ, Dept Gen & Transplantat Surg, Warsaw, Poland; [Tejpal, Neelam; Gong, Yongquan; Skelton, T. Spencer; Ganachari, Malathesh; Kloc, Malgorzata; Ghobrial, Rafik M.] Methodist Hosp, Res Inst, Houston, TX 77030 USA; [Bremer, Eric G.] Precis Biomarker Resources Inc, Evanston, IL USA	Medical University of Warsaw; The Methodist Hospital System; The Methodist Hospital - Houston	Lisik, W (corresponding author), Warsaw Med Univ, Dept Gen & Transplantat Surg, Warsaw, Poland.	mkloc@tmhs.org; RMGhobrial@tmhs.org	Ganachari, malathesha/B-3015-2011; Kloc, Malgorzata/AAF-6982-2020; Lisik, Wojciech/Q-8972-2018	Lisik, Wojciech/0000-0003-3020-3979	National Institutes of Health [RO1 AI49945]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049945] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the National Institutes of Health Grant RO1 AI49945 to RM Ghobrial, and fellowship from The Department of Surgery of The Methodist Hospital to TS Skelton. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson P, 1999, J IMMUNOL, V162, P2964; Al-Alwan MM, 2003, J IMMUNOL, V171, P4479, DOI 10.4049/jimmunol.171.9.4479; Angkachatchai V, 1999, J IMMUNOL, V163, P3819; Becart S, 2008, IMMUNITY, V29, P704, DOI 10.1016/j.immuni.2008.08.015; BELMONT HM, 1994, ARTHRITIS RHEUM, V37, P376, DOI 10.1002/art.1780370311; Brossard C, 2005, EUR J IMMUNOL, V35, P1741, DOI 10.1002/eji.200425857; BUTCHER GW, 1982, TRANSPLANTATION, V34, P161, DOI 10.1097/00007890-198210000-00001; Carrasco YR, 2006, EMBO J, V25, P889, DOI 10.1038/sj.emboj.7600944; Chiffoleau E, 2002, J IMMUNOL, V168, P5058, DOI 10.4049/jimmunol.168.10.5058; Choi SY, 1997, J VIROL, V71, P965, DOI 10.1128/JVI.71.2.965-970.1997; Colovai A I, 1996, Int Rev Immunol, V13, P161, DOI 10.3109/08830189609061745; Davis DM, 2004, TRENDS IMMUNOL, V25, P323, DOI 10.1016/j.it.2004.03.007; DIBARI MG, 2009, CANC IMMUNOL IMMUNOT; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; DUNN DL, 1990, CRIT CARE CLIN, V6, P955; Dustin ML, 2008, CELL, V132, P733, DOI 10.1016/j.cell.2008.02.016; Dustin ML, 2007, CURR OPIN CELL BIOL, V19, P529, DOI 10.1016/j.ceb.2007.08.003; Dustin ML, 2000, NAT IMMUNOL, V1, P23, DOI 10.1038/76877; Faure S, 2004, NAT IMMUNOL, V5, P272, DOI 10.1038/ni1039; Ghobrial RR, 1996, TRANSPLANTATION, V62, P1002, DOI 10.1097/00007890-199610150-00020; Gupta S, 2003, J BIOL CHEM, V278, P43541, DOI 10.1074/jbc.M308960200; HALL BM, 1982, TRANSPLANTATION, V33, P403, DOI 10.1097/00007890-198204000-00012; HAUSMANN R, 1993, CLIN EXP IMMUNOL, V91, P183; Huang YP, 2007, J CELL SCI, V120, P723, DOI 10.1242/jcs.000786; Ise W, 2005, J IMMUNOL, V175, P829, DOI 10.4049/jimmunol.175.2.829; Janssen E, 2006, IMMUNITY, V24, P787, DOI 10.1016/j.immuni.2006.03.024; Kamon H, 2006, EMBO J, V25, P4108, DOI 10.1038/sj.emboj.7601286; Kovanen PE, 2005, INT IMMUNOL, V17, P1009, DOI 10.1093/intimm/dxh283; Lajoie-Mazenc I, 2008, J BIOL CHEM, V283, P4155, DOI 10.1074/jbc.M709639200; Lee JH, 2004, J CELL BIOL, V167, P327, DOI 10.1083/jcb.200403091; Leuker CE, 2001, J EXP MED, V193, P755, DOI 10.1084/jem.193.6.755; Li BY, 2000, SCIENCE, V288, P2219, DOI 10.1126/science.288.5474.2219; Matsuo MY, 2004, MECH DEVELOP, V121, P771, DOI 10.1016/j.mod.2004.03.014; MOBLEY JL, 1994, BLOOD, V83, P1039, DOI 10.1182/blood.V83.4.1039.bloodjournal8341039; NAGAFUCHI A, 1991, CELL, V65, P849, DOI 10.1016/0092-8674(91)90392-C; Nijhara R, 2004, J IMMUNOL, V173, P4985, DOI 10.4049/jimmunol.173.8.4985; Ocana-Morgner C, 2009, BLOOD, V113, P1474, DOI 10.1182/blood-2008-04-152587; Pais-Correia Ana Monica, 2007, Current Immunology Reviews, V3, P170; Pernis AB, 2009, AUTOIMMUN REV, V8, P199, DOI 10.1016/j.autrev.2008.07.044; Rodriguez-Fernandez Jose Luis, 2005, Curr Opin Investig Drugs, V6, P1103; Sancho D, 2002, IMMUNOL REV, V189, P84, DOI 10.1034/j.1600-065X.2002.18908.x; Sanui T, 2003, IMMUNITY, V19, P119, DOI 10.1016/S1074-7613(03)00169-9; Satoh J, 2005, NEUROBIOL DIS, V18, P537, DOI 10.1016/j.nbd.2004.10.007; Sayegh M H, 1996, Int Rev Immunol, V13, P221, DOI 10.3109/08830189609061749; Semiletova NV, 2005, TRANSPLANTATION, V80, P1535, DOI 10.1097/01.tp.0000188952.10692.18; Semiltova N, 2003, TRANSPLANTATION, V75, P550, DOI 10.1097/01.TP.0000046942.02001.26; Singer JS, 2001, TRANSPLANTATION, V72, P1408, DOI 10.1097/00007890-200110270-00014; Tharaux PL, 2003, J IMMUNOL, V171, P96, DOI 10.4049/jimmunol.171.1.96; Toyo-oka K, 1999, INT IMMUNOL, V11, P2043, DOI 10.1093/intimm/11.12.2043; Trivedi HL, 2007, TRANSPL P, V39, P647, DOI 10.1016/j.transproceed.2007.01.047; Tskvitaria-Fuller I, 2006, J IMMUNOL, V177, P1708, DOI 10.4049/jimmunol.177.3.1708; VANDINTHERJANSSEN ACHM, 1991, J IMMUNOL, V147, P4207; VANTAGGIATO C, 2009, HUM MUTAT; Vicente-Manzanares M, 2004, NAT REV IMMUNOL, V4, P110, DOI 10.1038/nri1268; Villalba M, 2001, J CELL BIOL, V155, P331, DOI 10.1083/jcb.200107080; Yu H, 2001, J EXP MED, V194, P915, DOI 10.1084/jem.194.7.915; Yuhki N, 2003, GENOME RES, V13, P1169, DOI 10.1101/gr.976103; Zavazava N, 1996, NAT MED, V2, P1005, DOI 10.1038/nm0996-1005	58	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2009	4	12							e8020	10.1371/journal.pone.0008020	http://dx.doi.org/10.1371/journal.pone.0008020			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MU	19956540	Green Submitted, Green Published, gold			2022-12-25	WOS:000272828800004
J	Basak, A; Khatib, AM; Mohottalage, D; Basak, S; Kolajova, M; Bag, SS; Basak, A				Basak, Ajoy; Khatib, Abdel-Majid; Mohottalage, Dayani; Basak, Sarmistha; Kolajova, Maria; Bag, Subhendu Sekhar; Basak, Amit			A Novel Enediynyl Peptide Inhibitor of Furin That Blocks Processing of proPDGF-A, B and proVEGF-C	PLOS ONE			English	Article							PROPROTEIN CONVERTASES FURIN; POTENT INHIBITORS; PROTEIN INTERACTIONS; BERGMAN CYCLIZATION; KINETIC EVALUATION; HISTONE H1.2; AMINO-ACID; IN-VITRO; DESIGN; PC7	Background: Furin represents a crucial member of secretory mammalian subtilase, the Proprotein Convertase (PC) or Proprotein Convertase Subtilisin/Kexin (PCSK) superfamily. It has been linked to cancer, tumorgenesis, viral and bacterial pathogenesis. As a result it is considered a major target for intervention of these diseases. Methodology/Principal Findings: Herein, we report, for the first time, the synthesis and biological evaluation of a newly designed potent furin inhibitor that contains a highly reactive beta-turn inducing and radical generating "enediynyl amino acid" (Eda) moiety. "Eda" was inserted between P1 and P1' residues of hfurin(98-112) peptide, derived from the primary cleavage site of furin's own prodomain. The resulting hexadecapeptide derivative inhibited furin in vitro with IC50 similar to 40 nM when measured against the fluorogenic substrate Boc-RVRR-MCA. It also inhibited furin-mediated cleavage of a fluorogenic peptide derived from hSARS-CoV spike protein with IC50 similar to 193 nM. Additionally it also blocked furin-processing of growth factors proPDGF-A, B and VEGF-C that are linked to tumor genesis and cancer. Circular dichroism study showed that this inhibitor displayed a predominantly beta-turn structure while western blots confirmed its ability to protect furin protein from self degradation. Conclusion/Significance: These findings imply its potential as a therapeutic agent for intervention of cancer and other furin-associated diseases.	[Basak, Ajoy; Mohottalage, Dayani; Basak, Sarmistha; Kolajova, Maria] Univ Ottowa, Chron Dis Program, Dept Biochem Microbiol & Immunol, Ottawa Hosp Res Inst,Reg Prot Chem Ctr, Ottawa, ON, Canada; [Khatib, Abdel-Majid] Hosp St Louis, Inst Genet Mol, INSERM, Equipe AVENIR,UMRS940, Paris, France; [Khatib, Abdel-Majid] Univ Paris 07, Paris, France; [Bag, Subhendu Sekhar; Basak, Amit] Indian Inst Technol, Dept Chem, Kharagpur 721302, W Bengal, India; [Bag, Subhendu Sekhar] Indian Inst Technol, Dept Chem, Gauhati, Assam, India	University of Ottawa; Ottawa Hospital Research Institute; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kharagpur; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Guwahati	Basak, A (corresponding author), Univ Ottowa, Chron Dis Program, Dept Biochem Microbiol & Immunol, Ottawa Hosp Res Inst,Reg Prot Chem Ctr, Ottawa, ON, Canada.	abasak@ohri.ca	Bag, Subhendu Sekhar/AAF-2161-2020; KHATIB, Abdel-Majid/A-9948-2015	KHATIB, Abdel-Majid/0000-0001-6957-0384; Bag, Prof. Dr. Subhendu Sekhar/0000-0001-5232-4793	Canadian Institute for Health Research [MOP-69093, CTP 82946]; National Science and Engineering Research Council [238547-07]; Center for Catalysis Research and Innovation (U Ottawa); INCA; INSERM; La Ligue Contre le Cancer; Department of Science and Technology, Govt of India	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); National Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Center for Catalysis Research and Innovation (U Ottawa); INCA(Institut National du Cancer (INCA) France); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); La Ligue Contre le Cancer(Ligue nationale contre le cancer); Department of Science and Technology, Govt of India(Department of Science & Technology (India))	This research was supported by grants from Canadian Institute for Health Research operating MOP-69093 and Team CTP 82946, National Science and Engineering Research Council (238547-07), Center for Catalysis Research and Innovation (U Ottawa) to Ajoy Basak; from INCA, INSERM and La Ligue Contre le Cancer to AM Khatib and the Department of Science and Technology, Govt of India to Amit Basak. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGLIKER H, 1995, J MED CHEM, V38, P4014, DOI 10.1021/jm00020a016; Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343; Basak A, 2005, J MOL MED, V83, P844, DOI 10.1007/s00109-005-0710-0; Basak A, 2005, FEBS LETT, V579, P4813, DOI 10.1016/j.febslet.2005.07.062; Basak A, 2005, BIOORGAN MED CHEM, V13, P4096, DOI 10.1016/j.bmc.2005.03.038; Basak A, 2005, BIOORG MED CHEM LETT, V15, P2061, DOI 10.1016/j.bmcl.2005.02.051; Basak A, 2003, CHEM REV, V103, P4077, DOI 10.1021/cr020069k; Basak A, 2003, BIOCHEM J, V373, P231, DOI 10.1042/BJ20030120; BASAK A, 1995, INT J PEPT PROT RES, V46, P228; Basak A, 2002, BIOORG MED CHEM LETT, V12, P873, DOI 10.1016/S0960-894X(02)00029-X; Basak A, 1998, TETRAHEDRON LETT, V39, P1623, DOI 10.1016/S0040-4039(97)10856-5; Basak A, 2001, BIOCHEM J, V353, P537, DOI 10.1042/0264-6021:3530537; Basak A., 2002, J CHEM SOC P1, V15, P1805; BASAK A, 2000, J CHEM SOC P1, V12, P1955; BASAK A, 2009, BIOCH BIOPH IN PRESS; Basak A, 2008, CURR TOP MED CHEM, V8, P435, DOI 10.2174/156802608783955746; Basak A, 2007, CHEMBIOCHEM, V8, P1029, DOI 10.1002/cbic.200700007; Bergeron E, 2005, BIOCHEM BIOPH RES CO, V326, P554, DOI 10.1016/j.bbrc.2004.11.063; Bhattacharjya S, 2001, PROTEIN SCI, V10, P934, DOI 10.1110/ps.41301; Bhattacharjya S, 2007, BIOPOLYMERS, V86, P329, DOI 10.1002/bip.20748; Borders D. B., 1995, ENEDIYNE ANTIBIOTICS; Choy N, 2000, ORG LETT, V2, P3761, DOI 10.1021/ol006061j; Chretien M, 2008, EXPERT OPIN THER TAR, V12, P1289, DOI 10.1517/14728222.12.10.1289 ; Coppola J, 2008, NEOPLASIA, V10, P363, DOI 10.1593/neo.08166; Coppola JM, 2007, ANAL BIOCHEM, V364, P19, DOI 10.1016/j.ab.2007.01.013; Dutta S, 2009, BIOORGAN MED CHEM, V17, P3900, DOI 10.1016/j.bmc.2009.04.019; Fouad FS, 2005, J ORG CHEM, V70, P9789, DOI 10.1021/jo051403q; Fugere M, 2005, TRENDS PHARMACOL SCI, V26, P294, DOI 10.1016/j.tips.2005.04.006; Fugere M, 2007, MOL PHARMACOL, V71, P323, DOI 10.1124/mol.106.027946; Gawlik K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005031; Gredicak Matija, 2007, Acta Pharmaceutica (Zagreb), V57, P133, DOI 10.2478/v10007-007-0011-y; Han JB, 2006, FEBS J, V273, P4459, DOI 10.1111/j.1742-4658.2006.05451.x; Henrich S, 2003, NAT STRUCT BIOL, V10, P669, DOI 10.1038/nsb0803-669b; Henrich S, 2003, NAT STRUCT BIOL, V10, P520, DOI 10.1038/nsb941; Holyoak T, 2004, BIOCHEMISTRY-US, V43, P2412, DOI 10.1021/bi035849h; Jean F, 2000, P NATL ACAD SCI USA, V97, P2864, DOI 10.1073/pnas.050504297; Jiao GS, 2006, P NATL ACAD SCI USA, V103, P19707, DOI 10.1073/pnas.0606555104; Jones GB, 2000, ORG LETT, V2, P1863, DOI 10.1021/ol005926q; Jones GB, 2000, ORG LETT, V2, P811, DOI 10.1021/ol0055566; JONES RR, 1972, J AM CHEM SOC, V94, P660, DOI 10.1021/ja00757a071; Khatib AM, 2002, AM J PATHOL, V160, P1921, DOI 10.1016/S0002-9440(10)61140-6; Kido Hiroshi, 2008, J Mol Genet Med, V3, P167; Komiyama T, 2005, PROTEIN PEPTIDE LETT, V12, P415, DOI 10.2174/0929866054395220; Kowalska D, 2009, MOL PHARMACOL, V75, P617, DOI 10.1124/mol.108.051334; Nielsen P. E., 2004, PSEUDOPEPTIDES DRUG; Rabah N, 2006, J BIOL CHEM, V281, P7556, DOI 10.1074/jbc.M510607200; Rholam M, 2009, CELL MOL LIFE SCI, V66, P2075, DOI 10.1007/s00018-009-0007-5; Seidah NG, 2008, INT J BIOCHEM CELL B, V40, P1111, DOI 10.1016/j.biocel.2008.01.030; Seidah NG, 2002, ESSAYS BIOCHEM, V38, P79, DOI 10.1042/bse0380079; Shiryaev SA, 2007, J BIOL CHEM, V282, P20847, DOI 10.1074/jbc.M703847200; Siegfried G, 2005, ONCOGENE, V24, P6925, DOI 10.1038/sj.onc.1208838; Siegfried G, 2003, J CLIN INVEST, V111, P1723, DOI 10.1172/JCI200317220; Siegfried G, 2003, CANCER RES, V63, P1458; SIEZEN RJ, 1994, EUR J BIOCHEM, V222, P255, DOI 10.1111/j.1432-1033.1994.tb18864.x; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Wang SM, 2008, ACTA BIOCH BIOPH SIN, V40, P848, DOI 10.1111/j.1745-7270.2008.00470.x; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; ZEIN N, 1995, BIOCHEMISTRY-US, V34, P11591, DOI 10.1021/bi00036a035; ZEIN N, 1993, P NATL ACAD SCI USA, V90, P8009, DOI 10.1073/pnas.90.17.8009; Zhong M, 1999, J BIOL CHEM, V274, P33913, DOI 10.1074/jbc.274.48.33913	60	25	27	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2009	4	11							e7700	10.1371/journal.pone.0007700	http://dx.doi.org/10.1371/journal.pone.0007700			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MN	19956642	Green Submitted, Green Published, gold			2022-12-25	WOS:000272828100002
J	Yu, N; Zhao, HB				Yu, Ning; Zhao, Hong-Bo			Modulation of Outer Hair Cell Electromotility by Cochlear Supporting Cells and Gap Junctions	PLOS ONE			English	Article							GUINEA-PIG; INNER-EAR; MECHANICAL RESPONSES; VOLTAGE-DEPENDENCE; MEMBRANE; MOTILITY; CHARGE; AMPLIFICATION; CAPACITANCE; PRESTIN	Outer hair cell (OHC) or prestin-based electromotility is an active cochlear amplifier in the mammalian inner ear that can increase hearing sensitivity and frequency selectivity. In situ, Deiters supporting cells are well-coupled by gap junctions and constrain OHCs standing on the basilar membrane. Here, we report that both electrical and mechanical stimulations in Deiters cells (DCs) can modulate OHC electromotility. There was no direct electrical conductance between the DCs and the OHCs. However, depolarization in DCs reduced OHC electromotility associated nonlinear capacitance (NLC) and distortion products. Increase in the turgor pressure of DCs also shifted OHC NLC to the negative voltage direction. Destruction of the cytoskeleton in DCs or dissociation of the mechanical-coupling between DCs and OHCs abolished these effects, indicating the modulation through the cytoskeleton activation and DC-OHC mechanical coupling rather than via electric field potentials. We also found that changes in gap junctional coupling between DCs induced large membrane potential and current changes in the DCs and shifted OHC NLC. Uncoupling of gap junctions between DCs shifted NLC to the negative direction. These data indicate that DCs not only provide a physical scaffold to support OHCs but also can directly modulate OHC electromotility through the DC-OHC mechanical coupling. Our findings reveal a new mechanism of cochlear supporting cells and gap junctional coupling to modulate OHC electromotility and eventually hearing sensitivity in the inner ear.			Yu, N (corresponding author), Univ Kentucky, Med Ctr, Dept Surg Otolaryngol, Lexington, KY 40536 USA.	hzhao2@uky.edu			NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005989] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC 05989, R01 DC005989] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Ashmore J, 2008, PHYSIOL REV, V88, P173, DOI 10.1152/physrev.00044.2006; Bobbin RP, 2002, HAIR CELL MICROMECHANICS AND OTOACOUSTIC EMISSIONS, P91; Bobbin RP, 2001, NEUROREPORT, V12, P2923, DOI 10.1097/00001756-200109170-00034; BROWNELL WE, 1985, SCIENCE, V227, P194, DOI 10.1126/science.3966153; Dallos P, 2008, CURR OPIN NEUROBIOL, V18, P370, DOI 10.1016/j.conb.2008.08.016; DULON D, 1994, BIOCHEM BIOPH RES CO, V201, P1263, DOI 10.1006/bbrc.1994.1841; Flock A, 1999, J NEUROSCI, V19, P4498; Forge A, 2003, J COMP NEUROL, V467, P207, DOI 10.1002/cne.10916; Fridberger A, 1998, P NATL ACAD SCI USA, V95, P7127, DOI 10.1073/pnas.95.12.7127; GALE JE, 1994, P ROY SOC B-BIOL SCI, V255, P243, DOI 10.1098/rspb.1994.0035; He DZZ, 1999, P NATL ACAD SCI USA, V96, P8223, DOI 10.1073/pnas.96.14.8223; Hudspeth AJ, 2008, NEURON, V59, P530, DOI 10.1016/j.neuron.2008.07.012; IWASA KH, 1993, BIOPHYS J, V65, P492, DOI 10.1016/S0006-3495(93)81053-1; KAKEHATA S, 1995, BIOPHYS J, V68, P2190, DOI 10.1016/S0006-3495(95)80401-7; Santos-Sacchi J, 1998, J PHYSIOL-LONDON, V510, P225, DOI 10.1111/j.1469-7793.1998.225bz.x; Slepecky N. B., 1996, COCHLEA, V8, P44; Yu N, 2008, PFLUG ARCH EUR J PHY, V457, P453, DOI 10.1007/s00424-008-0522-5; Zhao HB, 2005, P NATL ACAD SCI USA, V102, P18724, DOI 10.1073/pnas.0506481102; Zhao HB, 1999, NATURE, V399, P359, DOI 10.1038/20686; Zhao HB, 2000, NEUROSCI LETT, V296, P105, DOI 10.1016/S0304-3940(00)01626-8; Zhao HB, 2000, J MEMBRANE BIOL, V175, P17, DOI 10.1007/s002320001051; Zhao HB, 2006, J COMP NEUROL, V499, P506, DOI 10.1002/cne.21113; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009; ZHU Y, 2009, PURINERGIC IN PRESS	24	31	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2009	4	11							e7923	10.1371/journal.pone.0007923	http://dx.doi.org/10.1371/journal.pone.0007923			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522NL	19936276	Green Published, gold, Green Submitted			2022-12-25	WOS:000272004800007
J	Ciota, AT; Jia, YQ; Payne, AF; Jerzak, G; Davis, LJ; Young, DS; Ehrbar, D; Kramer, LD				Ciota, Alexander T.; Jia, Yongqing; Payne, Anne F.; Jerzak, Greta; Davis, Lauren J.; Young, David S.; Ehrbar, Dylan; Kramer, Laura D.			Experimental Passage of St. Louis Encephalitis Virus In Vivo in Mosquitoes and Chickens Reveals Evolutionarily Significant Virus Characteristics	PLOS ONE			English	Article							WEST-NILE-VIRUS; PURIFYING SELECTION; INVERTEBRATE CELLS; GENETIC-VARIATION; MAMMALIAN-CELLS; MUTANT SPECTRUM; ADAPTATION; FLAVIVIRUSES; CALIFORNIA; ARBOVIRUS	St. Louis encephalitis virus (SLEV; Flaviviridae, flavivirus) was the major cause of epidemic flaviviral encephalitis in the U. S. prior to the introduction of West Nile virus (WNV) in 1999. However, outbreaks of SLEV have been significantly more limited then WNV in terms of levels of activity and geographic dispersal. One possible explanation for these variable levels of activity is that differences in the potential for each virus to adapt to its host cycle exist. The need for arboviruses to replicate in disparate hosts is thought to result in constraints on both evolution and host-specific adaptation. If cycling is the cause of genetic stability observed in nature and arboviruses lack host specialization, then sequential passage should result in both the accumulation of mutations and specialized viruses better suited for replication in that host. Previous studies suggest that WNV and SLEV differ in capacity for both genetic change and host specialization, and in the costs each accrues from specializing. In an attempt to clarify how selective pressures contribute to epidemiological patterns of WNV and SLEV, we evaluated mutant spectra size, consensus genetic change, and phenotypic changes for SLEV in vivo following 20 sequential passages via inoculation in either Culex pipiens mosquitoes or chickens. Results demonstrate that the capacity for genetic change is large for SLEV and that the size of the mutant spectrum is host-dependent using our passage methodology. Despite this, a general lack of consensus change resulted from passage in either host, a result that contrasts with the idea that constraints on evolution in nature result from host cycling alone. Results also suggest that a high level of adaptation to both hosts already exists, despite host cycling. A strain significantly more infectious in chickens did emerge from one lineage of chicken passage, yet other lineages and all mosquito passage strains did not display measurable host-specific fitness gains. In addition, increased infectivity in chickens did not decrease infectivity in mosquitoes, which further contrasts the concept of fitness trade-offs for arboviruses.			Ciota, AT (corresponding author), New York State Dept Hlth, Arbovirus Labs, Wadsworth Ctr, Slingerlands, NY USA.	ldk02@health.state.ny.us	; Ciota, Alexander/E-1634-2017	Van Slyke, Greta/0000-0003-2646-3030; Ehrbar, Dylan/0000-0001-7872-3338; Ciota, Alexander/0000-0001-6589-4728	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077669, N01AI025490] Funding Source: NIH RePORTER; NIAID NIH HHS [N01AI25490, R01 AI077669, R01-AI-077669] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37; Ciota AT, 2008, J GEN VIROL, V89, P1633, DOI 10.1099/vir.0.2008/000893-0; Ciota AT, 2007, J GEN VIROL, V88, P2398, DOI 10.1099/vir.0.83061-0; Ciota AT, 2007, J GEN VIROL, V88, P865, DOI 10.1099/vir.0.82606-0; Ciota AT, 2007, VIROLOGY, V357, P165, DOI 10.1016/j.virol.2006.08.005; Coffey LL, 2008, P NATL ACAD SCI USA, V105, P6970, DOI 10.1073/pnas.0712130105; Cooper LA, 2001, GENETICS, V157, P1403; Drake JW, 1999, P NATL ACAD SCI USA, V96, P13910, DOI 10.1073/pnas.96.24.13910; Dupuis AP, 2003, EMERG INFECT DIS, V9, P860; Greene IP, 2005, J VIROL, V79, P14253, DOI 10.1128/JVI.79.22.14253-14260.2005; Hayes EB, 2005, EMERG INFECT DIS, V11, P1167, DOI 10.3201/eid1108.050289a; Jerzak G, 2005, J GEN VIROL, V86, P2175, DOI 10.1099/vir.0.81015-0; Jerzak GVS, 2008, VIROLOGY, V374, P256, DOI 10.1016/j.virol.2008.02.032; Jerzak GVS, 2007, VIROLOGY, V360, P469, DOI 10.1016/j.virol.2006.10.029; Kramer LD, 1997, AM J TROP MED HYG, V57, P222, DOI 10.4269/ajtmh.1997.57.222; Kramer LD, 2001, ARCH VIROL, V146, P2341, DOI 10.1007/s007050170007; LINDSEY HS, 1976, J CLIN MICROBIOL, V4, P503; MARTINEZ MA, 1991, J VIROL, V65, P3954; May FJ, 2008, J GEN VIROL, V89, P1901, DOI 10.1099/vir.0.2008/000190-0; MITCHELL CJ, 1980, ST LOUIS ENCEPHALITI, P313; MONATH TP, 1996, FIELDS VIROLOGY, P961; Novella IS, 1999, J MOL BIOL, V287, P459, DOI 10.1006/jmbi.1999.2635; Payne AF, 2006, J VIROL METHODS, V134, P183, DOI 10.1016/j.jviromet.2006.01.003; Presloid JB, 2008, J MOL BIOL, V382, P342, DOI 10.1016/j.jmb.2008.06.080; Reisen WK, 2008, J MED ENTOMOL, V45, P1126, DOI 10.1603/0022-2585(2008)45[1126:DVICDC]2.0.CO;2; ROSEN L, 1974, AM J TROP MED HYG, V23, P1153, DOI 10.4269/ajtmh.1974.23.1153; TAYLOR WP, 1975, J GEN VIROL, V28, P59, DOI 10.1099/0022-1317-28-1-59; Trainor NB, 2007, VIROLOGY, V360, P398, DOI 10.1016/j.virol.2006.10.033; Turner PE, 2000, GENETICS, V156, P1465; Vasilakis N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000467; Vignuzzi M, 2006, NATURE, V439, P344, DOI 10.1038/nature04388; Weaver SC, 1999, J VIROL, V73, P4316, DOI 10.1128/JVI.73.5.4316-4326.1999; Zarate S, 2004, J VIROL, V78, P12236, DOI 10.1128/JVI.78.22.12236-12242.2004	33	42	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2009	4	11							e7876	10.1371/journal.pone.0007876	http://dx.doi.org/10.1371/journal.pone.0007876			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520OG	19924238	Green Published, Green Submitted, gold			2022-12-25	WOS:000271854200021
J	Voss, JE; Scally, SW; Taylor, NL; Atkinson, SC; Griffin, MDW; Hutton, CA; Parker, MW; Alderton, MR; Gerrard, JA; Dobson, RCJ; Dogovski, C; Perugini, MA				Voss, Jarrod E.; Scally, Stephen W.; Taylor, Nicole L.; Atkinson, Sarah C.; Griffin, Michael D. W.; Hutton, Craig A.; Parker, Michael W.; Alderton, Malcolm R.; Gerrard, Juliet A.; Dobson, Renwick C. J.; Dogovski, Con; Perugini, Matthew A.			Substrate-mediated Stabilization of a Tetrameric Drug Target Reveals Achilles Heel in Anthrax	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI DIHYDRODIPICOLINATE SYNTHASE; SIZE-DISTRIBUTION ANALYSIS; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; BACILLUS-ANTHRACIS; LYSINE BIOSYNTHESIS; SELF-ASSOCIATION; PURIFICATION; ULTRACENTRIFUGATION; EVOLUTION	Bacillus anthracis is a Gram-positive spore-forming bacterium that causes anthrax. With the increased threat of anthrax in biowarfare, there is an urgent need to characterize new antimicrobial targets from B. anthracis. One such target is dihydrodipicolinate synthase (DHDPS), which catalyzes the committed step in the pathway yielding meso-diaminopimelate and lysine. In this study, we employed CD spectroscopy to demonstrate that the thermostability of DHDPS from B. anthracis (Ba-DHDPS) is significantly enhanced in the presence of the substrate, pyruvate. Analytical ultracentrifugation studies show that the tetramer-dimer dissociation constant of the enzyme is 3-fold tighter in the presence of pyruvate compared with the apo form. To examine the significance of this substrate-mediated stabilization phenomenon, a dimeric mutant of Ba-DHDPS (L170E/G191E) was generated and shown to have markedly reduced activity compared with the wild-type tetramer. This demonstrates that the substrate, pyruvate, stabilizes the active form of the enzyme. We next determined the high resolution (2.15 angstrom) crystal structure of Ba-DHDPS in complex with pyruvate (3HIJ) and compared this to the apo structure (1XL9). Structural analyses show that there is a significant (91 angstrom(2)) increase in buried surface area at the tetramerization interface of the pyruvate-bound structure. This study describes a new mechanism for stabilization of the active oligomeric form of an antibiotic target from B. anthracis and reveals an "Achilles heel" that can be exploited in structure-based drug design.	[Voss, Jarrod E.; Scally, Stephen W.; Taylor, Nicole L.; Atkinson, Sarah C.; Griffin, Michael D. W.; Parker, Michael W.; Dobson, Renwick C. J.; Dogovski, Con; Perugini, Matthew A.] Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia; [Hutton, Craig A.] Univ Melbourne, Sch Chem, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia; [Parker, Michael W.] St Vincents Inst Med Res, Fitzroy, Vic 3065, Australia; [Alderton, Malcolm R.] Def Sci & Technol Org, Human Protect & Performance Div, Fishermans Bend, Vic 3207, Australia; [Gerrard, Juliet A.] Univ Canterbury, Sch Biol Sci, Christchurch 8020, New Zealand	University of Melbourne; University of Melbourne; St. Vincent's Institute of Medical Research; Defence Science & Technology; University of Canterbury	Perugini, MA (corresponding author), Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, 30 Flemington Rd, Parkville, Vic 3010, Australia.	perugini@unimelb.edu.au	Dobson, Renwick/AAZ-7020-2021; Hutton, Craig/M-2442-2013; Parker, Michael W/F-9069-2013; Dobson, Renwick/A-9188-2011	Dobson, Renwick/0000-0002-5506-4939; Hutton, Craig/0000-0002-2353-9258; Parker, Michael W/0000-0002-3101-1138; Atkinson, Sarah/0000-0002-3518-9785; Griffin, Michael/0000-0001-9845-7735; Perugini, Matthew/0000-0001-8052-5584; Scally, Stephen/0000-0002-4264-7772	Defense Threat Reduction Agency [AB07CBT004]; Australian Research Council Future Fellowship; Federation Fellowship	Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Australian Research Council Future Fellowship(Australian Research Council); Federation Fellowship	This work was supported in part by the Defense Threat Reduction Agency (Project ID AB07CBT004) and by an Australian Research Council Future Fellowship ( to M. A. P.) and a Federation Fellowship ( to M. W. P.).	Athamna A, 2004, J ANTIMICROB CHEMOTH, V53, P247, DOI 10.1093/jac/dkh016; Blagova E, 2006, PROTEINS, V62, P297, DOI 10.1002/prot.20684; Blickling S, 1997, BIOCHEMISTRY-US, V36, P24, DOI 10.1021/bi962272d; Blickling S, 1997, J MOL BIOL, V274, P608, DOI 10.1006/jmbi.1997.1393; Brey RN, 2005, ADV DRUG DELIVER REV, V57, P1266, DOI 10.1016/j.addr.2005.01.028; Burgess BR, 2008, J BIOL CHEM, V283, P27598, DOI 10.1074/jbc.M804231200; CREMER J, 1988, J GEN MICROBIOL, V134, P3221; Demeler B, 2004, ANAL BIOCHEM, V335, P279, DOI 10.1016/j.ab.2004.08.039; Demeler B, 2005, ANALYTICAL ULTRACENTRIFUGATION: TECHNIQUES AND METHODS, P210; DEREPPE C, 1992, PLANT PHYSIOL, V98, P813, DOI 10.1104/pp.98.3.813; Dobson RCJ, 2005, ACTA CRYSTALLOGR D, V61, P1116, DOI 10.1107/S0907444905016318; Dobson RCJ, 2004, J MOL BIOL, V338, P329, DOI 10.1016/j.jmb.2004.02.060; Domigan LJ, 2009, BBA-PROTEINS PROTEOM, V1794, P1510, DOI 10.1016/j.bbapap.2009.06.020; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Forouhar F, 2007, P NATL ACAD SCI USA, V104, P473, DOI 10.1073/pnas.0610007104; FRISCH DA, 1991, PLANT PHYSIOL, V96, P444, DOI 10.1104/pp.96.2.444; Girish TS, 2008, FEBS LETT, V582, P2923, DOI 10.1016/j.febslet.2008.07.035; Griffin MDW, 2008, J MOL BIOL, V380, P691, DOI 10.1016/j.jmb.2008.05.038; Hutton CA, 2007, MOL BIOSYST, V3, P458, DOI 10.1039/b705624a; Kefala G, 2008, BIOCHEM J, V411, P351, DOI 10.1042/BJ20071360; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Koch R, 1876, BEITR BIOL PFLANZ, V2, P277; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LABER B, 1992, BIOCHEM J, V288, P691, DOI 10.1042/bj2880691; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; LESLIE AGW, 1991, CRYSTALLOGRAPHIC COM, V5, P50; MATSUMURA M, 1984, BIOCHIM BIOPHYS ACTA, V786, P9, DOI 10.1016/0167-4838(84)90147-X; Melo RC, 2007, GENET MOL RES, V6, P946; Pearce FG, 2006, BIOCHEM J, V400, P359, DOI 10.1042/BJ20060771; Pedone E, 2003, BIOCHEM J, V373, P875, DOI 10.1042/BJ20021747; Perugini MA, 2000, J BIOL CHEM, V275, P36758, DOI 10.1074/jbc.M005565200; Perugini MA, 2005, EUR BIOPHYS J BIOPHY, V34, P469, DOI 10.1007/s00249-005-0491-y; Rice EA, 2008, ARCH BIOCHEM BIOPHYS, V480, P111, DOI 10.1016/j.abb.2008.09.018; Scapin G, 1998, ADV ENZYMOL RAMB, V72, P279; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SMITH H, 1956, NATURE, V178, P865, DOI 10.1038/178865a0; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014; Voss JE, 2009, ACTA CRYSTALLOGR F, V65, P188, DOI 10.1107/S1744309109000670; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Wolterink-van Loo S, 2008, EXTREMOPHILES, V12, P461, DOI 10.1007/s00792-008-0152-z; YUGARI YASUMI, 1965, J BIOL CHEM, V240, P4710	45	38	38	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5188	5195		10.1074/jbc.M109.038166	http://dx.doi.org/10.1074/jbc.M109.038166			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	19948665	hybrid, Green Published			2022-12-25	WOS:000275327200011
J	Shaban, NM; Harvey, S; Perrino, FW; Hollis, T				Shaban, Nadine M.; Harvey, Scott; Perrino, Fred W.; Hollis, Thomas			The Structure of the Mammalian RNase H2 Complex Provides Insight into RNA center dot DNA Hybrid Processing to Prevent Immune Dysfunction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AICARDI-GOUTIERES-SYNDROME; CRYSTAL-STRUCTURE; RNA/DNA HYBRID; SUBSTRATE-SPECIFICITY; TOPOISOMERASE-I; RIBONUCLEASE-H; TRANSCRIPTION; INITIATION; PROTEINS; PRIMER	The mammalian RNase H2 ribonuclease complex has a critical function in nucleic acid metabolism to prevent immune activation with likely roles in processing of RNA primers in Okazaki fragments during DNA replication, in removing ribonucleotides misinserted by DNA polymerases, and in eliminating RNA center dot DNA hybrids during cell death. Mammalian RNase H2 is a heterotrimeric complex of the RNase H2A, RNase H2B, and RNase H2C proteins that are all required for proper function and activity. Mutations in the human RNase H2 genes cause Aicardi-Goutieres syndrome. We have determined the crystal structure of the three-protein mouse RNase H2 enzyme complex to better understand the molecular basis of RNase H2 dysfunction in human autoimmunity. The structure reveals the intimately interwoven architecture of RNase H2B and RNase H2C that interface with RNase H2A in a complex ideally suited for nucleic acid binding and hydrolysis coupled to protein-protein interaction motifs that could allow for efficient participation in multiple cellular functions. We have identified four conserved acidic residues in the active site that are necessary for activity and suggest a two-metal ion mechanism of catalysis for RNase H2. An Okazaki fragment has been modeled into the RNase H2 nucleic acid binding site providing insight into the recognition of RNA center dot DNA junctions by the RNase H2. Further structural and biochemical analyses show that some RNase H2 disease-causing mutations likely result in aberrant protein-protein interactions while the RNase H2A subunit-G37S mutation appears to distort the active site accounting for the demonstrated substrate specificity modification.	[Shaban, Nadine M.; Harvey, Scott; Perrino, Fred W.; Hollis, Thomas] Wake Forest Univ, Bowman Gray Sch Med, Struct Biol Ctr, Dept Biochem, Winston Salem, NC 27157 USA	Wake Forest University; Wake Forest Baptist Medical Center	Hollis, T (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Struct Biol Ctr, Dept Biochem, Med Ctr Blvd, Winston Salem, NC 27157 USA.	thollis@wfubmc.edu			National Institutes of Health [R01-GM069962]; Alliance for Lupus Research [67692]; American Cancer Society [RSG-04-187-01-GMC]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069962] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alliance for Lupus Research; American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-GM069962 (to F. W. P.). This work was also supported by the Alliance for Lupus Research (Grant 67692 to F. W. P.) and the American Cancer Society (Grant RSG-04-187-01-GMC to T. H.).	Ayyagari R, 2003, J BIOL CHEM, V278, P1618, DOI 10.1074/jbc.M209801200; Baaklini I, 2004, MOL MICROBIOL, V54, P198, DOI 10.1111/j.1365-2958.2004.04258.x; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bergoglio V, 2003, J MOL BIOL, V331, P1017, DOI 10.1016/S0022-2836(03)00837-4; Brown TA, 2008, J BIOL CHEM, V283, P36743, DOI 10.1074/jbc.M806174200; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Cerritelli SM, 2009, FEBS J, V276, P1494, DOI 10.1111/j.1742-4658.2009.06908.x; Chapados BR, 2001, J MOL BIOL, V307, P541, DOI 10.1006/jmbi.2001.4494; Chon H, 2006, J MOL BIOL, V356, P165, DOI 10.1016/j.jmb.2005.11.017; Chon HG, 2009, NUCLEIC ACIDS RES, V37, P96, DOI 10.1093/nar/gkn913; Crow YJ, 2008, DEV MED CHILD NEUROL, V50, P410, DOI 10.1111/j.1469-8749.2008.02062.x; Crow YJ, 2006, NAT GENET, V38, P910, DOI 10.1038/ng1842; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; Dalhus B, 2009, NAT STRUCT MOL BIOL, V16, P138, DOI 10.1038/nsmb.1538; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; de Silva U, 2007, J BIOL CHEM, V282, P10537, DOI 10.1074/jbc.M700039200; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; EDER PS, 1993, BIOCHIMIE, V75, P123, DOI 10.1016/0300-9084(93)90033-O; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FRANK P, 1994, NUCLEIC ACIDS RES, V22, P5247, DOI 10.1093/nar/22.24.5247; Frank P, 1998, P NATL ACAD SCI USA, V95, P12872, DOI 10.1073/pnas.95.22.12872; Gaiser F, 2000, J MOL BIOL, V302, P1119, DOI 10.1006/jmbi.2000.4110; GILBERT W, 1986, NATURE, V319, P618, DOI 10.1038/319618a0; Haruki M, 2002, FEBS LETT, V531, P204, DOI 10.1016/S0014-5793(02)03503-2; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Horton NC, 1996, J MOL BIOL, V264, P521, DOI 10.1006/jmbi.1996.0658; Hraiky C, 2000, J BIOL CHEM, V275, P11257, DOI 10.1074/jbc.275.15.11257; Ide H, 1993, Nucleic Acids Symp Ser, P133; ITOH T, 1980, P NATL ACAD SCI-BIOL, V77, P2450, DOI 10.1073/pnas.77.5.2450; Jern P, 2008, ANNU REV GENET, V42, P709, DOI 10.1146/annurev.genet.42.110807.091501; Kamada K, 2003, P NATL ACAD SCI USA, V100, P2296, DOI 10.1073/pnas.262798199; Khaperskyy DA, 2008, MOL CELL BIOL, V28, P3757, DOI 10.1128/MCB.02272-07; Kopka ML, 2003, J MOL BIOL, V334, P653, DOI 10.1016/j.jmb.2003.09.057; Lai LH, 2000, STRUCTURE, V8, P897, DOI 10.1016/S0969-2126(00)00179-9; Maitra S., 2000, AMIDE LINKAGE STRUCT, P495; McElhinny SAN, 2003, MOL CELL BIOL, V23, P2309, DOI 10.1128/MCB.23.7.2309-2315.2003; Morita M, 2004, MOL CELL BIOL, V24, P6719, DOI 10.1128/MCB.24.15.6719-6727.2004; Muroya A, 2001, PROTEIN SCI, V10, P707, DOI 10.1110/ps.48001; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nowotny M, 2005, CELL, V121, P1005, DOI 10.1016/j.cell.2005.04.024; OGAWA T, 1980, ANNU REV BIOCHEM, V49, P421, DOI 10.1146/annurev.bi.49.070180.002225; Ohtani N, 1999, BIOCHEMISTRY-US, V38, P605, DOI 10.1021/bi982207z; OKAZAKI T, 1979, COLD SPRING HARB SYM, V43, P203, DOI 10.1101/SQB.1979.043.01.026; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pallan PS, 2008, CELL CYCLE, V7, P2562, DOI 10.4161/cc.7.16.6461; Perrino FW, 2009, J MOL MED-JMM, V87, P25, DOI 10.1007/s00109-008-0422-3; Qiu JZ, 1999, MOL CELL BIOL, V19, P8361, DOI 10.1128/mcb.19.12.8361; Rice G, 2007, AM J HUM GENET, V81, P713, DOI 10.1086/521373; Rice G, 2007, AM J HUM GENET, V80, P811, DOI 10.1086/513443; Rigby RE, 2008, BIOESSAYS, V30, P833, DOI 10.1002/bies.20808; Robert F, 2000, METH MOL B, V148, P383; Robert F, 1998, MOL CELL, V2, P341, DOI 10.1016/S1097-2765(00)80278-6; Rossi ML, 2006, CHEM REV, V106, P453, DOI 10.1021/cr040497l; Rydberg B, 2002, P NATL ACAD SCI USA, V99, P16654, DOI 10.1073/pnas.262591699; Skubak P, 2004, ACTA CRYSTALLOGR D, V60, P2196, DOI 10.1107/S0907444904019079; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; TEMIN HM, 1985, MOL BIOL EVOL, V2, P455; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Yang W, 2006, MOL CELL, V22, P5, DOI 10.1016/j.molcel.2006.03.013; Yang YG, 2007, CELL, V131, P873, DOI 10.1016/j.cell.2007.10.017	60	40	43	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3617	3624		10.1074/jbc.M109.059048	http://dx.doi.org/10.1074/jbc.M109.059048			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19923215	Green Published, hybrid			2022-12-25	WOS:000275254000013
J	Chen, JF; Chen, CL; Rawale, S; Chen, CA; Zweier, JL; Kaumaya, PTP; Chen, YR				Chen, Jingfeng; Chen, Chwen-Lih; Rawale, Sharad; Chen, Chun-An; Zweier, Jay L.; Kaumaya, Pravin T. P.; Chen, Yeong-Renn			Peptide-based Antibodies against Glutathione-binding Domains Suppress Superoxide Production Mediated by Mitochondrial Complex I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADH-UBIQUINONE OXIDOREDUCTASE; BOVINE HEART-MITOCHONDRIA; NITRIC-OXIDE; POSTISCHEMIC HEART; RADICAL FORMATION; OXIDATIVE STRESS; S-NITROSYLATION; GENERATION; PROTEINS; SITE	Complex I (NQR) is a critical site of superoxide (O-2(radical anion)) production and the major host of redox protein thiols in mitochondria. In response to oxidative stress, NQR-derived protein thiols at the 51- and 75-kDa subunits are known to be reversibly S-glutathionylated. Although several glutathionylated domains from NQR 51 and 75 kDa have been identified, their roles in the regulatory functions remain to be explored. To gain further insights into protein S-glutathionylation of complex I, we used two peptides of S-glutathionylated domain ((200)GAGAYI (C) under bar GEETALIESIEGK(219) of 51-kDa protein and (VDSDTL)-V-361 (C) under bar TEEVFPTAGAGTDLR(382) of 75-kDa protein) as chimeric epitopes incorporating a "promiscuous" T-cell epitope to generate two polyclonal antibodies, AbGSCA206 and AbGSCB367. Binding of AbGSCA206 and AbGSCB367 inhibited NQR-mediated O-2(radical anion). generation by 37 and 57%, as measured by EPR spin-trapping. To further provide an appropriate control, two peptides of non-glutathionylated domain ((21)SGDTTAPKKTSFGSLKDFDR(40) of 51-kDa peptide and (100)WNILTNSEKTKKAREGVMEFL(120) of 75-kDa peptide) were synthesized as chimeric epitopes to generate two polyclonal antibodies, Ab51 and Ab75. Binding of A51 did not affect NQR-mediated O-2(radical anion) generation to a significant level. However, binding of Ab75 inhibited NQR- mediated O-2(radical anion) generation by 35%. None of AbGSCA206, AbGSCB367, Ab51, or Ab75 showed an inhibitory effect on the electron transfer activity of NQR, suggesting that antibody binding to the glutathione-binding domain decreased electron leakage from the hydrophilic domain of NQR. When heart tissue homogenates were immunoprecipitated with Ab51 or Ab75 and probed with an antibody against glutathione, protein S-glutathionylation was enhanced in post-ischemic myocardium at the NQR 51-kDa subunit, but not at the 75-kDa subunit, indicating that the 51-kDa subunit of flavin subcomplex is more sensitive to oxidative stress resulting from myocardial infarction.	[Chen, Jingfeng; Chen, Chwen-Lih; Chen, Chun-An; Zweier, Jay L.; Chen, Yeong-Renn] Ohio State Univ, Coll Med, Davis Heart & Lung Res Inst, Div Cardiovasc Med,Dept Internal Med, Columbus, OH 43210 USA; [Rawale, Sharad; Kaumaya, Pravin T. P.] Ohio State Univ, Coll Med, Dept Obstet & Gynecol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Chen, YR (corresponding author), Northeastern Ohio Univ Coll Med & Pharm, Dept Integrat Med Sci, 4209 State Route 44, Rootstown, OH 44272 USA.	ychen1@neoucom.edu	Kaumaya, Pravin T. P/E-3354-2011		National Institutes of Health [HL83237, HL63744]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083237, R01HL063744] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL83237 (to Y.-R.C.) and HL63744 (to J.L.Z.).	Beer SM, 2004, J BIOL CHEM, V279, P47939, DOI 10.1074/jbc.M408011200; Beltran B, 2000, BRIT J PHARMACOL, V129, P953, DOI 10.1038/sj.bjp.0703147; Chen CL, 2007, BIOCHEMISTRY-US, V46, P5754, DOI 10.1021/bi602580c; Chen YR, 2007, J BIOL CHEM, V282, P32640, DOI 10.1074/jbc.M702294200; Chen YR, 2005, J BIOL CHEM, V280, P37339, DOI 10.1074/jbc.M503936200; Clementi E, 1998, P NATL ACAD SCI USA, V95, P7631, DOI 10.1073/pnas.95.13.7631; Costa NJ, 2003, ANTIOXID REDOX SIGN, V5, P291, DOI 10.1089/152308603322110878; Dakappagari NK, 2005, J BIOL CHEM, V280, P54, DOI 10.1074/jbc.M411020200; DULING DR, 1994, J MAGN RESON SER B, V104, P105, DOI 10.1006/jmrb.1994.1062; FREJAVILLE C, 1995, J MED CHEM, V38, P258, DOI 10.1021/jm00002a007; GALANTE YM, 1979, ARCH BIOCHEM BIOPHYS, V192, P559, DOI 10.1016/0003-9861(79)90126-7; Galkin A, 2005, J BIOL CHEM, V280, P30129, DOI 10.1074/jbc.M504709200; Gallogly MM, 2007, CURR OPIN PHARMACOL, V7, P381, DOI 10.1016/j.coph.2007.06.003; Gong X, 2003, J BIOL CHEM, V278, P25731, DOI 10.1074/jbc.M302361200; Guo YR, 1998, AM J PHYSIOL-HEART C, V275, pH1375; Hatefi Y, 1978, Methods Enzymol, V53, P11; Hurd TR, 2008, J BIOL CHEM, V283, P24801, DOI 10.1074/jbc.M803432200; Hurd TR, 2005, BIOCHEM SOC T, V33, P1390, DOI 10.1042/BST0331390; Hurd TR, 2005, ANTIOXID REDOX SIGN, V7, P999, DOI 10.1089/ars.2005.7.999; KOBSCONRAD S, 1993, J BIOL CHEM, V268, P25285; Kudin AP, 2004, J BIOL CHEM, V279, P4127, DOI 10.1074/jbc.M310341200; Kussmaul L, 2006, P NATL ACAD SCI USA, V103, P7607, DOI 10.1073/pnas.0510977103; Magnitsky S, 2002, J BIOENERG BIOMEMBR, V34, P193, DOI 10.1023/A:1016083419979; Ohnishi ST, 2005, J BIOENERG BIOMEMBR, V37, P1, DOI 10.1007/s10863-005-4117-y; Rahman I, 2006, NAT PROTOC, V1, P3159, DOI 10.1038/nprot.2006.378; REDFEARN ER, 1966, BIOCHIM BIOPHYS ACTA, V118, P413, DOI 10.1016/S0926-6593(66)80050-4; Roubaud V, 1997, ANAL BIOCHEM, V247, P404, DOI 10.1006/abio.1997.2067; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; Sundaram R, 2004, J BIOL CHEM, V279, P24141, DOI 10.1074/jbc.M313210200; Taylor ER, 2003, J BIOL CHEM, V278, P19603, DOI 10.1074/jbc.M209359200; Vasquez-Vivar J, 1998, P NATL ACAD SCI USA, V95, P9220, DOI 10.1073/pnas.95.16.9220; Vinogradov A D, 1979, Methods Enzymol, V55, P118; Wang PH, 1996, J BIOL CHEM, V271, P29223, DOI 10.1074/jbc.271.46.29223; Zhao X, 2005, CIRCULATION, V111, P2966, DOI 10.1161/CIRCULATIONAHA.104.527226; ZWEIER JL, 1989, J BIOL CHEM, V264, P18890	36	31	32	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5					3168	3180		10.1074/jbc.M109.056846	http://dx.doi.org/10.1074/jbc.M109.056846			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19940158	Green Published, hybrid			2022-12-25	WOS:000273829000032
J	Liang, CC; Wang, CR; Peng, X; Gan, BY; Guan, JL				Liang, Chun-Chi; Wang, Chenran; Peng, Xu; Gan, Boyi; Guan, Jun-Lin			Neural-specific Deletion of FIP200 Leads to Cerebellar Degeneration Caused by Increased Neuronal Death and Axon Degeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; INTRACELLULAR PROTEIN-DEGRADATION; AMYOTROPHIC-LATERAL-SCLEROSIS; CENTRAL-NERVOUS-SYSTEM; AUTOPHAGOSOME FORMATION; MOLECULAR MACHINERY; MOUSE MODELS; DISEASE; CELLS; MICE	FIP200 (FAK family-interacting protein of 200 kDa) is a conserved protein recently identified as a potential mammalian counterpart of yeast autophagy protein Atg17. However, it remains unknown whether mammalian FIP200 regulates autophagy in vivo. Here we show that neural-specific deletion of FIP200 resulted in cerebellar degeneration accompanied by progressive neuronal loss, spongiosis, and neurite degeneration in the cerebellum. Furthermore, deletion of FIP200 led to increased apoptosis in cerebellum as well as accumulation of ubiquitinated protein aggregates without any deficiency in proteasome catalytic functions. We also observed an increased p62/SQSTM1 accumulation in the cerebellum and reduced autophagosome formation as well as accumulation of damaged mitochondria in the mutant mice. Lastly, analysis of cerebellar neurons in vitro showed reduced JNK activation and increased susceptibility to serum deprivation-induced apoptosis in cerebellar neurons from the mutant mice. Taken together, these results provide strong genetic evidence for a role of FIP200 in the regulation of neuronal homeostasis through its function in autophagy in vivo.	[Liang, Chun-Chi; Wang, Chenran; Peng, Xu; Gan, Boyi; Guan, Jun-Lin] Univ Michigan, Sch Med, Dept Internal Med, Div Mol Med & Genet, Ann Arbor, MI 48109 USA; [Guan, Jun-Lin] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Guan, JL (corresponding author), Univ Michigan, Sch Med, Dept Internal Med, Div Mol Med & Genet, 109 Zina Pitcher,Rm 3027 BSRB, Ann Arbor, MI 48109 USA.	jlguan@umich.edu	Gan, Boyi/HDM-4206-2022; wang, chenran/N-6629-2013; Liang, Chun-Chi/D-7986-2016; Liang, Richard Chun-Chi/C-6989-2013	Liang, Chun-Chi/0000-0002-8345-8564; 	National Institutes of Health [GM52890]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052890] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM52890 (to J.- L. G.).	Akassoglou K, 2004, P NATL ACAD SCI USA, V101, P5075, DOI 10.1073/pnas.0401030101; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Bates B, 1999, NAT NEUROSCI, V2, P115, DOI 10.1038/5669; Bendiske J, 2003, J NEUROPATH EXP NEUR, V62, P451, DOI 10.1093/jnen/62.5.451; Berke SJS, 2003, CURR OPIN GENET DEV, V13, P253, DOI 10.1016/S0959-437X(03)00053-4; Bossy-Wetzel E, 2004, NAT MED, V10, pS2, DOI 10.1038/nm1067; Chano T, 2007, BRAIN RES, V1168, P97, DOI 10.1016/j.brainres.2007.06.075; Chano T, 2006, INT J MOL MED, V18, P425; Ciechanover A, 2003, NEURON, V40, P427, DOI 10.1016/S0896-6273(03)00606-8; Ciechanover Aaron, 2006, Hematology Am Soc Hematol Educ Program, P1; Craiu A, 1997, J BIOL CHEM, V272, P13437, DOI 10.1074/jbc.272.20.13437; DAHLSTRAND J, 1995, DEV BRAIN RES, V84, P109, DOI 10.1016/0165-3806(94)00162-S; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Fortun J, 2003, J NEUROSCI, V23, P10672; Frappart PO, 2007, EMBO J, V26, P2732, DOI 10.1038/sj.emboj.7601703; Gan B, 2008, CELL SIGNAL, V20, P787, DOI 10.1016/j.cellsig.2007.10.021; Gan BY, 2006, J CELL BIOL, V175, P121, DOI 10.1083/jcb.200604129; Ganley IG, 2009, J BIOL CHEM, V284, P12297, DOI 10.1074/jbc.M900573200; Goldowitz D, 1998, TRENDS NEUROSCI, V21, P375, DOI 10.1016/S0166-2236(98)01313-7; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hara T, 2009, AUTOPHAGY, V5, P85, DOI 10.4161/auto.5.1.7180; Hooper NM, 2003, TRENDS BIOTECHNOL, V21, P144, DOI 10.1016/S0167-7799(03)00026-X; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Iwata A, 2005, P NATL ACAD SCI USA, V102, P13135, DOI 10.1073/pnas.0505801102; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Klionsky DJ, 2005, J CELL SCI, V118, P7, DOI 10.1242/jcs.01620; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kundu M, 2008, ANNU REV PATHOL-MECH, V3, P427, DOI 10.1146/annurev.pathmechdis.2.010506.091842; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Matalon R, 2000, J GENE MED, V2, P165; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; Melov S, 1998, NAT GENET, V18, P159, DOI 10.1038/ng0298-159; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2007, ANNU REV NUTR, V27, P19, DOI 10.1146/annurev.nutr.27.061406.093749; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Puccio H, 2001, NAT GENET, V27, P181, DOI 10.1038/84818; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Ravikumar B, 2002, HUM MOL GENET, V11, P1107, DOI 10.1093/hmg/11.9.1107; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Sillitoe RV, 2007, ANNU REV CELL DEV BI, V23, P549, DOI 10.1146/annurev.cellbio.23.090506.123237; Simonsen A, 2009, J CELL BIOL, V186, P773, DOI 10.1083/jcb.200907014; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681; Suzuki K, 2007, FEBS LETT, V581, P2156, DOI 10.1016/j.febslet.2007.01.096; Ueda H, 2000, J CELL BIOL, V149, P423, DOI 10.1083/jcb.149.2.423; Wang VY, 2001, NAT REV NEUROSCI, V2, P484, DOI 10.1038/35081558; Wei HJ, 2009, J BIOL CHEM, V284, P6004, DOI 10.1074/jbc.M806375200; WOOD KA, 1993, NEURON, V11, P621, DOI 10.1016/0896-6273(93)90074-2; Wooten MW, 2008, J BIOL CHEM, V283, P6783, DOI 10.1074/jbc.M709496200	54	153	155	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5					3499	3509		10.1074/jbc.M109.072389	http://dx.doi.org/10.1074/jbc.M109.072389			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19940130	hybrid, Green Published			2022-12-25	WOS:000273829000064
J	Prescott, J; Lu, YN; Chang, ET; Sullivan-Halley, J; Henderson, KD; Clarke, CA; Ma, HY; Templeman, C; Deapen, D; Bernstein, L				Prescott, Jennifer; Lu, Yani; Chang, Ellen T.; Sullivan-Halley, Jane; Henderson, Katherine D.; Clarke, Christina A.; Ma, Huiyan; Templeman, Claire; Deapen, Dennis; Bernstein, Leslie			Reproductive Factors and Non-Hodgkin Lymphoma Risk in the California Teachers Study	PLOS ONE			English	Article							EXOGENOUS HORMONE USE; BREAST-CANCER; UNITED-STATES; WOMEN; PREGNANCY; EPIDEMIOLOGY; NEOPLASMS; CLASSIFICATION; PROGESTERONE; CONNECTICUT	Non-Hodgkin lymphoma (NHL) is a malignancy etiologically linked to immunomodulatory exposures and disorders. Endogenous female sex hormones may modify immune function and influence NHL risk. Few studies have examined associations between reproductive factors, which can serve as surrogates for such hormonal exposures, and NHL risk by subtype. Methodology/Principal Findings: Women in the California Teachers Study cohort provided detailed data in 1995-1996 on reproductive history. Follow-up through 2007 identified 574 women with incident B-cell NHL. Hazard rate ratios (RR) and 95% confidence intervals (CI) were estimated using Cox proportional hazards models to assess associations between reproductive factors and all B-cell NHL combined, diffuse large B-cell lymphomas, follicular lymphomas, and B-cell chronic lmphocytic leukemias/small lymphocytic lymphomas. Pregnancy was marginally associated with lower risk of B-cell NHL (RR = 0.84, 95% CI = 0.68-1.04). Much of the reduction in risk was observed after one full-term pregnancy relative to nulligravid women (RR = 0.75, 95% CI = 0.54-1.06; P for trend <0.01), particularly for diffuse large B-cell lymphomas (P for trend = 0.13), but not among women who had only incomplete pregnancies. Age at first full-term pregnancy was marginally inversely associated with B-cell NHL risk overall (P for trend = 0.08) and for diffuse large B-cell lymphomas (P for trend = 0.056). Breast feeding was not associated with B-cell NHL risk overall or by subtype. Conclusions: Full-term pregnancy and early age at first full-term pregnancy account for most of the observed reduction in B-cell NHL risk associated with gravidity. Pregnancy-related hormonal exposures, including prolonged and high-level exposure to progesterone during a full-term pregnancy may inhibit development of B-cell NHL.	[Prescott, Jennifer] Harvard Univ, Sch Publ Hlth, Program Mol & Genet Epidemiol, Boston, MA 02115 USA; [Prescott, Jennifer] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; [Prescott, Jennifer] Harvard Univ, Sch Med, Boston, MA USA; [Lu, Yani; Sullivan-Halley, Jane; Henderson, Katherine D.; Ma, Huiyan; Bernstein, Leslie] City Hope Natl Med Ctr, Duarte, CA 91010 USA; [Chang, Ellen T.; Clarke, Christina A.] No Calif Canc Ctr, Fremont, CA USA; [Chang, Ellen T.; Clarke, Christina A.] Stanford Univ, Sch Med, Div Epidemiol, Dept Hlth Res & Policy, Stanford, CA 94305 USA; [Templeman, Claire; Deapen, Dennis] Univ So Calif, Keck Sch Med, Dept Prevent Med, Kenneth Norris Jr Comprehens Canc Ctr, Los Angeles, CA 90033 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; City of Hope; Stanford University; University of Southern California	Prescott, J (corresponding author), Harvard Univ, Sch Publ Hlth, Program Mol & Genet Epidemiol, 665 Huntington Ave, Boston, MA 02115 USA.	LBernstein@coh.org	Chang, Ellen/E-3168-2010; Chang, Ellen/G-5700-2010		California Breast Cancer Act of 1993; National Institutes of Health [R01 CA77398]; California Breast Cancer Research Fund [97-10500]; NIH/National Institute on Aging (NIA) [5-T32-AG00037-29]; NATIONAL CANCER INSTITUTE [K05CA136967, R01CA077398] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000037] Funding Source: NIH RePORTER	California Breast Cancer Act of 1993; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Breast Cancer Research Fund; NIH/National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the California Breast Cancer Act of 1993, the National Institutes of Health (http://www.nih.gov/) grant R01 CA77398, and contract 97-10500 from the California Breast Cancer Research Fund (http://www.cbcrp.org/). JP was supported by NIH/National Institute on Aging (NIA) training grant 5-T32-AG00037-29. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adami HO, 1997, INT J CANCER, V70, P155, DOI 10.1002/(SICI)1097-0215(19970117)70:2<155::AID-IJC3>3.0.CO;2-W; BERNSTEIN L, 1992, CANCER RES, V52, pS5510; Bernstein L, 2002, CANCER CAUSE CONTROL, V13, P625, DOI 10.1023/A:1019552126105; Cerhan JR, 2002, CANCER CAUSE CONTROL, V13, P131, DOI 10.1023/A:1014354105164; Druckmann R, 2005, J STEROID BIOCHEM, V97, P389, DOI 10.1016/j.jsbmb.2005.08.010; Fisher SG, 2004, ONCOGENE, V23, P6524, DOI 10.1038/sj.onc.1207843; Frisch M, 1997, INT J CANCER, V71, P127, DOI 10.1002/(SICI)1097-0215(19970328)71:1<127::AID-IJC21>3.0.CO;2-E; Frisch M, 2006, EUR J EPIDEMIOL, V21, P673, DOI 10.1007/s10654-006-9035-8; HARRIS NL, 1994, BLOOD, V84, P1361; Hennessy BT, 2004, LANCET ONCOL, V5, P341, DOI 10.1016/S1470-2045(04)01490-1; Holly EA, 1999, AM J EPIDEMIOL, V150, P375, DOI 10.1093/oxfordjournals.aje.a010017; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; KLEIHUES P, 2001, WHO CLASSIFICATION T; Lee JS, 2008, AM J EPIDEMIOL, V168, P278, DOI 10.1093/aje/kwn119; LINDBERG BS, 1974, ACTA OBSTET GYN SCAN, P21; MACMAHON B, 1982, INT J CANCER, V30, P427, DOI 10.1002/ijc.2910300408; MOOR RM, 1968, P ROY SOC MED, V61, P1217, DOI 10.1177/003591576806111P206; Morton LM, 2007, BLOOD, V110, P695, DOI 10.1182/blood-2006-11-051672; Morton LM, 2009, INT J CANCER, V124, P2737, DOI 10.1002/ijc.24248; Morton LM, 2006, BLOOD, V107, P265, DOI 10.1182/blood-2005-06-2508; Muller AMS, 2005, ANN HEMATOL, V84, P1, DOI 10.1007/s00277-004-0939-7; Nelson RA, 2001, J CLIN ONCOL, V19, P1381, DOI 10.1200/JCO.2001.19.5.1381; OLSSON H, 1990, NEOPLASMA, V37, P185; Raghupathy R, 2008, FRONT BIOSCI-LANDMRK, V13, P985, DOI 10.2741/2737; Reynolds P, 2004, EPIDEMIOLOGY, V15, P746, DOI 10.1097/01.ede.0000134863.45834.50; ROSENBERG SA, 1982, CANCER, V49, P2112; Tanriverdi F, 2003, J ENDOCRINOL, V176, P293, DOI 10.1677/joe.0.1760293; Tavani A, 1997, LEUKEMIA RES, V21, P885, DOI 10.1016/S0145-2126(97)00062-3; TULCHINSKY D, 1972, AM J OBSTET GYNECOL, V112, P1095, DOI 10.1016/0002-9378(72)90185-8; VIHKO R, 1984, J STEROID BIOCHEM, V20, P231, DOI 10.1016/0022-4731(84)90209-7; Zhang YW, 2004, AM J EPIDEMIOL, V160, P766, DOI 10.1093/aje/kwh278; ZHENG TZ, 1992, CANCER, V70, P840, DOI 10.1002/1097-0142(19920815)70:4&lt;840::AID-CNCR2820700420&gt;3.0.CO;2-I	32	30	30	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2009	4	12							e8135	10.1371/journal.pone.0008135	http://dx.doi.org/10.1371/journal.pone.0008135			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MU	19956586	Green Published, gold, Green Submitted			2022-12-25	WOS:000272828800026
J	Sharma, A; Mohammad, F; Singh, P				Sharma, Abhay; Mohammad, Farhan; Singh, Priyanka			Gender Differences in a Drosophila Transcriptomic Model of Chronic Pentylenetetrazole Induced Behavioral Deficit	PLOS ONE			English	Article							SYNAPTIC PLASTICITY; GENE-EXPRESSION; BRAIN	A male Drosophila model of locomotor deficit induced by chronic pentylenetetrazole (PTZ), a proconvulsant used to model epileptogenesis in rodents, has recently been described. Antiepileptic drugs (AEDs) ameliorate development of this behavioral abnormality. Time-series of microarray profiling of heads of male flies treated with PTZ has shown epileptogenesis-like transcriptomic perturbation in the fly model. Gender differences are known to exist in neurological and psychiatric conditions including epileptogenesis. We describe here the effects of chronic PTZ in Drosophila females, and compare the results with the male model. As in males, chronic PTZ was found to cause a decreased climbing speed in females. In males, overrepresentation of Wnt, MAPK, TGF-beta, JAK-STAT, Cell communication, and Dorso-Ventral axis formation pathways in downregulated genes was previously described. Of these, female genes showed enrichment only for Dorso-Ventral axis formation. Surprisingly, the ribosomal pathway was uniquely overrepresented in genes downregulated in females. Gender differences thus exist in the Drosophila model. Gender neutral, the developmental pathway Dorso-Ventral axis formation may be considered as the candidate causal pathway in chronic pentylenetetrazole induced behavioral deficit. Prior evidence of developmental mechanisms in epileptogenesis may support potential usefulness of the fly model. Given this, gender specific pathways identified here may provide a lead for further understanding brain dimorphism in neuropsychiatric disorders.	[Sharma, Abhay; Mohammad, Farhan; Singh, Priyanka] Inst Genom & Integrat Biol, Council Sci & Ind Res, Delhi, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB)	Sharma, A (corresponding author), Inst Genom & Integrat Biol, Council Sci & Ind Res, Delhi Univ Campus, Delhi, India.	abhaysharma@igib.res.in	Mohd, Farhan/E-7184-2019; Singh, Priyanka/GRF-6098-2022	Mohd, Farhan/0000-0002-2465-1508; Sharma, Abhay/0000-0003-1306-1497	Council of Scientific and Industrial Research (CSIR), Government of India [NWP0034]	Council of Scientific and Industrial Research (CSIR), Government of India(Council of Scientific & Industrial Research (CSIR) - India)	The research was supported by NWP0034 grant of Council of Scientific and Industrial Research (CSIR), Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Christensen J, 2005, EPILEPSIA, V46, P956, DOI 10.1111/j.1528-1167.2005.51204.x; Cosgrove KP, 2007, BIOL PSYCHIAT, V62, P847, DOI 10.1016/j.biopsych.2007.03.001; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Elliott RC, 2003, J NEUROSCI, V23, P2218; Lemmens EMP, 2005, EPILEPSIA, V46, P1603, DOI 10.1111/j.1528-1167.2005.00252.x; Mohammad F, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-11; Nguon K, 2005, PROG BRAIN RES, V148, P343, DOI 10.1016/S0079-6123(04)48027-3; Nickel J, 2003, EPILEPSIA, V44, P1551, DOI 10.1111/j.0013-9580.2003.13603.x; Richter JD, 2009, GENE DEV, V23, P1, DOI 10.1101/gad.1735809; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vawter MP, 2004, NEUROPSYCHOPHARMACOL, V29, P373, DOI 10.1038/sj.npp.1300337	12	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2009	4	12							e8136	10.1371/journal.pone.0008136	http://dx.doi.org/10.1371/journal.pone.0008136			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MU	19956579	gold, Green Submitted, Green Published			2022-12-25	WOS:000272828800027
J	Hu, JB; Li, JZ; Qian, XG; Denic, V; Sha, BD				Hu, Junbin; Li, Jingzhi; Qian, Xinguo; Denic, Vlad; Sha, Bingdong			The Crystal Structures of Yeast Get3 Suggest a Mechanism for Tail-Anchored Protein Membrane Insertion	PLOS ONE			English	Article							ATPASE; TRANSLOCATION; RECOGNITION	Tail-anchored (TA) proteins represent a unique class of membrane proteins that contain a single C-terminal transmembrane helix. The post-translational insertion of the yeast TA proteins into the ER membrane requires the Golgi ER trafficking (GET) complex which contains Get1, Get2 and Get3. Get3 is an ATPase that recognizes and binds the C-terminal transmembrane domain (TMD) of the TA proteins. We have determined the crystal structures of Get3 from two yeast species, S. cerevisiae and D. hansenii, respectively. These high resolution crystal structures show that Get3 contains a nucleotide-binding domain and a "finger'' domain for binding the TA protein TMD. A large hydrophobic groove on the finger domain of S. cerevisiae Get3 structure might represent the binding site for TMD of TA proteins. A hydrophobic helix from a symmetry-related Get3 molecule sits in the TMD-binding groove and mimics the TA binding scenario. Interestingly, the crystal structures of the Get3 dimers from S. cerevisiae and D. hansenii exhibit distinct conformations. The S. cerevisiae Get3 dimer structure does not contain nucleotides and maintains an "open'' conformation, while the D. hansenii Get3 dimer structure binds ADP and stays in a "closed'' conformation. We propose that the conformational changes to switch the Get3 between the open and closed conformations may facilitate the membrane insertions for TA proteins.	[Hu, Junbin; Li, Jingzhi; Qian, Xinguo; Sha, Bingdong] Univ Alabama Birmingham, Dept Cell Biol, Birmingham, AL 35294 USA; [Denic, Vlad] Harvard Univ, Dept Mol & Cell Biol, Cambridge, MA 02138 USA	University of Alabama System; University of Alabama Birmingham; Harvard University	Hu, JB (corresponding author), Univ Alabama Birmingham, Dept Cell Biol, Birmingham, AL 35294 USA.	bdsha@uab.edu			NIH [R01 DK56203, R01 GM65959]; Army Research Office [51894LS]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065959, R01GM080261] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Army Research Office; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from NIH (R01 DK56203), NIH (R01 GM65959) and Army Research Office (51894LS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell BM, 2007, J CELL SCI, V120, P1743, DOI 10.1242/jcs.002410; Anderie I, 2007, EXP CELL RES, V313, P3189, DOI 10.1016/j.yexcr.2007.05.025; Auld KL, 2006, GENETICS, V174, P215, DOI 10.1534/genetics.106.058362; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Borgese N, 2007, CURR OPIN CELL BIOL, V19, P368, DOI 10.1016/j.ceb.2007.04.019; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hu JB, 2009, ACTA CRYSTALLOGR F, V65, P489, DOI [10.1107/S174430910901231, 10.1107/S1744309109012317]; Jonikas MC, 2009, SCIENCE, V323, P1693, DOI 10.1126/science.1167983; Kalbfleisch T, 2007, TRAFFIC, V8, P1687, DOI 10.1111/j.1600-0854.2007.00661.x; Kim PK, 2004, MOL CELL, V14, P523, DOI 10.1016/S1097-2765(04)00263-1; Kurdi-Haidar B, 1998, J BIOL CHEM, V273, P22173, DOI 10.1074/jbc.273.35.22173; KUTAY U, 1995, EMBO J, V14, P217, DOI 10.1002/j.1460-2075.1995.tb06994.x; Mateja A, 2009, NATURE, V461, P361, DOI 10.1038/nature08319; Mukhopadhyay R, 2006, FEBS LETT, V580, P3889, DOI 10.1016/j.febslet.2006.06.017; Osborne AR, 2005, ANNU REV CELL DEV BI, V21, P529, DOI 10.1146/annurev.cellbio.21.012704.133214; Schuldiner M, 2008, CELL, V134, P634, DOI 10.1016/j.cell.2008.06.025; Setoguchi K, 2006, EMBO J, V25, P5635, DOI 10.1038/sj.emboj.7601438; Shan SO, 2005, FEBS LETT, V579, P921, DOI 10.1016/j.febslet.2004.11.049; Shi K, 2007, BIOCHEM BIOPH RES CO, V363, P626, DOI 10.1016/j.bbrc.2007.09.015; Stefanovic S, 2007, CELL, V128, P1147, DOI 10.1016/j.cell.2007.01.036; SULOWAY CJ, 2009, P NATL ACAD SCI US; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Walter J, 2001, EMBO J, V20, P3124, DOI 10.1093/emboj/20.12.3124; Wickner W, 2005, SCIENCE, V310, P1452, DOI 10.1126/science.1113752; Zhou TQ, 2000, EMBO J, V19, P4838, DOI 10.1093/emboj/19.17.4838	25	49	51	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2009	4	11							e8061	10.1371/journal.pone.0008061	http://dx.doi.org/10.1371/journal.pone.0008061			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MQ	19956640	Green Published, Green Submitted, gold			2022-12-25	WOS:000272828400015
J	Saraswathi, R; Chowdhury, RP; Williams, SM; Ghatak, P; Chatterji, D				Saraswathi, Ramachandran; Chowdhury, Rakhi Pait; Williams, Sunanda Margrett; Ghatak, Payel; Chatterji, Dipankar			The Mycobacterial MsDps2 Protein Is a Nucleoid-Forming DNA Binding Protein Regulated by Sigma Factors sigma(A) and sigma(B)	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; ESCHERICHIA-COLI DPS; SMEGMATIS DPS; BACTERIA; MUTANTS; PROTECTION; SURVIVAL	The Dps (DNA-binding protein from starved cells) proteins from Mycobacterium smegmatis MsDps1 and MsDps2 are both DNA-binding proteins with some differences. While MsDps1 has two oligomeric states, with one of them responsible for DNA binding, MsDps2 has only one DNA-binding oligomeric state. Both the proteins however, show iron-binding activity. The MsDps1 protein has been shown previously to be induced under conditions of starvation and osmotic stress and is regulated by the extra cellular sigma factors sigma(H) and sigma(F). We show here, that the second Dps homologue in M. smegmatis, namely MsDps2, is purified in a DNA-bound form and exhibits nucleoid-like structures under the atomic force microscope. It appears that the N-terminal sequence of Dps2 plays a role in nucleoid formation. MsDps2, unlike MsDps1, does not show elevated expression in nutritionally starved or stationary phase conditions; rather its promoter is recognized by RNA polymerase containing sigma(A) or sigma(B), under in vitro conditions. We propose that due to the nucleoid-condensing ability, the expression of MsDps2 is tightly regulated inside the cells.	[Saraswathi, Ramachandran; Chowdhury, Rakhi Pait; Williams, Sunanda Margrett; Ghatak, Payel; Chatterji, Dipankar] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Saraswathi, R (corresponding author), Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India.	dipankar@mbu.iisc.ernet.in		Chatterji, Dipankar/0000-0002-9985-0632	Department of Biotechnology, Government of India; Department of Science and Technology, Government of India; Council of Scientific and Industrial Research, government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Department of Science and Technology, Government of India(Department of Science & Technology (India)); Council of Scientific and Industrial Research, government of India(Council of Scientific & Industrial Research (CSIR) - India)	This work is financially supported by the Department of Biotechnology and Department of Science and Technology, Government of India. R. S. and R. P. C are supported by a senior research fellowship and S. M. W. is supported by a junior research fellowship from the Council of Scientific and Industrial Research, government of India. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	ALMIRON M, 1992, GENE DEV, V6, P2646, DOI 10.1101/gad.6.12b.2646; Ceci P, 2005, J BIOL CHEM, V280, P34776, DOI 10.1074/jbc.M502343200; Ceci P, 2004, NUCLEIC ACIDS RES, V32, P5935, DOI 10.1093/nar/gkh915; Ceci P, 2007, NUCLEIC ACIDS RES, V35, P2247, DOI 10.1093/nar/gkm077; Chowdhury RP, 2007, J BACTERIOL, V189, P8973, DOI 10.1128/JB.01222-07; Chowdhury RP, 2007, BIOPHYS CHEM, V128, P19, DOI 10.1016/j.bpc.2007.02.005; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Frenkiel-Krispin D, 2004, MOL MICROBIOL, V51, P395, DOI 10.1046/j.1365-2958.2003.03855.x; Frenkiel-Krispin D, 2006, J STRUCT BIOL, V156, P311, DOI 10.1016/j.jsb.2006.05.014; Gupta S, 2003, J BIOL CHEM, V278, P5235, DOI 10.1074/jbc.M208825200; Gupta S, 2002, PROTEIN ENG, V15, P503, DOI 10.1093/protein/15.6.503; Ishihama A, 1999, GENES CELLS, V4, P135, DOI 10.1046/j.1365-2443.1999.00247.x; Kim J, 2004, NUCLEIC ACIDS RES, V32, P1982, DOI 10.1093/nar/gkh512; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; LEONG LM, 1992, ANAL BIOCHEM, V207, P317, DOI 10.1016/0003-2697(92)90018-3; MATIN A, 1989, ANNU REV MICROBIOL, V43, P293, DOI 10.1146/annurev.mi.43.100189.001453; Roy S, 2004, J MOL BIOL, V339, P1103, DOI 10.1016/j.jmb.2004.04.042; Roy S, 2008, J MOL BIOL, V375, P948, DOI 10.1016/j.jmb.2007.10.023; Roy S, 2007, J MOL BIOL, V370, P752, DOI 10.1016/j.jmb.2007.05.004; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; SPURIO R, 1992, MOL GEN GENET, V231, P201, DOI 10.1007/BF00279792; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Ueshima J, 2003, INFECT IMMUN, V71, P1170, DOI 10.1128/IAI.71.3.1170-1178.2003; Yamamoto Y, 2002, J BACTERIOL, V184, P2931, DOI 10.1128/JB.184.11.2931-2939.2002	24	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2009	4	11							e8017	10.1371/journal.pone.0008017	http://dx.doi.org/10.1371/journal.pone.0008017			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MQ	19956571	Green Published, gold, Green Submitted			2022-12-25	WOS:000272828400003
J	Liu, P; Lu, MP; Tian, B; Li, K; Garofalo, RP; Prusak, D; Wood, TG; Brasier, AR				Liu, Ping; Lu, Muping; Tian, Bing; Li, Kui; Garofalo, Roberto P.; Prusak, Deborah; Wood, Thomas G.; Brasier, Allan R.			Expression of an IKK gamma Splice Variant Determines IRF3 and Canonical NF-kappa B Pathway Utilization in ssRNA Virus Infection	PLOS ONE			English	Article							ALVEOLAR EPITHELIAL-CELLS; RIG-I; TRANSCRIPTION FACTOR; ANTIVIRAL RESPONSE; GENE-EXPRESSION; NEMO/IKK-GAMMA; INTERFERON; ACTIVATION; COMPONENT; IDENTIFICATION	Single stranded RNA (ssRNA) virus infection activates the retinoic acid inducible gene I (RIG-I)-mitochondrial antiviral signaling (MAVS) complex, a complex that coordinates the host innate immune response via the NF-kappa B and IRF3 pathways. Recent work has shown that the I kappa B kinase (IKK)gamma scaffolding protein is the final common adapter protein required by RIG-I.MAVS to activate divergent rate-limiting kinases downstream controlling the NF-kappa B and IRF3 pathways. Previously we discovered a ubiquitous IKK gamma splice-variant, IKK gamma Delta, that exhibits distinct signaling properties. Methodology/Principal Findings: We examined the regulation and function of IKK gamma splice forms in response to ssRNA virus infection, a condition that preferentially induces full length IKK gamma-WT mRNA expression. In IKK gamma Delta-expressing cells, we found increased viral translation and cytopathic effect compared to those expressing full length IKK gamma-WT. IKK gamma Delta fails to support viral-induced IRF3 activation in response to ssRNA infections; consequently type I IFN production and the induction of antiviral interferon stimulated genes (ISGs) are significantly attenuated. By contrast, ectopic RIG-I.MAVS or TNF alpha-induced canonical NF-kappa B activation is preserved in IKK gamma Delta expressing cells. Increasing relative levels of IKK gamma-WT to IKK gamma Delta (while keeping total IKK gamma constant) results in increased type I IFN expression. Conversely, overexpressing IKK gamma Delta (in a background of constant IKK gamma-WT expression) shows IKK gamma Delta functions as a dominant-negative IRF3 signaling inhibitor. IKK gamma Delta binds both IKK-alpha and beta, but not TANK and IKK epsilon, indicating that exon 5 encodes an essential TANK binding domain. Finally, IKK gamma Delta displaces IKK gamma WT from MAVS explaining its domainant negative effect. Conclusions/Significance: Relative endogenous IKK gamma Delta expression affects cellular selection of inflammatory/anti-viral pathway responses to ssRNA viral infection.	[Liu, Ping; Lu, Muping; Tian, Bing; Brasier, Allan R.] UTMB, Dept Med, Galveston, TX USA; [Li, Kui] Univ Tennessee, Ctr Hlth Sci, Dept Mol Sci, Memphis, TN 38163 USA; [Garofalo, Roberto P.] UTMB, Dept Pediat, Galveston, TX USA; [Garofalo, Roberto P.; Prusak, Deborah; Wood, Thomas G.; Brasier, Allan R.] UTMB, Sealy Ctr Mol Med, Galveston, TX USA; [Wood, Thomas G.] UTMB, Dept Biochem & Mol Biol, Galveston, TX USA	University of Texas System; University of Texas Medical Branch Galveston; University of Tennessee System; University of Tennessee Health Science Center; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Liu, P (corresponding author), UTMB, Dept Med, Galveston, TX USA.	arbrasie@utmb.edu	Wood, Thomas/GWZ-2481-2022; Wood, Thomas/B-6172-2012; Garofalo, Roberto P./AAF-7385-2022; Garofalo, Roberto P./ABL-2322-2022	Wood, Thomas/0000-0001-8962-8571; Brasier, Allan/0000-0002-5012-4090	NHLBI Proteomics Technologies in Airway Inflammation [N01-HV-28184]; NIEHS [P30 ES06676];  [P01 AI062885];  [RO1 GM086885]; DIVISION OF HEART AND VASCULAR DISEASES [N01HV028184] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI062885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006676] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086885] Funding Source: NIH RePORTER	NHLBI Proteomics Technologies in Airway Inflammation(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); ; ; DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by P01 AI062885 (to A. R. B.), RO1 GM086885 and NHLBI Proteomics Technologies in Airway Inflammation (N01-HV-28184). Core Laboratory support was from NIEHS grant P30 ES06676. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baril M, 2009, J VIROL, V83, P1299, DOI 10.1128/JVI.01659-08; Bonif M, 2006, BIOCHEM J, V394, P593, DOI 10.1042/BJ20051659; Bose S, 2003, P NATL ACAD SCI USA, V100, P10890, DOI 10.1073/pnas.1832775100; BRASIER AR, 1990, CURRENT PROTOCOLS MO; Chariot A, 2002, J BIOL CHEM, V277, P37029, DOI 10.1074/jbc.M205069200; Courtois G, 2001, TRENDS MOL MED, V7, P427, DOI 10.1016/S1471-4914(01)02154-2; Forbus J, 2006, PROTEOMICS, V6, P2656, DOI 10.1002/pmic.200500652; Foy E, 2005, P NATL ACAD SCI USA, V102, P2986, DOI 10.1073/pnas.0408707102; Foy E, 2003, SCIENCE, V300, P1145, DOI 10.1126/science.1082604; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Garcia-Sastre A, 1998, J VIROL, V72, P8550; Garofalo R, 1996, J VIROL, V70, P8773, DOI 10.1128/JVI.70.12.8773-8781.1996; Guo BC, 2007, J BIOL CHEM, V282, P11817, DOI 10.1074/jbc.M700017200; Hai T, 2006, J VIROL, V80, P4227, DOI 10.1128/JVI.80.9.4227-4241.2006; Hiscott J, 1999, J INTERF CYTOK RES, V19, P1, DOI 10.1089/107999099314360; Jamaluddin M, 1998, J VIROL, V72, P4849, DOI 10.1128/JVI.72.6.4849-4857.1998; Jamaluddin M, 2001, AM J PHYSIOL-LUNG C, V280, pL248, DOI 10.1152/ajplung.2001.280.2.L248; Jin DY, 1999, J BIOL CHEM, V274, P17402, DOI 10.1074/jbc.274.25.17402; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kumar H, 2006, J EXP MED, V203, P1795, DOI 10.1084/jem.20060792; Lehtonen A, 1997, J IMMUNOL, V159, P794; Li Kui, 2009, V510, P211, DOI 10.1007/978-1-59745-394-3_16; Lipniacki T, 2004, J THEOR BIOL, V228, P195, DOI 10.1016/j.jtbi.2004.01.001; Liu P, 2008, J BIOL CHEM, V283, P23169, DOI 10.1074/jbc.M802729200; Liu P, 2007, J VIROL, V81, P1401, DOI 10.1128/JVI.01740-06; May MJ, 2000, SCIENCE, V289, P1550, DOI 10.1126/science.289.5484.1550; Mercurio F, 1999, MOL CELL BIOL, V19, P1526; OSHIUMI H, 2008, J BIOL CHEM; Poyet JL, 2000, J BIOL CHEM, V275, P37966, DOI 10.1074/jbc.M006643200; Rothwarf DM, 1998, NATURE, V395, P297, DOI 10.1038/26261; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Smieja J, 2008, BIOINFORMATICS, V24, P2363, DOI 10.1093/bioinformatics/btn400; TENBERG R, 1980, HYPERTENSION, V2, P4, DOI 10.1161/01.HYP.2.1.4; Tian B, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-137; Tian B, 2005, J BIOL CHEM, V280, P17435, DOI 10.1074/jbc.M500437200; Tian B, 2002, J VIROL, V76, P6800, DOI 10.1128/JVI.76.13.6800-6814.2002; TIAN B, 2005, LANDES BIOSCIENCE; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Yamamoto Y, 2001, J BIOL CHEM, V276, P36327, DOI 10.1074/jbc.M104090200; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Ye JJ, 2000, J BIOL CHEM, V275, P9882, DOI 10.1074/jbc.275.13.9882; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yount JS, 2007, J VIROL, V81, P7316, DOI 10.1128/JVI.00545-07; Zandi E, 1999, MOL CELL BIOL, V19, P4547; Zhang SQ, 2000, IMMUNITY, V12, P301, DOI 10.1016/S1074-7613(00)80183-1; Zhao TJ, 2007, NAT IMMUNOL, V8, P592, DOI 10.1038/ni1465	47	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2009	4	11							e8079	10.1371/journal.pone.0008079	http://dx.doi.org/10.1371/journal.pone.0008079			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MN	19956647	Green Submitted, gold, Green Published			2022-12-25	WOS:000272828100016
J	Fowler, DW; Freedman, EA; Scannella, JB				Fowler, Denver W.; Freedman, Elizabeth A.; Scannella, John B.			Predatory Functional Morphology in Raptors: Interdigital Variation in Talon Size Is Related to Prey Restraint and Immobilisation Technique	PLOS ONE			English	Article							BEHAVIOR; BIRDS; PHYLOGENY; KESTRELS; ACCIPITRIDAE; FOOT; AVES	Despite the ubiquity of raptors in terrestrial ecosystems, many aspects of their predatory behaviour remain poorly understood. Surprisingly little is known about the morphology of raptor talons and how they are employed during feeding behaviour. Talon size variation among digits can be used to distinguish families of raptors and is related to different techniques of prey restraint and immobilisation. The hypertrophied talons on digits (D) I and II in Accipitridae have evolved primarily to restrain large struggling prey while they are immobilised by dismemberment. Falconidae have only modest talons on each digit and only slightly enlarged D-I and II. For immobilisation, Falconini rely more strongly on strike impact and breaking the necks of their prey, having evolved a 'tooth' on the beak to aid in doing so. Pandionidae have enlarged, highly recurved talons on each digit, an adaptation for piscivory, convergently seen to a lesser extent in fishing eagles. Strigiformes bear enlarged talons with comparatively low curvature on each digit, part of a suite of adaptations to increase constriction efficiency by maximising grip strength, indicative of specialisation on small prey. Restraint and immobilisation strategy change as prey increase in size. Small prey are restrained by containment within the foot and immobilised by constriction and beak attacks. Large prey are restrained by pinning under the bodyweight of the raptor, maintaining grip with the talons, and immobilised by dismemberment (Accipitridae), or severing the spinal cord (Falconini). Within all raptors, physical attributes of the feet trade off against each other to attain great strength, but it is the variable means by which this is achieved that distinguishes them ecologically. Our findings show that interdigital talon morphology varies consistently among raptor families, and that this is directly correlative with variation in their typical prey capture and restraint strategy.	[Fowler, Denver W.; Freedman, Elizabeth A.; Scannella, John B.] Montana State Univ, Museum Rockies, Bozeman, MT 59717 USA	Montana State University System; Montana State University Bozeman	Fowler, DW (corresponding author), Montana State Univ, Museum Rockies, Bozeman, MT 59717 USA.	df9465@yahoo.co.uk	Freedman, Elizabeth/J-1752-2012	Freedman, Elizabeth/0000-0002-5763-5272; Fowler, Denver/0000-0001-9188-4371	Museum of the Rockies graduate student fund	Museum of the Rockies graduate student fund	Support for the Museum of the Rockies graduate student fund was provided by Damaris Waggoner and David Sands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLANFORD WT, 1895, BIRDS, V3; BOND RICHARD M., 1942, WILSON BULL, V54, P81; BOND RICHARD M., 1936, CONDOR, V38, P72, DOI 10.2307/1363552; Csermely D, 1998, CONDOR, V100, P757, DOI 10.2307/1369762; CSERMELY D, 1989, B ZOOL, V56, P317; CSERMELY D, 1993, B ZOOL, V60, P211, DOI 10.1080/11250009309355812; Csermely D, 2003, J ETHOL, V21, P107, DOI 10.1007/s10164-002-0083-6; Csermely D, 1998, J AVIAN BIOL, V29, P10, DOI 10.2307/3677335; Csermely D, 2002, ITAL J ZOOL, V69, P239, DOI 10.1080/11250000209356466; Csermely D, 2006, ITAL J ZOOL, V73, P43, DOI 10.1080/11250000500502368; Csermely Davide, 1994, Avocetta, V18, P63; Einoder L, 2007, EMU, V107, P223, DOI 10.1071/MU06019; Einoder L, 2006, IBIS, V148, P515, DOI 10.1111/j.1474-919X.2006.00541.x; Einoder LD, 2007, AUK, V124, P773, DOI 10.1642/0004-8038(2007)124[773:AOTHMO]2.0.CO;2; Ericson PGP, 2006, BIOL LETTERS, V2, P543, DOI 10.1098/rsbl.2006.0523; FEDUCCIA A, 1993, SCIENCE, V259, P790, DOI 10.1126/science.259.5096.790; Glen CL, 2007, CURR BIOL, V17, pR911, DOI 10.1016/j.cub.2007.09.026; GOSLOW GE, 1971, AUK, V88, P815, DOI 10.2307/4083840; GOSLOW GE, 1972, AUK, V89, P47, DOI 10.2307/4084059; Griffiths CS, 2007, J AVIAN BIOL, V38, P587, DOI 10.1111/j.2007.0908-8857.03971.x; Griffiths CS, 2004, MOL PHYLOGENET EVOL, V32, P101, DOI 10.1016/j.ympev.2003.11.019; GRZIMEK B, 2002, BIRDS, V1; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Harris T., 1984, P 2 S AFR PRED BIRDS, P195; Hertel F, 1995, AUK, V112, P890, DOI 10.2307/4089021; Hopson JA, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P211; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Johnsgard P. A., 1990, HAWKS EAGLES FALCONS; Livezey Bradley C., 2006, Bulletin of Carnegie Museum of Natural History, V37, P1; Livezey BC, 2007, ZOOL J LINN SOC-LOND, V149, P1, DOI 10.1111/j.1096-3642.2006.00293.x; Newton I., 1986, SPARROWHAWK; PETERS DS, 1992, SCI SERIES NATURAL H, P29; Pike AVL, 2004, J ZOOL, V262, P73, DOI 10.1017/S0952836903004382; RUDEBECK G, 1950, OIKOS, V2, P65, DOI 10.2307/3564663; RUDEBECK G, 1951, OIKOS, V3, P200, DOI 10.2307/3565185; Sustaita D, 2008, J MORPHOL, V269, P283, DOI 10.1002/jmor.10577; Ward AB, 2002, AUK, V119, P1052, DOI 10.1642/0004-8038(2002)119[1052:FMORHI]2.0.CO;2; [No title captured]	38	61	64	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2009	4	11							e7999	10.1371/journal.pone.0007999	http://dx.doi.org/10.1371/journal.pone.0007999			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MK	19946365	Green Published, Green Submitted, gold			2022-12-25	WOS:000272827800011
J	Oliveri, M; Bonni, S; Turriziani, P; Koch, G; Lo Gerfo, E; Torriero, S; Vicario, CM; Petrosini, L; Caltagirone, C				Oliveri, Massimiliano; Bonni, Sonia; Turriziani, Patrizia; Koch, Giacomo; Lo Gerfo, Emanuele; Torriero, Sara; Vicario, Carmelo Mario; Petrosini, Laura; Caltagirone, Carlo			Motor and Linguistic Linking of Space and Time in the Cerebellum	PLOS ONE			English	Article							PREMOTOR CORTEX; MAGNETIC STIMULATION; HUNTINGTONS-DISEASE; PARIETAL CORTEX; FUTURE; FMRI; PERCEPTION; LANGUAGE; REPRESENTATION; MODULATION	Background: Recent literature documented the presence of spatial-temporal interactions in the human brain. The aim of the present study was to verify whether representation of past and future is also mapped onto spatial representations and whether the cerebellum may be a neural substrate for linking space and time in the linguistic domain. We asked whether processing of the tense of a verb is influenced by the space where response takes place and by the semantics of the verb. Principal Findings: Responses to past tense were facilitated in the left space while responses to future tense were facilitated in the right space. Repetitive transcranial magnetic stimulation (rTMS) of the right cerebellum selectively slowed down responses to future tense of action verbs; rTMS of both cerebellar hemispheres decreased accuracy of responses to past tense in the left space and to future tense in the right space for non-verbs, and to future tense in the right space for state verbs. Conclusions: The results suggest that representation of past and future is mapped onto spatial formats and that motor action could represent the link between spatial and temporal dimensions. Right cerebellar, left motor brain networks could be part of the prospective brain, whose primary function is to use past experiences to anticipate future events. Both cerebellar hemispheres could play a role in establishing the grammatical rules for verb conjugation.			Oliveri, M (corresponding author), Univ Palermo, Dipartimento Psicol, Palermo, Italy.	maxoliveri@unipa.it	Caltagirone, Carlo/B-4930-2013; Oliveri, Massimiliano/HDO-5602-2022; VICARIO, CARMELO/AAR-2521-2021; Koch, Giacomo/G-3155-2012	Lo Gerfo, Emanuele/0000-0003-1296-415X; Turriziani, Patrizia/0000-0003-4802-280X				Addis DR, 2007, NEUROPSYCHOLOGIA, V45, P1363, DOI 10.1016/j.neuropsychologia.2006.10.016; Bortolini U., 1972, LESSICO FREQUENZA LI; Bueti D, 2009, PHILOS T R SOC B, V364, P1831, DOI 10.1098/rstb.2009.0028; Casasanto D, 2008, COGNITION, V106, P579, DOI 10.1016/j.cognition.2007.03.004; Coull JT, 2008, CURR OPIN NEUROBIOL, V18, P137, DOI 10.1016/j.conb.2008.07.011; DEHAENE S, 1990, J EXP PSYCHOL HUMAN, V16, P626, DOI 10.1037/0096-1523.16.3.626; Eagleman DM, 2008, CURR OPIN NEUROBIOL, V18, P131, DOI 10.1016/j.conb.2008.06.002; FIEZ JA, 1992, BRAIN, V115, P155, DOI 10.1093/brain/115.1.155; Frassinetti F, 2009, PSYCHOL SCI, V20, P949, DOI 10.1111/j.1467-9280.2009.02390.x; Gangitano M, 2004, EUR J NEUROSCI, V20, P2193, DOI 10.1111/j.1460-9568.2004.03655.x; Gangitano M, 2001, NEUROREPORT, V12, P1489, DOI 10.1097/00001756-200105250-00038; Glenberg AM, 2002, PSYCHON B REV, V9, P558, DOI 10.3758/BF03196313; Kemmerer D, 2005, NEUROPSYCHOLOGIA, V43, P797, DOI 10.1016/j.neuropsychologia.2004.06.025; Koch G, 2007, EXP BRAIN RES, V179, P291, DOI 10.1007/s00221-006-0791-1; Lo Gerfo E, 2008, NEUROPSYCHOLOGIA, V46, P764, DOI 10.1016/j.neuropsychologia.2007.10.012; Oliveri M, 2004, J COGNITIVE NEUROSCI, V16, P374, DOI 10.1162/089892904322926719; Oliveri M, 2009, NEUROIMAGE, V46, P1173, DOI 10.1016/j.neuroimage.2009.03.042; Oliveri M, 2009, EXP BRAIN RES, V195, P489, DOI 10.1007/s00221-009-1834-1; Santiago J, 2007, PSYCHON B REV, V14, P512, DOI 10.3758/BF03194099; Schacter DL, 2007, NAT REV NEUROSCI, V8, P657, DOI 10.1038/nrn2213; Schacter DL, 2007, PHILOS T R SOC B, V362, P773, DOI 10.1098/rstb.2007.2087; Schubotz RI, 2004, J NEUROSCI, V24, P5467, DOI 10.1523/JNEUROSCI.1169-04.2004; Schubotz RI, 2002, NEUROIMAGE, V16, P920, DOI 10.1006/nimg.2002.1183; Schubotz RI, 2002, COGNITIVE BRAIN RES, V14, P357, DOI 10.1016/S0926-6410(02)00138-6; Schubotz RI, 2002, NEUROIMAGE, V15, P787, DOI 10.1006/nimg.2001.1043; Shin JC, 2003, J COGNITIVE NEUROSCI, V15, P1232, DOI 10.1162/089892903322598175; SILVERI MC, 1994, NEUROLOGY, V44, P2047, DOI 10.1212/WNL.44.11.2047; Szpunar KK, 2007, P NATL ACAD SCI USA, V104, P642, DOI 10.1073/pnas.0610082104; Teichmann M, 2005, BRAIN, V128, P1155, DOI 10.1093/brain/awh472; Teichmann M, 2006, J COGNITIVE NEUROSCI, V18, P1555, DOI 10.1162/jocn.2006.18.9.1555; Theoret H, 2001, NEUROSCI LETT, V306, P29, DOI 10.1016/S0304-3940(01)01860-2; TORRIERO S, 2008, J COGNITIVE NEUROSCI, V9, P1656; Torriero S, 2007, NEUROPSYCHOLOGIA, V45, P1208, DOI 10.1016/j.neuropsychologia.2006.10.007; Ullman MT, 1997, J COGNITIVE NEUROSCI, V9, P266, DOI 10.1162/jocn.1997.9.2.266; Umilta MA, 2001, NEURON, V31, P155, DOI 10.1016/S0896-6273(01)00337-3; Urgesi C, 2006, J NEUROSCI, V26, P7942, DOI 10.1523/JNEUROSCI.1289-06.2006; Vallesi A, 2008, COGNITION, V107, P501, DOI 10.1016/j.cognition.2007.10.011; Vicario CM, 2007, BRAIN COGNITION, V64, P68, DOI 10.1016/j.bandc.2006.12.002; Vicario CM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001716; Walsh V, 2003, TRENDS COGN SCI, V7, P483, DOI 10.1016/j.tics.2003.09.002	40	30	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2009	4	11							e7933	10.1371/journal.pone.0007933	http://dx.doi.org/10.1371/journal.pone.0007933			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	522NL	19936216	gold, Green Published, Green Submitted			2022-12-25	WOS:000272004800014
J	Pitteri, SJ; JeBailey, L; Faca, VM; Thorpe, JD; Silva, MA; Ireton, RC; Horton, MB; Wang, H; Pruitt, LC; Zhang, Q; Cheng, KH; Urban, N; Hanash, SM; Dinulescu, DM				Pitteri, Sharon J.; JeBailey, Lellean; Faca, Vitor M.; Thorpe, Jason D.; Silva, Melissa A.; Ireton, Renee C.; Horton, Marc B.; Wang, Hong; Pruitt, Liese C.; Zhang, Qing; Cheng, Kuang H.; Urban, Nicole; Hanash, Samir M.; Dinulescu, Daniela M.			Integrated Proteomic Analysis of Human Cancer Cells and Plasma from Tumor Bearing Mice for Ovarian Cancer Biomarker Discovery	PLOS ONE			English	Article							FACTOR-BINDING PROTEIN-2; GROWTH-FACTOR-BETA; QUANTITATIVE-ANALYSIS; STATISTICAL-MODEL; CARCINOMA-CELLS; ANALYSIS-SYSTEM; MOUSE MODEL; K-RAS; EXPRESSION; SERUM	Background: The complexity of the human plasma proteome represents a substantial challenge for biomarker discovery. Proteomic analysis of genetically engineered mouse models of cancer and isolated cancer cells and cell lines provide alternative methods for identification of potential cancer markers that would be detectable in human blood using sensitive assays. The goal of this work is to evaluate the utility of an integrative strategy using these two approaches for biomarker discovery. Methodology/Principal Findings: We investigated a strategy that combined quantitative plasma proteomics of an ovarian cancer mouse model with analysis of proteins secreted or shed by human ovarian cancer cells. Of 106 plasma proteins identified with increased levels in tumor bearing mice, 58 were also secreted or shed from ovarian cancer cells. The remainder consisted primarily of host-response proteins. Of 25 proteins identified in the study that were assayed, 8 mostly secreted proteins common to mouse plasma and human cancer cells were significantly upregulated in a set of plasmas from ovarian cancer patients. Five of the eight proteins were confirmed to be upregulated in a second independent set of ovarian cancer plasmas, including in early stage disease. Conclusions/Significance: Integrated proteomic analysis of cancer mouse models and human cancer cell populations provides an effective approach to identify potential circulating protein biomarkers.			Pitteri, SJ (corresponding author), Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA.	shanash@fhcrc.org; ddinulescu@rics.bwh.harvard.edu	Faça, Vitor M/A-3989-2013	Horton, Marc/0000-0002-9266-9611; FACA, VITOR MARCEL/0000-0003-3205-7944; Pitteri, Sharon/0000-0002-3119-873X	NATIONAL CANCER INSTITUTE [P50CA105009, P50CA083636, U01CA084301] Funding Source: NIH RePORTER; NCI NIH HHS [P50 CA83636, P50 CA105009, P50 CA083636, U01 CA084301] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Anand N, 2002, NAT GENET, V31, P301, DOI 10.1038/ng904; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Aunoble B, 2000, INT J ONCOL, V16, P567; Baril P, 2007, ONCOGENE, V26, P2082, DOI 10.1038/sj.onc.1210009; Baron-Hay S, 2004, CLIN CANCER RES, V10, P1796, DOI 10.1158/1078-0432.CCR-0672-2; Bast RC., 2003, J CLIN ONCOL, V21, P200, DOI [10.1200/JCO.2003.01.068, DOI 10.1200/JCO.2003.01.068]; Bauer M, 2008, BREAST CANCER RES TR, V108, P389, DOI 10.1007/s10549-007-9619-3; Bengtsson S, 2007, J PROTEOME RES, V6, P1440, DOI 10.1021/pr060593y; Bignotti E, 2007, AM J OBSTET GYNECOL, V196, P245, DOI 10.1016/j.ajog.2006.10.874; Bult CJ, 2008, NUCLEIC ACIDS RES, V36, pD724, DOI 10.1093/nar/gkm961; Carlson ME, 2007, CURR OPIN PHARMACOL, V7, P303, DOI 10.1016/j.coph.2007.02.004; Catasus L, 2004, HUM PATHOL, V35, P1360, DOI 10.1016/j.humpath.2004.07.019; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; De Cecco L, 2004, ONCOGENE, V23, P8171, DOI 10.1038/sj.onc.1207979; Dinulescu DM, 2005, NAT MED, V11, P63, DOI 10.1038/nm1173; Doghman M, 2007, J CLIN ENDOCR METAB, V92, P3253, DOI 10.1210/jc.2007-0342; Drummond AE, 2005, CELL TISSUE RES, V322, P107, DOI 10.1007/s00441-005-1153-1; Faca V, 2007, J PROTEOME RES, V6, P3558, DOI 10.1021/pr070233q; Faca V, 2006, J PROTEOME RES, V5, P2009, DOI 10.1021/pr060102+; Faca VM, 2008, PLOS MED, V5, P953, DOI 10.1371/journal.pmed.0050123; Faca VM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002425; Fehrmann RSN, 2007, ONCOLOGIST, V12, P960, DOI 10.1634/theoncologist.12-8-960; Flyvbjerg A, 1997, J CLIN ENDOCR METAB, V82, P2308, DOI 10.1210/jc.82.7.2308; Fontana A, 2005, INT J CANCER, V116, P686, DOI 10.1002/ijc.20584; Foster LJ, 2006, CELL, V125, P187, DOI 10.1016/j.cell.2006.03.022; GADDUCCI A, 1995, GYNECOL ONCOL, V58, P184, DOI 10.1006/gyno.1995.1207; Gagne JP, 2007, PROTEOME SCI, V5, DOI 10.1186/1477-5956-5-16; Gilks CB, 2005, GYNECOL ONCOL, V96, P684, DOI 10.1016/j.ygyno.2004.11.039; Gleave M, 2003, ANN NY ACAD SCI, V1002, P95, DOI 10.1196/annals.1281.020; Gortzak-Uzan L, 2008, J PROTEOME RES, V7, P339, DOI 10.1021/pr0703223; Grigoriadis A, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1604; Hanash SM, 2008, NATURE, V452, P571, DOI 10.1038/nature06916; Hellstrom I, 2003, CANCER RES, V63, P3695; Hennessy BT, 2008, ADV EXP MED BIOL, V617, P23, DOI 10.1007/978-0-387-69080-3_3; Hirano S, 2004, EUR J GYNAECOL ONCOL, V25, P187; Jakowlew SB, 2006, CANCER METAST REV, V25, P435, DOI 10.1007/s10555-006-9006-2; Jiang Xiao-Ting, 2004, Hepatobiliary Pancreat Dis Int, V3, P464; Jones MB, 2003, GYNECOL ONCOL, V88, pS136, DOI 10.1006/gyno.2002.6704; Katano K, 2002, CANCER RES, V62, P6559; Katoh M, 2007, CLIN CANCER RES, V13, P4042, DOI 10.1158/1078-0432.CCR-06-2316; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kersey PJ, 2004, PROTEOMICS, V4, P1985, DOI 10.1002/pmic.200300721; Kislinger T, 2006, CELL, V125, P173, DOI 10.1016/j.cell.2006.01.044; Knight PG, 2006, REPRODUCTION, V132, P191, DOI 10.1530/rep.1.01074; Kolasa IK, 2006, GYNECOL ONCOL, V103, P692, DOI 10.1016/j.ygyno.2006.05.007; KUK C, 2008, MOL CELL PROTEOMICS; Kulasingam V, 2008, NAT CLIN PRACT ONCOL, V5, P588, DOI 10.1038/ncponc1187; Kutteh WH, 1996, J SOC GYNECOL INVEST, V3, P216, DOI 10.1016/1071-5576(96)00013-5; Leivonen SK, 2007, INT J CANCER, V121, P2119, DOI 10.1002/ijc.23113; MacLean B, 2006, BIOINFORMATICS, V22, P2830, DOI 10.1093/bioinformatics/btl379; Mathieu A, 2004, CANCER-AM CANCER SOC, V101, P1908, DOI 10.1002/cncr.20571; Maxwell P, 1999, CANCER LETT, V139, P121, DOI 10.1016/S0304-3835(99)00009-9; Minagawa Y, 1999, JPN J CANCER RES, V90, P1373, DOI 10.1111/j.1349-7006.1999.tb00722.x; Mourskaia AA, 2007, ANTI-CANCER AGENT ME, V7, P504, DOI 10.2174/187152007781668689; NATHAN FE, 1994, CANCER, V73, P2853, DOI 10.1002/1097-0142(19940601)73:11<2853::AID-CNCR2820731131>3.0.CO;2-9; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nicosia SV, 2003, HEMATOL ONCOL CLIN N, V17, P927, DOI 10.1016/S0889-8588(03)00056-X; Nishio R., 2003, International Urology and Nephrology, V35, P189, DOI 10.1023/B:UROL.0000020306.08275.49; Ong SE, 2006, NAT PROTOC, V1, P2650, DOI 10.1038/nprot.2006.427; Palmer C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002633; Pauli C, 2002, ANTICANCER RES, V22, P3093; Pitteri SJ, 2008, J PROTEOME RES, V7, P1481, DOI 10.1021/pr7007994; Pupa SM, 2007, CANCER RES, V67, P4271, DOI 10.1158/0008-5472.CAN-06-4162; Rauch A, 2006, J PROTEOME RES, V5, P112, DOI 10.1021/pr0503533; Sadowski T, 2005, CELL MOL LIFE SCI, V62, P870, DOI 10.1007/s00018-005-4478-8; Sharma S, 2007, CLIN CANCER RES, V13, P5889, DOI 10.1158/1078-0432.CCR-07-0703; Tamakoshi K, 1996, GYNECOL ONCOL, V62, P67, DOI 10.1006/gyno.1996.0191; Thorpe JD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001281; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Vallier L, 2005, STEM CELL REV, V1, P119, DOI 10.1385/SCR:1:2:119; VOLBERG T, 1995, J CELL SCI, V108, P2253; Wakefield LM, 2007, CANCER CELL, V12, P293, DOI 10.1016/j.ccr.2007.10.002; Wang H, 2005, MOL CELL PROTEOMICS, V4, P618, DOI 10.1074/mcp.M400126-MCP200; Wang HX, 2002, ELECTROPHORESIS, V23, P3168, DOI 10.1002/1522-2683(200209)23:18<3168::AID-ELPS3168>3.0.CO;2-A; Wang WJ, 2007, ANAL CHEM, V79, P1002, DOI 10.1021/ac061613i; Wu R, 2007, CANCER CELL, V11, P321, DOI 10.1016/j.ccr.2007.02.016	77	52	55	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2009	4	11							e7916	10.1371/journal.pone.0007916	http://dx.doi.org/10.1371/journal.pone.0007916			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522NJ	19936259	Green Submitted, gold, Green Published			2022-12-25	WOS:000272004600018
J	Vijay, S; Swaminathan, S; Vaidyanathan, P; Thomas, A; Chauhan, LS; Kumar, P; Chiddarwar, S; Thomas, B; Dewan, PK				Vijay, Sophia; Swaminathan, Soumya; Vaidyanathan, Preetish; Thomas, Aleyamma; Chauhan, L. S.; Kumar, Prahlad; Chiddarwar, Sonali; Thomas, Beena; Dewan, Puneet K.			Feasibility of Provider-Initiated HIV Testing and Counselling of Tuberculosis Patients Under the TB Control Programme in Two Districts of South India	PLOS ONE			English	Article							THAILAND; CARE	Background: Provider-initiated HIV testing and counselling (PITC) is internationally recommended for tuberculosis (TB) patients, but the feasibility, effectiveness, and impact of this policy on the TB programme in India are unknown. We evaluated PITC of TB patients across two districts in India considered to have generalized HIV epidemics, Tiruchirappalli (population 2.5 million) and Mysore (population 2.8 million). Methodology/Principal Findings: Starting June 2007, healthcare providers in both districts were instructed to ascertain HIV status for all TB patients, and refer those with unknown HIV status to the nearest Integrated Counselling and Testing Centre (ICTC)-often in the same facility-for counselling and voluntary HIV testing. All TB patients registered from June 2007 to March 2008 were followed prospectively. Field investigators assessed PITC practices and abstracted data from routine TB programme records and HIV counselling registers to determine the proportion of TB patients appropriately evaluated for HIV infection. Patient records were traced to determine the efficiency of referral links to HIV care and antiretroviral treatment (ART). Between July 2007 and March 2008, 5299 TB patients were registered in both study districts. Of the 4701 with unknown HIV status at the time of TB treatment initiation, 3368 (72%) were referred to an ICTC, and 3111 (66%) were newly tested for HIV. PITC implementation resulted in the ascertainment of HIV status for 3709/5299 (70%) of TB patients, and detected 200 cases with previously undiagnosed HIV infection. Overall, 468 (8.8%) of all registered TB patients were HIV-infected; 177 (37%) were documented to have also received any ART. Conclusions: With implementation of PITC in India, HIV status was successfully ascertained for 70% of TB patients. Previously undiagnosed HIV-infection was detected in 6.4% of those TB patients newly tested, enabling referral for life-saving anti-retroviral treatment. ART uptake, however, was poor, suggesting that PITC implementation should include measures to strengthen and support ART referral, evaluation, and initiation.			Vijay, S (corresponding author), Natl TB Inst, Bangalore, Karnataka, India.	nti@ntiindia.org.in	chiddarwar, shital/N-5471-2015	chiddarwar, shital/0000-0001-8078-6573				[Anonymous], 2007, MANUAL ESTIMATING NA; *CENTR TB DIV, 2009, RNTCP PERF REP IND 4; Chakaya JM, 2008, INT J TUBERC LUNG D, V12, P424; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; *GOV IND MIN HLTH, 2008, HIV SENT SURV HIV ES; *GOV IND MIN HLTH, 2008, NAT FRAM JOINT TB HI; *GOV IND MIN HLTH, 2005, TECHN OP GUID TUB CO; Havlir DV, 2008, JAMA-J AM MED ASSOC, V300, P423, DOI 10.1001/jama.300.4.423; Jerene Degu, 2007, BMC Int Health Hum Rights, V7, P4, DOI 10.1186/1472-698X-7-4; *NAT AIDS CONTR OR, 2007, ANT TREATM GUID AD A; *NAT AIDS CONTR OR, 2008, UNGASS COUNTR PROGR; Nateniyom S, 2008, INT J TUBERC LUNG D, V12, P955; National AIDS Control Organization, 2008, OP GUID INT COUNS TE; National AIDS Control Organization ICMR-National Institute of Medical Statistics, 2018, HIV EST 2017 TECHN R; Odhiambo J, 2008, INT J TUBERC LUNG D, V12, pS63; Pope DS, 2008, JAIDS-J ACQ IMM DEF, V48, P190, DOI 10.1097/QAI.0b013e3181775926; Raizada N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002970; Sanguanwongse N, 2008, JAIDS-J ACQ IMM DEF, V48, P181, DOI 10.1097/QAI.0b013e318177594e; Thomas BE, 2007, INT J TUBERC LUNG D, V11, P1296; *WHO, WHOHTMTB2009411 GLOB; *WHO, 2004, INT POL COLL TB HIV; Zachariah R, 2005, INT J TUBERC LUNG D, V9, P238	22	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2009	4	11							e7899	10.1371/journal.pone.0007899	http://dx.doi.org/10.1371/journal.pone.0007899			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522NJ	19936067	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000272004600005
J	Simpson, JE; Folsom-O'Keefe, CM; Childs, JE; Simons, LE; Andreadis, TG; Diuk-Wasser, MA				Simpson, Jennifer E.; Folsom-O'Keefe, Corrine M.; Childs, James E.; Simons, Leah E.; Andreadis, Theodore G.; Diuk-Wasser, Maria A.			Avian Host-Selection by Culex pipiens in Experimental Trials	PLOS ONE			English	Article							WEST-NILE-VIRUS; BLOOD-FEEDING BEHAVIOR; NEW-YORK; ANOPHELES-ARABIENSIS; MOSQUITO SURVEILLANCE; DIPTERA-CULICIDAE; VECTOR COMPETENCE; INFECTION; ATTRACTIVENESS; PREFERENCE	Evidence from field studies suggests that Culex pipiens, the primary mosquito vector of West Nile virus (WNV) in the northeastern and north central United States, feeds preferentially on American robins (Turdus migratorius). To determine the contribution of innate preferences to observed preference patterns in the field, we conducted host preference trials with a known number of adult female C. pipiens in outdoor cages comparing the relative attractiveness of American robins with two common sympatric bird species, European starling, Sternus vulgaris and house sparrow, Passer domesticus. Host seeking C. pipiens were three times more likely to enter robin-baited traps when with the alternate host was a European starling (n = 4 trials; OR = 3.06; CI [1.42-6.46]) and almost twice more likely when the alternative was a house sparrow (n = 8 trials; OR = 1.80; CI = [1.22-2.90]). There was no difference in the probability of trap entry when two robins were offered (n = 8 trials). Logistic regression analysis determined that the age, sex and weight of the birds, the date of the trial, starting-time, temperature, humidity, wind-speed and age of the mosquitoes had no effect on the probability of a choosing a robin over an alternate bird. Findings indicate that preferential feeding by C. pipiens mosquitoes on certain avian hosts is likely to be inherent, and we discuss the implications innate host preferences may have on enzootic WNV transmission.			Simpson, JE (corresponding author), Yale Univ, Dept Epidemiol & Publ Hlth, Sch Publ Hlth, New Haven, CT 06520 USA.	maria.diuk@yale.edu						Anderson RA, 1997, J MED ENTOMOL, V34, P95, DOI 10.1093/jmedent/34.2.95; Andreadis TG, 2004, VECTOR-BORNE ZOONOT, V4, P360, DOI 10.1089/vbz.2004.4.360; Andreadis TG, 2001, EMERG INFECT DIS, V7, P670; Andreadis TG., 2005, CONN AES BULL, V996, P178; Apperson CS, 2002, J MED ENTOMOL, V39, P777, DOI 10.1603/0022-2585-39.5.777; Apperson CS, 2004, VECTOR-BORNE ZOONOT, V4, P71, DOI 10.1089/153036604773083013; Costantini C, 1998, AM J TROP MED HYG, V58, P56, DOI 10.4269/ajtmh.1998.58.56; Cruz-Pacheco G, 2005, B MATH BIOL, V67, P1157, DOI 10.1016/j.bulm.2004.11.008; Darbro JM, 2006, J MED ENTOMOL, V43, P83, DOI 10.1603/0022-2585(2006)043[0083:BTFSOW]2.0.CO;2; Darbro JM, 2007, AM J TROP MED HYG, V77, P488, DOI 10.4269/ajtmh.2007.77.488; Darbro JM, 2007, BEHAV ECOL, V18, P750, DOI 10.1093/beheco/arm043; DAY JF, 1984, J MED ENTOMOL, V21, P732, DOI 10.1093/jmedent/21.6.732; Dekker T, 1998, MED VET ENTOMOL, V12, P136, DOI 10.1046/j.1365-2915.1998.00073.x; Diatta M, 1998, T ROY SOC TROP MED H, V92, P270, DOI 10.1016/S0035-9203(98)91005-7; Duchemin JB, 2001, MED VET ENTOMOL, V15, P50, DOI 10.1046/j.1365-2915.2001.00276.x; EDMAN JD, 1974, J PARASITOL, V60, P874, DOI 10.2307/3278923; Garrett-Jones C., 1964, Bulletin of the World Health Organization, V30, P241; GILLIES MT, 1964, NATURE, V203, P852, DOI 10.1038/203852a0; Goddard LB, 2002, EMERG INFECT DIS, V8, P1385, DOI 10.3201/eid0812.020536; Hamer GL, 2008, J MED ENTOMOL, V45, P125, DOI 10.1603/0022-2585(2008)45[125:CPDCAB]2.0.CO;2; Hamer GL, 2009, AM J TROP MED HYG, V80, P268, DOI 10.4269/ajtmh.2009.80.268; HESS AD, 1968, MOSQ NEWS, V28, P386; Hodgson JC, 2001, J MED ENTOMOL, V38, P59, DOI 10.1603/0022-2585-38.1.59; KAY BH, 1979, MOSQ NEWS, V39, P68; Kent R, 2009, J MED ENTOMOL, V46, P380, DOI 10.1603/033.046.0226; Kilpatrick AM, 2006, P ROY SOC B-BIOL SCI, V273, P2327, DOI 10.1098/rspb.2006.3575; Knols BGJ, 1995, T ROY SOC TROP MED H, V89, P604, DOI 10.1016/0035-9203(95)90406-9; Kulasekera VL, 2001, EMERG INFECT DIS, V7, P722, DOI 10.3201/eid0704.010421; LEFEVRE T, 2009, TROP MED INT HEALTH, V14, P1; Lepore TJ, 2004, J AM MOSQUITO CONTR, V20, P321; Lord CC, 2000, J AM MOSQUITO CONTR, V16, P271; Lord CC, 2001, VECTOR-BORNE ZOONOT, V1, P299, DOI 10.1089/15303660160025921; Mboera LEG, 1999, ENTOMOL EXP APPL, V92, P83, DOI 10.1023/A:1003780811793; Molaei G, 2006, EMERG INFECT DIS, V12, P468, DOI 10.3201/eid1203.051004; MUKABANA WR, 2002, MALARIA J, P1; Pates HV, 2005, ENTOMOL EXP APPL, V114, P153, DOI 10.1111/j.1570-7458.2005.00249.x; Pates HV, 2001, B ENTOMOL RES, V91, P289, DOI 10.1079/BER200198; Patrican LA, 2007, EMERG INFECT DIS, V13, P1921, DOI 10.3201/eid1312.070275; Rappole JH, 2006, VECTOR-BORNE ZOONOT, V6, P128, DOI 10.1089/vbz.2006.6.128; Reddy MR, 2007, J MED ENTOMOL, V44, P211, DOI 10.1603/0022-2585(2007)44[211:EEQAOA]2.0.CO;2; Savage HM, 2007, VECTOR-BORNE ZOONOT, V7, P365, DOI 10.1089/vbz.2006.0602; SCOTT TW, 1990, J MED ENTOMOL, V27, P856, DOI 10.1093/jmedent/27.5.856; Shaman J, 2007, T ROY SOC TROP MED H, V101, P469, DOI 10.1016/j.trstmh.2006.11.007; Steib BM, 2001, CHEM SENSES, V26, P523, DOI 10.1093/chemse/26.5.523; Swaddle JP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002488; Tirados I, 2006, MED VET ENTOMOL, V20, P425, DOI 10.1111/j.1365-2915.2006.652.x; Trevejo RT, 2006, J AM MOSQUITO CONTR, V22, P37, DOI 10.2987/8756-971X(2006)22[37:CAOTCB]2.0.CO;2; Turell MJ, 2000, AM J TROP MED HYG, V62, P413, DOI 10.4269/ajtmh.2000.62.413; Turell MJ, 2001, J MED ENTOMOL, V38, P130, DOI 10.1603/0022-2585-38.2.130; Unnasch RS, 2006, ECOL MODEL, V192, P425, DOI 10.1016/j.ecolmodel.2005.07.011; White DJ, 2001, EMERG INFECT DIS, V7, P643; Wonham MJ, 2004, P ROY SOC B-BIOL SCI, V271, P501, DOI 10.1098/rspb.2003.2608; Zwiebel LJ, 2004, INSECT BIOCHEM MOLEC, V34, P645, DOI 10.1016/j.ibmb.2004.03.017	53	41	41	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2009	4	11							e7861	10.1371/journal.pone.0007861	http://dx.doi.org/10.1371/journal.pone.0007861			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520OG	19924251	Green Published, gold			2022-12-25	WOS:000271854200009
J	Pohl, NM; Tong, C; Fang, WF; Bi, XL; Li, TH; Yang, WC				Pohl, Nicole M.; Tong, Chang; Fang, Wenfeng; Bi, Xiuli; Li, Tianhong; Yang, Wancai			Transcriptional Regulation and Biological Functions of Selenium-Binding Protein 1 in Colorectal Cancer In Vitro and in Nude Mouse Xenografts	PLOS ONE			English	Article							EXPRESSION; SURVIVAL; PROGRESSION; HSP56	Background: It has been shown that selenium-binding protein 1 (SBP1) is significantly downregulated in different human cancers. Its regulation and function have not yet been established. Methodology and Principal Findings: We show that the SBP1 promoter is hypermethylated in colon cancer tissues and human colon cancer cells. Treatment with 59-Aza-29-deoxycytidine leads to demethylation of the SBP1 promoter and to an increase of SBP1 promoter activity, rescues SBP1 mRNA and protein expression in human colon cancer cells. Additionally, overexpression of SBP1 sensitizes colon cancer cells to H(2)O(2)-induced apoptosis, inhibits cancer cell migration in vitro and inhibits tumor growth in nude mice. Conclusion and Significance: These data demonstrate that SBP1 has tumor suppressor functions that are inhibited in colorectal cancer through epigenetic silencing.			Pohl, NM (corresponding author), Univ Illinois, Dept Pathol, Chicago, IL 60607 USA.	wyang06@uic.edu	Yang, Wancai/O-7655-2019; Yang, Wancai/G-3750-2010	Yang, Wancai/0000-0001-7437-9197; 	NATIONAL CANCER INSTITUTE [R01CA112081] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA112081, CA112081] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Chang PWG, 1997, J CELL BIOCHEM, V64, P217, DOI 10.1002/(SICI)1097-4644(199702)64:2<217::AID-JCB5>3.0.CO;2-#; GUOAN C, 2004, J PATHOL, V202, P321; He QY, 2004, PROTEOMICS, V4, P3276, DOI 10.1002/pmic.200300916; Huang KC, 2006, INT J CANCER, V118, P2433, DOI 10.1002/ijc.21671; Jeong JY, 2009, BIOCHEM BIOPH RES CO, V379, P583, DOI 10.1016/j.bbrc.2008.12.110; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kim H, 2006, PROTEOMICS, V6, P3466, DOI 10.1002/pmic.200500629; Laird PW, 2003, NAT REV CANCER, V3, P253, DOI 10.1038/nrc1045; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Li TH, 2008, MOL NUTR FOOD RES, V52, P1289, DOI 10.1002/mnfr.200700331; Pass HI, 2004, CLIN CANCER RES, V10, P849, DOI 10.1158/1078-0432.CCR-0607-3; Porat A, 2000, J BIOL CHEM, V275, P14457, DOI 10.1074/jbc.275.19.14457; Scortegagna M, 2009, CANCER RES, V69, P2638, DOI 10.1158/0008-5472.CAN-08-3643; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Yang MH, 1998, CANCER RES, V58, P3150	15	60	64	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2009	4	11							e7774	10.1371/journal.pone.0007774	http://dx.doi.org/10.1371/journal.pone.0007774			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520NG	19924303	Green Published, Green Submitted, gold			2022-12-25	WOS:000271851000001
J	Shepard, S; McCreary, M; Fedorov, A				Shepard, Samuel; McCreary, Mark; Fedorov, Alexei			The Peculiarities of Large Intron Splicing in Animals	PLOS ONE			English	Article							RNA SECONDARY STRUCTURES; GROUP-II INTRONS; SPLICEOSOMAL INTRONS; EXON; EVOLUTION; DROSOPHILA; POSITIONS; ELEMENTS; DATABASE; PUZZLES	In mammals a considerable 92% of genes contain introns, with hundreds and hundreds of these introns reaching the incredible size of over 50,000 nucleotides. These "large introns'' must be spliced out of the pre-mRNA in a timely fashion, which involves bringing together distant 59 and 39 acceptor and donor splice sites. In invertebrates, especially Drosophila, it has been shown that larger introns can be spliced efficiently through a process known as recursive splicing-a consecutive splicing from the 59-end at a series of combined donor-acceptor splice sites called RP-sites. Using a computational analysis of the genomic sequences, we show that vertebrates lack the proper enrichment of RP-sites in their large introns, and, therefore, require some other method to aid splicing. We analyzed over 15,000 non-redundant, large introns from six mammals, 1,600 from chicken and zebrafish, and 560 non-redundant large introns from five invertebrates. Our bioinformatic investigation demonstrates that, unlike the studied invertebrates, the studied vertebrate genomes contain consistently abundant amounts of direct and complementary strand interspersed repetitive elements (mainly SINEs and LINEs) that may form stems with each other in large introns. This examination showed that predicted stems are indeed abundant and stable in the large introns of mammals. We hypothesize that such stems with long loops within large introns allow intron splice sites to find each other more quickly by folding the intronic RNA upon itself at smaller intervals and, thus, reducing the distance between donor and acceptor sites.			Shepard, S (corresponding author), Univ Toledo, Dept Med, 2801 W Bancroft St, Toledo, OH 43606 USA.	alexei.fedorov@utoledo.edu		McCreary, Mark/0000-0002-5590-7748				Bechtel JM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-284; Belshaw R, 2006, HEREDITY, V96, P208, DOI 10.1038/sj.hdy.6800791; BOWEN R, 1998, NUCL ACID DOT PLOTS; Brosius J, 2003, GENETICA, V118, P99, DOI 10.1023/A:1024141306559; Buratti E, 2004, MOL CELL BIOL, V24, P10505, DOI 10.1128/MCB.24.24.10505-10514.2004; Burnette JM, 2005, GENETICS, V170, P661, DOI 10.1534/genetics.104.039701; Collins L, 2005, MOL BIOL EVOL, V22, P1053, DOI 10.1093/molbev/msi091; Dai LX, 2003, NUCLEIC ACIDS RES, V31, P424, DOI 10.1093/nar/gkg049; De Souza SJ, 1998, P NATL ACAD SCI USA, V95, P5094, DOI 10.1073/pnas.95.9.5094; Fedorov A, 2004, J MOL EVOL, V59, P718, DOI 10.1007/s00239-004-2660-5; Fedorov A, 2002, P NATL ACAD SCI USA, V99, P16128, DOI 10.1073/pnas.242624899; Fedorova L, 2005, CURR GENOMICS, V6, P589, DOI 10.2174/138920205775811416; Gish W, 1996, WUBLAST 2 0MP; Grellscheid SN, 2006, MOL CELL BIOL, V26, P2237, DOI 10.1128/MCB.26.6.2237-2246.2006; Hatton AR, 1998, MOL CELL, V2, P787, DOI 10.1016/S1097-2765(00)80293-2; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; LAMBOWITZ AM, 2006, RNA WORLD, P451; Lynch M, 2002, CURR OPIN GENET DEV, V12, P701, DOI 10.1016/S0959-437X(02)00360-X; Mathews DH, 2005, BIOINFORMATICS, V21, P2246, DOI 10.1093/bioinformatics/bti349; Ott S, 2003, Pac Symp Biocomput, P339; Pyle AM, 2007, TRENDS BIOCHEM SCI, V32, P138, DOI 10.1016/j.tibs.2007.01.005; Rogic S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-355; Rogozin IB, 2005, BRIEF BIOINFORM, V6, P118, DOI 10.1093/bib/6.2.118; Rogozin IB, 2003, CURR BIOL, V13, P1512, DOI 10.1016/S0960-9822(03)00558-X; Roy SW, 2006, NAT REV GENET, V7, P211, DOI 10.1038/nrg1807; Shepelev V, 2006, BRIEF BIOINFORM, V7, P178, DOI 10.1093/bib/bbl003; Smit A., REPEATMASKER OPEN 3; Sun HZ, 2000, MOL CELL BIOL, V20, P6414, DOI 10.1128/MCB.20.17.6414-6425.2000; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; Vicens Q, 2006, TRENDS BIOCHEM SCI, V31, P41, DOI 10.1016/j.tibs.2005.11.008	30	43	46	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2009	4	11							e7853	10.1371/journal.pone.0007853	http://dx.doi.org/10.1371/journal.pone.0007853			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520NG	19924226	Green Submitted, gold, Green Published			2022-12-25	WOS:000271851000010
J	Callahan, KP; Butler, JS				Callahan, Kevin P.; Butler, J. Scott			TRAMP Complex Enhances RNA Degradation by the Nuclear Exosome Component Rrp6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							QUALITY-CONTROL; MESSENGER-RNA; SACCHAROMYCES-CEREVISIAE; POLY(A) POLYMERASE; SUBUNIT; CORE; POLYADENYLATION; SURVEILLANCE; TRANSCRIPTS; INTERACTS	The RNA-processing exosome contains ribonucleases that degrade aberrant RNAs in archael and eukaryotic cells. In Saccharomyces cerevisiae, the nuclear/nucleolar 3'-5' exoribonuclease Rrp6 distinguishes the nuclear exosome from the cytoplasmic exosome. In vivo, the TRAMP complex enhances the ability of the nuclear exosome to destroy some aberrant RNAs. Previous reports showed that purified TRAMP enhanced RNA degradation by the nuclear exosome in vitro. However, the exoribonucleolytic component(s) of the nuclear exosome enhanced by TRAMP remain unidentified. We show that TRAMP does not significantly enhance RNA degradation by purified exosomes lacking Rrp6 in vitro, suggesting that TRAMP activation experiments with nuclear exosome preparations reflect, in part, effects on the activity of Rrp6. Consistent with this, we show that incubation of purified TRAMP with recombinant Rrp6 results in a 10-fold enhancement of the rate of RNA degradation. This increased activity results from enhancement of the hydrolytic activity of Rrp6 because TRAMP cannot enhance the activity of an Rrp6 mutant lacking a key amino acid side chain in its active site. We observed no ATP or polyadenylation dependence for the enhancement of Rrp6 activity by TRAMP, suggesting that neither the poly(A) polymerase activity of Trf4 nor the helicase activity of Mtr4 plays a role in the enhancement. These findings identify TRAMP as an exosome-independent enhancer of Rrp6 activity.	[Callahan, Kevin P.; Butler, J. Scott] Univ Rochester, Med Ctr, Dept Biochem & Biophys, Rochester, NY 14642 USA; [Butler, J. Scott] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Butler, J. Scott] Univ Rochester, Med Ctr, Ctr RNA Biol Genome Med, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester	Butler, JS (corresponding author), Box 672,601 Elmwood Ave, Rochester, NY 14642 USA.	scott_butler@urmc.rochester.edu			National Institutes of Health [GM-59898]; National Science Foundation [MCB-0817324]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059898] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-59898. This work was also supported by National Science Foundation Grant MCB-0817324.	Arigo JT, 2006, MOL CELL, V23, P841, DOI 10.1016/j.molcel.2006.07.024; Bayne EH, 2007, CELL, V129, P651, DOI 10.1016/j.cell.2007.05.004; Burkard KTD, 2000, MOL CELL BIOL, V20, P604, DOI 10.1128/MCB.20.2.604-616.2000; Butler JS, 2002, TRENDS CELL BIOL, V12, P90, DOI 10.1016/S0962-8924(01)02225-5; BUTLER JS, 1990, MOL CELL BIOL, V10, P2599, DOI 10.1128/MCB.10.6.2599; Callahan KP, 2008, NUCLEIC ACIDS RES, V36, P6645, DOI 10.1093/nar/gkn743; Chekanova JA, 2007, CELL, V131, P1340, DOI 10.1016/j.cell.2007.10.056; Davis CA, 2006, P NATL ACAD SCI USA, V103, P3262, DOI 10.1073/pnas.0507783103; Doma MK, 2007, CELL, V131, P660, DOI 10.1016/j.cell.2007.10.041; Dziembowski A, 2007, NAT STRUCT MOL BIOL, V14, P15, DOI 10.1038/nsmb1184; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Houseley J, 2006, EMBO REP, V7, P205, DOI 10.1038/sj.embor.7400612; Houseley J, 2007, EMBO J, V26, P4996, DOI 10.1038/sj.emboj.7601921; Kadaba S, 2006, RNA, V12, P508, DOI 10.1261/rna.2305406; Kadaba S, 2004, GENE DEV, V18, P1227, DOI 10.1101/gad.1183804; Krogan NJ, 2004, MOL CELL, V13, P225, DOI 10.1016/S1097-2765(04)00003-6; Kuai L, 2004, P NATL ACAD SCI USA, V101, P8581, DOI 10.1073/pnas.0402888101; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Liu QS, 2006, CELL, V127, P1223, DOI 10.1016/j.cell.2006.10.037; Lorentzen E, 2005, NAT STRUCT MOL BIOL, V12, P575, DOI 10.1038/nsmb952; Lorentzen E, 2005, MOL CELL, V20, P473, DOI 10.1016/j.molcel.2005.10.020; Lorentzen E, 2008, MOL CELL, V29, P717, DOI 10.1016/j.molcel.2008.02.018; Mullen TE, 2008, GENE DEV, V22, P50, DOI 10.1101/gad.1622708; Paolo SS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000555; Phillips S, 2003, RNA, V9, P1098, DOI 10.1261/rna.5560903; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Rougemaille M, 2007, EMBO J, V26, P2317, DOI 10.1038/sj.emboj.7601669; Schneider C, 2007, MOL CELL, V27, P324, DOI 10.1016/j.molcel.2007.06.006; Vanacova S, 2005, PLOS BIOL, V3, P986, DOI 10.1371/journal.pbio.0030189; Vanacova S, 2007, EMBO REP, V8, P651, DOI 10.1038/sj.embor.7401005; Vasiljeva L, 2006, MOL CELL, V21, P239, DOI 10.1016/j.molcel.2005.11.028; Wang SW, 2008, MOL CELL BIOL, V28, P656, DOI 10.1128/MCB.01531-07; Wang XY, 2008, RNA, V14, P107, DOI 10.1261/rna.808608; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030	34	76	76	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3540	3547		10.1074/jbc.M109.058396	http://dx.doi.org/10.1074/jbc.M109.058396			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19955569	Green Published, hybrid			2022-12-25	WOS:000275254000003
J	Donnelly, S; O'Neill, SM; Stack, CM; Robinson, MW; Turnbull, L; Whitchurch, C; Dalton, JP				Donnelly, Sheila; O'Neill, Sandra M.; Stack, Colin M.; Robinson, Mark W.; Turnbull, Lynne; Whitchurch, Cynthia; Dalton, John P.			Helminth Cysteine Proteases Inhibit TRIF-dependent Activation of Macrophages via Degradation of TLR3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IFN-BETA PROMOTER; FASCIOLA-HEPATICA; LIVER FLUKE; BORDETELLA-PERTUSSIS; MEDIATED CLEAVAGE; IMMUNE EVASION; CATHEPSIN L1; LIPOPOLYSACCHARIDE; PROTEINASES; INFECTION	Helminth pathogens prepare a Th2 type immunological environment in their hosts to ensure their longevity. They achieve this by secreting molecules that not only actively drive type 2 responses but also suppress type 1 responses. Here, we show that the major cysteine proteases secreted from the helminth pathogens Fasciola hepatica (FheCL1) and Schistosoma mansoni (SmCB1) protect mice from the lethal effects of lipopolysaccharide by preventing the release of inflammatory mediators, nitric oxide, interleukin-6, tumor necrosis factor alpha, and interleukin-12, from macrophages. The proteases specifically block the MyD88-independent TRIF-dependent signaling pathway of Toll-like receptor (TLR) 4 and TLR3. Microscopical and flow cytometric studies, however, show that alteration of macrophage function by cysteine protease is not mediated by cleavage of components of the TLR4 complex on the cell surface but occurs by degradation of TLR3 within the endosome. This is the first study to describe a parasite molecule that degrades this receptor and pinpoints a novel mechanism by which helminth parasites modulate the innate immune responses of their hosts to suppress the development of Th1 responses.	[Donnelly, Sheila] Natl Univ Ireland Maynooth, Dept Biol, Maynooth, Kildare, Ireland; [Dalton, John P.] Univ Technol Sydney, Inst Biotechnol Infect Dis, Sydney, NSW 2007, Australia; [O'Neill, Sandra M.] Dublin City Univ, Sch Nursing, Dublin 9, Ireland; [Stack, Colin M.] Univ Western Sydney, Sch Biomed & Hlth Sci, Campbelltown, NSW 2560, Australia; [Dalton, John P.] McGill Univ, Inst Parasitol, Ste Anne De Bellevue, PQ H9X 3V9, Canada	Maynooth University; University of Technology Sydney; Dublin City University; Western Sydney University; McGill University	Donnelly, S (corresponding author), Natl Univ Ireland Maynooth, Dept Biol, Maynooth, Kildare, Ireland.	sheila.donnelly@nuim.ie	Dalton, John/K-4457-2014; Stack, Colin M/D-4601-2009; Donnelly, Sheila/H-7733-2014; Turnbull, Lynne/A-2605-2012; Whitchurch, Cynthia/A-5954-2008	Turnbull, Lynne/0000-0002-9255-9033; Robinson, Mark/0000-0001-7191-0034; Stack, Colin/0000-0002-7539-7677; Whitchurch, Cynthia/0000-0003-2296-3791; Donnelly, Sheila/0000-0003-2005-3698	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL046703] Funding Source: NIH RePORTER; NHLBI NIH HHS [P01HL46703] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Andersen J, 2008, GENES IMMUN, V9, P168, DOI 10.1038/sj.gene.6364449; Balic A, 2006, INT IMMUNOL, V18, P1421, DOI 10.1093/intimm/dxl075; Berasain P, 2000, EXP PARASITOL, V94, P99, DOI 10.1006/expr.1999.4479; Brady MT, 1999, INFECT IMMUN, V67, P5372, DOI 10.1128/IAI.67.10.5372-5378.1999; Brannstrom K, 2009, INFECT IMMUN, V77, P1144, DOI 10.1128/IAI.01126-08; Carvalho L, 2009, IMMUNOLOGY, V126, P28, DOI 10.1111/j.1365-2567.2008.03008.x; Cavassani KA, 2008, J EXP MED, V205, P2609, DOI 10.1084/jem.20081370; Collins PR, 2004, J BIOL CHEM, V279, P17038, DOI 10.1074/jbc.M308831200; Elias D, 2007, EXPERT REV ANTI-INFE, V5, P475, DOI 10.1586/14787210.5.3.475; Elliott DE, 2007, INT J PARASITOL, V37, P457, DOI 10.1016/j.ijpara.2006.12.009; Goodridge HS, 2005, J IMMUNOL, V174, P284, DOI 10.4049/jimmunol.174.1.284; Huang JR, 2008, IMMUNOL INVEST, V37, P263, DOI 10.1080/08820130802083622; Jiang W, 2005, P NATL ACAD SCI USA, V102, P17077, DOI 10.1073/pnas.0504570102; Joshi AD, 2008, EUR J IMMUNOL, V38, P3436, DOI 10.1002/eji.200838629; Kanaji S, 2007, FEBS LETT, V581, P4260, DOI 10.1016/j.febslet.2007.07.072; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Kopitar-Jerala N, 2006, FEBS LETT, V580, P6295, DOI 10.1016/j.febslet.2006.10.055; Kuroda E, 2001, PARASITE IMMUNOL, V23, P305, DOI 10.1046/j.1365-3024.2001.00387.x; Lang KS, 2006, J CLIN INVEST, V116, P2456, DOI 10.1172/JCI28349; Lee ZH, 2001, J LEUKOCYTE BIOL, V69, P490; Li K, 2005, P NATL ACAD SCI USA, V102, P2992, DOI 10.1073/pnas.0408824102; MEEUSEN E, 1995, PARASITE IMMUNOL, V17, P37, DOI 10.1111/j.1365-3024.1995.tb00964.x; O'Neill SM, 2001, PARASITE IMMUNOL, V23, P541, DOI 10.1046/j.1365-3024.2001.00411.x; O'Neill SM, 2000, PARASITE IMMUNOL, V22, P147, DOI 10.1046/j.1365-3024.2000.00290.x; Park B, 2008, NAT IMMUNOL, V9, P1407, DOI 10.1038/ni.1669; Pearce EJ, 2002, NAT REV IMMUNOL, V2, P499, DOI 10.1038/nri843; Perera PY, 2001, J IMMUNOL, V166, P574, DOI 10.4049/jimmunol.166.1.574; Robinson MW, 2008, TRENDS BIOCHEM SCI, V33, P601, DOI 10.1016/j.tibs.2008.09.001; Sajid M, 2002, MOL BIOCHEM PARASIT, V120, P1, DOI 10.1016/S0166-6851(01)00438-8; Semnani RT, 2004, J IMMUNOL, V172, P6229, DOI 10.4049/jimmunol.172.10.6229; Siracusa MC, 2008, J LEUKOCYTE BIOL, V84, P1422, DOI 10.1189/jlb.0308199; SMITH AM, 1993, INT J PARASITOL, V23, P977, DOI 10.1016/0020-7519(93)90117-H; Stack CM, 2005, J IMMUNOL METHODS, V304, P151, DOI 10.1016/j.jim.2005.07.019; Stack CM, 2008, J BIOL CHEM, V283, P9896, DOI 10.1074/jbc.M708521200; Stack CM, 2007, J BIOL CHEM, V282, P16532, DOI 10.1074/jbc.M611501200; Stadecker MJ, 2004, IMMUNOL REV, V201, P168, DOI 10.1111/j.0105-2896.2004.00197.x; Sugawara S, 2000, J IMMUNOL, V165, P411, DOI 10.4049/jimmunol.165.1.411; SUNG CK, 1986, J PARASITOL, V72, P891, DOI 10.2307/3281841; Thomas KE, 2006, J BIOL CHEM, V281, P31119, DOI 10.1074/jbc.M604958200; Tort J, 1999, ADV PARASIT, V43, P161, DOI 10.1016/S0065-308X(08)60243-2; Tse K, 2007, ANN RHEUM DIS, V66, P77, DOI 10.1136/ard.2007.078998; van Liempt E, 2007, MOL IMMUNOL, V44, P2605, DOI 10.1016/j.molimm.2006.12.012; van Riet E, 2007, IMMUNOBIOLOGY, V212, P475, DOI 10.1016/j.imbio.2007.03.009; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668	46	101	107	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5					3383	3392		10.1074/jbc.M109.060368	http://dx.doi.org/10.1074/jbc.M109.060368			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19923225	hybrid, Green Published			2022-12-25	WOS:000273829000053
J	Bhattacharya, S; HuangFu, WC; Liu, JH; Veeranki, S; Baker, DP; Koumenis, C; Diehl, JA; Fuchs, SY				Bhattacharya, Sabyasachi; HuangFu, Wei-Chun; Liu, Jianghuai; Veeranki, Sudhakar; Baker, Darren P.; Koumenis, Constantinos; Diehl, J. Alan; Fuchs, Serge Y.			Inducible Priming Phosphorylation Promotes Ligand-independent Degradation of the IFNAR1 Chain of Type I Interferon Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CASEIN KINASE-I; CDC25A PROTEIN PHOSPHATASE; DOWN-REGULATION; ALPHA RECEPTOR; BETA-CATENIN; DEPENDENT DEGRADATION; UBIQUITIN LIGASE; HEPATITIS-C; PATHWAY; VIRUSES	Phosphorylation-dependent ubiquitination and ensuing down-regulation and lysosomal degradation of the interferon alpha/beta receptor chain 1 (IFNAR1) of the receptor for Type I interferons play important roles in limiting the cellular responses to these cytokines. These events could be stimulated either by the ligands (in a Janus kinase-dependent manner) or by unfolded protein response (UPR) inducers including viral infection (in a manner dependent on the activity of pancreatic endoplasmic reticulum kinase). Both ligand-dependent and -independent pathways converge on phosphorylation of Ser(535) within the IFNAR1 degron leading to recruitment of beta-Trcp E3 ubiquitin ligase and concomitant ubiquitination and degradation. Casein kinase 1 alpha (CK1 alpha) was shown to directly phosphorylate Ser535 within the ligand-independent pathway. Yet given the constitutive activity of CK1 alpha, it remained unclear how this pathway is stimulated by UPR. Here we report that induction of UPR promotes the phosphorylation of a proximal residue, Ser(532), in a pancreatic endoplasmic reticulum kinase-dependent manner. This serine serves as a priming site that promotes subsequent phosphorylation of IFNAR1 within its degron by CK1 alpha. These events play an important role in regulating ubiquitination and degradation of IFNAR1 as well as the extent of Type I interferon signaling.	[Bhattacharya, Sabyasachi; HuangFu, Wei-Chun; Liu, Jianghuai; Veeranki, Sudhakar; Fuchs, Serge Y.] Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA; [Bhattacharya, Sabyasachi; HuangFu, Wei-Chun; Liu, Jianghuai; Veeranki, Sudhakar; Fuchs, Serge Y.] Univ Penn, Sch Vet Med, Mari Lowe Ctr Comparat Oncol, Philadelphia, PA 19104 USA; [Koumenis, Constantinos] Univ Penn, Dept Radiat Oncol, Philadelphia, PA 19104 USA; [Diehl, J. Alan] Univ Penn, Dept Canc Biol, Philadelphia, PA 19104 USA; [Diehl, J. Alan] Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Baker, Darren P.] Biogen Idec Inc, Cambridge, MA 02142 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Biogen	Fuchs, SY (corresponding author), 380 S Univ Ave,Hill 316, Philadelphia, PA 19104 USA.	syfuchs@vet.upenn.edu	Koumenis, Constantinos/B-2002-2008	Liu, Jianghuai/0000-0002-2382-9140; Koumenis, Costas/0000-0001-5945-4726	National Institutes of Health [CA92900, CA104838]; NATIONAL CANCER INSTITUTE [P01CA104838, R01CA092900] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI073347] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants CA92900 (to S. Y. F.) and CA104838 (to J. A. D.).	Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; Amit S, 2002, GENE DEV, V16, P1066, DOI 10.1101/gad.230302; Bhatia N, 2006, J BIOL CHEM, V281, P19320, DOI 10.1074/jbc.M513203200; BILLARD C, 1986, BLOOD, V67, P821; Bustos VH, 2005, BIOCHEM J, V391, P417, DOI 10.1042/BJ20050717; Bustos VH, 2006, P NATL ACAD SCI USA, V103, P19725, DOI 10.1073/pnas.0609424104; Chen LH, 2005, MOL CELL BIOL, V25, P6509, DOI 10.1128/MCB.25.15.6509-6520.2005; CONSTANTINESCU SN, 1995, P NATL ACAD SCI USA, V92, P10487, DOI 10.1073/pnas.92.23.10487; CONSTANTINESCU SN, 1994, P NATL ACAD SCI USA, V91, P9602, DOI 10.1073/pnas.91.20.9602; Cullinan SB, 2003, MOL CELL BIOL, V23, P7198, DOI 10.1128/MCB.23.20.7198-7209.2003; DONELLADEANA A, 1985, BIOCHIM BIOPHYS ACTA, V829, P180, DOI 10.1016/0167-4838(85)90187-6; Donzelli M, 2004, CELL CYCLE, V3, P469; FLOTOW H, 1990, J BIOL CHEM, V265, P14264; Goldman LA, 1999, J INTERF CYTOK RES, V19, P15, DOI 10.1089/107999099314379; GUTTERMAN JU, 1994, P NATL ACAD SCI USA, V91, P1198, DOI 10.1073/pnas.91.4.1198; Hagen T, 2002, BIOCHEM BIOPH RES CO, V294, P324, DOI 10.1016/S0006-291X(02)00485-0; Hartwell D, 2009, INT J TECHNOL ASSESS, V25, P56, DOI 10.1017/S0266462309090084; He B, 2006, CELL DEATH DIFFER, V13, P393, DOI 10.1038/sj.cdd.4401833; HuangFu WC, 2008, FEBS LETT, V582, P3206, DOI 10.1016/j.febslet.2008.08.013; Jia JH, 2005, DEV CELL, V9, P819, DOI 10.1016/j.devcel.2005.10.006; Jiang J, 2006, CELL CYCLE, V5, P2457, DOI 10.4161/cc.5.21.3406; Jin J, 2008, J BIOL CHEM, V283, P19322, DOI 10.1074/jbc.M802474200; Jin JP, 2003, GENE DEV, V17, P3062, DOI 10.1101/gad.1157503; Kang T, 2008, CANCER CELL, V13, P36, DOI 10.1016/j.ccr.2007.12.002; Katze MG, 2002, NAT REV IMMUNOL, V2, P675, DOI 10.1038/nri888; Knippschild U, 2005, CELL SIGNAL, V17, P675, DOI 10.1016/j.cellsig.2004.12.011; Kumar KGS, 2008, J BIOL CHEM, V283, P18566, DOI 10.1074/jbc.M800991200; Kumar KGS, 2007, J CELL BIOL, V179, P935, DOI 10.1083/jcb.200706034; Kumar KGS, 2004, J BIOL CHEM, V279, P46614, DOI 10.1074/jbc.M407082200; Kumar KGS, 2003, EMBO J, V22, P5480; Lang K, 2008, EXPERT REV VACCINES, V7, P915, DOI 10.1586/14760584.7.7.915; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Liu J, 2008, BIOCHEM BIOPH RES CO, V367, P388, DOI 10.1016/j.bbrc.2007.12.137; Liu JH, 2009, MOL CELL BIOL, V29, P6401, DOI 10.1128/MCB.00478-09; Liu JH, 2009, CELL HOST MICROBE, V5, P72, DOI 10.1016/j.chom.2008.11.008; Luquin E, 2007, ANTIVIR RES, V76, P194, DOI 10.1016/j.antiviral.2007.06.004; Marijanovic Z, 2006, BIOCHEM J, V397, P31, DOI 10.1042/BJ20060272; MAXWELL BL, 1985, INT J CANCER, V36, P23, DOI 10.1002/ijc.2910360105; MEGGIO F, 1979, FEBS LETT, V106, P76, DOI 10.1016/0014-5793(79)80698-5; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Pan Y, 2006, MOL CELL BIOL, V26, P3365, DOI 10.1128/MCB.26.9.3365-3377.2006; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; ROACH PJ, 1991, J BIOL CHEM, V266, P14139; Shirogane T, 2005, J BIOL CHEM, V280, P26863, DOI 10.1074/jbc.M502862200; UMPHRESS JL, 1992, EUR J BIOCHEM, V203, P239, DOI 10.1111/j.1432-1033.1992.tb19852.x; WALLACH DFH, 1987, FUNDAMENTALS RECEPTO; Waris G, 2002, BIOCHEM PHARMACOL, V64, P1425, DOI 10.1016/S0006-2952(02)01300-X	48	38	38	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2318	2325		10.1074/jbc.M109.071498	http://dx.doi.org/10.1074/jbc.M109.071498			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19948722	Green Published, hybrid			2022-12-25	WOS:000273697800011
J	Schoenwaelder, SM; Ono, A; Nesbitt, WS; Lim, J; Jarman, K; Jackson, SP				Schoenwaelder, Simone M.; Ono, Akiko; Nesbitt, Warwick S.; Lim, Joanna; Jarman, Kate; Jackson, Shaun P.			Phosphoinositide 3-Kinase p110 beta Regulates Integrin alpha(IIb)beta(3) Avidity and the Cellular Transmission of Contractile Forces	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLATELET-AGGREGATION; PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHOLIPASE C-GAMMA-2; THROMBUS FORMATION; FOCAL ADHESIONS; SECRETED ADP; ACTIVATION; HEMOSTASIS; MECHANISM; RAP1B	Phosphoinositide (PI) 3-kinase (PI3K) signaling processes play an important role in regulating the adhesive function of integrin alpha(IIb)beta(3), necessary for platelet spreading and sustained platelet aggregation. PI3K inhibitors are effective at reducing platelet aggregation and thrombus formation in vivo and as a consequence are currently being evaluated as novel antithrombotic agents. PI3K regulation of integrin alpha(IIb)beta(3) activation (affinity modulation) primarily occurs downstream of G(i)-coupled and tyrosine kinase-linked receptors linked to the activation of Rap1b, AKT, and phospholipase C. In the present study, we demonstrate an important role for PI3Ks in regulating the avidity (strength of adhesion) of high affinity integrin alpha(IIb)beta(3) bonds, necessary for the cellular transmission of contractile forces. Using knock-out mouse models and isoform-selective PI3K inhibitors, we demonstrate that the Type Ia p110 beta isoform plays a major role in regulating thrombin-stimulated fibrin clot retraction in vitro. Reduced clot retraction induced by PI3K inhibitors was not associated with defects in integrin alpha(IIb)beta(3) activation, actin polymerization, or actomyosin contractility but was associated with a defect in integrin alpha(IIb)beta(3) association with the contractile cytoskeleton. Analysis of integrin alpha(IIb)beta(3) adhesion contacts using total internal reflection fluorescence microscopy revealed an important role for PI3Ks in regulating the stability of high affinity integrin alpha(IIb)beta(3) bonds. These studies demonstrate an important role for PI3K p110 beta in regulating the avidity of high affinity integrin alpha(IIb)beta(3) receptors, necessary for the cellular transmission of contractile forces. These findings may provide new insight into the potential antithrombotic properties of PI3K p110 beta inhibitors.	[Schoenwaelder, Simone M.; Ono, Akiko; Nesbitt, Warwick S.; Lim, Joanna; Jarman, Kate; Jackson, Shaun P.] Monash Univ, Australian Ctr Blood Dis, Melbourne, Vic 3004, Australia	Monash University	Schoenwaelder, SM (corresponding author), Monash Univ, Australian Ctr Blood Dis, 89 Commercial Rd, Melbourne, Vic 3004, Australia.	Simone.Schoenwaelder@med.monash.edu.au	Schoenwaelder, Simone/E-9506-2011; Jackson, Shaun P/E-9633-2011	Nesbitt, Warwick/0000-0001-5644-7053; Schoenwaelder, Simone/0000-0003-0465-5840; Jackson, Shaun/0000-0002-4750-1991	National Heart Foundation of Australia; National Health and Medical Research Council of Australia.	National Heart Foundation of Australia(National Heart Foundation of Australia); National Health and Medical Research Council of Australia.(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by grants from the National Heart Foundation of Australia and the National Health and Medical Research Council of Australia.	Banno A, 2008, BIOCHEM SOC T, V36, P229, DOI 10.1042/BST0360229; Bertoni A, 2002, J BIOL CHEM, V277, P25715, DOI 10.1074/jbc.M202791200; Bhatt DL, 2003, NAT REV DRUG DISCOV, V2, P15, DOI 10.1038/nrd985; BROMBERG ME, 1985, AM J PHYSIOL, V249, pC297, DOI 10.1152/ajpcell.1985.249.3.C297; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; Canobbio I, 2009, BLOOD, V114, P2193, DOI 10.1182/blood-2009-03-208074; Carman CV, 2003, CURR OPIN CELL BIOL, V15, P547, DOI 10.1016/j.ceb.2003.08.003; CARR ME, 1995, THROMB HAEMOSTASIS, V73, P499; Chrzanowska-Wodnicka M, 2005, J CLIN INVEST, V115, P680, DOI 10.1172/JCI200522973; COHEN I, 1989, BLOOD, V73, P1880; COHEN I, 1982, J CELL BIOL, V93, P775, DOI 10.1083/jcb.93.3.775; Coller BS, 2008, BLOOD, V112, P3011, DOI 10.1182/blood-2008-06-077891; Crawley JTB, 2007, J THROMB HAEMOST, V5, P95, DOI 10.1111/j.1538-7836.2007.02500.x; Crittenden JR, 2004, NAT MED, V10, P982, DOI 10.1038/nm1098; Dormond O, 2004, THROMB HAEMOSTASIS, V92, P151, DOI 10.1160/th03-11-0728; FOX JEB, 1993, ADV EXP MED BIOL, V344, P175; Gilcrease MZ, 2004, CANCER RES, V64, P7395, DOI 10.1158/0008-5472.CAN-04-1809; Gratacap MP, 1998, J BIOL CHEM, V273, P24314, DOI 10.1074/jbc.273.38.24314; GUINEBAULT C, 1993, BIOCHEM J, V292, P851, DOI 10.1042/bj2920851; Han JW, 2006, CURR BIOL, V16, P1796, DOI 10.1016/j.cub.2006.08.035; HARTWIG JH, 2007, PLATELETS; Jackson SP, 2007, BLOOD, V109, P5087, DOI 10.1182/blood-2006-12-027698; Jackson SP, 2005, NAT MED, V11, P507, DOI 10.1038/nm1232; Jackson SP, 2004, BIOCHEM SOC T, V32, P387, DOI 10.1042/BST0320387; JAKOBSEN E, 1973, Thrombosis Research, V3, P145, DOI 10.1016/0049-3848(73)90065-0; Jirouskova M, 2007, BLOOD, V109, P5260, DOI 10.1182/blood-2006-10-054015; Jones SL, 1998, P NATL ACAD SCI USA, V95, P9331, DOI 10.1073/pnas.95.16.9331; Kauffenstein G, 2001, FEBS LETT, V505, P281, DOI 10.1016/S0014-5793(01)02824-1; Kim S, 2002, BLOOD, V99, P3629, DOI 10.1182/blood.V99.10.3629; Krauss K, 1999, J BIOL CHEM, V274, P36921, DOI 10.1074/jbc.274.52.36921; Leon C, 2007, BLOOD, V110, P3183, DOI 10.1182/blood-2007-03-080184; Lova P, 2003, J BIOL CHEM, V278, P131, DOI 10.1074/jbc.M204821200; Lova P, 2002, J BIOL CHEM, V277, P12009, DOI 10.1074/jbc.M111803200; Lynch L, 2005, MOL BIOL CELL, V16, P51, DOI 10.1091/mbc.E04-05-0399; Maxwell MJ, 2004, J BIOL CHEM, V279, P32196, DOI 10.1074/jbc.M400746200; Mica OI, 2004, BIOCHEM J, V381, P13, DOI 10.1042/BJ20040434; Moser M, 2008, NAT MED, V14, P325, DOI 10.1038/nm1722; Nesbitt WS, 2009, NAT MED, V15, P665, DOI 10.1038/nm.1955; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Ono A, 2008, BLOOD, V112, P90, DOI 10.1182/blood-2007-12-127001; Osdoit S, 2001, J BIOL CHEM, V276, P6703, DOI 10.1074/jbc.M008945200; Pasquet JM, 1999, BIOCHEM J, V342, P171, DOI 10.1042/0264-6021:3420171; Payrastre B, 2000, BIOCHEM PHARMACOL, V60, P1069, DOI 10.1016/S0006-2952(00)00417-2; Petrich BG, 2007, J EXP MED, V204, P3103, DOI 10.1084/jem.20071800; Ruggeri ZM, 2007, CIRC RES, V100, P1673, DOI 10.1161/01.RES.0000267878.97021.ab; Schoenwaelder SM, 2007, J BIOL CHEM, V282, P28648, DOI 10.1074/jbc.M704358200; Schoenwaelder SM, 2009, BLOOD, V114, P663, DOI 10.1182/blood-2009-01-200345; Schoenwaelder SM, 1997, J BIOL CHEM, V272, P24876, DOI 10.1074/jbc.272.40.24876; Selheim F, 1999, BIOCHEM BIOPH RES CO, V263, P780, DOI 10.1006/bbrc.1999.1450; Shattil SJ, 1999, THROMB HAEMOSTASIS, V82, P318; Stephens LR, 1997, CELL, V89, P105, DOI 10.1016/S0092-8674(00)80187-7; Trumel C, 1999, BLOOD, V94, P4156, DOI 10.1182/blood.V94.12.4156.424k29_4156_4165; TRUSKEY GA, 1992, J CELL SCI, V103, P491; Vanhaesebroeck B, 1999, EXP CELL RES, V253, P239, DOI 10.1006/excr.1999.4701; Vanhaesebroeck B, 1997, TRENDS BIOCHEM SCI, V22, P267, DOI 10.1016/S0968-0004(97)01061-X; Watanabe N, 2003, BLOOD, V102, P541, DOI 10.1182/blood-2002-11-3327; Wymann MP, 1998, BBA-MOL CELL BIOL L, V1436, P127, DOI 10.1016/S0005-2760(98)00139-8	57	60	65	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2886	2896		10.1074/jbc.M109.029132	http://dx.doi.org/10.1074/jbc.M109.029132			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19940148	Green Published, hybrid			2022-12-25	WOS:000273697800064
J	Schuh, NR; Guerrero, MS; Schrecengost, RS; Bouton, AH				Schuh, Natasha R.; Guerrero, Michael S.; Schrecengost, Randy S.; Bouton, Amy H.			BCAR3 Regulates Src/p130(Cas) Association, Src Kinase Activity, and Breast Cancer Adhesion Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; CRK-ASSOCIATED SUBSTRATE; MEDIATED CELL-ADHESION; C-SRC; TYROSINE PHOSPHORYLATION; ANTIESTROGEN RESISTANCE; TAMOXIFEN RESISTANCE; COMPLEX-FORMATION; ADAPTER PROTEINS; DEPENDENT MANNER	The nonreceptor protein-tyrosine kinase c-Src is frequently overexpressed and/or activated in a variety of cancers, including those of the breast. Several heterologous binding partners of c-Src have been shown to regulate its catalytic activity by relieving intramolecular autoinhibitory interactions. One such protein, p130(Cas) (Cas), is expressed at high levels in both breast cancer cell lines and breast tumors, providing a potential mechanism for c-Src activation in breast cancers. The Cas-binding protein BCAR3 (breast cancer antiestrogen resistance-3) is expressed at high levels in invasive breast cancer cell lines, and this molecule has previously been shown to coordinate with Cas to increase c-Src activity in COS-1 cells. In this study, we show for the first time using gain- and loss-of-function approaches that BCAR3 regulates c-Src activity in the endogenous setting of breast cancer cells. We further show that BCAR3 regulates the interaction between Cas and c-Src, both qualitatively as well as quantitatively. Finally, we present evidence that the coordinated activity of these proteins contributes to breast cancer cell adhesion signaling and spreading. Based on these data, we propose that the c-Src/Cas/BCAR3 signaling axis is a prominent regulator of c-Src activity, which in turn controls cell behaviors that lead to aggressive and invasive breast tumor phenotypes.	[Schuh, Natasha R.; Guerrero, Michael S.; Schrecengost, Randy S.; Bouton, Amy H.] Univ Virginia Hlth Syst, Dept Microbiol, Charlottesville, VA 22908 USA	University of Virginia	Bouton, AH (corresponding author), Univ Virginia, Dept Microbiol, Box 800734, Charlottesville, VA 22908 USA.	ahb8y@virginia.edu			National Institutes of Health Training [T32 CA009109]; Department of Defense Breast Cancer Research [BC043365, BC050339]; Ruth L. Kirschstein National Research Service [CA130168];  [R01 CA096846]; NATIONAL CANCER INSTITUTE [T32CA009109, F31CA130168, R01CA096846] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK067629] Funding Source: NIH RePORTER	National Institutes of Health Training(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Breast Cancer Research(United States Department of Defense); Ruth L. Kirschstein National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Training Grant T32 CA009109 (to N. R. S., M. S. G., and R. S. S.) and Research Grant R01 CA096846 (to A. H. B.). This work was also supported by Department of Defense Breast Cancer Research Program Grants BC043365 (to N. R. S.) and BC050339 (to R. S. S.) and Ruth L. Kirschstein National Research Service Award CA130168 (to M. S. G.).	Blake RA, 2000, MOL CELL BIOL, V20, P9018, DOI 10.1128/MCB.20.23.9018-9027.2000; Bouton AH, 1997, HYBRIDOMA, V16, P403, DOI 10.1089/hyb.1997.16.403; Brinkman A, 2000, JNCI-J NATL CANCER I, V92, P112, DOI 10.1093/jnci/92.2.112; Burnham MR, 2000, MOL CELL BIOL, V20, P5865, DOI 10.1128/MCB.20.16.5865-5878.2000; Burnham MR, 1999, MOL CARCINOGEN, V26, P20, DOI 10.1002/(SICI)1098-2744(199909)26:1<20::AID-MC3>3.0.CO;2-M; Cabodi S, 2004, J CELL SCI, V117, P1603, DOI 10.1242/jcs.01025; Cai DP, 1999, J IMMUNOL, V163, P2104; Cary LA, 2002, MOL CELL BIOL, V22, P2427, DOI 10.1128/MCB.22.8.2427-2440.2002; Chodniewicz D, 2004, BBA-MOL CELL RES, V1692, P63, DOI 10.1016/j.bbamcr.2004.03.006; Dail M, 2004, J BIOL CHEM, V279, P41892, DOI 10.1074/jbc.M402929200; Defilippi P, 2006, TRENDS CELL BIOL, V16, P257, DOI 10.1016/j.tcb.2006.03.003; Dorssers LCJ, 2005, BREAST CANCER RES, V7, pR82, DOI 10.1186/bcr954; Felekkis KN, 2005, MOL CANCER RES, V3, P32; Feller SM, 2001, ONCOGENE, V20, P6348, DOI 10.1038/sj.onc.1204779; Finn RS, 2008, ANN ONCOL, V19, P1379, DOI 10.1093/annonc/mdn291; Gotoh T, 2000, J BIOL CHEM, V275, P30118, DOI 10.1074/jbc.M003074200; Hamasaki K, 1996, BIOCHEM BIOPH RES CO, V222, P338, DOI 10.1006/bbrc.1996.0745; Harte MT, 1996, J BIOL CHEM, V271, P13649, DOI 10.1074/jbc.271.23.13649; Honda H, 1999, BIOCHEM BIOPH RES CO, V262, P25, DOI 10.1006/bbrc.1999.1162; Huang JH, 2002, J BIOL CHEM, V277, P27265, DOI 10.1074/jbc.M203063200; Ishizawar R, 2004, CANCER CELL, V6, P209, DOI 10.1016/j.ccr.2004.09.001; Lu YM, 1999, J BIOL CHEM, V274, P10047, DOI 10.1074/jbc.274.15.10047; Makkinje A, 2009, CELL SIGNAL, V21, P1423, DOI 10.1016/j.cellsig.2009.05.006; MATSUDA M, 1990, SCIENCE, V248, P1537, DOI 10.1126/science.1694307; Nakamoto T, 1996, J BIOL CHEM, V271, P8959, DOI 10.1074/jbc.271.15.8959; Near RI, 2007, J CELL PHYSIOL, V212, P655, DOI 10.1002/jcp.21059; NOJIMA Y, 1995, J BIOL CHEM, V270, P15398, DOI 10.1074/jbc.270.25.15398; Pellicena P, 2001, J BIOL CHEM, V276, P28190, DOI 10.1074/jbc.M100055200; REYNOLDS AB, 1989, MOL CELL BIOL, V9, P3951, DOI 10.1128/MCB.9.9.3951; Riggins RB, 2003, J BIOL CHEM, V278, P28264, DOI 10.1074/jbc.M303535200; Riggins RB, 2007, CANCER LETT, V256, P1, DOI 10.1016/j.canlet.2007.03.016; Riggins RB, 2006, CANCER RES, V66, P7007, DOI 10.1158/0008-5472.CAN-05-3952; Rufanova VA, 2009, J CELL PHYSIOL, V219, P45, DOI 10.1002/jcp.21649; SAKAI R, 1994, EMBO J, V13, P3748, DOI 10.1002/j.1460-2075.1994.tb06684.x; Schlaepfer DD, 1997, MOL CELL BIOL, V17, P1702, DOI 10.1128/MCB.17.3.1702; Schrecengost RS, 2007, CANCER RES, V67, P6174, DOI 10.1158/0008-5472.CAN-06-3455; Shah AN, 2007, ANTI-CANCER DRUG, V18, P371, DOI 10.1097/CAD.0b013e32801265d7; Summy JM, 2003, CANCER METAST REV, V22, P337, DOI 10.1023/A:1023772912750; Ta HQ, 2008, CANCER RES, V68, P8796, DOI 10.1158/0008-5472.CAN-08-2426; Tice DA, 1999, P NATL ACAD SCI USA, V96, P1415, DOI 10.1073/pnas.96.4.1415; van Agthoven T, 1998, EMBO J, V17, P2799, DOI 10.1093/emboj/17.10.2799; van der Flier S, 2000, INT J CANCER, V89, P465, DOI 10.1002/1097-0215(20000920)89:5<465::AID-IJC11>3.0.CO;2-O; Vuori K, 1996, MOL CELL BIOL, V16, P2606; Xing LZ, 2000, MOL CELL BIOL, V20, P7363, DOI 10.1128/MCB.20.19.7363-7377.2000	44	21	22	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2309	2317		10.1074/jbc.M109.046631	http://dx.doi.org/10.1074/jbc.M109.046631			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19940159	Green Published, hybrid			2022-12-25	WOS:000273697800010
J	Roy, S; Martinez, D; Platero, H; Lane, T; Werner-Washburne, M				Roy, Sushmita; Martinez, Diego; Platero, Harriett; Lane, Terran; Werner-Washburne, Margaret			Exploiting Amino Acid Composition for Predicting Protein-Protein Interactions	PLOS ONE			English	Article							NETWORK	Background: Computational prediction of protein interactions typically use protein domains as classifier features because they capture conserved information of interaction surfaces. However, approaches relying on domains as features cannot be applied to proteins without any domain information. In this paper, we explore the contribution of pure amino acid composition (AAC) for protein interaction prediction. This simple feature, which is based on normalized counts of single or pairs of amino acids, is applicable to proteins from any sequenced organism and can be used to compensate for the lack of domain information. Results: AAC performed at par with protein interaction prediction based on domains on three yeast protein interaction datasets. Similar behavior was obtained using different classifiers, indicating that our results are a function of features and not of classifiers. In addition to yeast datasets, AAC performed comparably on worm and fly datasets. Prediction of interactions for the entire yeast proteome identified a large number of novel interactions, the majority of which co-localized or participated in the same processes. Our high confidence interaction network included both well-studied and uncharacterized proteins. Proteins with known function were involved in actin assembly and cell budding. Uncharacterized proteins interacted with proteins involved in reproduction and cell budding, thus providing putative biological roles for the uncharacterized proteins. Conclusion: AAC is a simple, yet powerful feature for predicting protein interactions, and can be used alone or in conjunction with protein domains to predict new and validate existing interactions. More importantly, AAC alone performs at par with existing, but more complex, features indicating the presence of sequence-level information that is predictive of interaction, but which is not necessarily restricted to domains.			Roy, S (corresponding author), Univ New Mexico, Albuquerque, NM 87131 USA.	sroy@cs.unm.edu			Howard Hughes Medical Institute [56005678] Funding Source: Medline; NHGRI NIH HHS [P41 HG001315, HG01315, U41 HG001315] Funding Source: Medline; NIGMS NIH HHS [R01 GM067593, GM67593, R25 GM060201, GM60201] Funding Source: Medline; NIMH NIH HHS [1R01MH076282, R01 MH076282] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM060201, R01GM067593] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH076282] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ben-Hur A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S2; Fong JH, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r11; GASCH AP, 2000, MOL BIOL CELL, P4421; Gomez SM, 2003, BIOINFORMATICS, V19, P1875, DOI 10.1093/bioinformatics/btg352; Huang H, 2009, BIOINFORMATICS, V25, P372, DOI 10.1093/bioinformatics/btn640; Ito T, 2000, P NATL ACAD SCI USA, V97, P1143, DOI 10.1073/pnas.97.3.1143; Jansen R, 2003, SCIENCE, V302, P449, DOI 10.1126/science.1087361; Joachims T, 1999, ADVANCES IN KERNEL METHODS, P169; Jothi R, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-173; Kann MG, 2007, PROTEINS, V67, P811, DOI 10.1002/prot.21347; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; LANGLEY P, 1992, AAAI-92 PROCEEDINGS : TENTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE, P223; Lasko TA, 2005, J BIOMED INFORM, V38, P404, DOI 10.1016/j.jbi.2005.02.008; Lee I, 2008, NAT GENET, V40, P181, DOI 10.1038/ng.2007.70; Li R, 1997, J CELL BIOL, V136, P649, DOI 10.1083/jcb.136.3.649; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Liu Y, 2005, BIOINFORMATICS, V21, P3279, DOI 10.1093/bioinformatics/bti492; Mahdavi MA, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-262; Martin S, 2005, BIOINFORMATICS, V21, P218, DOI 10.1093/bioinformatics/bth483; McCallum A, 1999, IJCAI-99: PROCEEDINGS OF THE SIXTEENTH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE, VOLS 1 & 2, P662; McCallum A. K., 2002, MALLET MACHINE LEARN; Ofran Y, 2003, J MOL BIOL, V325, P377, DOI 10.1016/S0022-2836(02)01223-8; Qiu J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000054; Quevillon E, 2005, NUCLEIC ACIDS RES, V33, pW116, DOI 10.1093/nar/gki442; QUEVILLON E, 2001, NUCL ACIDS RES, V33; RAGHAVACHARI B, 2008, NUCL ACIDS RES, V36; SHOEMAKER BA, 2007, PLOS COMPUT BIOL, V3, P4; Shoemaker BA, 2007, PLOS COMPUT BIOL, V3, P337, DOI 10.1371/journal.pcbi.0030042; Simonis N, 2009, NAT METHODS, V6, P47, DOI 10.1038/NMETH.1279; Sprinzak E, 2001, J MOL BIOL, V311, P681, DOI 10.1006/jmbi.2001.4920; STARK C, 2006, NUCLEIC ACIDS RES, V1, P34; SUN J, 2005, BIOINFORMATICS, V21, P16; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Werner-Washburne M, 2002, GENOME RES, V12, P1564, DOI 10.1101/gr.225402; Witten I.H., 2002, ACM SIGMOD REC, V31, P76, DOI 10.1145/507338.507355; Yu H., 2008, SCIENCE	38	51	53	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2009	4	11							e7813	10.1371/journal.pone.0007813	http://dx.doi.org/10.1371/journal.pone.0007813			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522NL	19936254	Green Submitted, Green Published, gold			2022-12-25	WOS:000272004800001
J	Xiong, NA; Huang, JS; Zhang, ZT; Zhang, ZW; Xiong, J; Liu, XY; Jia, M; Wang, F; Chen, CNA; Cao, XB; Liang, ZH; Sun, SG; Lin, ZC; Wang, T				Xiong, Nian; Huang, Jinsha; Zhang, Zhentao; Zhang, Zhaowen; Xiong, Jing; Liu, Xingyuan; Jia, Min; Wang, Fang; Chen, Chunnuan; Cao, Xuebing; Liang, Zhihou; Sun, Shenggang; Lin, Zhicheng; Wang, Tao			Stereotaxical Infusion of Rotenone: A Reliable Rodent Model for Parkinson's Disease	PLOS ONE			English	Article							ALPHA-SYNUCLEIN; RAT MODEL; DOPAMINERGIC-NEURONS; SUBSTANTIA-NIGRA; FOREBRAIN-BUNDLE; ANIMAL-MODELS; PC12 CELLS; DEGENERATION; GLUTATHIONE; SYSTEM	A clinically-related animal model of Parkinson's disease (PD) may enable the elucidation of the etiology of the disease and assist the development of medications. However, none of the current neurotoxin-based models recapitulates the main clinical features of the disease or the pathological hallmarks, such as dopamine (DA) neuron specificity of degeneration and Lewy body formation, which limits the use of these models in PD research. To overcome these limitations, we developed a rat model by stereotaxically (ST) infusing small doses of the mitochondrial complex-I inhibitor, rotenone, into two brain sites: the right ventral tegmental area and the substantia nigra. Four weeks after ST rotenone administration, tyrosine hydroxylase (TH) immunoreactivity in the infusion side decreased by 43.7%, in contrast to a 75.8% decrease observed in rats treated systemically with rotenone (SYS). The rotenone infusion also reduced the DA content, the glutathione and superoxide dismutase activities, and induced alpha-synuclein expression, when compared to the contralateral side. This ST model displays neither peripheral toxicity or mortality and has a high success rate. This rotenone-based ST model thus recapitulates the slow and specific loss of DA neurons and better mimics the clinical features of idiopathic PD, representing a reliable and more clinically-related model for PD research.			Xiong, NA (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Neurol, Union Hosp, Wuhan, Hubei, Peoples R China.	wangtaowh@yahoo.cn		Zhang, Zhentao/0000-0001-6708-1472				Alam M, 2004, BEHAV BRAIN RES, V151, P117, DOI 10.1016/j.bbr.2003.08.014; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Betarbet R, 2002, BIOESSAYS, V24, P308, DOI 10.1002/bies.10067; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Cao W, 2007, NUCL MED COMMUN, V28, P895, DOI 10.1097/MNM.0b013e3282f1ac9a; Chaudhuri KR, 2009, LANCET NEUROL, V8, P464, DOI 10.1016/S1474-4422(09)70068-7; Chung CY, 2005, HUM MOL GENET, V14, P1709, DOI 10.1093/hmg/ddi178; Dauer W, 2002, P NATL ACAD SCI USA, V99, P14524, DOI 10.1073/pnas.172514599; Drolet RE, 2004, NEUROTOXICOLOGY, V25, P761, DOI 10.1016/j.neuro.2004.05.002; Elbaz A, 2008, LANCET NEUROL, V7, P562, DOI 10.1016/S1474-4422(08)70118-2; Feng Yuan, 2006, Neurosci Bull, V22, P288; Fornai F, 2005, P NATL ACAD SCI USA, V102, P3413, DOI 10.1073/pnas.0409713102; HEIKKILA RE, 1984, SCIENCE, V224, P1451, DOI 10.1126/science.6610213; Huang JS, 2009, BRAIN RES, V1279, P1, DOI 10.1016/j.brainres.2009.05.011; JASSOLOPEZ D, 1995, J NEUROCHEM, V64, P794; JAVOYAGID F, 1980, NEUROLOGY, V30, P1326, DOI 10.1212/WNL.30.12.1326; Lakshmana MK, 1997, ANAL BIOCHEM, V246, P166, DOI 10.1006/abio.1996.9997; Landrigan PJ, 2005, ENVIRON HEALTH PERSP, V113, P1230, DOI 10.1289/ehp.7571; Langston JW, 1999, ANN NEUROL, V46, P598, DOI 10.1002/1531-8249(199910)46:4<598::AID-ANA7>3.0.CO;2-F; Lapointe N, 2004, FASEB J, V18, P717, DOI 10.1096/fj.03-0677fje; Ma R, 2009, NEUROPHARMACOLOGY, V56, P1027, DOI 10.1016/j.neuropharm.2009.02.006; Maingay M, 2006, NEUROBIOL DIS, V23, P522, DOI 10.1016/j.nbd.2006.04.007; MAREYSEMPER I, 1995, J NEUROSCI, V15, P5912; Martinez-Vicente M, 2008, J CLIN INVEST, V118, P777, DOI 10.1172/JCI32806; Martinez-Vicente M, 2007, LANCET NEUROL, V6, P352, DOI 10.1016/S1474-4422(07)70076-5; MOHANAKUMAR KP, 1994, ANN NY ACAD SCI, V738, P392; Ossowska K, 2005, EUR J NEUROSCI, V22, P1294, DOI 10.1111/j.1460-9568.2005.04301.x; Ozyurt H, 2006, ASIAN J ANDROL, V8, P189, DOI 10.1111/j.1745-7262.2006.00119.x; Parkinson J, 2002, J NEUROPSYCH CLIN N, V14, P223, DOI 10.1176/appi.neuropsych.14.2.223; PERRY TL, 1986, NEUROSCI LETT, V67, P269, DOI 10.1016/0304-3940(86)90320-4; Petroske E, 2001, NEUROSCIENCE, V106, P589, DOI 10.1016/S0306-4522(01)00295-0; Plowey ED, 2008, J NEUROCHEM, V105, P1048, DOI 10.1111/j.1471-4159.2008.05217.x; Priyadarshi A, 2001, ENVIRON RES, V86, P122, DOI 10.1006/enrs.2001.4264; Rahman I, 2006, NAT PROTOC, V1, P3159, DOI 10.1038/nprot.2006.378; Ravenstijn Paulien G. M., 2008, Journal of Pharmacological and Toxicological Methods, V57, P114, DOI 10.1016/j.vascn.2007.10.003; RIEDERER P, 1989, J NEUROCHEM, V52, P515, DOI 10.1111/j.1471-4159.1989.tb09150.x; SACHS C, 1975, BIOCHEM PHARMACOL, V24, P1, DOI 10.1016/0006-2952(75)90304-4; Saravanan KS, 2005, BRAIN RES, V1049, P147, DOI 10.1016/j.brainres.2005.04.051; Savitt JM, 2006, J CLIN INVEST, V116, P1744, DOI 10.1172/JCI29178; Saybasili H, 2001, ANTIOXID REDOX SIGN, V3, P1099, DOI 10.1089/152308601317203602; Schober A, 2004, CELL TISSUE RES, V318, P215, DOI 10.1007/s00441-004-0938-y; Sherer TB, 2003, EXP NEUROL, V179, P9, DOI 10.1006/exnr.2002.8072; Sindhu KM, 2005, BRAIN RES, V1051, P25, DOI 10.1016/j.brainres.2005.05.051; Solis O, 2007, SYNAPSE, V61, P450, DOI 10.1002/syn.20381; Tian YY, 2007, NEUROSCI LETT, V421, P239, DOI 10.1016/j.neulet.2007.05.033; UHL GR, 1985, NEUROLOGY, V35, P1215, DOI 10.1212/WNL.35.8.1215; Visanji NP, 2006, NEUROPHARMACOLOGY, V51, P506, DOI 10.1016/j.neuropharm.2006.04.015; Weiss ML, 2006, STEM CELLS, V24, P781, DOI 10.1634/stemcells.2005-0330; Xu Y, 2009, J HUAZHONG U SCI-MED, V29, P156, DOI 10.1007/s11596-009-0204-3; Yazdani U, 2006, EXP NEUROL, V200, P172, DOI 10.1016/j.expneurol.2006.02.002; Yokochi M, 2009, PARKINSONISM RELAT D, V15, pS25, DOI 10.1016/S1353-8020(09)70008-2; Zhang ZT, 2009, J HUAZHONG U SCI-MED, V29, P97, DOI 10.1007/s11596-009-0121-5; Zuber B, 2005, P NATL ACAD SCI USA, V102, P19192, DOI 10.1073/pnas.0509527102	53	78	85	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2009	4	11							e7878	10.1371/journal.pone.0007878	http://dx.doi.org/10.1371/journal.pone.0007878			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521QH	19924288	Green Published, gold, Green Submitted			2022-12-25	WOS:000271936700012
J	Georgel, P; Macquin, C; Bahram, S				Georgel, Philippe; Macquin, Cecile; Bahram, Seiamak			The Heterogeneous Allelic Repertoire of Human Toll-Like Receptor (TLR) Genes	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; INNATE IMMUNE-RESPONSE; CRYSTAL-STRUCTURE; CUTTING EDGE; SUSCEPTIBILITY; TOLL-LIKE-RECEPTOR-4; RECOGNITION; ASSOCIATION; MUTATIONS; RESISTANCE	Toll-Like Receptors (TLR) are critical elements of the innate arm of the vertebrate immune system. They constitute a multigenic family of receptors which collectively bind a diverse array of - exogeneous as well as endogeneous - ligands. An exponential burst of knowledge has defined their biological role in fight against infections and generation/modulation of auto-immune disorders. Hence, they could at least be conceptually recognized - despite being structurally unrelated - as innate counterparts to Major Histocompatibility Complex (MHC) molecules - equally recognizing antigenic ligands (albeit structurally more homogeneous i.e., peptides), again derived from self and/or non-self sources - preeminent this time in adaptive immunity. Our great disparities in face of infections and/or susceptibility to auto-immune diseases have provoked an intense search for genetic explanations, in part satisfied by the extraordinary MHC allelic repertoire. An equally in-depth and systematic analysis of TLR diversity is lacking despite numerous independent reports of a growing number of SNPs within these loci. The work described here aims at providing a preliminary picture of the allelic repertoire - and not purely SNPs - of all 10 human TLR coding sequences (with exception of TLR3) within a single cohort of up to 100 individuals. It appears from our work that TLR are unequally polymorphic: TLR2 (DNA alleles: 7/protein alleles: 3), 4 (4/3), 7 (6/3), 8 (9/2) and 9 (8/3) being comparatively least diverse whereas TLR1 (11/10), 5 (14/12), 6 (10/8) and 10 (15/10) show a substantial number of alleles. In addition to allelic assignment of a large number of SNPs, 10 new polymorphic positions were hereby identified. Hence this work depicts a first overview of the diversity of almost all human TLR genes, a prelude for large-scale population genetics as well as genetic association studies.			Georgel, P (corresponding author), Univ Strasbourg, Fac Med, Ctr Rech Immunol & Hematol, Lab Immunogenet Mol Humaine, Strasbourg, France.	siamak@unistra.fr	georgel, philippe/P-5676-2016; Bahram, Seiamak/GZA-7150-2022	georgel, philippe/0000-0001-6853-7080; Bahram, Seiamak/0000-0002-6928-9952				Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; Beutler B, 2009, IMMUNOL REV, V227, P248, DOI 10.1111/j.1600-065X.2008.00733.x; Bochud PY, 2007, LANCET INFECT DIS, V7, P531, DOI 10.1016/S1473-3099(07)70185-8; Bochud PY, 2007, AIDS, V21, P441, DOI 10.1097/QAD.0b013e328012b8ac; Casrouge A, 2006, SCIENCE, V314, P308, DOI 10.1126/science.1128346; Choe J, 2005, SCIENCE, V309, P581, DOI 10.1126/science.1115253; Chuang TH, 2001, BBA-GENE STRUCT EXPR, V1518, P157, DOI 10.1016/S0167-4781(00)00289-X; De Jager PL, 2006, ARTHRITIS RHEUM, V54, P1279, DOI 10.1002/art.21755; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Eid AJ, 2007, TRANSPLANTATION, V84, P511, DOI 10.1097/01.tp.0000276960.35313.bf; Garantziotis S, 2008, ANNU REV MED, V59, P343, DOI 10.1146/annurev.med.59.061206.112455; Hawn TR, 2007, EUR J IMMUNOL, V37, P2280, DOI 10.1002/eji.200737034; Hawn TR, 2005, P NATL ACAD SCI USA, V102, P2487, DOI 10.1073/pnas.0409831102; Hawn TR, 2003, J EXP MED, V198, P1563, DOI 10.1084/jem.20031220; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Henneke P, 2005, J IMMUNOL, V174, P6449, DOI 10.4049/jimmunol.174.10.6449; Hoebe K, 2005, NATURE, V433, P523, DOI 10.1038/nature03253; Jiang ZF, 2005, NAT IMMUNOL, V6, P565, DOI 10.1038/ni1207; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Johnson CM, 2007, J IMMUNOL, V178, P7520, DOI 10.4049/jimmunol.178.12.7520; Kijpittayarit S, 2007, CLIN INFECT DIS, V44, P1315, DOI 10.1086/514339; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Lazarus R, 2004, AM J RESP CRIT CARE, V170, P594, DOI 10.1164/rccm.200404-491OC; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Lorenz E, 2000, INFECT IMMUN, V68, P6398, DOI 10.1128/IAI.68.11.6398-6401.2000; Ma X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001318; Merx S, 2007, HUM MOL GENET, V16, P1225, DOI 10.1093/hmg/ddm070; Misch EA, 2008, CLIN SCI, V114, P347, DOI 10.1042/CS20070214; Mockenhaupt FP, 2006, J INFECT DIS, V194, P184, DOI 10.1086/505152; Morris RW, 2002, GENET EPIDEMIOL, V23, P221, DOI 10.1002/gepi.10200; Novak N, 2007, ALLERGY, V62, P766, DOI 10.1111/j.1398-9995.2007.01358.x; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Picard C, 2003, SCIENCE, V299, P2076, DOI 10.1126/science.1081902; Pirie FJ, 2005, TISSUE ANTIGENS, V66, P125, DOI 10.1111/j.1399-0039.2005.00454.x; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Robinson J, 2009, NUCLEIC ACIDS RES, V37, pD1013, DOI 10.1093/nar/gkn662; Schroder NW, 2005, LANCET INFECT DIS, V5, P156, DOI 10.1016/S1473-3099(05)70023-2; Smirnova I, 2003, P NATL ACAD SCI USA, V100, P6075, DOI 10.1073/pnas.1031605100; Smirnova I, 2001, GENETICS, V158, P1657; Smirnova I, 2000, GENOME BIOL, V1; SORENSEN TIA, 1988, NEW ENGL J MED, V318, P727, DOI 10.1056/NEJM198803243181202; Sun JL, 2005, JNCI-J NATL CANCER I, V97, P525, DOI 10.1093/jnci/dji070; Takeda K, 2005, INT IMMUNOL, V17, P1, DOI 10.1093/intimm/dxh186; Takeuchi O, 2002, J IMMUNOL, V169, P10, DOI 10.4049/jimmunol.169.1.10; Texereau J, 2005, CLIN INFECT DIS, V41, pS408, DOI 10.1086/431990; Viglianti GA, 2003, IMMUNITY, V19, P837, DOI 10.1016/S1074-7613(03)00323-6; Werling D, 2009, TRENDS IMMUNOL, V30, P124, DOI 10.1016/j.it.2008.12.001; Zhang SY, 2007, SCIENCE, V317, P1522, DOI 10.1126/science.1139522	52	38	48	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2009	4	11							e7803	10.1371/journal.pone.0007803	http://dx.doi.org/10.1371/journal.pone.0007803			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520OG	19924287	Green Published, Green Submitted, gold			2022-12-25	WOS:000271854200004
J	Pirnay, JP; Bilocq, F; Pot, B; Cornelis, P; Zizi, M; Van Eldere, J; Deschaght, P; Vaneechoutte, M; Jennes, S; Pitt, T; De Vos, D				Pirnay, Jean-Paul; Bilocq, Florence; Pot, Bruno; Cornelis, Pierre; Zizi, Martin; Van Eldere, Johan; Deschaght, Pieter; Vaneechoutte, Mario; Jennes, Serge; Pitt, Tyrone; De Vos, Daniel			Pseudomonas aeruginosa Population Structure Revisited	PLOS ONE			English	Article							CYSTIC-FIBROSIS PATIENTS; OUTER-MEMBRANE LIPOPROTEIN; FRAGMENT-LENGTH-POLYMORPHISM; I FERRIPYOVERDINE RECEPTOR; FIELD GEL-ELECTROPHORESIS; METALLO-BETA-LACTAMASE; POOR CLINICAL-OUTCOMES; INTENSIVE-CARE-UNIT; MOLECULAR EPIDEMIOLOGY; EXOENZYME-S	At present there are strong indications that Pseudomonas aeruginosa exhibits an epidemic population structure; clinical isolates are indistinguishable from environmental isolates, and they do not exhibit a specific (disease) habitat selection. However, some important issues, such as the worldwide emergence of highly transmissible P. aeruginosa clones among cystic fibrosis (CF) patients and the spread and persistence of multidrug resistant (MDR) strains in hospital wards with high antibiotic pressure, remain contentious. To further investigate the population structure of P. aeruginosa, eight parameters were analyzed and combined for 328 unrelated isolates, collected over the last 125 years from 69 localities in 30 countries on five continents, from diverse clinical (human and animal) and environmental habitats. The analysed parameters were: i) O serotype, ii) Fluorescent Amplified-Fragment Length Polymorphism (FALFP) pattern, nucleotide sequences of outer membrane protein genes, iii) oprI, iv) oprL, v) oprD, vi) pyoverdine receptor gene profile (fpvA type and fpvB prevalence), and prevalence of vii) exoenzyme genes exoS and exoU and viii) group I pilin glycosyltransferase gene tfpO. These traits were combined and analysed using biological data analysis software and visualized in the form of a minimum spanning tree (MST). We revealed a network of relationships between all analyzed parameters and non-congruence between experiments. At the same time we observed several conserved clones, characterized by an almost identical data set. These observations confirm the nonclonal epidemic population structure of P. aeruginosa, a superficially clonal structure with frequent recombinations, in which occasionally highly successful epidemic clones arise. One of these clones is the renown and widespread MDR serotype O12 clone. On the other hand, we found no evidence for a widespread CF transmissible clone. All but one of the 43 analysed CF strains belonged to a ubiquitous P. aeruginosa "core lineage" and typically exhibited the exoS(+)/exoU(-) genotype and group B oprL and oprD alleles. This is to our knowledge the first report of an MST analysis conducted on a polyphasic data set.			Pirnay, JP (corresponding author), Queen Astrid Mil Hosp, Burn Ctr, Lab Mol & Cellular Technol, Brussels, Belgium.	jean-paul.pirnay@mil.be	Van Eldere, Johan/AAI-8965-2020; Vaneechoutte, Mario/A-6189-2009; Cornelis, Pierre/H-3058-2019; Pot, Bruno DF/I-6645-2012	Vaneechoutte, Mario/0000-0002-4586-203X; Pirnay, Jean-Paul/0000-0002-6863-5219				ALLEMEERSCH D, 1988, EUR J CLIN MICROBIOL, V7, P265, DOI 10.1007/BF01963099; Alonso A, 1999, ENVIRON MICROBIOL, V1, P421, DOI 10.1046/j.1462-2920.1999.00052.x; Amsterdam D., 1991, ANTIBIOTICS LAB MED, P72; Anthony M, 2002, J CLIN MICROBIOL, V40, P2772, DOI 10.1128/JCM.40.8.2772-2778.2002; AOKI K, 1926, ZBL BAKTER         1, V98, P186; Armstrong D, 2003, J CLIN MICROBIOL, V41, P2266, DOI 10.1128/JCM.41.5.2266-2267.2003; Baysse C, 1999, J BACTERIOL, V181, P3849, DOI 10.1128/JB.181.12.3849-3851.1999; Bert F, 1996, J ANTIMICROB CHEMOTH, V37, P809, DOI 10.1093/jac/37.4.809; Bingen E, 1996, J CLIN MICROBIOL, V34, P3226, DOI 10.1128/JCM.34.12.3226-3229.1996; BODILIS J, 2009, ENV MICROBIOL   0421; Bradbury R, 2008, RESPIROLOGY, V13, P886, DOI 10.1111/j.1440-1843.2008.01383.x; Brimicombe RW, 2008, J CYST FIBROS, V7, P30, DOI 10.1016/j.jcf.2007.04.002; CASTRIC P, 1995, MICROBIOL-UK, V141, P1247, DOI 10.1099/13500872-141-5-1247; Chambers D, 2005, EUR RESPIR J, V26, P651, DOI 10.1183/09031936.05.00126704; Cheng K, 1996, LANCET, V348, P639, DOI 10.1016/S0140-6736(96)05169-0; CORNELIS P, 1989, INFECT IMMUN, V57, P3491, DOI 10.1128/IAI.57.11.3491-3497.1989; CORNELIS P, 1989, MOL MICROBIOL, V3, P421, DOI 10.1111/j.1365-2958.1989.tb00187.x; Crespo MP, 2004, J CLIN MICROBIOL, V42, P5094, DOI 10.1128/JCM.42.11.5094-5101.2004; Curran B, 2004, J CLIN MICROBIOL, V42, P5644, DOI 10.1128/JCM.42.12.5644-5649.2004; de Chial M, 2003, MICROBIOL-SGM, V149, P821, DOI 10.1099/mic.0.26136-0; De Vos D, 1998, J BACTERIOL, V180, P6551, DOI 10.1128/JB.180.24.6551-6556.1998; De Vos D, 2001, ARCH MICROBIOL, V175, P384, DOI 10.1007/s002030100278; DENAMUR E, 1993, FEMS MICROBIOL LETT, V110, P275, DOI 10.1111/j.1574-6968.1993.tb06334.x; Denayer S, 2007, J BACTERIOL, V189, P7663, DOI 10.1128/JB.00992-07; Deplano A, 2005, J CLIN MICROBIOL, V43, P1198, DOI 10.1128/JCM.43.3.1198-1204.2005; DeVos D, 1997, J CLIN MICROBIOL, V35, P1295, DOI 10.1128/JCM.35.6.1295-1299.1997; Dubois V, 2001, J CLIN MICROBIOL, V39, P2072, DOI 10.1128/JCM.39.6.2072-2078.2001; ELAICHOUNI A, 1994, J CLIN MICROBIOL, V32, P666, DOI 10.1128/JCM.32.3.666-671.1994; FARMER JJ, 1982, J CLIN MICROBIOL, V16, P266, DOI 10.1128/JCM.16.2.266-270.1982; Feltman H, 2001, MICROBIOL-SGM, V147, P2659, DOI 10.1099/00221287-147-10-2659; Ferguson MW, 2001, INFECT IMMUN, V69, P2198, DOI 10.1128/IAI.69.4.2198-2210.2001; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; Fleiszig SMJ, 1997, INFECT IMMUN, V65, P579, DOI 10.1128/IAI.65.2.579-586.1997; Fluge G, 2001, CLIN MICROBIOL INFEC, V7, P238, DOI 10.1046/j.1469-0691.2001.00247.x; Foght JM, 1996, MICROBIOL-UK, V142, P2333, DOI 10.1099/00221287-142-9-2333; Gallant CV, 2000, MICROBIOL-SGM, V146, P1891, DOI 10.1099/00221287-146-8-1891; Gessard C, 1882, CR ACAD SCI IV-PHYS, V94, P536; Ghysels B, 2004, MICROBIOL-SGM, V150, P1671, DOI 10.1099/mic.0.27035-0; Giammanco A, 1985, Eur J Epidemiol, V1, P104, DOI 10.1007/BF00141801; Goldberg J B, 2000, Trends Microbiol, V8, P55, DOI 10.1016/S0966-842X(99)01671-6; GRATTARD F, 1993, EUR J CLIN MICROBIOL, V12, P57, DOI 10.1007/BF01997061; HAMMAMI S, 2008, PATHOL BIOL PAR 1030; HANCOCK REW, 1983, INFECT IMMUN, V42, P170, DOI 10.1128/IAI.42.1.170-177.1983; Hauser AR, 2002, CRIT CARE MED, V30, P521, DOI 10.1097/00003246-200203000-00005; He JX, 2004, P NATL ACAD SCI USA, V101, P2530, DOI 10.1073/pnas.0304622101; Janssen P, 1996, MICROBIOL-UK, V142, P1881, DOI 10.1099/13500872-142-7-1881; Jelsbak L, 2007, INFECT IMMUN, V75, P2214, DOI 10.1128/IAI.01282-06; Jones AM, 2001, LANCET, V358, P557, DOI 10.1016/S0140-6736(01)05714-2; Kettner M, 1995, INFECTION, V23, P380, DOI 10.1007/BF01713571; Kiewitz C, 2000, J BACTERIOL, V182, P3125, DOI 10.1128/JB.182.11.3125-3135.2000; KOBAYASHI I, 1994, J ANTIBIOT, V47, P72, DOI 10.7164/antibiotics.47.72; Kulasekara BR, 2006, J BACTERIOL, V188, P4037, DOI 10.1128/JB.02000-05; Kus JV, 2004, MICROBIOL-SGM, V150, P1315, DOI 10.1099/mic.0.26822-0; KUZIO J, 1983, J BACTERIOL, V155, P203, DOI 10.1128/JB.155.1.203-212.1983; Lanotte P, 2004, J MED MICROBIOL, V53, P73, DOI 10.1099/jmm.0.05324-0; Lee DG, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r90; LEGAKIS NJ, 1987, EUR J CLIN MICROBIOL, V6, P300, DOI 10.1007/BF02017618; Lewis DA, 2005, AM J RESP CELL MOL, V33, P56, DOI 10.1165/rcmb.2004-0352OC; Libisch B, 2008, RES MICROBIOL, V159, P162, DOI 10.1016/j.resmic.2007.12.008; Lim A, 1997, MICROBIOL-SGM, V143, P1709, DOI 10.1099/00221287-143-5-1709; Lin HH, 2006, J CLIN MICROBIOL, V44, P4596, DOI 10.1128/JCM.01531-06; LIU PV, 1983, INT J SYST BACTERIOL, V33, P256, DOI 10.1099/00207713-33-2-256; Livermore DM, 2002, J ANTIMICROB CHEMOTH, V49, P289, DOI 10.1093/jac/49.2.289; Lomholt JA, 2001, INFECT IMMUN, V69, P6284, DOI 10.1128/IAI.69.10.6284-6295.2001; Loureiro MM, 2002, MEM I OSWALDO CRUZ, V97, P387, DOI 10.1590/S0074-02762002000300020; Mathee K, 2008, P NATL ACAD SCI USA, V105, P3100, DOI 10.1073/pnas.0711982105; McCallum SJ, 2001, LANCET, V358, P558, DOI 10.1016/S0140-6736(01)05715-4; Meyer JM, 2000, ARCH MICROBIOL, V174, P135, DOI 10.1007/s002030000188; Meyer JM, 1997, MICROBIOL-UK, V143, P35, DOI 10.1099/00221287-143-1-35; Mifsud AJ, 1997, J HOSP INFECT, V36, P105, DOI 10.1016/S0195-6701(97)90116-X; Morales G, 2004, J BACTERIOL, V186, P4228, DOI 10.1128/JB.186.13.4228-4237.2004; Muller-Premru M, 2000, ZBL BAKT-INT J MED M, V289, P857; O'Carroll MR, 2004, EUR RESPIR J, V24, P101, DOI 10.1183/09031936.04.00122903; Olson JC, 1999, INFECT IMMUN, V67, P2847, DOI 10.1128/IAI.67.6.2847-2854.1999; PENKETH A, 1983, AM REV RESPIR DIS, V127, P605, DOI 10.1164/arrd.1983.127.5.605; PICARD B, 1994, J MED MICROBIOL, V40, P313, DOI 10.1099/00222615-40-5-313; Pirnay JP, 2005, ENVIRON MICROBIOL, V7, P969, DOI 10.1111/j.1462-2920.2005.00776.x; Pirnay JP, 2002, ENVIRON MICROBIOL, V4, P872, DOI 10.1046/j.1462-2920.2002.00281.x; Pirnay JP, 2003, J CLIN MICROBIOL, V41, P1192, DOI 10.1128/JCM.41.3.1192-1202.2003; Pirnay JP, 2002, ENVIRON MICROBIOL, V4, P898, DOI 10.1046/j.1462-2920.2002.00321.x; PITT TL, 1986, J MED MICROBIOL, V21, P179, DOI 10.1099/00222615-21-2-179; PITT TL, 1989, EPIDEMIOL INFECT, V103, P565, DOI 10.1017/S095026880003096X; Pitt TL, 2002, THORAX, V57, P921, DOI 10.1136/thorax.57.11.921; Ragon M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000146; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; Riccio ML, 2005, ANTIMICROB AGENTS CH, V49, P104, DOI 10.1128/AAC.49.1.104-110.2005; RICHARD P, 1994, J INFECT DIS, V170, P377, DOI 10.1093/infdis/170.2.377; RIPP S, 1994, MOL ECOL, V3, P121, DOI 10.1111/j.1365-294X.1994.tb00112.x; Rocha CL, 2003, INFECT IMMUN, V71, P5296, DOI 10.1128/IAI.71.9.5296-5305.2003; ROMLING U, 1994, APPL ENVIRON MICROB, V60, P1734; Ruimy R, 2001, INFECT IMMUN, V69, P584, DOI 10.1128/IAI.69.1.584-588.2001; Savelkoul PHM, 1999, J CLIN MICROBIOL, V37, P3083, DOI 10.1128/JCM.37.10.3083-3091.1999; Schouls LM, 2004, J BACTERIOL, V186, P5496, DOI 10.1128/JB.186.16.5496-5505.2004; Schulert GS, 2003, J INFECT DIS, V188, P1695, DOI 10.1086/379372; Scott FW, 2004, J MED MICROBIOL, V53, P609, DOI 10.1099/jmm.0.45620-0; Sekiguchi JI, 2007, J CLIN MICROBIOL, V45, P979, DOI 10.1128/JCM.01772-06; Shen K, 2006, INFECT IMMUN, V74, P5272, DOI 10.1128/IAI.00546-06; Smith EE, 2005, J BACTERIOL, V187, P2138, DOI 10.1128/JB.187.6.2138-2147.2005; SMITH JM, 1993, P NATL ACAD SCI USA, V90, P4384, DOI 10.1073/pnas.90.10.4384; Speijer H, 1999, J CLIN MICROBIOL, V37, P3654, DOI 10.1128/JCM.37.11.3654-3661.1999; Spencer DH, 2003, J BACTERIOL, V185, P1316, DOI 10.1128/JB.185.4.1316-1325.2003; Spratt BG, 1999, PHILOS T R SOC B, V354, P701, DOI 10.1098/rstb.1999.0423; Tassios PT, 1998, J CLIN MICROBIOL, V36, P897, DOI 10.1128/JCM.36.4.897-901.1998; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; TRIAS J, 1990, J BIOL CHEM, V265, P15680; TRIAS J, 1990, ANTIMICROB AGENTS CH, V34, P52, DOI 10.1128/AAC.34.1.52; TSAKRIS A, 1992, EUR J EPIDEMIOL, V8, P865, DOI 10.1007/BF00145334; Tummler B, 2005, J BACTERIOL, V187, P3289, DOI 10.1128/JB.187.10.3289-3292.2005; Van Daele SG, 2005, EUR RESPIR J, V25, P474, DOI 10.1183/09031936.05.00050304; VANBELKUM A, 1996, ZENTRALBL BAKTERIOL, V1045, P249; Vandamme P, 1996, MICROBIOL REV, V60, P407, DOI 10.1128/MMBR.60.2.407-438.1996; Vauterin L, 2006, MOL IDENTIFICATION S, P141; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wareham DW, 2007, INT J MED MICROBIOL, V297, P227, DOI 10.1016/j.ijmm.2007.02.004; Watine J, 1999, PATHOL BIOL, V47, P457; Wiehlmann L, 2007, P NATL ACAD SCI USA, V104, P8101, DOI 10.1073/pnas.0609213104; Wolfgang MC, 2003, P NATL ACAD SCI USA, V100, P8484, DOI 10.1073/pnas.0832438100; ZIERDT CH, 1975, J CLIN MICROBIOL, V1, P521, DOI 10.1128/JCM.1.6.521-526.1975; 2001, PATHOL BIOL PARIS, V49, P620	119	156	161	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2009	4	11							e7740	10.1371/journal.pone.0007740	http://dx.doi.org/10.1371/journal.pone.0007740			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518VB	19936230	Green Submitted, Green Published, gold			2022-12-25	WOS:000271721900005
J	Pourcet, B; Pineda-Torra, I; Derudas, B; Staels, B; Glineur, C				Pourcet, Benoit; Pineda-Torra, Ines; Derudas, Bruno; Staels, Bart; Glineur, Corine			SUMOylation of Human Peroxisome Proliferator-activated Receptor alpha Inhibits Its Trans-activity through the Recruitment of the Nuclear Corepressor NCoR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PPAR-ALPHA; MOLECULAR CHARACTERIZATION; TRANSCRIPTIONAL ACTIVITY; SIGNALING PATHWAYS; RESPONSE ELEMENT; FATTY-ACIDS; CROSS-TALK; GAMMA; GENE; METABOLISM	The nuclear receptor peroxisome proliferator-activated receptor alpha (PPAR alpha) is a key regulator of genes implicated in lipid homeostasis and inflammation. PPAR alpha trans-activity is enhanced by recruitment of coactivators such as SRC1 and CBP/p300 and is inhibited by binding of corepressors such as NCoR and SMRT. In addition to ligand binding, PPAR alpha activity is regulated by post-translational modifications such as phosphorylation and ubiquitination. In this report, we demonstrate that hPPAR alpha is SUMOylated by SUMO-1 on lysine 185 in the hinge region. The E2-conjugating enzyme Ubc9 and the SUMO E3-ligase PIASy are implicated in this process. In addition, ligand treatment decreases the SUMOylation rate of hPPAR alpha. Finally, our results demonstrate that SUMO-1 modification of hPPAR alpha down-regulates its trans-activity through the specific recruitment of corepressor NCoR but not SMRT leading to the differential expression of a subset of PPAR alpha target genes. In conclusion, hPPAR alpha SUMOylation on lysine 185 down-regulates its trans-activity through the selective recruitment of NCoR.	[Glineur, Corine] Inst Pasteur, UR545, INSERM, F-59019 Lille, France; [Pourcet, Benoit; Derudas, Bruno; Staels, Bart; Glineur, Corine] UDSL, F-59000 Lille, France; [Pourcet, Benoit; Derudas, Bruno; Staels, Bart; Glineur, Corine] INSERM, U545, F-59000 Lille, France; [Pourcet, Benoit; Derudas, Bruno; Staels, Bart; Glineur, Corine] Univ Lille Nord France, F-59000 Lille, France; [Pineda-Torra, Ines] UCL, Div Med, London WC1 E6JJ, England	Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; University of London; University College London	Glineur, C (corresponding author), Inst Pasteur, UR545, INSERM, 01 Rue Prof Calmette,BP 245, F-59019 Lille, France.	Corine.Glineur@pasteur-lille.fr	Pourcet, Benoit/ABF-4625-2020; Staels, Bart/N-9497-2016	Pourcet, Benoit/0000-0002-6758-5467; Staels, Bart/0000-0002-3784-1503; Pineda Torra, Ines/0000-0002-7349-2208	Region Nord-Pas de Calais/FEDER; Fondation Coeur et Arteres; European Vascular Genomics Network	Region Nord-Pas de Calais/FEDER(Region Hauts-de-FranceEuropean Commission); Fondation Coeur et Arteres; European Vascular Genomics Network	This work was supported by grants from the Region Nord-Pas de Calais/FEDER, Fondation Coeur et Arteres, and European Vascular Genomics Network.	Blanquart C, 2002, J BIOL CHEM, V277, P37254, DOI 10.1074/jbc.M110598200; Braissant O, 1998, ENDOCRINOLOGY, V139, P2748, DOI 10.1210/en.139.6.2748; Brandt JM, 1998, J BIOL CHEM, V273, P23786, DOI 10.1074/jbc.273.37.23786; Davies L, 2008, MOL ENDOCRINOL, V22, P1331, DOI 10.1210/me.2007-0360; Davignon J, 2001, ADV EXP MED BIOL, V498, P49; Degerny C, 2005, J BIOL CHEM, V280, P24330, DOI 10.1074/jbc.M411250200; Delerive P, 1999, J BIOL CHEM, V274, P32048, DOI 10.1074/jbc.274.45.32048; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Diradourian C, 2005, BIOCHIMIE, V87, P33, DOI 10.1016/j.biochi.2004.11.010; Dowell P, 1999, J BIOL CHEM, V274, P15901, DOI 10.1074/jbc.274.22.15901; Feige JN, 2006, PROG LIPID RES, V45, P120, DOI 10.1016/j.plipres.2005.12.002; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Ghisletti S, 2007, MOL CELL, V25, P57, DOI 10.1016/j.molcel.2006.11.022; Ghisletti S, 2009, GENE DEV, V23, P681, DOI 10.1101/gad.1773109; Hwang EJ, 2009, BIOCHEM BIOPH RES CO, V378, P513, DOI 10.1016/j.bbrc.2008.11.072; Lefebvre P, 2006, J CLIN INVEST, V116, P571, DOI 10.1172/JCI27989; Leuenberger N, 2009, J CLIN INVEST, V119, P3138, DOI 10.1172/JCI39019; Liu MH, 2008, MOL ENDOCRINOL, V22, P1078, DOI 10.1210/me.2007-0547; Marx N, 1999, CIRCULATION, V99, P3125, DOI 10.1161/01.CIR.99.24.3125; Ohshima T, 2004, J BIOL CHEM, V279, P29551, DOI 10.1074/jbc.M403866200; Oishi Y, 2008, NAT MED, V14, P656, DOI 10.1038/nm1756; Palvimo JJ, 2007, BIOCHEM SOC T, V35, P1405, DOI 10.1042/BST0351405; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Poukka H, 2000, P NATL ACAD SCI USA, V97, P14145, DOI 10.1073/pnas.97.26.14145; Pourcet Benoit, 2006, Expert Opin Emerg Drugs, V11, P379, DOI 10.1517/14728214.11.3.379; RODRIGUEZ JC, 1994, J BIOL CHEM, V269, P18767; Schupp M, 2005, DIABETES, V54, P3442, DOI 10.2337/diabetes.54.12.3442; Shimizu M, 2006, MOL CELL BIOCHEM, V286, P33, DOI 10.1007/s11010-005-9052-z; Staels B, 1998, NATURE, V393, P790, DOI 10.1038/31701; Tojo M, 2002, J BIOL CHEM, V277, P46576, DOI 10.1074/jbc.M205987200; Vu-Dac N, 2003, J BIOL CHEM, V278, P17982, DOI 10.1074/jbc.M212191200; VUDAC N, 1994, J BIOL CHEM, V269, P31012; Yang SH, 2006, EMBO J, V25, P5083, DOI 10.1038/sj.emboj.7601383; Zhao J, 2007, CELL MOL LIFE SCI, V64, P3017, DOI 10.1007/s00018-007-7137-4	34	68	71	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					5983	5992		10.1074/jbc.M109.078311	http://dx.doi.org/10.1074/jbc.M109.078311			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	19955185	Green Submitted, Green Accepted, Green Published, hybrid			2022-12-25	WOS:000275367500001
J	Gu, FF; Jones, MK; Chen, JG; Patterson, JC; Catte, A; Jerome, WG; Li, L; Segrest, JP				Gu, Feifei; Jones, Martin K.; Chen, Jianguo; Patterson, James C.; Catte, Andrea; Jerome, W. Gray; Li, Ling; Segrest, Jere P.			Structures of Discoidal High Density Lipoproteins A COMBINED COMPUTATIONAL-EXPERIMENTAL APPROACH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESTRAINED MOLECULAR-DYNAMICS; HDL PARTICLES; APOA-I; ELECTRON-MICROSCOPY; MASS-SPECTROMETRY; APOLIPOPROTEIN AI; LIPID-BINDING; BELT MODEL; CONFORMATION; DOMAIN	Conversion of discoidal phospholipid (PL)-rich high density lipoprotein (HDL) to spheroidal cholesteryl ester-rich HDL is a central step in reverse cholesterol transport. A detailed understanding of this process and the atheroprotective role of apolipoprotein A-I (apoA-I) requires knowledge of the structure and dynamics of these various particles. This study, combining computation with experimentation, illuminates structural features of apoA-I allowing it to incorporate varying amounts of PL. Molecular dynamics simulated annealing of PL-rich HDL models containing unesterified cholesterol results in double belt structures with the same general saddle-shaped conformation of both our previous molecular dynamics simulations at 310 K and the x-ray structure of lipid-free apoA-I. Conversion from a discoidal to a saddle-shaped particle involves loss of helicity and formation of loops in opposing antiparallel parts of the double belt. During surface expansion caused by the temperature-jump step, the curved palmitoyloleoylphosphatidylcholine bilayer surfaces approach planarity. Relaxation back into saddle-shaped structures after cool down and equilibration further supports the saddle-shaped particle model. Our kinetic analyses of reconstituted particles demonstrate that PL-rich particles exist in discrete sizes corresponding to local energetic minima. Agreement of experimental and computational determinations of particle size/shape and apoA-I helicity provide additional support for the saddle-shaped particle model. Truncation experiments combined with simulations suggest that the N-terminal proline-rich domain of apoA-I influences the stability of PL-rich HDL particles. We propose that apoA-I incorporates increasing PL in the form of minimal surface bilayers through the incremental unwinding of an initially twisted saddle-shaped apoA-I double belt structure.	[Gu, Feifei; Jones, Martin K.; Chen, Jianguo; Patterson, James C.; Catte, Andrea; Li, Ling; Segrest, Jere P.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Gu, Feifei; Jones, Martin K.; Chen, Jianguo; Patterson, James C.; Catte, Andrea; Li, Ling; Segrest, Jere P.] Univ Alabama Birmingham, Atherosclerosis Res Unit, Birmingham, AL 35294 USA; [Jones, Martin K.; Patterson, James C.; Catte, Andrea; Segrest, Jere P.] Univ Alabama Birmingham, Ctr Computat & Struct Dynam, Birmingham, AL 35294 USA; [Patterson, James C.] Univ Alabama Birmingham, Dept Chem, Birmingham, AL 35294 USA; [Jerome, W. Gray] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Vanderbilt University	Li, L (corresponding author), 1808 7th Ave S,BDB 630, Birmingham, AL 35294 USA.	lili@uab.edu; segrest@uab.edu		Catte, Andrea/0000-0002-1124-1788; Li, Ling/0000-0002-9245-7387	National Institutes of Health [DK20539, CA68485, DK58404]; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL034343] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Drs. Vinod Mishra and Michael J. Jablonsky for their assistance in proton NMR and CD spectroscopy. We also thank the University of Alabama at Birmingham Information Technology and the Department of Mechanical Engineering for use of the IBM Blue Gene/L rack that they jointly maintain. EM analysis was performed in part through the use of the Vanderbilt University Medical Center Research EM Resource (supported by National Institutes of Health Grants DK20539, CA68485, and DK58404).	Anantharamaiah GM, 1996, METHOD ENZYMOL, V263, P267; BassolinoKlimas D, 1996, PROTEIN SCI, V5, P593; Bhat S, 2005, J BIOL CHEM, V280, P33015, DOI 10.1074/jbc.M505081200; Bhat S, 2007, BIOCHEMISTRY-US, V46, P7811, DOI 10.1021/bi700384t; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; BROUILLETTE CG, 1984, BIOCHEMISTRY-US, V23, P359, DOI 10.1021/bi00297a027; BROUILLETTE CG, 1982, J BIOL CHEM, V257, P12; Catte A, 2008, BIOPHYS J, V94, P2306, DOI 10.1529/biophysj.107.115857; Catte A, 2006, BIOPHYS J, V90, P4345, DOI 10.1529/biophysj.105.071456; Davidson WS, 2007, J BIOL CHEM, V282, P22249, DOI 10.1074/jbc.R700014200; Davidson WS, 2003, J BIOL CHEM, V278, P27199, DOI 10.1074/jbc.M302764200; Davidson WS, 1996, P NATL ACAD SCI USA, V93, P13605, DOI 10.1073/pnas.93.24.13605; Duong PT, 2006, J LIPID RES, V47, P832, DOI 10.1194/jlr.M500531-JLR200; Fang YL, 2003, BIOCHEMISTRY-US, V42, P13260, DOI 10.1021/bi0354031; Feller S E, 1997, Pac Symp Biocomput, P142; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Harvey SC, 1998, J COMPUT CHEM, V19, P726, DOI 10.1002/(SICI)1096-987X(199805)19:7<726::AID-JCC4>3.0.CO;2-S; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JI Y, 1995, J BIOL CHEM, V270, P11290, DOI 10.1074/jbc.270.19.11290; JONAS A, 1990, J BIOL CHEM, V265, P22123; JONAS A, 1986, METHOD ENZYMOL, V128, P553; Jones MK, 2009, BIOPHYS J, V96, P354, DOI 10.1016/j.bpj.2008.09.041; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; KERR ID, 1994, BIOPHYS J, V67, P1501, DOI 10.1016/S0006-3495(94)80624-1; Klon AE, 2002, J MOL BIOL, V324, P703, DOI 10.1016/S0022-2836(02)01143-9; Laccotripe M, 1997, J BIOL CHEM, V272, P17511, DOI 10.1074/jbc.272.28.17511; Li H, 1997, PROTEIN SCI, V6, P956, DOI 10.1002/pro.5560060502; Li HH, 2000, J BIOL CHEM, V275, P37048, DOI 10.1074/jbc.M005336200; Li L, 2004, J MOL BIOL, V343, P1293, DOI 10.1016/j.jmb.2004.09.017; Linsel-Nitschke P, 2005, NAT REV DRUG DISCOV, V4, P193, DOI 10.1038/nrd1658; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Maiorano JN, 2004, BIOCHEMISTRY-US, V43, P11717, DOI 10.1021/bi0496642; Martin DDO, 2006, J BIOL CHEM, V281, P20418, DOI 10.1074/jbc.M602077200; Mishra VK, 1998, BIOCHEMISTRY-US, V37, P10313, DOI 10.1021/bi980042o; Miyazaki M, 2009, BIOCHEMISTRY-US, V48, P7756, DOI 10.1021/bi900785x; Panagotopulos SE, 2001, J BIOL CHEM, V276, P42965, DOI 10.1074/jbc.M106462200; Rogers DP, 1997, BIOCHEMISTRY-US, V36, P288, DOI 10.1021/bi961876e; SANKARARAMAKRISHNAN R, 1995, BIOPHYS CHEM, V55, P215, DOI 10.1016/0301-4622(95)00006-J; Schlenkrich Michael, 1996, P31; SEGREST JP, 1974, FEBS LETT, V38, P247, DOI 10.1016/0014-5793(74)80064-5; Segrest JP, 1999, J BIOL CHEM, V274, P31755, DOI 10.1074/jbc.274.45.31755; SEGREST JP, 1994, CURR OPIN CARDIOL, V9, P404; Segrest JP, 2000, CURR OPIN LIPIDOL, V11, P105, DOI 10.1097/00041433-200004000-00002; Shao BH, 2006, J BIOL CHEM, V281, P9001, DOI 10.1074/jbc.C600011200; SorciThomas MG, 1997, J BIOL CHEM, V272, P7278, DOI 10.1074/jbc.272.11.7278; Tanaka M, 2006, BIOCHEMISTRY-US, V45, P4240, DOI 10.1021/bi060023b; TANFORD C, 1980, HYDROPHOBIC EFFECT, P112; vanAntwerpen R, 1997, J LIPID RES, V38, P659; Wu Z, 2007, NAT STRUCT MOL BIOL, V14, P861, DOI 10.1038/nsmb1284; Wu ZP, 2009, J BIOL CHEM, V284, P36605, DOI 10.1074/jbc.M109.039537; ZORICH NL, 1987, BIOCHIM BIOPHYS ACTA, V919, P181, DOI 10.1016/0005-2760(87)90206-2	52	66	66	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4652	4665		10.1074/jbc.M109.069914	http://dx.doi.org/10.1074/jbc.M109.069914			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	19948731	Green Published, hybrid			2022-12-25	WOS:000275274800044
J	Sun, SC; Hsu, PJ; Wu, FJ; Li, SH; Lu, CH; Luo, CW				Sun, Su-Chin; Hsu, Pei-Jen; Wu, Fang-Ju; Li, Sheng-Hsiang; Lu, Chung-Hao; Luo, Ching-Wei			Thyrostimulin, but Not Thyroid-stimulating Hormone (TSH), Acts as a Paracrine Regulator to Activate the TSH Receptor in Mammalian Ovary	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYROTROPIN RECEPTOR; BETA SUBUNIT; EXPRESSION; DIFFERENTIATION; MUTATIONS; PROTEIN; CLONING; BROWN; GENE	The thyroid-stimulating hormone receptor (TSHR), activated by either TSH or the newly discovered glycoprotein hormone thyrostimulin, plays a central role in the control of body metabolism. Interestingly, in addition to its thyroid expression, we discovered that the mRNA level of TSHR is periodically regulated in rat ovary by gonadotropins. Ovarian microdissection followed by real-time PCR analysis indicated that granulosa cells show the highest level of TSHR expression. Cultures of follicles and primary granulosa cells demonstrated that the level of TSHR is up-regulated and decreased by the gonadotropin-driven cAMP cascade and estradiol production, respectively. Furthermore, in contrast to the negligible expression of TSH in the ovary, we also found by real-time PCR and immunohistochemical analysis that thyrostimulin is expressed mainly in oocytes. Evolving before the appearance of gonadotropins, thyrostimulin is considered the most ancestral glycoprotein hormone. Therefore, the presence of thyrostimulin in the ovary suggests that it may have a primitive function in reproduction when it activates ovarian TSHR. Next, we generated recombinant thyrostimulin protein and characterized its non-covalent heterodimeric nature. Using purified recombinant thyrostimulin, we show that the human ovarian cell line NIH:OVCAR-3 also expresses endogenous and functional TSHR. Using cultured rat granulosa cells isolated from different ovarian stages, we found that treatments with thyrostimulin significantly increase cAMP production and the c-fos gene response in the presence of gonadotropins. Thus, this study demonstrates that oocyte-derived thyrostimulin and granulosa cell-expressed TSHR compose a novel paracrine system in the ovary, where the activity is tightly controlled by gonadotropins.	[Sun, Su-Chin; Hsu, Pei-Jen; Wu, Fang-Ju; Luo, Ching-Wei] Natl Yang Ming Univ, Dept Life Sci, Taipei 112, Taiwan; [Sun, Su-Chin; Hsu, Pei-Jen; Wu, Fang-Ju; Luo, Ching-Wei] Natl Yang Ming Univ, Inst Genome Sci, Taipei 112, Taiwan; [Li, Sheng-Hsiang; Lu, Chung-Hao] Mackay Mem Hosp, Dept Med Res, Tamsui 251, Taipei Country, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Mackay Memorial Hospital	Luo, CW (corresponding author), Natl Yang Ming Univ, Dept Life Sci, 155 Li Nong St,Sect 2, Taipei 112, Taiwan.	cwluo@ym.edu.tw			Yen Tjing Ling Medical Foundation [CI-97-1]; National Science Council [NSC97-2311-B-010-001-MY3]; Ministry of Education Aim for the Top University Plan in Taiwan	Yen Tjing Ling Medical Foundation; National Science Council(Ministry of Science and Technology, Taiwan); Ministry of Education Aim for the Top University Plan in Taiwan	This work was supported by Yen Tjing Ling Medical Foundation Grant CI-97-1, National Science Council Grant NSC97-2311-B-010-001-MY3, and the Ministry of Education Aim for the Top University Plan in Taiwan.	Abe E, 2003, CELL, V115, P151, DOI 10.1016/S0092-8674(03)00771-2; Aghajanova L, 2009, REPROD BIOMED ONLINE, V18, P337, DOI 10.1016/S1472-6483(10)60091-0; Balzan S, 2009, CELL BIOCHEM FUNCT, V27, P259, DOI 10.1002/cbf.1567; Brokken LJS, 2005, EXP CLIN ENDOCR DIAB, V113, P13, DOI 10.1055/s-2004-830516; Crisanti P, 2001, ENDOCRINOLOGY, V142, P812, DOI 10.1210/en.142.2.812; Davies TF, 2005, J CLIN INVEST, V115, P1972, DOI 10.1172/JCI26031; Dutton CM, 1997, THYROID, V7, P879, DOI 10.1089/thy.1997.7.879; Endo T, 2008, AM J PHYSIOL-ENDOC M, V295, pE514, DOI 10.1152/ajpendo.90433.2008; Francis T, 1991, Thyroid, V1, P223, DOI 10.1089/thy.1991.1.223; Goto-Kazeto R, 2009, GEN COMP ENDOCR, V161, P313, DOI 10.1016/j.ygcen.2009.01.009; HAMILTON TC, 1983, CANCER RES, V43, P5379; Heinrichs C, 2000, THYROID, V10, P387, DOI 10.1089/thy.2000.10.387; HSUEH AJW, 1992, TRENDS ENDOCRIN MET, V3, P164, DOI 10.1016/1043-2760(92)90166-X; Kleinau G, 2009, ENDOCR REV, V30, P133, DOI 10.1210/er.2008-0044; Kumar RS, 2000, MOL CELL ENDOCRINOL, V167, P1, DOI 10.1016/S0303-7207(00)00304-X; Li Chang, 2004, Endocr Regul, V38, P131; Ludgate M, 1999, ONCOGENE, V18, P4798, DOI 10.1038/sj.onc.1202864; Luo Ching-Wei, 2006, Chang Gung Med J, V29, P2; Luo CW, 2004, MOL ENDOCRINOL, V18, P2085, DOI 10.1210/me.2004-0066; Macdonald LE, 2005, P NATL ACAD SCI USA, V102, P2496, DOI 10.1073/pnas.0409849102; MENGISTU M, 1994, J ENDOCRINOL INVEST, V17, P437, DOI 10.1007/BF03347732; MIYAI K, 1971, NEW ENGL J MED, V285, P1043, DOI 10.1056/NEJM197111042851902; Mutinati M, 2010, ANIM REPROD SCI, V118, P1, DOI 10.1016/j.anireprosci.2009.05.019; Nagasaki H, 2006, J MOL ENDOCRINOL, V37, P39, DOI 10.1677/jme.1.01932; Nakabayashi K, 2002, J CLIN INVEST, V109, P1445, DOI 10.1172/JCI200214340; Okada SL, 2006, MOL ENDOCRINOL, V20, P414, DOI 10.1210/me.2005-0270; Rocha A, 2007, GEN COMP ENDOCR, V152, P89, DOI 10.1016/j.ygcen.2007.03.001; ROSELLIREHFUSS L, 1992, ENDOCRINOLOGY, V130, P1857, DOI 10.1210/en.130.4.1857; SAIARDI A, 1995, BIOCHEM J, V310, P491, DOI 10.1042/bj3100491; Strauss J F 3rd, 1988, Prog Clin Biol Res, V267, P177; Sudo S, 2005, ENDOCRINOLOGY, V146, P3596, DOI 10.1210/en.2005-0317; Tando Y, 2009, GEN COMP ENDOCR, V162, P329, DOI 10.1016/j.ygcen.2009.04.015; Themmen APN, 2000, ENDOCR REV, V21, P551, DOI 10.1210/er.21.5.551; Trudeau VL, 2009, ENDOCRINOLOGY, V150, P3446, DOI 10.1210/en.2009-0465; VASSART G, 1992, ENDOCR REV, V13, P596, DOI 10.1210/er.13.3.596; Vischer HF, 2003, J MOL ENDOCRINOL, V30, P227, DOI 10.1677/jme.0.0300227; Zhang W, 2009, J CELL MOL MED, V13, P4636, DOI 10.1111/j.1582-4934.2008.00670.x	37	56	60	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3758	3765		10.1074/jbc.M109.066266	http://dx.doi.org/10.1074/jbc.M109.066266			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19955180	Green Published, hybrid			2022-12-25	WOS:000275254000028
J	Vinas-Castells, R; Beltran, M; Valls, G; Gomez, I; Garcia, JM; Montserrat-Sentis, B; Baulida, J; Bonilla, F; de Herreros, AG; Diaz, VM				Vinas-Castells, Rosa; Beltran, Manuel; Valls, Gabriela; Gomez, Irene; Miguel Garcia, Jose; Montserrat-Sentis, Barbara; Baulida, Josep; Bonilla, Felix; Garcia de Herreros, Antonio; Diaz, Victor M.			The Hypoxia-controlled FBXL14 Ubiquitin Ligase Targets SNAIL1 for Proteasome Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; BETA-TRCP; TRANSCRIPTION FACTOR; CELL-MIGRATION; TUMOR; EXPRESSION; TWIST; PHOSPHORYLATION; REPRESSOR; PROTEINS	The transcription factor SNAIL1 is a master regulator of epithelial to mesenchymal transition. SNAIL1 is a very unstable protein, and its levels are regulated by the E3 ubiquitin ligase beta-TrCP1 that interacts with SNAIL1 upon its phosphorylation by GSK-3 beta. Here we show that SNAIL1 polyubiquitylation and degradation may occur in conditions precluding SNAIL1 phosphorylation by GSK-3 beta, suggesting that additional E3 ligases participate in the control of SNAIL1 protein stability. In particular, we demonstrate that the F-box E3 ubiquitin ligase FBXl14 interacts with SNAIL1 and promotes its ubiquitylation and proteasome degradation independently of phosphorylation by GSK-3 beta. In vivo, inhibition of FBXl14 using short hairpin RNA stabilizes both ectopically expressed and endogenous SNAIL1. Moreover, the expression of FBXl14 is potently down-regulated during hypoxia, a condition that increases the levels of SNAIL1 protein but not SNAIL1 mRNA. FBXL14 mRNA is decreased in tumors with a high expression of two proteins up-regulated in hypoxia, carbonic anhydrase 9 and TWIST1. In addition, Twist1 small interfering RNA prevents hypoxia-induced Fbxl14 downregulation and SNAIL1 stabilization in NMuMG cells. Altogether, these results demonstrate the existence of an alternative mechanism controlling SNAIL1 protein levels relevant for the induction of SNAIL1 during hypoxia.	[Montserrat-Sentis, Barbara; Baulida, Josep; Garcia de Herreros, Antonio; Diaz, Victor M.] Hosp Mar, Inst Municipal Invest Med, Programa Recerca Canc, E-08003 Barcelona, Spain; [Gomez, Irene; Miguel Garcia, Jose; Bonilla, Felix] Hosp Univ Puerta Hierro, Med Oncol Serv, E-28222 Majadahonda, Spain; [Garcia de Herreros, Antonio; Diaz, Victor M.] Univ Pompeu Fabra, Dept Ciencies Expt & Salut, E-08003 Barcelona, Spain	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Hospital Puerta de Hierro-Majadahonda; Pompeu Fabra University	de Herreros, AG (corresponding author), Hosp Mar, Inst Municipal Invest Med, Programa Recerca Canc, Parc Recerca Biomed Barcelona,Doctor Aiguader 88, E-08003 Barcelona, Spain.	agarcia@imim.es; vdiaz@imim.es	de Herreros, A Garcia/H-3104-2014; Díaz, Víctor Manuel/F-5013-2016; Viñas-Castells, Rosa/J-7722-2017	de Herreros, A Garcia/0000-0001-5270-0808; Díaz, Víctor Manuel/0000-0001-8561-7576; Viñas-Castells, Rosa/0000-0003-0610-4495	Ministerio de Ciencia y Tecnologia [SAF2006-00339]; Fundacio La Marato de TV3; Instituto Carlos III [RD06/0020/0040, RD06/0020/0020]; Generalitat de Catalunya [2005SGR00970]	Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacio La Marato de TV3; Instituto Carlos III(Instituto de Salud Carlos III); Generalitat de Catalunya(Generalitat de Catalunya)	This work was supported by Ministerio de Ciencia y Tecnologia Grant SAF2006-00339 and by a grant from the Fundacio La Marato de TV3 (to A. G. H.). This work was also supported in part by Instituto Carlos III Grants RD06/0020/0040 and RD06/0020/0020 and by Generalitat de Catalunya Grant 2005SGR00970.	Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Boutet A, 2006, EMBO J, V25, P5603, DOI 10.1038/sj.emboj.7601421; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Dominguez D, 2003, MOL CELL BIOL, V23, P5078, DOI 10.1128/MCB.23.14.5078-5089.2003; Escriva M, 2008, MOL CELL BIOL, V28, P1528, DOI 10.1128/MCB.02061-07; Franci C, 2006, ONCOGENE, V25, P5134, DOI 10.1038/sj.onc.1209519; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Hart M, 1999, CURR BIOL, V9, P207, DOI 10.1016/S0960-9822(99)80091-8; Kajita M, 2004, MOL CELL BIOL, V24, P7559, DOI 10.1128/MCB.24.17.7559-7566.2004; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Liu LP, 2006, MOL CELL, V21, P521, DOI 10.1016/j.molcel.2006.01.010; Ougolkov A, 2004, JNCI-J NATL CANCER I, V96, P1161, DOI 10.1093/jnci/djh219; Peinado H, 2003, J BIOL CHEM, V278, P21113, DOI 10.1074/jbc.M211304200; Peinado H, 2005, EMBO J, V24, P3446, DOI 10.1038/sj.emboj.7600781; Peinado H, 2008, NAT CELL BIOL, V10, P253, DOI 10.1038/ncb0308-253; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Sahlgren C, 2008, P NATL ACAD SCI USA, V105, P6392, DOI 10.1073/pnas.0802047105; Shirakihara T, 2007, MOL BIOL CELL, V18, P3533, DOI 10.1091/mbc.E07-03-0249; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Vega S, 2004, GENE DEV, V18, P1131, DOI 10.1101/gad.294104; Vernon AE, 2006, DEVELOPMENT, V133, P3359, DOI 10.1242/dev.02504; Wu Y, 2009, CANCER CELL, V15, P416, DOI 10.1016/j.ccr.2009.03.016; Wykoff CC, 2000, CANCER RES, V60, P7075; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691; Yook JI, 2005, J BIOL CHEM, V280, P11740, DOI 10.1074/jbc.M413878200; Yook JI, 2006, NAT CELL BIOL, V8, P1398, DOI 10.1038/ncb1508; Yuan BB, 2004, NUCLEIC ACIDS RES, V32, pW130, DOI 10.1093/nar/gkh366; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	30	126	130	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3794	3805		10.1074/jbc.M109.065995	http://dx.doi.org/10.1074/jbc.M109.065995			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19955572	hybrid, Green Published			2022-12-25	WOS:000275254000032
J	Freschauf, GK; Mani, RS; Mereniuk, TR; Fanta, M; Virgen, CA; Dianov, GL; Grassot, JM; Hall, DG; Weinfeld, M				Freschauf, Gary K.; Mani, Rajam S.; Mereniuk, Todd R.; Fanta, Mesfin; Virgen, Caesar A.; Dianov, Grigory L.; Grassot, Jean-Marie; Hall, Dennis G.; Weinfeld, Michael			Mechanism of Action of an Imidopiperidine Inhibitor of Human Polynucleotide Kinase/Phosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAND BREAK REPAIR; IONIZING-RADIATION; DNA; KINASE; XRCC1; BINDING; 3'-PHOSPHATASE; PROTEIN; DAMAGE; CELLS	The small molecule, 2-(1-hydroxyundecyl)-1-(4-nitrophenylamino)-6-phenyl-6,7a-dihydro-1H-pyrrolo[3,4-b] pyridine5,7(2H,4aH)-dione (A12B4C3), is a potent inhibitor of the phosphatase activity of human polynucleotide kinase/phosphatase (PNKP) in vitro. Kinetic analysis revealed that A12B4C3 acts as a noncompetitive inhibitor, and this was confirmed by fluorescence quenching, which showed that the inhibitor can form a ternary complex with PNKP and a DNA substrate, i.e. A12B4C3 does not prevent DNA from binding to the phosphatase DNA binding site. Conformational analysis using circular dichroism, UV difference spectroscopy, and fluorescence resonance energy transfer all indicate that A12B4C3 disrupts the secondary structure of PNKP. Investigation of the potential site of binding of A12B4C3 to PNKP using site-directed mutagenesis pointed to interaction between Trp(402) of PNKP and the inhibitor. Cellular studies revealed that A12B4C3 sensitizes A549 human lung cancer cells to the topoisomerase I poison, camptothecin, but not the topoisomerase II poison, etoposide, in a manner similar to small interfering RNA against PNKP. A12B4C3 also inhibits the repair of DNA single and double strand breaks following exposure of cells to ionizing radiation, but does not inhibit two other key strand-break repair enzymes, DNA polymerase beta or DNA ligase III, providing additional evidence that PNKP is the cellular target of the inhibitor.	[Freschauf, Gary K.; Mani, Rajam S.; Mereniuk, Todd R.; Fanta, Mesfin; Virgen, Caesar A.; Weinfeld, Michael] Cross Canc Inst, Dept Expt Oncol, Edmonton, AB T6G 1Z2, Canada; [Dianov, Grigory L.] Univ Oxford, Gray Inst Radiat Oncol & Biol, Oxford OX3 7DQ, England; [Grassot, Jean-Marie; Hall, Dennis G.] Univ Alberta, Dept Chem, Edmonton, AB T6G 2G2, Canada	University of Alberta; University of Oxford; University of Alberta	Weinfeld, M (corresponding author), Univ Alberta, Cross Canc Inst, Dept Oncol, 11560 Univ Ave, Edmonton, AB BT6G 1Z2, Canada.	michaelw@cancerboard.ab.ca	Hall, Dennis/E-6865-2016	Hall, Dennis/0000-0001-8555-6400	Canadian Institutes of Health Research and Alberta Cancer Foundation; Canadian Institutes of Health Research Drug Development Initiative; Natural Sciences and Engineering Research Council of Canada; MRC [G0700730] Funding Source: UKRI; Medical Research Council [G0700730] Funding Source: researchfish	Canadian Institutes of Health Research and Alberta Cancer Foundation(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research Drug Development Initiative(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from the Canadian Institutes of Health Research and Alberta Cancer Foundation (to M.W.), the Canadian Institutes of Health Research Drug Development Initiative, and Natural Sciences and Engineering Research Council of Canada (to D.G.H.).	Bernstein NK, 2008, ANTI-CANCER AGENT ME, V8, P358, DOI 10.2174/187152008784220311; Bernstein NK, 2005, MOL CELL, V17, P657, DOI 10.1016/j.molcel.2005.02.012; Breslin C, 2009, MOL CELL BIOL, V29, P4653, DOI 10.1128/MCB.00677-09; Chappell C, 2002, EMBO J, V21, P2827, DOI 10.1093/emboj/21.11.2827; CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; Donovan J W, 1973, Methods Enzymol, V27, P497; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; Freschauf GK, 2009, CANCER RES, V69, P7739, DOI 10.1158/0008-5472.CAN-09-1805; Ismail IH, 2004, ONCOGENE, V23, P873, DOI 10.1038/sj.onc.1207303; Jilani A, 1999, J BIOL CHEM, V274, P24176, DOI 10.1074/jbc.274.34.24176; Karimi-Busheri F, 1999, J BIOL CHEM, V274, P24187, DOI 10.1074/jbc.274.34.24187; Koch CA, 2004, EMBO J, V23, P3874, DOI 10.1038/sj.emboj.7600375; LEACH SJ, 1969, PHYS PRINCIPLES TECH, P101; Mani RS, 2007, J BIOL CHEM, V282, P28004, DOI 10.1074/jbc.M704867200; Mani RS, 2004, BIOCHEMISTRY-US, V43, P16505, DOI 10.1021/bi048615m; Mani RS, 2003, BIOCHEMISTRY-US, V42, P12077, DOI 10.1021/bi030127b; MANI RS, 1983, BIOCHEMISTRY-US, V22, P1734, DOI 10.1021/bi00276a033; Mani RS, 2001, BIOCHEMISTRY-US, V40, P12967, DOI 10.1021/bi011383w; Nitiss JL, 1996, MOL PHARMACOL, V50, P1095; O'Connor MJ, 2007, ONCOGENE, V26, P7816, DOI 10.1038/sj.onc.1210879; Plo I, 2003, DNA REPAIR, V2, P1087, DOI 10.1016/S1568-7864(03)00116-2; Rasouli-Nia A, 2004, P NATL ACAD SCI USA, V101, P6905, DOI 10.1073/pnas.0400099101; SELVIN PR, 1995, METHOD ENZYMOL, V246, P300; Ulaczyk-Lesanko A, 2007, J COMB CHEM, V9, P695, DOI 10.1021/cc0700344; Wells GJ, 2006, BIOORG MED CHEM LETT, V16, P1151, DOI 10.1016/j.bmcl.2005.11.086; Whitehouse CJ, 2001, CELL, V104, P107, DOI 10.1016/S0092-8674(01)00195-7; Wiederhold L, 2004, MOL CELL, V15, P209, DOI 10.1016/j.molcel.2004.06.003	27	35	37	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2351	2360		10.1074/jbc.M109.055764	http://dx.doi.org/10.1074/jbc.M109.055764			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19940137	Green Published, hybrid			2022-12-25	WOS:000273697800015
J	Zhu, H; Bendall, AJ				Zhu, Hui; Bendall, Andrew J.			Dlx5 Is a Cell Autonomous Regulator of Chondrocyte Hypertrophy in Mice and Functionally Substitutes for Dlx6 during Endochondral Ossification	PLOS ONE			English	Article							SKELETAL DEVELOPMENT; HOMEOBOX GENES; OSTEOBLAST DIFFERENTIATION; CARTILAGE DIFFERENTIATION; CBFA1-DEFICIENT MICE; INDIAN HEDGEHOG; BONE-FORMATION; EXPRESSION; FAMILY; RUNX2	The axial and appendicular skeleton of vertebrates develops by endochondral ossification, in which skeletogenic tissue is initially cartilaginous and the differentiation of chondrocytes via the hypertrophic pathway precedes the differentiation of osteoblasts and the deposition of a definitive bone matrix. Results from both loss-of-function and misexpression studies have implicated the related homeobox genes Dlx5 and Dlx6 as partially redundant positive regulators of chondrocyte hypertrophy. However, experimental perturbations of Dlx expression have either not been cell type specific or have been done in the context of endogenous Dlx5 expression. Thus, it has not been possible to conclude whether the effects on chondrocyte differentiation are cell autonomous or whether they are mediated by Dlx expression in adjacent tissues, notably the perichondrium. To address this question we first engineered transgenic mice in which Dlx5 expression was specifically restricted to immature and differentiating chondrocytes and not the perichondrium. Col2a1-Dlx5 transgenic embryos and neonates displayed accelerated chondrocyte hypertrophy and mineralization throughout the endochondral skeleton. Furthermore, this transgene specifically rescued defects of chondrocyte differentiation characteristic of the Dlx5/ 6 null phenotype. Based on these results, we conclude that the role of Dlx5 in the hypertrophic pathway is cell autonomous. We further conclude that Dlx5 and Dlx6 are functionally equivalent in the endochondral skeleton, in that the requirement for Dlx5 and Dlx6 function during chondrocyte hypertrophy can be satisfied with Dlx5 alone.	[Zhu, Hui; Bendall, Andrew J.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Zhu, H (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	abendall@uoguelph.ca			Natural Sciences and Engineering Research Council of Canada (NSERC) [RG249773-02]; Canadian Foundation for Innovation; Ontario Innovation Trust	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Ontario Innovation Trust	This work was supported by Discovery grant RG249773-02 from the Natural Sciences and Engineering Research Council of Canada and equipment grants from NSERC, the Canadian Foundation for Innovation and the Ontario Innovation Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acampora D, 1999, DEVELOPMENT, V126, P3795; Archer CW, 2003, INT J BIOCHEM CELL B, V35, P401, DOI 10.1016/S1357-2725(02)00301-1; Bendall AJ, 2003, INT J DEV BIOL, V47, P335; Bendall AJ, 2000, GENE, V247, P17, DOI 10.1016/S0378-1119(00)00081-0; Beverdam A, 2002, GENESIS, V34, P221, DOI 10.1002/gene.10156; Chen XW, 1996, ANN NY ACAD SCI, V785, P38, DOI 10.1111/j.1749-6632.1996.tb56242.x; Chin HJ, 2007, DEV GROWTH DIFFER, V49, P515, DOI 10.1111/j.1440-169x.2007.00940.x; Choi KY, 2002, EXP MOL MED, V34, P426, DOI 10.1038/emm.2002.60; Cohen MM, 2000, J CRAN GENET DEV BIO, V20, P84; Crochiere ML, 2008, INT J DEV BIOL, V52, P63, DOI 10.1387/ijdb.072322mc; Crowe R, 1999, DEVELOPMENT, V126, P987; de Crombrugghe B, 2001, CURR OPIN CELL BIOL, V13, P721, DOI 10.1016/S0955-0674(00)00276-3; de la Fuente L, 2005, DEV BIOL, V282, P294, DOI 10.1016/j.ydbio.2005.03.036; Depew MJ, 2002, SCIENCE, V298, P381, DOI 10.1126/science.1075703; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Eames B. Frank, 2003, Birth Defects Research, V69, P93, DOI 10.1002/bdrc.10016; Eames BF, 2004, DEV BIOL, V274, P188, DOI 10.1016/j.ydbio.2004.07.006; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; Enomoto H, 2000, J BIOL CHEM, V275, P8695, DOI 10.1074/jbc.275.12.8695; FERRARI D, 1995, MECH DEVELOP, V52, P257, DOI 10.1016/0925-4773(95)98113-O; Ferrari D, 2002, DEV BIOL, V252, P257, DOI 10.1006/dbio.2002.0862; Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652; Hall BK, 2000, BIOESSAYS, V22, P138, DOI 10.1002/(SICI)1521-1878(200002)22:2<138::AID-BIES5>3.3.CO;2-W; Hartmann C, 2000, DEVELOPMENT, V127, P3141; Hsu SC, 2006, MECH DEVELOP, V123, P819, DOI 10.1016/j.mod.2006.08.005; Huang RJ, 2000, ANAT EMBRYOL, V202, P375, DOI 10.1007/s004290000131; Inada M, 1999, DEV DYNAM, V214, P279, DOI 10.1002/(SICI)1097-0177(199904)214:4<279::AID-AJA1>3.0.CO;2-W; Jeong J, 2008, DEVELOPMENT, V135, P2905, DOI 10.1242/dev.019778; Karsenty G, 2003, NATURE, V423, P316, DOI 10.1038/nature01654; Kim IS, 1999, MECH DEVELOP, V80, P159, DOI 10.1016/S0925-4773(98)00210-X; Kobayashi T, 2005, ENDOCRINOLOGY, V146, P1012, DOI 10.1210/en.2004-1343; Komori T, 2005, J CELL BIOCHEM, V95, P445, DOI 10.1002/jcb.20420; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Lanske B, 1996, SCIENCE, V273, P663, DOI 10.1126/science.273.5275.663; Lee MH, 2003, J BIOL CHEM, V278, P34387, DOI 10.1074/jbc.M211386200; Lee MH, 2005, J BIOL CHEM, V280, P35579, DOI 10.1074/jbc.M502267200; Lefebvre Veronique, 2005, Birth Defects Research, V75, P200, DOI 10.1002/bdrc.20048; Mackie EJ, 2008, INT J BIOCHEM CELL B, V40, P46, DOI 10.1016/j.biocel.2007.06.009; Merlo GR, 2000, INT J DEV BIOL, V44, P619; Merlo GR, 2002, GENESIS, V33, P97, DOI 10.1002/gene.10098; Pacifici Maurizio, 2005, Birth Defects Research, V75, P237, DOI 10.1002/bdrc.20050; Panganiban G, 2002, DEVELOPMENT, V129, P4371; Robledo RF, 2002, GENE DEV, V16, P1089, DOI 10.1101/gad.988402; Rokutanda S, 2009, DEV BIOL, V328, P78, DOI 10.1016/j.ydbio.2009.01.009; Schipani E, 1997, P NATL ACAD SCI USA, V94, P13689, DOI 10.1073/pnas.94.25.13689; SIMEONE A, 1994, P NATL ACAD SCI USA, V91, P2250, DOI 10.1073/pnas.91.6.2250; Solomon Lauren A., 2008, Birth Defects Research, V84, P123, DOI 10.1002/bdrc.20124; Takeda S, 2001, GENE DEV, V15, P467, DOI 10.1101/gad.845101; Ueta C, 2001, J CELL BIOL, V153, P87, DOI 10.1083/jcb.153.1.87; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Wagner EF, 2001, CURR OPIN GENET DEV, V11, P527, DOI 10.1016/S0959-437X(00)00228-8; Xiao ZS, 2004, J BIOL CHEM, V279, P20307, DOI 10.1074/jbc.M401109200; Zhang SQ, 2009, J BONE MINER RES, V24, P1889, DOI [10.1359/JBMR.090502, 10.1359/jbmr.090502]; ZHAO GQ, 1994, DEV BIOL, V164, P37, DOI 10.1006/dbio.1994.1178; ZHOU G, 1995, J CELL SCI, V108, P3677; Zhu H, 2006, INT J DEV BIOL, V50, P71, DOI 10.1387/ijdb.052087hz; Zou HY, 1997, GENE DEV, V11, P2191, DOI 10.1101/gad.11.17.2191	57	17	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2009	4	11							e8097	10.1371/journal.pone.0008097	http://dx.doi.org/10.1371/journal.pone.0008097			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MQ	19956613	Green Submitted, gold, Green Published			2022-12-25	WOS:000272828400032
J	Dayon, A; Brizuela, L; Martin, C; Mazerolles, C; Pirot, N; Doumerc, N; Nogueira, L; Goizio, M; Teissie, J; Serre, G; Rischmann, P; Malavaud, B; Cuvillier, O				Dayon, Audrey; Brizuela, Leyre; Martin, Claire; Mazerolles, Catherine; Pirot, Nelly; Doumerc, Nicolas; Nogueira, Leonor; Goizio, Muriel; Teissie, Justin; Serre, Guy; Rischmann, Pascal; Malavaud, Bernard; Cuvillier, Olivier			Sphingosine Kinase-1 Is Central to Androgen-Regulated Prostate Cancer Growth and Survival	PLOS ONE			English	Article							INDUCED NEUROENDOCRINE DIFFERENTIATION; MYELOID-LEUKEMIA CELLS; RADICAL PROSTATECTOMY; DEPRIVATION THERAPY; ADENOCARCINOMA CELL; TUMOR-GROWTH; CYCLIC-AMP; PROGRESSION; APOPTOSIS; LNCAP	Background: Sphingosine kinase-1 (SphK1) is an oncogenic lipid kinase notably involved in response to anticancer therapies in prostate cancer. Androgens regulate prostate cancer cell proliferation, and androgen deprivation therapy is the standard of care in the management of patients with advanced disease. Here, we explored the role of SphK1 in the regulation of androgen-dependent prostate cancer cell growth and survival. Methodology/Principal Findings: Short-term androgen removal induced a rapid and transient SphK1 inhibition associated with a reduced cell growth in vitro and in vivo, an event that was not observed in the hormono-insensitive PC-3 cells. Supporting the critical role of SphK1 inhibition in the rapid effect of androgen depletion, its overexpression could impair the cell growth decrease. Similarly, the addition of dihydrotestosterone (DHT) to androgen-deprived LNCaP cells re-established cell proliferation, through an androgen receptor/PI3K/Akt dependent stimulation of SphK1, and inhibition of SphK1 could markedly impede the effects of DHT. Conversely, long-term removal of androgen support in LNCaP and C4-2B cells resulted in a progressive increase in SphK1 expression and activity throughout the progression to androgen-independence state, which was characterized by the acquisition of a neuroendocrine (NE)-like cell phenotype. Importantly, inhibition of the PI3K/Akt pathway-by negatively impacting SphK1 activity-could prevent NE differentiation in both cell models, an event that could be mimicked by SphK1 inhibitors. Fascinatingly, the reversability of the NE phenotype by exposure to normal medium was linked with a pronounced inhibition of SphK1 activity. Conclusions/Significance: We report the first evidence that androgen deprivation induces a differential effect on SphK1 activity in hormone-sensitive prostate cancer cell models. These results also suggest that SphK1 activation upon chronic androgen deprivation may serve as a compensatory mechanism allowing prostate cancer cells to survive in androgen-depleted environment, giving support to its inhibition as a potential therapeutic strategy to delay/prevent the transition to androgen-independent prostate cancer.	[Dayon, Audrey; Brizuela, Leyre; Martin, Claire; Mazerolles, Catherine; Goizio, Muriel; Teissie, Justin; Rischmann, Pascal; Malavaud, Bernard; Cuvillier, Olivier] Inst Pharmacol & Biol Struct, CNRS, Toulouse, France; [Dayon, Audrey; Brizuela, Leyre; Martin, Claire; Pirot, Nelly; Doumerc, Nicolas; Goizio, Muriel; Teissie, Justin; Rischmann, Pascal; Malavaud, Bernard; Cuvillier, Olivier] Univ Toulouse, UPS, IPBS, Toulouse, France; [Doumerc, Nicolas; Rischmann, Pascal; Malavaud, Bernard; Cuvillier, Olivier] CHU Toulouse, Hop Rangueil, Serv Urol & Transplantat Renale, Toulouse, France; [Mazerolles, Catherine] CHU Toulouse, Hop Rangueil, Lab Anat Pathol & Histol Cytol, Toulouse, France; [Nogueira, Leonor; Serre, Guy] CHU Toulouse, Hop Purpan, Lab Biol Cellulaire & Cytol, Toulouse, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse; CHU de Toulouse; CHU de Toulouse	Dayon, A (corresponding author), Inst Pharmacol & Biol Struct, CNRS, Toulouse, France.	olivier.cuvillier@ipbs.fr	CUVILLIER, Olivier/B-2567-2009; Nogueira, Leonor/L-2034-2014; Teissie, Justin/AAA-5697-2019; Brizuela, Leyre/B-1175-2010; CUVILLIER, Olivier/S-1631-2019; Golzio, Muriel/F-4715-2019	CUVILLIER, Olivier/0000-0003-3346-375X; Teissie, Justin/0000-0002-7588-8062; CUVILLIER, Olivier/0000-0003-3346-375X; Golzio, Muriel/0000-0002-7470-3708	Inserm; CNRS; Fondation pour la Recherche Medicale; Association pour la Recherche sur les Tumeurs de la Prostate; Institut National du Cancer	Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Association pour la Recherche sur les Tumeurs de la Prostate; Institut National du Cancer(Institut National du Cancer (INCA) France)	This work was supported by Inserm, CNRS, Fondation pour la Recherche Medicale, Association pour la Recherche sur les Tumeurs de la Prostate, and Institut National du Cancer (to OC). AD is recipient of the Ministere de l'Enseignement Superieur et de la Recherche and La Ligue Nationale Contre le Cancer. CM is recipient of the Ministere de l'Enseignement Superieur et de la Recherche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsson PA, 1999, ENDOCR-RELAT CANCER, V6, P503, DOI 10.1677/erc.0.0060503; BANG YJ, 1994, P NATL ACAD SCI USA, V91, P5330, DOI 10.1073/pnas.91.12.5330; Baron S, 2004, J BIOL CHEM, V279, P14579, DOI 10.1074/jbc.M306143200; Bonhoure E, 2008, LEUKEMIA, V22, P971, DOI 10.1038/leu.2008.95; Bonhoure E, 2006, LEUKEMIA, V20, P95, DOI 10.1038/sj.leu.2404023; Burchardt T, 1999, J UROLOGY, V162, P1800, DOI 10.1016/S0022-5347(05)68241-9; Cox ME, 1999, CANCER RES, V59, P3821; Cuvillier O, 1996, NATURE, V381, P800, DOI 10.1038/381800a0; Cuvillier O, 2001, BLOOD, V98, P2828, DOI 10.1182/blood.V98.9.2828; Edwards J, 2003, CLIN CANCER RES, V9, P5271; Eto M, 2003, PROSTATE, V57, P66, DOI 10.1002/pros.10275; French KJ, 2003, CANCER RES, V63, P5962; Goodin JL, 2002, MOL CARCINOGEN, V33, P88, DOI 10.1002/mc.10025.abs; Graff JR, 2000, J BIOL CHEM, V275, P24500, DOI 10.1074/jbc.M003145200; Hirano D, 2004, EUR UROL, V45, P586, DOI 10.1016/j.eururo.2003.11.032; Ismail AHR, 2002, PROSTATE, V51, P117, DOI 10.1002/pros.10066; Ito T, 2001, ONCOL REP, V8, P1221; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Johnson KR, 2005, J HISTOCHEM CYTOCHEM, V53, P1159, DOI 10.1369/jhc.4A6606.2005; Jongsma J, 2000, CANCER RES, V60, P741; Kamiya N, 2003, EUR UROL, V44, P309, DOI 10.1016/S0302-2838(03)00303-8; Kaplan-Lefko PJ, 2003, PROSTATE, V55, P219, DOI 10.1002/pros.10215; Kawamori T, 2006, FASEB J, V20, P386, DOI 10.1096/fj.05-4331fje; Kreisberg JI, 2004, CANCER RES, V64, P5232, DOI 10.1158/0008-5472.CAN-04-0272; Lu S, 2006, INT J ONCOL, V28, P245; Machwate M, 1998, MOL PHARMACOL, V54, P70, DOI 10.1124/mol.54.1.70; Malik SN, 2002, CLIN CANCER RES, V8, P1168; McCall P, 2008, BRIT J CANCER, V98, P1094, DOI 10.1038/sj.bjc.6604152; Murillo H, 2001, ENDOCRINOLOGY, V142, P4795, DOI 10.1210/en.142.11.4795; Nava VE, 2000, CANCER RES, V60, P4468; Olivera A, 1999, J CELL BIOL, V147, P545, DOI 10.1083/jcb.147.3.545; Paweletz CP, 2001, ONCOGENE, V20, P1981, DOI 10.1038/sj.onc.1204265; Pchejetski D, 2005, CANCER RES, V65, P11667, DOI 10.1158/0008-5472.CAN-05-2702; Pchejetski D, 2008, MOL CANCER THER, V7, P1836, DOI 10.1158/1535-7163.MCT-07-2322; Pchejetski D, 2007, CIRC RES, V100, P41, DOI 10.1161/01.RES.0000253900.66640.34; Pfeil K, 2004, PROSTATE, V58, P259, DOI 10.1002/pros.10332; Pitson SM, 2000, BIOCHEM J, V350, P429, DOI 10.1042/0264-6021:3500429; Pound CR, 1999, JAMA-J AM MED ASSOC, V281, P1591, DOI 10.1001/jama.281.17.1591; Ruckhaberle E, 2008, BREAST CANCER RES TR, V112, P41, DOI 10.1007/s10549-007-9836-9; Sauer L, 2009, INT J CANCER, V125, P2728, DOI 10.1002/ijc.24640; Shen R, 1997, Urol Oncol, V3, P67, DOI 10.1016/S1078-1439(97)00039-2; Shi XB, 2004, PROSTATE, V60, P257, DOI 10.1002/pros.20039; Shipley WU, 1999, JAMA-J AM MED ASSOC, V281, P1598, DOI 10.1001/jama.281.17.1598; Sobue S, 2006, LEUKEMIA, V20, P2042, DOI 10.1038/sj.leu.2404386; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Sun M, 2003, J BIOL CHEM, V278, P42992, DOI 10.1074/jbc.M306295200; Taha TA, 2005, J BIOL CHEM, V280, P17196, DOI 10.1074/jbc.M413744200; Van Brocklyn JR, 2005, J NEUROPATH EXP NEUR, V64, P695, DOI 10.1097/01.jnen.0000175329.59092.2c; Wu CY, 2006, PROSTATE, V66, P1125, DOI 10.1002/pros.20412; Xia P, 2000, CURR BIOL, V10, P1527, DOI 10.1016/S0960-9822(00)00834-4; Yang XZ, 2005, CANCER RES, V65, P5263, DOI 10.1158/0008-5472.CAN-05-0162; Yuan TC, 2007, ENDOCR-RELAT CANCER, V14, P531, DOI 10.1677/ERC-07-0061; Zelivianski S, 2001, BBA-MOL CELL RES, V1539, P28, DOI 10.1016/S0167-4889(01)00087-8; Zhang XQ, 2003, ONCOGENE, V22, P6704, DOI 10.1038/sj.onc.1206764; ZINCKE H, 1994, J UROLOGY, V152, P1850, DOI 10.1016/S0022-5347(17)32399-6	55	42	44	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2009	4	11							e8048	10.1371/journal.pone.0008048	http://dx.doi.org/10.1371/journal.pone.0008048			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MN	19956567	Green Published, gold, Green Submitted			2022-12-25	WOS:000272828100008
J	Gupta, V; Gupta, RK; Khare, G; Salunke, DM; Tyagi, AK				Gupta, Vibha; Gupta, Rakesh K.; Khare, Garima; Salunke, Dinakar M.; Tyagi, Anil K.			Crystal Structure of Bfr A from Mycobacterium tuberculosis: Incorporation of Selenomethionine Results in Cleavage and Demetallation of Haem	PLOS ONE			English	Article							ESCHERICHIA-COLI BACTERIOFERRITIN; CRYSTALLOGRAPHIC STRUCTURE DETERMINATION; IRON STORAGE; AZOTOBACTER-VINELANDII; DINUCLEAR SITE; FERRITIN; FERROXIDASE; EXPRESSION; RESOLUTION; OXIDATION	Emergence of tuberculosis as a global health threat has necessitated an urgent search for new antitubercular drugs entailing determination of 3-dimensional structures of a large number of mycobacterial proteins for structure-based drug design. The essential requirement of ferritins/bacterioferritins (proteins involved in iron storage and homeostasis) for the survival of several prokaryotic pathogens makes these proteins very attractive targets for structure determination and inhibitor design. Bacterioferritins (Bfrs) differ from ferritins in that they have additional noncovalently bound haem groups. The physiological role of haem in Bfrs is not very clear but studies indicate that the haem group is involved in mediating release of iron from Bfr by facilitating reduction of the iron core. To further enhance our understanding, we have determined the crystal structure of the selenomethionyl analog of bacterioferritin A (SeMet-BfrA) from Mycobacterium tuberculosis (Mtb). Unexpectedly, electron density observed in the crystals of SeMet-BfrA analogous to haem location in bacterioferritins, shows a demetallated and degraded product of haem. This unanticipated observation is a consequence of the altered spatial electronic environment around the axial ligands of haem (in lieu of Met52 modification to SeMet52). Furthermore, the structure of Mtb SeMet-BfrA displays a possible lost protein interaction with haem propionates due to formation of a salt bridge between Arg53-Glu57, which appears to be unique to Mtb BfrA, resulting in slight modulation of haem binding pocket in this organism. The crystal structure of Mtb SeMet-BfrA provides novel leads to physiological function of haem in Bfrs. If validated as a drug target, it may also serve as a scaffold for designing specific inhibitors. In addition, this study provides evidence against the general belief that a selenium derivative of a protein represents its true physiological native structure.	[Gupta, Vibha; Gupta, Rakesh K.; Khare, Garima; Tyagi, Anil K.] Univ Delhi S Campus, Dept Biochem, New Delhi, India; [Gupta, Rakesh K.] Univ Delhi, Ram Lal Anand Coll, New Delhi, India; [Salunke, Dinakar M.] Natl Inst Immunol, New Delhi 110067, India	University of Delhi; University of Delhi; Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Gupta, V (corresponding author), Univ Delhi S Campus, Dept Biochem, New Delhi, India.	dinakar@nii.res.in; aniltyagi@south.du.ac.in			Department of Biotechnology, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported by financial grant received from the Department of Biotechnology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM NG, 1991, BLOOD REV, V5, P19, DOI 10.1016/0268-960X(91)90004-V; Adams PD, 2004, J SYNCHROTRON RADIAT, V11, P53, DOI 10.1107/S0909049503024130; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Afonine PV, 2007, ACTA CRYSTALLOGR D, V63, P1194, DOI 10.1107/S0907444907046148; ANDREWS SC, 1995, J BIOL CHEM, V270, P23268, DOI 10.1074/jbc.270.40.23268; Andrews SC, 1998, ADV MICROB PHYSIOL, V40, P281, DOI 10.1016/S0065-2911(08)60134-4; Baaghil S, 2003, BIOCHEMISTRY-US, V42, P14047, DOI 10.1021/bi035253u; BERNARD AR, 1995, EUR J BIOCHEM, V230, P111, DOI 10.1111/j.1432-1033.1995.tb20540.x; Bonnett R, 1973, J Chem Soc Perkin 1, V9, P881; Carrondo MA, 2003, EMBO J, V22, P1959, DOI 10.1093/emboj/cdg215; Chen CY, 1999, MICROBIOL-SGM, V145, P2967, DOI 10.1099/00221287-145-10-2967; Cobessi D, 2002, ACTA CRYSTALLOGR D, V58, P29, DOI 10.1107/S0907444901017267; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Crichton R., 2001, INORGANIC BIOCH IRON; DAVIES K J A, 1986, Journal of Free Radicals in Biology and Medicine, V2, P155, DOI 10.1016/S0748-5514(86)80066-6; De Voss JJ, 1999, J BACTERIOL, V181, P4443, DOI 10.1128/JB.181.15.4443-4451.1999; Douglas T, 1998, PROTEIN SCI, V7, P1083, DOI 10.1002/pro.5560070502; FROLOW F, 1994, NAT STRUCT BIOL, V1, P453, DOI 10.1038/nsb0794-453; Gold B, 2001, MOL MICROBIOL, V42, P851, DOI 10.1046/j.1365-2958.2001.02684.x; GRANICK JL, 1978, J BIOL CHEM, V253, P5402; Gupta V, 2008, ACTA CRYSTALLOGR F, V64, P398, DOI 10.1107/S1744309108007240; ISHII DN, 1978, NATURE, V274, P372, DOI 10.1038/274372a0; Janowski R, 2008, PROTEIN SCI, V17, P1138, DOI 10.1110/ps.034819.108; Keren N, 2004, PLANT PHYSIOL, V135, P1666, DOI 10.1104/pp.104.042770; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEBRUN NE, 1995, BIOCHEM J, V312, P385, DOI 10.1042/bj3120385; Levine RL, 2000, IUBMB LIFE, V50, P301, DOI 10.1080/15216540051081056; Liu HL, 2004, FEBS LETT, V573, P93, DOI 10.1016/j.febslet.2004.07.054; Macedo S, 2003, NAT STRUCT BIOL, V10, P285, DOI 10.1038/nsb909; MANCUSO C, 2009, CURR DRUG METAB; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Miller CD, 2000, GENE, V247, P199, DOI 10.1016/S0378-1119(00)00095-0; O'Regan A, 2001, BRIT MED J, V323, P635, DOI 10.1136/bmj.323.7313.635b; Paoli M, 2002, DNA CELL BIOL, V21, P271, DOI 10.1089/104454902753759690; PATAI S, 1986, CHEM ORGANIC SELENIU; Pereira AS, 1998, BIOCHEMISTRY-US, V37, P9871, DOI 10.1021/bi980847w; Ponka P, 1999, AM J MED SCI, V318, P241, DOI 10.1097/00000441-199910000-00004; Powell AK, 1998, MET IONS BIOL SYST, V35, P515; Rachman H, 2006, MICROBES INFECT, V8, P747, DOI 10.1016/j.micinf.2005.09.011; Rodriguez GM, 2003, MOL MICROBIOL, V47, P1485, DOI 10.1046/j.1365-2958.2003.03384.x; Ryter SW, 2000, FREE RADICAL BIO MED, V28, P289, DOI 10.1016/S0891-5849(99)00223-3; Smith JL, 2004, CRIT REV MICROBIOL, V30, P173, DOI 10.1080/10408410490435151; Stadtman ER, 2006, FREE RADICAL RES, V40, P1250, DOI 10.1080/10715760600918142; Stewart GR, 2003, NAT REV MICROBIOL, V1, P97, DOI 10.1038/nrmicro749; Swartz L, 2006, BIOCHEMISTRY-US, V45, P4421, DOI 10.1021/bi060146w; Takagi H, 1998, J BIOL CHEM, V273, P18685, DOI 10.1074/jbc.273.30.18685; VERCELLOTTI GM, 1994, ARTIF CELL BLOOD SUB, V22, P207, DOI 10.3109/10731199409117415; WALLACE CJA, 1992, J BIOL CHEM, V267, P3852; Wang JL, 2006, BIOCHEMISTRY-US, V45, P61, DOI 10.1021/bi051645k; Yang XO, 2000, BIOCHEMISTRY-US, V39, P4915, DOI 10.1021/bi992631f	51	27	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2009	4	11							e8028	10.1371/journal.pone.0008028	http://dx.doi.org/10.1371/journal.pone.0008028			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MK	19946376	Green Published, Green Submitted, gold			2022-12-25	WOS:000272827800016
J	Ogura, T; Tan, AJ; Tsubota, T; Nakakura, T; Shiotsuki, T				Ogura, Takehiko; Tan, Anjiang; Tsubota, Takuya; Nakakura, Takayo; Shiotsuki, Takahiro			Identification and Expression Analysis of Ras Gene in Silkworm, Bombyx mori	PLOS ONE			English	Article							KINASE SIGNALING PATHWAYS; ACTIVATED PROTEIN-KINASE; DROSOPHILA EGF RECEPTOR; GTP-BINDING PROTEINS; SMALL GTPASES; COUPLED RECEPTORS; PROTHORACIC GLAND; TYROSINE KINASES; CELL-ADHESION; FISSION YEAST	Ras proteins play important roles in development especially for cell proliferation and differentiation in various organisms. However, their functions in the most insect species are still not clear. We identified three ras cDNAs from the silk worm, Bombyx mori. These sequences corresponded to three Ras of Drosophila melanogaster, but not to three mammalian Ras (HRas, K-Ras, N-Ras). Subsequently, the expression profiles of ras were investigated by quantitative real-time PCR using whole body of individuals from the embryonic to adult stages, and various tissues of 4th and 5th instar larvae. Each of three Bombyx ras showed different expression patterns. We also showed membrane localization of their products. These results indicate that the three Bombyx Ras are functional and have different roles.	[Tan, Anjiang; Tsubota, Takuya; Nakakura, Takayo; Shiotsuki, Takahiro] Natl Inst Agrobiol Sci, Invertebrate Gene Funct Res Unit, Tsukuba, Ibaraki, Japan; [Ogura, Takehiko] Kyoto Univ, Dept Appl Life Sci, Kyoto, Japan	National Institute of Agrobiological Sciences - Japan; Kyoto University	Shiotsuki, T (corresponding author), Natl Inst Agrobiol Sci, Invertebrate Gene Funct Res Unit, Tsukuba, Ibaraki, Japan.	shiotsuk@affrc.go.jp	Ogura, Takehiko/AAV-2708-2021	Tsubota, Takuya/0000-0002-5839-4570	Ministry of Education, Culture, Sports, Science and Technology, Japan [18580057]; Ministry of Agriculture, Forestry, and Fisheries; Japan Society for the Promotion of Science for Young Scientists	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Agriculture, Forestry, and Fisheries(Ministry of Agriculture Forestry & Fisheries - Japan); Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was partly supported by the Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN), grants-in-aid for Scientific Research (no. 18580057) from Ministry of Education, Culture, Sports, Science and Technology, Japan, and grants-in-aid for the "Insect Technology Project'' from the Ministry of Agriculture, Forestry, and Fisheries to TS. TO is a recipient of Research Fellowship from the Japan Society for the Promotion of Science for Young Scientists. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki T, 2000, J BIOCHEM, V127, P627, DOI 10.1093/oxfordjournals.jbchem.a022650; Arellano M, 1999, MICROSC RES TECHNIQ, V47, P51, DOI 10.1002/(SICI)1097-0029(19991001)47:1<51::AID-JEMT5>3.0.CO;2-3; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; Bardwell L, 2006, BIOCHEM SOC T, V34, P837, DOI 10.1042/BST0340837; BAUMANN P, 1993, DEVELOPMENT, P65; Bergmann A, 1998, ONCOGENE, V17, P3215, DOI 10.1038/sj.onc.1202586; Bhattacharya M, 2004, BIOCHEM SOC T, V32, P1040, DOI 10.1042/BST0321040; Bos JL, 2005, CURR OPIN CELL BIOL, V17, P123, DOI 10.1016/j.ceb.2005.02.009; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; BROCK HW, 1987, GENE, V51, P129, DOI 10.1016/0378-1119(87)90301-5; Caldwell PE, 2005, CURR BIOL, V15, P1785, DOI 10.1016/j.cub.2005.09.011; Chen GC, 2004, CURR BIOL, V14, P309, DOI 10.1016/j.cub.2004.01.056; Chubb JR, 2001, BBA-GEN SUBJECTS, V1525, P262, DOI 10.1016/S0304-4165(01)00111-8; Ciocan CM, 2005, ENVIRON SCI TECHNOL, V39, P3029, DOI 10.1021/es0400887; CLIFFORD RJ, 1989, GENETICS, V123, P771; de Gunzburg J, 1999, CELL BIOL TOXICOL, V15, P345, DOI 10.1023/A:1007645631013; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; DIAZBENJUMEA FJ, 1994, DEVELOPMENT, V120, P569; DIAZBENJUMEA FJ, 1990, P ROY SOC B-BIOL SCI, V242, P36, DOI 10.1098/rspb.1990.0100; DIAZGUERRA M, 1989, BIOCHEM BIOPH RES CO, V162, P802, DOI 10.1016/0006-291X(89)92381-4; Dunn KL, 2005, BIOCHEM CELL BIOL, V83, P1, DOI 10.1139/O04-121; Ehrhardt A, 2002, EXP HEMATOL, V30, P1089, DOI 10.1016/S0301-472X(02)00904-9; Eisenberg S, 2008, CELL SIGNAL, V20, P31, DOI 10.1016/j.cellsig.2007.07.012; Garcia P, 2006, YEAST, V23, P1031, DOI 10.1002/yea.1409; Hackney JF, 2007, DEV DYNAM, V236, P1213, DOI 10.1002/dvdy.21140; HAN M, 1990, CELL, V63, P921, DOI 10.1016/0092-8674(90)90495-Z; HARIHARAN IK, 1991, CELL, V67, P717, DOI 10.1016/0092-8674(91)90066-8; Hariharan IK, 2005, DEV CELL, V8, P303, DOI 10.1016/j.devcel.2005.02.006; HARVEY JJ, 1964, NATURE, V204, P1104, DOI 10.1038/2041104b0; Helmreich EJM, 2004, BIOL CHEM, V385, P1121, DOI 10.1515/BC.2004.146; Herrmann C, 1996, PROG BIOPHYS MOL BIO, V66, P1, DOI 10.1016/S0079-6107(96)00015-6; Huang CF, 1999, J EXP ZOOL, V283, P510, DOI 10.1002/(SICI)1097-010X(19990501)283:6<510::AID-JEZ2>3.3.CO;2-4; Huelsmann S, 2006, DEVELOPMENT, V133, P2915, DOI 10.1242/dev.02449; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; KIRSTEN WH, 1967, J NATL CANCER I, V39, P311; LEV Z, 1985, MOL CELL BIOL, V5, P1540, DOI 10.1128/MCB.5.6.1540; Li WX, 2005, DEV DYNAM, V232, P656, DOI 10.1002/dvdy.20295; Lowes VL, 2002, NEUROSIGNALS, V11, P5, DOI 10.1159/000057317; Ma QH, 2007, J PLANT GROWTH REGUL, V26, P369, DOI 10.1007/s00344-007-9022-7; MARGOLIS B, 1994, J AM SOC NEPHROL, V5, P1288; MARSHALL CJ, 1982, NATURE, V299, P171, DOI 10.1038/299171a0; McKay MM, 2007, ONCOGENE, V26, P3113, DOI 10.1038/sj.onc.1210394; Mishra S, 2005, CURR BIOL, V15, P366, DOI 10.1016/j.cub.2005.02.022; MOZER B, 1985, MOL CELL BIOL, V5, P885, DOI 10.1128/MCB.5.4.885; NEUMANSILBERBERG FS, 1984, CELL, V37, P1027; Nilson LA, 1999, CURR TOP DEV BIOL, V44, P203; Omerovic J, 2007, CELL MOL LIFE SCI, V64, P2575, DOI 10.1007/s00018-007-7133-8; Park HO, 2007, MICROBIOL MOL BIOL R, V71, P48, DOI 10.1128/MMBR.00028-06; Pasterkamp RJ, 2005, TRENDS CELL BIOL, V15, P61, DOI 10.1016/j.tcb.2004.12.005; Rajalingam K, 2007, BBA-MOL CELL RES, V1773, P1177, DOI 10.1016/j.bbamcr.2007.01.012; Reuther GW, 2000, CURR OPIN CELL BIOL, V12, P157, DOI 10.1016/S0955-0674(99)00071-X; Riddiford L M, 2000, Vitam Horm, V60, P1, DOI 10.1016/S0083-6729(00)60016-X; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Rybczynski R, 2006, MOL CELL ENDOCRINOL, V251, P78, DOI 10.1016/j.mce.2006.02.015; SANTOS E, 1989, FASEB J, V3, P2151, DOI 10.1096/fasebj.3.10.2666231; SCHEJTER ED, 1985, EMBO J, V4, P407, DOI 10.1002/j.1460-2075.1985.tb03643.x; Schweitzer R, 1997, TRENDS GENET, V13, P191, DOI 10.1016/S0168-9525(97)01091-3; SEGAL D, 1986, MOL CELL BIOL, V6, P2241, DOI 10.1128/MCB.6.6.2241; Sepp-Lorenzino L, 2001, PROSTATE CANCER P D, V4, P33, DOI 10.1038/sj.pcan.4500491; Shapiro P, 2002, CRIT REV CL LAB SCI, V39, P285, DOI 10.1080/10408360290795538; SHIH TY, 1980, NATURE, V287, P686, DOI 10.1038/287686a0; SHILO BZ, 1981, P NATL ACAD SCI-BIOL, V78, P6789, DOI 10.1073/pnas.78.11.6789; Shinoda T, 2003, P NATL ACAD SCI USA, V100, P11986, DOI 10.1073/pnas.2134232100; Silvius JR, 2002, J MEMBRANE BIOL, V190, P83, DOI 10.1007/s00232-002-1026-4; Smith CD, 2007, SCIENCE, V316, P1586, DOI 10.1126/science.1139815; SUNDARAM MV, 2006, RTK RAS MAPK SIGNALI, P1, DOI DOI 10.1895/WORMBOOK.1.80.1; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; VALENCIA A, 1991, BIOCHEMISTRY-US, V30, P4637, DOI 10.1021/bi00233a001; Walker JA, 2006, GENE DEV, V20, P3311, DOI 10.1101/gad.1466806; Wang H, 2006, DEV CELL, V10, P117, DOI 10.1016/j.devcel.2005.11.004; Ward RE, 2003, GENETICS, V165, P1397; WASSARMAN DA, 1995, CURR OPIN GENET DEV, V5, P44, DOI 10.1016/S0959-437X(95)90052-7; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Whitmarsh AJ, 2007, BBA-MOL CELL RES, V1773, P1285, DOI 10.1016/j.bbamcr.2006.11.011; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; Wilkins A, 2001, TRENDS GENET, V17, P41, DOI 10.1016/S0168-9525(00)02181-8; WILLECKE K, 1984, HUM GENET, V66, P132, DOI 10.1007/BF00286587	77	16	18	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2009	4	11							e8030	10.1371/journal.pone.0008030	http://dx.doi.org/10.1371/journal.pone.0008030			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MK	19946625	Green Submitted, Green Published, gold			2022-12-25	WOS:000272827800018
J	Garcia, JM; Pepin, S; Lagarde, N; Ma, ESK; Vogel, FR; Chan, KH; Chiu, SSS; Peiris, JSM				Garcia, Jean-Michel; Pepin, Stephanie; Lagarde, Nadege; Ma, Edward S. K.; Vogel, Frederick R.; Chan, Kwok H.; Chiu, Susan S. S.; Peiris, J. S. M.			Heterosubtype Neutralizing Responses to Influenza A (H5N1) Viruses Are Mediated by Antibodies to Virus Haemagglutinin	PLOS ONE			English	Article							I RANDOMIZED-TRIAL; HETEROTYPIC IMMUNITY; HEALTHY-ADULTS; INFECTION; VACCINE; SAFETY; IMMUNOGENICITY; PROTECTION; PIGS	Background: It is increasingly clear that influenza A infection induces cross-subtype neutralizing antibodies that may potentially confer protection against zoonotic infections. It is unclear whether this is mediated by antibodies to the neuraminidase (NA) or haemagglutinin (HA). We use pseudoviral particles (H5pp) coated with H5 haemagglutinin but not N1 neuraminidase to address this question. In this study, we investigate whether cross-neutralizing antibodies in persons unexposed to H5N1 is reactive to the H5 haemagglutinin. Methodology/Principal Findings: We measured H5-neutralization antibody titers pre-and post-vaccination using the H5N1 micro-neutralization test (MN) and H5pp tests in subjects given seasonal vaccines and in selected sera from European elderly volunteers in a H5N1 vaccine trial who had detectable pre-vaccination H5N1 MN antibody titers. We found detectable (titer >= 20) H5N1 neutralizing antibodies in a minority of pre-seasonal vaccine sera and evidence of a serological response to H5N1 in others after seasonal influenza vaccination. There was excellent correlation in the antibody titers between the H5N1 MN and H5pp tests. Similar correlations were found between MN and H5pp in the pre-vaccine sera from the cohort of H5N1 vaccine trial recipients. Conclusions/Significance: Heterosubtype neutralizing antibody to H5N1 in healthy volunteers unexposed to H5N1 is mediated by cross-reaction to the H5 haemagglutinin.			Garcia, JM (corresponding author), HKU Pasteur Res Ctr, Hong Kong, Hong Kong, Peoples R China.	jmgarcia@hku.hk; malik@hku.hk	Chan, Kwok Hung/ABD-5399-2021; Garcia, Jean-Michel/J-7166-2013; Peiris, Joseph Sriyal Malik/C-4380-2009	Garcia, Jean-Michel/0000-0002-6005-9982; Peiris, Joseph Sriyal Malik/0000-0001-8217-5995				Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; Bresson JL, 2006, LANCET, V367, P1657, DOI 10.1016/S0140-6736(06)68656-X; Chiu SS, 2007, PEDIATRICS, V119, P1076, DOI 10.1542/peds.2006-3176; Choi YK, 2005, J VIROL, V79, P10821, DOI 10.1128/JVI.79.16.10821-10825.2005; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Epstein SL, 2006, J INFECT DIS, V193, P49, DOI 10.1086/498980; Epstein Suzanne L, 2003, Expert Rev Anti Infect Ther, V1, P627, DOI 10.1586/14787210.1.4.627; GARCIA JM, J CLIN VIRO IN PRESS; Grebe KM, 2008, MICROBES INFECT, V10, P1024, DOI 10.1016/j.micinf.2008.07.002; Heinen PP, 2001, J GEN VIROL, V82, P2697, DOI 10.1099/0022-1317-82-11-2697; Hill A.V, 1910, J PHYSL, V40, piv, DOI DOI 10.1113/JPHYSIOL.1910.SP001386; Hui SL, 2006, VACCINE, V24, P5371, DOI 10.1016/j.vaccine.2006.04.032; Ichinohe T, 2007, J INFECT DIS, V196, P1313, DOI 10.1086/521304; Kashyap AK, 2008, P NATL ACAD SCI USA, V105, P5986, DOI 10.1073/pnas.0801367105; Katz JM, 1999, J INFECT DIS, V180, P1763, DOI 10.1086/315137; Khurana S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000049; Laddy DJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002517; Levie K, 2008, J INFECT DIS, V198, P642, DOI 10.1086/590913; Nefkens I, 2007, J CLIN VIROL, V39, P27, DOI 10.1016/j.jcv.2007.02.005; Sandbulte MR, 2007, PLOS MED, V4, P265, DOI 10.1371/journal.pmed.0040059; SCHULMAN JL, 1965, J BACTERIOL, V89, P170, DOI 10.1128/JB.89.1.170-174.1965; Seo SH, 2001, J VIROL, V75, P2516, DOI 10.1128/JVI.75.6.2516-2525.2001; SLEPUSHKIN A N, 1959, Bull World Health Organ, V20, P297; Stephenson I, 2003, LANCET, V362, P1959, DOI 10.1016/S0140-6736(03)15014-3; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Treanor JJ, 2006, NEW ENGL J MED, V354, P1343, DOI 10.1056/NEJMoa055778; Vong S, 2006, EMERG INFECT DIS, V12, P1542, DOI 10.3201/eid1210.060424; Wang TT, 2009, NAT STRUCT MOL BIOL, V16, P233, DOI 10.1038/nsmb.1574; YETTER RA, 1980, INFECT IMMUN, V29, P650; Yoshida R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000350	31	33	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2009	4	11							e7918	10.1371/journal.pone.0007918	http://dx.doi.org/10.1371/journal.pone.0007918			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522NL	19936250	Green Submitted, Green Published, gold			2022-12-25	WOS:000272004800003
J	Cironi, L; Provero, P; Riggi, N; Janiszewska, M; Suva, D; Suva, ML; Kindler, V; Stamenkovic, I				Cironi, Luisa; Provero, Paolo; Riggi, Nicola; Janiszewska, Michalina; Suva, Domizio; Suva, Mario-Luca; Kindler, Vincent; Stamenkovic, Ivan			Epigenetic Features of Human Mesenchymal Stem Cells Determine Their Permissiveness for Induction of Relevant Transcriptional Changes by SYT-SSX1	PLOS ONE			English	Article							HUMAN SYNOVIAL SARCOMA; PROTO-ONCOPROTEIN SYT; SOFT-TISSUE SARCOMAS; CTCF-BINDING SITES; FACTOR-II GENE; IN-VITRO; EPITHELIAL DIFFERENTIATION; FUSION PROTEINS; EXPRESSION; SSX	Background: A characteristic SYT-SSX fusion gene resulting from the chromosomal translocation t(X; 18)(p11; q11) is detectable in almost all synovial sarcomas, a malignant soft tissue tumor widely believed to originate from as yet unidentified pluripotent stem cells. The resulting fusion protein has no DNA binding motifs but possesses protein-protein interaction domains that are believed to mediate association with chromatin remodeling complexes. Despite recent advances in the identification of molecules that interact with SYT-SSX and with the corresponding wild type SYT and SSX proteins, the mechanisms whereby the SYT-SSX might contribute to neoplastic transformation remain unclear. Epigenetic deregulation has been suggested to be one possible mechanism. Methodology/Principal Findings: We addressed the effect of SYT/SSX expression on the transcriptome of four independent isolates of primary human bone marrow mesenchymal stem cells (hMSC). We observed transcriptional changes similar to the gene expression signature of synovial sarcoma, principally involving genes whose regulation is linked to epigenetic factors, including imprinted genes, genes with transcription start sites within a CpG island and chromatin related genes. Single population analysis revealed hMSC isolate-specific transcriptional changes involving genes that are important for biological functions of stem cells as well as genes that are considered to be molecular markers of synovial sarcoma including IGF2, EPHRINS, and BCL2. Methylation status analysis of sequences at the H19/IGF2 imprinted locus indicated that distinct epigenetic features characterize hMSC populations and condition the transcriptional effects of SYT-SSX expression. Conclusions/Significance: Our observations suggest that epigenetic features may define the cellular microenvironment in which SYT-SSX displays its functional effects.			Cironi, L (corresponding author), Univ Lausanne, Fac Biol & Med, CHU Vaudois, Inst Pathol,Div Expt Pathol, Lausanne, Switzerland.	Ivan.Stamenkovic@chuv.ch	Provero, Paolo/AAC-1930-2019; Suva, Mario/AAY-7798-2020	Suva, Mario/0000-0001-9898-5351; Kindler, Vincent/0000-0002-5349-1857				Allander SV, 2002, AM J PATHOL, V161, P1587, DOI 10.1016/S0002-9440(10)64437-9; Antonescu CR, 2000, DIAGN MOL PATHOL, V9, P1, DOI 10.1097/00019606-200003000-00001; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baird K, 2005, CANCER RES, V65, P9226, DOI 10.1158/0008-5472.CAN-05-1699; Barco R, 2007, MOL BIOL CELL, V18, P4003, DOI 10.1091/mbc.E07-05-0496; Barco R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005060; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; BLOUSHTAINQIMRO.N, 2009, CELL CYCLE, V8; Bozzi F, 2008, TRANSL ONCOL, V1, P95, DOI 10.1593/tlo.08121; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Brett D, 1997, HUM MOL GENET, V6, P1559, DOI 10.1093/hmg/6.9.1559; COLLAS P, 2008, BIOCH BIOPHYS ACTA; D'Arcy P, 2008, MOL CANCER RES, V6, P127, DOI 10.1158/1541-7786.MCR-07-0176; de Bruijn DRH, 2008, ONCOGENE, V27, P653, DOI 10.1038/sj.onc.1210688; de Bruijn DRH, 2007, GENE CHROMOSOME CANC, V46, P107, DOI 10.1002/gcc.20399; de Bruijn DRH, 2006, CANCER RES, V66, P9474, DOI 10.1158/0008-5472.CAN-05-3726; de Bruijn DRH, 2002, GENE CHROMOSOME CANC, V34, P285, DOI 10.1002/gcc.10073; de Bruijn DRH, 2001, ONCOGENE, V20, P3281, DOI 10.1038/sj.onc.1204419; dos Santos NR, 2001, GENE CHROMOSOME CANC, V30, P1, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1056>3.0.CO;2-G; Eid JE, 2000, CELL, V102, P839, DOI 10.1016/S0092-8674(00)00072-6; Francis P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-73; Friedrichs N, 2008, J PATHOL, V216, P428, DOI 10.1002/path.2438; Gendler K, 2008, NUCLEIC ACIDS RES, V36, pD298, DOI 10.1093/nar/gkm768; Grbesa I, 2006, CANCER LETT, V238, P224, DOI 10.1016/j.canlet.2005.07.003; Haldar M, 2008, CLIN ORTHOP RELAT R, V466, P2156, DOI 10.1007/s11999-008-0340-2; Haldar M, 2007, CANCER CELL, V11, P375, DOI 10.1016/j.ccr.2007.01.016; Hashimoto N, 2000, CANCER LETT, V149, P31, DOI 10.1016/S0304-3835(99)00336-5; Ideraabdullah FY, 2008, MUTAT RES-FUND MOL M, V647, P77, DOI 10.1016/j.mrfmmm.2008.08.008; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Ishida M, 2004, GENES CELLS, V9, P419, DOI 10.1111/j.1356-9597.2004.00737.x; Ito T, 2005, CANCER LETT, V224, P311, DOI 10.1016/j.canlet.2004.10.030; Ito T, 2004, LAB INVEST, V84, P1484, DOI 10.1038/labinvest.3700174; Kato H, 2002, J BIOL CHEM, V277, P5498, DOI 10.1074/jbc.M108702200; Kawai A, 2008, CLIN ORTHOP RELAT R, V466, P2099, DOI 10.1007/s11999-008-0330-4; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lim FL, 1998, ONCOGENE, V17, P2013, DOI 10.1038/sj.onc.1202122; LIU ZJ, 2009, J CELL BIOCH; Lubieniecka JM, 2008, CANCER RES, V68, P4303, DOI 10.1158/0008-5472.CAN-08-0092; Mancuso T, 2000, LAB INVEST, V80, P805, DOI 10.1038/labinvest.3780085; Monk D, 2006, HUM MOL GENET, V15, P1259, DOI 10.1093/hmg/ddl041; Morison IM, 2005, TRENDS GENET, V21, P457, DOI 10.1016/j.tig.2005.06.008; Nagai M, 2001, P NATL ACAD SCI USA, V98, P3843, DOI 10.1073/pnas.061036798; Nagayama S, 2002, CANCER RES, V62, P5859; Nakagawa H, 2001, P NATL ACAD SCI USA, V98, P591, DOI 10.1073/pnas.011528698; OHLSSON R, 1994, DEVELOPMENT, V120, P361; Perani M, 2005, J BIOL CHEM, V280, P42863, DOI 10.1074/jbc.M502963200; Perani M, 2003, ONCOGENE, V22, P8156, DOI 10.1038/sj.onc.1207031; Ponce ML, 2008, J CELL BIOCHEM, V104, P1342, DOI 10.1002/jcb.21711; Pretto D, 2006, ONCOGENE, V25, P3661, DOI 10.1038/sj.onc.1209413; Qiu XW, 2008, MOL ENDOCRINOL, V22, P1476, DOI 10.1210/me.2007-0474; Rikhof B, 2009, J PATHOL, V217, P469, DOI 10.1002/path.2499; Rosa N, 2004, DIAGN MOL PATHOL, V13, P52, DOI 10.1097/00019606-200403000-00009; Sandberg AA, 2002, CANCER GENET CYTOGEN, V133, P1, DOI 10.1016/S0165-4608(01)00626-4; Shen LL, 2007, BIOTECHNIQUES, V42, P48, DOI 10.2144/000112312; Sun Y, 2006, ONCOGENE, V25, P1042, DOI 10.1038/sj.onc.1209143; Suva D, 2004, J CELL PHYSIOL, V198, P110, DOI 10.1002/jcp.10396; Suva D, 2008, J CELL PHYSIOL, V214, P588, DOI 10.1002/jcp.21244; Suva ML, 2007, J PATHOL, V213, P117, DOI 10.1002/path.2208; Takai D, 2001, HUM MOL GENET, V10, P2619, DOI 10.1093/hmg/10.23.2619; Thaete C, 1999, HUM MOL GENET, V8, P585, DOI 10.1093/hmg/8.4.585; Tschoep K, 2007, CRIT REV ONCOL HEMAT, V63, P111, DOI 10.1016/j.critrevonc.2007.04.001; Tsuda M, 2005, ONCOGENE, V24, P7984, DOI 10.1038/sj.onc.1208942; Ulaner GA, 2003, ENDOCRINOLOGY, V144, P4420, DOI 10.1210/en.2003-0681; VU TH, 1994, NATURE, V371, P714, DOI 10.1038/371714a0; Wagner W, 2006, EXP HEMATOL, V34, P536, DOI 10.1016/j.exphem.2006.01.002; Wagner W, 2007, STEM CELL REV, V3, P239, DOI 10.1007/s12015-007-9001-1; Xie YT, 2002, ONCOGENE, V21, P5791, DOI 10.1038/sj.onc.1205700; Xie YT, 2002, CANCER RES, V62, P3861; Zardo G, 2008, LEUKEMIA, V22, P1503, DOI 10.1038/leu.2008.141; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891	70	35	39	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2009	4	11							e7904	10.1371/journal.pone.0007904	http://dx.doi.org/10.1371/journal.pone.0007904			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522NJ	19936258	Green Published, gold, Green Submitted			2022-12-25	WOS:000272004600008
J	Giliberto, L; Matsuda, S; Vidal, R; D'Adamio, L				Giliberto, Luca; Matsuda, Shuji; Vidal, Ruben; D'Adamio, Luciano			Generation and Initial Characterization of FDD Knock In Mice	PLOS ONE			English	Article							FAMILIAL BRITISH DEMENTIA; CEREBRAL AMYLOID ANGIOPATHY; BETA PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; A-BETA; TRANSGENIC MICE; PRESENILIN MUTATIONS; DANISH DEMENTIA; TALKING POINT; GENE	Background: Mutations in the integral membrane protein 2B [1], also known as BRI2 [2], a type II trans-membrane domain protein cause two autosomal dominant neurodegenerative diseases, Familial British and Danish Dementia [3]. In these conditions, accumulation of a C-terminal peptide (ABri and ADan) cleaved off from the mutated precursor protein by the pro-protein convertase furin [4], leads to amyloid deposition in the walls of blood vessels and parenchyma of the brain. Recent advances in the understanding of the generation of amyloid in Alzheimer's disease has lead to the finding that BRI2 interacts with the Amyloid Precursor Protein (APP), decreasing the efficiency of APP processing to generate A beta [5,6,7]. The interaction between the two precursors, APP and BRI2, and possibly between A beta and ABri or ADan, could be important in influencing the rate of amyloid production or the tendency of these peptides to aggregate. Methodology/Principal Findings: We have generated the first BRI2 Danish Knock-In (FDDKI) murine model of FDD, expressing the pathogenic decamer duplication in exon 6 of the BRI2 gene. FDDKI mice do not show any evident abnormal phenotype, with normal brain histology and no detectable amyloid deposition in blood vessel walls or parenchyma. Conclusions/Significance: This new murine mouse model will be important to further understand the interaction between APP and BRI2, and to provide insights into the molecular basis of FDD.			Giliberto, L (corresponding author), Feinstein Inst Med Res, Litwin Zucker Res Ctr Study Alzheimers Dis, North Shore LIJ, Manhasset, NY 11030 USA.	luciano.dadamio@einstein.yu.edu		D'Adamio, Luciano/0000-0002-2204-9441; D'Adamio, Luciano/0000-0002-9820-4882	NATIONAL INSTITUTE ON AGING [R01AG021588, R01AG022024, R21AG027139] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG22024, R01 AG022024, R21 AG027139, R01 AG021588, R01 AG21588] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Akiyama H, 2004, ACTA NEUROPATHOL, V107, P53, DOI 10.1007/s00401-003-0783-1; Bentahir M, 2006, J NEUROCHEM, V96, P732, DOI 10.1111/j.1471-4159.2005.03578.x; De Strooper B, 2007, EMBO REP, V8, P141, DOI 10.1038/sj.embor.7400897; Deleersnijder W, 1996, J BIOL CHEM, V271, P19475, DOI 10.1074/jbc.271.32.19475; Fotinopoulou A, 2005, J BIOL CHEM, V280, P30768, DOI 10.1074/jbc.C500231200; Giliberto L, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-12; Giliberto L, 2009, J BIOL CHEM, V284, P9027, DOI 10.1074/jbc.M805685200; Holton JL, 2002, J NEUROPATH EXP NEUR, V61, P254, DOI 10.1093/jnen/61.3.254; Holton JL, 2001, AM J PATHOL, V158, P515, DOI 10.1016/S0002-9440(10)63993-4; Kim JS, 2008, J NEUROSCI, V28, P6030, DOI 10.1523/JNEUROSCI.0891-08.2008; Kim SH, 1999, NAT NEUROSCI, V2, P984, DOI 10.1038/14783; LaFerla FM, 2005, TRENDS MOL MED, V11, P170, DOI 10.1016/j.molmed.2005.02.009; Matsuda S, 2005, J BIOL CHEM, V280, P28912, DOI 10.1074/jbc.C500217200; MATSUDA S, 2009, MATURATION BRI2 GENE; Matsuda S, 2008, J NEUROSCI, V28, P8668, DOI 10.1523/JNEUROSCI.2094-08.2008; Matsuda S, 2009, J BIOL CHEM, V284, P15815, DOI 10.1074/jbc.M109.006403; McGowan E, 2006, TRENDS GENET, V22, P281, DOI 10.1016/j.tig.2006.03.007; Pickford F, 2006, BRAIN PATHOL, V16, P80, DOI 10.1111/j.1750-3639.2006.tb00564.x; Pittois K, 1999, MAMM GENOME, V10, P54, DOI 10.1007/s003359900942; PLANT GT, 1990, BRAIN, V113, P721, DOI 10.1093/brain/113.3.721; Price DL, 2000, ANN NY ACAD SCI, V920, P179; Rostagno A, 2002, J BIOL CHEM, V277, P49782, DOI 10.1074/jbc.M206448200; Sanchez-Pulido L, 2002, TRENDS BIOCHEM SCI, V27, P329, DOI 10.1016/S0968-0004(02)02134-5; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Shen J, 2007, P NATL ACAD SCI USA, V104, P403, DOI 10.1073/pnas.0608332104; Tomidokoro Y, 2005, J BIOL CHEM, V280, P36883, DOI 10.1074/jbc.M504038200; Vidal R, 2000, P NATL ACAD SCI USA, V97, P4920, DOI 10.1073/pnas.080076097; Vidal R, 1999, NATURE, V399, P776; Vidal R, 2001, GENE, V266, P95, DOI 10.1016/S0378-1119(01)00374-2; Vidal R, 2009, BRAIN PATHOL, V19, P58, DOI 10.1111/j.1750-3639.2008.00164.x; Wakayama T, 1999, P NATL ACAD SCI USA, V96, P14984, DOI 10.1073/pnas.96.26.14984; Wolfe MS, 2007, EMBO REP, V8, P136, DOI 10.1038/sj.embor.7400896	32	27	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2009	4	11							e7900	10.1371/journal.pone.0007900	http://dx.doi.org/10.1371/journal.pone.0007900			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521QH	19924302	Green Published, Green Submitted, gold			2022-12-25	WOS:000271936700026
J	Harries, LW; Brown, JE; Gloyn, AL				Harries, Lorna W.; Brown, James E.; Gloyn, Anna L.			Species-Specific Differences in the Expression of the HNF1A, HNF1B and HNF4A Genes	PLOS ONE			English	Article							HEPATOCYTE NUCLEAR FACTOR-1-ALPHA; PANCREATIC BETA-CELLS; MUTATIONS; YOUNG; HAPLOINSUFFICIENCY; PHENOTYPES; MOUSE	Background: The HNF1A, HNF1B and HNF4A genes are part of an autoregulatory network in mammalian pancreas, liver, kidney and gut. The layout of this network appears to be similar in rodents and humans, but inactivation of HNF1A, HNF1B or HNF4A genes in animal models cause divergent phenotypes to those seen in man. We hypothesised that some differences may arise from variation in the expression profile of alternatively processed isoforms between species. Methodology/Principal Findings: We measured the expression of the major isoforms of the HNF1A, HNF1B and HNF4A genes in human and rodent pancreas, islet, liver and kidney by isoform-specific quantitative real-time PCR and compared their expression by the comparative Ct(Delta Delta Ct) method. We found major changes in the expression profiles of the HNF genes between humans and rodents. The principal difference lies in the expression of the HNF1A gene, which exists as three isoforms in man, but as a single isoform only in rodents. More subtle changes were to the balance of HNF1B and HNF4A isoforms between species; the repressor isoform HNF1B( C) comprised only 6% in human islets compared with 24-26% in rodents (p = 0.006) whereas HNF4A9 comprised 22% of HNF4A expression in human pancreas but only 11% in rodents (p = 0.001). Conclusions/Significance: The differences we note in the isoform-specific expression of the human and rodent HNF1A, HNF1B and HNF4A genes may impact on the absolute activity of these genes, and therefore on the activity of the pancreatic transcription factor network as a whole. We conclude that alterations to expression of HNF isoforms may underlie some of the phenotypic variation caused by mutations in these genes.			Harries, LW (corresponding author), Univ Exeter, Inst Biomed & Clin Sci, Peninsula Med Sch, Exeter, Devon, England.	L.W.Harries@exeter.ac.uk	Brown, James E/A-7503-2012; Harries, Lorna/D-2241-2014	Gloyn, Anna/0000-0003-1205-1844; Harries, Lorna/0000-0001-7791-8061	Medical Research Council [G0700222(81696), G0700222] Funding Source: Medline; Wellcome Trust [WT081278MA] Funding Source: Medline; MRC [G0700222] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		*APPL BIOS, 1997, US B APPL BIOS, V2, P11; BACH I, 1993, EMBO J, V12, P4229, DOI 10.1002/j.1460-2075.1993.tb06107.x; CEREGHINI S, 1992, DEVELOPMENT, V116, P783; Dukes ID, 1998, J BIOL CHEM, V273, P24457, DOI 10.1074/jbc.273.38.24457; Edghill EL, 2006, J MED GENET, V43, P84, DOI 10.1136/jmg.2005.032854; Ellard S, 2006, HUM MUTAT, V27, P854, DOI 10.1002/humu.20357; Ferrer J, 2002, DIABETES, V51, P2355, DOI 10.2337/diabetes.51.8.2355; Harries LW, 2008, DIABETES, V57, P1745, DOI 10.2337/db07-1742; Harries LW, 2006, HUM MOL GENET, V15, P2216, DOI 10.1093/hmg/ddl147; Harries LW, 2004, DIABETES, V53, P500, DOI 10.2337/diabetes.53.2.500; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; Horikawa Y, 1997, NAT GENET, V17, P384, DOI 10.1038/ng1297-384; HUANG J, 2008, DIABETES METAB RES R; Iwasaki N, 1998, DIABETES CARE, V21, P2144, DOI 10.2337/diacare.21.12.2144; Nakhei H, 1998, NUCLEIC ACIDS RES, V26, P497, DOI 10.1093/nar/26.2.497; Owen K, 2001, BEST PRACT RES CL EN, V15, P309, DOI 10.1053/beem.2001.0148; Pearson ER, 2004, DIABETES CARE, V27, P1102, DOI 10.2337/diacare.27.5.1102; Pontoglio M, 2000, EMBO REP, V1, P359, DOI 10.1093/embo-reports/kvd071; Shih DQ, 2000, DIABETES, V49, P832, DOI 10.2337/diabetes.49.5.832; Stoffel M, 1997, P NATL ACAD SCI USA, V94, P13209, DOI 10.1073/pnas.94.24.13209; Thomas H, 2002, BIOL CHEM, V383, P1691, DOI 10.1515/BC.2002.190; Wang L, 2004, ENDOCRINOLOGY, V145, P3941, DOI 10.1210/en.2004-0281; Welters HJ, 2006, J ENDOCRINOL, V190, P171, DOI 10.1677/joe.1.06768; Yeo GW, 2005, P NATL ACAD SCI USA, V102, P2850, DOI 10.1073/pnas.0409742102	24	59	61	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2009	4	11							e7855	10.1371/journal.pone.0007855	http://dx.doi.org/10.1371/journal.pone.0007855			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520NG	19924231	gold, Green Submitted, Green Accepted, Green Published			2022-12-25	WOS:000271851000012
J	Guha, M; Xia, F; Raskett, CM; Altieri, DC				Guha, M.; Xia, F.; Raskett, C. M.; Altieri, D. C.			Caspase 2-mediated tumor suppression involves survivin gene silencing	ONCOGENE			English	Article						caspase-2; survivin; NF kappa B; RIP1; tumor growth; gene expression	NF-KAPPA-B; WILD-TYPE P53; INDUCED APOPTOSIS; DRUG DISCOVERY; MELANOMA-CELLS; ACTIVATION; CANCER; PATHWAY; PHOSPHORYLATION; EXPRESSION	One of the pivotal functions of endogenous tumor suppression is to oppose aberrant cell survival, but the molecular requirements of this process are not completely understood. Here, we show that caspase 2, a death effector with largely unknown functions, represses transcription of the survivin gene, a general regulator of cell division and cytoprotection in tumors. This pathway involves caspase 2 proteolytic cleavage of the nuclear factor kappa B (NF kappa B) activator, RIP1. In turn, loss of RIP1 abolishes transcription of NF kappa B target genes, including survivin, resulting in deregulated mitotic transitions, enhanced apoptosis and suppression of tumorigenicity in vivo. Therefore, caspase 2 functions as an endogenous inhibitor of NF kappa B-dependent cell survival and this mechanism may contribute to tumor suppression in humans. Oncogene (2010) 29, 1280-1292; doi: 10.1038/onc.2009.428; published online 23 November 2009	[Guha, M.; Xia, F.; Raskett, C. M.; Altieri, D. C.] Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA 01609 USA	University of Massachusetts System; University of Massachusetts Worcester	Altieri, DC (corresponding author), Univ Massachusetts, Sch Med, Dept Canc Biol, LRB428,364 Plantat St, Worcester, MA 01609 USA.	dario.altieri@umassmed.edu			National Institutes of Health [CA78810, CA90917, CA118005]; NATIONAL CANCER INSTITUTE [R01CA090917, R01CA078810, R01CA118005] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Drs Bert Vogelstein, Michelle Kelliher and Neal Silverman for reagents. This work was supported by the National Institutes of Health grants CA78810, CA90917 and CA118005.	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Altieri DC, 2008, NAT REV CANCER, V8, P61, DOI 10.1038/nrc2293; Anand P, 2008, CANCER RES, V68, P8861, DOI 10.1158/0008-5472.CAN-08-1902; Baptiste-Okoh N, 2008, P NATL ACAD SCI USA, V105, P1937, DOI 10.1073/pnas.0711800105; Bergeron L, 1998, GENE DEV, V12, P1304, DOI 10.1101/gad.12.9.1304; Bouchier-Hayes L, 2009, MOL CELL, V35, P830, DOI 10.1016/j.molcel.2009.07.023; Castedo M, 2004, ONCOGENE, V23, P4362, DOI 10.1038/sj.onc.1207572; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Fesik SW, 2005, NAT REV CANCER, V5, P876, DOI 10.1038/nrc1736; Festjens N, 2007, CELL DEATH DIFFER, V14, P400, DOI 10.1038/sj.cdd.4402085; Ghosh JC, 2008, J BIOL CHEM, V283, P5188, DOI 10.1074/jbc.M705904200; Guha M, 2009, CANCER RES, V69, P4954, DOI 10.1158/0008-5472.CAN-09-0584; Ho LH, 2008, ONCOGENE, V27, P3393, DOI 10.1038/sj.onc.1211005; Ho LH, 2009, P NATL ACAD SCI USA, V106, P5336, DOI 10.1073/pnas.0811928106; Hoffman WH, 2002, J BIOL CHEM, V277, P3247, DOI 10.1074/jbc.M106643200; Janssens S, 2005, CELL, V123, P1079, DOI 10.1016/j.cell.2005.09.036; Jiang YY, 2004, J BIOL CHEM, V279, P40511, DOI 10.1074/jbc.M404496200; Kang BH, 2006, J BIOL CHEM, V281, P24721, DOI 10.1074/jbc.M603175200; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kawakami H, 2005, INT J CANCER, V115, P967, DOI 10.1002/ijc.20954; Krumschnabel G, 2009, CELL DEATH DIFFER, V16, P195, DOI 10.1038/cdd.2008.170; Lamkanfi M, 2005, J BIOL CHEM, V280, P6923, DOI 10.1074/jbc.M411180200; Lee CW, 2008, CANCER RES, V68, P5273, DOI 10.1158/0008-5472.CAN-07-6673; Li FZ, 1999, BIOCHEM J, V344, P305, DOI 10.1042/0264-6021:3440305; Li HL, 1997, J BIOL CHEM, V272, P21010, DOI 10.1074/jbc.272.34.21010; Li J, 2008, ONCOGENE, V27, P6194, DOI 10.1038/onc.2008.297; Lin Y, 1999, GENE DEV, V13, P2514, DOI 10.1101/gad.13.19.2514; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Makishi S, 2008, BRIT J HAEMATOL, V142, P583, DOI 10.1111/j.1365-2141.2008.07229.x; Mhaidat NM, 2007, MOL CANCER THER, V6, P752, DOI 10.1158/1535-7163.MCT-06-0564; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Mirza A, 2002, ONCOGENE, V21, P2613, DOI 10.1038/sj.onc.1205353; Mita AC, 2008, CLIN CANCER RES, V14, P5000, DOI 10.1158/1078-0432.CCR-08-0746; O'Connor DS, 2000, P NATL ACAD SCI USA, V97, P13103, DOI 10.1073/pnas.240390697; Rebe C, 2007, BLOOD, V109, P1442, DOI 10.1182/blood-2006-03-011585; Shi MG, 2009, CELL, V136, P508, DOI 10.1016/j.cell.2008.12.021; Shi YG, 2002, MOL CELL, V9, P459, DOI 10.1016/S1097-2765(02)00482-3; Shin MS, 2002, BLOOD, V99, P4094, DOI 10.1182/blood.V99.11.4094; Soung YH, 2004, HUM GENET, V115, P112, DOI 10.1007/s00439-004-1129-3; Srinivasula SM, 2008, MOL CELL, V30, P123, DOI 10.1016/j.molcel.2008.03.008; Stupack DG, 2006, NATURE, V439, P95, DOI 10.1038/nature04323; Tinel A, 2004, SCIENCE, V304, P843, DOI 10.1126/science.1095432; Tinel A, 2007, EMBO J, V26, P197, DOI 10.1038/sj.emboj.7601473; Troy CM, 2003, CELL DEATH DIFFER, V10, P101, DOI 10.1038/sj.cdd.4401175; Upton JP, 2008, MOL CELL BIOL, V28, P3943, DOI 10.1128/MCB.00013-08; Vaira V, 2007, ONCOGENE, V26, P2678, DOI 10.1038/sj.onc.1210094; Van de Craen M, 1999, CELL DEATH DIFFER, V6, P1117, DOI 10.1038/sj.cdd.4400589; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wang D, 1998, J BIOL CHEM, V273, P29411, DOI 10.1074/jbc.273.45.29411; Wang RH, 2008, MOL CELL, V32, P11, DOI 10.1016/j.molcel.2008.09.011; Wheatley SP, 2007, CELL CYCLE, V6, P1220, DOI 10.4161/cc.6.10.4179; Xia F, 2006, CANCER RES, V66, P3392, DOI 10.1158/0008-5472.CAN-05-4537; Yeung BHY, 2006, J BIOL CHEM, V281, P11923, DOI 10.1074/jbc.M508533200; You L, 2004, CANCER RES, V64, P5385, DOI 10.1158/0008-5472.CAN-04-1227; Zhou JB, 2009, BLOOD, V113, P4052, DOI 10.1182/blood-2008-05-156422	57	25	28	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 4	2010	29	9					1280	1292		10.1038/onc.2009.428	http://dx.doi.org/10.1038/onc.2009.428			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	563XJ	19935698	Green Accepted			2022-12-25	WOS:000275170600004
J	Noguchi, TQP; Gomibuchi, Y; Murakami, K; Ueno, H; Hirose, K; Wakabayashi, T; Uyeda, TQP				Noguchi, Taro Q. P.; Gomibuchi, Yuki; Murakami, Kenji; Ueno, Hironori; Hirose, Keiko; Wakabayashi, Takeyuki; Uyeda, Taro Q. P.			Dominant Negative Mutant Actins Identified in Flightless Drosophila Can Be Classified into Three Classes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; HYDROPHOBIC LOOP 262-274; RABBIT SKELETAL-MUSCLE; IN-VITRO MOTILITY; YEAST ACTIN; F-ACTIN; THIN-FILAMENTS; CROSS-LINKING; TROPOMYOSIN-BINDING; DICTYOSTELIUM ACTIN	Strongly dominant negative mutant actins, identified by An and Mogami (An, H. S., and Mogami, K. (1996) J. Mol. Biol. 260, 492-505), in the indirect flight muscle of Drosophila impaired its flight, even when three copies of the wild-type gene were present. Understanding how these strongly dominant negative mutant actins disrupt the function of wild-type actin would provide useful information about the molecular mechanism by which actin functions in vivo. Here, we expressed and purified six of these strongly dominant negative mutant actins in Dictyostelium and classified them into three groups based on their biochemical phenotypes. The first group, G156D, G156S, and G268D actins, showed impaired polymerization and a tendency to aggregate under conditions favoring polymerization. G63D actin of the second group was also unable to polymerize but, unlike those in the first group, remained soluble under polymerizing conditions. Kinetic analyses using G63D actin or G63D actin gelsolin complexes suggested that the pointed end surface is defective, which would alter the polymerization kinetics of wild-type actin when mixed and could affect formation of thin filament structures in indirect flight muscle. The third group, R95C and E226K actins, was normal in terms of polymerization, but their motility on heavy meromyosin surfaces in the presence of tropomyosin-troponin indicated altered sensitivity to Ca2+. Cofilaments in which R95C or E226K actins were copolymerized with a 3-fold excess of wild-type actin also showed altered Ca2+ sensitivity in the presence of tropomyosin-troponin.	[Noguchi, Taro Q. P.; Ueno, Hironori; Hirose, Keiko; Uyeda, Taro Q. P.] AIST, Res Inst Cell Engn, Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058562, Japan; [Noguchi, Taro Q. P.; Hirose, Keiko; Uyeda, Taro Q. P.] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Gomibuchi, Yuki; Murakami, Kenji; Wakabayashi, Takeyuki] Teikyo Univ, Sch Sci & Engn, Dept Biosci, Utsunomiya, Tochigi 3208551, Japan; [Uyeda, Taro Q. P.] Natl Inst Adv Ind Sci & Technol, Biomed Informat Res Ctr, Koto Ku, Tokyo 1350064, Japan	National Institute of Advanced Industrial Science & Technology (AIST); University of Tsukuba; Teikyo University; National Institute of Advanced Industrial Science & Technology (AIST)	Uyeda, TQP (corresponding author), AIST, Res Inst Cell Engn, Natl Inst Adv Ind Sci & Technol, 1-1-1 Higashi, Tsukuba, Ibaraki 3058562, Japan.	t-uyeda@aist.go.jp	Hirose, Keiko/M-5429-2018	Hirose, Keiko/0000-0003-4587-8346	Ministry of Science, Culture, Sports, and Technology	Ministry of Science, Culture, Sports, and Technology	This work was supported in part by grants-in-aid for scientific research from the Ministry of Science, Culture, Sports, and Technology (to T. U. and T. N.).	An HS, 1996, J MOL BIOL, V260, P492, DOI 10.1006/jmbi.1996.0417; ANSON M, 1995, BIOPHYS J, V68, P1991, DOI 10.1016/S0006-3495(95)80376-0; Belmont LD, 1999, P NATL ACAD SCI USA, V96, P29, DOI 10.1073/pnas.96.1.29; Bookwalter CS, 2006, J BIOL CHEM, V281, P16777, DOI 10.1074/jbc.M512935200; Cammarato A, 2005, J MOL BIOL, V347, P889, DOI 10.1016/j.jmb.2005.02.022; CARLIER MF, 1992, PHILOS T R SOC B, V336, P93, DOI 10.1098/rstb.1992.0048; CHEN X, 1993, J CELL BIOL, V123, P1185, DOI 10.1083/jcb.123.5.1185; COOK RK, 1992, J BIOL CHEM, V267, P9430; DOI Y, 1984, J BIOL CHEM, V259, P1868; EGELHOFF TT, 1991, METHOD ENZYMOL, V196, P319; Feng L, 1997, J BIOL CHEM, V272, P16829, DOI 10.1074/jbc.272.27.16829; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; Gordon S, 2006, P NATL ACAD SCI USA, V103, P4311, DOI 10.1073/pnas.0510109103; HARRIS DA, 1981, P NATL ACAD SCI-BIOL, V78, P6798, DOI 10.1073/pnas.78.11.6798; Hegyi G, 2006, FEBS J, V273, P1896, DOI 10.1111/j.1742-4658.2006.05197.x; HIROMI Y, 1986, CELL, V44, P293, DOI 10.1016/0092-8674(86)90763-4; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; Homsher E, 1996, BIOPHYS J, V70, P1881, DOI 10.1016/S0006-3495(96)79753-9; JOHANNES FJ, 1991, EMBO J, V10, P3951, DOI 10.1002/j.1460-2075.1991.tb04965.x; JOHARA M, 1993, P NATL ACAD SCI USA, V90, P2127, DOI 10.1073/pnas.90.6.2127; JOHNSON P, 1978, BIOCHEM BIOPH RES CO, V82, P1013, DOI 10.1016/0006-291X(78)90884-7; Kim E, 2002, BIOCHEMISTRY-US, V41, P86, DOI 10.1021/bi0113824; KOUYAMA T, 1981, EUR J BIOCHEM, V114, P33; KUROKAWA H, 1990, BIOCHEM BIOPH RES CO, V168, P451, DOI 10.1016/0006-291X(90)92342-W; KURTH MC, 1983, J BIOL CHEM, V258, P895; LEHMAN W, 1995, J MOL BIOL, V251, P191, DOI 10.1006/jmbi.1995.0425; MARGOSSIAN SS, 1982, METHOD ENZYMOL, V85, P55; Matsuura Y, 2000, J MOL BIOL, V296, P579, DOI 10.1006/jmbi.1999.3467; McGough A, 1997, J CELL BIOL, V138, P771, DOI 10.1083/jcb.138.4.771; MCKILLOP DFA, 1993, BIOPHYS J, V65, P693, DOI 10.1016/S0006-3495(93)81110-X; MIKI M, 1982, BIOCHEMISTRY-US, V21, P3661, DOI 10.1021/bi00258a021; MILLER CJ, 1995, BIOCHEMISTRY-US, V34, P2694, DOI 10.1021/bi00008a037; Miller CJ, 1996, BIOCHEMISTRY-US, V35, P16557, DOI 10.1021/bi962388+; Murakami K, 2005, J MOL BIOL, V352, P178, DOI 10.1016/j.jmb.2005.06.067; MURRAY JM, 1982, METHOD ENZYMOL, V85, P15; Nagasaki A, 2004, MOL BIOL CELL, V15, P435, DOI 10.1091/mbc.E03-05-0329; Nagasaki A, 2008, EXP CELL RES, V314, P1136, DOI 10.1016/j.yexcr.2007.12.002; NG R, 1980, P NATL ACAD SCI-BIOL, V77, P3912, DOI 10.1073/pnas.77.7.3912; Noguchi TQP, 2007, J BIOL CHEM, V282, P27721, DOI 10.1074/jbc.M703165200; Oosawa F., 1972, COLD SPRING HARB SYM, V37, P277; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; Posern G, 2002, MOL BIOL CELL, V13, P4167, DOI 10.1091/mbc.02-05-0068; PRINGLE JWS, 1981, J EXP BIOL, V94, P1; PROCHNIEWICZ E, 1990, J MOL BIOL, V216, P761, DOI 10.1016/0022-2836(90)90397-5; RAYMENT I, 1993, SCIENCE, V261, P58, DOI 10.1126/science.8316858; Saeki K, 1996, BIOCHEMISTRY-US, V35, P14465, DOI 10.1021/bi961292c; Schuler H, 2001, BBA-PROTEIN STRUCT M, V1549, P137, DOI 10.1016/S0167-4838(01)00255-2; SHORTLE D, 1982, SCIENCE, V217, P371, DOI 10.1126/science.7046050; Shvetsov A, 2002, BIOCHEMISTRY-US, V41, P10787, DOI 10.1021/bi020205f; Shvetsov A, 2008, J MOL BIOL, V375, P793, DOI 10.1016/j.jmb.2007.10.076; SOLOMON TL, 1988, J BIOL CHEM, V263, P19662; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; UYEDA TQP, 1990, J MOL BIOL, V214, P699, DOI 10.1016/0022-2836(90)90287-V; Vibert P, 1997, J MOL BIOL, V266, P8, DOI 10.1006/jmbi.1996.0800; WANG LL, 1981, CELL, V25, P637, DOI 10.1016/0092-8674(81)90171-9; WERTMAN KF, 1992, GENETICS, V132, P337; Yao XY, 2001, J BIOL CHEM, V276, P25598, DOI 10.1074/jbc.M011797200	57	6	6	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4337	4347		10.1074/jbc.M109.059881	http://dx.doi.org/10.1074/jbc.M109.059881			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	19933578	hybrid, Green Published			2022-12-25	WOS:000275274800010
J	Mashanov, GI; Nobles, M; Harmer, SC; Molloy, JE; Tinker, A				Mashanov, Gregory I.; Nobles, Muriel; Harmer, Stephen C.; Molloy, Justin E.; Tinker, Andrew			Direct Observation of Individual KCNQ1 Potassium Channels Reveals Their Distinctive Diffusive Behavior	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; REGULATORY VOLUME DECREASE; GREEN FLUORESCENT PROTEIN; CELL-SURFACE MICRODOMAINS; SINGLE-MOLECULE TRACKING; PLASMA-MEMBRANE; LIVING CELLS; TRANSIENT CONFINEMENT; CRYSTAL-STRUCTURE; SUBUNIT	We have directly observed the trafficking and fusion of ion channel containing vesicles and monitored the release of individual ion channels at the plasma membrane of live mammalian cells using total internal reflection fluorescence microscopy. Proteins were fused in-frame with green or red fluorescent proteins and expressed at low level in HL-1 and HEK293 cells. Dual color imaging revealed that vesicle trafficking involved motorized movement along microtubules followed by stalling, fusion, and subsequent release of individual ion channels at the plasma membrane. We found that KCNQ1-KCNE1 complexes were released in batches of about 5 molecules per vesicle. Toelucidate the properties of ion channel complexes at the cell membrane we tracked the movement of individual molecules and compared the diffusive behavior of two types of potassium channel complex (KCNQ1-KCNE1 and Kir6.2-SUR2A) to that of a G-protein coupled receptor, the A1 adenosine receptor. Plots of mean squared displacement against time intervals showed that mobility depended on channel type, cell type, and temperature. Analysis of the mobility of wild type KCNQ1-KCNE1 complexes showed the existence of a significant immobile subpopulation and also a significant number of molecules that demonstrated periodic stalling of diffusive movements. This behavior was enhanced in cells treated with jasplakinolide and was abrogated in a C-terminal truncated form (KCNQ1(R518X)-KCNE1) of the protein. This mutant has been identified in patients with the long QT syndrome. We propose that KCNQ1-KCNE1 complexes interact intermittently with the actin cytoskeleton via the C-terminal region and this interaction may have a functional role.	[Mashanov, Gregory I.; Molloy, Justin E.] Natl Inst Med Res, MRC, London NW7 1AA, England; [Nobles, Muriel; Harmer, Stephen C.; Tinker, Andrew] UCL, BHF Labs, London WC1E 6JJ, England; [Nobles, Muriel; Harmer, Stephen C.; Tinker, Andrew] UCL, Dept Med, London WC1E 6JJ, England	MRC National Institute for Medical Research; University of London; University College London; University of London; University College London	Molloy, JE (corresponding author), Natl Inst Med Res, MRC, Mill Hill, London NW7 1AA, England.	jmolloy@nimr.mrc.ac.uk; a.tinker@ucl.ac.uk	Harmer, Stephen/D-5512-2015	Harmer, Stephen/0000-0003-3909-6698; Molloy, Justin/0000-0002-8307-2450	Medical Research Council, UK; British Heart Foundation; Medical Research Council [MC_U117570592] Funding Source: researchfish; MRC [MC_U117570592] Funding Source: UKRI	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a Grant-in-aid from the Medical Research Council, UK (to G. M. and J. M.) and a grant from the British Heart Foundation (to M. N., S. H., and A. T.).	Angers S, 2002, ANNU REV PHARMACOL, V42, P409, DOI 10.1146/annurev.pharmtox.42.091701.082314; ASHCROFT SJH, 1990, CELL SIGNAL, V2, P197, DOI 10.1016/0898-6568(90)90048-F; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Benians A, 2005, J BIOL CHEM, V280, P13383, DOI 10.1074/jbc.M410163200; Bienengraeber M, 2004, NAT GENET, V36, P382, DOI 10.1038/ng1329; Briddon SJ, 2004, P NATL ACAD SCI USA, V101, P4673, DOI 10.1073/pnas.0400420101; Bubb MR, 2000, J BIOL CHEM, V275, P5163, DOI 10.1074/jbc.275.7.5163; Calloe K, 2007, BBA-MOL CELL RES, V1773, P764, DOI 10.1016/j.bbamcr.2007.02.008; Chen HJ, 2003, NEURON, V40, P15, DOI 10.1016/S0896-6273(03)00570-1; Ciruela F, 1995, J NEUROSCI RES, V42, P818, DOI 10.1002/jnr.490420610; Dickson RM, 1997, NATURE, V388, P355, DOI 10.1038/41048; Dietrich C, 2002, BIOPHYS J, V82, P274, DOI 10.1016/S0006-3495(02)75393-9; Dunne MJ, 2004, PHYSIOL REV, V84, P239, DOI 10.1152/physrev.00022.2003; FUNATSU T, 1995, NATURE, V374, P555, DOI 10.1038/374555a0; Gambin Y, 2006, P NATL ACAD SCI USA, V103, P2098, DOI 10.1073/pnas.0511026103; Giblin JP, 1999, J BIOL CHEM, V274, P22652, DOI 10.1074/jbc.274.32.22652; Gloyn AL, 2004, NEW ENGL J MED, V350, P1838, DOI 10.1056/NEJMoa032922; Howard RJ, 2007, NEURON, V53, P663, DOI 10.1016/j.neuron.2007.02.010; Hu KL, 2003, NEURON, V38, P417, DOI 10.1016/S0896-6273(03)00256-3; Huang LQ, 2001, CARDIOVASC RES, V51, P670, DOI 10.1016/S0008-6363(01)00350-9; John SA, 1998, J PHYSIOL-LONDON, V510, P333, DOI 10.1111/j.1469-7793.1998.333bk.x; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Kusumi A, 2005, ANNU REV BIOPH BIOM, V34, P351, DOI 10.1146/annurev.biophys.34.040204.144637; Marx SO, 2002, SCIENCE, V295, P496, DOI 10.1126/science.1066843; Mashanov GI, 2007, BIOPHYS J, V92, P2199, DOI 10.1529/biophysj.106.081117; Mashanov GI, 2004, J BIOL CHEM, V279, P15274, DOI 10.1074/jbc.M312140200; Mashanov GI, 2003, METHODS, V29, P142, DOI 10.1016/S1046-2023(02)00305-5; Nechyporuk-Zloy V, 2008, AM J PHYSIOL-CELL PH, V294, pC1096, DOI 10.1152/ajpcell.00252.2007; Nicolas CS, 2008, CARDIOVASC RES, V79, P427, DOI 10.1093/cvr/cvn085; Nobles M, 2005, P NATL ACAD SCI USA, V102, P18706, DOI 10.1073/pnas.0504778102; O'Connell KMS, 2005, J CELL SCI, V118, P2155, DOI 10.1242/jcs.02348; O'Connell KMS, 2006, J NEUROSCI, V26, P9609, DOI 10.1523/JNEUROSCI.1825-06.2006; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Priori SG, 1999, CIRCULATION, V99, P518, DOI 10.1161/01.CIR.99.4.518; SAFFMAN PG, 1975, P NATL ACAD SCI USA, V72, P3111, DOI 10.1073/pnas.72.8.3111; Sako Y, 2003, J PHARMACOL SCI, V93, P253, DOI 10.1254/jphs.93.253; SALKOFF L, 1995, NEURON, V15, P489, DOI 10.1016/0896-6273(95)90137-X; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Schmitt N, 2000, EMBO J, V19, P332, DOI 10.1093/emboj/19.3.332; Seino S, 1999, ANNU REV PHYSIOL, V61, P337, DOI 10.1146/annurev.physiol.61.1.337; Sheets ED, 1997, BIOCHEMISTRY-US, V36, P12449, DOI 10.1021/bi9710939; Stenham DR, 2003, FASEB J, V17, P2287, DOI 10.1096/fj.03-0107fje; Steyer JA, 1997, NATURE, V388, P474, DOI 10.1038/41329; Suzuki K, 2005, BIOPHYS J, V88, P3659, DOI 10.1529/biophysj.104.048538; Suzuki KGN, 2007, J CELL BIOL, V177, P717, DOI 10.1083/jcb.200609174; Tinker A., 2002, ASSEMBLY TARGETING I, P28; Ulbrich MH, 2007, NAT METHODS, V4, P319, DOI 10.1038/NMETH1024; vanTol BL, 2007, AM J PHYSIOL-CELL PH, V293, pC1010, DOI 10.1152/ajpcell.00071.2007; White SM, 2004, AM J PHYSIOL-HEART C, V286, pH823, DOI 10.1152/ajpheart.00986.2003; Wilson AJ, 2005, CARDIOVASC RES, V67, P476, DOI 10.1016/j.cardiores.2005.04.036; Yang SN, 2007, CELL METAB, V6, P217, DOI 10.1016/j.cmet.2007.08.002; Zhao S, 2006, DRUG METAB REV, V38, P141	52	19	20	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3664	3675		10.1074/jbc.M109.039974	http://dx.doi.org/10.1074/jbc.M109.039974			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19940153	Green Published, hybrid			2022-12-25	WOS:000275254000018
J	Orelli, B; McClendon, TB; Tsodikov, OV; Ellenberger, T; Niedernhofer, LJ; Scharer, OD				Orelli, Barbara; McClendon, T. Brooke; Tsodikov, Oleg V.; Ellenberger, Tom; Niedernhofer, Laura J.; Schaerer, Orlando D.			The XPA-binding domain of ERCC1 Is Required for Nucleotide Excision Repair but Not Other DNA Repair Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOLLIDAY JUNCTION RESOLVASE; INTERSTRAND CROSS-LINKS; XERODERMA-PIGMENTOSUM; DUAL-INCISION; NUCLEAR ABNORMALITIES; DROSOPHILA MUS312; CRYSTAL-STRUCTURE; COCKAYNE-SYNDROME; ENDONUCLEASE; CISPLATIN	The endonuclease ERCC1-XPF incises the damaged strand of DNA 5' to a lesion during nucleotide excision repair (NER) and has additional, poorly characterized functions in interstrand cross-link repair, double-strand break repair, and homologous recombination. XPA, another key factor in NER, interacts with ERCC1 and recruits it to sites of damage. We identified ERCC1 residues that are critical for the interaction with XPA and assessed their importance for NER in vitro and in vivo. Mutation of two conserved residues (Asn-110 and Tyr-145) located in the XPA-binding site of ERCC1 dramatically affected NER but not nuclease activity on model DNA substrates. In ERCC1-deficient cells expressing ERCC1(N110A/Y145A), the nuclease was not recruited to sites of UV damage. The repair of UV-induced (6-4) photoproducts was severely impaired in these cells, and they were hypersensitive to UV irradiation. Remarkably, the ERCC1(N110A/Y145A) protein rescues the sensitivity of ERCC1-deficient cells to cross-linking agents. Our studies suggest that ERCC1-XPF engages in different repair pathways through specific protein-protein interactions and that these functions can be separated through the selective disruption of these interactions. We discuss the impact of these findings for understanding how ERCC1 contributes to resistance of tumor cells to therapeutic agents such as cisplatin.	[Orelli, Barbara; Schaerer, Orlando D.] SUNY Stony Brook, Dept Pharmacol Sci & Chem, Stony Brook, NY 11794 USA; [McClendon, T. Brooke; Niedernhofer, Laura J.] Univ Pittsburgh, Dept Microbiol & Mol Genet, Pittsburgh, PA 15213 USA; [McClendon, T. Brooke; Niedernhofer, Laura J.] Univ Pittsburgh, Hillman Canc Ctr, Inst Canc, Pittsburgh, PA 15213 USA; [Tsodikov, Oleg V.] Univ Michigan, Coll Pharm, Dept Med Chem, Ann Arbor, MI 48109 USA; [Ellenberger, Tom] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Michigan System; University of Michigan; Washington University (WUSTL)	Scharer, OD (corresponding author), SUNY Stony Brook, Dept Pharmacol Sci & Chem, Chem 619, Stony Brook, NY 11794 USA.	orlando@pharm.stonybrook.edu	Schärer, Orlando D./AAF-8613-2021; Classen, Scott/AAY-8176-2020; Scharer, Orlando/B-8908-2008	Scharer, Orlando/0000-0003-2425-2715	National Institutes of Health [GM080454, CA092584, ES016114]; NATIONAL CANCER INSTITUTE [P01CA092584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016114] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052504, R01GM080454] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM080454 (to O. D. S.), CA092584 (to O. D. S. and T. E.), and ES016114 (to L. J. N.).	Ahmad A, 2008, MOL CELL BIOL, V28, P5082, DOI 10.1128/MCB.00293-08; Andersen SL, 2009, MOL CELL, V35, P128, DOI 10.1016/j.molcel.2009.06.019; BIGGERSTAFF M, 1993, EMBO J, V12, P3685, DOI 10.1002/j.1460-2075.1993.tb06043.x; Camenisch U, 2006, NAT STRUCT MOL BIOL, V13, P278, DOI 10.1038/nsmb1061; Cummings M, 2006, BIOCHEM PHARMACOL, V72, P166, DOI 10.1016/j.bcp.2006.04.025; de Laat WL, 1998, GENE DEV, V12, P2598, DOI 10.1101/gad.12.16.2598; de Laat WL, 1998, J BIOL CHEM, V273, P7835, DOI 10.1074/jbc.273.14.7835; De Silva IU, 2002, NUCLEIC ACIDS RES, V30, P3848, DOI 10.1093/nar/gkf479; DEVRIES A, 1995, NATURE, V377, P169, DOI 10.1038/377169a0; Dunand-Sauthier I, 2005, J BIOL CHEM, V280, P7030, DOI 10.1074/jbc.M412228200; Enzlin JH, 2002, EMBO J, V21, P2045, DOI 10.1093/emboj/21.8.2045; Evans E, 1997, EMBO J, V16, P6559, DOI 10.1093/emboj/16.21.6559; Fekairi S, 2009, CELL, V138, P78, DOI 10.1016/j.cell.2009.06.029; Fousteri M, 2006, MOL CELL, V23, P471, DOI 10.1016/j.molcel.2006.06.029; Friedberg EC, 2005, DNA REPAIR MUTAGENES; Gaillard PHL, 2001, NUCLEIC ACIDS RES, V29, P872, DOI 10.1093/nar/29.4.872; Gillet LCJ, 2006, CHEM REV, V106, P253, DOI 10.1021/cr040483f; Gossage L, 2007, CANCER TREAT REV, V33, P565, DOI 10.1016/j.ctrv.2007.07.001; Guggenheim ER, 2009, CHEMBIOCHEM, V10, P141, DOI 10.1002/cbic.200800471; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; HUANG JC, 1994, P NATL ACAD SCI USA, V91, P10394, DOI 10.1073/pnas.91.22.10394; Jamieson ER, 1999, CHEM REV, V99, P2467, DOI 10.1021/cr980421n; Jaspers NGJ, 2007, AM J HUM GENET, V80, P457, DOI 10.1086/512486; Lan L, 2004, DNA REPAIR, V3, P135, DOI 10.1016/j.dnarep.2003.10.005; Lehmann AR, 2003, BIOCHIMIE, V85, P1101, DOI 10.1016/j.biochi.2003.09.010; LI L, 1995, MOL CELL BIOL, V15, P1993; LI L, 1994, P NATL ACAD SCI USA, V91, P5012, DOI 10.1073/pnas.91.11.5012; Martin LP, 2008, CLIN CANCER RES, V14, P1291, DOI 10.1158/1078-0432.CCR-07-2238; MCWHIR J, 1993, NAT GENET, V5, P217, DOI 10.1038/ng1193-217; Mocquet V, 2008, EMBO J, V27, P155, DOI 10.1038/sj.emboj.7601948; Moggs JG, 1997, NUCLEIC ACIDS RES, V25, P480, DOI 10.1093/nar/25.3.480; Moggs JG, 1996, J BIOL CHEM, V271, P7177, DOI 10.1074/jbc.271.12.7177; Moser J, 2007, MOL CELL, V27, P311, DOI 10.1016/j.molcel.2007.06.014; Motycka TA, 2004, J BIOL CHEM, V279, P13634, DOI 10.1074/jbc.M313779200; Munoz IM, 2009, MOL CELL, V35, P116, DOI 10.1016/j.molcel.2009.06.020; Newman M, 2005, EMBO J, V24, P895, DOI 10.1038/sj.emboj.7600581; Niedernhofer LJ, 2006, NATURE, V444, P1038, DOI 10.1038/nature05456; Niedernhofer LJ, 2004, MOL CELL BIOL, V24, P5776, DOI 10.1128/MCB.24.13.5776-5787.2004; Nishino T, 2005, STRUCTURE, V13, P1183, DOI 10.1016/j.str.2005.04.024; Nishino T, 2005, STRUCTURE, V13, P143, DOI 10.1016/j.str.2004.11.008; Ogi T, 2006, NAT CELL BIOL, V8, P640, DOI 10.1038/ncb1417; Olaussen KA, 2007, NEW ENGL J MED, V357, P1559, DOI 10.1056/NEJMc072007; PARK CH, 1994, P NATL ACAD SCI USA, V91, P5017, DOI 10.1073/pnas.91.11.5017; Riedl T, 2003, EMBO J, V22, P5293, DOI 10.1093/emboj/cdg489; Rolig RL, 1998, MUTAGENESIS, V13, P357, DOI 10.1093/mutage/13.4.357; Salmon P, 2000, BLOOD, V96, P3392; Salmon Patrick, 2006, Curr Protoc Neurosci, VChapter 4, DOI 10.1002/0471142301.ns0421s37; Sgouros J, 1999, TRENDS BIOCHEM SCI, V24, P95, DOI 10.1016/S0968-0004(99)01355-9; Shivji MKK, 1999, METH MOL B, V113, P373; Sijbers AM, 1996, NUCLEIC ACIDS RES, V24, P3370, DOI 10.1093/nar/24.17.3370; Sijbers AM, 1996, CELL, V86, P811, DOI 10.1016/S0092-8674(00)80155-5; Staresincic L, 2009, EMBO J, V28, P1111, DOI 10.1038/emboj.2009.49; Sugasawa K, 1998, MOL CELL, V2, P223, DOI 10.1016/S1097-2765(00)80132-X; Sugasawa K, 2005, CELL, V121, P387, DOI 10.1016/j.cell.2005.02.035; Svendsen JM, 2009, CELL, V138, P63, DOI 10.1016/j.cell.2009.06.030; Tapias A, 2004, J BIOL CHEM, V279, P19074, DOI 10.1074/jbc.M312611200; Tian M, 2004, MOL CELL BIOL, V24, P1200, DOI 10.1128/MCB.24.3.1200-1205.2004; Tripsianes K, 2005, STRUCTURE, V13, P1849, DOI 10.1016/j.str.2005.08.014; Tripsianes K, 2007, NUCLEIC ACIDS RES, V35, P5789, DOI 10.1093/nar/gkm503; Tsodikov OV, 2007, EMBO J, V26, P4768, DOI 10.1038/sj.emboj.7601894; Tsodikov OV, 2005, P NATL ACAD SCI USA, V102, P11236, DOI 10.1073/pnas.0504341102; VANVUUREN AJ, 1993, EMBO J, V12, P3693, DOI 10.1002/j.1460-2075.1993.tb06044.x; Volker M, 2001, MOL CELL, V8, P213, DOI 10.1016/S1097-2765(01)00281-7; Wakasugi M, 1998, P NATL ACAD SCI USA, V95, P6669, DOI 10.1073/pnas.95.12.6669; Weeda G, 1997, CURR BIOL, V7, P427, DOI 10.1016/S0960-9822(06)00190-4; Wu Q, 2005, EMBO REP, V6, P551, DOI 10.1038/sj.embor.7400418; Yagi T, 1997, MUTAGENESIS, V12, P41, DOI 10.1093/mutage/12.1.41; Yildiz O, 2002, MOL CELL, V10, P1503, DOI 10.1016/S1097-2765(02)00782-7; Zamble DB, 1996, BIOCHEMISTRY-US, V35, P10004, DOI 10.1021/bi960453+; Zhang NX, 2002, MOL CELL BIOL, V22, P2388, DOI 10.1128/MCB.22.7.2388-2397.2002; Zhu GY, 2009, BIOCHEMISTRY-US, V48, P4916, DOI 10.1021/bi900389b; Zhu XD, 2003, MOL CELL, V12, P1489, DOI 10.1016/S1097-2765(03)00478-7	72	70	73	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3705	3712		10.1074/jbc.M109.067538	http://dx.doi.org/10.1074/jbc.M109.067538			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19940136	hybrid, Green Published			2022-12-25	WOS:000275254000022
J	Lidke, DS; Huang, F; Post, JN; Rieger, B; Wilsbacher, J; Thomas, JL; Pouyssegur, J; Jovin, TM; Lenormand, P				Lidke, Diane S.; Huang, Fang; Post, Janine N.; Rieger, Bernd; Wilsbacher, Julie; Thomas, James L.; Pouyssegur, Jacques; Jovin, Thomas M.; Lenormand, Philippe			ERK Nuclear Translocation Is Dimerization-independent but Controlled by the Rate of Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; ACTIVATED PROTEIN-KINASE; SIGNAL-REGULATED KINASE; EFFECTOR DOMAIN PROTEIN; MAP KINASE; NUCLEOCYTOPLASMIC TRANSPORT; LIVING CELLS; LOCALIZATION; MECHANISM; PEA-15	Upon activation, ERKs translocate from the cytoplasm to the nucleus. This process is required for the induction of many cellular responses, yet the molecular mechanisms that regulate ERK nuclear translocation are not fully understood. We have used a mouse embryo fibroblast ERK1-knock-out cell line expressing green fluorescent protein (GFP)-tagged ERK1 to probe the spatio-temporal regulation of ERK1. Real time fluorescence microscopy and fluorescence correlation spectroscopy revealed that ERK1 nuclear accumulation increased upon serum stimulation, but the mobility of the protein in the nucleus and cytoplasm remained unchanged. Dimerization of ERK has been proposed as a requirement for nuclear translocation. However, ERK1-Delta 4, the mutant shown consistently to be dimerization-deficient in vitro, accumulated in the nucleus to the same level as wild type (WT), indicating that dimerization of ERK1 is not required for nuclear entry and retention. Consistent with this finding, energy migration Forster resonance energy transfer and fluorescence correlation spectroscopy measurements in living cells did not detect dimerization of GFP-ERK1-WT upon activation. In contrast, the kinetics of nuclear accumulation and phosphorylation of GFP-ERK1-Delta 4 were slower than that of GFP-ERK1-WT. These results indicate that the differential shuttling behavior of the mutant is a consequence of delayed phosphorylation of ERK by MEK rather than dimerization. Our data demonstrate for the first time that a delay in cytoplasmic activation of ERK is directly translated into a delay in nuclear translocation.	[Pouyssegur, Jacques; Lenormand, Philippe] Univ Nice, CNRS, UMR6543, Inst Dev Biol & Canc,Ctr A Lacassagne, F-06189 Nice, France; [Jovin, Thomas M.] Max Planck Inst Biophys Chem, Lab Cellular Dynam, D-37077 Gottingen, Germany; [Huang, Fang; Thomas, James L.] Univ New Mexico, Dept Phys & Astron, Albuquerque, NM 87131 USA; [Wilsbacher, Julie] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75235 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Max Planck Society; University of New Mexico; University of Texas System; University of Texas Southwestern Medical Center Dallas	Lenormand, P (corresponding author), Univ Nice, CNRS, UMR6543, Inst Dev Biol & Canc,Ctr A Lacassagne, F-06189 Nice, France.	Philippe.LENORMAND@unice.fr	Lenormand, Philippe/N-5996-2018; Post, Janine N./E-9983-2011	Post, Janine N./0000-0002-6645-6583	European Union FP5 Project [QLRT-2000-02278]; CNRS, Centre A. Lacassagne, Association pour la Recherche sur le Cancer [3338]; American Cancer Society [IRG 192]; National Institutes of Health [DK34128]; Army Research Office [W911NF0510464]; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [P30CA118100] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019287, S10RR016918, S10RR014668, P20RR011830] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK034128, R01DK034128] Funding Source: NIH RePORTER	European Union FP5 Project; CNRS, Centre A. Lacassagne, Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerCentre National de la Recherche Scientifique (CNRS)); American Cancer Society(American Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Army Research Office; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by European Union FP5 Project QLRT-2000-02278 (MAP Kinase) (to T. M. J. and J. P.), the CNRS, Centre A. Lacassagne, Association pour la Recherche sur le Cancer Contract 3338, and American Cancer Society Grant IRG 192 (to D. S. L.). This work was supported in part by National Institutes of Health Grant DK34128 (to J. W.).; Supported by the Army Research Office Grant W911NF0510464.; Supported by a predoctoral fellowship from the Howard Hughes Medical Institute. Present address: Cancer Research, Global Pharmaceutical Research and Development, Abbott Laboratories, 100 Abbott Park Rd., Abbott Park, IL 60064.	Adachi M, 1999, EMBO J, V18, P5347, DOI 10.1093/emboj/18.19.5347; Adachi M, 2000, J CELL BIOL, V148, P849, DOI 10.1083/jcb.148.5.849; Ando R, 2004, SCIENCE, V306, P1370, DOI 10.1126/science.1102506; Brunet A, 1999, EMBO J, V18, P664, DOI 10.1093/emboj/18.3.664; Burack WR, 2005, J BIOL CHEM, V280, P3832, DOI 10.1074/jbc.M410031200; CANTOR CR, 1980, BIOPHYSICAL CHEM, V2, P560; Casar B, 2008, MOL CELL, V31, P708, DOI 10.1016/j.molcel.2008.07.024; CHEN RH, 1992, MOL CELL BIOL, V12, P915, DOI 10.1128/MCB.12.3.915; Chuderland D, 2008, MOL CELL, V31, P850, DOI 10.1016/j.molcel.2008.08.007; Chuderland D, 2008, J BIOL CHEM, V283, P11176, DOI 10.1074/jbc.M709030200; Costa M, 2006, J CELL SCI, V119, P4952, DOI 10.1242/jcs.03272; Dittrich P, 2001, BIOL CHEM, V382, P491, DOI 10.1515/BC.2001.061; ELSON EL, 1974, BIOPOLYMERS, V13, P1, DOI 10.1002/bip.1974.360130102; Formstecher E, 2001, DEV CELL, V1, P239, DOI 10.1016/S1534-5807(01)00035-1; Fujioka A, 2006, J BIOL CHEM, V281, P8917, DOI 10.1074/jbc.M509344200; Fukuda M, 1996, J BIOL CHEM, V271, P20024, DOI 10.1074/jbc.271.33.20024; Fukuda M, 1997, EMBO J, V16, P1901, DOI 10.1093/emboj/16.8.1901; Furuno T, 2001, J IMMUNOL, V166, P4416, DOI 10.4049/jimmunol.166.7.4416; Galli S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007541; Gautier I, 2001, BIOPHYS J, V80, P3000, DOI 10.1016/S0006-3495(01)76265-0; Gervais M, 2006, MOL BIOL CELL, V17, P3940, DOI 10.1091/mbc.E06-06-0501; HAUPTS U, 1995, P NATL ACAD SCI USA, V92, P3834, DOI 10.1073/pnas.92.9.3834; Horgan AM, 2003, EXP CELL RES, V285, P208, DOI 10.1016/S0014-4827(03)00037-5; Khokhlatchev AV, 1998, CELL, V93, P605, DOI 10.1016/S0092-8674(00)81189-7; Kohno M, 2006, ANN MED, V38, P200, DOI 10.1080/07853890600551037; Kosako H, 2009, NAT STRUCT MOL BIOL, V16, P1026, DOI 10.1038/nsmb.1656; Lefloch R, 2008, MOL CELL BIOL, V28, P511, DOI 10.1128/MCB.00800-07; LENORMAND P, 1993, J CELL BIOL, V122, P1079, DOI 10.1083/jcb.122.5.1079; Lidke DS, 2003, BIOCHEM SOC T, V31, P1020; Lidke KA, 2005, IEEE T IMAGE PROCESS, V14, P1237, DOI 10.1109/TIP.2005.852458; Mandl M, 2005, MOL CELL BIOL, V25, P1830, DOI 10.1128/MCB.25.5.1830-1845.2005; Matsubayashi Y, 2001, J BIOL CHEM, V276, P41755, DOI 10.1074/jbc.M106012200; Pages G, 1999, SCIENCE, V286, P1374, DOI 10.1126/science.286.5443.1374; Philipova R, 2005, J CELL SCI, V118, P5767, DOI 10.1242/jcs.02683; Ranganathan A, 2006, J BIOL CHEM, V281, P15645, DOI 10.1074/jbc.M513866200; Robinson MJ, 1998, CURR BIOL, V8, P1141, DOI 10.1016/S0960-9822(07)00485-X; SCHNEIDER MB, 1981, APPL OPTICS, V20, P1382, DOI 10.1364/AO.20.001382; Sur R, 2005, BIOCHEM J, V387, P315, DOI 10.1042/BJ20041713; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Terry LJ, 2007, SCIENCE, V318, P1412, DOI 10.1126/science.1142204; Torii S, 2004, DEV CELL, V7, P33, DOI 10.1016/j.devcel.2004.05.019; Volmat V, 2001, J CELL SCI, V114, P3433; Whitehurst A, 2004, MOL CELL BIOL, V24, P10145, DOI 10.1128/MCB.24.23.10145-10150.2004; Whitehurst AW, 2004, J BIOL CHEM, V279, P12840, DOI 10.1074/jbc.M310031200; Whitehurst AW, 2002, P NATL ACAD SCI USA, V99, P7496, DOI 10.1073/pnas.112495999; Widengren J, 1998, CELL MOL BIOL, V44, P857; Wilsbacher JL, 2006, BIOCHEMISTRY-US, V45, P13175, DOI 10.1021/bi061041w; Wolf I, 2001, J BIOL CHEM, V276, P24490, DOI 10.1074/jbc.M103352200; Yazicioglu MN, 2007, J BIOL CHEM, V282, P28759, DOI 10.1074/jbc.M703460200; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218	50	79	80	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5							3092	10.1074/jbc.M109.064972	http://dx.doi.org/10.1074/jbc.M109.064972			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19920141	Green Published, hybrid			2022-12-25	WOS:000273829000025
J	Chen, HL; Libertini, SJ; Wang, Y; Kung, HJ; Ghosh, P; Mudryj, M				Chen, Honglin; Libertini, Stephen J.; Wang, Yu; Kung, Hsing-Jien; Ghosh, Paramita; Mudryj, Maria			ERK Regulates Calpain 2-induced Androgen Receptor Proteolysis in CWR22 Relapsed Prostate Tumor Cell Lines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-WEIGHT FORMS; CYCLIN-E; CANCER XENOGRAFT; SUBCELLULAR-LOCALIZATION; SIGNALING PATHWAY; STEROID-BINDING; KINASE; ACTIVATION; PROGRESSION; GROWTH	Androgen ablation therapy is effective in treating androgen-dependent prostate tumors; however, tumors that can proliferate in castrate levels of androgen eventually arise. We previously reported that in CWR22Rv1 (Rv1) cells, the protease calpain 2 can cleave the androgen receptor (AR) into a constitutively active similar to 80,000 low molecular weight(LMW) form. In this study, we further dissect the mechanisms that produce the AR LMW forms using Rv1 cells and the related CWR22-R1 (R1) cells. The 39-amino acid insertional mutation in the Rv1-AR (E3DM-AR) sensitizes this AR to calpain 2 proteolysis. R1 cells encode the same AR molecule as the parental CWR22 xenograft. Using calpain 2 small interfering RNA and calpeptin, we find that calpain 2 plays a role in the generation of the LMW-AR in R1 cells. Furthermore, LMW-AR expression is regulated by the activation of calpain 2 by ERK 1 and 2. Inhibition of ERK phosphorylation or small interfering RNA-mediated decrease of ERK expression reduces LMW-AR levels in R1 cells. Conversely, activation of the MAPK pathway results in increased ERK phosphorylation and increased levels of LMW-AR. Finally, analyses of human tumor samples found that LMW-AR levels are higher in tumors that have an increased calpain/calpastatin ratio and/or increased levels of phospho-ERK (pERK). This suggests that a higher calpain/calpastatin ratio collaborates with activated ERK to promote the generation of the LMW-AR.	[Chen, Honglin; Libertini, Stephen J.; Mudryj, Maria] Univ Calif Davis, Dept Med Microbiol & Immunol, Davis, CA 19616 USA; [Wang, Yu; Ghosh, Paramita] Univ Calif Davis, Dept Urol, Davis, CA 95616 USA; [Kung, Hsing-Jien] Univ Calif Davis, Div Basic Sci, Ctr Canc, Davis, CA 95616 USA; [Kung, Hsing-Jien] Univ Calif Davis, Dept Biochem & Mol Med, Davis, CA 95616 USA; [Ghosh, Paramita; Mudryj, Maria] Vet Affairs No Calif Hlth Care Syst, Mather, CA 95655 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Mudryj, M (corresponding author), Univ Calif Davis, Dept Med Microbiol, 3147 Tupper Hall, Davis, CA 95616 USA.	mmudryj@ucdavis.edu	WANG, YU/E-4655-2013; Kung, Hsing-Jien/C-7651-2013		Department of Defense [PC051049]; Veterans Affairs Merit Award; Department of Defense Predoctoral Award [PC073557]; NATIONAL CANCER INSTITUTE [R01CA133209] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR012088] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); Veterans Affairs Merit Award(US Department of Veterans Affairs); Department of Defense Predoctoral Award(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by Department of Defense Grant PC051049 (to M. M.), Veterans Affairs Merit Award (to M. M.), and Department of Defense Predoctoral Award PC073557 (to H. C.).	Bacus SS, 2001, ONCOGENE, V20, P147, DOI 10.1038/sj.onc.1204062; Berrevoets CA, 2002, MOL CELL ENDOCRINOL, V198, P97, DOI 10.1016/S0303-7207(02)00373-8; Ceraline J, 2004, INT J CANCER, V108, P152, DOI 10.1002/ijc.11404; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; DEBOER W, 1987, J STEROID BIOCHEM, V28, P9, DOI 10.1016/0022-4731(87)90117-8; Dehm SM, 2008, CANCER RES, V68, P5469, DOI 10.1158/0008-5472.CAN-08-0594; Delk NA, 2009, CANCER RES, V69, P2817, DOI 10.1158/0008-5472.CAN-08-4182; DEWINTER JAR, 1991, J HISTOCHEM CYTOCHEM, V39, P927, DOI 10.1177/39.7.1865110; Glading A, 2000, J BIOL CHEM, V275, P2390, DOI 10.1074/jbc.275.4.2390; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Gregory CW, 1999, ENDOCRINOLOGY, V140, P2372, DOI 10.1210/en.140.5.2372; Gregory CW, 2001, J MOL ENDOCRINOL, V27, P309, DOI 10.1677/jme.0.0270309; Gregory CW, 2001, CANCER RES, V61, P4315; Guo ZY, 2009, CANCER RES, V69, P2305, DOI 10.1158/0008-5472.CAN-08-3795; Hu R, 2009, CANCER RES, V69, P16, DOI 10.1158/0008-5472.CAN-08-2764; JENSTER G, 1991, MOL ENDOCRINOL, V5, P1396, DOI 10.1210/mend-5-10-1396; Lakshmikuttyamma A, 2004, CANCER EPIDEM BIOMAR, V13, P1604; Lee HW, 2002, J BIOL CHEM, V277, P32624, DOI 10.1074/jbc.M200353200; Libertini SJ, 2005, CANCER RES, V65, P10700, DOI 10.1158/0008-5472.CAN-05-1666; Libertini SJ, 2007, CANCER RES, V67, P9001, DOI 10.1158/0008-5472.CAN-07-1072; Linja MJ, 2001, CANCER RES, V61, P3550; Louie MC, 2003, P NATL ACAD SCI USA, V100, P2226, DOI 10.1073/pnas.0437824100; Marcelli M, 2000, CANCER RES, V60, P944; Pelley RP, 2006, CANCER RES, V66, P11754, DOI 10.1158/0008-5472.CAN-06-2918; Porter DC, 2001, MOL CELL BIOL, V21, P6254, DOI 10.1128/MCB.21.18.6254-6269.2001; Porter DC, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.23.e101; Price DT, 1999, J UROLOGY, V162, P1537, DOI 10.1016/S0022-5347(05)68354-1; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Sawhney RS, 2006, J BIOL CHEM, V281, P8497, DOI 10.1074/jbc.M600787200; Shang YF, 2002, MOL CELL, V9, P601, DOI 10.1016/S1097-2765(02)00471-9; Tan J, 1997, MOL ENDOCRINOL, V11, P450, DOI 10.1210/me.11.4.450; Taplin ME, 2004, J CELL BIOCHEM, V91, P483, DOI 10.1002/jcb.10653; Tepper CG, 2002, CANCER RES, V62, P6606; Tilley WD, 1996, CLIN CANCER RES, V2, P277; Tompa P, 2004, J BIOL CHEM, V279, P20775, DOI 10.1074/jbc.M313873200; VISAKORPI T, 1995, NAT GENET, V9, P401, DOI 10.1038/ng0495-401; Wang XD, 2003, ONCOGENE, V22, P769, DOI 10.1038/sj.onc.1206166; Wingate H, 2005, J BIOL CHEM, V280, P15148, DOI 10.1074/jbc.M409789200; Xia L, 2002, J BIOL CHEM, V277, P35422, DOI 10.1074/jbc.M203940200; Yang HJ, 2008, J CELL PHYSIOL, V217, P569, DOI 10.1002/jcp.21565; Zhang WL, 1996, J BIOL CHEM, V271, P18825, DOI 10.1074/jbc.271.31.18825	41	29	30	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2368	2374		10.1074/jbc.M109.049379	http://dx.doi.org/10.1074/jbc.M109.049379			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19946123	hybrid, Green Published			2022-12-25	WOS:000273697800017
J	Olmo, VN; Grote, E				Olmo, Valerie N.; Grote, Eric			Prm1 Functions as a Disulfide-linked Complex in Yeast Mating	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE FUSION; CELL-CELL FUSION; INFLUENZA HEMAGGLUTININ; SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; PROTEIN; GLYCOPROTEIN-120; HEMIFUSION; TRIMERS; ELEGANS	Prm1 is a pheromone-induced membrane glycoprotein that promotes plasma membrane fusion in yeast mating pairs. HA-Prm1 migrates at twice its expected molecular weight on non-reducing SDS-PAGE gels and coprecipitates with Prm1-TAP, indicating that Prm1 is a disulfide-linked homodimer. The N terminus of a plasma membrane-localized GFP-Prm1 endocytic mutant projects into the cytoplasm, where it is protected from low pH quenching in live cells and from external protease in spheroplasts. In a revised topological map, Prm1 has four transmembrane domains and two large extracellular loops. Mutation of all four cysteines in the extracellular loops blocked disulfide bond formation and destabilized the Prm1 homodimer without preventing Prm1 transport to contact sites in mating pairs. Cys(120) in loop 1 and Cys(545) in loop 2 form disulfide cross-links in the Prm1 homodimer and are required for fusion activity. Cys(120) lies between a hydrophobic segment formerly thought to be a transmembrane domain and an amphipathic helix. An interaction between either of these regions and the opposing membrane could promote fusion.	[Olmo, Valerie N.; Grote, Eric] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Grote, E (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, 615 N Wolfe St, Baltimore, MD 21205 USA.	egrote@jhsph.edu			American Cancer Society; NATIONAL CANCER INSTITUTE [T32CA009110] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a Research Scholar award from the American Cancer Society (to E. G.).	Aguilar PS, 2007, MOL BIOL CELL, V18, P547, DOI 10.1091/mbc.E06-09-0776; Barbouche R, 2003, J BIOL CHEM, V278, P3131, DOI 10.1074/jbc.M205467200; Berditchevski F, 2001, J CELL SCI, V114, P4143; Blumenthal R, 1996, J CELL BIOL, V135, P63, DOI 10.1083/jcb.135.1.63; BRAAKMAN I, 1992, EMBO J, V11, P1717, DOI 10.1002/j.1460-2075.1992.tb05223.x; Chatterjee I, 2005, DEVELOPMENT, V132, P2795, DOI 10.1242/dev.01868; Chen EH, 2005, SCIENCE, V308, P369, DOI 10.1126/science.1104799; Chernomordik LV, 1998, J CELL BIOL, V140, P1369, DOI 10.1083/jcb.140.6.1369; Danieli T, 1996, J CELL BIOL, V133, P559, DOI 10.1083/jcb.133.3.559; Ellerman DA, 2006, DEV CELL, V10, P831, DOI 10.1016/j.devcel.2006.03.011; Erdman S, 1998, J CELL BIOL, V140, P461, DOI 10.1083/jcb.140.3.461; Li F, 2007, NAT STRUCT MOL BIOL, V14, P890, DOI 10.1038/nsmb1310; Fenouillet E, 2007, ANTIOXID REDOX SIGN, V9, P1009, DOI 10.1089/ars.2007.1639; Gallina A, 2002, J BIOL CHEM, V277, P50579, DOI 10.1074/jbc.M204547200; GAYNOR EC, 1994, J CELL BIOL, V127, P653, DOI 10.1083/jcb.127.3.653; Heiman MG, 2007, J CELL BIOL, V176, P209, DOI 10.1083/jcb.200609182; Heiman MG, 2000, J CELL BIOL, V151, P719, DOI 10.1083/jcb.151.3.719; Hua YY, 2001, P NATL ACAD SCI USA, V98, P8065, DOI 10.1073/pnas.131214798; Jin H, 2004, EUKARYOT CELL, V3, P1664, DOI 10.1128/EC.3.6.1664-1673.2004; Jin H, 2008, J CELL BIOL, V180, P813, DOI 10.1083/jcb.200705076; Juschke C, 2005, J CELL BIOL, V169, P613, DOI 10.1083/jcb.200503033; Leikina E, 2000, MOL BIOL CELL, V11, P2359, DOI 10.1091/mbc.11.7.2359; Lu XB, 2008, NAT STRUCT MOL BIOL, V15, P700, DOI 10.1038/nsmb.1433; Markovic I, 1998, J CELL BIOL, V143, P1155, DOI 10.1083/jcb.143.5.1155; Muller EM, 2003, J BIOL CHEM, V278, P38461, DOI 10.1074/jbc.M304089200; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Nolan S, 2006, MOL BIOL CELL, V17, P2439, DOI 10.1091/mbc.E05-11-1015; Pollard MG, 1998, MOL CELL, V1, P171, DOI 10.1016/S1097-2765(00)80018-0; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Rickman C, 2005, BIOCHEM J, V388, P75, DOI 10.1042/BJ20041818; RYSER HJP, 1994, P NATL ACAD SCI USA, V91, P4559, DOI 10.1073/pnas.91.10.4559; Sapir A, 2007, DEV CELL, V12, P683, DOI 10.1016/j.devcel.2007.03.003; SCHNEIDER BL, 1995, YEAST, V11, P1265, DOI 10.1002/yea.320111306; SCOTT JH, 1980, J BACTERIOL, V142, P414, DOI 10.1128/JB.142.2.414-423.1980; Singh M, 1999, J MOL BIOL, V290, P1031, DOI 10.1006/jmbi.1999.2796; Tang HY, 2004, CURR PROTOC PROTEIN; Ydenberg Casey A., 2008, V475, P3, DOI 10.1007/978-1-59745-250-2_1; Zhang NN, 2006, MOL BIOL CELL, V17, P3409, DOI 10.1091/mbc.E06-03-0177	38	10	10	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2284	2293		10.1074/jbc.M109.068874	http://dx.doi.org/10.1074/jbc.M109.068874			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19933274	Green Published, hybrid			2022-12-25	WOS:000273697800007
J	Thomas, RM; Chen, CX; Chunder, N; Ma, LZ; Taylor, J; Pearce, EJ; Wells, AD				Thomas, Rajan M.; Chen, Chunxia; Chunder, Neelanjana; Ma, Lingzhi; Taylor, Justin; Pearce, Edward J.; Wells, Andrew D.			Ikaros Silences T-bet Expression and Interferon-gamma Production during T Helper 2 Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DIFFERENTIATION; TRANSCRIPTION FACTOR; HISTONE ACETYLATION; REGULATORY ELEMENTS; LINEAGE COMMITMENT; GENE-EXPRESSION; PROMOTER; REPRESSION; GATA-3; LYMPHOCYTES	CD4+ T cells can be instructed by nonantigen-specific signals to differentiate into functionally distinct lineages with mutually exclusive patterns of cytokine production. The molecular events that drive interferon-gamma (IFN gamma) production during Th1 development are well understood, but mechanisms that silence this cytokine during Th2 polarization are not clear. In this study, we find that the tbx21 gene encoding the Th1 master regulator T-bet is a direct target of the transcriptional repressor Ikaros. In Th2 cells, which do not express T-bet, strong Ikaros binding could be detected at the endogenous tbx21 promoter, whereas this gene was not occupied by Ikaros in T-bet-expressing Th1 cells. Inhibition of Ikaros DNA binding activity during Th2 polarization resulted in loss of Ikaros promoter occupancy, increased T-bet expression, and inappropriate T-bet-dependent production of IFN gamma. Ikaros was also required for epigenetic imprinting of the ifn gamma locus during Th2 polarization, and loss of Ikaros function in vivo led to an inappropriate Th1 response to the parasite Shistosoma mansoni. These studies demonstrate that Ikaros, a factor with an established role in lymphocyte development, also regulates the development of peripheral T helper responses.	[Thomas, Rajan M.; Chen, Chunxia; Chunder, Neelanjana; Ma, Lingzhi; Wells, Andrew D.] Univ Penn, Sch Vet Med, Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Thomas, Rajan M.; Chen, Chunxia; Chunder, Neelanjana; Ma, Lingzhi; Wells, Andrew D.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Taylor, Justin; Pearce, Edward J.] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania	Wells, AD (corresponding author), Univ Penn, Sch Vet Med, Childrens Hosp Philadelphia, 916E Abramson Res Ctr,3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	adwells@mail.med.upenn.edu	Thomas, Rajan M/AAW-7207-2021		National Institutes of Health [AI070807, AI059881, AI032573, AI053825]; Biesecker Pediatric Liver Center at The Children's Hospital of Philadelphia; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070807, R56AI032573, R01AI032573, R21AI059881, R01AI053825] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biesecker Pediatric Liver Center at The Children's Hospital of Philadelphia; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI070807 (to A. W.), AI059881 (to A. W.), AI032573 (to E. P.), and AI053825 (to E. P.) and by the Biesecker Pediatric Liver Center at The Children's Hospital of Philadelphia.	Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Ansel KM, 2003, NAT IMMUNOL, V4, P616, DOI 10.1038/ni0703-616; Avitahl N, 1999, IMMUNITY, V10, P333, DOI 10.1016/S1074-7613(00)80033-3; Bandyopadhyay S, 2007, BLOOD, V109, P2878, DOI 10.1182/blood-2006-07-037754; Chen CX, 2006, J BIOL CHEM, V281, P36828, DOI 10.1074/jbc.M608848200; Cimmino L, 2008, J IMMUNOL, V181, P2338, DOI 10.4049/jimmunol.181.4.2338; Djuretic IM, 2007, NAT IMMUNOL, V8, P145, DOI 10.1038/ni1424; GEORGOPOULOS K, 1994, CELL, V79, P143, DOI 10.1016/0092-8674(94)90407-3; Georgopoulos K, 2002, NAT REV IMMUNOL, V2, P162, DOI 10.1038/nri747; GEORGOPOULOS K, 1992, SCIENCE, V258, P808, DOI 10.1126/science.1439790; Gomez-del Arco P, 2004, MOL CELL BIOL, V24, P2797, DOI 10.1128/MCB.24.7.2797-2807.2004; Jones B, 2006, EMBO J, V25, P2443, DOI 10.1038/sj.emboj.7601148; Kaminuma O, 2004, FEBS LETT, V570, P63, DOI 10.1016/j.febslet.2004.06.026; Kim J, 1999, IMMUNITY, V10, P345, DOI 10.1016/S1074-7613(00)80034-5; Koipally J, 2000, J BIOL CHEM, V275, P19594, DOI 10.1074/jbc.M000254200; Koipally J, 1999, EMBO J, V18, P3090, DOI 10.1093/emboj/18.11.3090; Lee GR, 2006, IMMUNITY, V24, P369, DOI 10.1016/j.immuni.2006.03.007; Lee HJ, 2000, J EXP MED, V192, P105, DOI 10.1084/jem.192.1.105; Mullen AC, 2002, NAT IMMUNOL, V3, P652, DOI 10.1038/ni807; Mullen AC, 2001, SCIENCE, V292, P1907, DOI 10.1126/science.1059835; Murphy KM, 2000, ANNU REV IMMUNOL, V18, P451, DOI 10.1146/annurev.immunol.18.1.451; Northrop JK, 2006, J IMMUNOL, V177, P1062, DOI 10.4049/jimmunol.177.2.1062; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; Pearce EJ, 2004, IMMUNOL REV, V201, P117, DOI 10.1111/j.0105-2896.2004.00187.x; PENIX L, 1993, J EXP MED, V178, P1483, DOI 10.1084/jem.178.5.1483; Penix LA, 1996, J BIOL CHEM, V271, P31964, DOI 10.1074/jbc.271.50.31964; Quirion MR, 2009, J IMMUNOL, V182, P741, DOI 10.4049/jimmunol.182.2.741; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543; Thomas RM, 2007, J IMMUNOL, V179, P7305, DOI 10.4049/jimmunol.179.11.7305; WINANDY S, 1995, CELL, V83, P289, DOI 10.1016/0092-8674(95)90170-1; Winders BR, 2004, J IMMUNOL, V173, P7377, DOI 10.4049/jimmunol.173.12.7377	33	41	42	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2545	2553		10.1074/jbc.M109.038794	http://dx.doi.org/10.1074/jbc.M109.038794			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19923223	hybrid, Green Published			2022-12-25	WOS:000273697800033
J	Zhou, HL; Luby-Phelps, K; Mickey, BE; Habib, AA; Mason, RP; Zhao, DW				Zhou, Heling; Luby-Phelps, Kate; Mickey, Bruce E.; Habib, Amyn A.; Mason, Ralph P.; Zhao, Dawen			Dynamic Near-Infrared Optical Imaging of 2-Deoxyglucose Uptake by Intracranial Glioma of Athymic Mice	PLOS ONE			English	Article							FLUORESCENT DEOXYGLUCOSE ANALOG; GROWTH-FACTOR RECEPTOR; IN-VIVO; BREAST-CANCER; MALIGNANT GLIOMA; COLORECTAL-CANCER; EXPRESSION; REGISTRATION; RESECTION; CONTRAST	Background: It is recognized that cancer cells exhibit highly elevated glucose metabolism compared to non-tumor cells. We have applied in vivo optical imaging to study dynamic uptake of a near-infrared dye-labeled glucose analogue, 2-deoxyglucose (2-DG) by orthotopic glioma in a mouse model. Methodology and Principal Findings: The orthotopic glioma model was established by surgically implanting U87-luc glioma cells into the right caudal nuclear area of nude mice. Intracranial tumor growth was monitored longitudinally by bioluminescence imaging and MRI. When tumor size reached >4 mm diameter, dynamic fluorescence imaging was performed after an injection of the NIR labeled 2-DG, IRDye800CW 2-DG. Real-time whole body images acquired immediately after i.v. infusion clearly visualized the near-infrared dye circulating into various internal organs sequentially. Dynamic fluorescence imaging revealed significantly higher signal intensity in the tumor side of the brain than the contralateral normal brain 24 h after injection (tumor/normal ratio, TNR = 2.8 +/- 0.7). Even stronger contrast was achieved by removing the scalp (TNR = 3.7 +/- 1.1) and skull (TNR = 4.2 +/- 1.1) of the mice. In contrast, a control dye, IRDye800CW carboxylate, showed little difference (1.1 +/- 0.2). Ex vivo fluorescence imaging performed on ultrathin cryosections (20 mu m) of tumor bearing whole brain revealed distinct tumor margins. Microscopic imaging identified cytoplasmic locations of the 2-DG dye in tumor cells. Conclusion and Significance: Our results suggest that the near-infrared dye labeled 2-DG may serve as a useful fluorescence imaging probe to noninvasively assess intracranial tumor burden in preclinical animal models.	[Zhou, Heling; Mason, Ralph P.; Zhao, Dawen] Univ Texas SW Med Ctr Dallas, Dept Radiol, Dallas, TX 75390 USA; [Luby-Phelps, Kate] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Mickey, Bruce E.] Univ Texas SW Med Ctr Dallas, Dept Neurol Surg, Dallas, TX 75390 USA; [Habib, Amyn A.] Univ Texas SW Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Zhou, HL (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Radiol, Dallas, TX 75390 USA.	Dawen.Zhao@UTSouthwestern.edu	Mason, Ralph/C-8472-2012	Mason, Ralph/0000-0001-7517-3721; Luby-Phelps, Katherine/0000-0002-8378-1409	North and Central Texas Clinical and Translational Science Initiative (NCTCTSI); NIH CTSA [UL1 RR024982]; DOD IDEA Award [W81XWH-08-1-0583]; Southwestern Small Animal Imaging Research Program [U24 CA126608]; NIH [1S10RR024757-01]; DOE [DE-FG02-05CH11280]; NIH BTRp [P41-RR02584]; NATIONAL CANCER INSTITUTE [U24CA126608] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024982, P41RR002584, S10RR024757] Funding Source: NIH RePORTER	North and Central Texas Clinical and Translational Science Initiative (NCTCTSI); NIH CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); DOD IDEA Award; Southwestern Small Animal Imaging Research Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOE(United States Department of Energy (DOE)); NIH BTRp; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported in part by the North and Central Texas Clinical and Translational Science Initiative (NCTCTSI) Pilot Grant Award as part of the NIH CTSA Grant UL1 RR024982 and DOD IDEA Award W81XWH-08-1-0583 (DZ). Imaging was fulfilled by the Southwestern Small Animal Imaging Research Program (U24 CA126608), the Caliper IVIS Spectrum under NIH 1S10RR024757-01 and the CRi Maestro was provided by the Joint Program in BME through a DOE grant # DE-FG02-05CH11280. MRI experiments were performed in the Advanced Imaging Research Center, an NIH BTRP # P41-RR02584 facility. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KE, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2717137; Barker FG, 2006, LANCET ONCOL, V7, P359, DOI 10.1016/S1470-2045(06)70669-6; Beattie BJ, 2007, MOL IMAGING, V6, P108, DOI 10.2310/7290.2007.00008; Burton JB, 2008, NAT MED, V14, P882, DOI 10.1038/nm.1727; Chang SK, 2008, CLIN CANCER RES, V14, P4146, DOI 10.1158/1078-0432.CCR-07-4536; Cheng Z, 2006, BIOCONJUGATE CHEM, V17, P662, DOI 10.1021/bc050345c; Diagaradjane P, 2008, CLIN CANCER RES, V14, P731, DOI 10.1158/1078-0432.CCR-07-1958; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Galie M, 2007, NEOPLASIA, V9, P900, DOI 10.1593/neo.07541; Hama Y, 2007, CANCER RES, V67, P3809, DOI 10.1158/0008-5472.CAN-06-3794; Hayashi K, 2007, CANCER RES, V67, P8223, DOI 10.1158/0008-5472.CAN-07-1237; Hillman EMC, 2007, NAT PHOTONICS, V1, P526, DOI 10.1038/nphoton.2007.146; Hoffman RM, 2005, NAT REV CANCER, V5, P796, DOI 10.1038/nrc1717; Hsu AR, 2007, J NUCL MED, V48, P445; Hsu AR, 2006, MOL IMAGING BIOL, V8, P315, DOI 10.1007/s11307-006-0059-y; Kaushal S, 2008, J GASTROINTEST SURG, V12, P1938, DOI 10.1007/s11605-008-0581-0; Ke S, 2003, CANCER RES, V63, P7870; Kovar JL, 2007, ANAL BIOCHEM, V367, P1, DOI 10.1016/j.ab.2007.04.011; Kovar JL, 2009, ANAL BIOCHEM, V384, P254, DOI 10.1016/j.ab.2008.09.050; Kremer P, 2009, NEUROSURGERY, V64, pS53, DOI 10.1227/01.NEU.0000335787.17029.67; Laws ER, 2003, J NEUROSURG, V99, P467, DOI 10.3171/jns.2003.99.3.0467; McCann CM, 2009, NEUROIMAGE, V45, P360, DOI 10.1016/j.neuroimage.2008.12.022; O'Neil RG, 2005, MOL IMAGING BIOL, V7, P388, DOI 10.1007/s11307-005-0011-6; Parungo CP, 2004, ANN SURG ONCOL, V11, P1085, DOI 10.1245/ASO.2004.03.054; Rehemtulla A, 2000, NEOPLASIA, V2, P491, DOI 10.1038/sj.neo.7900121; Runnels JM, 2006, MOL IMAGING, V5, P31, DOI 10.2310/7290.2006.00004; Sampath L, 2007, J NUCL MED, V48, P1501, DOI 10.2967/jnumed.107.042234; Serganova I, 2006, HEMATOL ONCOL CLIN N, V20, P1215, DOI 10.1016/j.hoc.2006.09.006; Sevick-Muraca EM, 2008, RADIOLOGY, V246, P734, DOI 10.1148/radiol.2463070962; Stummer W, 2006, LANCET ONCOL, V7, P392, DOI 10.1016/S1470-2045(06)70665-9; Tseng J, 2004, J NUCL MED, V45, P1829; Weissleder R, 2008, NATURE, V452, P580, DOI 10.1038/nature06917; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Zhang M, 2003, BIOCONJUGATE CHEM, V14, P709, DOI 10.1021/bc034038n; Zhang ZH, 2004, BIOSENS BIOELECTRON, V20, P643, DOI 10.1016/j.bios.2004.03.034; Zhao DW, 2008, FASEB J, V22, P2445, DOI 10.1096/fj.07-103713; Zou P, 2009, MOL PHARMACEUT, V6, P428, DOI 10.1021/mp9000052	37	47	47	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2009	4	11							e8051	10.1371/journal.pone.0008051	http://dx.doi.org/10.1371/journal.pone.0008051			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MQ	19956682	gold, Green Published			2022-12-25	WOS:000272828400010
J	Li, CY; He, XH; Zhu, SS; Zhou, HP; Wang, YY; Li, Y; Yang, J; Fan, JX; Yang, JC; Wang, GB; Long, YF; Xu, JY; Tang, YS; Zhao, GH; Yang, JR; Liu, L; Sun, Y; Xie, Y; Wang, HN; Zhu, YY				Li, Chengyun; He, Xiahong; Zhu, Shusheng; Zhou, Huiping; Wang, Yunyue; Li, Yan; Yang, Jing; Fan, Jinxiang; Yang, Jincheng; Wang, Guibin; Long, Yunfu; Xu, Jiayou; Tang, Yongsheng; Zhao, Gaohui; Yang, Jianrong; Liu, Lin; Sun, Yan; Xie, Yong; Wang, Haining; Zhu, Youyong			Crop Diversity for Yield Increase	PLOS ONE			English	Article							PLANT-SPECIES DIVERSITY; PRODUCTIVITY; BIODIVERSITY	Traditional farming practices suggest that cultivation of a mixture of crop species in the same field through temporal and spatial management may be advantageous in boosting yields and preventing disease, but evidence from large-scale field testing is limited. Increasing crop diversity through intercropping addresses the problem of increasing land utilization and crop productivity. In collaboration with farmers and extension personnel, we tested intercropping of tobacco, maize, sugarcane, potato, wheat and broad bean - either by relay cropping or by mixing crop species based on differences in their heights, and practiced these patterns on 15,302 hectares in ten counties in Yunnan Province, China. The results of observation plots within these areas showed that some combinations increased crop yields for the same season between 33.2 and 84.7% and reached a land equivalent ratio (LER) of between 1.31 and 1.84. This approach can be easily applied in developing countries, which is crucial in face of dwindling arable land and increasing food demand.	[Li, Chengyun; He, Xiahong; Zhu, Shusheng; Zhou, Huiping; Wang, Yunyue; Li, Yan; Yang, Jing; Liu, Lin; Sun, Yan; Xie, Yong; Wang, Haining; Zhu, Youyong] Yunnan Agr Univ, Key Lab Agrobiodivers & Pest Management, Educ Minist China, Kunming, Yunnan, Peoples R China; [Fan, Jinxiang] Plant Protect Stn Honghe Prefecture, Mengzi, Yunnan, Peoples R China; [Yang, Jincheng] Agrosci Res Inst Yuxi City, Yuxi, Yunnan, Peoples R China; [Wang, Guibin] Plant Protect Stn Chuxiong Prefecture, Chuxiong, Yunnan, Peoples R China; [Long, Yunfu] Plant Protect Stn Shiping Cty, Shiping, Yunnan, Peoples R China; [Xu, Jiayou] Agrosci Res Stn Hongxi Town, Mile, Yunnan, Peoples R China; [Tang, Yongsheng] Agr Technol Extens Ctr Qujing City, Qujing, Yunnan, Peoples R China; [Zhao, Gaohui] Agr Technol Extens Ctr Zhaotong City, Zhaotong, Yunnan, Peoples R China; [Yang, Jianrong] Agr Technol Extens Ctr Lincang City, Lincang, Yunnan, Peoples R China	Yunnan Agricultural University	Li, CY (corresponding author), Yunnan Agr Univ, Key Lab Agrobiodivers & Pest Management, Educ Minist China, Kunming, Yunnan, Peoples R China.	yyzhu@ynau.edu.cn	Zhou, Huiping/H-6875-2019; Zhou, Huiping/R-9888-2016; Zhou, Huiping/J-3639-2015	Zhou, Huiping/0000-0002-0050-372X; Zhou, Huiping/0000-0002-2346-6909; 	National Basic Research Program [2006CB100200]; Ministry of Science and Technology of China	National Basic Research Program(National Basic Research Program of China); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by the National Basic Research Program (No. 2006CB100200) and The Ministry of Science and Technology of China. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Altieri MA, 1999, AGR ECOSYST ENVIRON, V74, P19, DOI 10.1016/S0167-8809(99)00028-6; DAI XY, 1993, J YUNNAN AGR U, V8, P143; Dybzinski R, 2008, OECOLOGIA, V158, P85, DOI 10.1007/s00442-008-1123-x; Fischer G, 2002, GLOBAL AGROECOLOGICA; Flombaum P, 2008, P NATL ACAD SCI USA, V105, P6087, DOI 10.1073/pnas.0704801105; Fridley JD, 2002, OECOLOGIA, V132, P271, DOI 10.1007/s00442-002-0965-x; Leung Hei, 2003, Plant Disease, V87, P1156, DOI 10.1094/PDIS.2003.87.10.1156; Li L, 2007, P NATL ACAD SCI USA, V104, P11192, DOI 10.1073/pnas.0704591104; *MIN AGR PEOPL REP, 2007, 144312007 NYT MIN AG; *MIN AGR PEOPL REP, 2007, 124812006 NYT MIN AG; Morgado LB, 2008, SCI AGR, V65, P474, DOI 10.1590/S0103-90162008000500005; *NATESC, 2006, HDB CROP PEST FOR, P225; *STAT TOB MON ADM, 1996, YCT401996 STAT TOB M; Thrupp LA, 2000, INT AFF, V76, P265, DOI 10.1111/1468-2346.00133; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; Tilman D, 2006, NATURE, V441, P629, DOI 10.1038/nature04742; van Ruijven J, 2005, P NATL ACAD SCI USA, V102, P695, DOI 10.1073/pnas.0407524102; WALLEN V. R., 1957, CANADIAN JOUR PLANT SCI, V37, P337; Wang LiYa, 2005, Southwest China Journal of Agricultural Sciences, V18, P157; Willey R. W., 1979, Field Crop Abstracts, V32, P1; Yang H, 2000, LAND USE POLICY, V17, P73, DOI 10.1016/S0264-8377(00)00008-9; Zhu YY, 2000, NATURE, V406, P718, DOI 10.1038/35021046; Zhu YY, 2005, PHYTOPATHOLOGY, V95, P433, DOI 10.1094/PHYTO-95-0433	23	86	121	8	110	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2009	4	11							e8049	10.1371/journal.pone.0008049	http://dx.doi.org/10.1371/journal.pone.0008049			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MN	19956624	gold, Green Submitted, Green Published			2022-12-25	WOS:000272828100009
J	Nascimento, EJM; Braga-Neto, U; Calzavara-Silva, CE; Gomes, ALV; Abath, FGC; Brito, CAA; Cordeiro, MT; Silva, AM; Magalhaes, C; Andrade, R; Gil, LHVG; Marques, ETA				Nascimento, Eduardo J. M.; Braga-Neto, Ulisses; Calzavara-Silva, Carlos E.; Gomes, Ana L. V.; Abath, Frederico G. C.; Brito, Carlos A. A.; Cordeiro, Marli T.; Silva, Ana M.; Magalhaes, Cecilia; Andrade, Raoni; Gil, Laura H. V. G.; Marques, Ernesto T. A., Jr.			Gene Expression Profiling during Early Acute Febrile Stage of Dengue Infection Can Predict the Disease Outcome	PLOS ONE			English	Article							BOLSTERED ERROR ESTIMATION; T-CELL RESPONSES; HEMORRHAGIC-FEVER; PERIPHERAL-BLOOD; VIRUS-INFECTIONS; SHOCK-SYNDROME; ELEVATED LEVELS; SEVERITY; ACTIVATION; APOPTOSIS	Background: We report the detailed development of biomarkers to predict the clinical outcome under dengue infection. Transcriptional signatures from purified peripheral blood mononuclear cells were derived from whole-genome gene-expression microarray data, validated by quantitative PCR and tested in independent samples. Methodology/Principal Findings: The study was performed on patients of a well-characterized dengue cohort from Recife, Brazil. The samples analyzed were collected prospectively from acute febrile dengue patients who evolved with different degrees of disease severity: classic dengue fever or dengue hemorrhagic fever (DHF) samples were compared with similar samples from other non-dengue febrile illnesses. The DHF samples were collected 2-3 days before the presentation of the plasma leakage symptoms. Differentially-expressed genes were selected by univariate statistical tests as well as multivariate classification techniques. The results showed that at early stages of dengue infection, the genes involved in effector mechanisms of innate immune response presented a weaker activation on patients who later developed hemorrhagic fever, whereas the genes involved in apoptosis were expressed in higher levels. Conclusions/Significance: Some of the gene expression signatures displayed estimated accuracy rates of more than 95%, indicating that expression profiling with these signatures may provide a useful means of DHF prognosis at early stages of infection.			Nascimento, EJM (corresponding author), Fiocruz MS, Ctr Pesquisas Aggeu Magalhaes CPqAM, Dept Virol & Terapia Expt, Recife, PE, Brazil.	marques@pitt.edu	Marques, Ernesto T. A/L-4967-2013; Calzavara-Silva, Carlos/ABF-2829-2021; Marques, Ernesto/L-4514-2013; Publica, Inct Saude/J-9544-2013; Nascimento, Eduardo/J-4590-2014; Braga-Neto, Ulisses/ABI-2677-2020; Gil, Laura Helena Vega Gonzales/AAX-5319-2021	Marques, Ernesto T. A/0000-0003-3826-9358; Calzavara-Silva, Carlos/0000-0002-1406-6401; Marques, Ernesto/0000-0003-3826-9358; Nascimento, Eduardo/0000-0002-9851-2332; Gil, Laura Helena Vega Gonzales/0000-0002-8796-6080	NIAID NIH HHS [U19 AI056541, U19 AI56541] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI056541] Funding Source: NIH RePORTER; Direct For Computer & Info Scie & Enginr [0845407] Funding Source: National Science Foundation	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))		Acioli-Santos B, 2008, HUM IMMUNOL, V69, P122, DOI 10.1016/j.humimm.2008.01.005; Avirutnan P, 2006, J INFECT DIS, V193, P1078, DOI 10.1086/500949; Azeredo EL, 2006, CLIN EXP IMMUNOL, V143, P345, DOI 10.1111/j.1365-2249.2006.02996.x; Bandyopadhyay S, 2006, TROP MED INT HEALTH, V11, P1238, DOI 10.1111/j.1365-3156.2006.01678.x; BRAGA UMD, 2005, EURASIP BOOK SERIES; Braga-Neto U, 2004, PATTERN RECOGN, V37, P1267, DOI 10.1016/j.patcog.2003.08.017; Cardier JE, 2005, CYTOKINE, V30, P359, DOI 10.1016/j.cyto.2005.01.021; Chen HY, 2007, NEW ENGL J MED, V356, P11, DOI 10.1056/NEJMoa060096; Clementi M, 2006, REPROD TOXICOL, V21, P345, DOI 10.1016/j.reprotox.2005.08.006; Cordeiro MT, 2007, REV SOC BRAS MED TRO, V40, P605, DOI 10.1590/S0037-86822007000600001; Cordeiro MT, 2007, AM J TROP MED HYG, V77, P1128, DOI 10.4269/ajtmh.2007.77.1128; de Kruif MD, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000215; Deen JL, 2006, LANCET, V368, P170, DOI 10.1016/S0140-6736(06)69006-5; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Endy TP, 2004, J INFECT DIS, V189, P990, DOI 10.1086/382280; Fernandez-Mestre MT, 2004, TISSUE ANTIGENS, V64, P469, DOI 10.1111/j.1399-0039.2004.00304.x; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Green S, 1999, J INFECT DIS, V180, P1429, DOI 10.1086/315072; Green S, 1999, J MED VIROL, V59, P329, DOI 10.1002/(SICI)1096-9071(199911)59:3&lt;329::AID-JMV12&gt;3.0.CO;2-G; Green S, 2006, CURR OPIN INFECT DIS, V19, P429, DOI 10.1097/01.qco.0000244047.31135.fa; Hubbell E, 2002, BIOINFORMATICS, V18, P1585, DOI 10.1093/bioinformatics/18.12.1585; Hung NT, 2004, J INFECT DIS, V189, P221, DOI 10.1086/380762; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Juffrie M, 2000, INFECT IMMUN, V68, P702, DOI 10.1128/IAI.68.2.702-707.2000; Mangada MM, 2005, J IMMUNOL, V175, P2676, DOI 10.4049/jimmunol.175.4.2676; Mangada MM, 2002, J INFECT DIS, V185, P1697, DOI 10.1086/340822; Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887; Mongkolsapaya J, 2006, J IMMUNOL, V176, P3821, DOI 10.4049/jimmunol.176.6.3821; Mustafa AS, 2001, FEMS IMMUNOL MED MIC, V30, P229, DOI 10.1111/j.1574-695X.2001.tb01575.x; Myint KS, 2006, J INFECT DIS, V194, P600, DOI 10.1086/506451; Nascimento EJM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006782; OPAS - Organizacao Pan-Americana de Saude, 1995, DENG DENG HEM AM GUI, V548; Pang T, 2007, IMMUNOL CELL BIOL, V85, P43, DOI 10.1038/sj.icb.7100008; Pettiford JN, 2002, CLIN EXP IMMUNOL, V128, P110, DOI 10.1046/j.1365-2249.2002.01813.x; Ramilo O, 2007, BLOOD, V109, P2066, DOI 10.1182/blood-2006-02-002477; Sakuntabhai A, 2005, NAT GENET, V37, P507, DOI 10.1038/ng1550; SCHERER CA, 2007, VACCINE; Sierra B, 2007, HUM IMMUNOL, V68, P531, DOI 10.1016/j.humimm.2007.03.001; Sima C, 2005, PATTERN RECOGN, V38, P2472, DOI 10.1016/j.patcog.2005.03.026; Sima C, 2005, BIOINFORMATICS, V21, P1046, DOI 10.1093/bioinformatics/bti081; Simmons CP, 2007, J INFECT DIS, V195, P1097, DOI 10.1086/512162; Soundravally R, 2007, HUM IMMUNOL, V68, P973, DOI 10.1016/j.humimm.2007.09.007; Suharti C, 2002, THROMB HAEMOSTASIS, V87, P42, DOI 10.1055/s-0037-1612941; Tan GK, 2009, CURR OPIN INFECT DIS, V22, P302, DOI 10.1097/QCO.0b013e328329ae32; Tseng CS, 2005, FEMS IMMUNOL MED MIC, V43, P99, DOI 10.1016/j.femsim.2004.10.004; Ubol S, 2008, J INFECT DIS, V197, P1459, DOI 10.1086/587699; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; *WHO, 1999, TREATM DENG FEV DENG; Yunta M, 2003, ONCOGENE, V22, P1219, DOI 10.1038/sj.onc.1206183	49	61	61	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2009	4	11							e7892	10.1371/journal.pone.0007892	http://dx.doi.org/10.1371/journal.pone.0007892			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522NJ	19936257	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000272004600001
J	Simmerman, JM; Chittaganpitch, M; Levy, J; Chantra, S; Maloney, S; Uyeki, T; Areerat, P; Thamthitiwat, S; Olsen, SJ; Fry, A; Ungchusak, K; Baggett, HC; Chunsuttiwat, S				Simmerman, James Mark; Chittaganpitch, Malinee; Levy, Jens; Chantra, Somrak; Maloney, Susan; Uyeki, Timothy; Areerat, Peera; Thamthitiwat, Somsak; Olsen, Sonja J.; Fry, Alicia; Ungchusak, Kumnuan; Baggett, Henry C.; Chunsuttiwat, Supamit			Incidence, Seasonality and Mortality Associated with Influenza Pneumonia in Thailand: 2005-2008	PLOS ONE			English	Article							RISK-FACTORS; BURDEN; CHILDREN; HOSPITALIZATIONS; COMPLICATIONS; EPIDEMIOLOGY; DEATHS; COST	Background: Data on the incidence, seasonality and mortality associated with influenza in subtropical low and middle income countries are limited. Prospective data from multiple years are needed to develop vaccine policy and treatment guidelines, and improve pandemic preparedness. Methods: During January 2005 through December 2008, we used an active, population-based surveillance system to prospectively identify hospitalized pneumonia cases with influenza confirmed by reverse transcriptase-polymerase chain reaction or cell culture in 20 hospitals in two provinces in Thailand. Age-specific incidence was calculated and extrapolated to estimate national annual influenza pneumonia hospital admissions and in-hospital deaths. Results: Influenza was identified in 1,346 (10.4%) of pneumonia patients of all ages, and 10 influenza pneumonia patients died while in the hospital. 702 (52%) influenza pneumonia patients were less than 15 years of age. The average annual incidence of influenza pneumonia was greatest in children less than 5 years of age (236 per 100,000) and in those age 75 or older (375 per 100,000). During 2005, 2006 and 2008 influenza A virus detection among pneumonia cases peaked during June through October. In 2007 a sharp increase was observed during the months of January through April. Influenza B virus infections did not demonstrate a consistent seasonal pattern. Influenza pneumonia incidence was high in 2005, a year when influenza A(H3N2) subtype virus strains predominated, low in 2006 when A(H1N1) viruses were more common, moderate in 2007 when H3N2 and influenza B co-predominated, and high again in 2008 when influenza B viruses were most common. During 2005-2008, influenza pneumonia resulted in an estimated annual average 36,413 hospital admissions and 322 in-hospital pneumonia deaths in Thailand. Conclusion: Influenza virus infection is an important cause of hospitalized pneumonia in Thailand. Young children and the elderly are most affected and in-hospital deaths are more common than previously appreciated. Influenza occurs year-round and tends to follow a bimodal seasonal pattern with substantial variability. The disease burden varies significantly from year to year. Our findings support a recent Thailand Ministry of Public Health (MOPH) decision to extend annual influenza vaccination to older adults and suggest that children should also be targeted for routine vaccination.			Simmerman, JM (corresponding author), US Ctr Dis Control Collaborat, Thailand Minist Publ Hlth, Int Emerging Infect Program, Nonthaburi, Thailand.	msimmerman@cdc.gov						Akazawa M, 2003, VALUE HEALTH, V6, P107, DOI 10.1046/j.1524-4733.2003.00209.x; *ALPH RES CO LTD, 2004, THAIL FIG 2004 2005; Ampofo K, 2006, PEDIATRICS, V118, P2409, DOI 10.1542/peds.2006-1475; *CDC, 2008, THAIL COMM SEAS FLU; *CDC, 2007, PREV CONTR INFL REC; Chow A, 2006, EMERG INFECT DIS, V12, P114, DOI 10.3201/eid1201.050826; Clague Birgit, 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P488; Coffin SE, 2007, PEDIATRICS, V119, P740, DOI 10.1542/peds.2006-2679; COUCH RB, 1986, J INFECT DIS, V153, P431, DOI 10.1093/infdis/153.3.431; Fedson DS, 2004, PEDIATR INFECT DIS J, V23, pS74, DOI 10.1097/01.inf.0000108195.12141.cc; Gravenstein S, 2002, CLIN INFECT DIS, V35, P729, DOI 10.1086/341246; Hanshaoworakul W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006051; Heikkinen T, 2004, J INFECT DIS, V190, P1369, DOI 10.1086/424527; Javadi M, 2006, INT J INFECT DIS, V10, P129, DOI 10.1016/j.ijid.2005.01.007; JORDAN HT, 2008, THAILAND INT J INFEC, V13, P355; Katz MA, 2007, VACCINE, V25, P3827, DOI 10.1016/j.vaccine.2007.01.109; Kendal AP, 1982, CONCEPTS PROCEDURES; Kositanont Uraiwan, 2004, Journal of the Medical Association of Thailand, V87, P964; Li CK, 2006, PUBLIC HEALTH, V120, P517, DOI 10.1016/j.puhe.2006.03.004; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; Ng TP, 2002, ANN ACAD MED SINGAP, V31, P182; Olsen SJ, 2006, INT J INFECT DIS, V10, P439, DOI 10.1016/j.ijid.2006.06.004; Poehling KA, 2006, NEW ENGL J MED, V355, P31, DOI 10.1056/NEJMoa054869; POST B, 2008, BANGKOK POST VACCINA; Prapasiri Prabda, 2008, Southeast Asian Journal of Tropical Medicine and Public Health, V39, P706; Simmerman JM, 2008, INFLUENZA OTHER RESP, V2, P81, DOI 10.1111/j.1750-2659.2008.00045.x; Simmerman JM, 2006, VACCINE, V24, P4417, DOI 10.1016/j.vaccine.2005.12.060; Simmerman JM, 2004, VACCINE, V23, P182, DOI 10.1016/j.vaccine.2004.05.025; Stone B, 2004, J VIROL METHODS, V117, P103, DOI 10.1016/j.jviromet.2003.12.005; Suntarattiwong P, 2007, INFLUENZA OTHER RESP, V1, P177, DOI 10.1111/j.1750-2659.2007.00023.x; *THAIL MET DEP, 2005, NAT TEMP RAINF REP; *THAIL MIN STAT IN, 2007, THAI EC FACTS FIG RE; *THAIL MOPH INFL S, 2007, EP BO; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Viboud C, 2006, PLOS MED, V3, P468, DOI 10.1371/journal.pmed.0030089; WONG CM, 2004, COMUNICABLE INFECT D, V39; Wongsurakiat Phunsup, 2003, Journal of the Medical Association of Thailand, V86, P497; WRIGHT PF, 1980, AM J EPIDEMIOL, V112, P814, DOI 10.1093/oxfordjournals.aje.a113053; 2008, THAILAND FIGURES	40	122	126	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2009	4	11					A107	A114	e7776	10.1371/journal.pone.0007776	http://dx.doi.org/10.1371/journal.pone.0007776			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518IX	19936224	Green Published, gold			2022-12-25	WOS:000271685800012
J	Barott, K; Smith, J; Dinsdale, E; Hatay, M; Sandin, S; Rohwer, F				Barott, Katie; Smith, Jennifer; Dinsdale, Elizabeth; Hatay, Mark; Sandin, Stuart; Rohwer, Forest			Hyperspectral and Physiological Analyses of Coral-Algal Interactions	PLOS ONE			English	Article							CLIMATE-CHANGE; REEF COMMUNITY; MASS MORTALITY; ORGANIC-CARBON; PHASE-SHIFTS; COMPETITION; FLUORESCENCE; REFLECTANCE; DEGRADATION; MACROALGAE	Space limitation leads to competition between benthic, sessile organisms on coral reefs. As a primary example, reef-building corals are in direct contact with each other and many different species and functional groups of algae. Here we characterize interactions between three coral genera and three algal functional groups using a combination of hyperspectral imaging and oxygen microprofiling. We also performed in situ interaction transects to quantify the relative occurrence of these interaction on coral reefs. These studies were conducted in the Southern Line Islands, home to some of the most remote and near-pristine reefs in the world. Our goal was to determine if different types of coral-coral and coral-algal interactions were characterized by unique fine-scale physiological signatures. This is the first report using hyperspectral imaging for characterization of marine benthic organisms at the micron scale and proved to be a valuable tool for discriminating among different photosynthetic organisms. Consistent patterns emerged in physiology across different types of competitive interactions. In cases where corals were in direct contact with turf or macroalgae, there was a zone of hypoxia and altered pigmentation on the coral. In contrast, interaction zones between corals and crustose coralline algae (CCA) were not hypoxic and the coral tissue was consistent across the colony. Our results suggest that at least two main characteristic coral interaction phenotypes exist: 1) hypoxia and coral tissue disruption, seen with interactions between corals and fleshy turf and/or some species of macroalgae, and 2) no hypoxia or tissue disruption, seen with interactions between corals and some species of CCA. Hyperspectral imaging in combination with oxygen profiling provided useful information on competitive interactions between benthic reef organisms, and demonstrated that some turf and fleshy macroalgae can be a constant source of stress for corals, while CCA are not.	[Barott, Katie; Dinsdale, Elizabeth; Hatay, Mark; Rohwer, Forest] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Smith, Jennifer; Sandin, Stuart] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA	California State University System; San Diego State University; University of California System; University of California San Diego; Scripps Institution of Oceanography	Barott, K (corresponding author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.	katiebarott@gmail.com	Rohwer, Forest/AAC-5315-2019	dinsdale, elizabeth/0000-0002-2177-203X; Obura, David/0000-0003-2256-6649; Barott, Katie/0000-0001-7371-4870; Rohwer, Forest/0000-0003-1548-5429	San Diego State University; Gordon and Betty Moore Foundation; Canadian Institute for Advanced Research; National Geographic Society; National Science Foundation	San Diego State University; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Canadian Institute for Advanced Research(Canadian Institute for Advanced Research (CIFAR)); National Geographic Society(National Geographic Society); National Science Foundation(National Science Foundation (NSF))	Funding for this work was provided by San Diego State University, the Gordon and Betty Moore Foundation, and the Canadian Institute for Advanced Research. The Southern Line Islands expedition was organized and sponsored by the National Geographic Society. KB was supported by a National Science Foundation Graduate Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adey WH, 1998, J PHYCOL, V34, P393, DOI 10.1046/j.1529-8817.1998.340393.x; Alieva NO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002680; Anthony KRN, 2008, P NATL ACAD SCI USA, V105, P17442, DOI 10.1073/pnas.0804478105; BENAYAHU Y, 1981, B MAR SCI, V31, P514; Bou-Abdallah F, 2006, BBA-GEN SUBJECTS, V1760, P1690, DOI 10.1016/j.bbagen.2006.08.014; Bowler PG, 2001, CLIN MICROBIOL REV, V14, P244, DOI 10.1128/CMR.14.2.244-269.2001; CARPENTER RC, 1988, P NATL ACAD SCI USA, V85, P511, DOI 10.1073/pnas.85.2.511; CHORNESKY EA, 1983, BIOL BULL, V165, P569, DOI 10.2307/1541466; CHORNESKY EA, 1989, ECOLOGY, V70, P843, DOI 10.2307/1941353; Dinsdale EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001584; Gross EM, 2003, CRIT REV PLANT SCI, V22, P313, DOI 10.1080/713610859; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Hattery D, 2002, 31ST APPLIED IMAGERY PATTERN RECOGNITION WORKSHOP, PROCEEDINGS, P124; Heyward AJ, 1999, CORAL REEFS, V18, P273, DOI 10.1007/s003380050193; Hochberg EJ, 2004, CORAL REEFS, V23, P84, DOI 10.1007/s00338-003-0350-1; Hochberg EJ, 2000, CORAL REEFS, V19, P164, DOI 10.1007/s003380000087; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Hughes TP, 1999, LIMNOL OCEANOGR, V44, P932, DOI 10.4319/lo.1999.44.3_part_2.0932; JORDAN CF, 1969, ECOLOGY, V50, P663, DOI 10.2307/1936256; KAUFMAN YJ, 1992, IEEE T GEOSCI REMOTE, V30, P261, DOI 10.1109/36.134076; KAWAGUTI S, 1944, PHYSL REEF CORALS, V6; Kline DI, 2006, MAR ECOL PROG SER, V314, P119, DOI 10.3354/meps314119; Kuntz NM, 2005, MAR ECOL PROG SER, V294, P173, DOI 10.3354/meps294173; Lesser MP, 2004, SCIENCE, V305, P997, DOI 10.1126/science.1099128; LESSIOS HA, 1988, ANNU REV ECOL SYST, V19, P371, DOI 10.1146/annurev.es.19.110188.002103; LOGAN A, 1984, CORAL REEFS, V3, P131, DOI 10.1007/BF00301957; MAZEL CH, 1995, MAR ECOL PROG SER, V120, P185, DOI 10.3354/meps120185; Mazel CH, 1997, OPT ENG, V36, P2612, DOI 10.1117/1.601486; Mazel CH, 1997, P SOC PHOTO-OPT INS, V2963, P240, DOI 10.1117/12.266450; McCook LJ, 2001, CORAL REEFS, V19, P400, DOI 10.1007/s003380000129; McCook LJ, 1999, CORAL REEFS, V18, P357, DOI 10.1007/s003380050213; Miller MW, 1998, OCEANOGR MAR BIOL<D>, V36, P65; MORSE DE, 1988, J EXP MAR BIOL ECOL, V116, P193, DOI 10.1016/0022-0981(88)90027-5; Mumby PJ, 2004, MAR POLLUT BULL, V48, P219, DOI 10.1016/j.marpolbul.2003.10.031; Myers MR, 1999, CORAL REEFS, V18, P179, DOI 10.1007/s003380050177; Nugues MM, 2004, ECOL LETT, V7, P919, DOI 10.1111/j.1461-0248.2004.00651.x; Ostrander GK, 2000, P NATL ACAD SCI USA, V97, P5297, DOI 10.1073/pnas.090104897; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Pinter PJ, 2003, PHOTOGRAMM ENG REM S, V69, P647, DOI 10.14358/PERS.69.6.647; Rouse Jr. J.W., 1974, MONITORING VERNAL AD; Sabins FF, 1999, ORE GEOL REV, V14, P157, DOI 10.1016/S0169-1368(99)00007-4; Salih A, 2000, NATURE, V408, P850, DOI 10.1038/35048564; SALIH A, 1997, P AUSTR COR REEF SOC, P217; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; SCHLICHTER D, 1994, OECOLOGIA, V99, P124, DOI 10.1007/BF00317092; Smith JE, 2006, ECOL LETT, V9, P835, DOI 10.1111/j.1461-0248.2006.00937.x; Sutherland KP, 2004, MAR ECOL PROG SER, V266, P273, DOI 10.3354/meps266273; Tanner JE, 1997, J EXP MAR BIOL ECOL, V214, P19, DOI 10.1016/S0022-0981(97)00024-5; Thenkabail PS, 2000, REMOTE SENS ENVIRON, V71, P158, DOI 10.1016/S0034-4257(99)00067-X; Vermeij MJA, 2009, OECOLOGIA, V159, P325, DOI 10.1007/s00442-008-1223-7; VOGEL A, 2007, J BIOMED OPT, V12; WELLINGTON GM, 1980, OECOLOGIA, V47, P340, DOI 10.1007/BF00398527; Wilkinson C., 2004, STATUS CORAL REEFS W; Zawada DG, 2003, LIMNOL OCEANOGR, V48, P412, DOI 10.4319/lo.2003.48.1_part_2.0412	57	103	106	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2009	4	11							e8043	10.1371/journal.pone.0008043	http://dx.doi.org/10.1371/journal.pone.0008043			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MN	19956632	gold, Green Submitted, Green Published			2022-12-25	WOS:000272828100006
J	Suhr, ST; Chang, EA; Rodriguez, RM; Wang, K; Ross, PJ; Beyhan, Z; Murthy, S; Cibelli, JB				Suhr, Steven T.; Chang, Eun Ah; Rodriguez, Ramon M.; Wang, Kai; Ross, Pablo J.; Beyhan, Zeki; Murthy, Shashanka; Cibelli, Jose B.			Telomere Dynamics in Human Cells Reprogrammed to Pluripotency	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; CLONING; CANCER; LENGTH	Background: Human induced pluripotent stem cells (IPSCs) have enormous potential in the development of cellular models of human disease and represent a potential source of autologous cells and tissues for therapeutic use. A question remains as to the biological age of IPSCs, in particular when isolated from older subjects. Studies of cloned animals indicate that somatic cells reprogrammed to pluripotency variably display telomere elongation, a common indicator of cell "rejuvenation.'' Methodology/Principal Findings: We examined telomere lengths in human skin fibroblasts isolated from younger and older subjects, fibroblasts converted to IPSCs, and IPSCs redifferentiated through teratoma formation and explant culture. In IPSCs analyzed at passage five (P5), telomeres were significantly elongated in 6/7 lines by >40% and approximated telomere lengths in human embryonic stem cells (hESCs). In cell lines derived from three IPSC-teratoma explants cultured to P5, two displayed telomeres shortened to lengths similar to input fibroblasts while the third line retained elongated telomeres. Conclusions/Significance: While these results reveal some heterogeneity in the reprogramming process with respect to telomere length, human somatic cells reprogrammed to pluripotency generally displayed elongated telomeres that suggest that they will not age prematurely when isolated from subjects of essentially any age.	[Suhr, Steven T.; Chang, Eun Ah; Rodriguez, Ramon M.; Wang, Kai; Ross, Pablo J.; Beyhan, Zeki; Murthy, Shashanka; Cibelli, Jose B.] Michigan State Univ, Cellular Reprogramming Lab, Dept Anim Sci, E Lansing, MI 48824 USA; [Ross, Pablo J.; Cibelli, Jose B.] Programa Andaluz Terapia Celular & Med Regenerat, Andalucia, Spain	Michigan State University	Suhr, ST (corresponding author), Michigan State Univ, Cellular Reprogramming Lab, Dept Anim Sci, E Lansing, MI 48824 USA.	cibelli@anr.msu.edu	Rodriguez, Ramon Maria/AAF-9376-2019; wang, kai/G-4932-2011	Rodriguez, Ramon Maria/0000-0002-6770-5123; Goissis, Marcelo/0000-0002-7382-7477; Cibelli, Jose/0000-0002-2176-3854; Perkins, Guy/0000-0002-1834-6646	Naylor Family Foundation	Naylor Family Foundation	Funding was obtained from the Naylor Family Foundation, Michigan State University Vice President for Research and Graduate Studies and The Michigan Agricultural Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; Aubert G, 2008, PHYSIOL REV, V88, P557, DOI 10.1152/physrev.00026.2007; Blackburn EH, 2005, FEBS LETT, V579, P859, DOI 10.1016/j.febslet.2004.11.036; Cheung ALM, 2008, FRONT BIOSCI-LANDMRK, V13, P2075, DOI 10.2741/2825; Finkel T, 2007, NATURE, V448, P767, DOI 10.1038/nature05985; Greenberg RA, 1999, ONCOGENE, V18, P1219, DOI 10.1038/sj.onc.1202669; Harley CB, 2008, NAT REV CANCER, V8, P167, DOI 10.1038/nrc2275; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Harrington L, 2004, ONCOGENE, V23, P7283, DOI 10.1038/sj.onc.1207948; Hug N, 2006, CHROMOSOMA, V115, P413, DOI 10.1007/s00412-006-0067-3; KIPLING D, 1990, NATURE, V347, P400, DOI 10.1038/347400a0; Kubota C, 2004, NAT BIOTECHNOL, V22, P693, DOI 10.1038/nbt975; Lansdorp PM, 1996, HUM MOL GENET, V5, P685, DOI 10.1093/hmg/5.5.685; Lanza RP, 2000, SCIENCE, V288, P665, DOI 10.1126/science.288.5466.665; Marion RM, 2009, CELL STEM CELL, V4, P141, DOI 10.1016/j.stem.2008.12.010; MOYZIS RK, 1988, P NATL ACAD SCI USA, V85, P6622, DOI 10.1073/pnas.85.18.6622; Niida H, 2000, MOL CELL BIOL, V20, P4115, DOI 10.1128/MCB.20.11.4115-4127.2000; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Riethman H, 2008, ANNU REV GENOM HUM G, V9, P1, DOI 10.1146/annurev.genom.8.021506.172017; Rosler ES, 2004, DEV DYNAM, V229, P259, DOI 10.1002/dvdy.10430; Shiels PG, 1999, NATURE, V399, P316, DOI 10.1038/20580; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Wakayama T, 2000, NATURE, V407, P318, DOI 10.1038/35030301; Wu KJ, 1999, NAT GENET, V21, P220, DOI 10.1038/6010; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	25	216	221	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2009	4	12							e8124	10.1371/journal.pone.0008124	http://dx.doi.org/10.1371/journal.pone.0008124			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MU	19956585	Green Published, gold, Green Submitted			2022-12-25	WOS:000272828800018
